BIBLIOGRAFIA CLIQUE NO NÚMERO DO CAPÍTULO ABAIXO PARA ACESSAR A BIBLIOGRAFIA CORRESPONDENTE. 2019181716151413121110987654321 4039383736353433323130292827262524232221 6059585756555453525150494847464544434241 8079787776757473727170696867666564636261 10099989796959493929190898887868584838281 120119118117116115114113112111110109108107106105104103102101 140139138137136135134133132131130129128127126125124123122121 160159158157156155154153152151150149148147146145144143142141 179178177176175174173172171170169168167166165164163162161
Parte I CAPÍTULOS BÁSICOS
12. Carrel A. The surgery of blood vessels preserved in cold storage. Bull Johns Hopkins Hosp 1907;18:28. 13. Carrel A. Heterotransplantation of blood vessels preserved in cold storage. J Exper Med 1907;9:226. 14. Carrel A. Results of the transplantation of blood vessels, organs and limbs. JAMA 1908;51:1662. 15. Carrel A. Resultats eloignés de la transplantation des veines sur les artères. Rev Chir 1910;41:987. 16. Carrel A. Graft of the vena cava on the abdominal aorta. Ann Surg 1910;52:462. 17. Haimovici H. History of arterial grafting. J Cardiovasc Surg 1963;4:152. 18. Natali J. Jacques Outdot and his contribution to surgery of the aortic bifurcation. Ann Vasc Surg 1992;6:185. 19. Herzog M. Annapurna: O primeiro cume de mais de 8.000m conquistado pelo homem. Companhia das Letras; 1951. 20. Barker WF. Peripheral arterial disease. In: Series major problems in clinical surgery. Philadelphia: WB Saunders; 1966. p. 2, vol. 4. 21. Wilie E, Kerr E, Davies O. Experimental and clinical experiences with use of fascia lata applied as a graft about major arteries after thromboendarterectomy and aneurysmorrhaphy. Surg Gynec Obst 1951;93:257. 22. Barker WF, Cannon JA. An evaluation of endarterectomy. Arch Surg 1953;66:488. 23. Holden W. Reconstruction of femoral artery for arteriosclerotic thrombosis. Surgery 1950;27:417 24. Kunlin J, Bitry-Boély VM, Beaudry M. Treatment of arterial ischemia by long vein grafts. Rev Chir 1951;70:206. 25. Elkin DC. Aneurysm of the abdominal aorta. Treatment by ligation. Ann Surg 1940;112:895. 26. Souza LC. Contribuição para a História da evolução da cirurgia vascular no Brasil e seu patrono. In: Brito CJ, Mayall RC, Pinto-Ribeiro A. Doenças vasculares – Anais do 24o Congresso Bras de Angiologia. Rio de Janeiro: Teatral; 1983. pp. 219-24. 27. Matas R. Ligation of the abdominal aorta. Report of the ultimate result, one year, five months and nine days after ligation of the abdominal aorta for aneurysm at the bifurcation. Ann Surg 1925;81:457. 28. Brook B. Ligation of the aorta. A clinical and experiemental study. JAMA 1926;87:723. 29. Bigger IA. The surgical treatment of the abdominal aorta – Review of the literature and report of two cases, one apparently successful. Ann Surg 1940;112:879. 30. DeTakats G, Marshall MR. Surgical treatment of arterios-clerotic aneurysms of the abdominal aorta. Arch Surg 1952;74:307. 31. Page IH. The production of persistent arterial hypertension by cellophane perinephritis. JAMA 1939;113:2046. 32. Blakemore AH, Barry GK. Electrothermic coagulation of aortic aneurysms. JAMA 1938;3:1821. 33. Blakemore AH. Progressive constrictive occlusion of the abdominal aorta with wiring and electrothermic coagulation. Ann Surg 1951;133:447. 34. Harrison PW, Chandy J. A subclavian aneurysm cured by cellophane fibrosis. Ann Surg 1943;118:478-81. 35. Poppe JK. Cellophane treatment of syphilitic aneurysms with report of results in six cases. Am Heart J 1947;36:252-56. 36. Rea CE. The surgical treatment of aneurysm of the abdominal aorta. Minn Med 1948;31:153-56. 37. Yeager GH, Cowley A. Studies on the use of polythene as a fibrous tissue stimulant. Ann Surg 1948;128:509. 38. Cowen JR, Graver LM. The ruptured abdominal aneurysm of Albert Einstein. Surg Gynec Obst 1990;170:455. Lowenberg EL. Aneurysm of the abdominal aorta – Report of two cases treated by “Cutis Grafting”. Angiology 1950;1:396. 40. Gross RE, Bill Jr AH, Peirce EC II. Methods for preservation and transplantation of arterial grafts – Observations on arterial grafts in dogs – Report of transplantation of preserved arterial grafts in 9 human cases. Surg Gynec Obst 1949;88:689. 41. Outdot J. La greffe vasculaire dans les thromboses du carrefour aortique. Presse Med 1951;59:234. 42. Schafer PW, Hardin CA. The use of temporary polythene shunts to permit occlusion, resection and frozen hmologous graft replacement of vital segments. Surgery 1952;31:186. 43. Dubost C, Allary M, Deconomos N. Resection of an aneurysm of the abdominal aorta – Reestablishment of the continuity by a preserved human arterial graft, with result after five months. Arch Surg 1952;64:405. 44. DeBakey ME, Cooley DA. Surgical treatment of aneurysm of abdominal aorta by resection and restoration of continuity with homograft. Surg Gynec Obst 1953;97:257. 45. Voorhees AB, Jaretski A, Bkakemore AH. The use of tubes constructed from Vynion N cloth in bridging arterial defects. Ann Surg 1952;135:332. 46. Edwards WS, Tapp JS. Chemically treated nylon tubes as arterial grafts. Surgery 1955;38:61. 47. Hufnagel CA, Rabil P. Replacement of arterial segments, utilizing flexible orlon prostheses. Arch Surg 1955;70:105. 48. Harrison JH. Synthetic material as vascular prostheses. Amer J Surg 1958;95:3. 49. Julian OC, Deterling Jr RA, Su HH et al. Dacron tube and bifurcation arterial prosthese produced to specification. Surgery 1957;41:50. 50. Szilagyi E. An elastic dacron arterial substitute. Surg Clin North Am 1959;39:1523. 51. DeBakey ME, Cooley DA, Crawford ES et al. Clinical application of a new flexible knitted dacron arterial substitute. Arch Surg 1958;77:713.
HISTÓRIA DA CIRURGIA
3.
VASCULAR
1. Rebollo RA. William Harvey e a descoberta da circulação do sangue. Editora Unesp; 2012. 2. Romero RR. Marcello Malpighi – Founder of Microanatomy. Int J Morphol 2011;29:399. Maia MCM. Enxerto arterial Tese para provimento efetivo da cátedra de técnica operatória e cirurgia experimental da Faculdade Nacional de Medicina da Universidade do Brasil; 1955. 4. Thompson JE. Early history of aortic surgery. J Vasc Surg 1998;28:746-52. 5. Garrison FH. An introduction to the history of medicine. Philadelphia: WB Saunders; 1929. p. 217. 6. Schumacker Jr HB. Arterial suture technique and grafts: past, present and future. Surgery 1969;65:432. 7. Perry MO. John Hunter – Triumph and tragedy. J Vasc Surg 1993;17:7-14.
3 1Capítulo
REFERÊNCIAS BIBLIOGRÁFICAS
8. Matas R. Traumatic aneurysm of the left brachial artery. M News Phila 1888 Oct 27;53:462.
9. Dale WA, Charles CT. Autogenous vein grafts – And related aspects of peripheral arterial disease. Springfield, Illinois: Publisher; 1959. pp. 3-8. 10. Jaboulay M, Briau E. Recherches expérimentales sur la suture et la greffe artérielle. Lyon Méd 1896;81:97. 11. Carrel A. La transplantation des veines et ses applications chirurgicales. Presse Méd 1905;105:843.
SEÇÃO HISTÓRICO1
39.
62. Coggia M, Javeliart I, Di Centa I, Alfonsi P, Colacchio G et al. Total laparoscopic versus conventional abdominal aortic aneurysm repair: a case-control study. J Vasc Surg 2005;42(5):906-10.
52. Campbell DC, Books DH, Webster MW et al. The use of expanded microporous polytetrafluoroethylene for limb salvage: a preliminary report. Surgery 1976;79:485. 53. Creech O. Endo-aneurysmorrhaphy and treatment of aortic aneurysm. Ann Surg 1966;64:935. 54. Parodi JC, Palmaz JC, Barone HD. Transfemoral intraluminal graft implantation for abdominal aortic aneurysms. Ann Vasc Surg 1991;5:491. Seldinger SI. Catheter replacement of the needle in percutaneous arteriography. A new technique. Acta Radiol Suppl (Stockholm) 2008,434:47-52. Briefly presented 56. Dotter CT. Transluminally-placed coilspring endarterial tube grafts. Longterm patency in canine popliteal artery. Investigat Radiol 1969;4:329-32. 57. Palmaz JC. Balloon-expandable intravascular stent. AJR Am J Roentgenol 1988 June;150(6):1263-69.
64. Dion YM, Gracia CR, Ben El, Kadi HH. Totally laparoscopic abdominal aortic aneurysm repair. J Vasc Surg 2401;33(1):181-85.
55.
Parte I4 CAPÍTULOS BÁSICOS
59. Kolvenbach R. Hand-assisted laparoscopic abdominal aortic aneurysm repair. Semin Laparosc Surg 2001;8(2):168-77. 60. Chiu KM, Lin TY, Huang PH, Chu SH. Hand-assisted laparoscopic surgery for abdominal aortic aneurysm. J Formos Med Assoc 2004;103(9):724-6.
65. Barker WF. A History of vascular surgery. In: Moore W. (Ed.). Vascular surgery. 5th ed. Philadelphia: WB Saunders; 1598. pp. 1-19. 66. Eastcott HHG, Pickering GW, Rob CG. Reconstruction of internal carotid artery. Lancet 1954 Nov;13:994-96. 67. DeBakey ME. Successful carotid endarterectomy for cerebrovascular insufficiency – Nineteen-Year Follow-up. JAMA 1975;233:1083-85. 68. Cooley DA, Al-Naaman YD, Carton CA. Surgical treatment of arteriosclerotic occlusion of common carotid artery. J Neurosurg 1956;13:500-6. 69. Bernheim BM. Blood-vessel surgery in the war. Surg Gynec Obst 1920;30:564-67. 70. Rich NM, Spencer FC. Historical aspects of vascular trauma. In: Rich NM, Spencer FC. Vascular trauma. Philadelphia: WB Saunders; 1978. p. 3-21. 71. DeBakey ME, Simeone FA. Battle injuries of the arteries in World War II. An analysis of 2.471 cases. Ann Surg 1946;123:534. 72. Jahnke EJ, Howard JM. Primary repair of major arterial injuries. Arch Surg 1953;66:646-49. 73. Hughes CW. Acute vascular trauma in Korean War casualties – An analysis of 180 cases. Surg Gynec Obst 1954;99:91-100. 74. Rich NL, Hughes CW. Vietnam vascular registry: a preliminary report. Surgery 1969;65:218-26.
58. Espinosa G. Historia de la cirurgia vascular. Rev Col Bras Cir 2008;35(6).
63. Ludemann R, Swanström LL. Totally laparoscopic abdominal aortic aneurysm repair. Semin Laparosc Surg 1999;6(3):153-63.
61. Javeliart I, Coggia M, Di Centa I, Kitzis M, et al. Total laparoscopic abdominal aortic aneurysm repair with reimplantation of the inferior mesenteric artery. J Vasc Surg 2004;39(5):1115-7.
HISTÓRIA DA CIRURGIA ENDOVASCULAR
BIBLIOGRAFIA Allison R, Rose J. A brief history of EVAR and current devices. Interventional Radiology News 2014 March/April. Augustinos P, Ouriel K. Treatment of Venous Thromboembolism. Invasive Approaches to Treatment of Venous Thromboembolism. Circulation 2004;110:I-27- I-34. Criado FJ. The Biography of Dr Volodos. J Endovasc Ther 2013;20(Suppl):I-25. Jackson BM, Carpenter JP. Devices Used for Endovascular Aneurysm Repair: Past Present and Future. Sem Interv Radiol 2009;26(1);39-43. Meier B. Stenting, quite a legacy of Charles, Charles, and Arthur. Cathet Cardiovasc Diagn 1998;45:233-234. Payne MM. Charles Theodore Dotter: The Father of Intervention. Tex Heart Inst J Quinones-Baldrich2001;28:28-38.WJ,Deaton DH, Mitchel RS et al. Preliminary Experience with the Endovascular Technologies: Bifurcated Endovascular Aortic Prosthesis in a calf Model. J Vasc Surg 1995;22(4):370-381. Rasmussen TE, Cherry Jr KJ. Historical Perspectives in Vascular Surgery: The Evolution of Modern Trends In: Comprehensive Vascular and Endovascular Surgery. 2nd ed. Elsevier; 2009. Ring ME. How a dentist’s name became a synonym for a life-saving device: the story of Dr Charles Stent. J Hist Dent Roguin2001;49:77-80.A.Historical Perspectives in Cardiology. Stent: The Man and Word Behind the Coronary Metal Prosthesis. Circ Cardiovasc Interv Rosch2011;4:206-209.J,KellerFS,Kauffman JÁ. The Birth, Early Years and Future of Interventional Radiology. J Vasc Interv Radiol 2003;14:841-853. Schlosser FJV, Mojibian HR, Dardik A et al. Pitfalls and Complications of Fenestrated and Branched Endografts. Endovascular Today Vermassen2008;56-61.F.Peripheral Angiography IN: Lanzer P. Catheter Based Cardiovascular Interventions. Springer; 2013. pp. 315-324.
5 2Capítulo
10. Kempinas WG. Desenvolvimento do sistema vascular. In: Maffei et al. Doenças vasculares periféricas. 5. ed. volume 1. Rio de Janeiro: Editora Guanabara Koogan; 2016. pp. 2-13.
REFERÊNCIAS BIBLIOGRÁFICAS
8. Erden O, Imir A, Guvenal T et al. Investigation of the effects of heparin and low molecular weight heparin on E-cadherin and laminin expression in rat pregnancy by immunohistochemistry. Hum Reprod 2006 Nov;21(11):3014-8. PMID: 16997938. 22 9. Deepa PR, Varalakshmi P. Influence of a low-molecular-weight heparin derivative on the nitric oxide levels and apoptotic DNA damage in adriamycin-induced cardiac and renal toxicity. Toxicology 2006;217(2-3):176-83.
1. Pereira GC. Embriologia e histologia do sistema vascular. In: Brito CJ, Duque A, Merlo I, Murilo R, Filho VLF. Cirurgia vascular, cirurgia endovascular, angiologia. 2. ed. Volume 1. Rio de Janeiro: Editora Revinter; 2008. 2. Carneiro J, Junqueira, LC. Histologia básica. 13. ed. Rio de Janeiro: Editora Guanabara Koogan; 2017. 3. Carneiro J, Junqueira, LC. Biologia Celular e Molecular. 9. ed. Rio de Janeiro: Editora Guanabara Koogan; 2012. 4. Moore KL. Persaud TVN, Torchia MG. Embriologia básica. 9. ed. Rio de Janeiro: Elsevier; 2016. 5. Lammert E, Axnick J. Vascular Lumen Formation. Cold Spring Harb Perspect Med 2012;2:a006619. 6. Giordano JM. Embriologia do sistema vascular. In: Cronenwett et al Rutherford Cirurgia vascular. 6. ed. Volume 1. Rio de janeiro: Editora Di Livros; 2007 pp. 53-60.
12. Martinez-Corral I, Ulvmar MH, Stanczuk L et al. Nonvenous origin of dermal lymphatic vasculature. Circ Res 2015 May 8;116(10):1649-54.
7. Ribatti D, Nico B, Crivellato E. The development of the vascular system: a historical overview. Methods Mol Biol 2015;1214:1-14.
11. Bouchet A. Anatomie comparée et embryologie des systèmes veineux et lymphatique des membres infèrieurs. Phlébologie 1999;52:9-18.
6 3Capítulo EMBRIOLOGIA E HISTOLOGIA DO SISTEMA VASCULAR
13. Al-Rawi MA, Mansel RE, Jiang WG. Molecular and cellular mechanisms of lymphangiogenesis. Eur J Surg Oncol 2005 Mar;31(2):117-21. 14. Kato S, Shimoda H, Ji RC, Miura M. Lymphangiogenesis and expression of specific molecules as lymphatic endothelial cell markers. Anat Sci Int 2006 Jun;81(2):71-83. 15. P. Myers, J. Fasel, A. Kalangos, et al.Arteria lusória: Developmental anatomy, clinical, radiological and surgical aspects. Ann Cardiol Angeiol 2010;59:147-154. 16. Abuchaim DCS, Burger M, Berwanger SA, Faraco DL. Anel vascular associado a divertículo de Kommerell: relato de caso. Rev Bras Cir Cardiovasc 2007;22:3. 17. Bez LG et al. Persistência da artéria isquiática: relato de caso. J Vasc Bras 2006;5(3):233-6. 18. Di Fiori MSH. Atlas de histologia. 7. ed. Rio de Janeiro: Editora Guanabara Koogan; 1997. 19. Montenegro MRG, Mattar L. Estrutura da parede vascular. In: Maffei et al Doenças vasculares periféricas. 5. ed. volume 1. Rio de Janeiro: Editora Guanabara Koogan; 2016. pp. 130-140. 20. Dany CV, Bell WR, Kaiser D et al. Disorganization of cultured vascular endotelial cell monolayers by fibrinogen fragmente D. Science 1985; 227:487-90. 21. Cordellini S, Vassilieff VS. Decreased endothelium-dependent vasoconstriction to noradrenaline in acute-stresses rats is potentiated by previous chronic stress: nitric oxide involvment. Gen Pharmacol 1998;30(1):79-83. 22. Cordellini S. Função endotelial e controle do tônus vascular. In: Maffei et al Doenças vasculares periféricas. 5. ed. volume 1. Rio de Janeiro: Editora Guanabara Koogan; 2016. pp. 160-169. 23. Shimokawa H et al. Coronary spasm induced in atherosclerotic miniature swine. Science 1983;221:560-2. 24. Ulvmar MH, Makinen T. Heterogeneity in the lymphatic vascular system and its origin. Cardiovasc Res 2016;111:310-321.
SEÇÃO EMBRIOLOGIA2
20. Tourinho OB. Cirurgia das lesões arterioscleróticas aortoilíacas. Tese de Concurso. Faculdade de Medicina da UFRJ; 1977. 21. Fitzgerald JF, Stanczewski B. Graft thrombosis. In: Sawyer PN, Stillman RM (eds.). Vascular diseases, current controversies. New York: Appleton-Century-Crofts; 1981. 22. Hokanson DE, Strandness DE. Stress-strain characteristics of various arterial grafts. Surg Gynec & Obst 1968;127:57.
7. McDonald DA. Blood flow in arteries. Baltimore: Williams & Wilkins; 1960. p. 328. 8. Whittaker SRF, Winton FR. The apparent viscosity of blood flowing the isolated kind limb of the dog, and its variation with corpuscular concentration. J Thysical 1933;78:339. 9. Burton AC. On the physical equilibrium of small blood vessels. Amer J Physiol 1951;164:319-29.
3. Green H. Rushmer: structure and function of the cardiovascular system. Philadelphia: WB Saunders; 1972. 4. Wiederhielm CA. Distensibility characteristics of blood vessels. Fed Proc 1965;24:1075.
10. Van Citters RL, Wagner BM, Rushmer RF. Architecture of small arteries during vasoconstriction. Circulation Res 1962;10:668-75.
12. Strandness Jr DE. Flow dynamics in circulatory pathophysiology. In: Hwang, Normann. (Eds.). Cardiovascular flow dynamics and measurements. Baltimore: University Park Press; 1977. cap. 8. 13. Brech R, Bellhouse BJ. Flow in branching vessels. Cardiovascular Research 1973;7:593. 14. Feller I, Woodburme RT. Surgical anatomy in the abdominal aorta. Ann Surg 1961;154(6 Suppl):239-52.
15. Fergusson GC, Roach MR. Flow conditions at bifurcations as determined in glass models with reference to the focal distribution of vascular lesion. In: Bergel DH. Cardiovascular fluid dynamics. New York: Academic Press; 1972. p. 141, ca.14.
SEÇÃO 3
2. Tai NRM, Giudiceandrea A, Salacinski HJ et al. Vivo femoropopliteal arterial wall compliance in subjects with and without lower limb vascular disease. J Vasc Surg 1999;30:936-45.
16. Hoffman DC, Jepson RP. Muscle blood flow and sympathectomy. Surg Gynec Obst 1968;127:12.
REFERÊNCIAS BIBLIOGRÁFICAS
11. Ojha M, Johnston KW, Cobbold RSC. Evidence of a possible link between poststenotic dilation and wall shear stress. J Vasc Surg 1990;11:127.
17. Brito CJM. Cirurgia arterial reparadora. Tese da FM da UFRJ; 1970. 18. Malan E, Noseda G, Longo T. Approach to fluid dynamic problems in reconstructive vascular surgery. Surgery 1969;66:994. 19. Szilagyi DE, Whitcomb JG, Schenker W, Waibel P. The laws of fluid flow and arterial grafting. Surgery 1960;47:55.
PRINCÍPIOS HEMODINÂMICOS BÁSICOS
AVALIAÇÃO DO PACIENTE
7
23. Sharefkin JB, Diamond SL, Eskin SG et al. Fluid flow decreases preproendothelin mRNA levels and suppresses endothelin-1 peptide release in cultured human endothelial cells. J Vasc Surg 1991;14:1. 24. Okadone K, Yukizane T, MII S, Sugimachi K. Ultrastructural evidence of the effects of shear stress variation on intimal thickening in dogs, with arterially transplanted autologous grafts. J Cardiovasc Surg 1990;31:719. 25. Dewey CF, Bussolari SR, Gimbrone MA, Davis PF. The dynamic response of vascular endothelial cells to fluid shear stress. J Mech Eng 1981;103:177. 26. Davies PF. Flow mediated endothelial mechanotransduction. Physiol Rev 1995;75:519. 27. Crawford ES, De Bakey ME et al. Hemodynamic alterations in patients with cerebral arterial insufficiency before and after operation. Surgery 1960;48:76. 28. Rushmer RF. The arterial system; arteries and arterioles. In: Ruch P. Physiology and biophysics. Philadelphia: WB Saunders; 1960. cap. 31. 29. Capriglione LA, Duque FLV. Fluxo sanguíneo digital determinado pela calorimetria. In: Dittmer G (Eds.). Handbook of circulation The National Academy of Sciences. Philadelphia: WB Saunders; 1948. p. 1341. 30. Gillespie JA, Douglas DM. Obliterative vascular disease of the lower limb. London, and New York: Churchill Livingstone; 1961. 31. Lassen NA, Kampp M. Calf muscle blood flow during walking studied by the Xe133 method in normals and in patients with intermittent claudication. Scand J Clin Lab Invest 1965;17:447. 32. Sumner DS. Essential hemodynamic principles. In: Rutterford RB. Vascular surgery. 5th ed. Philadelphia: WB Saunders; 2000. cap. 7. 33. Mead J, Schoenfeld RC. Character of blood flow in the vasodilated fingers. J Appl Physiol 1950;2:680. 34. Rushmer RF. Cardiovascular dynamics. Philadelphia: WB Saunders; 1961. 35. Scheffler A, Rieger H. A comparative analysis of transcutaneous oximetry (tc PO2) during oxygen inhalation and leg dependency in severe peripheral arterial occlusive disease. J Vasc Surg 1992;16:218. 36. Ludbrook J. The musculovenous pumps of the human lower limb. Am Heart J 1966;71:635. 37. Burton AC. Transmural pressure, pressure gradients and resistance to flow in the vascular bed, physiology and biophysic of circulation Chicago: Year Book Medical Publishers; 1965. 38. Rushmer RF. Structure and function of the cardiovascular system Philadelphia: WB Saunders; 1972. 39. Roach MR. Reversibility of poststenotic dilatation in the femoral arteries of dog. Circ Res 1970;27:985. 40. May AC, De Weese JA, Rob CG. Hemodynamic effects of arterial stenosis. Surgery 1963;53:513. 41. May AC, Berg L van de, de Weese JA, Rob CG. Critical arterial stenosis. Surgery 1963;54:250. 42. Kindt GW, Youmans JR. The effect of stricture length on critical arterial stenosis. Surg Gyn Obst 1969;128:729. 43. Welch HJ, Belkin M, Kessler R et al. Superiority of balloon occlusion arteriography to reactive hyperemic arteriography in visualization of distal lower limb vessels. Ann Vasc Surg 1993;7:83-7. 44. Clarkson TB, Prichard RW, Morgan TM et al. Remodeling of coronary arteries in human and non human primates. JAMA 1994;271:289. 45. Santos MF, Souza Filho NS, Tarbine S et al. Contribuição do ultra-som intracoronário na avaliação diagnóstica da doença coronária. Rev Bras Cardiol Invas 1997;5(3):137. 46. Byard D, Fiddian RV, Quereau M et al. The fallacy of applying the Poiseuille Equation to segmental arterial stenosis. Am Heart J 1963;70:216.
1. Guyton AC. Venous return. In: Hamilton F, Dow P (Eds.). Handbook of physiology: circulation. Washington: American Physiological Society; 1963. p. 1099-1133.
6. Guyton H. Tratado de fisiologia médica. Rio de Janeiro: GuanabaraKoogan; 1997.
4Capítulo
5. Landis EM, Pappenheimer JR. Exchange of substances through the capillary walls. In: Hamilton F, Dow P (Eds.). Handbook of physiology: circulation. Washington: American Physiological Society; 1963. p. 961, Seção 2. vol. 2. cap. 29.
BIBLIOGRAFIA Abbott W, Maloney R, McCobe C et al. Arterial embolism a 44 year perspective. Am J Surg 1982;143:460. Brito CJ. Doença oclusiva crônica. In: Lane JC, van Bellen B. (Eds.). O exame do paciente vascular. São Paulo: Fundação BYK; 1995. p. 17-29. Brito CJ. Fístulas arteriovenosas traumáticas de longa duração. Revista CBC 1969;7:5-20. Brito CJ. Fístulas arteriovenosas traumáticas. In: Rossi M. (Ed.). Trauma vascular. Rio de Janeiro: Revinter; 2006. pp. 634-45. Gokkus K, et al: Popliteal entrapment syndrome. A systematic review of the literature and case presentation. Muscles Ligament Tendons J. 2014 GreenbergApr-Jun;4(2):141-148.RK,OurielK.Arterial thromboembolism. In: Rutherford RB. (Ed.). Vascular surgery. 5th ed. Philadelphia: WB Saunders; 2000. pp. 822-35. Guillaumon AT. Fístulas artério-venosas. In: Lane JC, van Bellen B Eds. O exame do paciente vascular. São Paulo: Fundação BYK; 1995. pp. 61-67. Lane LC. Isquemia aguda. In: Lane JC, van Bellen B. O exame do paciente vascular. São Paulo: Fundação BYK; 1995. pp. 30-35. Rutherford RB. Essentials of clinical evaluation. In: Rutherford RB (Ed.). Vascular surgery. 6th ed. Philadelphia: Elsevier Saunders; 2005. pp. Sumner1-13.DS. Hemodynamics and pathophysiology of arteriovenous fistulae. In: Rutherford RB. (Ed.). Vascular surgery. 5th ed. Philadelphia: WB Saunders; 2000. pp. 1400-25. Turnipseed W et al. Chronic compartment syndrome. An unusual cause for claudication. Ann Surg 210:557-562; discussion 562-563, 1989.
8 5Capítulo AVALIAÇÃO CLÍNICA DO PACIENTE COM ARTERIOPATIA
1. Robert T. Eberhardt JDR. Chronic Venous Insufficiency. Circulation 2005;111:2398-2409.
2. Maffei FHA, Santos MERC. Insuficiência Venosa Crônica – Prevalência, Etiopatogenia e Fisiopatologia. In: Maffei FHA et al. Doenças Vasculares Periféricas. 5. ed. Volume 2. Rio de Janeiro: Guanabara Koogan; 2016. p. 2020-2028.
11. Neves CRB, Wakassa TB, Silva ES. Anatomia medico-cirúrgica das veias dos membros inferiores. In: Maffei FHA et al Doenças Vasculares Periféricas. 4. ed. Volume 1. Rio de Janeiro: Guanabara Koogan; 2008. p. 122-139.
4. Eklöf B, Perrin M, Delis KT et al. Updated terminology of chronic venous disorders: the Veinterm transatlantic interdisciplinar consensus document. J Vasc Surg 2009;49:498-501.
21. Moraes IN. Exame do paciente com flebopatia. In: Propedêutica vascular. 2. ed. São Paulo: Sarvier; 1988. p. 133-138.
19. Do DD, Husmann M. Diagnosis of venous disease. Herz 2007 Feb;32(1):10-7.
9 6CapítuloAVALIAÇÃO CLÍNICA DO PACIENTE COM DOENÇA VENOSA REFERÊNCIAS BIBLIOGRÁFICAS
6. Silva MC, Couto EM. Insuficiência venosa crônica – Diagnóstico e Tratamento Clínico. In: Maffei FHA et al Doenças Vasculares Periféricas 5. ed. Volume 2. Rio de Janeiro: Guanabara Koogan; 2016. p. 2029-2137.
3. Wittens C, Davies AH et al. Management of Chronic Venous Disease. Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS) Eur J Vasc Endovasc Surg 2015;49:678-737.
23. Wrona M, Jöckel KH, Pannier F, et al. Association of Venous Disorders with Leg Symptoms: Results from the Bonn Vein Study. Eur J Vasc Endovasc Surg 2015 Sep;50(3):360-7.
16. Stick C, Jaeger H, Witzleb E. Measurements of volume and venous pressure in the human lower leg during walking and running. J Appl Physiol 1992;72:2.063-8.
25. Castro Santos MER. Exame Clínico no Paciente Varicoso. In: Maffei FHA et al. Doenças Vasculares Periféricas. 5. ed. Volume 1. Rio de Janeiro: Guanabara Koogan; 2016. p. 776-788.
26. Agus GB, Allegra PL, Antignani G et al. Guidelines for the diagnosis and therapy of the vein and lymphatic disorders. Inter Angiol 2005;24:107-68. 27. Matousek V, Prerovsky I. A contribution to the problem of the inheritance of primary varicose veins. Hum Hered 1974;24:225-35. 28. Maffei FHA. Diagnóstico Clínico das Doenças Venosas Periféricas In: Maffei FHA et al. Doenças Vasculares Periféricas. 5. ed. Volume 1. Rio de Janeiro: Guanabara Koogan; 2016. p. 758-775. 29. Marchiori A, Mosena L, Prins MH, Prandoni P. The risk of recurrent venous thromboembolism among heterozygous carriers of factor V Leiden or prothrombin G20210A mutation. A systematic review of prospective studies. Haematologica 2007 Aug;92(8):1107-14.
17. Maffei FHA, Silveira PRM. Varizes dos membros inferiores –Epidemiologia, Patologia, Etiopatogenia e Fisiopatologia. In: Maffei FHA et al. Doenças Vasculares Periféricas. 5. ed. Volume 2. Rio de Janeiro: Guanabara Koogan; 2016. p: 1938-1952.
7. Rabe E, Guex JJ, Uskas A et al. Epidemiology of chronic venous disorders in geographically diverse populations: results from the Vein Consult Program. Int Angiol 2012;31:105e15. 8. Evans CJ, Fowkes FG, Ruckley V, Lee AJ. Prevalence of varicose veins and chronic venous insufficiency in men and women in the general population: Edinburgh Vein Study. J Epidemiol Community Health 1999;53:149e53. 9. Pannier F, Rabe E Progression in venous pathology. Phlebology 2015 Mar;30(1 Suppl):95-7.
30. Ho WK, Hankey GJ, Quinlan DJ, Eikelboom JW. Risk of recurrent venous thromboembolism in patients with common thrombophilia: a systematic review. Arch Intern Med 2006 Apr 10;166(7):729-36. 31. Gloviczki P, Comerota AJ, Dalsing MC et al. The care of patients with varicose veins and associated chronic venous diseases: Clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg 2011;53:2S-48S. 32. O’Leary DP, Chester JF, Jones SM. Management of varicose veins according to reason for presentation. Ann R Coll Surg Engl 1996;78:214-6. 33. Roncato C, Lefant PY. Images in clinical medicine. Thrombosis of the inferior vena cava and dilated veins of the trunk. N Engl J Med 2011;364:2535. 34. A.A. Ramelet, M. Monti. Differential diagnosis of clinical signs of venous insufficiency of the lower limbs. In: Phlebology The Guide. 4. ed. Elsevier; 1999. p. 129-140 35. Haig AJ, Park P, Henke PK et al. Reliability of the clinical examination in the diagnosis of neurogenic versus vascular claudication. Spine J 2013 Dec;13(12):1826-34. 36. Burrus MT, Werner BC, Starman JS et al. Chronic leg pain in athletes. Am J Sports Med 2015 Jun;43(6):1538-47. 37. Harwin JBS, Richardson ML. “Tennis leg”: gastrocnemius injury is a far more common cause than plantaris rupture. Radiol Case Rep. 2017 Mar;12(1):120-123. 38. Delgado GJ, Chung CB, Lektrakul N et al. Tennis leg: clinical US study of 141 patients and anatomic investigation of four cadavers with MR imaging and US. Radiology 2002 Jul;224(1):112-9. 39. Herman AM, Marzo JM. Popliteal cysts: a current review. Orthopedics 2014 Aug;37(8):e678-84. 40. Merlino G, Valente M, Serafini A et al. Restless legs syndrome: diagnosis, epidemiology, classification and consequences. Neurol Sci 2007 Jan;28 (Suppl 1):S37-46). 41. Zucconi M, Ferini-Strambi L. Epidemiology and clinical findings of restless legs syndrome. Sleep Med 2004;5:293-9. 42. Young G. Leg cramps. BMJ Clin Evid 2015 May;13;2015. 43. Hirai M. Prevalence and characteristics of muscle cramps in patients with varicose veins. Vasa 2000;29:269-73. 44. Santos MERC. Insuficiência venosa superficial. In: Thomaz JB, Belczak CEQ (eds.). Tratado de flebologia e linfologia. Rio de Janeiro: Rubio; 2006. p. 168-79.
24. Giannoukas AD, Tsetis D, Ioannou C et al. Clinical presentation and anatomic distribution of chronic venous insufficiency of the lower limb in a typical Mediterranean population. Int Angiol 2002;21:187-92.
22. Marston WA. Evaluation of varicose veins: what do the clinical signs and symptoms reveal about the underlying disease and need for intervention? Semin Vasc Surg 2010 Jun;23(2):78-84.
18. Lundvall J, Mellander S, Westling H et al. Fluid transfer between and tissues during exercise. Acta Physiol Scand 1972;85:258-65.
10. De Castro-Silva M. Chronic venous insufficiency of the lower limbs and its socioeconomic significance. Int Angiol 1991;10:152.
20. A.A. Ramelet, M. Monti. History and cllinical examination. In: Phlebology The Guide 4. Ed. Elservier; 1999. p. 209-216.
12. Netter, Frank H. In: Atlas of human anatomy. Novartis, 1997. Seção VII Membro Inferior 489-512. 13. Brum O. Varizes dos membros inferiores. In: Angiologia Básica. São Paulo: Fundo editorial BYK; 1989. p. 168-180. 14. Mózes G, Carmichael SW, Gloviczki P. Development and anatomy of the venous system. In Gloviczki P, Yao JS, eds. Handbook of Venous Disorders. 2nd ed. New York, NY: Arnold; 2001. p. 11-24.
5. Carpentier PH Maricq HR, Biro C et al. Prevalence, risk factors, and patterns of chronic disorders of lower limbs: A population-based study in France. J Vasc Surg 2004;40:650-9.
15. Beede-Dimmer JL, Pfeifer JR, Engle JS, Schottenfeld D. The Epidemiology of Chronic venous insufficiency and varicose veins. Ann Epidemiol 2005;15:175-184.
57. Nicolaides AN. Chronic venous disease and the leukocyte-endothelium interaction: from symptoms to ulceration. Angiology 2005-56(Suppl. 1):S11-9. Ely JW, Osheroff JA, Chambliss ML, Ebell MH. Approach to leg edema of unclear etiology. J Am Board Fam Med 2006 Mar-Apr;19(2):148-60. Erratum in J Am Board Fam Med 2008 Jan-Feb;21(1):86.
52. Choi YR, Hong CG. Repair of tibialis anterior muscle herniation using periosteum. Orthopedics 2014 Nov;37(11):748-50.
62. Ramos LO, Mattos PC, Figueredo GL et al. Pre-tibial myxedema: treatment with intralesional corticosteroid. An Bras Dermatol 2015 May-Jun;90(3 Suppl 1):143-6.
58.
51.
63. Kim WB, Mistry N, Alavi A et al. Pretibial Myxedema: Case Presentation and Review of Treatment Options. Int J Low Extrem Wounds 2014 Jun;13(2):152-154. 64. Rothacker KM, Kaye J. Insulin oedema and treatment-induced neuropathy occurring in a 20-year-old patient with Type 1 diabetes commenced on an insulin pump. Diabet Med 2014 Jan;31(1):e6-e10.
66. Juergens JL, Lofgren KA. Chronic venous insufficiency (postphlebitic syndrome, chronic venous stasis). In: Juergens JL, Spittell Jr JA, Fairbairn JF. Pheriperal vascular diseases. 5th ed. Philadelphia: W.B. Saunders; 1980. p. 809-21. 67. Uhl JF, Cornu-Thénard A, Carpentier PH et al. Clinical and hemodynamic significance of corona phlebectatica in chronic venous disorders. J Vasc Surg 2005 Dec;42(6):1163-8. 68. Kim J, Richards S, Kent PJ. Clinical examination of varicose veins – a validation study. Ann R Coll Surg Engl 2000-82:171-5. 69. Hoffmann WH, Toonder IM, Wittens CHA, Value of the Trendelenburg tourniquet test in the assessment of primary varicose veins Phlebology 2004 June; 1. 70. Bhasin N, Scott DJ. How should a candidate assess varicose veins in the MRCS clinical examination? A vascular viewpoint. Ann R Coll Surg Engl 2006 May;88(3):309-12. 71. Owaidah T, AlGhasham N, AlGhamdi S et al. Evaluation of the usefulness of a D dimer test in combination with clinical pretest probability score in the prediction and exclusion of Venous Thromboembolism by medical residents. Thromb J 2014 Nov 28;12(1):28. 72. Silveira PC, Ip IK, Goldhaber SZ et al. Performance of Wells Score for Deep Vein Thrombosis in the Inpatient Setting. JAMA Intern Med 2015 Jul;175(7):1112-7.
54.
61. Suehiro K, Morikage N, Murakami M et al. A study of leg edema in immobile patients. Circ J 2014;78(7):1733-9.
65. Trayes KP1, Studdiford JS, Pickle S, Tully AS. Edema: diagnosis and management. Am Fam Physician 2013 Jul 15;88(2):102-10.
53. Rabe E, Pannier F. Clinical, aetiological, anatomical and pathological classification (CEAP): gold standard and limits. Phlebology 2012 Mar;27 Suppl 1:114-8. Maffei FHA, Magaldi C, Pinho SZ et al. Varicose veins and chronic venous insufficiency in Brazil: prevalence among 1755 inhabitants of a country town. Int J Epidemiol 1986-15:210-7. Eklof B, Rutherford RB, Bergan JJ et al. Revision of the CEAP classification for chronic venous disorders: consensus statement. J Vasc Surg 2004-40:1248-52. 56. Grada AA, Phillips TJ. Lymphedema: Pathophysiology and clinical manifestations. J Am Acad Dermatol 2017 Dec;77(6):1009-1020.
Parte I10 CAPÍTULOS BÁSICOS 45. Bradbury A, Evans C, Allan P et al. What are the symptoms of varicose veins? Edinburgh vein study cross sectional population survey. BMJ 1999;318:353-6. 46. Bradbury A, Ruckley CV. Clinical assessment of patients with venous disease. In: Gloviczki P, Yao JST. Handbook of venous disorders Guidelines of the American Venous Forum. 2nd ed. London: Arnold; 2001. p. 71-83. 47. Ramelet AAM. Monti Venous insufficiency and varicose veins: classification and differential diagnosis. In: Phlebology The Guide. 4. ed. Elservier; 1999. p. 87-102. 48. McAree BJ, O’Donnell ME, Fitzmaurice GJ et al. Inferior vena cava thrombosis: a review of current practice. Vasc Med 2013;18:32-43.
60. Vignes S. Lipedema: a misdiagnosed entity. J Mal Vasc 2012 Jul;37(4):213-8.
73. Di Nisio M, van Es N, Büller HR. Deep vein thrombosis and pulmonary embolism. Lancet 2016 Dec 17;388(10063):3060-3073. 74. Spandorfer J, Galanis T. In the Clinic. Deep venous thrombosis. Ann Intern Med 2015 May 5;162(9):ITC1 75. Geersing GJ, Zuithoff NP, Kearon C et al. Exclusion of deep vein thrombosis using the Wells rule in clinically important subgroups: individual patient data meta-analysis. BMJ 2014 Mar 10;348:g1340. 76. H. Bounameaux. Deep vein thrombosis of the lower limbs. In: Ramelet AA, Monti M. Phlebology The Guide. 4. ed. Elsevier; 1999. p. 187-195. 77. Mumoli N, Invernizzi C, Luschi R et al. Phlegmasia cerulea dolens. Circulation 2012 Feb 28;125(8):1056-7.
59. Evans NS, Ratchford EV. The swollen leg. Vasc Med 2016 Dec;21(6):562-564.
55.
49. Presti C, Junior FM, Merlo I, Moraes MRS. Grupo de estudo: Kikuchi R, Junior WC, Moura MRL. Projeto Diretrizes SBACV 1 Insuficiência Venosa Crônica: Diagnóstico e Tratamento Elaboração final: novembro de 2015.
50. Greiner M1, Gilling-Smith GL. Leg varices originating from the pelvis: diagnosis and treatment. Vascular 2007 Mar-Apr;15(2):70-8. Hartung O. Embolization is essential in the treatment of leg varicosities due to pelvic venous insufficiency. Phlebology. 2015 Mar;30(1 Suppl):81-5.
2. Sumner DS. Plethysmography in arterial and venous diagnosis. In: Zweibel WJ (Ed.): Introduction to vascular ultrasonography. New York: Grune & Stratton; 1982. p. 315.
14. Satomura S, Kaneko Z. Ultrasonic blood rheograph. Proc. 3rd International Conf. Med. Electronics; 1960. p. 254.
12. Johnston KW, Maruzzo BC, Cobbold RSC. Doppler methods for quantitative measurements and localization of peripheral arterial occlusive disease by analysis of the blood velocity waveform. Ultrasound Med Biol 1978;4:209-13.
3. Sumner DS. Volume plethysmography in vascular disease: An overview. In: Bernstein EF (ED.): Noninvasive diagnostic techniques in vascular disease. St. Louis: Mosby; 1978. p 68.
27. Malvezzi L, Castronuovo JJ Jr., Swayne LC et al. The correlation between three methods of the skin perfusion pressure measuremente radionuclide washout, laser Doppler flow, and photoplethysmography. J Vasc Surg 1992;15:823-30.
28. Larsen JF, Jensen BV, Christensen KS, Egelblad K. Forefoot transcutaneous oxygen tension at different leg positions in patients with peripheral vascular disease. Eur J Vasc Surg 1990;4:185-9.
34.
36. DeFrang RD, Taylor LM, Porter JM. Basic data related to amputations. Ann Vasc Surg 1991;5:202-7. 37. Aune S, Pedersen OM, Trippestad A. Surveillance of above knee prothetic femoropopliteal bypass. Eur J Vasc Endovasc Surg 1998;16:509-12. 38. Ricco JB, Pearce WH, Yao JST et al. The use of operative pre-bypass arteriography and Doppler ultrasound recordings to select patients for extended femoropopliteal bypass. Ann Surg 1983;198:646-52. 39. Kresowik TF, Hoballah JJ, Sharp WJ et al. Intraoperative B-mode sonography is a useful adjunct to peripheral arterial reconstruction. Ann Vasc Surg 1993;7:33-8. 40. Fasih T, Rudol G, Ashour H et al. Surveillance versus nonsurveillance for femoro-popliteal bypass graft. Angiology 2004;55(3):251-6. 41. Hoballah JJ, Nazzal MM, Ryan SM. Is color duplex surveillance of infra inguinal polytetrafluorethylene grafts worthwhile? Am J Surg 1997;174:131-5. 42. Gross WS, Louis D. Doppler hemodynamic assessment of obscure symptomatology in the upper extremity. J Hand Surg 1978;3:467-71. 43. Gilfollan RS, Leeds FH, Spotts RR. The prediction of healing in ischemic lesions of the foot. A comparison of Doppler ultrasound and elevation reactive hyperemina. J Cardiovasc Surg 1985;26:15-8. Tumbuli TL, Dymowski JJ, Zalut TE. A prospective study of hand-held Doppler ultrasonography by emergency physicians in the evaluation of suspected deep-vein thrombosis. Ann Emer Med 1990;19:691-5.
VASCULAR
5. Criado E, Farber MA, Marston WA. The role of air plethismography in the diagnosis of chronic venous insufficiency. J Vasc Surg 1998;27:660-70.
13. Kato K, Kakusho O, Izumei T. A new ultrasonic Doppler flowmeter that can detect flow directions. Med Ultrasound 1968;5:28-31.
26. Chaudry H, Holland A, Dormandy J. Comparison of graded versus constant treadmill tests protocols for quantifying intermittent claudication. Vasc Med 1997;2:93-7.
23. Hajibandeh S, Hajibandeh S, Shah S. Prognostic significance of ankle brachial pressure index: a systematic review and meta-analysis. Vascular 2017;25(2):208-24. 24. Creager MA. Clinical assessment of the patient with claudication: The role of the vascular laboratory. Vasc Med 1997;2:231-7.
30. Nielsen SL, Lassen NA. Cold sensitivity of the digital arteries evaluated by mesasurement of digital blood pressure after local cooling. J Applied Physiol 1977;43:907-10.
LABORATÓRIO
31. Van Bellen B. Role of the non-invasive methods in assessing treatment with vasoactive drugs. Microcirculation and ischemic vascular diseases. Clinical and therapeutic approaches. New York: Biomedical Information Corp.; 1981. p. 355. 32. Currie IC, Wilson YG, Baird RN. Post-occlusive hyperaemic duplex scan: a new method of aortoiliac assessment. Br J Surg 1995;82:1226-9. 33. Heintz SE, Bene GE, Slaymaler EE. Value of arterial pressure measurements in the proximal and distal part of the thigh in arterial occlusive disease. Surg Gynecol Obstet 1978;146:337-41. Moneta GL, Yeager RA, Lee RW, Porter JM. Noninvasive localization of arterial occlusive disease: A comparison of segmental Doppler pressures and arterial duplex mapping. J Vasc Surg 1993;17:578-82.
16. Strandness Jr. DE, McCutcheon EP, Rushmer RF. Application of a transcutaneous Doppler flowmeter in evaluation of occlusive arterial disease. Surg Gynecol Obstet 1966;122:1039-45.
19. McLafferty RB, Moneta GL, Taylor LM Jr. Ability of ankle-brachial index to detect lower extremity arteriosclerosis disease progression. Arch Surg 1997;132:836-41.
REFERÊNCIAS BIBLIOGRÁFICAS
9. Van Bemmelen PS, Van Ramshorst D, Eikelboom BC. Photoplethysmography reexamined: Lack of correlation with duplex scanning. Surgery 1992;112:544-8.
4. Bays RA, Healy DA, Atnip RG et al. Validation of air plethysmography, photoplethysmography and duplex ultra-sonography in the evaluation of severe venous stasis. J Vasc Surg 1994;20:721-5.
18. Baker JD, Dix D. Variability of Doppler ankle pressures with arterial occlusive disease: An evaluation of ankle index and brachial-ankle pressure gradient. Surgery 1981;89:134-41.
25. Cachovan M, Rogatti W, Creutzig A. Treadmill testing for evaluation fo claudication. Comparison of constant-load and graded exercise test. Eur J Vasc Endovasc Surg 1997;14:238-43.
11. Gosling RG, King DH. Processing arterial Doppler signals for clinical data. In Vlieger M, Homes JH, Kazner E et al. (Eds): Handbook of Clinical Ultrasound. New York: Wiley; 1978. p. 613.
1. Oesterling C, Kalia A, Chetcuti T, Walker S. Atypical leg symptoms: does routine measurement of the ankle brachial pressure index (ABPI) in primary care benefit patients? London J Prim Care 2015;7(5):97-102.
22. Dhanowar RK, Nath L, Tiwari PK. A clinical study of peripheral vascular disease in diabetes mellitus with special reference to ankle brachial pressure index and colour Doppler ultrasonography. Int J Contemp Med Res 2016;3(7):1899-903.
29. Naidu S, Baskerville PA, Goss DE, Roberts VC. Raynaud’s phenomenon and cold stress testing: A new approach. Eur J Vasc Surg 1994;8:567-73.
35. Verta Jr. MS, Gross W, van Bellen B. Forefoot perfusion pressure and minor amputation for gangrene. Surgery 1997;6(80):729-33.
15. Yao JST. Heamodynamic studies in peripheral arterial disease. Br J Surg 1970;57:762-70.
20. Velescu A, Clara A, Marti R et al. Abnormally high ankle-brachial index is associated with all-cause and cardiovascular mortality: teh REGICOR Study. Eur J Vasc Endovasc Surg 2017; 54(3):370-7.
11 7Capítulo
17. Nicolaides NA, Angelides NS. Waveform index and resistance factor using directional Doppler ultrasound and a zero-crossing detector. In: Nicolaides NA, Yao JST (Eds.): Investigation of vascular disorders. New York; Churchill Livingstone; 1981. p. 291.
7. Nicolaides NA, Miles C. Photoplethysmography in the assessment of venous insufficiency. J Vasc Surg 1987;5:405-8.
8. Sarin S, Shields DA, Scurr JH, Coleridge Smith PD. Photoplethysmography: A valuable noninvasive tool in the assessment of venous dysfunction? J Vasc Surg 1992;116:154-62.
21. Mallipeddi VP, Kullo I, Afzal N et al. Association of ankle brachial pressure index with limb outcomes in peripheral artery disease: a community-based study. JACC 2017;69(11):1298.
44.
10. Doppler C. Uber das farbige licht der dopplesterne und einiger anderer gestirne des himmels. Abh K Bohn Ges Wiss 1842;2:465.
6. Abramovitz HR, Queral LA, Flinn WR et al. The use of photopletysmography in the assessment of venous insufficiency. A comparison to venous pressure measurements. Surgery 1979;8:434-41.
13. Halm EA, Browner WS, Tubau JF et al. Echocardiography for assessing cardiac risk in patients having noncardiac surgery. Ann Inter Med 1996 Sep 15;125(6):433-41.
25. Devereaux PJ. Rationale and design of the PeriOperative ISchemic Evaluation-2 (POISE-2) trial: An international 2 × 2 factorial randomized controlled trial of acetyl-salicylic acid vs placebo and clonidine vs placebo in patients undergoing noncardiac surgery. Am Heart J 2014 Jun 1;167(6):804-9.
4. McArdle WD, Katch FI, Katch VL. Exercise physiology: nutrition, energy, and human performance. Lippincott Williams & Wilkins; 2010.
18. Knuuti J, Bengel F, Bax JJ et al. Risks and benefits of cardiac imaging: an analysis of risks related to imaging for coronary artery disease. Eur Heart J 2013 Dec 29;35(10):633-8.
16. Kayano D, Nakajima K, Ohtake H, Kinuya S. Gated myocardial perfusion SPECT for preoperative risk stratification in patients with noncardiac vascular disease. Ann Nucl Med 2009 Feb 1;23(2):173-81.
2. Mackey WC, Fleisher LA, Haider S et al. Perioperative myocardial ischemic injury in high-risk vascular surgery patients: incidence and clinical significance in a prospective clinical trial. J Vasc Surg 2006 Mar 1;43(3):533-8.
8. Lee TH, Marcantonio ER, Mangione CM et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 1999 Sep 7;100(10):1043-9. 9. Palda VA. Guidelines for assessing and managing the perioperative risk from coronary artery disease associated with major noncardiac surgery. Ann Intern Med 1997;127:309-12.
24. Landesberg G, Beattie WS, Mosseri M et al. Perioperative myocardial infarction. Circulation 2009 Jun 9;119(22):2936-44.
26. Ashes C, Judelman S, Wijeysundera DN et al. Selective β1-Antagonism with Bisoprolol Is Associated with Fewer Postoperative Strokes than Atenolol or MetoprololA Single-center Cohort Study of 44,092 Consecutive Patients. Anesthesiology 2013 Oct 1;119(4):777-87. 27. Mashour GA, Sharifpour M, Freundlich RE et al. Perioperative metoprolol and risk of stroke after noncardiac surgery. Anesthesiology 2013 Dec 1;119(6):1340-6. 28. McGirt MJ, Perler BA, Brooke BS et al. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors reduce the risk of perioperative stroke and mortality after carotid endarterectomy. J Vasc Surg 2005 Nov 1;42(5):829-36. 29. Kennedy J, Quan H, Buchan AM et al. Statins are associated with better outcomes after carotid endarterectomy in symptomatic patients. Stroke 2005 Oct 1;36(10):2072-6.
15. Padma S, Sundaram PS. Current practice and recommendation for presurgical cardiac evaluation in patients undergoing noncardiac surgeries. World J Nucl Med 2014 Jan;13(1):6.
10. Fleisher LA, Fleischmann KE, Auerbach AD et al. 2014 ACC/ AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014; 64(22):e77-e137.
17. Schwitter J, Wacker CM, Wilke N et al. MR-IMPACT II: Magnetic Resonance Imaging for Myocardial Perfusion Assessment in Coronary artery disease Trial: perfusion-cardiac magnetic resonance vs. singlephoton emission computed tomography for the detection of coronary artery disease: a comparative multicentre, multivendor trial. Eur Heart j 2012 Mar 4;34(10):775-81.
12. Kristensen SD, Knuuti J, Saraste A et al. 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). Eur Heart J 2014 Aug 1;35(35):2383-431.
14. Sicari R, Nihoyannopoulos P, Evangelista A et al. Stress echocardiography expert consensus statement-executive summary: european association of echocardiography (a registrated branch of the ESC). Eur Heart J 2009;30(3):278-89.
19. Nagele P, Brown F, Gage BF et al. High-sensitivity cardiac troponin T in prediction and diagnosis of myocardial infarction and longterm mortality after noncardiac surgery. Am Heart J 2013 Aug 1;166(2):325-32.
20. Martinez EA, Nass CM, Jermyn RM et al. Intermittent cardiac troponin-I screening is an effective means of surveillance for a perioperative myocardial infarction. J Cardiothorac Vasc Anesth 2005 Oct 1;19(5):577-82.
5. Cangiani LM, Carmona MJ, Torres ML et al. Tratado de anestesiologia. 8. ed. SAESP; 2017. 6. ASo A. ASA physical status classification system. 7. Bertges DJ, Goodney PP, Zhao Y et al. The Vascular Study Group of New England Cardiac Risk Index (VSG-CRI) predicts cardiac complications more accurately than the revised cardiac risk index in vascular surgery patients. J Vasc Surg 2010 Sep 1;52(3):674-83.
30. Verzini F, De Rango P, Parlani G et al. Effects of statins on early and late results of carotid stenting. J Vasc Surg 2011 Jan 1;53(1):71-9.
REFERÊNCIAS BIBLIOGRÁFICAS
11. Pinho C, Grandini PC, Gualandro DM et al. Multicenter study of perioperative evaluation for noncardiac surgeries in Brazil (EMAPO). Clinics 2007 Feb;62(1):17-22.
31. Durham CA, Ehlert BA, Agle SC et al. Role of statin therapy and angiotensin blockade in patients with asymptomatic moderate carotid artery stenosis. Ann Vasc Surg 2012 Apr 1;26(3):344-52. 32. Kertai MD, Boersma E, Westerhout CM et al. Association between long-term statin use and mortality after successful abdominal aortic aneurysm surgery. Am J Med 2004 Jan 15;116(2):96-103. 33. Leurs LJ, Visser P, Laheij RJ et al. Statin use is associated with reduced all-cause mortality after endovascular abdominal aortic aneurysm repair. Vascular 2006 Jan 1;14(1):1-8. 34. Raux M, Cochennec F, Becquemin JP. Statin therapy is associated with aneurysm sac regression after endovascular aortic repair. J Vasc Surg 2012 Jun 1;55(6):1587-92. 35. Heart Protection Study Collaborative Group. Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions. J Vasc Surg 2007 Apr 1;45(4):645-54. 36. Feringa HH, van Waning VH, Bax JJ et al. Cardioprotective medication is associated with improved survival in patients with peripheral arterial disease. J Am Coll Cardiol 2006 Mar 21;47(6):1182-7.
3. Ainsworth BE, Haskell WL, Whitt MC et al. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 2000 Sep 1;32(9; SUPP/1):S498-504.
21. Biccard BM, Naidoo P. The role of brain natriuretic peptide in prognostication and reclassification of risk in patients undergoing vascular surgery. Anaesthesia 2011 May 1;66(5):379-85.
12 8Capítulo AVALIAÇÃO PRÉ-OPERATÓRIA EM CIRURGIA VASCULAR
1. Marques AC, Bellen BV, Caramelli B et al. Atualização e enfoque em operações vasculares arteriais da II Diretriz de Avaliação Perioperatória da Sociedade Brasileira de Cardiologia. Arq Bras Cardiol 2013 Oct;101(4):02-32.
22. Rodseth RN, Biccard BM, Le Manach Y et al. The prognostic value of pre-operative and post-operative B-type natriuretic peptides in patients undergoing noncardiac surgery: B-type natriuretic peptide and N-terminal fragment of pro-B-type natriuretic peptide: a systematic review and individual patient data meta-analysis. J Am Coll Cardiol 2014 Jan 21;63(2):170-80. 23. Sankar A, Beattie WS, Wijeysundera DN. How can we identify the high-risk patient?. Curr Opin Crit Care 2015 Aug;21(4):328.
39. Xavier HT, Izar MC, Faria Neto JR et al. V Diretriz brasileira de dislipidemias e prevenção da aterosclerose. Arq Bras Cardiol 2013 Oct;101(4):1-20.
43. Mattos LA, Neto L, Rassi Junior A et al. Diretrizes da Sociedade Brasileira de Cardiologia: intevenção coronária percutânea e métodos adjuntos diagnósticos em cardiologia intervencionista (II Edição-2008). Rev Bras Cardiol Invasiva 2008;16(2, supl. 2):9-88.
44. Gualandro DM, Yu PC, Caramelli B et al. 3rd Guideline for Perioperative Cardiovascular Evaluation of the Brazilian Society of Cardiology. Arqu Bras Cardiol 2017 Sep;109(3):1-04.
55. Savonitto S, D’urbano M, Caracciolo M et al. Urgent surgery in patients with a recently implanted coronary drug-eluting stent: a phase II study of ‘bridging’antiplatelet therapy with tirofiban during temporary withdrawal of clopidogrel. Br J Anaesth 2010 Jan 3;104(3):285-91.
40. Ramaswamy S, Wilson JA, Colvin L. Non-opioid-based adjuvant analgesia in perioperative care. Continuing Education in Anaesthesia. Critical Care & Pain 2013 Feb 14;13(5):152-7.
42. Roshanov PS, Rochwerg B, Patel A et al. Withholding versus Continuing Angiotensin-converting Enzyme Inhibitors or Angiotensin II Receptor Blockers before Noncardiac SurgeryAn Analysis of the Vascular events In noncardiac Surgery patIents cOhort evaluatioN Prospective Cohort. Anesthesiology 2017 Jan 1;126(1):16-27.
60. KearonC, Akl EA,Comerota AJ et al. American College of Chest Physicians. Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012;141(2 Suppl):e419S-94S. Erratum in: Chest 2012;142(6):1698-704. 61. Spyropoulos AC, Douketis JD. How I treat anticoagulated patients undergoing an elective procedure or surgery. Blood 2012 Oct 11;120(15):2954-62. 62. Schulman S, Crowther MA. How I treat with anticoagulants in 2012: new and old anticoagulants, and when and how to switch. Blood 2012 Mar 29;119(13):3016-23. 63. Lai A, Davidson N, Galloway SW, Thachil J. Perioperative management of patients on new oral anticoagulants. Br J Surg 2014 Jun 1;101(7):742-9. 64. Siegal DM, Curnutte JT, Connolly SJ et al. Andexanet alfa for the reversal of factor Xa inhibitor activity. N Engl J Med 2015 Dec 17;373(25):2413-24. 65. Eagle KA, Rihal CS, Mickel MC et al. CASS Investigators. Cardiac risk of noncardiac surgery: influence of coronary disease and type of surgery in 3368 operations. Circulation 1997 Sep 16;96(6):1882-7. 66. Hassan SA, Hlatky MA, Boothroyd DB et al. Outcomes of noncardiac surgery after coronary bypass surgery or coronary angioplasty in the Bypass Angioplasty Revascularization Investigation (BARI). Am J Med 2001 Mar 1;110(4):260-6. 67. McFalls EO, Ward HB, Moritz TE et al. Coronary-artery revascularization before elective major vascular surgery. N Eng J Med 2004 Dec 30;351(27):2795-804.
68. Poldermans D, Schouten O, Vidakovic R et al. A clinical randomized trial to evaluate the safety of a noninvasive approach in high-risk patients undergoing major vascular surgery: the DECREASE-V Pilot Study. J Am Coll Cardiol 2007 May 1;49(17):1763-9. 69. Grines CL. American Heart Association; American College of Cardiology; Society for Cardiovascular Angiography and Interventions; American College of Surgeons; American Dental Association; American College of Physicians. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American. Circulation 2007;115:813-8.
47. Burger W, Chemnitius JM, Kneissl GD, Rücker G. Low dose aspirin for secondary cardiovascular prevention–cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation–review and meta analysis. J Int Med 2005 May 1;257(5):399-414.
37. Ward RP, Leeper NJ, Kirkpatrick JN et al. The effect of preoperative statin therapy on cardiovascular outcomes in patients undergoing infrainguinal vascular surgery. Int J Cardiol 2005 Oct 10;104(3):264-8.
51. Stone DH, Goodney PP, Nolan BW et al. Clopidogrel Is Not Associated With Major Bleeding Complications During Peripheral Arterial Surgery. J Vasc Surg 2010 Sep 1;52(3):802.
38. Aiello FA, Khan AA, Meltzer AJ et al. Statin therapy is associated with superior clinical outcomes after endovascular treatment of critical limb ischemia. J Vasc Surg 2012 Feb 1;55(2):371-80.
Capítulo 8 13AvAliAção Pré- oPer AtóriA em CirurgiA vA sCul Ar
48. Bedenis R, Lethaby A, Maxwell H et al. Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery Cochrane Library 2015 Jan 1. 49. McCollum C, Alexander C, Kenchington G et al. Antiplatelet drugs in femoropopliteal vein bypasses: a multicenter trial. J Vasc Surg 1991 Jan 1;13(1):150-62. 50. Schoenefeld E, Donas K, Radicke A et al. Perioperative use of aspirin for patients undergoing carotid endarterectomy. Vasa 2012 Jul 1;41(4):282-7.
41. De Hert S, Staender S, Fritsch G et al. Pre-operative evaluation of adults undergoing elective noncardiac surgery: Updated guideline from the European Society of Anaesthesiology. Eur J Anaesth (EJA) 2018 Jun 1;35(6):407-65.
45. Burger W, Chemnitius JM, Kneissl GD, Rücker G. Low dose aspirin for secondary cardiovascular prevention–cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation–review and meta analysis. J Int Med 2005 May 1;257(5):399-414.
58. Machado FS. Perioperatório do paciente em uso de anticoagulante. Perioperatório: procedimentos clínicos: Sarvier 2004:105-9.
57. Kearon C, Akl EA, Comerota AJ et al. Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2012 Feb 1;141(2):e419S-96S.
54. Smith PK, Goodnough LT, Levy JH et al. Mortality Benefit With Prasugrel in the TRITON–TIMI 38 Coronary Artery Bypass Grafting Cohort: Risk-Adjusted Retrospective Data Analysis. Journal of the Am Coll Cardiol 2012 Jul 31;60(5):388-96.
56. Capodanno D, Musumeci G, Lettieri C et al. Impact of bridging with perioperative low-molecular-weight heparin on cardiac and bleeding outcomes of stented patients undergoing non-cardiac surgery. Thromb Haemost 2015;114(2):423-31.
70. Brilakis ES, Orford JL, Fasseas P et al. Outcome of patients undergoing balloon angioplasty in the two months prior to noncardiac surgery. Am J Cardiol 2005 Aug 15;96(4):512-4.
46. Biondi-Zoccai GG, Lotrionte M, Agostoni P et al. A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50 279 patients at risk for coronary artery disease. Eur Heart J 2006 Oct 19;27(22):2667-74.
52. Burdess A, Nimmo AF, Garden OJ. Randomized controlled trial of dual antiplatelet therapy in patients undergoing surgery for critical limb ischemia. J Vasc Surg 2010 Dec 1;52(6):1727. 53. Held C, Åsenblad N, Bassand JP et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: results from the PLATO (Platelet Inhibition and Patient Outcomes) trial. J Am Coll Cardiol 2011 Feb 8;57(6):672-84.
59. O’shaughnessy DF, Atterbury C, Maggs PB et al. Guidelines for the use of fresh frozen plasma, cryoprecipitate and cryosupernatant. Br J Haematol 2004 Jul 1;126(1):11-28.
8. Armstrong EC. The well-built clinical question: The key to finding the best evidence efficiently. WMJ 1999 Mar-Apr;98(2):25-8
13. Badger S, Forster R, Blair PH et al. Cochrane Database Syst Rev 2017 May 26;5:CD005261.
1. Arif E. Jinha, Article 50 million: An estimate of the number of scholarly articles in existence. Learned Publishing 2010; 23:258-263.
2. Alper et al. How much effort is needed to keep up with the literature relevant for primary care? J Med Libr Assoc 2004 Oct;92(4):429-437.
14 9Capítulo DECISÕES CLÍNICAS EM CIRURGIA VASCULAR
3. McAlister FA1, Clark HD, van Walraven C et al. The medical review article revisited: has the science improved? Ann Intern Med 1999 Dec 21;131(12):947-51.
5. Huang X, Lin J, Demner-Fushman D. Evaluation of PICO as a Knowledge Representation for Clinical Questions. AMIA Annu Symp Proc 2006:359-36. 6. baseada-em-evidencias-delineamento-dos-problemas-clinicos/https://pebmed.com.br/1o-passo-do-ciclo-de-tomada-de-decisao-
7. Croft P, Altman DG, Deeks JJ et al. The science of clinical practice: disease diagnosis or patient prognosis? Evidence about “what is likely to happen” should shape clinical practice Timmis. BMC Med 2015;13:20.
4. Ho GJ, Liew SM, Ng CJ, et al. Development of a Search Strategy for an Evidence Based Retrieval Service. PLoS ONE 11(12): e0167170.
9. Thiese MS. Study design types: an overview. Biochemia Medica 2014;24(2):199-210. 10. Grimes DA, Schulz KF. Descriptive studies: what they can and cannot do. Lancet 2002 Jan 12;359(9301):145-9. 11. Ponce OJ, Alvarez-Villalobos N, Shah R et al. What does expert opinion in guidelines mean? a meta-epidemiological study. Evid Based Med 2017 Oct;22(5):164-169. 12. https://www.ncbi.nlm.nih.gov/pubmedhealth/what-is-a-systematic-review/
REFERÊNCIAS BIBLIOGRÁFICAS
15. Costa RHR, de Loiola Cisneros L, Luz AR. Vascular Diseases for the NonSpecialist 2017;366:151-165 (Springer, Cham).
3. Norgren L et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 2007;45:S5-S67.
16. Costa RHR et al. Diabetic foot ulcer carries high amputation and mortality rates, particularly in the presence of advanced age, peripheral artery disease and anemia. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2017;11:S583-S587.
15 10CapítuloNOVOS CONCEITOS EM ISQUEMIA DE MEMBRO –O SISTEMA DE CLASSIFICAÇÃO SVS-WIfI (WOUND, ISCHEMIA AND foot INFECTION) REFERÊNCIAS BIBLIOGRÁFICAS
12. Gregg EW et al. Changes in Diabetes-Related Complications in the United States, 1990–2010. N Eng J Med 2014;370:1514-1523.
17. Rezende KF et al. Internações por Pé Diabético: Comparação entre o Custo Direto Estimado e o Desembolso do SUS. 1-8 (2008). 18. https://passofirme.wordpress.com/2012/11/11/maioria-de-pacientes-com-pe-diabetico-atendidos-no-rj-acaba-amputada/.Visibilizadoem18/07/2018.
2. Rutherford RB et al. Recommended standards for reports dealing with lower extremity ischemia: Revised version. J Vasc Surg 1997;26, 517-538.
1. Mills JL et al. The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: Risk stratification based on Wound, Ischemia, and foot Infection (WIfI). 1-17 (2018).
7. Ward R et al. Outcomes of Critical Limb Ischemia in an Urban, Safety Net Hospital Population with High WIfI Amputation Scores. 1-6 (2018).
14. Morbach S et al. The German and Belgian accreditation models for diabetic foot services. Diabetes Metab Res Rev 2016;32:318-325.
10. Aiello A et al. Treatment of peripheral arterial disease in diabetes: A consensus of the Italian Societies of Diabetes (SID, AMD), Radiology (SIRM) and Vascular Endovascular Surgery (SICVE). Nutr Metab Cardiovasc Dis 2014;24:355-369.
11. Hingorani A. et al. The management of diabetic foot: A clinical practice guideline by the Society for Vascular Surgery in collaboration with the American Podiatric Medical Association and the Society for Vascular Medicine. J Vasc Surg 2016;63:3S-21S.
4. Elgzyri T, Larsson J, Thörne J et al. Outcome of Ischemic Foot Ulcer in Diabetic Patients Who Had no Invasive Vascular Intervention. Eur J Vasc Endovasc Surg 2013;46:110-117.
13. Gottrup F. A New Concept of a Multidisciplinary Wound Healing Center and a National Expert Function of Wound Healing. Arch Surg 2001;136:765-772.
8. Cull DL et al. An early validation of the Society for Vascular Surgery Lower Extremity Threatened Limb Classification System. J Vasc Surg 2014;60:1535-1542.
9. Darling JD et al. Predictive Ability of the SVS WIfI Classification System Following Infrapopliteal Endovascular Interventions for CLI. 1-16 (2018).
19. Leite JO et al. General outcomes and risk factors for minor and major amputations in Brazil. Vascular 2017,26:291-300.
6. Zhan LX, Branco BC, Armstrong DG, Mills JL. The Society for Vascular Surgery lower extremity threatened limb classification system based on Wound, Ischemia, and foot Infection (WIfI) correlates with risk of major amputation and time to wound healing. 1-6 (2018).
5. Marston WA et al. Natural history of limbs with arterial insufficiency and chronic ulceration treated without revascularization. J Vasc Surg 2006;44:108-114.e1.
REFERÊNCIAS BIBLIOGRÁFICAS
1. Roth GA, Johnson C, Abajobir A et al. Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015. J Am Coll Cardiol 2017;70(1):1-25.
14. Marik PE, Monnet X, Teboul JL. Hemodynamic parameters to guide fluid therapy. Ann Intensive Care 2011 Mar;1(1):1.
7. Kisten T, Biccard BM. Incidence and hospital mortality of vascular surgery patients with perioperative myocardial infarction (PMI) or myocardial injury after non-cardiac surgery (MINS). South African J Anaesth Analg 2017;23(3):64-8.
SEÇÃO ANESTESIA4
16 11Capítulo ANESTESIA EM CIRURGIA VASCULAR
28. Guay JKS. Epidural pain relief versus systemic opioid-based pain relief for abdominal aortic surgery (Cochrane Reviews). Cochrane Database Syst Rev 2016;(1). 29. Edwards MS, Andrews JS, Edwards AF et al. Results of endovascular aortic aneurysm repair with general, regional, and local/monitored anesthesia care in the American College of Surgeons National Surgical Quality Improvement Program database. J Vasc Surg 2011;54(5):1273-82.
3. Kristensen SD, Knuuti J, Saraste A et al. 2014 ESC/ESA Guidelines on non-cardiac surgery: Cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: Cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesth. Eur Heart J 2014;35(35):2383-431.
9. Bauer SM, Cayne NS, Veith FJ. New developments in the preoperative evaluation and perioperative management of coronary artery disease in patients undergoing vascular surgery. J Vasc Surg 2010;51(1):242-51.
13. Vincent J, Pelosi P, Pearse R et al. Perioperative cardiovascular monitoring of high-risk patients: a consensus of 12. Crit Care 2015 Dec;19(1):224.
2. Faxon DP, Fuster V, Libby P et al. Atherosclerotic vascular disease conference. Writing group III: Pathophysiology. Circulation 2004;109(21):2617-25.
4. Fleisher LA, Fleischmann KE, Auerbach AD et al. 2014 ACC/ AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery A report of the American College of Cardiology/American Heart Association task force on practice guidelines. Vol. 130. Circulation 2014: 278-333.
6. Marques A, Bellen B, Caramelli B et al. Atualização e enfoque em operações vasculares arteriais da II Diretriz de Avaliação Perioperatória da Sociedade Brasileira de Cardiologia. Arq Bras Cardiol 2013;101:2-32.
25. Futier E, Lefrant JY, Guinot PG et al. Effect of Individualized vs Standard Blood Pressure Management Strategies on Postoperative Organ Dysfunction Among High-Risk Patients Undergoing Major Surgery. JAMA 2017;318(14):1346. 26. Wolfswinkel LV, Lindsay TF, Beattie WS. Association between Intraoperative Hypotension and Myocardial Injury after Vascular Surgery. Anesthesiology 2016;(1):35-44. 27. Funk DJ, HayGlass KT, Koulack J et al. A randomized controlled trial on the effects of goal-directed therapy on the inflammatory response open abdominal aortic aneurysm repair. Crit Care 2015;19(1):1-9.
20. Frank SM, Beattie CCR et al. Unintentional Hypothermia is Associated with Postoperative Myocardial Ischemia. Anesthesiology 1993;(78):468-76.
21. Frank SM, Fleisher LA, Breslow MJ et al. Perioperative maintenance of normothermia reduces the incidence of morbid cardiac events. A randomized clinical trial. JAMA 1997;277(14):1127-34.
24. Young Park W, Thompson JS, Lee KK. Effect of Epidural Anesthesia and Analgesia on Perioperative Outcome. Ann Surg 2001;234(4):560-71.
23. Norris EJ, Beattie C, Perler BA et al. Double-masked randomized trial comparing alternate combinations of intraoperative anesthesia and postoperative analgesia in abdominal aortic surgery. Anesthesiology 2001;95(5):1054-67.
17. Smith RN, Nolan JP. Central venous catheters. BMJ 2013 Nov;347(nov11 4):f6570-f6570.
10. Liu ZJ, Fu WG, Guo ZY et al. Updated systematic review and metaanalysis of randomized clinical trials comparing carotid artery stenting and carotid endarterectomy in the treatment of carotid stenosis. Ann Vasc Surg 2012;26(4):576-90.
18. Green D, Paklet L. Latest developments in peri-operative monitoring of the high-risk major surgery patient. Int J Surg 2010;8(2):90-9. 19. Sessler DI. Perioperative Thermoregulation and Heat Balance. Lancet 2016;(387):2655-64.
30. Setacci F, Sirignano P, Kamargianni V et al. Inguinal Field Block for Femoral Artery Exposure During Endovascular Aneurysm Repair. J Endovasc Ther 2013;20(5):655-62. 31. Buth J, Harris PL, Van Marrewijk C, Fransen G. The significance and management of different types of endoleaks. Semin Vasc Surg 2003;16(2):95-102. 32. Perry RJT, Martin MJ, Eckert MJ et al. Colonic ischemia complicating open vs endovascular abdominal aortic aneurysm repair. J Vasc Surg 2008;48(2):272-7. 33. Biancari F, Catania A, D’Andrea V. Elective endovascular vs. open repair for abdominal aortic aneurysm in patients aged 80 years and older: Systematic review and meta-analysis. Eur J Vasc Endovasc Surg [Internet] 2011;42(5):571-6. 34. Wong GTC, Lee EYP, Irwin MG. Contrast induced nephropathy in vascular surgery. Br J Anaesth 2016;117:ii63-ii73. 35. Sterling KA, Tehrani T, Rudnick MR. Clinical significance and preventive strategies for contrast-induced nephropathy. Curr Opin Nephrol Hypertens 2008;17(6):616-23. 36. Jentzer JC, Coons JC, Link CB, Schmidhofer M. Pharmacotherapy Update on the Use of Vasopressors and Inotropes in the Intensive Care Unit. J Cardiovasc Pharmacol Ther 2015;20(3):249-60. 37. Gelman S. The Pathophysiology of Aortic Cross-clamping and Unclamping. Anesthesiology 1995;(82):1026-60.
8. Antoniou GA, Chalmers N, Georgiadis GS et al. A meta-analysis of endovascular versus surgical reconstruction of femoropopliteal arterial disease. J Vasc Surg 2013 Jan;57(1):242-53.
22. Rigg JRA, Jamrozik K, Myles PS et al. Design of the Multicenter Australian Study of Epidural Anesthesia and Analgesia in Major Surgery: The MASTER Trial. Control Clin Trials 2000;21(3):244-56.
12. Leung JM, Voskanian A, Bellows WH, Pastor D. Automated electrocardiograph ST segment trending monitors: Accuracy in detecting myocardial ischemia. Anesth Analg 1998;87(1):4-10.
11. Warner DS, Eltzschig HK. Perioperative Organ Injury. Anesthesiology 2018;119(December 2013):1474-89.
15. Kim SH, Lilot M, Sidhu KS et al. Accuracy and Precision of Continuous Noninvasive Arterial Pressure Monitoring Compared with Invasive Arterial Pressure. Anesthesiology 2014;120(5):1080-97.
5. Duceppe E, Parlow J, Macdonald P et al. Canadian Cardiovascular Society Guidelines on Perioperative Cardiac Risk Assessment and Management for Patients Who Undergo Noncardiac Surgery. Can J Cardiol 2017;33(1):17-32.
16. Peter L, Noury N, Cerny M. A review of methods for non-invasive and continuous blood pressure monitoring: Pulse transit time method is promising? IRBM 2014 Oct;35(5):271-82.
47.
Capítulo 11 17AnestesiA em CirurgiA vA sCul Ar
39. Dieplinger B, Egger M, Luft C et al. Comparison between activated clotting time and anti-activated factor X activity for the monitoring of unfractionated heparin therapy in patients with aortic aneurysm undergoing an endovascular procedure. J Vasc Surg 2018;1-8.
53. Shemesh D, Raikhinstein Y, Orkin D et al. Anesthesia for vascular access surgery. J Vasc Access 2014;15(Suppl 7):S38-44.
49.
52. Craig RG, Hunter JM. Recent developments in the perioperative management of adult patients with chronic kidney disease. Br J Anaesth 2008;101(3):296-310.
67. Vogel TR, Dombrovskiy VY, Carson JL et al. Infectious complications after elective vascular surgical procedures. J Vasc Surg 2010;51(1):122-30. 68. Crimi E, Hill CC. Postoperative ICU management of vascular surgery patients. Anesthesiol Clin 2014;32(3):735-57. 69. Kehlet M, Jensen LP, Schroeder TV. Risk Factors for Complications after Peripheral Vascular Surgery in 3,202 Patient Procedures. Ann Vasc Surg 2016;36:13-21. 70. Bennett KM, Kent KC, Schumacher J et al. Targeting the most important complications in vascular surgery. J Vasc Surg 2017;65(3):793-803. 71. Nowygrod R, Egorova N, Greco G et al. Trends, complications, and mortality in peripheral vascular surgery. J Vasc Surg 2006;43(2):205-16. 72. Pereira KSM, de Oliveira JCP, de Carvalho FC, van Bellen B. Complicações cardíacas em cirurgia vascular. J Vasc Bras 2016;15(1):16-20.
42. Brott TG, Halperin JL, Abbara S et al. 2011 arterytheAANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVSASA/ACCF/AHA/AANN/guidelineonmanagementofpatientswithextracranialcarotidandvertebraldisease. J Am Coll Cardiol 2011;57(8):e16-94. Lewis SC, Warlow CP, Bodenham AR et al. General anaesthesia versus local anaesthesia for carotid surgery (GALA): a multicentre, randomised controlled trial. Lancet 2008;372(9656):2132-42. Vaniyapong T, Chongruksut W, Rerkasem K. Local versus general anaesthesia for carotid endarterectomy (Review ). Cochrane Syst Rev 2013;(12):12-4. Tang TY, Walsh SR, Gillard JH et al. Carotid Sinus Nerve Blockade to Reduce Blood Pressure Instability Following Carotid Endarterectomy: A Systematic Review and. Eur J Vasc Endovasc Surg 2007;311:304-11.
46. Gallego-Ligorit L, Vives M, Vallés-Torres J et al. Use of Dexmedetomidine in Cardiothoracic and Vascular Anesthesia. J Cardiothorac Vasc Anesth 2018;32(3):1426-38. Hart WMGJ. Critical limb ischemia: the burden of ilness in the UK. Br J Med Econ 1995;(8):211-21. Library PM. A randomised , blinded , trial of clopidogrel versus aspirin in patients at risk of ischaemic event. Lancet 1996;348:1329-39. Colhoun, Colhoun H. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet 2004;364(9435):685-96. Ghanami RJ, Hurie J, Andrews JS et al. Anesthesia-based evaluation of outcomes of lower-extremity vascular bypass procedures. Ann Vasc Surg 2013;27(2):199-207.
51. Walsh M, Kurz A, Turan A et al. Relationship between Intraoperative Mean. Anesthesiology 2013;119(3):507-15.
54. Aitken E, Jackson A, Kearns R et al. Articles E ff ect of regional versus local anaesthesia on outcome after arteriovenous fi stula creation: a randomised controlled trial. Lancet 2016;6736(16):1-8.
38. Chee YE, Liu SE, Irwin MG. Management of bleeding in vascular surgery. Br J Anaesth 2016;117(July):ii85-ii94.
48.
45.
58. Wu L, Zhao H, Wang T et al. Cellular signaling pathways and molecular mechanisms involving inhalational anesthetics-induced organoprotection. J Anesth 2014;28(5):740-58.
62. Jivraj N, Liew F, Marber M. Ischaemic postconditioning: Cardiac protection after the event. Anaesthesia. 2015;70(5):598-612.
40. Mozaffarian D, Benjamin EJ, Go AS et al. Heart disease and stroke statistics-2016 update a report from the American Heart Association. Vol. 133. Circulation 2016:38-48.
41. Howell GMS, Makaroun MS, Chaer RA. Current Management of Extracranial Carotid Occlusive Disease. J Am Coll Surg 2009;208(3):442-53.
50.
59. Twine CP, Ferguson S, Boyle JR. Benefits of remote ischaemic preconditioning in vascular surgery. Eur J Vasc Endovasc Surg 2014;48(2):215-9. 60. Walsh SR, Nouraei SA, Tang TY et al. Remote ischemic preconditioning for cerebral and cardiac protection during carotid endarterectomy: Results from a pilot randomized clinical trial. Vasc Endovascular Surg 2010;44(6):434-9. 61. Zhao Z-Q, Corvera JS, Halkos ME et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol – Hear Circ Physiol 2003;285(2):H579-88.
44.
55. Bradley T, Frca MBC, Teare T et al. Anaesthetic management of patients requiring vascular access surgery for renal dialysis. BJA Educ 2017;17(8):269-74.
63. Ma D, Lim T, Xu J et al. Xenon Preconditioning Protects against Renal Ischemic-Reperfusion Injury via HIF-1 Activation. J Am Soc Nephrol 2009;20(4):713-20. 64. Kim M, Park SW, Kim M et al. Isoflurane post-conditioning protects against intestinal ischemia-reperfusion injury and multiorgan dysfunction via transforming growth factor-β1 generation. Ann Surg 2012;255(3):492-503. 65. Gu J, Sun P, Zhao H et al. Dexmedetomidine provides renoprotection against ischemia-reperfusion injury in mice. Crit Care 2011;15(3). 66. Wang ZX, Huang CY, Hua YP et al. Dexmedetomidine reduces intestinal and hepatic injury after hepatectomy with inflow occlusion under general anaesthesia: A randomized controlled trial. Br J Anaesth 2014;112(6):1055-64.
43.
56. Pac-Soo CK, Mathew H, Ma D. Ischaemic conditioning strategies reduce ischaemia/reperfusion-induced organ injury. Br J Anaesth 2015;114(2):204-16.
57. Schaper J, Schaper W. Reperfusion of ischemic myocardium: Ultrastructural and histochemical aspects. J Am Coll Cardiol 1983;1(4):1037-46.
20. Rodseth RN, Biccard BM, Le Manach Y et al. The prognostic value of pre-operative and post-operative B-type natriuretic peptides in patients undergoing noncardiac surgery: B-type natriuretic peptide and N- terminal fragmente of pro-B-type natriuretic peptide: a systematic review and individual patient data meta-analysis. J Am Coll Cardiol 2014;63:170-80. 21. Schonberger RB, Fontes ML, Selzer A. Anesthesia for patients with hypertension. All topics are updated as new evidence becomes available and our peer review process is complete. Literature review corrente through: oct 2018. | This topic last update: Sep 20, 2018.
13. Wallace AW et al. Association of the Pattern of Use of Perioperative b-Blockade and Postoperative Mortality. Anesthesiology 2010;113:794-805
10. Eagle KA, Berger PB, Calkins H et al. American College of Cardiology American Heart Association Task Force on practice guidelines. ACC AHA guideline update for perioperative cardiovascular evaluation for an perioperative cardiovascular evaluation for an cardiac surgery-executive summary a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. Circulation 2002;105;157-67.
2. Pulliam A, Warrick A, Diachun CAB. (2016). Open Abdominal Aortic Surgery. Int Anesthesiol Clin 54(2):102-120
6. Fleisher LA, Fleischmann KE, Uretsky BF, Wijeysundera DN et al 2014 ACC AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Pacients Undergoing Noncardiac Surgery. J Am Coll Cardiol 2014;64(22):77-137.
14. Devereaux PJ, Yang H, Yusuf S, Guyatt G, Leslie K, Villar JC et al. POISE Study Group. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet 2008;371:1839-1847.
11. Fleisher LA, Beckman JA, Brown KA et al. ACC/AHA 2000 guideline update on perioperative cardiovascular evaluation for noncardiac surgery: focused update on perioperative beta-Blocker therapyA report of the American college of Cardiology/American Heart Association Task Force on practice. Anest Analg 2007;104:15-26.
8. De Hert S, Staender S, Fritsch G et al. Pre-operative evalution of adults undergoing elective noncardiac surgery: Update guideline from the European Society of Anaesthesiology. Eur J Anaesthesiol 2018;35:407-465.
1. Golden MA, Donaldson MC, Whittemore AD et al. Evolving, experience with thoracoabdominal aortic aneurysm repair at a single institution. J Vasc Surg 1991;13:792
4. Mariño JCS, Martins ACP, Sobrinho ACSC. Aneurisma da Aorta Toracoabdominal Diagnóstico e Tratamento. In: Maffei FHA et al Doenças vasculares periféricas. 5. ed. Rio de Janeiro; Guanabara Koogan; 2016. p. 1436-63.
15. Hajibandeh S, Antoniou AS, Torella F, Antoniou G. Effect of betablockers on perioperative outcomes in vascular and endovascular surgery: a systematic review and meta-analysis. Br J Anaesth 2017 Jan 1;118(1):11-21
22. Bor-Seng-Shu E, Kita WS, Figueiredo EG, Paiva WS, Fonoff ET, Teixeira MJ, Panerai RB. Cerebral hemodynamics: concepts of clinical importance. Arq Bras Neuro-Psiquatr 2012;70(5). 23. Jordan JD, Powers WJ. Cerebral autoregulation and acute ischemic stroke. Am J Hypertens 2012 Sep;25(9):946-50.
18 12Capítulo ANESTESIA EM CIRURGIA DA AORTA REFERÊNCIAS BIBLIOGRÁFICAS
16. Iwanaga Y, Nishi I, Furuichi S et al. B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: comparison between systolic and diastolic heart failure. J Am Coll Cardiol 2006 Feb 21;47(4):742-8.
27. Fayad A, Ansari MT, Yang H, Ruddy T, Wells GA. Perioperative Diastolic Dysfunction in Patients Undergoing Noncardiac Surgery Is an Independent Risk Factor for Cardiovascular Events: A Systematic Review and Meta-analysis. Anesthesiology 2016;125:72-91. 28. Hammill BG, Curtis LH, Bennett-Guerrero E, O’Connor CM, Jollis LG, Schulman KA, Hernandez AF. Impact of Heart Failure on Patients Undergoing Major Noncardiac Surgery. Anesthesiology 2008;108:559-67. 29. Turan A, Mascha EJ, Roberman MD, Turner PL. Smoking and Perioperative Outcomes Anesthesiology 2011;114:837-46. 30. Smetana GW. Preoperative pulmonar evaluation: Identifying and reducing risks for pulmonary complications. Cleve Clin J Med 2006;73:S36-S41. 31. Fischer SP, Bader AM, Sweitzer B. Preoperative Evaluation. In: Miller RD, editor. Miller´s anesthesia. 7th ed. New York, NY: Churchill Living-sotone; 2010. p. 1001-66. 32. Degani-Costa LH, Faresin SM, Falcão LFR. Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brasilb Massachusetts General Hospital, Harvard Medical School, Massachusetts, EUA Recebido em 14 de setembro de 2012; aceito em 19 de novembro de 2012. Avaliação pré-operatória do paciente pneumopata. Braz J Anesth (English Edition) 2014 Jan-Feb;64(1):22-34.
5. Wolters U, Wolf T, Stuutzer H, Schruoder T. ASA classification and perioperative variables as predictors of postoperative outcome. Br J Anesth 1996;77:217-222.
3. Carvalho F, Brito V, Tribulatto E et al. Estudo Prospectivo da Morbimortalidade Precoce e Tardia da Cirurgia do Aneurisma de Aorta Abdominal. Arq Bras Cardiol Abril 2005;84(04).
17. Wang TJ, Larson MG, Levy D et al. Plasma natruretic peptide levels and the risk of cardiovascular events and death. N Englang J Med 2004 Feb 12;350(7)655-63.
7. Fleisher LA, Fleischmann KE, Auerbach AD et al. 2014 ACC/ AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014;130(24):2215-45.
9. Stout KK, Daniels CJ, Aboulhosn JA, Bozkurt B, Broberg CS, Colman JM, Van Hare GF. 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease. xecutive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 2019;73(12):1494-1563.
18. Karthikeyan G, Moncur RA, Levine O et al. Is a pre-operative brain natriuretic peptide or N-terminal pro B-type natriuretic peptide measurement na independente predictor of adverse cardiovascular outcomes within 30 days of noncardiac surgery? A systematic review and meta-analysis of observational studies. J Am Coll Cardiol 2009;54:1599-606. 19. Lurate Buse GA, Koller MT, Burkhart C et al. The predictive value of preoperative natriuretic peptide concentrations in adults undergoing surgery: a systematic review and meta-analysis. Anesth Analg 2011;112:1019-33.
24. Norris EJ. In: Miller RD, editor. Miller´s anesthesia. Anesthesia for Vascular Surgery. 8th ed. Philadelphia: Elsevier Saunders; 2015. p. 2106-2157. 25. Carvalho ATY, Santos VP, Filho AR, Karakhaian W et. al. Fatores de morbimortalidade na cirurgia eletiva do aneurisma da aorta abdominal infra-renal: experiência de 134 casos. J Vasc Bras 2008;7(3):214-224. 26. Varon J, Marik PE. Perioperative hypertension management. Vasc Health Risk Manag 2008 Jun;4(3):615-627.
12. Spertus JA, Eagle KA, Krumholz HM et al. American College of Cardiology and American Heart Association methodology for the selection and cration of performance measures for quantifying the quality of cardiovascular care. J Am Coll Cardiol 2005;45:1147-1156.
71. Lumb AB, Slinger P. Hypoxic Pulmonary Vasoconstriction Physiology and Anesthetic Implications. Anesthesiology 2015;122:932-46. 72. Bryan T, Diepen S, Bhutani M et al. The effects of dobutamine and dopamine on intrapulmonary shunt and gas exchange in healthy humans. J Appl Physiol Aug 2012;113(4):541-548.
59. Amorim F, Pinheiro B, Romaldini H. Metabolic and Hemodynamic Effects of Saline Infusion to Maintain Volemia on Temporary Abdominal Aortic Occlusion. Arq Bras Cardiol 2002 Oct;79(4).
65. Grandini, PC. Estudo multicêntrico de avaliação perioperatória para operações não-cardiacas. São Paulo. Tese (Doutorado) – Faculdade de Medicina, Universidade de São Paulo; 2002.
44.
57. Fiorentino M, Castelano G, Kellum J.Differences in acute kidney injury ascertainment for clinical and preclinical studies. Nephrol Dial Transplant 2017;32(11):1789-1805.
36.
38.
53. Subramaniam K, Caldwell JC. Anesthesia for Descending Aortic Surgery. Anesth Periop Care Aortic Surg 2011;211-237.
61. Bapoje SR, Whitaker JF, Schulz T, Chu ES, Albert RK. Preoperative evaluation of the patient with pulmonary disease. Chest 2007 Nov;132(5):1637-1645.
33.
47.
63. Lohser J, Slinger P. Lung Injury After One-Lung Ventilation: A Review of the Pathophysiologic Mechanisms Affecting the Ventilated and the Collapsed Lung. Anesth Analg 2015 Aug;121(2):302-318.
37.
48.
43.
56. Levin A. The cardiovascular effects of aortic clamping and unclamping. South African J Anaesth Analg 2010;16(2):62-71.
Capítulo 12 19AnestesiA em CirurgiA AortA Smetana GW, Lawrence VA, Cornell JE. Preoperative Pulmonary Risk Stratification for Noncardiothoracic Surgery: Systematic Review for the American College of Physicians. Ann Intern Med 2006;144:581-595. Vinik AI, Ziegler D. Diabetic Cardiovascular Autonomic Neuropathy. Circulation 2007 Jan 23;115(3):387-397. 35. Pop-Busui R. Cardiac Autonomic Neuropathy in Diabetes. A clinical perspective. Diabetes Care 2010 Feb;33(2):434-41. Srilata Moningi, Sapna Nikhar, and Gopinath Ramachandran. Autonomic disturbances in diabetes: Assessment and anaesthetic implications. Ind J Anaesth 2018 Aug;62(8):575-583 Ahmed AH, Shankar K, Eftekhari H, Munir M, Robertson J, Brewer A, Stupin IV, Casscells SW. Silent myocardial ischemia: Current perspectives and future directions. Exp Clin Cardiol 2007;12(4):189-196. Pontes JPJ, Mendes FF, Vasconcelos MM, Batista NR. Evaluation and perioperative management of patients with diabetes mellitus. A challenge for the anesthesiologist. Rev Bras Anestesiol 2018;68(1):75-86. 39. Weiskopf RB, Gu W, Pagel PS, Warltier DC, Kersten JR. Modifying Cardiovascular Risk in Diabetes Mellitus. Anesthesiology 2003;98;3:774-9. Vaughn SB, LeMaire SA, Collard CD. Case Scenario: Anesthetic Considerations for Thoracoabdominal Aortic Aneurysm Repair. Anesthesiology 2011;115:1093-1102. Funk DJ, HayGlass KT, Koulack J, Harding G, Boyd A, Brinkman R. A randomized controlled trial on the effects of goal-directed therapy on the inflammatory response open abdominal aortic aneurysm repair. Crit Care 2015;19:247 42. Makkad B, Pilling S. Management of thoracic aneurysm. Semin Cardiothorac Vascular Anesth 2005;9(3):227-240. Mehran R, E. Nikolsky. Contrast-induced nephropathy: Definition, epidemiology, and patients at risk. Kidney Int Suppl 2006;(100):S11-S15. Gelman S. The pathophysiology of aortic cross-clamping and unclamping. Anesthesiology 1995;82:1026-60. 45. Cuzick LM, Lopez AR, Cooper JR. Pathophysiology of Aortic Crossclamping In: Chiesa R, Melissano G, Zangrillo A. (eds). ThoracoAbdominal Aorta. Springer, Milano. Ellard L, Djaiani G. Anaesthesia for vascular emergencies. Anaesthesia 2013;68(Suppl. 1):72-83. Al-Hashimi M, Thompson J. Anaesthesia for elective open abdominal aortic aneurysm repair. Anaesth Crit Care Pain 2013 Dec 1;3(6):208-212. Rahimi AS Rowe VL. Abdominal Aortic Aneurysm Guidelines Updated: Nov 05; 2018 49. Moerman A, Bové T, François K, Jacobs S, Deblaere I, Wouters P, Hert SD. The Effect of Blood Pressure Regulation During Aortic Coarctation Repair on Brain, Kidney, and Muscle Oxygen Saturation Measured by Near-Infrared Spectroscopy: A Randomized, Clinical Trial. Anesth Analg 2013 Apr;116:760-6. Oliver WC, Nuttall GA, Cherry KJ et al. A Comparison of Fenoldopam with Dopamine and Sodium Nitroprusside in Patients Undergoing Cross-Clamping of the Abdominal Aorta. Anesth Analg 2006;103(4). Cernaianu AC, Olah A, Cilley JH, Gaprindashvili T, Gallucci JG, DelRossi AJ. Effect of sodium nitroprusside on paraplegia during cross-clamping of the thoracic aorta. Ann Thorac Surg 1993 Nov;56:1035-7.
64. Uemura S, Sugiyama K, Inoue Y et al. Difficulty in left-sided double –lumen tube placement in patients undergoing surgical graft replacement of the descending aorta is predicted from tracheobronchial compression. Masui 2012 Feb;61(2):138-42.
58. Soskic L, Davidovic L, Milicic B et al. Effect of hypertonichyperoncotic solution infusion on tissue perfusion during surgical treatment of the abdominal aorta. Vojnsanet Pregl 2007 oct;64(10):685-9.
60. Pasin L, Nardelli P, Belletti A, Greco M, Landoni G, Cabrini L, Chiesa R, Zangrillo A. Pulmonary Complications after Open Abdominal Aortic Surgery: A Systematic Review and Meta-Analysis. J Cardiothorac Vasc Anesth 2017 Apr;21(2):562-568.
55. Zammert M, Gelman S. (2016). The pathophysiology of aortic crossclamping. Best Pract Res Clin Anaesthesiol 2016;30(3):257-269.
67. Campos J. Lung isolation in patients with difficult airways. In: Slinger P, editor. Priciples and Pratice of Anesthesia for Thoracic Surgery. Nova York: Springer-Verlag; 2011. p. 247-58.
73. Malbouisson LM, Oliveira RA. Ventilação mecânica protetora intraoperatória: o que há de novo? Rev Bras Ter Intensiva 2017;29(4):404-407. 74. Zarbock A, Koyner JL, Hoste EAJ, Kellum JA. Update on Perioperative Acute Kidney Injury. Anesth Analg. 2018 Nov;127(5):1236-1245. 75. Huynh TTT, Statius RG, Miller CC, Villa MA, Estrera AL, Azizzadeh A, Porat EE, Goodrick JS, Safi, HJ. Glomerular filtration rate is superior to serum creatinine for prediction of mortality after thoracoabdominal aortic surgery. J Vasc Surg 2005;42;2:206-212. 76. Meersch M, Schmidt C, Zarbock A. Perioperative Acute Kidney Injury: An Under-Recognized Problem. Anesth Analg 2017 Oct;125(4):1223-1232. 77. Berlauk JF, Abrams JH, Gilmour IJ et al. Preoperative optimization of cardiovascular hemodynamics improves outcome in peripheral vascular surgery. A prospective, randomized clinical trail. Ann Surg 1991;214:289-299. 78. Shin SR, Kim WH, Kim DJ et al. Prediction and Prevention of Acute Kidney Injury after Cardiac Surgery. Biomed Res Int 2016;2016:2985148. 79. Sear JW. Kidney dysfunction in the postoperative period. Br J Anaesth 2005;95(1):20-32. 80. Brienza N, Giglio MT, Marucci M. (2010). Preventing acute kidney injury after noncardiac surgery. Curr Opin Crit Care 2010;16(4):353-358. 81. Kellum JA, Decker JM. Use of dopamine in acute renal failure: a meta-analysis. Crit Care Med 2001;29:1526-1531. 82. Woo EB, Tang AT, el-Gamel A et al. Dopamine therapy for patients at risk of renal dysfunction following cardiac surgery: science or fiction? Eur J Cardiothorac Surg 2002;22:106-111. 83. Hiratzka LF, Bakris GL, Beckman JA, et al. CCF/AHA/AATS/ACR/ ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with thoracic aortic disease: Executive
41.
46.
52. Bernard EO, Schmid ER, Lachat ML, Germann RC. Nitroglycerin to control blood pressure during endovascular stentgrafting of descending thoracic aortic aneurysms. J Vasc Surg 200;31(4):790-793.
54. Praveen Kumar Neema, Arun Vijayakumar, S Manikandan, Ramesh Chandra Rathod. Infrarenal abdominal aortic aneurysm repair in presence of coronary artery disease: Optimization of myocardial stress by controlled phlebotomy. Ann Cardiac Anaesth 2009;12:133-135.
40.
50.
34.
62. Compton CN, Dillavou ED, Sheehan MK, Rhee RY, Makaroun MS. Is abdominal aortic aneurysm repair appropriate in oxygen-dependent chronic obstructive pulmonary disease patients? J Vasc Surg 2005 Oct;42(4):650-653.
68. Subramaniam k, Park K, Subramaniam B et al Anesthesia and Perioperative Care for Aortic Surgery. Nova York: Springer-Verlag; 2011. p. 216-217. 69. Kumar A, Dutta V, Negi S et al. Vascular airway compreaaion management in a case of aortic arch and descending thoracic aortic aneurysm. Ann Car Anaesth 2016 Jul-Sep;19(3):568-571.
51.
70. Bitker L, Richard JC. Intensive alveolar recruitment strategy in the post-cardiac surgery setting: one PEEP level may not fit all. J Thorac Dis 2017 Aug; 9(8):2288-2292.
dA
66. Barr J, Sepehripour A, Jarral O et al. A review of the surgical management of right-sided aortic arch aneurysms. Int Cardio Vasc Thorac Surg July 2016;23:156-162.
109. Boezeman RP, van Dongen EP, Morshuis WJ et al. Spinal near-infrared spectroscopy measurements during and after thoracoabdominal aortic aneurysm repair: a pilot study. Ann Thorac Surg 2015;99:1267-1274.
108. Bergeron EJ, Mosca MS, Aftab M, Justison G, Reece TB. Neuroprotection Strategies in aortic Surgery. Cardiol Clin 2017 Aug;35(3):453-465.
122. Vincent JL, Rhodes A, Perel A et al. Clinical review: Update on hemodynamic monitoring - a consensus of 16. Crit Care 2011;15:229.
125. Vincent JL, Pelosi P, Pearse R, Payen D, Perel A, Hoeft A et al Perioperative cardiovascular monitoring of high-risk patients: a consensus of 12. Crit Care 2015;19:224.
103. Safi HJ, Miller CC, Carr C, Iliopoulos DC, Dorsay DA, Baldwin JC. Importance of intercostal artery reattachment during thoracoabdominal aortic aneurysm repair. J Vasc Surg 1998;27(1):58-68. 104. Griepp EB, Griepp RB. The collateral network concept: minimizing paraplegia secondary to thoracoabdominal aortic aneurysm resection. Tex Heart Inst J 2010;37:672-674.
121. Ultee KHJ, Zettervall SL, Soden PA, Darling J, Bertges DJ, Verhagen HJM, Schermerhorn ML. Incidence of and risk factors for bowel ischemia after abdominal aortic aneurysm repair. J Vasc Surg 2016;64(5):1384-1391.
106. Jacobs MJ, Mess W, Mochtar B, Nijenhuis RJ, Statius RG, Schurink GWH. The value of motor evoked potentials in reducing paraplegia during thoracoabdominal aneurysm repair. J Vasc Surg 2006;43(2):239-246.
99. Epstein NE. Cerebrospinal fluid drains reduce risk of spinal cord injury for thoracic/thoracoabdominal aneurysm surgery: A review. Surg Neurol Int 2018;9:48. 100. Griepp RB, Griepp EB. Spinal cord perfusion and protection during descending thoracic and thoracoabdominal aortic surgery: the collateral network concept. Ann Thorac Surg 2007;83(2):S865-9 (discussion S90–2). Safi HJ, Miller CC, Subramaniam MH et al. Thoracic aortic thoracoabdominal aortic aneurysm repair using cardiopulmonary bypass, profund hyporthemia, and circulatory arrest via left side of the chest incision. J Vasc Surg 1998;28:591-598. 102. Clifton GL, Miller ER, Choi SC et al. Lack of effect of induction of hypothermia after acute brain injury. N Engl J Med 2001;44:556-563
101.
118. Kunihara T, Kubota S, Wakasa S, Shiiya N, Matsui Y. (2011). Prevention of Spinal Cord Injury After Thoracoabdominal Aortic Aneurysm Repair, Diagnosis and Treatment of Abdominaland Thoracic Aortic Aneurysms Including the Ascending Aorta and the Aortic Arch, Prof. Reinhart Grundmann (Ed.), ISBN: 978-953307-524-2, InTech, Available from: aneurysm-repairprevention-of-spinal-cord-injury-after-thoracoabdominal-aortic-aneurysms-including-the-ascending-aorta-and-the-aorticarch/books/diagnosis-andtreatment-of-abdominal-and-thoracic-aortic-http://www.intechopen.com/
119. Acher C. It is not just assisted circulation, hypothermic arrest, or clamp and sew. J Thorac Cardiovasc Surg 2010;140(6):S136-41.
123. Dietz NM, Joyner MJ, Warner MA. Blood Substitutes: Fluids, Drugs, or Miracle Solutions? Anesth Analg 1996;82:390-405.
105. Afifi RO, Sandhu HK, Zaidi ST, Trinh E, Tanaka A, Miller CC et al. Intercostal artery management in thoracoabdominal aortic surgery: To reattach or not to reattach? J Thorac Cardiovasc Surg 2018;155(4):1372-1378.
Parte I20 CAPÍTULOS BÁSICOS summary. A report of the American College of Cardiology Foundation, American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society for Vascular Medicine. J Am Coll Cardiol 2010; 55:1509. 84. Curling PE et al. Renal perfusion during thoracoabdominal aortic operations: Cold crystalloid is superior to normothermic blood. Ann Thorac Surg 2002;73:730-738. 85. Lemaire SA, Jones MM, Conklin LD et al. Randomized comparison of cold blood and cold crystalloid renal perfusion for renal protection during thoracoabdominal aortic aneurysm repair. J Vasc Surg 2009;49:11. 86. Svensson LG, Crawford ES, Hess KR, Coselli JS, Safi HJ. Experience with 1509 patients undergoing thoracoabdominal aortic operations. J Vasc Surg 1993;17:357-70 87. Conrad MF, Crawford RS, Davison JK, Cambria RP. Thoracoabdominal aneurysm repair: a 20-year perspective. Ann Thorac Surg 2007;83:S856-61. 88. Juvonen T, Biancari F, Rimpiläinen J, Satta J, Rainio P, Kiviluoma K. Strategies for Spinal Cord Protection during Descending Thoracic and Thoracoabdominal Aortic Surgery: Up-to-date Experimental and Clinical Results – A review. Scand Cardiovasc J 2002;36(3):136-160. 89. Tanaka A, Safi HJ, Estrera AL. Current strategies of spinal cord protection during thoracoabdominal aortic surgery. Gen Thorac Cardiovasc Surg 2018 Jun;66(6):307-314. 90. Okita Y. Fighting spinal cord complication during surgery for thoracoabdominal aortic disease. Gen Thorac Cardiovasc Surg 2011 Feb;59(2):79-90. 91. Riambau V, Bockler D, Brunkwall J et al. Management of descending thoracic aorta diseases: clinical practice guidelines of the European Society for Vascular Surgery (ESVS). Eur J Vasc Surg 2017;53:4-52. 92. Arora L, Hosn MA. Spinal cord perfusion protection for thoracoabdominal aortic aneurysm surgery. Curr Opin Anaesthesiol 2019;32:72-79. 93. Godet G, Bertrand M, Fléron MH et al. Cerebrospinal fluid drainage and thoracic endovascular aneurysm repair. Asian Cardiovasc Thorac Ann 2017 Nov;25(9):608-617. 94. Fedorow CA, Moon MC, Mutch, W A et al. Lumbar Cerebrospinal Fluid Drainage for Thoracoabdominal Aortic Surgery: Ratinale and Practical Considerations for Management. Anesth Analg 2010;111(1):46-58. 95. Weiss SJ, Hogan MS, MCGarvey ML, Carpenter JP, Cehung, AT. Successful treatment of delayed onset paraplegia after suprarenal abdominal aortic aneurysm repair. Anesthesiology 2002;97;2:504506. 96. Dardik A, Perler BA, Roseborough GS et al. Subdural hematoma after thoracoabdominal aortic aneurysm repair: An underreported complication of spinal fluid drainage? J Vasc Surg 2002;35:631-639. 97. Settepani F, Van Dongen EP, Schepens MA et al. Intracerebellar hematoma following thoracoabdominal aortic repair: An unreported complication of cerebrospinal fluid drainage. Eur J Cardiothorac Surg 2003;24:659-61. 98. Cheung AT, Pochettino A, Guvakov DV et al. The Safety of lumbar drains in thoracic aortic operations performed with extracorporeal circulation. Ann Thorac Surg 2003;76:1190-1197.
110. Et CD, von Aspern K, Gudehus S, Luehr M, Girrbach FF, Ender J, Mohr FW. Near-infrared Spectroscopy Monitoring of the Collateral Network Prior to, During, and After Thoracoabdominal Aortic Repair: A Pilot Study. Eur J Vasc Endovasc Surg 2013;46(6):651-656. 111. Dorotta I, Kimball-Jones P, Applegate R 2nd. Deep hypothermia and circulatory arrest in adults. Semin Cardiothorac Vasc Anesth 2007 Mar;11(1):66-76. 112. Laschinger JC, Cunningham JN Jr, Cooper MM et al. Prevention of ischemic spinal cord injury following aortic cross-clamping: use of corticosteroids. Ann Thorac Surg 1984; 38:500-507. 113. Kirshner DL, Kirshner RL, Heggeness LM et al. Spinal cord ischemia: an evaluation of pharmacologic agents in minimizing paraplegia after aortic occlusion. J Vasc Surg 1989; 9:305-308. 114. Svyatets M, Tolani K, Zhang M et al. Perioperative management of deep hypothermic circulatory arrest. J Cardiothorac Vasc Anesth 2010;24(4):644-55. 115. Kunihara T, Matsuzaki K, Shiiya N et al. Naloxone lowers cerebrospinal fluid levels of excitatory amino acids after thoracoabdominal aortic surgery. J Vasc Surg 2004;40:681-690. 116. Lima B, Nowicki ER, Blackstone EH et al. Spinal cord protective strategies during descending and thoracoabdominal aortic aneurysm repair in the modern era: the role of intrathecal papaverine. J Thorac Cardiovasc Surg 2012;143:945-952. 117. Etz CD, Weigang E, Hartert M et al. Contemporary spinal cord protection during thoracic and thoracoabdominal aortic surgery and endovascular aortic repair: a position paper of the vascular domain of the European Association for Cardio-Thoracic Surgery. Eur J Cardiothorac Surg 2015;47:943-957.
107. Tanaka Y, Kawaguchi M, Noguchi Y, Yoshitani K, Kawamata M, Masui K, Yamada Y. Systematic review of motor evoked potentials monitoring during thoracic and thoracoabdominal aortic aneurysm open repair surgery: a diagnostic meta-analysis. J Anesth 2016:30(6):1037-1050.
124. Gregory FH, Ottoboni AL. Aspectos atuais da reposição volêmica. Atualização em Anestesiologia 1999;(IV):99-110.
120. Cambria RP, Davison JK, Carter C et al. Epidural cooling for spinal cord protection during thoracoabdominal aneurysm repair: A fiveyear experience. J Vasc Surg 2000;31: 1093-1102.
130.
152. Monk TG, Weldon BC, Garvan CW et al. Predictors of cognitive dysfunction after major noncardiac surgery. Anesthesiology 2008;108(1):18-30.
154. Bueno MAS, Pieri A, Sampaio RO, Santos OFP, Vaidotas M. Condutas em emergências. São Paulo: Atheneu; 2009. p. 575-82.
dA AortA 126.
147. Zangrillo A, Mizzi A, Biondi-Zoccai G et al. Recombinant activated factor VII in cardiac surgery: A meta-analysis, J Cardiothorac Vasc Anesth 2009;23:34.
149. Madrid E, Urrútia G, Roqué I, Figuls M et al. Active body surface warming systems for preventing complications caused by inadvertent perioperative hypothermia in adults. Cochrane Database Syst Rev 2016;4:CD0090016.
153. Böhner H, Hummel T, Habel U, Miller C, Reinbott S, Yang Q et al. Predicting Delirium After Vascular Surgery - A Model Based on Preand Intraoperative Data. Ann Surg 2003;238:149-156.
136. Spahn DR, Leone BJ, Reves JG et al. Cardiovascular and coronary physiology of acute isovolemic hemodilution: A review of nonoxygen-carrying and oxygen-carrying solutions. Anesth Analg1994;78:1000-21.
151. Dunkan D, Sankar A, Beattie WS, Wijeysundera DN. Alha-2 adrenergic agonists for the prevention of cardiac complications among adults undergoing surgery. Cochrane Databese Syst Rev 20118;3:CD004126.
143. Ker K, Edwards P, Perel P, Shakur H, Roberts I. Effect of tranexamic acid on surgical bleeding: systematic review and cumulative metaanalysis. BMJ 2012;344:e3054. 144. Vorweg M, Hartmann B, Knuttgen D, Jahn MC, Doehn M. Management of fulminante fibrinolysis during abdominal aortic surgery. J Cardiothorac Vasc Anesth 2001;5(6):764-7.
139.
142. Tanaka KA, Bollinger D, Vadlamudi R et al. Rotation tromboelastometry (ROTEM)-based coagulation management in cardiac surgery and major trauma. J Cardiothorac Vasc Anesth 2012;26:1083-1093.
Capítulo 12 21AnestesiA em CirurgiA Vicent JL. Annual Update in Intensive Care and Emergency Medicine. Springer; 2012. 127. Siegenthaler N, Giraud R, Piriou V et al. Microcirculatory alterations in critically ill patients: pathophysiology, monitoring and treatments. Ann Fr Anesth Reanim. 2010;9:135-144. 128. Nouria S, Elatrous S, Dimassi S et al . Effects of norepinephrine on static and dynamic preload indicators in experimental hemorrhagic shock. Crit Care Med 2005;33:2339-2343. Boussat S, Jacques T, Levy B et al. Intravascular volume monitoring and extravascular lung water in septic patients with pulmonary edema. Int Care Med 2002;8:712-718. Innerhofer P, Fries D, Margreiter J et al . The effects of perioperatively administered colloids and crystalloids on primary platelet-mediated hemostasis and clot formation. Anesth Analg 2002;95;858-865 131. Minto G, Scott MJ, Miller TE. Monitoring Needs and Goal-directed Fluid Therapy Within an Enhanced Recovery Program. Anesthesiol Clin 2015;33(1):35-49.
129.
137. Samoila G, Ford RT, Glasbey JC et al. The Significance of Hypothermia in Abdominal Aortic Aneurysm Repair. Ann Vasc Surg 2017;38:323. Ashworyh A, Klein A. Cell salvage as part of a blood conservation strategy in anaesthesia: Br J Anaesteth 2010;105(4):401-416. Shantikumar S, Patel S, Handa A. The role of Cell Salvage Autotransfusion in Abdominal Aortic Aneurysm Surgery. Eur J Vasc Endovasc Surg 2011 Nov;42(5):577-584. 140. American Society of Anesthesiology Task Force on Blood Component Therapy. Practice Guidelines for Blood Component Therapy. Anesthesiology 1996;84:732-747
132. Hoste EA, Maitland K, Brudney CS, Mehta R, Vincent JL, Yates D et al Four phases of intravenous fluid therapy: a conceptual model. Br J Anaesth 2014;113. 133. Myles PS, Bellomo R, Corcoran T, Forbes A, Peyton P, Story D, Christophi C, Leslie K, S. McGuinness, R. Parke, J. Serpell, M.T.V. Chan, T. Painter, S. McCluskey, G. Minto et al. Restritictive versus Liberal Fluid Therapy for major Abdominal Surgery. N Eng J Med 2018;378(24):2263-2274.
146. Tritapepe L, De Santis V, Vitale D et al. Recombinant activated Factor VII for refractory bleeding after acute aortic dissection surgery: A propensity score analysis. Crit Care Med 2007;35:1685.
134. American Society of Anesthesiologists Task Force on Perioperative Blood Management. Pactice guidelines for perioperative blood management: na updatereport by the American Society of Anesthesioologists Task Force on Perioperative Blood Mangement. Anesthesiology 2015;122:241. 135. Carson JL, Grossman BJ, Kleinman S et al. Red Blood cell tranfusion: a clinical practice guideline from de AABB. Ann Intern Med 2012;157:49.
148. De Roberts E, Kozek-Langenecker AS, Tufano R, Romano GM et al Coagulopathy induced by acidosis, hypothermia and hypocalcaemia in severe bleeding. Minerva Anestesiol 2015 Jan;81(1):65-75.
155. Roizen MF, Beaupre PN, Alpert RA, Kremer P, Cahalan MK, Shiller N, Sohn YJ, Cronnelly R, Lurz FW, Enrenfeld WK, Stoney RJ. Monitoring with two-dimensional transesophageal echocardiography: Comparison of myocardial function in patients undergoing supraceliac, suprarenal-infraceliac, or infrarenal aortic occlusion. J Vasc Surg 1984;1:300-305.
138.
141. Gidauskas E, Kempfer J, Kuntze T, Borger MA et al. Thromboelastometrically guided transfusion during aortic surgery with circulatory arrest: A prospective randomized trial. J Thorac Cardiovasc Surg 2010;140(5):117-1124.
158. Tanaka K, Ludwig LM, Kersten JR, Pagel PS, Warltier DC. Mechanisms of Cardioprotection by Volatile Anesthetics. Anesthesiology 2004;100:707-21. 159. Lindholm EE, Aune E, Noren CB et al. The anestesia in abdominal aortic surgery (ABSENT) study: a prospective, randomized, controlled trial comparin troponin T release with fentanylsevoflurane and propofol-remifentanyl anestesia in major cascular surgery. Anesthesiology 2013;119:802.
160. Novalija E, Stowe DF. Prior preconditioning by ischemia or sevoflurane improves cardiac work per oxygen use in isolated guinea pig hearts after global ischemia. Adv Exp Med Biol 1998;454:533. 161. Müllenheim J, Ebel D, Fräbdorf J, Preckel B, Thämer V, Schlack W. Anesthesiology 2002; 96:934940. 162. Serita R, Morisaki H, Morita Y, Innami, Y, Satoh T, Kosugi S, Kotake Y, Takeda J. Br. J. Anaesth. 2002; 89:888-895. 163. Robert J. Moraca, MD, David G. Sheldon,MD, Richard C. Thrirby, MD. The Role of Epidural Anesthesia and Anagesia in Surgical Practice. Ann Surg 2003;238(5):663-673. 164. Shaikh SI, Kumari RV, Hegde G et al. Perioperative Considerations and Management of Patients Receiving Anticoagulants. Anesth Essays Res 2017;11(1):10-16. 165. EB, Joshi GP, Nationwide incidence of serious complications of epidural analgesia in the United States. Acta Anaesthesiol Scand 2016;60:810. 166. Jacobs MJ. Brain and spinal cord protection during aortic surgery. Tex Heart Inst J 2010; 37(6):667-8.
150. Lindenauer PK, Pekow P, Wang K, Mamidi KD et al. Perioperative beta blocker therapy and mortality after major noncardiac surgery. N Eng J Med 2005;353(4):349-361.
145. Makhija N, Sarupria A, Choudhary SK et al. Comparison of epsilon aminocaproic acid and tranexamic acid in thoracic aortic surgery: clinical efficacy and safety. J Cardiothorac Vasc Anesth 2013;26(6):1201-1207.
156. Lindholm EE. Perioperative aspects of abdominal aortic surgery; focus on choice of anesthetics. Acta Anaesthesiol Scand 2016;60:411. 157. Kahn RA, Stone ME, Moskowitz DM. Anesthetic Consideration for Descending Thoracic Aortic Aneurysm Repair. Semin Cardiothorac Vasc Anesth 2007 Sep;11(3):205-23.
REFERÊNCIAS BIBLIOGRÁFICAS
7. Beach K. Princípios Físicos e Instrumentos de Ultrassonografia: Visão Geral. In: Diagnóstico vascular. Rio de Janeiro: Di Livros; 2008. 8. Wells PN. Ultrasound in vascular pathologies. Eur Radiol 1998;8(6):849-57.
1. Satomura S. Study of flow patterns in peripheral arteries by ultrasonics. J Acoust Soc Jpn 1959;15:151-8. Strandness DE Jr, Schultz RA, Summer DS, Rushmer RF. Ultrasonic flow detection: a useful technique in the evaluation of peripheral vascular disease. Am J Surg 1967;113:311-20. McCleod FD Jr. Progress report: Directional Doppler blood flow meter. NRG 33-010-074, Cornell University; 1969. 4. Hokanson DE, Mozersky DJ, Summer DS, Strandness DE Jr. Ultrasonic arteriography: a new aproach to arterial visualization. Biomed Eng 1971;6:420. Barber FE, Baker DW, Strandness DE Jr. Ultrasonic duplex echo Doppler scanner. IEEE Trans Biomed Eng 1974;21:109-113.
10. Frinking PJA, Bouakaz A, Kirkhorn J et al. Ultrasound contrast imaging: current and new potencial methods. Ultrasound in Med Biol 2000;26(6):965-75.
6. Salles-Cunha S, Morais Filho D. Princípios básicos de ultrassonografia vascular. In: Guia Prático de Ultrassonografia Vascular. Rio de Janeiro: Di Livros; 2016.
22 13Capítulo ECOCOLOR DOPPLER – PRINCÍPIOS FÍSICOS
5.
16. Johnston KW, Maruzzo BC, Kassam M, Cobbold RSC. Methods of obtaining, processing and quantifying Doppler blood velocity waveforms. In: Nicolaides NA, Yao JST ed. Investigation of Vascular Disorders. New York. Churchill Livingstone; 1981. p. 545-48.
17. Gerlock AJ, Giyanani VL, Krebs C. Applications of Noninvasive Vascular Techniques. Philadelphia: WB Saunders Co;1988. p. 283-298.
2.
14. Krenkrau FW. Diagnostic Ultrasound: Principles, Instruments and Exercises. Philadelphia: WB Saunders Co; 1989. p. 178-183.
15. Morais Filho D. Análise Espectral do Fluxo Arterial. In: Nectoux JL ed. Ultrassonografia Vascular: Revinter; 2000. p. 14-16.
MÉTODOS DE IMAGEM – PRINCÍPIOS GERAIS
3.
11. Salles-Cunha SX, Morais Filho D. Princípios básicos. In: Guia Prático de Ultrassonografia Vascular. Rio de Janeiro: Di Livros; 2001. 12. Desser TS, Jefrey RB. Tissue harmonic imaging techniques: physical principles and clinical applications. Semin Ultrasound ST MR 2001;22(Suppl 1):1-10.
SEÇÃO 5
9. Lencioni R, Cioni D, Bartolozzi C. Tissue harmonic and contrast-specific imaging: back to gray scale in ultrasound. Eur Radiol 2002;12:151-65.
13. Halacy DS Jr. They gave their names to science. G.P.Putman’s Sons. New York; 1967. p. 41-49.
18. Beach KW, Strandness DE Jr. Pulsed Doppler ultrasound for blood velocity measurements. In: Bernstein EF ed. Vascular Diagnosis Mosby; 1983. p. 83-89. 19. Krenkrau FW. Principles of color flow imaging. J Vasc Technol 1991;15(3):104-111. 20. Erickson SJ. Neck, orbit and neonatal brain. In: Foley WD ed. Color Doppler Flow Imaging. Andover; 1991, p. 29-50. 21. Hoyer PF, Schimid R, Wunsch L, Vester U. Color Doppler energy: a new technique to study tissue perfusion in renal transplants. Pedriatr Nephrol 1999;13:559-63. 22. Weskott HP. B-flow: a new method for detecting blood flow. Ultraschall Med 2000;21(2):59-65. 23. Chiao R. B-flow: a new way of visualizing vascular hemodynamics. Vasc US Today 2000;5(9):125-36. 24. Kroger K, Massalha K, Dobonicci G, Rudofsky G. Siescape: a new sonography dimension with fictive images. Ultrasound Med Biol 1998;24:1125-9. 25. Rosenthal SJ, Harisson LA, Nannette MS et al. Siescape imaging measurements. Clinical notes – Siemens Medical Systems, 1997. 26. Engelhorn CA, Engelhorn AL, Lourenço MA et al. Acurácia da imagem ultra-sonográfica expandida no diagnóstico das obstruções arteriais do segmento infra-inguinal. J Vasc Br 2001;(1):55-64. 27. Ebru Yılmaz, Ayhan Yılmaz, Ahmet Aslan et al. Real-Time Elastography for Differentiation of Breast Lesions. Pol J Radiol 2017;82:664-669. 28. Öztürk M, Yildirim R. Evaluation of Pancreas with Strain Elastography in Children with Type 1 Diabetes Mellitus. Pol J Radiol 2017 Dec 15;82:767-772. 29. Ippolito D, Schiavone V, Talei Franzesi CR et al. Real-Time Elastography: Noninvasive Diagnostic Tool in the Evaluation of Liver Stiffness in Patients with Chronic Viral Hepatitis, Correlation with Histological Examination. Dig Dis 2018 Apr;26:1-9.
15. Material and patient weight on hepatic enhancement. Radiology ijlink?linkType=ABST&journalCode=radiology&resid=195/2/3531995;195:353–357http://www.ajronline.org/cgi/
18. Rist C, Nikolaou K, Kirchin MA et al. Contrast bolus optimization for cardiac 16-slice computed tomography: comparison of contrast medium formulations containing 300 and 400 milligrams of iodine per milliliter. Invest Radiol 2006;41:460-467.
11. Barrett JF, Keat N. Artifacts in CT: Recognition and Avoidance. RadioGraphics 2004;24:1679-1691.
19. Cademartiri F, Mollet NR, van der Lugt A et al. Intravenous contrast material administration at helical 16-detector row CT coronary angiography: effect of iodine concentration on vascular attenuation. Radiology 2005;236:661-665. 20. Bae KT, Heiken JP, Brink JA. Aortic and hepatic peak enhancement at CT effect of contrast medium injection rate: pharmacokinetic analysis and experimental porcine model. Radiology 1998;206:455-464.
16. Platt JF, Reige KA, Ellis JH. Aortic enhancement during abdominal CT angiography: correlation with test injections, flow rates, and patient demographics. AJR 1999;172:53-56.
23 14CapítuloPRINCÍPIOS DA ANGIOTOMOGRAFIA REFERÊNCIAS BIBLIOGRÁFICAS 1. Mould RF. Invited review: Rõntgen and the discovery of X-rays. Br J Radiol 1995;68:1145-1176. 2. Bukovics B. Biography of Johann Radon. In: Gindikin S, Michor P eds. 75 Years of Radon Transform. International Press Incorporated;1994. p. 13-18. 3. Cormack AM. Facts. Nobelprize.org. Nobel Media AB 2014. Web. 9 Jul 2018. laureates/1979/cormack-facts.html.http://www.nobelprize.org/nobel_prizes/medicine/ 4. Hounsfield GN. Biographical. Nobelprize.org. Nobel Media AB 2014. Web. 9 Jul laureates/1979/hounsfield-bio.html.2018.http://www.nobelprize.org/nobel_prizes/medicine/ 5. Hsieh J. Computed Tomography: Principles, Design, Artifacts and Recent Advances. SPIE Press Book 2003;113. 6. Mahesh M, Cody DD. AAPM/RSNA Physics Tutorial for Residents. RadioGraphics 2007;27:1495-1509. 7. Dalrymple NC, Prasad SR, El-Merhi FM et al. Price of Isotropy in Multidetector CT. RadioGraphics 2007;27:49-62. 8. Rydberg J, Buckwalter KA, Caldemeyer KS et al. Multisection CT: Scanning Techniques and Clinical Applications. Radio Graphics 2000;20:1787-1806.
21. Bae KT, Seeck BA, Hildebolt CF et al. Contrast enhancement in cardiovascular MDCT: effect of body weight, height, body surface area, body mass index, and obesity. AJR 2008;190:777-784.
22. Boiselle PM, Reynolds KF, Ernst A. Multiplanar and Three-Dimensional Imaging of the Central Airways with Multidetector CT. A JR 2002 Aug;179:301-308. 23. Beigelman-Aubry C, Hill C, Guibal A et al. Multi–Detector Row CT and Postprocessing Techniques in the Assessment of Diffuse Lung Disease RadioGraphics 2005;25:1639-1652. 24. Shimada I, Rooney SJ, Farnet PA et al. Reproducibility of thoracic aortic diameter measurements using computed tomography scans. Eur J Cardiothorac Surg 1999;16:59-62.
12. Bae KT, Heiken JP. Scan and contrast administration principles for MDCT. Eur Radiol 2005;15:46-59.
9. Mahesh M. Search for isotropic resolution in CT from conventional through multiple-row detector. RadioGraphics 2002;22:949-962. 10. McCollough CH, Bruesewitz MR, Kofler JM Jr. CT dose reduction and dose management tools: overview of available options. RadioGraphics 2006;26:503-512.
13. Kormano M, Partanen K, Soimakallio S, Kivimaki T. Dynamic contrast enhancement of the upper abdomen: effect of contrast medium and body weight. Invest Radiol 1983;18:364-367.
14. Heiken JP, Brink JA, McClennan BL et al. Dynamic incremental CT: effect of volume and concentration of contrast material and patient weight on hepatic enhancement. Radiology 1995;195:353-357.
17. Bae KT. Technical aspects of contrast delivery in advanced CT. Appl Radiol 2003;32[suppl]:12-19.
3. Shellock FG. MRISafety. Your information resource for MRI safety, bioeffects & patient management. Disponível em: http://mrisafety. com/. Acessado em 28/05/2018.
18. Dellegrottaglie S, Rajagopalan S. MR Techniques for Vascular Imaging. In: Mukherjee D, Rajagopalan, editors. CT and MR angiography of the peripheral circulation. Practical approach with clinical protocols United Kingdom: Informa Healthcare; 2007. p. 169-183
6. ACR Committee on Drugs and Contast Media. ACR Manual on Contrast Media. Version 2017;10.3.
13. Meaney JF, Sheehy N. MR angiography of the peripheral arteries. Magn Reson Imaging Clin N Am 2005;13(1):91-111.
21. Kalmar PI, Koestenberger M, Marterer R et al. Gadolinium-free MR in coarctation-can contrast-enhanced MR angiography be replaced? Clin Imaging 2016;40(3):414-8.
19. Foo TK, Polzin JA, Thomasson DM. MR angiography physics: an update. Magn Reson Imaging Clin N Am 2005;13(1):1-22.
REFERÊNCIAS BIBLIOGRÁFICAS
1. Edelman RR. The history of MR imaging as seen through the pages of radiology. Radiology 2014;273(2 Suppl):S181-200.
12. Korosec FR. Principles of Magnetic Resonance Angiography. In: Rubin GD, Rofsky NM, editors. CT and MR angiography: Comprehensive vascular assessment. Philadelphia, PA: Lippincott Williams & Wilkins; 2009. p. 52-86.
10. Chandra T, Pukenas B, Mohan S, Melhem E. Contrast-enhanced magnetic resonance angiography. Magn Reson Imaging Clin N Am 2012;20(4):687-98.
7. Puac P, Rodríguez A, Vallejo C et al. Safety of Contrast Material Use During Pregnancy and Lactation. Magn Reson Imaging Clin N Am 2017;25(4):787-97.
8. Pooley RA. AAPM/RSNAphysics tutorial for residents: fundamental physics of MR imaging. Radiographics 2005;25(4):1087-99.
20. Wheaton AJ, Miyazaki M. Non-contrast enhanced MR angiography: physical principles. J Magn Reson Imaging 2012;36(2):286-304.
15. Rubin GD, Sedati P, Wei JL. Postprocessing and Data Analysis. In: Rubin GD, Rofsky NM, editors. CT and MR angiography: Comprehensive vascular assessment. Philadelphia, PA: Lippincott Williams & Wilkins; 2009. p. 188-251.
16. Miyazaki M, Lee VS. Nonenhanced MR angiography. Radiology 2008;248(1):20-43.
17. Morita S, Masukawa A, Suzuki K et al. Unenhanced MR angiography: techniques and clinical applications in patients with chronic kidney disease. Radiographics 2011;31(2):E13-33.
22. Edelman RR, Sheehan JJ, Dunkle E et al. Quiescent-interval singleshot unenhanced magnetic resonance angiography of peripheral vascular disease: Technical considerations and clinical feasibility. Magn Reson Med 2010;63(4):951-8. 23. Xu JL, Shi DP, Li YL et al. Non-enhanced MR angiography of renal artery using inflow-sensitive inversion recoverypulse sequence: a prospective comparison with enhanced CT angiography. Eur J Radiol 2011;80(2):e57-63. 24. Angeretti M, Lumia D, Cani A et al. Non-enhanced MR angiography of renal arteries: comparison with contrast-enhanced MR angiography. Acta Radiol 2013;54:749-56.
24 15Capítulo PRINCÍPIOS DA ANGIORRESSONÂNCIA MAGNÉTICA
14. Douek PC, Hernandez-Hoyos M, Orkisz M. Imagem Processing in Contrast-Enhanced MR Angiography. In: Schneider G, Prince MR, Meaney JFM, Ho VB. Magnetic Resonance Angiography. Techniques, indications and practical applications. Springer; 2005. p. 55-64.
11. Ho VB, Corse WR, Maki JH. Contrast-Enhanced MR Angiography: Theory and Technical Optimization. In: Schneider G, Prince MR, Meaney JFM, Ho VB. Magnetic Resonance Angiography. Techniques, indications and practical applications. Springer; 2005. p. 23-42.
4. Kanal E, Barkovich AJ, Bell C et al. ACR guidance document on MR safe practices. J Magn Reson Imaging 2013;37(3):501-30.
2. Weidman EK, Dean KE, Rivera W et al. MRI safety: a report of current practice and advancements in patient preparation and screening. Clin Imaging 2015;39(6):935-7.
5. Moreno Escobosa MC, Cruz Granados S. Paramagnetic Contrast Media: Hypersensitivity and Cross-Reactivity. J Investig Allergol Clin Immunol 2018;28(1):60-2.
9. Bitar R, Leung G, Perng R et al. MR pulse sequences: what every radiologist wants to know but is afraidc to ask. Radiographics 2006;26(2):513-37.
3. Radiation Effects Research Foundation. 4. Hiroshima, Japan. http://www.rerf.or.jp/library/dl_e/index.html.
5. Council NR. Health risks from exposure to low levels of ionizing radiation: BEIR VII – Phase 2, 2006. Committee to Assess Health Risks from Exposure to Low Levels of Ionizing Radiation. Washington, DC, National Academies Press.
20. Berrington de Gonzales A et al. Projected cancer risks from computed tomographic scans performed in the United States in 2007. Arch Int Med 2009;169:2071-2077.
2. Schauer DA, Linton OW. National Council on Radiation Protection and Measurements report shows substantial medical exposure increase. Radiology 2009;253(2):293-296.
9. Hendee WR, O’Connor MK. Radiation risks of medical imaging: separating fact from fantasy. Radiology 2012;264(2):312-321.
12. Image Gently. Página da internet acessada em novembro de 2012 (http://www.pedrad.org/associations/5364/ig/).
15. Comissão Nacional de Energia Nuclear.Diretrizes básicas de proteção radiológica. 2011, CNEN-NN-3.01, Brasil.
18. Mayo-Smith WW, Hara AK, Mahesh M et al. How I do it: managing radiation dose in CT. Radiology 2014;273(3):657-672.
23. Funama Y, Awai K, Nakayama Y et al. Radiation dose reduction without degradation of low-contrast detectability at abdominal multisection CT with a low-tube voltage technique: phantom study. Radiology 2005;237:905-10. 24. Diederich S, Lenzen H, Windmann R et al. Pulmonary nodules: experimental and clinical studies at low-dose CT. Radiology 1999;213:289-98. 25. Mayo JR, Kim KI, MacDonald SL et al. Reduced radiation dose helical chest CT: effect on reader evaluation of structures and lung findings. Radiology 2004;232:749-56. 26. Goldsweig AM, Abbott JD, Aronow HD. Physician and Patient Radiation Exposure During Endovascular Procedures. Current Treatment Options in Cardiovascular Medicine, 2017. 27. Vaño E. Radiation exposure to cardiologists: how it could be reduced. Heart on line 2003;89:1123-1124. 28. Tsapaki V et al. Level of patient and operator dose in the largest cardiac centre in Greece. Radiation Protection Dosimetry 2008;129(1-3):71-73. 29. ACC/HRS/NASCI/SCAI/SCCT Expert Consensus Document on Optimal Use of Ionizing Radiation in Cardiovascular Imaging: Best Practices for Safety and Effectiveness. JACC 2018;71(24). 30. Vanõ E. Radiation exposure to medical staff in interventional and cardiac radiology. Brit J Radiol 1998;71:954-96. 31. Miller DL, Balter S, Schueler BA et al. Clinical Radiation Management for Fluoroscopically Guided Interventional Procedures. Radiology 2010 November;257(2):321-332.
17. Delichas M et al. Radiation exposure to cardiologists performing interventional cardiology procedures. Eur J Radiol 2003;48:268-273.
25 16CapítuloRISCOS DA RADIAÇÃO NOS PROCEDIMENTOS DIAGNÓSTICOS E TERAPÊUTICOS
1. National Council on Radiation Protection and Measurements. Ionizing radiation exposure of the population of the United States. National Council on Radiation Protection report no. 160. Bethesda, Md: National Council on Radiation Protection and Measurements, 2009.
14. Comissão Nacional de Energia Nuclear. Fatores de Ponderação para as Grandezas de Proteção Radiológica. PR-3.01/002, 2011, Brasil.
7. Pearce MS et al. Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study. Lancet 2012;380(9840):499-505.
10. Medicine A APM.Position statement of the American Association of Physicists in Medicine. Radiation risks from medical imaging procedures. 2011, página da internet: http://www.aapm.org. acessada em novembro de 2012.
11. Image Wisely. Radiation safety in adult medical imaging. Página da internet acessada em novembro de 2012 (http://imagewisely.org).
16. Ministério do Trabalho e do Emprego. Portaria nº 485, de 11 de novembro de 2005. Aprova a Norma Regulamentadora nº32 –“segurança e saúde no trabalho em estabelecimentos de assistência à saúde.”, 16 nov. 2005, Diário Oficial da União, Poder Executivo, Brasília, DF.
19. Mettler FA Jr, Bhargavan M, Faulkner K et al. Radiologic and nuclear medicine studies in the United States and worldwide: frequency, radiation dose, and comparison with other radiation sources—1950–2007. Radiology 2009;253(2):520-531.
REFERÊNCIAS BIBLIOGRÁFICAS
21. Radiological Society of North America: Exposure to ionizing radiation and estimate of secondary cancers in the era of high speed CT scanning. Presentation to 96th Scientific Assembly and Annual Meeting, December 1, 2010.
22. United States Nuclear Regulatory Commission: (accessedhttp://www.nrc.gov/reading-rm/basicref/glossary/alara.htmlALARA,January20,2011).
6. Preston DL et al. Studies of mortality of atomic bomb survivors. Report 13: Solid cancer and noncancer disease mortality: 1950-1997. Radiat Res 2003;160(4):381-407.
8. Doss M.Shifting the Paradigm in Radiation Safety. Dose-Response 2012;10:562-583.
13. Marin D, Nelson RC, Schindera ST et al. Abdominal CT: Improved Image Quality and Decreased Radiation Dose with Adaptive Statistical Iterative Reconstruction Algorithm: Initial Clinical Experience. Radiology 2009;254(1):145-153.
15. Yoshida WB. Contrastes utilizados em angiografias. In: Maffei FHA, Lastória S, Yoshida WB, Rollo HA. Doenças vasculares periféricas. 3. ed. Rio de Janeiro, RJ: Medsi; 2002. p. 360-5. 16. Moura R. Angiografia por subtração digital. In: Maffei FHA, Lastória S, Yoshida WB, Rollo HA. Doenças vasculares periféricas. 3. ed. Rio de Janeiro, RJ: Medsi; 2002. p. 383-98. 17. Lanziotti L. Injetor intra-vascular de CO2:Estudo in vivo de viabilidade inicial de dispositivo de e de qualidade de imagem. Tese de doutoramento FMUSP. São Paulo; 2015. 18. Moore W. Endovascular Surgery. California: Saunders; 2001. p. 32-41. 19. Moore WS. Vascular and Endovascular Surgery. California: Saunders; 2006. p. 19-31. 20. Osborn AG. Diagnostic Neuroradiology. Washington: Mosby; 1994. p. 18-32. 21. Rutherford RB. Vascular Surgery. Colorado: Saunders; 1989. p. 25-36. 22. Peixoto CCS, Rossi M. Trauma Vascular. Rio de Janeiro: Revinter; 2006. p. 174-188. 23. Peixoto CCS, Brito CJ. Cirurgía Endovascular e Angiologia. Revinter; 2008. p. 396-416. 24. Peixoto CCS, Brito CJ. Cirurgia Endovascular e Angiologia. Revinter; 2014. p. 527-534.
26 17Capítulo ANGIOGRAFIAS EM GERAL REFERÊNCIAS BIBLIOGRÁFICAS 1. Abrams HL. Abrams’ Angiography : Intervencional Radiology. In: Baum S, Pentecost MJ (eds). 2. ed. 2006. p. 25-36. 2. Bakal CW. Vascular and Interventional Radiology. Thieme; 2002. p. 16-24. 3. Brito CJ. Cirurgia Vascular. Rio de Janeiro: Revinter; 2002. p. 25-34. 4. Brum O. Angiologia Básica. Fundo Editorial Byk; 1989. p. 190-207. 5. Carnevale FC. Radiologia Intervencionista e Cirurgia Endovascular São Paulo: Revinter; 2006. p. 31-44. 6. Dyet JF. Textbook of Endovascular Procedures. Philadelphia: Churchill Livingstone; 2000. p. 31-45. 7. HaimovicH. Vascular Surgery. New York: Appleton & Lange; 1989. p. 76-93. 8. Hallett JW. Comprehensive Vascular and Endovascular Surgery. Boston: Mosby; 2004. p. 23-36. 9. Lasjaunias P. Surgical Neuro-angiography. Bicêtre: Springer; 2001. p. 17-26. 10. Lobato AC. Cirurgia Endovascular. São Paulo; 2006. p. 19-24. 11. Maffei FH. Doenças Vasculares Periféricas. São Paulo: Medsi; 2002. p. 21-32. 12. Martorell F. Enfermidades Vasculares. Barcelona; 1972. p. 22-31. 13. Medina JG. Radiología Intervencionista. Vigo: Marban; 1997. p. 23-33. 14. Laranja SMR, Schor N. Nefrotoxicidade por contrastes radiológicos. In: Schor N, Boim MA, Santos OFP. Insuficiência renal aguda – fisiopatologia clínica e tratamento. São Paulo, SP: Sarvier; 1997. p. 129-32.
27 18Capítulo
12. Araujo JD, Rossi MA, Silva DR. Experimental study of a biograft as aorto-aortic bypass. Int Angiol 1991;10(3):117-121.
6.
REFERÊNCIAS
8.
11. Rosenberg N, Henderson J, Douglas JF et al. the use of arterial implants prepared by enzymatic modification of arterial heterografts. Arch Surg 1957;74-89.
14. Castro Souza L. Medicina Militar Brasileira: Nomes Marcantes e Fatos Notáveis. Rev Bras Med 1973;30(10). 15. Revista Brasil Médico 1889 maio 25: 149.
10. Ochsner JL. Allogenic Vein . In: Dardik H (ed). Graft Materials in Vascular Surgery. Chicago: Year Book Medical Publishers; 1978. p. 243-247.
17. Rutherford RB. Atlas of Vascular Surgery: Basic Technics and Exposures. Philadelphia, Pennsylvania: W.B. Saunders Company. 18. Quintos RJ, Veith FJ. Techniques for Thromboembolectomy of Native Arteries and Bypass Grafts. In: Rutherford RB(ed). Vascular Surgery. Vol. 1, Philadelphia:W.B. Saunders; 2000. p. 486-493.
4.
CIRÚRGICAS
3.
19. Fogarty TJ, Cranley JJ, Krause RJ et al. A method for extraction of arterial emboli and thrombi. Surg Ginecol Obst 1963;116:241. 20. Fogarty TJ, Hermam GD. New techniques for clot extractive and managing acute thromboembolic limb ischemia. In: Veith FJ(ed). Current critical problems in vascular surgery. vol.3,St. Louis: Quality Medical Publishing; 1991. p. 197-203. 21. Dos Santos JC. Sur la désobstruccion des thromboses artérielles anciennes. Mem Acad Chir 1947;73:409. 22. Messina LM, Stoney RJ. Endarterectomy. In: Rutherford RB(ed). Vascular Surgery. Vol.1, Philadelphia:W.B. Saunders; 2000. p. 493-499. 23. Conte MS, Bandyk DF, Clowes AW et al. Risk factors, medical therapies and perioperative events in limb salvage surgery: Observations from the PREVENT III multicenter trial. J Vasc Surg 2005;42(3):456-65.
SEÇÃO 6 MATERIAIS E TÉCNICAS CIRÚRGICAS BÁSICAS
1.
13. Castro Souza L. Contribuição para história da evolução da cirurgia vascular e seu patrono. Anais do 24º Congresso Brasileiro de Angiologia, 1983.
7.
16. Puech LP. Apresentação do Serviço de Cirurgia Vascular do Hospital das Clínicas da Faculdade de Medicina da U.S.P. - Boletim nº 4 da Regional São Paulo da SBACV maio, 2000 - pag. 6.
TÉCNICAS BÁSICAS NA RECONSTRUÇÃO VASCULAR BIBLIOGRÁFICAS Carrel A. La téchnique opératoire des anastomoses vasculaires et la transplantation de viscères. Lyon Méd 1902:98:859. 2. Carrel A. The surgery of blood vessels. Johns Hopkins Med J 1907;18:18. Carrel A. Heterotransplantation of blood vessels preserved in cold storage. J Exp Med 1907;9:226. McLean J. The thromboplastic action of cephalin. Am J Physiol 1916;41:250. 5. Best CH. Heparin and vascular occlusion. Can Med Assoc J 1936;35:621. Moniz E. L’encephalographie artérielle, son importance dans la localization des tumeurs cérébrales. Rev Neurol (Paris) 1927;2:72. Dos Santos R, Lamas A, Pereira CJ. Lártériographie des membres, de l’aorte et ses branches abdominales. Bull Soc Natl Chir 1929;55:587. Dardik H, Dardik I. Successful arterial substitution with modified human umbilical vein. Ann Surg 1976;183:252. 9. Araújo JD, Bilaqui A, Ardito RV et al. O uso da veia do cordão umbilical humano como enxerto arterial. Rev AMB 1981;27(4):116-118.
16. Gross RE, Bill Jr AH, Peirce II EC. Methods for preservation and transplantation of arterial grafts. Observations on arterial grafts in dogs. Report of transplantation of preserved arterial grafts in 9 human cases. Surg Gynec & Obst 1949;88:689.
27. Rosemberg N, Gaughran ERL, Henderson J. The use of segmental arterial implants prepared by enzymatic modification of heterologous blood vessels. Surg Forum 1956;6:242. 28. Nabseth DC, Wilson JT, Tan B et al. Fetal arterial heterografts. Arch Surg 1960;81:929. 29. Dardik H, Dardik I. Successful arterial substitution with modified human umbilical vein. Ann Surg 1976;183:253. 30. Campbell DC, Brooks DH, Webster MW et al. The use of expanded microporous polytetrafluoroethylene for limb salvage: a preliminary report. Surgery 1976;79:485. 31. Sparks CH. Autogenous grafts made to order. Ann Thorac Surg 1969;8:104. 32. Sparks CH. Silicone mandril method for growing reinforced autogenous femoropopliteal artery grafts in situ. Ann Surg 1973;177:293. 33. Perloff LJ, Christie BA, Ketharanathan V et al. A new replacement for small vessels. Surgery 1981;89:31. 34. De Mol van Otterloo JCA, Van Bockel JH, Ponfoort ED et al. The effects of aortic reconstruction and collagen impregnation of Dacron prostheses on the complement system. J Vasc Surg 1992;16:774. 35. Gozna ER, Mason WF, Marble AE, Winter DA, Dolan FG. Necessity for elastic properties in synthetic arterial grafts. Can J Surg 1974;17(3):176-9. 36. Greenwald SE, Berry CL. Improving vascular grafts: the importance of mechanical and haemodynamic properties. J Pathol 2000;190(3):292-9. 37. Al-Khaffaf H, Charlesworth D. Albumin-coated vascular prostheses: a five-year follow-up. J Vasc Surg 1996;23:686. 38. Jonas RA, Zermer G, Schoen FJ et al. A new sealant for knitted dacron prostheses: minimally cross-linked gelatin. J Vasc Surg 1988;7:414. 39. Drury JK, Ashton TR, Cunningham JD et al. Experimental and clinical experience with a gelatin impregnated Dacron prosthesis. Ann Vasc Surg 1987;1:542. 40. Norgren L, Holtas S, Persson G et al. Systemic response to collagen impregnated versus non-treated Dacron velour grafts for aortic and aortofemoral reconstructions. Eur J Vasc Surg 1990;4:379. 41. Stegmann TH, Haverich A, Borst HG. Clinical experience with a new collagen-coated Dacron double-velour prosthesis. Thorac Cardiovasc Surg 1986;34:54. 42. Freishlag JA, Moore WS. Clinical experience with a collagenimpregnated knitted Dacron vascular graft. Ann Vasc Surg 1990;4:449. 43. Canadian Multicenter Hemashield Study Group. Immunological response to collagen-impregnated vascular grafts: a randomized prospective study. J Vasc Surg 1990;12:741. 44. Goldman M, McCollum CN, Hawker RJ et al. The influence of porosity, velour, and maturity on thrombogenicity. Surgery 1982;92:947. 45. Nunn DB, Carter MM, Donohue MT et al. Postoperative dilation of knitted dacron aortic bifurcation graft. J Vasc Surg 1990;12:291. 46. Blumenberg RM, Gelfand ML, Barton EA et al. Clinical significance of aortic graft dilation. J Vasc Surg 1991;14:175. 47. Nunn DB. Structural failure of Dacron arterial grafts. Semin Vasc Surg 1999;12(1):83-91. Wilson SE, Krug R, Mueller G, Wilson L. Late disruption of Dacron aortic grafts. Ann Vasc Surg 1997;11(4):383-6. Claggett GP, Solander JM, Eddleman WL, et al. Dilation of knitted Dacron aortic prosthesis and anastomotic false aneurysms. Etiologic considerations. Surgery 1983;93:9.
19. Dubost C, Allary M, Deconomos N. Resection of an aneurysm of the abdominal aorta. Reestablishment of the continuity by a preserved human arterial graft, with results after five months. Arch Surg 1952;64:405.
2.
25. Szilagyi E. An elastic dacron arterial substitute. S Clin North America 1959;39:1523. 26. DeBakey ME, Cooley DA, Crawford ES et al. Clinical application of a new flexible knitted dacron arterial substitute. Arch Surg 1958;77:713.
48.
20. Voorhees AB, Jaretski A, Blakemore AH. The use of tubes constructed from Vinyon N cloth in bridging arterial defects. Ann Surg 1952;135:332. 21. Edwards WS, Tapp JS. Chemically treated nylon tubes as arterial grafts. Surgery 1955;38:61. 22. Hufnagel CA, Rabil P. Replacement of arterial segments, utilizing flexible orlon prostheses. Arch Surg 1955;70:105. 23. Harrison JH. Synthetic material as vascular prostheses. Amer J Surg 1958;95:3. 24. Julian OC, Deterling Jr RA, Su HH, et al. Dacron tube and bifurcation arterial prostheses produced to specification. Surgery 1957;41:50.
28 19Capítulo ENXERTOS VASCULARES
7.
18. Schafer PW, Hardin CA. The use of temporary polythene shunts to permit occlusion, resection, and frozen Homologous Graft replacement of vital vessel segments. Surgery 1951;31:186.
REFERÊNCIAS BIBLIOGRÁFICAS
17. Outdot J. La greffe vasculaire dans the thromboses du carrefour aortique. Presse Med 1951;59:234.
1. Jaboulay M, Brian E. Recherches expérimentales sur la suture et la greffe artérielle. Lyon Méd 1896;81:97. Gluck T. Die modern Chirurgie des circulationsapparates. Berl Klin 1898;70:1. 3. Goyannes J. Nuevos trabajos de cirugía vascular, substitución de las arterias por venas o arterioplastia venosa aplicada como nuevo método al tratamiento de los aneurismas. El Siglo Med 1906;53:546. 4. Lexer E. Die ideale operation des arteriellen und des arteriellevenosen aneurysma. Arch Klin Chir 1907;83:459. 5. Pringle JH. Two cases of vein grafting for the maintenance of direct arterial circulation. Lancet 1913;1:795. Holden W. Reconstruction of femoral artery for arteriosclerotic thrombosis. Surgery 1950;27:417. Kunlin J. Le traitement de l’arterite oblitérante par la greffe veineuse. Arch Mal Coeur 1949;42:371. 8. Kunlin J, Bitry-Boely VM, Beaudry M. Treatment of arterial ischemia by long vein grafts. Rev Chir 1951;70:206. 9. Carrel A. The surgery of blood vessels preserved in cold storage. Bull Johns Hopkins Hosp 1907;18:28. 10. Carrel A. Heterotransplantation of blood vessels preserved in cold storage. J Exper Med 1907;9:226. 11. Carrel A. Results of the transplantation of blood vessels, organs and limbs. JAMA 1908;51:1662. 12. Carrel A. Resultalts eloignés de la transplantation des veines sur les artères. Rev Chir 1910;41:987. 13. Carrel A. Graft of the vena cava on the abdominal aorta. Ann Surg 1910;52:462. 14. Schuck H. Nobel, the man and his prizes. Norman: Univ. Oklahoma Press; 1951. p. 256. 15. DeBakey ME, Simeone FA. Battle injuries of the arteries in World War II – An analysis of 2,471 cases. Ann Surg 1946;123:534.
6.
49.
71. Fields C, Cassiano A, Allen C et al. Endothelial cell seeding of a 4-mm I.D. polyurethane vascular graft. J Biomater Appl 2002;17(1):45-70.
76. Cowie SE, Ma I, Lee SK et al. Nosocomial MRSA infection in vascular surgery patients: impact on patient outcome. Vasc Endovasc Surg 2005;39:327-334.
68. Xue L, Greisler HP. Prosthetic grafts. In: Rutherford R. (Ed.). Vascular surgery. 6th ed. Philadelphia: Elsevier Saunders; 2005. p. 723-40.
63. Brewster LP, Greiler HP. Vascular grafts: characteristics and rational selection. In: Moore W. (Ed.). Vascular and endovascular surgery: a comprehensive review. 8th ed. Philadelphia: Elsevier Saunders; 2013. p. 282-96. 64. Allen RD, Yuill E, Nankivell BJ et al. Australian multicentre evaluation of a new polyurethane vascular access graft. Aust N Z J Surg 1996;66(11):738-42.
65. Glickman MH, Stokes GK, Ross JR et al. Multicenter evaluation of a polytetrafluoroethylene vascular access graft as compared with the expanded polytetrafluoroethylene vascular access graft in hemodialysis applications. J Vasc Surg 2001;34(3):465-72. 66. Zhang Z, Marois Y, Guidoin RG et al. Vascugraft polyurethane arterial prosthesis as femoro-popliteal and femoro-peroneal bypasses in humans: pathological structural and chemical analyses of four excised grafts. Biomaterials 1997;18(2):113-24.
50.
75. Orton DF, LeVeen RF, Saigh JA et al. Aortic prosthetic graft infections: radiologic manifestations and implications for management. Radiographics 2000;20:977-993.
57. Raju S. PTFE for hemodialysis access: techniques for insertion and management of complications. Ann Surg 1987;206:666.
62. Stratton JR, Thiele BL, Ritchie JL. Natural history of platelet deposition on Dacron aortic bifurcation grafts in the first year after implantation. Am J Cardiol 1983;52:371.
72. Zetrenne E, McIntosh BC, McRae MH et al. Prosthetic vascular graft infection: a multi-center review of surgical management. Yale J Biol Med 2007;80:113-121. 73. FitzGerald SF, Kelly C, Humphreys H. Diagnosis and treatment of prosthetic aortic graft infections: confusion and inconsistency in the absence of evidence or consensus. J Antimicrob Chemother 2005;56(6):996-9.
58. Griffiths GD, Nagy J, Black D et al. Randomized clinical trial of distal anastomotic interposition vein cuff in infrainguinal polytetrafluoroethylene bypass grafting. Br J Surg 2004;91:560.
74. Kaebnick HW, Bandyk DF, Bergamini TW et al. The microbiology of explanted vascular prostheses. Surgery 1987;102:756-762.
Capítulo 19 29enxertos vA sCul Ares Moore WS. Infection in prosthetic vascular grafts. In: Moore WS, ed. Vascular surgery. 5th ed. Philadelphia: WB Saunders Co; 1998. p. 711. 51. Veith FJ, Gupta S, Daly V. Management of early and late thrombosis of PTFE femoropopliteal bypass grafts: favorable prognosis with appropriate reoperation. Surgery 1980;87:581. 52. Abbott WM, Purcell PN. Vascular grafts. In: Moore WS, ed. Vascular surgery. 5th ed. Philadelphia: WB Saunders Co; 1998. p. 406. 53. Mehigan DG, Fitzpatrick B, Browne HI et al. Is compliance mismatch the major cause of anastomotic arterial aneurysms? Analysis of 42 cases. J Cardiovasc Surg 1985;26:147. 54. Sottiurai VA, Yao JST, Flinn WR et al. Intimal hyperplasia and neointima: an ultrastructural analysis of thrombosed grafts in human. Surgery 1983;93:809. 55. Veith FJ, Gupta SK, Ascer E et al. Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded PTFE grafts in infrainguinal reconstruction. J Vasc Surg 1986;3:104. 56. Rosenthal D, Evans D, McKinsey J et al. Prosthetic above-knee femoropopliteal bypass grafts for intermittent claudication. J Cardiovasc Surg 1990;31:462.
67. Marois Y, Pâris E, Zhang Z et al. Vascugraft microporous polyesterurethane arterial prosthesis as a thoracoabdominal bypass in dogs. Biomaterial 1996;17(13):1289-300.
69. Khorasani MT, Shorgashti S. Fabrication of microporous thermoplastic polyurethane for use as small-diameter vascular graft material. I. Phase-inversion method. J Biomed Mater Res B Appl Biomater 2006;76(1):41-48. 70. Yuan J, Chen L, Jiang X et al. Chemical graft polymerization of sulfobetaine monomer on polyurethane surface for reduction in platelet adhesion. Colloids Surf B Biointerfaces 2004;39(1-2):87-94.
59. Sterpetti AV, Schultz RD, Feldhaus RJ et al. 7-year experience with polytetrafluoroethylene as above-knee femoropopliteal bypass graft: is it worthwhile to preserve the autologous saphenous vein? J Vasc Surg 1985;2:907. 60. Faries PL, LoGerfo FW, Arora S et al. A comparative study of alternative conduits for lower extremity revascularization: all-autogenous conduit versus prosthetic grafts. J Vasc Surg 2000;32:1080. 61. Pourdeyhimi B, Wagner D. On the correlation between the failure of vascular grafts and their structural and material properties: a critical analysis. J Biomedical Mat Res 1986;20(3):375-409.
77. Lee BY, Tsui BY, Bailey RR et al. Should vascular surgery patients be screened preoperatively for methicillin-resistant Staphylococcus aureus? Infect Control Hosp Epidemiol 2009;30:1158-1165. 78. Kieffer E, Bahnini A, Kishas F et al. In situ allograft replacement infrarenal aortic prosthetic grafts: results in 43 patients. J Vasc Surg 1993;17:349. 79. Fujitani RM, Bassiouny HS, Gevertz BL et al. Cryopreserved saphenous vein allogenic homografts: an alternative conduit in lower extremity arterial reconstruction in infected fields. J Vasc Surg 1992;15:519. 80. Dardik H, Ibrahim IM, Sprayregen S et al. Clinical experience with modified human umbilical cord vein for arterial bypass. Surgery 1976;79:618. 81. Araujo JD. Veia do cordão umbilical humano com o enxerto arterial. Medicina de Hoje 1978;9:578. 82. Araujo JD, Anacleto JC, Brail DM. O uso da veia do cordão umbilical humano como enxerto arterial. Rev Ass Med Bras 1981;27:116. 83. Eickhoff JH, Broome A, Ericsson BF et al. Four years’ results of a prospective randomized clinical trial comparing polytetrafluoroethylene and modified human umbilical vein for below-knee femoropopliteal bypass. J Vasc Surg 1987;6:506. 84. Aslders GJ, Vroonhoven TJMV. Polytetrafluoroethylene versus human umbilical vein in above-knee femoropopliteal bypass: sixyear results of a randomized clinical trial. J Vasc Surg 1992;16:816. 85. Johnson WC, Squires JW. Axillo-femoral (PTFE) and infrainguinal revascularization (PTFE and umbilical vein). J Cardiovasc Surg 1991;32:344. 86. McCollum C, Kenchington G, Alexander C et al. PTFE or HUV for femoropopliteal bypass: a multicentre trial. Eur J Vasc Surg 1991;5:435. 87. Hasson JE, Newton WD, Waltman AC et al. Mural degeneration in the glutaraldehyde-tanned umbilical vein graft: incidence and implications. J Vasc Surg 1986;4:243. 88. Rosemberg N, Thompson JE, Keshishian JM et al. The modified bovine arterial graft. 89. Wylie EJ. Vascular replacement with arterial autograft. Surgery 1965;57:14. 90. Stoney RJ, Wylie EJ. Arterial autografts. Surgery 1980;67:18. 91. Cambria RP, Brewster DC, L’Italien GJ et al. The durability of different reconstructive techniques for atherosclerotic renal artery disease. J Vasc Surg 1994;20:76. 92. Spray TL, Roberts WC. Fundamentals of clinical cardiology: changes in saphenous veins used as aortocoronary bypass grafts. Am Heart J 1977;94:500. 93. Towne JB. The autogenous vein. In: Rutherford RB. (Ed.). Vascular surgery. 4th ed. Philadelphia: WB Saunders; 1995. p. 482. 94. Shah DM, Chang BB, Leopold PW et al. The anatomy of the greater saphenous venous system. J Vasc Surg 1986;3:273. 95. Clagett GP, Valentine RJ, Hagino RT. Autogenous aortoiliac/femoral reconstruction from superficial femoral-popliteal veins: feasibility and durability. J Vasc Surg 1997;25:255. 96. Ali AT, Modrall JG, Hocking H, Valentine J, Spencer H, Eidt JF, Clagett GP. Long-term results of the treatment of aortic graft infection by in situ replacement with femoral popliteal vein grafts. J Vasc Surg 2009;50(1):30-39. 97. Modrall JG, Hocking JA, Timaran CH, Rosero EB, Arko FR, Valentine RJ, Clagett GP, Late incidence of venous insufficiency aftes deep vein harvest. J Vasc Surg 2007;46:520-525. 98. Shepard AD, Eldrup-Jorgensen J, Keough EM et al. Endothelial cell seeding of small-caliber synthetic grafts in the baboon. Surgery 1986;99:319. 99. Hering MB, Gardner A, Glover JL. Seeding human arterial prostheses with mechanically derived endothelium: the detrimental effect of smoking. J Vasc Surg 1984;2:279. 100. Conklin BS, Wu H, Lin PH et al. Basic fibroblast growth factor coating and endothelial cell seeding of a decellularized heparincoated vascular graft. Artif Organs 2004;28(7):668-75. 101. Huber TS, Welling TH, Sarkar R et al. Effects of retroviral-mediated tissue plasminogen activator gene transfer and expression on
118. Sanchez LA, Suggs WD, Veith FJ et al. Is surveillance to detect failing polytetrafluoroethylene bypasses worthwhile?: Twelve-year experience with ninety-one grafts. J Vasc Surg 1993;18:981-989.
114. Maufus M, and Pernod G. Antithrombotic therapy after infrainguinal bypass. J Vasc Surg 2014;60:1367-1375.
112. Greisler HP. Arterial regeneration over absorbable prostheses. Arch Surg 1982;177:1425.
110. Greisler HP, Endean ED, Klosak JJ et al. Polygalactin 910/ polydioxanone biocomponent totally resorbable vascular prosthesis. J Vasc Surg 1988;7:697. 111. Galletti PM, Aebischer P, Sashen HF et al. Experience with fully resorbable aortic grafts in the dog. Surgery 1988;103:231.
102. Gott VL, Whiffen JD, Dutton RC. Heparin bonding on colloiding graphite surfaces. Science 1963;142:1927.
106. Gessaroli M, Tarantini S, Leone M et al. A comparison of femorocrural bypasses performed with modified heparin-bonded expanded polytetrafluorethylene grafts and those with great saphenous vein grafts to treat critical limb ischemia. Ann Vasc Surg 2015;29:1255-1264.
115. Van Oostenbrugge TJ, de Vries JP, Berger P et al. Outcome of endovascular reintervention for significant stenosis at infrainguinal bypass anastomoses. J Vasc Surg 2014;60:696-701. 116. Norgren L, Hiatt WR, Dormandy JA et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 2007;45:S5-S67.
113. Neville RF, Capone A, Amdur R et al. A comparison of tibial artery bypass performed with heparin-bonded expanded polytetrafluoroethylene and great saphenous vein to treat critical limb ischemia. J Vasc Surg 2012;56:1008-14.
109. Heyligers JM, Lisman T, Verhagen HJ et al. A heparin-bonded vascular graft generates no systemic effect on markers of hemostasis activation or detectable heparin-induced thrombocytopeniaassociated antibodies in humans. J Vasc Surg 2008; 47:324-329.
107. Greco RS, Kim HC, Denetz AP et al. Patency of a small vessel prosthesis bonded to tissue plasminogen activator and iloprost. Ann Vasc Surg 1995;9:140.
104. Peeters P, Verbist J, Deloose K, et al: Will heparin-bonded PTFE replace autologous venous conduits in infrapopliteal bypass? Ital J Vasc & Endovasc Surg 2008;15:143-148. 105. Daenens K, Schepers S, Fourneau I et al. Heparin-bonded ePTFE grafts compared with vein grafts in femoropopliteal and femorocrural bypasses: 1- and 2-year results. J Vasc Surg 2009; 49:1210-1216.
Parte I30 CAPÍTULOS BÁSICOS adherence and proliferation of canine endothelial cells seeded onto expanded polytetrafluoroethylene. J Vasc Surg 1995;22(6):795-803.
103. Esquivel CO, Bjorck CG, Bergentz SE et al. Reduced thrombogenic characteristics of expanded polytetrafluoroethylene and polyurethane arterial grafts after heparin bonding. Surgery 1984;95:102.
117. Bandyk DF. Surveillance after lower extremity arterial bypass. Perspect Vasc Surg Endovasc Ther 2007;19:376-383.
108. Devine C, and McCollum C: Heparin-bonded Dacron or polytetrafluorethylene for femoropopliteal bypass: five-year results of a prospective randomized multicenter clinical trial. J Vasc Surg 2004;40:924-931.
ENDOPRÓTESES STENT GRAFTS
31 20Capítulo
Kruger J. Fundamental aspects of the corrosion of metallic implants. In: Rubin LR. Biomaterials in reconstructive surgery. St. Louis: Mosby; 1983. p. 145-57. Lawrence DD, Charnsangavej C, Wright KC et al. Percutaneous endovascular graft: experimental evaluation. Radiology 1987;163:357-60. Maleux G, Koolen M, Heye S, Nevelsteen. Limb Occlusion after Endovascular Repair of Abdominal Aortic Aneurysms with Supported Endografts. J Vasc Intervent Rad 2008;19(10):1409-12. Melissano G, Civillini E, Bertoglio L et al. Initial clinical experience with the modified Zenith “Pro-Form” TX2 thoracic endograft. J Endovasc Ther Mertens2001;17(4):463-70.J,HouthoofdS,Daenens K et al. Long-term results after endovascular abdominal aortic aneurysm repair using Cook Zenith endograft. J Vasc Surg 2011;54:48-57. Nano Endoluminal Endoprótese Apolo [Internet]. Produtos Endovascular [acesso em 20 nov 2012]. Disponível em: http://www.nano.com.br/ Bataginiprodutos_vantagens.php.NC,HardyD,Daniel G et al. Endovascular Aneurysm Sealing System: Device Description, Technique of Implantation and Literature Review, Seminars in Vascular Surgery. Oderich GS, Silveira PG. Initital Experience With the GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis. An overview of device characteristics and case reports from the first three worldwide implantation procedures. Supplement – Endovascular Today – March 2016. Palma JH, Souza JAM, Alves CMR et al. Self-expandable aortic swtentgrafts for treatment of descending aortic dissections. Ann Thorac Surg Palmaz2002;73:1138-42.JC,SibbittRR, Reuter SR et al. Expandable intraluminally graft: a preliminary study. Radiology 1985;156:73-7. Parodi JC, Palmaz JC, Barone D. Transfemoral intraluminal graft implantation for abdominal aortic aneurysms. Ann Vasc Surg 1991;5:491-9. Perdikides T, Georgiadis GS, Efthimios DA et al. The Aorfix Stent-Graft to Teat Infrarenal Abdominal Aortic Aneurysms with Angulated Necks and/or Tortuous Iliac Arteries: Midterm Results. J Endovasc Ther Pértile2009;16(5):567-76.LB.Caracterização mecânica e eletroquímica da liga NiTi. Dissertação de Mestrado: Engenharia de Materiais. Curso de Pós Graduação em Ciência e Engenharia de Materiais, Florianópolis, UFSC; 2005. Qu L, Raithel D. From clinical trials to clinical practice: 612 cases treated with the Powerlink stent-graft for endovascular repair of AAA. J Cardiovasc Surg 2009;50(2):131-7. Rancic Z, Pecoraro F, Pfammatter T et al. The use of Endurant stentgraft for abdominal aortic aneurysm: the story about extension of instruction for use with persistent good results of stent-graft latest generation. J Cardiovasc Surg 2012;53(5):579-94. Rodel SGJ, Geelkerken RH, Prescott RJ et al. The Anaconda AAA Stent Graft System: 2-Year Clinical and Technical Results of a Multicentre Clinical Evaluation. Eur J Vasc Endovasc Surg 2009;38(6):732-40. Rouwer EV, Torsello G, Vries JPPM et al. Final results of the prospective European trial of the Endurant stent graft for endovascular abdominal aortic aneurysm repair. Eu J Vasc Endovasc Surg 2011;42(4):489-97. Saratzis N, Nikolaos M, Saratzis A et al. Anaconda Aortic Stent-Graft: Single-Center Experience of a New Commercially Availiable Devide for Abdominal Aortic Aneurysms. J Endovasc Ther 2008;15(1):33-41.
Hogg ME, Morasch MD, Park T et al. Long term sac behavior after endovascular abdominal aortic aneurysm repair with the Excluder lowpermeability endoprosthesis. J Vasc Surg 2011;53(5):1178-83. Kelly AJ, Nykamp M, Danielson L et al. A novel endovascular debranching technique using physician-assembled endografts for repair of thoracoabdominal aneurysms. J Vasc Surg 2014;60:1177-85.
E
BIBLIOGRAFIA Balko A, Piasecki GJ, Shah DM et al. Transfemoral placement of intraluminal polyurethone prosthesis for abdominal aortic aneurysms. J Surg Res 1986;40:305-9 Bockler D, Riambau V, Fitridge R et al. Worldwide experience with the Endurant Stent graft: review of the literature. J Cardiovasc Surg Braile2011;52(5):669-81.BiomédicaEndoprótese Dominus e Endoprótese Linus [Internet]. Produtos Endovascular [acesso em 10 dez 2012]. Disponível em: http:// Brewsterwww.braile.com.br/lista-produtos.asp?id=12.LP,KasirajanK.ThoracicEndovascular Aneurysm Repair for Thoracic Aneurysms: What we know, What to expect. Ann Vasc Surg Bronzino,2011;25(6):856-65.JD.
The biomedical engineering hand book. 2nd Ed Vol I Carpenter JP. Endologix Investigators. Midterm results of the multicenter trial of the Powerlink bifurcated system for endovascular aortic aneurysm repair. J Vasc Surg 2004;40(5):849-59. Carpenter JP; Endologix Investigators. Midterm results of the multicenter trial of the Powerlink bifurcated system for endovascular aortic aneurysm repair. J Vasc Surg 2004;40(5):849-59. Chiu KY, Cheng FT, Man HC. Cavitation erosion resistence of AiSi 316L stainless steel laser surface modified with NiTi. Mat Sci Engineer Cho2005;392:348-358.JS,DillavouED,Rhee RY, Makaroun MS. Late abdominal aortic aneurysm enlargement after endovascular repair with the Excluder device. J Vasc Surg 2004;39(6):1236-41. Cook Medical Zenith [Internet]. Vascular division / Aortic interventions [acesso em 03 de abril 2018]. Disponível em: http://www.cookmedical. com /products Coppi G, Silingardi R, Tasselli S et al. Endovascular treatment of abdominal aortic aneurysms with the Powerlink Endograft System: influence of placement on the bifurcation and use of a proximal extension on early and late outcomes. J VAsc Surg 2008;48(4):785-801. Cragg A, Lend G, Rysavy J et al. Non surgical placement of arterial endoprosthesis: a new technique using nitinol wire. Radiology Criado1983;147:261-3.F. Techniques of endoluminal abdominal aortic aneurysms repair with the Talent stent-graft a manual. 1a Ed. Miami: World Medical,1997. Dotter CT, Buschmann RW, Mckinney MK, Rosch J. Transluminal expandable nitinol coil stent grafting: preliminary report. Radiology Dotter1983;147:259-60.CT.Transluminally-placed coilsprings endarterial tube graft: long-term patency in the canine popliteal artery. Invest Radiol Endologix1969;4:329-32.AFX[Internet].
Products [acesso em 12 abril 2018]. Disponível em: http://www.endologix.com /products/AFX. Endologix Nellix [Internet]. Products [acesso em 12 abril 2018]. Disponível em: http://www.endologix.com /products/nellix. Endologix Ovation [Internet]. Products [acesso em 12 abril 2018]. Disponível em: http://www.endologix.com /products/ovation. Franklin RN, Silveira PG, Timi JRR et al. Tomographic Measurements of Gutters and Analysis of the Conformability of Stent Grafts in the Octopus Technique for Endovascular Thoracoabdominal Aneurysm Repair. Ann Vasc Surg 2016 May;33:202-209. Guidoin R, Douville Y, Basle MF et al. Biocompatibility Studies of the Anaconda Stent-Graft and Observations of Nitinol Corrosion Resistence. J Endovasc Ther 2004;11:385-403. Hanawa T, Ota M. Calcium phosphate naturally formed on titanium in electrolyte solution. Biomaterials 1991;12:767-74. Hiramoto JS, Reilly LM, Schneider DB et al. Long-term outcome and reintervention after endovascular abdominal aortic aneurysm repair using Zenith stent graft. J Vasc Surg 2007;45(3):461-6. Hiramoto JS, Reilly LM, Schneider DB et al. Long-term outcome and reintervention after endovascular abdominal aortic aneurysm repair using Zenith stent graft. J Vasc Surg 2007;45(3):461-6.
Trivascular Ovation [Internet]. Products overview [acesso em 10 abril 2018]. Disponível em: http://www.trivascular.com /products. Vandy F, Upchurch GR. Endovascular Aneurysm Repair: Current Status. Circ Cardiovasc Interv 2012;5:871-82. Volodos NC, Karpovich Ip, Troyon VI et al. Clinical experience of the use of a self-fixing synthetic prosthesis for remote endoprosthetics of the thoracic and the abdominal aorta and iliac arteries through the femoral artery and as intraoperative endoprosthesis for aorta reconstruction. VASA Volodos1991;33:93-5NC,Shekhamin VE, Karpovich IP et al. Self fixing synthetic prosthesis for endoprosthetics of the vessels. Vestn Khin Im II Grek Weale1986;137:123-5.AR,Balasubramaniam K, Macierewicz J et al. Outcome and safety of Aorfix stent graft in highly angulated necks – a prospective observational study (Arbier 2). Eur J Endovasc Surg 2011;41(3):337-43. Williams DF, Williams RL. Degradative effects of the biological environment on metals and ceramics. In: Ratner BD, Hoffman AS, Achoen FJ, Lemons JE. Biomaterials Science; an introduction to materials in medicine. Vol. 1. San Diego: Academic Press, 1996. p. 260-67. Zipfel B, Buz S, Dusterhoft V, Hetzer R. Initial Experience with Abdominal Aneurysm Repair using the E-vita Abdominal Stent-Graft: A SingleCenter Study. J Endovasc Ther 2009;16:577.
Parte I32 CAPÍTULOS BÁSICOS Schoenhoff FS, Schmidli J, Eckstein FS et al. The frozen elephant trunk: An interesting hybrid endovascular-surgical technique to treat complex pathologies of the thoracic aorta. J Vasc Surg 2007;45:597-9. Silveira PG, von Ristow A, Galego GN. The easiness in correcting placement: The Apolo model. Sillabus - III Vascular Monographies –Endovascular Surgery for AAA. Barcelona november 2-3, 2000. Silveira PG,Barbosa LG, Narciso FR, et al. The Gore Global Registry for Endovascular Aortic Treatment (GREAT). Real-world experience in Brazil and worldwide with the GORE EXCLUDER AAA Endoprosthesis, GORE C3 Delivery System, GORE TAG Thoracic Endoprosthesis, and Conformable GORE TAG Thoracic Endoprosthesis. Supplement –Endovascular Today – February 2014. Sivamurthy N, Schneider DB, Reilly LM et al. Adjunctive primary stenting of Zenith endograft limbs during endovascular abdominal aortic aneurysm repair: Implications for limb patency. J Vasc Surg 2006;43(4):662-70. Smeds MR, Jacobs DL, Peterson GJ, Peterson BG. Short-term outcomes of the C3 excluder for patients with abdominal aortic aneurysms and unfavorable proximal aortic seal zones. Ann Vasc Surg 2013;27(1);8-15. Stokmans RA, Teijink JAW, Forbes TL et al. Early Results from the ENGAGE Registry: Real-world Performance of the Endurant Stent Graft for Endovascular AAA Repair in 1262 Patients. Eur J of Vasc Endovasc Surg 2012;44(4);369-75.
3. Kaufman J, Lee M. Vascular and interventional radiology. Philadelphia: Mosby; 2004.
10. Sampaio FJB, Uflacker R. Renal anatomy applied to urology, endourology and interventional radiology. New York: Thieme; 1993.
8. Agnelli G. Rationale for the use of platelet aggregation inhibitors in PAD patients. Vasc Med 2001;6(Suppl 1):13-5. 9. Castañeda-Zúñiga W. Interventional radiology, 3rd ed. Baltimore: Williams & Wilkins; 1997.
15. Manninen HI, Rasanen H. Intravascular ultrasound in interventional radiology. Eur Radiol 2000;10(11):1754-62.
1. Seldinger SI. Catheter placement of needles in percutaneous arteriography: a new technique. Acta Radiol 1953;39:368-76.
2. Odman P. Percutaneous selective angiography of the main branches of the aorta. Acta Radiol 1956;45:1-14.
4. Kandarpa K, Aruny J. Handbook of interventional radiologic procedures, 3rd ed. Baltimore: Lippincott Williams & Wilkins; 2001.
33 21Capítulo
18. Pannu N, Wiebe N, Tonelli M; Alberta Kidney Disease Network Prophylaxis strategies for contrast-induced nephropathy. JAMA 2006;295:2765-79.
20. Liu R, Nair D, Ix J et al. N-acetylcysteine for the prevention of contrastinduced nephropathy. A systematic review and meta-analysis. J Gen Intern Med 2005 Feb.;20(2):193-200. 21. Birck R, Krzossok S, Markowetz F et al. Acetylcysteine for prevention of contrast nephropathy: meta-analysis. Lancet 2003 Aug. 23;362(9384):598-603.
22. Marenzi G, Assanelli E, Marana I et al. N-acetylcysteine and contrastinduced nephropathy in primary angioplasty. NEJM 2006 June 29;354(26):2773-82.
26. Yamada R, Bracewell S, Bassaco B et al. Transradial versus transfemoral arterial access in liver cancer embolization: randomized trial to assess patient satisfaction. J Vasc Interv Radiol. 2018 Jan;29(1):38-43.
11. Pukin L. Devices and techniques for endovascular surgery: catheters, stents, coated stents and stent-grafts. Mount Sinai J Med 2003 Nov.;70(6):386-92.
14. Metz JA, Yock PG, Fitzgerald PJ. Intravascular ultrasound: basic interpretation. Cardiol Clin 1997;15(1):1-15.
17. Levy E, Viscoli CM, Horwitz RI. The effect of acute renal failure on mortality. A cohort analysis. JAMA 1996;275:1489-94.
TRATAMENTO ENDOVASCULAR –FUNDAMENTOS E TÉCNICAS BÁSICAS
13. Das R, Ahmed K, Athanasiou T et al. Arterial closure devices versus manual compression for femoral haemostasis in interventional radiological procedures: a systematic review and meta-analysis. Cardiovasc Intervent Radiol 2011;34(4):723-38.
27. Barbeau GR, Arsenault F, Dugas L et al. Evaluation of the ulnopalmar arterial arches with pulse oximetry and plethysmography: comparison with the Allen’s test in 1010 patients. Am Heart J. 2004 Mar;147(3):489-93.
REFERÊNCIAS BIBLIOGRÁFICAS
25. Elmstahl B, Nyman U, Leander P et al. Gadolinium contrast media are more nephrotoxic than a low osmolar iodine medium employing doses with equal x-ray attenuation in renal arteriography: an experimental study in pigs. Acad Radiol 2004;11:1219-28.
5. Baum S, Pentecost M. Abram’s angiography interventional radiology 2nd ed. Baltimore: Lippincott Williams & Wilkins; 2006. 6. Uflacker R. Radiologia intervencionista. São Paulo: Sarvier; 1987. 7. Kumar P, Ravi R, Sundar G, Shiach C. Direct oral anticoagulants: an overview for the interventional radiologist. Cardiovasc Intervent Radiol 2017;40(3):321-30.
16. Cockroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-4.
12. Hallet JW, Mills JL, Earnshaw JJ et al. Comprehensive vascular and endovascular surgery. Spain: Mosby; 2004.
19. Merten GJ, Burgess WP, Gray LV et al. Prevention of contrast-induced nephropathy with sodium bicarbonate. JAMA 2004;291:2328-34.
23. Gemery J, Geldon I, Reid S et al. Acute renal failure after arteriography with a gadolinium-based contrast agent. AJR Am J Roentgenol 1998;171:1277-8. 24. Thomsen HS. Guidelines for contrast media from the European Society of Urogenital Radiology. AJR Am J Roentgenol 2003;181:1463-71.
1. Prolo DJ, Hanbery JW. Intraluminal occlusion of a carotid-cavernous sinus fistula with a balloon catheter.Technical note. J Neurosurg 1971;35(2):237-42.
8. Yakes WF, Engelwood CO, Baker R. Cardiopulmonare collapse: sequelae of ethanol embolotherapy. Radiology 1993;189:145. 9. Struk D, Rankin RN, Karlik SJ. Stabilility studies on chemoembolization mixtures. Dialysis studies of doxorubicin and lipiodol with Avitene, Gelfoam, and Angiostat. Invest Radiol 1993 Nov;28(11):1024-7.
16. Rabkin JE, Astafjev VI, Gothman LN et al. Transcatheter embolization in the management of pulmonary hemorrhage. Radiology 1987;163(2):361-5.
21. Worthington-Kirsch RL, Popky GL, Hutchins FL. Uterine arterial embolization for the management of leiomyomas: quality-of-life assessment and clinical response. Radiology 1998;208(3):625-9.
15. Ramakantan R, Bandekar VG, Gandhi MS et al. Massive hemoptysis due to pulmonary tuberculosis: control with bronchial artery embolization. Radiology 1996;200(3):691-4.
19. Goodwin SC, Vedantham S, McLucas B et al. Preliminary experience with uterine artery embolization for uterine fibroids. J Vasc Interv Radiol 1997;8(4):517-26. 20. Bradley EA, Reidy JF, Forman RG et al. Transcatheter uterine artery embolisation to treat large uterine fibroids. Br J Obstet Gynaecol 1998;105(2):235-40.
11. Roberts AC. Bronchial artery embolization therapy. J Thorac Imaging 1990;5(4):60-72.
12. Uflacker R, Kaemmerer A, Picon PD et al. Bronchial artery embolization in the management of hemoptysis: technical aspects and long-term results. Radiology 1985;157(3):637-44.
31. Demeritt JS, Elmasri FF, Esposito MP et al. Relief of benign prostatic hyperplasia-related bladder outlet obstruction after transarterial polyvinyl alcohol prostate embolization. J Vasc Interv Radiol 2000;11(6):767-70. 32. Sun F, Sanchez FM, Crisóstomo V et al. Benign prostatic hyperplasia: transcatheter arterial embolization as potential treatment –Preliminary study in pigs. Radiology 2008;246(3):783-9. 33. Carnevale FC, Antunes AA, Leal Filho JMM et al. Prostatic artery embolization as a primary treatment for benign prostatic hyperplasia: preliminary results in two patients. J Vasc Interv Radiol 2010;33:355-61. 34. Pisco JM, Pinheiro LC, Bilhim T et al. Prostatic arterial embolization to treat benign prostatic hyperplasia. J Vasc Interv Radiol 2011;22:11-9. 35. Pisco JM. Prostatic artery embolisation: a promising alternative treatment for benign prostatic hyperplasia. Endovascular Today 2012:65-68. Disponível em: http://bmctoday.net/evtoday/pdfs/ et0412F6_Pisco.pdf 36. Sapoval M, Daroles J, Tinto HS et al. Techniques and considerations for the safe treatment of benign prostatic hyperplasia. Endovascular Today 2012:1-6. Disponível em: http://bmctoday.net/evtoday/pdfs/ et0412_F5_Sapoval.pdf 37. Carnevale FC, Antunes AA. Prostatic artery embolization for enlarge prostates due to benign prostatic hyperplasia. How I do it. Cardiovasc Intervent Radiol. 2013 Dec;36(6):1452-63. 38. Andrade G, Khoury HJ, Garzón WJ et al. Radiation exposure of patients and interventional radiologists during prostatic artery embolization: a prospective single-operator study. J Vasc Interv Radiol 2017 Apr;28(4):517-21. 39. Mordasini L, Hechelhammer L, Diener PA et al. Prostatic artery embolization in the treatment of localized prostate cancer: A bicentric prospective proof-of-concept study of 12 patients. J Vasc Radiol 2018;29:589-97. 40. Montague DK, Jarow J, Broderick GA et al. American Urological Association guideline on the management of priapism. J Urol 2003 Oct;170(4 Pt 1):1318-24. 41. El-Bahnasawy MS, Dawood A, Farouk A. Low-flow priapism: risk factors for erectile dysfunction. BJU Int 2002 Feb;89(3):285-90. 42. Gottsch HP, Berger RE, Yang CC. Priapism: comorbid factors and treatment outcomes in a contemporary series. Adv Urol 2012;672624.
29. Michel F, Dubruille T, Cercueil JP et al. Arterial embolization for massive hematuria following. 30. Kato T, Nemoto R, Mori H, Takahashi M et al. Arterial chemoembolization with microencapsulated anticancer drug: an approach to selective cancer chemotherapy with sustained effects. JAMA 1981;245(11):1123-7.
22. Emberton M, Andriole GL, De La Rosette J et al. Benign prostatic hyperplasia. A progressive disease of aging men. Urology 2003;61:267-73.
34 22Capítulo EMBOLIZAÇÃO TERAPÊUTICA
5. Golzarina J, Siskin GP, Sharafuddin M et al. Embolizations tools. In: Golzarian J. (Ed.). Vascular embolotherapy: a comprehensive approach. Berlin Heildelberg: Springer-Verlag; 2006. vol. 1.
18. Burn PR, McCall JM, Chinn RJ et al. Uterine fibroleiomyoma: MR imaging appearances before and after embolization of uterine arteries. Radiology 2000;214(3):729-34.
17. Ravina JH, Herbreteau D, Ciraru-Vigneron N et al. Arterial embolization to treat uterine myomata. Lancet 1995;346(8976):671-2.
13. Cohen AM, Doershuk CF, Stern RC. Bronchial artery embolization to control hemoptysis in cystic fibrosis. Radiology 1990;175(2):401-5.
2. Serbinenko FA. Balloon catheterization and occlusion of major cerebral vessels. J Neurosurg 1974;41(2):125-45.
27. Mitchell ME, Waltman AC, Athanasoulis CA et al. Control of massive prostatic bleeding with angiographic techniques. Br J Urol 1976;115:692-5. 28. Appleton DS, Sibley GNA, Doyle PT. Internal iliac artery embolisation for the control of severe bladder and prostate haemorrhage. Br J Urol 1988;61(1):45-47.
3. Debrun G, Lacour P, Caron JP et al. Inflatable and released balloon technique experimentation in dog – Application in man. Neuroradiology 1975;9(5):267-71.
10. Valji K. Pulmonary and bronchial arteries. In: Valji K. (Ed.). Vascular and interventional radiology. Philadelphia: WB Saunders; 1999. p. 259-82.
23. Ziada A, Rosenblum M, Crawford ED. Benign prostatic hyperplasia: an overview. Urology 1999;53(3;3a):1-6.
24. Guess HA, Arrighi HM, Metter EJ et al. Cumulative prevalence of prostatism matches the autopsy prevalence of benign prostatic hyperplasia. Prostate 1990;17(3):241-6.
25. AUA Practice Guidelines Committee. AUA guideline on management of benign prostatic hyperplasia. I. Diagnosis and treatment recommendations. Br J Urol 2003;170(2;1):530-47.
26. Appleton DS, Sibley GNA, Doyle PT. Internal iliac artery embolisation for the control of severe bladder and prostate haemorrhage. Br J Urol 1988;61(1):45-7.
6. Drolet BA, Scott LA, Esterli NB et al. Early surgical intervention in a patient with a Kasabach Merritt phenomenon. J Pediatr 2001;138:756-58.
REFERÊNCIAS BIBLIOGRÁFICAS
7. Hanafi M, Orliaghet G, Meyer P et al. Embolie pulmonair eau cours de la sclerotherapie percutanée d’un angiome veineux sous anesthesie generale chez un enfant. Ann Fr Anesth Reanim 2001;20:556-8.
4. Debrum G, Drake C, Peerless SJ et al.The treatment of carotid cavernous sinus and vertebral fistule by detachable balloons. Review of 43 cases. Annual Meeting of American Association of Neurological Surgeons: New York; 1980.
14. Hayakawa K, Tanaka F, Torizuka T et al. Bronchial artery embolization for hemoptysis: immediate and long-term results. Cardiovasc Intervent Radiol 1992;15(3):154-9.
69. Gonzalez EM, Gomez R, Garcia I et al. Liver transplantation in malignant primary hepatic neoplasms. Am J Surg 1992;163(4):395-400.
74. Ota H, Nagano H, Sakon M et al. A case of successful treatment of advanced hepatocellular carcinoma with tumor thrombi in the major portal branches and inferior vena cava with combined intraarterial 5-fluorouracil, adriamycin and cisplatin therapy. Gan To Kagaku Ryoho 2003;30(11):1673-77.
47. Llovet JM, Bruix J. Novel advancements in the management of hepatocellular carcinoma in 2008. J Hepatol 2008;48(Suppl 1):S20-S37.
55. Meza-Junco J, Montano-Loza AJ, Liu DM et al. Locoregional radiological treatment for hepatocellular carcinoma: which, when and how? Cancer Treat Rev 2012;38:54-62.
44.
80. Hind D, Tappenden P, Tumur I et al. The use of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer: systematic review and economic evaluation. Health Technol Assess 2008;12(15):iii-ix, xi-162. 81. Lammer J, Malagari K, Vogl T et al. Prospective randomized study do doxorubicin-eluting-bead embolization carcinoma: results of the Precision V Study. Cardiovasc Intervent Radiol 2010;33(1):41-52. 82. Fouad H, Metzger T, Tatum C et al. Hepatic arterial therapy with drug-eluting beads in the management of metastatic bronchogenic carcinoma to the liver: a multi-institutional registry. J Oncol 2012;2012:292131. 83. May BJ, Talenfeld AD, Madoff DC. Uptate on portal vein embolization: evidence-based outcomes, controversies, and novel strategies. J Vasc Interv Radiol 2013;24:241-54. 84. Van Lienden KP, Van den Esschert JW, Graaf W, Bipat S et al. Portal vein embolization before liver resection: a systematic review. Cardiovasc Intervent Radiol 2013;36:25-34. 85. Lupattelli T, Abubacker Z, Morgan R et al. Embolization of a renal artery aneurysm using ethylene vinyl alcohol copolymer (Onyx). J Endovasc Ther 2003;10(2):366-70. 86. Marchiori A, Ristow AV, Guimaraes M et al. Predictive factors for the de development of type II endoleaks. J Endovasc Ther 2011;18:299-305. 87. Gallagher KA, Ravin RA, Meltzer AJ et al. Meterm outcomes after treatment of type II endoleaks associated with aneurysm sac expansion. J Endovasc Ther 2012;19:182-92.
50. Bruix J, Sala M, Llovet JM. Chemoembolization for hepatocellular carcinoma. Gastroenterology 2004;127(5 Suppl 1):S179-S188.
56. Cohen AD, Kemeny NE. An update on hepatic arterial infusion chemotherapy for colorectal cancer. Oncologist 2003;8(6):553-6.
45.
62. Reed RA, Teitelbaum GP, Daniels JR et al. Prevalence of infection following hepatic chemoembolization with cross-linked collagen with administration of prophylactic antibiotics. J Vasc Interv Radiol 1994;5(2):367-71.
49. Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 2003;37:429-42.
46. Bruix J, Sherman M. Practice Guidelines Committee; American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology 2005;42:1208-36.
68. Moreno P, Jaurrieta E, Figueras J et al. Orthotopic liver transplantation: treatment of choice in cirrhotic patients with hepatocellular carcinoma? Transplant Proc 1995;27(4):2296-8.
75. Wada H, Nagano H, Dono K et al. Successful treatment for advanced cholangiocellular carcinoma with intrahepatic metastasis and/or portal vein tumor thrombi by intraarterial chemotherapy combined with 5-fluorouracil, adriamycin and cisplatin (FAP) – Two cases report. Gan To Kagaku Ryoho 2004;31(11):1711-3.
64. Brown DB, Pilgram TK, Darcy MD et al. Hepatic arterial chemoembolization for hepatocellular carcinoma: comparison of survival rates with different embolic agents. J Vasc Interv Radiol 2005;16(12):1661-6.
66. Bismuth H, Morino M, Sherlock D et al. Primary treatment of hepatocellular carcinoma by arterial chemoembolization. Am J Surg 1992;163(4):387-94.
59. Lammer J, Malagary K, Vogl T et al. Prospective randomized study of doxorubicin-eluting-bead embolization of the hepatocellular carcinoma: results of de Precision V Study. Cardiovasc Intervent Radiol 2010;33:41-52.
60. Martin RC, Scoggins CR, Tomalty D et al. Irinotecan drug-eluting beads in the treatment of chemo-naive unresectable colorectal liver metastasis with concomitant systemic fluorouracil and oxaliplatin: results of pharmacokinetics and phase I trial. J Gastrointest Surg 2012;16(8):1531-8.
63. Clouse ME, Stokes KR, Kruskal JB et al. Chemoembolization for hepatocellular carcinoma: epinephrine followed by a doxorubicinethiodized oil emulsion and gelatin sponge powder. J Vasc Interv Radiol 1993;4(6):717-25.
73. Sumie S, Yamashita F, Ando E et al. Interventional radiology for advanced hepatocellular carcinoma: comparison of hepatic artery infusion chemotherapy and transcatheter arterial lipiodol chemoembolization. AJR Am J Roentgenol 2003;181(5):1327-34.
57. Sullivan RD, Norcross JW, Watkins Jr E. Chemotherapy of metastatic liver cancer by prolonged hepatic-artery infusion. N Engl J Med 1964;270:321-7.
58. Poon RTP, Tso WK, Pang RWC et al. A phase I/II trial of chemoembolization for hepatocellular carcinoma using a novel intra-arterial drug eluting bead. Clin Gastroenterol Hepatol 2007;5:1100-8.
53. Song DS, Choi JY, Yoo SH et al. DC bead transarterial chemoembolization is effective in hepatocellular carcinoma refractory to conventional transarteral chemoembolization: a pilot study. Gut Liver 2013 Jan;7(1):89-95.
51. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003;362:1907-17.
76. Martinelli DJ, Wadler S, Bakal CW et al. Utility of embolization or chemoembolization as second-line treatment in patients with advanced or recurrent colorectal carcinoma. Cancer 1994;74(6):1706-12.
48. Lo CM, Ngan H, Tso WK et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 2002;35:1164-71.
61. Martin RC, Robbins K, Tomalty D et al. Transarterial chemoembolization (TACE) using irinotecan-loaded beads for the treatment of unresectable metastases to the liver in patients with colorectal cancer: an interim report. World J Surg Oncol 2009;3(7):80.
78. Sakamoto I, Aso N, Nagaoki K et al. Complications associated with transcatheter arterial embolization for hepatic tumors. Radiographics 1998;18(3):605-19.
65. Miura T, An M, Matsumoto Y et al. Transcatheter oily chemoembolization and intermittent hepatic artery infusion chemotherapy in the management of advanced hepatocellular carcinoma. Gan To Kagaku Ryoho 1998;25(9):1262-5.
43. Broderick GA, Harkaway R. Pharmacologic erection: time-dependent changes in the corporal environment. Int J Impot Res 1994;6:9-16. Montague DK, Jarow J, Broderick GA, Dmochowski RR, Heaton JP, Lue TF et al. American Urological Association guideline on the management of priapism. J Urol 2003 Oct;170(4 Pt 1):1318-24. Parkin DM, Bray F, Ferlay J, Pisani P. CA-Global cancer statistics, 2002. Cancer J Clin 2005;55:74-108.
Capítulo 22 35emboliz Ação ter APêutiCA
70. Harnois DM, Steers J, Andrews JC et al. Preoperative hepatic artery chemoembolization followed by orthotopic liver transplantation for hepatocellular carcinoma. Liver Transpl Surg 1999;5(3):192-9.
79. Llovet JM, Real MI, Montana X et al. Arterial embolization or chemoembolization versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 2002;359(9319):1734-9.
52. Marelli L, Stigliano R, Triantos C et al. Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies. Cardiovasc Intervent Radiol 2007;30:6-25.
72. Richard HM, Silberzweig JE, Mitty HA et al. Hepatic arterial complications in liver transplant recipients treated with pretransplantation chemoembolization for hepatocellular carcinoma. Radiology 2000;214(3):775-9.
67. Takaki H, Yamakado K, Uraki J et al. Radiofrequency ablation combined with chemoembolization for the treatment of hepatocellular carcinomas larger than 5 cm. J Vasc Interv Radiol 2009;20:217-29.
71. Martin M, Tarara D, Wu YM et al. Intrahepatic arterial chemoembolization for hepatocellular carcinoma and metastatic neuroendocrine tumors in the era of liver transplantation. Am Surg 1996;62(9):724-32.
77. Lang EK, Brown Jr CL. Colorectal metastases to the liver: selective chemoembolization. Radiology 1993;189(2):417-22.
54. Lammer J, Malagari K, Vogl T et al. Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study. Cardiovasc Intervent Radiol 2010;33:41-52.
100. Kalman D, Varenhorst E. The role of arterial embolization in renal cell carcinoma. Scand J Urol Nephrol 1999;33(3):162-70.
115. Albrecht RM, Schermer CR, Morris A. Nonoperative management of blunt splenic injuries: factors influencing success in age 55 years. Ann Surg 2002;68(3):227-31.
128. Harned RK, Thompson HR, Kumpe DA et al. Partial splenic embolization in five children with hypersplenism: effects of reduced-volume embolization on efficacy and morbidity. Radiology 1998;209(3):803-6. 129. Kimura F, Itoh H, Ambiru S et al. Long-term results of initial and repeated partial splenic embolization for the treatment of chronic idiopathic thrombocytopenic purpura. AJR Am J Roentgenol 2002;179(5):1323-6.
102.
103.
97. Sathanandam S, Justino H, Waller BR 3rd et al. The Medtronic Micro Vascular Plug™ for vasculare embolization in children with congenital heart diseases. J Interv Cardiol 2017 Apr;30(2):177-184.
116. Link DP, Seibert JA, Gould J et al. On-line monitoring of sequential blood flow reduction during splenic embolization. Acta Radiol 1989;30(1):101-3. 117. Sclafani SJ, Shaftan GW, Scalea TM et al. Nonoperative salvage of computed tomography-diagnosed splenic injuries: utilization of angiography for triage and embolization for hemostasis. J Trauma 1995;39(5):818-27. 118. Bessoud B, Denys A. Main splenic artery embolization using coils in blunt splenic injuries: effects on the intrasplenic blood pressure. Eur Radiol 2004;14(9):1718-9. 119. McDermott VG, Shlansky-Goldberg R, Cope C. Endovascular management of splenic artery aneurysms and pseudoaneurysms. Cardiovasc Intervent Radiol 1994;17(4):179-84. 120. Guillon R, Garcier JM, Abergel A et al. Management of splenic artery aneurysms and false aneurysms with endovascular treatment in 12 patients. Cardiovasc Intervent Radiol 2003;26(3):256-60. 121. Kim BS, Do HM, Razavi M. N-butyl cyanoacrylate glue embolization of splenic artery aneurysms. J Vasc Interv Radiol 2004;15(1):91-4. 122. Peck-Radosavljevic M. Hypersplenism. Eur J Gastroenterol Hepatol 2001;13(4):317-23. 123. Sangro B, Bilbao I, Herrero I et al. Partial splenic embolization for the treatment of hypersplenism in cirrhosis. Hepatology 1993;18(2):309-14. 124. Romano M, Giojelli A, Capuano G et al. Partial splenic embolization in patients with idiopathic portal hypertension. Eur J Radiol 2004;49(3):268-73.
134. Borges L, Dias E, Cassio I. Método combinado de embolização da artéria esplénica e esplenectomia laparoscópica — caso clínico. Combined technique of splenic artery embolization and laparoscopic splenectomy. Case report. Disponível em: https://doi.org/10.1016/ S1646-706X(13)70007-7. 135. Madoff DC, Denys A, Wallace MJ et al. Splenic arterial inter ventions: Anatomy, indications, technical considerations and potential complications. Radio Graphics 2005;25:191-211. 136. He XH, Gu JJ, Li WT et al. Comparison of total splenic artery embolization and partial splenic embolization for hyper splenism. World J Gastroenterol 2012;18:3138-44. 137. Hirota S, Ichikawa S, Matsumoto S et al. Interventional radiologic treatment for idiopathic portal hypertension. Cardiovasc Intervent Radiol 1999;22(4):311-4. 138. Sato T, Yamazaki K, Toyota J et al. Gastric varices with splenic vein occlusion treated by splenic arterial embolization. J Gastroenterol 2000;35(4):290-5.
109.
101. Klimberg I, Hunter P, Hawkins IF et al. Preoperative angioinfarction of localized renal cell carcinoma using absolute ethanol. J Urol 1985;133(1):21-4. Bakar CW, Cynamon J, Lakritz PS et al. Value of preoperative renal artery embolization in reducing blood transfusion requirements during nephrectomy for renal cell carcinoma. J Vasc Interv Radiol 1993;4(6):727-31. Lanigan D, Jurriaans E, Hammonds JC et al. The current status of embolization in renal cell carcinoma — a survey of local and national practice. Clin Radiol 1992;46(3):176-8. 104. Wallace S, Chuang VP, Swanson D et al. Embolization of renal carcinoma. Radiology 1981;138(3):563-70. Lin PH, Bush RL, Eraso A et al. Intraoperative renal artery embolization with concomitant nephrectomy: a novel treatment approach for renal cell carcinoma, with potencial benefits of cost saving and reduction of postinfarction syndrome. Endovascular Today 2005. p. 28-88. Disponível em: Bastounis E, Pikoulis E, Georgopoulos S et al. Surgery for renal artery aneurysms: a combined series of two large centers. Eur Urol 1998;33(1):22-7. Pfeiffer T, Reiher L, Grabitz K et al. Reconstruction for renal artery aneurysm: operative techniques and long-term results. J Vasc Surg 2003;37(2):293-300. Rundback JH, Rizvi A, Rozenblit GN et al. Percutaneous stentgraft management of renal artery aneurysms. J Vasc Interv Radiol 2000;11(9):1189-93. Cabello R, Acosta D, Echenagusia M et al. Renal allograft laceration treated by superselective embolization. J Endovasc Ther 2006;13(2):260-3. Klein GE, Szolar DH, Breinl E et al. Endovascular treatment of renal artery aneurysms with conventional non-detachable microcoils and Guglielmi detachable coils. Br J Urol 1997;79(6):852-60.
130. Nio M, Hayashi Y, Sano N et al. Long-term efficacy of partial splenic embolization in children. J Pediatr Surg 2003;38(12):1760-2.
131. Poulin EC, Mamazza J, Schlachta CM. Splenic artery embolization before laparoscopic splenectomy: an update. Surg Endosc 1998;12:870-5.
88. Rayt HS, Sandford RM, Salem M et al. Conservative managment of type 2 endoleaks is not associated with increased risk of aneurysm rupture. J Endovasc Surg 2009;38:718-23. 89. Silverberg D, Baril DT, Ellozy SH et al. An 8 year experience with type II endoleaks: natural history suggests selective intervention is a safe approach. J Endovasc Surg 2006;44:453-9. 90. Rosinvalle S et al. Aneurysm sac “trombization” and stabilization in evar: a technique to reduce the risk of type II endoleak. J Endovasc Ther 2010;17:517-24. 91. Hinckliffe RJ, Singh-Ranger R, Whitaker SC et al. Type II endoleak: transperitonealsacotomy and ligation of side branch endoleaks responsible for aneurysm sac expansion. J Endovasc Ther 2002;9:539-42. 92. Shimohira M, Hashizume T, Suzuki Y et al. Triaxial System for Embolization of Type II Endoleak After Endovascular Aneurysm Repair. J Endovasc Ther 2013;20:200-4. 93. Teigen C, Moyle H, Patel R et al. Experience using the penumbra ruby coil in the peripheral vasculature: ACE Multicenter Study Preliminary Results. JVIR 2015:26;148. 94. Matsuura JH, Rosenthal D, Jerius H et al.Traumatic carotid artery dissection and pseudoaneurysm treated with endovascular coils and stent. J Endovasc Surg 1997;4(4):339-43.
99. Mebust WK, Weigel JW, Lee KR et al. Renal cell carcinoma: angioinfarction. J Urol 1984;131(2):231-5.
107.
Parte I36 CAPÍTULOS BÁSICOS
110.
113. Velmahos GC, Chan LS, Kamel E et al. Nonoperative management of splenic injuries: have we gone too far? Arch Surg 2000;135(6):674-81.
114. Wahl WL, Ahrns KS, Chen S et al. Blunt splenic injury: operation versus angiographic embolization. Surgery 2004;136(4):891-9.
132. Reso A, Brar MS, Church N, et al. Outcome of laparoscopic splenectomy with preoperative splenic artery embolization for massive splenomegaly. Surg Endosc 2010;24:2008-12.
133. Wu Z, Zhou J, Pankaj P, Peng B. Comparative treatment and literature review for laparoscopic splenectomy alone versus preoperative splenic artery embolization splenectomy Surg Endosc 2012;26:2758-66.
125. Athale UH, Kaste SC, Bodner SM et al. Splenic rupture in children with hematologic malignancies. Cancer 2000;88(2):480-90. 126. Pringle KC, Spigos DG, Tan WS et al. Partial splenic embolization in the management of thalassemia major. J Pediatr Surg 1982;17(6):884-91. 127. Jonasson O, Spigos DG, Mozes MF. Partial splenic embolization: experience in 136 patients. World J Surg 1985;9(3):461-67.
98. Brown DB. Concepts, considerations, and concerns on the cutting edge of radiofrequency ablation. J Vasc Interv Radiol 2005;16(5):597-613.
105.
111. Bratby MJ, Lehmann ED, Bottomley J et al. Endovascular embolization of visceral artery aneurysms with ethylenevinyl alcohol (Onyx): a case series. Cardiovasc Intervent Radiol 2006;29:1125-8. 112. Rautio R, Haapanen A. Transcatheter embolization of a renal artery aneurysm using ethylene vinyl alcohol copolymer. Cardiovasc Intervent Radiol 2007;30:300-3.
95. Mager JJ, Overtoom TT, Blauw H et al. Embolotherapy of pulmonary arteriovenous malformations: long-term results in 112 patients. J Vasc Interv Radiol 2004;15(5):451-6. 96. Cil B, Canyigit M, Ozkan OS et al. Bilateral multiple pulmonary arteriovenous malformations: endovascular treatment with the amplatzer vascular plug. J Vasc Interv Radiol 2006;17(1):141-5.
108.
PDFarticles/1105/EVT1105_F1_Linrenal.pdfhttp://www.evtoday.com/ 106.
176. Kauvar DS, Lefering R, Wade CE. Impact of hemorrhage on trauma outcome: an overview of epidemiology, clinical presentations, and therapeutic considerations. J Trauma. 2006;60(6 Suppl):S3-11.
168. Morrison J, Reva V, Lars Lönn L et al. Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA). Management. In: Dubose JJ, Jonathan JM, Reva VA, Matsumoto J, Matsumura Y. Top Stent: The art of endovascular hybrid Trauma and bleeding. Publisher: Örebro University Hospital, c/o Kärl Thorax Kliniken Södra Grev Rosengatan, 701 85 Örebro, Sweden. 2017. p. 77-98.
148. Atar E, Feldman G, Neyman H et al. Percutaneous treatment of a celiac artery aneurysm using a stent graft. Isr Med Assoc J 2004;6(6):370-1.
145. McMullan DM, McBride M, Livesay JJ et al. Celiac artery aneurysm: a case report. Tex Heart Inst J 2006;33(2):235-40.
183. Capasso P, Simons C, Trotteur G et al. Treatment of symptomatic pelvic varices by ovarian vein embolization. Cardiovasc Intervent Radiol 1997;20(2):107-11.
142. Rimoldi P, Belli LS, Rondinara GF et al. Recurrent HBV/HDV infections under different immunoprophylaxis protocols. Transplant Proc 1993;25(4):2675-6.
154. Ghassemi A, Javit D, Dillon EH. Thrombin injection of a pancreaticoduodenal artery pseudoaneurysm after failed attempts at transcatheter embolization. J Vasc Surg 2006;43(3):618-22.
156. Chan RP, David E. Reperfusion of splanchnic artery aneurysm following transcatheter embolization: treatment with percutaneous thrombin injection. Cardiovasc Intervent Radiol 2004;27(3):264-7.
149. Atkins BZ, Ryan JM, Gray JL. Treatment of a celiac artery aneurysm with endovascular stent grafting – A case report. Vasc Endovascular Surg 2003;37(5):367-73.
174. Russo RM, Girda E, Kennedy V, Humphries MD. Two lives, one REBOA: hemorrhage control for urgent cesarean hysterectomy in a Jehovah’s Witness with placenta percreta. J Trauma Acute Care Surg 2017;83(3):551-3. 175. Karkos CD, Bruce IA, Lambert ME. Use of the intra-aortic balloon pump to stop gastrointestinal bleeding. Ann Emerg Med 2001;38(3):328-31.
184. Venbrux AC, Chang AH, Kim HS et al. Pelvic congestion syndrome (pelvic venous incompetence): impact of ovarian and internal iliac vein embolotherapy on menstrual cycle and chronic pelvic pain. J Vasc Interv Radiol 2002;13(2):171-8.
178. Miura F, Takada T, Ochiai T, Asano T et al. Aortic occlusion balloon catetertecnique is useful for uncontrollable massive intra-abdominal bleeding after hepato-pancreato-biliary surgery. J Gastrointest Surg 2016;10(4):519-22.
152. Syed M, Shaikh A, Neravetla S. Celiac artery aneurysm embolization by coil occlusion. Ann Vasc Surg 2005;19(1):113-9.
162. Martinelli T, Thony F, Declety P, Sengel C et al. Intra-aortic balloon occlusion to salvage patients with life-threatening hemorrhagic shocks from pelvic fractures. J Trauma 2010;68(4):942-8.
159. Hollis Jr HW, Luethke JM, Yakes WF et al. Percutaneous embolization of an internal iliac artery aneurysm: technical considerations and literature review. J Vasc Interv Radiol 1994;5(3):449-51.
140. Taniai N, Onda M, Tajiri T et al. Endoscopic Variceal Ligation (EVL) combined with Partial Splenic Embolization (PSE). Hepatogastroenterology 1999;46(29):2849-53.
169. Tal Hörer, Top Stent. The art of endovascular hybrid trauma management. Editor Örebro University hospital.
139. Xu RY, Liu B, Lin N. Therapeutic effects of endoscopic variceal ligation combined with partial splenic embolization for portal hypertension. World J Gastroenterol 2004;10(7):1072-74.
173. Manzano Nunez R, Naranjo MP, Foianini E, Ferrada P, Rincon E, García-Perdomo HA, et al. A meta-analysis of resuscitative endovascular balloon occlusion of the aorta (REBOA) or open aortic cross-clamping by resuscitative thoracotomy in non-compressible torso hemorrhage patients. World J Emerg Surg 2017;12(1):30.
177. Okada A, Nakamoto O, Komori M, Arimoto H, Rinka H, Nakamura H. Resuscitative endovascular balloon occlusion of the aorta as an adjunct for hemorrhagic shock due to uterine rupture: a case report. Clin Case Rep 2017;5(10):1565-8.
179. Clark JA, Pugash RA, Faughnan ME et al. Multidisciplinary team interested in the treatment of pulmonary arteriovenous fistulas or malformations (PAVFs). World J Surg 2001;25(2):254-5.
150. Jorna FH, Verhoeven EL, Bos WT et al. Treatment of a ruptured thoracoabdominal aneurysm with a stent-graft covering the celiac axis. J Endovasc Ther 2006;13(6):770-4.
163. Stannard A, Eliason JL, Rasmussen TE. Resuscitative endovascular balloon occlusion of the aorta (REBOA) as an adjunct for hemorrhagic shock. J Trauma 2011;71(6):1869-72.
164. Moore LJ, Brenner M, Kozar RA, Pasley J et al. Implementation of resuscitative endovascular balloon occlusion of the aorta as an alternative to resuscitative thoracotomy for noncompressible truncal hemorrhage. J Trauma Acute Care Surg 2015;79(4):523-30 (discussion 30-2).
155. Luchs SG, Antonacci VP, Reid SK et al. Vascular and interventional case of the day. Pancreatic head pseudoaneurysm treated with percutaneous thrombin injection. AJR Am J Roentgenol 1999;173(3):830, 833-34.
143. Uflacker R, Selby JB, Chavin K et al. Transcatheter splenic artery occlusion for treatment of splenic artery steal syndrome after orthotopic liver transplantation. Cardiovasc Intervent Radiol 2002;25(4):300-6.
181. Chen YM, Wang IK, Ng KK et al. Nutcracker syndrome: an overlooked cause of hematuria. Chang Gung Med J 2002;25(10):700-5.
144. Watanabe Y, Todani T, Noda T. Changes in splenic volume after partial splenic embolization in children. J Pediatr Surg 1996;31(2):241-4.
153. Schoder M, Cejna M, Langle F et al. Glue embolization of a ruptured celiac trunk pseudoaneurysm via the gastroduodenal artery. Eur Radiol 2000;10(8):1335-7.
157. Sparrow P, Asquith J, Chalmers N. Ultrasonic-guided percutaneous injection of pancreatic pseudoaneurysm with thrombin. Cardiovasc Intervent Radiol 2003;26(3):312-5.
165. Belenkiy SM, Batchinsky AI, Rasmussen TE, Cancio LC et al. Resuscitative endovascular balloon occlusion of the aorta for hemorrhage control: past, present, and future. J Trauma Acute Care Surg 2015;79(4 Suppl. 2):S236-S242.
170. Ribeiro Júnior MAF, Brenner M, Nguyen et al. Resuscitative endovascular balloon occlusion of the aorta (REBOA): na uptdated review. Rev Col Bras Cir [online] 2018;45(1):e1709. 171. Okada Y, Narumiya H, Ishi W, Iiduka R. Anatomical landmarks for safely implementing resuscitative balloon occlusion of the aorta (REBOA) in zone 1 without fluoroscopy. Scand J Trauma Resusc Emerg Med 2017;25(63):1-5.
161. Araujo AP. Controle de hemorragia abdominal grave com cateter balão fluxo-dirigível via artéria braquial: modelo experimental. 2006. 101 f. Doutorado (Departamento de Cirurgia). Universidade Federal do Rio de Janeiro – RJ.
146. Wolf RK, Carmichael PA, Clark JH. Celiac artery aneurysmectomy with pancreatectomy. J Vasc Surg 1986;3(5):817-9.
Capítulo 22 37emboliz Ação ter APêutiCA
166. Moore LJ, Martin CD, Harvin JA et al. Resuscitative endovascular balloon occlusion of the aorta for control of noncompressible truncal hemorrhage in the abdomen and pelvis. Am J Surg 2016 Dec;212(6):1222-30.
182. Perkov D, Vrkić Kirhmajer M, Novosel L, Popić Ramač J. Transcatheter ovarian vein embolisation without renal vein stenting for pelvic venous congestion and nutcracker anatomy. Vasa 2016;45(4):337-41.
141. Palsson B, Hallen M, Forsberg AM et al. Partial splenic embolization: long-term outcome. Langenbecks Arch Surg 2003;387(11-12):421-6.
172. Du Bose JJ, Scalea TM, Brenner M, Skiada D. AAST AORTA Study Group. The AAST prospective Aortic Occlusion for Resuscitation in Trauma and Acute Care Surgery (AORTA) registry: Data on contemporary utilization and outcomes of aortic occlusion and resuscitative balloon occlusion of the aorta (REBOA). J Trauma Acute Care Surg 2016 Sep;81(3):409-19.
158. Manazer JR, Monzon JR, Dietz PA et al. Treatment of pancreatic pseudoaneurysm with percutaneous transabdominal thrombin injection. J Vasc Surg 2003;38(3):600-2.
147. Graham JM, Mc Collum CH, Debakey ME. Aneurysms of the splanchnic arteries. Am J Surg 1980;140(6):797.
151. Misumi T, Nishikawa K, Yasudo M et al. A case of successful transcatheter arterial embolization of ruptured celiac artery aneurysm (abstract). Jpn J Thorac Cardiovasc Surg 2000;29:389-92.
160. Kritpracha B, Comerota AJ. Unilateral lower extremity paralysis after coil embolization of an internal iliac artery aneurysm. J Vasc Surg 2004;40(4):819-21.
167. Costantini TW, Coimbra R, Holcomb JB et al. AAST Pelvic Fracture Study Group. Current management of hemorrhage from severe pelvic fractures: Results of an American Association for the Surgery of Trauma multi-institutional trial. J Trauma Acute Care Surg 2016 May;80(5):717-23; discussion 723-5.
180. Prasad V, Chan RP, Faughnan ME. Embolotherapy of pulmonary arteriovenous malformations: efficacy of platinum versus stainless steel coils. J Vasc Interv Radiol 2004;15(2):153-60.
198. Maleux G, Stockx L, Wilms G et al. Ovarian vein embolization for the treatment of pelvic congestion syndrome: long-term technical and clinical results. J Vasc Interv Radiol 2000;11(7):859-64.
190. Howard F. Causes of chronic pelvic pain in women. Uptodate on line, 2009. Disponível em: www.uptodateonline.com 191. Venbrux AC, Lambert DL. Embolization of the ovarian veins as a treatment for patients with chronic pelvic pain caused by pelvic venous incompetence (pelvic congestion syndrome). Curr Opin Obstet Gynecol 1999;11(4):395-9.
186. Kim HS, Malhotra AD, Rowe PC et al. Embolotherapy for pelvic congestion syndrome: long-term results. J Vasc Interv Radiol 2006;17(2):289-97.
185. Maleux G, Stockx L, Wilms G et al. Ovarian vein embolization for the treatment of pelvic congestion syndrome: long-term technical and clinical results. J Vasc Interv Radiol 2000;11(7):859-64.
192. Ratnam LA, Marsh P, Holdstock JM et al. Pelvic vein embolisation in the management of varicose veins. Cardiovasc Intervent Radiol 2008;31:1159-64. 193. Boomsa JHB, Potocky V, Kievit CEL et al. Phebography and embolization in women with pelvic vein insuffiency. Medicamundi 1998;42(2):22-9.
197. Venbrux AC, Chang AH, Kim HS et al. Pelvic Congestion Syndrome (Pelvic Venous Incompetence): impact of ovarian and internal iliac vein embolotherapy on menstrual cycle and chronic pelvic pain. Vasc Interv Radiol 2002;13:171-8.
200. Rozenblit AM, Ricci ZJ, Tuvia J et al. Incompetent and dilated ovarian veins a common CT finding in asymptomatic parous women. AJR 2001;176:119-22. 201. Oxford Centre for Evidence Based Medicine. Is of evidence and grades of recommendations. Disponível em: <http://cebm.jr2.ox.ac. uk/docs/old_levels.html>. 202. Lopez AJ. Female Pelvic Vein Embolization: Indications, Techniques, and Outcomes. CVIR 2015;38:806-20. 203. Borghi C, Dell’Atti L. Pelvic congestion syndrome: the current state of the literature. Arch Gynecol Obstet 2016;293:291-301. 204. Dorobisz TA, Garcarek JS, Kurcz J et al. Diagnosis and treatment of pelvic congestion syndrome: Single-center experiences. Adv Clin Exp Med 2017 Mar-Apr;26(2):269-76. 205. Leal Monedero J, ZubicoaEzpeleta S, Perrin M. Management of left renal vein compression in patients presenting left gonadal vein reflux. Phlebology 2017 Jan 1:268355517723992. 206. Siqueira FM, Monsignore LM, Rosa-E-Silva JC, Poli-Neto OB et al. Evaluation of embolization for periuterine varices involving chronic pelvic pain secondary to pelvic congestion syndrome. Clinics (Sao Paulo) 2016 Dec 1;71(12):703-8. 207. Rabe E, Pannier F. Response to letter regarding Embolization is not essential in the treatment of leg varices due to pelvic venous insufficiency. Phlebology 2016 Sep;31(8):589. 208. Daniels JP, Champaneria R, Shah L et al. Effectiveness of embolization or sclerotherapy of pelvic veins for reducing chronic pelvic pain: a systematic review. J Vasc Interv Radiol 2016 Oct;27(10):1478-86.
Parte I38 CAPÍTULOS BÁSICOS
187. Cordts PR, Eclavea A, Buckley PJ et al. Pelvic congestion syndrome: early clinical results after transcatheter ovarian vein embolization. J Vasc Surg 1998;28(5):862-8.
196. Kim SH, Malhotra AD, Rowe PC et al. Embolotherapy for pelvic congestion syndrome: long-term results. J Vasc Interv Radiol 2006;17:289-97.
195. Chung MH, Huh CY. Comparison of treatments for pelvic congestion syndrome. Tohoku J Exp Med 2003;201:131-8.
194. Creton D, Hennequin L, Kohler F et al. Embolization of symptomatic pelvic veins in women presenting with non-saphenous varicose veins of pelvic origin: three-year follow-up. Eur J Vasc Endovasc Surg 2007;34:112-7.
188. D’Amato R, Figueira Gonçalves JM, Palmero Tejera JM. Pulmonary embolism due to metal coil migration after treatment of pelvic varices. Arch Bronconeumol 2017;53(2):72. 189. Marcelin C. Embolization of ovarian vein for pelvic congestion syndrome with ethylene vinyl alcohol copolymer (Onyx®). Diagn Interv Imaging 2017 Dec;98(12):843-8.
199. Ashour MA, Hisham DA, Solimam ET et al. Role of descending venography and endovenous embolization in treatment of females with lower extremity varicose veins, vulvar and posterior thigh varices. Saudi Med J 2007;28(2):206-12.
9. Younes HK. Retrograde Transpopliteal Access Is Safe and Effective –It Shoul Be Added to the vascular Surgeon’s Portifolio. Ann Vascular Surgery (Elsevier) 2015;29:260-265.
8. Pappy R, Hennebry TA, Aby-Fadel MS. Retrograde Access via the Popliteal Artery to Facilitate the Re-entry Technique for Recaocitrant Superficial Femoral Artery Chronic Total Occlusions – 2011. https:// doi.org/10.1002/ccd.23039. Acesso em: 12 set 2018.
10. Met R, Van Lienden KP, Koelemay MJ et al. Subintimal angioplasty for peripheral arterial occlusive disiese: a systematic review. Cardiovasc Intervent Radiol 2008;31:687e97.
1. Major RH. The history of physical diagnosis. In: Delp MH, Manning RT eds. Major’s physical diagnosis. Philadelphia: WB Saunders; 1968. p. 1-12. 2. Faivre J. Études experimentales sur les lesions organique du co eur. Gaz Med Paris 1856;727. 3. Bleichroeder F. Intra-arterielle therapie. Berl Klin Wchschr 1912;1503. 4. Seldinger SI. Catheter replacement of the needle in percutaneous arteriography: a new technique. Acta Radiologica [Old Series] 39:5, 368-376. 5. Cronenwett JL, Johnston KW et al Rutherford: Cirurgia Vascular. 8. ed. Rio de Janeiro: Editora Elsevier; 2016. Vol 2, 88. p.1304-1321.
20. Coppola JT, Staniloae C. Radial Access for Peripheral Vascular Procedures. Endovascular Today. Janeiro, 2012. 21. SOS TA et al. Brachial and Axillary Access. Endovascular Today. 2010. 22. Harris W, Warner CJ, Hnath JC et al. Percutaneous axillary access for endovascular interventions. J Vasc Surg 2018;68(2):555-559. 23. Araújo S. Acesos Venosos Centrais e Arteriais Periféricos – Aspectos Técnicos e Práticos. RBTI. Volume 15 – Número 2 – Abril/Junho 2003. 24. Dexheimer Neto FL, Teixeira C, Oliveira RP. Acesso venoso central guiado por ultrassom: qual a evide ncia? Rev Bras Ter Intensiva 2011; 23(2):217-221. 25. Merrer J, De Jonghe B, Golliot F et al. French Catheter Study Group in Intensive Care. Complications of femoral and subclavian venous catheterization in critically ill patients: a randomized controlled trial. JAMA 2001;286(6):700-7. 26. Feller-Kopman D. Ultrasound-guided internal jugular access: a proposed standardized approach and implications for training and practice. Chest 2007;132(1):302-9. 27. Lobato AC. Cirurgia Endovascular. 3. ed. vol 1. Ed. ICVE. 2015;32:563-570. 28. Theodoro D, Bausano B, Lewis L et al. A descriptive comparrison o fus-guided cvc of the internal jugular vein to landmark-based sv cannulation. Acad Med 2010;17(4):416-22. 29. Parienti J J, Mongardon N, Mégarbane B et al. Intravascular Complications of Central Venous Catheterization by Insertion Site. N Engl J Med 2015;373:1220-1229. 30. Flato UAP, Petisco GM, Santos FB. Punc ão venosa guiada por ultrasom em unidade de terapia intensiva. Rev Bras Ter Intensiva 2009;21(2):190-6. 31. Stone PA et al. Femoral pseudoaneurysms after percutaneous access. 60. ed. J Vasc Surg 2014;60:1359-66. 32. MCGee DC, Gould MK. Preventing Complications of Central Venous Catheterization. Waltham: N Engl J Med 2003;348:1123-33. 33. Lo RC et al. Routine use of ultrasound-guided access reduces access-site related complications after lower extremity percutaneous revascularization. Boston: J Vasc Surg 2015 February;61(2):405-412. 34. Nogueira dos Santos AC et al. Pseudoaneurismas: Quando e Como Tratá-Los. Rio de Janeiro: Arq Bras Cardiol:imagem Cardiovasc 2013;26(4):289-307. 35. Azevedo A C A et al. Pseudoaneurisma de Artéria Femoral Associado a Fístula Arteriovenosa Iatrogênica. Belo Horizonte: Arq Bras Cardiol: Imagem Cardiovasc 2015;28(4):231-235. 36. Vaz MAC, Fernandes PP. Quilotórax. São Paulo: J Bras Pneumol 2006;32(supl 4):s197-s203. 37. Lauricella LL, Terra RM. Manejo do quilotórax. 25. ed. São Paulo: Pneumologia Paulista Vol. 25, p. 13-18, No.13/2011, 2011. 38. Carlotti AP. Acesso vascular. Medicina (Ribeirão Preto. Online), v. 45, n. 2, p. 208-214, 30 jun. 2012.
12. Monteiro-Baker M et al. Retrograde approach for complex popliteal and tibioperoneal occlusios. J EndovascTher 2008;15:594-604.
ACESSOS PERCUTÂNEOS E DISPOSITIVOS SELADORES
16. Stavroulakis K, Usai MV, Torsello G et al. Efficacy and Safety of Transbrachial Access for Iliac Endovascular Interventions. J Endovasc Ther 2016;23(3):454-460.
18. Kumar AJ, Jones LE, Kollmeyer KR et al. Radial artery access for peripheral endovascular procedures. J Vasc Surg 2017;66(3):820-825.
REFERÊNCIAS BIBLIOGRÁFICAS
17. Fischman AM, Swinburne NC, Patel RS. A Technical Guide Describing the Use of Transradial Access Technique for Endovascular Interventions. Techn Vasc Interv Radiol 2015;15:1089-2516.
15. Kret MR, Dalman RL, Kalish J, Mell M. Arterial cutdown reduces complications after brachial access for peripheral vascular intervention. J Vasc Surg 2016;64(1):149-154.
7. Ahn HY, Lee HJ, Lee HJ et al. Assessment of the optimal site of femoral artery puncture and angiographic anatomical study of the common femoral artery. J Korean Neurosurg Soc 2014 Aug;56(2):91-9.
11. Fussaro et al. Retrograde pedal artery access for below-the-knee percutaneous revascularization. Journal of Cardiovascular Medicine 2007;8(3).
13. Alvarez-Tostado JA, Moise MA, Bena JF et al. The brachial artery: A critical access for endovascular procedures. J Vasc Surg 2009;49(2):378-385.
14. Franz RW, Tanga CF, Herrmann JW. Treatment of peripheral arterial disease via percutaneous brachial artery access. J Vasc Surg 2017;66(2):461-465.
6. Bhatty S et al Femoral Vascular. Access-site complications in the cardiac catheterization laboratory: diagnosis and management.
19. Gupta S, Nathan S, Perlowski AA. Basics of Radial Artery Access Cardiac Interventions today. Julho/Agosto, 2013.
39 23Capítulo
41.
1. Rahman MS, Woollard K. Atherosclerosis. Adv Exp Med Biol 2017;1003:121-44.
7. Dzau VJ. Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies 1249-1256. Nat Med 2002;8(11):1211-7.
21. Hansen PR. Chronic Inflammatory Diseases and Atherosclerotic Cardiovascular Disease: Innocent Bystanders or Partners in Crime? Curr Pharm Des 2018;24(3):281-90.
12. Aschoff L. Atherosclerosis. In: Lectures on pathology. Cap.131. New York: Hoeber Inc; 1904. p.153. 13. Peng J, Luo F, Ruan G, Peng R, Li X. Hypertriglyceridemia and atherosclerosis. Lipids Health Dis 2017;16(1):233. 14. Kannel WB, McGee DL. Update on some epidemiological features of Intermitent claudication: the Framingham Study. J Am Geriatr Soc 1985;33:13-8.
8. Aboyans V, Sevestre MA, Désormais I, Lacroix P, Fowkes G, Criqui MH. Epidemiology of lower extremity artery disease. Presse Med 2018;47(1):38-46.
9. Haimovici H, De Palma RC. Atherosclerosis. Biologic and surgical considerations. In: Haimovici H, Ascer E, Hollier LH et al (Eds.). Vascular surgery principles and techniques, 4th ed. Cambridge, MA: Blackwell Science; 1996:127. 10. Lobstein J. Traité d’anatomie pathologique. Paris: Levrault; 1829.
5. Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global burden of disease study. Lancet 1997;349:1436-42.
11. Marchand F. Ubberarteriosklerose.Verhandl des Kungresses fur innere. Med 1904;21:23.
16. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990’s. Nature 1993;362:801-9.
25. Fujii S, Sugiura T, Dohi Y, Ohte N. MicroRNA in atherothromobosis: is it useful as a disease marker? Thromb J 2016;14(Suppl 1):21.
35. Jonsson AL, Bäckhed F. Role of gut microbiota in atherosclerosis. Nat Rev Cardiol 2017;14(2):79-87. 36. Ascher S, Reinhardt C. The gut microbiota: An emerging risk factor for cardiovascular and cerebrovascular disease. Eur J Immunol 2018;48(4):564-75. Yu EP, Bennett MR. The role of mitochondrial DNA damage in the development of atherosclerosis. Free Radic Biol Med 2016;100:223-30. Plakkal A J, Paul A, Goo YH. Lipid droplet-associated proteins in atherosclerosis (Review). Mol Med Rep 2016;13(6):4527-34. Long A, Long B, Koyfman A. Non-traditional risk factors for atherosclerotic disease: A review for emergency physicians. Am J Emerg Med 2018;36(3):494-7. 40. Libby, P. The vascular biology of atherosclerosis. In: Braunwald`s heart disease:a textbook of cardiovascular medicine. 8th ed. Philadelphia: Sounders Elsevier 2008; 1(38):985-1022. Reis PEO. Blue toe syndrome. J Vasc Bras 2005;4(4):391-3. Steinberg D. Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime. Nat Med 2002;8(11):1211-7. Abdu TAM, Elhaddt, Pfeifer M, Clayton RN Endotheial dysfunction in endocrine disease. Trends Endocrinol Metabol 2001;12:257-65. 44. Bracamonte MP, Miller VM. Vascular effects of estrogens:arterial protection versus venus thrombotic risk. Trends Endocrinol Metabol 2001;12:204-9. Sloop GD, Weidman JJ, St Cyr JA. Atherothrombosis is a Thrombotic, not Inflammatory Disease. Cureus 2017 5;9(12):e1909. Ross R. Cell biology of atherosclerosis. Annu Rev Physiol 1995;57:791-804. Busse R, Fleming I. Regulation of endothelium-derived vasoactive autacoid production by hemodinamic forces. Trends Pharmacol Sci 2003;24:2428.
20. Martinez BK, White CM. The Emerging Role of Inflammation in Cardiovascular Disease. Ann Pharmacother 2018;52(8):801-9.
28. Bakogiannis C, Sachse M, Stamatelopoulos K, Stellos K. Platelet-derived chemokines in inflammation and atherosclerosis. Cytokine 2017;1. Pii: S1043-4666 (17):30270-3.
29. Ndrepepa G, Colleran, Kastrati A. Gamma-glutamyl transferase and the risk of atherosclerosis and coronary heart disease. Clin Chimica Acta 2018;(476):130-8.
40 24Capítulo
22. Pignatelli P, Menichelli D, Pastori D, Violi F. Oxidative stress and cardiovascular disease: new insights. Kardiol Pol 2018;76(4):713-22.
26. Pereira-da-Silva T, Coutinho CM, Carrusca C, Cruz FR, Napoleão P, Mota CM. Circulating microRNA profiles in different arterial territories of stable atherosclerotic disease: a systematic review. Am J Cardiovasc Dis 2018;8(1):1-13.
45.
17. Ross R. Atherosclerosis an inflammatory disease. N Engl J Med 1999;340:115-26.
ETIOPATOGENIA E EVOLUÇÃO DA DOENÇA ATEROSCLERÓTICA
15. Schwertani A, Choi H Y, Genest J. HDLs and the pathogenesis of atherosclerosis. Cur Op Cardiol 2018;33(3):311-6.
27. Tanaka K, Sata M. Roles of perivascular adipose tissue in the pathogenesis of atherosclerosis. Frontie Physiol 2018;(9):1-9.
38.
42.
30. Chen FH, Liu T, Xu L, Zhang L, Zhou XB. Association of serum vitamin D level and carotid atherosclerosis: a systematic review and metaanalysis. J Ultrasound Med 2018;(37)6:1287-576.
REFERÊNCIAS BIBLIOGRÁFICAS
43.
3. Anderson RE et al. A population based autopsy study of sudden, unexpected deaths from natural causes among persons 5 to 39 years old during a 12 years period. Hum Pathol 1994;25(12):1332-40.
24. Lusis AJ. Genetics of atherosclerosis. Trends in Genetics 2012;28(6):267-75.
46.
47.
32. Katsiki N, Mantzoros C, Mikhailidis DP. Adiponectin, lipids and atherosclerosis Curr Opin Lipidol 2017;28(4):347-54. 33. Vitek L. Bilirubin and atherosclerotic diseases. Physiol Res 2017 Apr 5;66(Supp 1):S11-S20. 34. Xia XD, Zhou Z, Yu XH, Zheng XL, Tang CK. Myocardin: A novel player in atherosclerosis. Atherosclerosis 2017;257:266-78.
SEÇÃO 7
19. Badimon L, Peña E, Arderiu G, PAdró T, Slevin M, Vilagur G, ChivaBlanch G. C-Reactive protein in atherothrombosis and angiogenesis. Front Immunol 2018;9:430.
23. Kovacic S, Bakran M. Genetic susceptibility to atherosclerosis. Stroke Research and Treatment 2012;1-5.
39.
ETIOPATOGENIA DA DOENÇA ARTERIAL
4. Hansson GK. Inflammation, atherosclerosis and coronary artery disease. N Engl J Med 2005;352:1685-95.
6. Teo KK, Dokainish H. The Emerging Epidemic of Cardiovascular Risk Factors and Atherosclerotic Disease in Developing Countries. Can J Cardiol 2017;33(3):358-65.
2. Ellulu MS, Patimah I, Khaza’ai H, Rahmat A, Abed Y, Ali F. Atherosclerotic cardiovascular disease: a review of initiators and protective factors. Inflammopharmacology 2016;24(1):1-10.
18. Pothineni NVK, Subramany S, Kuriakose K, Shirazi LF, Romeo F, Shah PK, Mehta JL. Infections, atherosclerosis, and coronary heart disease. Eur Heart J 2017;38(43):3195-201.
37.
31. Zhu P, Sun W, Zhang C, Song Z, Lin S. The role of neuropeptide Y in the pathophysiology of atherosclerotic cardiovascular disease. Int J Cardiol 2016;1(220): 235-41.
57. Reis et al. Isquemia de Membros Inferiores: perspectiva atual da terapia celular e terapia gênica. Rev Bras Cardiol 2012;25(4):330-9.
59. Cushing SD, Berliner JA, Valente AJ et al. Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc Natl Acad Sci USA 1990;87:5134-8. 60. Weber C, Noels H. Atherosclerosis: current pathogenesis and therapeutic options. Nat Med 2011;17(11):1410-22.
74. Guaricci AI, De Santis D, Carbone M et al. Coronary atherosclerosis assessment by coronary ct angiography in asymptomatic diabetic population: a critical systematic review of the literature and future perspectives. Biomed Res Int 2018;15:8927281.
52. Zhu YN, Fan WJ, Zhang C et al. Role of autophagy in advanced atherosclerosis (Review). Mol Med Rep 2017;15(5):2903-8.
69. Quillard T, Libby P. Molecular imaging of atherosclerosis for improving diagnostic and therapeutic development. Circ Res 2012;111(2):231-44.
73. Andrews JPM, Fayad ZA, Dweck MR. New methods to image unstable atherosclerotic plaques. Atherosclerosis 2018;272:118-28.
70. Friedman MH, Hutchins GM, Bargeron CB et al. Correlation Between intimal thickness and fluid shear stress in human arteries. Atherosclerosis 1981;39:345.
65. Camejo G, Hurt-Camejo E, Wiklund O et al. Association of apo B lipoproteins with arterial proteoglycans: pathological significance and molecular basis. Atherosclerosis 1998;139:205-22.
75. Dwivedi A, Al’Aref SJ, Lin FY et al. Evaluation of Atherosclerotic Plaque in Non-invasive Coronary Imaging. Korean Circ J 2018;48(2):124-33.
53. Glagov S, Weisenberg E, Zarins CK et al. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 1987;316(22):1371-5.
48.
58. Li H, Reddick RL, Maeda N. Lack of apoA-I is not associated with increased susceptibility to atherosclerosis in mice. Arterioscler Thromb 1993;13:1814-21.
68. Chatterjee S, Ghosh N. Oxidized low density lipoprotein stimulates aortic smooth muscle cell proliferation. Glycobiology 1996;6:303-11.
76. Kolossváry M, Szilveszter B, Merkely B et al. Plaque imaging with CT-a comprehensive review on coronary CT angiography based risk assessment. Cardiovasc Diagn Ther 2017;7(5):489-506.
62. Soehnlein O. Multiple roles for neutrophils in atherosclerosis. Circ Res 2012;110(6):875-88.
dA doenç
71. Tangelder GJ, Slaaf DW, Arts T et al. Wall shear rate in arterioles in vivo: least estimates from platelet velocity profiles. Am J Physiol 1988:254:H1059. 72. Souilhol C, Harmsen MC, Evans PC et al. Endothelial-mesenchymal transition in atherosclerosis. Cardiovasc Res 2018;114(4):565-77.
55. Davies MJ, Richardson PD, Woolf N. Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content. Br Heart J 1993;69:377-81.
50.
51.
67. Hessler JR, Morel DW, Lewis LJ et al. Lipoprotein oxidation and lipoprotein-induced cytotoxicity. Arteriosclerosis 1983;3:215-22.
61. Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature 2011;473(7347):317-25.
Capítulo 24 41e tioPAtogeniA e e volução A AterosClerótiCA Finney AC, Stokes KY, Pattillo CB, Orr AW. Integrin signaling in atherosclerosis. Integrin signaling in atherosclerosis. Cell Mol Life Sci 2017;74(12):2263-82. Glass CK, Witztum JL. Atherosclerosis the road ahead. Cell 2001;104(4):503-16. Monajemi H, Arkenbout EK, Pannekoek H. Gene expression in atherogenesis. Thromb Haemost 2001;86:404-12. Dong ZM, Chapman SM, Brown AA et al. The combined role of P- and E-selectin in atheroslerosis. J Clin Invest 1998;102:145-52.
56. Libby P, Aikawa M. Stabilization of atherosclerotic plaques: new mechanisms and clinical targets. Nature Med 2002;11:1257-62.
54. Li AC, Glass CK. The macrophage foam cell as a target for therapeutic intervention. Nat Med 2002;8(11):1235-42.
64. Han KH, Han IO, Green SR et al. Expression of the monocyte chemoattractant protein-1 receptor CCR2 is increased in hypercholesterolemia: differential effects of plasma lipoproteins on monocyte function. J Lipid Res 1999;40:1053-1063.
66. McMurray HF, Parthasarathy S, Steinberg D. Oxidatively modified low density lipoprotein is a chemoattractant for human T lymphocytes. J Clin Invest 1993;92:1004-8.
49.
63. Camaré C, Pucelle M, Nègre-Salvayre A et al. Angiogenesis in the atherosclerotic plaque. Redox Biol 2017;12:18-34.
3. Newby AC. An overview of the vascular response to injury: a tribute to the late Russell Ross. Toxicol Lett 2000;112-113:519-29.
11. Chervu A, Moore WS. An overview of intimal hyperplasia. Surgery Gynecol Obstet 1990;171:433-47.
HIPERPLASIA BIBLIOGRÁFICAS
22. Pasa MB. Estudo morfométrico do espessamento intimal secundário ao implante de stent em artérias carótidas de suínos. Dissertação (Mestrado em Cirurgia). Faculdade de Medicina, Universidade Federal do Rio Grande do Sul. Porto Alegre: UFRGS; 2001.
6. Chamley-Campbell JH, Campbell GR. What controls smooth muscle phenotype? Atherosclerosis 1981;40:347-57.
18. Touchard AG, Schwartz RS. Preclinical restenosis models: challenges and successes. Toxicol Pathol 2006;34:11-8.
19. Perkins LEL. Preclinical models of restenosis and their application in the evaluation of drug-eluting stent systems. Veterinary Pathology 2010;47(1):58-76. 20. Coats Jr WD, Currier JW, Faxon DP. Remodeling and restenosis: insights from animal studies. Semin Interv Cardiol 1997;2:153-8.
21. Andersen HR, Mæng M, Thorwest M et al. Remodeling rather than neointimal formation explains luminal narrowing after deep vessel wall injury: insights from a porcine coronary (re)stenosis model. Circulation 1996;93:1716-24.
13. Bauters C, Marotte F, Hamon M et al. Accumulation of fetal fibronectin mRNAs after balloon denudation of rabbit arteries. Circulation 1995;92:904-11.
15. Booth RFG, Martin JF, Honey AC et al. Rapid development of atherosclerotic lesions in the rabbit carotid artery induced by perivascular manipulation. Atherosclerosis 1989;76:257-68.
INTIMAL REFERÊNCIAS
42 25Capítulo
9. Hoffmann R, Mintz GS, Mehran R et al. Tissue proliferation within and surrounding Palmaz-Schatz stents is dependent on the aggressiveness of stent implantation technique. Am J Cardiol 1999;83:1170-4. 10. Schwartz SM, Reidy MA, De Blois D. Factors important in arterial narrowing. J Hypertension 1996;14(5):S71-81.
12. Sottiurai VS, Yao JST, Flinn WR et al. Intimal hyperplasia and neointima: an ultrastructural analysis of thrombosed grafts in humans. Surgery 1983 June;93(6):809-17.
2. Gibbons GH, Dzau VJ. The emerging concept of vascular remodeling. N Engl J Med 1994;330(20):1431-8.
8. Casscells W. Migration of smooth muscle and endothelial cells. Critical events in restenosis. Circulation 1992;86:723-9.
14. Wilenski RL, March KL, Gradus-pizlo I et al. Vascular injury, repair, and restenosis after percutaneous transluminal angioplasty in the atherosclerotic rabbit. Circulation 1995;92:2995-3005.
17. Fanelli C, Aronoff R. Restenosis following coronary angioplasty. Am. Heart J 1990 Feb;119(2 Pt 1):357-65.
1. Kunlin J. Long vein transplantation in treatment of ischemia caused by arteritis. Rev Chir 1951;70:206-35.
4. Geary RL, Nikkari ST, Wagner WD et al. Wound healing: a paradigm for lumen narrowing after arterial reconstruction. J Vasc Surg 1998;27:96-106.
7. Ip JH, Fuster V, Badimon L et al. Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation. J Am Coll Cardiol 1990;15:1667-87.
16. Echave V, Koornick AR, Haimov M et al. Intimal hyperplasia as a complication of the use of the polytetrafluoroethylene graft for femoral-popliteal bypass. Surgery 1979 Dec;86(6):791-6.
5. Owens GK, Vernon SM, Madsen CS. Molecular regulation of smooth muscle cell differentiation. J Hypertension 1996;14(5):S55-64.
23. Grudtner MA. Análise morfométrica da parede arterial após o implante de stent em aorta abdominal de suínos – Estudo comparativo entre stents metálicos não recobertos e recobertos com PTFE. Dissertação (Mestrado em Cirurgia). Faculdade de Medicina, Universidade Federal do Rio Grande do Sul. Porto Alegre: UFRGS; 2001. 24. Dutra CF. Análise morfométrica digital na parede aórticas de suínos após o implante de stents não revestidos versus revestidos com Dacron. Dissertação (Mestrado em Cirurgia). Faculdade de Medicina, Universidade Federal do Rio Grande do Sul. Porto Alegre: UFRGS; 2001. 25. Castro Jr C. Análise morfométrica da reação intimal secundária ao implante de stent em artérias ilíacas submetidas à angioplastia: estudo experimental em suínos. Dissertação (Mestrado em Cirurgia). Faculdade de Medicina, Universidade Federal do Rio Grande do Sul. Porto Alegre: UFRGS; 2003. 26. Wang X, Chai H, Lin PH et al. Mouse models of neointimal hyperplasia: techniques and applications. Med Sci Monit 2006;12:177-85. 27. Ward MR, Kanellakis P, Ramsey D et al. Response to balloon injury is vascular bed specific: a consequence of de novo vessel structure? Atherosclerosis 2000;151:407-14. 28. Krueger KD, Mitra AK, Del Core MG et al. A comparison of stentinduced stenosis in coronary and peripheral arteries. J Clin Pathol 2006;59:575-9. 29. Verheye S, Salame MY, Robinson KA et al. Short- and long-term histopathologic evaluation of stenting using a self-expanding nitinol stent in pig carotid and iliac arteries. Catheter Cardiovasc Interv 1999;48:316-23. 30. Harnek J, Zoucas E, Stenram U et al. Insertion of self-expandable nitinol stents without previous balloon angio-plasty reduces restenosis compared with PTA prior to stenting. Cardiovasc Intervent Radiol 2002;25:430-6. 31. Castro Jr C, Pereira AH, Pasa MB. Morphometric analysis of the intimal reaction after stent implantation in iliac arteries submitted to angioplasty in pigs. Acta Cir Bras 2006;21:139-43. 32. Houbballah R, Robaldo A, Albadawi H et al. A novel model of accelerated intimal hyperplasia in the pig iliac artery. Int J Exp Path 2011;92:422-7. 33. Liu MW, Roubin GS, King SB III. Restenosis following coronary angioplasty potential biological determinants and role of intimal hyperplasia. Circulation 1989;79:1374-87. 34. Sprague AH, Khalil RA. Inflammatory cytokines in vascular dysfunction and vascular disease. Biochem Pharmacol 2009;78(6):539-52. 35. Kornowski R, Hong MK et al. In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia. J Am Coll Cardiol 1998;31:224-30. 36. Lowe HC, Schwartz RS, Mac Neill BD et al. The porcine coronary model of in-stent restenosis: current status in the era of drugeluting stents. Catheter Cardiovasc Interv 2003;60:515-23. 37. Siow RCM, Churchman AT. Adventitial growth factor signalling and vascular remodelling: Potential of perivascular gene transfer from the outside-in. Cardiovascular Research 2007;75:659-68. 38. Goel SA, Guo LW, Liu B et al. Mechanisms of post-intervention arterial remodeling. Cardiovasc Res 2012;96:363-71. 39. Mintz GS, Popma JJ, Pichard AD et al. Intravascular ultrasound assessment of the mechanisms and predictors of restenosis following coronary angioplasty. J Invasive Cardiol 1996;8:1-14. 40. Pasterkamp G, Galis ZS, de Kleijn DP. Expansive arterial remodeling: location, location, location. Arterioscler Thromb Vasc Biol 2004;24:650-7. 41. Gertz SD, Barry WL, Gimple LW et al. Predictors of luminal narrowing by neointima after angioplasty in atherosclerotic rabbits. Cardiovasc Res 1997;36:396-407. 42. Faxon DP, Coats W, Currier J. Remodeling of the coronary artery after vascular injury. Prog Cardiovasc Dis 1997;40:129-40.
47.
66. Nakazawa G, Finn AV, John MC et al. The significance of preclinical evaluation of sirolimus-, paclitaxel-, and zotarolimus-eluting stents. Am J Cardiol 2007 Oct 22;100(8B):36M-44M.
69. Lammer J, Bosiers M, Zeller T et al. First clinical trial of nitinol selfexpanding everolimus-eluting stent implantation for peripheral arterial occlusive disease. J Vasc Surg 2011;54:394-401.
70. Dake MD, Ansel GM, Jaff MR et al. Durable clinical effectiveness with paclitaxel-eluting stents in the femoropopliteal artery: 5-year results of the zilver ptx randomized trial. Circulation 2016 Apr 12;133(15):1472-83.
71. Liu X, Zheng G, Wen S. Drug-eluting stents versus control therapy in the infrapopliteal disease: A meta-analysis of eight randomized controlled trials and two cohort studies. Int J Surg 2017 Aug;44:166-75.
72. Spreen M, Martens JM, Knippenberg B et al. Long-term follow-up of the PADI Trial: percutaneous transluminal angioplasty versus drugeluting stents for infrapopliteal lesions in critical limb ischemia. J Am Heart Assoc 2017;6. 73. Scheller B, Hehrlein C, Bocksch W et al. Treatment of coronary instent restenosis with a paclitaxel-coated balloon catheter. N Engl J Med 2006;355:2113-24. 74. Unverdorben M, Vallbracht C, Cremers B et al. Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis. Circulation 2009;119:2986-94. 75. Navarese EP, Austin D, Gurbel PA et al. Drug-coated balloons in treatment of in-stent restenosis: a meta-analysis of randomised controlled trials. Clin Res Cardiol 2012 Dec 20. 76. Indermuehle A, Bahl R, Lansky AJ et al. Drug-eluting balloon angioplasty for in-stent restenosis: a systematic review and meta-analysis of randomised controlled trials. Heart 2013 Mar;99(5):327-33. 77. Dhakam S, Jafferani A, Ahmed H et al. Safety and efficacy of drugeluting balloons in the treatment of drug-eluting in-stent restenosis: experience of a tertiary care hospital. J Invasive Cardiol 2012 July;24(7):335-8. 78. Minar E, Schillinger M. Innovative technologies for SFA occlusions: drug coated balloons in SFA lesions. J Cardiovasc Surg 2012 Aug.;53(4):481-6. 79. Wöhrle J. Drug-coated balloons for coronary and peripheral interventional procedures. Curr Cardiol Rep 2012 Oct;14(5):635-41. 80. Schnorr B, Albrecht T. Drug-coated balloons and their place in treating peripheral arterial disease. Expert Rev Med Devices 2013 Jan;10(1):105-14. 81. Barkat M, Torella F, Antoniou GA. Drug-eluting balloon catheters for lower limb peripheral arterial disease: the evidence to date. Vasc Healt Risk Manag 2016 May 12;12:199-208. 82. Herten M, Torsello GB, Schonefeld E et al. Critical appraisal of paclitaxel balloon angioplasty for femoral-popliteal arterial disease. Vascular Health Manag 2016 Aug 29;12:341-56. 83. Cassese S, Ndrepepa G, LiistroF et al. Drug-coated balloons for revascularization of infrapopliteal arteries: A metaanalysis of randomized trials. JACC Cardiovasc Interv 2016 May 23;9(10):1072-80. 84. Gijsen FJ, Oortman RM, Wentzel JJ et al. Usefulness of shear stress pattern in predicting neointima distribution in sirolimus-eluting stents in coronary arteries. Am J Cardiol 2003;92(11):1325-8. 85. Gomez-Lara J, Garcia-Garcia HM, Onuma Y et al. A comparison of the conformability of everolimus-eluting bioresorbable vascular scaffolds to metal platform coronary stents. JACC Cardiovasc Interv. 2010;3(11):1190-8. 86. Tamai H, Igaki K, Kyo E et al. Initial and 6-month results of biodegradable poly-l-lactic acid coronary stents in humans. Circulation 2000;102(4):399-404. 87. Ghimire G, Spiro J, Kharbanda R et al. Initial evidence for the return of coronary vasoreactivity following the absorption of bioabsorbable magnesium alloy coronary stents. Euro Intervention 2009;4(4):481-4. 88. Grube E. Bioabsorbable stent: the Boston Scientific and REVA technology. EuroPCR 2009 May 19-22, Barcelona, Spain. 89. Jabara R, Chronos N, Robinson K. Novel bioabsorbable salicylatebased polymer as a drug-eluting stent coating. Catheter Cardiovasc Interv 2009;4(4):481-4. 90. Jabara RPL, Geva S, Chen J et al. Novel fully bio- absorbable salicylate-based sirolimus eluting stent. Euro Intervention 2009;(Suppl F):F58-64. 91. Serruys PW, Ormiston JA, Onuma Y et al. A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods. Lancet 2009;373(9667):897-910.
52.
57. Schillinger M, Sabeti S, Loewe C et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 2006;354:1879-88.
65. Grudtner MA, de Lara Elesbão JL, Gutierrez PS et al. Histological analysis of cobalt-chromium stents with and without Camouflage® polymer coating: experimental porcine carotid artery model. Vascular 2011 Apr;19(2):89-96.
67. Farb A, John M, Acampado E et al. Oral everolimus inhibits in-stent neointimal growth. Circulation 2002 Oct 29;106(18):2379-84.
54. Kobayashi Y, De Gregorio J, Kobayashi N et al. Stented segment length as an independent predictor of restenosis. J Am Coll Cardiol 1999;34:651-9.
50.
64. Finn AV, Joner M, Nakazawa G et al. Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation 2007;115:2435-41.
51.
46.
45.
48.
61. Newsome LT, Kutcher MA, Royster RL. Coronary artery stents: Part I. Evolution of percutaneous coronary intervention. Anesth Analg 2008;107:552-69. 62. Schwartz RS, Chronos NA et al. Preclinical restenosis models and drug-eluting stents: still important, still much to learn. J Am Coll Cardiol 2004;44:1373-85.
49.
Capítulo 25 43HiPerPl A siA intimAl 43. Glagov S, Weisenberg E, Zarins CK et al. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 1987;316:1371-5. Virmani R, Farb A. Pathology of in-stent restenosis. Curr Opin Lipidol 1999;10:499-506. Hoffmann R, Mintz GS, Dussaillant GR et al. Patterns and mechanisms of in-stent restenosis. A serial intravascular ultrasound study. Circulation 1996;94:1247-54. Muhlestein JB, Zidar JP, Blazing MA. The vascular biology of restenosis: an overview. In: Interventional cardiovascular medicine, principles and practice, 2nd ed. Philadelphia: Churchill Livingstone; 2002. Welt FG, Rogers C. Inflammation and restenosis in the stent era. Arterioscler Thromb Vasc Biol 2002;22:1769-76. Schwartz RS, Huber KC et al. Restenosis and proportional neointimal response to coronary artery injury: Results in a porcine model. J Am Coll Cardiol 1992;19:267-74. Toutouzas K, Colombo A, Stefanadis C. Inflammation and restenosis after percutaneous coronary interventions. Eur Heart J 2004;25:1679-87. Welt FG, Tso C, Edelman ER et al. Leukocyte recruitment and expression of chemokines following different forms of vascular injury. Vasc Med 2003;8:1-7. Rogers C, Welt FG, Karnovsky MJ et al. Monocyte recruitment and neointimal hyperplasia in rabbits. Coupled inhibitory effects of heparin. Arterioscler Thromb Vasc Biol 1996;16:1312-8. Curcio A, Torella D, Indolfi C. Mechanisms of smooth muscle cell proliferation and endothelial regeneration after vascular injury and stenting? – Approach to Therapy. Circ J 2011;75:1287-96.
56.
53. de Feyter PJ, Vos J, Rensing BJ. Anti-restenosis trials. Curr Interv Cardiol Rep 2000;2:326-31.
55. Hoffmann R, Mintz GS. Coronary in-stent restenosis - Predictors, treatment and prevention. Eur Heart J 2000;21:1739-49. Krankenberg H, Schluter M, Steinkamp HJ et al. Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST). Circulation 2007;116:285-92.
58. Bosiers M, Torsello G, Gissler HM et al. Nitinol stent implantation in long superficial femoral artery lesions: 12-month results of the DURABILITY I study. J Endovasc Ther 2009;16(3):261-9.
68. Duda SH, Bosiers M, Lammers J et al. Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial. J Endovasc Ther 2006;13:701-10.
59. Feiring AJ, Wesolowski AA, Lade S. Primary stent-supported angioplasty for treatment of below-knee critical limb ischemia and severe claudication: early and one-year outcomes. J Am Coll Cardiol 2004;44:2307-14. 60. Rand T, Basile A, Cejna M et al. PTA versus carbofilm-coated stents in infrapopliteal arteries: pilot study. Cardiovasc Intervent Radiol 2006;29:29-38.
63. Rodrigues H, Gonçalves FB, Alves G et al. Intra-stent stenosis on superficial femoral artery: Current solutions for a growing problem. Angiol Cir Vasc 2013;9:78-83.
44.
108. O’Donohoe MK, Schwartz LB, Radic ZS et al. Chronic ACE inhibition reduces intimal hyperplasia on experimental vein grafts. Ann Surg 1991;214:727-32.
Parte I44 CAPÍTULOS BÁSICOS
95. Rogers C, Edelman ER, Simon DI. A monoclonal antibody to the b2-leukocite integrin Mac-1 reduces intimal tickening after stent implantation in rabbits. Procc Natl Acad Sci 1998;95:10134-9. 96. Joviliano EE, Piccinato CE, Dellalibera-Joviliano R et al. Inflammatory markers and restenosis in peripheral percutaneous angioplasty with intravascular stenting: current concepts. Ann Vasc Surg 2011;25:846-55. 97. Haverkate F, Thompson SG, Pyke SD et al. Production of C-reactive protein and risk of coronary events in stable and unstable angina. Lancet 1997;349:462-6. 98. Buffon A, Liuzzo G, Biascucci LM et al. Preprocedural serum levels of C-reactive protein predict early complica- tions and late restenosis after coronary angioplasty. J Am Coll Cardiol 1999;34:1512-21.
112. Hausleiter J, Kastrati A, Mehilli J et al. Randomized, doubleblind, placebo-controlled trial of oral sirolimus for restenosis prevention in patients with in-stent restenosis: the Oral Sirolimus to Inhibit Recurrent In-stent Stenosis (OSIRIS) trial. Circulation 2004;110:790-5.
99. Capek P, McLean GK, Berkowitz HD. Femoropopliteal angioplasty: factors influencing long term success. Circulation 1991;83:I70-80. 100. França LHG. Hiperplasia intimal após implante de stent em aorta de suínos submetidos à hiper-homocisteinemia induzida. Tese (Doutorado). Faculdade de Medicina, Universidade Federal do Rio Grande do Sul. Porto Alegre: UFRGS; 2007. 101. Rahmani M, Cruz RP, Granville DG et al. Allograft vaculopathy versus atherosclerosis. Cir Res 2006;99:801-15. 102. McCann RL, Hagen PO, Fuchs JCA. Acetyl salicylic acid and dipyridamole decrease intimal hyperplasia in experimental vein grafts. Ann Surg 1980;191:238-43. 103. Landymore RW, MacAulay MA, Manku MS. The effect of low, medium and high dose Acetyl salicylic acid on intimal proliferation in autologous vein grafts used for arterial reconstruction. Eur J Cardio Thorac Surg 1990;4:441-4. 104. Kohler TR, Kirkman T, Clowes A. Effect of heparin on adaptation of vein grafts to arterial circulation. Arteriosclerosis 1989;9:523-8.
111. Lee SW, Park SW, Kim YH et al. Drug-eluting stenting followed by cilostazol treatment reduces late restenosis in patients with diabetes mellitus the Declare-Diabetes plus robotic totally endoscopic coronary artery bypass. Circulation 2008;114:I473-6.
107. El-Sanadiki MN, Cross KS, Murray JJ et al. Reduction of intimal hyperplasia and enhanced nreactivity of experimental vein bypass graft with verapamil treatment. Ann Surg 1990;212:87-96.
110. Gupta G, Agrawal T, Rai V et al. Vitamin D Supplementation Reduces Intimal Hyperplasia and Restenosis following Coronary Intervention in Atherosclerotic Swine. PLoS ONE 11(6):e0156857.
113. Robertson L, Ghouri MA, Kovacs F. Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment. Cochrane Database Syst Rev 2012;8:CD002071. 114. Dindyal S, Kyriakides C. A review of cilostazol, a phosphodiesterase inhibitor, and its role in preventing both coronary and peripheral arterial restenosis following endovascular therapy. Recent Pat Cardiovasc Drug Discov 2009 Jan;4(1):6-14.
106. Akkaya G, Bilen C, Gençpinar T et al. Effects of rivaroxaban on intimal hyperplasia and smooth muscle cell proliferation at the carotid artery anastomosis site in rabbits. Anatol J Cardiol 2017; 18:261-65.
109. Davies MG, Fulton GJ, Barber L et al. Characterisation of angiotensin II receptor mediated responses and inhibition of intimal hyperplasia in experimental vein grafts by the specific angiotensin II receptor inhibitor, L 158, 809. Eur J Vasc Endovasc Surg 1996;12(2):151-61.
92. Chu TM, Chan YC, Cheng SW. Evidence for treating peripheral arterial diseases with biodegradable scaffolds. J Cardiovasc Surg 2017 Feb;58(1):87-94. 93. van Haelst ST, Peeters Weem SM, Moll FL et al. Current status and future perspectives of bioresorbable stents in peripheral arterial disease. J Vasc Surg 2016 Oct;64(4):1151-1159. 94. Tanaka H, Sukhova GK, Swanson SG et al. Sustained activation of vascular cells and leukocites in the rabbit aorta after balloon injury. Circulation 1993;88:1788-803.
115. Setacci C, Castelli P, Chiesa R et al. Restenosis: a challenge for vascular surgeon. J Cardiovasc Surg (Torino) 2012 Dec;53(6):735-46. 116. Longui JA. Efeitos do cilostazol na hiperplasia neointimal em artérias ilíacas de suínos submetidos a angioplastia transluminal Dissertação (Mestrado em Cirurgia). Faculdade de Medicina, Universidade Federal do Rio Grande do Sul. Porto Alegre: UFRGS; 2012.
105. Hirsch GM, Karnosky MJ. Inhibition of vein graft intimal proliferative lesions in the rat by heparin. Am J Path 1991;139:581-7.
14.
5. Santos JE, Guimarães AC, Diament J. Consenso brasileiro sobre dislipidemias detecção, avaliação e tratamento. Arq Bras Endocrinol Metab 2009;43:287-305. Gusmão A, Montenegro L, Santos V. Investigação diagnóstica das dislipidemias. In: Villar L et al. Endocrinologia clínica, 4. ed. Rio de Janeiro: Guanabara Koogan; 2009. p. 787-802.
15. Blom DJ, Byrnes P, Jones S et al. Dysbetalipoproteinaemia – Clinical and pathophysiological features. S Afr Med J 2002;92:892-97.
18. Gillett MJ, Burnett JR. Manifestations of familial hypercholesterolaemia. Inter Med J 2005;35:63-4.
22. van der Kallen CJ, Voors-Pette C, de Bruin TW. Abdominal obesity and expression of familial combined hyperlipidemia. Obes Res 2004;12:2054-61.
8.
3. Simões CCS, Bregman SR, Oliveira SMM. A qualidade da informação sobre a mortalidade no brasil recente e avaliação do impacto das causas violentas no número de “anos de vida perdidos”. In: Indicadores Sociodemográficos e de Saúde no Brasil – IBGE; 2009. 4. Vance JE. Molecular and cell biology of phosphatidylserine and phosphatidylethanolamine metabolism. Prog Nucleic Acid Res Mol Biol 2003;75:69-111.
23. Gaddi A, Cicero AF, Odoo FO et al. Athaeroscloerosis and metabolic diseases study group. Practical guidelines for familial combined hyperlipidemia diagnosis: an up-date. Vasc Health Risck Manag 2007;3:877-86. 24. Ejarque I, Real JT, Chaves FJ et al. Clinical and biochemical characteristics of familial ligand-defective apo B 100 in a South European population. Med Clin (Barc) 2004;123:456-9. 25. Soutar AK, Naoumova RP. Autosomal recessive hypercholesterolemia. Semin Vasc Med 2004;4:241-8. 26. Moghadasian MH. Cerebrotendinous xanthomatosis: clinical course, genotypes and metabólica backgrounds. Clin Invest Med 2004;27:42-50. 27. Berge KE. Sitosterolemia: a gateway to new knowledge about cholesterol metabolism. Ann Med 2003;35:502-11. 28. Schippling S, Orth M, Beisiegel U et al. Severe Tangier disease with a novel ABCA1 gene mutation. Neurology 2008;71:1454-5. 29. Ayyobi AF, McGladdery SH, Chan S et al. Lechitin: cholesterol acyltransferase (LCAT) deficiency and risk of vascular disease: 25 year follow-up. Atherosclerosis 2004;177:361-6. 30. Navab M, Anantharamaiah GM, Reddy ST et al. Mechanisms of disease: proatherogenic HDL – An evolving field. Nat Clin Pract Endocrinol Metab 2006;2:504-11. 31. Nagano M, Yamashita S, Hirano K et al. Molecular mechanisms of cholesteryl ester transfer protein deficiency in Japanese. J Atheroscler Thromb 2004;11:110-21. 32. Neves C, Alves M, Medina JL et al. Thyroid diseases, dyslipidemia and cardiovascular pathology. Rev Port Cardiol 2008;27:1211-36. 33. Vilar L, Freitas MC, Canadas V et al. Lipid profile and high sensitivity C reactive protein levels in subclinical and overt primary hipothyroidism. Arq Bras Endocrinol Metab 2008;52:S482. 34. Thompson PD, Clarkson P, Karas RH. Statin-associated myopathy. JAMA 2003;289:1681-90. 35. Diekman T, Lansberg PJ, Kastelein JJ et al. Prevalence and correction of hypothyroidism in a large cohort of patients referred for dyslipidemia. Arch Intern Med 1995;155:1490-5. 36. Chahil TJ, Grinsberg HN. Diabetic dyslipidemia. Endocrinol Metab Clin North Am 2006;35:491-510, vii-viii. 37. Neeli H, Gadi R, Rader DJ. Managing diabetic dyslipidemia: beyond statin therapy. Curr Diab Rep 2009;9:11-7. 38. Cornier MA, Dabelea D, Hernandez TL et al. The metabolic syndrome. Endocr Rev 2008;29:777-822. 39. Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH et al.2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014;129:S1-45. 40. Dujovne CA, Ettinger MP, McNeer JF, Lipka LJ, LeBeaut AP, Suresh R et al. Efficacy and safety of a potent new selective cholesterol absorption inhibitor, ezetimibe, in patients with primary hypercholesterolemia. Am J Cardiol. 2002;90:1092-7. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001;285(19):2486-97. 42. Taylor FC, Huffman M, Ebrahim S. Statin therapy for primary prevention of cardiovascular disease. JAMA. 2013;310:2451-2. Bertoluci et al. Brazilian guidelines on prevention of cardiovascular disease in patients with diabetes: a position statement from the Brazilian Diabetes Society (SBD), the Brazilian Cardiology Society
DISLIPIDEMIA REFERÊNCIAS BIBLIOGRÁFICAS
7. Nordestgaard BG, Langsted A, Mora S, Kolovou G, Baum H, Bruckert R et al. Fasng is not rounely required for determinaon of a lipid profile: clinical and laboratory implicaons including flagging at desirable concentraon cut points — a joint consensus statement from the European Atherosclerosis Society and European Federaon of Clinical Chemistry and Laboratory Medicine. Eur Heart J 2016;37(25):1944 58. Driver SL, Marn SS, Gluckman TJ, Clary JM, Blumenthal RS and Stone NJ. Fasng or nonfasng lipid measurements. it depends on the queson. JACC 2016;67(10):1227 34. Consenso Brasileiro para a Normazação da Determinação Laboratorial do Perfil Lipídico versão 1.13. Disponível em www.sbpc.org.br/ upload/conteudo/consenso_jejum_dez2016_final.pdf
9.
41.
21. de Graaf J, van der Vleuten G, Stalenhoef AF. Diagnostic criteria in relation to the pathogenesis of familial combined hyperlipidemia. Semin Vasc Med 2004;4:229-40.
43.
2. Goldstein JL, Brown MS. The LDL receptor. Arterioscler Thromb Vasc Biol 2009;29:431-8.
10. Novazzi JP, Fonseca FAH, Monteiro CMC. Diagnóstico e classificação das dislipidemias. In: Martinez TLR. (Ed.). Manual de condutas clínicas em dislipidemias. São Paulo: Medline; 2003. p. 133-40. Cox RA. The hyperlipidemias. Bol Assoc Med PR 2003;95:36-44. Defeshe JC, Ferreira Jr JR, Martinez TLR. Dislipidemias primárias. In: Martinez TLR. (Ed.). Manual de condutas clínicas em dislipidemias. São Paulo: Medline; 2003. p. 121-32. Santamarina-Fojo S. The familial chylomicronemia syndrome. Endocrinol Metab Clin North Am 1998;27:551-67. Smit JW, Diamant M. Genetically defined hyperlipidemia. Pharmacogenomics 2004;5:295-304.
17. Smelt AH, de Beer F. Apolipoprotein E and familial dysbetalipoproteinemia: clinical, biochemical and genetic aspects. Semin Vasc Med 2004;4:249-57.
45 26Capítulo
13.
1. Semenkovich CF, Goldberg AC, Goldberg IJ. Disorders of lipid metabolism. In: Melmed S et al. (Eds.). Williams textbook of endocrinology, 12th ed. Philadelphia: WB Saunders; 2011. p. 1633-74.
20. Hopkins PN, Heiss G, Ellison RC et al. Coronary artery disease risk in familial combined hyperlipidemia and familial hypertriglyceridemia: a case-control comparison from the National Heart, Lung, and Blood Institute Family Heart Study. Circulation 2003;108:519-23.
19. vanWissen S, Smilde TJ, Trip MD et al. Long-term safety and efficacy of high-dose atorvastatin treatment in patients with familial hypercholesterolemia. Am J Cardiol 2005;95:264-6.
16. Mahley RW, Huang Y, Rall Jr SC. Pathogenesis of type III hyperlipoproteinemia (dysbetalipoproteinemia). Questions, quandaries, and paradoxes. J Lipid Res 1999;40:1933-49.
6.
12.
11.
50.
49. Jeger R, Dieterle T. Statins: have we found the holly Grail? Swiss Med Wkly 2012;142:w13515. Gotto Jr MA. Statins, cardiovascular disease and drug safety. Am J Cardiol 2006;97(Suppl):3C-97C. Mays ME, Dujvone CA. Pleiotropic effects: should statins be considered an essential component in the treatment of dyslipidemia? Curr Atheroscler Rep 2008;10:45-52.
52. Izar MCO. Dislipidemias: como diagnosticar e tratar. Rev Bras Med 2011;68:42-60.
48. Ginsberg HN. Review: efficacy and mechanisms of action of statins in the treatment of diabetic dyslipidemia. J Clin Endocrinol Metab 2006;91:383-92.
Parte I46 CAPÍTULOS BÁSICOS (SBC) and the Brazilian Endocrinology and Metabolism Society (SBEM). Diabetol Metab Syndr 2017;9:53.
51.
64. Schwartz GG, Bessac L, Berdan LG, Bhatt DL, Bittner V, Diaz R et al. Effect of alirocumab, a monoclonal antibody to PCSK9 on longterm cardiovascular outcomes following acute coronary syndromes rationale and design of the ODISSEY outcomes trial. Am Heart J 2014;168(5):682-9. 65. Wierzbicki AS, Hardman TC, Viljoen A. New lipid-lowering drugs: an update. Int J Clin Pract 2012;66:270-80. 66. Barter PJ, Caulfield M, Eriksson M et al. Effects of torcetrapib in patients at high risk for coronary events. N Engl J Med 2007;357:2109-22. 67. Schwartz GG, Olsson AG, Abt M et al. Effects of dalcetrapib in patients with a recent acute coronary syndrome. N Engl J Med 2012;367:2089-99.
56. The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease. JAMA 1984;251:351-64. 57. Bell DS, O’Keefe JH. Rediscovering bile acid sequestrants. Diabetes Obes Metab 2009;11:1114-21. 58. Remick J, Weintraub H, Setton R et al. Fibrate therapy: an update. Cardiol Rev 2008;16:129-41. 59. Eaton CB. Hyperlipidemia. Prim Care 2005;32:1027-55. 60. Landray MJ, Haynes R, Hopewell JC, Parish S, Aung T, Tomson J et al.Effects of extended-release niacin with laropiprant in highrisk patients. N Engl J Med. 2014;371:203-12. 61. Kromhout D, Giltay EJ, Geleijnse JM. Alpha Omega Trial Group. n-3 fatty acids and cardiovascular events after myocardial infarction. N Engl J Med 2010;363:2015-26. 62. Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Ketchum SB et al. Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia. N Engl J Med. 2019 Jan 3;380(1):11-22. 63. Sabatine MS, Giugliano RP, Keech A, Honarpour N, Wiviott SD, Murphy SA et al. Evolocumab and clinical outcomes in patients with cardiovascular disease. N Engl J Med. 2017 Mar 16. [Epub ahead of print]
53. Baigent C, Landray MJ, Reith C et al. The effects of lowering LDL cholesterol with sinvastatina plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial. Lancet 2011;377:2181-92.
45. Sposito AC, Caramelli B, Fonseca FA et al. IV Diretriz brasileira sobre dislipidemias e prevenção da aterosclerose departamento de aterosclerose da sociedade brasileira de cardiologia. Arq Bras Cardiol 2007;88(S1):1-19.
47. Jellinger PS, Simith DA, Mehta AE et al. American Association of clinical endocrinologists’ guidelines for management of dyslipidemia and prevention of atherosclerosis. Endocr Pract 2012;18:1-78.
55. Cannon CP, Blazing MA, Giugliano RP, McCagg A, White JA, Theroux P et al. Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes. N Engl J Med. 2015;372:2387-97.
44. Faludi AA, Izar MCO, Saraiva JFK, Chacra APM, Bianco HT, Afiune Neto A et al. Atualização da Diretriz Brasileira de Dislipidemias e Prevenção da Aterosclerose – 2017. Arq Bras Cardiol 2017;109(2Supl.1):1-76.
46. Grundy SM, Cleeman JI, Bairey CN. Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines. Circulation 2004;110:227-39.
54. Kouvelos GN, Arnaoutoglou EM, Matsagkas MI et al. Effects of rosuvastatin with or without ezetimibe on clinical outcomes in patients undergoing elective vascular surgery: results of a pilot study. J Cardiovasc Pharmacol Ther 2013;18:5-12.
14. Sörelius K et al. Endovascular Treatment of Mycotic Aortic Aneurysms Clinical Perspective: A European Multicenter Study. Circulation 2014;130(24):2136-2142.
17. Enc Y et al. Peripheral mycotic aneurysms in infective endocarditis. J Heart Valve Dis 2005;14(3):310-316.
47 27Capítulo
13. Chen I-Ming et al. Ten-year experience with surgical repair of mycotic aortic aneurysms. J Chinese Med Associat 2005;68(6):265-271.
16. Jia X et al. Open and endovascular repair of primary mycotic aortic aneurysms: a 10-year single-center experience. J Endovasc Ther 2013;20(3):305-310.
7. Brophy CM et al. Decreased tissue inhibitor of metalloproteinases (TIMP) in abdominal aortic aneurysm tissue: a preliminary report. J Surg Res 1991;50(6):653-657.
8. Mozaffarian D, Roger VL et al. Heart disease and stroke statistics—2013 update: a report from the American Heart Association. Circulation 2013;127:e6-e245.
ANEURISMA ARTERIAL REFERÊNCIAS BIBLIOGRÁFICAS
12. Demarche M et al. Femoral anastomotic aneurysms: pathogenic factors, clinical presentations and treatment. A study of 142 cases. Cardiovasc Surg 1999;7(3):315-322.
18. Osler W. The Gulstonian lectures, on malignant endocarditis. Bri Med J 1885;1(1263):522.
5. Lijnen HR. Metalloproteinases in development and progression of vascular disease. Pathophysiol Haemost Thromb 2003;33(5-6):275-281.
10. Austin EH, Wolfe WG. Aneurysm of aberrant subclavian artery with a review of the literature. J Vasc Surg 1985;2(4):571-577.
9. Rutherford RB. Infected Asterial Aneurysms. In: Rutheford RB (Ed.). Vascular Surgery and Endovascular Therapy. 9th ed. 2019. Cap 144. p. 1906-1917.
4. Brown SL et al. Bacteriologic and surgical determinants of survival in patients with mycotic aneurysms. J Vasc Surg 1984;1(4):541-547.
11. Corriere MA, Guzman RJ. True and false aneurysms of the femoral artery. In: Seminars in vascular surgery. WB Saunders; 2005. p. 216-223.
19. Richard L. Kraden and H. Thomas Aretz. In Cardiac Infections. In: Diagnostic Pathology of Infection Disease; 2018 20. Flanigan DP. Aneurysms of the Peripheral Arteris. In: Vascular and Endovascular Surgery: A comprehensive. 8th ed. 2013. cap. 44. 21. Simões Garcia S, Gadelha Figueiredo E, Teixeira JM. Aneurismas infecciosos: incidência, diagnóstico e tratamento. Arq Bras Neurocir 2011;30(3):146-9. 22. Austin EH, Wolfe WG. Aneurysm of aberrant subclavian artery with a review of the literature. J Vasc Surg 1985;2(4):571-577. 23. Gelabert HA. Primary arterial infections and antibiotic prophylaxis. In: Moore W. (Ed.). Vascular surgery. 5th ed. Philadelphia: WB Saunders; 1998. p.168-89. 24. Trairatvorakul P, Sriphojanart S, Sathapatayavongs B. Abdominal aortic aneurysms infected with Salmonella: problems of treatment. J Vasc Surg 1990;12(1):16-19. 25. Porter JM, Taylor LM, Harris EJ. No atherosclerotic vascular disease. In: Moore WS. (Ed.). Vascular surgery. 3rd ed. Philadelphia: WB Saunders; 1991. p. 97-130. 26. Ballweg J et al. Use of Palmaz stents in a newborn with congenital aneurysms and coarctation of the abdominal aorta. Catheterizat Cardiovasc Intervent 2006;68(4):648-652. 27. Rutherford RB. Arterial aneurysms: etiologic considerations. In: Rutherford RB. (Ed.). Vascular surgery. 3rd ed. Philadelphia: WB Saunders; 1989. p. 238-45. 28. Bush RL, Atkins PLMD. Carotid Artery Aneurysms. In: Rutherford RB (Ed.). Vascular Surgery and Endovascular Therapy. 9th ed. Cap. 94. 2019. p. 1242-1254. 29. Melliere D et al. Some popliteal aneurysms are congenital. Cardiovasc Surg 1998;6(1):42-49. 30. Mozaffarian D, Roger VL et al. Heart disease and stroke statistics—2013 update: a report from the American Heart Association. Circulation 2013;127:e6-e245. 31. Rehring TF et al. Regression of perianeurysmal fibrosis and ureteral dilation following endovascular repair of inflammatory abdominal aortic aneurysm. Ann Vasc Surg 2001;15:591-593. 32. Brito CJ, Fernandes DC, Fonseca Filho VL et al. Aneurismas anastomóticos da aorta abdominal. Cir Vasc Ang 1985;1:6-9. 33. Lawrence PF et al. Vascular low-frequency disease consortium. The current management of isolated degenerative femoral artery aneurysms is too aggressive for their natural history. J Vasc Surg 2014;59:343-9. 34. Stanley C. Extra cranial Carotid Artery Aneuryms. In: Current Therapy in Vascular and Endovascular Surgery; 2014.
6. Rasmussen TE et al. Genetic similarity in inflammatory and degenerative abdominal aortic aneurysms: a study of human leukocyte antigen class II disease risk genes. J Vasc Surg 2001;34(1):84-89.
15. González I et al. Symptomatic peripheral mycotic aneurysms due to infective endocarditis: a contemporary profile. Medicine 2014;93(1).
3. Johnston KW et al. Suggested standards for reporting on arterial aneurysms. J Vasc Surg 1991;13(3):452-458.
1. Peter F, Lawrence DA, Rigberg. Arterial Aneuryms: Etiology, Epidemiology and Natural History. In: Rutherford’s Vascular Surgery and Endovascular Therapy. 9th ed. 2019. Cap 69. 2. Rutherford RB. Arterial aneurysms: general considerations. In: Rutherford RB. (Ed.). Vascular surgery. 7th ed. Philadelphia: WB Saunders; 2010. p.1920-27.
14. Sala F, Hassen-Khodja R, Lecis A et al. Long-term outcome of femoral above-knee popliteal artery bypass using autologous saphenous vein versus expanded polytetrafluoroethylene grafts. Ann Vasc Surg 2003 July;17(4):401-7.
17. Prager M, Polterauer P, Bohmig HJ et al. Collagen versus gelatincoated Dacron versus stretch polytetrafluoroethylene in abdominal aortic bifurcation graft surgery: results of a seven-year prospective, randomized multicenter trial. Surgery 2001 Sept;130(3):408-14.
29. Baldwin ZK, Pearce BJ, Curi MA et al. Limb salvage after infrainguinal bypass graft failure. J Vasc Surg 2004 May;39(5):951-7. 30. Landry GJ, Moneta GL, Taylor Jr LM et al. Long-term outcome of revised lower-extremity bypass grafts. J Vasc Surg 2002 Jan;35(1):56-62. 31. Landry GJ, Moneta GL, Taylor Jr LM et al. Choice of autogenous conduit for lower extremity vein graft revisions. J Vasc Surg 2002 Aug;36(2):238-43. 32. Conrad MF, Shepard AD, Rubinfeld IS et al. Long-term results of catheter-directed thrombolysis to treat infrainguinal bypass graft occlusion: the urokinase era. J Vasc Surg 2003 May;37(5):1009-16.
20. Denguir R, Kaouel K, Gharsallah N et al. Cross over bypasses iliofemoral and femoro-femoral. Indications and results about 60 cases. Ann Cardiol Angeiol (Paris) 2004 Jan;53(1):29-33.
22. Kim YW, Lee JH, Kim HG et al. Factors affecting the long-term patency of crossover femorofemoral bypass graft. Eur J Vasc Endovasc Surg 2005 Oct;30(4):376-80. 23. Klinkert P, Post PN, Breslau PJ et al. Saphenous vein versus PTFE for above-knee femoropopliteal bypass. A review of the literature. Eur J Vasc Endovasc Surg 2004 Apr;27(4):357-62.
3. Pereira CE, Albers M, Romiti M et al. Meta-analysis of femoropopliteal bypass grafts for lower extremity arterial insufficiency. J Vasc Surg 2006 Sept;44(3):510-7.
24. Johnson WC, Lee KK. A comparative evaluation of polytetrafluoroethylene, umbilical vein, and saphenous vein bypass grafts for femoral-popliteal above-knee revascularization: a prospective randomized Department of Veterans Affairs cooperative study. J Vasc Surg 2000 Aug;32(2):268-77.
13. Berglund J, Bjorck M, Elfstrom J et al. Long-term results of above knee femoro-popliteal bypass depend on indication for surgery and graft-material. Eur J Vasc Endovasc Surg 2005 Apr;29(4):412-8.
21. Onohara T, Komori K, Kume M et al. Multivariate analysis of longterm results after an axillobifemoral and aortobifemoral bypass in patients with aortoiliac occlusive disease. J Cardiovasc Surg (Torino) 2000 Dec;41(6):905-10.
9. Nguyen LL, Conte MS, Menard MT et al. Infrainguinal vein bypass graft revision: factors affecting long-term outcome. J Vasc Surg 2004 Nov;40(5):916-23.
48 28Capítulo
16. Davidovic L, Vasic D, Maksimovic R et al. Aortobifemoral grafting: factors influencing long-term results. Vascular 2004 May-June;12(3):171-8.
4. Townley WA, Carrell TW, Jenkins MP et al. Critical limb ischemia in the dialysis-dependent patient: infrainguinal vein bypass is justified. Vasc Endovascular Surg 2006 Sept-Oct;40(5):362-6.
8. Goshima KR, Mills JL Sr, Hughes JD. A new look at outcomes after infrainguinal bypass surgery: traditional reporting standards systematically underestimate the expenditure of effort required to attain limb salvage. J Vasc Surg 2004 Feb;39(2):330-5.
19. Melliere D, Desgranges P, de Wailly GW et al. Extensive unilateral iliofemoral occlusions: durability of four techniques of arterial reconstructions. Vascular 2004 Sept-Oct;12(5):285-92.
33. Breukink SO, Vrouenraets BC, Davies GA et al. Thrombolysis as initial treatment of peripheral native artery and bypass graft occlusions in a general community hospital. Ann Vasc Surg 2004 May;18(3):314-20. EM CIRURGIA VASCULAR
12. Mingoli A, Sapienza P, Feldhaus RJ et al. Femorofemoral bypass grafts: factors influencing long-term patency rate and outcome. Surgery 2001 Apr;129(4):451-8.
15. Taylor SM, Kalbaugh CA, Blackhurst DW et al. Determinants of functional outcome after revascularization for critical limb ischemia: an analysis of 1000 consecutive vascular interventions. J Vasc Surg 2006 Oct;44(4):747-55.
SEÇÃO 8 COMPLICAÇÕES
7. Chung J, Bartelson BB, Hiatt WR et al. Wound healing and functional outcomes after infrainguinal bypass with reversed saphenous vein for critical limb ischemia. J Vasc Surg 2006 June;43(6):1183-90.
10. Galaria II, Surowiec SM, Tanski WJ et al. Popliteal-to-distal bypass: identifying risk factors associated with limb loss and graft failure. Endovasc Surg 2005 Sept-Oct;39(5):393-400.
25. Faries PL, Logerfo FW, Arora S et al. A comparative study of alternative conduits for lower extremity revascularization: allautogenous conduit versus prosthetic grafts. J Vasc Surg 2000 Dec;32(6):1080-90. 26. Panneton JM, Hollier LH, Hofer JM. Multicenter randomized prospective trial comparing a pre-cuffed polytetrafluoroethylene graft to a vein cuffed polytetrafluoroethylene graft for infragenicular arterial bypass Ann Vasc Surg 2004 Mar;18(2):199-206.
1. Henke PK, Blackburn S, Proctor MC. Patients undergoing infrainguinal bypass to treat atherosclerotic vascular disease are underprescribed cardioprotective medications: effect on graft patency, limb salvage, and mortality. J Vasc Surg 2004 Feb;39(2):357-65.
2. Chew DK, Nguyen LL, Owens CD et al. Comparative analysis of autogenous infrainguinal bypass grafts in African Americans and Caucasians: the association of race with graft function and limb salvage. J Vasc Surg 2005 Oct;42(4):695-701.
6. Desai TR, Meyerson SL, Skelly CL et al. Patency and limb salvage after infrainguinal bypass with severely compromised (“blind”) outflow. Arch Surg 2001 June;136(6):635-42.
COMPLICAÇÕES EM CIRURGIA ARTERIAL
REFERÊNCIAS BIBLIOGRÁFICAS
27. Oderich GS, Panneton JM, Yagubyan M et al. Comparison of precuffed and vein-cuffed expanded polytetrafluoroethylene grafts for infragenicular arterial reconstructions: a case-matched study. Ann Vasc Surg 2005 Jan;19(1):49-55. 28. Kashyap VS, Ahn SS, Quinones-Baldrich WJ et al. Infrapopliteallower extremity revascularization with prosthetic conduit: a 20-year experience. Vasc Endovascular Surg 2002 July-Aug;36(4):255-62.
5. Probst H, Saucy F, Dusmet M et al. Clinical results of autologous infrainguinal revascularization using grafts originating distal to the femoral bifurcation in patients with mild inflow disease. J Cardiovasc Surg (Torino) 2006 Aug;47(4):437-43.
11. Kreienberg PB, Darling RC 3rd, Chang BB et al. Adjunctive techniques to improve patency of distal prosthetic bypass grafts: polytetrafluoroethylene with remote arteriovenous fistulae versus vein cuffs. J Vasc Surg 2000 Apr;31(4):696-701.
18. Ghansah JN, Murphy JT. Complications of major aortic and lower extremity vascular surgery. Semin Cardiothorac Vasc Anesth 2004 Dec;8(4):335-61.
52. Kayllioglu SL, Dinc T, Sozen I et al. Postoperative fluid management. World J Crit Care Med 2015 Aug 4;4(3):192-201. 53. Joshi GP. Intraoperative fluid management. UpToDate 2018 Jun. 54. Myles PS, Bellomo R, Corcoran T et al. Restrictive versus liberal fluid therapy for major abdominal surgery.. New Engl J Med. No prelo em maio 2018. Friedli S, Mahler F. Venous and lymphatic reasons for edema – The swollen leg from the angiologist’s point of view. Ther Umsch 2004 Nov;61(11):643-7. 56. AbuRahma AF, Woodruff BA, Lucente FC. Edema after femoropopliteal bypass surgery: lymphatic and venous theories of causation. J Vasc Surg 1990 Mar;11(3):461-7.
34. Zuckerman DA, Alderman MG, Idso MC et al. Follow-up of infrainguinal graft thrombolysis: analysis of predictors of clinical success. Arch Surg 2003 Feb;138(2):198-202.
42.
44.
36. Dorffler-Melly J, Buller HR, Koopman MM et al. Antithrombotic agents for preventing thrombosis after infrainguinal arterial bypass surgery. Cochrane Database Syst Rev 2003;(4):CD000536.
43.
45. Tawes Jr RL, Sydorak GR, Duvall TB et al. Avoiding coagulopathy in vascular surgery. Am J Surg 1990 Aug.;160(2):212-6.
48. Muniz G, Asensio F, Asuero MS et al. Warm air convection system and heat loss during vascular surgery. Rev Esp Anestesiol Reanim 1996 June-July;43(6):197-200.
51. Muntean W. Rational perioperative use of clotting factor concentrates and fresh frozen plasma (FFP). Acta Anaesthesiol Scand Suppl 1997;111:263-4.
41.
47. Camus Y, Delva E, Co-hen S et al. The effects of warming intravenous fluids on intraoperative hypothermia and postoperative shivering during prolonged abdominal surgery. Acta Anaesthesiol Scand 1996 Aug;40(7):779-82.
55.
57. Sacchi G, Weber E, Agliano M et al. The structure of superficial lymphatics in the human thigh: precollectors. Anat Rec 1997 Jan;247(1):53-62. 58. Tyndall SH, Shepard AD, Wilczewski JM et al. Groin lymphatic complications after arterial reconstruction. J Vasc Surg 1994 May;19(5):858-63.
59. Kent KC, Bartek S, Kuntz KM et al. Prospective study of wound complications in continuous infrainguinal incisions after lower limb arterial reconstruction: incidence, risk factors, and cost. Surgery 1996 Apr;119(4):378-83.
38. Brown J, Lethaby A, Maxwell H et al. Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery. Cochrane Database Syst Rev 2008 Oct 8;(4):CD000535.
46. Vanni SM, Braz JR, Modolo NS et al. Preoperative combined with intraoperative skin-surface warming avoids hypothermia caused by general anesthesia and surgery. J Clin Anesth 2003 Mar;15(2):119-25.
Capítulo 28 49ComPliCAções em CirurgiA ArteriAl
49. Hiippala ST, Myllyla GJ, Vahtera EM. Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates. Anesth Analg 1995:81:360-5.
50. Hardy JF, de Moerloose P, Samama CM. The coagulopathy of massive transfusion. Vox Sang 2005 Oct;89(3):123-7.
35. Collins TC, Souchek J, Beyth RJ. Benefits of antithrombotic therapy after infrainguinal bypass grafting: a meta-analysis. Am J Med 2004 July 15;117(2):93-9.
60. Haaverstad R, Johnsen H, Saether OD et al. Lymph drainage and the development of post-reconstructive leg oedema is not influenced by the type of inguinal incision. A prospective randomised study in patients undergoing femoropopliteal bypass surgery. Eur J Vasc Endovasc Surg 1995 Oct;10(3):316-22.
61. Shermak MA, Yee K, Wong L et al. Surgical management of groin lymphatic complications after arterial bypass surgery. Plast Reconstr Surg 2005 June;115(7):1954-62.
39. Geraghty AJ, Welch K. Antithrombotic agents for preventing thrombosis after infrainguinal arterial bypass surgery. Cochrane Database Syst Rev 2011 June 15;(6):CD000536. 40. Abbruzzese TA, Havens J, Belkin M et al. Statin therapy is associated with improved patency of autogenous infrainguinal bypass grafts. J Vasc Surg 2004 June;39(6):1178-85. Shames ML, Thompson RW. Abdominal aortic aneurysms. Surgical treatment. Cardiol Clin 2002 Nov;20(4):563-78. Daly KJ, Torella F, Ashleigh R et al. Screening, diagnosis and advances in aortic aneurysm surgery. Gerontology 2004 Nov-Dec;50(6):349-59. Mercer KG, Spark JI, Berridge DC et al. Randomized clinical trial of intraoperative autotransfusion in surgery for abdominal aortic aneurysm. Br J Surg 2004 Nov;91(11):1443-8. Adam DJ, Haggart PC, Ludlam CA et al. Coagulopathy and hyperfibrinolysis in ruptured abdominal aortic aneurysm repair. Ann Vasc Surg 2004 Sept.;18(5):572-7.
62. Roberts JR, Walters GK, Zenilman ME et al. Groin lymphorrhea complicating revascularization involving the femoral vessels. Am J Surg 1993 Mar;165(3):341-4. 63. Schwartz MA, Schanzer H, Skladany M et al. A comparison of conservative therapy and early selective ligation in the treatment of lymphatic complications following vascular procedures. Am J Surg 1995 Aug;170(2):206-8. 64. Kwaan JH, Bernstein JM, Connolly JE. Management of lymph fistula in the groin after arterial reconstruction. Arch Surg 1979 Dec;114(12):1416-8.
65. Weaver MV, Tadros RO, Phangureh VS A novel approach to the management of a recurrent lymphocele following a femoral-femoral bypass. J Vasc Surg 2014;59:1109-11. 66. Uchinami M, Morioka K, Doi K et al. Retroperitoneal laparoscopic management of a lymphocele after abdominal aortic surgery: a case report. J Vasc Surg 2005 Sept;42(3):552-5.
67. Garrett Jr HE, Richardson JW, Howard HS et al. Retroperitoneal lymphocele after abdominal aortic surgery. J Vasc Surg 1989 Sept;10(3):245-53. 68. Sanger R, Wilmshurst CC, Clyne CA. Chylous ascites following aneurysm surgery. Eur J Vasc Surg 1991 Dec;5(6):689-92. 69. Blessios GA, Rokkas CK, Neulander O et al. Laparoscopic management of large retroperitoneal lymphoceles complicating aortic surgery. Surg Endosc 2002 Jan;16(1):218. Epub 2001 Oct. 13. 70. Allaham AH, Estrera AL, Miller CC 3rd et al. Chylothorax complicating repairs of the descending and thoracoabdominal aorta. Chest 2006 Oct;130(4):1138-42. 71. Minami H, Mukohara N, Shida T. Postoperative chylothorax in patients with a thoracic aortic aneurysm. Ann Thorac Cardiovasc Surg 2006 Apr;12(2):116-20. 72. Stringel G, Teixeira JA. Thoracoscopic ligation of the thoracic duct. JSLS 2000 July-Sept;4(3):239-42. 73. Kilic D, Sahin E, Gulcan O et al. Octreotide for treating chylothorax after cardiac surgery. Tex Heart Inst J 2005;32(3):437-39. 74. Platis IE, Nwogu CE. Chylothorax. Thorac Surg Clin 2006 Aug;16(3):209-14. 75. Dahlerup F. Obduktionsbericht. Ugeskr Laeger 1844;1:215. 76. Matchett WJ, McFarland DR, Eidt JF et al. Blue toe syndrome: treatment with intra-arterial stents and review of therapies. J Vasc Interv Radiol 2000 May;11(5):585-92. 77. Baumann DS, McGraw D, Rubin BG et al. An institutional experience with arterial atheroembolism. Ann Vasc Surg 1994 May;8(3):258-65. 78. Khan AM, Jacobs S. Trash feet after coronary angiography. Heart 2003 May;89(5):e17. 79. Kuhan G, Raptis S. Trash foot following operations involving the abdominal aorta. Aust N Z J Surg 1997 Jan;67(1):21-4. 80. Rauh G, Spengel FA. Blue toe syndrome after initiation of low-dose oral anticoagulation. Eur J Med Res 1998 June 17;3(6):278-80. 81. Bols A, Nevelsteen A, Verhaeghe R. Atheromatous embolization precipitated by oral anticoagulants. Int Angiol 1994 Sept;13(3):271-4. 82. Ridker PM, Michel T. Streptokinase therapy and cholesterol embolization. Am J Med 1989;87:357. 83. Fisher Jr DF, Clagett GP, Brigham RA et al. Dilemmas in dealing with the blue toe syndrome: aortic versus peripheral source. Am J Surg 1984 Dec;148(6):836-9. 84. Kvilekval KH, Yunis JP, Mason RA et al. After the blue toe: prognosis of noncardiac arterial embolization in the lower extremities. J Vasc Surg 1993 Feb;17(2):328-34. 85. Hayashida N, Murayama H, Pearce Y et al. Shaggy aorta syndrome after acute arterial macroembolism: report of a case. Surg Today 2004;34(4):354-6. 86. Dougherty MJ, Calligaro KD. Endovascular treatment of embolization of aortic plaque with covered stents. J Vasc Surg 2002 Oct;36(4):727-31. 87. Carroccio A, Olin JW, Ellozy SH et al. The role of aortic stent grafting in the treatment of atheromatous embolization syndrome: results after a mean of 15 months follow-up. J Vasc Surg 2004 Sept;40(3):424-9. 88. Pardy BJ, Lewis JD, Eastcott HH. Preliminary experience with prostaglandins E1 and I2 in peripheral vascular disease. Surgery 1980;88:826-32.
37. Conte MS, Bandyk DF, Clowes AW et al. Risk factors, medical therapies and perioperative events in limb salvage surgery: observations from the PREVENT III multicenter trial. J Vasc Surg 2005 Sept;42(3):456-64;discussion 464-65.
117. O’Connor S, Andrew P, Batt M, Becquemin JP. A systematic review and meta-analysis of treatments for aortic graft infection. J Vasc Surg 2006;44:38-45.
110. Nukuda H, van Rij AM, Packer SG et al. Pathology of acute and chronic ischaemic neuropathy in atherosclerotic peripheral vascular disease. Brain 1996;119:1149. 111. Kelly CJ, Augustine C, Rooney BP et al. An investigation of the pathophysiology of ischaemic neuropathy. Eur J Vasc Surg 1991;5:535. 112. Korthals JK, Maki T, Gieron MA. Nerve and muscle vulnerability to ischemia. J Neurol Sci 1985;71:283.
120. Baddour LM, Bettmann MA, Bolger AF, Epstein AE, Ferrieri P, Gerber MA et al. Nonvalvular cardiovascular device-related infections. Circulation 2003;108:2015-2031. 121. Oderich GS, Panneton JM, Bower TC, Cherry KJ Jr, Rowland CM, Noel AA et al. Infected aortic aneurysms: aggressive presentation, complicated early outcome, but durable results. J Vasc Surg 2001;34:900-908. 122. Bandyk DF, Berni GA, Thiele BL, Towne JB. Aortofemoral graft infection due to Staphylococcus epidermidis. Arch Surg 1984;119:102-108. 123. Bandyk DF. Vascular graft infections: epidemiology, microbiology, pathogenesis, and prevention. In: Bernhard VM, Towne JB, eds. Complication in Vascular Surgery. St. Louis, MO: Quality Medical Publishing; 1991. p. 223-234. 124. Antonios VS, Noel AA, Steckelberg JM, Wilson WR, Mandrekar JN, Harmsen WS, Baddour LM. Prosthetic vascular graft infection: a risk factor analysis using a case-control study. J Infect 2006;53:49-55. 125. Bandyk DF, Novotney ML, Back MR, Johnson BL, Schmacht DC. Expanded application of in situ replacement for prosthetic graft infection. J Vasc Surg 2001;34:411-419. 126. Kilic A, Arnaoutakis DJ, Reifsnyder T, Black III JH, Abularrage CJ, Perler BA et al. Management of infected vascular grafts Vasc Med 2016;21(1):53-60. 127. Wilson WR, Mayo Clinic Infectious Diseases Subspecialities Update May 7-9; 2015 128. Vogel TR, Symons R, Flum DR. The incidence and factors associated with graft infection after aortic aneurysm repair. J Vasc Surg 2008;47:264-269. 129. Samson RH, Veith FJ, Janko GS, Gupta SK, Scher LA. A modified classification and approach to the management of infections involving peripheral arterial prosthetic grafts. J Vasc Surg 1988;8:147-153.
108. Lang PM, Schober GM, Rolke R et al. Sensory neuropathy and signs of central sensitization in patients with peripheral arterial disease. Pain 2006 Sept;124(1-2):190-200.
Parte I50 CAPÍTULOS BÁSICOS
89. Parodi JC, Patel St, Parodi Fee et al. Modern trends. In: Rorigues HE, Pearce WH, Yao JS. Vascular surgery – The ischemic extremity. People’s Medical: UXA; 2010. p. 313-37, c. 28. 90. Olson SA, Glasgow RR. Acute compartment syndrome in lower extremity musculoskeletal trauma. J Am Acad Orthop Surg 2005 Nov;13(7):436-44. 91. McQueen M, Gaston P, Court-Brown C. Acute compartment syndrome: who´s at risk? J Bone Joint Surg 2000;82-B:200-3.
130. Wilson WR, Bower TC, Creager MA, Sepideh AH, O’Gara PT et al Vascular Graft Infections, Mycotic aneurysms, and endovascular Infections: a scientic statement from the American Heart Association. Circulation 2016;134:e412-e460.
115. Chiesa R, Astore D, Frigerio S, Garriboli L, Piccolo G, Castellano R et al. Vascular prosthetic graft infection: epidemiology, bacteriology, pathogenesis and treatment. Acta Chir Belg 2002;102:238-247.
95. Simms MS, Terry TR. Well leg compartment syndrome after pelvic and perineal surgery in the lithotomy position. Postgrad Med J 2005 Aug;81(958):534-6.
97. Cooper GG. A method of single-incision, four compartment fasciotomy of the leg. Eur J Vasc Surg 1992 Nov;6(6):659-61. 98. Haimovici H. Muscular, renal, and metabolic complications of acute arterial occlusions: myonephropathic-metabolic syndrome. Surgery 1979 Apr;85(4):461-8. 99. Scharman EJ, Troutman WG. Prevention of kidney injury following rhabdomyolysis: a systematic review. Ann Pharmacother 2013 Jan;47(1):90-105. 100. Collinge C, Kuper M. Comparison of three methods for measuring intracompartmental pressure in injured limbs of trauma patients. J Orthop Trauma 2010;24:364. 101. Hammerberg EM, Whitesides TE Jr, Seiler JG 3rd. The reliability of measurement of tissue pressure in compartment syndrome. J Orthop Trauma 2012;26:24. 102. McQueen MM, Duckworth AD, Aitken SA, Court-Brown CM. The estimated sensitivity and specificity of compartment pressure monitoring for acute compartment syndrome. J Bone Joint Surg Am 2013;95:673. 103. Calton Jr WC, Franklin DP, Elmore JR et al. Ultrasound-guided thrombin injection is a safe and durable treatment for femoral pseudoaneurysms. Vasc Surg 2001 Sept-Oct;35(5):379-83. 104. Araujo AP, Gomes CFA, DiMaio AB et al. Curativo compressivo prolongado para tratamento de pseudoaneurisma pós-cateterismo. J Vasc Bras 2003;(1):29-32.
131. Sharif MA, Lee B, Lau LL, Ellis PK, Collins AJ, Blair PH et al. Prosthetic stent graft infection after endovascular abdominal aortic aneurysm repair. J Vasc Surg 2007;46:442-448.
134. Lewis SS, Cox GM, Stout JE. Clinical utility of indium 111-labeled white blood cell scintigraphy for evaluation of suspected infection. Open Forum Infect Dis 2014;17(2):ofu089. 135. Fiorani P, Speziale F, Rizzo L, De Santis F, Massimi GJ, Taurino M et al. Detection of aor- tic graft infection with leukocytes labeled with technetium 99m- hexametazime. J Vasc Surg 1993;17:87-95.
133. Brunner MC, Mitchell RS, Baldwin JC, James DR, Olcott C 4th, Mehigan JT et al. Prosthetic graft infection: limitations of indium white blood cell scanning. J Vasc Surg 1986;3:42-48.
118. Kieffer E, Bahnini A, Koskas F, Ruotolo C, Le Blevec D, Plisson- nier D. In situ allograft replacement of infected infrarenal aortic prosthetic grafts: results in forty-three patients. J Vasc Surg 1993;17:349-355. 119. Swain TW 3rd, Calligaro KD, Dougherty MD. Management of infected aortic prosthetic grafts. Vasc Endovasc Surg 2004;38:75-82.
132. Fatima J, Duncan AA, de Grandis E, Oderich GS, Kalra M, Gloviczki P et al. Treatment strategies and outcomes in patients with infected aortic endografts. J Vasc Surg 2013;58:371-379.
138. Tegler G, Sörensen J, Björck M, Savitcheva I, Wanhainen A. Detection of aortic graft infection by 18-fluorodeoxyglucose positron emission tomography combined with computed tomography. J Vasc Surg 2007;45:828-830.
96. Rose S, Fiebrich M, Weber P et al. Neutrophil activation after skeletal muscle ischemia in humans. Shock 1998;9(1):21-6.
113. Andary MT ,O’Connor RC, Mahal BS. Ischemic monomelic neuropathy. Medscape 2017 Jun. 114. Sohail MR, Wilson WR, Baddour LM. Infections of nonvalvular cardiovascular diseases. In Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett’s Principles and Practices of Infectious Diseases. Philadelphia, PA: Churchill Livingston/Elsevier; 2010. p. 1127-1142.
136. Shahidi S, Eskil A, Lundof E, Klaerke A, Jensen BS. Detection of abdominal aortic graft infection: comparison of magnetic resonance imaging and indium-labeled white blood cell scanning. Ann Vasc Surg 2007;21:586-592. 137. Lauwers P, Van den Broeck S, Carp L, Hendriks J, Van Schil P, Blockx P. The use of positron emission tomography with (18) F-fluorodeoxyglucose for the diagnosis of vascular graft infection. Angiology 2007;58:717-724.
116. Hayes PD, Nasim A, London NJ, Sayers RD, Barrie WW, Bell PR et al. In situ replacement of infected aortic grafts with rifampicin-bonded prostheses: the Leicester experience (1992 to 1998). J Vasc Surg 1999(30):92-98.
109. Wilbourn AJ, Furlan AJ, Hulley W et al. Ischemic monomelic neuropathy. Neurology 1983 Apr;33(4):447-51.
106. Pinto DM, Dias Jr JO, Fonseca BL et al. Experiência inicial com o uso de adesivo tecidual contendo trombina para tratamento do pseudoaneurisma femoral. J Vasc Bras 206;5(1):30-6.
107. McKenzie D, Nukada H, van Rij AM et al. Endoneurial microvascular abnormalities of sural nerve in non-diabetic chronic atherosclerotic occlusive disease. J Neurol Sci 1999;162:84-8.
105. Lonn L, Olmarker A, Geterud K et al. Treatment of femoral pseudoaneurysms. Percutaneous US-guided thrombin injection versus US-guided compression. Acta Radiol 2002 July;43(4):396-400.
92. Jensen SL, Sandermann J. Compartment syndrome and fasciotomy in vascular surgery. A review of 57 cases. Eur J Vasc Endovasc Surg 1997 Jan;13(1):48-53. 93. Beraldo S, Dodds SR. Lower limb acute compartment syndrome after colorectal surgery in prolonged lithotomy position. Dis Colon Rectum 2006 Oct;49:1-9. 94. Wassenaar EB, van den Brand JG, van der Werken C. Compartment syndrome of the lower leg after surgery in the modified lithotomy position: report of seven cases. Dis Colon Rectum 2006 Sept;49(9):1449-53.
144. Oderich GS, Bower TC, Cherry KJ Jr, Panneton JM, Sullivan TM, Noel AA et al. Evolution from axillofemoral to in situ prosthetic reconstruction for the treatment of aortic graft infections at a single center. J Vasc Surg 2006;43:1166-1174.
141. Dosluoglu HH, Schimpf DK, Schultz R, Cherr GS. Preservation of infected and exposed vascular grafts using vacuum assisted closure without muscle flap coverage. J Vasc Surg 2005;42:989-92.
139. Antony S, Terrazas S. A retrospective study: Clinical experience using vacuum-assisted closure in the treatment of wounds. J Natl Med Assoc 2004;96:1073-7.
147. Daenens K, Fourneau I, Nevelsteen A. Ten-year experience in autogenous reconstruction with the femoral vein in the treatment of aortofemoral prosthetic infection. Eur J Vasc Endovasc Surg 2003;25:240-245.
150. Brown KE, Heyer K, Rodriguez H et al. Arterial reconstruction with cryopreserved human allografts in the setting of infection: A single-center experience with midterm follow-up. J Vasc Surg 2009;49:660-666.
143. Oelbrabdt B, Guelinckx PJ, Nevelsteen A. Use of the superior pedicled rectus abdominais flap to cover infected aortic grafts. Br J Pastic SURG 2003; (56)280-831. Laustsen J, Bille S, Christensen J. Transposition of the sartorius muscle in the treatment of infected vascular grafts in the groin. Eur J Vasc Surg 1988;2(2) 111-13.
146. Gordon LL, Hagino RT, Jackson MR et al. Complex aortofemoral prosthetic infections: the role of autogenous superficial femoropopliteal vein reconstruction. Arch Surg 1999;134:615-620.
145. Young RM, Cherry KJ Jr, Davis PM et al. The results of in situ prosthetic replacement for infected aortic grafts. Am J Surg 1999;178:136-140.
154. Taguchi S, Mori A, Suzuki R et al. Technique for using pedicled latissimus dorsi muscle flaps to wrap prosthetic grafts in an infected thoracic aorta. Ann Vasc Surg 2013;27:1223-7.
140. Demaria RG, Giovannini UM, Teot L, Frapier JM, Albat B. Topical negative pressure therapy. A very useful new method to treat severe infected vascular approaches in the groin. J Cardiovasc Surg 2003;44:757-61.
149. Chung J, Clagett GP. Neoaortoiliac System (NAIS) proce- dure for the treatment of the infected aortic graft. Semin Vasc Surg 2011;24:220-226.
142. Dosluoglu HH, Loghmanee C, Ourandath L, Cherr GS, Harris LM, Dryski ML Management of early (30 day) vascular groin infections using vacuum-assisted closure alone without muscle flap coverage in a consecutive patient series J Vasc Surg 2010;51:1160-6.
148. Ali AT, Modrall JG, Hocking J et al. Long-term results of the treatment of aortic graft infection by in situ replacement with femoral popliteal vein grafts. J Vasc Surg 2009;50:30-39.
153. Kieffer E, Petitjean C, Richard T, Godet G, Dhobb M, Ruotolo C. Exclusion-bypass for aneurysms of the descending thoracic and thoracoabdominal aorta. Ann Vasc Surg 1986;1(2):182-195.
152. Harlander-Locke MP, Harmon LK, Lawrence PF et al. The use of cryopreserved aortoiliac allograft for aortic reconstruction in the United States. J Vasc Surg 2014;59:669-674.
156. Yamashiro S, Arakaki R, Kise Y et al. Potential role of omental wrapping to prevent infection after treatment for infectious thoracic aortic aneurysms. Eur J Cardiothorac Surg 2013;43:1177-82.
155. Takano T, Terasaki T, Wada Y et al. Treatment of prosthetic graft infection after thoracic aorta replacement. Ann Thorac Cardiovasc Surg 2014;20:304-9.
Capítulo 28 51ComPliCAções em CirurgiA ArteriAl
157. Widmer MK, Krueger T, Lardinois D et al. A comparative evaluation of intrathoracic latissimus dorsi and serratus anterior muscle transposition. Eur J Cardiothorac Surg 2000;18:435-439.
158. Mixter RC, Turnipseed WD, Smith Jr DJ, Acher AW, Rao VK e Dibbell DG. Rotational muscle flaps: A new technique for covering infected vascular grafts, J Vasc Surg 1989;9(3):472-478.
151. Bisdas T, Bredt M, Pichlmaier M et al. Eight-year experience with cryopreserved arterial homografts for the in situ reconstruction of abdominal aortic infections. J Vasc Surg 2010;52:323-330.
18. Bergquist D, Jonsson K, Weibull H. Complications after percutaneous transluminal angioplasty of peripheral and renal arteries. Acta Radiol 1987;28:3-12.
16. Greenfield AJ. Femoral, popliteal and tibial arteries: percutaneous transluminal angioplasty. Am J Radiol 1980;135:927-35.
26. Kang SS, Labropoulos N, Mansour MA et al. Percutaneous ultrasound guided thrombin injection: a new method for treatment postcatheterization femoral pseudoaneurysms. J Vasc Surg 1998;27:1032-8.
13. Kent KC, Moscucci M, Gallagher SG et al. Neuropathy after cardiac catheterization: incidence, clinical patterns, and long-term outcome. J Vasc Surg 1994;19:1008-13.
29. Perings SM, Kelm M, Jax T et al. A prospective study on incidence and risk factors of arteriovenous fistulae following transfemoral cardiac catheterization. Int J Cardiol 2003;88:223-8.
33. Nikolsky E, Mehran R, Halkin A et al. Vascular complications associated with arteriotomy closure devices in patients undergoing percutaneous coronary procedures. A meta-analysis. J Am Coll Cardiol 2004;44:1200-9. 34. Cleveland KO, Gelfand MS. Invasive staphylococcal infections complications percutaneous transluminal angioplasty: three cases and review. Clin Infect Dis 1995;21:93-6. 35. Smith TP, Cruz CP, Moursi MM et al. Infectious complications resulting from use of hemostatic puncture closure devices. Am J Surg 2001;182:658-62. 36. Frazee BW, Flaherty JP. Septic endarteritis of the femoral artery following angioplasty. Rev Infect Dis 1991;13:620-3. 37. Brummitt CF, Kravitz GR, Granrud GA et al. Femoral endarteritis due to Staphylococcus aureus complicating percutaneous transluminal coronary angioplasty. Am J Med 1989;86:822-4. 38. Becker GJ, Katzen BT, Dake MD. Noncoronary angioplasty. Radiology 1989;170:921-40. 39. O’Keeffe St, Woods BO, Beckmann CF. Percutaneous transluminal angioplasty of the peripheral arteries. Cardiol Clin 1991;9:515. 40. Samson RH, Sprayregen S, Veith FJ et al. Management of angioplasty complications, unsuccessful procedures, and early and late failures. Ann Surg 1984;199:234. 41. Weibull H, Bergqist D, Jonsson K et al. Complications after percutaneous transluminal angioplasty in the iliac, femoral, and popliteal arteries. J Vasc Surg 1987;5:681. 42. Higginson A, Alaeddin F, Fishwick G et al. ‘Push and park’. An alternative strategy for management of embolic complication during balloon angioplasty. Eur J Vasc Endovasc Surg 2001;21:279-82. 43. Gaines PA, Cumberland DC, Kennedy A et al. Cholesterol embolisation; a lethal complication of vascular catheterisation. Lancet 1988;1:168-70. 44. Fine MJ, Kapoor WN, Falanga V. Cholesterol crystal embolization: a review of 221 cases in the English literature. Angiology 1987;38:769-84.
23. Kamineni R, Kelly L, Heuser RR. Complications of peripheral interventions. In: Heuser RR, Biamino G (Eds.). Peripheral vascular stenting, 2nd ed. London: Taylor & Francis; 2005. p. 187-98.
25. Lonn L, Olmarker A, Geterud K et al. Treatment of femoral pseudoaneurysms. Percutaneous US-guided thrombin injection versus US-guided compression. Acta Radiologica 2002;43(4):396-400.
52 29Capítulo COMPLICAÇÕES EM CIRURGIA ENDOVASCULAR REFERÊNCIAS BIBLIOGRÁFICAS
30. Johnson LW, Lozner EC, Johnson S et al. Coronary arteriography 19841987: a report of the registry of the Society for Cardiac Angiography and Interventions. Cathet Cardiovasc Diagn 1989;17:5-10. 31. Humphries AW. Evaluation if the natural history and result of treatment involving the lower extremities. New York: Mcgraw-Hill; 1973. 32. Schulz-Schüpke S, Helde S, Gewalt S et al. Comparison of vascular closure devices vs manual compression after femoral artery puncture. The ISAR-CLOSURE randomized clinical trial. JAMA 2014;312:1981-7.
27. Kresowik TF, Khoury MD, Miller BV, et al. A prospective study of the incidence and natural history of femoral vascular complications after percutaneous transluminal coronary angioplasty. J Vasc Surg 1991;13:328-33.
19. Benson LM, Wunderly D, Perry B et al. Determining best practice: Comparison of three methods of femoral sheath removal after cardiac interventional procedures. Heart Lung 2005;34:115-21.
10. Singh H, Cardella JF, Cole PE et al. Quality improvement guidelines for diagnostic arteriography. J Vasc Interv Radiol 2003;14:283-8.
4. Fraedrich G, Beck F, Bonzai T et al. Acute surgical intervention for complications of percutaneous transluminal angioplasty. Eur J Vasc Surg 1987;1:197-203.
14. Starck EE, McDermott HJ, Crummy AB et al. Angioplasty of the popliteal and tibial arteries. Semin Intervent Radiol 1984;1:296-77.
20. Kent KC, Moscucci M, Mansour KA et al. Retroperitoneal hematoma after cardiac catheterization: prevalence, risk factors, and optimal management. J Vasc Surg 1994;20:905-10.
9. Juran NB. Minimizing bleeding complications of percutaneous coronary intervention and glycoprotein IIb-IIIa antiplatelet therapy. Am Heart J 1999;138:297-306.
2. Gardiner G, Meyerovitz M, Stokes K et al. Complications of transluminal angioplasty. Radiology 1986;159:201-8.
3. Tegtmeyer C, Hartwell G, Selby B et al. Results and complications of angioplasty in aortoiliac disease. Circulation 1991;83(suppl I):53-60.
17. Zeitler E. Percutaneous dilatation and recanalization of iliac and femoral arteries. Cardiovasc Intervent Radiol 1980;3:207-12.
8. Levine GN, Kern MJ, Berger PB et al. Management of patients undergoing percutaneous coronary revascularization. Ann Intern Med 2003;139:123-36.
1. Lewis D, Bullbulia R, Murphy P et al. Vascular surgical intervention for complications of cardiovascular radiology: 13 years experience in a single centre. Ann R Coll Surg Engl 1999;81:23-6.
28. Kent KC, McArdle CR, Kennedy B et al. A prospective study of the clinical outcome of femoral pseudoaneurysms and arteriovenous fistulas induced by arterial punture. J Vasc Surg 1993;17:125-31.
5. Pentecost MJ, Crique MH, Dorros G et al. Guidelines for peripheral percutaneous transluminal angioplasty of the abdominal aorta and lower extremity vessels. Circulation 1994;89:511-31.
7. Fellmeth BD, Roberts AC, Bookstein JJ et al. Postangiographic femoral artery injuries: nonsurgical repair with US-guided compression. Radiology 1991;178:671-5.
6. Matsi PJ, Manninen HI. Complications of lower limb percutaneous angioplasty: a prospective analysis of 410 procedures on 295 consecutives patients. Cardiovasc Intervent Radiol 1999;21:361-6.
22. Wixon CL, Philpott JM, Bogey WM et al. Duplex directed thrombin injection as a method to treat femoral artery pseudoaneurysms. J Am Coll Surg 1998;18:464-6.
11. Braun RM, Newman J, Thacher B. Injury to the brachial plexus as a result of diagnostic arteriography. J Hand Surg 1978;3:90-4.
24. Morgan R, Belli A. Current treatment methods for postcatheterization pseudoaneurysms. J Vasc Interv Radiol 2003;14:697-710.
12. Lyon BB, Hansen BA, Mygind T. Peripheral nerve injury as a complication of axillary arteriography. Acta Neurol Scand 1975;51:29-36.
15. van Andel GJ, van Erp WFM, Krepel VM et al. Percutaneous transluminal dilatation of the iliac artery: long-term results. Radiology 1985;156:321-3.
21. Grines CL, Bakalyar D et al. Predictors of bleeding complications following coronary angioplasty. Circulation 1991;84:II-591.
48.
Capítulo 29 53ComPliCAções em CirurgiA endovA sCul Ar
46.
55. Vano E, Goicolea J, Galvan C et al. Skin radiation injuries in patients following repeated coronary angioplasty procedures. Br J Radiol 2001;74:1023-31.
54. Koenig TR, Mettler FA, Wagner LK. Skin injuries from fluoroscopically guided procedures: part 2, review of 73 cases and recommendations for minimizing dose delivered to patient. AJR 2001;177:13-20.
56. Archambeau JO, Pezner R, Wasserman T. Pathophysiology of irradiated skin and breast. Int J Radiat Oncol Biol Phys 1995;31:1171-85.
52. Sharafuddin MJ, MArja AE. Current status of carbon dioxide angiography. J Vasc Surg 2017;66:618-37.
47.
53. Koenig TR, Wolff D, Mettler FA et al. Skin injuries from fluoroscopically guided procedures: part 1, characteristics of radiation injury. AJR 2001;177:3-11.
45. Schachtrupp A, Chalabi K, Fischer U et al. Septic endarteritis and fatal iliac wall rupture after endovascular stenting of the common iliac artery. Cardiovasc Surg 1999;7:183-6. Deiparine MK, Ballard JL, Taylor FC et al. Endovascular stent infection. J Vasc Surg 1996;23:529-33. Barrett Bj, Parfrey PS. Preventing nephropathy induced by contrast medium. N Eng J Med 2006;354:379-86. Marenzi G, Marana I, Lauri G et al. The prevention of radioconstrastagent-induced nephropathy by hemofiltration. N Eng J Med 2003;349:1331-8.
50. Mueller C, Buerkle G, Buettner HJ et al. Prevention of contrast mediaassociated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med 2002;162:329-36.
49. Pannu N, Wiebe N, Tonelli M. Prophylaxis strategies for contrastinduced nephropathy. J Am Med Assoc 2006;295:2765-79.
51. Merten GJ, Burgess WP, Gray LV et al. Prevention of contrast-induced nephropathy with sodium bicarbonate. A randomized controlled trial. J Am Med Assoc 2004;291:2328-34.
1. Schillinger M, Sabeti S, Loewe C et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 2006;354:1879-1888.
54 30Capítulo ESTENOSE INTRA-STENT REFERÊNCIAS BIBLIOGRÁFICAS
17. Bosiers M, Deloose K, Callaert J et al. Superiority of stent-grafts for instent restenosis in the superficial femoral artery: twelve-month results from a multicenter randomizes trial. J Endovasc Ther 2015;22:1-10. 18. Dippel EJ, Makam P, Kovach R et al. Randomized controlled study of excimer laser atherectomy for treatment of femoropopliteal in-stent restenosis: initial results from the EXCITE ISR trial (Excimer Laser Randomized Controlled Study for Treatment of Femoropopliteal In-Stent Restenosis). JACC Cardiovasc Interv 2015;8(1 pt A):92-101. 19. Gandini R, Del Giudice C, Merolla S et al. Treatment of chronic SFA in-stent occlusion with combined laser atherectomy and drugeluting balloon angioplasty in patients with critical limb ischemia: a single-center, prospective, randomized study. J Endovasc Ther 2013;20:805-814. 20. Laird JR Jr, Yeo KK, Rocha-Singh K et al. Excimer laser with adjunctive balloon angioplasty and heparin-coated self-expanding stent grafts for the treatment of femoropopliteal artery in-stent restenosis: twelve-month results from the SALVAGE study. Catheter Cardiovasc Interv 2012;80:852-859.
10. Koizumi A, Kumakura H, Kanai H et al. Ten-year patency and factors causing restenosis after endovascular treatment of iliac artery lesions. Circ J 2009;73:860-866.
14. Kinstner CM, Lammer J, Willfort-Ehringer A et al. Paclitaxel-eluting balloon versus standard balloon angioplasty in in-stent restenosis of the superficial femoral and proximal popliteal artery: 1-year results of the PACUBA trial. JACC Cardiovasc Interv 2016;9:1386-92.
11. Tosaka A, Soga Y, Iida O et al. Classification and clinical impact of restenosis after femoropopliteal stenting. J Am Coll Cardiol 2012;59:16-23.
13. Krakenberg H, Tubler T, Ingwerson M et al. Drug-coated balloon versus standard balloon for superficial femoral artery in-stent restenosis: the randomized femoral artery in-stent restenosis (FAIR) trial. Circulation 2015;132:2230-6.
4. Rocha-Singh KJ, Jaff MR, Crabtree TR et al. Performance goals and endpoint assessments for clinical trials of femoropopliteal bare nitinol stents in patients with symptomatic peripheral arterial disease. Catheter Cardiovasc Intervent 2007;69:910-19.
7. Mehran R, Dangas G, Abizaid AS et al. Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. Circulation 1999;100:1872-1878.
5. Ho KJ, Owens CD. Diagnosis, classification and treatment of femoropopliteal artery in-stent restenosis. J Vasc Surg 2017;65:545-57
15. Ott I, Cassese S, Groha P et al. ISAR-PEBIS (Paclitaxel-eluting balloon versus conventional balloon angioplasty for in-stent restenosis of superficial femoral artery): a randomized trial. J Am Heart Assoc 2017;6:e006321. 16. Zeller T, Dake MD, Tepe G et al. Treatment of femoropopliteal instent restenosis with paclitaxel-eluting stents. JACC Cardiovasc Interv 2013;6:274-81.
2. Scheinert D, Scheinert S, Sax J et al. Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J Am Coll Cardiol 2005;45:312-5.
3. Iida O, Nanto S, Uematsu M et al. Influence of stent fracture on the long-term patency in the femoro-popliteal artery J Am Coll Cardiol Intv 2009;2:665-71.
8. Soga Y, Yokoi H, Urakawa T et al. Clinical impact of self-expandable stent diameter after femoropopliteal stenting. Cardiovasc Interv Ther 2011;26:3-44. 9. Kudo T, Chandra FA, Ahn SS. Long-term outcomes and predictors of iliac angioplasty with selective stenting. J Vasc Surg 2005;42:466-475.
6. Hoffmann R, Mintz GS, Dussaillant GR et al. Patterns and mechanisms of in-stent restenosis. A serial intravascular ultrasound study. Circulation 1996;94:1247-1254.
12. Stabile E, Virga V, Salemme L et al. Drug-eluting balloon for treatment of superficial femoral artery in-stent restenosis. J Am Coll Cardiol 2012;60:1739-42.
8. Goudeketting SR, Wille J, van den Heuvel DAF et al. Midterm SingleCenter Results of Endovascular Aneurysm Repair With Additional EndoAnchors. J Endovasc Ther 2018 Dec 26;issue 1:90-100.
4. Antonopoulos CN, Kakisis JD, Giannakopoulos GT et al. Rupture after endovascular abdominal aortic aneurysm repair: A multicenter study. Vasc Endovasc Surg 2014 Oct-Nov;48(7-8):476-81.
11. Lin PH1, Chen AY, Vij A. Hypogastric artery preservation during endovascular aortic aneurysm repair: is it important? Semin Vasc Surg 2009 Sep;22(3):193-200.
10. Chaikof EL, Brewster DC, Dalman RL et al. SVS practice guidelines for the care of patients with an abdominal aortic aneurysm: executive summary. J Vasc Surg 2009;(50):880-96.
5. Rajani RR, Arthurs ZM, Srivastava SD et al. Repairing immediate proximal endoleaks during abdominal aortic aneurysm repair. J Vasc Surg 2011;53(5):1174-7.
55 31Capítulo
2. Golzarian J, Valenti D. Endoleakage after endovascular treatment of abdominal aortic aneurysms: Diagnosis, significance and treatment. Eur Radiol 2006 Dec;16(12):2849-57. Epub 2006 Apr 11.
6. Chen J, Stavropoulos SW. Management of endoleaks. Semin Intervent Radiol 2015 Sep;32(3):259-64.
1. White GH, Yu W, May J, Chaufour X, Stephen MS. Endoleak as a complication of endoluminal grafting of abdominal aortic aneurysms: classification, incidence, diagnosis, and management. J Endovasc Surg 1997;4:152-68.
7. Ierardi AM, Franchin M, Fontana F et al. The role of ethylene-vinyl alcohol copolymer in association with other embolic agents for the percutaneous and endovascular treatment of type Ia endoleak. Radiol Med 2018;123:638-42.
9. Goudeketting SR, van Noort K, Vermeulen JJM et al. Analysis of the position of EndoAnchor implants in therapeutic use during endovascular aneurysm repair. J Vasc Surg 2018 Dec 19. Epub Ahead of Print.
REFERÊNCIAS BIBLIOGRÁFICAS
12. Moulakakis KG, Klonaris C, Kakisis J et al. Treatment of Type II Endoleak and Aneurysm Expansion after EVAR. Ann Vasc Surg 2017 Feb;39:56-66. 13. Maleux G, Poorteman L, Laenen A et al. Incidence, etiology, and management of type III endoleak after endovascular aortic repair. J Vasc Surg 2017;66(4):1056-64. 14. Orrico M, Ronchey S, Setacci C et al. The “bare branch” for safe spinal chord ischemia prevention after total endovascular repair of thoracoabdominal aneurysms. J Vasc Surg 2018 Nov 26. 15. Gleason TG. Endoleaks after endovascular aortic stent-grafting: impact, diagnosis, and management. Semin Thorac Cardiovasc Surg 2009 Winter;21(4):363-72.
3. Veith FJ, Baum RA, Ohki T et al. Nature and significance of endoleaks and endotension: summary of opinions expressed at an international conference. J Vasc Surg 2002 35:1029-35.
ENDOLEAK: TIPOS E TRATAMENTOS
Parte II MEDICAMENTOSATERAPÊUTICA E HEMOTERÁPICA
19. Hirsh J. Heparin. N Engl J Med 1991;324:1565-74.
3. Levi CE, Cate H, van der Poll T. Endothelium: interface between coagulation and inflammation. Crit Care Med 2002;30(Suppl):S220-24.
13. Ginsberg J. Pharmacology of heparin-related compounds and coumarin derivations. In: Loscalzo J, Schafer AI. Thrombosis and hemorrhage. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2003. p. 1142. 14. Marques MA. Os novos anticoagulantes orais no Brasil. J Vasc Bras 2013;12(3):185-186.
6. Stein PD, Alpert JS, Copeland J et al. Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves. Chest 1995;108(Suppl):371S-79S.
11. DeYoung E, Minocha J. Inferior vena cava filters: guidelines, best practice, and expanding indications. Semin Intervent Radiol 2016;33:65-70.
16. Ellis JE, Klock A, Klafta JM et al. Escolha da anestesia e da monitorização intraoperatória para a revascularização da extremidade inferior. Cl Cir N Am 1995;4:679-92.
REFERÊNCIAS BIBLIOGRÁFICAS
ANTICOAGULANTES
2. Hack CE. Tissue factor pathway of coagulation in sepsis. Crit Care Med 2000;28(Suppl): S25-30.
9. Kraiss LW, Johansen K. Intervenção farmacológica para evitar o insucesso do enxerto. Cl Cir Am N 1995;4:775-86.
12. Longo de Oliveira ALM, Marques MA Profilaxia de tromboembolismo venoso na gestação. J Vasc Bras 2016;15(4):293-301.
5. Lastória S, Maffei FHA. Oclusões arteriais agudas. In: Maffei FHA. Doenças vasculares periféricas. 2. ed. Rio de Janeiro: Medsi; 1995. p. 387-418.
7. Laupacis A, Albers G, Dalen J et al. Antithrombotic therapy in atrial fibrillation. Chest 1998;114(Suppl):579S-89S.
18. Ageno W et al. Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2012;141(2 Suppl):e44s-e88s.
21. Raschke RA, Reilly BM, Guidry JR et al. The weight-based heparin dosing normogram compared with standard care normogram: a randomized controlled trial. Ann Intern Med 1993;119:874-81.
8. Cikrit D, Dalsing MC. Stent endovascular arterial no membro inferior. Cl Cir Am N 1998; 4:113-25.
1. Franco RF. Fisiologia da coagulação, anticoagulação e fibrinólise. Medicina (Ribeirão Preto) 2001;34:229-37.
26. Olson ST, Björk I, Sheffer R et al. Role of the antithrombin-binding pentasaccharide in heparin acceleration of antithrombinproteinase reactions: resolution of the antithrombin conformational change contribution to heparin rate enhancement. J Biol Chem 1992;267:12528-38. 27. Yusuf S, Mehta SR, Chrolavicius S et al. Comparison of fondaparinux and enoxaparin in acute coronary syndromes. N Engl J Med 2006;354:1464-76. 28. Bauer KA. Fondaparinux sodium: a selective inhibitor of factor Xa. Am J Health Syst Pharm 2001;58 (Suppl 2):S14. 29. Nagler M, Haslauer M, Wuillemin WA. Fondaparinux - data on efficacy and safety in special situations. Thromb Res 2012;129:407. 30. Garcia DA et al. Parenteral anticoagulants. Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2012;141(2 Suppl):e24s-e43s. 31. Furie B, Furie BC. Molecular basis of vitamin K-dependent gammacarboxilation. Blood 1990;75:1753-62. 32. Fortes Jr AT. Doses iniciais de varfarina sódica no tratamento anticoagulante de pacientes portadores de tromboembolismo. Dissertação de mestrado em cirurgia – Área de concentração: bases gerais da cirurgia e cirurgia experimental. Faculdade de Medicina de Botucatu (UNESP) 2000. p. 19-23. 33. Pattacini C, Manotti C, Pini M et al. A comparative study on the quality of oral anticoagulant therapy. Thromb Haemost 1994;71:188-91. 34. Hirsh J, Poller L. The international normalized radio. Arch Intern Med. 1994;154:282-88. 35. Hyman BT, Landas SK, Ashman RF et al. Warfarin-related purple toes syndrome and cholesterol microembolization. Am J Med 1987;82:1233-37. 36. Hirsh J, Weitz JI. New antithrombotic agents. Lancet 1999;353:1431-36. 37. Oliveira LCO, Franco RF. Novas drogas anticoagulantes. Medicina (Ribeirão Preto) 2001;34:276-81. 38. Hirsh J. Tratamento anticoagulante atual – Necessidades clínicas não atendidas. Thromb Research 2003;109: S1-S8. 39. Bates SM, Weitz JI. The mechanism of action of thrombin inhibitors. J Invasive Cardiol 2000;12(Suppl F):27F-32F. 40. Sarich TC, Wolzt M, Erikson UG et al. Effects of ximelagatran, an oral thrombin inhibitor, r-hirudin and enoxaparin on thrombin generation and platelet activation in healthy male subjects. J Am Coll Cardiol 2003;41:557-64. 41. Nisio MD, Middeldorp S, Buller HR. Direct thrombin Inhibitors. N Engl Med 2005;353:1028-40. 42. Cannon CP, Tracy R. Clotting for the Clinician: An overview of thrombosis and antithrombotic therapy. J Thromb and Thrombolysis 1995;2:95-116. 43. Cannon CP, Braunwald E. Hirudin: initial results in acute myocardial infarction, unstable angina and angioplasty. J Am Coll Cardiol 1995;25(Suppl):30s-37s. 44. Parry MA, Maragonore JM, Stone SR. Kinetics mechanism for the interaction of Hirulog with thrombin. Biochemistry 1994;33:14807-14. 45. Maraganore JM, Bourdon P, Jablonski J et al. Design and characterization of hirulogs: a novel class of bivalent peptide inhibitors of thrombin. Biochemistry 1990;29:7095-101. 46. Bitti JA, Stroni J. Treatment with bivalirudin (Hirulog) as compared with heparin during coronary angioplasty for unstable or post infarction angina. Hirulog Angioplasty Study Investigators. N Engl Med 1995;333(12):764-69. 47. Mc Keage K, Plosker GL. Argatroban. Drugs 2001;61:515-22. 48. Friedman RJ et al. Dabigatran versus enoxaparin for prevention of venous thromboembolism after hip or knee arthroplasty: a pooled analysis of three trials. Thromb Res 2010;126(3):175-82.
4. Hammerschlak N, Rosenfeld LGM. Utilização da heparina e dos anticoagulantes orais na prevenção e tratamento da trombose venosa profunda e da embolia pulmonar. Arq Bras Cardiol 1996;67:209-13.
20. Hirsh J, Levine MN. Review: low molecular heparin. Blood 1992;79:1.
17. Weibert RY. Oral anticoagulant therapy in patients undergoing dental surgery. Clin Pharmacol 1992;11:857-64.
10. Bick RL. Coagulação intravascular disseminada: critérios objetivos para o diagnóstico e tratamento. Cl Med Am N 1994;3:529-62.
22. Monagle P, Chan A. Management of venous thromboembolism in pediatric patients. In: Ginsberg J, Kearon C, Hirsh J. (Ed.). Critical decisions in thrombosis and haemostasis. Decker: Hamilton BC; 1998. p. 93. 23. Michelson AD, Bovill E, Monagle P et al. Antithrombotic therapy in children. Chest 1998;114:748-69. 24. Fejgin MD, Lourwood DL. Low molecular weight heparins and their use in obstetrics and gynecology. Obstet Gynecol Surv 1994;49:424-31. 25. Sanson BJ, Lensing AWA, Prins MH et al. Safety of low-molecular weight heparin in pregnancy: a systematic review. Thromb Haemost 1999;81:668-72.
15. Madura JA, Rookstool M, Wease G. The management of patients on chronic coumadin therapy undergoing subsequent surgical procedures. Am Surg 1994;60:542-47.
59 32Capítulo
57. Siegal DM et al. Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity. N Engl J Med 2015;373:2413-2424.
55. Agnelli G. Oral Apixaban for the Treatment of Acute Venous Thromboembolism. N Engl J Med 2013;369:799-808.
60 Parte IITERAPÊUTICA MEDICAMENTOSA E HEMOTERÁPICA
49. Schulman S et al. Treatment of acute venous thromboembolism with dabigatran or warfarin and pooled analysis. Circulation 2014;129(7):764-772.
52. Prins MH. Oral rivaroxaban versus enoxaparin with vitamin K antagonist for the treatment of symptomatic venous thromboembolism in patients with cancer (EINSTEIN-DVT and EINSTEIN-PE): a pooled subgroup analysis of two randomized controlled trials. The Lancet Hematology 2014;1(1):e37-e46.
50. Pollack CV et al. Idarucizumab for Dabigatran Reversal — Full Cohort Analysis. N Engl J Med 2017;377:431-441.
54. The EINSTEIN–PE Investigators. Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism. N Engl J Med 2012;366:1287-1297.
51. Yoshida RA, Yoshida WB, Rollo HA. Novos anticoagulantes para a profilaxia do tromboembolismo venoso em cirurgias ortopédicas de grande porte. J Vasc Bras 2011;10(2):145-53.
56. The Hokusai-VTE Investigators. Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism. N Engl J Med 2013;369:1406-1415.
58. Connolly SJ et al. Andexanet Alfa for Acute Major Bleeding Associated With Factor Xa Inhibitors. N Engl J Med 2016;375:1131-1141.
53. Romualdi E, Donadini MP, Ageno W. Oral rivaroxaban after symptomatic venous thromboembolism: the continued treatment study (EINSTEIN-extension study). Expert Rev Cardiovasc Ther 2011;9(7):841-4.
59. Connolly SJ et al. Dabigatran versus Warfarin in Patients with Atrial Fibrillation. N Engl J Med 2009;361:1139-1151. 60. Kearon C et al. Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report. Chest 2016;149:315-352.
13. Burch JW, Stanford PW, Majerus PW. Inhibition of platelet prostaglandin synthetase by oral aspirin. J Clin Invest 1979;61:314-9.
23. Brezina K. Care of patient receiving Reo-Pro following angioplasty. J Invest Cardiol 1994;6(Suppl A):38A-42A.
15. Patrono C, Coller B, Dalen JE et al. Platelet-active drugs: the relationships among dose, effectiveness and side effects. Chest 1998;114(Suppl):470S-88.
3.
61 33Capítulo
25. Wiviott SD, Braunwald E, McCabe CH et al. Triton-Timi 38 investigators. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2007;357(20):2001-15.
18. Diener HC, Cunha L, Forbes C et al. European stroke prevention study: II. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. N Neurol Sci 1996;143:1-13.
24. Wiviott SD, Trenk D, Frelinger AL et al. Principle-Timi 44 investigators. Prasugrel compared with high loading and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: the prasugrel in comparison to clopidogrel for inhibition of platelet activation and aggregation-thrombolysis in myocardial infarction 44 trial. Circulation 2007;116(25):2923-32.
38.
16. Anand SS, Bosch J, Wikelboom JW et al. Rivaroxaban with or without Aspirin in patients with stable peripheral or carotid artery disease: an international, randomized, double-blind, placebo-controlled trial. Lancet 2018;391:219-29.
10. Elwood PC, Renaud S, Sharp DS et al. Ischemic heart disease and platelet aggregation. The Caerphilly Collaborative Heart Disease Study. Circulation 1991;83:38-44.
5.
1. Borissoff JI, Spronk HMH, Cate HT. The hemostatic system as a modulator of atherosclerosis. New Engl J Med 2011;364(18):1746-60.
28. Jones WS, Baumgartner I, Hiatt WR et al. Ticagrelor compared with clopidogrel in patients with prior lower extremity revascularization for peripheral artery disease. Circulation 2017; 135:241. 29. Berger JS, Katona BG, Jones WS et al. Design and rationale for the effects of ticragelor and clopidogrel in patients with peripheral artery disease (EUCLID Trial). Am Heart J 2018;175-96. 30. Morrow DA, Braunwald E, Bonaca MP et al. Voropaxar in the secundary prevention of atherothrombotic events. N Engl J Med 2012;366:1404. 31. Bonaca MP, Scirica BM, Creager MA et al. Vorapaxar in patients with peripheral artery disease: results from TRA2P-TIMI 50. Circulation 2013;127:1522. 32. Hess H, Mietaschik A, Deischel G. Drug-induced inhibition of platelet function delays progression of peripheral occlusive arterial disease. Lancet 1985;1:415-21. 33. Stiegler H, Hess H, Mietaschk A et al. Einfluss von ticlopidin auf die periphere obliterierende arteriopathie. Dtsch Med Wschr 1984;109:1240-43. 34. Arcan JC, Blanchard J, Boissel JP et al. Multicenter double-blind study of ticloplidine in the treatment of intermittent claudication and the prevention of its complications. Angiology 1988;39:801-11. 35. Balsano F, Coccheri S, Libretti A et al. Ticlopidine in the treatment of intermittent claudication: A 21-month double-blind trial. J Lab Clin Med 1989;114:84-91. 36. Ala-Kulju K, Ketonen P, Salo J et al. Effect of antiplatelet and anticoagulant therapy on patency of femorotibial bypass grafts. J Cardiovasc Surg 1990;31:651-5. 37. Becquemin JP. Effect of ticlopidine on the long-term patency of saphenous-vein bypass grafts in the legs. N Engl J Med 1997;337:1726-31. McCollum C, Alexander C, Kenchington G et al. Antiplatelet drugs in femoropopliteal vein bypasses: a multicenter trial. J Vasc Surg 1991;13:150-62. 39. Criqui MH, Langer RD, Fronek A et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 1992;326:381-86. 40. Antiplatelet Trialists’ Collaboration. Secondary prevention of vascular disease by prolonged antiplatelet treatment. Br Med J 1988;96:320-31. 41. Akay OM, Canturk Z, Akin E et al. Aspirin-resistence frequency: a prospective study in 280 healthy Turkish volunteers. Clin Appl Thromb Hemost 2009;15(1):98-102. 42. Shenkman B, Matetsky S, Feper P et al. Variable reponsiveness to clopidogrel and aspirin among patients with acute coronary syndrome as assessed by platelet functions tests. Thromb Res 2008;122:336-45. 43. Wang TH, Bhatt DL, Topol EJ. Aspirin and clopidogrel resistance: an emerging clinical entity. Eur Heart J 2006;27(6):647-54. 44. Oliveira DCO, Silva RF, Silva DJ et al. Resistência à aspirina: realidade ou ficção? Arq Bras Cardiol 2010;95(3):e91-e94. 45. Catella-Lawson F, Reilly MP, Kapoor SC et al. Cyclooxygenase inhibitors and the antiplatelet effects of aspirin. N Engl J Med 2001;345:1809-17. 46. Jung-Wom S, Bon-Kwon K, Shy-Ying Z et al. Increased risk of atherothrombotic events associated with cytochrome P4503A5 polimorphism in patients taking clopidogrel. CMAJ 2006;174(12):1729.
21. Coller BS. Monoclonal antibodies to platelet glycoprotein Iib/IIIa as antithrombotic agents. Ann N Y Acad Sci 1991;614:193-213.
17. Fitzgerald GA. Dipyridamole. N Engl J Med 1987;316:1247-57.
27. Hamm CW, Bassand JP, Agewall S et al. ESC Committee for Practice Guidelines. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent STsegment elevation of the European Society of Cardiology (ESC). Eur Heart J 2011;32(23):2999-3054.
12. Batlouni, M. Antiplaquetários. In: Batlouni M, Ramires JAF. Farmacologia e terapêutica cardiovascular. São Paulo: Atheneu; 1999. p. 327-52.
7. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993;362:801-5.
6. Reidy MA, Fingerle J, Lindner V. Factors controlling the development of arterial lesions after injury. Circulation 1992;87(Suppl III):43-52.
11. Fuster V, Badimon L, Badimon J et al. The pathogenesis of coronary artery disease and the acute coronary syndromes (part I). N Engl J Med 1992;326:212-20.
14. Patrono C. Pharmacology of antiplatelet agents. In: Loscalzo J, Schafer AI. Thrombosis and hemorrhage. 3rd ed. Philadelphia: Lippincott; 2003. p. 1141.
2. D’Amico EA, Oliveira GA, Bydlowski SP et al. Drogas que interferem na função plaquetária. In: Maffei, FHA. Doenças vasculares periféricas, 2. ed. Rio de Janeiro: Medsi; 1995. p. 387-418. McNamara DB, Champion HC, Kadowitz PJ. Controle farmacológico da doença vascular periférica. Cl Cir Am N 1998;3:81-98.
19. Gardell SJ. Ticlopidine and clopidogrel: antithrombotic agents that block ADP-mediated platelet activation. Perspectives in Drug Design 1993;2:521-6.
20. Caprie Steering Committee. A randomized, blinded trial of clopidogrel versus aspirin in patients at risk of ischaemic events (Caprie). Lancet 1996;48:1329-39.
4. Willard JE, Lange RA, Hillis LD. The use of aspirin in ischemic heart disease. N Engl J Med 1992;327:175. Gawaz M, Langer H, May AE. Platelets in inflammation and atherogenesis. J Clin Invest 2005;115:3378-84.
8. Fuster V, Chesebro JH. Role of platelet-inhibitor drugs in the management of arterial thromboembolic in atherosclerotic disease. Mayo Clinic Proc 1981;56:265-75. 9. Coffino RC. Coagulation y thrombosis. In: Castilho J, MartinezVilla E. (Eds.). Trombosis, farmacos antitromboticos e enfermedad cerebrovascular. Barcelona: J Uriach; 1995. p. 2103-1.
22. The EPIC Investigators. Use of monoclonal antibody against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 1994;330:956-61.
26. Wallentin L, Becker RC, Budaj A et al. Plato investigators. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2009;361(11):1045-57.
REFERÊNCIAS BIBLIOGRÁFICAS
ANTIAGREGANTES PLAQUETÁRIOS
20. Higgins DL, Bennett WF. Tissue plasminogen activator: the biochemistry and pharmacology of variants produced by mutagenesis. Annu Rev Pharmacol Toxicol 1990;30:91-121.
21. Rijken DC, Collen D. Purification and characterization of the plasminogen activator secreted by human melanoma cells in culture. J Biol Chem 1981;256(13):7035-41.
24. Graor RA, Risius B, Young JR et al. Peripheral artery and bypass graft thrombolysis with recombinant human tissue-type plasminogen activator. J Vasc Surg 1986;3(1):115-24. 25. Verstraete M, Hess H, Mahler F et al. Femoro-popliteal artery thrombolysis with intra-arterial infusion of recombinant tissuetype plasminogen activator--report of a pilot trial. Eur J Vasc Surg 1988;2(3):155-9. 26. Weimar W, Stibbe J, van Seyen AJ et al. Specific lysis of an iliofemoral thrombus by administration of extrinsic (tissue-type) plasminogen activator. Lancet 1981;2(8254):1018-20. 27. Paoni NF, Refino CJ, Brady K et al. Involvement of residues 296-299 in the enzymatic activity of tissue-type plasminogen activator. Protein Eng 1992;5(3):259-66. 28. Katzen BT, van Breda A. Low dose streptokinase in the treatment of arterial occlusions. AJR Am J Roentgenol 1981;136(6):1171-8. 29. Graor RA OJ, Bartholomew JR. Efficacy and safety of intra-arterial local infusion of streptokinase, urokinase, or tissue plasmynogen activator for peripheral arterial occlusion: A retrospective review. J Vasc Med Biol 1990;2:310. 30. Camerota AJ WJ. Thrombolitic therapy for peripheral vascular disease. Philadelphia: JB Limppincott; 1995. 31. Fogarty TJ, Cranley JJ, Krause RJ et al. A method for extraction of arterial emboli and thrombi. Surg Gynecol Obstet 1963;116:241-4. 32. Fogarty TJ. Catheter technic for arterial embolectomy. J Cardiovasc Surg (Torino). 1967;8(1):22-8. 33. Fogarty TJ. Sudden arterial occlusion: surgical aspects. Cardiovasc Clin 1971;3(1):173-82. 34. Fogarty TJ CJ, Krause RJ et al. Complications in vascular surgery. Philadelphia: JB Lippincott; 1973. p. 95. McNamara TO, Bomberger RA. Factors affecting initial and 6 month patency rates after intraarterial thrombolysis with high dose urokinase. Am J Surg 1986;152(6):709-12. 36. Sicard GA, Schier JJ, Totty WG et al. Thrombolytic therapy for acute arterial occlusion. J Vasc Surg 1985;2(1):65-78. 37. Hess H. Thrombolytic therapy in peripheral vascular disease. Br J Surg 1990;77(10):1083-4. TO. M. Thrombolysis as the initial therapy for the acutely ischemic limb. Semin Vasc Surg 1992;5. 39. McNamara TO. Thrombolysis as the initial treatment for acute lower limb ischemia. Thrombolytic therapy for peripheral vascular disease Philadelphia: JB Lippincott; 1994. p. 253. 40. Ricotta JJ, Green RM, DeWeese JA. Use and limitations of thrombolytic therapy in the treatment of peripheral arterial ischemia: results of a multi-institutional questionnaire. J Vasc Surg 1987;6(1):45-50. 41. Blaisdell FW, Steele M, Allen RE. Management of acute lower extremity arterial ischemia due to embolism and thrombosis. Surgery 1978;84(6):822-34. 42. Price C, Jacocks MA, Tytle T. Thrombolytic therapy in acute arterial thrombosis. Am J Surg 1988;156(6):488-91. Belkin M, Donaldson MC, Whittemore AD et al. Observations on the use of thrombolytic agents for thrombotic occlusion of infrainguinal vein grafts. J Vasc Surg 1990;11(2):289-94; discussion 95-6. 44. Leopold JA KJ, Localzo J. Pharmacology of antiplatelet agents. In Loscalzo J, Shafer AI. Baltimore; William & Wilkins; 1998. 45. Patrono C. Pharmacology of antiplatelet agents. Loscalzo J, Schafer AL. Baltimore: William & Wilkins; 1998. Lijnen HR, Collen D. Strategies for the improvement of thrombolytic agents. Thromb Haemost 1991;66(1):88-110. Rutherford RB. Rutherford’s vascular surgery, 6th ed. Philadelphia: Saunders; 2007 July 1. p. 256.
46.
8. Collen D. On the regulation and control of fibrinolysis. Edward Kowalski Memorial Lecture. Thromb Haemost 1980;43(2):77-89.
23. Lijnen HR, Van Hoef B, De Cock F, Collen D. Effect of fibrin-like stimulators on the activation of plasminogen by tissue-type plasminogen activator (t-PA)--studies with active site mutagenized plasminogen and plasmin resistant t-PA. Thromb Haemost 1990;64(1):61-8.
35.
19. Cragg AH, Smith TP, Corson JD et al. Two urokinase dose regimens in native arterial and graft occlusions: initial results of a prospective, randomized clinical trial. Radiology 1991;178(3):681-6.
16. Wun TC, Schleuning WD, Reich E. Isolation and characterization of urokinase from human plasma. J Biol Chem 1982;257(6):3276-83.
3. Tillett WS, Sherry S, Read CT. The use of streptokinase-streptodornase in the treatment of chronic empyema; with an interpretive discussion of enzymatic actions in the field of intrathoracic diseases. J Thorac Surg 1951;21(4):325-41. 4. Astrup T, Permin PM. Fibrinolysis in the animal organism. Nature 1947;159(4046):681.
18. Bode C, Matsueda GR, Hui KY, Haber E. Antibody-directed urokinase: a specific fibrinolytic agent. Science 1985;229(4715):765-7.
1. Tillett WS, Garner RL. The fibrinolytic activity of Hemolytic Streptococci. J Exp Med 1933;58(4):485-502.
14. Berni GA, Bandyk DF, Zierler RE et al. Streptokinase treatment of acute arterial occlusion. Ann Surg 1983;198(2):185-91.
15. Braun MA NA, Vogelzang RL. Interventional radiology procedure manual. New York: Churchill Livingstone; 1997 Feb 1.
6. Masini G. Intravenous urokinase in acute myocardial infarction: a critical review of an italian multicentre experience. Drug Investigation 1991;3:368. 7. RN R. Choosing a thrombolytic agent in acute myocardial infarction. Pharm Therap 1992;17:617.
13. Fletcher AP, Alkjaersig N, Smyrniotis FE, Sherry S. The treatment of patients suffering from early myocardial infarction with massive and prolonged streptokinase therapy. Trans Assoc Am Physicians 1958;71:287-96.
43.
5. Rush DS, Gewertz BL, Lu CT et al. Selective infusion of streptokinase for arterial thrombosis. Surgery 1983;93(6):828-33.
2. Tillett WS, Sherry S. The effect in patients of streptococcal fibrinolysin and streptococcal desoxyribonuclease on fibrinous, purulent, and sanguinous pleural exudations. J Clin Invest 1949;28(1):173-90.
10. Robbins KC. Fibrinolytic therapy: biochemical mechanisms. Semin Thromb Hemost 1991;17(1):1-6.
17. Declerck PJ, Lijnen HR, Verstreken M et al. A monoclonal antibody specific for two-chain urokinase-type plasminogen activator. Application to the study of the mechanism of clot lysis with singlechain urokinase-type plasminogen activator in plasma. Blood 1990;75(9):1794-800.
62 34Capítulo TRATAMENTO TROMBOLÍTICO
11. Edelberg JM, Pizzo SV. Lipoprotein(a) inhibits plasminogen activation in a template-dependent manner. Blood Coagul Fibrinolysis 1991;2(6):759-64.
38.
REFERÊNCIAS BIBLIOGRÁFICAS
12. Fletcher AP, Alkjaersig N, Sherry S. The maintenance of a sustained thrombolytic state in man. I. Induction and effects. J Clin Invest 1959;38(7):1096-110.
9. Coller BS. Platelets and thrombolytic therapy. N Engl J Med 1990;322(1):33-42.
22. Berridge DC, Gregson RH, Makin GS, Hopkinson BR. Tissue plasminogen activator in peripheral arterial thrombolysis. Br J Surg 1990;77(2):179-82.
47.
65. Haumer M, Atteneder M, Ahmadi R et al. Coadministration of lowdose urokinase and abciximab in thrombolysis for lower limb ischemia. a safety study. Thromb Res 2001;103 Suppl 1:S143-9.
55. Ouriel K, Kandarpa K, Schuerr DM, Hultquist M, Hodkinson G, Wallin B. Prourokinase versus urokinase for recanalization of peripheral occlusions, safety and efficacy: the PURPOSE trial. J Vasc Interv Radiol 1999;10(8):1083-91.
93. Enden T, Haig Y, Klow NE et al. Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial. Lancet 2012;379(9810):31-8. 94. Vedantham S, Vesely TM, Sicard GA et al. Pharmacomechanical thrombolysis and early stent placement for iliofemoral deep vein thrombosis. J Vasc Interv Radiol 2004;15(6):565-74. 95. Sharifi M, Bay C, Mehdipour M et al. Thrombus Obliteration by Rapid Percutaneous Endovenous Intervention in Deep Venous Occlusion (TORPEDO) trial: midterm results. J Endovasc Ther 2012;19(2):273-80. 96. Vedantham S, Goldhaber SZ, Julian JA et al. Pharmacomechanical catheter-directed thrombolysis for deep-vein thrombosis. N Engl J Med 2017;377(23):2240-52. 97. de Bono DP, More RS. Prevention and management of bleeding complications after thrombolysis. Int J Cardiol 1993;38(1):1-6.
62. Ward AS, Andaz SK, Bygrave S. Peripheral thrombolysis with tissue plasminogen activator. Results of two treatment regimens. Arch Surg 1994;129(8):861-5. Braithwaite BD, Jones L, Yusuf SW et al. Aspirin improves the outcome of intra-arterial thrombolysis with tissue plasminogen activator. Thrombolysis Study Group. Br J Surg 1995;82(10):1357-8.
61. Sullivan KL, Gardiner GA Jr., Shapiro MJ et al. Acceleration of thrombolysis with a high-dose transthrombus bolus technique. Radiology 1989;173(3):805-8.
67. Schweizer J, Kirch W, Koch R et al. Short- and long-term results of abciximab versus aspirin in conjunction with thrombolysis for patients with peripheral occlusive arterial disease and arterial thrombosis. Angiology 2000;51(11):913-23.
57. Braithwaite BD, Buckenham TM, Galland RB, Heather BP, Earnshaw JJ. Prospective randomized trial of high-dose bolus versus lowdose tissue plasminogen activator infusion in the management of acute limb ischaemia. Thrombolysis Study Group. Br J Surg 1997;84(5):646-50.
56. Mahler F, Schneider E, Hess H, Steering Committe SoLT. Recombinant tissue plasminogen activator versus urokinase for local thrombolysis of femoropopliteal occlusions: a prospective, randomized multicenter trial. J Endovasc Ther 2001;8(6):638-47.
48. Perler BA, Osterman FA, Mitchell SE et al. Balloon dilatation versus surgical revision of infra-inguinal autogenous vein graft stenoses: long-term follow-up. J Cardiovasc Surg (Torino) 1990;31(5):656-61. Yoshida WB RH, Moura R. Tratamento das oclusões arteriais agudas de extremidades inferiores com doses baixas de estreptoquinase: Resultados iniciais. Cir Vas Ang 1989;5. Ouriel K, Veith FJ, Sasahara AA. A comparison of recombinant urokinase with vascular surgery as initial treatment for acute arterial occlusion of the legs. Thrombolysis or Peripheral Arterial Surgery (TOPAS) Investigators. N Engl J Med 1998;338(16):1105-11.
73. Graor RA, Risius B, Young JR et al. Thrombolysis of peripheral arterial bypass grafts: surgical thrombectomy compared with thrombolysis. A preliminary report. J Vasc Surg 1988;7(2):347-55.
68. Tepe G, Schott U, Erley CM et al. Platelet glycoprotein IIb/IIIa receptor antagonist used in conjunction with thrombolysis for peripheral arterial thrombosis. AJR Am J Roentgenol 1999;172(5):1343-6.
63.
64. Duda SH, Tepe G, Luz O et al. Peripheral artery occlusion: treatment with abciximab plus urokinase versus with urokinase alone--a randomized pilot trial (the PROMPT Study). Platelet Receptor Antibodies in Order to Manage Peripheral Artery Thrombosis. Radiology 2001;221(3):689-96.
79. Gardiner GA. Thrombolythic therapy in peripheral vascular disease. Philadelphia: JB Lippincott; 1995. 80. Sullivan KL, Gardiner GA Jr., Kandarpa K et al. Efficacy of thrombolysis in infrainguinal bypass grafts. Circulation 1991;83(2 Suppl):I99-105. 81. Gardiner GA Jr., Koltun W, Kandarpa K et al. Thrombolysis of occluded femoropopliteal grafts. AJR Am J Roentgenol 1986;147(3):621-6. 82. Van Breda A. Thrombolysis in arterial bypass grafts. Semin Thromb Hemost 1991;17(1):7-13. 83. Comerota AJ, Rubin RN, Tyson RR et al. Intra-arterial thrombolytic therapy in peripheral vascular disease. Surg Gynecol Obstet 1987;165(1):1-8. 84. van Breda A, Robison JC, Feldman L et al. Local thrombolysis in the treatment of arterial graft occlusions. J Vasc Surg 1984;1(1):103-12. 85. Katzen BT. Thrombolytic therapy for peripheral vascular disease. Philadelphia: JB Lippincott; 1995. 86. Mewissen MW MP, Beyer GA et al. Symptomatic native arterial occlusion: Early experience with over-the-wire thrombolysis. J Vasc Inter Radiol 1991;1:43. 87. Valji K, Roberts AC, Davis GB, Bookstein JJ. Pulsed-spray thrombolysis of arterial and bypass graft occlusions. AJR Am J Roentgenol 1991;156(3):617-21. 88. Flinn WR MW, Silva MB, Amble S. Thrombolytic therapy for peripheral vascular disease. Philadelphia: JB Lippincott; 1995. 89. Hynes BG, Margey RJ, Ruggiero N 2nd et al. Endovascular management of acute limb ischemia. Ann Vasc Surg 2012;26(1):110-24. 90. Atar S, Rosenschein U. Perspectives on the role of ultrasonic devices in thrombolysis. J Thromb Thrombolysis 2004;17(2):107-14. 91. Cushman M. Epidemiology and risk factors for venous thrombosis. Semin Hematol 2007;44(2):62-9.
50.
77. Perler BA, White RI Jr., Ernst CB, Williams GM. Low-dose thrombolytic therapy for infrainguinal graft occlusions: an idea whose time has passed? J Vasc Surg 1985;2(6):799-805. 78. Cohen JR, Mannick JA, Couch NP, Whittemore AD. Recognition and management of impending vein-graft failure. Importance for longterm patency. Arch Surg 1986;121(7):758-9.
53. Weaver FA, Comerota AJ, Youngblood M et al. Surgical revascularization versus thrombolysis for nonembolic lower extremity native artery occlusions: results of a prospective randomized trial. The STILE Investigators. Surgery versus Thrombolysis for Ischemia of the Lower Extremity. J Vasc Surg 1996;24(4):513-21;discussion 21-3.
60. Schweizer J, Altmann E, Stosslein F et al. Comparison of tissue plasminogen activator and urokinase in the local infiltration thrombolysis of peripheral arterial occlusions. Eur J Radiol 1996;22(2):129-32.
54. Ouriel K, Veith FJ, Sasahara AA. Thrombolysis or peripheral arterial surgery: phase I results. TOPAS Investigators. J Vasc Surg 1996;23(1):64-73; discussion 4-5.
70. Quinones-Baldrich WJ, Baker JD, Busuttil RW, Machleder HI, Moore WS. Intraoperative infusion of lytic drugs for thrombotic complications of revascularization. J Vasc Surg 1989;10(4):408-17.
74. Taylor LM Jr., Porter JM, Baur GM et al. Intraarterial streptokinase infusion for acute popliteal and tibial artery occlusion. Am J Surg 1984;147(5):583-8.
51. Results of a prospective randomized trial evaluating surgery versus thrombolysis for ischemia of the lower extremity. The STILE trial. Ann Surg 1994;220(3):251-66; discussion 66-8.
52. Comerota AJ WF, Hosking JD et al. Results of a prospective, randomized trial of surgery versus thrombolysis for occluded lower extremity by-pass grafts. Am J Surg 1996;172.
58. Meyerovitz MF, Goldhaber SZ, Reagan K et al. Recombinant tissuetype plasminogen activator versus urokinase in peripheral arterial and graft occlusions: a randomized trial. Radiology 1990;175(1):75-8.
66. Ouriel K, Castaneda F, McNamara T et al. Reteplase monotherapy and reteplase/abciximab combination therapy in peripheral arterial occlusive disease: results from the RELAX trial. J Vasc Interv Radiol 2004;15(3):229-38.
69. Moran KT JE, Persson AV. The role of thrombolytic therapy in surgical practice. Br J Surg 1989;76:298.
63Capítulo 34 tr AtAmento trombolítiCo
72. Bandyk DF, Bergamini TM, Towne JB et al. Durability of vein graft revision: the outcome of secondary procedures. J Vasc Surg 1991;13(2):200-8; discussion 9-10.
49.
59. Ouriel K, Shortell CK, Azodo MV et al. Acute peripheral arterial occlusion: predictors of success in catheter-directed thrombolytic therapy. Radiology 1994;193(2):561-6.
71. Parent FN 3rd, Bernhard VM, Pabst TS 3rd et al. Fibrinolytic treatment of residual thrombus after catheter embolectomy for severe lower limb ischemia. J Vasc Surg 1989;9(1):153-60.
75. Wyffels PL, DeBord JR, Marshall JS et al. Increased limb salvage with intraoperative and postoperative ankle level urokinase infusion in acute lower extremity ischemia. J Vasc Surg 1992;15(5):771-8; discussion 8-9. 76. Cotton LT, Flute PT, Tsapogas MJ. Popliteal artery thrombosis treated with streptokinase. Lancet 1962;2(7265):1081-3.
92. Casey ET, Murad MH, Zumaeta-Garcia M et al. Treatment of acute iliofemoral deep vein thrombosis. J Vasc Surg 2012;55(5):1463-73.
14. Kroese AJ, Stranden E. How critical is chronical critical leg ischaemia? Ann Chir Gynaecol 1998;87:141-144.
42.
13. Ryer EJ, Trocciola SM, DeRubertis B et al. Analysis of outcomes following failed endovascular treatment of chronic limb ischemia. Ann Vasc Surg 2006 Jul;20(4):440-6.
28. Tateishi-Yuyama E, Matsubara H, Murohara T et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet 2002;360(9331):427-35.
29. Takeshita S, Weir L, Chen D et al. Therapeutic angiogenesis following arterial gene transfer of vascular endothelial growth factor in a rabbit model of hindlimb ischemia. Biochem Biophys Res Commun 1996;227(2):628-35.
18. The ICAI Group. Long-term mortality and its predictors in patients with critical leg ischaemia. Eur J Vasc Endovasc Surg 1997;14:91-95.
16. Ross JS, Stagliano NE, Donovan MJ et al. Atherosclerosis: a cancer of the blood vessels? Am J Clin Pathol 2001;116(Suppl):S97-S107.
20. European Consensus on Critical Limb Ischaemia. Lancet 1989;i:737-738. 21. Giovanoni M. Desenvolvimento vascular. In: Lopes AC. Diagnóstico e tratamento. Barueri: Manole; 2006. v. 2. p. 3-5.
31. Bobek V, Taltynov O, Pinterova D, Kolostova K. Gene therapy of the ischemic lower limb--Therapeutic angiogenesis. Vascul Pharmacol 2006;44(6):395-405.
32. Ferrara N, Alitalo K. Clinical applications of angiogenic growth factors and their inhibitors. Nat Med 1999;5(12):1359-64.
15. Rosén L. Analytic decision-making in patients with critical limb ischaemia. Ann Chir Gynaecol 1998;87:145-148.
33. Ohara N, Koyama H, Miyata T et al. Adenovirus-mediated ex vivo gene transfer of basic fibroblast growth factor promotes collateral development in a rabbit model of hind limb ischemia. Gene Ther 2001;8(11):837-45. 34. Ishii S, Koyama H, Miyata T et al. Appropriate control of ex vivo gene therapy delivering basic fibroblast growth factor promotes successful and safe development of collateral vessels in rabbit model of hind limb ischemia. J Vasc Surg 2004;39(3):629-38. 35. Springer ML, Chen AS, Kraft PE et al. VEGF gene delivery to muscle: potential role for vasculogenesis in adults. Mol Cell 1998;2(5):549-58. 36. Malecki M, Przybyszewska M, Janik P. Construction of a bicistronic proangiogenic expression vector and its application in experimental angiogenesis in vivo. Acta Biochim Pol 2003;50(3):875-82. 37. Chae JK, Kim I, Lim ST et al. Coadministration of angiopoietin-1 and vascular endothelial growth factor enhances collateral vascularization. Arterioscler Thromb Vasc Biol 2000;20(12):2573-8. 38. Mann MJ. Gene therapy for peripheral arterial disease. Mol Med Today 2000;6(7):285-91. 39. Yla-Herttuala S, Martin JF. Cardiovasc Gene Ther 2000;355(9199):213-22. 40. Hiltunen MO, Laitinen M, Turunen MP et al. Intravascular adenovirus-mediated VEGF-C gene transfer reduces neointima formation in balloon-denuded rabbit aorta. Circulation 2000;102(18):2262-8. 41. Hiltunen MO, Turunen MP, Turunen AM et al. Biodistribution of adenoviral vector to nontarget tissues after local in vivo gene transfer to arterial wall using intravascular and periadventitial gene delivery methods. FASEB J 2000;14(14):2230-6. Asahara T, Chen D, Tsurumi Y et al. Accelerated restitution of endothelial integrity and endothelium-dependent function after phVEGF165 gene transfer. Circulation 1996;94(12):3291-302.
43. Nishida K, Doita M, Takada T et al. Sustained transgene expression in intervertebral disc cells in vivo mediated by microbubble-enhanced ultrasound gene therapy. Spine 2006;31(13):1415-9.
44. Riesbeck K, Chen D, Kemball-Cook G et al. Expression of hirudin fusion proteins in mammalian cells: a strategy for prevention of intravascular thrombosis. Circulation 1998;98(24):2744-52.
25. Reynolds LP, Grazul-Bilska AT, Redmer DA. Angiogenesis in the female reproductive organs:pathological implications. Int J Exp Pathol 2002;83(4):151-63. 26. Folkman J.Tumor angiogenesis: therapeutic implications. N Engl J Med 1971;285(21):1182-6.
12. Becker F, Robert-Ebadi H, Ricco JB et al. Chapter I: Definitions, epidemiology, clinical presentation and prognosis. Eur J Vasc Endovasc Surg 2011;42 Suppl 2:S4-12.
22. Hara H, Oh-hashi K, Yoneda S et al. Elevated neprilysin activity in vitreous of patients with proliferative diabetic retinopathy. Mol Vis 2006;12:977-82.
17. Second European consensus document on chronic critical leg ischemia. Eur J Vasc Surg 1992;6:(Suppl A).
19. Rutherford RB. Recommended standards for reports on vascular disease and its management. In: Calloow AD, Ernst CB eds. Vascular surgery: theory and practice. Stamford, Appleton& Lange; 1995. p. 1145-1159.
30. Tsurumi Y, Kearney M, Chen D et al. Treatment of acute limb ischemia by intramuscular injection of vascular endothelial growth factor gene. Circulation 1997;96(9 Suppl):II-382-8.
45. Kuo MD, Waugh JM, Yuksel E et al.1998 ARRS President’s Award. The potential of in vivo vascular tissue engineering for the treatment of vascular thrombosis: a preliminary report. American Roentgen Ray Society. AJR Am J Roentgenol 1998;171(3):553-8.
23. Bauer SM, Bauer RJ, Liu ZJ et al. Vascular endothelial growth factor-C promotes vasculogenesis, angiogenesis, and collagen constriction in three-dimensional collagen gels. J Vasc Surg 2005;41(4):699-707.
24. Reynolds LP, Killilea SD, Redmer DA. Angiogenesis in the female reproductive system. FASEB J 1992;6(3):886-92.
64 35Capítulo PRINCÍPIOS DA TERAPIA GÊNICA PARA ISQUEMIA CRÔNICA CRÍTICA DOS MEMBROS REFERÊNCIAS BIBLIOGRÁFICAS 1. Mangi AA, Dzau VJ. Gene therapy for cardiovascular disease and vascular grafts. In: Templeton NS. Gene and cell therapy. New York, Marcel Deckker; 2000. p. 515-529. 2. htt://em.wikipedia.org/wiki/Gene_therapy 3. Han SW. Terapia gênica para isquemia de membros. In: Lopes AC. Diagnóstico e tratamento.Barueri, Manole; 2006. v. 2. p. 58-62. 4. http://www.futurepundit.com/archives/000982.html 5. http://www.wiley.co.uk/genetherapy/clinical/ 6. Norgren L, Hiatt WR, Dormandy JA et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg 2007;33 Suppl 1:S1-75. 7. International Association for Study of Pain®. http://www.iasp-pain. org. 8. DeWeese JA, Leather R, Porter J. Practice guidelines: lower extremity revascularization. J Vasc Surg 1993;18(2):280-94. 9. Fontaine R, Kim M, Kieny R. Die Chirurgische Behandlung der peripheren Durch-Blutungsstorungen. Helv Chir Acta 1954;21:499-452. 10. Rutherford RB. The definition of critical limb ischemia: advantages and limitations. In: Branchereau A, Jacobs M. Critical limb ischemia Armonk (NY), Futura; 1999. p. 1-9. 11. Setacci C, de Donato G, Teraa M et al. Chapter IV: Treatment of critical limb ischaemia. Eur J Vasc Endovasc Surg 2011 Dec;42 Suppl 2:S43-59.
27. Longhese MP, Foiani M, Muzi-Falconi M et al. DNA damage checkpoint in budding yeast. EMBO J 1998;17(19):5525–5528.
46. Pan S, Kleppe LS, Witt TA et al. The effect of vascular smooth muscle cell-targeted expression of tissue factor pathway inhibitor
77. Tateno K, Minamino T, Toko H et al. Critical roles of muscle-secreted angiogenic factors in therapeutic neovascularization. Circ Res 2006;98(9):1194-202. 78. Kunieda T, Minamino T, Katsuno T et al. Cellular senescence impairs circadian expression of clock genes in vitro and in vivo. Circ Res 2006;98(4):532-9. 79. Dvorak HF, Nagy JA, Feng D et al. Vascular permeability factor/ vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. Curr Top Microbiol Immunol 1999;237:97-132. 80. Ng YS, D’Amore PA. Therapeutic angiogenesis for cardiovascular disease. Curr Control Trials Cardiovasc Med 2001;2(6):278-285. 81. Boodhwani M, Sodha NR, Laham RJ, Sellke FW. The future of therapeutic myocardial angiogenesis. Shock 2006;26(4):332-41. 82. Li J, Post M, Volk R et al. PR39, a peptide regulator of angiogenesis. Nat Med 2000;6(1):49-55. Erratum in: Nat Med 2000;6(3):356. 83. Yoon YS, Johnson IA, Park JS et al. Therapeutic myocardial angiogenesis with vascular endothelial growth factors. Mol Cell Biochem 2004;264(1-2):63-74. 84. Losordo DW, Dimmeler S. Therapeutic angiogenesis and vasculogenesis for ischemic disease: part II: cell-based therapies. Circulation 2004;109(22):2692-7. 85. Losordo DW, Dimmeler S. Therapeutic angiogenesis and vasculogenesis for ischemic disease. Part I: angiogenic cytokines. Circulation 2004;109(21):2487-91. 86. Semenza GL. Regulation of physiological responses to continuous and intermittent hypoxia by hypoxia-inducible factor 1. Exp Physiol 2006 Sep;91(5):803-6. 87. Semenza GL.Therapeutic angiogenesis: another passing phase? Circ Res 2006;98(9):1115-6. 88. Yamashita J, Itoh H, Hirashima M, et al. Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature 2000;408(6808):92-6. 89. Matsumoto R, Omura T, Yoshiyama M et al. Vascular endothelial growth factor-expressing mesenchymal stem cell transplantation for the treatment of acute myocardial infarction. Arterioscler Thromb Vasc Biol 2005;25(6):1168-73.
58. Baumgartner I, Rauh G, Pieczek A et al. Lower-extremity edema associated with gene transfer of naked DNA encoding vascular endothelial growth factor. Ann Intern Med 2000;132(11):880-4.
55. Baumgartner I, Pieczek A, Manor O et al. Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation 1998;97(12):1114-23.
66. Mann MJ, Whittemore AD, Donaldson MC et al. Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomised, controlled trial. Lancet 1999;354(9189):1493-8. 67. Conte MS, Lorenz TJ, Bandyk DF et al. Design and rationale of the PREVENT III clinical trial: edifoligide for the prevention of infrainguinal vein graft failure. Vasc Endovascular Surg 2005;39(1):15-23. 68. Roberts WG, Palade GE. Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J Cell Sci 1995;108(Pt 6):2369-79. 69. Eriksson A, Cao R, Roy J et al. Small GTP-binding protein Rac is an essential mediator of vascular endothelial growth factor-induced endothelial fenestrations and vascular permeability. Circulation 2003;107(11):1532-8.
73. Alitalo K, Carmeliet P. Molecular mechanisms of lymphangiogenesis in health and disease. Cancer Cell 2002;1(3):219-27.
76. Safran M, Kaelin WG Jr. HIF hydroxylation and the mammalian oxygen-sensing pathway. J Clin Invest 2003;111(6):779-83.
90. Farah SB. DNA: segredos & mistérios. São Paulo: Savier, 2000. 276p. 91. Matte US. Genômica: Aspectos éticos, legais e sociais. In: Mir L. Genômica. São Paulo, Atheneu; 2004. p. 1067-1090. 92. Simpson AJG, Parra JC, Perez JF. Projetos genoma no Brasil: revolução na biotecnologia brasileira. In: Mir L. Genômica. São Paulo: Atheneu; 2004. p. 1091-1100. 93. Mir L, Zatz M. Cientistas racionais ou falsos Deuses? Parte I: Ética na ciência, medicina e política científica. In: Mir L. Genômica. São Paulo: Atheneu; 2004. p. 1101-1108. 94. Mir L, Zatz M. Parte II: Ética no dia-dia do geneticista. In: Mir L. Genômica. São Paulo: Atheneu; 2004. p. 1109-1114. 95. Nardi NB, Ventura AM. Terapia gênica. In: Mir L. Genômica. São Paulo, Atheneu; 2004. p. 625-642. 96. www.planalto.gov.br/ccivil_03/_ato2004-2006/2005/lei/l11105.htm 97. Caso Jesse. http://www.ufrgs.br/bioetica/jesse.htm 98. http://www.med.upenn.edu/ight 99. pm02Fall.pdfhttp://www.uphs.upenn.edu/prnews/publications/Penn_Medicine/ 100. Silberner J. A gene therapy death. Hastings Cent Rep 2000;30(2):6.
64. Folkman J. Therapeutic angiogenesis in ischemic limbs. Circulation 1998;97(12):1108-10. 65. Rissanen TT, Vajanto I, Yla-Herttuala S. Gene therapy for therapeutic angiogenesis in critically ischaemic lower limb - on the way to the clinic. Eur J Clin Invest 2001;31(8):651-66.
53. Shah PB, Lotun K, Losordo DW. Cardiovascular gene therapy. In: Templeton NS. Gene and cell therapy. New York: Marcel Deckker; 2000. p. 707-719.
56. Laitinen M, Hartikainen J, Hiltunen MO et al. Catheter-mediated vascular endothelial growth factor gene transfer to human coronary arteries after angioplasty. Hum Gene Ther 2000;11(2):263-70.
61. Grines CL, Watkins MW, Helmer G et al. Angiogenic Gene Therapy (AGENT) trial in patients with stable angina pectoris. Circulation 2002;105(11):1291-7.
65Capítulo 35 PrinCíPios dA ter APiA gêniCA PAr A isquemiA CrôniCA CrítiCA dos membros in a murine model of arterial thrombosis. Thromb Haemost 2004;92(3):495-502.
75. Ku DD, Zaleski JK, Liu S, Brock TA. Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries. Am J Physiol 1993;265(2 Pt 2):H586-92.
60. Makinen K, Manninen H, Hedman M et al. Increased vascularity detected by digital subtraction angiography after VEGF gene transfer to human lower limb artery: a randomized, placebo-controlled, double-blinded phase II study. Mol Ther 2002;6(1):127-33.
70. Maxwell PH, Ratcliffe PJ. Oxygen sensors and angiogenesis. Semin Cell Dev Biol 2002;13(1):29-37.
63. Hedman M, Hartikainen J, Syvanne M et al. Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia: phase II results of the Kuopio Angiogenesis Trial (KAT). Circulation 2003;107(21):2677-83.
51. Muhs A, Heublein B, Schletter J et al. Preclinical evaluation of inducible nitric oxide synthase lipoplex gene therapy for inhibition of stent-induced vascular neointimal lesion formation. Hum Gene Ther 2003;14(4):375-83.
62. Hedman M, Yla-Herttuala S. Gene therapy for the treatment of peripheral vascular disease and coronary artery disease. Drugs Today (Barc) 2000;36(9):609-17.
72. Makinen T, Jussila L, Veikkola T et al. Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3. Nat Med 2001;7(2):199-205.
50. Wang K, Kessler PD, Zhou Z et al. Local adenoviral-mediated inducible nitric oxide synthase gene transfer inhibits neointimal formation in the porcine coronary stented model. Mol Ther 2003;7(5 Pt 1):597-603.
54. Isner JM, Pieczek A, Schainfeld R et al. Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb. Lancet 1996;348(9024):370-4.
47. Kupfer JM, Ruan XM, Liu G et al. High-efficiency gene transfer to autologous rabbit jugular vein grafts using adenovirus-transferrin/ polylysine-DNA complexes. Hum Gene Ther 1994;5(12):1437-43.
71. Szuba A, Skobe M, Karkkainen MJ et al. Therapeutic lymphangiogenesis with human recombinant VEGF-C. FASEB J 2002;16(14):1985-7.
59. Thurston G, Rudge JS, Ioffe E et al.Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat Med 2000 Apr;6(4):460-3.
52. Pasic M, Muller-Glauser W, von Segesser L et al. Endothelial cell seeding improves patency of synthetic vascular grafts: manual versus automatized method. Eur J Cardiothorac Surg 1996;10(5):372-9.
74. Partanen TA, Paavonen K. Lymphatic versus blood vascular endothelial growth factors and receptors in humans. Microsc Res Tech 2001;55(2):108-21.
57. Rajagopalan S, Shah M, Luciano A et al. Adenovirus-mediated gene transfer of VEGF(121) improves lower-extremity endothelial function and flow reserve. Circulation 2001;104(7):753-5.
48. Kibbe MR, Tzeng E, Gleixner SL et al. Adenovirus-mediated gene transfer of human inducible nitric oxide synthase in porcine vein grafts inhibits intimal hyperplasia. J Vasc Surg 2001;34(1):156-65.
49. Mann MJ, Gibbons GH, Kernoff RS et al. Genetic engineering of vein grafts resistant to atherosclerosis. Proc Natl Acad Sci U S A 1995;92(10):4502-6.
101. Woo SL.Policy statement of the American Society of Gene Therapy on reporting of patient adverse events in gene therapy trials. Mol Ther 2000;1(1):7-8. Steele FR. Gene therapy on the RAC. Mol Ther 2000;1(1):1-2. Friedmann T. Changing roles for academia and industry in genetics and gene therapy. Mol Ther 2000;1(1):9-11.
66 Parte IITERAPÊUTICA MEDICAMENTOSA E HEMOTERÁPICA
103.
104. Emmerich J. Current state and perspective on medical treatment of critical leg ischemia: gene and cell therapy. Int J Low Extrem Wounds 2005;4(4):234-41.
105. Dahse R, Fiedler W, Ernst G. Telomeres and telomerase: biological and clinical importance. Clin Chem 1997;43(5):708-14.
107. Davies MG. Critical limb ischemia: cell and molecular therapies for limb salvage. Methodist Debakey Cardiovasc J 2012;8(4):20-7.
111. Belch J, Hiatt WR, Baumgartner I et al. Effect of fibroblast growth factor NV1FGF on amputation and death: a randomised placebocontrolled trial of gene therapy in critical limb ischaemia. Lancet 2011;377(9781):1929-37. 112. Van Belle E, Nikol S, Norgren L et al. Insights on the role of diabetes and geographic variation in patients with critical limb ischaemia. Eur J Vasc Endovasc Surg 2011;42(3):365-73. 113. Muona K, Makinen K, Hedman M et al. 10-year safety follow-up in patients with local VEGF gene transfer to ischemic lower limb. Gene Therapy 2012;19:392–395. 114. Iyer SR, Annex BH. Therapeutic Angiogenesis for Peripheral Artery Disease: Lessons Learned in Translational Science. JACC Basic Transl Sci 2017;2(5):503-512. 115. Samura M, Hosoyama T, Takeuchi Y et al. Therapeutic strategies for cell-based neovascularization in critical limb ischemia. J Transl Med 2017;15(1):49. 116. Qadura M, Terenzi DC, Verma S et al. Concise Review: Cell Therapy for Critical Limb Ischemia: An Integrated Review of Preclinical and Clinical Studies. Stem Cells 2018;36(2):161-171.
106. Blackburn EH. Telomeres and telomerase: the means to the end (Nobel lecture). Angew Chem Int Ed Engl 2010;49(41):7405-21.
108. Setacci C, de Donato G, Teraa M et al. Chapter IV: Treatment of critical limb ischaemia. Eur J Vasc Endovasc Surg 2011 Dec;(42 Suppl 2):S43-59. 109. Dohmen A, Eder S, Wulf Euringer et al. Chronic Critical Limb Ischemia. Dtsch Arztebl Int 2012;109(6):95-101. 110. http://clinicaltrials.gov/ct2/show/NCT00566657
102.
7. Galyfos G, Geropapas G, Sigala F et al. Meta-Analysis of Studies Evaluating the Effect of Cilostazol on Major Outcomes after carotid stenting. J Endovasc Ther 2016;23(1):186-195.
8. Teramoto S et al. Antiplatelet cilostazol, an inhibitor of type III phosphodiesterase, improves swallowing function in patients with a history of stroke. J Geriatr Soc 2008;56(6):1153-4.
1. Peripheral Arterial Diseases Antiplatelet Consensus Group. Antiplatelet therapy in peripheral arterial disease. Consensus statement. Eur J Vasc Endovasc Surg 2003;26(1):1-16.
5. Kawamura K, Fujita S, Tani T et al. Effect of Cilostazol, a new antithrombotic drug, on an experimental model of peripheral circulation insufficiency. Arzneimittelforschung 1985;35:1154-6.
9. Bedenis R, Stewart M, Cleanthis M et al. Cilostazol for intermittent claudication. Cochrane Database of Systematic Reviews 2014, Issue 10. Art. No.: CD003748. 10. Dawson DL, DeMaioribus CA, Hagino RT et al. The effect of withdrawal of drugs treating intermittent claudication. Am J Surg 1999;178:141-146. 11. Mandell GL. ARDS, neutrophils, and pentoxifylline. Am Rev Respir Dis 1988;138(5):1103-5.
REFERÊNCIAS BIBLIOGRÁFICAS
12. Salhiyyah K, Senanayake E, Abdel-Hadi M et al. Pentoxifylline for intermittent claudication. Cochrane Database of Systematic Reviews 2012, Issue 1. Art. No.: CD005262. 13. Adhoute G, Bacourt F, Barral M et al. Naftidrofuryl in chronic arterial disease. Results of a six month controlled multicenter study using naftidrofuryl tablets 200 mg. Angiology 1986;37:160-167. 14. de Backer TLM, Vander Stichele R, Lehert P, Van Bortel L. Naftidrofuryl for intermittent claudication. Cochrane Database of Systematic Reviews 2012, Issue 12. Art. No.: CD001368. 15. de Backer TLM, Vander Stichele R. Buflomedil for intermittent claudication. Cochrane Database of Systematic Reviews 2013, Issue 3. Art. No.: CD000988. 16. Stewart M, Morling JR, Maxwell H. Padma 28 for intermittent claudication. Cochrane Database of Systematic Reviews 2016, Issue 3. Art. No.: CD007371. 17. Brass EP, Koster D, Hiatt WR, Amato, A. Systematic review and metaanalysis of propionyl-l-carnitine effects on exercise performance in patients with claudication. Vascular Medicine 2013;18(1):3-12.
DROGAS VASODILATADORAS
36Capítulo
67
2. Leng GC, Lee AJ, Fowkes FG et al. Incidence, natural history and cardiovascular events in symptomatic and asymptomatic. Int J Epidemiol 1996;25(6):1172-81.
3. McDermott MM, Liu K, Ferrucci L et al. Greater sedentary hours and slower walking speed outside the home predict faster declines in functioning and adverse calf muscle changes in peripheral arterial disease. J Am Coll Cardiol 2011;57(23):2356-64.
4. Regensteiner JG, Steiner JF, Hiatt WR. Exercise training improves functional status in patients with peripheral arterial disease. J Vasc Surg 1996;23:104-15
6. Regensteiner JG, Hiatt WR. Current medical therapies for patients with peripheral arterial disease: a critical review. Am J Med 2002;112:49-57.
Lima ALLM, Fernandes TD, Godoy-Santos AL et al. Directrices panamericanas para el tratamiento de infecciones en úlceras neuropáticas de las extremidades inferiores. Rev Panam Infectol 2011;13(1 Supl 1):S10. Lima ALLM, Fernandes TD, Godoy-Santos AL et al. Diretrizes Brasileiras para o Tratamento das Infecções em Úlceras Neuropáticas dos Membros Inferiores. BJID 2010;14(1):11-71. Lima ALLM, Oliveira PR, Paula AP. Acinetobacter infection. N Engl J Med 2008 Jun;26:358. Lima ALLM, Oliveira PRD. Antibioticoprofilaxia em cirurgia ortopédica. In: Infecções Ortopédicas-abordagem multidisciplinar. Ed. Atheneu; 2013. p. Lima23-30.ALLM, Oliveira PRD. Uso de antimicrobianos em pacientes ortopédicos. In: Melhorando o uso de antimicrobianos em hospitais – Associação Paulista de Estudos e Controle de Infecção Hospitalar. São Paulo; 2007. Lipsky BA, et al. The value of a wound score for diabetic foot infections in predicting treatment outcome: A prospective analysis from the SIDESTEP trial. Wound Rep Reg 2009;17:671-77. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention of surgical site infection. Infect Control Hosp Epidemiol Matthaiou2007;20:247-276.DK,Pepas G, Falagas ME. Meta-analysis on Surgical Infections
ANTIBIÓTICO EM CIRURGIA VASCULAR
BIBLIOGRAFIA Anderson DJ et al. Strategies to prevent surgical site infections in acute care hospitals. Infection Control and Hosp Epidemiology 2014. SHEA/ IDSA Update. Bicudo EL. Antibioticoterapia nas infecções no Pé Diabético. In: Lima ALLM. Infecções ortopédicas abordagem multidisciplinar. Ed. Atheneu; 2013. p. 279-284. Bratzler D, Houck P et al Use of Antimicrobial Prophylaxis for Major Surgery. Baseline Results From the National Surgical Infection Prevention Project. Arch Surg 2005;140:174-182. Classen DC, Evans NS et al. The timing of prophylatic administration of antibiotics and the risk of surgical wound infection. New Engl J Med Fletcher1992;326:281.N,Sofianos D, Berkes MB, Obremskey WT. Prevention of Perioperative Infection. J Bone Joint Surg Am 2007;89:1605-1618. Global guidelines for the prevention of surgical site infections. World Health Organization; 2016. Guia de Utilização de Anti-infecciosos e recomendações para a prevenção de infecções relacionadas a assistência à saúde. HC-FMUSP 2018-2020. Haynes AB, Weiser TG et al. A Surgical Safety Checklist to Reduce Morbidity and Mortality in a Global Population. N Engl J Med Health2009;360:491-9.ProtectionAgency. Mandatory surveillance of surgical site infection in orthopaedic surgery: April 2004 to March 2005. London: Health Protection Agency; October 2005. Kirby JP, Mazuski JE. Prevention of Surgical Site Infection. Surg Clin N Am Legout2009;89:365-389.L,Sarraz-Bournet et al. Characteristics and prognosis in patients with prosthetic vascular graft infection: a prospective cohort study. Clin Microbiol Inf 2012;18(4):352-58.
68 37Capítulo
Infect Dis Clin N Am 2009;23:405-430. Medidas de prevenção de Infecção Relacionada à Assistência à Saúde. Agência Nacional de Vigilância Sanitária/MS. Série: Segurança e Qualidade em Serviços de Saude, 2017. Murilo R. Tratamento cirúrgico vascular do pé diabético. In: Lima ALLM. Infecções ortopédicas-abordagem multidisciplinar. Ed. Atheneu; 2013. p. Vardakas269-278.K et al. Factors associated with treatment failure in patients with diabetic foot infections: An analysis of data from randomized controlled trials. Diab Res Clin Prac 2008;80:344-51.
HEMOTERAPIA
27. Riskin DJ, Tsai TC, Riskin L et al. Massive Transfusion Protocols: The Role of Aggressive Resuscitation Versus Product Ratio in Mortality Reduction. J Am Coll Surg 2009 Aug;209(2):198-205. 28. Silverboard H, Aisiku I, Martin GS et al. The role of acute blood transfusion in the development of acute respiratory distress syndrome in patients with severe trauma. J Trauma 2005 Sep;59(3):717-23. 29. Charles A, Shaikh AA, Walters M et al. Blood transfusion is an independent predictor of mortality after blunt trauma. Am Surg 2007 Jan;73(1):1-5. 30. Johansson PI, Ostrowski SR, Secher NH. Management of major blood loss: An update: Management of major blood loss. Acta Anaesthesiol Scand 2010 Oct;54(9):1039-49. 31. Wikkelsoe AJ, Afshari A, Wetterslev J et al. Monitoring patients at risk of massive transfusion with Thrombelastography or Thromboelastometry: a systematic review: TEG/ROTEM to guide massive transfusion. Acta Anaesthesiol Scand 2011 Nov;55(10):1174-89.
10. Green L, Bolton-Maggs P, Beattie C et al. British Society of Haematology Guidelines on the spectrum of fresh frozen plasma and cryoprecipitate products: their handling and use in various patient groups in the absence of major bleeding. Br J Haematol 2018 Apr;181(1):54-67.
EM CIRURGIA VASCULAR
7. Estcourt LJ, Birchall J, Allard S et al. Guidelines for the use of platelet transfusions. Br J Haematol 2017 Feb;176(3):365–94.
2. Junqueira PC. Auto-transfusão [Obtenção de Grau de Acadêmico]. [Rio de Janeiro]: Academia Nacional de Medicina; 1992. Hamilton C, Carroll C. Strategies to avoid intraoperative blood transfusion. Anaesth Intensive Care Med 2016 Feb 1;17(2):70-3.
23. Frank SM, Beattie C, Christopherson R et al. Unintentional hypothermia is associated with postoperative myocardial ischemia. The Perioperative Ischemia Randomized Anesthesia Trial Study Group. Anesthesiology 1993 Mar;78(3):468-76.
69 38Capitulo
11. Treleaven J, Gennery A, Marsh J et al. Guidelines on the use of irradiated blood components prepared by the British Committee for Standards in Haematology blood transfusion task force: Guidelines. Br J Haematol 2011 Jan;152(1):35-51.
24. American Association of Blood Banks. Technical Manual of the American Association of Blood Banks – Standards for Blood Banks and Transfusion Services. 18th ed. Bethesda; 1998.
17. Society for the Advancement of Blood Management. Administrative and Clinical Standards for Patients Blood Management Programs; 2014. 18. Sihler KC, Napolitano LM. Massive Transfusion. Chest 2009 Dec;136(6):1654-67.
25. Ganter MT, Brohi K, Cohen MJ et al. Role of the alternative pathway in the early complement activation following major trauma. Shock 2007 Jul;28(1):29-34. 26. Markiewski MM, Nilsson B, Nilsson Ekdahl K et al. Complement and coagulation: strangers or partners in crime? Trends Immunol 2007 Apr;28(4):184-92.
16. Gombotz H. Patient Blood Management: A Patient-Orientated Approach to Blood Replacement with the Goal of Reducing Anemia, Blood Loss and the Need for Blood Transfusion in Elective Surgery. Transfus Med Hemotherapy 2012;39(2):67-72.
22. Ganter MT, Pittet J-F. New insights into acute coagulopathy in trauma patients. Best Pract Res Clin Anaesthesiol 2010 Mar;24(1):15-25.
1. Ministério da Saúde. Consolidação das normas sobre as ações e os serviços de saúde do Sistema Único de Saúde. Seç. 1, Portaria de Consolidação no 5, de 28 de Setembro de 2017 set 3, 2017. p. 360.
6. Klein AA, Arnold P, Bingham RM et al. AAGBI guidelines: the use of blood components and their alternatives. Anaesthesia 2016 Jul;71(7):829-42.
12. Pan American Health Organizations. Recomendations for the estimation the need for blood and blood components; 2010.
21. Broder G, Weil MH. Excess lactate: an index of reversibility of shock in human patients. Science 1964 Mar 27;143(3613):1457-9.
9. Saadeh C, Sfeir J. Discontinuation of preoperative clopidogrel is unnecessary in peripheral arterial surgery. J Vasc Surg 2013 Dez;58(6):1586-92.
14. Charles KS, De Freitas L, Ramoutar R et al. Blood utilisation in a developing society: what is the best index of efficiency? Transfus Med [Internet]. 30 de abril de 2018 [citado 12 de junho de 2018]; Disponível em: http://doi.wiley.com/10.1111/tme.12534
20. Hearnshaw S, Travis S, Murphy M. The role of blood transfusion in the management of upper and lower intestinal tract bleeding. Best Pract Res Clin Gastroenterol 2008 Apr;22(2):355-71.
13. White MJ, Hazard SW, Frank SM et al. The Evolution of Perioperative Transfusion Testing and Blood Ordering. Anesth Analg 2015 Jun;120(6):1196-203.
19. Moore EE. Thomas G. Orr Memorial Lecture. Staged laparotomy for the hypothermia, acidosis, and coagulopathy syndrome. Am J Surg 1996 Nov;172(5):405-10.
32. Pabinger I, Fries D, Schöchl H et al. Tranexamic acid for treatment and prophylaxis of bleeding and hyperfibrinolysis. Wien Klin Wochenschr 2017 May;129(9-10):303-16. 33. Bolton-Maggs PHB. Serious hazards of transfusion - conference report: celebration of 20 years of UK haemovigilance: Serious hazards of transfusion – conference report. Transfus Med 2017 Dec;27(6):393-400. 34. Blumberg N. Abstracts of the AABB Annual Meeting and CTTXPO. San Diego, California, USA. Transfusion (Paris) 2011;51 Suppl 3:1A-297A. 35. Toy P, Gajic O, Bacchetti P et al. Transfusion-related acute lung injury: incidence and risk factors. Blood 2012 Feb 16;119(7):1757-67. 36. Agência Nacional de Vigilância Sanitária. Hemovigilância: manual técnico para investigação das reações transfusionais imediatas e tardias não infecciosas; 2007. p. 124. 37. Vamvakas EC, Blajchman MA. Blood Still Kills: Six Strategies to Further Reduce Allogeneic Blood Transfusion-Related Mortality. Transfus Med Rev 2010 Apr;24(2):77-124. 38. Li G, Rachmale S, Kojicic M et al. Incidence and transfusion risk factors for transfusion-associated circulatory overload among medical intensive care unit patients: TACO in medical ICU. Transfusion (Paris) 2011 Feb;51(2):338-43. 39. Opelz G, Sengar DP, Mickey MR, Terasaki PI. Effect of blood transfusions on subsequent kidney transplants. Transplant Proc 1973 Mar;5(1):253-9. 40. Gantt CL. Red blood cells for cancer patients. Lancet Lond Engl 1981 Aug 15;2(8242):363. 41. Vamvakas EC, Blajchman MA. Transfusion-related immunomodulation (TRIM): An update. Blood Rev 2007 Nov;21(6):327-48.
REFERÊNCIAS BIBLIOGRÁFICAS
8. Jones DW, Schermerhorn ML, Brooke BS et al. Perioperative clopidogrel is associated with increased bleeding and blood transfusion at the time of lower extremity bypass. J Vasc Surg 2017 Jun;65(6):1719-1728.e1.
15. Subramanian A, Rangarajan K, Kumar S et al. Reviewing the blood ordering schedule for elective orthopedic surgeries at a level one trauma care center. J Emerg Trauma Shock 2010;3(3):225.
3.
4. Canadian Blood Services. Clinical Guide to Transfusion. Canada; 2007. 5. Carson JL. Red Blood Cell Transfusion: A Clinical Practice Guideline From the AABB. Ann Intern Med 2012 Jul 3;157(1):49.
Parte III CERVICAL
ANATOMIA BIBLIOGRÁFICAS
APLICADA À REGIÃO CERVICAL REFERÊNCIAS
1. Frank H. Netter FH. Atlas de Anatomia Humana. 6. ed. Editora Elsevier; 2015. 2. Sobotta. Atlas de Anatomia Humana. 24. ed. Editora Gen; 2018. 3. Van De Graaff. Anatomia Humana. 6. ed. Editora Manole; 2002. 4. Standring S. Gray’s Anatomia. 40. ed. Editora Elsevier; 2011. 5. Roon AJ, Christensen N. Evaluation and treatment of penetrating cervical injuries. J Trauma 1979:391-7. 6. Irish JC, Hekkenberg R, Gullane PJ et al. Penetrating and blunt neck trauma: 10-year review of a Canadian experience. Can J Surg 1997;40(1):33-8. 7. Wind GG, Valentine RJ. Exposições Anatômicas em Cirurgia Vascular 3. ed. Editora Di Livros; 2014. 8. Moore K L, Dallet AF, Agur AM. Anatomia Orientada para a Clínica 6. ed. Editora Gen; 2011. 9. Prometheus Atlas de Anatomia. 2. ed. Editora Gen; 2013. 10. O’Rahilly GG. 4. ed. Editora Guanabara;1985. 11. Fernandes GJM . Eponímia: glossário em Anatomia; Etimologia: dicionário etimológico da nomenclatura anatômica. São Paulo: Editora Pleiade; 1999. 12. Michalinos A, Chatzimarkos M, Arkadopoulos N et al. Anatomical Considerations on Surgical Anatomy of the Carotid Bifurcation. Anat Res Int 2016:1-8.
13. Dalman RL, Mulholland MW. Operative Techniques in Vascular Surgery. Editora Wolters Kluwer; 2015. 14. Ohkura K, Shiiya N, Washiyama N et al. Vertebral artery variations in thoracic aortic patients. Eur J Cardio-Thoracic Surg 2014;46(1):27-31.
15. Katsanos AH, Kosmidou M, Kyritsis AP, Giannopoulos S. Is vertebral artery hypoplasia a predisposing factor for posterior circulation cerebral ischemic events? A comprehensive review. Eur Neurol 2013;70(1-2):78-83. 16. Zavala-Alarcon E, Emmans L, Little R, Bant A. Percutaneous intervention for posterior fossa ischemia. A single center experience and review of the literature. Int J Cardiol 2008;127(1):70-7.
17. Sugiura T, Imoto K, Uchida K et al. Evaluation of the vertebrobasilar system in thoracic aortic surgery. Ann Thorac Surg 2011;92(2):568-70. 18. Snell R. Anatomia clínica para estudantes de medicina. Editora Guanabara; 1999.
73 39Capítulo
VIAS DE AOS VASOS CERVICAIS
74 40Capítulo
ACESSO
BIBLIOGRAFIA Ballard JL, Killeen JD. Anatomy and surgical exposure of the vascular system. In: Moore W. (Ed.). Vascular surgery. Philadelphia: WB Saunders; 1998. p. 44-66. Bismulth H. Les anastomoses porto caves tronculaires. Techniques chirurgicales. Appareil digestif. Encyl Med Chir Paris; 2006. p. 408. Branchereau A, Ondon’Dong F. Extended medial approach to the popliteal artery without muscular division. Ann Vasc Surg 1989;3:77-80. Cherry Jr KJ, McCullough JL et al. Technical principles of direct innominate artery revascularization: a comparison of endarterectomy and bypass grafts. J Vasc Surg 1989;9:718. Crawford ES, De Bakey ME et al. Thrombo-obliterative disease of the great vessels arising from the aortic arch. J Thorac Cardiovasc Surg Dardick1962;43:38.H,Dardick I, Veith FJ. Exposure of the tibioperoneal arteries by a single lateral approach. Surgery 1974;75:377. Elkin DC, Kelly RP. Arteriovenous aneurysm: exposure of the tibial and peroneal vessels by resection of the fibula. Ann Surg 1945;122:529-45. Fiolle J, Delmas J. Découverte des vaisseaux profonds par des voies d’accès larges. Paris: Masson; 1940. Fisher DF, Clagett GP, Parker JI et al. Mandibular subluxation for high carotid exposure. J Vasc Surg 1984;1:727-33. Fisher Jr DF, Fry WJ. Collateral mesenteric circulation. Surg Gynecol Obstet Goldsmith1987;164:487.MM3d, Postma DS, Jones FD. The surgical exposure of penetrating injuries to the carotid artery at the skull base. Otalaryngol Head Neck Surg 1986;95:278-84. Haimovici H, Ernest CB, Berguer R. Exposição cirúrgica dos vasos. In: Haimovici H. (Ed.). Cirurgia vascular: princípios e técnicas. 4. ed. Rio de Janeiro: Di-Livros; 2000. p. 351. Haimovici H. Arterial circulation of the extremities. In: Schwartz CJ, Werthessen NT, Wolf A. (Eds.) Structure and function of the circulation New York: Plenum; 1980. p. 425-85, v. 1. Hall-Craggs ECB. The upper limb. In: Hall-Craggs. (Ed.) Anatomy Baltimore: Williams & Wilkins; 1995. p. 160, cap. 64. Henderson JM, Warren WD, Milikan WJ et al. Distal splenorenal shunt with splenopancreatic disconnection: a 4-year assessment. Ann Surg Hertzer1989;210:332-39.NR,Felaman BJ, Beven EG, Tucker HM. A prospective study of the incidence of injury to the cranial nerves during carotid endarterectomy. Surg Gynecol Obstet 1980;151:781. International Anatomical Nomenclature Committee. Nomina anatômica 5. ed. México: Medsi; 1984. Johansen K, Banayk D et al. Temporary intraluminal shunts: resolution of a management dilemma in complex vascular injuries. J Trauma Madden1982;22:395-401.JL. Atlas de técnicas cirúrgicas. 2. ed. São Paulo: Roca; 1987. p. Mattox212-351.KL,Hieshberg A. Access control and repair techniques. In: Rich NM. (Ed.). Vascular trauma. 2. ed. Philadelphia: Saunders; 2004. p. Monson137-64.DO, Saletta JD, Frecark RJ. Carotid and vertebral trauma. J Trauma Nascimento-Silva1969;9(12):987-99.JLC. Anatomia médico-cirúrgica do sistema vascular. In: Brito CJ. (Ed.). Cirurgia vascular. Rio de Janeiro: Revinter; 2002. p. Netter25-76.FH.The head and neck In: Netter FH. (Eds.). Atlas of human anatomy. Hanover: Library of Congress Catalog; 1997. p. 28. Petroianu A. Anatomia cirúrgica. Rio de Janeiro: Guanabara Koogan; 1999. Rich NM, Spencer FC. Vascular trauma. Philadelphia: WB Saunders; 1978. Ristow AV. Traumatismos vasculares dos membros Urgências vasculares Rio de Janeiro: Cultura Médica; 1983. p. 19-61. Rossi M, Brito CJ, Cury RCP. Principais vias de acesso utilizadas no trauma vascular. In: Rossi M. (Ed.) Trauma vascular. Rio de Janeiro: Revinter; 2006. p. 58-73. Rossi M. Vias de acesso mais utilizadas em cirurgia vascular In: Brito CJ. (Ed.). Cirurgia vascular. Rio de Janeiro: Revinter; 2002. p. 77-104. Rutherford RB. Atlas de cirurgia vascular. Técnicas e exposições básicas. Rio de Janeiro: Di-Livros; 1998. Simonian GT, Pappas PJ, Padberg Jr FT et al. Mandibular subluxation for distal internal carotid exposure: technical considerations. J Vasc Surg Snell1999;30:1116.RS.Anatomia humana. 2. ed. Rio de Janeiro: Medsi; 1984. Stoney RJ, Effeney DJ. Comprehensive vascular exposures. Philadelphia: Lippincott-Raven; 1998. Testut L. Traité D’anatomie humaine. 4. ed. Paris: Octave Doin; 1900, v. 2. Trout HH, Giodano JM. Anomalies of the inferior vena cava. J Vasc Surg Valentine1986;3:924.RJ,Wind GG. Anatomic exposures in vascular surgery. 2. ed. Philadelphia: Lippincott Williams & Wilkins; 2003. Valentine RJ, Wind GG. Anatomy of commonly exposed arteries. In: Rutherford RB. (Ed.). Vascular surgery. 5. ed. Philadelphia: WB Saunders; 2000. p. 48-60. Yeo CJ, Cameron JL, Lillemore KD, et al. Pancreaticoduodenectomy for cancer of the head of the pancreas: 201 patients. Ann Surg 1995;221:721-29.
25. Moneta GL, Edwards JM, Chitwood RW et al. Correlation of North American Symptomatic Carotid Endarterectomy Trial (NASCET) angiographic definition of 70% to 99% internal carotid artery stenosis with duplex scanning. J Vasc Surg 1993;17(1):152-157; discussion 157-159.
12. Sandri JL. Endarterectomia carotídeo somente com Duplex. In: Nectoux JL ed. Ultrassonografia Vascular. Rio de Janeiro: Revinter; 2000. p. 71-75.
9. Dawson DL, Zierler RE, Strandness DE Jr. et al. The role of duplex scanning and arteriography before carotid endarterectomy: a prospective study. J Vasc Surg 1993;18(4):673-680; discussion 680-673.
29. Arous EJ, Baril DT, Robinson WP et al. Institutional differences in carotid artery duplex diagnostic criteria result in significant variability in classification of carotid artery stenoses and likely lead to disparities in care. Circ Cardiovasc Qual Outcomes 2014;7(3):423-429.
26. Faught WE, Mattos MA, van Bemmelen PS et al. Color-flow duplex scanning of carotid arteries: new velocity criteria based on receiver operator characteristic analysis for threshold stenoses used in the symptomatic and asymptomatic carotid trials. J Vasc Surg 1994;19(5):818-827; discussion 827-818.
21. Thorton J, AM AK, SK SP, Darling S. Anatomic distribuition of the carotid bulb as determined by duplex ultrasound. J Vasc Ultrasound 2015;39(1):34-38. 22. Uflaker R. Artérias da cabeça e pescoço. In: Uflaker R ed. Atlas de Anatomia Vascular. Rio de janeiro: Revinter; 2003. 23. Wood MM, Romine LE, Lee YK et al. Spectral Doppler signature waveforms in ultrasonography: a review of normal and abnormal waveforms. Ultrasound Q 2010;26(2):83-99. 24. Oates CP, Naylor AR, Hartshorne T et al. Joint recommendations for reporting carotid ultrasound investigations in the United Kingdom. Eur J Vasc Endovasc Surg 2009;37(3):251-261.
2. Jonas DE, Feltner C, Amick HR et al. Screening for asymptomatic carotid artery stenosis: a systematic review and meta-analysis for the U.S. Preventive Services Task Force. Ann Intern Med 2014;161(5):336-346.
14. Pontes SM, Barros FS, Jacque CM et al. Mapeamento ecográfico da bifurcação das artérias carótidas extracranianas, para planejamento cirúrgico:diferenças baseadas no gênero do paciente. J Vasc Bras 2011;10:222-227.
36. Petisco ACGP, Barbosa JEM, Saleh MH et al. Doppler Ecografia das artérias carótidas: Critérios de velocidades validados pela arteriografia. Arq Bras Cardiol: Imagem Cardiovasc 2015;28(1):17-24.
1. Roger VL, Go AS, Lloyd-Jones DM et al. Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation 2012;125(1):e2-e220.
17. Rubin JM, Adler RS. Power Doppler expands standard color capability. Diagn Imaging (San Franc) 1993;15(12):66-69.
ECOCOLOR DOPPLER DAS CARÓTIDAS VERTEBRAIS
11. Wain RA, Lyon RT, Veith FJ et al. Accuracy of duplex ultrasound in evaluating carotid artery anatomy before endarterectomy. J Vasc Surg 1998;27(2):235-242; discussion 242-234.
30. Arous EJ, Simons JP, Flahive JM et al. National variation in preoperative imaging, carotid duplex ultrasound criteria, and threshold for surgery for asymptomatic carotid artery stenosis J Vasc Surg 2015;62(4):937-944. 31. Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. JAMA 1995;273(18):1421-1428.
34. Bartlett ES, Walters TD, Symons SP, Fox AJ. Quantification of carotid stenosis on CT angiography. AJNR Am J Neuroradiol 2006;27(1):13-19.
75 41Capítulo
10. Ammar CP, Helmer SD, Ammar AD. Carotid Duplex Ultrasonography: Additional Imaging Is Rarely Necessary for Appropriate Treatment Planning for Carotid Artery Disease. Am Surg 2017;83(4):377-380.
28. AbuRahma AF, Srivastava M, Stone PA et al. Critical appraisal of the Carotid Duplex Consensus criteria in the diagnosis of carotid artery stenosis. J Vasc Surg 2011;53(1):53-59; discussion 59-60.
19. Scissons R, Cunha SS, Altenburg L et al. Quantification of Doppler velocity meassuerements Doppler cursor alignment parallel to wall versus parallel to flow stream. J Vasc Tech 1998;22(1):17-21. 20. von Reutern GM, Goertler MW, Bornstein NM et al. Grading carotid stenosis using ultrasonic methods. Stroke 2012;43(3):916-921.
E
3. Saúde-Brasil Md. Indicadores e dados básicos 2012. Accessed 24/0/2014, 2014.
REFERÊNCIAS BIBLIOGRÁFICAS
6. Paraskevas KI, Spence JD, Veith FJ, Nicolaides AN. Identifying which patients with asymptomatic carotid stenosis could benefit from intervention. Stroke (United States) 2014;45:3720-3724.
27. Grant EG, Benson CB, Moneta GL et al. Carotid artery stenosis: grayscale and Doppler US diagnosis-Society of Radiologists in Ultrasound Consensus Conference. Radiology 2003;229(2):340-346.
15. Brott TG, Halperin JL, Abbara S et al. 2011 SocietyInterventionalforSocietySocietyofAmericanForceCollegearterytheAANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVSASA/ACCF/AHA/AANN/guidelineonmanagementofpatientswithextracranialcarotidandvertebraldisease:executivesummary:areportoftheAmericanofCardiologyFoundation/AmericanHeartAssociationTaskonPracticeGuidelines,andtheAmericanStrokeAssociation,AssociationofNeuroscienceNurses,AmericanAssociationNeurologicalSurgeons,AmericanCollegeofRadiology,AmericanofNeuroradiology,CongressofNeurologicalSurgeons,ofAtherosclerosisImagingandPrevention,SocietyCardiovascularAngiographyandInterventions,SocietyofRadiology,SocietyofNeuroInterventionalSurgery,forVascularMedicine,andSocietyforVascularSurgery. J Am Coll Cardiol 2011;57(8):1002-1044.
13. Chiesa R, Melissano G, Castellano R et al. Carotid endarterectomy: experience in 5425 cases. Ann Vasc Surg 2004;18(5):527-534.
8. Conrad MF, Boulom V, Mukhopadhyay S et al. Progression of asymptomatic carotid stenosis despite optimal medical therapy. J Vasc Surg 2013;58(1):128-135.e121.
7. Singh TD, Kramer CL, Mandrekar J et al. Asymptomatic Carotid Stenosis: Risk of Progression and Development of Symptoms. Cerebrovasc Dis 2015;40(5-6):236-243.
35. Barlinn K, Floegel T, Kitzler HH et al. Multi-parametric ultrasound criteria for internal carotid artery disease-comparison with CT angiography. Neuroradiology 2016;58(9):845-851.
18. Freire CMV, Alcantara ML, Santos SN et al. Recomendação para quantificação pelo ultrassom da doença aterosclerótica das artérias carótidas e vertebrais:Grupo de trabalho do Departamento de Imagem Cardiovascular da Sociedade Brasileira de Cardiologia-DIC/ SBC. Arq Bras Cardiol: Imagem Cardiovasc 2015;28 (nº especial):1-64.
4. Ricotta JJ, Aburahma A, Ascher E et al. Updated Society for Vascular Surgery guidelines for management of extracranial carotid disease: executive summary. J Vasc Surg 2011;54(3):832-836.
16. Christopher T. Finite amplitude distortion-based inhomogeneous pulse echo ultrasonic imaging. IEEE Trans Ultrason Ferroelectr Freq Control 1997;44(1):125-139.
32. Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet 1998;351(9113):1379-1387. 33. Rothwell PM, Gibson RJ, Slattery J, Warlow CP. Prognostic value and reproducibility of measurements of carotid stenosis. A comparison of three methods on 1001 angiograms. European Carotid Surgery Trialists’ Collaborative Group. Stroke 1994;25(12):2440-2444.
5. Helfre M, Grange C, Riche B et al. Usefulness of a systematic screening of carotid atherosclerosis in asymptomatic people with type 2 diabetes for cardiovascular risk reclassification. Ann Endocrinol (Paris) 2017;78(1):14-19.
48. Wong YS, Ong CT, Sung SF et al. Association Between Abnormal Course of Carotid Artery and Cerebrovascular Disease. Acta Neurol Taiwan 2014;23(3):90-94.
63. Saba L, Tamponi E, Raz E et al. Correlation between fissured fibrous cap and contrast enhancement: preliminary results with the use of CTA and histologic validation. AJNR Am J Neuroradiol 2014;35(4):754-759.
50. Metz H, Murray-Leslie RM, Bannister RG et al. Kinking of the internal carotid artery. Lancet 1961;1(7174):424-426. 51. Togay-Isikay C, Kim J, Betterman K et al. Carotid artery tortuosity, kinking, coiling: stroke risk factor, marker, or curiosity? Acta Neurol Belg 2005;105(2):68-72.
52. Illuminati G, Ricco JB, Calio FG et al. Results in a consecutive series of 83 surgical corrections of symptomatic stenotic kinking of the internal carotid artery. Surgery 2008;143(1):134-139.
46. Beach KW, Leotta DF, Zierler RE. Carotid Doppler velocity measurements and anatomic stenosis: correlation is futile. Vasc Endovascular Surg 2012;46(6):466-474.
53. Preiss JE, Itum DS, Reeves JG et al. Carotid duplex criteria for patients with contralateral occlusion. J Surg Res 2015;193(1):28-32. Clevert DA, Kubisch C, Weckbach S et al. B-flow and color Doppler sonography findings in iatrogenic carotid-jugular arteriovenous fistula. Clin Hemorheol Microcirc 2010;44(1):19-25. Kakkos SK, Nicolaides AN, Kyriacou E et al. Computerized texture analysis of carotid plaque ultrasonic images can identify unstable plaques associated with ipsilateral neurological symptoms. Angiology 2011;62(4):317-328.
57. Nicolaides AN, Kakkos SK, Kyriacou E et al. Asymptomatic internal carotid artery stenosis and cerebrovascular risk stratification. J Vasc Surg 2010;52(6):1486-1496.e1481-1485.
64. Mughal MM, Khan MK, DeMarco JK et al. Symptomatic and asymptomatic carotid artery plaque. Expert Rev Cardiovasc Ther 2011;9(10):1315-1330.
68. Nicolaides A, Sabetai M, Kakkos SK et al. The Asymptomatic Carotid Stenosis and Risk of Stroke (ACSRS) study. Aims and results of quality control. Int Angiol 2003;22(3):263-272. 69. De Bray JM BJ, Dauzat JM. Consensus concerning the morphology and the risk of carotid plaques. Cerebrovasc Dis 1997;7:289-296. 70. Johnson JM, Kennelly MM, Decesare D et al. Natural history of asymptomatic carotid plaque. Arch Surg 1985;120(9):1010-1012.
75. Menezes F, Silveira T, Salles-Cunha S et al. Comparações preliminares entre a histologia virtual ultrassonográfica in vivo e os achados histopatológicos da placa carotídea produto de endarterectomia. J Vasc Bras 2013;12(3):193-201.
56. Petty GW, Brown RD Jr., Whisnant JP et al. Ischemic stroke subtypes: a population-based study of incidence and risk factors. Stroke 1999;30(12):2513-2516.
54.
80. Yuan J, Usman A, Das T et al. Imaging Carotid Atherosclerosis Plaque Ulceration: Comparison of Advanced Imaging Modalities and Recent Developments. AJNR Am J Neuroradiol 2017;38(4):664-671. 81. Mohebali J, Patel VI, Romero JM et al. Acoustic shadowing impairs accurate characterization of stenosis in carotid ultrasound examinations. J Vasc Surg 2015;62(5):1236-1244. 82. Mathiesen EB, Bonaa KH, Joakimsen O. Echolucent plaques are associated with high risk of ischemic cerebrovascular events in carotid stenosis: the tromso study. Circulation 2001;103(17):2171-2175. 83. Griffin MB, Kyriacou E, Pattichis C et al. Juxtaluminal hypoechoic area in ultrasonic images of carotid plaques and hemispheric symptoms. J Vasc Surg 2010;52(1):69-76. 84. Kakkos SK, Griffin MB, Nicolaides AN et al. The size of juxtaluminal hypoechoic area in ultrasound images of asymptomatic carotid plaques predicts the occurrence of stroke. J Vasc Surg 2013;57(3):609-618.e601; discussion 617-608. 85. AbuRahma AF, Wulu JT Jr., Crotty B. Carotid plaque ultrasonic heterogeneity and severity of stenosis. Stroke 2002;33(7):1772-1775. 86. Verhoeven B, Hellings WE, Moll FL et al. Carotid atherosclerotic plaques in patients with transient ischemic attacks and stroke have unstable characteristics compared with plaques in asymptomatic and amaurosis fugax patients. J Vasc Surg 2005;42(6):1075-1081.
47. Morimoto N, Morimoto K, Morimoto Y et al. Reverse diastolic flow in the common carotid artery in severe aortic regurgitation, causing brain ischemia. J Thorac Cardiovasc Surg 2008;135(5):1176-1177.
59. Griffin M, Nicolaides A, Kyriacou E. Normalisation of ultrasonic images of atherosclerotic plaques and reproducibility of grey scale median using dedicated software. Int Angiol 2007;26(4):372-377.
60. Huibers A, de Borst GJ, Wan S et al. Non-invasive Carotid Artery Imaging to Identify the Vulnerable Plaque: Current Status and Future Goals. Eur J Vasc Endovasc Surg 2015;50(5):563-572.
55.
76 Parte IIICERVICAL 37. Sherry-French, Burns K. Combination of Duplex Ultrasound Data Improves Positive Predictive Value for Carotid Stenoses Greater Than 70 Percent. J Vasc Ultrasound 2016;40(1):9-13. 38. Tahmasebpour HR, Buckley AR, Cooperberg PL, Fix CH. Sonographic examination of the carotid arteries. Radiographics 2005;25(6):1561-1575. 39. Yadav J. Functional occlusions of the carotid artery (string signs): to treat or not to treat? JACC Cardiovasc Intervent 2010;3(3):305-306. 40. Clair DG, Greenberg RK. Diagnosis and treatment of proximal carotid lesions. Semin Vasc Surg 2000;13(2):103-108. 41. Matos JM, Barshes NR, McCoy S et al. Validating common carotid stenosis by duplex ultrasound with carotid angiogram or computed tomography scan. J Vasc Surg 2014;59(2):435-439.
43.
67. Ostling G, Persson M, Hedblad B, Goncalves I. Comparison of grey scale median (GSM) measurement in ultrasound images of human carotid plaques using two different softwares. Clin Physiol Funct Imaging 2013;33(6):431-435.
42. Street DL, Ricotta JJ, Green RM, DeWeese JA. The role of external carotid revascularization in the treatment of ocular ischemia. J Vasc Surg 1987;6(3):280-282. Adel JG, Bendok BR, Hage ZA et al. External carotid artery angioplasty and stenting to augment cerebral perfusion in the setting of subacute symptomatic ipsilateral internal carotid artery occlusion. Case report. J Neurosurg 2007;107(6):1217-1222.
65. Gronholdt ML, Nordestgaard BG, Schroeder TV et al. Ultrasonic echolucent carotid plaques predict future strokes. Circulation 2001;104(1):68-73.
61. Saito H, Kuroda S, Hirata K et al. Validity of dual MRI and F-FDG PET imaging in predicting vulnerable and inflamed carotid plaque. Cerebrovasc Dis 2013;35(4):370-377.
44. Ascer E, Gennaro M, Pollina RM et al. The natural history of the external carotid artery after carotid endarterectomy: implications for management. J Vasc Surg 1996;23(4):582-585; discussion 585-586.
87. Sun J, Song Y, Chen H et al. Adventitial perfusion and intraplaque hemorrhage: a dynamic contrast-enhanced MRI study in the carotid artery. Stroke 2013;44(4):1031-1036. 88. Qiao Y, Etesami M, Astor BC et al. Carotid plaque neovascularization and hemorrhage detected by MR imaging are associated with recent cerebrovascular ischemic events. AJNR Am J Neuroradiol 2012;33(4):755-760. 89. Huang H, Virmani R, Younis H et al. The impact of calcification on the biomechanical stability of atherosclerotic plaques. Circulation 2001;103(8):1051-1056.
58. Geroulakos G, Ramaswami G, Nicolaides A et al. Characterization of symptomatic and asymptomatic carotid plaques using high-resolution real-time ultrasonography. Br J Surg 1993;80(10):1274-1277.
76. Malgor R, Wood E, Lavarone O, Labropoulos N. Stratifying risk: asymptomatic carotid disease. J Vasc Bras 2012;11(1):43-52.
74. Naqvi TZ, Lee MS. Carotid intima-media thickness and plaque in cardiovascular risk assessment. JACC Cardiovasc Imaging 2014;7(10):1025-1038.
72. Barros F, Prezotti B, Sandri G, Salles-Cunha S. Trombo Móvel na Carótida Interna: Planejamento Cirúrgico Definido pela Ultrassonografia Vascular. Arq Bras Cardiol: Imagem Cardiovasc 2013;26(4):335-340.
71. Muraki M, Mikami T, Yoshimoto T et al. New criteria for the sonographic diagnosis of a plaque ulcer in the extracranial carotid artery. AJR Am J Roentgenol 2012;198(5):1161-1166.
45. Bendick. P. Cardiac effects on peripheral vascular wave forms. J Vasc Ultrasound 2011;25(4):237-243.
49. Yu J, Qu L, Xu B et al. Current Understanding of Dolichoarteriopathies of the Internal Carotid Artery: A Review. Int J Med Sci 2017;14(8):772-784.
62. Brinjikji W, Huston J, 3rd, Rabinstein AA et al. Contemporary carotid imaging: from degree of stenosis to plaque vulnerability. J Neurosurg 2016;124(1):27-42.
73. Cires-Drouet RS, Mozafarian M, Ali A et al. Imaging of high-risk carotid plaques: ultrasound. Semin Vasc Surg 2017;30(1):44-53.
77. A AT, Kumar A, Gupta A etal. Ultrasound-Based Automated Carotid Lumen Diameter/Stenosis Measurement and its Validation System. J Vasc Ultrasound 2016;40(3):120-134.
78. O’Donnell TF Jr., Erdoes L, Mackey WC et al. Correlation of B-mode ultrasound imaging and arteriography with pathologic findings at carotid endarterectomy. Arch Surg 1985;120(4):443-449. 79. Sitzer M, Muller W, Rademacher J et al. Color-flow Doppler-assisted duplex imaging fails to detect ulceration in high-grade internal carotid artery stenosis. J Vasc Surg 1996;23(3):461-465.
66. Kingstone L, Torres C, Currie G. Systematic Literature Review of Ultrasonography for Morphology and Characterization of Vulnerable Carotid Artery Plaques. J Vasc Ultrasound 2012;36(3):191-198.
128. Randazzo M, Azuka C, Khariton K. Ultrasound-Guided Percutaneous Thrombin Injection of Common Carotid Pseudoaneurysm following Carotid Endarterectomy Is Possible. J Vasc Ultrasound 2016;40(1):35-37. 129. Millet JD, Cavallo JJ, Scoutt LM, Gunabushanam G. Sonographic Evaluation of Complications of Extracranial Carotid Artery Interventions. J Ultrasound Med 2018;37(3):769-781.
108. Tendera M, Aboyans V, Bartelink ML et al. ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). Eur Heart J 2011;32(22):2851-2906.
97. Saba L, Caddeo G, Sanfilippo R et al. CT and ultrasound in the study of ulcerated carotid plaque compared with surgical results: potentialities and advantages of multidetector row CT angiography. AJNR Am J Neuroradiol 2007;28(6):1061-1066.
105. Barnett HJM, Taylor DW, Haynes RB et al. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 1991;325(7):445-453.
111. Guay J, Ochroch EA. Carotid endarterectomy plus medical therapy or medical therapy alone for carotid artery stenosis in symptomatic or asymptomatic patients: a meta-analysis. J Cardiothorac Vasc Anesth 2012;26(5):835-844.
118. Kallmayer M, Tsantilas P, Zieger C et al. Ultrasound surveillance after CAS and CEA: what’s the evidence? J Cardiovasc Surg (Torino) 2014;55(2 Suppl 1):33-41.
125. Archie JP. The endarterectomy-produced common carotid artery step: a harbinger of early emboli and late restenosis. J Vasc Surg 1996;23(5):932-939. 126. Garg K, Rockman CB, Lee V et al. Presentation and management of carotid artery aneurysms and pseudoaneurysms. J Vasc Surg 2012;55(6):1618-1622.
99. Saito K, Nagatsuka K, Ishibashi-Ueda H et al. Contrastenhanced ultrasound for the evaluation of neovascularization in atherosclerotic carotid artery plaques. Stroke 2014;45(10):3073-3075.
119. Roth SM, Back MR, Bandyk DF et al. A rational algorithm for duplex scan surveillance after carotid endarterectomy. J Vasc Surg 1999;30(3):453-460.
130. Bamford J, Sandercock P, Dennis M et al. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 1991;337(8756):1521-1526.
106. Yuan J, Makris G, Patterson A et al. Relationship between carotid plaque surface morphology and perfusion: a 3D DCE-MRI study. Magma 2018;31(1):191-199.
109. Guidelines for patient selection and performance of carotid artery stenting. Intern Med J 2011;41(4):344-347.
103. Baradaran H, Al-Dasuqi K, Knight-Greenfield A et al. Association between Carotid Plaque Features on CTA and Cerebrovascular Ischemia: A Systematic Review and Meta-Analysis. AJNR Am J Neuroradiol 2017;38(12):2321-2326.
110. Orrapin S, Rerkasem K. Carotid endarterectomy for symptomatic carotid stenosis. Cochrane Database Syst Rev 2017;6:Cd001081.
115. Ascher E, Hingorani A, Marks N et al. Mini skin incision for carotid endarterectomy (CEA): a new and safe alternative to the standard approach. J Vasc Surg 2005;42(6):1089-1093.
117. Cull DL, Cole T, Miller B et al. The value of a carotid duplex surveillance program for stroke prevention. Ann Vasc Surg 2011;25(7):887-894.
112. Naylor AR, Gaines PA, Rothwell PM. Who benefits most from intervention for asymptomatic carotid stenosis: patients or professionals? Eur J Vasc Endovasc Surg 2009;37(6):625-632.
114. Montorsi P, Galli S, Ravagnani PM, Roffi M. Symptomatic Carotid Artery Disease: Revascularization. Prog Cardiovasc Dis 2017;59(6):601-611.
102. Saba L, Yuan C, Hatsukami TS et al. Carotid Artery Wall Imaging: Perspective and Guidelines from the ASNR Vessel Wall Imaging Study Group and Expert Consensus Recommendations of the American Society of Neuroradiology. AJNR Am J Neuroradiol 2018;39(2):E9-e31.
104. van den Bouwhuijsen QJA, Vernooij MW, Verhaaren BFJ et al. Carotid Plaque Morphology and Ischemic Vascular Brain Disease on MRI. AJNR Am J Neuroradiol 2017;38(9):1776-1782.
93. van den Bouwhuijsen QJ, Bos D, Ikram MA et al. Coexistence of Calcification, Intraplaque Hemorrhage and Lipid Core within the Asymptomatic Atherosclerotic Carotid Plaque: The Rotterdam Study. Cerebrovasc Dis 2015;39(5-6):319-324.
100. Abbott AL. Medical (nonsurgical) intervention alone is now best for prevention of stroke associated with asymptomatic severe carotid stenosis: results of a systematic review and analysis. Stroke 2009;40(10):e573-583.
90. Cheng GC, Loree HM, Kamm RD et al. Distribution of circumferential stress in ruptured and stable atherosclerotic lesions. A structural analysis with histopathological correlation. Circulation 1993;87(4):1179-1187.
95. Momjian-Mayor I, Kuzmanovic I, Momjian S et al. Accuracy of a novel risk index combining degree of stenosis of the carotid artery and plaque surface echogenicity. Stroke 2012;43(5):1260-1265.
101. Marquardt L, Geraghty OC, Mehta Z, Rothwell PM. Low risk of ipsilateral stroke in patients with asymptomatic carotid stenosis on best medical treatment: a prospective, population-based study. Stroke 2010;41(1):e11-17.
94. Hofman A, Brusselle GG, Darwish Murad S et al. The Rotterdam Study: 2016 objectives and design update. Eur J Epidemiol 2015;30(8):661-708.
98. Ten Kate GL, van den Oord SC, Sijbrands EJ et al. Current status and future developments of contrast-enhanced ultrasound of carotid atherosclerosis. J Vasc Surg 2013;57(2):539-546.
127. Adam EJ. Carotid Artery Aneurysm. J Vasc Ultrasound 2017;41(1):13-17.
91. Wahlgren CM, Zheng W, Shaalan W et al. Human carotid plaque calcification and vulnerability. Relationship between degree of plaque calcification, fibrous cap inflammatory gene expression and symptomatology. Cerebrovasc Dis 2009;27(2):193-200.
77Capítulo 41 eCoColor doPPler dA s C ArótidA s e vertebr Ais
120. Ricco JB, Camiade C, Roumy J, Neau JP. Modalities of surveillance after carotid endarterectomy: impact of surgical technique. Ann Vasc Surg 2003;17(4):386-392. 121. Aburahma AF. Duplex criteria for determining >/=50% and >/=80% internal carotid artery stenosis following carotid endarterectomy with patch angioplasty. Vascular 2011;19(1):15-20. 122. AbuRahma AF, Srivastava M, AbuRahma Z et al. The value and economic analysis of routine postoperative carotid duplex ultrasound surveillance after carotid endarterectomy. J Vasc Surg 2015;62(2):378-383. 123. Al Shakarchi J, Lowry D, Nath J et al. Duplex ultrasound surveillance after carotid artery endarterectomy. J Vasc Surg 2016;63(6):1647-1650. 124. Ascher E, Markevich N, Kallakuri S et al. Intraoperative carotid artery duplex scanning in a modern series of 650 consecutive primary endarterectomy procedures. J Vasc Surg 2004;39(2):416-420.
131. Caplan LR, Amarenco P, Rosengart A et al. Embolism from vertebral artery origin occlusive disease. Neurology 1992;42(8):1505-1512.
132. Nicolau C, Gilabert R, Chamorro A et al. Doppler sonography of the intertransverse segment of the vertebral artery. J Ultrasound Med 2000;19(1):47-53. 133. Buckenham TM, Wright IA. Ultrasound of the extracranial vertebral artery. Br J Radiol 2004;77(913):15-20. 134. Vicenzini E, Ricciardi MC, Sirimarco G et al. Extracranial and intracranial sonographic findings in vertebral artery diseases. J Ultrasound Med 2010;29(12):1811-1823. 135. Chuang YM, Chan L, Wu HM et al. The clinical relevance of vertebral artery hypoplasia. Acta Neurol Taiwan 2012;21(1):1-7. 136. Hua Y, Meng XF, Jia LY et al. Color Doppler imaging evaluation of proximal vertebral artery stenosis. AJR Am J Roentgenol 2009;193(5):1434-1438. 137. Kliewer MA, Hertzberg BS, Kim DH et al. Vertebral artery Doppler waveform changes indicating subclavian steal physiology. AJR Am J Roentgenol 2000;174(3):815-819.
116. Norris JW, Halliday A. Is ultrasound sufficient for vascular imaging prior to carotid endarterectomy? Stroke 2004;35(2):370-371.
113. Kakkos SK, Kakisis I, Tsolakis IA, Geroulakos G. Endarterectomy achieves lower stroke and death rates compared with stenting in patients with asymptomatic carotid stenosis. J Vasc Surg 2017;66(2):607-617.
92. Shaalan WE, Cheng H, Gewertz B et al. Degree of carotid plaque calcification in relation to symptomatic outcome and plaque inflammation. J Vasc Surg 2004;40(2):262-269.
96. Eliasziw M, Streifler JY, Fox AJ et al. Significance of plaque ulceration in symptomatic patients with high-grade carotid stenosis. North American Symptomatic Carotid Endarterectomy Trial. Stroke 1994;25(2):304-308.
107. Paraskevas KI, Mikhailidis DP, Veith FJ. Comparison of the five 2011 guidelines for the treatment of carotid stenosis. J Vasc Surg 2012;55(5):1504-1508.
14. Chen CJ, Lee TH, Hsu HL et al. Multi-Slice CT Angiography in Diagnosing Total Versus Near Occlusions of the Internal Carotid Artery. Comparison With Catheter Angiography. Stroke 2004 Jan;35(1):83-5. Epub 2003 Dec 18.
DOS VASOS
16. Wholey MH, Al-Mubarek N. Updated review of the global carotid artery stent registry. Catheter Cardiovasc Interv 2003;60:259-266.
REFERÊNCIAS BIBLIOGRÁFICAS
2. Bajzer CT. Thoracic aorta and the great vessels. Guide to Peripheral and Cerebrovascular Intervention. London: Remedica; 2004. 3. Wasty N, Abidi M, Tanwir A et al. Feasibility of the 3D RCA catheter to engage the brachiocephalic vessels during carotid angiography and stenting. Catheter Cardiovasc Interv 2011;77:742-745.
78 42Capítulo
7. Schulz UGR, Rothwell PM. Major variation in carotid bifurcation anatomy: a possible risk factor for plaque development? Stroke 2001;32(11):2522-2529.
11. Bladin CF, Alexandrov AV, Murphy J et al. Carotid Stenosis Index: A New Method of Measuring Internal Carotid Artery Stenosis. Stroke 1995;26:230-234.
17. Uchiyama N, Misaki K, Mohri M et al. Association between carotid plaque composition assessed by multidetector computed tomography and cerebral embolism after carotid stenting. Neuroradiology 2012 May;54(5):487-93.
1. Baadh A, Rockman C, Mitnick J, Robin, Lim R. Bovine arch and carotid artery atherosclerosis: Are they related? Clinical Imaging 2014;38(5):681-5.
8. Ferguson GG, Eliasziw M, Barr HW et al. The North American Symptomatic Carotid Endarterectomy Trial: surgical results in 1415 patients. Stroke 1999;30:1751–58. 9. Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet 1998;351(9113):1379-1387.
18. Misaki K, Uchiyama N, Mohri M et al. Prediction of carotid artery in-stent restenosis by quantitative assessment of vulnerable plaque using computed tomography. J Neuroradiol 2016 Feb;43(1):18-24.
12. Bartlett ES, Walters TD, Symons SP et al. Carotid Stenosis Index Revisited with Direct CT Angiography Measurement of Carotid Arteries to Quantify Carotid Stenosis. Stroke 2007 Feb;38(2):286-291.
15. CAVATAS Investigators. Endovascular versus surgical treatment in patients with carotid stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): a randomised trial. Lancet 2001;357:1729-1737.
5. Tsantilas P, Kuehnl AB, Erich E et al. Anatomic criteria determining high-risk carotid surgery patients. J Cardiovasc Surg 2017:58:152-160.
ANGIOTOMOGRAFIA CERVICAIS
20. Schievink WI. Spontaneous dissection of the carotid and vertebral arteries. N Engl J Med 2001;344:898-906. 21. Rouhart F, Zagnoli F, Goas JY, Mocquard Y. Cerebral ischemic arterial accidents in young adults. 40 cases. Rev Neurol (Paris) 1993;149:547-53. 22. James M, Provenzale and Basar Sarikaya. Comparison of test performance characteristics of MRI, MR Angiography, and CT Angiography in the Diagnosis of Carotid and Vertebral Artery Dissection: A Review of the Medical Literature. AJR 2009 Oct;192(4):1167-1174. 23. Rodallec MH, Marteau V, Gerber S et al. Craniocervical Arterial Dissection: Spectrum of Imaging Findings and Differential Diagnosis. RadioGraphics 2008;28:1711-172. 24. Pasquini M, Trystram D, Oppenheim C et al. Dysplasie fibromusculaire cervicale et intracrânienne. Press Med 2011;40:713-719. 25. Houser OW, Baker HL . Fibromuscular dysplasia and other uncommon diseases of the cervical carotid artery: angiographic aspects. Am J Roentgenol Radium Ther Nucl Med 1968;104(1):201-21. 26. Olin JW, Froehlich J, Gu X et al.The United States Registry for Fibromuscular Dysplasia: results in the first 447 patients. Circulation 2012;125(25):3182-3190. 27. Harrison EG Jr, McCormack LJ.Pathologic classification of renal arterial disease in renovascular hypertension. Mayo Clin Proc 1971;46(3):161-167. 28. Stanley J. Renal artery fibrodysplasia. In: Novick A, Scoble J, Hamilton G eds. Renal Vascular Disease. London: WB Saunders; 1996. p. 21-23. 29. Kincaid OW, Davis GD, Hallermann FJ, Hunt JC. Fibromuscular dysplasia of the renal arteries. Arteriographic features, classification, and observations on natural history of the disease. Am J Roentgenol Radium Ther Nucl Med 1968;104(2):271-282. 30. Pannier-Moreau I, Grimbert P, Fiquet-Kempf B et al.Possible familial origin of multifocal renal artery fibromuscular dysplasia. J Hypertens 1997;15(12 Pt 2):1797-1801. 31. Touze E, Oppenheim C, Trystram D et al .Fibromuscular dysplasia of cervical and intracranial arteries. Int J Stroke 2010;5(4):296-305. 32. Debette S, Leys D.Cervical-artery dissections: predisposing factors, diagnosis, and outcome. Lancet Neurol 2009;8(7):668-678. 33. Cloft HJ, Kallmes DF, Kallmes MH et al. Prevalence of cerebral aneurysms in patients with fibromuscular dysplasia: a reassessment. J Neurosurg 1998;88(3):436-440. 34. Erickson D, Kudva YC, Ebersold MJ et al. Benign paragangliomas: Clinical presentation and treatment outcomes in 236 patients. J Clin Endocrinol Metab 2001;86(11):5210-5216. 35. Santos RJ, Domingues R, Nontalvão P et al. Paraganglioma, caracterização clínica e funcional de 40 casos. Rev Port Endocrinol Diabetes Metabol 2012. 36. Shamblin WR, ReMine WH, Sheps SG, Harrison EG Jr. Carotid body tumor (chemodectoma). Clincopathologic analysis of ninety cases. Am J Surg 1971;122(6):732-9.
6. Ozgur Z, Govsa F, Ozgur T. Anatomic evaluation of the carotid artery bifurcation in cadavers: implications for open and endovascular therapy. Surg Radiol Anat 2008;30(6):475-480.
19. Gorlitzer M, Heine B, Mendel H et al. Redo surgery for carotid artery stenosis: when and how? Cardiovasc Surg 2000;8:366–371.
10. 2011ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVSGuidelineontheManagementofPatientswithExtracranialCarotidandVertebralArteryDisease;2011.
13. Bartlett ES, Walters TD, Symons SP, Fox AJ. Quantification of carotid stenosis on CT angiography. AJNR Am J Neuroradiol 2006;27:13-19.
4. McNamara JR, Fulton GJ, Manning BJ. Three-dimensional computed tomographic reconstruction of the carotid artery: identifying high bifurcation. Eur J Vasc Endovasc Surg 2015;49(2):147-153.
9. Fitzpatrick LA, Berkovitz N, Dos Santos MP et al. Vulnerable carotid plaque imaging and histopathology without a dedicated MRI receiver coil. Neuroradiol J 2017;30(2):120-8.
5. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 1991;325(7):445-53.
15. Varennes L, Tahon F, Kastler A et al. Fibromuscular dysplasia: what the radiologist should know: a pictorial review. Insights Imaging 2015;6(3):295-307.
79
16. Choi PM, Singh D, Trivedi A et al. Carotid Webs and Recurrent Ischemic Strokes in the Era of CT Angiography. AJNR Am J Neuroradiol 2015;36(11):2134-9.
ANGIORRESSONÂNCIA BIBLIOGRÁFICAS
8. Brinjikji W, Huston J 3rd, Rabinstein AA et al. Contemporary carotid imaging: from degree of stenosis to plaque vulnerability. J Neurosurg 2016;124(1):27-42.
43Capítulo
10. Rafailidis V, Chryssogonidis I, Tegos T et al. Imaging of the ulcerated carotid atherosclerotic plaque: a review of the literature. Insights Imaging 2017;8(2):213-25.
3. Adla T, Adlova R. Multimodality Imaging of Carotid Stenosis. Int J Angiol 2015 Sep;24(3):179-84.
11. Haider AS, Gottlich C, Osumah T et al. Delayed Endovascular Stenting for Severe Vertebral Artery Stenosis with Precarious Thrombosis. Cureus 2017;9(5):e1277.
12. Maravilla KR, Chu B. MR angiography of extracranial carotid and vertebral arteries. In: Schneider G, Prince MR,Meaney JFM, Ho VB eds. Magnetic Resonance Angiography. Techniques, indications and practical applications. Springer; 2005. p. 81-102.
13. Touzé E, Oppenheim C, Trystram D et al. Fibromuscular dysplasia of cervical and intracranial arteries. Int J Stroke 2010;5(4):296-305.
17. Robertson JJ, Koyfman A. Cervical Artery Dissections: A Review. J Emerg Med 2016;51(5):508-18
18. Schicho A, Luerken L, Meier R et al. Incidence of traumatic carotid and vertebral artery dissections: results of cervical vessel computed tomography angiogram as a mandatory scan component in severely injured patients. Ther Clin Risk Manag 2018;14:173-8.
1. Sasson AD, Wasserman BA. Cervical Vasculature. In: Rubin GD, Rofsky NM eds. CT and MR angiography: Comprehensive vascular assessment Philadelphia, PA: Lippincott Williams & Wilkins; 2009. p. 449-81.
7. Lettau M, Sauer A, Heiland S et al. Carotid artery stents: in vitro comparison of different stent designs and sizes using CT angiography and contrast-enhanced MR angiography at 1.5T and 3T. AJNR Am J Neuroradiol 2009;30(10):1993-7.
14. O’Connor SC, Poria N, Gornik HL. Fibromuscular dysplasia: an update for the headache clinician. Headache 2015;55(5):748-55.
4. European Carotid Surgery Trialists’ Collaborative Group. MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis. Lancet 1991;337(8752):1235-43.
6. Bladin CF, Alexandrov AV, Murphy J et al. Carotid Stenosis Index. A new method of measuring internal carotid artery stenosis. Stroke 1995;26(2):230-4.
2. Benjamin EJ, Blaha MJ, Chiuve SE et al. Heart disease and stroke statistics—2017 update: a report from the American Heart Association. Circulation 2017;135(10):e146-e603.
MAGNÉTICA DOS VASOS CERVICAIS REFERÊNCIAS
80 44Capítulo ANGIOGRAFIA DOS VASOS CERVICAIS REFERÊNCIAS BIBLIOGRÁFICAS 1. Osborn, AG. Diagnostic Neuroradiology. Washington: Mosby; 1994. p. 18-32. 2. Peixoto, CCS, Rossi, M. Trauma Vascular. Rio de Janeiro: Revinter; 2006. p. 174-188. 3. Peixoto, CCS, Brito,CJ. Cirurgía Endovascular e Angiologia. Rio de Janeiro: Revinter; 200. p. 396-416. 4. Peixoto,CCS. Brito CJ. Cirurgia Endovascular e Angiologia. Rio de Janeiro: Revinter; 2014. p. 527-534. 5. Rutherford, RB. Vascular Surgery. Colorado: Saunders; 1989. p. 25-36.
15. Nordanstig J et al. National experience with extracranial carotid artery aneurysms: epidemiology, surgical treatment strategy, and treatment outcome. Ann Vasc Surg 2014;28(4):882-886.
45.
48.
22. Van Den Berg JC, Engelberger S. Endovascular treatment of extracranial carotid artery aneurysms. J Cardiovasc Surg (Torino) 2015;56:547-557.
17. Cina C, Althani H, Pasenau J et al. Kommerell’s diverticulum and rightsided aortic arch: A cohort study and review of the literature. J Vasc Surg 2004;39:131-39.
40.
44.
7. Wickham J, Martin P. Aneurysm of the subclavian artery in association with cervical abnormality. Br J Surg 1963;50:205-9.
24. Tabata M, Kitagawa T, Saito T et al. Extracranial carotid aneurysm in Takayasu’s arteritis. J Vasc Surg 2001;34:739-42.
ANEURISMAS DOS VASOS CERVICAIS BIBLIOGRÁFICAS
10. Pulli R, Dorigo W, Innocenti A et al. A 20-year experience with surgical management of true and false internal carotid artery aneurysms. Eur J Vasc Endovasc Surg 2013;45(1):1-6.
4. Silvestre L, Fernandes RF, Gimeìnez J et al. Degenerative carotid aneurysm presented with disphagia. Angiol Cir Vasc 2010;6(4):202-6. 5. Reid M. Aneurysms in the John Hopkins Hospital. Arch Surg 1926;12:1. 6. Cury M, Greenberg R, Morales J et al. Supra-aortic vessels aneurysms: Diagnosis and prompt intervention. J Vasc Surg 2009;49:4-10.
12. Hobson II R, Isreal M, Lynch T. Axilosubclaveian arterial aneurysms. In: Bergan J, Yao J. (Eds.). Aneurysms – Diagnosis and treatment. New York: Grune and Strataon; 1982.
19. Cury M, Greenberg R, Morales J et al. Supra-aortic vessels aneurysms: Diagnosis and prompt intervention. J Vasc Surg 2009;49:4-10. 20. Welleweerd JC, den Ruijter HM, Nelissen BG et al. Management of extracranial carotid artery aneurysm. Eur J Vasc Endovasc Surg 2015;50:141-147.
2. Jong KP et al. Extracranial carotid artery aneurysms. Eur J Vasc Surg 1989;3:557-562. 3. Rosset E, Albertini JN, Magnan PE et al. Surgical treatment of extracranial internal carotid artery aneurysms. J Vasc Surg 2000;31(4):713-23.
1. Welling RE, Taha A, Goel T et al. Extracranial carotid artery aneurysms. Surgery 1983;93:319-323.
9. Zhou W, LinP, Bush R et al. Carotid artery aneurysm: evolution of management over two decades. J Vasc Surg 2006;43:493-96.
27. Hertzer N. Extracranial carotid aneurysms: a new look at an old problem. J Vasc Surg 2000;31:823-25. 28. DeJong K, Zondrvan P, van Hurk H. Extracranial carotid aneurysms. Eur J Vasc Surg 1989;3:557-62. 29. Slovut D, Olin J. Fibromuscular dysplasia. N Engl J Med 2004;350:1862-71. 30. Vierhout B, Zeebregts C, van den Dungen J et al. Changing profiles of diagnostic and treatment options in subclavian artery aneurysms. Eur J Vasc Endovasc Surg 2010;40:27-34. 31. Xu C et al. Aneurysmal and occlusive atherosclerosis of the human abdominal aorta. J Vasc Surg 2001;33:91-96. 32. Zarins CK et al. Atherosclerotic enlargement of the human abdominal aorta. Atherosclerosis 2001;155:157-164. 33. Shipley AM et al. Aneurysm in the cervical portion of the internal carotid artery: an analytical study of the cases recorded in the literature between August 1, 1925, and July 31, 1936. 34. Jarrett M, Libertiny G, Gould S et al. Carotid artery aneurysm in a child with tuberous sclerosis. Eur J Vasc Endovasc Surg 1998;16:80-81. 35. Berard X, Corpataux JM, Taoufiq H et al. Don’t trust a vein graft to treat carotid aneurysm in patients with Behçet disease. J Vasc Surg 2010;52:471-74. 36. Kieffer E, Chiche L, Koskas F et al. Aneurysms of the innominate artery: Surgical treatment of 27 patients. J Vasc Surg 2001;34:222-28. 37. Bouarhroum A, Sedki N, Bouziane Z et al. Extracranial carotid aneurysm in Behçet disease: Report of two new cases. J Vasc Surg 2006;43:627-30. 38. Singh R, Barry M, Ireland A et al. Current diagnosis and management of blunt internal carotid artery injury. Eur J Vasc Endovasc Surg 2004;27:577-84. 39. Moulakakis K, Mylonas S, Avgerinos E et al. An Update of the role of endovascular repair in blunt carotid artery trauma. Eur J Vasc Endovasc Surg 2010;40:312-19. Donas K, Schulte S, Pitoulias G et al. Surgical outcome of Degenerative versus postreconstructive extracranial carotid artery aneurysms. J Vasc Surg 2009;49:93-98. 41. Lane RJ, Weisman RA. Carotid artery aneurysms: an otolaryngologic perspective. Laryngoscope 1980;90:897-911. 42. Worley GA, Hern JD, O’Sullivan GJ et al. Mycotic aneurysm of the external carotid artery. J Laryngol Otol 1998;112(8):793-95. Pickering GW. On the clinical recognition of structural disease of the peripheral vessels. Br Med J 1933;16(2):1106-10. Symonds CP. Cervical rib: thrombosis of subclavian artery. Contralateral Hemiplegia of sudden onset, probably embolic. Proc R Soc Med 1927 June;20(8):1244-45. Zhou W, Lin PH, Bush RL et al. Carotid artery aneurysm: evolution of management over two decades. J Vasc Surg 2006;43:493-496. Li Z, Chang G, Yao C et al. Endovascular stenting of extracranial carotid artery aneurysm: a systematic review. Eur J Vasc Endovasc Surg 2011;42:419-426. 47. Garg K, Rockman CB, Lee V et al. Presentation and management of carotid artery aneurysms and pseudoaneurysms. J Vasc Surg 2012;55:1618-1622. Wickham J, Martin P. Aneurysm of the subclavian artery in association with cervical abnormality. Br J Surg 1963;50:205-9. Peck A, Mercier C, Thomassin J et al. Surgical access to the distal cervical internal carotid artery. J Fr Otorrhino-Laryngol 1983;32:401.
25. Berard X, Corpataux JM, Taoufiq H et al. Don’t trust a vein graft to treat carotid aneurysm in patients with Behçet disease. J Vasc Surg 2010;52:471-74. 26. Zhou W, Lin P, Bush R et al. Carotid artery aneurysm: evolution of management over two decades. J Vasc Surg 2006;43:493-96.
8. El-Sabrout R, Cooley D. Extracranial carotid artery aneurysms: Texas Heart Institute experience. J Vasc Surg 2000;31:702-12.
46.
16. Coldwell DM et al. Treatment of posttraumatic internal carotid arterial pseudoaneurysms with endovascular stents. J Trauma 2000;48:470-472.
14. Attigah N, Kulkens S, Zausig N et al. Surgical therapy of extracranial carotid artery aneurysms: long-term results over a 24-year period. Eur J Vasc Endovasc Surg 2009;37:127-133.
18. Yang C, Shu C, Li M et al. Aberrant subclavian artery pathologies and kommerell’s diverticulum: a review and analysis of published endovascular/hybrid treatment options. J Endovasc Ther 2012;19:373-82.
23. Kieffer E, Chiche L, Koskas F et al. Aneurysms of the innominate artery: Surgical treatment of 27 patients. J Vasc Surg 2001;34:222-28.
43.
49.
21. Pourier VE, De Borst GJ. Which carotid artery aneurysms need to be treated (and how)? J Cardiovasc Surg (Torino) 2016;57:152-157.
81 45Capítulo
11. Bower TC, Pairolero PC, Hallett Jr JW et al. Brachiocephalic aneurysm: the case for early recognition and repair. Ann Vasc Surg 1991;5(2):125-32.
REFERÊNCIAS
13. Douglas DA, Adelman MA, Esposito R et al. Surgical repair of a left subclavian artery aneurysm causing stenosis of a left internal mammary graft-a case report. Vasc Endovascular Surg 2005;39(3):281-85.
51. Berard X, Corpataux JM, Taoufiq H et al. Don’t trust a vein graft to treat carotid aneurysm in patients with Behçet disease. J Vasc Surg 2010;52:471-74.
58. Szopinski P, Ciostek P, Kielar M et al. A series of 15 patients with extracranial carotid artery aneurysms: surgical and endovascular treatment. Eur J Vasc Endovasc Surg 2005;29:256-61.
62. Li Z, Chang G, Yao C et al. Endovascular stenting of extracranial carotid artery aneurysm: a systematic review. Eur J Vasc Endovasc Surg 2011;42(4):419-26.
73. Sumimura J, Nakao K, Miyata M et al. Vertebral aneurysm of the neck. J Cardiovasc Surg (Torino) 1988;29:63-5. 74. Chyatte D, Elefteriades J, Kim B. Profound hypothermia and circulatory arrest for aneurysm surgery. Case report. J Neurosurg 1989;70:489-91.
75. Wakui K, Kobayashi S, Takemae T et al. Large thrombosed vertebral artery aneurysm managed with extracranial-intracranial bypass surgery and aneurysmectomy. Case report. J Neurosurg 1992;77:624-7.
54. Ktenidis K, Lioupis A, Megalopoulos A et al. New exposure technique for management of giant internal carotid artery aneurysm. J Vasc Surg 2011;54:522-25. 55. Davidovic L, Kostic D, Maksimovic Z et al. Carotid artery aneurysms. Vascular 2004;12(3):166-70.
66. Kieffer E, Chiche L, Koskas F, Bahnini A. Aneurysms of the innominate artery: surgical treatment of 27 patients. J Vasc Surg 2001;2:222-228. 67. Garcia-Porrua C, Pego-Reigosa R, Piñeiro A et al. Supraclavicular pulsatile mass as presenting sign of brachiocephalic trunk aneurysm in the long-term follow-up of giant cell arteritis. Arthritis Rheum 2005;53(3):475-6.
56. Brock RC. Astley cooper and carotid artery ligation. Guys Hosp Rep 1968;117(3):219-24. In: Rutherford Vascular Surgery. 6th ed. Philadelphia: Elsevier Saunders; 2005. 57. Faggioli G, Freyre A, Stella A et al. Extracranial internal carotid artery aneurysms: Results of a surgical series with long-term follow-up. J Vasc Surg 1996;23:587-95.
52. Symonds CP. Cervical rib: thrombosis of subclavian artery. Contralateral Hemiplegia of sudden onset, probably embolic. Proc R Soc Med 1927 June;20(8):1244-45.
63. Kraus TW, Paetz B, Richter GM, Allenberg JR. The isolated posttraumatic aneurysm of the brachiocephalic artery after blunt thoracic contusion. Ann Vasc Surg 1993;7:275-81. 64. Tiesenhausen K, Amann W, Thalhammer M, Koch G. Posttraumatic aneurysm of the brachiocephalic trunk: a rare injury. Unfallchirurg 1999;102:808-810.
71. Yasui T, Komiyama M, Nishikawa M et al. Fusiform vertebral artery aneurysms as a cause of dissecting aneurysms. Report of two autopsy cases and a review of the literature. J Neurosurg 1999;91:139-44.
87.
82 Parte IIICERVICAL
68. Amaral JF, Dr. Grigoriev, Dorfman GS, Carney WI Jr. Pseudo-aneurisma da artéria vertebral. Uma complicação rara da cateterização da artéria subclávia. Arch Surg 1990;125:546-7.
77. MacSweeney ST, Holden A, Harltley D, Lawrence-Brown M. Endovascular repair of subclavian artery aneurysm. J Vasc Surg 1996;24:304-305. 78. Tassiopoulos AK, Nadalin BA, Labropoulos N et al. Endovascular repair of a symptomatic subclavian artery aneurysm in a patient with marfan syndrome: A case report. Vasc Endovascular Surg 2006;40:409-413. 79. Li L, Yu H, Qi Y et al. Simultaneous kissing stent technique with stent grafts for subclavian artery aneurysm: A case report. Ann Vasc Surg 2015;29:1316. e1317-1319. 80. McCann RL. Basic data related to peripheral artery aneurysms. Ann Vasc Surg 1990;4:411-414. 81. Tabata M, Kitagawa T, Saito T et al. Extracranial carotid aneurysm in Takayasu’s arteritis. J Vasc Surg 2001;34:739-742. 82. Smith BL, Munschauer CE, Diamond N, Rivera F. Ruptured internal carotid aneurysm resulting from neurofibromatosis: Treatment with intraluminal stent graft. J Vasc Surg 2000;32:824-828. 83. Welleweerd JC, Moll FL, de Borst GJ. Technical options for the treatment of extracranial carotid aneurysms. Expert Rev Cardiovasc Ther 2012;10:925-931. 84. Coldwell DM, Novak Z, Ryu RK et al. Treatment of posttraumatic internal carotid arterial pseudoaneurysms with endovascular stents. J Trauma 2000;48:470-472. 85. Welleweerd JC, de Borst GJ, de Groot D et al. Bare metal stents for treatment of extracranial internal carotid artery aneurysms: Longterm results. J Endovasc Ther 2015;22:130-134. 86. Miyachi S, Ishiguchi T, Taniguchi K et al. Endovascular stenting of a traumatic dissecting aneurysm of the extracranial internal carotid artery--case report. Neurol Med Chir (Tokyo) 1997;37:270-274. Li Z, Chang G, Yao C et al. Endovascular stenting of extracranial carotid artery aneurysm: A systematic review. Eur J Vasc Endovasc Surg 2011;42:419-426.
50. Jarrett M, Libertiny G, Gould S et al. Carotid artery aneurysm in a child with tuberous sclerosis. Eur J Vasc Endovasc Surg 1998;16:80-81.
60. Bakoyiannis CN, Georgopoulos SE, Tsekouras NS et al. Surgical management of extracranial internal carotid aneurysms by cervical approach. ANZ J Surg 2006;76(7):612-17.
61. Radak D, Davidoviæ L, Vukobratov V et al. Carotid artery aneurysms: Serbian multicentric study. Ann Vasc Surg 2007;21(1):23-29.
72. Blickenstaff KL, Weaver FA, Yellin AE et al. Trends in the management of traumatic vertebral artery injuries. Am J Surg 1989;158:101-6.
76. Becker GJ, Benenati JF, Zemel G et al. Percutaneous placement of a balloon-expandable intraluminal graft for life-threatening subclavian arterial hemorrhage. J Vasc Interv Radiol 1991;2:225-229.
53. Caparrelli D, Tabulov D, Freischlag J. Subclavian artery aneurysm secondary to cervical rib. Arch Surg 2006;141:513-14.
59. Davidovic L, Kostic D, Maksimovic Z et al. Carotid artery aneurysms. Vascular 2004;12(3):166-70.
69. Anand VK, Raila FA, McAuley JR, Reed JM. Large pseudoaneurysm of the extracranial vertebral artery. Otolaryngol Head Neck Surg 1993;109:1057-60. 70. Reid JD, Weigelt JA. Forty-three cases of vertebral artery trauma. J Trauma 1988;28:1007-12.
65. Yamashiro S, Ilha K, Horikawa Y et al. A case of traumatic aneurysm of the brachiocephalic artery. Jpn J Thorac Cardiovasc Surg 1998;46:889-92.
15. Falk E. Coronary plaque disruption. Circulation 1995;92:657-71.
16. Rohde LE, Lee RT. Pathophysiology of atherosclerotic plaque development and rupture: an overview. Sem Vasc Med 2003;3(4):347-54.
3. Naylor R. Why is the management of asymptomatic carotid disease so controversial? Surgeon 2015;13(1):34-43.
41. Sutton-Tyrrell K, Wolfson Jr SK, Kuller LH. Blood pressure treatment slows the progression of carotid stenosis in patients with isolated systolic hypertension. Stroke 1994;25(1):44-50.
2. Ay H, Arsava EM, Andsberg G et al. Pathogenic ischemic stroke phenotypes in the NINDS-stroke genetics network. Stroke 2014;45(12):3589-96.
6. Bensenor I, Goulart AC, Szwarcwald SL. Prevalência de acidente vascular cerebral e de incapacidade associada no Brasil: Pesquisa Nacional de Saúde – 2013. Arq NeuroPsiqui 2015;73(9):1-5.
4. Wolfe CD. The impact of stroke. Br Med Bull 2000;56(2):275-86.
22. Rudd JH, Warburton EA, Fryer TD et al. Imaging atherosclerotic plaque inflammation with [18F]fluorodeoxyglucose positron emission tomography. Circulation 2002;105(23):2708-11.
32. Gupta A, Marshal RS. Moving beyond luminal stenosis: imaging strategies for stroke prevention in asymptomatic carotid stenosis. Cerebrovasc Dis 2015;39(5-6):253-61. 33. Brott TG, Halperin JL, Abbara S et al. ASA/ACCF/AHA/AANN/AANS/ ACR/ASNR/ CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guidelines on the management of patients with extracranial carotid and vertebral artery disease. J Am Coll Cardiol 2011;124(4):489-532.
11. Störk S, van den Beld AW, von Schacky C et al. Carotid artery plaque burden, stiffness, and mortality risk in elderly men: a prospective, population-based cohort study. Circulation 2004;110(3):344-8.
20. Altaf N, Kandiyil N, Hosseini A et al. A comparative study of carotid plaque morphology microemboli Risk factors associated with cerebrovascular recurrence in symptomatic carotid disease assessment and the European Carotid Surgery Trial risk model. J Am Heart Assoc 2014;3(3):e000173.
25. Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial. Lancet 1998;351(9113):1379-87.
38. Abbott AL. Medical (nonsurgical) intervention alone is now best for prevention of stroke associated with asymptomatic severe carotid stenosis: results of a systematic review and analysis. Stroke 2009;40(10):e573-83
14. Kistler JP, Ropper AH, Heros RC. Therapy of ischemic cerebral vascular disease due to atherothrombosis. N Engl J Med 1984;311(2):100-5.
7. Gowers WR. On a case of simultaneous embolism of central retinal and middle cerebral arteries. Lancet 1875;794-96.
18. Takaya N, Yuan C, Chu B et al. Association between carotid plaque characteristics and subsequent ischemic cerebrovascular events: a prospective assessment with MRI--initial results. Stroke 2006;37(3):818-23.
19. Saam T, Hetterich H, Hoffmann V et al. Meta-analysis and systematic review of the predictive value of carotid plaque hemorrhage on cerebrovascular events by magnetic resonance imaging. J Am Coll Cardiol 2013;62(12):1081-1091.
8. Fisher M. Occlusion of the internal carotid artery. Arch Neurol Psych 1951;65(3):346. 9. Ku DN, Giddens DP. Hemodynamics of the normal human carotid bifurcation: in vitro and in vivo studies. Ultrasound Med Biol 1985;11(1):13-26. 10. Hollander M, Bots ML, Del Sol AI et al. Carotid plaques increase the risk of stroke and subtypes of cerebral infarction in asymptomatic elderly: the Rotterdam study. Circulation 2002;105(24):2872-7.
23. Flaherty ML, Kissela B, Khoury JC et al. Carotid artery stenosis as a cause of stroke. Neuroepidemiol 2013;40(1):36-41.
1. Truelsen T, Begg S, Mathers C. The global burden of cerebrovascular disease. World Health Organization, 2000. healthinfo/statistics/bod_cerebrovasculardiseasestroke.pdf.http://www.who.int/
27. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis. JAMA 1995;273(18):1421-8.
5. Bejot Y, Benatru I, Rouaud P et al. Epidemiology of stroke in Europe: Geographic and environmental difference. J Neurol Sci 2007;262(1-2):85-8.
36. Halliday AW, Thomas D, Mansfield A. The Asymptomatic Carotid Surgery Trial – (ACST). Eur J Vasc Surg 1995;14(1):18-20. 37. Halliday A, Harrison M, Hayter E et al. 10-year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis (ACST-1). Lancet 2010;376(9746):1074-84.
28. Oates C, Naylor AR, Hartshorne T et al. Reporting carotid ultrasound investigations in the United Kingdom. Eur J Vasc Endovasc Surg 2009;37(3):251-61. 29. Jonas DE, Feltner C, Amick HR et al. Screening for asymptomatic carotid stenosis; a systematic review and meta-analysis for the US Preventive Taskforce. Ann Int Med 2014;161(5):336-46.
39. Marquardt L, Geraghty OC, Mehta Z, Rothwell PM. Low risk of ipsilateral stroke in patients with asymptomatic carotid stenosis on best medical treatment: a prospective, population-based study. Stroke 2010;41(1):e11-7. 40. Paraskevas KI, Kalmykov EL, Naylor AR. Stroke/death rates following carotid artery stenting and carotid endarterectomy in contemporary administrative dataset registries: a systematic review. Eur J Vasc Endovasc Surg 2016;51(1):3-12.
42. Mancia G, Fagard R, Narkiewicz K. ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the
83 46CapítuloLESÕES OBSTRUTIVAS DAS CARÓTIDAS EXTRACRANIANAS REFERÊNCIAS BIBLIOGRÁFICAS
12. Fisher CM. Observations of the fundus oculi in transient monocular blindness. Neurology 1959;9(5):333-47. 13. Fisher CM, Karnes WE. Local embolism. J Neuropathol Experim Neurol 1965;24:174.
30. Gray-Weale AC, Graham JC, Burnett JR et al. Carotid artery atheroma: comparison of preoperative B-mode ultrasound appearance with carotid endarterectomy specimen pathology. J Cardiovasc Surg 2009;29(6):676-81. 31. Geroulakos G, Ramaswami G, Nicolaides A et al. Characterisation of symptomatic and asymptomatic carotid plaques in high-resolution real time ultrasonography. Br J Surg 1993;80(10):1274-7.
21. Mallat Z, Nakamura T, Ohan J et al. The relationship of hydroxyeicosatetraenoic acids and F2-isoprostanes to plaque instability in human carotid atherosclerosis. J Clin Invest 1999;103(3):421-7.
17. Lovett JK, Gallagher PJ, Hands LJ et al. Histological correlates of carotid plaque surface morphology on lumen contrast imaging. Circulation 2004;110(15):2190-7.
34. Ricotta JJ, Aburahma A, Ascher E et al. Updated Society for Vascular Surgery guidelines for management of extracranial carotid disease. J Vasc Surg 201154(3):e1-31. 35. Wardlaw JM, Chappell FM, Stevenson M et al. Accurate, practical and cost-effective assessment of carotid stenosis in the UK. Health Tech Assess 2006;10(30):iii-iv, ix-x, 1-182.
26. Ferguson GG, Eliasziw M, Barr HW et al. The North American Symptomatic Carotid Endarterectomy Trial: surgical results in 1415 patients. Stroke 1999;30(9):1751-8.
24. Rothwell PM, Eliasziw M, Gutnikov SA et al. Carotid Endarterectomy Trialists Collaboration. Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. Lancet 2014;363(9413):915-24.
64. Paraskevas KI, Veith FJ, Spence JD. How to identify which patients with asymptomatic carotid stenosis could benefit from endarterectomy or stenting. Stroke Vasc Neurol 2018;0:e000129.
59. Meschia JF, Bushnell C, Boden-Albala B et al. Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2014;45(12):3754-832.
55. Shahidi S, Owen-Falkenberg A, Gottschalksen B et al. Risk of early recurrent stroke in symptomatic carotid stenosis after best medical therapy and before endarterectomy. Int J Stroke 2016;11(1):41-51.
80. Mas JL, Trinquart L, Leys D et al. Endarterectomy Versus Angioplasty in Patients with Symptomatic Severe Carotid Stenosis (EVA 3S TRIAL): results up to 4 years from a randomised multicentre trial. Lancet Neurol 2008;7(10):885-92.
84 Parte IIICERVICAL management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypert 2013;31(7):1281-357.
62. Conrad MF, Boulom V, Baloum V et al. Progression of asymptomatic carotid stenosis despite optimal medical therapy. J Vasc Surg 2013;58(1):128-35.e1.
47. Herder M, Johnsen SH, Arntzen KA, Mathiesen EB. Risk factors for progression of carotid intima-media thickness and total plaque area: a 13-year follow-up study: the Tromso Study. Stroke 2012;43(7):1818-23.
72. Bonati LH, Dobson J, Featherstone RL et al. International Carotid Stenting Study Investigators. Long-term outcomes after stenting versus endarterectomy for treatment of symptomatic carotid stenosis: the International Carotid Stenting Study (ICSS) randomised trial. Lancet 2015;385(9967):529-38.
50. Park J-M, Kang K, Cho Y-J et al. Comparative effectiveness of pre-stroke aspirin on stroke severity and outcome. Ann Neurol 2016;79(4):560-8.
56. Bissaco D, Carmo M, Iacopo B et al. Medical Therapy Before Carotid Endarterectomy: Changes Over a 13-Year Period and Comparison Between Asymptomatic and Symptomatic Patients. Angiology 2017;69(2):113-119.
71. Paraskevas KI, Mikhailidis DP, Veith FJ, Spence JD. Definition of best medical treatment in asymptomatic and symptomatic carotid artery stenosis. Angiology 2016;67(5):411-9.
51. Naylor AR, Ricco JB, de Borsi GK et al. Management of Atherosclerotic Carotid and Vertebral Artery Disease: 2017 Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg 2018;55(1):3-81.
45.
65. King A, Markus HS. Doppler embolic signals in cerebrovascular disease and prediction of stroke risk: a systematic review and metaanalysis. Stroke 2009. 66. Kakkos SK, Sabetai M, Tegos T et al. Asymptomatic Carotid Stenosis and Risk of Stroke (ACSRS) Study Group. Silent embolic infarcts on computed tomography brain scans and risk of ipsolateral hemispheric events in patients with asymptomatic internal carotid. J Vasc Surg 2009. 67. Naylor AR, Gaines PA, Rothwell PM. “Who benefits most from intervention for asymptomatic carotid stenosis: patients or professionals?” Eur J Vasc Endovasc Surg 2009;40(12):3711-7.
44.
81. Eckstein HH, Ringleb P, Allenberg JR et al. Results of the StentProtected Angioplasty versus Carotid Endarterectomy (SPACE) study to treat symptomatic stenoses at 2 years: a multinational, prospective, randomised trial. Lancet Neurol 2008;7(10):893-902.
82. Ederle J, Dobson J, Featherstone RL et al. Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (International Carotid Stenting Study): an interim analysis of a rand. Lancet 2010;375(9719):985-97. 83. Brott TG, Hobson 2nd RW, Howard G, Roubin GS et al. CREST Investigators. Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med 2010;363:11-23. 84. Bonati LH, Lyrer P, Ederle J et al. Percutaneous transluminal balloon angioplasty and stenting for carotid artery stenosis. Cochrane Database Syst Rev 2012 Sep 12;(9):CD000515. 85. Yadav JS, Wholey MH, Kuntz RE et al. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med 2004;351:1493-1501. 86. Fokkema M, Vrijenhoek JEP, Den Ruijter HM et al. Stenting versus endarterectomy for restenosis following prior ipsilateral carotid endarterectomy. an individual patient data meta-analysis. Ann Surg 2015;261(3):598-604.
58. de Weerd M, Greving JP, Hedblad B et al. Prevalence of asymptomatic carotid artery stenosis in the general population: an individual participant data meta-analysis. Stroke 2010; 41(6):1294-7.
48. Furie KL, Kasner SE, Adams RJ et al. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association Stroke Council. Stroke 2011;42(1):227-76.
49. Tendera M, Aboyans V, Bartelink M-L et al. ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries. Eur Heart J 2011;32(22):2851-906.
68. Conrad MF, Michalczyk MJ, Opalacz A et al. The natural history of asymptomatic severe carotid artery stenosis. J Vasc Surg 2014;60(5):1218-25. 69. Vikatmaa P, Mitchell D, Jensen LP et al. Variation in clinical practice in carotid surgery in nine countries 2005-2010. Lessons from VASCUNET and recommendations for the future of national clinical audit. Eur J Vasc Endovasc Surg 2012; 44(1):11-7.
52. Bhatt DL, Keith AA, Fox MB et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med 2006;354:1706-17.
54. Batchelder AJ, Hunter J, Cairns V et al. Dual antiplatelet therapy prior to expedited carotid surgery reduces recurrent events prior to surgery without increasing perioperative bleeding complications. Eur J Vasc Endovasc Surg 2015;50(4):412-9.
70. Lichtman JH, Jones MR, Leifheit EC et al. Carotid endarterectomy and carotid artery stenting in the US Medicare population, 1999-2014. JAMA 2017;318(11):1035-1046.
77. Rothwell PM, Warlow CP. Timing of TIASs preceding stroke: time window for prevention is very short. Neurology 2005;64(5):817-20.
79. Rothwell PM, Coull AJ, Giles MF et al. Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 - Oxford Vascular Study. Lancet 2004;363(9425):1925-33.
60. McColgan P, Bentley P, McCarron M, Sharma P. Evaluation of the clinical utility of a carotid bruit. QJM 2012;105(12):1171-7.
73. Rosenfield K, Matsumura JS, Chaturvedi S et al. Randomized trial of stent versus surgery for asymptomatic carotid stenosis. N Engl J Med 2016;374(11):1011-20.
43. Scholtes VP, Peeters W, van Lammeren GW et al. Type 2 diabetes is not associated with an altered plaque phenotype among patients undergoing carotid revascularization. A histological analysis of 1455 carotid plaques. Atherosclerosis 2014;235(2):418-23. ADVANCE Collaborative Group et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008; 358:60-2572. Action to Control Cardiovascular Risk in Diabetes Study Group et al. Effects of intensive glucose lowering in type 2 diabetes. The N Engl J Med 2008;358:2545-59.
76. Johnston SC, Rothwell PM, Nguyen-Huynh N et al. Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack. Lancet 2007;369(9558):283-92.
61. Kakkos SK, Nicolaides AN, Charalambous I, Asymptomatic Carotid Stenosis and Risk of Stroke (ACSRS) Study Group. Predictors and clinical significance of progression or regression of asymptomatic carotid stenosis. J Vasc Surg 2014;59(4):956-967.e1.
46. Weerd M, Greving JP, Hedblad B et al. Prediction of asymptomatic carotid artery stenosis in the general population identification of high-risk groups. Stroke 2014;45(8):2366-71.
57. O’Leary DH, Polak JF, Kronmal RA et al. Distribution and correlates of sonographically detected carotid artery disease in the Cardiovascular Health Study. Stroke 1992;23(12):1752-60.
63. Markus HS, King A, Shipley M et al. Asymptomatic Carotid Emboli Study (ACES): a prospective observational study. Lancet Neurol 2010;9(7):663-71.
74. Brott TG, Howard G, Roubin GS et al. Long-term results of stenting versus endarterectomy for carotid-artery stenosis. N Engl J Med 2016;374(11):1021-31.
75. Murros KE, Evans GW, Toole JF et al. Cerebral infarction in patients with transient ischemic attacks. J Neurol 1989;236(3):182-4.
78. Kennedy F, Brown MM. Chapter 6.1 page 379-387 Epidemiology and aetiology os stroke Oxford Texbook of Vascular Surgery Oxford University press. First Edition. 2016.
53. Payne DA, Jones CI, Hayes PD et al. Beneficial effects of clopidogrel combined with aspirin in reducing cerebral emboli in patients undergoing carotid endarterectomy. Circulation 2004;109(12):1476-81.
99. Naylor AR. Management of prosthetic patch infection after carotid endarterectomy. J Cardiovasc Surg 2016.
87. Schermerhorn ML, Fokkema M, Goodney P et al. The impact of Centers for Medicare and Medicaid Services high-risk criteria on outcome after carotid endarterectomy and carotid artery stenting in the SVS Vascular Registry. J Vasc Surg 2015;57(5):1318-24.
95. Bennett KM, Scarborough JE, Shortell CK. Predictors of 30-day postoperative stroke or death after carotid endarterectomy using the 2012 carotid endarterectomy-targeted American College of Surgeons National Surgical Quality Improvement Program database. J Vasc Surg 2015;61(1):103-11.
117. Lee VH, Brown RD Jr, Mandrekar JN, Mokri B. Incidence and outcome of cervical artery dissection: a population-based study. Neurol 2006;67(10):1809-12.
90. Eastcott HH, Pickering GW, Rob CG. Reconstruction of internal carotid artery in a patient with intermittent attacks of hemiplegia. Lancet 1954;267(6846):994-6.
119. Engelter ST, Rutgers MP, Hatz F et al. Intravenous thrombolysis in stroke attributable to cervical artery dissection. Stroke 2009;40(12):3772-6.
94. AbuRahma AF, Stone PA, Srivastava M et al. The effect of surgeon’s specialty and volume on the perioperative outcome of carotid endarterectomy. J Vasc Surg 2013; 58(3):666-72.
118. Dittrich R, Dziewas R, Ritter MA et al. Negative ultrasound findings in patients with cervical artery dissection. Negative ultrasound in CAD. J Neurol 2006; 253(4):424-33.
110. Olin JW, Froehlich J, Gu X et al. The United States Registry for Fibromuscular Dysplasia: results in the first 447 patients. Circulation 2012;125(25):3182-90.
113. Kim ES, Olin JW, Froehlich JB et al. Clinical manifestations of fibromuscular dysplasia vary by patient sex: a report of the United States registry for fibromuscular dysplasia. J Am Coll Cardiol 2013;62(21):2026-2028. 114. Olin JW, Gornik HL, Bacharach JM et al. Fibromuscular dysplasia: state of the science and critical unanswered questions: a scientific statement from the American Heart Association. Circulation 2014;129(9):1048-78.
111. Ganesh SK, Morissette R, Xu Z, et al. Clinical and biochemical profiles suggest fibromuscular dysplasia is a systemic disease with altered TGFβ expression and connective tissue features. FASEB J 2014;28(8):3313-24.
91. Kresowik TF, Bratzler D, Karp HR et al. Multistate utilization, processes, and outcomes of carotid endarterectomy. J Vasc Surg 2001;33(2):227-34.
92. McGirt MJ, Perler BA, Brooke BS et al. 3hydroxy-3-methylglutaryl coenzyme A reductase inhibitors reduce the risk of perioperative stroke and mortality after carotid endarterectomy. J Vasc Surg 2005;42(5):829-36.
108. D’Agostino RS, Svensson LG, Neumann DJ et al. Screening carotid ultrasonography and risk factors for stroke in coronary artery surgery patients. Ann Thorac Surg 1996;62(6):1714-23.
112. Kiando SR, Tucker NR, Castro-Vega LJ et al. PHACTR1 Is a Genetic Susceptibility Locus for Fibromuscular Dysplasia Supporting Its Complex Genetic Pattern of Inheritance. PLoS Genetics 2016;12(10):e1006367.
93. Rerkasem K, Rothwell PM. Systematic review of randomized controlled trials of patch angioplasty versus primary closure and different types of patch materials during carotid endarterectomy. Asian J Surg 2011;34(1):32-40.
101. DeBakey ME. Regarding “A randomized study on eversion versus standard carotid endarterectomy. Study design and preliminary results: The Everest trial.” J Vasc Surg 1998;28(4):753.
115. Debette S, Markus HS. The genetics of cervical artery dissection: a systematic review. Stroke 2009;40(6):e459-66.
116. Debette S, Leys D. Cervical-artery dissections: predisposing factors, diagnosis, and outcome. Lancet Neurol 2009; 8(7):668-78.
109. Illuminati G, Ricco JB, Calio F et al. Shortterm results of a randomized trial examining timing of carotid endarterectomy in patients with severe asymptomatic unilateral carotid stenosis undergoing coronary artery bypass grafting. J Vasc Surg 2011;54(4):993-9;discussion 998-9.
98. Patel RB, Beaulieu P, Homa K et al. Shared quality data are associated with increased protamine use and reduced bleeding complications after carotid endarterectomy in the Vascular Study Group of New England. J Vasc Surg 2013;58(6):1518-1524.e1.
104. Rantner B, Kollerits B, Roubin GS et al. Early endarterectomy carries a lower procedural risk than early stenting in patients with symptomatic stenosis of the internal carotid artery: results from 4 randomized controlled trials. Stroke 2017;48:1580-7.
107. Naylor AR, Bown MJ. Stroke after cardiac surgery and its association with asymptomatic carotid disease: an updated systematic review and meta-analysis. Eur J Vasc Endovasc Surg 2011;41(5):607-24.
97. Hye RJ, Mackey A, Hill MD et al. Incidence, outcomes, and effect on quality of life of cranial nerve injury in the Carotid Revascularization Endarterectomy versus Stenting Trial. J Vasc Surg 2015;61(5):1208-14.
88. Cid dos Santos J. Sur la désobstruction dês thromboses artérielles anciennes. Memoiries Achademie De Chirurgie 1947;73(18-19):409-11.
100. Demirel S, Goosen K, Bruijnen H et al. Systematic review and meta-analysis of post-carotid endarterectomy hypertension after eversion versus conventional carotid endarterectomy. J Vasc Surg 2017;65(3):868-882.
89. Debakey ME. Successful carotid endarterectomy for cerebrovascular insufficiency. Nineteen year follow up. JAMA 1975;233(10):1083-5.
96. Bond R, Narayan S, Rothwell PM, Warlow CP, on behalf of the European Carotid Surgery Trialists’ Collaborative Group. Clinical and radiological risk factors for operative stroke and death in the European Carotid Surgery Trial. Eur J Vasc Endovasc Surg 2002;23(2):108-16.
103. Rankin J. Cerebral vascular accidents in patients over the age of 60. Scottish Med J 1957;2(5):200-15.
85Capítulo 46 lesões obstrutivA s dA s C ArótidA s e xtr ACr AniAnA s
105. Capoccia L, Sbarigia E, Speziale F et al. The need for emergency surgical treatment in carotid-related stroke in evolution and crescendo transient ischemic attack. J Vasc Surg 2012;55(6):1611-7.
106. Naylor AR, Mehta Z, Rothwell PM, Bell PRF. Carotid artery disease and stroke during coronary artery bypass: a critical review of the literature. Eur J Vasc Endovasc Surg 2002;23(4):283-94.
102. Etheredge SN. A simple technic for carotid endarterectomy. Am J Surg 1970;120(2):275-8.
3. Raitakari OT, Juonala M, Kahonen M et al. Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study. JAMA 2003;290(17):2277-83.
9. Johnston SC, O’Meara ES, Manolio TA et al. Cognitive impairment and decline are associated with carotid artery disease in patients without clinically evident cerebrovascular disease. Ann Intern Med 2004;140(4):237-47.
13. Avelar WM, D’Abreu A, Coan AC et al. Asymptomatic carotid stenosis is associated with gray and white matter damage. Int J Stroke 2015;10(8):1197-203.
86 47Capítulo A MELHOR TERAPIA PARA ISQUEMIA CEREBROVASCULAR REFERÊNCIAS BIBLIOGRÁFICAS
11. Oliveira GdP, Guillaumon AT, Brito IBd et al. O impacto da revascularização carotídea sobre a função cognitiva. J Vasc Bras 2014;13(2):116-22.
23. Furie KL, Kasner SE, Adams RJ et al. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the american heart association/american stroke association. Stroke 2011;42(1):227-76.
2. Li S, Chen W, Srinivasan SR et al. Childhood cardiovascular risk factors and carotid vascular changes in adulthood: the Bogalusa Heart Study. JAMA 2003;290(17):2271-6.
15. Naylor AR, Ricco JB, de Borst GJ et al. Editor’s Choice - Management of Atherosclerotic Carotid and Vertebral Artery Disease: 2017 Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg 2018;55(1):3-81.
32. Lazar HL, Bao Y, Rivers S et al. High tissue affinity angiotensinconverting enzyme inhibitors improve endothelial function and reduce infarct size. Ann Thorac Surg 2001;72(2):548-53; discussion 53-4. 33. Arnold M, Nedeltchev K, Sturzenegger M et al. Thrombolysis in patients with acute stroke caused by cervical artery dissection: analysis of 9 patients and review of the literature. Arch Neurol 2002;59(4):549-53.
7. Hosoda K. The Significance of Cerebral Hemodynamics Imaging in Carotid Endarterectomy: A Brief Review. Neurol Med Chir (Tokyo) 2015;55(10):782-8.
19. Sacco RL, Adams R, Albers G et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke 2006;37(2):577-617.
24. Elmer PJ, Obarzanek E, Vollmer WM et al. Effects of comprehensive lifestyle modification on diet, weight, physical fitness, and blood pressure control: 18-month results of a randomized trial. Ann Intern Med 2006;144(7):485-95.
17. Spence JD. Management of asymptomatic carotid stenosis. Neurol Clin 2015;33(2):443-57.
35.
10. Kirkness CJ. Cerebral blood flow monitoring in clinical practice. AACN Clin Issues 2005;16(4):476-87.
14. Hobson RW, Mackey WC, Ascher E et al. Management of atherosclerotic carotid artery disease: clinical practice guidelines of the Society for Vascular Surgery. J Vasc Surg 2008;48(2):480-6.
21. Lewington S, Clarke R, Qizilbash N et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002;360(9349):1903-13.
18. Goldstein LB, Adams R, Alberts MJ et al. Primary prevention of ischemic stroke: a guideline from the American Heart Association/ American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: the American Academy of Neurology affirms the value of this guideline. Stroke 2006;37(6):1583-633.
30. Taddei S, Virdis A, Ghiadoni L et al. Effects of angiotensin converting enzyme inhibition on endothelium-dependent vasodilatation in essential hypertensive patients. J Hypertens 1998;16(4):447-56.
22. Wang JG, Staessen JA, Li Y et al. Carotid intima-media thickness and antihypertensive treatment: a meta-analysis of randomized controlled trials. Stroke 2006;37(7):1933-40.
27. Goldstein LB, Adams R, Alberts MJ et al. Primary prevention of ischemic stroke: a guideline from the American Heart Association/ American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2006;113(24):e873-923.
4. Spence JD, Coates V, Li H et al. Effects of intensive medical therapy on microemboli and cardiovascular risk in asymptomatic carotid stenosis. Arch Neurol 2010;67(2):180-6.
26. Naidech AM, Weisberg LA. Treatment of chronic hypertension for the prevention of stroke. South Med J 2003;96(4):359-62.
1. Kieltyka L, Urbina EM, Tang R et al. Framingham risk score is related to carotid artery intima-media thickness in both white and black young adults: the Bogalusa Heart Study. Atherosclerosis 2003;170(1):125-30.
16. Kipskidze N. Textbook of interventional cardiovascular pharmacology. London: Informa Healthcare; 2007. 646p.
31. Enseleit F, Hurlimann D, Luscher TF. Vascular protective effects of angiotensin converting enzyme inhibitors and their relation to clinical events. J Cardiovasc Pharmacol 2001;37 Suppl 1:S21-30.
20. James PA, Oparil S, Carter BL et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014;311(5):507-20.
12. Germano da Paz O, Guillaumon AT, Lopes TM et al. Carotid stenting versus endarterectomy cognitive outcomes. Ann Vasc Surg 2014;28(4):893-900.
5. Paraskevas KI, Mikhailidis DP, Veith FJ, Spence JD. Definition of Best Medical Treatment in Asymptomatic and Symptomatic Carotid Artery Stenosis. Angiology 2016;67(5):411-9.
28. Webb AJ, Fischer U, Mehta Z, Rothwell PM. Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis. Lancet 2010;375(9718):906-15.
8. Nielsen HB. Systematic review of near-infrared spectroscopy determined cerebral oxygenation during non-cardiac surgery. Front Physiol 2014;5:93.
25. Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 2009;338:b1665.
6. Spence JD, Song H, Cheng G. Appropriate management of asymptomatic carotid stenosis. Stroke Vasc Neurol 2016;1(2):64-71.
29. Wald DS, Law M, Morris JK et al. Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trials. Am J Med 2009;122(3):290-300.
34. Forrester JS. Prevention of plaque rupture: a new paradigm of therapy. Ann Intern Med 2002;137(10):823-33. Chobanian AV, Bakris GL, Black HR et al. Seventh report of the Joint National Committee on Prevention, Detection,
65. Weir BK, Kongable GL, Kassell NF et al. Cigarette smoking as a cause of aneurysmal subarachnoid hemorrhage and risk for vasospasm: a report of the Cooperative Aneurysm Study. J Neurosurg 1998;89(3):405-11.
60. Sillesen H, Amarenco P, Hennerici MG et al. Atorvastatin reduces the risk of cardiovascular events in patients with carotid atherosclerosis: a secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke 2008;39(12):3297-302. 61. Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. JAMA 1995;273(18):1421-8.
70. Juvela S, Hillbom M, Palomaki H. Risk factors for spontaneous intracerebral hemorrhage. Stroke 1995;26(9):1558-64.
41. King P, Peacock I, Donnelly R. The UK prospective diabetes study (UKPDS): clinical and therapeutic implications for type 2 diabetes. Br J Clin Pharmacol 1999;48(5):643-8.
84. Group ES, Halkes PH, van Gijn J et al. Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial. Lancet 2006;367(9523):1665-73.
83. Shinohara Y, Katayama Y, Uchiyama S et al. Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial. Lancet Neurol 2010;9(10):959-68.
48. You RX, Thrift AG, McNeil JJ et al. Ischemic stroke risk and passive exposure to spouses’ cigarette smoking. Melbourne Stroke Risk Factor Study (MERFS) Group. Am J Public Health 1999;89(4):572-5. Otsuka R, Watanabe H, Hirata K et al. Acute effects of passive smoking on the coronary circulation in healthy young adults. JAMA 2001;286(4):436-41. Tsiara S, Elisaf M, Mikhailidis DP. Influence of smoking on predictors of vascular disease. Angiology 2003;54(5):507-30. Katsiki N, Hatzitolios AI, Mikhailidis DP. Passive smoking: the democratic right of nonsmokers to survive. Angiology 2011;62(7):520-2.
58. Collins R, Armitage J, Parish S et al. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet 2003;361(9374):2005-16.
66. Boden-Albala B, Sacco RL. Lifestyle factors and stroke risk: exercise, alcohol, diet, obesity, smoking, drug use, and stress. Curr Atheroscler Rep 2000;2(2):160-6.
87Capítulo 47 A melHor ter APiA PAr A isquemiA CerebrovA sCul Ar Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42(6):1206-52.
39. Hurst RT, Lee RW. Increased incidence of coronary atherosclerosis in type 2 diabetes mellitus: mechanisms and management. Ann Intern Med 2003;139(10):824-34.
68. Goude D, Fagerberg B, Hulthe J, group AIRs. Alcohol consumption, the metabolic syndrome and insulin resistance in 58-yearold clinically healthy men (AIR study). Clin Sci (Lond) 2002;102(3):345-52.
47. Sharrett AR, Ding J, Criqui MH et al. Smoking, diabetes, and blood cholesterol differ in their associations with subclinical atherosclerosis: the Multiethnic Study of Atherosclerosis (MESA). Atherosclerosis 2006;186(2):441-7.
78. Paraskevas KI, Spence JD, Veith FJ, Nicolaides AN. Identifying which patients with asymptomatic carotid stenosis could benefit from intervention. Stroke 2014;45(12):3720-4.
79. Antithrombotic Trialists C. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002;324(7329):71-86. 80. Diener HC, Cunha L, Forbes C et al. European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 1996;143(1-2):1-13.
81. Committee CS. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet 1996;348(9038):1329-39.
44.
57. Amarenco P, Lavallee P, Touboul PJ. Statins and stroke prevention. Cerebrovasc Dis 2004;17 Suppl 1:81-8.
51.
54. Crouse JR, Byington RP, Furberg CD. HMG-CoA reductase inhibitor therapy and stroke risk reduction: an analysis of clinical trials data. Atherosclerosis 1998;138(1):11-24.
74. He K, Merchant A, Rimm EB et al. Folate, vitamin B6, and B12 intakes in relation to risk of stroke among men. Stroke 2004;35(1):169-74.
76. Wassertheil-Smoller S, Hendrix SL, Limacher M et al. Effect of estrogen plus progestin on stroke in postmenopausal women: the Women’s Health Initiative: a randomized trial. JAMA 2003;289(20):2673-84.
63. Ridker PM. Inflammatory biomarkers, statins, and the risk of stroke: cracking a clinical conundrum. Circulation 2002;105(22):2583-5.
77. Spence JD. Rational Medical Therapy Is the Key to Effective Cardiovascular Disease Prevention. Can J Cardiol 2017;33(5):626-34.
46. Wannamethee SG, Shaper AG, Whincup PH, Walker M. Smoking cessation and the risk of stroke in middle-aged men. JAMA 1995;274(2):155-60.
37. Jorgensen L, Jenssen T, Joakimsen O et al. Glycated hemoglobin level is strongly related to the prevalence of carotid artery plaques with high echogenicity in nondiabetic individuals: the Tromso study. Circulation 2004;110(4):466-70.
55. Schwartz GG, Olsson AG, Ezekowitz MD et al. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA 2001;285(13):1711-8.
50.
40. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352(9131):854-65.
52. Faxon DP, Fuster V, Libby P et al. Atherosclerotic Vascular Disease Conference: Writing Group III: pathophysiology. Circulation 2004;109(21):2617-25.
43. Ockene IS, Miller NH. Cigarette smoking, cardiovascular disease, and stroke: a statement for healthcare professionals from the American Heart Association. American Heart Association Task Force on Risk Reduction. Circulation 1997;96(9):3243-7. Wilson PW, Hoeg JM, D’Agostino RB et al. Cumulative effects of high cholesterol levels, high blood pressure, and cigarette smoking on carotid stenosis. N Engl J Med 1997;337(8):516-22. Kawachi I, Colditz GA, Stampfer MJ et al. Smoking cessation and decreased risk of stroke in women. JAMA 1993;269(2):232-6.
56. Collins R, Armitage J. High-risk elderly patients PROSPER from cholesterol-lowering therapy. Lancet 2002;360(9346):1618-9.
53. Hebert PR, Gaziano JM, Chan KS, Hennekens CH. Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomized trials. JAMA 1997;278(4):313-21.
59. Holdaas H, Fellstrom B, Jardine AG et al. Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial. Lancet 2003;361(9374):2024-31.
73. Ingrosso D, Cimmino A, Perna AF et al. Folate treatment and unbalanced methylation and changes of allelic expression induced by hyperhomocysteinaemia in patients with uraemia. Lancet 2003;361(9370):1693-9.
71. Leppala JM, Paunio M, Virtamo J et al. Alcohol consumption and stroke incidence in male smokers. Circulation 1999;100(11):1209-14.
75. Schwartz SM, Petitti DB, Siscovick DS et al. Stroke and use of lowdose oral contraceptives in young women: a pooled analysis of two US studies. Stroke 1998;29(11):2277-84.
82. Huang Y, Cheng Y, Wu J et al. Cilostazol as an alternative to aspirin after ischaemic stroke: a randomised, double-blind, pilot study. Lancet Neurol 2008;7(6):494-9.
36. Leys D, Kwiecinski H, Bogousslavsky J et al. Prevention. European Stroke Initiative. Cerebrovasc Dis 2004;17 Suppl 2:15-29.
72. McCully KS. Homocysteine and vascular disease. Nat Med 1996;2(4):386-9.
62. Halliday A, Mansfield A, Marro J et al. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial. Lancet 2004;363(9420):1491-502.
42. Hemmingsen B, Lund SS, Gluud C et al. Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus. Cochrane Database Syst Rev 2013(11):CD008143.
38. Emerging Risk Factors C, Sarwar N, Gao P et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 2010;375(9733):2215-22.
45.
67. Djousse L, Ellison RC, Beiser A, et al. Alcohol consumption and risk of ischemic stroke: The Framingham Study. Stroke 2002;33(4):907-12.
69. Ding J, Eigenbrodt ML, Mosley TH, Jr et al. Alcohol intake and cerebral abnormalities on magnetic resonance imaging in a communitybased population of middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) study. Stroke 2004;35(1):16-21.
64. Lee CD, Folsom AR, Blair SN. Physical activity and stroke risk: a meta-analysis. Stroke 2003;34(10):2475-81.
49.
88 Parte IIICERVICAL
85. Shin SH, Stout CL, Richardson AI et al. Carotid angioplasty and stenting in anatomically high-risk patients: Safe and durable except for radiationinduced stenosis. J Vasc Surg 2009;50(4):762-7; discussion 7-8.
87. International Carotid Stenting Study i, Ederle J, Dobson J et al Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (International Carotid Stenting Study): an interim analysis of a randomised controlled trial. Lancet 2010;375(9719):985-97.
86. Ricotta JJ, Aburahma A, Ascher E et al. Updated Society for Vascular Surgery guidelines for management of extracranial carotid disease: executive summary. J Vasc Surg 2011;54(3):832-6.
88. Mas JL, Chatellier G, Beyssen B et al. Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. N Engl J Med 2006;355(16):1660-71.
89. Brott TG, Hobson RW, 2nd, Howard G, Roubin GS, Clark WM, Brooks W, et al. Stenting versus endarterectomy for treatment of carotidartery stenosis. N Engl J Med 2010;363(1):11-23.
90. Nicolaides AN, Kakkos S, Griffin M et al. Severity of asymptomatic carotid stenosis and risk of ipsilateral hemispheric ischaemic events: results from the ACSRS study. Nicolaides et al.: EJVES 2005; 30: 275284. Eur J Vasc Endovasc Surg 2006;31(3):336.
39. Fisher M, Paganini-Hill A, Martin A et al. Carotid plaque pathology: thrombosis, ulceration, and stroke pathogenesis. Stroke 2005;36(2):253-257. 40. Golledge J, Cuming R, Ellis M, et al. Carotid plaque characteristics and presenting symptom. Br J Surg 1997;84(12):1697-1701.
41. Milei J, Parodi JC, Ferreira M et al. Atherosclerotic plaque rupture and intraplaque hemorrhage do not correlate with symptoms in carotid artery stenosis. J Vasc Surg 2003;38(6):1241-1247.
16. Hobson RW, 2nd, Towne J. Carotid endarterectomy for asymptomatic carotid stenosis. Stroke 1989;20(5):575-576.
20. Yadav JS, Roubin GS, Iyer S et al. Elective stenting of the extracranial carotid arteries. Circulation 1997;95(2):376-381.
19. Beebe HG, Clagett GP, DeWeese JA et al. Assessing risk associated with carotid endarterectomy. A statement for health professionals by an Ad Hoc Committee on Carotid Surgery Standards of the Stroke Council, American Heart Association. Circulation 1989;79(2):472-473.
18. Das MB, Hertzer NR, Ratliff NB et al. Recurrent carotid stenosis. A five-year series of 65 reoperations. Ann Surg 1985;202(1):28-35.
28. Kachel R. Results of balloon angioplasty in the carotid arteries. J Endovasc Surg 1996;3(1):22-30.
33. Bosniak MA. An Analysis of Some Anatomic-Roentgenologic Aspects of the Brachiocephalic Vessels. Am J Roentgenol Rad Ther Nucl Med 1964;91:1222-1231.
17. Sacco RL, Wolf PA, Kannel WB, McNamara PM. Survival and recurrence following stroke. The Framingham study. Stroke 1982;13(3):290-295.
24. Kerber CW, Cromwell LD, Loehden OL. Catheter dilatation of proximal carotid stenosis during distal bifurcation endarterectomy. Am J Neuroradiol 1980;1(4):348-349.
25. Theron J, Raymond J, Casasco A, Courtheoux F. Percutaneous angioplasty of atherosclerotic and postsurgical stenosis of carotid arteries. Am J Neuroradiol 1987;8(3):495-500. 26. Theron J, Courtheoux P, Alachkar F et al. New triple coaxial catheter system for carotid angioplasty with cerebral protection. Am J Neuroradiol 1990;11(5):869-874; discussion 875-867. 27. Mehran R, Roubin GS, New G. Neurologic events after carotid stenting with distal protection using an occlusion ballon: final results from CAFÉ USA trial. AHA Meeting; 12 november, 2001; Anaheim, USA.
37. Kolodgie FD, Gold HK, Burke AP et al. Intraplaque hemorrhage and progression of coronary atheroma. N Engl J Med 2003;349(24):2316-2325. 38. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005;352(16):1685-1695.
23. Wholey MH, Wholey M, Mathias K et al. Global experience in cervical carotid artery stent placement. Catheter Cardiovasc Intervent 2000;50(2):160-167.
7. Grüntzig A, Hopf H. Perkutane Rekanalisation chronischer arterieller Verschlüsse mit einen neuen Katheter: Modifikation der Dottertechnik. Deutsch Med Wochenschr 1974(99):2502-2505.
8. Mathias K. [A new catheter system for percutaneous transluminal angioplasty (PTA) of carotid artery stenoses]. Fortschr Med 1977;95(15):1007-1011.
11. Diethrich EB, Ndiaye M, Reid DB. Stenting in the carotid artery: initial experience in 110 patients. J Endovasc Surg 1996;3(1):42-62.
14. Tinoco EC, Araújo JO, Anderson P, Botelho AC. Implante de stent de Palmaz em carótida: Relato de caso. Rev Angiol Cir Vasc 1995;4(4):133-136.
9. Mathias K. [Catheter treatment of arterial occlusive disease of supraaortic vessels]. Der Radiologe 1987;27(12):547-554.
32. Shaw JA, Gravereaux EC, Eisenhauer AC. Carotid stenting in the bovine arch. Catheter Cardiovasc Interv 2003;60(4):566-569.
4. Moore WS, Barnett HJ, Beebe HG et al. Guidelines for carotid endarterectomy. A multidisciplinary consensus statement from the Ad Hoc Committee, American Heart Association. Circulation 1995;91(2):566-579.
1. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 1991;325(7):445-453.
31. Bijuklic K, Wandler A, Hazizi F, Schofer J. The PROFI study (Prevention of Cerebral Embolization by Proximal Balloon Occlusion Compared to Filter Protection During Carotid Artery Stenting): a prospective randomized trial. J Am Coll Cardiol 2012;59(15):1383-1389.
TRATAMENTO ENDOVASCULAR DAS ESTENOSES CAROTÍDEAS E VERTEBRAIS
2. MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis. European Carotid Surgery Trialists’ Collaborative Group. Lancet 1991;337(8752):1235-1243.
89 48Capítulo
REFERÊNCIAS BIBLIOGRÁFICAS
21. Wholey MH, Wholey MH, Jarmolowski CR et al. Endovascular stents for carotid artery occlusive disease. J Endovasc Surg 1997;4(4):326-338.
12. Diethrich EB, Marx P, Wrasper R, Reid DB. Percutaneous techniques for endoluminal carotid interventions. J Endovasc Surg 1996;3(2):182-202.
3. Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. JAMA 1995;273(18):1421-1428.
6. Dotter C, Judkins MP. Transluminal treatment of arterioscleroitc obstruction: description of a new technique and a preliminary report of its applications. Circulation 1964(20):654-670.
15. Whisnant JP, Matsumoto N, Elveback LR. Transient cerebral ischemic attacks in a community. Rochester, Minnesota, 1955 through 1969. Mayo Clinic Proceedings 1973;48(3):194-198.
10. Theron JG, Payelle GG, Coskun O et al. Carotid artery stenosis: treatment with protected balloon angioplasty and stent placement. Radiology 1996;201(3):627-636.
29. Parodi JC, La Mura R, Ferreira LM et al. Initial evaluation of carotid angioplasty and stenting with three different cerebral protection devices. J Vasc Surg 2000;32(6):1127-1136. 30. Mousa AY, Campbell JE, Aburahma AF, Bates MC. Current update of cerebral embolic protection devices. J Vasc Surg 2012;56(5):1429-1437.
35. Messina L, Sarkar R, Zelenok G. Cerebrovascular occlusive disease. In: Greenfield L, Mulholland M, Oldhan K, eds. Surgery: Scientific Principles and Practice. 3rd ed. Philadelphia: Lippincott Willians & Wilkins; 2001. p. 1670-1684. 36. Farb A, Burke AP, Tang AL et al. Coronary plaque erosion without rupture into a lipid core. A frequent cause of coronary thrombosis in sudden coronary death. Circulation 1996;93(7):1354-1363.
42. Spagnoli LG, Mauriello A, Sangiorgi G et al. Extracranial thrombotically active carotid plaque as a risk factor for ischemic stroke. JAMA 2004;292(15):1845-1852.
5. Endovascular versus surgical treatment in patients with carotid stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): a randomised trial. Lancet 2001;357(9270):1729-1737.
34. Henry M, Amor M, Masson I et al. Angioplasty and stenting of the extracranial carotid arteries. J Endovasc Surg 1998;5(4):293-304.
22. Wholey MH. Regarding “Stent deformation and intimal hyperplasia complicating treatment of a post-carotid endarterectomy intimal flap with a Palmaz stent”. J V Surg 1997;26(5):897-899.
13. Roubin GS, Yadav S, Iyer SS, Vitek J. Carotid stent-supported angioplasty: a neurovascular intervention to prevent stroke. Am J Cardiol 1996;78(3A):8-12.
66. Liapis CD, Bell PR, Mikhailidis D et al. ESVS guidelines. Invasive treatment for carotid stenosis: indications, techniques. Eur J Vasc Endovasc Surg 2009;37(4 Suppl):1-19. 67. Sfyroeras GS, Koutsiaris A, Karathanos C et al. Clinical relevance and treatment of carotid stent fractures. J Vasc Surg 2010;51(5):1280-1285.
68. Naylor AR, Bolia A, Abbott RJ et al. Randomized study of carotid angioplasty and stenting versus carotid endarterectomy: a stopped trial. J Vasc Surg 1998;28(2):326-334.
53. New G, Roubin GS, Iyer SS, Vitek JJ. Carotid artery stenting: rationale, indications, and results. Compr Ther 1999;25(8-10):438-445.
45. Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet 1998;351(9113):1379-1387.
47. Nicolaides AN. Asymptomatic carotid stenosis and risk of stroke. Identification of a high risk group (ACSRS). A natural history study. Int Angiol 1995;14(1):21-23.
62. Schoser BG, Heesen C, Eckert B, Thie A. Cerebral hyperperfusion injury after percutaneous transluminal angioplasty of extracranial arteries. J Neurol 1997;244(2):101-104. 63. Gonzalez A, Mayol A, Gil-Peralta A et al. Hyperperfusion syndrome as a complication of percutaneous transluminal angioplasty of the internal carotid artery. Rev Neurol 1999;29(10):923-925.
50. Biasi GM, Ferrari SA, Nicolaides AN et al. The ICAROS registry of carotid artery stenting. Imaging in Carotid Angioplasties and Risk of Stroke. J Endovasc Ther 2001;8(1):46-52.
69. Alberts MJ. Results of a multicenter proapective randomized trial of carotid artery stenting vs. carotid endarterectomy. [abstract]. Stroke 2001;32:325d. 70. Brooks WH, McClure RR, Jones MR et al. Carotid angioplasty and stenting versus carotid endarterectomy: randomized trial in a community hospital. J Am Coll Cardiol 2001;38(6):1589-1595.
46. Molloy J, Markus HS. Asymptomatic embolization predicts stroke and TIA risk in patients with carotid artery stenosis. Stroke 1999;30(7):1440-1443.
43. Sitzer M, Puac D, Buehler A et al. Internal carotid artery angle of origin: a novel risk factor for early carotid atherosclerosis. Stroke 2003;34(4):950-955.
61. Setacci C, de Donato G, Chisci E et al. Is carotid artery stenting in octogenarians really dangerous? J Endovasc Ther 2006;13(3):302-309.
59. Stanziale SF, Marone LK, Boules TN et al. Carotid artery stenting in octogenarians is associated with increased adverse outcomes. J Vasc Surg 2006;43(2):297-304.
64. Abou-Chebl A, Yadav JS, Reginelli JP et al. Intracranial hemorrhage and hyperperfusion syndrome following carotid artery stenting: risk factors, prevention, and treatment. J Amer Coll Cardiol 2004;43(9):1596-1601. 65. Iancu A, Grosz C, Lazar A. Acute carotid stent thrombosis: review of the literature and long-term follow-up. Cardiovasc Revasc Med 2010;11(2):110-113.
54. Ahmadi R, Willfort A, Lang W et al. Carotid artery stenting: effect of learning curve and intermediate-term morphological outcome. J Endovasc Ther 2001;8(6):539-546.
75. Group SC, Ringleb PA, Allenberg J et al. 30 day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: a randomised non-inferiority trial. Lancet 2006;368(9543):1239-1247. 76. Carotid revascularization using endarterectomy or stenting systems (CARESS): phase I clinical trial. J Endovasc Ther 2003;10(6):1021-1030. 77. Carotid Revascularization Using Endarterectomy or Stenting Systems (CaREES) phase I clinical trial: 1-year results. J Vasc Surg 2005;42:213-219. 78. Hobson RW, 2nd. CREST (Carotid Revascularization Endarterectomy versus Stent Trial): background, design, and current status. Sem Vasc Surg 2000;13(2):139-143. 79. Roubin GS, Hobson RW 2nd, White R et al. CREST and CARESS to evaluate carotid stenting: time to get to work! J Endovasc Ther 2001;8(2):107-110. 80. Brott TG, Hobson RW, 2nd, Howard G et al. Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med 2010;363(1):11-23. 81. Gray WA, Simonton CA, Verta P. Overview of the 2011 Food and Drug Administration Circulatory System Devices Panel meeting on the ACCULINK and ACCUNET Carotid Artery Stent System. Circulation 2012;125(18):2256-2264. 82. Lal BK, Beach KW, Roubin GS et al. Restenosis after carotid artery stenting and endarterectomy: a secondary analysis of CREST, a randomised controlled trial. Lancet 2012;11(9):755-763. 83. De Borst GJ. Recruiting RCTs comparing CAS, CEA and best medical treatment for asymptomatic carotid stenosis. J Cardiovasc Surg 2015;56(6):837-844. 84. Reiff T, Stingele R, Eckstein HH et al. Stent-protected angioplasty in asymptomatic carotid artery stenosis vs. endarterectomy: SPACE2 - a three-arm randomised-controlled clinical trial. Int J Stroke 2009;4(4):294-299.
85. Rudarakanchana N, Dialynas M, Halliday A. Asymptomatic Carotid Surgery Trial-2 (ACST-2): rationale for a randomised clinical trial comparing carotid endarterectomy with carotid artery stenting in patients with asymptomatic carotid artery stenosis. Eur J Vasc Endovasc Surg 2009;38(2):239-242. 86. Featherstone R. European Carotid Surgery Trial 2. Updated 2016. 87. Brott TG. Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial ( CREST-2 ). Updated 2016. 88. I SRm. Registry of Transcarotid Artery Revascularization in Patients with significant Carotid Artery Disease. Updated 2016. 89. Sundt TM Jr., Smith HC, Campbell JK et al. Transluminal angioplasty for basilar artery stenosis. Mayo Clinic Proceedings 1980;55(11):673-680. 90. Malek AM, Higashida RT, Phatouros CC et al. Treatment of posterior circulation ischemia with extracranial percutaneous balloon angioplasty and stent placement. Stroke 1999;30(10):2073-2085. 91. Bamford J, Sandercock P, Dennis M et al. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 1991;337(8756):1521-1526. 92. Caplan LR. Brain embolism, revisited. Neurology 1993;43(7):1281-1287. 93. Castaigne P, Lhermitte F, Gautier JC et al. Arterial occlusions in the vertebro-basilar system. A study of 44 patients with post-mortem data. Brain 1973;96(1):133-154.
52. Roubin GS, New G, Iyer SS et al. Immediate and late clinical outcomes of carotid artery stenting in patients with symptomatic and asymptomatic carotid artery stenosis: a 5-year prospective analysis. Circulation 2001;103(4):532-537.
90 Parte IIICERVICAL
49. Ohki T, Marin ML, Lyon RT et al. Ex vivo human carotid artery bifurcation stenting: correlation of lesion characteristics with embolic potential. J Vasc Surg 1998;27(3):463-471.
55. Wholey MH, Wholey M, Bergeron P et al. Current global status of carotid artery stent placement. Catheter Cardiovasc Diagn 1998;44(1):1-6.
71. Yadav JS. Carotid stenting in high-risk patients: design and rationale of the SAPPHIRE trial. Cleve Clin J Medic 2004;71 Suppl 1:S45-46. 72. Coward LJ, Featherstone RL, Brown MM. Percutaneous transluminal angioplasty and stenting for carotid artery stenosis (Cochrane Review). In: The Cochrane Library. 2006. Oxford.(1).
58. Hobson RW, 2nd, Howard VJ, Roubin GS et al. Carotid artery stenting is associated with increased complications in octogenarians: 30day stroke and death rates in the CREST lead-in phase. J Vasc Surg 2004;40(6):1106-1111.
44. Markus H. Pathophysiology. In: Chaturvedi S, Rothwell PM (Eds.). Carotid Artery Stenosis: Current and Emerging Treatments. 1st ed. Boca Raton, FL: Taylor & Francis Group; 2005. p. 31-54.
51. Biasi GM, Tshomba Y, Deleo G. Plaque type can determine the need for asymptomatic carotid intervention. In: Greenhalgh RM (Ed.). The Evidence for Vascular or Endovascular Reconstruction. 1st ed. London, UK: W.B. SAUNDERS; 2002. p.1-5.
48. Biasi GM, Sampaolo A, Mingazzini P et al. Computer analysis of ultrasonic plaque echolucency in identifying high risk carotid bifurcation lesions. Eur J Vasc Endovasc Surg 1999;17(6):476-479.
56. Wholey MH, Al-Mubarak N, Wholey MH. Updated review of the global carotid artery stent registry. Catheter Cardiovasc Interv 2003;60(2):259-266.
60. Longo GM, Kibbe MR, Eskandari MK. Carotid artery stenting in octogenarians: is it too risky? Ann Vasc Surg 2005;19(6):812-816.
57. Eskandari MK, Longo GM, Matsumura JS et al. Carotid stenting done exclusively by vascular surgeons: first 175 cases. Ann Surg 2005;242(3):431-436; discussion 436-438.
73. Gray WA, Hopkins LN, Yadav S et al. Protected carotid stenting in high-surgical-risk patients: The ARCHeR results. J Vasc Surg 2006;44(2):258-269. 74. Mas JL, Chatellier G, Beyssen B et al. Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. N Engl J Med 2006;355(16):1660-1671.
102. Lin YH, Juang JM, Jeng JS et al. Symptomatic ostial vertebral artery stenosis treated with tubular coronary stents: clinical results and restenosis analysis. J Endovasc Ther 2004;11(6):719-726.
96. Reivich M, Holling HE, Roberts B, Toole JF. Reversal of blood flow through the vertebral artery and its effect on cerebral circulation. N Engl J Med 1961;265:878-885.
108. Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries (SSYLVIA): study results. Stroke 2004;35(6):1388-1392 109. Antoniou GA, Murray D, Georgiadis GS et al. Percutaneous transluminal angioplasty and stenting in patients with proximal vertebral artery stenosis. J Vasc Surg 2012;55(4):1167-1177. 110. Jain SP, Ramee SR, White CJ, Roubin GS. Treatment of atheroscleroticvertebral artery disease by endoluminal stenting: results from a US multicenter study. J Am Coll Cardiol 2000:84A-86A. 111. Chastain HD 2nd, Campbell MS, Iyer S et al. Extracranial vertebral artery stent placement: in-hospital and follow-up results. J Neurosurg 1999;91(4):547-552. 112. Lugmayr H, Kastner M, Frohler W et al. Sirolimus-eluting stents for the treatment of symptomatic extracranial vertebral artery stenoses: early experience and 6-month follow-up. Rofo 2004;176(10):1431-1435. 113. Compter A, van der Worp HB, Schonewille WJ et al. VAST: Vertebral Artery Stenting Trial. Protocol for a randomised safety and feasibility trial. Trials 2008;9:65.
95. Caplan LR. Atherosclerotic Vertebral Artery Disease in the Neck. Curr Treat Options Cardiovasc Med 2003;5(3):251-256.
98. Mintz EP, Gruberg L, Kouperberg E, Beyar R. Vertebral artery stenting using distal emboli protection and transcranial Doppler. Catheter Cardiovasc Interv 2004;61(1):12-15.
100. Wehman JC, Hanel RA, Guidot CA et al. Atherosclerotic occlusive extracranial vertebral artery disease: indications for intervention, endovascular techniques, short-term and long-term results. J Intervent Cardiol 2004;17(4):219-232.
97. Piotin M, Spelle L, Martin JB et al. Percutaneous transluminal angioplasty and stenting of the proximal vertebral artery for symptomatic stenosis. AJNR Am J Neuroradiol 2000;21(4):727-731.
101. Motarjeme A. Percutaneous transluminal angioplasty of supra-aortic vessels. J Endovasc Surg 1996;3(2):171-181.
107. Yu W, Smith WS, Singh V et al. Long-term outcome of endovascular stenting for symptomatic basilar artery stenosis. Neurology 2005;64(6):1055-1057.
94. Koenigsberg RA, Pereira L, Nair B et al. Unusual vertebral artery origins: examples and related pathology. Catheter Cardiovasc Interv 2003;59(2):244-250.
99. Jaeger HJ, Mathias KD, Drescher R et al. Diffusion-weighted MR imaging after angioplasty or angioplasty plus stenting of arteries supplying the brain. AJNR Am J Neuroradiol 2001;22(7):1251-1259
103. Ko YG, Park S, Kim JY et al. Percutaneous interventional treatment of extracranial vertebral artery stenosis with coronary stents. Yonsei Med J 2004;45(4):629-634.
106. Gomez CR, Misra VK, Liu MW et al. Elective stenting of symptomatic basilar artery stenosis. Stroke 2000;31(1):95-99.
104. Nahser HC, Henkes H, Weber W et al. Intracranial vertebrobasilar stenosis: angioplasty and follow-up. AJNR Am J Neuroradiol 2000;21(7):1293-1301.
91Capítulo 48 tr AtAmento endovA sCul Ar dA s estenoses C Arotíde A s e vertebr Ais
105. Chow MM, Masaryk TJ, Woo HH et al. Stent-assisted angioplasty of intracranial vertebrobasilar atherosclerosis: midterm analysis of clinical and radiologic predictors of neurological morbidity and mortality. AJNR Am J Neuroradiol 2005;26(4):869-874.
5. Ristow AV, Massière BV, Correa MP. Doença oclusiva do tronco braquiocefálico e da carótida extracraniana. In: Lobato AC et al. e(Eds.). Cirurgia endovascular. 2. ed. São Paulo: ICVE; 2010. p. 853-96.
12. North RR, Fields WS, DeBakey ME et al. Brachial-basilar insufficiency syndrome. Neurology 1962;12:810-20.
11. Cate WR, Scott HW. Cerebral ischemia of central origin: relief by subclavian-vertebral artery endarterectomy. Surgery 1959;45:19-31.
9. Bahnson HT, Spencer FC, Quattlebaum JK. Surgical treatment of occlusive disease of the carotid artery. Ann Surg 1959;149:711.
4. Ristow AV, Pedron C. Correção endovascular da doença oclusiva das artérias subclávia e vertebral. In: Lobato AC. (Ed.). Cirurgia endovascular. São Paulo: ICVE-SP; 2006. p. 210-15.
15.
16.
21. Berguer R, Andaya LV, Bauer RB. Vertebral artery bypass. Arch Surg 1976;111:976-79.
1. Kiefer E. Chirurgie des troncs supra-aortiques. In: Techniques chirurgicales – Chirurgie vasculaire. Encicl Méd Chir. Paris: Elsevier; 1987. p. 43-120, cap. 12.
8. Oudot J, Roge R, Delahaye G et al. Greffe vasculaire em Y pour anévrisme traumatique du tronc artériel brachio-cephalique. Presse Méd 1953;61:449-51.
23. Carney AL, Anderson EM. Carotid distal vertebral artery by-pass for carotid artery occlusion. Clin EEG 1978;9:105-9. 24. George B, Laurian C. The vertebral artery – Pathology and surgery Wien: Springer; 1987. 25. Walt AJ. The story of vertebrobasilar surgery. In: Bergher R, Bauer RB e(Eds.). Vertebro-basilar arterial occlusive disease. New York: Raven; 1984. 26. Lanz TV, Wachsmuth W. Praktische anatomie- Hals. Berlin: Springer; 1955. 27. Kieffer E. Chirurgie de l’artère vertébrale. In: Techniques chirurgicales –Chirurgie vasculaire. Encicl Méd Chir. Paris: Elsevier; 1986. cap. 11. 28. Ristow Av. Traumatismos vasculares dos troncos supraórticos. Curitiba: Anais do XXXII Congr Bras Angiol Cir Vasc; 1997. p. 249-52.
2. Berguer R, Kiefer E. Surgery of the arteries to the head. New York: Springer; 1992.
13. Parrot JC. The subclavian steal syndrome. Arch Surg 1964;88:661-65. 14. Warren WD, Fomon JJ. Rerouting arterial flow to relieve ischemia. Ann Surg 1966;163:131-36. Ehrenfeld WK, Levin SM, Wylie EJ. Venous crossover grafts for arterial insufficiency. Ann Surg 1968;167:287-91. Myers WO, Lawton BR, Sautter RD. Axillo-axillary bypass graft. JAMA 1971;217:216-21.
7. Hass WK, Fields WS. North RR et al. Joint study of extracranial arterial occlusion II: Arteriography. JAMA 1961;203:961-78.
29. Toledo FV, Araújo AP, Beer A et al. Tratamento cirúrgico da arterite primária da aorta. In: Bonamigo TP, Burihan E, Cinelli M, Ristow AV e(Eds.). Doenças da aorta e seus ramos. São Paulo: Fundo Ed Byk; 1991. p. 292-301. 30. Gama AD, Souza JE. Doença de Takayasu. Lisboa: Abbott; 1987. 31. Fisher CM. The circle of Willis: anatomical variations. Vasc Dis 1965;2:99-105. 32. Reivich M, Holling HE, Roberts J et al. Reversal of blood flow through vertebral artery and its effect on cerebral circulation. New Engl J Med 1961;265:878-85. 33. Hallet JW, Bower TC, Cherry KR et al. Brachiocephalic reconstruction. In: Meyer FB. (Ed.). Sundt’s occlusive cerebrovascular disease. Philadelphia: Saunders; 1994. p. 389-416. 34. Vollmar JF. Verschlüsse der supraaortische Äste. In: Vollmar JF. Rekonstruktive chirurgie der arterien. 4th ed. Stuttgart: Thieme; 1996. p. 284-338. 35. Cherry KJ, McCullough JL, Hallet JW et al. Technical principles of direct innominate artery revascularization: a comparison between endarterectomy and bypass grafts. J Vasc Surg 1989;9:718-23. 36. Ruel GJ, Jacobs HKHM, Gregoire JD et al. Innominate artery occlusive disease: surgical approach and long term results. J Vasc Surg 1991;14:405-12. 37. Edwards Jr WH. Vertebral artery reconstruction: indication and techniques. Sem Vasc Surg 1996;9:105-10. 38. Kieffer E, Sabatler J, Koskas F et al. Atherosclerotic innominate artery occlusive disease: early and long term results of surgical reconstruction. J Vasc Surg 1995;21:326-37. 39. Thévenet A, Ruotollo C. Surgical repair of vertebral artery stenosis. J Cardiovasc Surg 1984;25:101-10. 40. Wylie EJ, Effeney DJ. Surgery of the aortic arch branches and vertebral arteries. Surg Clin N Am 1979;59:669-81. 41. Branchereau A, Magnan DE. Results of vertebral artery reconstruction. J Cardiovasc Surg 1990;31:320-26. 42. Diaz FG, Ausman JI, Shroutz J et al. Combined reconstruction of the vertebral and carotid artery in one single procdeure. Neurosurgey 1983;12:629-35. 43. Deriú GP. Surgical management of extracranial vertebral artery occlusive disease. J Cardiovasc Surg 1991;32:413-19. 44. Ewald E. Tratamento cirúrgico das lesões extracranianas da artéria vertebral extracraniana. Tese. Pontifícia Universidade Católica do Rio de Janeiro, 1992. 45. Criado FJ, Queral LA, Twena M. Is endovascular intervention justified for the disease of the supra-aortic trunks? In: Geenhalg RM, Folkes FGR. (Eds.). Trials and tribulations of vascular surgery. London: Saunders; 1996. p. 131-50. 46. Motarjeme A. Percutaneous transluminal angioplasty of supra-aortic vessels. J Endovasc Surg 1996;3(2):171-81. 47. Guimarães T, Marques MA, Rosário MA et al. Arterite de Takayasu. Rev Angiol Cir Vascular RJ 2012:6;31-33. 48. Melissano G, Chiesa R, Sheiban I et al. Intraoperative stenting of the internal carotid artery after unsuccessful eversion endarterectomy. J Vasc Surg 1999;30:355-56. 49. Cina CS, Safar HA, Lagana A et al. Subclavian carotid transposition and bypass grafting: consecutive cohort study and systematic review. J Vasc Surg 2002;35:422-29. 50. Qureshi MA, Martin Z, Greenberg RK. Endovascular management of patients with Takayasu arteritis: stents vs stent-grafts. Semin Vasc Surg 2011;24:44-52. Kim HJ, Lee CS, Kim JS et al. Outcomes after endovascular treatment of symptomatic patients with Takayasu’s arteritis. Interv Neuroradiol 2011;17:252-60.
51.
REFERÊNCIAS BIBLIOGRÁFICAS
92 49Capítulo OCLUSÕES CRÔNICAS DOS TRONCOS SUPRA-AÓRTICOS E DAS VERTEBRAIS – TRATAMENTO CIRÚRGICO
6. Fields WS, Lemak NA. Joint study of extracranial arterial occlusion: VII. JAMA 1972;222:1139-43.
3. Hallett JW. Brachiocephalic arterial revascularization: a surgical perspective. In: Whittemore AD, Bandyk DF, Cronenwett JL. Advances in vascular surgery. St Louis: Mosby; 1997. p. 27-41, vol. 5.
22. Cormier JM, Laurian C. Surgical management of vertebro-basilar insufficiency. J Cardiovasc Surg 1976;11:205-15.
18. Wylie EJ, Ehrenfeld WK. Surgical techniques in extracranial occlusive cerebrovascular disease. London: Saunders; 1970. 19. Carney AL, Emmanuelle R, Anderson EM. Surgery of the vertebral artery. Chicago: Medicam AV; 1976.
20. Clark K, Perry UM. Carotid vertebral anastomosis: an alternative for repair of the subclavian steal syndrome. Ann Surg 1963;414:416-22.
17. Contorni L. II circolo collaterale vertebro-vertebrale nella obliterazione dell”arterio subclávia all sua origine. Minerva Chir 1960;15:268-71.
10. Davis JB, Grove WJ, Julian OC. Thrombotic occlusion of the branches of the aortic arch, Martorell syndrome. Report of a case treated surgically. Ann Surg 1956;144:124-26.
61. Brancereau A, Malikov S, Valerio N. Chirurgie des troncs supraaortiques: techniques et indications. In: Techniques chirurgicales –Chirurgie vasculaire. Encicl Méd Chir. Paris: Elsevier; 2006. p. 43-124.
62. Zhou W, Reardon M, Peden EK et al. Hybrid approach to complex thoracic aortic aneurysms in high-risk patients: surgical challenges and clinical outcomes. J Vasc Surg 2006;44:688-93.
74. Ohrlander T, Sonesson B, Ivancef K et al. The chimney graft: a technique for preserving or rescuing aortic branch vessels in stentgraft sealing zones. J Endovasc Ther 2008;15:427.
76. Bokoyannis C, Kalles V, Ekonomopoulos K et al. Hybrid procedures in the treatment of thoracoabdominal aortic aneurysms: a systematic review. J Endovasc Ther 2009;16:44. 77. Kawagichi M, Yamada M, Furuya H et al. Hyperfusion syndrome following bilateral aorto-carotid bypass: a study of transcranial Doppler. No To Shinkei 1991;43:555-58. 78. Breen JC, Caplan LR, DeWitt LD et al. Brain edema after carotid surgery. Neurology 1996;46:175-81. 79. Shinno K, Ueda S, Uno M. Hyperperfusion syndrome after carotid endarterectomy. Evaluation using diffusion-weighted magnetic resonance imaging. Neur Med Chir (Tokio) 1998;38:557-61. 80. Sproul G. Femoral-axillary bypass for cerebral vascular insufficiency. Arch Chir 1971;103:746-47. 81. Vasconcelos JOM, Fernandes RA, Oliveira RSC et al. Derivação fêmoroaxilar direita para revascularização cerebral e do membro superior direito. Cir Vasc Angio 1995;11:19-23. 82. Ristow AV, Cury JM, Medeiros MC. Aneurismas dos troncos supraaórticos e seus ramos. In: Bonamigo TP, Burihan E, Cinelli M et al. (Eds.). Doenças da aorta e seus ramos. São Paulo: Fundo Editorial BYK; 1991. p. 72-83. 83. Vogt DP, Hertzer NR, O’Hara PJ. Brachiocephalic arterial reconstruction. Ann Surg 1982;196:541-52. 84. Crawford ES, Stowe CL, Powers RW. Occlusion of innominate, common carotid and subclavian arteries: long term results of surgical treatment. Surgery 1983;95:781-91. 85. Loftus JP, Cherry KJ. Surgical treatment of innominate atherosclerosis. In: Ernst CB, Stanley JC. (Eds.). Current therapy in vascular surgery. St Louis: Mosby; 1995. p. 96-99. 86. Baiocchi MTP, Guillaumon AT, Lane JC et al. Lesões da artéria subclávia. Alternativas técnicas para reconstrução cirúrgica? Cir Vasc Angiol 1998;14:67-72. 87. Romitti M, Mazzetti MPV, Romitti N et al. Cirurgia reconstrutiva e angioplastia no tratamento de portadores de oclusões crônicas das artérias subclávias. Cir Vasc Angiol 1997;13:65-70. 88. AbuRahma AF, Robinson PA, Jennings TG. Carotid-subclavian bypass grafting with pPTFe grafts for symptomatic subclavian artery stenosis or occlusion: a 20-year experience. J Vasc Surg 2000;32:411-19. 89. Berguer R, Flynn LM, Kline RA et al. Surgical reconstruction of the extracranial vertebral artery: management and outcomes. J Vasc Surg 2000;31:9-18. 90. Vliet JA, Palamba HW, Scharn DM et al. Arterial reconstruction for subclavian obstrutive disease: a comparison of extrathoracic procedures. Eur J Vasc Endovasc Surg 1995;9:454-58. 91. Schardey HM, Meyer G, Rau HG et al. Subclavian carotid transposition: an analysis of clinical series and a review of the literature. Eur J Vasc Endovasc Surg 1996;12:431-36. 92. Jenkins JS, Subramanian R. Endovascular treatment for vertebrobasilar insufficiency. Curr Treat Options Cardiovasc Med 2002;4(5):385-91. 93. Ristow Av, Vescovi A. Massière BV. Oclusões crônicas dos troncos supra-aórticos e das vertebrais. In: Brito CJ (Ed.). Cirurgia Vascular. Rio de Janeiro: Revinter; 2013. p. 1587-1621. 94. Araújo AP, Gomes CFA. Obstruções dos troncos supra-aórticos –Tratamento endovascular. In: Brito CJ (Ed.). Cirurgia Vascular. Rio de Janeiro: Revinter; 2013. p. 1623-1640. 95. Muresian H, Extensive cerebrovascular arterial revascularizartion. In: Muresian H (Ed.) Arterial revascularization of the head and neck. Suiça: Springer; 2016. p. 277-300.
66. Vieira RD, Ristow AV, Massiere BV et al. Tratamiento endovascular de las lesiones traumáticas de la aorta descendente con endoprótesis apolo: experiencia de diez años. Rev Argentina Cir Cardiovasc 2011;9:183-91.
93Capítulo 49 oClusões CrôniCA s dos tronCos suPr A AórtiCos e dA s vertebr Ais – tr AtAmento CirúrgiCo
53. Thévenet A, Chaptal PA, Negre E. L’arret circulatoire en hypothermie profonde dans la chirurgie des branches de la crosse aortique. Ann Chir Thorac Cardiovasc 1978;7:69-71.
52. Armon MP, Beard JD. Surgical intervention for the supra-aortic vessels. In: Geenhalgh R. (Ed.). Vascular and endovascular opportunities London: Saunders; 2000. p. 169-76.
60. Kato N, Shimono T, Mizumoto T et al. Aortic arch aneurysms: treatment with extraanatomical bypass and endovascular stentgrafting. Cardiovasc Intervet Radiol 2002;25:419-22.
64. Bergeron P, Mangialardi N, Costa P et al. Great vessel management for endovascular exclusion of aortic arch aneurysms and dissections. Eur J Vasc Endovasc Surg 2006;32:38-45.
69. Ishimaru I, Criado FJ, Clark S et al. Endovascular repair of thoracic aortic aneurysms and dissections: a 5-year experience. In: Becquemin JP. (Ed.). Controversies and update. Torino: Minerva Medica; 2003. p. 325-32.
72. Larzon T, Gruger G, Friberg Ö et al. Experiences on intentional carotid stenting in endovascular repair of aortic arch aneurysms- two case reports. Eur J Vasc Endovasc Surg 2005;30:147.
58. Ross CB, Ranval TJ. Intraoperative use of stents for the management of unacceptable distal internal carotid artery end points during carotid endarterectomy: short-term and midterm results. J Vasc Surg 2000;32:420-28.
57. Berguer R. Distal vertebral artery by-pass: technique of the “occipital connection” and potential uses. J Vasc Surg 1985;2:621-26.
73. Larzon T, Eliasson K, Gruber G. Top fenestrating technique in stentgrafting of aortic diseases with mid-term follow-up. J Cardiovasc Surg 2008;49:317.
67. Criado FJ, Barnatan MF, Rizk Y et al. Technical strategies to expand stent-graft applicability in aortic arch and proximal descending thoracic aorta. J Endovasc Ther 2002;9(Suppl 2):II32-38.
71. Ristow AV, Gress MHT, Vescovi A et al. Oclusões crônicas dos troncos supra-aórticos e vertebrais. In: Brito CJ et al. (Eds.). Cirurgia vascular. 2. ed. Rio de Janeiro: Revinter; 2008. p. 1062-97.
56. Kieffer E, Rancurel G, Richard T. Reconstruction of the distal cervical vertebral artery. In: Bergher R, Bauer E. (Eds.). Vertebro-basilar arterial occlusive disease. New York: Raven; 1984.
63. Melissano G, Civilini E, Bertoglio L et al. Endovascular treatment of aortic arch aneurysms. Eur J Vasc Endovasc Surg 2005;29:131-38.
54. Palazzo JCC, Ristow AV. Síndrome de compressão neurovascular da cintura escapular – Etiopatogenia e diagnóstico. J Bras Med 1982;43(3):25-41.
75. Criado FJ. A percutaneous technique for preservation of arch patency during thoracic aortic repair: retrograde catheterization and stenting. J Endovasc Ther 2007;14:54.
70. Matsumara JS, Rizvi AZ. Left subclavian artery revascularization. Society for Vascular Surgery Practice Guidelines. J Vasc Surg 2010;52(Suppl):65S-70S.
59. Uurto IT, Lautamatti V, Zeitlin R et al. Long term outcome of surgical revascularization of supraaortic vessels. World J Surg 2002;26:1503-6.
55. Palazzo JCC, Ristow AV. Síndrome de compressão neuro-vascular da cintura escapular. Diagnóstico diferencial e tratamento. J Bras Med 56(4):28-38.
65. Ristow Av, Massiere BV, Beer F. Intramural hematoma and penetrating aortic ulcers. In: Chiesa R et al. (Eds.). Aortic surgery and anesthesia –How to do it IV. In: Milano, Italy: Springer-Verlag; 2010. p. 555-66.
68. Bergeron P, De Chaumaray T, Gay J et al. Endovascular treatment of aortic thoracic aneurysms. J Cardiovasc Surg 2003;44:349-61.
9. Davis JB, Grove WJ, Julian OC. Thrombic occlusion of branches of aortic arch. Martorell´s syndrome: Report of case treated surgically. Ann Surg 1956;144:124-26.
18. Becker GJ, Katzen BT, Dake MD. Noncoronary angioplasty. Radiology 1989;170:921-40.
2. Fields WS, Lemak NA. Joint study of extracranial arterial occlusion. Subclavian steal. A review of 168 cases. JAMA 1972;222:1139-43.
14. Vogt DP, Hertzer NR, Ohara PJ et al. Brachiocephalic arterial reconstruction. Ann Surg 1982;196:541-52.
16. Perler BA, Williams GM. Carotid-subclavian bypass: a decade of experience. J Vasc Surg 1990;12:716-22.
19. Queral LA, Criado FJ. The treatment of focal aortic arch branch lesions with Palmaz stents. J Vasc Surg 1996;23:368-75.
25. Brountzos EN, Petersen B, Binkert C et al. Primary stenting of subclavian and innominate artery occlusive disease: a single center’s experience. Cardiovasc Intervent Radiol 2004;27:616-23.
6. Hallet JH. Braquiocephalic arterial revascularization: a surgical perspective. Adv Vasc Surg 1997;5:27-41.
15. Crawford ES, Debakey ME, Morris GC et al. Surgical treatment of occlusion of the innominate, common carotid, and subclavian arteries: a 10-Year experience. Surgery 1969;65:17-31.
45.
17. Bachman DM, Kim RM. Transluminal dilatation for subclavian steal syndrome. AJR 1980;135:995-96.
3. Akers DL, Markowitz IA, Kerstein MD. The value of aortic study in the evaluation of cerebrovascular insufficiency. Am J Surg 1987;154:230-32.
7. Martorell F, Fabre J. El síndrome de obliteracion de los troncos supraaorticos. Med Clin 1944;2:26-30.
4. Allie DE, Herbert CJ, Lirtzman MD et al. Intraoperative innominate and common carotid intervention combined with carotid endarterectomy: a “True” endovascular surgical approach. J Endovasc Ther 2004;11:258-62.
20. Lyon RD, Shonnard KM, McCarter DL et al. Supra-aortic arterial stenosis: Manegement with Palmaz balloon-expandable intraluminal stents. J Vasc Interv 1996;7:825-35.
94 50Capítulo OBSTRUÇÕES DOS TRONCOS SUPRA-AÓRTICOS –TRATAMENTO ENDOVASCULAR REFERÊNCIAS BIBLIOGRÁFICAS
22. Kumar K, Dorros G, Bates MC et al. Primary stent deployment in occlusive subclavian artery disease. Cathet Cardiovasc Diagn 1995;34:281-85. 23. Sullivan TM, Gray BH, Bacharach JM et al. Angioplasty and primary stenting of the subclavian, innominate, and common carotid arteries in 83 patients. J Vasc Surg 1998;28:1059-65.
24. Queral LA, Criado FJ. The treatment of focal aortic arch branch lesions with Palmaz stents. J Vasc Surg 1996;23:368-75.
21. Sucoka BL. Percutaneous transluminal stent placement to treat subclavian steal syndrome. JVIR 1996;7:351-56.
26. Peterson BG, Resnick SA, Morasch MD et al. Aortic arch vessel stenting: a single-center experience using cerebral protection. Arch Surg 2006;141:560-63.
27. Ruebben A, Tettoni S, Muratore P et al. Feasibility of intraoperative balloon angioplasty and additional stent placement of isolated stenosis of the brachiocephalic trunk. J Thorac Cardiovasc Surg 1998;115:1316-20. 28. Palchik E, Bakken AM, Wolford HY et al. Evolving strategies in treatment of isolated symptomatic innominate artery disease. Vasc Endovascular Surg 2008;42:440-40. Epub, 2008 Jul 11. 29. Mordasini P, Gralla J, Do DD et al. Percutaneous and open retrograde endovascular stenting of symptomatic high-grade innominate artery stenosis: technique and follow-up. AJNR Am Neuroradiol 2011 Oct.;32:1726-31. 30. Rayer EJ, Oderich GS. Two-wire (0.014 & 0.018-Inch) technique to facilitate innominate artery stenting under embolic protection J Endovasc Ther 2010;17:652-56. 31. Meda N, Verma H, Tripathi RK. Long term results of endovascular interventions for subclavian and innominate arterial occlusive disease. Indian J Vasc Endovasc Surg 2015;2:2-6 32. de Borst GJ, Hazenberg CE. How should I treat a patient with a tandem carotid artery atherosclerotic stenosis involving the internal carotid artery and the innominate proximal common carotid artery? Eur J Vasc Endovasc Surg 2015;50:257-258. 33. Sfyroeras GS, Karathanos C, George A. Antoniou GA et al. A metaanalysis of combined endarterectomy and proximal balloon angioplasty for tandem disease of the arch vessels and carotid bifurcation. J Vasc Surg 2011;54:534-40. 34. Clouse WD, Emel A, Ergul EA et al. Retrograde stenting of proximal lesions with carotid endarterectomy increases risk. J Vasc Surg 2016;63:1517-23. 35. Cherry KJ, McCullough JL, Hallet JW et al. Technical principles of direct innominate artery revascularization: A comparison between endarterectomy and bypass grafts. J Vasc Surg 1989;9(5):718-23. 36. Ruel GJ, Jacobs HKHM, Gregoire JD et al. Innominate artery occlusive disease: surgical approach and long-term results. J Vasc Surg 1991;14:405-12. 37. Kieffer E, Sabatler J, Koskas F et al. Atherosclerotic innominate artery occlusive disease. Early and long-term results of surgical reconstruction. J Vasc Surg 1995;21:326-37. 38. Reivich M, Holling HE, Roberts J et al. Reversal of blood flow through vertebral artery and its effect on cerebral circulation. New Engl J Med 1961;265:878-85. 39. Contorni L. II circolo colaterale verterbro-vertebrale nella obliterazione della artéria subclávia alla sue origine. Minerva Chir 1960;15(26):73-80. 40. Bergher R, Kiefer E. Surgery of the arteries to the head. New York: Springer; 1992. 41. Levien LJ, Benn CA, Veller MG et al. Retrograde balloon angioplasty of brachiocephalic or common carotid artery stenosis at the time of carotid endarterectomy. Eur J Vasc Endovasc Surg 1998 June;15(6):521-27. 42. Vitek JJ. Subclavian artery angioplasty and the origin of the vertebral artery. Radiology 1989;170:407-9. 43. Henry M, Amor M, Henry I et al. Percutaneous transluminal angioplasty of the subclavian arteries. J Endovasc Surg 1999;6:33-41. 44. Sidhu OS, Morgan MB, Walters HL et al. Technical report: combined carotid bifurcation endarterectomy and intra-operative transluminal angioplasty of a proximal common artery stenosis: an alternative to extrathoracic bypass. Clin Radiol 1998;53:444-47. Arko FR, Buckley CJ, Lee SD et al. Combined carotid endarterectomy with transluminal angioplasty and primary stenting of the supraaórtico vessels. J Cardiovasc Surg (Torino) 2000 Oct.;41(5):737-42.
13. Thompson BW, Read RC, Campbell GS. Operative correction of proximal blocks of the subclavian or innominate arteries. J Cardiovasc Surg 1980;21:125-30.
10. DeBakey ME, Morris GC, Jordan GL et al. Segmental tromboobliterative disease of the great vessels arising from the aortic arch JAMA 1958;166:998-1003.
5. Terminologia Anatômica – Terminologia Anatômica Internacional. São Paulo: Editora Manole; 2001.
1. Tyras DH, Barner HB. Coronary-subclavian steal. Arch Surg 1977;112:1125-27.
12. Ligush Jr J, Criado E, Keagy BA. Innominate artery occlusive disease: management with central reconstructive techniques. Surgery 1997;121:556-62.
11. Diethrich EB, Garret HE, Ameriso J et al. Oclusive disease of the common carotid and subclavian arteries treated by carotid-subclavian bypass. Am J Surg 1967;114:800-8.
8. Shimizu K, Sano K. Pulseless disease. J Neuropathol Clin Neurol 1951;1:37-47.
54. Lutz HJ, Do DD, Schroth, G et al. Hybrid therapy of symptomatic stenosis of the innominate artery. Eur J Vasc Endovasc Surg 2002;24(2):18-5.
52. Kashyap VS, Franklin KS, Fitzpatrick CM. Bilateral brachial artery occlusion decreases internal carotid artery volume flow: a simple adjunct for cerebral protection? J Endovasc Ther 2005;12:454-60.
50. Peterson BG, Resnick SA, Morasch MD et al. Aortic arch vessel stenting: A single-center experience using cerebral protection. Arch Surg 2006;141:560-64.
49. Hadjipetrou P, Cox S, Piemonte T et al. Percutaneous revascularization of atherosclerotic obstruction of aortic arch 0vessels. J Am Coll Cardiol 1999;33:1238-45.
46. Vitek JJ, Raymon BC, Oh SJ. Innominated artery angioplasty. AJNR 1984;5:113-14.
53. Ringelstein EF, Zeumer H. Delayed revesal of vertebral artery blood flow following percutaneous transluminal angioplasty for subclavian steal syndrome. Neuroradiology 1984;26:189-98.
48. Motarjeme A, Keifer JW, Zuska AJ. Percutaneous transluminal angioplasty of the brachiocephalic arteries. AJR 1982;138:457-62.
95Capítulo 50 obstruções dos tronCos suPr A AórtiCos – tr AtAmento endovA sCul Ar
51. Ruebben A, Tettoni S, Muratore P et al. Feasibility of intraoperative balloon angioplasty and additional stent placement of isolated stenosis of the brachiocephalic trunk. J Thorac Cardiovasc Surg 1988;115:1316-20.
47. Motarjeme A, Keifer JW, Zuska AJ. Percutaneous transluminal angioplasty of the vertebral arteries. Radiology 1981;139:715-17.
1. Mitchell RO, Richardson JD, Lambert GE. Characteristics, surgical management, and outcome in 17 carotid body tumors. Am Surg 1996;62:1034-7. Williams MD, Phillips MJ, Nelson WR et al. Carotid body tumor. Arch Surg 1992;127:963-8.
18. Saldana MJ, Salem LE, Travezan R. High altitude hypoxia and chemodectomas. Human Pathol 1973;4(2):251-263.
26. Matticari S, Credi G, Pratesi C et al. Diagnosis and surgical treatment of the carotid body tumors. Arch Surg 1997;132:279-84.
17. Heath D. he human carotid body in health and disease. J Pathol 1991;164(1):1-8.
8. Bergan JJ, Yao JST. Yearbook of vascular surgery. St Louis: Yearbook Medical Publishers; 1990:165. 9. Antonitsis P, Saratzis N, Velissaris I et al. Management of cervical paragangliomas: review of 15-year experience. Langernbecks Arch Surg 2006;391(4):396-402.
96 51Capítulo TUMOR DO CORPO CAROTÍDEO REFERÊNCIAS BIBLIOGRÁFICAS
16. Liapis CD, Evangelidakis EK, Papavassiliou VG et al. Role of malignancy and preoperative embolization in the management of carotid body tumors. World J Surg 2000;24:1526-30.
13. Davidoc LB, Djukic VB, Vasic DM et al. Diagnosis and treatment of carotid body paragangliomas: 21 years of experience at a clinical center of Servia. World J Surg Oncol 2005;3(1):10. 14. Van den Berg R. Imaging and management of head and neck paragangliomas. Eur Radiol 2005;15:1310-18.
21. Rodrigues-Cuevas S, Lopez-Garza J, Labastida-Almendaro S. Carotid body tumors in inhabitants of altitudes higer than 2000 meters above sea level. Head Neck 1998;20:374-8.
27. Lee JH, Barich F, Karnell LH et al. National cancer data base report on malignant paragangliomas of the head and neck. Cancer 2002;94:730-7.
6. Luna-Ortiz K, Rascon-Ortiz M, Villavicencio-Valencia V et al Carotid body tumors: review of a 20-year experience. Oral Oncology 2005;41:56-61. 7. Knight TT, Gonzalez JA, Rary JM, Rush DS. Current concepts for the surgical management of carotid body tumor. Am J Surg 2006;191:104-10.
10. Ichikawa H. Innervation of the carotid body: immunohistochemical, denervation, and retrograde tracing studies. Microsc Res Tech 2002;59:188-95. 11. Berne RM, Levy MN. Physiology. St. Louis: C.V. Mosby Company; 1988. 12. Wang SJ, Wang MB, Barauskas TM et al. Surgical management of carotid body tumors. Otolaryngol Head Neck Surg 2000;123:202-6.
3. Shamblin WR, ReMine WH, Sheps SG et al. Carotid body tumor (chemodectoma): clinicopathologic analysis of ninety cases. Am J Surg 1971;122:732-9.
25. Muhm M, Polterauer P. Diagnostic and therapeutic approaches to carotid body tumors. Arch Surg 1997;132:278-84.
28. Jansen JC, van den Berg R, Kuiper A et al. Estimation of growth rate in patients with head and neck paragangliomas influences the treatment proposal. Cancer 2000;88(12):2811-2816
29. Langerman A, Athavale SM, Rangarajan SV et al. Natural history of cervical paragangliomas: outcomes of observation of 43 patients. Arch Otolaryngol Head Neck Surg 2012;138(4):341-345
15. Pellitteri PK, Rinaldo A, Myssiorek D et al. Paragangliomas of the head and neck. Oral Oncology 2004;40:563-75.
4. Maxwell JG, Jones SW, Wilson E et al. Carotid body tumor excision: adverse outcomes of adding carotid endarterectomy. J Am Coll Surg 2004;198:36-41. 5. Patetsios P, Gable DR, Garrett WV et al. Management of carotid body paragangliomas and review of a 30 year experience. Ann Vasc Surg 2002;16:331-37.
22. Drovdlic CM, Myers EN, Peters JA et al. Proportion of heritable paraganglioma cases and associated clinical characteristics. Laryngoscope 2001;111:1822-7.
30. Liapis C. Changing trends in management of carotid body tumors. Am Surg 1996;62:1034-7. 31. Hollander EF, Visser, MJT, van Baalen JM. Accessory thyroid gland at carotid bifurcation presenting as a carotid body tumor: case report and review of the literature. J Vasc Surg 2004;39:260-2. 32. David Taïeb, Alexandre Kaliski, Carsten C et al. Current Approaches and Recent Developments in the Management of Head and Neck Paragangliomas. Endocr Rev 2014 Oct;35(5):795-819. 33. Gujrathi CS, Donald PJ. Current trends in the diagnosis and management of head and neck paragangliomas. Curr Opin Otolaryngol Head Neck Surg 2005;13:339-42. 34. Ikejiri K. Functional carotid body tumor: report of a case and review of the literature. Surgery 1996;119(2):222-5. 35. Stoeckli SJ, Schuknecht B, Alkadhi M et al. Evaluation of paragangliomas presenting as a cervical mass on color-coded Doppler sonography. Laryngoscope 2002;112(1):143-6. 36. Bernhardt S. Sonography of the carotid body tumor. JDMS 2006;22:85-9. 37. Atefi S, Nikeghbalian S, Yarmohammadi H et al. Surgical management of carotid body tumors: report of two cases. Radiol 1979;132:409-410. 38. Arnold SM, Strecker R, Scheffer K et al. Dynamic contrast enhancement of para gangliomas of the head and neck: evaluation with time-resolved 2D MR projection angiography. Eur Radiol 2003;13:1608-11. 39. Hallet JW Jr, Nora JD, Hollier. Trends in neurovascular complications of surgical management for carotid body and cervical paragangliomas. A 50-year experience with 153 tumors. J Vasc Surg 1988;7:251-63. 40. Gordon Taylor G. Carotid body tumors. Br J Surg 1940;28:163. 41. Simonian GT, Pappas PJ, Padberg FT Jr et al. Mandibular subluxation for distal internal carotid exposure: technical considerations. J Vasc Surg 1999;30:1116-20. 42. Evenson LJ, Mendenhall WM, Parsons JT et al. Radiotherapy in the management of chemodectomas of the carotid body and glomus vagale. Head Neck 1998;20:609-13. 43. Pandya SK, Nagpal RD, Desai AP, Purohit AT. Death following external carotid arterial embolization for a functionating glomus jugular chemodectoma. J Neurosurg 1978;48:1030. 44. Tikkakoski T, Luotonen J, Leinonen S et al. Preoperative embolization in the management of neck paragangliomas. Laryngoscope 1997;107:821-26. 45. Power AH, Bower TC, Kasperbauer J et al. Impact of preoperative embolization on outcomes of carotid body tumor resections JVasc Surg 2012;56:979-89 46. Abud DG, Mounayer C, Benndorf G et al. Intratumoral injection of cyanoacrilate glue in head and neck paragangliomas. AJNR Am J Neuroradiol 2004;25:1457-62.
19. Baysal BE, Myers EN. Etiopathogenesis and clinical presentation of carotid body tumors. Microsc Res Tech 2002;59:256-61. 20. Baysal BE. Paragangliomas of the head and neck. Otolaryngol Clin North Am 2001;34:863-79.
2.
23. Pawlu C, Bausch B, Neumann HPH. Mutations of the SDHB and SDHD genes. Familial Cancer 2005;4:49-54. 24. Neumann HPH, Bausch B, Mc Whinney SR et al. Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med 2002;346:1459-66.
52. Robertson D, Beck C, Gary T et al. Classification of autonomic disorders. Int Angiology 1993;12:92-103.
47. Derdeyn DP, Neely JG. Direct puncture embolization for paragangliomas: promising results but preliminary data. AJNR Am J Neuroradiol 2004;25:1453-4. Hu K, Persky MS. Multidisciplinary management of paragangliomas of the head and neck, part 1. Oncology 2003;17:983-93.
97Capítulo 51 tumor do CorPo C Arotídeo
48.
51. Robertson D, Hollister AS, Biaggioni I et al. The diagnosis and treatment of baroreflex failure. N Engl J Med 1993;329:1449-55.
49. Krupski WC, Efferney DJ, Ehrenfeld WK et al. Cervical chemodectoma: technical considerations and management options. Am J Surg 1982;144:217.
54. Netterville JK, Reilly KM, Robertson D et al. Carotid body tumors: a review of 30 patients with 46 tumors. Laryngoscope 1995;105:115-26.
53. De Toma G, Nicolanti V, Plocco M et al. Baroreflex failure after bilateral excision of carotid body tumors: an underestimated problem. J Vasc Surg 2000;31:806-10.
50. Hu K, Persky MS. The multidisciplinary management of paragangliomas of the head and neck, part 2. Oncology 2003;17:1143-61.
14. Pokorny WJ, McGill CW, Harberg FJ. Use of azygous vein for central catheter insertion. Surgery 1985;97:362.
15. Oram-Smith JC, Mullen JL, Harken AH et al. Direct right atrial cannulation for parenteral nutrition. JPEN 1983;7:580-81.
17. Coit DG, Turnbull ADM. Long-term central vascular access through the gonadal vein. Surg Gynecol Obstet 1992;175:362-64.
30. Karakitsos D, Labropoulos N, De Groot E et al. Real-time ultrasoundguided catheterisation of the internal jugular vein: a prospective comparison with the landmark technique in critical care patients. Critical Care 2006;10:R162.
33. Boyce JM, Pittett D. HICPAC committee and HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force: guideline for hand hygiene in health-care settings. MMWR Recommendations and Reports 2002;51(RR16):1-44.
32. East D, Jacoby K. The effect of a nursing staff education program on compliance with central line care policy in the cardiac intensive care unit. Pediatr Nurs 2005;31:182-84.
6. Hickman RO, Buckner CD, Clife RA et al. A modified right atrial catheter for access to the venous system in marrow transplant recipients. Surg Gynecol Obstet 1979;148:871-75.
21. Raad I, Davis S, Becker M et al. Low infection rate and long durability of nontunneled Silastic catheters. Arch Intern Med 1993;153:1791-96.
13. Malt RA, Kempster M. Direct azygos vein and superior vena cava cannulation for parenteral nutrition. JPEN 1983;7:580-81.
18. Stavropoulos SW, Pan JJ, Clark TW et al. Percutaneous transhepatic venous access for hemodialysis. J Vasc Interv Radiol 2003;14:1187-1190.
1. Cosnett JE. The origins of intravenous fluid therapy. Lancet 1989;1:768-71.
23. Maki DG, Weise CE, Saratin HW. A semiquantitative culture method for identifying intravenous catheter-related infection. N Engl J Med 1977;296:1305-9. 24. Darouiche RO et al. A comparison of two antimicrobial-impregnated central venous catheters. N Engl J Med 1999;340:1. 25. Zürcher M, Tramèr M, Walder B. Colonization and bloodstream infection with single- versus multi-lumen central venous catheters: a quantitative systematic review. Anesth Analg 2004;99:177-82. 26. Deshpande KS, Hatem C, Ulrich HL et al. The incidence of infectious complications of central venous catheters at the subclavian, internal jugular, and femoral sites in an intensive care unit population. Crit Care Med 2005;33(1):13-20. 27. Lorente L, Villegas J, Martin MM et al. Catheter-related infection in critically ill patients. Intens Care Med 2004;30:1681-84. 28. Durbec O, Viviand X, Potie F et al. A prospective evaluation of the use of femoral venous catheters in critically ill adults. Crit Care Med 1997;25:1986-89.
31. Warren DK, Zack JE, Mayfield JL et al. The effect of an education programme on the incidence of central venous catheter associated bloodstream infection in a medical ICU. Chest 2004;126:1612-18.
11. Grant JP. Handbook of total parenteral nutrition. Philadelphia: WB Saunders; 1980. 12. Alexander HR. Vascular access in the cancer patient. Philadelphia: JB Lippincott; 1984.
3.
19. Po CL, Koolpe HA, Allen S et al. Transhepatic PermCath for hemodialysis. Am J Kidney Dis 1994;24:590-591.
20. Rahman S, Kuban JD. Dialysis Catheter Placement in Patients With Exhausted Access. Tech Vasc Interv Radadiol 2017;20:65-74.
10. Brown JM. Peripherally inserted central venous catheters: use in home care. J Intraven Nurs 1989;12:144-50.
5.
8. Niederhuber JE, Ensminger W, Gyves JW et al. Totally implanted venous and arterial access system to replace external catheters in cancer treatment. Surgery 1982 Oct;92(4):706-12.
9. Anderson AJ, Krasnow SH, Boyer MW et al. Clots can frequently be aspirated from Groshong catheters (abstract). Am Assoc Cancer Res 1988;29:228.
4.
29. Reusch S, Walder B, Tramer MR. Complications of central venous catheters: internal jugular versus subclavian access – a systematic review. Crit Care Med 2002;30:454-60.
16. Boddie Jr AW. Translumbar catheterization of the inferior vena cava for long-term angioaccess. Surg Gynecol Obstet 1989;168:55-56.
7. Wagman LD, Kirkemo A, Johnston MR. Venous access; a prospective, randomized study of the Hickman catheter. Surg Gynecol Obstet 1984;95:303-8.
98 52Capítulo ACESSOS VENOSOS CENTRAIS COM DISPOSITIVOS DE LONGA PERMANÊNCIA REFERÊNCIAS BIBLIOGRÁFICAS
22. Brothers TE, Von Moll LK, Niederhuber JE et al. Experience with subcutaneous infusion ports in three hundred patients. Surg Gynecol Obstet 1988;166-295-301.
2. Zimmermann B. Intravenous tubing for parenteral therapy. Science 1945;101:567-68. Roy RB, Wilkinson RH, Bayliss CE. The utilization of long nylon catheters for prolonged intravenous infusions. Can Med Assoc J 1967;96:94-97. Seldinger SI. Catheter replacement of the needle in percutaneous arteriography; a new technique. Acta Radiol 1953;39:368. Broviac JW, Cole JJ, Schribner BH. A silicone rubber atrial catheter for prolonged parenteral alimentation. Surg Gynecol Obstet 1973;136:602-6.
34. Mimoz O, Villeminey S, Ragot S et al. Chlorhexidine-based antiseptic solution vs alcohol-based povidone–iodine for central venous catheter care. Arch Inter Med 2007;167(19):2066-72.
30. Harris KA, Niesobska V, Carroll SE et al. Extra-anatomic bypass grafting: A rational approach. Canad J Surg Journal canadien de chirurgie 1989;32:113-116.
18. Pagni S, Denatale RW, Sweeney T et al. Primary aorto-duodenal fistula secondary to infected abdominal aortic aneurysms: The role of local debridement and extra-anatomic bypass. J Cardiovasc Surg 1999;40:31-35.
27. Hepp W, de Jonge K, Pallua N. Late results following extra-anatomic bypass procedures for chronic aortoiliac occlusive disease. J Card Surg 1988;29:181-185. 28. Rutherford RB, Patt A, Pearce WH. Extra-anatomic bypass: A closer view. J Vasc Surg 1987;6:437-446. 29. LoGerfo FW, Johnson WC, Corson JD et al. A comparison of the late patency rates of axillobilateral femoral and axillounilateral femoral grafts. Surgery 1977;81:33-38; discussion 38-40.
15.
21. Calligaro KD, Ascer E, Veith FJ et al. Unsuspected inflow disease in candidates for axillofemoral bypass operations: A prospective study. J Vasc Surg 1990;11:832-837.
14.
7. Blaisdell WF, Hall AD. Axillary-femoral artery bypass for lower extremity ischemia. Surgery 1963;54:563.
6. Louw JH. The treatment of combined aortoiliac and femoropopliteal occlusive disease by splenofemoral and axillofemoral bypass grafts. Surgery 1964;55:387-395.
9. Sauvage LR, Wood SJ. Unilateral axillary bilateral femoral bifurcation graft: A procedure for the poor risk patient with aortoiliac disease. Surgery 1966;60:573-577.
2. McCaughan JJ, Kahn SP. Crossover graft for unilateral occlusive disease of the iliofemoral arteries. Ann Surg 1960;151.
1. Freeman NE, Leeds FH. Operations on large arteries; application of recent advances. Calif Medic 1952;77:229-233.
8. Vetto RM. The treatment of unilateral iliac artery obstruction with a transabdominal, subcutaneous, femorofemoral graft. Surgery 1962;52:343-345.
16. Lehnert T, Gruber HP, Maeder N, Allenberg JR. Management of primary aortic graft infection by extra-anatomic bypass reconstruction. Eur J Vasc Surg 1993;7:301-307.
12. Ehrenfeld WK, Levin SM, Wylie EJ. Venous crossover bypass grafts for arterial insufficiency. Ann Surg 1968;167:287-291.
33. Bliss BP, Barrett GS. Axillo-femoral and axillo-profunda bypass grafts. Their use for limb salvage in the bad-risk patient with occlusion or infection of the abdominal aorta and iliac arteries. Ann Royal Coll Surg Engl 1972;50:268-273.
5. Louw JH. Splenic-to-femoral and axillary-to-femoral bypass grafts in diffuse atherosclerotic occlusive disease. Lancet 1963;1:1401.
37. White GH, Donayre CE, Williams RA et al. Exertional disruption of axillofemoral graft anastomosis. ‘The axillary pullout syndrome’. Arch Surg 1990;125:625-627.
REFERÊNCIAS BIBLIOGRÁFICAS
36. Kempczinski R, Penn I. Upper extremity complications of axillofemoral grafts. Am J Surg 1978;136:209-211
20. Walker S. Regarding “occluding aortic endoluminal stent graft combined with extra-anatomic axillofemoral bypass as alternative management of abdominal aortic aneurysms for patients at high risk with complex anatomic features: A preliminary report”. J Vasc Surg 1999;30:386.
34. Ray LI, O’Connor JB, Davis CC et al. Axillofemoral bypass: A critical reappraisal of its role in the management of aortoiliac occlusive disease. Am J Surg 1979;138:117-128. 35. Rutherford RB, Mitchell MB. Extra-anatomic bypass. In: Rutherford RB et al. (Eds.). Vasc Surg. Philadelphia: WB Saunders; 2000. p. 981-997.
24. Fields WS, Lemak NA. Joint study of extracranial arterial occlusion. Vii. Subclavian steal--a review of 168 cases. JAMA 1972;222:1139-1143.
4. Blaisdell WF, DeMattei GA, Dauder PJ. Extraperitoneal thoracic aorta to femoral bypass graft as replacement for an infected aortic bifurcation prosthesis. Am J Surg 1961;102:583.
31. Passman MA, Taylor LM, Moneta GL et al. Comparison of axillofemoral and aortofemoral bypass for aortoiliac occlusive disease. J Vasc Surg 1996;23:263-269; discussion 269-271.
3. Lewis CD. A subclavian artery as the means of blood-supply to the lower half of the body. Br J Surg 1961;48:574-575.
38. Bandyk DF, Thiele BL, Radke HM. Upper-extremity emboli secondary to axillofemoral graft thrombosis. Arch Surg 1981;116:393-395. Mawatari K, Muto Y, Funahashi S et al. The potential risk for upper extremity thromboembolism in patients with occluded axillofemoral bypass grafts: Two case reports. Vasc Surg 2001;35:67-71. 40. Christenson JT, Broome A, Norgren L, Eklof B. The late results after axillo-femoral bypass grafts in patients with leg ischaemia. J Cardiovasc Surg 1986;27:131-135. Oblath RW, Green RM, DeWeese JA, Rob CG. Extra-anatomic bypass of the abdominal aorta: Management of postoperative thrombosis. Ann Surg 1978;187:647-652. 42. Harris EJ Jr, Taylor LM Jr, McConnell DB et al. Clinical results of axillobifemoral bypass using externally supported polytetrafluoroethylene. J Vasc Surg 1990;12:416-420; discussion 420-411. 43. el-Massry S, Saad E, Sauvage LR et al. Axillofemoral bypass with externally supported, knitted dacron grafts: A follow-up through twelve years. J Vasc Surg 1993;17:107-114; discussion 114-105.
41.
26. Ascer E, Veith FJ, Gupta SK et al. Comparison of axillounifemoral and axillobifemoral bypass operations. Surgery 1985;97:169-175.
13. Myers WO, Lawton BR, Sautter RD. Axillo-axillary bypass graft. JAMA 1971;217:826. Brito C, Fonseca VR. Restauração no segmento aorto-ilíaco. In: Bonamigo TP et al. (Eds.). Doenças da aorta e seus ramos: Diagnóstico e tratamento. São Paulo: Fundo Editorial Byk; 1991:229-237. Parodi JC, Palmaz JC, Barone HD. Transfemoral intraluminal graft implantation for abdominal aortic aneurysms. Ann Vasc Surg 1991;5:491-499.
19. Le Minh T, Motte S, Hoang AD et al. Occluding aortic endoluminal stent graft combined with extra-anatomic axillofemoral bypass as alternative management of abdominal aortic aneurysms for patients at high risk with complex anatomic features: A preliminary report. J Vasc Surg 1998;28:651-656.
99 53CapítuloDERIVAÇÕES EXTRA-ANATÔMICAS – PARTE CERVICAL
17. Schmitt DD, Seabrook GR, Bandyk DF, Towne JB. Graft excision and extra-anatomic revascularization: The treatment of choice for the septic aortic prosthesis. J Cardiovasc Surg 1990;31:327-332.
39.
10. Shaw R, Baue A. Management of sepsis complicating arterial reconstructive surgery. Surgery 1962;53:75.
23. Crawford ES, De Bakey ME, Morris GC Jr, Howell JF. Surgical treatment of occlusion of the innominate, common carotid, and subclavian arteries: A 10 year experience. Surgery 1969;65:17-31.
11. Lyons C, Galbraith G. Surgical treatment of atherosclerotic occlusion of the internal carotid artery. Ann Surg 1957;146:487-496; discussion 496-488.
25. Eugene J, Goldstone J, Moore WS. Fifteen year experience with subcutaneous bypass grafts for lower extremity ischemia. Ann Surg 1977;186:177-183.
22. Gross WS, Flanigan P, Kraft RO, Stanley JC. Chronic upper extremity arterial insufficiency. Etiology, manifestations, and operative management. Arch Surg 1978;113:419-423.
32. Paladino C, Sampere CT, Guasch J, Sanchez Casalongue M. Hemodynamic evaluation of extra-anatomic revascularization of the aorto-iliac sector. Angiologia 1989;41:17-19.
47.
53. Baird RJ, Ropchan GV, Oates TK et al. Ascending aorta to bifemoral bypass--a ventral aorta. J Vasc Surg 1986;3:405-410.
54. Schneider JR. Extra-anatomic bypass. In: Rutherford RB et al. (Eds.). Vascular surgery. Philadelphia: Elsevier Inc; 2005. p. 1137-1151.
49.
45.
58. Bjork VO. Aneurysm and occlusion of the right subclavian artery. Acta Chirurgica Scandinavica 1965;356:103-109. 59. Cina CS, Safar HA, Lagana A et al. Subclavian carotid transposition and bypass grafting: Consecutive cohort study and systematic review. J Vasc Surg 2002;35:422-429. 60. Criado FJ, Barnatan MF, Rizk Y et al. Technical strategies to expand stent-graft applicability in the aortic arch and proximal descending thoracic aorta. J Endovasc Ther 2002;9 Suppl 2:II32-38. 61. Criado FJ, Clark NS, Barnatan MF. Stent graft repair in the aortic arch and descending thoracic aorta: A 4-year experience. J Vasc Surg 2002;36:1121-1128. 62. Kato M, Kaneko M, Kuratani T. New operative method for distal aortic arch aneurysm: Combined cervical branch bypass and endovascular stent-graft implantation. J Thorac Cardiovasc Surg 1999;117:832-834. 63. Kato N, Shimono T, Hirano T et al. Aortic arch aneurysms: Treatment with extra-anatomical bypass and endovascular stent-grafting. Cardiovasc Intervent Radiol 2002;25:419-422.
44.
51. Frantz SL, Kaplitt MJ, Beil AR Jr., Stein HL. Ascending aorta-bilateral femoral artery bypass for the totally occluded infrarenal abdominal aorta. Surgery 1974;75:471-475.
III
55. Passman MA, Farber MA, Criado E et al. Descending thoracic aorta to iliofemoral artery bypass grafting: A role for primary revascularization for aortoiliac occlusive disease? J Vasc Surg 1999;29:249-258. 56. McMillan WD, McCarthy WJ. Minimally invasive thoracoscopic thoraco-femoral bypass: A case report. Cardiovasc Surg (London, England) 1999;7:251-254.
100 ParteCERVICAL Ward RE, Holcroft JW, Conti S, Blaisdell FW. New concepts in the use of axillofemoral bypass grafts. Arch Surg 1983;118:573-576. Welch HJ, Belkin M. Acute limb ischemia resulting from graft failure. In: Strandness DE Jr (Ed.). Vascular diseases – surgical & interventional therapy. New York: Churchill Livingstone Inc; 1994. p. 379. Smith RB 3rd, Perdue GD Jr, Hyatt HC, Ansley JD. Management of the infected aortofemoral prosthesis including use of an axillopopliteal bypass. Am Surg 1977;43:65-73. Ascer E, Veith FJ, Gupta S. Axillopopliteal bypass grafting: Indications, late results, and determinants of long-term patency. J Vasc Surg 1989;10:285-291. Veith FJ, Moss CM, Daly V et al. New approaches to limb salvage by extended extra-anatomic bypasses and prosthetic reconstructions to foot arteries. Surgery 1978;84:764-774. Keller MP, Hoch JR, Harding AD et al. Axillopopliteal bypass for limb salvage. J Vasc Surg 1992;15:817-822.
52. Baird RJ, Madras PN. Ascending aorta to bilateral femoral artery graft via a ventral subcutaneous route. Ann Surg 1977;186:210-212.
57. Brener BJ, Brief DK, Veith FJ. Extraanatomic bypasses. In: Veith FJ et al. (Eds). Vascular surgery. Principles and practice. New York: McGraw Hill, Inc; 1994. p. 485.
46.
48.
50. Schumacker HB Jr. Coarctation of the aorta. J Indiana State Med Assoc 1968;61:334-336.
Parte IV TÓRAX
7. Ugalde P, Camargo Jde J, Deslauriers J. Lobes, fissures, and bronchopulmonary segments. Thorac Surg Clin 2007;17:587-599.
17. Mandarim-de-Lacerda CA. Anatomia do coração: clínica e cirúrgica. Rio de Janeiro: Revinter; 1990. p. 133.
29. Mandarim-de-Lacerda CA, Penteado CV. Topographical and morphometrical study of the atrioventricular junctional area of the cardiac conduction system in the Macaca fascicularis Raffles, 1821. Anat Anz 1988;167:57-61.
REFERÊNCIAS BIBLIOGRÁFICAS
3. Tubbs RS, Loukas M, Salter EG, Oakes WJ. Wilhelm Erb and Erb’s point. Clin Anat 2007;20:486-488.
6. Jackson CL. Segmental bronchi and the bronchopulmonary segments. Am J Surg 1955;89:319-323.
18. Anderson RH, Becker AE. Cardiac anatomy. An integrated text and colour atlas. Edinburgh: Churcill Livingstone; 1980. p. 185.
13. Carter BW, Benveniste MF, Madan R et al. ITMIG Classification of Mediastinal Compartments and Multidisciplinary Approach to Mediastinal Masses. Radiographics 2017;37:413-436.
21. Anderson RH, Boyett MR, Dobrzynski H, Moorman AF. The anatomy of the conduction system: implications for the clinical cardiologist. J Cardiovasc Transl Res 2013;6:187-196.
26. James TN, Sherf L. Specialized tissues and preferential conduction in the atria of the heart. Am J Cardiol 1971;28:414-427.
15. Weber KT, Clark WA, Janicki JS, Shroff SG. Physiologic versus pathologic hypertrophy and the pressure-overloaded myocardium. J Cardiovasc Pharmacol 1987;10 Suppl 6:S37-50.
103 54Capítulo
APLICADA À REGIÃO TORÁCICA
12. Myers PO, Fasel JH, Kalangos A, Gailloud P. Arteria lusoria: developmental anatomy, clinical, radiological and surgical aspects. Ann Cardiol Angeiol (Paris) 2010;59:147-154.
22. Ahmed SH, el-Rakhawy MT, Abdalla A, Harrison RG. A new conception of coronary artery preponderance. Acta Anat (Basel) 1972;83:87-94.
25. James TN. The Connecting Pathways between the Sinus Node and a-V Node and between the Right and the Left Atrium in the Human Heart. Am Heart J 1963;66:498-508.
27. Anderson RH, Ho SY, Smith A, Becker AE. The internodal atrial myocardium. Anat Rec 1981;201:75-82.
9. Riquet M, Hidden G, Debesse B. Direct lymphatic drainage of lung segments to the mediastinal nodes. An anatomic study on 260 adults. J Thorac Cardiovasc Surg 1989;97:623-632.
2. Wraight WM, Tweedie DJ, Parkin IG. Neurovascular anatomy and variation in the fourth, fifth, and sixth intercostal spaces in the midaxillary line: a cadaveric study in respect of chest drain insertion. Clin Anat 2005;18:346-349.
11. Deslauriers J. Anatomy of the neck and cervicothoracic junction. Thorac Surg Clin 2007;17:529-547.
16. Weber KT, Sun Y, Tyagi SC, Cleutjens JP. Collagen network of the myocardium: function, structural remodeling and regulatory mechanisms. J Mol Cell Cardiol 1994;26:279-292.
ANATOMIA
24. Noheria A, Desimone CV, Lachman N et al. Anatomy of the coronary sinus and epicardial coronary venous system in 620 hearts: an electrophysiology perspective. J Cardiovasc Electrophysiol 2013;24:1-6.
1. Machado-de-Sousa O. Anatomia Topográfica. Parte Geral. São Paulo: Rossolillo; 1970. p. 204.
23. Mandarim-de-Lacerda CA, Ramos e Souza DS, Bonfim V. Morphometric and statistical study of the presence of myocardial bridges over the anterior intraventricular branch (anterior descending) of the left coronary artery in Brazilian subjects. Arq Bras Cardiol 1987;49:19-23.
30. Meier MA, Lucchese FA, Oliveira JA et al. Surgical anatomy of the conduction system in congenital heart defects. Arq Bras Cardiol 1984;43:437-448.
19. Mandarim-de-Lacerda CA. Dissecção e microscopia ótica dos feixes miocárdicos do septo interatrial humano. Arq Bras Cardiol 1982;39:31-34.
8. Welter S, Stocker C, Dicken V et al. Lung segment geometry study: simulation of largest possible tumours that fit into bronchopulmonary segments. Thorac Cardiovasc Surg 2012;60:93-100.
28. Anderson RH, Christoffels VM, Moorman AF. Controversies concerning the anatomical definition of the conduction tissues. Anat Rec B New Anat 2004;280:8-14.
14. Fujimoto K, Hara M, Tomiyama N et al. Proposal for a new mediastinal compartment classification of transverse plane images according to the Japanese Association for Research on the Thymus (JART) General Rules for the Study of Mediastinal Tumors. Oncol Rep 2014;31:565-572.
10. Aquino SL, Duncan G, Taber KH et al. Reconciliation of the anatomic, surgical, and radiographic classifications of the mediastinum. J Comput Assist Tomogr 2001;25:489-492.
20. Nathan H, Eliakim M. The junction between the left atrium and the pulmonary veins. An anatomic study of human hearts. Circulation 1966;34:412-422.
5. Mirilas P, Siatitsas Y, Skandalakis JE. Benign anatomical mistakes: inferior pulmonary ligament. Am Surg 2002;68:922-926.
4. Finley DJ, Rusch VW. Anatomy of the pleura. Thorac Surg Clin 2011;21:157-163, vii.
104 55Capítulo
VIAS DE ACESSO AOS VASOS TORÁCICOS
BIBLIOGRAFIA Ballard JL, Killeen JD. Anatomy and surgical exposure of the vascular system. In: Moore W. (Ed.). Vascular surgery. Philadelphia: WB Saunders; 1998. p. 44-66. Bismulth H. Les anastomoses porto caves tronculaires. Techniques chirurgicales. Appareil digestif. Encyl Med Chir Paris 2006. p. 408. Branchereau A, Ondon’Dong F. Extended medial approach to the popliteal artery without muscular division. Ann Vasc Surg 1989;3:77-80. Cherry Jr KJ, McCullough JL et al. Technical principles of direct innominate artery revascularization: a comparison of endarterectomy and bypass grafts. J Vasc Surg 1989;9:718. Crawford ES, De Bakey ME et al. Thrombo-obliterative disease of the great vessels arising from the aortic arch. J Thorac Cardiovasc Surg Dardick1962;43:38.H,Dardick I, Veith FJ. Exposure of the tibioperoneal arteries by a single lateral approach. Surgery 1974;75:377. Elkin DC, Kelly RP. Arteriovenous aneurysm: exposure of the tibial and peroneal vessels by resection of the fibula. Ann Surg 1945;122:529-45. Fiolle J, Delmas J. Découverte des vaisseaux profonds par des voies d’accès larges. Paris: Masson; 1940. Fisher DF, Clagett GP, Parker JI et al. Mandibular subluxation for high carotid exposure. J Vasc Surg 1984;1:727-33. Fisher Jr DF, Fry WJ. Collateral mesenteric circulation. Surg Gynecol Obstet Goldsmith1987;164:487.MM3d, Postma DS, Jones FD. The surgical exposure of penetrating injuries to the carotid artery at the skull base. Otalaryngol Head Neck Surg 1986;95:278-84. Haimovici H, Ernest CB, Berguer R. Exposição cirúrgica dos vasos. In: Haimovici H. (Ed.). Cirurgia vascular: princípios e técnicas. 4. ed. Rio de Janeiro: Di-Livros; 2000. p. 351. Haimovici H. Arterial circulation of the extremities. In: Schwartz CJ, Werthessen NT, Wolf A. (Eds.) Structure and function of the circulation New York: Plenum; 1980. p. 425-85, v. 1. Hall-Craggs ECB. The upper limb. In: Hall-Craggs. (Ed.) Anatomy Baltimore: Williams & Wilkins; 1995. p. 160, cap. 64. Henderson JM, Warren WD, Milikan WJ et al. Distal splenorenal shunt with splenopancreatic disconnection: a 4-year assessment. Ann Surg Hertzer1989;210:332-39.NR,Felaman BJ, Beven EG, Tucker HM. A prospective study of the incidence of injury to the cranial nerves during carotid endarterectomy. Surg Gynecol Obstet 1980;151:781. International Anatomical Nomenclature Committee. Nomina anatômica 5. ed. México: Medsi; 1984. Johansen K, Banayk D et al. Temporary intraluminal shunts: resolution of a management dilemma in complex vascular injuries. J Trauma Madden1982;22:395-401.JL. Atlas de técnicas cirúrgicas. 2. ed. São Paulo: Roca; 1987. p. Mattox212-351.KL,Hieshberg A. Access control and repair techniques. In: Rich NM. (Ed.). Vascular trauma. 2nd ed. Philadelphia: Saunders; 2004. p. Mouson137-64.DO, Saletta JD, Frecark RJ. Carotid and vertebral trauma. J Trauma Nascimento-Silva1969;9(12):987-99.JLC.Anatomia médico-cirúrgica do sistema vascular. In: Brito CJ. (Ed.). Cirurgia vascular. Rio de Janeiro: Revinter; 2002. p. 25-76. Netter FH. The head and neck In: Netter FH. (Eds.). Atlas of human anatomy. Hanover: Library of Congress Catalog; 1997. p. 28. Petroianu A. Anatomia cirúrgica. Rio de Janeiro: Guanabara Koogan, 1999. Rich NM, Spencer FC. Vascular trauma. Philadelphia: WB Saunders, 1978. Ristow AV. Traumatismos vasculares dos membros. Urgências vasculares Rio de Janeiro: Cultura Médica; 1983. p. 19-61. Rossi M, Brito CJ, Cury RCP. Principais vias de acesso utilizadas no trauma vascular. In: Rossi M. (Ed.) Trauma vascular. Rio de Janeiro: Revinter; 2006. p. 58-73. Rossi M. Vias de acesso mais utilizadas em cirurgia vascular In: Brito CJ. (Ed.). Cirurgia vascular. Rio de Janeiro: Revinter, 2002. p. 77-104. Rutherford RB. Atlas de cirurgia vascular. Técnicas e exposições básicas. Rio de Janeiro: Di-Livros; 1998. Simonian GT, Pappas PJ, Padberg Jr FT et al. Mandibular subluxation for distal internal carotid exposure: technical considerations. J Vasc Surg Snell1999;30:1116.RS.Anatomia humana. 2. ed. Rio de Janeiro: Medsi; 1984. Stoney RJ, Effeney DJ. Comprehensive vascular exposures. Philadelphia: Lippincott-Raven; 1998. Testut L. Traité D’anatomie humaine. 4 éme ed. Paris: Octave Doin, 1900; v. Trout2.HH, Giodano JM. Anomalies of the inferior vena cava. J Vasc Surg Valentine1986;3:924.RJ,Wind GG. Anatomic exposures in vascular surgery. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 2003. Valentine RJ, Wind GG. Anatomy of commonly exposed arteries. In: Rutherford RB. (Ed.). Vascular surgery. 5th ed. Philadelphia: WB Saunders; 2000. p. 48-60. Yeo CJ, Cameron JL, Lillemore KD, et al. Pancreaticoduodenectomy for cancer of the head of the pancreas: 201 patients. Ann Surg 1995;221:721-29.
4.
17. Dinkel HP, Triller J. Pulmonary arteriovenous malformations: embolotherapy with superselective coaxial catheter placement and filling of venous sac with guglielmi detachable coils. Radiology 2002;223:709-714. 18. Jaskolka J, Wu L, Chan RP. Imaging of hereditary hemorrhagic telangectasia. AJR 2004;183:307-314. 19. Raymond GS, Miller RM, Muller NL et al. Congenital thoracic lesions that mimic neoplastic disease on chest radiographis of adults. AJR 1997;168:763-769. 20. Westra JS, Hill JA, Alejos JC et al. Three dimensional helical CT of pulmonary arteries in infants and children with congenital heart disease. AJR 1999;173:109-115. 21. Kim HC, Chung JW, P JH et al. Role of CT Venography in the Diagnosis and Treatment of Benign Thoracic Central Venous Obstruction. Korean J Radiol 2003 Sep;4(3).
2.
10. Coche E et al. Diagnosis of Acute Pulmonary Embolism in Outpatients: Comparation of Thin-collimation Multi-detector Row Spiral CT and Planar Ventilation-Perfusion Scintigraphy. Radiology 2003;229:757-765.
11. Kavanagh EC et al. Risk of Pulmonary Embolism After Negative MDCT Pulmonary Angiography Findings. Am J Roentgenology 2003;182:499-504.
15. Dournes G, Verdier D, Montaudon M et al. Dual-energy CT perfusion and angiography in chronic thromboembolic pulmonary hypertension: diagnostic accuracy and concordance with radionuclide scintigraphy. Eur Radiol 2014;24:42. 16. Frase RS, Muller NL, Colman NC, Pare PD. Diagnosis of Diseases of the Chest. 4th ed. W.B. Saunders Company; 1999. p. 655-662.
5.
6.
DOS VASOS TORÁCICOS REFERÊNCIAS
12. Zhang LJ, Lu GM, Meinel FG et al. Computed tomography of acute pulmonary embolism: state-of-the-art. Eur Radiol 2015;25:2547–2557
1.
13. Thieme SF, Becker CR, Hacker M et al. Dual energy CT for the assessment of lung perfusion: correlation to scintigraphy. Eur J Radiol 2008;68:369-374. 14. Chae EJ, Seo JB, Jang YM et al. Dual-energy CT for assessment of the severity of acute pulmonary embolism: pulmonary perfusion defect score compared with CT angiographic obstruction score and right ventricular/left ventricular diameter ratio. AJR 2010;194:604-610
105 56Capítulo
7.
8.
3.
ANGIOTOMOGRAFIA BIBLIOGRÁFICAS Tsolakis CC et al. Pulmonary Sequestration: Experience with eight consecutive cases. Scand Cardiovasc J 1997;31:229-232. Tokel K et al. Coil embolization of pulmonary sequestration in two infants: a safe alternative to surgery. AJR 2000;175:993-995. Frazier AA et al. From the Archives of the AFIP – Intralobar Sequestration: Radiolgic-Pathologic Correlation. Radiographics 1997;17:725-745. Frazier A.A et al. From the Archives of the AFIP – Intralobar Sequestration: Radiolgic-Pathologic Correlation. Radiographics 1997;17:725-745. Ikezoe J et al. Bronchopulmonaruy sequestration: CT assessment. Radiology 1990;176:375-379. Wolfe TR, Hartsell SC. Pulmonary Embolism: Making sense of the diagnostic evaluation. Annals of Emergency Medicine 2001 May;37:504-514. Barritt D, Jordn S. Anticoagulant drugs in the treatment of pulmonary embolism: a controlled trial. Lancet 1960;1:1309-1312. Mordan B, Sharon E, Jelin N. Factor contributing to the incorrect diagnosis of pulmonary embolism disease. Chest 1972;62:388-393. 9. Remy-Jardin M, Remy J, Baghaie F et al. Clinical value of thin collimation in the diagnostic workup of pulmonary embolism. Am J Roentgenology 2000;175:407- 411.
4. Litmanovich D, Bankier AA, Cantin L et al. CT and MRI in the diseases of the aorta. AJR Am J Roentgenol 2009;193(4):928-40.
7. Lavall D, Schäfers HJ, Böhm M, Laufs U. Aneurysms of the ascending aorta. Dtsch Arztebl Int 2012;109(13):227-33.
5. Ho N, Mohadjer A, Desai MY. Thoracic aortic aneurysms: state of the art and current controversies Expert Rev Cardiovasc Ther 2017;15(9):667-80.
8. Vilacosta I, San Román JA. Acute aortic syndrome. Heart 2001;85(4):365-8.
10. Strayer RJ. Thoracic Aortic Syndromes. Emerg Med Clin North Am 2017;35(4):713-25.
18. Dijkema EJ, Leiner T, Grotenhuis HB. Diagnosis, imaging and clinical management of aortic coarctation. Heart 2017;103(15):1148-55.
15. Bluemke DA. Definitive diagnosis of intramural hematoma of the thoracic aorta with MR Imaging. Radiology 1997;204(2):319-21.
13. Hartnell GG. Imaging of aortic aneurysms and dissection: CT and MRI. J Thorac Imaging 2001;16(1):35-46.
17. Stanson AW, Kazmier FJ, Hollier LH et al. Penetrating atherosclerotic ulcers of the thoracic aorta: natural history and clinicopathologic correlations. Ann Vasc Surg 1986;1(1):15-23.
3. Morita 3 S, Masukawa A, Suzuki K et al. Unenhanced MR angiography: techniques and clinical applications in patients with chronic kidney disease. Radiographics 2011;31(2):E13-33.
6. Dudzinski DM, Isselbacher EM. Diagnosis and management of thoracic aortic diseases. Curr Cardiol Rep 2015;17(12):106.
1. Schneider G. MR Angiography of the thoracic aorta. In: Schneider G, Prince MR, Meaney JFM, Ho VB. Magnetic Resonance Angiography. Techniques, indications and practical applications. Springer; 2005. p. 141-161.
9. Mussa FF, Horton JD, Moridzadeh R et al. Acute Aortic Dissection and Intramural Hematoma: A Systematic Review. JAMA 2016;316(7):754-63.
106 57Capítulo ANGIORRESSONÂNCIA MAGNÉTICA DOS VASOS TORÁCICOS REFERÊNCIAS BIBLIOGRÁFICAS
19. Shepherd B, Abbas A, McParland P, Fitzsimmons S, Shambrook J, Peebles C, et al. MRI in adult patients with aortic coarctation: diagnosis and follow-up. Clin Radiol 2015;70(4):433-45.
20. Gach P, Dabadie A, Sorensen C et al. Multimodality imaging of aortic coarctation: From the fetus to the adolescent. Diagn Interv Imaging 2016 May;97(5):581-90.
2. Siegel MJ, Earls JP. Thoracic Vascular Anomalies. In: Rubin GD, Rofsky NM (Eds). CT and MR angiography: Comprehensive vascular assessment. 1ª edição. Philadelphia, PA: Lippincott Williams & Wilkins; 2009. p. 544-94.
21. Kalmar PI, Koestenberger M, Marterer R et al. Gadolinium-free MR in coarctation-can contrast-enhanced MR angiography be replaced? Clin Imaging 2016;40(3):414-8. 22. Karaosmanoglu AD, Khawaja RD, Onur MR, Kalra MK. CT and MRI of aortic coarctation: pre- and postsurgical findings. AJR Am J Roentgenol 2015;204(3):W224-33.
11. Macura KJ, Corl FM, Fishman EK, Bluemke DA. Pathogenesis in acute aortic syndromes: aortic dissection, intramural hematoma, and penetrating atherosclerotic aortic ulcer. AJR Am J Roentgenol 2003;181(2):309-16.
12. Khan A, Nair CK. Clinical, diagnostic, and management perspectives of aortic dissection. Chest 2002;122(1):311-28.
14. Ciccone MM, Dentamaro I, Masi F et al. Advances in the diagnosis of acute aortic syndromes: Role of imaging techniques. Vasc Med 2016;21(3):239-50.
23. Bossone E, Pluchinotta FR, Andreas M et al. Aortitis. Vascul Pharmacol 2016;80:1-10. 24. Hartlage GR, Palios J, Barron BJ et al. Multimodality imaging of aortitis. JACC Cardiovasc Imaging 2014;7(6):605-19. 25. Murphy DJ, Keraliya AR, Agrawal MD et al. Cross-sectional imaging of aortic infections. Insights Imaging 2016;7(6):801-18. 26. Barra L, Kanji T, Malette J, Pagnoux C. Vascular Imaging modalities for the diagnosis and disease activity assessment of Takayasu’s arteritis: A systematic review and meta-analysis. Autoimmun Rev 2018;17(2):175-87. 27. Gaballah M, Goldfisher R, Amodio JB. The Utility of MRI in the Diagnosis of Takayasu Arteritis. Case Rep Pediatr 2017;2017:7976165. 28. Choe YH, Han BK, Koh EM et al. Takayasu’s arteritis: assessment of disease activity with contrast-enhanced MR imaging. AJR Am J Roentgenol 2000;175(2):505-11. 29. John RA, Keshava SN, Danda D. Correlating MRI with clinical evaluation in the assessment of disease activity of Takayasu’s arteritis. Int J Rheum Dis 2017l;20(7):882-6.
16. Murray JG, Manisali M, Flamm SD et al. Intramural hematoma of the thoracic aorta: MR image finding and their prognostic implications. Radiology 1997;204(2):349-55.
107 58CapituloANGIOGRAFIA DOS VASOS TORÁCICOS REFERÊNCIAS BIBLIOGRÁFICAS 1. Perler BA. Vascular Intervention A Clinical Approach. New York: Thieme Medical Publishers, Inc; 1998. p. 21-34. 2. Uflacker R. Radiologia Intervencionista. São Paulo: Sarvier; 1987. p. 28-41. 3. Uflacker R. Atlas of Vascular Anatomy. Carolina do Sul: Williams & Wilkins; 1997. White, RA.
ANEURISMA DO ARCO AÓRTICO BIBLIOGRÁFICAS
5. Malone CD, Urbania TH, Crook SE, Hope MD. Bovine aortic arch: a novel association with thoracic aortic dilation. Clin Radiol 2012;67:28-31.
10. de la Cruz KI, Green SY, Preventza OA, Coselli JS. Aortic Arch Replacement in Patients With Chronic Dissection: Special Considerations. Semin Cardiothorac Vasc Anesth 2016. 11. Preventza O, Garcia A, Cooley DA et al. Total aortic arch replacement: A comparative study of zone 0 hybrid arch exclusion versus traditional open repair. J Thorac Cardiovasc Surg 2015;150:1591-600.
14. Zierer A, Risteski P, El-Sayed Ahmad A et al. The impact of unilateral versus bilateral antegrade cerebral perfusion on surgical outcomes after aortic arch replacement: a propensity-matched analysis. J Thorac Cardiovasc Surg 2014;147:1212-7;discussion 7-8.
20. Iba Y, Minatoya K, Matsuda H et al. Contemporary open aortic arch repair with selective cerebral perfusion in the era of endovascular aortic repair. J Thorac Cardiovasc Surg 2013;145:S72-7.
26. Crawford ES, Kirklin JW, Naftel DC et al. Surgery for acute dissection of ascending aorta. Should the arch be included? J Thorac Cardiovasc Surg 1992;104:46-59.
3. Maxwell BG, Harrington KB, Beygui RE, Oakes DA. Congenital anomalies of the aortic arch in acute type-a aortic dissection: implications for monitoring, perfusion strategy, and surgical repair. J Cardiothorac Vasc Anesth 2014;28:467-72.
16. Preventza O, Garcia A, Cooley DA et al. Reoperations on the total aortic arch in 119 patients: Short- and mid-term outcomes, focusing on composite adverse outcomes and survival analysis. J Thorac Cardiovasc Surg 2014.
18. Leshnower BG, Kilgo PD, Chen EP. Total arch replacement using moderate hypothermic circulatory arrest and unilateral selective antegrade cerebral perfusion. J Thorac Cardiovasc Surg 2014;147:1488-92.
1. Coselli JS, LeMaire SA. Aortic arch surgery: principles, strategies, and outcomes. In: Chichester UK, Hoboken NJ. Wiley-Blackwell; 2008.
25. Preventza O, Cervera R, Cooley DA et al. Acute type I aortic dissection: Traditional versus hybrid repair with antegrade stent delivery to the descending thoracic aorta. J Thorac Cardiovasc Surg 2014;148:119-25.
REFERÊNCIAS
24. Czerny M, Schmidli J, Adler S et al. Current options and recommendations for the treatment of thoracic aortic pathologies involving the aortic arch: an expert consensus document of the European Association for Cardio-Thoracic surgery (EACTS) and the European Society for Vascular Surgery (ESVS). Eur J Cardiothorac Surg 2018.
22. Erbel R, Aboyans V, Boileau C et al. 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases: Document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adultThe Task Force for the Diagnosis and Treatment of Aortic Diseases of the European Society of Cardiology (ESC). Eur Heart J 2014;35:2873-926.
4. Dumfarth J, Plaikner M, Krapf C et al. Bovine aortic arch: predictor of entry site and risk factor for neurologic injury in acute type a dissection. Ann Thorac Surg 2014;98:1339-46.
27. Svensson LG, Blackstone EH, Apperson-Hansen C et al. Implications from Neurologic Assessment of Brain Protection for Total Arch Replacement from a Randomized Trial. J Thorac Cardiovasc Surg 2015. 28. Englum BR, He X, Gulack BC et al. Hypothermia and cerebral protection strategies in aortic arch surgery: a comparative effectiveness analysis from the STS Adult Cardiac Surgery Database. Eur J Cardiothorac Surg 2017;52:492-8. 29. Gutsche J, Feinman J, Silvay G et al. Practice variations in the conduct of hypothermic circulatory arrest for adult aortic arch repair: focus on an emerging European paradigm. Heart, Lung and Circulation 2014;6:43-51. 30. Ziganshin BA, Rajbanshi BG, Tranquilli M et al. Straight deep hypothermic circulatory arrest for cerebral protection during aortic arch surgery: Safe and effective. J Thorac Cardiovasc Surg 2014;148:888-98; discussion 98-900. 31. Estrera AL, Miller CC, Lee TY et al. Integrated cerebral perfusion for hypothermic circulatory arrest during transverse aortic arch repairs. Eur J Cardiothorac Surg 2010;38:293-8. 32. Crawford ES, Crawford JL, Safi HJ, Coselli JS. Redo operations for recurrent aneurysmal disease of the ascending aorta and transverse aortic arch. Ann Thorac Surg 1985;40:439-55. 33. Kazui T, Washiyama N, Muhammad BA et al. Total arch replacement using aortic arch branched grafts with the aid of antegrade selective cerebral perfusion. Ann Thorac Surg 2000;70:3-8; discussion -9. 34. Spielvogel D, Halstead JC, Meier M et al. Aortic arch replacement using a trifurcated graft: simple, versatile, and safe. Ann Thorac Surg 2005;80:90-5; discussion 5.
6. Patel HJ, Deeb GM. Open aortic arch reconstruction. Ann Cardiothorac Surg 2013;2:181-3. 7. Di Eusanio M, Berretta P, Cefarelli M et al. Long-term outcomes after aortic arch surgery: results of a study involving 623 patients. Eur J Cardiothorac Surg 2014. 8. Sood V, Patel HJ, Williams DM et al. Open and endovascular repair of the nontraumatic isolated aortic arch aneurysm. J Vasc Surg 2014;60:57-63. 9. Preventza O, Coselli JS. Saccular Aneurysms of the Transverse Aortic Arch: Treatment Options Available in the Endovascular EraBased on a Presentation at the 2013 VEITH Symposium, November 19-23, 2013 (New York, NY, USA). Aorta (Stamford). 2015;3:61-6.
23. Hiratzka LF, Bakris GL, Beckman JA et al. 2010 ACCF/AHA/AATS/ ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with Thoracic Aortic Disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine. Circulation 2010;121:e266-369.
13. Quintana E, Bajona P, Schaff HV et al. Open aortic arch reconstruction after previous cardiac surgery: Outcomes of 168 consecutive operations. J Thorac Cardiovasc Surg 2014.
108 59Capítulo
15. Tanaka Y, Mikamo A, Suzuki R et al. Mortality and morbidity after total aortic arch replacement. Ann Thorac Surg 2014;97:1569-75.
17. Okita Y, Miyata H, Motomura N, Takamoto S. A study of brain protection during total arch replacement comparing antegrade cerebral perfusion versus hypothermic circulatory arrest, with or without retrograde cerebral perfusion: Analysis based on the Japan Adult Cardiovascular Surgery Database. J Thorac Cardiovasc Surg 2014.
21. Easo J, Weigang E, Holzl PP et al. Influence of operative strategy for the aortic arch in DeBakey type I aortic dissection - analysis of the German Registry for Acute Aortic Dissection type A (GERAADA). Ann Cardiothorac Surg 2013;2:175-80.
19. Girardi LN, Shavladze N, Sedrakyan A, Neragi S. Safety and efficacy of retrograde cerebral perfusion as an adjunct for cerebral protection during surgery on the aortic arch. J Thorac Cardiovasc Surg 2014.
12. Shrestha M, Martens A, Kruger H et al. Total aortic arch replacement with the elephant trunk technique: single-centre 30-year results. Eur J Cardiothorac Surg 2014;45:289-95; discussion 95-6.
2. Popieluszko P, Henry BM, Sanna B et al. A systematic review and meta-analysis of variations in branching patterns of the adult aortic arch. J Vasc Surg 2018;68:298-306 e10.
48. Di Marco L, Pacini D, Murana G et al. Total aortic arch replacement with frozen elephant trunk (Thoraflex). Ann Cardiothorac Surg 2018;7:451-3.
52. Czerny M, Rylski B, Kari FA et al. Technical details making aortic arch replacement a safe procedure using the Thoraflex Hybrid prosthesis. Eur J Cardiothorac Surg 2017;51:i15-i9.
49. Tian DH, Wan B, Di Eusanio M, Yan TD. Systematic review protocol: the frozen elephant trunk approach in aortic arch surgery. Ann Cardiothorac Surg 2013;2:578.
109Capítulo 59 AneurismA do ArCo AórtiCo
36.
57. Urbanski PP, Luehr M, Di Bartolomeo R et al. Multicentre analysis of current strategies and outcomes in open aortic arch surgery: heterogeneity is still an issue. Eur J Cardiothorac Surg 2016.
35. LeMaire SA, Price MD, Parenti JL et al. Early outcomes after aortic arch replacement by using the Y-graft technique. Ann Thorac Surg 2011;91:700-7; discussion 7-8. Spielvogel D. Aortic arch replacement using a trifurcated graft. Multimed Man Cardiothorac Surg 2012;2012:mms002. 37. Spielvogel D, Etz CD, Silovitz D et al. Aortic arch replacement with a trifurcated graft. Ann Thorac Surg 2007;83:S791-5; discussion S824-31. 38. Spielvogel D, Mathur MN, Lansman SL, Griepp RB. Aortic arch reconstruction using a trifurcated graft. Ann Thorac Surg 2003;75:1034-6. 39. Spielvogel D, Strauch JT, Minanov OP et al. Aortic arch replacement using a trifurcated graft and selective cerebral antegrade perfusion. Ann Thorac Surg 2002;74:S1810-4; discussion S25-32.
55. Shrestha M, Kaufeld T, Beckmann E et al. Total aortic arch replacement with a novel 4-branched frozen elephant trunk prosthesis: Single-center results of the first 100 patients. J Thorac Cardiovasc Surg 2016;152:148-59 e1. 56. Roselli EE, Rafael A, Soltesz EG et al. Simplified frozen elephant trunk repair for acute DeBakey type I dissection. J Thorac Cardiovasc Surg 2013;145:S197-201.
44. Algarni KD, Yanagawa B, Rao V, Yau TM. Profound hypothermia compared with moderate hypothermia in repair of acute type A aortic dissection. J Thorac Cardiovasc Surg 2014;148:2888-94.
45. Coselli JS, LeMaire SA, Carter SA, Conklin LD. The reversed elephant trunk technique used for treatment of complex aneurysms of the entire thoracic aorta. Ann Thorac Surg 2005;80:2166-72; discussion 72. 46. Coselli JS, Oberwalder P. Successful repair of mega aorta using reversed elephant trunk procedure. J Vasc Surg 1998;27:183-8.
50. Tian DH, Wan B, Di Eusanio M et al. A systematic review and meta-analysis on the safety and efficacy of the frozen elephant trunk technique in aortic arch surgery. Ann Cardiothorac Surg 2013;2:581-91.
51. Kato M, Ohnishi K, Kaneko M et al. New graft-implanting method for thoracic aortic aneurysm or dissection with a stented graft. Circulation 1996;94:Ii188-93.
47. Hanif H, Dubois L, Ouzounian M et al. Aortic Arch Reconstructive Surgery With Conventional Techniques vs Frozen Elephant Trunk: A Systematic Review and Meta-Analysis. Can J Cardiol 2018;34:262-73.
40. Preventza O, Price MD, Spiliotopoulos K et al. In elective arch surgery with circulatory arrest, does the arterial cannulation site really matter? A propensity score analysis of right axillary and innominate artery cannulation. J Thorac Cardiovasc Surg 2017. 41. Sabik JF, Lytle BW, McCarthy PM, Cosgrove DM. Axillary artery: an alternative site of arterial cannulation for patients with extensive aortic and peripheral vascular disease. J Thorac Cardiovasc Surg 1995;109:885-90; discussion 90-1. 42. Preventza O, Coselli JS, Price MD et al. Elective primary aortic root replacement with and without hemiarch repair in patients with no previous cardiac surgery. J Thorac Cardiovasc Surg 2017;153:1402-8. 43. Preventza O, Price MD, Simpson KH et al. Hemiarch and Total Arch Surgery in Patients With Previous Repair of Acute Type I Aortic Dissection. Ann Thorac Surg 2015;100:833-8.
53. Shrestha M, Fleissner F, Ius F et al. Total aortic arch replacement with frozen elephant trunk in acute type A aortic dissections: are we pushing the limits too far? Eur J Cardiothorac Surg 2014. 54. Shrestha M, Haverich A, Martens A. Total aortic arch replacement with the frozen elephant trunk procedure in acute DeBakey type I aortic dissections. Eur J Cardiothorac Surg 2017;51:i29-i34.
3. Crawford ES, WA HS, Saleh SA, Normann NA. Graft replacement of aneurysm in descending thoracic aorta: results without bypass or shunting. Surgery 1981;89:73.
17. Svensson LG, Crawford ES. Degenerative aortic aneurysms. In: Svensson & Crawford (Eds.). Cardiovascular and vascular disease of the aorta. Philadelphia. WB Saunders Co; 1997. p. 29-41.
19. Coselli JS, LeMaire AS. Left heart bypass reduces paraplegia rates after thoracoabdominal aortic aneurysm repair. Ann Thorac Surg 1999;67:1931-34.
15. Anacleto A, Morales MM. Cirurgia Vascular e Endovascular-Abordagem Prática. In: Nelson Wolosker et al. 1. ed. Rio de Janeiro: Atheneu; 2017. 16. Stone DH, Brewster DC, Kwoleck CJ et al. Stent Graft versus open surgical repair of the thoracic aorta: Mid-term results. J Vasc Surg 2006;44:1188-97.
14. Coady MA, Rizzo JA, Elefteriades JA. Elaborando critérios para intervenção cirúrgica em Aneurismas da aorta torácica. Clin Cardiol Am Norte 1999;1083-1099.
20. Hollier LH, Mena J. Thoracoabdominal aortic aneurysms. In: Haimovici H (Ed). Haimovici’s Vascular Surgery. 4th ed. USA. Blackwell Sciency. 1996. p. 786-796.
110 60Capítulo ANEURISMAS DA AORTA TORÁCICA –TRATAMENTO CIRÚRGICO REFERÊNCIAS BIBLIOGRÁFICAS
5. Hannuksela M, Lundqvist S, Carlberg B. Thoracic aorta--dilated or not? Scand Cardiovasc J 2006;40(3):175-8.
22. Anacleto A, Morales MM, Anacleto JC. Cirurgia Vascular Cirurgia Endovascular-Angiologia. In: Brito CJ et al. 3. ed. Rio de Janeiro: Revinter; 2014. 23. Gharagozloo F, Neville RF, Cox JL. Spinal Cord Protection During Surgical Procedures on the Descending Thoracic and Thoracoabdominal Aorta: A Critical Overview. Sem Thorac Cardiovasc Surg 1998;10:73-86.
6. Crawford ES, Crawford JL, Safi HJ et al. Thoracoabdominal aortic aneurysms: Preoperative and intraoperative factors determining immediate and long-term results of operations in 605 patients. J Vasc Surg 1986;3:389-404. Hirose Y, Hamada S, Takamiya TA N et al. Aortic aneurysms: growth rates measured with CT. Radiology 1992;185:249-252. Rengier F, Geisbüsch P, Vosshenrich R et al. Cross-sectional imaging studies: what can we learn and what do we need to know? Semin Vasc Surg 2007 Jun;20(2):108-114.
1. Johnston KW, Rutherford RB, Tilson MD et al. Suggested standards for reporting on arterial aneurysms. Subcommittee on Reporting Standards for Arterial Aneurysms, Ad HOC Committee on Reporting Standards, Society for Vascular Surgery and North American Chapter, International Society for Cardiovascular Surgery. J Vasc Surg 1991;13:452-58.
7.
4. Juvonen T, Ergin MA, Galla JD et al. Prospective study of the natural history of thoracic aortic aneurysms. Ann Thorac Surg 1997;63:1533-45.
9. Flamm SD. State-of-the-Art Computed Tomography Angiography of Acute Aortic Syndrome. Semin Ultrasound CT MR 2012 Jun;33(3):222-34.
11. Von Tengg-Koblig H, Weber TF, Rengier F et al. Endovascular aneurysm repair: state-of-the-art imaging techniques for preoperative planning and surveillance. J Cardiovasc Surg (Torino) 2009 Aug;50(4):423-38. Lavall D, Schafers HJ, Bohm M, Laufs U. Aneurysms of the Ascending Aorta. Dtsch Arztebl Int 2012 109(13):227-33. Bickerstaff LK, Hollier LH, Cherry KJ et al. Thoracic aortic aneurysms: a population-based study. Surgery 1982;92:1103-1108.
21. Reddy DJ, Ernst CB. Infected aneurysms. In: Rutherford RB (Ed.). Vascular Surgery. 4th ed Philadelphia. WB Saunders Co; 1995. p. 1139-1153.
25. Svensson LG. Management of Segmental Intercostal and Lumbar Arteries During Descending and Thoracoabdominal Aneurysm Repairs. Sem Thorac Cardiovasc Surg 1998;10(1):45-49. 26. Crawford ES, Mizrahi EM, Kenneth RH et al. The impact of distal aortic perfusion and somatosensory evoked potential monitoring on prevention of paraplegia after aortic aneurysm operation. J Thorac Cardiovasc Surg 1988;95:357-67.
2. Rutherford RB. Arterial Aneurysms: General Considerations. In: Rutherford RB (Ed.). Vascular Surgery. 7th ed. Philadelphia: WB Saunders; 2010. p. 1920-27.
27. Gloviczki P, Bower TC. Visceral and Spinal Cord Protection During Thoracoabdominal Aortic Reconstructions. Sem Vasc Surg 1992;5:163-173. 28. Svensson LG, Crawford ES, Hess KR et al. Experience with 1509 pacients undergoing thoracoabdominal aortic operations. J Vasc Surg 1993;17:357-370. 29. Jex RK, Schaff HV, Piehler JM. Early and late results following repair of dissections of the descending thoracic aorta. J Vasc Surg 1986;3:226. 30. Asante-Siaw J, Tyrell J, Hoschtitzky A, Dunning J. Does theuse of a centrifugal pump offer any additional benefit for patients having open heart surgery? Interac Cardiovasc Thorac Surg 2006;5:128-34. 31. Kaplan DK, Atsumi N, D’Ambra MN et al. Distal circulatory support for thoracic aortic operations: Effects on intracranial pressure. Ann Thorac Surg 1995;59:448-452. 32. Blaisdell FW, Cooley DA. The mechanism of paraplegia after temporary thoracic aortic occlusion and its relationship to spinal fluid pressure. Surgery 1962;51:351-355. 33. Miyamoto K, Keno A, Wada T et al. A new and simple method of preventing spinal cord damage following temporary occlusion of the thoracic aorta by draining the cerebrospinal fluid. J Cardiovasc Surg 1960;16:188-99. 34. Coselli JS. Contemporary management and results of thoracoabdominal aortic aneurysm surgery. In: Chiesa R, Melissano G (Eds.). Gli Aneurismi dell’ Aorta Addominale. Milano. Europa Scienze Umane Editice; 1996. p. 269-284. 35. Panneton JM, Hollier LH. Nondissecting thoracoabdominal aortic aneurysms: part I. Ann Vasc Surg 1995;9:503-514. 36. Coselli JS, LeMaire AS, Cooley DA et al. Outcomes of 3309 thoracoabdominal aortic aneurysm repairs. J Thorac Cardiovasc Surg 2016;151(5):1323-1337. 37. Vega JS, Zamorano JG, Pereira NC et al. Síndrome aórtico agudo. Revisión de la literatura y actualización del tema. Rev Med Chile 2014;142:344-352. 38. Hansen CJ, Bui H, Donayre CE et al. Complications of endovascular repair of high-risk and emergent descending thoracic aortic aneurysms and dissections. J Vasc Surg 2004; 40:228-34. 39. Daily PO, Trueblood HW, Stinson EB et al. Management of acute aortic dissections. Ann Thoracic Surg 1970; 10:237-47. 40. Wheat MW JR, Palmer RF et al. Treatment of dissecting Aneurysms of the aorta without surgery. J Thorac Cardiovasc Surg 1965;50:364-73. 41. Nienaber CA, Rousseau H, Eggebrecht H et al. Randomized Comparison of strategies for type B aortic dissection: the INvestigation of STEnt Grafts in Aortic Dissection (INSTEAD Trial). Circulation 2009;120:2519-2528. 42. Nienaber CA, Rousseau H, Eggerbrecht H et al. Endovascular repair of type B aortic dissection: long-term results of the randomized
24. Acher CW, Wynn MM. Multifactoral Nature of Spinal Cord Circulation. Seminars in Thoracic and Cardiovascular. Surgery 1998;10(1):7-10.
13.
12.
10. Chin AS. Imaging modalities for the thoracic aorta. J Cardiovasc Surg (Torino) 2008 Aug;49(4):429-47.
18. Kouchoukos NT, Daily BB, Rokkas CK et al. Hypothermic bypass and circulatory arrest for operations on the descending thoracic and thoracoabdominal aorta. Ann Thorac Surg 1995;60(1):67-77.
8.
54. Ishikawa K. Diagnostic approach and proposed criteria for the clinical diagnosis of Takayasu’s arteriopathy. J Am Coll Cardiol 1988;12:964-72.
55. Atik FA, Navia JL, Svensson LG et al. Surgical treatment of pseudoaneurysm of the thoracic aorta. J Thorac Cardiovasc Surg 2006;132:379-85.
49.
52. Van Der Linden J, Hadjinikolaou L, Bergman P et al. Posoperative stroke in cardiac surgery is related to the location and extend of atheroslerotic disease in the ascending aorta. J AM Coll Cardiol 2001;38:131-35.
50.
57. Parmley LF, Mattingly TW, Manion WC, Jphmke EJ Jr. Non penetrating injury of the aorta. Circulation 1958;17(6):1086-101.
111Capítulo 60 AneurismA s dA AortA toráCiCA – tr AtAmento CirúrgiCo investigation of stent grafts in aortic dissection trial. Circ Cardiovasc Interv 2013;6:407-16. Criado FJ. Aortic Dissection: A 250-year perspective. Tex Heart Inst J 2011;38(6):694-700. Garzon G, Fernandez-Velilla M et al. Endovascular stent-graft treatment of thoracic aortic disease. Radiographics 2005 Oct;25(1): S229-44. Kato M. Actitude Chirurgica en la diseccion aórtica aguda tipo B. In: Vilacosta I & San Roman JA. Diseccion Aortica. Harcourt Brace 1997;159-71. Anacleto A, Morales MM. Medicina Cardiovascular: reduzindo o impacto das doenças. In: Kalil Filho R et al. 1. ed. São Paulo: Atheneu; 2016. Shennan T. Dissecting aneurysms. Medical Research Council, Special Report Series. 1934;193. Stanson AW, Welch TJ, Ehman RL, Sheedy PF II. A variant of aortic dissection: computer tomography and magnetic resonance findings. Cardiovasc Imaging 1989;1:55-9. Evangelista A, Mukherjee D, Metha RH et al. Accute intramural Haematoma of the aorta: a mystery in evolution. Circulation 2005;111:1063-70 Hollier LH, Kaznier FJ, Ochner J et al. Shaggy aorta with atheromatous embolization to visceral vessels. Ann Vasc Siurg 1991;5(5):439-44. Kukuda I, Daitoku K, Minakawa M, Fukuda W. Shaggy and calcified aorta: surgical implication. Gen Thorac Cardiovasc Surg 2013;16:3e01-13.
44.
43.
58. Miller EL. Potential Long-term complications of endovascular stent grafting for blunt thoracic aortic injury. Scientific World Journal 2012; 2012:897489. 59. Von Oppel UO, Dunne TT, De Groot et al. Traumatic aortic rupture: twenty-year meta-analysis of mortality and risk of paraplegia. Ann Thorac Surg 1994;58:58. 60. Davidovic L, Ducic S, Vujcic A. Is late open conversion after TEVAR more risky than primary open repair of descending thoracic aneurysms? Ed. Minerva Medica. J Cardiovascular Surgery 2018 June; 26. 61. Melisano G, Tshomba Y, Mascia D et al. Late open conversion after TEVAR. J Cardiovasc Surg (Torino) 2016;57(4):491-7. 62. Davidovic L, Sladojevic M, Koncar I et al. Complication after Thoracic Endovascular Aortic Repair: What is the role of an open surgical conversion? Ann Vasc Surg 2018;47:238-246. 63. Canaud L, Alric P, Gandet T et al. Open surgical secondary procedures after thoracic endovascular aortic repair. Eur J Vasc Endovasc Surg 2013;46:667. 64. Czerny M, Reser D, Eggebrecht H et al. Aorto-bronchial and aortopulmonary fistulation after thoracic endovascular aortic repair: an analysis from the European Registry of Endovascular Aortic Repair Complications. Eur J Cardiothorac Surg 2015; 48:252-7. 65. Czerny M, Eggebrecht H, Sodeckc G et al. New insights regarding the incidence, presentation and treatment options of aorto oesophageal fistulation after thoracic endovascular aortic repair: the European Registry of Endovascular Aortic Repair Complictions. Eur J Cardiothorac Surg 2014; 45:452-457.
48.
46.
45.
47.
56. Dumont E, Carrier M, Cartier R et al. Repair of aortic false aneurysm using deep hypothermia and circulatory arrest. Ann Thorac Surg 2004;78:117-21.
53. Ribakove GH, Katz ES, Galloway AC et al. Surgical Implications of transesofageal Echocardiography to grade the atheromatous aortic arch. Ann Thorc Surg 1992;53:758-63.
51.
13. Kolvenbach RR, Karmeli R, Pinter LS, Zhu Y, Lin F, Wassiljew S et al. Endovascular management of ascending aortic pathology. J Vasc Surg 2011;53:1431-37.
22. Eggebrecht H, Nienaber CA, Neuhäuser M, Baumgart D, Kische S, Schmermund A et al. Endovascular stent–graft placement in aortic dissection: a meta-analysis. Eur Heart J 2006;27:489-98. 23. Mitchell RS, Ishimaru S, Ehrlich MP, Iwase T, Lauterjung L, Shimono T et al. First International Summit on Thoracic Aortic Endografting: roundtable on thoracic aortic dissection as an indication for endografting. J Endovasc Ther 2002;9:98-105.
6. Coady MA, Davies RR, Roberts M, Goldstein LJ, Rogalski MJ, Rizzo JA et al. Familial patterns of thoracic aortic aneurysms. Arch Surg 1999;134:361.
7. Elefteriades JA. Natural history of thoracic aortic aneurysms: indications for surgery, and surgical versus nonsurgical risks. Ann Thorac Surg 2002;74:S1877-S1880.
14. Lee W. Partial right atrial inflow occlusion for TEVAR. Endovasc Today 2009;10:39-44.
15. Metcalfe MJ, Karthikesalingam A, Black SA, Loftus IM, Morgan R, Thompson MM. The first endovascular repair of an acute type A dissection using an endograft designed for the ascending aorta. J Vasc Surg 2012;55:220-22.
38.
10. Kuzmik GA, Sang AX, Elefteriades JA. Natural history of thoracic aortic aneurysms. J Vasc Surg 2012;56:565-71.
12. Criado FJ, Clark NS, Barnatan MF. Stent graft repair in the aortic arch and descending thoracic aorta: a 4-year experience. Journal of vascular surgery: official publication, the Society for Vascular Surgery [and] International Society for Cardiovascular Surgery, North American Chapter 2002;36:1121.
112 61Capítulo ANEURISMAS DA AORTA TORÁCICA –TRATAMENTO ENDOVASCULAR REFERÊNCIAS BIBLIOGRÁFICAS
1. Garcia-Madrid C, Josa M, Riambau V, Mestres C-A, Muntana J, Mulet J. Endovascular versus open surgical repair of abdominal aortic aneurysm: a comparison of early and intermediate results in patients suitable for both techniques. Eur J Vasc Endovasc Surg 2004;28:365-72.
37.
3. Kälsch H, Lehmann N, Möhlenkamp S, Becker A, Moebus S, Schmermund A et al. Body-surface adjusted aortic reference diameters for improved identification of patients with thoracic aortic aneurysms: Results from the population-based Heinz Nixdorf Recall study. Int J Cardiol 2011. 4. Elefteriades JA, Rizzo JA. Epidemiology, prevalence, incidence, trends. Acute Aortic Disease. New York, NY: Informa Healthcare; 2008. p. 89-98.
24. Ferreira M, Monteiro M, Lanziotti L, Abuhadba G, Capotorto L. Deliberate subclavian artery occlusion during aortic endovascular repair: is it really that safe? Eur J Vasc Endovasc Surg 2007;33:664-67.
8. Hiratzka LF, Bakris GL, Beckman JA, Bersin RM, Carr VF, Casey DE et al. ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with thoracic aortic disease. J Am Coll Cardiol 2010;55:e27-e129.
11. Davies JE, Sundt TM. Surgery Insight: the dilated ascending aorta— indications for surgical intervention. Nat Clin Pract Cardiovasc Med 2007;4:330-39.
28. Brittenden J, McBride K, McInnes G, Gillespie IN, Bradbury AW. The use of endovascular stents in the treatment of penetrating ulcers of the thoracic aorta. J Vasc Surg 1999;30:946-49. 29. Kazerooni EA, Bree RL, Williams DM. Penetrating atherosclerotic ulcers of the descending thoracic aorta: evaluation with CT and distinction from aortic dissection. Radiology 1992;183:759-65.
19. Razzouk A, Gundry S, Wang N, Heyner R, Sciolaro C, Van Arsdell G et al. Pseudoaneurysms of the aorta after cardiac surgery or chest trauma. Am Surg 1993;59:818-23.
9. Hoffjan S, Waldmüller S, Blankenfeldt W, Kötting J, Gehle P, Binner P et al. Three novel mutations in the ACTA2 gene in German patients with thoracic aortic aneurysms and dissections. Eur J Human Genet 2011;19:520-24.
16. Dumont E, Carrier M, Cartier R, Pellerin M, Poirier N, Bouchard D et al. Repair of aortic false aneurysm using deep hypothermia and circulatory arrest. Ann Thorac Surg 2004;78:117-20.
35.
17. Katsumata T, Moorjani N, Vaccari G, Westaby S. Mediastinal false aneurysm after thoracic aortic surgery. Ann Thorac Surg 2000;70:547-52.
2. Isselbacher EM. Thoracic and abdominal aortic aneurysms. Circulation 2005;111:816-28.
25. Görich J, Asquan Y, Seifarth H, Krämer S, Kapfer X, Orend K-H et al. Initial experience with intentional stent-graft coverage of the subclavian artery during endovascular thoracic aortic repairs. J Endovasc Ther 2002;9:39-43.
26. Zoli S, Etz CD, Roder F, Mueller CS, Brenner RM, Bodian CA et al. Longterm survival after open repair of chronic distal aortic dissection. Ann Thorac Surg 2010;89:1458. 27. Stanson AW, Kazmier FJ, Hollier LH, Edwards WD, Pairolero PC, Sheedy PF et al. Penetrating atherosclerotic ulcers of the thoracic aorta: natural history and clinicopathologic correlations. Ann Vasc Surg 1986;1:15-23.
5. Clouse WD, Hallett Jr JW, Schaff HV, Gayari MM, Ilstrup DM, Melton III LJ. Improved prognosis of thoracic aortic aneurysms. JAMA 1998;280:1926-29.
20. Fu W, Dong Z, Wang Y, Guo D, Xu X, Chen B et al. Strategies for managing the insufficiency of the proximal landing zone during endovascular thoracic aortic repair. Chinese Medical Journal -BeijingEnglish Edition 2005;118:1066.
30. Tittle SL, Lynch RJ, Cole PE, Singh HS, Rizzo JA, Kopf GS, Elefteriades JA. Midterm follow-up of penetrating ulcer and intramural hematoma of the aorta. J Thorac Cardiovasc Surg 2002;123:1051-59. 31. Berguer R. The short retropharyngeal route for arterial bypass across the neck. Ann Vasc Surg 1986;1:127-30. 32. Murad MH, Rizvi AZ, Malgor R, Carey J, Alkatib AA, Erwin PJ et al. Comparative effectiveness of the treatments for thoracic aortic transection. J Vasc Surg 2011;53(1):193. 33. Clough RE, Mani K, Lyons OT, Bell RE, Zayed HA, Waltham M et al. Endovascular treatment of acute aortic syndrome. J Vasc Surg 2011 Dec;54(6):1580-7. Epub 2011 Sep 25. 34. Kiguchi M, Chaer RA. Endovascular repair of thoracic aortic pathology. Expert Rev Med Devices 2011 Jul;8(4):515-25. Lee WA, Martin TD, Hess PJ Jr, Beaver TM, Klodell CT. First United States experience of the TX2 Pro-Form thoracic delivery system. J Vasc Surg 2010 Dec;52(6):1459-63. 36. https://www.cookmedical.com/data/IFU_PDF/I-ALPHA-THORACIC-442-02.PDF https://www.cookmedical.eu/data/IFU_PDF/I-TX2-PRO-FORM-361-04.PDF Matsumura JS, Cambria RP, Dake MD, Moore RD, Svensson LG, Snyder S. International controlled clinical trial of thoracic endovascular aneurysm repair with the Zenith TX2 endovascular graft: 1-year results. J Vasc Surg 2008;47(2):247. 39. Greenberg RK, O’Neill S, Walker E, Haddad F, Lyden SP, Svensson LG et al. Endovascular repair of thoracic aortic lesions with the Zenith TX1 and TX2 thoracic grafts: intermediate-term results. J Vasc Surg 2005 Apr;41(4):589-96.
18. Sullivan KL, Steiner RM, Smullens SN, Griska L, Meister SG. Pseudoaneurysm of the ascending aorta following cardiac surgery. CHEST J 1988;93:138-43.
21. Bergeron P, Mangialardi N, Costa P, Coulon P, Douillez V, Serreo E et al. Great vessel management for endovascular exclusion of aortic arch aneurysms and dissections. Eur J Vasc Endovasc Surg 2006;32:38-45.
49. Stefanov F, Morris L, Elhelali A, Kavanagh EP, Lundon V, Hynes N et al. Insights from complex aortic surgery with a Streamliner device for aortic arch repair (STAR). J Thorac Cardiovasc Surg 2016 Nov;152(5):1309-1318.e5.
51. Vaislic CD, Fabiani JN, Chocron S, Robin J, Costache VS, Villemot JP et al. One-year outcomes following repair of thoracoabdominal aneurysms with the multilayer flow modulator: report from the STRATO trial. J Endovasc Ther 2014 Feb;21(1):85-95.
50. Hynes N, Sultan S, Elhelali A, Diethrich EB, Kavanagh EP, Sultan M et al. Systematic Review and Patient-Level Meta-analysis of the Streamliner
52. Sultan S, Hynes N, Sultan M, MFM Collaborators. When not to implant the multilayer flow modulator: lessons learned from application outside the indications for use in patients with thoracoabdominal pathologies. J Endovasc Ther 2014 Feb;21(1):96-112.
43. Cho JS, Haider SE, Makaroun MS. Endovascular therapy of thoracic aneurysms: Gore TAG trial results. Semin Vasc Surg 2006 Mar;19(1):18-24.
54. Ferreira M, Chuter T, Hartley D, Lanziotti L, Abuhadba G, Monteiro M, Capotorto L. Hybrid repair of aortic arch aneurysms: a totally extrathoracic approach with branched endografts in two patients. Vascular 2007;15:79-83. 55. Safi HJ, Bartoli S, Hess KR, Shenaq SS, Viets JR, Butt GR, Sheinbaum R, Doerr HK, Maulsby R, Rivera VM. Neurologic deficit in patients at high risk with thoracoabdominal aortic aneurysms: the role of cerebral spinal fluid drainage and distal aortic perfusion. J Vasc Surg 1994;20:434-443. 56. Safi HJ, Miller III CC, Azizzadeh A, Iliopoulos DC. Observations on delayed neurologic deficit after thoracoabdominal aortic aneurysm repair. J Vasc Surg 1997;26:616-622. 57. Fattori R, Lovato L, Buttazzi K, Di Bartolomeo R, Gavelli G. Extension of dissection in stent-graft treatment of type B aortic dissection: lessons learned from endovascular experience. J Endovasc Ther 2005;12:306-311. 58. Melissano G, Tshomba Y, Civilini E, Chiesa R. Disappointing results with a new commercially available thoracic endograft. J Vasc Surg 2004;39:124-130. 59. Idu MM, Reekers JA, Balm R, Ponsen K-J, de Mol BAJM, Legemate DA. Collapse of a stent-graft following treatment of a traumatic thoracic aortic rupture. J Endovasc Ther 2005;12(4):503-7.
44. Thompson M, Ivaz S, Cheshire N, Fattori R, Rousseau H, Heijmen R et al. Early results of endovascular treatment of the thoracic aorta using the Valiant endograft. Cardiovasc Intervent Radiol 2007 Nov;30(6):1130-8. Epub 2007 Aug 21. 45. Funovics M, Blum M, Langenberger H, Plank C, Schoder M, Edelhauser G, Gottardi R et al. Endovascular repair of the descending aorta and the aortic arch with the Relay stent graft. Ann Thorac Surg 2009 Aug;88(2):637-40.
40. Torsello GF, Inchingolo M, Austermann M, Torsello GB, Panuccio G, Bisdas T et al. Durability of a low-profile stent graft for thoracic endovascular aneurysm repair. J Vasc Surg 2017;66(6):1638. Epub 2017 Jun 8. 41. Starnes BW, Dwivedi AJ, Giglia JS, Woo K, Yeh C, TRANSFIX Study Investigators. Endovascular repair for blunt thoracic aortic injury using the Zenith Alpha low-profile device. J Vasc Surg 2015;62(6):1495. Epub 2015 Sep 26. 42. https://www.goremedical.com/sites/g/files/ypyipe811/files/resources/assets/2018-03/20044572.pdf.
48. Uchida N, Katayama A, Higashiue S, Shiono M, Hata M, Minami K et al. A new device as an open stent graft for extended aortic repair: a multicentre early experience in Japan. Eur J Cardiothorac Surg 2016 Apr;49(4):1270-8.
113Capítulo 61 AneurismA s dA AortA toráCiCA – tr AtAmento endovA sCul Ar
53. Ozsvath KJ, Roddy SP, Darling RC, Byrne J, Kreienberg PB, Choi D, Paty PSK, Chang BB, Mehta M, Shah DM. Carotid-carotid crossover bypass: is it a durable procedure? J Vasc Surg 2003;37:582-585.
Multilayer Flow Modulator in the Management of Complex Thoracoabdominal Aortic Pathology. J Endovasc Ther 2016;23(3):501. Epub 2016 Mar 17.
47. Zipfel B, Buz S, Hammerschmidt R, Krabatsch T, Duesterhoeft V, Hetzer R. Early clinical experience with the E-vita thoracic stentgraft system: a single center study. J Cardiovasc Surg (Torino) 2008 Aug;49(4):417-28.
46. Riambau V, RESTORE collaborators. European experience with Relay: a new stent graft and delivery system for thoracic and arch lesions. J Cardiovasc Surg (Torino) 2008 Aug;49(4):407-15.
7. Wheat MJ, Palmer R, Bartley T, Seelman RC. Treatment of dissecting aneurysms of the aorta without surgery. J Thorac Cardiovasc Surg 1965;50:364-73. 8. Daily PO, Trueblood HW, Stinson ER et al. Management of acute aortic dissections. Ann Thorac Surg 1970;10:237-247.
25. Gsell O. Wandnekrosen der aorta als selbständige erkrankung und ihre beziehung sur spontanruptur. Virchows Arch Pathol Anat 1928;270:1-36.
9. Criado FJ. Aortic Dissection: a 250 year perspective. Tex Heart Inst J 2011;38(6):696-700.
16. Booher AM, Isselbacher EM, Nienaber CA et al. The IRAD classification system for characterizing survival after aortic dissection. Am J Med 2013;126(8):730.e22.
4. Hirst AE Jr, Johns VJ Jr, Kime SW Jr. Dissecting aneurysm of the aorta: a review of 505 cases. Medicine 1958;37:217-279.
3. Murad H, Garcia ML, Carmo PR Jr. Recomendações SOCERJ –Dissecção Aguda da Aorta 2003. Revista da SOCERJ; 2003.
17. De Dake MD, Thompson M, van Sambeek M et al. DISSECT: A new mnemonic-based approach to the categorization of aortic dissection. Eur J Vasc Endovasc Surg 2013;46(2):175-90.
33. Meszaros I, Morocz J, Szllavi J et al. Epidemiology and clinicopathology of aortic dissection. Chest 2000;117:1271-1278.
18. Buja LM, Krueger GRF. Netter’s Illustrated Human Pathology. 1st ed. Philadelphia: Elsevier Saunders; 2013.
14. Guilmet D, Bachet J, Goudot B et al. Aortic dissection: Anatomic types and surgical approaches. J Cardiovasc Surg 1993;34:23-32.
15. Tsai TT, Nienaber CA, Eagle KA. Acute aortic syndromes. Circulation 2005;112(24):3802-13.
12. DeBakey ME, Henley WS, Cooley DA et al. Surgical management of dissecting aneurysms of the aorta. J Thorac Cardiovasc Surg 1965;49:130-149. 13. Svensson LG, Labib SB, Eisenhauer AC et al. Intimal tear without hematoma. Circulation 1999;99:1331-1336.
1. Vilacosta I, San Román JA. Disección aórtica. Madrid: Harcourt Brace; 1997.
19. Roberts CS, Roberts WC. Aortic dissection with the entrance tear in the descending thoracic aorta. Ann Surg 1991;213:356-368. 20. Sidawy A, Perler B. Rutherford RB. Vascular surgery. 9th ed. Philadelphia: Elsevier Saunders; 2018. 21. Davies RR, Goldstein LJ, Coady MA et al. Yearly rupture or dissection rates for thoracic aortic aneurysms: simple prediction based on size. Ann Thorac Surg 2002;73:17-27, discussion 27–8. 22. Tolenaar JL, van Keulen JW, Jonker FH et al. Morphologic predictors of aortic dilatation in type B aortic dissection. J Vasc Surg 2013;58:1220-5. 23. Peterss S et al. Changing pathology of the thoracic aorta from acute to cronic dissection. J Am Coll Cardiol 2016 Sep 6;68(10):1054-65. 24. Karmonik C, Duran C, Shah DJ et al. Preliminary findings in quantification of changes in septal motion during follow-up of type B aortic dissections. J Vasc Surg 2012;55:1419-26.
114 62Capítulo DISSECÇÃO AÓRTICA REFERÊNCIAS BIBLIOGRÁFICAS
5. DeBakey ME, Cooley DA, Creech O. Surgical consideration of dissecting aneurysm of the aorta. Ann Surg 1955;142:586-612.
10. Dake MD, Kato N, Mitchell RS et al. Endovascular stent-graft placement for the treatment of acute aortic dissection. N Engl J Med 1999;340:1546-1552.
26. Erdheim J. Medionecrosis aortae idiopathica cystica. Virchows Arch Pathol Anat 1930;276:187-229. 27. Prokop EK, Palmer RF, Wheat MW Jr. Hydrodynamic forces in dissecting aneurysms. In vitro studies in a tygon model and in dog aortas. Circ Res 1970;27:121-127. 28. Carney WI, Rheinlander HF, Cleveland RJ et al. Control of acute aortic dissection. Surgery 1975;78:114-120. 29. Marfan AB. Un cas de déformation congénital des quatre membres plus prononcée aux extrémitiés caractérisée par l’allongement des os avec un certain degré d’amincissement. Bull Mém Soc Méd Hôp (Paris) 1896;13:220-226. 30. 2010 revised Ghent Nosology. National Marfan Foundation; 2011. http://www.marfan.org/dx/revised-ghent-nosology.
34. Hagan PG, Nienaber CA, Isselbacher EM et al. The International Registry of Acute Aortic Dissection (IRAD): new insights into an old disease. JAMA 2000;283:897-903. 35. El Habbal MH. Cardiovascular manifestation of Marfan’s syndrome in the young. Am Heart J 1992;123(3):752-757. 36. Schnitker MA, Major MC, Bayer CA. Dissecting aneurysm of the aorta in young individuals, particularly in association with pregnancy: with report of a case. Ann Int Med 1944;20:486-511. 37. Januzzi JL, Isselbacher EM, Fattori R et al. Characterizing the young patient with aortic dissection: results from the International Registry Aortic Dissection (IRAD). J Am Coll Cardiol 2004;43:665-669. 38. Isselbacher EM. Epidemiology of thoracic aortic aneurysms, aortic dissection, intramural hematoma and penetrating atherosclerotic ulcers. In: Baliga RR, Nienaber CA, Isselbacher EM, Eagle KA. Aortic Dissection and Related Syndromes. New York: Springer; 2007. p. 3-15. 39. Masuda Y, Yamada Z, Morooka N et al. Prognosis of patients with medically treated aortic dissections. Circulation 1991;84(5):1117-13. 40. Slater EE, DeSanctis RW. The clinical recognition of dissecting aortic aneurysm. Am J Med 1976 May 10;60(5):625-33. 41. Spittell PC, Spittell JA Jr, Joyce JW et al. Clinical features and differential diagnosis of aortic dissection: experience with 236 cases (1980 through 1990). Mayo Clin Proc 1993 Jul;68(7):642-51. 42. Isselbacher EM. Aortic dissection. In: Braunwald E, Zipes DP, Libby P, Bonow RO. Braunwald’s heart disease – A textbook of cardiovascular medicine. 7th ed. Philadelphia: Elsevier Saunders; 2005. p. 1415-1431. 43. Erbel R, Alfonso F, Boileau C et al. Diagnosis and management of aortic dissection: task force report of the European Society of Cardiology. Eur Heart J 2001;22:1642-1681. 44. Suzuki T, Distante A, Zizza A et al. Diagnosis of acute aortic dissection by D-dimer: the International Registry of Acute Aortic Dissection substudy on Biomarkers (IRAD-Bio) experience. Circulation 2009;119:2702-2707. 45. Hartnell GG. Imaging of aortic aneurysms and dissection: CT and MRI. J Thoracic Imaging 2001;16:35. 46. Baliga RR, Nienaber CA, Isselbacher EM, Eagle KA. Aortic dissection and related syndromes. New York: Springer; 2007. Riambau V, Böckler D, Brunkwall J et al. Editor’s Choice e Management of Descending Thoracic Aorta Diseases Clinical Practice
31. Mandel W, Evans EW, Walford RL. Dissecting aneurysm during pregnancy. N Engl J Med 1954;251:1059. 32. de Sa M, Moshkovitz Y, Butany J, David TE. Histologic abnormalities of the ascending aorta and pulmonary trunk in patients with bicuspid aortic valve disease: clinical relevance to the Ross procedure. J Thorac Cardiovasc Surg 1999 Oct;118(4):588-94.
47.
2. Macura KJ, Corl FM, Fishman EK et al. Pathogenesis in acute aortic syndromes: aortic dissection, intramural hematoma and penetrating atherosclerotic aortic ulcer. Am J Roentgenol 2003;181:309-316.
6. DeBakey ME, Henley WS, Cooley DA et al. Surgical treatment of dissecting aneurysm of the aorta. Analysis of seventy-two cases. Circulation 1961 Aug;24:290-303.
11. Nienaber CA, Fattori R, Lund G et al. Nonsurgical reconstruction of thoracic aortic dissection by stent-graft placement. N Engl J Med 1999;340:1539-1545.
55. Mohr-Kahaly S, Erbel R, Kearney P et al. Aortic intramural hematoma visualized by tranesophageal echocardiography: findings and prognostic implications. J Am Coll Cardiol 1994;23:658-664.
73. Harris JA, Bis KG, Glover JL et al. Penetrating atherosclerotic ulcers of the aorta. J Vasc Surg 1994;19:90-99. 74. Coady MA, Rizzo JA, Hammond GL et al. Penetrating ulcer of the thoracic aorta: what is it? How do we recognize it? How so we mange it? J Vasc Surg 1998;27:1006-16.
52. Bavaria JE, Brinster DR, Gorman RC et al. Advances in the treatment of acute type A dissection: an integrated approach. Ann Thorac Surg 2002 Nov;74(5):S1848-52; discussion S1857-63.
115Capítulo 62 disseCção AórtiCA Guidelines of the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg 2017;53:4e52.
75. Quint LE, Williams DM, Francis IR et al. Ulcer like lesions of the aorta: imaging features and natural history. Radiology 2000;218:719-723. 76. Demers P, Miller DC, Mitchell RS et al. Stent-graft repair of penetrating atherosclerotic ulcers in the descending thoracic aorta: mid-term results. Ann Thorac Surg 2004;77:81-6.
57. Nakashima M, Kaji S, Murai R et al. Detection of Micro Intimal Tear at a Very Early Stage in Patients With Acute. Aortic Intramural Hematoma. Circulation 2016;134:A13989.
56. von Kodolitsch Y, Csosz SK, Koschyk DH et al. Intramural hematoma of the aorta – Predictors of progression to dissection and rupture. Circulation 2003;107:1158-63.
59. Ganaha G, Miller D, Sugimoto K et al. Prognosis of aortic intramural hematoma with and without penetrating atherosclerotic ulcer: a clinical and radiological analysis. Circulation 2002;106:342-348.
60. Evangelista A, Mukherjee D, Mehta RH et al. International Registry of Aortic Dissection (IRAD) Investigators. Acute intramural hematoma of the aorta: a mystery in evolution. Circulation 2005 Mar 1;111(8):1063-70. 61. Gutschow SE, Walker CM, Martínez-Jiménez S et al. Emerging Concepts in Intramural Hematoma Imaging. Radiographics 2016 May-Jun; 36(3):660-74. 62. Vilacosta I, San Román JA, Ferreirós J et al. Natural history and serial morphology of aortic intramural hematoma. A novel variant of aortic dissection. Am Heart J 1997 Sep;134(3):495-507. 63. Elefteriades JA. Cardiology clinics – Diseases of the aorta Philadelphia: Saunders; 1999. 64. Nienaber CA, von Kodolitsch Y, Petersen B et al. Intramural hemorrhage of the thoracic aorta. Diagnostic and therapeutic implications. Circulation 1995;92:2959-2968. 65. Vilacosta I, San Román JA, Peral V et al. Imaging aortic intramural hematoma. Identification of two groups of patients. Circulation 1995;92(1):307. 66. Tittle SL, Lynch RJ, Cole PE et al. Midterm follow-up of penetrating ulcer and intramural hematoma of the aorta. J Thorac Cardiovasc Surg 2002;123:1051-1059. 67. Kaji S, Akasaka T, Horibata Y et al. Long-term prognosis of patients with type A aortic intramural hematoma. Circulation 2002;106:I248-52. 68. Kaji S, Akasaka T, Katayama M et al. Long-term prognosis of patients with type B aortic intramural hematoma. Circulation 2003;108:307-311. 69. Palma JH, de Souza JA, Rodrigues Alves CM et al. Self-expandable aortic stent–grafts for treatment of descending aortic dissections. Ann Thorac Surg 2002;73:1138-1141. 70. Nienaber CA, Powell JT. Management of acute aortic syndromes. Eur Heart J 2012 Jan; 33(1):26-35b. 71. Shennan T. Dissecting aneurysms. Special report nº 193. Med Res Council (Great Britain) 1935;86:1933-1934. 72. Stanson AW, Kazmier FJ, Hollier LH et al. Penetrating atherosclerotic ulcers of the thoracic aorta: natural history and clinic pathological correlations. Ann Vasc Surg 1986;1:15-23.
48. Nienaber CA, von Kodolitsch Y, Nicolas V et al. The diagnosis of thoracic aortic dissection by noninvasive imaging procedures. N Engl J Med 1993;328:1-9.
53. Krukenberg E. Beiträge zur frage des aneurysma dissecans. Beitr Path Anat Allg Path 1920;67:329-351.
49. Moore AG, Eagle KA, Bruckman D et al. Choice of computed tomography, transesophageal echocardiography, magnetic resonance imaging, and aortography in acute aortic dissection: international registry of acute aortic dissection (IRAD). Am J Cardiol 2002;89:1235-1238.
50. Yamada E, Matsumura M, Kyo S, Omoto R. Usefulness of a prototype intravascular ultrasound imaging in evaluation of aortic dissection and comparison with angiographic study, transesophageal echocardiography, computed tomography, and magnetic resonance imaging. Am J Cardiol 1995 Jan 15;75(2):161-5.
58. Wilson SK, Hutchins GM. Aortic dissecting aneurysms: causative factors in 204 subjects. Arch Pathol Lab Med 1982 Apr;106(4):175-80.
54. Yamada T, Tada S, Harada J. Aortic dissection without intimal rupture: diagnosis with MR imaging and CT. Radiology 1988;168:347-352.
77. Sailer J, Peloschek P, Rand T et al. Endovascular treatment of aortic type B dissection and penetrating ulcer using commercially available stent-grafts. Am J Roentgenol 2001;177:1365-1369. 78. DeSanctis RW, Doroghazi RM, Austen WG et al. Aortic dissection. N Engl J Med 1987;317:1060-1067. 79. Isselbacher EM, Cigarroa JE, Eagle KA. Cardiac tamponade complicating proximal aortic dissection. Is pericardiocentesis harmful? Circulation 1994 Nov;90(5):2375-8. 80. Nienaber CA, von Kodolitsch Y. Therapeutic management of patients with Marfan syndrome: focus on cardiovascular involvement. Cardiol Rev 1999;7:332-341 81. Erbol R,Aboyans S, Boileau C et al. 2014 Guidelines on the diagnosis and treatment of aortic diseases. Eur Heart J 2014;35:2873-2926. 82. Scholl FG, Coady MA, Davies R, Rizzo JA, Hammond GL, Kopf GS et al. Interval or permanent nonoperative management of acute type A aortic dissection. Arch Surg 1999 Apr;134(4):402-5; discussion 405-6. 83. Bavaria JE, Pochettino A, Brinster DR et al. New paradigms and improved results for the surgical treatment of acute type A dissection. Ann Surg 2001 Sep;234(3):336-42; discussion 342-3. 84. Most H, Reinhard B, Gahl B et al. Is surgery in acute aortic dissection type A still contraindicated in the presence of preoperative neurological symptoms? Eur J Cardiothoracic Surg 2015;48:945-950. 85. Wheat MW Jr, Palmer RF. Dissecting aneurysms of the aorta. Curr Probl Surg 1971 Jul;1-43. 86. Gardner TJ, Spray TL. Operative cardiac surgery. 5th ed. London: Arnold; 2004. 87. Griepp RB, Stinson EB, Hollingsworth JF, Buehler D. Prosthetic replacement of the aortic arch. J Thorac Cardiovasc Surg 1975;70:1051-1063. 88. Crawford ES, Svensson LG, Coselli JS et al. Aortic dissection and dissecting aortic aneurysms. Ann Surg 1988 Sep;208(3):254-73. 89. Bachet J, Guilmet D, Goudot B et al. Cold cerebroplegia. J Thorac Cardiovasc Surg 1991;102:85-93; discussion 93-4. 90. Kamiya H, Hagl C, Kropivnitskaya I et al. Quick proximal arch replacement with moderate hypothermic circulatory arrest. Ann Thorac Surg 2007 Mar;83(3):1055-8. 91. Pacini D, Leone A, Di Marco L et al. Antegrade selective cerebral perfusion in thoracic aorta surgery: safety of moderate hypothermia. Eur J Cardiothorac Surg Apr 2007;31(4):618-22. 92. Usui A, Holta T, Kiroura M. Retrograde cerebral perfusion through a superior vena caval cannula protects the brain. Ann Thorac Surg 1992;53(1):47-53. 93. Reich DL, Uysal S, Ergin MA, Griepp RB. Retrograde cerebral perfusion as a method of neuroprotection during thoracic aortic surgery. Ann Thorac Surg 2001 Nov;72(5):1774-82. 94. Uchida N, Shibamura H, Katayama A et al. Operative Strategy for Acute Type A Aortic Dissection: Ascending Aortic or Hemiarch Versus Total Arch Replacement With Frozen ElephantTrunk. Ann Thorac Surg 2009 March;87:773-777. 95. Roselli EA, Rafael A, Soltesz EG et al. Simplified frozen elephant trunk repair for acute DeBakey type I dissection. J Thorac Cardiovasc Surg 2013 March;145:S197-S201. 96. Kallenbach K, Baraki H, Khaladj N et al. Aortic valve-sparing operation in Marfan syndrome: what do we know after a decade? Ann Thorac Surg 2007 Feb;83(2):S764-8; discussion S785-90. 97. Gorlittzer M,Weiss,G, Moidl R et al. Repair of stent graft- induced retrograde type A aortic dissecxtion using the E-vita open prosthesis. Eur J Cardiothorac Surg 2012; 42:566-570 98. Di Bartolomeo R, Pantaleo, A, Berretta P et al. Frozen elephant trunk in acute aortic dissection. J Thorac Cardiovasc Surg 2015;105-S109. 99. Fattouch K, Sampognaro R, Navarra E et al. Long term results after repair of type A acute aortic dissection accorrding to false lumen patency. Ann Thorac Surg 2009;88:1244-1250. 100. Trimarchi S, Nienaber CA, Rampoldi V et al. International registry of acute aortic dissection investigators. Contemporary results of surgery in acute type A aortic dissection: The International Registry
51. von Kodolitsch Y, Nienaber CA, Dieckmann C et al. Chest radiography for the diagnosis of acute aortic syndrome. Am J Med 2004 Jan 15;116(2):73-7.
110. Fattori R, Montgomery D, Lovato L et al. Survival after endovascular therapy in patients with type B aortic dissection: a report from the International Registry of Acute Aortic Dissection (IRAD). JACC Cardiovasc Interv 2013;6(8):876-82.
103. Tsai TT, Evangelista A, Nienaber CA et al. Long-term survival of patients presenting with type A acute aortic dissection: insights from the International Registry of Acute Aortic Dissection (IRAD). Circulation 2006;114:1350-1356.
140. Canaud L, Ozdemir BA, Patterson BO et al. Retrograde aortic dissection after thoracic endovascular aortic repair. Ann Surg 2014;260(2):389-95.
144. Erbel R, Oelert H, Meyer J et al. Effect of medical and surgical therapy on aortic dissection evaluated by transesophageal echocardiography. Implications for prognosis and therapy. The European Cooperative Study Group on Echocardiography. Circulation 1993;87:1604-1615.
102. Rampoldi V, Trimarchi S, Eagle KA et al. International registry of acute aortic dissection (IRAD) Investigators. Simple risk models to predict surgical mortality in acute type A aortic dissection: The International Registry of Acute Aortic Dissection score. Ann Thorac Surg 2007 Jan;83(1):55-61.
104. Zeeshan A, Woo EY, Bavaria JE et al. Thoracic endovascular aortic repair for acute complicated type B aortic dissection: superiority relative to conventional open surgical and medical therapy. J Thorac Cardiovasc Surg 2010;140(6 Suppl):S109-15 [discussion: S142-S146].
111. Durham CA, Cambria RP, Wang LJ et al. The natural history of medically managed acute type B aortic dissection. J Vasc Surg 2015;61(5):1197
112. Nienaber CA, Rousseau H, Eggebrecht H et al. Randomized comparison of strategies for type B aortic dissection: the Investigation of Stent Grafts in Aortic Dissection (INSTEAD) trial. Circulation 2009;120:2519-2528. Nienaber CA, Kische, Akim SI et al. Strategies for subacute/chronic type B aortic dissection: The Investigation of Stent Grafts in Patients with Type B Aortic Dissection (INSTEAD) trial 1-year outcome. J Thorac Cardiovasc Surg 2010 December;140:S101-S108. Bossone E, Pyeritz RE, O’Gara P et al. Acute aortic dissection in blacks: insights from the International Registry of Acute Aortic Dissection. Am J Med 2013;126:909-915. Nienaber CA, Kische S, Rousseau H et al. Endovascular repair of type B aortic dissection: long-term results of the randomized investigation of stent grafts in aortic dissection trial. Circ Cardiovasc Interv 2013;6:407-416. 116. Lombardi JV, Cambria RP, Nienaber CA et al. Aortic remodeling after endovascular treatment of complicated type B aortic dissection with the use of a composite device design. J Vasc Surg 2014;59(6):1544-54.
113.
116 Parte IVTÓRAX of Acute Aortic Dissection experience. J Thorac Cardiovasc Surg 2005 Jan;129(1):112-22.
123. Marui A, Mochizuki T, Koyama T et al. Degree of fusiform dilatation of the proximal descending aorta in type B acute aortic dissection can predict late aortic events. J Thorac Cardiovasc Surg 2007;134(5):1163-70.
118. Sigman MM, Palmer OP, Ham SW et al. Aortic morphologic findings after thoracic endovascular aortic repair for type B aortic dissection. JAMA Surg 2014;149(9):977-83. 119. Shimono T, Kato N, Yasuda F et al. Transluminal stentgraft placements for the treatments of acute onset and chronic aortic dissections. Circulation 2002;106(suppl.1):I-241-7.
109. Matsuda Y, Yamada Z, Norooka N. Prognosis of patients with medically treat aortic dissections. Circulation 1991;84(Suppl 3):07-13.
141. Gottardi R, Funovics M, Eggers N et al. Supraaortic transposition for combined vascular and endovascular repair of aortic arch pathology. The Ann Thorac Surg 2008;86(5):1524-9. 142. Czerny M, Funovics M, Sodeck G et al. Longterm results of thoracic endovascular aortic repair in atherosclerotic aneurysms involvingthe descending aorta. J Thorac Cardiovasc Surg 2010;140(6 Suppl):S179-84 [discussion: S185-90].
143. Alfson DB, Ham SW. Type B Aortic Dissections: Current Guidelines for Treatment. Cardiol Clin 2017 Aug;35(3):387-410.
115.
108. Schorr JS, Yerliglu ME, Galla JD. Selective management of acute type B aortic dissection: longterm follow-up. Ann Thorac Surg 1996;61:1339-1341.
126. Evangelista A, Salas A, Ribera A et al. Long-term outcome of aortic dissection with patent false lumen: predictive role of entry tear size and location. Circulation 2012;125:3133-41. 127. Trimarchi S, Jip L. Tolenaar JL, Jonker FHW, Murray B, Tsai TT, Eagle KA, Rampoldi V, Verhagen HJM, van Herwaarden JA, Moll FL, Muhs BE, and Elefteriades JA. Importance of false lumen thrombosis in type B aortic dissectionprognosis. J Thorac Cardiovasc Surg 2013 March;145:S208-S212.
117. Brunkwall J, Kasprzak P, Verhoeven E et al. Endovascular repair of acute uncomplicated aortic type B dissection promotes aortic remodelling: 1 year results of the ADSORB trial. Eur J Vasc Endovasc Surg 2014;48(3):285-91.
105. Luebke T, Brunkwall J. Type B aortic dissection: a review of prognostic factors and meta-analysis of treatment options. Aorta (Stamford) 2014;2(6):265-78.
106. Eggebrecht H, Nienaber CA, Neuhäuser M et al. Endovascular stentgraft placement in aortic dissection: a meta-analysis. Eur Heart J 2006;27(4):489-98.
114.
120. Kato M, Bai H, Sato K et al. Determining surgical indications for acute type B dissection based on enlargement of aortic diameter during the chronic phase. Circulation 1995;92(9 Suppl):II107-12.
128. Sueyoshi E, Sakamoto I, Uetani M. Growth rate of affected aorta in patients with type B partially closed aortic dissection. Ann Thorac Surg 2009;88:1251-7. 129. Loewe C, Czerny M, Sodeck GH et al. A new mechanism by which an acute type B aortic dissection is pri- marily complicated, becomes complicated, or remains uncomplicated. Ann Thorac Surg 2012;93:1215-22.
130. Weiss G, Wolner I, Folkmann S et al. The location of the primary entry tear in acute type B aortic dissection affect early outcome. Eur J Cardiothorac Surg 2012;42:571-576. 131. Svensson L, Kouchoukos N, Miller DC et al. Expert Consensus Document on the Treatment of Descending Thoracic Aortic Disease Using Endovascular Stent-Grafts. Ann Thorac Surg 2008 January;85:S1-S41.
133. Griepp RB, Griepp EB. Spinal cord perfusion and protection during descending thoracic and thoracoabdominal aortic surgery: the collateral network concept. Ann Thorac Surg 2007 Feb;83(2):S865-9; discussion S890-2.
101. Westaby S, Saito S, Katsumata T. Acute type A dissection: conservative methods provide consistently low mortality. Ann Thorac Surg 2002 Mar;73(3):707-13.
136. Kouchoukos NT, Rokkas CK. Hypothermic cardiopulmonary bypass for spinal cord protection: rationale and clinical results. Ann Thorac Surg 1999;67:1940-1958. 137. Estrera AL, Miller CC, Goodrick J et al. Update on outcomes of acute type B aortic dissection. Ann Thorac Surg 2007 Feb;83(2):S842-5; discussion S846-50. 138. Rocchi G, Lofiego C, Biagini E et al. Transesophageal echocardiography – guided algorithm for stent-graft implantation in aortic dissection. J Vasc Surg 2004;40:880-885 139. Dong ZH, Fu WG, Wang YQ et al. Retrograde type A aortic dissection after endovascular stent graft placement for treatment of type B dissection. Circulation 2009;119(5):735-41.
134. Murad H. Estudo dos métodos para prevenir isquemia medular em cirurgia da aorta descendente. [Tese de (mestrado)] – UFRJ, 1978. 135. Cooley DA, Golino A, Frazier OH. Single-clamp technique for aneurysms of the descending thoracic aorta: report of 132 consecutive cases. Eur J Cardiothorac Surg 2000 Aug;18(2):162-7.
122. Winnerkvist A, Lockowandt U, Rasmussen E et al. A prospective study of medically treated acute type B aortic dissection. Eur J Vasc Endovasc Surg 2006;32(4):349-55.
132. Gottardi R, Dumfarth J, Holfeld J et al. Symptomatic spinal cord malperfusion after stent-graft coverage of the entire descending aorta. Eur J Cardiothorac Surg 2010;37:1081-1085.
121. Kunishige H, Myojin K, Ishibashi Y et al. Predictors of surgical indications for acute type B aortic dissection based on enlargement of aortic diameter during the chronic phase. Jpn J Thorac Cardiovasc Surg 2006;54(11):477-82.
124. Song JM, Kim SD, Kim JH et al. Long-term predictors of descending aorta aneurysmal change in patients with aortic dissection. J Am Coll Cardiol 2007;50:799-804. 125. van Bogerijen GH, Tolenaar JL, Rampoldi V et al. Predictors of aortic growth in uncomplicated type B aortic dissection. J Vasc Surg 2014;59:1134-43.
145. Fattori R, Napoli G, Lovato L et al. Descending thoracic aortic diseases: stent-graft repair. Radiology 2003;229:176-183.
107. Moulakakis KG, Mylonas SN, Dalainas I et al. Management of complicated and uncomplicated acute type B dissection. A systematic review and metaanalysis. Ann Cardiothorac Surg 2014;3(3):234-46.
117Capítulo 62 disseCção AórtiCA
148. Hata Y1, Iida O1, Asai M et al. Endovascular entry closure using Amplatzer vascular plug for the aortic dissection in sub-acute phase. J Cardiol Cases 2017 Dec 9;17(4):111-115.
149. Furukawa T, Uchida N, Yamane Y, Yamada K. A pitfall of false lumen embolization in chronic aortic dissection: intimal injury caused by the embolization device edge. Interact Cardiovasc Thorac Surg 2017 Jan;24(1):153-155.
150. Kölbel et al. Addressing persistent false lumen flow in chronic aortic dissection: the knickerbocker technique. J Endovasc Ther 2014 Feb;21(1):117-22.
151. Vedantham S, Picus D, Sanchez LA et al. Percutaneous management of ischemic complications in patients with type-B aortic dissection. J Vasc Interv Radiol 2003;14:181-193.
146. Kato N, Hirano T, Shimono T et al. Treatment of chronic aortic dissection by transluminal endovascular stent-graft placement: preliminary results. J Vasc Interv Radiol 2001;12:835-840.
147. Lopera J, Patino JH, Urbina C et al. Endovascular treatment of complicated type-B aortic dissection with stent-grafts: midterm results. J Vasc Interv Radiol 2003;14:195-203.
153. Panneton JM, Teh SH, Cherry KJ et al. Aortic fenestration for acute or chronic aortic dissection: an uncommon but effective procedure. J Vasc Surg 2000;32:711-721. 154. Williams DM, Brothers TE, Messina LM. Relief of mesenteric ischemia in type III aortic dissection with percutaneous fenestration of the aortic septum. Radiology 1990;174:450-2.
155. Williams DM, Lee DY, Hamilton BH et al. The dissected aorta: percutaneous treatment of ischemic complications – Principles and results. J Vasc Interv Radiol 1997;8:605-25.
156. Slonim SM, Nyman U, Semba CP et al. Aortic dissection: percutaneous management of ischaemic complications with endovascular stents and balloon fenestration. J Vasc Surg 1996;23:241-51; discussion 251-3.
152. Fann JI, Sarris GE, Mitchell RS et al. Treatment of patients with aortic dissection presenting with peripheral vascular complications. Ann Surg 1990;212:705-713.
157. Nienaber CA, Kische, Akim SI et al. Strategies for subacute/chronic type B aortic dissection: The Investigation of Stent Grafts in Patients with Type B Aortic Dissection (INSTEAD) trial 1-year outcome. J Thorac Cardiovasc Surg 2010 December;140:S101-S108.
19. Rizvi AZ, Kalra M, Bjarnason H et al. Benign superior vena cava syndrome: Stenting is now the first line of treatment. J Vasc Surg 2008 Feb;47(2):372-80.
23. Smayra T, Otal P, Chabbert V et al. Long-Term Results of Endovascular Stent Placement in the Superior Caval Venous System. Cardiovasc Intervent Radiol 2001 Oct 17;24(6):388-94. 24. Davidson CJ, Newman GE, Sheikh KH et al. Mechanisms of angioplasty in hemodialysis fistula stenoses evaluated by intravascular ultrasound. Kidney Int 1991 Jul;40(1):91-5.
13. Breault S, Doenz F, Jouannic AM, Qanadli SD. Percutaneous endovascular management of chronic superior vena cava syndrome of benign causes: long-term follow-up. Eur Radiol 2017 Jan;27(1):97-104.
20. Schifferdecker B, Shaw JA, Piemonte TC, Eisenhauer AC. Nonmalignant superior vena cava syndrome: Pathophysiology and management. Cathet Cardiovasc Intervent 2005;65(3):416-23.
25. Singer-Jordan J, Papura S. Cutting Balloon Angioplasty for Primary Treatment of Hemodialysis Fistula Venous Stenoses: Preliminary Results. J Vasc Intervent Radiol 2005 Jan;16(1):25-9.
118 63Capítulo SÍNDROME DA VEIA CAVA SUPERIOR REFERÊNCIAS BIBLIOGRÁFICAS
35. Sawada S, Fujiwara Y, Koyama T et al. Application of Expandable Metallic Stents to the Venous System. Acta radiol 1992 Jan;33(2):156-9. 36. Elson JD, Becker GJ, Wholey MH, Ehrman KO. Vena Caval and Central Venous Stenoses: Management with Palmaz Balloon-expandable Intraluminal Stents. J Vasc Intervent Radiol 1991 May;2(2):215-23.
15. Kalra M, Gloviczki P, Andrews JC et al. Open surgical and endovascular treatment of superior vena cava syndrome caused by nonmalignant disease. J Vasc Surg 2003 Aug;38(2):215-23.
37. Barshes NR, Annambhotla S, Sayed El HF et al. Percutaneous Stenting of Superior Vena Cava Syndrome: Treatment Outcome in Patients with Benign and Malignant Etiology. Vascular 2016 Jun 23;15(5):314-21. 38. Sfyroeras GS, Antonopoulos CN, Mantas G et al. A Review of Open and Endovascular Treatment of Superior Vena Cava Syndrome of Benign Aetiology. Europ J Vasc Endovasc Surg 2017 Feb;53(2):238-54. 39. Iafrati M, Maloney S, Halin N. Radiofrequency thermal wire is a useful adjunct to treat chronic central venous occlusions. J Vasc Surg 2012 Feb;55(2):603-6. 40. Maloney SP, Halin N, Iafrati M. Radiofrequency Thermal Wire: A Useful Adjunct To Treat Chronic Central Venous Occlusions. J Vasc Surg 2010 Oct;52(4):1121. 41. Horikawa M, Quencer KB. Central Venous Interventions. Tech Vasc Int Radiol 2017 Mar;20(1):48-57. 42. Dinkel H-P, Mettke B, Schmid F et al. Endovascular Treatment of Malignant Superior Vena Cava Syndrome:Is Bilateral Wallstent
14. Ferris EB, Gloviczki PB, Pairolero PC et al. Reconstruction of large veins for nonmalignant venous occlusive disease. J Vasc Surg 1992 Nov;16(5):0750-61.
16. Sherry CS, Diamond NG, Meyers TP, Martin RL. Successful treatment of superior vena cava syndrome by venous angioplasty. AJR Am J Roentgenol 1986 Oct;147(4):834-5. 17. Qanadli SD, Hajjam El M, Mignon F et al. Subacute and chronic benign superior vena cava obstructions: endovascular treatment with self-expanding metallic stents. AJR Am J Roentgenol 1999 Jul;173(1):159-64.
26. Sprouse LR II, Lesar CJ, Meier GH III et al. Percutaneous treatment of symptomatic central venous stenosis angioplasty. J Vasc Surg 2004 Mar;39(3):578-82. 27. Tordoir J, Canaud B, Haage P et al. EBPG on Vascular Access. Nephrol Dial Transplant 2007 May 1;22(Supplement 2):ii88-ii117. 28. Chee CE, Bjarnason H, Prasad A. Superior vena cava syndrome: an increasingly frequent complication of cardiac procedures. Nat Clin Pract Cardiovasc Med 2007 Apr 1;4(4):226-30. 29. Haage P, Vorwerk D, Piroth W et al. Treatment of Hemodialysisrelated Central Venous Stenosis or Occlusion: Results of Primary Wallstent Placement and Follow-up in 50 Patients. Radiology 1999 Jul 8;212(1):175-80. 30. Mickley V. Central venous catheters: many questions, few answers. Nephrol Dial Transplant 2002 Aug 1;17(8):1368-73. 31. Mickley V, Görich J, Rilinger N et al. Stenting of central venous stenoses in hemodialysis patients: Long-term results. Kidney Int 1997 Jan 1;51(1):277-80. 32. Dammers R, de Haan MW, Planken NR et al. Central vein obstruction in hemodialysis patients: Results of radiological and surgical intervention. Eur J Vasc Endovasc Surg 2003 Sep;26(3):317-21.
8. Stanford W, Doty DB. The role of venography and surgery in the management of patients with superior vena cava obstruction. Ann Thoracic Surg 1986 Feb;41(2):158-63.
21. Yim CD, Sane SS, Bjarnason H. Superior vena cava stenting. Radiologic Clinics of NA 2000 Mar;38(2):409-24.
12. Superior Vena Cava Syndrome with Malignant Causes. N Engl J Med 2008 Mar 6;358(10):1083-3.
10. Straka C, Ying J, Kong F-M et al. Review of evolving etiologies, implications and treatment strategies for the superior vena cava syndrome. Springerplus 2016;5(1):229. 11. Chang CJ, Ko PJ, Hsu LA et al. Highly increased cell proliferation activity in the restenotic hemodialysis vascular access after percutaneous transluminal angioplasty: implication in prevention of restenosis. Am J Kidney Dis 2004 Jan;43(1):74-84.
33. Rösch J, Uchida BT, Hall LD et al. Gianturco-Rösch expandable Z-stents in the treatment of superior vena cava syndrome. Cardiovasc Intervent Radiol 1992 Sep 1;15(5):319-27. 34. Carrasco CH, Charnsangavej C, Wright KC et al. Use of the Gianturco Self-expanding Stent in Stenoses of the Superior and Inferior Venae Cavae. J Vasc Intervent Radiol 1992 May;3(2):409-19.
4. Lickfett L. Incidence of venous obstruction following insertion of an implantable cardioverter defibrillator. A study of systematic contrast venography on patients presenting for their first elective ICD generator replacement. Europace 2004 Jan;6(1):25-31. 5. Yu JB, Wilson LD, Detterbeck FC. Superior Vena Cava Syndrome–A Proposed Classification System and Algorithm for Management. J Thor Oncol 2008 Aug;3(8):811-4.
3. Rice TW, Rodriguez RM, Light RW. The Superior Vena Cava Syndrome. Medicine 2006 Jan;85(1):37-42.
18. Charnsangavej C, Carrasco CH, Wallace S et al. Stenosis of the vena cava: preliminary assessment of treatment with expandable metallic stents. Radiology 1986 Nov;161(2):295-8.
22. Kee ST, Kinoshita L, Razavi MK et al. Superior vena cava syndrome: treatment with catheter-directed thrombolysis and endovascular stent placement. Radiology 1998 Jan;206(1):187-93.
6. Carter MM, Tarr RW, Mazer MJ, Carroll FE. The “aortic nipple” as a sign of impending superior vena caval syndrome. Chest 1985 Jun;87(6):775-7.
1. Ahmann FR. A reassessment of the clinical implications of the superior vena caval syndrome. J Clin Oncol 1984 Aug;2(8):961-9.
2. Webb WR, Gamsu G, Speckman JM et al. Computed tomographic demonstration of mediastinal venous anomalies. AJR Am J Roentgenol 1982 Jul;139(1):157-61.
9. Rowell NP, Gleeson FV. Steroids, radiotherapy, chemotherapy and stents for superior vena caval obstruction in carcinoma of the bronchus. In: Rowell NP (Ed.). Cochrane Database Syst Rev. Chichester, UK: John Wiley & Sons, Ltd; 2001. p. 183(4):CD001316.
7. Sheth S, Ebert MD, Fishman EK. Superior Vena Cava Obstruction Evaluation With MDCT. AJR Am J Roentgenol 2010 Apr;194(4):W336-46.
58. Kovalik EC, Newman GE, Suhocki P et al. Correction of central venous stenoses: Use of angioplasty and vascular Wallstents. Kidney Int 1994 Apr;45(4):1177-81. 59. Kovalik EC, Schwab SJ. Can Venous Stenosis Be Prevented? Sem Dial 2002 Jan 5;12(3):144-5. 60. Kundu S. Review of Central Venous Disease in Hemodialysis Patients. J Vasc Intervent Radiol 2010 Jul;21(7):963-8. 61. III. NKF-K/DOQI Clinical Practice Guidelines for Vascular Access: Update 2000. Am J Kidney Dis 2001 Jan;37(1): S137-81. 62. Aruny JE, Lewis CA, Cardella JF et al. Quality Improvement Guidelines for Percutaneous Management of the Thrombosed or Dysfunctional Dialysis Access. J Vasc Intervent Radiol 1999 Apr;10(4):491-8. 63. Bakken AM, Protack CD, Saad WE et al. Long-term outcomes of primary angioplasty and primary stenting of central venous stenosis in hemodialysis patients. J Vasc Surg 2007 Apr;45(4):776-83. 64. Surowiec SM, Fegley AJ, Tanski WJ et al. Endovascular Management of Central Venous Stenoses in the Hemodialysis Patient: Results of Percutaneous Therapy. Vasc Endovascular Surg 2016 Aug 19;38(4):349-54. 65. Sapoval MR, Turmel-Rodrigues LA, Raynaud AC et al. Cragg Covered Stents in Hemodialysis Access: Initial and Midterm Results. J Vasc Intervent Radiol 1996 May;7(3):335-42. 66. Quinn SF, Kim J, Sheley RC. Transluminally Placed Endovascular Grafts for Venous Lesions in Patients on Hemodialysis. Cardiovasc Intervent Radiol 2003 Aug 1;26(4):365-9. 67. Gloviczki P et al Handbook of Venous and Lymphatic Disorders Guidelines of the American Venous Forum – 4th Edition. CRC Press; 2017.
52. Janne d’Othée B, Tham JC, Sheiman RG. Restoration of Patency in Failing Tunneled Hemodialysis Catheters: A Comparison of Catheter Exchange, Exchange and Balloon Disruption of the Fibrin Sheath, and Femoral Stripping. J Vasc Intervent Radiol 2006 Jun;17(6):1011-5.
119Capítulo 63 síndrome dA veiA C AvA suPerior Placement Superior to Unilateral Placement? J Endovasc Ther 2003 Aug;10(4):788-97.
49. Lund GB, Lieberman RP, Haire WD et al. Translumbar inferior vena cava catheters for long-term venous access. Radiology 1990 Jan;174(1):31-5. Crummy AB, Carlson P, McDermott JC, Andrews D. Percutaneous transhepatic placement of a Hickman catheter. AJR Am J Roentgenol 1989 Dec;153(6):1317-8. Mathur MN, Storey DW, White GH, Ramsey-Stewart G. percutaneous insertion of long-term venous access catheters via the external iliac vein. ANZ J Surg 1993 Nov;63(11):858-63.
56. Beathard GA. Percutaneous Angioplasty For the Treatment of Venous Stenosis: A Nephrologist’s View. Sem Dial 2007 Oct 1;8(3):166-70.
54. Isfort P, Penzkofer T, Goerg F, Mahnken AH. Stenting of the superior vena cava and left brachiocephalic vein with preserving the central venous catheter in situ. Korean J Radiol 2011 Sep;12(5):629-33.
53. Haller C, Déglise S, Saucy F et al. Placement of Hemodialysis Catheters Through Stenotic or Occluded Central Thoracic Veins. Cardiovasc Intervent Radiol 2009 May 16;32(4):695-702.
46. Horton MG, Mewissen MW, Rilling WS et al. Hemodialysis Catheter Placement Directly into Occluded Central Vein Segments: A Technical Note. J Vasc Intervent Radiol 1999 Sep;10(8):1059-62. Foley AM. Translumbar inferior vena cava catheter: An unconventional dialysis access. J Vasc Nurs 2015 Jun;33(2):79-80.
55. Fagedet D, Thony F, Timsit JF et al. Endovascular Treatment of Malignant Superior Vena Cava Syndrome: Results and Predictive Factors of Clinical Efficacy. Cardiovasc Intervent Radiol 2011 Dec 7;36(1):140-9.
50.
51.
57. Neglen P, RajuS. Balloon Dilation and Stenting of Chronic Iliac Vein Obstruction: Technical Aspects and Early Clinical Outcome. J Endovasc Ther 2000 April;7(2):79-91.
44. Forauer AR, Brenner B, Haddad LF, Bocchini TP. Placement of Hemodialysis Catheters Through Dilated External Jugular and Collateral Veins in Patients with Internal Jugular Vein Occlusions. AJR Am J Roentgenol 2000 Feb;174(2):361-2.
47.
48. Andrews JC. Translumbar approach to the inferior vena cava for chronic venous access. Oper Tech Gen Surg 2001 Dec;3(4):238-42.
43. Lanciego C, Pangua C, Chacón JI et al. Endovascular Stenting as the First Step in the Overall Management of Malignant Superior Vena Cava Syndrome. AJR Am J Roentgenol 2009 Aug;193(2):549-58.
45. Funaki B, Zaleski GX, Leef JA, Rosenblum JD. Radiologic placement of long-term hemodialysis catheters in occluded jugular or subclavian veins or through patent thyrocervical collateral veins. AJR Am J Roentgenol 1998 May;170(5):1194-6.
13. British Thoracic Society. British Thoracic Society guidelines for the management of suspected acute pulmonary embolism. Thorax 2003;58:470-84.
27. Kearon C, Ginsberg JS, Hirsh J. The role of venous ultrasonography in the diagnosis of suspected deep venous thrombosis and pulmonary embolism. Ann Intern Med 1998;129(12):1044-1049.
120 64Capítulo
23. Righini M, Goehring C, Bounameaux H, Perrier A. Effects of age on the performance of common diagnostic tests for pulmonary embolism. Am J Med 2000;109(5):357-361.
15. Morpurgo M, Schmid C. The spectrum of pulmonary embolism –Clinicopathologic correlations. Chest 1995;107(Suppl 1):18s-20s.
31. Bova C, Greco F, Misuraca G et al. Diagnostic utility of echocardiography in patients with suspected pulmonary embolism. Am J Emerg Med 2003;21(3):180-183.
32. Kurzyna M, Torbicki A, Pruszczyk P et al. Disturbed right ventricular ejection pattern as a new Doppler echocardiographic sign of acute pul- monary embolism. Am J Cardiol 2002;90(5):507-511.
3. Giuntini C, DiRicco G, Mrini C et al. Pulmonary embolism: epidemiology. Chest 1995;107(Suppl 1):3s-9s.
6. Barreto SSM, Faccin CS, Silva PM et al. Estratificação de risco e profilaxia para tromboembolia venosa em pacientes internados em hospital geral universitário. J Pneumol 1998;24(5):298-302.
24. Schouten HJ, Geersing GJ, Koek HL, et al. Diagnostic accuracy of conventional or age adjusted D-dimer cut-off values in older patients with suspected venous thrombo- embolism: systematic review and meta-analysis. BMJ 2013;346:f2492.
20. Rodger MA, Carrier M, Jones GN et al. Diagnostic Value of Arterial Blood Gas Measurement in Suspected Pulmonary Embolism. Am J Respir Crit Care Med 2000;162(6):2105-2108. 21. Leclercq MG, Lusitan JG, Van Marjwij K et al. Rulling out clinically suspected pulmonary embolism by assessment of clinical probability and D-dimer levels: a management study. Thromb Haemost 2003;58:470-84.
16. Wagenvoort CA. Pathology of pulmonary thromboembolism. Chest 1995;107(Suppl 1):10s-17s.
REFERÊNCIAS BIBLIOGRÁFICAS
33. Torbicki A, Galie` N, Covezzoli A et al. Right heart thrombi in pulmonary embolism: results from the International Cooperative Pulmonary Embolism Registry. J Am Coll Cardiol 2003;41(12):2245-2251. 34. Gray HW, Neilly JB. The role and value of ventilation perfusion imaging in pulmonary embolism. In: Oudkerk M, Van Beek EJR, tem Cate JN. Pulmonary embolism – Epidemiology, diagnosis and treatment Berlin: Blackwell Science; 1999. p. 84-123. 35. Goldhaber SZ. Treatment of pulmonary thromboembolism. Intern Med 1999;38:620-25. 36. Karterman RY. Interventional radiology of the chest. In: Slone RM, Gutierrez FR, Fisher AJ. Led. New York: MacGraw-Hill; 1999. p. 303-4. 37. Lange S, Walsh G. Radiology of chest diseases. 2nd ed. Stuttgart, New York: Thieme; 1998. 38. Lorut C et al. A noninvasive diagnostic strategy including spiral computed tomography in patients with suspected pulmonary embolism. Am J Respir Crit Care Med 2000;162:1413-18. Stein PD et al. Multidetector computed tomography for acute pulmonary embolism. N Engl J Med 2006;354:2317-27. 40. Garvey CJ, Hanlon R. Computed tomography in clinical practice. BMJ 2002;324:1077-80. 41. Goldhaber SZ. Multislice computed tomography for pulmonary embolism – A technological Marvel. N Engl J Med 2005;352:1812-14. 42. Becattini C, Agnelli G, Vedovati MC et al. Multidetector computed tomography for acute pulmonary embolism: diagnosis and risk stratification in a single test. Eur Heart J 2011;32(13):1657-1663. 43. Chan CM, Woods C, Shorr AF. The validation and reproducibility of the pulmonary embolism severity index. J Thromb Haemost 2010;8(7):1509-1514. Donze J, Le Gal G, Fine MJ et al. Prospective validation of the Pulmonary Embolism Severity Index. A clinical prognostic model for pulmonary embolism. Thromb Haemost 2008;100(5):943-948.
44.
26. Becattini C, Vedovati MC, Agnelli G. Prognostic value of troponins in acute pulmonary embolism. Circulation 2007;116:427.
30. Grifoni S, Olivotto I, Cecchini P, et al. Short-term clinical outcome of patients with acute pulmonary embolism, normal blood pressure, and echocardiographic right ventricular dysfunction. Circulation 2000;101(24):2817-2822.
7. Barreto SSM, Silva PM, Faccin CS et al. Profilaxia para tromboembolia venosa em uma unidade de tratamento intensivo. J Pneumol 2000;26(1):15-19.
10. Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 1999;353(9162):1386-1389.
39.
12. Crowther MA, Kelton JG. Congenital thrombophilic states associated with venous thrombosis: a qualitative overview and proposed classification system. Ann Intern Med 2003;138(2):128-34.
1. Heit JA. Epidemiology of venous thromboembolism. Nat Ver Cardiol 2015;12(8):464-474.
11. Palla A, Giuntini C. Highlights and final remarks. Chest 1995:107(Suppl 1):56s-57s.
28. Perrier A, Bounameaux H. Ultrasonography of leg veins in patients suspected of having pulmonary embolism. Ann Intern Med 1998;128(3):243-245. 29. Le Gal G, Righini M, Sanchez O et al. A positive compression ultrasonography of the lower limb veins is highly predictive of pulmonary embolism on computed tomography in suspected patients. Thromb Haemost 2006;95(6):963-966.
4. Barreto SSM, Albuquerque GC. Tromboembolismo pulmonar. In: Lopes AC. Tratado de clínica médica. São Paulo: Roca; 2006. p. 2694-709, cap. 237. 5. American Thoracic Society. The diagnostic approach to acute venous thromboembolism. Clinical Practice Guideline. Am J Respir Crit Care Med 1999;160:1043-66.
25. Righini M, Van Es J, den Exter PL et al. Age-adjusted D-dimer cutoff levels to rule out pulmonary embolism: the ADJUST-PE study. JAMA 2014;311(11):1117-1124.
14. Hyers TM. Venous thromboembolism. Am J Respir Crit Care Med 1999;159:1-14.
8. Heit JA et al. Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study. Arch Intern Med 2000;160:761-768. 9. Fedullo PF, Rubin LJ, Kerr KM et al. The natural history of acut e and chronic thromboembolic disease: the search for the missing link. Eur Resp J 2000;15:435-37.
22. Carrier M, Righini M, Djurabi RK, et al. VIDAS D-dimer in combination with clinical pre-test probability to rule out pulmonary embolism. A systematic review of management outcome studies. Thromb Haemost 2009;101(5):886-892.
TROMBOEMBOLISMO PULMONAR
2. Huang W, Goldberg RJ, Anderson FA et al. Secular trends in occurrence of acute venous thromboembolism: the Worcester VTE study (1985–2009). Am J Med 2014;127:829.e5–839.e5.
17. Martins HS. Embolia pulmonar. Emergências clínicas – Abordagem prática – Disciplina de emergências clínicas/Hospital das Clínicas. FMUSP 2010;517-31, cap. 37. 18. European Respiratory Society. 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J 2014;35:3033-3080. 19. Stein PD, Beemath A, Matta F et al. Clinical Characteristics of Patients With Acute Pulmonary Embolism: Data from PIOPED II. Am J Med 2007;120:871.
60. Agnelli G, Buller HR, Cohen A et al. Oral apixaban for the treatment of acute venous thromboembolism. N Engl J Med 2013;369(9):799-808. 61. Buller HR, Decousus H, Grosso MA et al. Edoxaban versus warfarin for the treatment of symptomatic venous thrombo- embolism. N Engl J Med 2013;369(15):1406-1415. 62. Pollack CV, Reilly PA, Ryn JV et al. Idarucizumab for Dabigatran Reversal – Full Cohort Analysis. N Engl J Med 2017; 377:431-441 63. Connolly SJ, Milling TJ, Eikelboom JW et al. Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors. N Engl J Med 2016;375:1131-1141 64. Konstantinides S, Geibel A, Heusel G et al. Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N Engl J Med 2002;347(15):1143-1150. 65. Meyer G, Vicaut E, Danays T et al. Fibrinolysis for patients with intermediate-risk pulmonary embolism. N Engl J Med 2014;370(15): 1402-1411. 66. Goldhaber SZ. Thrombolysis for pulmonary embolisml. N Eng J Med 2002;347:1131-32. 67. Arcasoy SM, Kreit JW. Thrombotic therapy of pulmonary embolism: a comprehensive review of current evidence. Chest 1999;115:1695-707.
49.
51. Kearon C, Akl EA, Ornelas J et al. Antithrombotic Therapy for VTE Disease: Chest. 2016;149(2):315-352.
58. Schulman S, Kearon C, Kakkar AK et al. Dabigatran versus warfarin in the treatment of acute venous thromboembolism. N Engl J Med 2009;361(24):2342-2352. 59. Schulman S, Kakkar AK, Goldhaber SZ et al. Treatment of acute venous thromboembolism with dabigatran or warfarin and pooled analysis. Circulation 2014;129(7):764-772.
56. Ageno W, Gallus AS, Wittkowsky A et al. Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012;141:44S.
55. Konstantinides S et al. Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N Engl J Med 2002;347:1143-50.
45.
54. Michota FA. Venous thromboembolism prophylaxis in the medically ill patient. Clin Chest Med 2003;24:93-101.
48.
47.
46.
121Capítulo 64 tromboembolismo PulmonAr Jimenez D, Aujesky D, Moores L et al. Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. Arch Intern Med 2010;170(15):1383-1389. Weitz JI. New anticoagulants for treatment of venous thromboembolism. Circulation 2004;110(Suppl 1):I19-26. Tovey C, Wyatt S. Diagnosis, investigation, and management of deep vein thrombosis. MBJ 2003;326:1180-84. Terra-Filho M, Menna-Barreto S. Recomendações para manejo de tromboembolia pulmonar. J Bras de Pneumol 2010;36(Supl 1):S1-68. Clagett GP, Anderson Jr FA, Heit J et al. Prevention of venous thromboembolism. Fourt ACCP Consensus Conference on Antithrombotic Therapy. Chest 1995;108(Suppl):312s-28s. Kearon C, Akl EA, Comerota AJ et al. Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis. 9th ed. Am College Chest Physicians Tromboembolismo Venoso Seção XIV Evidence-Based Clinical Practice Guidelines. Chest 2012;141:419S.
50.
57. Buller HR, Prins MH, Lensin AW et al. Oral rivar-oxaban for the treatment of symptomatic pulmonary embolism. N Engl J Med 2012;366(14):1287-1297.
52. Garcia DA, Baglin TP, Weitz JI et al. Parenteral anticoagulants: antithrombotic therapy and prevention of thrombosis. 9th ed. American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012;141:24S.
53. Hirsh J, Hoak J. Management of deep vein thrombosis and puolmonary embolism: a statement for health care professionals. Circulation 1996;93:2212-45.
11. Barbosa MAO, Oliveira DC, Barbosa AT et al. Tratamento do tromboembolismo pulmonar maciço por fragmentação percutânea do trombo. Arq Bras Cardiol 2007;88(3):279-284.
1. Jamieson SW. Historical perspective: surgery for chronic thromboembolic disease. Semin Thorac Cardiovasc Surg 2006 Fall;18(3):218-222.
5. Davies MJ, Arsiwala SS, Moore HM et al. Extracorporeal membrane oxygenation for the treatment of massive pulmonary embolism. Ann Thorac Surg 1995 Dec;60(6):1801-1803.
2. Thistlethwaite PA, Jamieson SW. Surgery for pulmonary embolism. In: Selke FW, Del Nildo PJ, Swanson SJ. Sabiston & Spencer Surgery of the Chest. Philadelphia: Elsevier Saunders; 2007. p. 1723-1739.
8. Kadner A, Schmidli J, Schonhoff F et al. Excellent outcome after surgical treatment of massive pulmonary embolism in critically ill patients. J Thorac Cardiovasc Surg 2008;136448-51. 9. Uflacker R. Interventional Therapy for Pulmonary Embolism. J Vasc Interv Radiol 2001;12:147-164.
7. Stein PD, Alnas M, Beemath A, Patel NR. Outcome of pulmonar embolectomy. Am J Cardiol 2007;99:421-3.
16. Bartlett RH, Roloff DW, Custer JR et al. Extracorporeal life support: the University of Michigan experience. JAMA 2000;283:904-908.
18. Thistlethwaite PA, Madani MM, Kemp AD et al. Venovenous extracorporeal life support after pulmonary endarterectomy: indications, techniques, and outcomes. Ann Thorac Surg 2006;82:2139-2146.
14. Kucher N Catheter embolectomy for acute pulmonary embolism. Chest 2007;132:657-63.
17. Moazami N, McCarthy PM. Temporary Circulatory Support. In: Cohn LH, Edmunds LH Jr (Eds.). Cardiac Surgery in the Adult. New York: McGraw-Hill; 2003. p. 495-520.
15. Oudkerk M, Van Beek EJR, ten Cate JW. Pulmonary embolism. Boston: Blackwell Science; 1999.
10. De Gregório MA, Gimeno MJ, Mainar A et al. Mechanical and Enzymatic Thrombolysis for Massive Pulmonary Embolism. J Vasc Interv Radiol 2002;13:163-169.
20. Pengo V, Lensing AWA, Prins MH et al. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med 2004;350:2257-2264.
REFERÊNCIAS BIBLIOGRÁFICAS
3. Jamieson SW, Madani MM.Pulmonary embolism and Pulmonary thromboendarterectomy. In: Cohn LH and Adams DH (Eds.). Cardiac surgery in the adult. 5th ed. New York: McGraw-Hill; 2018. p. 1127-1144. 4. Mattox KL, Feldtman RW, Beall AC, De Bakey ME. Pulmonary embolectomy for acute massive pulmonary embolism. Ann Surg 1982 Jun;195(6):726-731.
6. Schmid C, Zietlow S, Wagner TO et al. Fulminant pulmonary embolism: symptoms, diagnostics, operative technique, and results. Ann Thorac Surg 1991 Nov;52(5):1102-1105; discussion 1105-1107.
122 65Capítulo EMBOLIA PULMONAR – TRATAMENTO CIRÚRGICO
12. Verstraete M, Miller GAH, Bounameaux H et al. Intravenous and intrapulmonary recombinant tissue-type plasminogen activator in the treatment of acute massive pulmonary embolism. Circulation 1988;77:353-360.
13. Torbicki A1, Perrier A, Konstantinides S et al. Guidelines on the diagnosis and management of acute pulmonary embolism: The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J 2008 Sep;29(18):2276-2315.
19. Benotti JR, Ockene IS, Alpert JS, Dalen JE. The clinical profile of unresolved pulmonary embolism. Chest 1983 Dec;84(6):669-678.
21. Wolf M, Boyer-Neumann C, Parent F et al. Thrombotic risk. factors in pulmonary hypertension. Eur Respir J 2000;15:395-399. 22. Riedel M, Stanek V, Widimsky J, Prerovsky I. Longterm follow-up of patients with pulmonary thromboembolism: late prognosis and evolution of hemodynamic and respiratory data. Chest 1982;81:151-158. 23. Wray CJ, Auger WR. Evaluation of patients for pulmonary endarterectomy. Semin Thorac Cardiovasc Surg 2006 Fall;18(3):223-229. 24. Madani MM, Jamieson SW. Pulmonary Endarterectomy for Chronic Thromboembolic Disease. Op Tech Thorac Cardiovasc Surg 2006;11(4):264-274. 25. Kouchoukos NT, Blackstone EH, Doty DB et al. Diseases of the pulmonary artery. In: Kirklin/Barrat-Boyes. Cardiac Surgery. 3rd ed. Salt Lake City: Churchill Livingston; 2003. p. 1908-1909. 26. Dartevelle P, Fadel E, Chapelier A et al. Angioscopic videoassisted pulmonary endarterectomy for post-embolic pulmonary hypertension. Eur J Cardiothorac Surg 1999;16:38-43. 27. Fan E, Needham DM, Stewart TE. Ventilatory management of acute lung injury and acute respiratory distress syndrome. JAMA 2005 Dec 14;294(22):2889-2896. 28. Adams A, Fedullo PF. Postoperative management of the patient undergoing pulmonary endarterectomy. Semin Thorac Cardiovasc Surg 2006 Fall;18(3):250-256. 29. Rubens FD, Bourke M, Hynes M, et al. Surgery for chronic thromboembolic pulmonary hypertension - inclusive experience from a national referral center. Ann Thorac Surg 2007 Mar;83(3):1075-1081. 30. Dartevelle P, Faddel E, Mussot S. Risk factors and basic mechanismsof chronic Thrmboembolic pulmonar hypertension: a current understanding. Eur Respirator J 2013;41:462-8. 31. Thistlethwaite PA, Madani M, Jamieson SW. Outcomes of pulmonary endarterectomy surgery. Semin Thorac Cardiovasc Surg 2006 Fall;18(3):257-264. 32. Madani MM, Auger WR, Pretorius V et al. Pulmonary endarterectomy: recente changes in a single institution’s experienca of more than 2700 patients. Ann Thorac Surg 2012;94:97-104. 33. Berman M, Hardman G, Sharples L et al. Pulmonary endarterectomy: outcomes in patients aged >70. Eur J Cardiothoracic Surg 2012;41:e154-e160. 34. Jatene F. Tratamento cirurgico do tromboembolismo pulmonar crônico: Análise dos resultados imediatos e tardios. Tese de livre docência. Universidade de São Paulo; 1997. 35. Scudeller PG. Avaliação do impactode mudanças técnicas introduzidas na operação de tromboendarterectomia pulmonar ao longo de 10 anos: estudo retrospectivo no InCor – HCFMUSP. Tese de Doutorado Universidade de São Paulo; 2018. 36. Cannon JF, Su L, Kiely DG et al. Dynamic risk stratification of patient long term outcome after pulmonar endarterectomy: results from United Kingdom National Cohort. Circulation 2016;133:1761-71. 37. Fukui S, Ogo T, Morita Y et al. Right ventricular reverse remodeling after balloon pulmonary angioplasty. Eur Respir J 2014 May;43(5):1394-402.
12. Barrit DW, Jordan SC. Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial. Lancet 1960;1:1309-1312.
13. Verstraete M, Miller GAH, Bounameaux H, et al . Intravenous and intrapulmonary recombinant tissue-type plasminogen activator in the treatment of acute massive pulmonary embolism. Circulation 1988;77:353-360.
16. Murphy JM, Mulvihill N. Mulcahy D et al . Percutaneous catheter and guidewire fragmentation with local administration of recombinant tissue plasminogen activator as a treatment for massive pulmonary embolism. Eur Radiol 1999;9:959-964.
9. Marques LJ. Tromboembolismo Pulmonar . Ribeirão Preto: Medicina. 1998 abr/jun;31 : 257-265.
5. Fava M, Loyola S, Flores P, Huete I. Mechanical fragmentation and pharmacologic thrombolysis in massive pulmonary embolism. J Vasc Interv Radiol 1997;8:261-266.
7. Schmitz-Rode T, Günther RW, Pfeffer JG et al . Acute massive pulmonary embolism: use of a rotatable pigtail catheter for diagnosis and fragmentation therapy. Radiology 1995;197:157-162.
123 66Capítulo
23. Cela MC, Amplatz K. Nonsurgical pulmonary embolectomy. In: Cope C (Ed.). Current Techniques in Interventional Radiology Philadelphia: Current Medicine. 1994;12:1-12.
18. Eng J, Krishnan JA, Segal JB et al . Accuracy of CT in the Diagnosis of Pulmonary Embolism: A Systematic Literature Review . Am J Roentgenol 2004;183:1819-27.
TRATAMENTO DO TROMBOEMBOLISMO PULMONAR MACIÇO
11. Honoring PB, Frederick HB. Pulmonary Embolism: What’s Wrong with This Diagnosis? AJR 2000;174;1489-1497.
24. Mainar A, Herrera M, Tobio R et al. Mechanical and enzymatic thrombolysis for massive pulmonary embolism. J Vasc Interv Radiol 2002;13(2 Pt 1):163-9.
17. Tajima H, Kumazaki T, Kawamata H et al . Development of rotational digital angiography system: clinical value in acute pulmonary thromboembolism. Comput Method Program Biomed 2001;66:111-114.
20. Fava M, Loyola S, Meneses L. Tromboembolismo pulmonar con compromiso hemodinámico: tratamiento con trombólisis farmacológica y fragmentación mecánica. Caso clínico. Rev Med Chile 2005;133(12):1477-82.
REFERÊNCIAS BIBLIOGRÁFICAS
14. Arquivos Brasileiros de Cardiologia - Volume 83, Suplemento I, agosto 2004. 15. Kumazaki T, Nakazawa K, Abe Y et al. Hybrid treatment of acute massive pulmonary thromboembolism: mechanical fragmentation with a modified rotating pigtail catheter, local fibrinolytic therapy, and clot aspiration followed by systemic fibrinolytic therapy. AJR 2004;183(3):589-95.
ENDOVASCULAR
1. Dalen JE, Alper JS. Natural history of pulmonary embolism. Prog Cardiovasc Dis 1995;17:259-270.
10. Uflacker R. Interventional Therapy for Pulmonary Embolism. J Vasc Interv Radiol 2001;12(2):147-64.
8. Krivec B, Voga G, Zuran I et al . Diagnosis and treatment of shock due to massive pulmonary embolism: approach with transesophageal echocardiography and intrapulmonary thrombolysis. Chest 1997;112:1310-1316.
22. Giuntini C, DiRicco G, Marini C et al . Pulmonary embolism: Epidemiology. Chest 1995;107(Supl):S3-S9.
21. Goldhaber SZ. Pulmonary Embolism. Lancet 2004;363:1295-305.
19. Revel MP, Petrover D, Hemigou A et al . Diagnosing Pulmonary Embolism with four-Detector Row Helicoidal CT: Prospective Evaluation of 216 Outpatients and Inpatients. Radiology 2005;234:265-73.
27. Konstantinides S, Geibel A, Olschewski M et al . Association between thrombolytic treatment and the prognosis of hemodynamically stable patients with major pulmonary embolism: results of a multicenter registry. Circulation 1997;96:882-888. 28. Uflacker R, Rajagopalan PR, Vujic I, Stutley JE. Treatment of thrombosed dialysis grafts: randomized trial of surgical thrombectomy versus mechanical thrombectomy with the Amplatz device. J Vasc Interv Radiol 1996;7:185-192. 29. Gurbel PA, Witty LA, Pieper KS, Stack RS. Pharmacomechanical thrombolysis of experimental pulmonary emboli: rapid low dose intraembolic therapy. Chest 1994;106:1558-1562. 30. Saxon RR, Benenati JF, Teigen C et al . Utility of a Power Aspiration–Based Extraction Technique as an Initial and Secondary Approach in theTreatment of Peripheral Arterial Thromboembolism: Results of the Multicenter PRISM Trial. J Vasc Interv Radiol 2018 Jan;29(1):92-100. 31. Miller GAH, Sutton GC, Kerr IH et al . Comparison of streptokinase and heparin in treatment of isolated acute massive pulmonary embolism. Br Med J 1971;2:681-684. 32. Goldhaber SZ, Kessler CM, Heit J. Randomized controlled trial of recombinant tissue plasminogen activator versus urokinase in treatment of acute pulmonary embolism. Lancet 1988;1:293-298. 33. Tennant SN, Dixon J, Venable TC et al. Intracoronary thrombolysis in patients with acute myocardial infarction: comparison of the efficacy of urokinase versus streptokinase. Circulation 1984;69:756. 34. Urokinase-streptokinase-pulmonary embolism (USPET) trial. Phase 2 results. JAMA 1974;229:1606-1613. 35. Goldhaber SZ. Tissue plasminogen activator in acute pulmonary embolism. Chest 1989;95:S282-S289. 36. Thorpe P. Long term follow-up of aggressive catheter technique for massive pulmonary embolus thrombolysis. J Vasc Interv Radiol 1997;8:184. 37. Goldhaber SZ, De Rosa M, Visani L. International cooperativa pulmonary embolism registry detects high mortality rate [abstract]. Circulation 1997;96(suppl):1591. 38. Ribeiro A, Lindmarker P, Juhlin Dannfelt A et al . Echocardiography Doppler in pulmonary embolism: right ventricular dysfunction as a predictor of mortality rate. Am Heart J 1997;134:479-87. 39. Brady AJB, Crake T, Oakley CM. Percutaneous catheter fragmentation and distal dispersion of proximal pulmonary embolus. Lancet 1991; 338:1186-1189. 40. Essop MR, Middlemt S, Skoularigis J, Sareli P. Simultaneous mechanical clot fragmentation and pharmacologic thrombolysis in acute massive pulmonary embolism. Am J Cardiol 1992;69:427-430. 41. Brady AJB, Crake T, Oakley CM. Percutaneous fragmentation and dispersion versus pulmonary embolectomy by catheter device in massive pulmonary embolism. Chest 1992;102:1305-1306.
2. Lilienfeld DE, Chan E, Ehland J et al . Mortality from pulmonary embolism. Prog Cardiovasc Dis 1975;17:259-270.
4. Cela MC, Amplatz K. Nonsurgical pulmonary embolectomy. In: Cope C (Ed.). Current techniques in interventional Radiology Philadelphia: Current Medicine; 1994. 12:1-12.
6. Elliot CG. Pulmonary physiology during pulmonary embolism. Chest 1992;101(Supl):1635-1715.
3. Giuntini C, DiRicco G, Marini C et al . Pulmonary embolism: Epidemiology. Chest 1995;107(Supl):S3-S9.
25. Belkin M, Belkin B, Bucknam CA et al . Intraarterial fibrinolytic therapy: efficacy of streptokinase versus urokinase. Arch Surg 1986;121:769. 26. The UKEP Study Research Group. The UKEP study. Multicenter clinical trial on two loca regimens of urokinase in massive pulmonary embolism. Eur Heart J 1987;8:2-10.
45. Eng J, Krishnan JA, Segal JB et al . Accuracy of CT in the Diagnosis of Pulmonary Embolism: A Systematic Literature Review. Am J Roentgenol 2004;183:1819-27. 46. Peixoto, CCS, Brito CJ. Cirurgia Endovascular e Angiologia . Rio de Janeiro: Revinter; 2014. p. 527-534.
124 Parte IVTÓRAX
43. Singhal S, Henderson R, Horsfield K et al . Morphometry of human pulmonary arterial tree. Circ Res 1973;33:190-7. 44. PIOPED Investigators. Value of the ventilation/perfusion scan in acute pulmonary embolism: results of the Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED). JAMA 1990;263: 2753-9.
42. Brady AJB, Crake T, Oakley CM. Simultaneous mechanical clot fragmentation and pharmacologic thrombolysis in acute massive pulmonary embolism. Am J Cardiol 1992;70:836.
22. Remy-Jardim M, Remy J, Masson P et al. CT Angiography of thoracic outlet syndrome: Evaluation of imaging protocols for the detection of arterial stenosis. J Comput Assist Tomograf 2000;24:349-61. 23. Francisco MC, Yang JH, Barella SM et al. Estudo por imagem da síndrome do desfiladeiro torácico. Rev Brás Reumatol 2006;(45)5:353-55. 24. Demondion X, Bacqueville E, Paul C et al. Thoracic outlet: Assessment with MR imaging in asyntomatic and syntomatic population. Radiology 2003;227:461-8. 25. Bogalho L, Seixas I, Martins JM, Pisco JM. Angiography in throracic outlet syndrome. Acta Méd Port 1998;11:33-6. 26. Hagspiel KD, Spinosa DJ, Angle JF, Matsumoto AH. Diagnosis of vascular compression at the thoracic outlet using gadolinium enhanced high-resolution ultrafast MR Angiography in abduction and adduction. Cardiovasc Intervent Radiol 2000;23:152-64. 27. Lord JW. Surgical Management of shoulder girdle syndromes. Arch Surg 1953;66:69. 28. Voelkel A. Conservative treatment. In: Sanders RJ (Ed.). Thoracic outlet syndrome - A common sequela of neck injuries. JB Lippincott Company; 1991. 9. p. 121-50. 29. Roos DB. Transaxillary approach for first rib resection to relieve thoracic outlet syndrome. Ann Surg 1966;163:354-8. 30. Johnson CR. Treatment of thoracic outlet syndrome by removal of first rib and related entrapments through postero-lateral approach. A 22 years experience. J Thorac Cardiovasc Surg 1974;68:536. 31. Martinez BD, Wiegand CS, Evans P et al. Computer-assisted instrumentation during endoscopic transaxillary first rib resection for thoracic outlet syndrome: a safe alternate approach. Vascular 2005;13:327-35. 32. Urschel Jr HC. Dorsal sympathectomy and management of thoracic outlet syndrome with VATS. Ann Thorac Surg 1993;56:717-20. 33. Ohtsuka T, Wolf RK, Dunsker SB. Port-access first-rib resection. Surg Endosc 1999;13:940-2. 34. Candia-de la Rosa RF, Pérez-Rodríguez A, Candia-García R, PalaciosSolís JM. Endoscopic transaxillary first rib resection for thoracic outlet syndrome: a safe surgical option. Cir Cir 2010;78:53-9.
125 67CapítuloSÍNDROMES COMPRESSIVAS NEUROVASCULARES CERVICOTORACOAXILARES (SÍNDROME DO DESFILADEIRO)
18. Araújo JD. Síndromes compressivas do desfiladeiro cérvico-torácico. In: Brito CJ, Mayall RC, Ribeiro AP. Doenças Vasculares. Anais do 24º Congresso Brasileiro de Angiologia. Rio de Janeiro, 1983, Ed. Teatral. p. 157-72.
REFERÊNCIAS BIBLIOGRÁFICAS
1. Peet RM, Hendricksen JD, Anderson TP, Martin GM. Thoracic outlet syndrome: evaluation of a therapeutic exercise program. Proc Staff Meet Mayo Clin 1956;31:281. 2. Cooper A. On Exostosis. In: Cooper, Cooper, Travers. Surgical Essays 3th ed. London; 1821. p. 128. 3. Adson AW, Coffey JR. Cervical ribs: A method of anterior aproach for relief of symptoms by division of the scalenus anticus. Ann Surg 1927;85:839. 4. Coote H. Exostosis of the left Transverse Process of the Seventh Cervical Vertebra Surrounded by Blood Vessels and Nerves: Successful Removal. Lancet 1861;1:360. 5. Murphy T. Brachial neuritis caused by pressure of first rib. Aust Med J 1910;15:582. 6. Falconer MA, Weddell G. Costoclavicular compression of the subclavian artery and vein: relation to the scalenus anticus syndrome. Lancet 1943;2:593. 7. Naffziger HW, Grant WT. Neuritis of the Brachial Plexus Mechanical in Origin. The Scalenus Anticus Syndrome. Surg Gynec & Obst 1938;67:722. 8. Wright IS. The Neurovascular Syndrome produced by Hyperabduction of the arms. Am heart J 1945;29:1. 9. Sanders RJ. Thoracic outlet syndrome – A common sequela of neck injuries. JB Lippincott Company, 1991. 10. Roos DB. The place for scalenectomy and first rib resection in thoracic outlet syndrome. Surgery 1982;92:1077. 11. Roos DR. New concepts of Thoracic Outlet Syndrome that explain etiology, symptoms, diagnosis and treatment. Vasc Surg 1979;13:313-21. Stoney RJ, Cheng SWK et al. Neurogenic thoracic outlet syndrome. In: Rutherford RB. 4th ed. Saunders Company; 1995; 69. p. 976-91. Mercier C, Huguet JF. Les syndromes vasculaires de la traversée thoraco-brachiale. Paris Masson; 1976. 14. Fairbain JF, Campbell K, Spencer Payne W. Neurovascular compression syndromes of thoracic outlet. In: Juergers JL, Spittell Jr JA, Fairbain II JF (Eds.). Peripheral vascular disease. Philadelphia; WB Saunders Company; 1980. p. 629-53.
19. Madrid N. Síndromes compressivas do desfiladeiro cérvico-torácico. In: Britto CJ, Mayall RC, Ribeiro AP. Doenças Vasculares. Anais do 24º Congresso Brasileiro de Angiologia. Rio de Janeiro: Ed. Teatral; 1983. p. 172-82.
13.
20. Chin EE, Zimmerman PT, Grant EG. Sonografic evaluation of upper extremity deep venous thrombosis. J Ultrasound Med 2005;24:829-38.
21. Polac JF, Yucel EK, Bettman MA et al. Suspected upper extremity deep vein thrombosis. On line publication, Reston VA. American College of Radiology (ACR) 2005(National Guideline Clearinghouse) www. guideline.gov.
12.
17. Sachatello CR. The axilo-pectoral muscle (Langer’s axillary arch): a cause of axillary vein obstruction. Surgery 1977;81:610.
16. Araújo JD, Anacleto JC, Braile DM et al. Compressão recíproca entre artéria axilar e plexo braquial: uma outra etiologia para síndrome do desfiladeiro cervical. Rev Ass Med Bras 1979; 25:359.
35. Jancovici R, Lang-Lazdunski L, Pons F et al. Complications of videoassisted thoracic surgery: a five-year experience. Ann Thorac Surg 1996;61:533-7. 36. Abdellaoui A et al. Endoscopic assisted transaxillary first rib resection. Interact Cardio Vasc Thorac Surg 2007;6:644-46 37. Ghefter MC et al. Síndrome do desfiladeiro torácico – ressecção de costela cervical por videotoracoscopia. J Vasc Bras 2012;11(3):219-25. 38. Kunkel JM, Machleder MI. Treatment of Paget-Schröetter syndrome: a staged multidisciplinary approach. Arch Surg 1990;124:1153-8. 39. Machleder HI. Evaluation of a new treatment strategy for Paget–Schröetter’s syndrome: Spontaneous thrombosis of the axillary–subclavian vein. J Vasc Surg 1993;17:305. 40. Stallworth JM, Quinn JG, Aken AF. Is first rib resection necessary for thoracic outlet syndrome? Ann Surg 1977;185:581.
15. Telford ED, Mottershead S. Pressure at the cervicobrachial junction. An operative and anatomical study. J Bone Joint Surg 1948; 30B:249.
3. Ackerknecht E. The history of the discovery of the vegetative (autonomic) nervous system. Med Hist 1974;18(1):1-8.
8. Puech Leão L. A simpatectomia no tratamento das arteriopatias periféricas obliterantes crônicas. São Paulo. Tese (Doutorado) –Faculdade de Medicina da Universidade de São Paulo; 1953. 9. Kauffman P. Simpatectomias. In: Raia AA, Zerbini EJ (Eds.). Clínica cirúrgica Alípio Corrêa Netto. 4. ed. São Paulo: Sarvier; 1994. p. 84-101.
27. Stefaniak T, Cwigon M, Laski D. In the search for the treatment of compensatory sweating. Sci World J 2012. 28. Gruszkiewicz J, Doron Y, Guilburd J. Hyperhidrosis and its surgical treatment. Acta Neurochir 1986;81(3-4):128-31.
6. Telford E, Stopford J. Thrombo-angiitis obliterans with special reference to its pathology and the results of sympathectomy. Br Med J 1935 Apr 27;1(3877):863-6.
10. DeBakey M, Burch G, Ray T. Hemometakinesia; therapeutic application to peripheral vascular disease. J Mich State Med Soc 1948;47(6):636-9.
17. Cacione DG, Moreno DH, Nakano LC, Baptista-Silva JC. Surgical sympathectomy for Buerger’s disease. JRSM Open 2017;8(8):205427041771766.
14. Cerfolio RJ, Ribas J, Campos M De et al. The Society of Thoracic Surgeons Expert Consensus for the Surgical Treatment of Hyperhidrosis. Ann Thorac Surg 2011;91(5):1642-8.
18. Lau H, Cheng S. Buerger’s disease in Hong Kong: a review of 89 cases. Aust N Z J Surg 1997;67(5):264-9.
12. Kuntz A. Distribution of the sympathetic rami to the brachial plexus. Arch Surg 1927;15:871-3.
SIMPATECTOMIA CERVICOTORÁCICA
11. Gask G, Ross J. The Surgery of the simpathetic nervous system. 2. ed. 1937. p. 35-54.
30. Neumayer C, Zacherl J, Holak G, Al E. Limited endoscopic thoracic sympathetic block for hyperhidrosis of the upper limb: reduction of compensatory sweating by clipping T4. Surg Endos 2004;18(1):152-6.
126 68Capítulo
32. Yazbek G, Wolosker N, de Campos J. Palmar hyperhidrosis – which is the best level of denervation using video-assisted thoracoscopic sympathectomy: T2 or T3 ganglion? J Vasc Surg 2005;42(2):281-5.
25. Kocher G, Taha A, Ahler M, Schmid R. Is clipping the preferable technique to perform sympathicotomy? A retrospective study and review of the literature. Langenbecks Arch Surg 2015;400(1):107-12. 26. Stori Jr W, Coelho M, Guimarães O. Bloqueio por clipagem de gânglios simpáticos torácicos no tratamento da hiper-hidrose. An Bras Dermatol 2006;81(5):425-32.
20. Albazaz R, Wong YT, Homer-Vanniasinkam S. Complex Regional Pain Syndrome: A Review. Ann Vasc Surg 2008 Mar;22(2):297-306. 21. Straube S, Derry S, Moore RA, McQuay HJ. Cervico-thoracic or lumbar sympathectomy for neuropathic pain and complex regional pain syndrome. Cochrane Database Syst Rev 2003;(2):CD002918.
31. Wilkinson H. Percutaneous radiofrequncy upper thoracic sympathectomy: a new tecnique. Neurosurgery 1984;15(6):811-4.
19. Barreto Jr E, Nascimento J, de Castro A. Bloqueio neurolítico da cadeia simpática lombar melhora dor crônica em paciente portadora de isquemia crítica de membro inferior. Rev Br Anest 2018;68(1):100-3.
4. White J, Smithwick R. The autonomic nervous system: anatomy, physiology, and surgical application. New York: Macmillan; 1941. p. 7-21. 5. Adson A. The surgical indications for sympathetic ganglionectomy and trunk resection in the treatment of diseases resulting from vasomotor spasm of peripheral arteries. Bull N Y Acad Med 1930;6(1):17-32.
22. Atkins HJ. Simpatectomy by the axillary approach. Lancet (London, England). 1954;266(6811):538-9. 23. Palumbo L, Lulu D. Anterior transthoracic upper dorsal sympathectomy. Arch Surg 1966;92:247-57. 24. Krasna MJ. Thoracoscopic Sympathectomy: A Standardized Approach to Therapy for Hyperhidrosis. Ann Thorac Surg 2008;85(2).
1. Jonnesco T. Traitement chirurgical de l’angine de poitrine par la resection du sympathique cervico-thoracique. Bull l’Acad med 1920 Oct;84:93. 2. Puech-Leão P. Cirurgia do sistema nervoso simpático – Bases técnicas. In: Goffi FS (Ed.). Técnica cirúrgica: bases anatômicas, fisiopatológicas e técnicas da cirurgia. 4. ed. São Paulo: Atheneu; 1996.
29. de Campos J, Wolosker N, Takeda F et al. The body mass index and level of resection: predictive factors for compensatory sweating after sympathectomy. Clin Aut Res 2005;15(2):116-20.
7. Smithwick R. Modified dorsal sympathectomy for vascular spasm (Raynaud’ s disease) of the upper extremity: a preliminary report. Ann Surg 1936;104:339-50.
REFERÊNCIAS BIBLIOGRÁFICAS
13. Musa R, Qurie A. Raynaud Disease (Raynaud Phenomenon, Raynaud Syndrome) [Updated 2018 Sep 29]. Treasure Island (FL): StatPearls Publishing- 2018.
36.
37.
33. de Campos RJ, Kauffman P, Wolosker N. Axillary hyperhidrosis: T3/T4 versus T4 thoracic sympathectomy in a series of 276 cases. J Laparoendosc Adv Surg Tech A 2006;16(6):598-603. 34. Munia M, Wolosker N, Kauffman P. A randomized trial of T3-T4 versus T4 sympathectomy for isolated axillary hyperhidrosis. J Vasc Surg 2007;45(1):130-3. 35. Lyra R, de Campos J, Kang D. Guidelines for the prevention, diagnosis and treatment of compensatory hyperhidrosis. J Bras Pneumol 2008;34(11):967-77. Haxton H. The technique and results of upper limbs sympathectomy. J Cardiovasc Surg (Torino) 1970;11:27-30. Mickelberg A, Mickelberg J, Kux P. Simpatectomias técnicas. In: In: Goffi FS. Técnica cirúrgica. 3 ed. São Paulo: Atheneu; 1990. p. 279-90..
15. Leiderman DBD, Milanez de Campos JR, Kauffman P et al. The relation between age and outcomes of thoracic sympathectomy for hyperhidrosis: The older the better. J Thorac Cardiovasc Surg 2018;156(4):1748-56.
16. Li DC, Hulbert A, Waldbaum B et al. Endoscopic thoracic sympathectomy for primary focal hyperhidrosis: impact on psychosocial symptomatology and psychotropic medication use. Eur J Cardiothorac Surg 2018 Nov 1;54(5):904-11.
REFERÊNCIAS BIBLIOGRÁFICAS
3. Kux E. 1239 Cases of thorascopic sympathectomy and vagotomy; preliminary report. Dtsch Med Wochenschr 1953;78:1590. 4. Drott C. The history of cervicothoracic sympathectomy. Eur J Surg 1994:Suppl 572:5-7. Kauffman P, Milanez JRC, Jatene F, Puech-Leão P. Simpatectomia cervicotorácica por vídeotoracoscopia: Experiência inicial. Rev Colégio Brasileiro de Cirurgiões 1998;25:235-9. 6. Kauffman P, de Campos JRM, Wolosker N et al. Thoracoscopic cervicothoracic sympathectomy: an eight-year experience. Braz Vasc Surg 2003;2:22-8. 7. Teivelis MP, Varella AY, Wolosker N. Expanded level of sympathectomy and incidence or severity of compensatory hyperhidrosis. J Thorac Cardiovasc Surg 2014;148:2443-4. 8. Kauffman P. Simpatectomias. In: Raia AA, Zerbine EJ (Eds.). Clínica Cirúrgica Alípio Corrêa Netto. 4ª.ed. São Paulo: Sarvier; 1988. p. 84-101. 9. Goetz RH, Marr JAS. The importance of the second thoracic ganglion for the sympathetic supply of the upper extremities with a description of two new approaches for its removal. Clin Proc (Cape Town) 1944;3:102-14, 10. Kao MC, Chen YL, Lin JY et al. Endoscopic sympathectomy treatment for craniofacial hyperhidrosis. Arch Surg 1996;131:1091-4.
22. Sato K, Kang WH, Saga KT. Biology of sweat glands and their disorders. I. Normal sweat gland function. J Am Acad Dermatol 1989;20:537-63.
CERVICOTORÁCICA POR VIDEOTORACOSCOPIA – TÉCNICA OPERATÓRIA
23. Bovell DL, Clunes MT, Elder HY et al. Ultrastruture of the hyperhidrotic eccrine sweat gland. Brit J Dermatol 2001;145:298-301. 24. Karimian-Teherani D, Panhofer P, Ringhofer C et al. New epidemiological aspects of patients with severe hyperhidrosis presenting for sympathetic surgery. J Eur Acad Dermatol Venereol 2009;23:651-5. 25. Amir M, Arish A, Weinstein Y et al. Impairment in quality of life among patients seeking surgery for hyperhidrosis (excessive sweating): preliminary results. Isr J Psychiatry Relat Sci 2000;37:25-31 26. Haider A, Solish N. Focal hyperhidrosis: diagnosis and management. CMAJ 2005;172:69-75. 27. Strutton DR, Kowalski JW, Glaser DA, Stang PE. US prevalence of hyperhidrosis and impact on individuals with axillary hyperhidrosis: results from a national survey. J Am Acad Dermatol 2004;51:241-8. 28. Kauffman P, Cinelli Jr. M, Wolosker M, Puech-Leão LE. Tratamento da hiperidrose palmar pela simpatectomia cérvico-torácica. Rev Ass Med Bras 1978;24:29-30. 29. Westphal FL, Carvalho MAN, Lima LC et al. Prevalência de hiperidrose entre estudantes de medicina. Rev Col Bras Cir 2011;38:392-7. 30. Ro KM, Cantor RM, Lange KL, Ahn SS. Palmar hyperhidrosis: evidence of genetic transmission. J Vasc Surg 2002;35:382-6. 31. Kauffman P, Campos JRM, Indicações da simpatectomia na hiperidrose primária. In: Saad Jr. R,Carvalho WR, Ximenes Neto M, Forte V(Ed.). Cirurgia Torácica Geral. 2. Ed. São Paulo: Atheneu; 2011. p. 801-7. 32. Campos JRM, Kauffman P, Werebe EC et al. Questionário de qualidade de vida em pacientes com hiperidrose primária. J Pneumol 2003;29:178-81. 33. Hashmonai M, Caneron AEP, Connery CP et al. The etiology of primary hyperhidrosis: a systematic review. Clin Auton Res 2017;27:379-83 34. De Moura Júnior NB, das Neves Pereira JC, de Campos JR et al. Preservation of α-3 neuronal nicotinic acetylcholine receptor expression in sympathetic ganglion after brain death. Mol Neurobiol 2012;45:362-5. 35. De Oliveira FR, Moura NB Jr, de Campos JR et al. Morphometric analysis of thoracic ganglion neurons in subjects with and without primary palmar hyperhidrosis. Ann Vasc Surg 2014;28:1023-9. 36. De Moura Júnior NB, das-Neves-Pereira JC, de Oliveira FR et al Expression of acetylcholine and its receptor in human sympathetic ganglia in primary hyperhidrosis. Ann Thorac Surg 2013;95:465-70. 37. Hornberger J, Grimes K, Naumann M et al. Recognition, diagnosis, and treatment of primary focal hyperhidrosis. J Am Acad Dermatol 2004;51:274-86. 38. Adar R, Kurchin A, Zweig A, Mozes M. Palmar hyperhidrosis and its surgical treatment: a report of 100 cases. Ann Surg 1977;186:34-41. 39. Drott C, Claes G, Olsson-Rex L et al. Succesful treatment of facial blushing by endoscopic transthoracic sympathectomy. Br J Dermatol 1998;138:639-43. 40. Wolosker N, Campos JR, Kauffman P et al. The use of oxybutynin for treating facial hyperhidrosis. An BraS Dermatol 2011;86:451-6. 41. Wolosker N, de Campos JR, Kauffman P et al. The use of oxyutynin for treating axillary hyperhidrosis.Ann Vasc Surg 2011;25:1057-62. 42. Wolosker N, de Campos JR, Kauffman P et al. An alternative to treat palmar hyperhidrosis: use of oxybutynin. Clin Auton Res 2011;21:389-93. 43. Wolosker N, A randomized placebo-controlled trial of oxybutynin for the initial treatment of palmar and axillary hyperhidrosis. J Vasc Surg 2012;55:1696-700.
21. Haider A, Solish N. Hyperhidrosis: an approach to diagnosis and management. Dermat Nurs 2004; 16:515-7.
SIMPATECTOMIA
13. Chung IH, Oh CS, Koh KS et al. Anatomic variations of the T2 nerve root (including the nerve of Kuntz) and their implications for sympathectomy. J Thorac Cardiovasc Surg 2002;123:498-501.
1. Bresciani CJC, Gama-Rodrigues JJ. Cirurgia minimamente invasiva. In: Gama-Rodrigues JJ, Machado MCC; Rasslan S (Eds.). Clínica Cirúrgica. Barueri-SP: Manole; 2008. p. 2113-2136 2. Kotzareff A. Resection partielle de tronc simpathetique cervical droit pour hyperhidrose unilaterale. Rev Med Suisse Romande 1920;40:111-3.
20. Maga P, Kuzdzał J, Nizankowski R et al. Long-term effects of thoracic sympathectomy on microcirculation in the hands of patients with primary Raynaud disease. J Thorac Cardiovasc Surg 2007;133:1428-33.
11. Kuntz A. The autonomic nervous system. Philadelphia: Lea&Febiger; 1947. 12. Ramsaroop L, Singh B, Moodley J et al. Anatomical basis for a successful upper limb sympathectomy in the thoracoscopic era. Cin Anat 2004;17:294-9.
15. Cage GW. Eccrine and apocrine secretory glands. In: Fitzpatrick TB et al. (Eds.). Dermatology in General Medicine. New York: McGraw-Hill; 1971. p.103-9.
16. Hurley HJ. Diseases of the eccrine sweat glands. In: Moschella SL, Hurley HJ– (Eds.). Dermatology. 3rd ed . Philadelphia: WB Saunders; 1992. p. 1514-37.
127 69Capítulo
19. Stephenson EA, Berul CI. Electrophysiological interventions for inherited arrhythmia syndromes. Circulation 2007;116:1062-80.
18. Albazaz R, Wong YT, Homer-Vanniasinkam S. Complex regional pain syndrome: a review. Ann Vasc Surg 2008;22:297-306.
17. Chou SH, Kao EL, Lin CC et al. The importance of classification in sympathetic surgery and a proposed mechanism for compensatory hyperhidrosis: experience with 464 cases. Surg Endosc 2006; 20:1749-53.
14. Kim H, Hong YJ, Hwang JJ et al. Topographical considerations under video-scope guidance in the T3,4 levels sympathetic surgery. Eur J Cardiothorac Surg 2008;33:786-9.
5.
128 Parte IVTÓRAX 44. Wolosker N, Teivelis MP, Krutman M et al. Puech-Leão P. Long-Term efficacy of oxybutynin for palmar and plantar hyperhidrosis in children younger than 14 years. Pediatr Dermatol 2015;32:663-7. 45. Olin JW, Shih A. Thromboangiitis obliterans (Buerger’s disease). Curr Opin Rheumatol 2006; 18:18-24. 46. Sayin A, Bozkurt AK, Tüzün H et al. Surgical treatment of Buerger’s disease: experience with 216 patients. Cardiovasc Surg 1993;1:377-80. 47. Wolosker N, Kauffman P. Thoracic sympathectomy. In: Cronenwett JL, Johnston KW (Ed.). Rutherford´s Vascular Surgery. 7th ed. Philadelphia: WB Saunders; 2010. p. 1854-64. 48. Aburhama AF, Rutherford RB. Causalgia and post-traumatic pain syndromes. In: Rutherford RB (Ed.). Vascular Surgery. Philadelphia: WB Saunders; 2000. p. 908-16. 49. Osenbach RK. Complex Regional Pain Syndromes. Seminars in Neurosurgery 2004;15:81-92 . 50. Hassantash SA, Afrakhteh M, Maer RV. Causalgia: a meta-analysis of the literature. Arch Surg 2003;138:1226-31. 51. Cepeda MS, Carr DB, Lau J. Local anesthetic sympathetic blockade for complex regional pain syndrome. Cochrane Database Syst Rev 2005;4:CD004598. 52. Singh B, Moodley J, Shaik AS, Robbs JV. Sympathectomy for complex regional pain syndrome. J Vasc Surg 2003;7: 508-11. 53. Schwartz PJ. Idiopathic long QT syndrome: progress and questions. Am Heart J 1985;109:399-411. 54. Schwartz PJ. Another role for the sympathetic nervous system in the long QT syndrome? J Cardiovasc Electrophysiol 2001;12:500-502. 55. Moss AJ, Zareba W, Hall WJ et al. Effectiveness and limitations of ß-blocker therapy in congenital long QT syndrome. Circulation 2000;101:616-623. 56. Ouriel K, Moss AJ. Long QT syndrome: an indication for cervicothoracic sympathectomy. Cardiovasc Surg 1995;3(5):475-8. 57. Schwartz PJ, Locati EH, Moss AJ et al. Left cardiac sympathetic denervation in the therapy of congenital long QT syndrome. Circulation 1991:84;503-511. 58. Hederman WP. Present and future trends in thoracoscopic sympathectomy. Eur J Surg 1994; suppl. 572:17-9. 59. Matsumoto Y, Ueyama T, Endo M et al. Endoscopic thoracic sympathicotomy for Raynaud´s phenomenon. J Vasc Surg 2002;36:57-61. 60. Coffman JD. Raynaud’s phenomenon. Current Treatment Options in Cardiovascular Medicine 2000;2(3):219-26. 61. Cerfolio RJ, De Campos JR, Bryant AS, et al. The Society of Thoracic Surgeons expert consensus for the surgical treatment of hyperhidrosis. Ann Thorac Surg 2011;91:1642-8.
62. Harris RJ, Benveniste G, Pfitzner J. Cardiovascular collapse caused by carbon insufflation during one-lung anesthesia for thoracoscopic dorsal sympathectomy. Anaesth Intensive Care 2002;30:86-9. 63. Yazbek G, Wolosker N, de Campos JR et al. Palmar hyperhidrosis – which is the best level of denervation using video-assisted thoracoscopic sympathectomy: T2 or T3 ganglion? J Vasc Surg 2005; 2:281-5.
67. Wenxiong Zhang W, Yu D, Jiang H et al. Video-assisted thoracoscopic sympathectomy for palmar hyperhidrosis: A meta-analysis of randomized controlled trials. PLoS One 2016;11(5):e0155184.
73. Munia MA, Wolosker N, Kauffman P et al. A randomized trial of T3T4 versus T4 sympathectomy for isolated axillary hyperhidrosis. J Vasc Surg 2007;45:130-3. 74. Kao MC. Thoracoscopic sympathectomy for craniofacial hyperhidrosis. Eur J Cardiothorac Surg 2001;19:951-2.
69. Wolosker N, Yazbek G, Ishy A et al. Is sympathectomy at T4 level better than at T3 level for treating palmar hyperhidrosis? J Laparoendosc Adv Surg Tech A 2008;18:102-6. 70. Wolosker N, Varella AY, Teivelis MP et al. Regarding “optimal level of sympathectomy for primary palmar hyperhidrosis: T3 versus T4 in a retrospective cohort study”. Int J Surg 2014;12(8):788.
64. Yoon do H, Ha Y, Park YG, Chang JW. Thoracoscopic limited T-3 sympathicotomy for primary hyperhidrosis: prevention for compensatory hyperhidrosis. J Neurosurg 2003;99:39-43. 65. Yoon SH, Rim DC. The selective T3 sympathicotomy in patients with essential hyperhidrosis. Acta Neurochir (Wien) 2003;145:467-71. 66. Dewey TM, Herbert MA, Hill SL et al. One year follow-up after thoracoscopic sympathectomy for hyperhidrosis: outcomes and consequences. Ann Thorac Surg 2006;81:1227-32.
71. Ishy A, de Campos JR, Wolosker N et al. Objective evaluation of patients with palmar hyperhidrosis submitted to two levels of sympathectomy: T3 and T4. Interact Cardiovasc Thorac Surg 2011;12:545-8.
68. Sang HW, Li GL, Xiong P et al. Optimal targeting of sympathetic chain levels for treatment of palmar hyperhidrosis: an updated systematic review. Surg Endosc 2017;31(11):4357-4369.
72. Ribas Milanez de Campos J, Kauffman P, Wolosker N et al. Axillary hyperhidrosis: T3/T4 versus T4 thoracic sympathectomy in a series of 276 cases. J Laparoendosc Adv Surg Tech A 2006;16:598-603.
75. Fukuda JM, Varella AYM, Teivelis MP et al.Video-Assisted Thoracoscopic Sympathectomy for Facial Hyperhidrosis: The Influence of the Main Site of Complaint. Ann Vasc Surg 2018;46:337-344. 76. Goetz RH. Sympathectomy for the upper extremities. In: Dale WA. Management of arterial occlusive disease. Chicago: Year book Medical Publishers; 1971. p. 431-445. 77. Goetz RH. Angiopastic vascular disorders. In: Haimovici H. The surgical management of vascular diseases. Philadelphia. Lippincot; 1970. p. 55. 78. Ray BS. Sympathectomy of upper extremity: evaluation of surgical methods. J Neurosurg 1953;10;634-33. 79. Murray JG, Thompson JW. Collateral sprouting in autonomic nervous system. Brit M Bull 1957;13:213. 80. de Campos JRM, Kauffman P, Kang DWW. Simpatectomia torácica no tratamento da hiper-hidrose primária. In: Moraes IN (Ed.). Tratado de Clínica Cirúrgica. São Paulo; Roca; 2005. p. 1015-9. 81. Andrade Fo LO, Kuzniec S, Wolosjer N et al. Technical difficulties and complications of sympathectomy in the treatment of hyperhidrosis: An analysis of 1731 cases. Ann Vasc Surg (no prelo) 82. Reisfeld R. Azygos lobe in endoscopic thoracic sympathectomy for hyperhidrosis. Surg Endosc 2005;19: 964-6. 83. Kauffman P, Wolosker N, de Campos JR et al. Azygos lobe: a difficulty in vídeo-assisted thoracic sympathectomy. Ann Thorac Surg 2010;89:e57-9. 84. Atkinson JLD, Fode-Thomas NC, Fealey RD et al. Endoscopic transthoracic limited Sympathotomy for palmar-plantar hyperhidrosis: outcomes and complications during a 10-year period. Mayo Clin Proc 2011;86:721-9. 85. Lin CC, Mo LR, Lee LS et al. Thoracoscopic T2 block by clipping: a better and reversible operation for the treatment of hyperhidrosis palmaris: experience with 326 cases. Eur J Surg 1998 Suppl; 580:13-6. 86. Whitson BA, Andrade RS, Dahlberg PS, Maddaus MA. Evolution of clipping for thoracoscopic sympathectomy in symptomatic hyperhidrosis. Surg Laparosc Endosc Percutan Tech 2007;17:287-90. 87. Telaranta T. Secondary sympathetic chain reconstruction after endoscopic thoracic sympathicotomy. Eur J Surg 1998;164:17-8. 88. Neumayer C, Zacherl J, Holak G et al. Experience with limited endoscopic thoracic sympathetic block for hyperhidrosis and facial blushing. Clin Auton Res 2003;suppl 1:152-7. 89. Hynes CF, Yamaguchi S, Bond CD, Marshall MB. Reversal of sympathetic interruption by removal of clips. Ann Thorac Surg 2015;99(3):1020-3. 90. Assalia A, Bahouth H, Ilivitzki A et al. Thoracoscopic Sympathectomy for primary palmar hyperhidrosis: resection versus transection –A prospective Trial. World J Surg 2007;31:1976-9. 91. de Campos JR, Wolosker N, Takeda FR et al. The body mass index and level of resection: predictive factors for compensatory sweating after sympathectomy. Clin Auton Res 2005;15:116-20. 92. Dobosz L, Cwalina N, Stefaniak T. Influence of Body Mass Index on Compensatory Sweating in Patients after Thoracic Sympathectomy due to Palmar Hyperhidrosis. Thorac Cardiovasc Surg 2017;65:497-502. 93. Lin TS, Wang NP, Huang LC. Pitfalls and complication avoidance associated with transthoracic endoscopic sympathectomy for primary hyperhidrosis (analysis of 2200 cases). Int J Surg Investig 2001;2:377-85. 94. Amjadi K, Alvarez GG, Vanderhelst E et al. The prevalence of blebs or bullae among young healthy adults: a thoracoscopic investigation. Chest 2007;132:1140-5. 95. Shachor D, Jedeikin R, Olsfanger D et al. Endoscopic transthoracic sympathectomy in the treatment of primary hyperhidrosis. A review of 290 sympathectomies. Arch Surg 1994 ;129:241-4. 96. Atherton WG, Morgan WE. False aneurysm of an intercostal artery after thoracoscopic sympathectomy. Ann R Coll Surg Engl 1997;79:229- 30. 97. Gossot D, Kabiri H, Caliandro R et al. Early complications of thoracic endoscopic sympathectomy: a prospective study of 940 procedures. Ann Thoracic Surg 2001;71:1116-19.
120. Neves S, Uchoa PC, Wolosker N et al. Long-Term Comparison of Video-Assisted Thoracic Sympathectomy and Clinical Observation for the Treatment of Palmar Hyperhidrosis in Children Younger Than 14. Pediatr Dermatol 2012;29:575-9.
122. Wolosker N, Yazbek G, Milanez de Campos JR et al. Evaluation of plantar hyperhidrosis in patients undergoing video-assisted thoracoscopic sympathectomy. Clin Auton Res 2007;17:172-6.
124. Loureiro Mde P, de Campos JR, Kauffman P et al. Endoscopic lumbar sympathectomy for women: effect on compensatory sweat. Clinics (Sao Paulo) 2008;63:189-96. 125. De Campos JRM, Lembrança L, Fukuda JM et al. Evaluation of patients who underwent resympathectomy for treatment of primary hyperhidrosis. Interact Cardiovasc Thorac Surg 2017 Nov 1;25(5):716-719. 126. Asking B, Svartholm E. Degeneration activity: a transient effect following sympathectomy for hyperhidrosis. Eur J Surg 1994;572:41-2. 127. Licht PB, Pilegaard HK. Gustatory side effects after thoracoscopic sympathectomy. Ann Thorac Surg 2006;81:1043-7. 128. Neumayer C, Panhofer P, Zacherl J, Bischof G. Effect of endoscopic thoracic sympathetic block on plantar hyperhidrosis. Arch Surg 1995;140:676-80. 129. Libson S, Kirshtein B, Mizrahi S, Lantsberg L. Evaluation of compensatory sweating after bilateral thoracoscopic sympathectomy for palmar hyperhidrosis. Surg Laparosc Endosc Percutan Tech 2007;17:511-3. 130. Baumgartner F, Konecny J. Compensatory hyperhidrosis after sympathectomy: level of resection versus location of hyperhidrosis. Ann Thorac Surg 2007;84:1422. 131. Yazbek G, Wolosker N, Kauffman P et al. Twenty months of evolution following sympathectomy on patients with palmar hyperhidrosis: sympathectomy at the T3 level is better than at the T2 level. Clinics (Sao Paulo) 2009;64:743-9.
133. Steiner Z, Cohen Z, Kleiner O et al. Do children tolerate thoracoscopic sympathectomy better than adults? Pediatr Surg Int 2008;24:343-7.
134. Gossot D. Sympathectomie selective endoscopique pour hyperhidrose palmaire. La Presse Medicale 1995;24:1739-42.
119. Wolosker N, Munia MA, Kauffman P et al. Is gender a predictive factor for satisfaction among patients undergoing sympathectomy to treat palmar hyperhidrosis? Clinics (Sao Paulo) 2010;65:583-6.
109. Li X, Tu YR, Lin M et al. Endoscopic thoracic sympathectomy for palmar hyperhidrosis: a randomized control trial comparing T3 and T2-4 ablation. Ann Thorac Surg 2008;85:1747-51.
138. Thomsen LL, Mikkelsen RT, Derejko M et al. Sympathetic block by metal clips may be a reversible operation. Interact Cardiovasc Thorac Surg 2014;19:908-13. 139. Telaranta T. Secondary sympathetic chain reconstruction after endoscopic thoracic sympathicotomy. Eur J Surg 1998;164(suppl)580:17-8. 140. Haam SJ, Seung, Park SY et al. Sympathetic nerve reconstruction for compensatory hyperhidrosis after sympathetic surgery for primary hyperhidrosis. J Korean Med Sci 2010;25:597-601.
148. Thune TH, Ladegaard L, Licht PB. Thoracoscopic sympathectomy for Raynaud’s phenomenon: a long term follow-up study. Eur J Vasc Endovasc Surg 2006;32:198-202 .
137. Sugimura H, Spratt EH, Compeau CG et al. Thoracoscopic sympathetic clipping for hyperhidrosis: long-term results and reversibility. J Thorac Cardiovasc Surg 2009;137:1370-6.
98. Serra Mitjans M, Callejas Pérez MA, Rubio Garay M. Chylothorax after thoracic sympathectomy by videothorascopy. Arch Bronconeumol 2002;38:198-9. 99. Lai CL, Chen WC, Liu YB, Lee YT. Bradycardia and permanent pacing after bilateral thoracoscopic T2 sympathectomy for primary hyperhidrosis. Pacing Clin Eletrophysiol 2001;24:524-5. 100. Lin C-C, Mo L-R, Hwang M-H. Intraoperative cardiac arrest: a rare complication of T2,3-sympathicotomy for treatment of hyperhidrosis palmaris. Two case report. Eur J Surg Suppl 1994; 572:43-45. 101. de Campos JR, Wolosker N, Yazbek G et al. Comparison of pain severity following video-assisted thoracoscopic sympathectomy: electric versus harmonic scalpels. Interact Cardiovasc Thorac Surg 2010;10:919-22. 102. Chon SH, Suk Choi MS. Brachial plexus injury with emphasis on axillary nerve paralysis after thoracoscopic sympathicotomy for axillary hyperhidrosis. Surg Laparosc Endosc Percutan Tech 2006;16:432-4. 103. Ojimba TA, Cameron AEP. Drawbacks of endoscopic thoracic sympathectomy. Br J Surg 2004;91:264-269. 104. Krasna MJ. The role of surgical treatment of hyperhidrosis. Mayo Clin Proc 2011;86:717-8.
129Capítulo 69 simPAteC tomiA CerviCotoráCiCA Por videotor ACosCoPiA
107. Doolabh N, Horswell S, Williams M et al. Thoracoscopic sympathectomy for hyperhidrosis: indications and results. Ann Thorac Surg 2004;77:410-4. 108. Dumont P, Denoyer A, Robin P. Long-term results of thoracoscopic sympathectomy for hyperhidrosis. Ann Thorac Surg 2005;78:1801-7.
105. Lesèche G, Castier Y, Thabut G et al. Endoscopic transthoracic sympathectomy for upper limb hyperhidrosis: limited sympathectomy does not reduce postoperative compensatory sweating. J Vasc Surg 2003;37:124-8. 106. Loscertales J, Tristán AA, Loscertales MC et al. Thoracoscopic sympathectomy for palmar hyperhidrosis. Immediate results and postoperative quality of life. Arch Bronconeumol 2004;40:67-71.
110. Miller DL, Bryant AS, Force SD, Miller JL Jr. Effect of sympathectomy level on the incidence of compensatory hyperhidrosis after sympathectomy for palmar hyperhidrosis. J Thorac Cardiovasc Surg 2009;138:581-5. 111. Gossot D, Debrosse D, Grunenwald D. Sympathectomie thoracique endoscopique pour hyperhidrose axillaire isolée. Ann Dermatol Venereol 2000;127:1065-7. 112. Lin TS, Fang HY. Transthoracic endoscopic sympathectomy for craniofacial hyperhidrosis: analysis of 46 cases. J Laparoendosc Adv Surg Tech A 2000;10:243-7. 113. Licht PB, Ladegaard L, Pilegaard HK. Thoracoscopic sympathectomy for isolated facial blushing. Ann Thorac Surg 2006;81:1863-6. 114. Licht PB, Pilegaard HK, Ladegaard L. Sympathicotomy for Isolated Facial Blushing: A Randomized Clinical Trial. Ann Thorac Surg 2012;94:401-5. 115. de Campos JR, Kauffman P, Werebe EC et al. Quality of life, before and after thoracic sympathectomy: report on 378 operated patients. Ann Thorac Surg 2003;76:886-91. 116. Wolosker N, de Campos JR, Kauffman P et al. Evaluation of quality of life over time among 453 patients with hyperhidrosis submitted to endoscopic thoracic sympathectomy. J Vasc Surg 2012;55:154-6. Raposio E, Caruana G. Video-assisted Thoracic Sympathicotomy for the Treatment of Palmar and Axillary Hyperhidrosis: A 17-Year Experience. Surg Laparosc Endosc Percutan Tech 2015;25:417-9.
118. Wolosker N, Yazbek G, de Campos JR et al. Quality of life before surgery is a predictive factor for satisfaction among patients undergoing sympathectomy to treat hyperhidrosis. J Vasc Surg 2010;51:1190-4.
121. Laje P, Rhodes K, Magee L, Klarich MK. Thoracoscopic bilateral T3 sympathectomy for primary focal hyperhidrosis in children. Pediatr Surg 2017;52(2):313-316.
132. Munia MA, Wolosker N, Kaufmann P et al. Sustained benefit lasting one year from T4 instead of T3-T4 sympathectomy for isolated axillary hyperhidrosis. Clinics (Sao Paulo) 2008;63:771-4.
135. Reisfeld R, Nguyen R, Pnini A. Endoscopic thoracic sympathectomy for hyperhidrosis: experience with both cauterization and clamping methods. Surg Laparosc Endosc Percut Tech 2002;12:255-67.
123. Wolosker N, Teivelis MP, Kauffman P, Campos JR. Regarding “Impact of transthoracic endoscopic sympathectomy on plantar hyperhidrosis”. Ann Ital Chir 2014;85(4):405.
136. Lin CC, Wu HH. Endoscopic t4-sympathetic block by clamping(ESB4) in treatment of hyperhidrosis palmaris et axillaris – experience of 165 cases. Ann Chir Gynaecol 2001;90:167-9.
117.
141. Wong RH, Ng CS, Wong JK, Tsang S. Needlescopic video-assisted thoracic surgery for reversal of thoracic sympathectomy. Interact Cardiovasc Thorac Surg 2012;14:350-2. 142. Ishibashi H, Hayakawa N, Yamamoto H et al. Thoracoscopic sympathectomy for Buerger’s disease: a report on the successful treatment of four patients. Surg Today 1995;25:180-3. 143. De Giacomo T, Rendina EA, Venuta F et al. Thoracoscopic sympathectomy for symptomatic arterial obstruction of the upper extremities. Ann Thorac Surg 2002;74:885-8. 144. Lee AD, Agarwal S, Sadhu D. A 7-year experience with thoracoscopic sympathectomy for critical upper limb ischemia. World J Surg 2006;30:1644-7. 145. Krasna MJ, Jiao X, Sonett J et al. Thoracoscopic Sympathectomy. Surg Laparosc Endosc Percutan Tech 2000;10:314-8. 146. Hwang SW, Thomas JG, Whitehead WE et al. Left thorascopic sympathectomy for refractory long QT syndrome in children. J Neurosurg Pediatr 2011;8:455-9. 147. Surman TL, Stuklis RG, Chan JC. Thoracoscopic Sympathectomy for Long QT Syndrome. Literature Review and Case Study. Heart Lung Circ 2018 Feb 13. pii: S1443-9506(18)30067-2.
– téCniCA oPer AtóriA
Parte V TORACOABDOMINAL
BIBLIOGRAFIA Berguer R, Kieffer E. Surgery of the arteries of the head. New York: Springer-Verlag; 1992. Grant JCB. An Atlas of Anatomy. 6th ed. Baltimore: Williams & Wilkins; Haimovici1972. H, Ascer A, Hollier LH, Strandness Jr. E, Towne JB. Haimovici’s vascular surgery — principles and techniques. 4th ed. New York: Blackwell Science; 1996. Hamilton WJ. Tratado de anatomia humana. Rio de Janeiro: Interamericana; 1982. Larsen W. Human embryology. London and New York: Churchill Livingstone; 1993. Maffei FHA. Doenças vasculares periféricas. 2. ed. Rio de Janeiro: Medsi; Netter1995.F. Atlas of human anatomy. Ciba-Geigy; 1994. Netter F. The ciba collection of medical illustrations. Nervous system. 12th ed. Ciba-Geigy; 1990. V. 1. Netter F. The ciba collection of medical illustrations. Digestive system 12th ed. Ciba-Geigy; 1990. V. 3. Netter F. The ciba collection of medical illustrations. Heart. 12th ed. CibaGeigy; 1990. V. 5. Netter F. The ciba collection of medical illustrations. Sistema músculoesquelético. 12th ed. Ciba-Geigy; 1990. V. 8. Netto B. Manual de dissecção. 4. ed. O livro médico Ltda., São Paulo: Atheneu; 1983. Putz R, Pabst R. Sobotta — atlas de anatomia humana. 20. ed. Rio de Janeiro: Guanabara-Koogan; 1995. Rohen J, Yokochi C. Anatomia humana — atlas fotográfico de anatomia sistêmica e regional. 2. ed. São Paulo: Editora Manole; 1989. Romanes GJ. Cunningham’s manual of practical anatomy. 14th ed. London: Oxford University Press; 1976. Rutherford R. Atlas de cirurgia vascular. Rio de Janeiro: Interlivros; 1998. Shandall AA, Leather RP, Corson JD et al. Use of the short saphenous vein in situ for popliteal-to-distal artery bypass. Am J Surg 1987;154:240-4. Smith D, Larsen JL. On the symmetry and asymmetry of the bifurcation of the common carotid artery. Neuroradiology 1979;17:245. Spatelholz W. Atlas de anatomia humana. 16. ed. São Paulo: Editora Roca; Stoney1988.R, Effeney D. Vascular exposures. Philadelphia: Lippincott Raven; Testut1998.L, Jacob O, Billet H. Atlas de disección por regiones. Barcelona: Salvat Editores; 1975. Testut L, Jacob O. Tratado de anatomia topográfica com aplicações médico-cirúrgicas. Barcelona: Salvat Editores; 1975. Testut L, Latarjet A. Tratado de anatomia humana. 9. ed. Barcelona: Salvat Editores; 1968. Uflacker R. Atlas of vascular anatomy. Baltimore: Williams & Wilkins; Valentine1997. J. In: Ouriel K. The posterior approach to popliteal-crural bypass. J Vasc Surg 1994;19:78-9. Vieira de Mello A, Nascimento Silva JLC, Portilho MA. Visualização arteriográfica pré-operatória dos arcos plantares. Radiol Bras Williams1984;17:138-47.P,Warwick R, Dyson M, Bannister L. Gray anatomia. 37. ed. Rio de Janeiro: Guanabara-Koogan; 1995. Williams PL, Warwick R, Dyson M, Bannister LH. Gray anatomia. 37. ed. Rio de Janeiro: Guanabara-Koogan; 1995. p. 763-5. Wolf-Heidegger G. Atlas de anatomia humana. 2. ed. Rio de Janeiro: Guanabara-Koogan; 1972.
133 70Capítulo
ANATOMIA APLICADA À REGIÃO TORACOABDOMINAL
VIAS DE ACESSO AOS VASOS TORACOABDOMINAIS
134 71Capítulo
BIBLIOGRAFIA Ballard JL, Killeen JD. Anatomy and surgical exposure of the vascular system. In: Moore W. (Ed.). Vascular surgery. Philadelphia: WB Saunders; 1998. p. 44-66. Bismulth H. Les anastomoses porto caves tronculaires. Techniques chirurgicales. Appareil digestif. Encyl Med Chir Paris 2006. p. 408. Branchereau A, Ondon’Dong F. Extended medial approach to the popliteal artery without muscular division. Ann Vasc Surg 1989;3:77-80. Cherry Jr KJ, McCullough JL et al. Technical principles of direct innominate artery revascularization: a comparison of endarterectomy and bypass grafts. J Vasc Surg 1989;9:718. Crawford ES, De Bakey ME et al. Thrombo-obliterative disease of the great vessels arising from the aortic arch. J Thorac Cardiovasc Surg Dardick1962;43:38.H,Dardick I, Veith FJ. Exposure of the tibioperoneal arteries by a single lateral approach. Surgery 1974;75:377. Elkin DC, Kelly RP. Arteriovenous aneurysm: exposure of the tibial and peroneal vessels by resection of the fibula. Ann Surg 1945;122:529-45. Fiolle J, Delmas J. Découverte des vaisseaux profonds par des voies d’accès larges. Paris: Masson; 1940. Fisher DF, Clagett GP, Parker JI et al. Mandibular subluxation for high carotid exposure. J Vasc Surg 1984;1:727-33. Fisher Jr DF, Fry WJ. Collateral mesenteric circulation. Surg Gynecol Obstet Goldsmith1987;164:487.MM3d, Postma DS, Jones FD. The surgical exposure of penetrating injuries to the carotid artery at the skull base. Otalaryngol Head Neck Surg 1986;95:278-84. Haimovici H, Ernest CB, Berguer R. Exposição cirúrgica dos vasos. In: Haimovici H. (Ed.). Cirurgia vascular: princípios e técnicas. 4. ed. Rio de Janeiro: Di-Livros; 2000. p. 351. Haimovici H. Arterial circulation of the extremities. In: Schwartz CJ, Werthessen NT, Wolf A. (Eds.) Structure and function of the circulation New York: Plenum; 1980. p. 425-85, v. 1. Hall-Craggs ECB. The upper limb. In: Hall-Craggs. (Ed.) Anatomy Baltimore: Williams & Wilkins; 1995. p. 160, cap. 64. Henderson JM, Warren WD, Milikan WJ et al. Distal splenorenal shunt with splenopancreatic disconnection: a 4-year assessment. Ann Surg Hertzer1989;210:332-39.NR,Felaman BJ, Beven EG, Tucker HM. A prospective study of the incidence of injury to the cranial nerves during carotid endarterectomy. Surg Gynecol Obstet 1980;151:781. International Anatomical Nomenclature Committee. Nomina anatômica 5. ed. México: Medsi; 1984. Johansen K, Banayk D et al. Temporary intraluminal shunts: resolution of a management dilemma in complex vascular injuries. J Trauma Madden1982;22:395-401.JL. Atlas de técnicas cirúrgicas. 2 ed. São Paulo: Roca; 1987. p. Mattox212-351.KL,Hieshberg A. Access control and repair techniques. In: Rich NM. (Ed.). Vascular trauma. 2nd ed. Philadelphia: Saunders; 2004. p. Mouson137-64.DO, Saletta JD, Frecark RJ. Carotid and vertebral trauma. J Trauma Nascimento-Silva1969;9(12):987-99.JLC. Anatomia médico-cirúrgica do sistema vascular. In: Brito CJ. (Ed.). Cirurgia vascular. Rio de Janeiro: Revinter; 2002. p. Netter25-76.FH.The head and neck In: Netter FH. (Eds.). Atlas of human anatomy. Hanover: Library of Congress Catalog; 1997. p. 28. Petroianu A. Anatomia cirúrgica. Rio de Janeiro: Guanabara Koogan; 1999. Rich NM, Spencer FC. Vascular trauma. Philadelphia: WB Saunders; 1978. Ristow AV. Traumatismos vasculares dos membros. Urgências vasculares. Rio de Janeiro: Cultura Médica; 1983. p. 19-61. Rossi M, Brito CJ, Cury RCP. Principais vias de acesso utilizadas no trauma vascular. In: Rossi M. (Ed.) Trauma vascular. Rio de Janeiro: Revinter; 2006. p. 58-73. Rossi M. Vias de acesso mais utilizadas em cirurgia vascular In: Brito CJ. (Ed.). Cirurgia vascular. Rio de Janeiro: Revinter; 2002. p. 77-104. Rutherford RB. Atlas de cirurgia vascular. Técnicas e exposições básicas. Rio de Janeiro: Di-Livros; 1998. Simonian GT, Pappas PJ, Padberg Jr FT et al. Mandibular subluxation for distal internal carotid exposure: technical considerations. J Vasc Surg Snell1999;30:1116.RS.Anatomia humana. 2. ed. Rio de Janeiro: Medsi; 1984. Stoney RJ, Effeney DJ. Comprehensive vascular exposures. Philadelphia: Lippincott-Raven; 1998. Testut L. Traité D’anatomie humaine. 4 éme ed. Paris: Octave Doin; 1900. v. Trout2.HH, Giodano JM. Anomalies of the inferior vena cava. J Vasc Surg Valentine1986;3:924.RJ,Wind GG. Anatomic exposures in vascular surgery. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 2003. Valentine RJ, Wind GG. Anatomy of commonly exposed arteries. In: Rutherford RB. (Ed.). Vascular surgery. 5th ed. Philadelphia: WB Saunders; 2000. p. 48-60. Yeo CJ, Cameron JL, Lillemore KD et al. Pancreaticoduodenectomy for cancer of the head of the pancreas: 201 patients. Ann Surg 1995;221:721-29.
4. Ishimaru S. Endografting of the aortic arch. J Endovasc Ther 2004;11(Suppl II): II-62-II-71.
20. Saad NE, Saad WE, Davies MG et al. Pseudoaneurysms and the role of minimally invasive techniques in their management. Radiographics 2005;25 Suppl 1:S173-S189.
7. Lee EY, Siegel MJ, Hildebolt CF et al. MDCT Evaluation of Thoracic Aortic Anomalies in Pediatric Patients and Young Adults: Comparison of Axial, Multiplanar, and 3D Images. AJR 2004;182:774-84.
12. Rumman RK, Nickel C, Matsuda-Abedini M et al. Disease Beyond the Arch: A Systematic Review of Middle Aortic Syndrome in Childhood. Am J Hyperten 2015 July;28(Issue 7):833-46.
ANGIOTOMOGRAFIA DOS VASOS TORACOABDOMINAIS
16. Dejaco C, Ramiro S, Duftner C et al. EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice. Ann Rheum Dis 2018;0:1-8.
11. Karaosmanoglu AD, Khawaja RDA, Onur MR et al. CT and MRI of Aortic Coarctation: Pre- and Postsurgical Findings. Am J Roentgenol 2015;204:3, W224-W233.
1. Elefteriades JA. Natural history of thoracic aortic aneurysms: indications for surgery, and surgical versus nonsurgical risks. Ann Thorac Surg 2002;74(5):S1877-S1880; discussion S1892–S1898.
6. Raymond GS, Miller RM, Muller NL et al. Congenital thoracic lesions that mimic neoplastic disease on chest radiographis of adults. AJR 1997;168:763-9.
5. Criado FJ. Mapping the aorta: a new look at vascular anatomy in the era of endograft repair. J Endovasc Ther 2010 Feb;17(1):68-72.
8. Celoria GC, Patton RB. Congenital absence of the aortic arch. Am Heart J 1959;58:407-13. 9. Das KM, Momenah TS, Larsson SG. Williams-Beuren Syndrome: Computed Tomography Imaging Review. Pediatr Cardiol 2014;35(8):1309.
15. Hoey E, Ganeshan A, Nadarr S et al. Evaluation of the Aortic Root With MRI and MDCT Angiography: Spectrum of Disease Finding. AJR 2012;199:W175-W186.
13. Cohen JR, Birnbaum E. Coarctation of the abdominal aorta. J Vasc Surg 1988;8:160-4.
135 72Capítulo
2. Wolak A, Gransar H, Thomson LE et al. Aortic size assessment by noncontrast cardiac computed tomography: normal limits by age, gender, and body surface area. J Am Coll Cardiol Cardiovasc Imaging 2008;1(2):200-209.
14. Okazaki T, Shinagawa S, Mikage H. Vasculitis syndrome - Diagnosis and therapy. Gen Fam Med 2017;18:72-8.
17. Coady MA, Rizzo JA, Goldstein LJ, Elefteriades JA. Natural History, Pathogenesis, and Etiology of Thoracic Aortic Aneurysms and Dissections. Cardiol Clin 1999;17:615-35.
3. Mitchell RS, Ishimaru S, Ehrlich MP et al. First International Summit on Thoracic Aortic Endografting: roundtable on thoracic aortic dissection as an indication for endografting. J Endovasc Ther 2002;9(suppl II):II-98-II105.
18. SchwartzLB, Clark ET, Gewertz BL. Anastomotic and other pseudoaneurysms.
In: Rutherford RB (Ed.). Vascular surgery, 5th ed. Philadelphia, Pa: Saunders; 2000. p. 752-63.
REFERÊNCIAS BIBLIOGRÁFICAS
10. Kimura-Hayama ET, Meléndez G, Mendizábal AL et al. Uncommon congenital and acquired aortic diseases: role of multidetector CT angiography. RadioGraphics 2010;30:79-98.
19. Munera F, Soto JA, Palacio D et al. Diagnosis of arterial injuries caused by penetrating trauma to the neck: comparison of helical CT angiography and conventional angiography. Radiology 2000;216(2):356-62.
21. Dudzinski DM, Isselbacher EM. Diagnosis and management of thoracic aortic disease. Curr Cardiol Rep. 2015;17:106.
22. Clouse WD, Hallett JW Jr, Schaff HV et al. Improved prognosis of thoracic aortic aneurysms: a population-based study. JAMA 1998;280(22):1926-29.
23. Olsson C, Thelin S, Ståhle E et al. Thoracic aortic aneurysm and dissection: increasing prevalence and improved outcomes reported in a nationwide population-based study of more than 14,000 cases from 1987 to 2002. Circulation 2006;114(24):2611-8. 24. Albornoz G, Coady MA, Roberts M et al. Familial thoracic aortic aneurysms and dissections--incidence, modes of inheritance, and phenotypic patterns. Ann Thorac Surg 2006 Oct; 82(4):1400-5.
25. Feldman DN, Roman MJ. Aneurysms of the sinus of Valsalva. Cardiology 2006;106:73-81. 26. Sakakibara S, Konno S. Congenital aneurysm of the sinus of Valsalva associated with ventricular septal defect. Am Heart J 1968;75:595-603. 27. Bricker AO, Avutu B, Mohammed TLH et al. Valsalva Sinus Aneurysms: Findings at CT and MR Imaging. RadioGraphics 2010;30:99-110. 28. Sternbergh III WC, Gonze MD, Garrard CL, Money SR. Abdominal and thoracoabdominal aortic aneurysm. Surg Clin North Am 1998;78:828-43. 29. Yoshioka K, Niinuma H, Ohira A et al. MR Angiography and CT angiography of the Artery of Adamkiewicz: Noninvasive Preoperative Assessment of Thoracoabdominal Aortic Aneurysm. Radiographics 2003;23:1215-25. 30. Crawford ES. Thoraco-abdominal and abdominal aortic aneurysms involving renal, superior mesenteric, celiac arteries. Ann Surg 1974 May;179(5):763-72. 31. Elefteriades JA, Farkas EA. Thoracic aortic aneurysm clinically pertinent controversies and uncertainties. J Am Coll Cardiol 2010;55(9):841-57. 32. Prinssen M, Verhoeven EL, Buth J et al. A randomized trial comparing conventional and endovascular repair of abdominal aortic aneurysms. N Engl J Med 2004;351:1607-18. 33. Lederle FA, Wilson SE, Johnson GR et al. Immediate repair compared with surveillance of small abdominal aortic aneurysms. N Engl J Med 2002;346:1437-44. 34. Svensson LG, Labib SB, Eisenhauer AC, Butterly JR. Intimal tear without hematoma: an important variant of aortic dissection that can elude current imaging techniques. Circulation 1999;99:1331-6. Bhalla S, Menias CO, Heiken JP. CT of acute abdominal aortic disorders. Radiol Clin North Am 2003;41:1152-69. 36. Castañer E, Andreu M, Gallardo X et al. CT in Nontraumatic Acute Thoracic Aortic Disease: Typical and Atypical Features and Complications. Radiographics 2003;23:S93-S110. 37. Lempel JK, Frazier AA, Jeudy J et al. Aortic arch dissection: a controversy of classification. Radiology 2014;271:848-55. 38. DeBakey ME, Henly WS, Cooley DA et al. Surgical management of dissecting aneurysms of the aorta. J Thorac Cardiovasc Surg 1965;49:130-49. 39. Daily PO, Trueblood HW, Stinson EB et al. Management of acute aortic dissections. Ann Thorac Surg 1970;10(3):237-47. 40. Lansman SL, Raissi S, Ergin MA, Griepp RB. Urgent operation for acute transverse aortic arch dissection. J Thorac Cardiovasc Surg 1989;97(3):334. 41. Valentine RJ, Boll JM, Hocking KM et al. Aortic arch involvement worsens the prognosis of type B aortic dissections. J Vasc Surge 2016;64(5):1212-8. 42. Osada H, Kyogoku M, Ishidou M et al. Aortic dissection in the outer third of the media: what is the role of the vasa vasorum in the triggering process? Eur J Cardiothorac Surg 2013;43(3):e82-e88. Published December 31, 2012.
35.
54. Quint LE, Francis IR, Williams DM et al. Evaluation of thoracic aortic disease with the use of helical CT and multiplanar reconstructions: comparison with surgical findings. Radiology 1996;201: 37-41.
60. Amerding MD, Rubin GD, Beaulieu CF et al. Aortic Aneurysmal Disease: Assessment of Stent-Graft Treatment – CT versus Conventional Angiography. Radiology 2000;215:138-46. 61. Brito CJ. Cirurgia Vascular, Cirurgia Endovascular e Angiologia. Rio de Janeiro: Revinter; 2002. 62. Therasse E, Soulez G, Giroux MF et al. Stent-graft placement for the treatment of thoracic aortic diseases. RadioGraphics 2005;25:157-73.
51. Lederle FA, Freischlag JA, Kyriakides TC et al. Outcomes following endovascular vs open repair of abdominal aortic aneurysm: a randomized trial. JAMA 2009;302:1535-42.
47. Wu MT, Wang YC, Huang YL et al. Intramural blood pools accompanying aortic intramural hematoma: CT appearance and natural course. Radiology 2011;258(3):705-13.
52. Lawler LP, FRCR, Fishman EK. Multidetector row computed tomography of the aorta and peripheral arteries. Cardiol Clin 2003;21:607-29.
Parte V136 TORACOABDOMINAL
55. Yoshioka K, Niinuma H, Ohira A et al. MR Angiography and CT angiography of the Artery of Adamkiewicz: Noninvasive Preoperative Assessment of Thoracoabdominal Aortic Aneurysm. Radiographics 2003;23:1215-25.
63. Iezzi R, Cotroneo AR, Marano R et al. Endovascular treatment of thoracic aortic diseases: follow-up and complications with multi-detector computed tomography angiography. Eur J Radiol 2008;65:365-76. 64. Ishida M, Kato N, Hirano T et al. Thoracic CT findings following endovascular stent-graft treatment for thoracic aortic aneurysm. J Endovasc Ther 2007;14:333-41. 65. Hoang JK, Martinez S, Hurwitz LM. MDCT Angiography of Thoracic Aorta Endovascular Stent-Grafts: Pearls and Pitfalls. Am J Roentgenol 2009 Feb.;192:515-24. 66. Parmer SS, Carpenter JP, Stavropoulos SW et al. Endoleaks after endovascular repair of thoracic aortic aneurysms. J Vasc Surg 2006;44:447-52. 67. Sundaram B, Quint LE, Patel S et al. CT appearance of thoracic aortic graft complications. AJR 2007;188:1273-7. 68. Svensson LG, Kouchoukos NT, Miller DC et al. Expert consensus document on the treatment of descending thoracic aortic disease using endovascular stent-grafts. Ann Thorac Surg 2008;85[suppl 1]:S1-S41. 69. Chaikof EL, Blankensteijn JD, Harris PL et al. Reporting standards for endovascular aortic aneurysm repair. J Vasc Surg 2002;35:1048-60. 70. Tatas K, Ling L, Dunning J, Shrivastava V. Static sac size with a type II endoleak post-endovascular abdominal aortic aneurysm repair: surveillance or embolization? Interact Cardiovasc Thorac Surg. 2012 Sep;15(3):462-6. 71. Müller-Wille R, Wohlgemuth WA, Heiss P et al. Transarterial Embolization of Type II Endoleaks after EVAR: The Role of Ethylene Vinyl Alcohol Copolymer (Onyx). Cardiovasc Intervent Radiol 2013 Feb 9.
48. Chin AS, Willemink MJ, Kino A et al. Acute Limited Intimal Tears of the Thoracic Aorta. J Am Coll Cardiol 2018 June;71(24):2773-85.
45. Park KH, Lim C, Choi JH et al. Prevalence of aortic intimal defect in surgically treated acute type A intramural hematoma. Ann Thorac Surg 2008;86(5):1494.
57. Oderich GS, Ribeiro M, Reis de Souza L et al. Endovascular repair of thoracoabdominal aortic aneurysms using fenestrated and branched endografts. J Thorac Cardiovasc Surg 2017;153:S32-41.
50. EVAR trial participants. Endovascular aneurysm repair versus open repair in patients with abdominal aortic aneurysm (EVAR trial 1): randomised controlled trial. Lancet 2005;365:2179-86.
56. Hu DK, Pisimisis GT and Sheth RA. Repair of abdominal aortic aneurysms: preoperative imaging and evaluation. Cardiovasc Diagn Ther 2018;8(Suppl 1):S157-S167.
49. Shiga T, Wajima Z, Apfel CC et al. Diagnostic accuracy of transesophageal echocardiography, helical computed tomography, and magnetic resonance imaging for suspected thoracic aortic dissection: systematic review and meta-analysis. Arch Intern Med 2006;166:1350-6.
53. Prokop M, Galanski M. Spiral and Multislice Computed Tomography of the Body. Editora Thieme; 2003. c. 24. p. 870-91.
46. Sueyoshi E, Sakamoto I, Uetani M, Matsuoka Y. CT analysis of the growth rate of aortic diameter affected by acute type B intramural hematoma. AJR Am J Roentgenol 2006;186(6 suppl 2):S414-S420.
44. Sueyoshi E, Matsuoka Y, Sakamoto I et al. Fate of intramural hematoma of the aorta: CT evaluation. J Comput Assist Tomogr 1997;21(6):931-8.
43. Nienaber CA, von Kodolitsch Y, Petersen B et al. Intramural hemorrhage of the thoracic aorta: diagnostic and therapeutic implications. Circulation 1995;92(6):1465-72.
58. Quint LE, Francis IR, Williams DM et al. Synthetic interposition grafts of the thoracic aorta: postoperative appearance on serial CT studies. Radiology 1999;211:317-24. 59. Sakai T, Dake MD, Semba CP et al. Descending thoracic aortic aneurysm: thoracic CT findings after endovascular stent-graft placement. Radiology 1999;212:169-74.
137 73CapítuloANGIORRESSONÂNCIA MAGNÉTICA DOS VASOS TORACOABDOMINAIS REFERÊNCIAS BIBLIOGRÁFICAS
12. Backes WH, Nijenhuis RJ, Mess WH et al. Magnetic resonance angiography of collateral blood supply to spinal cord in thoracic and thoracoabdominal aortic aneurysm patients. J Vasc Surg 2008;48(2):261-71. 13. Hartnell GG. Imaging of aortic aneurysms and dissection: CT and MRI. J Thorac Imaging 2001;16(1):35-46. 14. Folley WD, Pereles FS. Abdominal Aorta. In: Rubin GD, Rofsky NM (Eds.). CT and MR angiography: Comprehensive vascular assessment. Philadelphia, PA: Lippincott Williams & Wilkins; 2009. p. 719-71.
18. John RA, Keshava SN, Danda D. Correlating MRI with clinical evaluation in the assessment of disease activity of Takayasu’s arteritis. Int J Rheum Dis 2017;20(7):882-6.
5. Crawford ES, Crawford JL, Safi HJ et al J Vasc Surg 1986;3(3):389-404.
10. Hiroshi T, Hitoshi O, Kenji M et al. The impact of preoperative identification of the Adamkiewicz artery on descending and thoracoabdominal aortic repair. J Thorac Cardiovasc Surg 2016;151(1):122-8. 11. Griepp RB, Griepp EB. Spinal cord perfusion and protection during descending thoracic and thoracoabdominal aortic surgery: the collateral network concept. Ann Thorac Surg 2007;83(2):S865-9; discussion S890-2. Review.
6. Safi HJ, Miller CC 3rd. Ann Thorac Surg 1999;67(6):1937-9.
8. Green DB, Palumbo MC, Lau C. Imaging of Thoracoabdominal Aortic Aneurysms. J Thorac Imaging 2018;33(6):358-65.
15. Gaballah M, Goldfisher R, Amodio JB. The Utility of MRI in the Diagnosis of Takayasu Arteritis. Case Rep Pediatr 2017;2017:7976165. 16. Bossone E, Pluchinotta FR, Andreas M et al. Aortitis. Vascul Pharmacol 2016;80:1-10. 17. Choe YH, Han BK, Koh EM et al. Takayasu’s arteritis: assessment of disease activity with contrast-enhanced MR imaging. AJR Am J Roentgenol 2000;175(2):505-11.
1. Schneider G. MR Angiography of the thoracic aorta. In: Schneider G, Prince MR, Meaney JFM, Ho VB. Magnetic Resonance Angiography. Techniques, indications and practical applications. Springer; 2005. p. 141-161.
2. Siegel MJ, Earls JP. Thoracic Vascular Anomalies. In: Rubin GD, Rofsky NM (Eds.). CT and MR angiography: Comprehensive vascular assessment. Philadelphia, PA: Lippincott Williams & Wilkins; 2009. p. 544-94.
4. Crawford ES, Snyder DM, Cho GC, Roehnm JO Jr. Progress in treatment of thoracoabdominal and abdominal aortic aneurysms involving celiac, superior mesenteric, and renal arteries. Ann Surg 1978;188(3):404-22.
7. Hiratzka LF, Bakris GL, Beckman JA, et al. 2010 ACCF / AHA / AATS /ACR /ASA /SCA /SCAI /SIR /STS /SVM Guidelines for the diagnosis and management of patients with thoracic aortic disease: Executive summary: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine. Anesth Analg 2010;A111(2):279-315.
3. Orr N, Minion D, Bobadilla JL. Thoracoabdominal aortic aneurysm repair: current endovascular perspectives. Vasc Health Risk Manag 2014;19(10):493-505.
9. Nijenhuis RJ, Jacobs MJ, Jaspers K et al. Comparison of magnetic resonance with computed tomography angiography for preoperative localization of the Adamkiewickz artery in thoracoabdominal aortic aneurysm patients. J Vasc Surg 2007;45(4):677-85. Epub 2007 Feb 15. Erratum in: J Vasc Surg 2007 May;45(5):1903.
138 74Capítulo ANGIOGRAFIA DOS VASOS TORACOABDOMINAIS REFERÊNCIAS BIBLIOGRÁFICAS 1. Carnevale FC. Radiologia Intervencionista e Cirurgia Endovascular. São Paulo: Revinter; 2006. p. 31-44. 2. Haimovic H. Vascular Surgery. New York: Appleton & Lange; 1989. p. 76-93. 3. Lasjaunias P. Surgical Neuro-angiography. Bicêtre: Springer; 2001. p. 17-26. 4. Lobato AC. Cirurgia Endovascular. São Paulo: Instituto de Cirurgia Vascular e Endovascular; 2006. p. 19-24. 5. Maffei FH. Doenças Vasculares Periféricas. São Paulo: Medsi; 2002. p. 21-32. 6. Martorell F. Enfermidades Vasculares. Barcelona; 1972. p. 22-31. 7. Moura R. Angiografia por subtração digital. In: Maffei FHA, Lastória S, Yoshida WB, Rollo HA. Doenças vasculares periféricas. 3. ed. Rio de Janeiro, RJ: Medsi; 2002. p. 383-98. 8. Peixoto CCS, Brito CJ. Cirurgía Endovascular e Angiología. Rio de Janeiro: Revinter; 2008. p. 396-416. 9. Peixoto CCS, Brito CJ. Cirurgia Endovascular e Angiología. Rio de Janeiro: Revinter; 2014. p. 527-534.
DA AORTA TORACOABDOMINAL
REFERÊNCIAS BIBLIOGRÁFICAS
3. Anacleto JC, Braile DM, Sanches RP et al. Dissecção aórtica. In: Bonamigo TP (Ed.). Doenças da aorta e seus ramos. São Paulo: Fundo Editorial BYK; 1991. p. 439-487.
4. Asante-Siaw J, Tyrell J, Hoschtitzky A, Dunning J. Does these of a centrifugal pump offer any additional benefit for patients having open heart surgery? Interac Cardiovasc Thorac Surg 2006;5:128-34.
7. Bickerstaff LK, Hollier LH, Cherry KJ et al. Thoracic aortic aneurysms: a population-based study. Surgery 1982;92:1103-1108.
11. Blaisdell FW, Cooley DA. The mechanism of paraplegia after temporary thoracic aortic occlusion and its relationship to spinal fluid pressure. Surgery 1962;51:351-355.
15. Bower TC, Murray MJ, Gloviczki P et al. Effects of thoracic aortic occlusion and cerebrospinal fluid drainage on regional spinal cord blood flow in dogs: Correlation with neurologic outcome. J Vasc Surg 1988;9:135-44.
16. Braughler JM, Hall ED. Central nervous system trauma and stroke. I Biochemical considerations for oxygen radical formation and lipid peroxidation. Free Rad Biol Med 1989;6:289-301.
14. Bourchier RG, Gloviczki P, Larson MV et al. The mechanisms and prevention of intravascular fluid loss after occlusion of the supraceliac aorta in dogs. J Vasc Surg 1991;13:637-45.
12. Böckler D, Schumacher H, Klemm K et al. Hybrid procedures as a combined endovascular and open approach for pararenal and thoracoabdominal aortic pathologies. Langerbecks Arch Surg 2007;392:715-23
17. Breckwoldt W, Genco CM, Connolly RJ et al. Spinal Cord Protection During Aortic Occlusion: Efficacy of Intrathecal Tetracaine. Ann Thorac Surg 1991;51:959-63.
ANEURISMAS –TRATAMENTO CIRÚRGICO
2. Anacleto A, Anacleto JC. Proteção medular e visceral na cirurgia do aneurisma torácico e toracoabdominal. In: Bonamigo & Von Ristow (Eds.). Aneurismas. Porto Alegre: AGE; 1999. p. 266.
8. Biglioli P, Spirito R, Agrifoglio M et al. Surgery of descending thoracic aortic aneurysms with centrifugal pump support. Cardiovasc Surg 1997;5:99-103. 9. Biglioli P, Spirito R, Pompilio G et al. Descending thoracic aorta aneurysmectomy: left-left centrifugal pump versus simple clamping technique. Cardiovasc Surg 1995;3:511-518.
10. Black SA, Wolfe JH, Clark M et al. Complex thoracoabdominal aortic aneurysms: endovascular exclusion with visceral revascularization. J Vasc Surg 2006;43:1081-89; discussion 1089.
21. Carlson DE, Karp RB, Kouchoukos NT. Surgical treatment of aneurysm of the descending thoracic aorta: an analysis of 85 patients. Ann Thorac Surg 1983;35:58. 22. Carrel A, Guthrie C. Resultats du patching dès arteries. Comptes rendus hebdomadaires dès seances et memoires de la Societé de Biologie 1906:1009. 23. Carrel A, Guthrie CC. Uniterminal and biterminal venous transplantation. Surg Gynecol Obstet 1906;2:266. 24. Carrel A. On the experimental surgery of the thoracic aorta and the heart. Ann Surg 1910;52:83. 25. Chiesa R, Tshomba Y, Melissano G et al. Hybrid approach to thoracoabdominal aortic aneurysms in patients with prior aortic surgery. J Vasc Surg 2007;45:1128-35. 26. Choudhury NA, Malyszko J, Ahmed MH et al. Plasma serotonin and platelet aggregation during ischemia-reperfusion in dogs: effect of dipyridamole and coenzyme Q10. Haemostasis 1996;26(1):38-44. 27. Chuter TA, Rapp JH, Hiramoto JS et al. Endovascular treatment of thoracoabdominal aortic aneurysm. J Vasc Surg 2008;47:6-16. 28. Coady MA, Davies RR, Roberts M. Familial patterns of thoracic aortic aneurysms. Arch Surg 1999;134(4):361-67. 29. Coady MA, Rizzo JÁ, Elefteriades JÁ. Elaborando critérios para intervenção cirúrgica em Aneurismas da aorta torácica. Clin Cardiol Am Norte 1999 nov:1083-1099. 30. Cohen JR, Angus L, Asher A. Disseminated intravascular coagulation as a result of supraceliac clamping: Implications for thoracoabdominal aneurysm repair. Ann Vasc Surg 1987;1:552-557. 31. Connoly JE, Kountz SL, Boyd RJ. Left bypass: experimental and clinical observations on its regulation with particular reference to maintenance of maximal renal blood flow. J Thorac Cardiovasc Surg 1962;44:577-89. 32. Cooley DA, DeBakey ME. Sucessful resection of aneurysm of thoracic aorta and replacement by graft. JAMA 1953;152:673. 33. Cooley DA. Single-Clamp Repair of Aneurysms of the Descending Thoracic Aorta. Sem Thorac Cardiovasc Surg 1998;10(1):87-90. 34. Coselli JS, LeMaire AS. Left heart bypass reduces paraplegia rates after thoracoabdominal aortic aneurysm repair. Ann Thorac Surg 1999;67:1931-34. 35. Coselli JS, LeMaire AS. Técnicas cirúrgicas: aorta tóraco-abdominal. Clin Cardiol Am Norte 1999 Nov:993-1010. 36. Coselli JS, LeMaire SA, Prevetza O et al. Outcomes of 3309 thoracoabdominal arotic aneyrism repais. J Thorac Cardiovascr Surg 2016;151(5):1323-37. 37. Coselli JS, LeMaire SA. Surgical techniques. Thoracoabdominal aorta. Cardiol Clin 1999 Nov;17(4):751-65. 38. Coselli JS. Contemporary management and results of thoracoabdominal aortic aneurysm surgery. In: Chiesa R & Melissano G (Eds.). Gli Aneurismi dell’ Aorta Addominale. Milano. Europa Scienze Umane Editice 1996:269-284. 39. Coselli JS. Thoracoabdominal aortic aneurysm. In: Rutherford RB (Ed.). Vascular Surgery. Co, 4. Ed. Philadelphia: WB Saunders; 1995. p. 1069-1087. 40. Cosseli JS. Strategies for renal and visceral protection in thoracoabdominal aortic surgery. J Thorac Cardiovasc Surg 2010;140:147-149. 41. Cox GS, O’Hara PJ, Hertzer NR et al. Thoracoabdominal aneurysm repair: A representative experience. J Vasc Surg 1996;15:780-8. 42. Crawford ES, DeNatale RW. Thoracoabdominal aortic aneurysm: observations regarding the natural course of the disease. J Vasc Surg 1986;3:578-582. 43. Crawford ES, Coselli JS, Safi HJ. Partial cardiopulmonary bypass, hypothermic circulatory arrest, and posterolateral exposure for
18. Cambria RP, Brewster DC, Lauterbach SR et al. Thoracoabdominal aneurysm repair: results with 337 operations performed over a 15year interval. Ann Surg 2002;236(4):471-79.
13. Borst HG, Jurmann M, Bühner B, Laas J. Risk of replacement of descending aorta with a standardized left heart bypass technique. J Thorac Cardiovasc Surg 1994;107:126-33.
5. Bavaria JE, Appoo JJ, Makaroun MS et al. Endovascular stent grafting versus open surgical repair of descending thoracic aortic aneurysms in low-risk patients: a multicenter comparative trial. J Thorac Cardiovasc Surg 2007;133:369-77.
19. Cambria RP, Davison K, Giglia JS et al. Mesenteric shunting decreases visceral ischemia during thoracoabdominal aneurysm repair. J Vasc Surg 1998;27:745-749. 20. Cambria RP, Davison K. Regional Hypothermia for Prevention of Spinal Cord Ischemic Complications After Thoracoabdominal Aortic Surgery: Experience With Epidural Cooling. Semin Thorac Cardiovasc Surg 1998;10(1):61-65.
1. Acher CW, Wynn MM. Multifactoral Nature of Spinal Cord Circulation. Seminars in Thoracic and Cardiovascular. Surgery 1998;10(1):7-10.
139 75Capítulo
6. Berguer R, Porto J, Fedoronko B et al. Selective deep hypothermia of the spinal cord prevents paraplegia after aortic cross-clamping in the dog model. J Vasc Surg 1992;15:62-72.
81. Hirose Y, Hamada S, Takamiya N et al. Aortic aneurysms: growth rates measured with CT. Radiology 1992;185:249-252. 82. Hollier LH, Mena J. Thoracoabdominal aortic aneurysms. In: Haimovici H (Ed.). Haimovici’s Vascular Surgery. 4th ed. USA: Blackwell Sciency; 1996. p.786-796. 83. Hollier LH. Protecting the brain and spinal cord. J Vasc Surg 1987;5:524-528. 84. Jacnkzack D, Garcarek J, Bogdaneck R et al. Eight-years follow-up of a high-risk patient treated for Crawford type II thoracoabdominal aortic aneurysm (TAAA) repair with a multistage hybrid openendovascular repair. Ann Thorac Cadiovasc Surg 2013;20:1-4. 85. Jacobs MJ, de Mol BA, Legemate DA et al. Retrograde aortic and selective organ perfusion during thoracoabdominal aortic aneurysms repair. Eur J Vasc Endovasc Surg 1997;14(5):360-6. 86. Javid M, Julian OC, Dye WS et al. Complications of abdominal aortic grafts. Arch Surg 1962;85:650. 87. Jex RK, Schaff HV, Piehler JM. Early and late results following repair of dissections of the descending thoracic aorta. J Vasc Surg 1986;3(2):226-37. 88. Jonker FH, Trimarchi S, Verhagen HJ et al. Meta-analysis of open versus endovascular repair for ruptured descending thoracic aortic aneurysm. Vasc Surg 2010;51:1026-32. 89. Jonker FH, Verhagen HJ, Liu PH et al. Open surgery versus endovascular repairs of ruptured thoracic aortic aneurysms. J Vasc Surg 2010;53:1210-16. 90. Juvonen T, Ergin MA, Galla JD et al. Prospective study of the natural history of thoracic aortic aneurysms. Ann Thorac Surg 1997;63:1533-45. 91. Kaihara S, Egawa H, Inomata Y et al. Serotonin as a useful parameter for cold and warm ischemic injury in small bowel transplantation. Transplantation 1997;64(3):405-10. 92. Kaplan DK, Atsumi N, D’Ambra MN et al. Distal circulatory support for thoracic aortic operations: Effects on intracranial pressure. Ann Thorac Surg 1995;59:448-452. 93. Kashyap VS, Cambria RP, Davison JK et al. Renal failure after thoracoabdominal aortic surgery. J Vasc Surg 1997;26:949-57.
69. Gloviczki P, Bower TC. Visceral and Spinal Cord Protection During Thoracoabdominal Aortic Reconstructions. Sem Vasc Surg 1992;5:163-173. 70. Godet G, Fleron MH, Vicaut E, Zubicki A et al. Risk factors for acute postoperative renal failure in thoracic or thoracoabdominal aortic surgery: a prospective study. Anesth Analg 1997;85(6):1227-32.
57. DeBakey ME, Crawford ES, Garret HE et al. Surgical considerations in the treatment of aneurysms of the thoracoabdominal aorta. Ann Surg 1965;162:650.
61. Eldrup-Jorgense J, Bredenberg Z. Repair of type III and type IV thoracoabdominal aortic aneurysms by using a long beveled anastomosis: a description of technique. Surgery 1998;123:351-355.
48. Crawford ES, Walker HS, Saleh SA et al. Graft replacement of aneurysm in descending thoracic aorta: results without bypass or shunting. Surgery 1981;89:73.
44. Crawford ES, Crawford JL, Safi HJ et al. Thoracoabdominal aortic aneurysms: Preoperative and intraoperative factors determining immediate and long-term results of operations in 605 patients. J Vasc Surg 1986;3:389-404.
74. Griep RB, Ergin MA, Galla JD et al. Natural history of descending thoracic and thoracoabdominal aneurysms. Ann Thorac Surg 1999;67(6):1927-30.
62. Elmore JR, Gloviczki P, Harper CM et al. Failure of motor evoked potentials to predict neurologic outcome in experimental thoracic aortic occlusion. J Vasc Surg 1991;14:131-9. 63. Ergin MA, Galla JD, Lansman SL. Distal perfusion methods for surgery of the descending aorta. Semin Thorac Cardiovasc Surg 1991;3:293-299. 64. Etheredge SN, Yee J, Smith JV. Sucessful resection of a large aneurysm of the upper abdominal aorta and replacement with homograft. Surgery 1955;38:1071-1081. 65. EVAR trial participants. Endovascular aneurysm repair versus open repair in patients with abdominal aortic aneurysm (EVAR trial 1): randomised controlled trial. Lancet 2005;365:2179-86. 66. Fikar CR, Koch S. Etiologic factors of acute aortic dissection in children and young adults. Clin Pediatr 2000;39(2):71-80.
55. Davison J, Cambria R, Vierra D. Epidural cooling for regional spinal cord hypothermia during thoracoabdominal aneurysm repair. J Vasc Surg 1994;20:304-310.
76. Haan P, Kalkman CJ, Jacobs MJ. Spinal Cord Monitoring With Myogenic Motor Evoked Potentials: Early Detection of Spinal Cord Ischemia as an Integral Part of Spinal Cord Protective Strategies During Thoracoabdominal Aneuysm Surgery. Semin Thorac Cardiovasc Surg 1998;10(1):19-24. 77. Hassoun HT, Miller III CC, Huynh TT et al. Cold visceral improves early survival in patients with acute renal failure after thoracoabdominal aortic aneurysm repair. J Vasc Surg 2004. 78. Heinemann MK, Brassel F, Herzog T et al. The Role of Spinal Angiography in Operations on the Thoracic Aorta: Myth or Reality? Ann Thorac Surg 1998;65:346-51. 79. Heistad DD, Harrison DG, Armstrong ML. Serotonin and experimental vascular disease. Int J Cardiol 1987;14(2):205-12. 80. Hess PJ, Seeger JM, Huber TS et al. Exogenously administered interleukin-10 decreases pulmonary neutrophil infiltration in a tumor necrosis factor-dependent murine model of acute visceral ischemia. J Vasc Surg 1997;26:113-8.
45. Crawford ES, Hess KR, Coselli JS et al. Ruptured aneurysm of the descending thoracic and thoracoabdominal aorta. Ann Surg 1991;213(5):417-26.
56. de Cruz KI, LeMaire SA, Weldon SA, Coselli JS. Thoracoabdominal aortic aneurysm repair with a branched graft. Ann Cardiothorac Surg 2012;1(3):381-93.
60. Donas KP, Czerny M, Guber I et al. Hybrid open-endovascular repair for thoracoabdominal aortic aneurysms: current status and level of evidence. Eur J Vasc Endovasc Surg 2007;34:528-33.
50. Crawford JL, Stowe CL, Safi HJ et al. Inflammatory aneurysms of the aorta. J Vasc Surg 1985;2:113-124.
46. Crawford ES, Mizrahi EM, Kenneth RH et al. The impact of distal aortic perfusion and somatosensory evoked potential monitoring on prevention of paraplegia after aortic aneurysm operation. J Thorac Cardiovasc Surg 1988;95:357-67.
58. DeBakey ME, Creech O, Morris GC. Aneurysm of thoracoabdominal aorta involving the celiac, superior mesenteric and renal arteries: report of four cases treated by resection and homograft replacement. Ann Surg 1956;144:549.
71. Godet G, Samama CM, Ankri A. Mechanisms and predictors of hemorrhagic complications during surgery of thoracoabdominal aortic aneurysm. Ann Fr Anesth Reanim 1990;9:415-422.
75. Griepp RB, Ergin MA, Galla JD et al. Minimizing Spinal Cord Injury During Repair of Descending Thoracic and Thoracoabdominal Aneurysms: The Mount Sinai Approach. Semin Thorac Cardiovasc Surg 1998;10:25-28.
72. Gott VF, Whiffen JD, Dutton RC. Heparin bonding on colloidal graphite surfaces. Science 1963;142:1297. 73. Granke K, Hollier LH, Zdrahal P et al. Longitudinal study of cerebral spinal fluid drainage in polyethylene glycol-conjugated superoxide dismutase in paraplegia associated with thoracic aortic crossclamping. J Vasc Surg 1991;13:615-21.
53. Dake MD, Miller DC, Semba CP et al. Transluminal placement of endovascular stent-grafts for the treatment of descending thoracic aortic aneurysm. N Eng J Med 1994;331:1729-1734.
47. Crawford ES, Snyder DM, Cho GC et al. Progress in treatment of thoracoabdominal and abdominal aortic aneurysms involving celiac, superior mesenteric and renal arteries. Ann Surg 1978;188:404-422.
Parte V140 TORACOABDOMINAL thoracic aortic aneurysm operation. J Thorac Cardiovasc Surg 1987;94(6):824-7.
59. Del Rossi AJ, Cernaianu AC, Cilley JH et al. Preventive effect of Fluosol-DA for paraplegia encountered after surgical treatment of the thoracic aorta. J Thorac Cardiovasc Surg 1990;99:665-9.
67. Gertler JP, Cambria RP, Brewster DC et al. Coagulation changes during thoracoabdominal aneurysm repair. J Vasc Surg 1996;24:936-45. 68. Gharagozloo F, Neville RF, Cox JL. Spinal Cord Protection During Surgical Procedures on the Descending Thoracic and Thoracoabdominal Aorta: A Critical Overview. Sem Thorac Cardiovasc Surg 1998;10:73-86.
51. Crawford S, Rubio PA. Reappraisal of adjuncts to avoid ischemia in the treatment of aneurysms of descending thoracic aorta. J Thorac Cardiovasc 1973;66:693-704.
54. Davies RR, Goldstein LJ, Coady MA et al. Yearly rupture or dissection rates for thoracic aortic aneurysms: simple prediction based on size. Ann Thorac Surg 2002;75:17-28.
52. Dake MD, Miller DC, Mitchell RS et al. The “first generation” of endovascular stent-grafts for patients with aneurysms of the descending thoracic aorta. J Thorac Cardiovasc Surg 1998;116:689-703.
49. Crawford ES. Thoraco-abdominal and abdominal aortic aneurysm involving renal, superior mesenteric, and celiac arteries. Ann Surg 1974;179:763-772.
103. Laschinger JC, Cunningham JN, Baumann FG et al. Monitoring of somatosensory evoked potentials during surgical procedures on the thoracoabdominal aorta (III). J Thorac Cardiovasc Surg 1987;94:271-4.
122. Nienaber CA, von Kodolitsch Y, Nicolas V et al. The diagnosis of thoracic aortic dissection by noninvasive imaging procedures. N Engl J Med 1993;328:1-9. 123. Ouriel K, Smedira NG, Ricotta JJ. Protection of the Kidney after temporary ischemia: Free radical scavengers. J Vasc Surg 1985;2:49-53. 124. Panneton JM, Hollier LH. Nondissecting thoracoabdominal aortic aneurysms: part I. Ann Vasc Surg 1995;9:503-514.
141. Safi HJ, Miller CC. Spinal cord protection in descending thoracic and thoracoabdominal aortic repair. Ann Thorac Surg 1999;67:1937-9. 142. Salzano R, Ellison LH, Altonji PF. Regional deep hypothermia of the spinal cord protects against ischemic injury during thoracic aortic cross-clamping. Ann Thorac Surg 1994;57:65-70.
118. McCullough J, Hollier LH, Nugent M. Paraplegia after thoracic aortic occlusion: Influence of cerebrospinal fluid drainage. J Vasc Surg 1988;7:153-60.
Capítulo 75 141AneurismA s dA AortA tor ACoAbdominAl – tr AtAmento CirúrgiCo
113. Makaroun MS, Dillavou ED, Wheatley GH et al. Five-year results of endovascular treatment with the Gore TAG device compared with open repair of thoracic aortic aneurysms. J Vasc Surg 2008;47:912-18.
115. Matas R. An operation for the radical cure of aneurysm based upon arteriorrhaphy. Ann Surg 1903;37:161. 116. Matas R. Endo-aneurysmorrhaphy. Surg Gynecol Obstet 1920;30:456.
104. Laschinger JC, Cunningham JN, Cooper MM et al. Monitoring of somatosensory evoked potentials during surgical procedures on the thoracoabdominal aorta (I). J Thorac Cardiovasc Surg 1987;94:260-5.
111. Linch MF, Peterson D, Baker V. Centrifugal blood pumping for open hearth surgery. MMA 1998;9:536-37.
106. Le May DR, Neal BS, Zelenock GB. Paraplegia in the rat induced by aortic cross-clamping: Model characterization and glucose exacerbation of neurologic deficit. J Vasc Surg 1987;6:383-90.
108. Lemaire SA, Jones MM, Conklin LD, Carter SA et al. Randomized comparison of cold blood and cold crystalloid renal perfusion for renal protection during thoracoabdominal aortic aneurysm repair. J Vasc Surg 2009;49(1):11-19.
117. Mattox KL, Burch JM, Richardson R et al Retroperitoneal vascular injury. Surg Clin North Am 1990;70:635-653.
125. Parodi JC, Palmaz JC, Barone HD. Transfemoral intraluminal graft implantation for abdominal aortic aneurysms. Ann Vasc Surg 1991;5:491-499. 126. Pennell RC, Hollier LH, Hallett JW et al. Inflammatory abdominal aortic aneurysms: a thirty-year review. J Vasc Surg 1985;2:859-869. 127. Reddy DJ, Ernst CB. Infected aneurysms. In: Rutherford RB (Ed.). Vascular Surgery. 4. ed. Philadelphia: WB Saunders Co; 1995. p. 1139-1153. 128. Reilly LM, Chuter TA. Endovascular repair of thoracoabdominal aneurysm: design, options, device construct, patient selection and complications. J Cardiovasc Surg 2009;50:447-60. 129. Resch TA, Greenberg RK, Lyden SP et al. Combined staged procedures for the treatment of thoracoabdominal aneurysms. J Endovasc Ther 2006;13:481-9. 130. Robertazzi RR, Cunningham JN. Intraoperative Adjuncts of Spinal Cord Protection. Sem Thorac Cardiovasc Surg 1998;10(1):29-34. 131. Robertazzi RR, Cunningham JN. Monitoring of Somatosensory Evoked Potentials: A Primer on the Intraoperative Detection of Spinal Cord Ischemia During Aortic Reconstructive Surgery. Semin Thorac Cardiovasc Surg 1998;10(1):11-17. 132. Robertazzi, RR, Acinapura AJ. The Efficacy of Left Atrial to Femoral Artery Bypass in the Prevention of Spinal Cord Ischemia During Aortic Surgery. Semin Thorac Cardiovasc Surg 1998;10:67-71. 133. Rokkas CK, Kouchoukos NT. Profound Hypothermia for Spinal Cord Protection in Operations on the Descending Thoracic and Thoracoabdominal Aorta. Semin Thorac Cardiovasc Surg 1998;10(1):57-60. 134. Rollwagen FM, Li YY, Pacheco ND et al. Systemic sepsis following hemorrhagic shock: alleviation with oral interleukin-6. Mil Med 1997;162(5):366-70. 135. Rothman S. Synaptic release of excitatory amino acid neuro transmitter mediates anoxic neuronal death. J Neuroschi 1984;4:1884-1891. 136. Rubin GD, Walker PJ, Dake MD et al. Three-dimensional spiral computed tomographic angiography: an alternative imaging modality for the abdominal aorta and its branches. J Vasc Surg 1993;18:656-65. 137. Safi HJ, Campbell MP, Ferreira ML et al. Spinal Cord Protection in Descending Thoracic and Thoracoabdominal Aortic Aneurysm Repair. Semin Thorac Cardiovasc Surg 1998;10:41-44. 138. Safi HJ, Campbell MP, Miller CC et al. Cerebral spinal fluid drainage and distal aortic perfusion decrease the incidence of neurological deficit: the results of 343 descending and thoracoabdominal aortic aneurysms repairs. Eur J Vasc Endovasc Surg 1997;14(2):118-24. 139. Safi HJ, Huynh TT, Estrera AL et al. Aneurismas Aórticos Toracoabdominais. In: Rutherford RB. (Ed.). Cirurgia vascular. Rio de Janeiro: Elsevier (tradução DiLivros); 2007. p. 1490-511. 140. Safi HJ, Miller CC, Yawn DH et al. Impact of distal aortic and visceral perfusion on liver function during thoracoabdominal and descending thoracic aortic repair. J Vasc Surg 1998;27:145-53.
109. Leurs LJ, Bell R, Degrieck Y et al. Endovascular treatment of thoracic aortic diseases: combined experience from the EUROSTAR and United Kingdom Thoracic Endograft registries. J Vasc Surg 2004;40:670-80.
96. Köksoy C, LeMaire SA, Curling PE et al. Renal perfusion during thoracoabdominal aortic operation: cold crystalloid is superior to normothermic blood. Ann Thorac Surg 2002. 97. Kouchoukos N, Wareing TH, Izumoto H et al. Elective hypothermic cardiopulmonary bypass and circulatory arrest for spinal cord protection during operations on the thoracoabdominal aorta. J Thorac Cardiovasc Surg 1990;99:659-64. 98. Kouchoukos NT, Daily BB, Rokkas CK et al. Hypothermic bypass and circulatory arrest for operations on the descending thoracic and thoracoabdominal aorta. Ann Thorac Surg 1995;60(1):67-77. 99. Krause GS, White BC, Aust SD. Brain cell death following ischemia and reperfusion: A proposed biochemical sequence. Crit Care Med 1988;16:714-726. 100. Krupski WC. Arterial Aneurysms: Overview. In: Rutherford RB(Ed.). Vascular Surgery. 4th ed. Philadelphia: WB Saunders Company; 1994. p. 1025-32.
107. Leijdekkers VJ, Wirds JW, Vahlt AC et al. The visceral perfusion system and distal bypass during thoracoabdominal aneurysm surgery: an alternative for physiological blood flow? Cardiovasc Surg 1999;7(2):219-224.
110. Levy PJ, Tabares AH, Olin JW et al. Disseminated intravascular coagulation associated with acute ischemic hepatitis after elective aortic aneurysm repair: comparative analysis of 10 cases. J Cardiothorac Vasc Anesth 1997;11(2):141-8.
101. Lan NH, Hollier LH. Adjunctive Therapy for Spinal Cord Protection During Thoracoabdominal Aortic Aneurysm Repair. Semin Thorac Cardiovasc Surg 1998;10(1):35-39. 102. Lane JS, Todd KE, Lewis MP et al. Interleukin-10 reduces the systemic inflammatory response in a murine model of intestinal ischemia/ reperfusion. Surgery 1997;122(2):288-94.
114. Marini CP, Levison J, Caliendo F et al. Control of Proximal Hypertension During Aortic Cross-Clamping: Its Effect on Cerebrospinal Fluid Dynamics and Spinal Cord Perfusion Pressure. Sem Thorac Cardiovasc Surg 1998;10:51-56.
119. Melville GW, Bruce AP, Burdick JF. Angiographic localization of spinal cord blood supply and its relationship to postoperative paraplegia. J Vasc Surg 1991;13:23-35.
120. Mitchell RS, Miller DC, Dake MD et al. Thoracic aortic aneurysm repair with an endovascular stent-graft: the “first generation”. Ann Thorac Surg 1999;67:1971-158.
94. Kazmers A, Zwolak R, Appelman HD et al. Pharmacologic interventions in acute mesenteric ischemia: Improved survival with intravenous glucagon, methylprednisolone and prostacyclin. J Vasc Surg 1984;472-81. 95. Kieffer E. The Role of Spinal Cord Arteriography Before Descending Thoracic/Thoracoabdominal Aneurysmectomy. Semin Vasc Surg 1992;5(3):141-145.
121. Miyamoto K, Keno A, Wada T et al. A new and simple method of preventing spinal cord damage following temporary occlusion of the thoracic aorta by draining the cerebrospinal fluid. J Cardiovasc Surg 1960;16:188-99.
112. Lobato AC, Camachi-Lobato L. A new technique to enhance endovascular thoracoabdominal aortic aneurysm therapy-the sandwich technique. Semin Vasc Surg 2012;25:153-60.
105. Lassnigg A, Schmidlin D, Mouhieddine M et al. Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. J Am Soc Nephrol 2004;15(6):1597-605.
152. Svensson LG, Crawford ES . Cardiovascular and vascular disease of the aorta Philadelphia: Saunders; 1997.
149. Svensson LG, Crawford ES, Hess KR et al. Experience with 1509 patients undergoing thoracoabdominal aortic operations. J Vasc Surg 1993;17:357-370.
150. Svensson LG, Crawford ES, Hess KR et al. Variables predictive of outcome in 832 patients undergoing repairs of the descending thoracic aorta. Chest 1993;104:1248-1253.
Parte V142 TORACOABDOMINAL
151. Svensson LG, Crawford ES, Hess KR. Deep hypothermia with circulatory arrest: Determinants of stroke and early mortality in 656 patients. J Thorac Cardiovasc Surg 1993;106:19-31.
158. Tsomba Y, Leopardi M, Mascia D. Automated-pressure controlled cerebrospinal fluid drainage during open thoracoabdominal aortic aneurysm repair. J Vasc Surg 2017;66(1):37-44.
145. Selle JG, Robicsek F, Daugherty HK, Cook JW. Thoracoabdominal aortic aneurysms: a review and current status. Coll Works Cardiopulm Dis 1979;22:79-90.
153. Svensson LG, Crawford ES. Diagnosis and evaluation of aortic disease. In: Svensson & Crawford (Eds.). Cardiovascular and vascular disease of the aorta. Philadelphia: WB Saunders C. 1997. p. 6-28.
148. Svensson LG, Coselli J, Safi HJ et al. Appraisal of adjuncts to prevent acute renal failure after surgery on the thoracic or thoracoabdominal aorta. J Vasc Surg 1989;10:230-9.
155. Svensson LG, Loop FD. Prevention of spinal cord ischemia in aortic surgery. In: Bergan JJ, Yao JST (Eds.). Arterial Surgery New Diagnostic and Operative Techniques. Philadelphia: PA Grune & Stratton; 1988. p. 273-285.
146. Spencer FC, Zimmenman JM. The influence of ligation of intercostal arteries on paraplegia in dogs. Surg Forum 195;9:340-2.
160. Veith FJ, Gholdsmith J, Leather RP et al. The need of quality assurance in vascular surgery. J Vasc Surg 1991;13:523-526.
165. Zhou W, Reardon M, Peden EK et al. Hybrid approach to complex thoracic aortic aneurysms in high risk patients: surgical challenges and clinical outcomes. J Vasc Surg 2006;44:688-93162.
159. Vasilaks A, Rozar Jr GE, Hill RC, Murray GF. Left atrial to femoral arterial bypass using the Biomedicus pump for operations of the thoracic aorta. Am Surg 1990;56:802-05.
157. Thadhani RM, Pascual M, Bonventre JU. Acute renal failure. N Eng J Med 1996;334(22):1448-60.
162. Walberg E, Dimuzio PJ, Stoney RJ. Aortic clamping during elective operations for infrarenal disease. The influence of clamping time on renal function. J Vasc Surg 2002;36(1)10-18. 163. White RA, Donayre CE, Walot I et al. Endovascular exclusion of descending thoracic aortic aneurysms and chronic dissections: initial clinical results with the AneuRx device. J Vasc Surg 2001;33:927-34.
143. Sayers RP, Thompson MM, Nasim A et al. Surgical management of 671 abdominal aortic aneurysms: a 13 year review from a single centre. Eur J Vasc Endovasc Surg 1997;13(3):322-327.
144. Schepens MAAM, Vermeulen FEE, Morshuis WJ et al. Impact of left heart bypass on the results of thoracoabdominal aortic aneurysm repair. Ann Thorac Surg 1999;67:1983-87.
156. Svensson LG. Management of Segmental Intercostal and Lumbar Arteries During Descending and Thoracoabdominal Aneurysm Repairs. Sem Thorac Cardiovasc Surg 1998;10(1):45-49.
147. Sutera SP, Mehrjard MH. Deformation and fragmentation of human red blood cells in turbulent shear flow. Biophys J 1975;15:1-10.
161. Wait RB, White G, Davis JH. Beneficial effects of verapamil on postischemic renal failure. Surgery 1983;94:276-282.
164. Wisselink W, Becker MO, Nguyen JH. Protecting the ischemic spinal cord during aortic clamping: The influence of selective hypothermia and spinal cord perfusion pressure. J Vasc Surg 1994;19:788-795.
154. Svensson LG, Grum DF, Bednarki M. Appraisal of crebrospinal fluid alterations during aortic surgery with intrathecal papaverine administration and cerobrospinal fluid drainage. J Vasc Surg 1990;11:423-429.
4. Huynh TTT, Miller CC, Estrera AL et al. Determinants of hospital length of stay after thoracoabdominal aortic aneurysm repair. J Vasc Surg 2002;35:648-53.
17. Ferreira M, Ferreira D, Cunha R, Bicalho G, Rodrigues R. Advanced Technical Considerations for Implanting the t-Branch Off-the-Shelf Multibranched Stent-Graft to Treat Thoracoabdominal Aneurysms. J Endovascular Therapy 2018 Jun;25(4):450-5.
20. Sfyroeras GS, Dalainas I, Giannakopoulos TG et al. Flow-diverting stents for the treatment of arterial aneurysms. J Vasc Surg 2012 Sept.;56(3):839-46.
9. Fulton JJ, Farber MA, Marston WA et al. Endovascular stent-graft repair of pararenal and type IV thoracoabdominal aortic aneurysms with adjunctive visceral reconstruction. J Vasc Surg 2005;41:191-98.
3. Crawford ES, Crawford JL, Safi HJ et al. Thoracoabdominal aortic aneurysms: preoperative and intraoperative factors determining immediate and long-term results of operations in 605 patients. J Vasc Surg 1986;3:389-404.
19. Fiorucci B, Kölbel T, Rohlffs F et al. Right brachial access is safe for branched endovascular aneurysm repair in complex aortic disease. J Vasc Surg 2017;66:360-66.
ANEURISMA –
14. Reidy JF, Rowe PH, Ellis FG. Technical report: splenic artery aneurysm embolization. The preferred technique to surgery. Clin Radiol 1990;41:281-82.
31. Kasirajan K. Branched grafts for thoracoabdominal aneurysms: offlabel use of FDA-approved devices. J Endovasc Ther 2011;18:471-76. 32. Park JH, Chung JW, Choo IW et al. Fenestrated stentgrafts for preserving visceral arterial branches in the treatment of abdominal aortic aneurysms: preliminary experience. J Vasc lntervent Radiol 1996;7:819-23. 33. Criado FJ. Mapping the aorta: a new look at vascular anatomy in the era of endograft repair. J Endovasc Ther 2010;17:68. 34. Beck AW, Bos WTGJ, Vourliotakis G et al. Fenestrated and branched endograft repair of juxtarenal aneurysms after previous open aortic reconstruction. J Vasc Surg 2009;49:1387-94.
16. Chuter TAM, Reilly LM, Park KH, Hiramoto JS, Sweet MP. A Standardized Multi-Branched Thoracoabdominal Stent-Graft for Endovascular Aneurysm Repair. J Endovasc Ther 2009;16:359-64.
1. Crawford ES. Thoraco-abdominal and abdominal aortic aneurysms involving renal, superior mesenteric, celiac arteries. Ann Surg 1974;179:763. 2. Svensson LG, Crawford ES, Hess KR et al. Experience with 1509 patients undergoing thoracoabdominal aortic operations. J Vasc Surg 1993;17:357-70.
12. Sunder-Plassmann L, Orend KH. Stent grafting of the thoracic aortacomplications J Cardiovascr Surg 2005;46:121.
25. Sweet MP, Hiramoto JS, Park KH et al. A standardized multi-branched thoracoabdominal sent-graft for endovascular aneurysm repair. J Endovasc Ther 2009 June;16(3):359-64. 26. Chuter T, Greenberg RK. Standardized off-the-shelf components for multibranched endovascular repair of thoracoabdominal aortic aneurysms.
8. Ferreira M, Lanziotti L, Cunha R. Best surgical option for thoracoabdominal aneurysm repair-the endovascular approach. Ann Cardiothoracic 2012;1(3):345-49.
15. Nincheri Kunz M, Pantalone D, Borri A et al. Management of true splenic artery aneurysms. Two case reports and review of the literature. Minerva Chir 2003;58:247-56.
22. Jabr AB, Sonesson B, Lindblad B et al. Chimney grafts preserve visceral flow and allow safe stenting of juxtarenal aortic occlusion. J Vascular Surg 2013 Feb.;57(2):399-405.
DA AORTA TORACOABDOMINAL
143 76Capítulo
10. Kotsis T, Scharrer-Pamler R, Kapfer X et al. Treatment of thoracoabdominal aortic aneurysms with a combined endovascular and surgical approach. J lnt Angiol 2003;22:125.
7. Ferreira M, Lanziotti L, Monteiro M. Branched devices for thoracoabdominal aneurysm repair; early experience. J Vasc Surg 2008;48:30S-36S.
11. Rimmer J, Wolfe JH. Type Ill thoracoabdominal aortic aneurysm repair: a combined surgical and endovascular approach. Eur J Vasc Endovasc Surgery 2003;26:677.
23. Nordon IM, Hinchliffe RJ, Manning B et al. Toward an “off-the-shelf” fenestrated endograft for management of short-necked abdominal aortic aneurysms: an analysis of current graft morphological diversity. J Endovasc Ther 2010;17:78-85. 24. Park KH, Hiramoto JS, Reilly LM et al. Variation in the shape and length of the branches of a thoracoabdominal aortic stent graft; implications for the role of standard off-the-shelf components. J Vasc Surg 2010;51:572-76.
J Endovasc Ther 2005 Oct.;12(5)1574-8.
35. Hnath JC, Mehta M, Taggert JB, Sternbach Y, Roddy SP, Kreienberg PB et al. Strategies to improve spinal cord ischemia in endovascular thoracic aortic repair: Outcomes of a prospective cerebrospinal fluid drainage protocol. J Vasc Surg 2008;48:836-40. 36. Mangialardi N, Lachat M, Esposito A, Puippe G, Orrico M, Alberti V et al. The “Open Branch” Technique: A New Way to Prevent Paraplegia After Total Endovascular Repair of Thoracoabdominal Aneurysm. Catheter Cardiovasc Interv 2016 Mar;87(4):773-80.
13. Greenberg RK, O’neill S, Walker E et al. Endovascular repair of thoracic aortic lesions with the Zenith TX1 and TX2 thoracic grafts: intermediate-term results. ACC Current J Rev 2005;14:63.
Perspect Vasc Surg Endovasc Ther 2011;23:195-201. 27. Kolvenbach RR, Yoshida R, Pinter L et al. Urgent endovascular treatment of thoraco-abdominal aneurysms using a sandwich technique and chimney grafts-a technical description. Eur J Vasc Endovasc Surg 2011;41:54-60. 28. Wolford HY, Surowiec SM, Hsu JH et al. Stacked proximal aortic cuffs: an “off-the-shelf” solution for treating focal thoracic aortic pathology.
5. Chuter TA, Gordon RL, Reilly LM et al. Multi-branched stent-graft for type Ill thoracoabdominal aortic aneurysm. JVIR 2001;12:391.
6. Ferreira M, Lanziotti L, Cunha R. Endovascular repair of thoracoabdominal aneurysms: results of the first 48 cases. Ann Cardiothoracic 2012;1(3):304-10.
21. Lazaris AM, Maheras AN, Vasdekis SN. A multilayer sent in the aorta may not seal the aneurysm, thereby leading to rupture. J Vasc Surg 2012 Sept.;56(3):829-31.
29. Stanley BM, Semmens JB, Lawrence-Brown MMD et al. Fenestration in endovascular grafts for aortic aneurysm repair: new horizons for preserving blood flow in branch vessels. J Endovasc Ther 2001 Feb.;8(1):16-24. 30. Manning BJ, Hinchliffe RJ, lvancev K et al. Ready-to-fenestrate sent grafts in the treatment of juxtarenal aortic aneurysms: proposal for an off-the-shelf device. Eur J Vasc Endovasc Surg 2010;39:431-35.
18. Ferreira M, Katsargyris A, Rodrigues E, Ferreira D, Cunha R, Bicalho G et al. “Snare-ride”: a bailout technique to catheterize target vessels with unfriendly anatomy in branched endovascular aortic repair. J Endovasc Ther 2017;24:556-58.
37. Adolph E, Holdt-Lehmann B, Chatterjee T, Paschka S, Prott A, Schneider H et al. Renal Insufficiency Following radiocontrast exposure trial (REINFORCE): A randomized comparison of sodium bicarbonate versus sodium chloride hydration for the prevention of contrast-induced nephropathy. Coron Artery Dis 2008;19:413-9. 38. Lewington A, MacTier R, Hoefield R, Sutton A, Smith D, Downes M. On Behalf of the Renal Association, British Cardiovascular Intervention Society and the Royal College of Radiologists. Prevention of Contrast Induced Acute Kidney Injury (CI-AKI) in Adult Patients.
TRATAMENTO ENDOVASCULAR REFERÊNCIAS BIBLIOGRÁFICAS
39. Ozcan EE, Guneri S, Akdeniz B, Akyildiz IZ, Senaslan O, Baris N et al Sodium bicarbonate, N-acetylcysteine, and saline for prevention of radiocontrast-induced nephropathy. A comparison of 3 regimens for protecting contrast-induced nephropathy in patients undergoing coronary procedures. A single-center prospective controlled trial. Am Heart J 2007;154:539-44.
47. Bosiers MJ, Bisdas T, Donas KP, Torsello G, Austermann M. Early experience with the first commercially available off-theshelf multibranched endograft (t-branch) in the treatment of thoracoabdominal aortic aneurysms. J Endovasc Ther 2013 Dec;20(6):719-25. 48. de Niet A, Post RB, Reijnen MMPJ, Zeebregts CJ, Tielliu IFJ. Geometric changes over time in bridging stents after branched and fenestrated endovascular repair for thoracoabdominal aneurysm. J Vasc Surg 2019 Mar;2:S0741-5214(19)30161-2.
Parte V144 TORACOABDOMINAL
41. Lee SR, Jeong MH, Rhew JY et al. Simultaneous coronary subclavian and vertebral-subclavian steal syndrome. Circulation J 2003;67:464-66.
43. Ferreira M, Monteiro M, Lanziotti L et al. Deliberate subclavian artery occlusion during aortic endovascular repair: is it really that safe? Eur J Vasc Endovasc Surg 2007;33:664-67.
40. Fisher CM. A new vascular syndrome “the Subclavian steal”. N Engl J Med 1961;265:912-13.
45. Görich J, Asquan Y, Seifarth H et al. initial experience with intentional stent-graft coverage of the subclavian artery during endovascular thoracic aortic repairs. J Endovasc Ther 2002;9:39-42.
46. Verhoeven ELG, Katsargyris A, Bekkema F, Oikonomou K, Zeebregts CJAM, Ritter W et al. Ten-year Experience with Endovascular Repair ofThoracoabdominal Aortic Aneurysms: Results from 166 Consecutive Patients. Eur J Vasc Endovasc Surg 2015;49:524-53.
49. Walker J, Kaushik S, Hoffman M, Gasper W, Hiramoto J, Reilly L, Chuter T. Long-term durability of multibranched endovascular repair of thoracoabdominal and pararenal aortic aneurysms. J Vasc Surg 2019 Feb;69(2):341-347.
42. Bergeron P, Coulon P, De Chaumaray T et al. Great vessels transposition and aortic arch exclusion. J Cardiovasc Surg (Torino) 2005;46:141-47.
44. Cinà CS, Safar HA, Laganà A et al. Subclavian carotid transposition and bypass grafting: consecutive cohort study and systematic review. J Vasc Surg 2002;35:422-29.
6. Dryjski M, Driscoll RC, Blair MA et al. The small abdominal aortic aneurysm: the eternal dilemma. J Cardiovasc Surg 1994;35:95-100.
8. Geroulakos G, Nicolaides A. Infrarenal abdominal aortic aneurysms less than five centimeters in diameter: the surgeon’s dilemma. Eur J Vasc Surg 1992;6:622-661. 9. Choksy SA, Wilmink AB, Quick CR. Ruptured abdominal aortic aneurysm in the Huntingdon district: a 10-year experience. Ann Royal Coll Surg Engl 1999;81:27-31 10. Hall AJ, Busse EFG, McCarville DJ, Burgess JJ. Aortic wall tension as a predictive factor for abdominal aortic aneurysm rupture: improving the selection of patients for abdominal aortic aneurysm repair. Ann Vasc Surg 2000;14:152-157.
15. Doyle BJ, Hoskins PR, McGloughlin TM. Computational rupture prediction of AAAs: what needs to be done next? J Endovasc Ther 2011;18:226-229.
4. Brewster DC. Presidential address: what would you do if it were your father? Reflections on endovascular abdominal aortic aneurysm repair. J Vasc Surg 2001;33:1139-1147.
16. Raghavan ML, Vorp DA, Federle MP et al. Wall stress distribution on three-dimensionally reconstructed models of human abdominal aortic aneurysm. J Vasc Surg 2000;31:760-769.
145 77CapítuloANEURISMAS DA AORTA TORACOABDOMINAL –TRATAMENTO POR STENT DIRECIONADOR DE FLUXO REFERÊNCIAS BIBLIOGRÁFICAS
17. Truijers M, Pol JA, SchultzeKool LJ et al. Wall stress analysis in small asymptomatic, symptomatic and ruptured abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 2007;33:401-407.
28. Ku DN, Giddens DP, Zarins CK et al. Pulsatile flow and atherosclerosis in the human carotid bifurcation: positive correlation between plaque location and low oscillating shear stress. Arteriosclerosis 1985;5:293-302. 29. Chen XL, Varner SE, Rao AS et al. Laminar shear stress induction of antioxidant response element-mediated genes in endothelial cells: a novel anti-inflammatory mechanism. J Biol Chem 2003;278:703-711. 30. White JV, Haas K, Phillips S et al. Adventitial elastolysis is a primary event in aneurysm formation. J Vasc Surg 1993;17:371-380. 31. Shang EK, Nathan DP, Woo EY et al. Local wall thickness in finite element models improves prediction of abdominal aortic aneurysm growth. J Vasc Surg 2015;61:217-23. 32. Raghavan ML et al. Failure properties of ruptured and unruptured abdominal aortic aneurysms. In: Proceedings of Summer Bioengineering Conference (SBC2009-204060).
11. Fillinger MF, Raghavan ML, Marra SP et al. In vivo analysis of mechanical wall stress and abdominal aortic aneurysm rupture risk. J Vasc Surg 2002;36:589-597.
14. Gasser TC, Nchimi A, Swedenborg J et al. A novel strategy to translate the biomechanical rupture risk of abdominal aortic aneurysms to their equivalent diameter risk: method and retrospective validation. Eur J Vasc Endovasc Surg 2014;47:288-295.
13. Chandra S, Raut SS, Jana A et al. Fluidstructure interaction modeling of abdominal aortic aneurysms: the impact of patient-specific inflow conditions and fluid/solid coupling. J Biomech Eng 2013;135:81001.
19. Campa JS, Greenhalgh RM, Powel JT. Elastin degradation in abdominal aortic aneurysms. Atherosclerosis 1987;65:13-21.
22. Rizzo RJ, McCarthy WJ, Dixit SN et al. Collagen types and matrix protein content in human abdominal aortic aneurysms. J Vasc Surg 1989;10:365-373. 23. Ruddy JM, Jones JA, Spinale FG et al. Regional heterogeneity within the aorta: relevance to aneurysm disease. J Thorac Cardiovasc Surg 2008;136:1123-1130. 24. Sakalihasan N, Heyeres A, Nusgens BV et al. Modifications of the extracellular matrix of aneurysmal abdominal aortas as a function of their size. Eur J Vasc Surg 1993;7:633-637. 25. Sakalihasan N, Delvenne P, Nusgens BV et al. Activated forms of MMP2 and MMP9 in abdominal aortic aneurysms. J Vasc Surg 1996;24:127-133. 26. Reeps C, Essler M, Pelisek J et al. Increased 18F-fluorodeoxyglucose uptake in abdominal aortic aneurysms in positron emission/ computed tomography is associated with inflammation, aortic wall instability, and acute symptoms. J Vasc Surg 2008;48:417-423. 27. Gasser TC, Auer M, Labruto F et al. Biomechanical rupture risk assessment of abdominal aortic aneurysms: model complexity versus predictability of finite element simulations. Eur J Vasc Endovasc Surg 2010;40:176-185.
33. Pane B, Spinella G, Perfumo MC et al. Italian experience with the Multilayer Flow Modulator for treatment of complex aortic disease. In: Palombo D (Ed.). The current role of Multilayer Flow Modulator Stents in complex aortic pathology. Torino: Minerva Med; 2017. p. 45-57. 34. Sultan S, Hynes N, Kavanagh EP et al. How does the Multilayer Flow Modulator work? The science behind the technical innovation J Endovasc Ther 2014;21:814-821. 35. Vorp DA, Raghavan ML, Muluk SC et al. Wall strength and stiffness of aneurysmal and nonaneurysmal abdominal aorta. Ann N Y Acad Sci 1996;800:274-27. 36. Vallabhaneni SR, Gilling-Smith GL, How TV et al. Heterogeneity of tensile strength and matrix metalloproteinase activity in the wall of abdominal aortic aneurysms. J Endovasc Ther 2004;11:494-502. 37. Vorp DA, Raghavan ML, Webster MW. Mechanical wall stress in abdominal aortic aneurysm: influence of diameter and asymmetry. J Vasc Surg 1998;27:632-639. 38. Sultan S, Hynes N, Tawfick W. Disruptive endovascular technology with multilayer flow modulator stents (MFM) as a therapeutic option in the management of thoracoabdominal aortic aneurysms: early results from the global independent MFM registry. Ital J Vasc Endovasc Surg 2012;19:215-228. 39. Sultan S, Sultan M, Hynes N. Early mid-term results of the first 103 cases of multilayer flow modulator stent done under indication for use in the management of thoracoabdominal aortic pathology from the independent global MFM registry. J Cardiovasc Surg (Torino) 2014;55:21-32.
18. Venkatasubramanian AK, Fagan MJ, Mehta T et al. A comparative study of aortic wall stress using finite element analysis for ruptured and non-ruptured abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 2004;28:168-176.
21. Reilly JM. Plasminogen activors in abdominal aortic aneurysmal disease. Ann N Y Acad Sci 1996;800:151-156.
1. Ouriel K, Green RM, Donayre C et al. An evaluation of new methods of expressing aortic aneurysm size: relationship to rupture. J Vasc Surg 1992;15:12-20.
7. Darling RC, Messina CR, Brewster DC, Ottinger LW. Autopsy study of unoperated abdominal aortic aneurysms. Circulation 1977;56:161-164.
3. Moore, WS, Rutherford, RB. Transfemoral endovascular repair of abdominal aortic aneurysm: results of the North American EVT Phase I Trial. J Vasc Surg 1996; 23:543-553.
2. Bengtsson H, Sonesson B, Bergqvist D. Incidence and prevalence of abdominal aortic aneurysms, estimated by necropsy studies and population screening by ultrasound. In: Proceedings. Volume 800 of the Annals of the New York Academy of Sciences, United States.
20. Menashi S, Campa JS, Greenhalgh RM et al. Collagen in abdominal aortic aneurysm: typing, content and degradation. J Vasc Surg 1987;6:578-582.
5. Hallin A, Bergqvist D, Holmberg L. Literature review of surgical management of abdominal aortic aneurysm. Eur J Vasc Endovasc Surg 2001;22:197-204.
12. Fillinger MF, Marra SP, Raghavan ML, Kennedy FE. Prediction of rupture risk in abdominal aortic aneurysm during observation: wall stress versus diameter. J Vasc Surg 2003;37:724-732.
52. Augsburger L1, Reymond P, Fonck E et al. Methodologies to assess blood flow in cerebral aneurysms: current state of research and perspectives. J Neuroradiol 2009;36:270-7.
58. Coselli JS, Bozinovski J, LeMaire SA. Open surgical repair of 2286 thoracoabdominal aortic aneurysms. Ann Thorac Surg 2007;83:S862-864.
40. Sultan S, Hynes N, Sultan M, on behalf of the MFM Collaborators. When not to implant the Multilayer Flow Modulator: lessons learned from applications outside the indications for use in patients with thoracoabdominal pathologies. J REndovas c Ther 2014;21:96-112.
50.
Parte V146 TORACOABDOMINAL
43. Inzoli F, Boschetti F, Zappa M et al. Biomechanical factors in abdominal aortic aneurysm rupture. Eur J Vasc Surg 1993;7,667-674.
46.
53. Rigberg DA, McGory ML, Zingmond DS et al. Thirty-day mortality statistics understimate the risk of repair of thoracoabdominal aortic aneurysms: a statewide experience. J Vasc Surg 2006;43:217-222.
48.
41. Wang DHJ, Makaroun MS, Webster MW, Vorp DA. Effect of intraluminal thrombus on wall stress in patient-specific models of abdominal aortic aneurysm. J Vasc Surg 2002;36:598-604.
44. Coen M, Gabbiani G, Bochaton-Piallat ML. Myofibroblast-mediated adventitial remodeling: an underestimated player in arterial pathology. Arterioscler Thromb Vasc Biol 2011;31:2391-2396.
55. Schepens MA, Heijmen RH, Ranschaert W et al. Thoracoabdominal aortic repair: results of conventional open surgery. Eur J Vasc Endovasc Surg 2009;37:640-645.
56. Patel VI, Lancaster RT, Conrad MF et al. Open surgical repair of thoracoabdominal aneurysms – the Massachusetts General Hospital experience. Ann Cardiothorac Surg 2012;1:320-324.
54. Conrad MF, Crawford RS, Davison JK et al. Thoracoabdominal aneurysm repair: a 20-year perspective. Ann Thorac Surg 2007;83:S856-S861.
42. Vorp DA, Mandarino WA, Webster MW, Gorcsan 3rd J. Potential influence of intraluminal thrombus on abdominal aortic aneurysm as assessed by a new non-invasive method. Cardiovasc Surg 1996;4:732-739.
49.
59. Armstrong N, Burgers L, Deshpande S et al. The use of fenestrated and branched endovascular aneurysm repair for juxtarenal and thoracoabdominal aneurysms: a systematic review and costeffectiveness analysis. Health Technol Assess 2014;18:1-66.
60. Ferreira M, Lanziotti L Cunha R, d’Utra G. Endovascular repair of thoracoabdominal aneurysms: results of the first 48 cases. Ann Cardiothorac Surg 2012;1:304-10.
47.
45. Lazaris AM, Maheras AN, Vasdekis SN. A multilayer stent in the aorta may not seal the aneurysm, thereby leading to rupture. J Vasc Surg 2012;56:829-831. Kolvenbach RR. Contemporary strategies for repair of complex thorcoabdominl aortic aneurysms: real-world experiences. In: Palombo D (Ed.). The current role of Multilayer Flow Modulator Stents in complex aortic pathology. Torino: Minerva Med; 2017. p. 17-30. Vaislic CD, Fabiani JN, Chocron S et al. Three-year outcomes with the Multilayer Flow Modulator repair of trhoracoabdomnal aneurysms: a follow up report from the STRATO Trial. J Endovasc Ther 2016;23:762-72. Collin J, Murie JA. Endovascular treatment of abdominal aortic aneurysm: a failed experiment. Br J Surg 2001;88:1281-1282. Paravastu SC, Jayarajasingam R, Cottam R et al. Endovascular repair of abdominal aortic aneurysm. Cochrane Database Syst Rev 2014;1:CD004178. NICE. campaign+shareaholic&utm_fecebook&utm_source+socialnetworknovember-2018-vascularpexperts-offer-theyr-opinions/?utn.criminalizes-evar-in-aaa-guidelines-study-to-be-published-https://infomeddnews.com/2018/06/nice-uk-documentKulcsár Z1, Augsburger L, Reymond P et al. Flow diversion treatment: intra-aneurismal blood flow velocity and WSS reduction are parameters to predict aneurysm thrombosis. Acta Neurochir (Wien) 2012;154:1827-34.
61. de Groot IB, Ligtenberg G, Vijgen S. Endovasculaire Behandeling van Complexe Aneurysmata van de Aorta August 10, 2012.
51.
57. Safi HJ, Estrera AL, Azizzadeh A et al. Progress and future challenges in thoracoabdominal aortic aneurysm management. World J Surg 2008;32:355-360.
de+aorta.Endovasculaire+behandeling+van+complexe+aneurysmata+van+endovasculairebehandeling-van-complexe-aneurysmata-van-dedocumenten/publicaties/rapporten-en-standpunten/2012/1208-zorginstituutnederland.nl/binaries/content/documents/zinl-www/https:www/aorta/pdf.AccessedFebruary23,2016.
62. Raux M, Patel VI, Cochennec F et al. A propensity-matched comparison of outcomes for fenestrated endovascular aneurysm repair and open surgical repair of complex abdominal aortic aneurysms. J Vasc Surg 2014;60:858-863 63. Hynes N, Sultan S, Elhelali A et al. Systematic review and patient-level meta-analysis of the streamliner multilayer flow modulator in the management of complex thoracoabdominal aortic pathology. J Endovasc Ther 2016;23(3):501-512 64. Ristow Av, Vescovi A, Abreu RC. Treatment of paravisceral and thoracoabdominal aneurysms in high-risk patients over 80 years of age. In: Palombo D (Ed.). The current role of Multilayer Flow Modulator Stents in complex aortic pathology. Torino: Minerva Med; 2017. p. 69-78. 65. Cavalcante RN, Nishinari K, Yazbek G et al. Severe visceral ischemia and death after multilayer stent deployment for treatment of a thoracoabdominal aortic aneurysm. J Vasc Surg 2015;62:1632-5. 66. Crawford ES, DeNatale R. Thoracoabdominal aortic aneurysm: Observations regarding the natural course of the disease. J Vasc Surg 1986;3:578-82. 67. Hansen PA, Richards JMJ, Tambyraja AL et al. Natural history of thoraco-abdominal aneurysm in high-risk patients. Eur J Vasc Endovasc Surg 2010;39:266-70. 68. Costache V, Boicean A, Costache A et al. Treatment of complex aortic aneurysms and dissections with the Multilayer Flow Modulator. In: Palombo D (Ed.). The current role of Multilayer Flow Modulator Stents in complex aortic pathology. Torino: Minerva Med; 2017. p. 58-68. 69. Ushida N. Open stent grafting for complex diseases of the thoracic aorta: clinical utility. Gen Thorac Cardiovasc Surg 2013;61:118-26.
16. Donas KP, Torsello G, Bisdas T et al. Early outcomes for fenestrated and chimney endografts in the treatment of pararenal aortic pathologies are not significantly different: a systematic review with pooled data analysis. J Endovasc Ther 2012;19:723-8.
23. Lee JT, Lee GK, Chandra V, Dalman RL. Comparison of fenestrated endografts and the snorkel/chimney technique. J Vasc Surg 2014 Oct;60(4):849-56; discussion 856-7.
20. Konstantinos P, Donas JT, Lachat LM et al. Veith on behalf of the PERICLES investigators Collected World Experience About the Performance of the Snorkel/Chimney Endovascular Technique in the Treatment of Complex Aortic Pathologies. The PERICLES Registry Ann Surg 2015;262:546-553.
147 78Capítulo
10. Coscas R, Kobeiter H, Desgranges P, Becquemin JP. Technical aspects, current indications, and results of chimney graft for juxtarenal aortic aneurysms. J Vasc Surg 2011;53:1520-6.
15. Donas KP, Pecoraro F, Torsello G et al. Use of covered chimney stents for pararenal aortic pathologies is safe and feasible with excellent patency and low incidence of endoleaks. J Vasc Surg 2012;55:659-65.
9. Criado FJ. Parallel grafts in perspective: Definitions and a new classification. Vasc Dis Manag 2013;10:1.
17. Pecoraro F, Pfammatter T, Mayer D et al. Multiple periscope and chimney grafts to treat ruptured thoracoabdominal and pararenal aortic aneurysms. J Endovasc Ther 2011;18:642-9.
21. Konstantinos PD, Torsello GB, Piccoli G et al. The PROTAGORAS study to evaluate the performance of the Endurant stent graft for patients with pararenal pathologic processes treated by the chimney/snorkel endovascular technique. J Vasc Surg 2016;63:1-7.
2. Criado FJ. A percutaneous technique for preservation of arch branch patency during thoracic endovascular aortic repair (TEVAR): retrograde catheterization and stenting. J Endovasc Ther 2007;14(1):54-58.
8. Kasirajan K. Branched grafts for thoracoabdominal aneurysms: off-label use of FDA-approved devices. J Endovasc Ther 2011;18(4):471-476.
3. Larzon T, Gruber G, Friberg O et al. Experiences of intentional carotid stenting in endovascular repair of aortic arch aneurysms–two case reports. Eur J Vasc Endovasc Surgery 2005;30(2):147-151.
11. Allaqaband S, Jan MF, Bajwa T. “The chimney graft”da simple technique for endovascular repair of complex juxtarenal abdominal aortic aneurysms in no-option patients. Catheter Cardiovasc Interv 2010;75:1111-5.
12. DonasKP, PecoraroF, BisdasT et al. CT angiography at 24 months demonstrates durability of EVAR with the use of chimney grafts for pararenal aortic pathologies. J Endovasc Ther 2013;20:1-6.
22. Pecoraro F, Veith FJ, Puippe G et al. Mid- and Longer-term Follow up of Chimney and/or Periscope Grafts and Risk Factors for Failure. Eur J Vasc Endovasc Surg 2016 May;51(5):664-73.
COMPLEXOS – TÉCNICA CHAMINÉ E SANDUÍCHE REFERÊNCIAS
ANEURISMAS BIBLIOGRÁFICAS
6. Lobato AC. Sandwich technique for aortoiliac aneurysms extending to the internal iliac artery or isolated common/internal iliac artery aneurysms: a new endovascular approach to preserve pelvic circulation. J Endovasc Ther 2011;18(1):106-111.
7. Lobato AC, Camacho-Lobato L. Endovascular treatment of complex aortic aneurysms using the sandwich technique. J Endovasc Ther 2012;19(6):691-706.
14. Lee JT, Greenberg JI, Dalman RL. Early experience with the snorkel technique for juxtarena aneurysms. J Vasc Surg 2012;55:935-46.
5. Lachat M, Frauenfelder T, Mayer D et al. Complete endovascular renal and visceral artery revascularization and exclusion of a ruptured type IV thoracoabdominal aortic aneurysm. J Endovasc Ther 2010;17(2):216-220.
1. Greenberg RK, Clair D, Srivastava S et al. Should patients with challenging anatomy be offered endovascular aneurysm repair? J Vasc Surg 2003;38(5):990-996.
4. Criado FJ. Chimney grafts and bare stents: aortic branch preservation revisited. J Endovasc Ther 2007;14(6):823-824.
19. Scali S, Feezor RJ, Chang CK et al. Critical analysis of results after chimney endovascular aortic aneurysm repair raises cause for concern. J Vasc Surg 2014;2:1-10.
18. Schiro A, Antoniou GA, Ormesher D et al. The chimney technique in endovascular aortic aneurysm repair: late ruptures after successful single renal chimney stent grafts. Ann Vasc Surg 2013;27:835-43.
13. Lachat M, Veith FJ, Pecoraro F et al. Chimney and periscope grafts observed over 2 years after their use to revascularize 169 renovisceral branches in 77 patients with complex aortic aneurysms. J Endovasc Ther 2013;20:597-605.
24. Ullery BW, Tran K, Itoga NK et al. Natural history of gutter-related type Ia endoleaks after snorkel/chimney endovascular aneurysm repair. J Vasc Surg 2017 Apr;65(4):981-990. 25. Ronchey S, Fazzini S, Scali S et al. Collected Transatlantic Experience From the PERICLES Registry: Use of Chimney Grafts to Treat PostEVAR Type Ia Endoleaks Shows Good Midterm Results. J Endovasc Ther 2018 Aug;25(4):492-498 26. Scali ST, Beck AW, Torsello G et al. Identification of optimal device combinations for the chimney endovascular aneurysm repair technique within the PERICLES registry. J Vasc Surg 2018 Jul;68(1):24-35. 27. Caradu C, Bérard X, Midy D, Ducasse E. Influence of Anatomic Angulations in Chimney and Fenestrated Endovascular Aneurysm Repair. Ann Vasc Surg 2017 Aug;43:104-114. 28. Lobato AC, Camacho-Lobato L. The sandwich technique to treat complex aortoiliac or isolated iliac aneurysms: results of midterm follow-up. J Vasc Surg 2013 Feb;57 (2 Suppl):26S-34S. 29. Ricci C, Ceccherini C, Cini M et al. Single-center experience and 1-year follow-up results of “sandwich technique” in the management of common iliac artery aneurysms during EVAR. Cardiovasc Intervent Radiol 2012 Oct;35(5):1195-200. 30. DeRubertis BG, Quinones-Baldrich WJ, Greenberg JI et al. Results of a double-barrel technique with commercially available devices for hypogastric preservation during aortoilac endovascular abdominal aortic aneurysm repair. J Vasc Surg 2012 Nov;56(5):1252-9. 31. Massmann A, Mosquera Arochena NJ, Shayesteh-Kheslat R, Buecker A. Endovascular anatomic reconstruction of the iliac bifurcation with covered stentgrafts in sandwich-technique for the treatment of complex aorto-iliac aneurysms. Int J Cardiol 2016 Nov 1;222:332-339.
6. Oderich GS, Tallarita T. Classification Systems Relevant to Complex Endovascular Aortic Repair. Endovascular Aortic Repair: Springer; 2017. p. 73-93.
30. Grabitz K, Sandmann W, Stühmeier K et al. The risk of ischemic spinal cord injury in patients undergoing graft replacement for thoracoabdominal aortic aneurysms. J Vasc Surg 1996;23(2):230-40. 31. Safi HJ, Estrera AL, Miller CC et al. Evolution of risk for neurologic deficit after descending and thoracoabdominal aortic repair. Ann Thorac Surg 2005;80(6):2173-9. 32. Mokri B. The Monro–Kellie hypothesis applications in CSF volume depletion. Neurology 2001;56(12):1746-8. 33. Svensson LG, Crawford ES, Hess KR et al. Experience with 1509 patients undergoing thoracoabdominal aortic operations. J Vasc Surg 1993;17(2):357-70. 34. Rigberg DA, McGory ML, Zingmond DS et al. Thirty-day mortality statistics underestimate the risk of repair of thoracoabdominal aortic aneurysms: a statewide experience. J Vasc Surg 2006;43(2):217-22. 35. Oderich GS, Rosero EB, Ricotta JJ et al. RR28. In-Hospital Mortality of Open Thoracoabdominal Aortic Aneurysm Repair in the United States Prior to Widespread Use of Hybrid and Endovascular Branched Techniques. J Vasc Surg 2009;49(5):S55. 36. Tenorio ER, Oderich GS, Sandri GA et al. Impact of onlay fusion and cone beam computed tomography on radiation exposure and technical assessment of fenestrated-branched endovascular aortic repair. J Vasc Surg 2018. 37. Tenorio ER, Oderich GS, Sandri GA et al. SS01. Prospective Nonrandomized Study to Evaluate Cone Beam Computed Tomography for Technical Assessment of Standard and Complex Endovascular Aortic Repair. J Vasc Surg 2018;67(6):e82. 38. Mendes BC, Oderich GS, Correa MP, Kanamori KS. Endovascular Repair of Complex Aortic Pathology. Curr Surg Rep 2013;1(2):67-77.
12. Bertoglio L, Mascia D, Cambiaghi T et al. Percutaneous axillary artery access for fenestrated and branched thoracoabdominal endovascular repair. J Vasc Surg 2018;68(1):12-23.
148 79Capítulo
ANEURISMAS DE BIBLIOGRÁFICAS
11. Oderich GS, Tallarita T, Kalra M et al. SS23. Contemporary Results of Open Complex Abdominal Aortic Aneurysm Repair Using a Standardized Classification for Comparison with Fenestrated Endografts. J Vasc Surg 2011;53(6 Supplement):27S-8S.
15. Albornoz G, Coady MA, Roberts M et al. Familial thoracic aortic aneurysms and dissections—incidence, modes of inheritance, and phenotypic patterns. Ann Thorac Surg 2006;82(4):1400-5.
17. Scali ST, Beck AW, Torsello G et al. Identification of optimal device combinations for the chimney endovascular aneurysm repair technique within the PERICLES registry. J Vasc Surg 2018.
4. Verhoeven E, Katsargyris A, Oikonomou K et al. Fenestrated endovascular aortic aneurysm repair as a first line treatment option to treat short necked, juxtarenal, and suprarenal aneurysms. Eur J Vasc Endovasc Surg 2016;51(6):775-81.
26. Achneck HE, Rizzo JA, Tranquilli M, Elefteriades JA. Safety of thoracic aortic surgery in the present era. Ann Thorac Surg 2007;84(4):1180-5. 27. Etz CD, Kari FA, Mueller CS et al. The collateral network concept: a reassessment of the anatomy of spinal cord perfusion. J Thorac Cardiovasc Surg 2011;141(4):1020-8. 28. Griepp RB, Griepp EB. Spinal cord perfusion and protection during descending thoracic and thoracoabdominal aortic surgery: the collateral network concept. Ann Thorac Surg 2007;83(2):S865-S9. 29. O’Callaghan A, Mastracci TM, Eagleton MJ. Staged endovascular repair of thoracoabdominal aortic aneurysms limits incidence and severity of spinal cord ischemia. J Vasc Surg 2015;61(2):347-54.e1.
AORTA ABDOMINAL COMPLEXOS REFERÊNCIAS
2. Park JH, Chung JW, Choo IW et al. Fenestrated stent-grafts for preserving visceral arterial branches in the treatment of abdominal aortic aneurysms: preliminary experience. J Vasc Intervent Radiol 1996;7(6):819-23.
5. Johnston KW, Rutherford RB, Tilson MD et al. Suggested standards for reporting on arterial aneurysms. J Vasc Surg 1991;13(3):452-8.
3. Mastracci TM, Eagleton MJ, Kuramochi Y et al. Twelve-year results of fenestrated endografts for juxtarenal and group IV thoracoabdominal aneurysms. J Vasc Surg 2015;61(2):355-64.
1. Nordon I, Hinchliffe R, Holt P et al. Modern treatment of juxtarenal abdominal aortic aneurysms with fenestrated endografting and open repair–a systematic review. Eur J Vasc Endovasc Surg 2009;38(1):35-41.
19. Oderich GS, Farber MA, Silveira PG et al. Technical aspects and 30day outcomes of the prospective early feasibility study of the GORE
18. Oderich GS, Greenberg RK, Farber M et al. Results of the United States multicenter prospective study evaluating the Zenith fenestrated endovascular graft for treatment of juxtarenal abdominal aortic aneurysms. J Vasc surgery 2014;60(6):1420-8. e5.
13. Tenorio ER, Mirza AK, Kärkkäinen JM, Oderich G. Lessons learned and learning curve of fenestrated and branched endografts. J Cardiovasc Surg 2019;60(1):23-34.
EXCLUDER Thoracoabdominal Branched Endoprosthesis (TAMBE) to treat pararenal and extent IV thoracoabdominal aortic aneurysms. J Vasc Surg 2019.
16. Quiñones-Baldrich WJ, Panetta TF, Vescera CL, Kashyap VS. Repair of type IV thoracoabdominal aneurysm with a combined endovascular and surgical approach. J Vasc Surg 1999;30(3):555-60.
14. Ribeiro M, Macedo T, Vrtiska T, Oderich G. Planning endovascular aortic repair with standard and fenestrated-branched endografts. J Cardiovasc Surg 2017;58(2):204-17.
20. Mirza AK, Tenorio ER, Kärkkäinen JM et al. Technical video of endovascular repair of chronic postdissection thoracoabdominal aortic aneurysm using a five-vessel preloaded fenestrated-branched stent graft. J Vasc Surg 2019;69(1):296-302. e1.
9. Wanhainen A, Verzini F, Van Herzeele I et al. European society for vascular surgery (ESVS) 2019 clinical practice guidelines on the management of abdominal aorto-iliac artery aneurysms. Eur J Vasc Endovasc Surg 2018. 10. West CA, Noel AA, Bower TC et al. Factors affecting outcomes of open surgical repair of pararenal aortic aneurysms: a 10-year experience. J Vasc Surg 2006;43(5):921-8. e1.
21. Dijkstra ML, Eagleton MJ, Greenberg RK et al. Intraoperative C-arm cone-beam computed tomography in fenestrated/branched aortic endografting. J Vasc Surg 2011;53(3):583-90. 22. Kobeiter H, Nahum J, Becquemin J-P. Zero-contrast thoracic endovascular aortic repair using image fusion. Circulation 2011;124(11):e280-e2. 23. Sarac TP, Clair DG, Hertzer NR et al. Contemporary results of juxtarenal aneurysm repair. J Vasc Surg 2002;36(6):1104-11. 24. Gupta PK, Mactaggart JN, Natarajan B et al. Predictive factors for mortality after open repair of paravisceral abdominal aortic aneurysm. J Vasc Surg 2012;55(3):666-73. 25. Tenorio ER, Eagleton MJ, Kärkkäinen JM, Oderich G. Prevention of spinal cord injury during endovascular thoracoabdominal repair. J Cardiovasc Surg 2019;60(1):54-65.
7. Chaikof EL, Dalman RL, Eskandari MK et al. The Society for Vascular Surgery practice guidelines on the care of patients with an abdominal aortic aneurysm. J Vasc Surg 2018;67(1):2-77. e2. 8. Riambau V, Böckler D, Brunkwall J et al. Editor’s choice–management of descending thoracic aorta diseases: clinical practice guidelines of the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg 2017;53(1):4-52.
55. Ambler G, Boyle J, Cousins C et al. Early results of fenestrated endovascular repair of juxtarenal aortic aneurysms in the United Kingdom. Circulation 2012;125(22):2707-15.
50. Georgiadis GS, van Herwaarden JA, Antoniou GA et al. Fenestrated stent grafts for the treatment of complex aortic aneurysm disease: A mature treatment paradigm. Vasc Med 2016;21(3):223-38.
58. Kristmundsson T, Sonesson B, Dias N et al. Outcomes of fenestrated endovascular repair of juxtarenal aortic aneurysm. J Vasc Surg 2014;59(1):115-20.
46. Katsargyris A, Oikonomou K, Klonaris C et al. Comparison of outcomes with open, fenestrated, and chimney graft repair of juxtarenal aneurysms: are we ready for a paradigm shift? J Endovasc Ther 2013;20(2):159-69.
41. Dowdall JF, Greenberg RK, West K et al. Separation of components in fenestrated and branched endovascular grafting--branch protection or a potentially new mode of failure? Eur J Vasc Endovasc Surg 2008;36(1):2-9. Epub 2008 Apr 25.
56. Katsargyris A, Oikonomou K, Kouvelos G et al. Comparison of outcomes for double fenestrated endovascular aneurysm repair versus triple or quadruple fenestrated endovascular aneurysm repair in the treatment of complex abdominal aortic aneurysms. J Vasc Surg 2017;66(1):29-36.
61. Amiot S, Haulon S, Becquemin JP et al. Fenestrated endovascular grafting: the French multicentre experience. Eur J Vasc Endovasc Surg 2010;39(5):537-44.
59. Grimme FA, Zeebregts CJ, Verhoeven EL et al. Visceral stent patency in fenestrated stent grafting for abdominal aortic aneurysm repair. J Vasc Surg 2014;59(2):298-306. 60. Ziegler P, Avgerinos ED, Umscheid T et al. Fenestrated endografting for aortic aneurysm repair: a 7-year experience. J Endovasc Ther 2007;14(5):609-18.
62. Sveinsson M, Sobocinski J, Resch T et al. Early versus late experience in fenestrated endovascular repair for abdominal aortic aneurysm. J Vasc Surg 2015;61(4):895-901.
67. Greenhalgh R, Campus CC. Endovascular aneurysm repair versus open repair in patients with abdominal aortic aneurysm (EVAR trial 1): randomised controlled trial. Surgery 2005;5:6.
70. van Schaik TG, Yeung KK, Verhagen HJ et al. Long-term survival and secondary procedures after open or endovascular repair of abdominal aortic aneurysms. J Vasc Surg 2017;66(5):1379-89. 71. Mastracci TM, Greenberg RK, Eagleton MJ, Hernandez AV. Durability of branches in branched and fenestrated endografts. J Vasc Surg 2013;57(4):926-33. 72. Canavati R, How TV, Brennan JA et al. Fractured superior mesenteric artery stents after fenestrated endovascular aneurysm repair. J Vasc Surg 2013;57(2):511-4. 73. Troisi N, Donas KP, Austermann M et al. Secondary procedures after aortic aneurysm repair with fenestrated and branched endografts. J Endovasc Ther 2011;18(2):146-53. 74. Verhoeven E, Vourliotakis G, Bos W et al. Fenestrated stent grafting for short-necked and juxtarenal abdominal aortic aneurysm: an 8-year single-centre experience. Eur J Vasc Endovasc Surg 2010;39(5):529-36. 75. Tambyraja A, Fishwick N, Bown M et al. Fenestrated aortic endografts for juxtarenal aortic aneurysm: medium term outcomes. Eur J Vasc Endovasc Surg 2011;42(1):54-8. 76. Sun Z, Stevenson G. Transrenal fixation of aortic stent-grafts: short-to midterm effects on renal function—a systematic review. Radiology 2006;240(1):65-72. 77. Cross J, Gurusamy K, Gadhvi V et al. Fenestrated endovascular aneurysm repair. Br J Surg 2012;99(2):152-9. 78. Mastracci T, Carrell T, Constantinou J et al. Editor’s Choice–effect of branch stent choice on branch-related outcomes in complex aortic repair. Eur J Vasc Endovasc Surg 2016;51(4):536-42.
52. Marzelle J, Presles E, Becquemin J. WINDOWS trial participants. Results and factors affecting early outcome of fenestrated and/ or branched stent grafts for aortic aneurysms: a multicenter prospective study. Ann Surg 2015;261(1):197-206.
39. Greenberg RK, Sternbergh WC 3rd, Makaroun M et al. Intermediate results of a United States multicenter trial of fenestrated endograft repair for juxtarenal abdominal aortic aneurysms. J Vasc Surg 2009;50(4):730-7.e1.
44.
68. Schermerhorn ML, Buck DB, O’Malley AJ et al. Long-term outcomes of abdominal aortic aneurysm in the Medicare population. N Engl J Med 2015;373(4):328-38. 69. Roy I, Millen A, Jones S et al. Long term follow up of fenestrated endovascular repair for juxtarenal aortic aneurysm. Br J Surg 2017;104(8):1020-7.
63. Haddad F, Greenberg RK, Walker E et al. Fenestrated endovascular grafting: the renal side of the story. J Vasc Surg 2005;41(2):181-90. 64. Patel SD, Constantinou J, Simring D et al. Results of complex aortic stent grafting of abdominal aortic aneurysms stratified according to the proximal landing zone using the Society for Vascular Surgery classification. J Vasc Surg 2015;62(2):319-25. e2. 65. Ahanchi SS, Carroll M, Almaroof B, Panneton JM. Anatomic severity grading score predicts technical difficulty, early outcomes, and hospital resource utilization of endovascular aortic aneurysm repair. J Vasc Surg 2011;54(5):1266-72. 66. Kristmundsson T, Sonesson B, Malina M, Resch T. Association between the SVS/AAVS anatomical severity grading score and operative outcomes in fenestrated endovascular repair of juxtarenal aortic aneurysm. J Endovasc Ther 2013;20(3):356-65.
43. Greenberg RK, Qureshi M. Fenestrated and branched devices in the pipeline. J Vasc Surg 2010;52(4 Suppl):15S-21S. Tenorio ER, Kärkkäinen JM, Mendes BC et al. Outcomes of Directional Branches Using Self-Expandable Versus Balloon-Expandable Stent Grafts During Endovascular Repair of Thoracoabdominal Aortic Aneurysms. J Vasc Surgy 2019;69(3):e26. Greenberg R, Haulon S, O’Neill S et al. Primary endovascular repair of juxtarenal aneurysms with fenestrated endovascular grafting. Eur J Vasc Endovasc Surg 2004;27(5):484-91.
57. O’Neill S, Greenberg R, Haddad F et al. A prospective analysis of fenestrated endovascular grafting: intermediate-term outcomes. Eur J Vasc Endovasc Surg 2006;32(2):115-23.
79. Martin-Gonzalez T, Pincon C, Maurel B et al. Renal outcomes following fenestrated and branched endografting. Eur J Vasc Endovasc Surg 2015;50(4):420-30. 80. Sandri GdA, Oderich GS, Tenorio ER et al. Impact of aortic wall thrombus on late changes in renal function among patients treated by fenestrated-branched endografts. J Vasc Surg 2018. 81. Ribeiro M, Oderich GS, Macedo T et al. Assessment of aortic wall thrombus predicts outcomes of endovascular repair of complex aortic aneurysms using fenestrated and branched endografts. J Vasc Surg 2017;66(5):1321-33. 82. Linsen MA, Jongkind V, Nio D et al. Pararenal aortic aneurysm repair using fenestrated endografts. J Vasc Surg 2012;56(1):238-46. 83. De Souza L, Oderich G, Farber M et al. Editor’s Choice–Comparison of Renal Outcomes in Patients Treated by Zenith® Fenestrated and Zenith® Abdominal Aortic Aneurysm Stent grafts in US Prospective Pivotal Trials. Eur J Vasc Endovasc Surg 2017;53(5):648-55. 84. Jain AK, Oderich GS, Tenorio ER et al. VESS10. Natural History of Target Vessel Endoleaks After Fenestrated-Branched Endovascular Aortic Repair. J Vasc Surg 2018;67(6):e53-e4. 85. O’Callaghan A, Greenberg RK, Eagleton MJ et al. Type Ia endoleaks after fenestrated and branched endografts may lead to component instability and increased aortic mortality. J Vasc Surg 2015;61(4):908-14.
Capítulo 79 149AneurismA s de AortA AbdominAl ComPlexos
40. Lee WA, Brown MP, Nelson PR, Huber TS. Total percutaneous access for endovascular aortic aneurysm repair (“Preclose” technique). J Vasc Surg 2007;45(6):1095-101.
47. Rao R, Lane TR, Franklin IJ, Davies AH. Open repair versus fenestrated endovascular aneurysm repair of juxtarenal aneurysms. J Vasc Surg 2015;61(1):242-55. e5. 48. Graves HL, Jackson BM (Eds.). The current state of fenestrated and branched devices for abdominal aortic aneurysm repair. Seminars in interventional radiology. Thieme Medical Publishers; 2015 49. Donas KP, Torsello G, Bisdas T et al. Early outcomes for fenestrated and chimney endografts in the treatment of pararenal aortic pathologies are not significantly different: a systematic review with pooled data analysis. J Endovasc Ther 2012;19(6):723-8.
54. De Bruin JL, Baas AF, Buth J et al. Long-term outcome of open or endovascular repair of abdominal aortic aneurysm. N Engl J Med 2010;362(20):1881-9.
53. Greenberg RK, Sternbergh III WC, Makaroun M et al. Intermediate results of a United States multicenter trial of fenestrated endograft repair for juxtarenal abdominal aortic aneurysms. J Vasc Surg 2009;50(4):730-7. e1.
45.
51. Georgiadis GS, Saengprakai W, Georgakarakos E et al. Endovascular treatment of complex abdominal and thoracoabdominal type IV aortic aneurysms with fenestrated technology. J Cardiovasc Surg 2017;58(4):574-90.
42. Sweet MP, Hiramoto JS, Park KH et al. A standardized multi-branched thoracoabdominal stent-graft for endovascular aneurysm repair. J Endovasc Ther 2009;16(3):359-64.
88. Moulakakis KG, Mylonas SN, Avgerinos E et al. The chimney graft technique for preserving visceral vessels during endovascular treatment of aortic pathologies. J Vasc Surg 2012;55(5):1497-503.
92. Dijkstra ML, Eagleton MJ, Greenberg RK et al. Intraoperative C-arm cone-beam computed tomography in fenestrated/branched aortic endografting. J Vasc Surg 2011;53(3):583-90.
93. Semmens JB, Lawrence-Brown MM, Hartley DE et al. Outcomes of fenestrated endografts in the treatment of abdominal aortic aneurysm in Western Australia (1997–2004). J Endovasc Ther 2006;13(3):320-9.
95. Scurr J, Brennan J, Gilling Smith G et al. Fenestrated endovascular repair for juxtarenal aortic aneurysm. Br J Surg 2008;95(3):326-32. 96. Beck AW, Bos WT, Vourliotakis G et al. Fenestrated and branched endograft repair of juxtarenal aneurysms after previous open aortic reconstruction. J Vasc Surg 2009;49(6):1387-94. 97. Haulon S, Amiot S, Magnan PE et al. An analysis of the French multicenter experience of fenestrated aortic endografts: mediumterm outcomes. Ann Surg 2010;251(2):357-62. 98. Starnes BW. Physician-modified endovascular grafts for the treatment of elective, symptomatic, or ruptured juxtarenal aortic aneurysms. J Vasc Surg 2012;56(3):601-7. 99. Quiñones-Baldrich WJ, Holden A, Mertens R et al. Prospective, multicenter experience with the Ventana Fenestrated System for juxtarenal and pararenal aortic aneurysm endovascular repair. J Vasc Surg 2013;58(1):1-9. 100. Blankensteijn LL, Dijkstra ML, Tielliu IF et al. Midterm results of the fenestrated Anaconda endograft for short-neck infrarenal and juxtarenal abdominal aortic aneurysm repair. J Vasc Surg 2017;65(2):303-10. 101. Colgan FE, Bungay PM, Burfitt N et al. Operative and 1-Year Outcomes of the Custom-Made Fenestrated Anaconda Aortic Stent Graft—A UK Multicenter Study. Ann Vasc Surg 2018;46:257-64.
94. Muhs BE, Verhoeven EL, Zeebregts CJ et al. Midterm results of endovascular aneurysm repair with branched and fenestrated endografts. J Vasc Surg 2006;44(1):9-15.
90. Donas KP, Pecoraro F, Bisdas T et al. CT angiography at 24 months demonstrates durability of EVAR with the use of chimney grafts for pararenal aortic pathologies. J Endovasc Ther 2013;20(1):1-6.
89. Rancic Z, Pfammatter T, Lachat M et al. Periscope graft to extend distal landing zone in ruptured thoracoabdominal aneurysms with short distal necks. J Vasc Surg 2010;51(5):1293-6.
91. Lee JT, Varu VN, Tran K, Dalman RL. Renal function changes after snorkel/chimney repair of juxtarenal aneurysms. J Vasc Surg 2014;60(3):563-70.
87. Donas KP, Lee JT, Lachat M et al. Collected world experience about the performance of the snorkel/chimney endovascular technique in the treatment of complex aortic pathologies: the PERICLES registry. Ann Surg 2015;262(3):546-53.
86. Oikonomou K, Kasprzak P, Schierling W et al. Graft complexity–related outcomes of fenestrated endografting for abdominal aortic aneurysms. J Endovasc Ther 2017;24(2):230-6.
Parte V150 TORACOABDOMINAL
31. Oderich GS, Panneton JM, Macedo TA et al. Intraoperative duplex ultrasound of visceral revascularizations: optimizing technical success and outcome. J Vasc Surg 2003;38(4):684-91. 32. Schermerhorn ML, Buck DB, O’Malley AJ et al. Long-Term Outcomes of Abdominal Aortic Aneurysm in the Medicare Population. N Engl J Med 2015;373(4):328-38. 33. Tallarita T, Sobreira ML, Oderich GS. Results of open pararenal abdominal aortic aneurysm repair: Tabular review of the literature. Ann Vasc Surg 2011;25(1):143-9. 34. Brewster DC, Franklin DP, Cambria RP et al. Intestinal ischemia complicating abdominal aortic surgery. Surgery 1991;109(4):447-54. 35. Longo WE, Lee TC, Barnett MG et al. Ischemic colitis complicating abdominal aortic aneurysm surgery in the U.S. veteran. J Surg Res 1996;60(2):351-4. 36. Blogowski W, Dolegowska B, Pikula E et al. The effect of PGE administration on the activity of oxidative system in erythrocytes and platelets during ischemia reperfusion injury and on postoperative renal function in patients undergoing open abdominal aortic aneurysm reconstruction. J Biol Regul Homeost Agents 2012;26(3):429-38. 37. Dawidson IJA, Willms CD, Sandor ZF et al. Ringers Lactate with or without 3-Percent Dextran-60 as Volume Expanders during Abdominal Aortic-Surgery. Crit Care Med 1991;19(1):36-42. Borkon MJ, Zaydfudim V, Carey CD et al. Retroperitoneal repair of abdominal aortic aneurysms offers postoperative benefits to male patients in the Veterans Affairs Health System. Ann Vasc Surg 2010;24(6):728-32.
9. Chaikof EL, Dalman RL, Eskandari MK et al. The Society for Vascular Surgery practice guidelines on the care of patients with an abdominal aortic aneurysm. J Vasc Surg 2018;67(1):2-77 e2.
38.
11. Lederle FA, Johnson GR, Wilson SE et al. The aneurysm detection and management study screening program: validation cohort and final results. Aneurysm Detection and Management Veterans Affairs Cooperative Study Investigators. Arch Intern Med 2000;160(10):1425-30.
12. Participants TUSAT. Mortality results for randomised controlled trial of early elective surgery or ultrasonographic surveillance for small abdominal aortic aneurysms. The UK Small Aneurysm Trial Participants. Lancet 1998;352(9141):1649-55.
29. Thompson M, Holt P, Loftus I, Forbes TL. Debate: whether abdominal aortic aneurysm surgery should be centralized at higher-volume centers. J Vasc Surg 2011;54(4):1208-14. 30. Nicholson ML, Baker DM, Hopkinson BR, Wenham PW. Randomized controlled trial of the effect of mannitol on renal reperfusion injury during aortic aneurysm surgery. Br J Surg 1996;83(9):1230-3.
13. Ruiz de Galarreta S, Cazon A, Anton R, Finol EA. A Methodology for Verifying Abdominal Aortic Aneurysm Wall Stress. J Biomech Eng 2017;139(1).
23. Eslami MH, Rybin DV, Doros G, Farber A. Description of a risk predictive model of 30-day postoperative mortality after elective abdominal aortic aneurysm repair. J Vasc Surg 2017;65(1):65-74 e2. 24. Alshaikh HN, Bohsali F, Gani F et al. Statin intensity and postoperative mortality following open repair of intact abdominal aortic aneurysm. BJS Open 2018;2(6):411-8.
REFERÊNCIAS
17. Frydman G, Walker PJ, Summers K et al. The value of screening in siblings of patients with abdominal aortic aneurysm. Eur J Vasc Endovasc Surg 2003;26(4):396-400.
18. Johansen K, Koepsell T. Familial tendency for abdominal aortic aneurysms. JAMA 1986;256(14):1934-6.
20. Elmore JR, Hallett JW, Gibbons RJ et al. Myocardial Revascularization before Abdominal Aortic Aneurysmorrhaphy - Effect of Coronary Angioplasty. Mayo Clin Proc 1993;68(7):637-41.
25. Durazzo AE, Machado FS, Ikeoka DT et al. Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial. J Vasc Surg 2004;39(5):967-75; discussion 75-6. 26. Feringa HH, Schouten O, Karagiannis SE et al. Intensity of statin therapy in relation to myocardial ischemia, troponin T release, and clinical cardiac outcome in patients undergoing major vascular surgery. J Am Coll Cardiol 2007;50(17):1649-56. 27. Schouten O, Boersma E, Hoeks SE et al. Fluvastatin and perioperative events in patients undergoing vascular surgery. N Engl J Med 2009;361(10):980-9.
28. Faggioli G, Scalone L, Mantovani LG et al. Preferences of Patients, Their Family Caregivers and Vascular Surgeons in the Choice of Abdominal Aortic Aneurysms Treatment Options: The PREFER Study. Eur J Vasc Endovasc 2011;42(1):26-34.
10. Wanhainen A, Verzini F, Van Herzeele I et al. Editor’s ChoiceEuropean Society for Vascular Surgery (ESVS) 2019 Clinical Practice Guidelines on the Management of Abdominal Aorto-iliac Artery Aneurysms. Eur J Vasc Endovasc Surg 2019;57(1):8-93.
6. Choke E, Vijaynagar B, Thompson J et al. Changing epidemiology of abdominal aortic aneurysms in England and Wales: older and more benign? Circulation 2012;125(13):1617-25.
DE AORTA ABDOMINAL
21. Baas AF, Janssen KJ, Prinssen M et al. The Glasgow Aneurysm Score as a tool to predict 30-day and 2-year mortality in the patients from the Dutch Randomized Endovascular Aneurysm Management trial. J Vasc Surg 2008;47(2):277-81.
16. Baird PA, Sadovnick AD, Yee IM et al. Sibling risks of abdominal aortic aneurysm. Lancet 1995;346(8975):601-4.
14. Soto B, Vila L, Dilme JF et al. Increased Peak Wall Stress, but Not Maximum Diameter, Is Associated with Symptomatic Abdominal Aortic Aneurysm. Eur J Vasc Endovasc 2017;54(6):706-11.
151 80Capítulo
19. Darling RC, Brewster DC, Darling RC et al. Are Familial Abdominal Aortic-Aneurysms Different. J Vasc Surg 1989;10(1):39-43.
2. Silverberg E, Boring CC, Squires TS. Cancer statistics, 1990. CA Cancer J Clin 1990;40(1):9-26.
5. Anjum A, Powell JT. Is the incidence of abdominal aortic aneurysm declining in the 21st century? Mortality and hospital admissions for England & Wales and Scotland. Eur J Vasc Endovasc Surg 2012;43(2):161-6.
7. Dua A, Koprowski S, Upchurch G et al. Progressive shortfall in open aneurysm experience for vascular surgery trainees with the impact of fenestrated and branched endovascular technology. J Vasc Surg 2017;65(1):257-61.
ANEURISMAS COMPLEXOS – TRATAMENTO CIRÚRGICO BIBLIOGRÁFICAS
4. Anjum A, von Allmen R, Greenhalgh R, Powell JT. Explaining the decrease in mortality from abdominal aortic aneurysm rupture. Br J Surg 2012;99(5):637-45.
8. Dua A, Upchurch GR, Lee JT et al. Predicted shortfall in open aneurysm experience for vascular surgery trainees. J Vasc Surg 2014;60(4):945-9.
22. van Beek SC, Reimerink JJ, Vahl AC et al. Editor’s Choice--External Validation of Models Predicting Survival After Ruptured Abdominal Aortic Aneurysm Repair. Eur J Vasc Endovasc Surg 2015;49(1):10-6.
15. Bertges DJ, Goodney PP, Zhao YY et al. The Vascular Study Group of New England Cardiac Risk Index (VSG-CRI) predicts cardiac complications more accurately than the Revised Cardiac Risk Index in vascular surgery patients. J Vasc Surg 2010;52(3):674-83.
1. Holt PJE, Thompson MM. Abdominal Aortic Aneurysms: Evaluation and Decision Making. In: Cronenwett JL, Wayne JK (Eds.). Rutherford’s Vascular Surgery. 8th ed. Elsevier Saunders; vol. 2. 2014. p. 1999-2023.
3. Lederle FA, Johnson GR, Wilson SE et al. Prevalence and associations of abdominal aortic aneurysm detected through screening. Aneurysm Detection and Management (ADAM) Veterans Affairs Cooperative Study Group. Ann Intern Med 1997;126(6):441-9.
44. Prinssen M, Verhoeven EL, Buth J et al. A randomized trial comparing conventional and endovascular repair of abdominal aortic aneurysms. N Engl J Med 2004;351(16):1607-18.
53. Knott AW, Kalra M, Duncan AA et al. Open repair of juxtarenal aortic aneurysms (JAA) remains a safe option in the era of fenestrated endografts. J Vasc Surg 2008;47(4):695-701.
64. Poulias GE, Doundoulakis N, Skoutas B et al. Juxtarenal abdominal aneurysmectomy. J Cardiovasc Surg (Torino). 1992;33(3):324-30. 65. Jean-Claude JM, Reilly LM, Stoney RJ, Messina LM. Pararenal aortic aneurysms: the future of open aortic aneurysm repair. J Vasc Surg 1999;29(5):902-12. 66. Wahlberg E, Dimuzio PJ, Stoney RJ. Aortic clamping during elective operations for infrarenal disease: The influence of clamping time on renal function. J Vasc Surg 2002;36(1):13-8.
45. Schermerhorn ML, Giles KA, Sachs T et al. Defining perioperative mortality after open and endovascular aortic aneurysm repair in the US Medicare population. J Am Coll Surg 2011;212(3):349-55.
54. West CA, Noel AA, Bower TC et al. Factors affecting outcomes of open surgical repair of pararenal aortic aneurysms: a 10-year experience. J Vasc Surg 2006;43(5):921-7; discussion 7-8.
46. van Schaik TG, Yeung KK, Verhagen HJ et al. Long-term survival and secondary procedures after open or endovascular repair of abdominal aortic aneurysms. J Vasc Surg 2017;66(5):1379-89.
41. Matsen SL, Krosnick TA, Roseborough GS et al. Preoperative and intraoperative determinants of incisional bulge following retroperitoneal aortic repair. Ann Vasc Surg 2006;20(2):183-7.
51. Deery SE, Lancaster RT, Baril DT et al. Contemporary outcomes of open complex abdominal aortic aneurysm repair. J Vasc Surg 2016;63(5):1195-200.
56. Shortell CK, Johansson M, Green RM, Illig KA. Optimal operative strategies in repair of juxtarenal abdominal aortic aneurysms. Ann Vasc Surg 2003;17(1):60-5.
62. Kudo FA, Nishibe T, Miyazaki K et al. Postoperative renal function after elective abdominal aortic aneurysm repair requiring suprarenal aortic cross-clamping. Surg Today 2004;34(12):1010-3. 63. Illuminati G, D’Urso A, Ceccanei G et al. Surgical treatment of pararenal aortic aneurysms in the elderly. J Cardiovasc Surg (Torino) 2007;48(6):705-10.
48. O’Donnell TFX, Boitano LT, Deery SE et al. Factors associated with postoperative renal dysfunction and the subsequent impact on survival after open juxtarenal abdominal aortic aneurysm repair. J Vasc Surg 2018. 49. Sarac TP, Clair DG, Hertzer NR et al. Contemporary results of juxtarenal aneurysm repair. J Vasc Surg 2002;36(6):1104-11.
47. Freischlag JA, Kyriakides TC, Stroupe KT et al. Extended Follow-Up of Open vs. Endovascular Repair for Abdominal Aortic Aneurysm: the OVER Trial. J Am Coll Surgeons 2018;227(4):E1-E.
59. Sharp WJ, Bashir M, Word R et al. Suprarenal clamping is a safe method of aortic control when infrarenal clamping is not desirable Ann Vasc Surg 2008;22(4):534-40.
58. Qvarfordt PG, Stoney RJ, Reilly LM et al. Management of pararenal aneurysms of the abdominal aorta. J Vasc Surg 1986;3(1):84-93.
60. Ayari R, Paraskevas N, Rosset E et al. Juxtarenal aneurysm. Comparative study with infrarenal abdominal aortic aneurysm and proposition of a new classification. Eur J Vasc Endovasc Surg 2001;22(2):169-74. 61. Allen BT, Anderson CB, Rubin BG et al. Preservation of renal function in juxtarenal and suprarenal abdominal aortic aneurysm repair. J Vasc Surg 1993;17(5):948-58; discussion 58-9.
43. Patel R, Sweeting MJ, Powell JT et al. Endovascular versus open repair of abdominal aortic aneurysm in 15-years’ follow-up of the UK endovascular aneurysm repair trial 1 (EVAR trial 1): a randomised controlled trial. Lancet 2016;388(10058):2366-74.
Parte V152 TORACOABDOMINAL
50. Pearce JD, Edwards MS, Stafford JM et al. Open repair of aortic aneurysms involving the renal vessels. Ann Vasc Surg 2007;21(6):676-86.
52. O’Donnell TFX, Boitano LT, Deery SE et al. Hospital Volume Matters: The Volume-Outcome Relationship in Open Juxtarenal AAA Repair. Ann Surg 2018.
42. Lederle FA, Freischlag JA, Kyriakides TC et al. Long-term comparison of endovascular and open repair of abdominal aortic aneurysm. N Engl J Med 2012;367(21):1988-97.
39. Hall KA, Peters B, Smyth SH et al. Abdominal wall hernias in patients with abdominal aortic aneurysmal versus aortoiliac occlusive disease. Am J Surg 1995;170(6):572-5; discussion 5-6.
40. Papadimitriou D, Pitoulias G, Papaziogas B et al. Incidence of abdominal wall hernias in patients undergoing aortic surgery for aneurysm or occlusive disease. Vasa 2002;31(2):111-4.
55. United Kingdom ETI, Greenhalgh RM, Brown LC et al. Endovascular versus open repair of abdominal aortic aneurysm. N Engl J Med 2010;362(20):1863-71.
57. Chong T, Nguyen L, Owens CD et al. Suprarenal aortic cross-clamp position: a reappraisal of its effects on outcomes for open abdominal aortic aneurysm repair. J Vasc Surg 2009;49(4):873-80.
12. Pasha SF, Glowiczki P, Stanson AW et al. Splanchnic artery aneurysms. Mayo Clin Proc 2007;82:472-79. 13. Cordova AC, Sumpio BE. Visceral artery aneurysms and pseudoaneurysms – should they all be managed by endovascular techniques? Ann Vasc Dis 2013;6:687-93.
14. Stanley JC, Wakefield TW, Graham LM et al. Clinical importance and management of splanchnic artery aneurysms. J Vasc Surg 1986;836-40.
11. Cardoso Neto J, Ristow Av, Massière BV et al. Dissecção aguda das artérias viscerais: O que fazer na falência do tratamento conservador? Rev Angiol Cir Vasc RJ 2013;11:1-15.
ANEURISMAS DAS ARTÉRIAS VISCERAIS
16. Shaney CJ, Shah NL, Messina LM. Common splancnic artery aneurysms. Ann Vasc Surg 1996;10:315-21.
17. Bush RHL. Visceral artery aneurysms. In: Calow AD, Ernst CB (Eds.). Vascular surgery – Theory and practice. Stanford: Appleton & Lange; 1995. p. 901-19.
15. Barret JM, van Hooydonc JE, Boehn FH. Pregnancy related rupture of arterial aneurysms. Obstet Gynecol Surg 1982;37:557-66.
10. Zhang WW, Killeen JD, Chiriano J et al. Management of symptomatic isolated visceral artery dissection: is emergent intervention mandatory? Ann Vasc Surg 2009;23:90-94.
1. Stanley JC. Aneurysms of the celiac and mesenteric circulation. In: Yao ST, Pearce WH (Ed.). Aneurysms – New findings and treatment Norwalk: Appleton & Lange; 1994. p. 423-37. 2. Upchurch GR, Zelenock GB, Stanley JC. Splanchnic artery aneurysms. In: Rutherford RB (Ed.). Vascular surgery. 6th ed. Philadelphia: Elsevier Saunders; 2005. p. 1565-81.
5. Ristow AV, Massière BV. (Eds.). Diagnóstico vascular por imagem. Rio de Janeiro: Revinter; 2008.
19. Lumsden AB, Smith III RB. Treatment of visceral artery aneurysms. In: Calligaro KD (Ed.). Diagnosis and treatment of aortic and peripheral arterial aneurysms. Philadelphia: WB Saunders; 1999. p. 307-19. 20. Brocker JA, Maher JL, Smith RW. True pancreaticoduodenal aneurysms with celiac stenosis or occlusion. Am J Surg 2012;204:762-768.
153 81Capítulo
21. Graham LM, Stanley JC, Whitehouse WM et al. Celiac artery: historic (1745-1949) vs. contemporary (1950-1984); di15ferences in etiology and clinical importance. J Vasc Surg 1985;5:757.
22. Trastek VF, Pairolero PC, Bernatz PE. Splenic artery aneurysms. World J Surg 1985;9:378-83. 23. Chiesa R, Astore D, Guzzo G et al. Visceral artery aneurysms. Ann Vasc Surg 2005;19:24-28. 24. Stanley JC, Fry WJ. Pathogenesis and clinical significance of splenic artery aneurysms. Surgery 1974;76:889-909. 25. Abbas MA, Stone WM, Martin LG et al. Splenic artery aneurysms – two decades of experience at the Mayo Clinic. Ann Vasc Surg 2002;16:442-49. 26. Hodsworth RJ, Gunn A. Ruptured splenic artery aneurysms in pregnancy. A review. Br J Obstet Ginaecol 1992;99:595-97. 27. Wiley EJ, Brinkley FM, Palubinkas AJ. Extrarenal fibromuscular hyperplasia. Am J Surg 1966;112:149-55. 28. DeVries JE, Schattenkerk ME, Malt RA. Complications of splenic artery aneurysms other than intraperitoneal rupture. Surgery 1982;91:200-4. 29. Pulli R, Dorigo W, Troisi N et al. Surgical treatment of visceral artery aneurysms: a 25-year experience. J Vasc Surg 2008;48:334-42. 30. Erskine JM. Hepatic artery aneurysms. Vasc Surg 1973;7:106-9. 31. Harlaftis NN, Akin JT. Hemobilia from ruptured hepatic artery aneurysm: report of a case and literature review. Am J Surg 1977;133:229-33. 32. Jeans PL. Hepatic artery aneurism and biliary surgery. Aust N Z J Surg 1988;58:889-95. 33. Jacobs PPM, van Ughelen FAAM, Bruyninckx CMA et al. Haemoperitoneum caused by dissecting aneurysm of the gastroepiploic artery. Eur J Vasc Surg 1994;8:236-40. 34. Reber PU, Baer HU, Patel Ag et al. Life-threatening upper intestinal bleeding caused by extra-hepatic pseudoaneurysm after pancreatoduodenectectomy. Surgery 1998;124:114-19. 35. Stanley JC, Thompson NW, Fry WJ. Splanchnic artery aneurysms. Arch Surg 1970;101:689-76. 36. Stone WM, Abbas M, Cherry KJ. Superior mesenteric artery aneurysms: is presence an indication of intervention? J Vasc Surg 2002;36:234-40. 37. Stanley JC. Natural story of renal artery stenosis and aneurysms. In: Caligaro KD (Ed.). Modern management of renovascular hypertension and renal salvage. Baltimore: Williams and Wilkins; 1996. p. 15-23. 38. Mc Carron JP, Marschal VF, Witsell II JC. Indications for surgery in renal artery aneurysms. J Urol 1975;114:177-85. 39. Harrow BR, Sloane JA. Aneurysm of renal; artery: report of five cases. J Urol 1959;81:35-41. 40. Sharif MA, O’Donnell ME, Johnston LC et al. Successful surgical management of ruptured true pacreaticoduodenal artery aneurysm following failed trans catheter embolization. Vascular 2007;15:231-34. Stanley JC, Messina LM, Zelenock GB. Splanchnic and renal artery aneurysms. In: Moore W (Ed.). Vascular surgery. 5th ed. Philadelphia: WB Saunders; 1998. p. 486-82. 42. Girishkumar H, Beniwaal J, Narashima V. Aneurysm of the right colic artery. J Cardiovasc Surg 1997;38:305-7. 43. Mandelbaum I, Kaiser GD, Lemple RE. Gastric intramural aneurysm as a cause of massive gastrointestinal hemorrhage. Ann Surg 1962;155:199-202. 44. Eckhauser FE, Stanley JC, Zelenock GB et al. Gastroduodenal and pancreático-duodenal artery aneurysms: a complication of pancreatitis causing spontaneous gastrointestinal hemorrhage. Surgery 1980;88:335-39. 45. White AF, Baum S, Buranasiri S. Aneurysms secondary to pancreatitis. Am J Roentgen 1976;127:393-99. 46. Granke K, Hollier LH, Bowen JC. Pancreticoduodenal artery aneurysms: changing patterns. South Med J 1990;83:918-25.
41.
REFERÊNCIAS BIBLIOGRÁFICAS
6. Hislop SJ, Patel SA, Abt PL et al. Therapy of renal artery aneurysms in New York State: Outcomes of patients undergoing open and endovascular repair. Ann Vasc Surg 2009;23:194-200. 7. Sachdev U, Baril DT, Ellozy SH et al. Management of aneurysms involving branches of the celiac and mesenteric arteries: a comparison of surgical and endovascular therapy. J Vasc Surg 2006;44:718-24.
3. Huang YK, Hsieh HC, Tsai FC et al. Visceral artery aneurysm: risk factor analysis and therapeutic option. Eur J Vasc Endovasc Surg 2007;33:293-301.
18. Brems JJ, Hiatt JR, Klein AS et al. Splenic artery aneurysm rupture following orthotopic liver transplantation. Transplantation 1988;45:1136-37.
8. Ristow Av, Vescovi A, Massiére BV, Peixoto CC, Martin HS. Aneurismas das Artérias Viscerais. In: Brito CJ et al. Cirurgia Vascular. 3a ed. Rio de Janeiro: Revinter; 2013. p. 879-900. 9. Ristow Av, Peixoto CC, Martin HS et al. Visceral artery aneurysms: embolization, stent grafts or open surgery – What treatment for which Lesion? In: Becquemin JP (Ed.). Controversies and updates in vascular surgery. Torino: Minerva Medica; 2010. p. 65-71.
4. Calligaro KD, Dougherty MJ. Renal artery aneurysms and arteriovenous fistulae. In Rutherford RB (Ed.). Vascular surgery. 6th ed. Philadelphia: Elsevier Saunders; 2005. p. 1861-70.
65.
74. Baroudi S, Bastiano B, Balci N et al. Bilateral renal artery dissection following extreme exertion. Clin Nephro 2011; 76 (4): 334-339.
76. Afshinnis F, Sundaram B, Rao P et al. Evaluation of characteristics, associations and clinical course of isolated spontaneous renal artery dissection. Nephrol Dial Transplant 2013;28:2089-2098.
75. Araki T, Nakamura M, Imamura T et al. Bilateral spontaneous renal artery dissection. J Cardiol Cases 2011;4:e101-e105.
73. Bumpus HC Jr. A case of renal hypertension. Trans Am Assoc Genitourin Surg 1945;37:135-140
72. Yoshida RA, Yoshida WB, Kolvenbach R et al. Dissecção Espontânea Isolada da Artéria Mesentérica Superior: Qual a melhor abordagem terapêutica? J Vasc Bras 2013;12(1):34-39.
58. Yun WS et al. Clinical and angiographic follow-up of spontaneous isolated superior mesenteric artery dissection Eur J Vasc Endovasc Surg 2009;37:572-77. 59. Rivera AMQ. Manejo conservador de tres casos de disección espontánea de la artéria mesentérica superior. Angiología 2012;64(1):7-12.
68. Wang HC, Chen JH, Hsiao CC et al. Spontaneous dissection of the celiac artery: a case report and literature review. Am J Emerg Med 2013. 69. Yun WS et al. Clinical and Angiographic Follow-up of Spontaneous Isolated Superior Mesenteric Artery Dissection. Eur J Vasc Endovasc Surg 2009;37:572-577.
70. Subhas et al. Spontaneous Isolated Superior Mesenteric Artery Dissection: A Case Report and Literature Review with Management Algorithm. An Vasc Surg 2009;23(6):788-98.
67. Watring NJ et al. Spontaneous superior mesenteric artery dissection: an unusual cause of abdominal pain. J Emerg Med 2010;39(5):576-78.
71. Morris JT et al. Three isolated superior mesenteric artery dissections: Update of previous case reports, diagnostics, and treatment options. J Vasc Surg 2008;47(3):649-653.
64. Gobble RM et al. Endovascular treatment of spontaneous dissections of the superior mesenteric artery. J Vasc Surg 2009;50:1326-32. Wadhwani R et al. Color Doppler sonographic diagnosis of dissecting aneurysm of the superior mesenteric artery. J Clin Ultrasound 2001;29:247-49. 66. Nordanstig J, Gerdes J, Kocys AE. Spontaneous isolated dissection of the celiac trunk with rupture of the proximal splenic artery: a case report. Eur J Vasc Endovasc Surg 2009;37:194-97.
Parte V154 TORACOABDOMINAL 47. DeParrot M, Berney T, Delaveal J et al. Management of true aneurysms of the pancreaticoduodenal artery. Ann Surg 1999;229:416-22. 48. Carr JA, Cho JS, Shepard AD et al. Visceral pseudoaneurysms due to pancreatic pseudoscysts: rare but lethal complication of pancreatitis. J Vasc Surg 2000;32:722-26. 49. Trevisani MF, Ricci MA, Michaels MM et al. Multiple mesenteric artery aneurysms complicating bacterial endocarditis. Ann Surg 1987;122:823-27. 50. Dietrich NA, Caccioppo JC, Ying DPW. Massive gastrointestinal hemorrage caused by rupture of a jejunal branch aneurysm. J Vasc Surg 1988;8:187-89. 51. Tessier DJ, Abbas MA, Fowl RJ et al. Management of rare mesenteric branch aneurysm. Ann Vasc Surg 2002;26:586-89. 52. McNamara MR, Bakshi KR. Mesenteric artery aneurysms. In: Bergan J, Yao JT (Eds.). Aneurysms – Diagnosis and treatment. New York: Grune&Statton; 1981. p. 285-99. 53. Chaillou P, Moussu P, Noel SF et al. Spontaneous Dissection of the Celiac Artery. Ann Vasc Surg 1997:413-415. 54. Conrad MF, Cambria RP. Aortic Dissection. In: Cronenwett JL, Johnston KM et al. Rutherford’s vascular surgery. 7th ed. Philadelphia: Elsevier; 2010. 55. Bauersfeld SR. Dissecting aneurysm of the aorta: a presentation of fifteen cases and a review of the recent literature. Ann Intern Med 1947;26:873e9. 56. Dong Z. Treatment of symptomatic isolated dissection of superior mesenteric artery J Vasc Surg 2013;57:69S-76S. 57. Wang HC. Spontaneous dissection of the celiac artery: a case report and literature review. Am J Emerg Med 2013;31(6):1000.e3-5.
60. Min SI et al. Current strategy for the treatment of symptomatic spontaneous isolated dissection of superior mesenteric artery. J Vasc Surg 2011;54:461-66. 61. Cho BS et al. Treatment Guidelines for Isolated Dissection of the Superior Mesenteric Artery Based on Follow-up CT Findings. Eur J Vasc Endovasc Surg 2011;41:780-85. 62. Sakamoto I et al. Imaging appearances and management of isolated spontaneous dissection of the superior mesenteric artery. Eur J Radiol 2007;64:103-10. 63. Subhas G et al. Spontaneous isolated superior mesenteric artery dissection: a case report and literature review with management algorithm. Ann Vasc Surg 2009;23(6):788-98.
77. Edmonson DA, Towne JB, Foley DW. Cocaine-induced renal artery dissection and thrombosis leading to renal infarction. WMJ 2004;103:66-69. 78. Orhan O, Kultigin T, Osman K. An exceedingly rare cause of secondary hypertension: bilateral renal artery dissection possibly secondary to extracorporeal shock-wave lithotripsy. Intern Med 2011;50(21):2633-2636. 79. Meyers DS, Grim CE, Keitzer WF. Fibromuscular dysplasia of the renal artery with medial dissection. A case simulating polyarteritis nodosa. Am J Med 1974;56:412-416. 80. Gewertz BL, Stanley JC, Fry WJ. Renal artery dissections. Arch Surg 1977;112:409-414. 81. Winzelberg GG, Hull JD, Agar JW et al. Elevation of serum lactate dehydrogenase levels in renal infarction. JAMA 1979;242:268-269. 82. Beroniade V, Roy P, Froment D et al. Primary renal artery dissection. Presentation of two cases and brief review of the literature. Am J Nephrol 1987;7:382-389. 83. Stoney JS, Effeney DJ. Comprehensive vascular exposures. Philladelphia: Lippincot-Raven; 1998. p. 198. 84. Parfitt J, Chalmers RTA, Wolfe JHN et al. Visceral aneurysms in Ehlers-Danlos Syndrome: case report and review of the literature. J Vasc Surg 200;31:1248-51. 85. Weber T, Hanish E, Baum RP et al. Late results of heterotopic autotransplantation of splenic tissue into the great heromentum. World J Surg 1998;22:883-89. 86. Marques RG, Petroianu A, Coelho JMCO et al. Regeneration of splenicautotransplants. Ann Hematol 2002;81:622-26. 87. Matsumoto K, Ohgami M, Shirasugi N et al. A first-case report to the successful laparoscopic repair of a splenic artery aneurysm. Surgery 1988;123:247-48. 88. Arca MJ, Gagner M, Heniford BT et al. Splenic artery aneurysm: methods of laparoscopic repair. J Vasc Surg 1999;30:184-88. 89. Muscari F, Bossavy JP, Chaufour X et al. A laparoscopic exclusion of asplenic artery aneurysms: a case report. Vasc Endovasc Surg 2003;37:297-300. 90. Reardorn PR, Otah E, Craig ES et al. Laparoscopic resection of splenic artery aneurysm. Surg Endosc 2005;19:488-93. 91. Sandri JL, Bonamigo TP, Jacques CM et al. Aneurismas das artérias viscerais. In Brito CJ (Ed.). Cirurgia Vascular. Rio de Janeiro: Revinter; 2007. p. 581-94. 92. Michels NA. Collateral arterial pathways to the liver after ligation of the hepatic artery and removal of the celiac axis. Cancer 1953;6:708. 93. Barral X, Lorin S, Granmougin D et al. Chirurgie de l’artèrerenale II. Techniques Chirurgicales – ChirurgieVasculaire 43-110-B. Encycl Med Chir Paris: Elsevier; 2002. p. 15. 94. Marone E, Mascia D, Kahlberg A et al. Is open repair still the gold standard in visceral artery aneurysm management. Ann Vasc Surg 2011;25:936-46. 95. Ghariani MZ, Georg Y, Ramirez C et al. Long-term results of surgical treatment of aneuryms of digestive arteries. Ann Vasc Surg 2013;27:954-8. 96. Bockel JH, van derAkker PJ, Chang PC et al. Extracorporeal renal artery for renovascular hypertension. J Vasc Surg 1991;13:102-11. 97. Laganá D, Carrafiello G, Mangini M et al. Multimodal approach to endovascular treatment of visceral artery aneurysms and pseudoaneurysms. Eur J Radiology 2006;59:104-11. 98. Tulsyan N, Kashyap VS, Greenberg RK et al. The endovascular management of visceral artery aneurysms and pseudoaneurysms. J Vasc Surg 2007;45:276-83. 99. Fankhauser GT, Stone WM, Oderich GS et al. The minimally invasive management of visceral artery aneurysms and pseudoaneurysms. J Vasc Surg 2011;53:966-70 100. Koganemaru M, Abe T, Nonoshita M et al. Follow-up of true visceral artery aneurysms after coil embolization by threedimensional contrast-enhanced MR angiography. Diagn Interv Radiol 2014;20:129-35. 101. Young S, Shrestha P, Golzarian J. Visceral artery aneurysms: six tips from approach to treatment. Endov Today 2016;15:37-40. 102. Huang Y, Souza LR, Oderich GS, Stone WM. Visceral aneurysms. In: Oderich GS (Ed.). Mesenteric vascular Disease. New York, Springer; 1915. p. 431-457. 103. Joviliano EE, Ribeiro MS. Aneurismas esplâncnicos: como seguir e como tratar. In: Presti C (Ed.). Conceitos Atuais em Doença Vascular Periférica. São Paulo, SBAVC-SP-SENAC; 2017. p. 125-8.
15. Tilsed JV et al. ESTES guidelines: acute mesenteric ischaemia. Eur J Trauma Emerg Surg 2016 Apr;42(2):253-70.
REFERÊNCIAS
2.
4.
5.
3.
INTESTINAL AGUDA:
1.
17. Ierardi AM et al. The role of endovascular therapy in acute mesenteric ischemia. Ann Gastroenterol 2017;30(5):526-533.
26. Luther B, Mamopoulos A, Lehmann C, Klar E. The Ongoing Challenge of Acute Mesenteric Ischemia. Visc Med 2018;34:215-221. 27. Wright CB, Hobson RW. Prediction of intestinal viability using Doppler ultrasound technique. Am J Surg 1975;129:642.
16. Menke J et al. Diagnostic accuracy of multidetector CT in acute mesenteric ischemia: systematic review and meta-analysis. Radiology 2010 Jul;256(1):93-101.
ISQUEMIA DIAGNÓSTICO E TRATAMENTO BIBLIOGRÁFICAS Duran M et al. The importance of open emergency surgery in the treatment of acute mesenteric ischemia. World Journal of Emergency surgery: WJES 2015 Sep 26;10(45). estava no início do capítulo. Ottinger L, Austen WG. A study of 136 patients with mesenteric infarction. Surg Gynecol Obstet 1967;124:1251. Slater H, Elliott PW. Primary mesenteric infarction. Ann J Surg 1972;123:309. Singh RP, Shah RC, Lee ST. Acute mesenteric vascular occlusion: a review of 32 patients. Surgery 1975;78:613. Smith Jr JS, Patterson LT. Acute mesenteric infarction. Ann Surg 1976;44:744. 6. Kairaluoma MI, Karkola P, Heikkinen E et al. Mesenteric infarction. Am J Surg 1977;133:188. 7. Hertzer NR, Beven EG, Humphries AW. Acute intestinal ischemia. Am Surg 1978;44:744. 8. Sachs SM, Morton JH, Schwatrz SI. Acute mesenteric ischemia. Surgery 1982;92:646. 9. Levy PJ, Krausz MM, Manny J. Acute mesenteric ischemia: improved results: a retrospective review of ninety-two patients. Surgery 1990;107:372. 10. Heijkant T, Teijink J, Buurman W. Challenges in diagnosing mesenteric ischemia. W J Gastroenterol 2013;19(9):1338-41. 11. Ottinger LW. The surgical management of acute occlusion of the superior mesenteric artery. Ann Surg 1978;188:721.
28. Carter MS, Fantini GA, Sammartano RJ et al. Qualitative and quantitative fluorescein fluorescense in determining intestinal viability. Am J Surg 1984;147:117. 29. Pearce WH, Jones DN, Warren GH et al. The use of infrared photoplethysmography in identifying early intestinal ischemia. Arch Surg 1987;122:108. 30. Locke R, Hauser CJ, Shoemaker WC. The use of surface oximetry to assess bowel viability. Arch Surg 1984;119:1252. 31. Oohata Y, Mibu R, Hotokezaka M et al. Comparison of blood flow assessment between laser Doppler velocimetry and the hydrogen gas clearance method in ischemic intestine in dogs. Am J Surg 1990;160:511. 32. Bulkley GB, Zuidema GD, Hamilton SR et al. Intraoperative determination of small intestinal viability following ischemic injury. Ann Surg 1981;193:628. 33. Park WM, Gloviczki P, Cherry KJ Jr et al. Contemporary management of acute mesenteric ischemia: Factors associated with survival. J Vasc Surg 2002;35:445-52. 34. Flaherty MJ, Lie JT, Haggitt RC. Mesenteric inflammatory venoocclusive disease. Am J Surg Pathol 1994;18:779. 35. Ruis X, Escalante JF et al. Mesenteric infarction. World J Surg 1979;3:489-96. 36. Evans G, Yellin AE, Weaver FA et al. Sinistral (left-sided) portal hypertension. Ann Surg 1990;56:758. 37. Clavien PA, Durig M, Harder F. Venous mesenteric infarction, a particular entity. Br J Surg 1987;74:500. 38. Soper NJ, Rikkers LF, Miller FJ. Gastrointestinal hemorrhage associated with chronic mesenteric venous occlusion. Gastroenterology 1985;88:1964. 39. Miller VE, Berland LL. Pulsed Doppler duplex sonography and CT scan of portal venous thrombosis. Am J Roentgenol 1985;145:73. 40. Clavien PA, Huber O, Mirescu D et al. Contrast enhanced CT scan as a diagnostic procedure in mesenteric ischemia due to mesenteric venous thrombosis. Br J Surg 1989;76:93. 41. Subramanyam BR, Balthazar J, Lefleur RS et al. Portal venous thrombosis: correlative analysis of sonography, CT and angiography. Am J Gastroenterol 1984;79:773. 42. Rahmouni A, Mathieu D, Golli M et al. Value of CT and sonography in the conservative management of acute splenoportal and superior mesenteric venous thrombosis. Gastrointest Radiol 1992;17(2):135. 43. Naitove A, Weissman RE. Primary mesenteric venous thrombosis. Ann Surg 1965;161:516. 44. Poplausky MR, Kaufman JA, Geller SG et al. Mesenteric venous thrombosis treated with urokinase via the superior mesenteric artery. Gastroenterology 1996;110:1633. 45. Bilbao JI, Rodriguez-Cabello J, Longo J et al. Portal thrombosis: percutaneous transhepatic treatment with urokinase – A case report. Gastrointest Radiol 1989;14:326. 46. Rivitz SM, Geller SC, Hahn C et al. Treatment of acute mesenteric venous thrombosis with transjugular intramesenteric urokinase infusion. J Vasc Intervent Radiol 1995;6:219. 47. Robin P, Gruel Y, Lang M et al. Complete thrombolysis of mesenteric vein occlusion with recombinant tissue-type plasminogen activator. Lancet 1988;1(2):1391. 48. Sehgal M, Haskal ZJ. Use of transjugular intra-hepatic portosystemic shunts during lytic therapy of extensive portal splenic and mesenteric venous thrombosis: long-term follow-up. J Vasc Interv Radiol 2000;11:61-5. 49. Inahara T. Acute superior mesenteric venous thrombosis treatment by thrombectomy. Ann Surg 1971;174:956.
19. Bjornsson S, Bjorck M, Block T et al. Thrombosis for acute occlusion of the superior mesenteric artery. J Vasc Surg 2011;54:1734-42.
155 82Capítulo
20. Arthurs ZM, Titus J, Bannazadeh M et al. A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia. J Vasc Surg 2011;53:698-704.
25. Kazmers A. Intestinal ischemia caused by venous thrombosis. In: Rutherford RB. (Ed.). Vascular surgery. 5th ed. Philadelphia: WB Saunders; 2000. p. 1524-31.
12. Bala M et al. Acute mesenteric ischemia: guidelines of the World Society of Emergency Surgery. World J Emerg Surg: WJES 2017 Aug 7;12(38).
22. Ryer E, Kalra M, Oderich G et al. Revascularization for acute mesenteric ischemia. J Vasc Surg 2012;55:182-89.
13. Elliott Jr JP, Hageman JH, Szilagyi E et al. Arterial embolization: Problems of source, multiplicity, recurrence, and delayed treatment. Surgery 1980;88:833.
18. Arthurs Z, Titus J, Clair D. A comparison of endovascular revascularization with traditional therapy for the treatment os acute mesenteric ischemia. J Vasc Surg 2011;53:698-705.
21. Schermerhorn M, Giles K, Hamdan A et al. Mesenteric revascularization: management and outcomes in the United States, 1988-2006. J Vasc Surg 2009;50:341-48.
23. Bergan JJ. Recognition and treatment of intestinal ischemia. Surg Clin North Am 1967;47:109. 24. Kazmers A. Operative management of acute mesenteric ischemia. Ann Vasc Surg 1998;12:187-197
14. Silva J, White C. Ischemic bowel syndromes. Prim Care Clin Office Pract 2013;40:143-17.
54. Yanar F, Agcaoglu O, Gok AFK et al. The management of mes- enteric vein thrombosis: a single institution’s experience. Turk J Trauma Emerg Surg 2013;19(3):223-8.
Parte V156 TORACOABDOMINAL
56. Bergan JJ, McCarthy WJ, Flinn WR et al. Nontraumatic mesenteric vascular emergencies. J Vasc Surg 1987;5:903.
51. Kawauchi M, Tada Y, Asano K et al. Angiographic demonstration of mesenteric arterial changes in postcoartectomy syndrome. Surgery 1985;98:602. 52. Gewurtz BL, Zarins CK. Postoperative vasospasm after antegrade mesenteric revascularization: a report of three cases. J Vasc Surg 1991;14:382.
57. Hildebrand HD, Zierler RE. Mesenteric vascular disease. Am J Surg 1980;139:188.
50. Ende N. Infarction of the bowel in cardiac failure. N Engl J Med 1958;258:879.
53. Siegelman SS, Sprayragen S, Boley SJ. Angiographic diagnosis of mesenteric arterial vasoconstriction. Diagn Radiol 1974;112:533.
55. Boley SJ, Sprayragen S, Seigelman SS et al. Initial results from an aggressive roentgenological and surgical approach to acute mesenteric ischemia. Surgery 1977;82:848.
2. Crawford ES, Morris Jr GC, Myhre HO et al. Celiac axis, superior mesenteric artery, and inferior mesenteric artery occlusion: surgical considerations. Surgery 1977;82:856. Zelenock GB, Graham LM, Whitehouse WM et al. Splanchnic arteriosclerotic disease and intestinal angina. Arch Surg 1980;115:497. MacFarlane SD, Beebe HG. Progress in chronic mesenteric arterial ischemia. J Cardiovasc Surg 1989;30:178. Baur GM, Millay DJ, Taylor Jr LM et al. Treatment of chronic visceral ischemia. Am J Surg 1984;148:138.
14. Moneta GL, Lee RW, Yeager RL et al. Mesenteric artery duplex scanning: a blinded prospective study. J Vasc Surg 1993;17:79.
9.
11. Schneider DB, Schneider PA, Reilly LM et al. Reoperation for recurrent chronic visceral ischemia. J Vasc Surg 1998;27:276.
16. LaBombard FE, Musson A, Bowersox JC et al. Hepatic artery duplex as an adjunct in the evaluation of chronic mesenteric ischemia. J Vasc Tech 1992;16:7.
24. Laissy JP, Trillaud H, Douek P. MR angiography: noninvasive vascular imaging of the abdomen. Abdom Imaging 2002;27:488-506.
17. Moneta GL, Taylor DC, Helton WS et al. Duplex ultrasound measurement of postprandial intestinal blood flow: effect of meal composition. Gastroenterology 1988;95:1294.
157 83CapítuloISQUEMIA INTESTINAL CRÔNICA: DIAGNÓSTICO E TRATAMENTO
25. Menke J et al. Diagnostic accuracy of multidetector CT in acute mesenteric ischemia: systematic review and meta-analysis. Radiology 2010 Jul;256(1):93-101.
47.
REFERÊNCIAS BIBLIOGRÁFICAS
15. Zwolak RM, Fillinger MR, Walsh DB et al. Mesenteric and celiac duplex scanning: a validation study. J Vasc Surg 1998;27:1078.
7. Hollier LH, Bernatz PE, Pairolero PC et al. Surgical management of chronic intestinal ischemia: a reappraisal. Surgery 1981;90:940. 8. Stoney RJ, Ehrenfeld EK, Wylie EJ. Revascularization methods in chronic visceral ischemia. Ann Surg 1977;186:468. Beebe HG, MacFarlane S, Raker EJ. Supraceliac aortomesenteric bypass for intestinal ischemia. J Vasc Surg 1987;5:749. Olofsson PA, Connelly DP, Stoney RJ. Surgery of the celiac and mesenteric arteries. In: Haimovici H (Ed.). Vascular surgery: principals and techniques. Norwalk, CN: Appleton Lange; 1989. p. 750.
12. Marston A, Clarke JMF, Garcia J et al. Intestinal function and intestinal blood supply. Gut 1985;26:656.
40.
18. Gentile AT, Moneta GL, Lee RW et al. Usefulness of fasting and postprandial duplex ultrasound examinations for predicting highgrade superior mesenteric artery stenosis. Am J Surg 1995;169:476.
5.
13. Moneta GL, Yeager RL, Dalman R et al. Duplex ultrasound criteria for diagnosis of splanchnic artery stenosis or occlusion. J Vasc Surg 1991;14:511.
27. Taylor Jr LM, Porter JM. Treatment of chronic intestinal ischemia, Section in Taylor LM Jr. (guest Ed.). Mesenteric ischemia. In: Rutherford RB (Ed.) Semin Vasc Surg 1990;3:186. 28. Heiss SG, Li KC. Magnetic resonance angiography of mesenteric arteries. Invest Radiol 1998;33(9):670-81. 29. Li KC, Hopkins KL, Dalman RL et al. Simultaneous measurement of flow in the superior mesenteric vein and artery with cine phasecontrast MR imaging: value in diagnosis of chronic mesenteric ischemia. Radiology 1995;194:327-30. 30. Burkart DJ, Johnson CD, Reading CC et al. MR measurements of mesenteric venous flow: prospective evaluation in healthy volunteers and patients with suspected mesenteric ischemia. Radiology 1995;194:801-6. 31. Thomas JH, Blake K, Pierce GE et al. The clinical course of asymptomatic mesenteric arterial stenosis. J Vasc Surg 1998;27:840-44. 32. Kolkman et al. Diagnosis and treatment of chronic mesenteric ischemia: An update; Best Pract Res Clin Gastroenterol 2017 Feb; 31(1):49-57. 33. Shaw RS, Maynard EP III. Acute and chronic thrombosis of the mesenteric arteries associated with malabsorption: a report of two cases successfully treated by endarterectomy. N Engl J Med 1958;258:874. 34. Connolly JE, Stemmer EA. Intestinal gangrene as the result of mesenteric arterial steal. Am J Surg 1973;126:197. 35. Hajipour B, Somi MH, Saberifar F et al. Sinvastatin attenuates intestinal ischemia/reperfusion induced injury in rat. Folia Morphol (Warsz) 2009;68(3):156-162. 36. Slijper N, Sukhotnik I, Chemodanov E et al. Effect of simvastatin on intestinal recovery following gut ischemia-reperfusion injury in a rat. Pediatr Surg Int 2010;26(1):105-110. 37. Furrer J, Gruntzig A, Kugelmeier J et al. Treatment of abdominal angina with percutaneous dilation of an arteria mesenterica superior stenosis. Cardiovasc Intervent Radiol 1980;3:43. 38. Golden DA, Ring EJ, McLean GK et al. Percutaneous angioplasty in the treatment of abdominal angina. Am J Roentgen 1982;139:247. Odurny A, Sniderman KW, Colapinto RF. Intestinal angina: percutaneous transluminal angioplasty of the celiac and superior mesenteric arteries. Radiology 1988;167:59. Birch SJ, Colapinto FR. Transluminal dilatation in the management of mesenteric angina: a report of two cases. J Can Assoc Radiol 1982;33:46. 41. Roberts L, Wertman DA, Mills SR et al. Transluminal angioplasty of the superior mesenteric artery: an alternative to surgical revascularization. Am J Roentgen 1983;141:1039. 42. Wilms G, Baert AL. Transluminal angioplasty of superior mesenteric artery and celiac trunk. Ann Radiol 1986;29:535. 43. Levy PJ, Haskell L, Gordon RL. Percutaneous transluminal angioplasty of splanchinic arteries: an alternative method to elective revascularization in chronic visceral ischemia. Eur J Radiol 1987;7:239. 44. Mcshane MD, Proctor A, Spencer P et al. Mesenteric angioplasty for chronic intestinal ischemia. Eur J Vasc Surg 1992;6:333-36. 45. Allen RC, Martin GH, Rees CR et al. Mesenteric angioplasty in the treatment of chronic intestinal ischemia. J Vasc Surg 1996;24:415. 46. Oderich G, Bower T, Sulivan T et al. Open versus endovascular revascularization for chronic mesenteric ischemia: risk-stratified outcomes. J Vasc Surg 2009;49:1472-79. Malgor RD, Oderich GS, McKusick MA et al. Results of single and twovessel mesenteric artery stents for chronic mesenteric ischemia. Ann Vasc Surg 2010;24(8):1094-1101.
10.
39.
6. Rapp JH, Reilly LM, Qvarfordt PG et al. Durability of endarterectomy and antegrade grafts in the treatment of chronic visceral ischemia. J Vasc Surg 1986;3:799.
1. Balaz P, Rokosny S, Bafrnec J. Mesenteric ischemia, new trends, diagnostic methods and algorithms to significantly reduce mortality and morbidity. Bratisl Lek Listy 2013;114(3):158-65.
4.
19. Mitchell EL, Moneta GL. Mesenteric duplex scanning. Perspect Vasc Surg Endovasc Ther 2006;18(2):175-83.
21. Gaa J, Laub G, Edelmann RR et al. First clinical results of ultrafast, contrast-enhanced 2-phase 3D-angiography of the abdomen. Rofo 1998;169:135-39.
26. van Dijk et al. Vascular imaging of the mesenteric vasculature Best Practice & Researc Clin Gastroenterol 31 (2017) 3-14.
22. Gilfeather M, Holland GA, Siegelman ES et al. Gadolinium-enhanced ultrafast three-dimensional spoiled gradient-echo MR imaging of the abdominal aorta and visceral and iliac vessels. Radiographics 1997;17: 423-32. 23. Sun MY, Maykel JA. Ischemic colitis. Clin Colon Rectal Surg 2007;20:5-12.
20. Ginsburg M et al. ACR Appropriateness Criteria Imaging of Mesenterich Ischemia. J Am Coll Radiol 2018;15:S332-S340.
3.
58. Barret M, Martineau C, Rahmi G et al. Chronic Mesenteric Ischemia: A Rare Cause of Chronic Abdominal Pain. Am J Med 2015;128(12):1363. e1-1363.e8.
59. Oderich GS, Macedo TA, Malgor RD et al. Anatomic measurements and factors associated with embolic events during superior mesenteric artery stenting: implications for use of embolic protection devices. Society for Clinical Vascular Surgery Annual Symposium; 2009.
62. Mitchell E, Chang Y, Landry G et al. Duplex criteria for native superior mesenteric artery stenosis overestimate stenosis in stented superior mesenteric artery. J Vasc Surg 2009;50:335-40.
61. Oderich et al Comparison of covered stents versus bare metal stents for treatment of chronic atherosclerotic mesenteric arterial disease. J Vasc Surg 2013;58(5).
55. Kasirajan K, O’Hara PJ, Gray BH et al. Chronic mesenteric ischemia: open surgery versus percutaneous angioplasty and stenting. J Vasc Surg 2001;33(1):63-71. 56. Silva JA, White CJ, Collins TJ et al. Endovascular therapy for chronic mesenteric ischemia. J Am Coll Cardiol 2006;47(5):944–950.
65. Tegmeyer CJ, Selby JB. Balloon angioplasty of the visceral arteries (renal and mesenteric circulation): indications, results, and complications. In: Moore WS, Ahn SS (Eds.). Endovascular surgery Philadelphia: WB Saunders; 1989. p. 223-57. 66. Oderich GS, Macedo TA, Malgor RD et al. RR26. Natural history of mesenteric artery stent restenosis and clinical and anatomic predictors for reintervention in patients with chronic mesenteric ischemia. J Vasc Surg 2009;49(5):e1-e2-Supplement.
Parte V158 TORACOABDOMINAL
53. Erben et al. Improved mortality in treatment of patients with endovascular interventions for chronic mesenteric ischemia. J Vasc Surg 2018 June; 67(6): 1805-1812. 54. Lima et al. Endovascular Versus Surgical Revascularization for Chronic Mesenteric Ischemia: Insights From the National Inpatient Sample Database, JACC Cardiovasc Interv 2017 Dec 11;10(23):2440-2447.
48. Tallarita T, Oderich G, Macedo T et al. Reinterventions for stent restenosis in patients treated for atherosclerotic mesenteric artery disease. J Vasc Surg 2011;54:1422-29.
49. Oderich GS, Tallarita T, Gloviczki P et al. Mesenteric artery complications during angioplasty and stent placement for atherosclerotic chronic mesenteric ischemia. J Vasc Surg 2012;55(4):1063-1071.
50. Pillai et al. Quality Improvement Guidelines for Mesenteric Angioplasty and Stent Placement for the Treatment of Chronic Mesenteric Ischemia. J Vasc Interv Radiol 2018;29(5):642-647.
57. Dias NV, Acosta S, Resch T et al. Mid-term outcome of endovascular revascularization for chronic mesenteric ischaemia. Br J Surg 2010;97(2):195-201.
52. Mendes et al. Superior mesenteric artery stenting using embolic protection device for treatment of acute or chronic mesenteric ischemia. J Vasc Surg 2018;68(4):1071-1078.
63. Baker A, Chew V, Li C et al. Application of duplex ultrasound imaging in determining in-stent stenosis during surveillance after mesenteric artery revascularization. J Vasc Surg 2012;5:134-72.
64. AbuRahma A, Campbel J, Stone P et al. Perioperative and late clinical outcomes of 105 percutaneous transluminal stentings of the celiac and superior mesenteric arteries over the past decade. J Vasc Surg 2013 Apr;57(4):1052-61.
67. Mikkelsen WP. Intestinal angina: its surgical significance. Am J Surg 1957;94:262. 68. Bergan JJ, Yao JST. Chronic intestinal ischemia. In: Rutherford RB (Ed.). Vascular surgery. 3rd ed. Philadelphia: WB Saunders; 1989. p. 1097. 69. Taylor Jr LM et al. Treatment of chronic intestinal ischemia. In: Rutherford RB (Ed.). Vascular surgery 5th ed. Philadelphia: WB Saunders; 2000. p. 1532. 70. Wylie EJ, Stoney RJ, Ehrenfeld WK. Visceral atherosclerosis. In: Manual of vascular surgery. New York: Springer-Verlag, 1980. p. 211. 71. Cooley DA, Wukasch DC. Techniques in vascular surgery. Philadelphia: WB Saunders; 1979. p. 120. 72. McAfee MK, Cherry KJ, Naessens JM et al. Influence of complete revascularization on chronic mesenteric ischemia. Am J Surg 1992;164:220. 73. Gentile AT, Moneta GL, Taylor Jr LM et al. Isolated bypass to the superior mesenteric artery for intestinal ischemia. Arch Surg 1994;129:926. 74. Kieny R, Batellier J, Kretz JG. Aortic reimplantation of the superior mesenteric artery for atherosclerotic lesions of the visceral arteries: sixty cases. Ann Vasc Surg 1990;4:122. 75. Foley MI, Moneta GL, Abou-Zamzam AM et al. Revascularization of the superior mesenteric artery alone for treatment of intestinal ischemia. J Vasc Surg 2000;32:37. 76. Gewertz BL, Zarins CK. Postoperative vasospasm after antegrade mesenteric revascularization: a report of three cases. J Vasc Surg 1991;14:382. 77. Ryer E, Oderich G, Bower T et al. Differences in anatomy and outcomes in patients treated with open mesenteric revascularization before and after the endovascular era. J Vasc Surg 2011;53:111-18.
60. Oderich et al. Multicenter study of retrograde open mesenteric artery stenting through laparotomy for treatment of acute and chronic mesenteric ischemia. J Vasc Surg 2018;68(2):470-480.e1.
51. Oderich G, Tallarita T, Gloviczki P et al. Mesenteric artery complications during angioplasty and stent placement for atherosclerotic chronic mesenteric ischemia. J Vasc Surg 2012;55:103-71.
14. Hallstrom S, Koidl B, Muller U et al. Cardiodepressant factor isolated from blood blocks Ca2+ current in cardiomyocytes. Am J Physiol 1991;260;H869-76.
19. Park PO, Haglund U, Bulkely GB et al. The sequence of development of intestinal tissue injury following strangulation ischemia and reperfusion. Surgery 1990;107:574-80.
28. Perko MJ, Schroeder TV, Geroulakos G. Management of acute visceral ischemia. In: Geroulakos G, Cherry KJ. (Ed.). Diseases of the visceral circulation. London: Arnold; 2002. p. 80-87, cap. 6. 29. Freitas B, Bausback Y, Schuster J, Ulrich M, Bräunlich S, Schmidt A, Scheinert D. Thrombectomy Devices in the Treatment of Acute Mesenteric Ischemia: Initial Single-Center Experience. Ann Vasc Surg. 2018 Aug;51:124-131. 30. Resch TA, Acosta S, Sonesson B. Endovascular techniques in acute arterial mesenteric ischemia. Semin Vasc Surg 2010 Mar;23(1):29-35. 31. Grendell JH, Ockner RK. Mesenteric venous thrombosis. Gastroenterology 1982;82:358-72. 32. Grisham A, Lohr J, Guenther JM et al. Deciphering mesenteric venous thrombosis: Imaging and treatment. Vasc Endovasc Surg 2005;39:473-79. 33. Abdu RA, Zakhour BJ, Dalli DJ. Mesenteric venous thrombosis – 1911 to 1984. Surgery 1987;101:383-88. 34. Rhee RY, Glovieczki P, Mendonca CT et al. Mesenteric venous thrombosis: still a lethal disease in the 1990s. J Vasc Surg 1994;20:688-97. 35. Harward TRS, Green D, Bergan JJ et al. Mesenteric venous thrombosis. J Vasc Surg 1989;9:328-33. 36. Brunaud L, Antunes L, Collinet-Adler S et al. Acute mesenteric venous thrombosis: Case for nonoperative treatment. J Vasc Surg 2001;34:673-79. 37. Paquet KJ, Raschke E, Popov S et al. The fibrinolytic therapy of thrombosed portal vein and shunts in liver cirrhosis with portal hypertension and prehepatic block. J Cardiovasc Surg 1971;12:147-51. 38. Hollingshead M, Burke CT, Mauro MA et al. Transcatheter thrombolytic therapy for acute mesenteric and portal vein thrombosis. J Vasc Interv Radiol 2005;16:651-61. 39. Yankes JR, Uglietta JP, Grant J et al. Percutaneous transhepatic recanalization and thrombolysis of the superior mesenteric vein. AJR 1988;151:289-90. 40. Goldberg MF, Kim HS. Threatment of acute superior mesenteric vein thrombosis with percutaneous techniques. AJR 2003;181:1305-7. Leung DA, Matsumoto AH, Hagspiel KD et al. Endovascular Interventions for Acute and Chronic Mesenteric Ischemia. In: Baum S, Pentecost M. (Ed.). Abram’s angiography: interventional radiology. Philadelphia: Lippincott Williams Wilkins; 2005. p. 398-414, cap. 63. 42. Henao EA, Bohannon WT, Silva Jr MB. Treatment of portal venous thrombosis with selective superior mesenteric artery infusion of recombinant tissue plasminogen activator. J Vasc Surg 2003;38:1411-15. 43. Uflacker R, Alves M, Cantisani GG et al. Treatment of portal vein obstruction by percutaneous transhepatic angioplasty. Gastroenterology 1985;88:176-80. 44. Bilbao JI, Vivas I, Elduayen B et al. Limitations of percutaneous techniques in the treatment of portal vein thrombosis. Cardiovasc Intervent Radiol 1999;22:417-22. 45. Uflacker R. Mechanical thrombectomy in acute and subacute thrombosis with use of the Amplatz device: arterial and venous applications. J Vasc Interv Radiol 1997;8:923-32. Uflacker R. Applications of percutaneous mechanical thrombectomy in transjugular intrahepatic portosystemic shunt and portal vein thrombosis. Tech Vasc Interv Radiol 2006;6:59-69.
3. Perko MJ, Schroeder TV, Geroulakos G. Management of acute visceral ischemia. In: Geroulakos G, Cherry KJ (Ed.). Diseases of the visceral circulation. London: Arnold; 2002, cap. 6.
ISQUEMIA – TRATAMENTO POR CATETER
24. Rheudasil JM, Stewart MT, Shellack JV et al. Surgical treatment of chronic mesenteric artery insufficiency. J Vasc Surg 1988;8:495-500.
17. Chiu CJ, McArdle AH, Brown R et al. Intestinal mucosal lesion in lowflow states. Arch Surg 1970;101:478-83.
10. Folkow B, Lewis DH, Lundgren O et al. The effect of graded vasoconstrictor fibre stimulation on the intestinal resistance and capacitance vessels. Acta Phyiol Scand 1964;61:445-57.
41.
159 84Capítulo
46.
9. Folkow B, Lewis DH, Lundgren O et al. The effect of the sympathetic vasoconstrictor fibres on the distribution of capillary blood flor in the intestine. Acta Physiol Scand 1964;61:458-66.
18. Bounous G. Acute necrosis of the intestinal mucosa. Gastroenterology 1982;82:1457-67.
16. Hashimoto E, Thal AP. The lung lesion produced by materials released from the superior mesenteric vein after superior mesenteric arterial occlusion. Jpn Circ J 1971;35:1071-80.
5. Boley SJ, Brandt LJ. Mesenteric ischemia. In: Baum S, Pentecost MJ (Ed.). Abrams’ angiography interventional radiology. Philadelphia, Lippincott Williams & Wilkins; 2005. p. 1615-35, cap. 63.
27. Aakhus T, Evensen A. Angiography in acute superior mesenteric arterial insufficiency. Acta Radiol 1978;19;945.
13. Lundgren O, Haglund U. On the chemical nature of the blood borne cardiotoxic material released from the feline small bowel in regional shock. Acta Physiol Scand 1978;103:59-70.
2. Ende N. Infarction of the bowel in cardiac failure. N Engl J Med 1958;258:879.
15. Farrington GH, Saravis CA, Cossette GR et al. Blood-borne factors in the pulmonary response to sepsis (acute experimental peritonitis). Surgery 1970;68:136-44.
REFERÊNCIAS BIBLIOGRÁFICAS
20. Fine J, Frank ED, Ravin HA et al. The bacterial factor in traumatic shock. New Engl J Med 1959;260:214-20. 21. Deitch EA. Multiple organ failure. Pathophysiology and potential future therapy. Ann Surg 1992;216:117-34.
4. Landis MS, Rajan DK, Simons ME et al. Percutaneous management of chronic mesenteric ischemia: Outcomes after intervention. J Vasc Interv Radiol 2005;16:1319-25.
23. Sedman PC, Macfie J, Sager P et al. The prevalence of gut translocation in humans. Gastroenterology 1994;107:643-49.
25. Boley SJ, Sprayregen S, Siegelman SS et al. Initial results from an aggressive approach to acute mesenteric ischemia. Surgery 1977;82:848. 26. Aakhus T, Brabrand G. Angiography in acute superior mesenteric arterial insufficiency. Acta Radiol 1967;6:1.
12. Lillehei RC. The intestinal factor in irreversible hemorrhagic shock. Surgery 1957;42:1043-54.
6. Johnson PC, Hanson KM. Effect of arterial pressure on arterial and venous resistance of intestine. J Appl Physiol 1962;17:503-8. 7. Haglund UH. Pathophysiology of the visceral circulation. In: Geroulakos G, Cherry KJ (Ed.). Diseases of the visceral circulation London: Arnold; 2002. cap. 2. 8. Folkow B. Regional adjustments of intestinal blood flow. Gastroenterology 1967;52:423-432.
1. Boley SJ, Sprayregen S, Veith JF et al. An aggressive roentgenologic and surgical approach to acute mesenteric ischemia. In: Nyhus N (Ed.). Surgery annual. New York. Appleton-Century-Crofts, 1973.
VISCERAL
22. Brathwaite CEM, Ross SE, Nagele R et al. Bacterial translocation occurs in humans after traumatic injury: evidence using immunofluorescence. J Trauma 1993;34:586-90.
11. Lundgren O. Studies on blood flow distribution and countercurrent exchange in the small intestine. Acta Physiol Scand Suppl 1967;303:1-42.
69. Oderich GS, Macedo TA, Malgor R et al. Natural history of mesenteric artery stent restenosis and clinical and anatomic predictors for re-intervention in patients with mesenteric ischemia. J Vasc Surg 2009;49(1 Suppl):54S. 70. Tallarita T, Oderich GS, Macedo TA et al. Reinterventions for stent restenosis in patients treated for atherosclerotic mesenteric artery disease. J Vasc Surg 2011;54(5):1422-29.
72. Binns JC, Isaacson P. Age-related changes in the colonic blood supply: their relevance to ischaemic colitis. Gut 1978;19:384-90. 73. Wittenberg J, Athanasoulis CA, Williams Jr LF. Ischemic colitis. Radiology and pathophysiology. Am J Roentgenol 1975;123:287-300. 74. Lewis MI. Reversible ischemic colitis. Dis Colon Rectum 1973;16:121-26. 75. Reeders JW, Rosenbusch G, Tytgat GN. Ischaemic colitis associated with carcinoma of the colon. Eur J Radiol 1982;2:41-47.
77. Dutton-Gaddis JG, Oyekan TB, Haraway GD et al. Middle colic artery rupture in a patient with ANCA associated vasculitis: a case report. J Okla State Med Assoc 2004 Sept.;97(9):364-66.
50. Boley SJ, Brandt LJ. Mesenteric ischemia. In: Baum S, Pentecost M. (Ed.). Abram’s angiography: interventional radiology. Philadelphia: Lippincott Williams Wilkins; 2002. p. 1615-35, cap. 63.
78. Gaubitz M, Domschke W. Intestinal vasculitis – A diagnostictherapeutic challenge. Z Gastroenterol 2000;38:181-92.
53. Beger H, Apitzsch D, Meves M. Die arteria coelica-kompression. Langenbecks Arch Chir 1976;341:253-69. 54. Reilly L, Ammar A, Stoney R et al. Late results following operative repair for celiac artery compression syndrome. J Vasc Surg 1985;2:79-91.
56. Antonsson JB, Boyle CC 3rd, Kruithoff KL et al. Validation of tonometric measurement of gut intramural pH during endotoxemia and mesenteric occlusion in pigs. Am J Physiol 1990;59(4):519-23.
68. Razavi M, Chung HH. Endovascular management of chronic mesenteric ischemia. Tech Vasc Interv Radiol 2004;7:155-59.
48. Rossi C, Zambruni A, Ansaloni F et al. Combined mechanical and pharmacologic thrombolysis for portal vein thrombosis in liver-graft recipients and in candidates for liver transplantation. Transplantation 2004;78:938-40. Elliott JW. The operative relief of gangrene of the intestine due to occlusion of the mesenteric vessels. Ann Surg 1895;21:9.
60. Mensink PB, Geelkerken RH, Huisman AB et al. Twenty-four hour tonometry in patients suspected of chronic gastrointestinal ischemia. Dig Dis Sci 2008;53(1):133-39.
85.
65. Landis MS, Rajan DK, Simons ME et al. Percutaneous management of chronic mesenteric ischemia: outcomes after intervention. J Vasc Interv Radiol 2005;16:1319-25.
76. Tervaert JW, Boeve WJ, Kolkman JJ et al. Gastrointestinal surgery and gastroenterology. Mesenteric abnormalities in generalized vascular disease. Ned Tijdschr Geneeskd 2002;146:250-55.
84.
86.
67. Sivamurthy N, Rhodes JM, Lee D et al. Endovascular versus open mesenteric revascularization: immediate benefits do not equate with short-term functional outcomes. J Am Coll Surg 2006;202:859-67.
58. Kolkman JJ, Groeneveld AB, van Der Berg FG et al. Increased gastric PCO2 during exercise is indicative of gastric ischaemia: a tonometric study. Gut 1999;44(2):163-67.
49.
51. Bergqvist D. Celiac artery compression syndrome. In: Geroulakos G, Cherry KJ. (Ed.). Diseases of the visceral circulation. London: Arnold; 2002. p. 80-87, cap. 6.
55. Colapinto R, McLoughlin M, Weisbrod G. The routine lateral aortogram and the celiac compression syndrome. Radiology 1972;103:557-63.
79. Jennette JC, Falk RJ, Andrassy K et al. Nomenclature of systemic vasculitis. Arthritis Rheum 1994;37:187-92. 80. Hunder CG, Arend WP, Bloch DA et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Arthritis Rheum 1990;33:1065-67. 81. Alarcon-Segovia D. The necrotizing vasculitides: a new pathogenic classification. Med Clin North Am 1977;61:241-60. 82. Fauci AS, Haynes BF, Katz P. The spectrum of vasculitis: clinical, pathologic, immunologic, and therapeutic considerations. Ann Intern Med 1978:89;660-76. 83. Pagnoux C, Mahr A, Cohen P et al. Presentation and outcome of gastrointestinal involvement in systemic necrotizing vasculitides: analysis of 62 patients with polyarteritis nodosa, microscopic polyangiitis, Wegener granulomatosis, Churg-Strauss syndrome, or rheumatoid arthritis-associated vasculitis. Medicine 2005;84:115-28. Jennette JC, Falk RJ. Small-vessel vasculitis. N Engl J Med 1997;20:1512-23. Ha HK, Lee SH, Rha SE et al. Radiologic features of vasculitis involving the gastrointestinal tract. Radiographics 2000;20:779-94. Reiman S, Fisher R, Dodds C et al. Mesenteric arteriographic findings in a patient with Strongyloides stercoralis hyperinfection. JVIR 2002;13:635-38.
59. Otte JA, Geelkerken RH, Oostveen E et al. Clinical impact of gastric exercise tonometry on diagnosis and management of chronic gastrointestinal ischemia. Clin Gastroenterol Hepatol 2005;3(7):660-66.
57. Kolkman JJ, Otte JA, Groeneveld AB. Gastrointestinal luminal PCO2 tonometry: an update on physiology, methodology and clinical applications. Br J Anaesth 2000;84(1):74-86.
64. Jimenez JG, Huber TS, Ozaki CK et al. Durability of antegrade synthetic aortomesenteric bypass for chronic mesenteric ischemia. J Vasc Surg 2002;35:1078-84.
Parte V160 TORACOABDOMINAL 47. Lopera JE, Correa G, Brazzini A et al. Percutaneous transhepatic treatment of symptomatic mesenteric venous thrombosis. J Vasc Surg 2002;36:1058-61.
63. Oderich GS, Erdoes LS, Lesar C, Mendes BC, Gloviczki P, Cha S, Duncan AA, Bower TC. Comparison of covered stents versus bare metal stents for treatment of chronic atherosclerotic mesenteric arterial disease. J Vasc Surg 2013 Nov;58(5):1316-23.
66. Sharafuddin MJ, Olson CH, Sun S et al. Endovascular treatment of celiac and mesenteric arteries stenoses: applications and results. J Vasc Surg 2003;38:692-98.
62. Uflacker R, Goldany MA, Constant S. Resolution of mesenteric angina with percutaneous transluminal angioplasty of a superior mesenteric artery stenosis using a balloon catheter. Gastrointest Radiol 1980;5:367-69.
61. van Petersen AS, Kolkman JJ, Beuk RJ et al. Multidisciplinary Study Group of splanchnic ischemia. Open or percutaneous revascularization for chronic splanchnic syndrome. J Vasc Surg 2010;51(5):1309-16.
52. Harjola PT. A rare obstruction of the coeliac artery. Report of a case. Ann Chir Gynaecol Fenn 1963;2:547-50.
71. Meyers MA. Griffiths’ point: critical anastomosis at the splenic flexure. Significance in ischemia of the colon. Am J Roentgenol 1976;126:77-94.
9. Wong JM, Hansen KJ, Oskin TC et al. Surgery after failed percutaneous renal artery angioplasty. J Vasc Surg 1999;30:468-82.
8. Dean RH, Callis JT, Smith BM, Meacham PW. Failed percutaneous transluminal renal angioplasty: experience with lesions requiring operative intervention. J Vasc Surg 1987;6:301-7.
17. Martinez AG, Novick AC, Hayes JM. Surgical treatment of renal artery stenosis after failed percutaneous transluminal angioplasty. J Urol 1990;144:1094-6. 18. Edwards MS, Craven BL, Stafford J et al. Distal embolic protection during renal artery angioplasty and stenting. J Vasc Surg 2006;44:128-35.
7. Balzer KM, Neuschafer S, Sagban TA et al. Renal artery revascularization after unsuccessful percutaneous therapy: a single centre experience. Langenbecks Arch Surg 2012;397:111-5.
26. Ritchie J, Chrysochou C, Kalra PA. Contemporary management of atherosclerotic renovascular disease: before and after ASTRAL. Nephrology (Carlton) 2011;16:457-67. 27. Tobe SW, Atri M, Perkins N, Pugash R, Bell CM. Renal athersosclerotic revascularization evaluation (RAVE study): study protocol of a randomized trial [NCT00127738]. BMC Nephrol 2007;8:4.
6. Abela R, Ivanova S, Lidder S, Morris R, Hamilton G. An analysis comparing open surgical and endovascular treatment of atherosclerotic renal artery stenosis. Eur J Vasc Endovasc Surg 2009;38:666-75.
13. Stanley JC, Criado E, Upchurch GR Jr et al. Pediatric renovascular hypertension: 132 primary and 30 secondary operations in 97 children. J Vasc Surg 2006;44:1219-28; discussion 28-9.
1. Cherr GS, Hansen KJ, Craven TE et al. Surgical management of atherosclerotic renovascular disease. J Vasc Surg 2002;35:236-45.
15. Fiala LA, Jackson MR, Gillespie DL, O’Donnell SD, Lukens M, Gorman P. Primary stenting of atherosclerotic renal artery ostial stenosis. Ann Vasc Surg 1998;12:128-33.
161 85CapítuloCIRURGIA DA ARTÉRIA RENAL NA ERA DA INTERVENÇÃO ENDOVASCULAR REFERÊNCIAS BIBLIOGRÁFICAS
14. Rocha-Singh KJ, Mishkel GJ, Katholi RE et al. Clinical predictors of improved long-term blood pressure control after successful stenting of hypertensive patients with obstructive renal artery atherosclerosis. Catheter Cardiovasc Interv 1999;47:167-72.
3. Kashyap VS, Schneider F, Ricco JB. Role of interventions for atherosclerotic renal artery stenoses. J Vasc Surg 2011;54:563-70;discussion 70. 4. Investigators A, Wheatley K, Ives N et al. Revascularization versus medical therapy for renal-artery stenosis. N Engl J Med 2009;361:1953-62.
5. Cooper CJ, Murphy TP, Cutlip DE et al. Stenting and medical therapy for atherosclerotic renal-artery stenosis. N Engl J Med 2014;370:13-22.
2. Hansen KJ, Cherr GS, Craven TE et al. Management of ischemic nephropathy: dialysis-free survival after surgical repair. J Vasc Surg 2000;32:472-81; discussion 81-2.
10. Lacombe M, Ricco JB. Surgical revascularization of renal artery after complicated or failed percutaneous transluminal renal angioplasty. J Vasc Surg 2006;44:537-44.
11. Knipp BS, Dimick JB, Eliason JL et al. Diffusion of new technology for the treatment of renovascular hypertension in the United States: surgical revascularization versus catheter-based therapy, 1988-2001. J Vasc Surg 2004;40:717-23.
16. Novick AC. Management of renovascular disease. A surgical perspective. Circulation 1991;83:I167-71.
12. Murphy TP, Soares G, Kim M. Increase in utilization of percutaneous renal artery interventions by medicare beneficiaries, 1996-2000. AJR Am J Roentgenol 2004;183:561-8.
19. Cambria RP, Brewster DC, L’Italien G et al. Simultaneous aortic and renal artery reconstruction: evolution of an eighteen-year experience. J Vasc Surg 1995;21:916-24; discussion 25. 20. Lacombe M. Traitement chirurgical des lésions artérielles rénales chez l’enfant. Chirurgie 1999;124:264-71. 21. O’Neill JA, Jr. Long-term outcome with surgical treatment of renovascular hypertension. J Pediatr Surg 1998;33:106-11. 22. McTaggart SJ, Gulati S, Walker RG, Powell HR, Jones CL. Evaluation and long-term outcome of pediatric renovascular hypertension. Pediatr Nephrol 2000;14:1022-9. 23. Moncure AC, Brewster DC, Darling RC, Abbott WM, Cambria RP. Use of the gastroduodenal artery in right renal artery revascularization. J Vasc Surg 1988;8:154-9. 24. Murray SP, Kent C, Salvatierra O, Stoney RJ. Complex branch renovascular disease: management options and late results. J Vasc Surg 1994;20:338-45; discussion 46. 25. Martinez A, Novick AC, Cunningham R, Goormastic M. Improved results of vascular reconstruction in pediatric and young adult patients with renovascular hypertension. J Urol 1990;144:717-20.
19. Mehrabi A, Fonouni H, Wente M et al. Wound complications following kidney and liver transplantation. Clin Transplant 2006;20 Suppl 17:97-110. LEITURAS SUGERIDAS Almueilo SH, Alsulaiman RM. Acute colonic pseudo-obstruction caused by mycophenolate mofetil in a kidney transplant recipient. Exp Clin Transplant 2015;13(2):196-199. Danovitch GM. Handbook of kidney transplantation. 5th ed. Lippincott Williams & Wilkins; 2010. Duty BD, Barry JM. Diagnosis and management of ureteral complications following renal transplantation. Asian J Urol 2015;2(4):202-207. Golriz M, Klauss M, Zeier M, Mehrabi A. Prevention and management of lymphocele formation following kidney transplantation. Transplant Rev (Orlando) 2017;31(2):100-105. Haberal M, Boyvat F, Akdur A et al. Surgical Complications After Kidney Transplantation. Exp Clin Transplant 2016;14(6):587-595. Hernández D, Rufino M, Armas S et al. Retrospective analysis of surgical complications following cadaveric kidney transplantation in the modern transplant era. Nephrol Dial Transplant Kolli2006;21(10):2908-2915KP,LaBergeJM.Interventional Management of Vascular Renal Transplant Complications. Tech Vasc Interv Radiol 2016;19(3):228-236. Koneru B, Selby R, O’Hair DP et al. Nonobstructing colonic dilatation and colon perforations following renal transplantation. Arch Surg Lucewicz1990;125(5):610-613.A,WongG,Lam VW et al. Management of primary symptomatic lymphocele after kidney transplantation: a systematic review. Transplantation 2011;92(6):663-673. Makrantonaki E, Wlaschek M, Scharffetter-Kochanek K. Pathogenesis of wound healing disorders in the elderly. J Dtsch Dermatol Ges 2017;15(3):255 275. Moris D, Bokos J, Vailas M et al. Renal paratransplant hernia revealed: a review of the literature. Hernia 2017;21(3):363-367. Morris P, Knechtle SJ. Kidney Transplantation – principles and practice. 6th ed. Philadelphia (PA): Elsevier Saunders; 2014. Ngo AT, Markar SR, De Lijster MS et al. A Systematic Review of Outcomes Following Percutaneous Transluminal Angioplasty and Stenting in the Treatment of Transplant Renal Artery Stenosis. Cardiovasc Intervent Radiol O’Callaghan2015;38(6):1573-1588.JM,MorganRD,Knight SR, Morris PJ. Systematic review and meta-analysis of hypothermic machine perfusion versus static cold storage of kidney allografts on transplant outcomes. Br J Surg 2013 PelleritoJul;100(8):991-1001.J,PolakJF.Introdução à Ultrassonografia Vascular. 6. ed. São Paulo: Elsevier Brasil; 2013. Pereira AFM, Galante NZ, Park SI et al. Fatores de risco para deiscência de ferida cirúrgica em receptores de transplante renal. J Bras Nefrol Røine2008;30(3):200-204.E,BjørkIT,OyenO. Targeting risk factors for impaired wound healing and wound complications after kidney transplantation. Transplant Proc 2010;42(7):2542-2546. Sugi MD, Albadawi H, Knuttinen G et al. Transplant artery thrombosis and outcomes. Cardiovasc Diagn Ther 2017;7(Suppl 3):S219-S227. Taha M, Davis NF, Power R et al. Increased mid-abdominal circumference is a predictor for surgical wound complications in kidney transplant ecipients: A prospective cohort study. Clin Transplant 2017;31(5). Valente JF, Hricik D, Weigel K et al. Comparison of sirolimus vs. mycophenolate mofetil on surgical complications and wound healing in adult kidney transplantation. Am J Transplant 2003;3(9):1128-1134. Voiculescu A, Schmitz M, Hollenbeck M et al. Management of arterial stenosis affecting kidney graft perfusion: a single-centre study in 53 patients. Am J Transplant 2005;5(7):1731-1738. Zargar-Shoshtari MA, Soleimani M, Salimi H, Mehravaran K. Symptomatic lymphocele after kidney transplantation: a single-center experience. Urol J 2008;5(1):34-36.
12. Nashan B, Abbud-Filho M, Citterio F. Prediction, prevention, and management of delayed graft function: where are we now? Clin Transplant 2016 Oct;30(10):1198-208.
TRANSPLANTE RENAL BIBLIOGRÁFICAS
5. Huaman MA, Vilchez V, Mei X et al. Donor positive blood culture is associated with delayed graft function in kidney transplant recipients: a propensity score analysis of the UNOS database. Clin Transplant 2016 Apr;30(4):415-20.
17. Associação Brasileira de Transplante de Órgãos. Registro Brasileiro de Transplantes de 2017: Dimensionamento dos Transplantes no Brasil e em cada estado (2010-2017). In: São Paulo: Associação Brasileira de Transplante de Órgãos; 2017.
4. Moers C, Smits JM, Maathuis MH et al. Machine perfusion or cold storage in deceased-donor kidney transplantation. N Engl J Med 2009 Jan 1;360(1):7-19.
6. Redfield RR, Scalea JR, Zens TJ et al. Predictors and outcomes of delayed graft function after living-donor kidney transplantation. Transpl Int 2016 Jan;29(1):81-7.
7. Fuller BJ, Lee CY. Hypothermic perfusion preservation: the future of organ preservation revisited? Cryobiology 2007 Apr;54(2):129-45.
15. Hall IE, Bhangoo RS, Reese PP et al. Glutathione S-transferase isoenzymes in perfusate from pumped kidneys are associated with delayed graft function. Am J Transplant 2014 Apr;14(4):886-96.
16. Tedesco-Silva H Jr, Mello Offerni JC, Ayres Carneiro V et al. Randomized trial of machine perfusion versus cold storage in recipients of deceased donor kidney transplants with high incidence of delayed graft function. Transplant Direct 2017 Apr 18;3(5):e155.
18. Witte MB, Barbul A. General principles of wound healing. Surg Clin North Am 1997;77(3):509-528.
8. Calne RY, Pegg DE, Pryse-Davies J, Brown Fl. Renal preservation byicecooling: an experimental study relating to kidney transplantation from cadavers. Br Med J 1963 Sep 14;2(5358):651-5.
9. Treckmann J, Moers C, Smits JM et al. Machine perfusion versus cold storage for preservation of kidneys from expanded criteria donors after brain death. Transpl Int 2011 Jun;24(6):548-54.
REFERÊNCIAS
1. Henry SD, Guarrera JV. Protective effects of hypothermic ex vivo perfusion on ischemia/reperfusion injury and transplant outcomes. Transplant Rev 2012 Apr;26(2):163-75.
10. Siedlecki A, Irish W, Brennan DC. Delayed graft function in the kidney transplant. Am J Transplant 2011 Nov;11(11):2279-96.
162 86Capítulo
3. Yuan X, Theruvath AJ, Ge X et al. Machine perfusion or cold storage in organ transplantation: Indication, mechanisms, and future perspectives. Transpl Int 2010Jun;23(6):561-70.
11. Salvadori M, Rosso G, Bertoni E. Update on ischemia-reperfusion injury in kidney transplantation: Pathogenesis and treatment. World J Transplant 2015 Jun 24;5(2):52-67.
13. Bon D, Chatauret N, Giraud S et al. New strategies to optimize kidney recovery and preservation in transplantation. Nat Rev Nephrol 2012 May 1;8(6):339-47.
2. ABTO, Registro Brasileiro de Transplantes, ano XXII n. 3, 2017.
14. Belzer FO, Ashby BS, Gulyassy PF, Powell M. Successful seventeen-hour preservation and transplantation of human-cadaver kidney. N Engl J Med 1968 Mar 14;278(11):608-10.
Parte VI ABDÔMEN E PELVE
8. Norwood MG, Lloyd GM, Bown MJ, Fishwick G, London NJ, Sayers RD. Endovascular abdominal aortic aneurysm repair. Postgrad Med J 2007;83(975):21-7.
21. Al Jalbout N, Moreland AJ. Syncope in a middle aged female: Splenic artery aneurysm revisited. Clin Imaging 2018;52:8-10.
APLICADA À REGIÃO ABDOMINAL E PÉLVICA REFERÊNCIAS
17. Burdan F, Dworzanski W, Cendrowska-Pinkosz M, Burdan M, Dworzanska A. Anatomical eponyms - unloved names in medical terminology. Folia Morphol (Warsz) 2016;75(4):413-38.
19. Algieri RD, Ferrante MS, Ugartemendía JS, Bernadou MdlM, Pina L, Escalant AÁ. Trígono Cistohepático: Área Crítica Anatómica para la Seguridad Quirúrgica. Int J Morphol 2014;32(3):860-5.
16. Kotarac M, Radovanovic N, Lekic N, Raznatovic Z, Djordjevic V, Lekic D et al. Surgical treatment of median arcuate ligament syndrome: Case report and review of literature. Srpski Arhiv Celokupno Lekarstvo 2015;143(1-2):74-8.
14. Yakushiji E, Ota S, Komatsu T, Ayaori M, Ikewaki K. Massive Hemoptysis due to Right Inferior Phrenic Artery-to-Right Pulmonary Artery Fistula in the Right Middle Lobe of the Lung. Intern Med 2017;56(6):687-9.
165 87Capítulo
ANATOMIA BIBLIOGRÁFICAS
13. Hyun D, Cho SK, Shin SW, Park KB, Lee SY, Park HS et al. Combined transarterial chemoembolization of the right inferior phrenic artery and radiofrequency ablation for small hepatocellular carcinoma near the diaphragm: its efficacy and safety. Abdom Radiol (NY) 2018.
11. Hardman RL, Lopera JE, Cardan RA, Trimmer CK, Josephs SC. Common and rare collateral pathways in aortoiliac occlusive disease: a pictorial essay. AJR Am J Roentgenol 2011;197(3):W519-24.
6. Testut L, Jacob O. Tratado de Anatomía Topográfica con aplicaciones médicoquirúrgicas. 8.ed. Madrid: Salvat; 1952. 7. Machado R, Teixeira G, Loureiro L, Oliveira P, Almeida R. A idade e o tratamento endovascular do aneurisma da aorta abdominal. Estado da arte. Angiol Cir Vasc 2016;12(1):31-4.
22. Ozakin E, Cetinkaya O, Baloglu Kaya F, Acar N, Cevik AA. A Rare Cause of Acute Abdominal Pain: Splenic Infarct (Case Series). Turk J Emerg Med 2015;15(2):96-9. 23. Pandey SK, Bhattacharya S, Mishra RN, Shukla VK. Anatomical variations of the splenic artery and its clinical implications. Clin Anat 2004;17(6):497-502.
1. Testut L, Latarjet A. Tratado de Anatomía Humana. 9.ed. Barcelona: Salvat; 1958. 2. Latarjet M, Liard AR. Anatomía Humana. 4.ed. Madrid: Editorial Medica Pan-Americana; 2011. 3. Gardner E, Gray DJ, O’Rahilly RR. Anatomia - Estudo Regional do Corpo Humano. 4. ed. Rio de Janeiro: Guanabara Koogan; 1978. 4. Goss CM, editor. Gray Anatomia. 29.ed. Rio de Janeiro: Guanabara Koogan; 1977. 5. Alcântara ML, Santos SN, Freire CMV, Cantisano AL, Teodoro JAR, Porto CLL et al. Recomendações para Avaliação Ultrassonográfica da Aorta Abdominal e Ramos: Grupo de Trabalho do Departamento de Imagem Cardiovascular da Sociedade Brasileira de Cardiologia – DIC – SBC. Arq Bras Cardiol 2016;29(Especial):e1-e68.
24. Zeon SK, Kim SG, Huyn JA, Kim Y-S. Angiographic branching patterns of the splenic artery. Int J Angiol 1998;7(1):57-61. 25. Baranski AG, Lam HD, Braat AE, Schaapherder AF. The dorsal pancreatic artery in pancreas procurement and transplantation: anatomical considerations and potential implications. Clin Transplant 2016;30(10):1360-4. 26. Tsutsumi M, Arakawa T, Terashima T, Aizawa Y, Kageyama I, Kumaki K et al. Morphological analysis of the branches of the dorsal pancreatic artery and their clinical significance. Clin Anat 2014;27(4):645-52. 27. Loukas M, Wartmann CT, Louis RG, Jr., Tubbs RS, Ona M, Curry B et al. The clinical anatomy of the posterior gastric artery revisited. Surg Radiol Ana 2007;29(5):361-6. 28. Velasquez CA, Saeyeldin A, Zafar MA, Brownstein AJ, Erben Y. A systematic review on management of nutcracker syndrome. J Vasc Surg Venous Lymphat Disord 2018;6(2):271-8. 29. Hangge PT, Gupta N, Khurana A, Quencer KB, Albadawi H, Alzubaidi SJ et al. Degree of Left Renal Vein Compression Predicts Nutcracker Syndrome. J Clin Med 2018;7(5). 30. Roy A, Gisel JJ, Roy V, Bouras EP. Superior Mesenteric Artery (Wilkie’s) Syndrome as a Result of Cardiac Cachexia. J Gen Intern Med 2005;20(10):C3-4. 31. Lange JF, Komen N, Akkerman G, Nout E, Horstmanshoff H, Schlesinger F et al. Riolan’s arch: confusing, misnomer, and obsolete. A literature survey of the connection(s) between the superior and inferior mesenteric arteries. Am J Surg 2007;193(6):742-8. 32. Gourley EJ, Gering SA. The meandering mesenteric artery: a historic review and surgical implications. Dis Colon Rectum 2005;48(5):996-1000. 33. Dyer RB, Regan JD, Kavanagh PV, Khatod EG, Chen MY, Zagoria RJ. Percutaneous nephrostomy with extensions of the technique: step by step. Radiographics 2002;22(3):503-25. 34. Dawson DL, Hellinger JC, Terramani TT, Najibi S, Martin LG, Lumsden AB. Iliac Artery Kinking with Endovascular Therapies: Technical Considerations. J Vasc Intervent Radiol 2002;13(7):729-33. Peters M, Syed RK, Katz M, Moscona J, Press C, Nijjar V et al. MayThurner syndrome: a not so uncommon cause of a common condition. Proc (Bayl Univ Med Cent) 2012;25(3):231-3. 36. Leite TFO, Pires LAS, Goke K, Silva JG, Chagas CAA. Corona Mortis: anatomical and surgical description on 60 cadaveric hemipelvises. Rev Col Bras Cir 2017;44(6):553-9. 37. Takase K, Sawamura Y, Igarashi K, Chiba Y, Haga K, Saito H et al Demonstration of the artery of Adamkiewicz at multidetector row helical CT. Radiology 2002;223(1):39-45. 38. Amato ACM, Stolf NAG. Anatomia da circulação medular. J Vasc Bras 2015;14(3):248-52. 39. Melissano G, Civilini E, Bertoglio L, Calliari F, Campos Moraes Amato A, Chiesa R. Angio-CT imaging of the spinal cord vascularisation: a pictorial essay. Eur J Vasc Endovasc Surg 2010;39(4):436-40. 40. Al Talalwah W, Al Dorazi SA, Soames R. The origin variability of the iliolumbar artery and iatrogenic sciatica. Eur J Orthop Surg Traumatol 2015;25 Suppl 1:S199-204. 41. Rusu MC, Cergan R, Dermengiu D, Curca GC, Folescu R, Motoc AG et al. The iliolumbar artery-anatomic considerations and details on the common iliac artery trifurcation. Clin Anat 2010;23(1):93-100.
12. Chung JW, Kim HC, Choi YH, Kim SJ, Lee W, Park JH. Patterns of aortic involvement in Takayasu arteritis and its clinical implications: evaluation with spiral computed tomography angiography. J Vasc Surg 2007;45(5):906-14.
18. Tago M, Oda Y, Furukawa NE, Yamashita SI. Spontaneous dissection limited to left gastric artery. Clin Case Rep 2017;5(10):1712-3.
20. Nasser HA, Kansoun AH, Sleiman YA, Mendes VM, Van Vyve E, Kachi A et al. Different laparoscopic treatment modalities for splenic artery aneurysms: about 3 cases with review of the literature. Acta Chir Belg 2018:1-7.
15. Moore KL, Dalley II AF, Agur AMR. Clinically oriented anatomy. 7.ed. Philadelphia: Lippincott Williams & Wilkins; 2014.
10. Bourantas CV, Loh HP, Sherwi N, Tweddel AC, de Silva R, Lukaschuk EI et al. Atherosclerotic disease of the abdominal aorta and its branches: prognostic implications in patients with heart failure. Heart Fail Rev 2012;17(2):229-39.
35.
9. Mikolajczyk-Stecyna J, Korcz A, Gabriel M, Pawlaczyk K, Oszkinis G, Slomski R. Risk factors in abdominal aortic aneurysm and in Polish population aortoiliac occlusive disease and differences between them [corrected]. Sci Rep 2013;3:3528.
61. Scholten A, Cisco RM, Vriens MR, Shen WT, Duh QY. Variant adrenal venous anatomy in 546 laparoscopic adrenalectomies. JAMA Surg 2013;148(4):378-83.
74. LePage PA, Villavicencio JL, Gomez ER, Sheridan MN, Rich NM. The valvular anatomy of the iliac venous system and its clinical implications. J Vasc Surg 1991;14(5):678-83.
47. Tubbs RS, Shoja MM, Loukas M, editors. Bergman’s Comprehensive Encyclopedia of Human Anatomic Variation. New Jersey: Wiley Blackwell; 2016. 48. Bergman RA, Thompson SA, Afifi AK, Saadeh F. Compendium of human anatomic variation: text, atlas and world literature. Baltimore: Urban & Schwarzenberg; 1988. Noussios G, Dimitriou I, Chatzis I, Katsourakis A. The Main Anatomic Variations of the Hepatic Artery and Their Importance in Surgical Practice: Review of the Literature. J Clin Med Res 2017;9(4):248-52.
166 Parte VIABDÔMEN E PELVE
55. Baque P, Karimdjee B, Iannelli A, Benizri E, Rahili A, Benchimol D et al. Anatomy of the presacral venous plexus: implications for rectal surgery. Surg Radiol Anat 2004;26(5):355-8.
57. Beckett D, Dos Santos SJ, Dabbs EB, Shiangoli I, Price BA, Whiteley MS. Anatomical abnormalities of the pelvic venous system and their implications for endovascular management of pelvic venous reflux. Phlebology 2017:268355517735727.
53. Lolis E, Panagouli E, Venieratos D. Study of the ascending lumbar and iliolumbar veins: surgical anatomy, clinical implications and review of the literature. Ann Anat 2011;193(6):516-29.
50. Meissner MH. Lower Extremity Venous Anatomy. Semin Intervent Radiol 2005;22(3):147-56.
46. Kandhari VK, Desai MM, Bava SS, Wade RN. Avascular Necrosis of Acetabulum: The Hidden Culprit of Resistant Deep Wound Infection and Failed Fixation of Fracture Acetabulum - A Case Report. J Orthop Case Rep 2015;5(4):36-9.
Evaluation of the origin and branching patterns of the iliolumbar artery and its implications on pelvic and vertebral surgery. Saudi Med J 2016;37(4):457-60.
42. Koc T, Gilan IY, Aktekin M, Kurtoglu Z, Dagtekin A, Aytac G et al
62. Skandalakis JE, Skandalakis LJ, Skandalakis PN, Mirilas P. Hepatic surgical anatomy. Surg Clin North Am 2004;84:413-35.
56. Cicinelli E, Einer-Jensen N, Galantino P, Alfonso R, Nicoletti R. The vascular cast of the human uterus: from anatomy to physiology. Ann N Y Acad Sci 2004;1034:19-26.
60. Bubb K, du Plessis M, Hage R, Tubbs RS, Loukas M. The internal anatomy of the inferior vena cava with specific emphasis on the entrance of the renal, gonadal and lumbar veins. Surg Radiol Anat 2016;38(1):107-14.
51. Goke K, Pires LAS, Leite TFdO, Chagas CAA. Rare origin of the obturator artery from the external iliac artery with two obturator veins. J Vasc Bras 2016;15(3):250-3.
72. Ito T, Ikeda Y. A case of double inferior vena cava with renal, ovarian and iliac vein variation. Anat Sci Int 2018;93(1):139-43. 73. Onkar D, Onkar P, Mitra K. Isolated bilateral external iliac vein aplasia. Surg Radiol Anat 2013;35(1):85-7.
54. Wieslander CK, Rahn DD, McIntire DD, Marinis SI, Wai CY, Schaffer JI et al. Vascular anatomy of the presacral space in unembalmed female cadavers. Am J Obstet Gynecol 2006;195(6):1736-41.
45. Han Y, Liu P, Chen C, Duan H, Chen L, Xu Y et al. A digital anatomical study of the corona mortis in females. Minim Invasive Ther Allied Technol 2017;26(2):111-8.
43. Teli CG, Kate NN, Kothandaraman U. Morphometry of the iliolumbar artery and the iliolumbar veins and their correlations with the lumbosacral trunk and the obturator nerve. J Clin Diagn Res 2013;7(3):422-6.
69. Giambelluca D, Caruana G, Cannella R, Picone D, Midiri M. The “caput medusae” sign in portal hypertension. Abdom Radiol (NY). 2018 Sep;43(9):2535-2536. 70. Khan UD. Mondor disease: a case report and review of the literature. Aesthet Surg J 2009;29(3):209-12. 71. Sharma M, Rameshbabu CS. Collateral pathways in portal hypertension. J Clin Exp Hepatol 2012;2(4):338-52.
67. Pires LAS, Chagas CAA, Leite TFO, Babinski MA. Accessory Hepatic Veins and Their Surgical Implication. Academia Anatomica International 2018;4(1). 68. Cestaro G, Furino E, Solimeno G, Gentile M, Benassai G, Massa S et al. The role of superficial epigastric vein sparing in the treatment of chronic venous disease: A retrospective study. Acta Phlebologica 2014;15(3):143-7.
59. Cardinot TM, Aragao AH, Babinski MA, Favorito LA. Rare variation in course and affluence of internal iliac vein due to its anatomical and surgical significance. Surg Radiol Anat 2006;28(4):422-5.
58. Hayashi S, Naito M, Hirai S, Terayama H, Miyaki T, Itoh M et al Proposal for a new classification of variations in the iliac venous system based on internal iliac veins: a case series and a review of double and left inferior vena cava. Anat Sci Int 2013;88(4):183-8.
49.
63. Elsayes KM, Shaaban AM, Rothan SM, Javadi S, Madrazo BL, Castillo RP et al. A Comprehensive Approach to Hepatic Vascular Disease. Radiographics 2017;37(3):813-36. 64. Chu Q, Li Z, Zhang S-M, Hu D-Y, Xiao M. Relationship between encephalopathy and portal vein-vena cava shunt: Value of computed tomography during arterial portography. World J Gastroenterol 2004;10(13):1939-42.
75. Cavalcante LP, Souza JEdS, Pereira RM, Bernardes MV, Amanajás AMdS, Parisati MH, et al. Iliac vein compression syndrome: literature review. J Vasc Bras 2015;14(1):78-83. 76. Rozen WM, Tran TM, Ashton MW, Barrington MJ, Ivanusic JJ, Taylor GI. Refining the course of the thoracolumbar nerves: a new understanding of the innervation of the anterior abdominal wall. Clin Anat 2008;21(4):325-33. 77. Modaghegh MS, Hafezi S. Endovascular Treatment of Thromboangiitis Obliterans (Buerger’s Disease). Vasc Endovascular Surg 2018;52(2):124-30. 78. Maguire SC, Fleming CA, O’Brien G, McGreal G. Lumbar sympathectomy can improve symptoms associated with ischaemia, vasculitis, diabetic neuropathy and hyperhidrosis affecting the lower extremities-a single-centre experience. Ir J Med Sci 2018 Nov;187(4):1045-1049. 79. Cacione DG, Moreno DH, Nakano LC, Baptista-Silva JC. Surgical sympathectomy for Buerger’s disease. JRSM Open 2017;8(8):2054270417717666. 80. Prabhakar D, Venkat D, Cooper GS. Celiac Axis Compression Syndrome: A Syndrome of Delayed Diagnosis? Gastroenterol Hepatol 2017;13(3):192-4. 81. Rongies-Kosmol M, Jakimowicz T. Celiac artery compression syndrome. Mini-review. Acta Angiol 2015;21(1):21-4. 82. Sisu AM, Stana LG, Petrescu CI, Motoc A. Macroscopic, mesoscopic and microscopic morphology of the gastric plexus – ontogeny of the celiac ganglion. Rom J Morphol Embryol 2012;53(3):591-6. 83. Kaplan R, Schiff-Keren B, Alt E. Aortic Dissection as a Complication of Celiac Plexus Block. Anesthesiology 1995;83:632-5. 84. Sett SS, Taylor DC. Aortic pseudoaneurysm secondary to celiac plexus block. Ann Vasc Surg 1991;5(1):88-91. 85. Zhang XM, Zhao QH, Zeng NL, Cai CP, Xie XG, Li CJ et al. The celiac ganglia: anatomic study using MRI in cadavers. AJR Am J Roentgenol 2006;186(6):1520-3. 86. Norvell JE. The aorticorenal ganglion and its role in renal innervation. J Comp Neurol 1968;133(1):101-11. 87. Loukas M, Du Plessis M, Louis RG, Tubbs RS, Wartmann CT, Apaydin N. The subdiaphragmatic part of the phrenic nerve - morphometry and connections to autonomic ganglia. Clinical Anatomy 2016;29(1):120-8. 88. Nano M, Dal Corso H, Ferronato M, Solej M, Hornung JP. Can intestinal innervation be preserved in pancreatoduodenectomy for cancer? Results of an anatomical study. Surg Radiol Anat 2003;25(1):1-5. 89. Sata Y, Head GA, Denton K, May CN, Schlaich MP. Role of the Sympathetic Nervous System and Its Modulation in Renal Hypertension. Front Med (Lausanne) 2018;5:82. 90. Hoogerwaard AF, de Jong MR, Elvan A. Renal Nerve Stimulation as Procedural End Point for Renal Sympathetic Denervation. Curr Hypertens Rep 2018;20(3):24. 91. Doumas M, Stavropoulos K, Imprialos KP, Athyros VG, Karagiannis A. Renal sympathetic denervation: Ashes to ashes or rebirth from the ashes? J Clin Hypertens (Greenwich) 2018;20(4):634-6. 92. Hoye NA, Wilson LC, Wilkins GT, Jardine DL, Putt TL, Samaranayaka A et al. Endovascular Renal Denervation in End-Stage Kidney Disease
44. Honma S, Sonomura T. The middle rectal artery arising from the lateral sacral artery. Anat Sci Int 2018.
52. Unruh KP, Camp CL, Zietlow SP, Huddleston PM. 3rd. Anatomical variations of the iliolumbar vein with application to the anterior retroperitoneal approach to the lumbar spine: a cadaver study. Clin Anat 2008;21(7):666-73.
65. Ruano CA, Lourenço J, Vieira L, Marques Â. Avaliação eco-doppler na cirrose hepática. Acta Radiológica Portuguesa 2015;27(105):21-6. 66. Geleto G, Getnet W, Tewelde T. Mean Normal Portal Vein Diameter Using Sonography among Clients Coming to Radiology Department of Jimma University Hospital, Southwest Ethiopia. Ethiop J Health Sci 2016;26(3):237.
167Capítulo 87 AnAtomiA APliCAdA à região AbdominAl e PélviCA Patients: Cardiovascular Protection-A Proof-of-Concept Study. Kidney Int Rep 2017;2(5):856-65.
93. Motoc A, Rusu MC, Jianu AM. The spermatic ganglion in humans: an anatomical update. Rom J Morphol Embryol 2010;51(4):719-23.
95. Correia JA, De-Ary-Pires B, Pires-Neto MA, De Ary-Pires R. The developmental anatomy of the human superior hypogastric plexus: A morphometrical investigation with clinical and surgical correlations. Clin Anat 2010;23(8):962-70. 96. Gorostidi M, Escobar PF. Nerve-Sparing Superior Hypogastric Plexus Para-Aortic Lymphadenectomy: Clinical Implications and Feasibility. J Minim Invasive Gynecol 2016;23(4):467-8.
94. Acar HI, Kuzu MA. Important points for protection of the autonomic nerves during total mesorectal excision. Dis Colon Rectum 2012;55(8):907-12.
102. Kung TA, Waljee JF, Curtin CM, Wei JT, Montie JE, Cederna PS. Interpositional Nerve Grafting of the Prostatic Plexus after Radical Prostatectomy. Plastic Reconstruct Surg 2015;3(7):e452.
98. Rothlisberger R, Aurore V, Boemke S, Bangerter H, Bergmann M, Thalmann GN et al. The Anatomy of the Male Inferior Hypogastric Plexus: What Should We Know for Nerve Sparing Surgery. Clin Anat 2018 Sep;31(6):788-796. 99. Xenos ES, Stevens SL, Freeman MB, Pacanowski JP, Cassada DC, Goldman MH. Erectile function after open or endovascular abdominal aortic aneurysm repair. Ann Vasc Surg 2003;17(5):530-8.
100. Schaik Jv, van Baalen JM, Visser MJT, DeRuiter MC. Nerve-preserving aortoiliac reconstruction surgery: Anatomical study and surgical approach. J Vasc Surg 2001;33(5):983-9.
97. Mauroy B, Demondion X, Drizenko A, Goullet E, Bonnal JL, Biserte J et al. The inferior hypogastric plexus (pelvic plexus): its importance in neural preservation techniques. Surg Radiol Anat 2003;25(1):6-15.
101. Diaz-Feijoo B, Bradbury M, Perez-Benavente A, Franco-Camps S, GilMoreno A. Nerve-Sparing Technique during Laparoscopic Radical Hysterectomy: Critical Steps. J Minim Invasive Gynecol 2018 Nov - Dec;25(7):1144-1145.
BIBLIOGRAFIA Ballard JL, Killeen JD. Anatomy and surgical exposure of the vascular system. In: Moore W. (Ed.). Vascular surgery. Philadelphia: WB Saunders; 1998. p. 44-66. Bismulth H. Les anastomoses porto caves tronculaires. Techniques chirurgicales. Appareil digestif. Encyl Med Chir Paris 2006. p. 408. Branchereau A, Ondon’Dong F. Extended medial approach to the popliteal artery without muscular division. Ann Vasc Surg 1989;3:77-80. Cherry Jr KJ, McCullough JL et al. Technical principles of direct innominate artery revascularization: a comparison of endarterectomy and bypass grafts. J Vasc Surg 1989;9:718. Crawford ES, De Bakey ME et al. Thrombo-obliterative disease of the great vessels arising from the aortic arch. J Thorac Cardiovasc Surg 1962;43:38. Dardick H, Dardick I, Veith FJ. Exposure of the tibioperoneal arteries by a single lateral approach. Surgery 1974;75:377. Elkin DC, Kelly RP. Arteriovenous aneurysm: exposure of the tibial and peroneal vessels by resection of the fibula. Ann Surg 1945;122:529-45. Fiolle J, Delmas J. Découverte des vaisseaux profonds par des voies d’accès larges. Paris: Masson; 1940. Fisher DF, Clagett GP, Parker JI et al. Mandibular subluxation for high carotid exposure. J Vasc Surg 1984;1:727-33. Fisher Jr DF, Fry WJ. Collateral mesenteric circulation. Surg Gynecol Obstet Goldsmith1987;164:487.MM3d, Postma DS, Jones FD. The surgical exposure of penetrating injuries to the carotid artery at the skull base. Otalaryngol Head Neck Surg 1986;95:278-84. Haimovici H, Ernest CB, Berguer R. Exposição cirúrgica dos vasos. In: Haimovici H. (Ed.). Cirurgia vascular: princípios e técnicas. 4.ed. Rio de Janeiro: Di-Livros; 2000. p. 351. Haimovici H. Arterial circulation of the extremities. In: Schwartz CJ, Werthessen NT, Wolf A. (Eds.) Structure and function of the circulation. New York: Plenum; 1980. p. 425-85, v. 1. Hall-Craggs ECB. The upper limb. In: Hall-Craggs. (Ed.) Anatomy Baltimore: Williams & Wilkins; 1995. p. 160, cap. 64. Henderson JM, Warren WD, Milikan WJ et al. Distal splenorenal shunt with splenopancreatic disconnection: a 4-year assessment. Ann Surg Hertzer1989;210:332-39.NR,Felaman BJ, Beven EG, Tucker HM. A prospective study of the incidence of injury to the cranial nerves during carotid endarterectomy. Surg Gynecol Obstet 1980;151:781. International Anatomical Nomenclature Committee. Nomina anatômica 5. ed. México: Medsi; 1984. Johansen K, Banayk D, et al. Temporary intraluminal shunts: resolution of a management dilemma in complex vascular injuries. J Trauma Madden1982;22:395-401.JL. Atlas de técnicas cirúrgicas. 2nd ed. São Paulo: Roca; 1987. p. Mattox212-351.KL,Hieshberg A. Access control and repair techniques. In: Rich NM. (Ed.). Vascular trauma. 2nd ed. Philadelphia: Saunders; 2004. p. 137-64. Mouson DO, Saletta JD, Frecark RJ. Carotid and vertebral trauma. J Trauma Nascimento-Silva1969;9(12):987-99.JLC. Anatomia médico-cirúrgica do sistema vascular. In: Brito CJ. (Ed.). Cirurgia vascular. Rio de Janeiro: Revinter; 2002. p. Netter25-76.FH.The head and neck In: Netter FH. (Eds.). Atlas of human anatomy. Hanover: Library of Congress Catalog; 1997. p. 28. Petroianu A. Anatomia cirúrgica. Rio de Janeiro: Guanabara Koogan; 1999. Rich NM, Spencer FC. Vascular trauma. Philadelphia: WB Saunders; 1978. Ristow AV. Traumatismos vasculares dos membros. Urgências vasculares. Rio de Janeiro: Cultura Médica; 1983. p. 19-61. Rossi M, Brito CJ, Cury RCP. Principais vias de acesso utilizadas no trauma vascular. In: Rossi M. (Ed.) Trauma vascular. Rio de Janeiro: Revinter; 2006. p. 58-73. Rossi M. Vias de acesso mais utilizadas em cirurgia vascular. In: Brito CJ. (Ed.). Cirurgia vascular. Rio de Janeiro: Revinter; 2002. p. 77-104. Rutherford RB. Atlas de cirurgia vascular. Técnicas e exposições básicas. Rio de Janeiro: Di-Livros; 1998. Simonian GT, Pappas PJ, Padberg Jr FT et al. Mandibular subluxation for distal internal carotid exposure: technical considerations. J Vasc Surg Snell1999;30:1116.RS.Anatomia humana. 2. ed. Rio de Janeiro: Medsi; 1984. Stoney RJ, Effeney DJ. Comprehensive vascular exposures. Philadelphia: Lippincott-Raven; 1998. Testut L. Traité D’anatomie humaine. 4 éme ed. Paris: Octave Doin; 1900. v. Trout2.HH, Giodano JM. Anomalies of the inferior vena cava. J Vasc Surg Valentine1986;3:924.RJ,Wind GG. Anatomic exposures in vascular surgery. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 2003. Valentine RJ, Wind GG. Anatomy of commonly exposed arteries. In: Rutherford RB. (Ed.). Vascular surgery. 5th ed. Philadelphia: WB Saunders; 2000. p. 48-60. Yeo CJ, Cameron JL, Lillemore KD et al. Pancreaticoduodenectomy for cancer of the head of the pancreas: 201 patients. Ann Surg 1995;221:721-29.
VIAS DE ACESSO AOS VASOS ABDOMINAIS
168 88Capítulo
9. Di Fabio F, Obrand D, Satin R, Gordon PH. Intra-abdominal venous and arterial thromboembolism in inflammatory bowel disease. Dis Colon Rectum 2009;52(2):336-342.
3. Bolen MA, Brinza E, Renapurkar RD et al. Screening CT Angiography of the Aorta, Visceral Branch Vessels, and Pelvic Arteries in Fibromuscular Dysplasia. JACC 2017 May;10(5):554-561.
11. Ha C, Magowan S, Accortt NA et al. Risk of arterial thrombotic events in inflammatory bowel disease. Am J Gastroenterol 2009;104(6):1445-1451.
41.
40.
13. Shabana FP, Gloviczki P, Stanson AW et al. Splanchnic Artery Aneurisms. Mayo Clinic Proceedings 82(4):472-479.
8. Cardin F, Fratta S, Perissinotto E et al. Clinical correlation of mesenteric vascular disease in older patients. Aging Clin Exp Res 2012;24(3 suppl):43-46.
ANGIOTOMOGRAFIA DOS VASOS ABDOMINAIS BIBLIOGRÁFICAS
7. Moawad J, Gewertz BL. Chronic mesenteric ischemia: clinical presentation and diagnosis. Surg Clin North Am 1997;77(2):357-369.
REFERÊNCIAS
12. Vokurka J, Olejnik J, Jedlicka V et al. Acute mesenteric ischemia. Hepatogastroenterology 2008;55(85):1349-1352.
20. Pannu HK, Maley WR, Fishman EK. Liver Transplantation: Preoperative CT. Evaluation. Radiographics 2001;21:S133-S146.
169 89Capítulo
23. Patel S, Kazerrooni EA, Cascade PN. Pulmonary Embolism: Optimization of Small Pulmonary Artery Visualization at MultiDetector Row CT. Radiology 2003;227:455-460.
18. Erbay N, Raptopoulos V, Pomfret EA et al. Living Donor Liver Transplantation in Adults: Vascular Variants Important in Surgical Planning for donor liver recipients. AJR Am J Roentgenol 2003;181:109-14.
19. Kruskal JB, Raptopoulos V. How I do it: Pre-operative CT scanning for adult living right lobe liver transplantation. Eur radiol 2002;12:1423-1431.
21. Kamel IR, Kruskal JB, Pomfret EA et al. Impact of Multidetector CT on Donor Selection and Surgical Planning Before Living Adult Right Lobe Liver Transplantation. AJR 2001;176:193-200.
2. Cooper CJ, Murphy TP, Cutlip DE et al. Stenting and medical therapy for atherosclerotic renal-artery stenosis. N Engl J Med 2014;370:13-22.
42.
22. Limanond P, Raman SS, Ghobrial RM et al. Preoperative Imaging in Adult-to-Adult Living Related Liver Transplant Donors. What surgeons want to know. J Compu Assist Tomogr 2004;28:149-157.
6. Prakash RT, Rajini T, Mokhasi V et al. Coeliac trunk and its branches: anatomical variations and clinical implications. Singapore Med J 2012;53(5):329-331.
10. Cappell MS. Intestinal (mesenteric) vasculopathy. II. Ischemic colitis and chronic mesenteric ischemia. Gastroenterol Clin North Am 1998;27(4):827-860.
14. Stanley JC, Wakefield TW, Graham LM et al. Clinical importance and management of splanchnic artery aneurysms. J Vasc Surg 1986;3:836-840.
4. Klausner JQ, Lawrence PF, Harlander-Locke MP et al. The contemporary management of renal artery aneurysms. J Vasc Surg 2015;61(4):978-984.
15. Carr SC, Pearce WH, Vogelzang RL et al. Current management of visceral artery aneurysms. Surgery 1996;120:627-633.
17. Otah E, Cushin BJ, Rozenblit GN et al. Visceral artery pseudoaneurysms following pancreatoduodenectomy. Arch Surg 2002;137:55-59.
38.
24. Loud PA, Katz DS, Klippenstein DL et al. Combined CT venography and pulmonary angiography in suspected thromboembolic disease: diagnostic accuracy for deep venous evaluation. AJR Am J Roentgenol 2000;174:61-65. 25. Cham MD, Yankelevitz DF, Shaham D et al. Deep venous thrombosis: detection by using indirect CT venography. Radiology 2000;216:744-751. 26. Abdelmoumene Y, Chevallier P, Barghouth G et al. Optimization of Multidetector CT Venography Performed with Elastic Stocking on Patients’ Lower Extremities: A Preliminary Study of Nonthrombosed Veins. AJR 2003;180:1093-1094. 27. Cho ES. CT Venography for Deep Vein Thrombosis Using a Low Tube Voltage (100 kVp) Setting Could Increase Venous Enhancement and Reduce the Amount of Administered Iodine. Korean J Radiol 2013;14(2):183-193. 28. Baek HJ, Choo KS, Nam KJ et al. Comparison of Image Qualities of 80 kVp and 120 kVp CT Venography Using Model-Based Iterative Reconstruction at Same Radiation Dose. J Korean Soc Radiol 2018;78(4):235-241. 29. Kavanagh EC et al. Risk of Pulmonary Embolism After Negative MDCT Pulmonary Angiography Findings. Am J Roentgenology 2004;182:499-504. 30. Loud PA, Katz DS, Bruce DA et al. Deep Venous Thrombosis with Suspected Pulmonary Embolism: Detection with Combined CT Venography and Pulmonary Angiography. Radiology 2001;219:498-502. 31. Cham MD, Yankelevitz DF, Henschke CI. Thromboembolic Disease Detection at Indirect CT Venography versus CT Pulmonary Angiography. Radiology 2005;234:591-594. 32. Katz SD, Loud PA, Bruce D. Combined CT Venography and Pulmonary Angiography: A Comprehensive Review. Radiographics 2002;22:S3-S19. 33. May R, Thurner J. The cause of the predominantly sinistral occurrence of thrombosis of the pelvic veins. Angiology 1957;8(5):419-427. 34. Taheri SA, Williams J, Powell S et al. Iliocaval compression syndrome. Am J Surg 1987;154(2):169-172. 35. Moudgill N, Hager E, Gonsalves C et al. May-Thurner syndrome: case report and review of the literature involving modern endovascular therapy. Vascular 2009;17(6):330-335. 36. de Schepper A. “Nutcracker” phenomenon of the renal vein and venous pathology of the left kidney [in Dutch]. J Belge Radiol 1972;55(5):507-511. 37. Kurklinsky AK, Rooke TW. Nutcracker phenomenon and nutcracker syndrome. Mayo Clin Proc 2010;85(6):552-559. Morasch M, Ebaugh J, Chiou A et al. Mesenteric venous thrombosis: a changing clinical entity. J Vasc Surg 2001;34:680-684. 39. Rhee RY, Gloviczki P, Mendonca CT et al. Mesenteric venous thrombosis: still a lethal disease in the 1990s. J Vasc Surg 1994;20:688-697. Orr DW et al. Chronic Mesenteric Venous Thrombosis: Evaluation and Determinants of Survival During Long-Term Follow-up. Clinical Gastroenterol Hepatol 2007;5(1):80-86. Violi NV, Fournier N, Duran R et al. Acute Mesenteric Vein Thrombosis: Factors Associated with Evolution to Chronic Mesenteric Vein Thrombosis. Am J Roentgenol 2014;203(1):54-61. Lezzi R, Posa A, Carchesio F et al. Multidetector-row CT imaging evaluation of superior and inferior vena cava normal anatomy and caval variants: Report of our cases and literature review with embryologic correlation. Phlebology 2018 May. 43. Enjolras O. Classification and management of the various superficial vascular anomalies: hemangiomas and vascular malformations J Dermatol 1997;24:701-710.
1. Hansen KJ, Edwards MS, Craven TE et al. Prevalence of renovascular disease in the elderly: a population-based study. J Vasc Surg 2002 Sep;36(3):443-51.
16. Shanley CJ, Shah NL, Messina LM. Common splanchnic artery aneurysms: splenic, hepatic, and celiac. Ann Vasc Surg 1996;10:315-322.
5. Iezzi R, Cotroneo AR, Giancristofaro D et al. Multidetector-row CT angiographic imaging of the celiac trunk: anatomy and normal variants. Surg Radiol Anat 2008;30(4):303-310.
16. Gaballah M, Goldfisher R, Amodio JB. The Utility of MRI in the Diagnosis of Takayasu Arteritis. Case Rep Pediatr 2017;2017:7976165.
13. Hartlage GR, Palios J, Barron BJ et al. Multimodality imaging of aortitis. JACC Cardiovasc Imaging 2014;7(6):605-19.
2. Angeretti M, Lumia D, Cani A et al. Non-enhanced MR angiography of renal arteries: comparison with contrast-enhanced MR angiography. Acta Radiol 2013;54:749-56.
5. Litmanovich D, Bankier AA, Cantin L et al. CT and MRI in the diseases of the aorta. AJR Am J Roentgenol 2009;193(4):928-40. 6. Hallett RL, Ullery BW, Fleischmann D. Abdominal aortic aneurysms: pre- and post-procedural imaging. Abdom Radiol 2018;43(5):1044-66.
11. Ahmed S, Raman SP, Fishman EK. CT angiography and 3D imaging in aortoiliac occlusive disease: collateral pathways in Leriche syndrome. Abdom Radiol 2017;42(9):2346-57.
10. Macura KJ, Corl FM, Fishman EK, Bluemke DA. Pathogenesis in acute aortic syndromes: aortic dissection, intramural hematoma, and penetrating atherosclerotic aortic ulcer. AJR Am J Roentgenol 2003;181(2):309-16.
14. Murphy DJ, Keraliya AR, Agrawal MD et al. Cross-sectional imaging of aortic infections. Insights Imaging 2016;7(6):801-18.
7. Haulon S, Lions C, McFadden EP et al. Prospective evaluation of magnetic resonance imaging after endovascular treatment of infrarenal aortic aneurysms. Eur J Vasc Endovasc Surg 2001;22(1):62-9. 8. Alerci M, Oberson M, Fogliata A et al. Prospective, intraindividual comparison of MRI versus MDCT for endoleak detection after endovascular repair of abdominal aortic aneurysms. Eur Radiol 2009;19(5):1223-31.
15. Barra L, Kanji T, Malette J et al. Imaging modalities for the diagnosis and disease activity assessment of Takayasu’s arteritis: A systematic review and meta-analysis. Autoimmun Rev 2018;17(2):175-87.
17. Forbess L, Bannykh S. Polyarteritis nodosa. Rheum Dis Clin North Am 2015;41(1):33-46. 18. Varennes L, Tahon F, Kastler A et al. Fibromuscular dysplasia: what the radiologist should know: a pictorial review. Insights Imaging 2015;6(3):295-307. 19. Narula N, Kadian-Dodov D, Olin JW. Fibromuscular Dysplasia: Contemporary Concepts and Future Directions. Prog Cardiovasc Dis 2018 Mar 10. pii: S0033-0620(18)30057-4.
12. Bossone E, Pluchinotta FR, Andreas M et al. Aortitis. Vascul Pharmacol 2016;80:1-10.
3. Xu JL, Shi DP, Li YL et al. Non-enhanced MR angiography of renal artery using inflow- sensitive inversion recovery pulse sequence: a prospective comparison with enhanced CT angiography. Eur J Radiol 2011;80(2):e57-63.
22. Naidu SG, Menias CO, Oklu R et al. Segmental Arterial Mediolysis: Abdominal Imaging of and Disease Course in 111 Patients. AJR Am J Roentgenol 2018;210(4):899-905. 23. Zucker EJ, Ganguli S, Ghoshhajra BB et al. Imaging of venous compression syndromes. Cardiovasc Diagn Ther. 2016;6(6):519-32. 24. White JM, Comerota AJ. Venous Compression Syndromes. Vasc Endovascular Surg 2017;51(3):155-68.
1. Piacentino F, Fontana F, Micieli C et al. Nonenhanced MRI Planning for Endovascular Repair of Abdominal Aortic Aneurysms: Comparison With Contrast-Enhanced CT Angiography. Vasc Endovascular Surg 2018;52(1):39-45.
4. Folley WD, Pereles FS. Abdominal Aorta. In: Rubin GD, Rofsky NM (Eds.). CT and MR angiography: Comprehensive vascular assessment. Philadelphia, PA: Lippincott Williams & Wilkins; 2009. p. 719-71.
20. Alhalabi K, Menias C, Hines R et al. Imaging and clinical findings in segmental arterial mediolysis (SAM). Abdom Radiol 2017;42(2):602-11. 21. Pillai AK, Iqbal SI, Liu RW et al. Segmental arterial mediolysis. Cardiovasc Intervent Radiol 2014;37(3):604-12.
9. Stefaniak K, Stanisic M, Gabriel M, Oszkinis G. Diagnostic imaging methods applied in long-term surveillance after EVAR. Will computed tomography angiography be replaced by other methods? Postepy Kardiol Interwencyjnej 2016;12(1):6-12.
170 90Capítulo ANGIORRESSONÂNCIA MAGNÉTICA DOS VASOS ABDOMINAIS REFERÊNCIAS BIBLIOGRÁFICAS
171 91CapítuloANGIOGRAFIA DOS VASOS ABDOMINAIS REFERÊNCIAS BIBLIOGRÁFICAS 1. Abrams HL. Abrams’ Angiography: Intervencional Radiology (Eds.). In: Stanley B, Michael J. Pentecost. 2nd ed. 2006. p. 25-36. 2. Maffei FH. Doenças Vasculares Periféricas. São Paulo: Medsi; 2002. p. 21-32. 3. Peixoto CCS, Rossi M. Trauma Vascular. Rio de Janeiro: Revinter; 2006. p. 174-188. 4. Peixoto CCS, Brito CJ. Cirurgía Endovascular e Angiologia. Rio de Janeiro: Revinter; 2008. p. 396-416. 5. Peixoto CCS, Brito CJ. Cirurgia Endovascular e Angiologia. Rio de Janeiro: Revinter; 2014. p. 527-534.
2. Goldberg BB, Ostrum BJ, Isard HJ, MD. Ultrasonic Aortography. JAMA 1966;198(4):353-58.
22. White GH, Yu W, May J, Chaufour X, Stephen MS. Endoleak as a complication of endoluminal grafting of abdominal aortic aneurysms: classification, incidence, diagnosis and management. J Endovasc Surg 1997 May;4:2:152-68.
1. Segal BL, Likoff W, Asperger Z, Kingsley B. Ultrasound diagnosis of an abdominal aortic aneurysm. Am J Cardiol 1966 Jan;17(1):101-3.
14. Cronenwett JL, Johnston KW. The United Kingdom Small Aneurysm Trial: implications for surgical treatment of abdominal aortic aneurysms. J Vasc Surg 1999;29:191-4. 15. Mower WR, Quiñones WJ, Gambhir SS. Effect of intraluminal thrombus on abdominal aortic aneurysm wall stress. J Vasc Surg 1997;26:602-8.
6. Polak JF. Ultrasound assessment of abdominal aorta. In: Pellerito JS and Polak JF (eds). Introducion to Vascular Ultrasonography Philadelphia: Elsevier; 2012. p. 450-65.
19. Zwiebel WJ. Aortic and iliac aneurism. In: Zwiebel WJ (ed.). Introduction to vascular ultrasonography. Philadelphia: Saunders; 1992. p. 351-66. 20. Huang PL, Chua S, Guo GB, Fu M. Mycotic aneurysm leading to iliac arteriovenous fistula diagnosed by vascular duplex color scan. Ultrasound Med 1998;17:513-6.
4. Shaikh H, Bhimji SS. Anatomy, abdomen and pelvis, superior mesenteric artery. Stat Pearls {internet}. Treasure Island (FL): StatPearls Publishing; 2018-2018 Sep 13. PMID: 30137844.
9. Back MR, Novotney M, Roth SM, Elkins D, Farber S, Cuthbertson D et al. Utility of duplex surveillance following iliac artery angioplasty and primary stenting. J Endovasc Ther 2001 Dec; 8(6):629-37.
12. Menashi S, Campa JS, Greenhalgh RM, Powell JT. Collagen in abdominal aortic aneurysm: typing, content, and degration. J Vasc Surg 1990;11:260-9.
5. Pellerito JS. Anatomy and normal Doppler signatures of abdominal vessels. In: Pellerito JS and Polak JF (eds). Introduction to Vascular Ultrasonography. 6th ed. Philadelphia: Elsevier; 2012. p. 439-49.
17. Slot HB, Strijbosch L, Greep JM. Interobserver variability in single plane aortography. Surgery 1981;90:497-502. 18. Sekkal S, Cornu E, Christides C, Virot P, Laskar M, Serhal C et al Isolated iliac aneurysm: Regarding seventy-seven cases in fortyeight patients. J Mal Vasc 1993;18:13-7.
7. Krnic A, Vucic N, Sucic Z. Duplex scanning compared with intraarterial angiography in diagnosing peripheral arterial disease: three analytical approaches. Vasa 2006 May;35(2):86-91.
8. Katsamouris AN, Giannoukas AD, Tsetis D, Kostas T, Petinarakis I, Gourtsoyiannis N. Can ultrasound replace arteriography in the management of chronic arterial occlusive disease of the lower limb? Eur J Vasc Endovasc Surg 2001 Feb;21(2):155-9.
10. de Morais Filho D, Thomazinho F, Motta F, Perozin IS, Sardinha WE, Silvestre JMS et al. Sequencial spectrum analysis in the follow-up of revascularized patiente. J Vasc Bras 2009;8(2):112-24.
32. Voiculescu A, Schmitz M, Plum J, Hollenbeck M, Vupora S, Jung G et al. Duplex ultrasound and renin ratio predict treatment failure after revascularization for renal artery stenosis. Am J Hypertens 2006 Jul;19(7):756-63. 33. Soares GM, Murphy TP, Singha MS, Parada A, Jaff M. Renal artery duplex ultrasonography as a screening and surveillance tool to detect renal artery stenosis: a comparison with current reference standard imaging. J Ultrasound Med 2006 Mar;25(3):293-8. Apel RG, Freedman BI, Hansen KJ. Renovascular disease and progressive renal in- sufficiency. Sem Dial 1995;8:285-93. 35. Gifford RW, Leiner T, de Haan MW, Nelemans PJ, van Engelshoven JM, Vasbinder GB. Contemporary imaging techniques for the diagnosis of renal artery stenosis. Eur Radiol 2005 Nov;15(11):2219-29. 36. Gifford RW. Epidemiology and clinical manifestations of renovascular hypertension. In: Stanley J, Ernest C, Fry W (eds). Renovascular Hipertension. Philadelphia: WB Saunders; 1984. 37. Guzman RP, Zierler RE, Isaacson JA, Bergelin RO, Strandness DE. Renal atrofy and arterial stenosis: A prospective study with Duplex Ultrasound. Hypertension 1994;23:346-50. 38. Vaughan ED Jr. Renovascular hypertension. Curr Opin Urol 1998 Mar;8(2):125-8. 39. Blaufox DM. When renal artery stenosis is a clinical consideration, should I perform a captopril scan or digital subtraction angiography of the renal arteries? AJR 1994;163:742-3. 40. Chen CC, Hoffer PB, Vahjen G et al. Patients at high risk for renal artery stenosis: a simple method of renal scintigraphic analysis with Tc-99 in DTPA and captopril. Radiology 1990;176:365-70. 41. Bjorkman H, Eklof H, Wadstrom J, Andersson LG, Nyman R, Magnusson A.Split renal function in patients with suspected renal
34.
3. Gray H, Goss CM. As artérias. In: Gray H, Goss CM (Eds.). Gray Anatomia. Rio de Janeiro: Guanabara-Koogan; 1977. p. 462-551.
13. Smith FCT, Grimshaw GM, Paterson IS, Shearman CP, Hamer JD. Ultrasonographic screening for abdominal aortic aneurysm in an urban community. Br J Surg 1993;80:1406-9.
21. González LJ, Gallego GM, Martinez AA. Chronic post-traumatic pseudoaneurysm of the abdominal aorta diagnosed by duplex Doppler ultrasonography. A case report. Acta Radiol 1997;38:121-3.
172 92Capítulo ECOGRAFIA VASCULAR DOS VASOS ABDOMINAIS REFERÊNCIAS BIBLIOGRÁFICAS
23. Brewster DC, Geller SC, Kaufman JA, Cambria RP, Gertler JP, LaMuraglia GM et al. Initial experience with endovascular aneurysm repair: Comparison of early results with outcome of conventional open repair. J Vasc Surg 1998;27:992-1005. 24. Beeman BR, Murtha K, Doerr K, McAfee-Bennett S, Dougherty MJ, Calligaro KD. Duplex ultrasound factors predicting persistent type II endoleak and increasing AAA sac diameter after EVAR. J Vasc Surg 2010;52(5):1147-52. 25. Sandford RM, Bown MJ, Fishwick G et al. Duplex ultrasound scanning is reliable in the detection of endoleak following endovascular aneurysm repair. Eur J Vasc Endovasc Surg 2006;32(5):537-41. 26. Karthikesalingam A, Kumar S, Anandarajah JJ, Hinchliffe RJ, Poponiecki JD, Thompson MM et al. Predictive value of peak systolic velocity for the development of graft limb complications after endovascular aneurysm repair. J Endovasc Ther 2012;19:428-33. 27. Blom AS, Troutman D, Beeman B, Yarchoan M, Dougherty MJ, MD, Calligaro KD. Duplex ultrasound imaging to detect limb Stenosis or kinking of endovascular device. J Vasc Surg 2012;55:1577-80.
11. Lindholt JS, Juul S, Fasting H, Henneberg EW. Cost-effectiveness analysis of screening for abdominal aortic aneurysms based on five year results from a randomised hospital based mass screening trial. Eur J Vasc Endovasc Surg 2006 Jul;32(1):9-15.
28. Thompson MM, Boyle JR, Hartshorn T, Maltezos C, Nasim A, Sayers RD et al. Comparison of computed tomography and duplex imaging in assessing aortic morphology following endovascular aneurysm repair. Br J Surg 1998;85(3):346-50. 29. Gasper, WJ, Christopher DO. The Superior Mesenteric and Celiac Arteries. In: Handbook of Endovascular Peripheral Interventions 2012:267-283. 30. Lam EY, McLafferty RB, Taylor LM Jr, Moneta GL, Edwards JM, Barton RE et al. Inferior epigastric artery pseudoaneurysm: a complication of paracentesis. J Vasc Surg 1998;28:566-9. 31. Wagner WH, Cossman DV, Treiman RL, Foran RF, Levin PM, Cohen JL. Hemosuccuspancreaticus from intraductal rupture of a primary splenic artery aneurysm. J Vasc Surg 1994;19:158-64.
16. Inzoli F, Boschetti F, Zappa M. Biomechanical factors in abdominal aortic aneurysm rupture. Eur J Vasc Surg 1993;7:667-74.
44.
60. Engelhorn CA, Engelhorn ALV. Hipertensão renovascular. In: Engelhorn CA, Moraes Filho D, Barros FS, Coelho NA. Guia Prático de Ultra-sonografia Vascular. Rio de Janeiro: DiLivros; 2006. p. 99-110. 61. Merritt CRB. Transplante de órganos: hígado, riñón y pâncreas. In: Taylor KJW, Burns PN e Wells PNT (eds.). Doppler: applicaciones clínicas de la ecografía Doppler. Madrid: Marbán Libros; 1998. p. 203-20. Baxter GM. Ultrasound of renal transplantation. Clin Radiol 2001;56:802-818. 63. Taylor KJW, Marks WH. Use of Doppler imaging for evaluation of dysfunction in renal allografts. Am J Roentgenology 1990;155:536-37. 64. Sciascia N, Di Scioscio V, Zompatori M, Faenza A, Cristino S, Zambianchio L et al. Evaluation of the resistive index for the diagnosis of acute renal rejection in renal allografts from the same donor. Radiol Med 2002;103(3):225-32. 65. Engelhorn ALV, Engelhorn CA. Síndrome compressiva do tronco celíaco. In: Engelhorn CA, Moraes Filho D, Barros FS, Coelho NA. Guia Prático de Ultra-sonografia Vascular. Rio de Janeiro: DiLivros; 2006. p. 93-7. 66. Flinn WR, Rizzo RJ, Park JS, Sandager GP. Mapeamento duplex para avaliação da isquemia mesentérica. Clínicas Cirúrgicas da América do Norte. Diagnóstico não invasivo das doenças vasculares. W.S. Saunders Company; 1990. p. 99-117. 67. Flinn WR, Lilly MP, Rizzo RJ, Sandager GP. Noninvasive assessment of mesenteric and celiac artery blood flow. Vascular Diagnosis. In: Bernstein EF (ed.). Vascular Diagnosis. 4th ed. St Louis: Mosby; 1993. p. 695-98. 68. Moneta GL, Yeager RA, Dalman R et al. Duplex ultrasound criteria for diagnosis of splanchnic artery or occlusion. JVS 1991;14:780-8. 69. Zwolak RM, Fillinger MF, Walsch DB et al. Mesenteric and celiac duplex scanning: a validation study. J Vasc Surg 1998;27:1078-88. 70. Perko MJ, Just S, Schroeder TV. Importance of diastolic velocities in the detection of celiac and mesenteric artery disease by duplex ultrasound. J Vasc Surg 1997;26:288-93. 71. AbuRahma AF, Stone PA, Srivastava M, Dean LS, Keiffer T, Hass SM, et al. Mesenteric/celiac duplex ultrasound interpretation criteria revisited. J Vasc Surg 2012;55(2):428-36 e 426. 72. Zierler RE, Jordan WD, Lal BK et al. The society for vascular surgery practice guidelines on follow-up after vascular surgery arterial procedures. J Vasc Surg 2018;68:256-84. 73. Gray H, Goss CM. As veias. In: Gray H, Goss CM (eds.). Gray Anatomia. Rio de Janeiro:Guanabara-Koogan; 1977. p. 552-97. 74. Uflacker R. Veias do abdome e pelve. In: Uflacker R (ed.). Atlas de anatomia. Rio de Janeiro: Revinter; 2003. p. 635-728. 75. Szatmari V, Sotonyi P, Voros K. Normal duplex Doppler waveforms of major abdominal blood vessels in dogs: a review. Vet Radiol Ultrasound 2001;42(2):93-107. 76. Fowkes FJ, Price JF, Fowkes FG. Incidence of diagnosed deep vein thrombosis in the general population: systematic review. Eur J Vasc Endovasc Surg 2003 Jan;25(1):1-5. 77. Heit JA, Melton LJ 3rd, Lohse CM, Petterson TM, Silverstein MD, Mohr DN et al. Incidence of venous thromboembolism in hospitalized patients vs community residents. Mayo Clin Proc 2001 Nov;76(11):1102-10. 78. Prandoni P. Cancer and venous thromboembolism. Clinical implications of strong association. Pathophysiol Haemost Thromb 2006;35(1-2):111-5. 79. Le Gal G, Prins AM, Righini M, Bohec C, LacutK, Germain P et al. Diagnostic value of a negative single complete compression ultrasound of the lower limbs to exclude the diagnosis of deep venous thrombosis in pregnant or postpartum women: a retrospective hospital-based study. Thromb Res 2006;118(6):691-7. 80. Barros FS, Pontes SM, Silva WP, Prezotti BB, Sandri JL. Identificação pelo eco-Doppler colorido de fístula arteriovenosa no na trombose venosa profunda. J Vasc Br 2006;5(3):224-8. 81. Labropoulos N, Batí AF, Amaral S, Leon L, Borge M, Rodríguez H, Kalman P. Neovascularization in acutethrombosis. J Vasc Surg 2005 Sep;42(3):515-8. 82. Prandoni P, Lensing AW, Bernardi E, Villalta S, Bagatella P, Girolami A. DERECUS Investigators Group. The diagnostic value of compression ultrasonography in patients with suspected recurrent deep vein thrombosis. Thromb Haemost 2002 Sep;88(3):402-6. 83. Bianek-Bodzak A, Sliwinski W, Mielcarek P. Doppler evaluation of external iliac vein hemodynamic changes caused by lymphocele after lymphadenectomy for cervical cancer. Clin Ultrasound 2006 Oct;34(8):393-7. 84. Moreland NC, Ujiki M, Matsumura JS, Morasch MD, Eskandari MK, Pearce WH et al. Decreased incidence of left common iliac vein compression in patients with abdominal aortic aneurysms. J Vasc Surg 2006 Sep;44(3):595-600. 85. Engelhorn CA, Engelhorn ALV. Hipertensão renovascular. In: Engelhorn CA, Moraes Filho D, Barros FS, Coelho NA. Guia Prático de Ultra-sonografia Vascular. Rio de Janeiro: DiLivros; 2006. p. 219-23. 86. Rudoloff U, Holmes RJ, Prem JT, Faust GR, Moldwin R, Siegel D. Ann Vasc Surg 2006;20:120-9. 87. Engelhron ALV, Engelhron CA. Síndrome de Quebra-nozes. In: Engelhron CA, Filho MD, Barros FS, Coelho NA (edts.). Guia Prático de Ultra-sonografia Vascular. Rio de Janeiro: Di Livros; 2006. p. 111-15. 88. Scultetus AH, Villavicencio JL, Gillespie DL. The nutcracker syndrome: Its role in the pelvic venous disorders. J Vasc Surg 2001;34(5):812-19. 89. Kim SH, Cho SW, Kim HD, Chung JW, Park JH, Han MC. Nutcracker syndrome: diagnosis with Doppler US. Radiology 1996;198:93-7. 90. Pallwein L, Pinggera G, Schuster AH, Klauser A, Weirich HG, Recheis W et al. The influence of left renal vein entrapment on outcome
50.
54. Nchimi A, Biquet JF, Brisbois D et al. Duplex ultrasound as first-line screening test for patients suspected of renal artery stenosis: prospective evaluation in high-risk group. Eur Radiol 2003;13:1413-419.
42.
173Capítulo 92 eCogr AfiA vA sCul Ar dos vA sos AbdominAis artery stenosis: a comparison between gamma camera renography and two methods of measurement with computed tomography. Acta Radiol 2006 Feb;47(1):107-13. Mann SJ, Pickering TG, Sos TA, Uzzo RG, Sarkar S, Friend K et al. Captopril renography in the diagnosis of renal artery stenosis: Accuracy and limitations. Am J Med 1991;90:30-40. Safakianakis GN, Bourgoignie JJ, Georgiou M, Guerra JJ Jr. Diagnosis of renovascular hypertension with ACE inhibition scintigraphy. Rad Clin N Am 1993;31:831-48. Taylor DC, Kettler MD, Moneta GL et al: Duplex ultrasound scanning in the diagnosis of renal artery stenosis: A prospective evaluation. J Vasc Surg 1988;7:363-69.
46. Olin JW, Piedmonte MR, Young JR et al. The utility of duplex ultrasound scanning of the renal arteries for diagnosing significant renal artery stenosis. Ann Intern Med 1995;122:833-8.
45. Strandness DE Jr. Mapeamento duplex no diagnóstico da hipertensão renovascular. In: Clínicas cirúrgicas da América do Norte –Diagnóstico não invasivo das doenças vasculares. Rio de Janeiro: Interlivros; 1990. p. 109-117.
52. Williams GJ, Macaskill P, Chan SF et al. Comparative accuracy of renal duplex sonographic parameters in the diagnosis of renal artery stenosis: paired and unpaired analysis. AJR Am J Roentgenol 2007;188:798-811.
57. Berland LL, Koslin DB, Routh WD, Keller FS. Renal artery stenosis: prospective evaluation of diagnosis with color duplex US compared with angiography. Work in progress. Radiology 1990;174:421-423.
49. Engelhorn CA, Engelhorn AL, Cassou MF. Estenose da artéria renal: necessidade de validação dos critérios diagnósticos no laboratório vascular. J Vasc Br 2005;4(3):243-8. Zieler RE. Is duplex scanning the best screening test for renal artery stenosis? Semin Vasc Surg 2001;14(3):177-85. Zalunardo N, Tuttle KR. Atherosclerotic renal artery stenosis: current status and future directions. Curr Opin Nephrol Hypertens 2004;13(6):613-21.
51.
48. Hua HT, Hood DB, Jensen CC et al. The use of color flow duplex scanning to detect significant renal artery stenosis. Ann Vasc Surg 2000;14(2):118-24.
47. Miralles M, Cairols M, Cotillas J et al. Value of Doppler parameters in the diagnosis of renal artery stenosis. J Vasc Surg 1996;23:428-435.
53. Voiculescu A, Hofer M, Hetzel GR et al. Noninvasive investigation for renal artery stenosis: contrast-enhanced magnetic resonance angiography and color Doppler sonography as compared to digital subtraction angiography. Clin Exp Hypertens 2001;23:521-31.
55. Handa N, Fukunaga R, Uehara A et al. Echo-Doppler velocimeter in the diagnosis of hypertensive patients: the renal artery Doppler technique. Ultrasound Med Biol 1986;12(12):945-52.
62.
58. Desberg AL, Paushter DM, Lammert GK et al. Renal artery stenosis: evaluation with color Doppler flow imaging. Radiology 1990;177:749-753.
43.
59. Zieler RE. Vascular diagnosis of renovascular disease. In: MA Mansour and N Labropoulos (eds). Vascular Diagnosis. Elsevier: Pennsylvania; 2005. p. 333-40.
56. Handa N, Fukunaga R, Etani H, Yoneda S, Kimura K, Kamada T. Efficacy of echo-Doppler examination for the evaluation of renovascular disease. Ultrasound Med Biol 1988;14:1-5.
106. Cinara IS, Davidovic LB, Kostic DM, Cvetkovic SD, Jakovljevic NS, Koncar IB. Aorto-caval fistulas: a review of eighteen years experience. Acta Chir Belg 2005 Nov-Dec;105(6):616-20.
97. Hartung O, Grisoli D, Boufi M, Marani I, Hakam Z, Barthelemy P et al. Endovascular stenting in the treatment of pelvic vein congestion caused by nutcracker syndrome: lessons learned from the first five cases. J Vasc Surg 2005 Aug;42(2):275-80.
99. Kim JY, Choi D, GukKo Y, Park S, Jang Y, Lee do Y. Percutaneous treatment of deep vein thrombosis in May - Thurnersyndrome. Cardiovasc Intervent Radiol 2006 Jul-Aug;29(4):571-5.
105. Huerta S, Bui TD, Nguyen TH, Banimahd FN, Porral D, Dolich MO. Predictors of mortality and management of patients with traumatic inferior vena cava injuries. Am Surg 2006 Apr;72(4):290-6.
107. Lyon M, Blaivas M, Brannam L. Sonographic measurement of the inferior vena cava as amarker of blood loss. Am J Emerg Med 2005 Jan;23(1):45-50.
101. Gil J R, Pérez A M, Arias J B, Pascual F B, Romero E S. Agenesis of the inferior vena cava associated with lower extremities and pelvic venous thrombosis. J Vasc Surg 2006;44:1114-16.
91. Kim WS, Cheon JE, Kim IO, Kim SH, Yeon KM, Kim KM et al Hemodynamic investigation of the left renal vein in pediatric varicocele: Doppler US, Venography and pressure measurements. Radiology 2006 Aug 14; [Epub ahead of print].
98. Thompson CS, Cohen MJ, Wesley JM. Endovascular treatment of obliterative hepatocavopathy with inferior vena cava occlusion and renal vein thrombosis. J Vasc Surg 2006 Jul;44(1):206-9.
108. Corriere MA, Passman MA, Guzman RJ, Dattilo JB, Naslund TC. Comparison of bedside transabdominal duplex ultrasound versus contrast venography for inferior vena cava filter placement: what is the best imaging modality? Ann Vasc Surg 2005;19(2):229-34. 109. Rogério AN, Mauro CF, Cristina MOH.Placement of inferior vena cava filter guided by ultrasound: report of two cases. J Vasc Br 2006;5(1):71-3. 110. Erden A. Budd-Chiari syndrome: A review of imaging findings. Eur J Radiol 2007 Jan;61(1):44-56. 111. Chaubal N, Dighe M, Hanchate V, Thakkar H, Deshmukh H, Rathod K. Sonographyin Budd-Chiari syndrome. J Ultrasound Med 2006 Mar;25(3):373-9. 112. Koslin DB, Mulligan AS, Berland LL. Duplex assesment of portal venous system and splanchnic vasculature. In: Zwiebel W. Introduction to vascular ultrasonography. 3 ed. Saunders; 1992. p. 751-56. 113. Gayani S, Bolondi L, Li Bassi S et al. Effects of meal on portal hemodinamics in healthy humans and in patients with cronic liver disease. Hepatology 1989;815-19. 114. Amitrano L, Brancaccio V, Guardascione MA, Margaglione M, Sacco M, Martino R et al. Portal vein thrombosis after variceal endoscopic sclerotherapy in cirrhotic patients: role of genetic thrombophilia. Endoscopy 2002 Jul;34(7):535-8. 115. Rossi S, Rosa L, Ravetta V, Cascina A, Quaretti P, Azzaretti A et al. Contrast-enhanced versus conventional and color Doppler sonography for thedetection of thrombosis of the portal and hepatic venous systems. AJR Am J Roentgenol 2006 Mar;186(3):763-73.
100. Yun SS, Kim KH, Sung GY, Lee do S, Kim JS, Moon IS et al. Deep venous thrombosis caused by congenital absence of inferior vena cava, combined with hyperhomocysteinemia. Ann Vasc Surg 2004;18:124-29.
92. Hartung O, Grisoli D, Boufi M, Marani I, Hakam Z, Barthelemy P et al Endovascular stenting in the treatment pf pelvic congestion caused by nutcracker syndrome. Vasc Surg 2005 Aug;42(2):275-80.
104. Hetzel G, Gabriel P, Rompel O, Ritter W, Raithel D. Aortocaval fistula after stent-graft repair. J Endovasc Ther 2006 Feb;13(1):117-20.
174 Parte VIABDÔMEN E PELVE after surgical varicocele repair: a color Doppler sonographic demonstration. J Ultrasound Med 2004 May;23(5):595-601.
102. Sneed D, Hamdallah I, Sardi A. Absence of the retrohepatic inferior vena cava: what the surgeon should know. Am Surg 2005;71:502-04.
93. May R, Thurner J. Ein gefabsporn in der vena iliaca communis sinistra als ursache der uberwiegend linksseitigen beckenve nentrombosen. Z Kreisl-Forsch 1956;45:912-22. 94. Cocket FB, Lea Thomas ML. The iliac vein compression syndrome. Brit J Surg 1965;52:816-25.
103. Iriz E, Ozdogan ME, Erer D, Uslu M, Koksal P, Kurtipek O. A giant aortocaval fistula due to abdominal aortic aneurysm. Int J Cardiol 2006 Oct 10;112(3):e78-80.
95. Amorim JE. Compressão da veia ilíaca comum direita: avaliação clínica, flebográfica e pelo mapeamento duplex. São Paulo, 1996. [Tese (Doutorado), Escola Paulista de Medicina, Universidade Federal de São Paulo]. 96. Raju S, Neglen P. High prevalence of nonthrombotic iliac vein lesions in chronic venous disease: a permissive role in pathogenicity. J Vasc Surg 2006 Jul;44(1):136-43.
ANEURISMAS DA AORTA BIBLIOGRÁFICAS
3. Gillum RF. Epidemiology of aortic aneurysm in the United States. J Clin Epidemiol 1995;48(11):1289-98.
1. Kuivaniemi H, Platsoucas CD, Tilson MD. Aortic aneurysms: an immune disease with a strong genetic component. Circulation 2008;117:242-52.
7. Svensjö S, Björck M, Gurtelschmid M et al. Low prevalence of abdominal aortic aneurysm among 65-year-old Swedish men indicates a change in the epidemiology of the disease. Circulation 2011;124(10):1118-23.
5. Best VA, Price JF, Fowkes FG. Persistent increase in the incidence of abdominal aortic aneurysm in Scotland, 1981-2000. Br J Surg 2003;90(12):1510-5.
18. Dua A, Kuy S, Lee CJ et al. Epidemiology of aortic aneurysm repair in the United States from 2000 to 2010. J Vasc Surg 2014;59:1512-7.
26. Darling RC, Brewster DC, Darling RC et al. Are familial abdominal aortic aneurysms different? J Vasc Surg 1989;10(1):39-43. 27. Kuivaniemi H, Shibamura H, Arthur C et al. Familial abdominal aortic aneurysms: collection of 233 multiplex families. J Vasc Surg 2003;37(2):340-5. 28. Wahlgren CM, Larsson E, Magnusson PK et al. Genetic and environmental contributions to abdominal aortic aneurysm development in a twin population. J Vasc Surg 2010;51(1):3-7. 29. Linné A, Lindström D, Hultgren R. High prevalence of abdominal aortic aneurysms in brothers and sisters of patients despite a low prevalence in the population. J Vasc Surg 2012;56(2):305-10.
32. Hinterseher I, Krex D, Kuhlisch E et al. Analysis of tissue inhibitor et al. Analysis of metalloproteinase-2 gene polymorphisms in a caucasian population with abdominal aortic aneurysms. Zentralbl Chir 2008;133(4):332-7.
37. Silence J, Collen D, Lijnen HR. Reduced atherosclerotic plaque but enhanced aneurysm formation in mice with inactivation of the tissue inhibitor of metalloproteinase-1 (TIMP-1) gene. Circ Res 2002;90(8):897-903. 38. Watanabe T, Sato A, Sawai T et al. The elevated level of circulating matrix metalloproteinase-9 in patients with abdominal aortic aneurysms decreased to levels equal to those of healthy controls after an aortic repair. Ann Vasc Surg 2006;20(3):317-21. 39. Lorelli DR, Jean-Claude JM, Fox CJ et al. Response of plasma matrix metalloproteinase-9 to conventional abdominal aortic aneurysm repair or endovascular exclusion: implications for endoleak. J Vasc Surg 2002;35(5):916-22. 40. Ogata Y, Enghild JJ, Nagase H. Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9. J Biol Chem 1992;267(6):3581-4.
ABDOMINAL REFERÊNCIAS
16. Rouwet EV, Torsello G, de Vries JP et al. Final results of the prospective European trial of the Endurant stent graft for endovascular abdominal aortic aneurysm repair. Eur J Vasc Endovasc Surg 2011;42:489-97.
30. Sandford RM, Bown MJ, London NJ et al. The genetic basis of abdominal aortic aneurysms: A Review. Eur J Vasc Endovasc Surg 2007;33:381-90.
19. Becquemin JP, Pillet JC, Lescalie F et al. A randomized controlled trial of endovascular aneurysm repair versus open surgery for abdominal aortic aneurysms in low - to moderate-risk patients. J Vasc Surg 2011;53:1167-73. 20. Long A. Abdominal aortic aneurysms in elderly subjects. Rev Prat 2009;59(3):363-72.
10. Singh K, Bønaa KH, Jacobsen BK et al. Prevalence of and risk factors for abdominal aortic aneurysms in a population-based study: the tromso study. Am J Epidemiol 2001;154(3):236-44.
11. Johnson G, Avery A, McDougal EG et al. Aneurysms of the abdominal aorta. Incidence in blacks and whites in North Carolina. Arch Surg 1985;120(10):1138-40.
21. Hultgren R, Granath F, Swedenborg J. Different disease profiles for women and men with abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 2007;33(5):556-60. 22. Villard C, Swedenborg J, Eriksson P et al. Reproductive history in women with abdominal aortic aneurysms. J Vasc Surg 2011;54(2):341-5.e1-2. 23. Clifton MA. Familial abdominal aortic aneurysms. Br J Surg 1977;64(11):765-6. 24. Tilson MD, Seashore MR. Fifty families with abdominal aortic aneurysms in two or more first-order relatives. Am J Surg 1984;147(4):551-3. 25. Johansen K, Koepsell T. Familial tendency for abdominal aortic aneurysms. JAMA 1986;256(14):1934-6.
33. Freestone T, Turner RJ, Coady A et al. Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 1995;15(8):1145-51. 34. Ailawadi G, Eliason JL, Upchurch Jr GR. Current concepts in the pathogenesis of abdominal aortic aneurysm. J Vasc Surg 2003;38:584-8. 35. Longo GM, Xiong W, Greiner TC et al. Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. J Clin Invest 2002;110(5):625-32. 36. Hovsepian DM, Ziporin SJ, Sakurai MK et al. Elevated plasma levels of matrix metalloproteinase-9 in patients with abdominal aortic aneurysms: a circulating marker of degenerative aneurysm disease. J Vasc Interv Radiol 2000;11(10):1345-52.
12. Yii MK. Epidemiology of abdominal aortic aneurysm in an Asian population. ANZ J Surg 2003;73(6):393-5.
4. Filipovic M, Goldacre MJ, Roberts SE et al. Trends in mortality and hospital admission rates for abdominal aortic aneurysm in England and Wales, 1979-1999. Br J Surg 2005;92(8):968-75.
175 93Capítulo
8. Norman PE, Spilsbury K, Semmens JB. Falling rates of hospitalization and mortality from abdominal aortic aneurysms in Australia. J Vasc Surg 2011;53(2):274-7.
15. Turnbull IC, Criado FJ, Sanchez L et al. Five-year results for the talent enhanced low profile system abdominal stent graft pivotal trial including early and long-term safety and efficacy. J Vasc Surg 2010;51(3):537-44.
2. Harder Y, Notter H, Nussbaumer P et al. Popliteal aneurysm: diagnostic workup and results of surgical treatment. World J Surg 2003;27(7):788-92.
17. Levin DC, Rao VM, Parker L et al. Endovascular repair vs. open surgical repair of abdominal aortic aneurysms: comparative utilization trends from 2001 to 2006. J Am Coll Radiol 2009;6:506-9.
6. Sandiford P, Mosquera D, Bramley D. Trends in incidence and mortality from abdominal aortic aneurysm in New Zealand. Br J Surg 2011;98(5):645-51.
31. Tamarina NA, McMillan WD, Shively VP et al. Expression of matrix metalloproteinases and their inhibitors in aneurysms and normal aorta. Surgery 1997;122(2):264-71;discussion 271-72.
13. LaMorte WW, Scott TE, Menzoian JO. Racial differences in the incidence of femoral bypass and abdominal aortic aneurysmectomy in Massachusetts: relationship to cardiovascular risk factors. J Vasc Surg 1995;21(3):422-31.
9. Lederle FA. The rise and fall of abdominal aortic aneurysm. Circulation 2011;124:1097-9.
14. Jordan WD, Moore WM Jr, Melton JG et al. Secure fixation following EVAR with the Powerlink XL system in wide aortic necks: results of a prospective, multicenter trial. J Vasc Surg 2009;50:979-86.
52. Xiong F, Zhao JC. Quantification and location of Chlamydia pneumoniae-specific antigen in the walls of abdominal aortic aneurysms. Ann Vasc Surg 2011;25(2):256-63.
60. Gordon IL, Kohl CA, Arefi M et al. Spinal cord injury increases the risk of abdominal aortic aneurysm. Am Surg 1996;62(3):249-52.
63. Ailawadi G, Knipp BS, Lu G et al. A nonintrinsic regional basis for increased infrarenal aortic MMP-9 expression and activity. J Vasc Surg 2003;37(5):1059-66.
42. Nishimoto M, Takai S, Fukumoto H et al. Increased local angiotensin II formation in aneurysmal aorta. Life Sci 2002;71(18):2195-205.
65. Zatina MA, Zarins CK, Gewertz BL et al. Role of medial lamellar architecture in the pathogenesis of aortic aneurysms. J Vasc Surg 1984;1(3):442-8.
66. Dalman RL, Tedesco MM, Myers J et al. AAA disease: mechanism, stratification, and treatment. Ann N Y Acad Sci 2006;1085:92-109.
57. Truijers M, Kurvers HA, Bredie SJ et al. In vivo imaging of abdominal aortic aneurysms: increased FDG uptake suggests inflammation in the aneurysm wall. J Endovasc Ther 2008;15(4):462-7.
75. Alcorn HG, Wolfson SK, Sutton-Tyrrell K et al. Risk factors for abdominal aortic aneurysms in older adults enrolled in The Cardiovascular Health Study. Arterioscler Thromb Vasc Biol 1996;16(8):963-70. 76. Blanchard JF, Armenian HK, Friesen PP. Risk factors for abdominal aortic aneurysm: results of a case-control study. Am J Epidemiol 2000;151(6):575-83.
79. Lindholt JS, Henneberg EW, Juul S et al. Impaired results of a randomized double blinded clinical trial of propanolol versus placebo on the expansion rate of small abdominal aortic aneurysms. Int Angiol 1999;18(1):52-7.
67. Lederle FA, Johnson GR, Wilson SE et al. The aneurysm detection and management study screening program: validation cohort and final results. Aneurysm detection and management veterans affairs cooperative study investigators. Arch Intern Med 2000;160(10):1425-30.
62. Yeung JJ, Kim HJ, Abbruzzese TA et al. Aortoiliac hemodynamic and morphologic adaptation to chronic spinal cord injury. J Vasc Surg 2006;44(6):1254-65.
54. Pires LJ, Gutierrez PS. Morphometrical quantification of Chlamydia pneumoniae and Mycoplasma pneumoniae in human atherosclerotic abdominal aortic aneurysms. Rev Bras Cir Cardiovasc 2007;22(3):322-31.
53. Witkiewicz W, Gnus JJ, Drohomirecka A. The role of Chlamydia pneumoniae in the pathogenesis of abdominal aortic aneurysm. Pol Merkur Lekarski 2005;18(105):346-50.
59. Dimakakos P, Arapoglou B, Katsenis K et al. Ischemia of spinal cord following elective operative procedures of the infrarenal abdominal aorta. J Cardiovasc Surg (Torino) 1996;37(3):243-7.
64. Dobrin PB. Pathophysiology and pathogenesis of aortic aneurysms. Current concepts. Surg Clin North Am 1989;69(4):687-703.
74. Kent KC, Zwolak RM, Egorova NN et al. Analysis of risk factors for abdominal aortic aneurysm in a cohort of more than 3 million individuals. J Vasc Surg 2010;52(3):539-48.
41. Tromp G, Gatalica Z, Skunca M et al. Elevated expression of matrix metalloproteinase-13 in abdominal aortic aneurysms. Ann Vasc Surg 2004;18(4):414-20.
49. Yajima N, Masuda M, Myiazaki M et al. Oxidative stress is involved in the development of experimental abdominal aortic aneurysm: a study of the transcription profile with complementary DNA microarray. J Vasc Surg 2002;36(2):379-85.
71. Bengtsson H, Bergqvist D, Sternby NH. Increasing prevalence of abdominal aortic aneurysms. A necropsy study. Eur J Surg 1992;158(1):19-23. 72. Police SB, Thatcher SE, Charnigo R et al. Obesity promotes inflammation in periaortic adipose tissue and angiotensin IIinduced abdominal aortic aneurysm formation. Arterioscler Thromb Vasc Biol 2009;29(10):1458-64.
77. Suh GY, Les AS, Tenforde AS et al. Hemodynamic changes quantified in abdominal aortic aneurysms with increasing exercise intensity using mr exercise imaging and image-based computational fluid dynamics. Ann Biomed Eng 2011;39(8):2186-202. 78. Les AS, Shadden SC, Figueroa CA et al. Quantification of hemodynamics in abdominal aortic aneurysms during rest and exercise using magnetic resonance imaging and computational fluid dynamics. Ann Biomed Eng 2010;38(4):1288-313.
55. Jagadesham VP, Scott DJ, Carding SR. Abdominal aortic aneurysms: an autoimmune disease? Trends Mol Med 2008;14(12):522-9.
80. Propanolol Aneurysm Trial Investigators. Propanolol for small abdominal aortic aneurysms: results of a randomized trial. J Vasc Surg 2002;35(1):72-9. 81. Holmes DR, PetrinecD, Wester W et al. Indomethacin prevents elastase-induced abdominal aortic aneurysms in the rat. J Surg Res 1996;63(1):305-9. 82. Miralles M, Wester W, Sicard GA et al. Indomethacin inhibits expansion of experimental aortic aneurysms via inhibition of the cox2 isoform of cyclooxygenase. J Vasc Surg 1999;29(5):884-92. 83. Hosokawa Y. Effects of angiotensin receptor blocker and calcium channel blocker on experimental abdominal aortic aneurysms in a hamster model. Kurume Med 2010;57(1-2):1-8. 84. Thompson RW, Baxter BT. MMP inhibition in abdominal aortic aneurysms. Rationale for a prospective randomized clinical trial. Ann NY Acad Sci 1999;878:159-78. 85. Prall AK, Longo GM, Mayhan WG et al. Doxycycline in patients with abdominal aortic aneurysms and in mice: comparison of serum levels and effect on aneurysm growth in mice. J Vasc Surg 2002;35(5):923-9. 86. Curci JA, Mao D, Bohner DG et al. Preoperative treatment with doxycycline reduces aortic wall expression and activation of matrix metalloproteinases in patients wirh abdominal aortic aneurysms. J Vasc Surg 2000;31(2):325-42. 87. Baxter BT, Pearce WH, Waltke EA et al. Prolonged administration of doxycycline in patients with small asymptomatic abdominal aortic aneurysms: report of a prospective (PhaseII) multicenter study. J Vasc Surg 2002;36(1):1-12. 88. Mosorin M, Juvonen J, Biancari F et al. Use of doxycycline to decrease the growth rate of abdominal aortic aneurysms: a randomized, double-blind, placebo-controlled pilot study. J Vasc Surg 2001;34(4):606-10.
47. Ramos-Mozo P, Madrigal-Matute J, Martinez-Pinna R et al. Proteomic analysis of polymorphonuclear neutrophils identifies catalase as a novel biomarker of abdominal aortic aneurysm: potential implication of oxidative stress in abdominal aortic aneurysm progression. Arterioscler Thromb Vasc Biol 2011;31(12):3011-9.
69. Lederle FA, LarsonJC, Margolis KL et al. Abdominal aortic aneurysm events in the women’s health initiative: cohort study. BMJ 2008;337:a1724. 70. Lederle FA. Should abdominal aortic aneurysm be managed differently in women? Scand J Surg 2008;97(2):125-7.
61. Vollmar JF, Paes E, Pauschinger P et al. Aortic aneurysms as late sequelae of above- knee amputation. Lancet 1989;2(8667):834-5.
68. Wilmink AB, Quick CR. Epidemiology and potential for prevention of abdominal aortic aneurysm. Br J Surg 1998;85(2):155-62.
176 Parte VIABDÔMEN E PELVE
50. Mazur E, Niedzwiadek J, Wolski A et al. Chlamydia pneumoniae infection in abdominal aortic aneurysm (AAA) patients and its clinical impact. Pol J Pathol 2004;55(4):155-64.
43. Daugherty A, Manning MW, Cassis LA. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J Clin Invest 2000;105(11):1605-12.
44. Miller FJ, Sharp WJ, Fang X et al. Oxidative stress in human abdominal aortic aneurysms: a potential mediator of aneurismal remodeling. Arteriocler Thromb Vasc Biol 2002;22(4):560-5.
46. Pyo R, Lee JK, Shipley JM et al. Targeted gene disruption of matrix metalloproteinase-9 (gelatinase-B) suppresses development of experimental abdominal aortic aneurysms. J Clin Invest 2000;105(11):1641-9.
51. Wolski A, Korobowicz E, Siezieniewska Z et al. Immunofluorescence in situ and the serologic indices of Chlamydia pneumoniae infection in patients with an abdominal aortic aneurysm. Pol J Pathol 2002;53(4):223-8.
56. Reeps C, Essler M, Pelisek J et al. Increased 18F-fluorodeoxyglucose uptake in abdominal aortic aneurysms in positron emission/ computed tomography is associated with inflammation, aortic wall instability, and acute symptons. J Vasc Surg 2008;48(2):417-23.
45. Katrancioglu N, Manduz S, Karahan O et al. The role of the CCR2 gene polymorphism in abdominal aortic aneurysms. Angiology 2011;62(2):140-3.
73. Golledge J, Clancy P, Jamrozik K et al. Obesity, adipokines, and abdominal aortic aneurysm: health in men study. Circulation 2007;116(20):2275-9.
48. Mahmoud KM, Ammar AS. Effect of N-acetylcysteine on cardiac injury and oxidative stress after abdominal aortic aneurysm repair. A randomized controlled trial. Acta Anaesthesiol Scand 2011;55(8):1015-21.
58. Hoshina K, Sho E, Sho M et al. Wall shear stress and strain modulate experimental aneurysm cellularity. J Vasc Surg 2003;37(5):1067-74.
109. Lippert S, Callaham ML, Lo B. Perceptions of conflict of interest disclosures among peer reviewers. PLoS One 2011;6(11):e26900. 110. Lee YK, Chung CY, Koo KH et al. Conflict of interest in the assessment of thromboprophylaxis after total joint arthroplasty: a systematic review. J Bone Joint Surg Am 2012;94(1):27-33.
116. Biancari F, Anttila V, Juvonen J et al. Durability of open repair of infrarenal abdominal aortic aneurysm: a 15-year follow-up study. J Vasc Surg 2002;35(1):87-93. 117. Conrad MF, Crawford RS, Pedraza JD et al. Long-term durability of open abdominal aortic aneurysm repair. J Vasc Surg 2007;46(4):669-75. 118. Yusuf S, Collins R, Peto R. Why do we need some large, simple randomized trials? Statist Med 1984;3:409-20. 119. The United Kingdom EVAR Trial Investigators. Endovascular versus open repair of abdominal aortic aneurysm. N Engl J Med 2010;362:1863-71. 120. EVAR trial participants. Endovascular aneurysm repair and outcome in patients unfit for open repair of abdominal aortic aneurysm (EVAR Trial 2): randomized controlled trial. Lancet 2005;365(9478):2187-92. 121. Brown LC, Thompson SG, Greenhalgh RM et al. Endovascular aneurysm repair trial participants. Incidence of cardiovascular events and death after open or endovascular repair of abdominal aortic aneurysm in the randomized EVAR trial 1. Br J Surg 2011;98(7):935-42. 122. Wyss TR, Brown LC, Powell JT et al. Rate and predictability of graft rupture after endovascular and open abdominal aortic aneurysm repair: data from the EVAR trials. Ann Surg 2010;252(5):805-12.
108. Simundic AM. Biochemia medica introduces the revised policy on statement of conflict of interest. Biochem Med 2011;21(2):104-5.
97. Takagi H, Matsui M, Umemoto T. A meta analysis of clinical studies of statins for prevention of abdominal aortic aneurysm expansion. J Vasc Surg 2010;52(6):1675-81.
111. Elliot BM. Society for vascular surgery. Conflict of interest and the society for vascular surgery. J Vasc Surg 2011;54(3 Suppl):3S-11S. 112. Dinis da Gama A. The future of vascular surgery in a rapidly changing world: quo vadis? J Vasc Surg Br 2002;1(3):175-80.
131. Bevis PM, Windhaber RA, Lear PA et al. Randomized clinical trial of mesh versus sutured wound closure after open abdominal aortic aneurysm surgery. Br J Surg 2010;97(10):1497-502.
133. Cochennec F, Javerliat I, Di Centa I et al. A comparison of total laparoscopic and open repair of abdominal aortic aneurysms. J Vasc Surg 2012;55(6):1549-53.
177Capítulo 93 AneurismA s dA AortA AbdominAl
134. Paraskevas K, Mikhailidis D, Veith F. Endovascular versus open repair of abdominal aortic aneurysms: Interpreting the landmark United Kingdom EVAR 1 results. J Endovasc Ther 2010;17(5):599-601.
114. Hallet JW, Marshall DM, Petterson TM et al. Graff-related complications after abdominal aortic aneurysm repair: reassurance from a 36-year population-based experience. J Vasc Surg 1997;25(2):277-84.
135. Hannan EL, O’Donnell JF, Kilburn H et al. Investigation of the relationship between volume and mortality for surgical procedures performed in New York State hospitals. JAMA 1989;262(4):503-10.
136. Dimick JB, Stanley JC, Axelrod DA et al. Variation in death rate after abdominal aortic aneurysmectomy in the United States: impact of hospital volume, gender, and age. Ann Surg 2002;235(4):579-85.
103. Timothy AM, Chuter and Darren Schneider. Abdominal aortic aneuryms: endovascular treatment. In: Cronenwett & Johnston (Ed.). Rutherford’s vascular surgery. 7th ed. Philadelphia: WB Saunders; 2010. p. 1972-93.
113. Lederle FA, Freischlag JA, Kyriakides TC et al. Open versus endovascular repair (OVER). Outcomes following endovascular vs open repair of abdominal aortic aneurysm: a randomized trial. JAMA 2009;302(14):1535-42.
138. Johnston KW. Nonruptured abdominal aortic aneurysm: six-year follow-up results from the multicenter prospective Canadian aneurysm study. Canadian Society for Vascular Surgery Aneurysm Study Group. J Vasc Surg 1994;20(2):163-70.
115. Mukai S, Yao H, Myiamoto T et al. The long-term follow-up results of elective surgical treatment for abdominal aortic aneurysms. Ann Thorac Cardiovasc Surg 2002;8(1):38-41.
127. Becquemin JP, Pillet JC, Lescalie F et al. A randomized controlled trial of endovascular aneurysm repair versus open surgery for abdominal aortic aneurysms in low-to moderate-risks patients. J Vasc Surg 2011;53:1167-73.
137. Odero A, Arici V, Bozzani A. Endovascular repair of abdominal aortic aneurysm. N Engl J Med 2010;363(15):1480; author reply 1481-82.
94. Shouten O, van Laanen JH, Boersma E et al. Statins are associated with a reduced infrarenal abdominal aortic aneurysm growth. Eur J Vasc Endovasc Surg 2006;32(1):21-6.
100. Twine CP, Williams IM. Systematic review and meta-analysis of the effects of statin therapy on abdominal aortic aneurysms. Br J Surg 2011;98(3):346-53.
128. Adye B, Luna G. Incidence of abdominal wall hernia in aortic surgery. Am J Surg 1998;175(5):400-2.
101. Rahman MN, Khan JA, Mazari FA et al. A randomized placebo controlled trial of the effect of preoperative statin use on matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in areas of low and peak wall stress in patients undergoing elective open repair of abdominal aortic aneurysm. Ann Vasc Surg 2011;25(1):32-8.
90. Yamawaki-Ogata A, Hashizume R, Satake M et al. A doxycycline loaded, controlled-release, biodegradable fiber for the treatment of aortic aneurysms. Biomaterials 2010;31(36):9554-64.
89. Sho E, Chu J, Sho M et al. Continuous periaortic infusion improves doxycycline efficacy in experimental aortic aneurysms. J Vasc Surg 2004;39(6):1312-21.
123. Chaar CI, Eid R, Park T et al. Delayed open conversions after endovascular aortic aneurysm repair. J Vasc Surg 2012;55(6):1562-69.e1. 124. Prinssen M, Buskens E, de Jong SE et al. DREAM trial participants. Cost-effectiveness of conventional and endovascular repair of abdominal aortic aneurysms: results of a randomized trial. J Vasc Surg 2007;46(5):883-90. 125. Koelemay MJ, Balm R. Surgery for abdominal aortic aneurysm: open or endovascular repair? Ned Tijdschr Geneeskd 2010;154:A2548. 126. De Bruin JL, Baas AF, Buth J et al. DREAM Study Group. Long-term outcome of open or endovascular repair of abdominal aortic aneurysm. N Engl J Med 2010;362(20):1881-9.
102. Parodi JC, Palmaz JC, Barone HD. Transfemoral intraluminal graft implantation for abdominal aortic aneurysms. Ann Vasc Surg 1991;5(6):491-9.
92. Vammen S, Lindholt JS, Ostergaard LJ et al. Reduction of the expansion rate of small abdominal aortic aneurysms with roxithromycin. Results from a randomized controlled trial. Ugeskr Laeger 2002;164(50):5916-9.
104. Rutherford RB, Johnston KW. Potential problems with industrysupported clinical research. J Vasc Surg 2000;31:1060-76.
95. Sukhija R, Aronow WS, Sandhu R et al. Mortality and size of abdominal aortic aneurysm at long-term follow-up of patients not treated surgically and treated with and without statins. Am J Cardiol 2006;97(2):279-80.
96. Baxter BT, Terrin MC, Dalman RL. Medical management of small abdominal aortic aneurysms. Circulation 2008;117(14):1883-9.
129. Gruppo M, Mazzalai F, Lorenzetti R et al. Midline abdominal wall incision hernia after aortic reconstructive surgery. Surgery 2012;151(6):882-8. 130. Augestad KM, Wilsgaard T, Solberg S. Incisional hernia after surgery for abdominal aortic aneurysm. Tidsskr Nor Laegeforen 2002;122(1):22-4.
98. Karrowni W, Dughman S, Hajj GP et al. Statin therapy reduces growth of abdominal aortic aneurysms. J Investig Med 2011;59(8):1239-43.
132. Llaguna OH, Avgerinos DV, Nagda P et al. Does prophylactic biologic mesh placement protect against the development of incisional hernia in high-risk patients? World J Surg 2011;35(7):1651-5.
105. Porter JM. Presidential address: reflections. J Vasc Surg 2001;33:213-9. 106. Jones JW, McCullough LB. Surgeon-industry relationships: Ethically responsible management of conflicts of interest. J Vasc Surg 2002;35:825-6. 107. Jones JW, McCullough LB. Intentional over-treatment: the unmentionable conflict-of-interest. J Vasc Surg 2007;46(3):605-7.
99. Ferguson CD, Clancy P, Bourke B et al. Association of statin prescription with small abdominal aortic aneurysm progression. Am Heart J 2010;159(2):307-13.
91. Hogh A, Vammen S, Ostergaard L et al. Intermitent roxithromycin for preventing progression of small abdominal aortic aneurysms: long-term results of a small clinical trial. Vasc Endovascular Surg 2009;43(5):452-6.
93. Takagi H, Matsui M, Umemoto T. Antibiotics for preventing progression of abdominal aortic aneurysms: a meta-analysis of randomized trials. Vasc and Endov Surg 2010;44(7):613-4.
144. Schermerthorn ML, O’Malley AJ, Jhaveri A et al. Endovascular vs open repair of abdominal aortic aneurysms in the Medicare population. N Engl J Med 2008;358(5):464-74.
170. Karkos CD, Mukhopadhyay U, Papakostas I et al. Abdominal aortic aneurysm: the role of clinical examination and opportunistic detection. Eur J Vasc Endovasc Surg 2000;19(3):299-303.
151. Golden MA, Whittemore AD, Donaldson MC et al. Selective evaluation and management of coronary artery disease in patients undergoing repair of abdominal aortic aneurysms. A 16-year experience. Ann Surg 1990;212(4):415-20.
172. Torella M, De Santo LS, Della Corte A et al. Extensive retroperitoneal fibrosis with duodenal and ureteral obstruction associated with giant inflammatory aneurysm of the abdominal aorta. Tex Heart Inst J 2003;30(4):311-3.
176. Deitch JS, Heller JA, McGagh D et al. Abdominal aortic aneurysm causing duodenal obstruction: two cases reports and review of the literature. J Vasc Surg 2004;40(3):543-7.
175. Mertens R, Kramer A, Valdés F. Ilio femoral thrombosis: an infrequent complication of an aortic and iliac aneurysm. Report of two cases. Rev Med Chil 1999;127(4):459-62.
180. Filis KA, Lagoudianakis EE, Markogiannakis H et al. Complete abdominal aortic aneurysm thrombosis and obstruction of both common iliac arteries with intrathrombotic pressures demonstrating a continuing risk of rupture: a case report and review of the literature. J Medical Case Reports 2009;3:9292.
158. Jongkind V, Yeung KK, Akkersdijk GJ et al. Juxtarenal aortic aneurysm repair. J Vasc Surg 2010;52(3):760-7.
150. Green RM, Ricotta JJ, Ouriel K et al. Results of supraceliac aortic clamping in the difficult elective resection of infrarenal abdominal aortic aneurysm. J Vasc Surg 1989;9(1):124-34.
162. Reise JA, Sheldon H, Earnshaw J et al. Patience preference for surgical method of abdominal aortic aneurysm repair: postal survey. Eur J Vasc Endovasc Surg 2010;39(1):55-61.
140. Baron JF, Mundler O, Bertrand M et al. Dipyridamole-thallium scintigraphy and gated radionuclide angiography to assess cardiac risk before abdominal aortic surgery. N Engl J Med 1994;330(10):663-9.
149. Perry MO, Calcagno D. Abdominal aortic aneurysm surgery: the basic evaluation of cardiac risk. Ann Surg 1988;208(6):738-42.
156. Malas MB, Freischlag JA. Interpretation of the results of OVER in the context of EVAR Trial, DREAM, and the EUROSTAR Registry. Semin Vasc Surg 2010;23:165-9.
153. Sicard Ga, Reilly JM, Rubin BG et al. Transabdominal versus retroperitoneal incision for abdominal aortic surgery: report of a prospective randomized trial. J Vasc Surg 1995;21:174-81.
154. Hertzer NR, Mascha EJ, Karafa MT et al. Open infrarenal abdominal aortic aneurysm repair: the Cleveland clinic experience from 1989 to 1998. J Vasc Surg 2002;35(6):1145-54.
166. United Nations, Department of Economic and Social Affairs, Population Division (2007). World Population Prospects: The 2006 Revision, Highlights, Working Paper ESA/P/WP.202.
174. Kashyap VS, Fang R, Fitzpatrick CM et al. Caval and ureteral obstruction secondary to an inflammatory abdominal aortic aneurysm. J Vasc Surg 2003;38(6):1416-21.
181. Suliman AS, Raffetto JD, Seidman CS et al. Acute thrombosis of abdominal aortic aneurysms – report of two cases and review of the literature. Vasc Endovascular Surg 2003;37(1):71-5.
165. Thompson M, Holt P, Loftus I. Part-one: all major arterial interventions should now be performed in high volume centres—abdominal aortic aneurysms. Eur J vasc Endovasc Surg 2011;42(4):411-4.
168. Chervu A, Clagett GP, Valentine RJ. Role of physical examination in detection of abdominal aortic aneurysms. Surgery 1995;117:454-7.
141. Wen SW, Simunovic M, Williams JI et al. Hospital volume, calendar age, and short term outcomes in patients undergoing repair of abdominal aortic aneurysms: the Ontario experience, 1988-92. J Epidemiol Community Health 1996;50(2):207-13.
177. Criado FJ. Acute thrombosis of abdominal aortic aneurysm. Tex Heart Inst J 1982;9(3):367-71.
147. Reigel MM, Hollier LH, Kazmier FJ et al. Late survival in abdominal aortic aneurysm patients: The role of selective myocardial revascularization on the basis of clinical symptoms. J Vasc Surg 1987;5:222-7.
161. Landry G, Lau I, Liem T et al. Open abdominal aortic aneurysm repair in the endovascular era: effect of clamp site on outcomes. Arch Surg 2009;144(9):811-6.
157. Stroupe KT, Lederle FA, Matsumura JS et al. Open Versus Endovascular Repair (OVER) Veterans Affairs Cooperative Study Group. Cost-effectiveness of open versus endovascular repair of abdominal aortic aneurysm in the OVER trial. J Vasc Surg 2012;56(4):901-9.e2.
164. Landon BE, O’Malley AJ, Giles K et al. Volume-outcome relationships and abdominal aortic aneurysm repair. Circulation 2010;122:1290-7.
155. Menard MT, Chew DK, Chan RK et al. Outcome in patients at high risk after open surgical repair of abdominal aortic aneurysm. J Vasc Surg 2003;37(2):285-92.
179. Hirose H, Takagi M, Hashiyada H et al. Acute occlusion of an abdominal aortic aneurysm: case report and review of the literature. Angiology 2000;51(6):515-23.
145. The United Kingdom EVAR Trial Investigators. Endovascular versus open repair of abdominal aortic aneurysm. N Engl J Med 2010;362:1863-71.
178. Miani S, Mattioli A, Bordoni MG et al. Clinical aspects, diagnosis and therapy of thrombosis of an abdominal aortic aneurysm. Minerva Chir 1989;44(20):2153-6.
148. Bernstein EF, Dilley RB, Randolph HF. The improving long-term outlook for patients over 70 years of age with abdominal aortic aneurysms. Ann Surg 1988;207(3):318-22.
152. Cambria RP, Brewster DC, Abbott WM et al. The impact of selective use of dipyridamole-thallium scans and surgical factors on the current morbidity of aortic surgery. J Vasc Surg 1992;15(1):43-50.
171. Muluk SC, Gertler JP, Brewster DC et al. Presentation and patterns of aortic aneurysms in young patients. J Vasc Surg 1994;20(6):887-8.
139. Abu Rahma AF, Robinson PA, Boland JP et al. Elective resection of 332 abdominal aortic aneurysms in a southern West Virginia community during a recent five-year period. Surgery 1991;109(3 Pt 1):244-51.
159. Tsai S, Conrad MF, Patel VI et al. Durability of open repair of juxtarenal abdominal aortic aneurysms. J Vasc Surg 2012;56(1):2-7.
173. Nevelsteen A, Lacroix H, Stockx L et al. Inflammatory abdominal aortic aneurysm and bilateral endovascular graft and bilateral ureteric stenting. Ann Vasc Surg 1999;13(2):222-4.
184. Vandecandelaere M, Cotton A, Cortet B et al. Abdominal aortic aneurysm. A rare cause of destructive lesions of the spine. Rev Rhum Engl Ed 1996;63(4):296-9. 185. Latif S, Wasti A, Grundy DJ et al. Direct erosion of lumbar spine by an abdominal aortic aneurysm, resulting in paraparesis: unusual presentation. Case report. Paraplegia 1995;33(8):480-1. 186. Chatlani PT, Van Dessel MG, Krishnan KR et al. Abdominal aortic aneurysm presenting as paraplegia: case report. Paraplegia 1989;27(2):146-7. 187. Marston WA, Ahlquist R, Johnson G et al. Misdiagnosis of ruptured abdominal aortic aneurysms. J Vasc Surg 1992;16(1):17-22. 188. Cohen JR. Ruptured abdominal aneurysms. In: Rutherford RB. (Ed.). Vascular surgery. 5th ed. Philadelphia: WB Saunders; 2000. p. 1296. 189. Dorrucci V, Veraldi GF, Dusi R et al. Chronic rupture of abdominal aortic aneurysms. (Report of 3 cases). Ann Ital Chir 2000;71(2):247-50.
178 Parte VIABDÔMEN E PELVE
142. Kazmers A, Jacobs L, Perkins A et al. Abdominal aortic aneurysm repair in Veterans Affairs medical centers. J Vasc Surg 1996;23(2):191-200.
146. Crawford ES, Saleh SA, Babb JW et al. Infrarenal abdominal aortic aneurysm: factors influencing survival after operation performed over a 25-year period. Ann Surg 1981;193(6):669-709.
160. Sarac TP, Clair DG, Hertzer NR et al. Contemporary results of juxtarenal aneurysm repair. J Vasc Surg 2002;36(6):1104-11.
182. Baxter BT, McGee GS, Flinn WR et al. Distal embolization as a presenting symptom of aortic aneurysms. Am J Surg 1990;160(2):197-201. 183. Suzuki Y, Kato J, Kyoraku Y et al. Cholesterol embolism in a patient with inflammatory abdominal aortic aneurysm. Intern Med 1999;38(11):861-4.
163. The Leapfrog Group. Factsheet: evidence-based hospital referral. Accesso em: 23 Apr. 2009. Disponível em: wwwleapfroggroup.org/midia/file/factsheet_EBHR.pdf><http://
143. Prinssen M, Verhoeven EL, Buth J et al. A randomized trial comparing conventional and endovascular repair of abdominal aortic aneurysms. N Engl J Med 2004;351(16):1607-18.
167. Lederle FA, Simel DL. The rational clinical examination. Does this patient have abdominal aortic aneurysm? JAMA 1999;281(10):77-82.
169. Lederle FA, Walker JM, Reinke DB. Selective screening for abdominal aortic aneurysms with physical examination and ultrasound. Arch Intern Med 1988;148(8):1753-6.
220. Katz DA, Littenberg B, Cronenwett JL. Management of small abdominal aortic aneurysms. Early surgery vs Watchful waiting. JAMA 1992;268(19):2678-86.
203. Lindholt JS, Juul S, Fasting H et al. Hospital costs and benefits of screening for abdominal aortic aneurysms. Results from a randomised population screening trial. Eur J Vasc Endovasc Surg 2002;23(1):55-60. 204. Takagi H, Goto SN, Matsui M et al. A further meta-analysis of population-based screening for abdominal aortic aneurysm. J Vasc Surg 2010;52(4):1103-8.
197. Norman PE, Jamrozik K, Lawrence-Brown MM et al. Population based randomised controlled trial on impact of screening on mortality from abdominal aortic aneurysm. BMJ 2004;329(7477):1259.
217. Silvertein MD, Pitts SR, Chaikof EL et al. Abdominal aortic aneurysm (AAA): cost-effectiveness of screening, surveillance of intermediatesized AAA, and management of symptomatic AAA. Proc (Bayl Univ Med Cent) 2005;18(4):345-67.
198. Lindholt JS, Juul S, Fasting H et al. Screening reduced abdominal aortic aneurysm mortality-secondary publication. Results from a Danish randomized screening trial. Ugeskr Laeger 2005;167(15):1641-4. 199. Sillesen H, Schroeder TV. Screening reduced mortality in abdominal aortic aneurysm. Ugeskr Laeger 2005;167(15):1621. 200. Longo C, Upchurch GR. Abdominal aortic aneurysm screening: recommendations and controversies. Vasc Endovascular Surg 2005;39(3):213-9.
192. Al-Koteesh J, Masannat Y, James NV et al. Chronic contained rupture of abdominal aortic aneurysm presenting with longstanding back pain. Scott Med 2005;50(3):122-3.
190. Jones CS, Reilly MK, Dalsing MC et al. Chronic contained rupture of abdominal aortic aneurysms. Arch Surg 1986;121(5):542-6.
194. Yashar JJ, Halman GL, Cooley DA. Fistula between aneurysm of aorta and left renal vein. Report of a case. Arch Surg 1969;99:546.
212. Jones A, Cahill D, Gardham R. Outcome in patients with a large abdominal aortic aneurysm considered unfit for surgery. Br J Surg 1998;85(10):1382-4. 213. Nevitt MP, Ballard DJ, Hallett JW. Prognosis of abdominal aortic aneuryms. A population-based study. N Engl J Med 1989;321(15):1040-2.
196. Heather BP, Poskitt KR, Earnshaw JJ et al. Population screening reduces mortality rate from aortic aneurysm in men. Br J Surg 2000;87(6):750-3.
211. Vorp DA, Raghavan ML, Webster MW. Mechanical wall stress in abdominal aortic aneurysm: influence of diameter and asymmetry. J Vasc Surg 1998;27(4):632-9.
205. Lindholt JS, Norman PE. Meta-analysis of postoperative mortality after elective repair of abdominal aortic aneurysms detected by screening. Br J Surg 2011;98(5):619-22. 206. Miranda-Usua Y, Whitworth JD, Tillett J. Does ultrasound screening for abdominal aortic aneurysm reduce mortality? J Fam Pract 2012;61(1):51-60.
202. Vardulaki KA, Walker NM, Couto E et al. Late results concerning feasibility and compliance from a randomized trial of ultrasonographic screening for abdominal aortic aneurysm. Br J Surg 2002;89(7):861-4.
209. Mofidi R, Goldie VJ, Kelman J et al. Influence of sex on expansion rate of abdominal aortic aneurysms. Br J Surg 2007;94(3):310-4.
214. Reed WW, Hallett JW, Damiano MA et al. Learning from the last ultrasound. A population-based study of patients with abdominal aortic aneurysm. Arch Intern Med 1197;157(18):2064-8.
216. Ritter RG, Nelson K, Adili F et al. Abdominal aortic aneurysm: screening and surveillance. Hamostaseologie 2004;24(3):151-6.
224. Sharp MA, Collin J. A myth exposed: fast grown in diameter does not justify precocious abdominal aortic aneurysm repair. Eur J Vasc Endovasc Surg 2003;25(5):408-11.
227. Brown LC, Powell JT. Risk factors for aneurysm rupture in patients kept under ultrasound surveillance. UK Small Aneurysm Trial Partipants. Ann Surg 1999;230(3):289-96. 228. Hunter JC, Smyth SH, Aguirre ML et al. Incidence and histologic characteristics of blebs in patients with abdominal aortic aneurysms. J Vasc Surg 1996;24(1):93-101. 229. Cagir B, Lee BY, Herz BL. Aortic blebs: an indication for urgent surgery. Hosp Pract (Off Ed)1993;28(10A):73-6.
223. Nicholls SC, Gardner JB, Meissner MH et al. Rupture in small abdominal aortic aneurysms. J Vasc Surg 1998;28(5):884-8.
193. Fenster MS, Dent JM, Tribble C et al. Aortocaval fistula complicating abdominal aortic aneurysm: case report and literature review. Cathet Cardiovasc Diagn 1996;38(1):75-9.
210. Wanhainem A, Lundkvist J, Bergqvist D et al. Cost-effectiveness of screening women for abdominal aortic aneurysm. J Vasc Surg 2006;43(5):908-14.
219. Lederle FA, Wilson SE, Johnson GR et al. Immediate repair compared with surveillance of small abdominal aortic aneurysms. N Engl J Med 2002;346(19):1437-44.
179Capítulo 93 AneurismA s dA AortA AbdominAl
208. Henriksson M, Lundgren F. Decision-analytical model with lifetime estimation of costs and heatlth outcomes for one-time screening for abdominal aortic aneurysm in 65-year-old men. Br J Surg 2005;92(8):976-83.
215. Guirguis EM, Barber GG. The natural history of abdominal aortic aneurysms. Am J Surg 1991;162(5):481-3.
195. Wilmink TB, Quick CR, Hubbard CS et al. The influence of screening on the incidence of ruptured abdominal aortic aneurysms. J Vasc Surg. 1999;30(2):203-8.
230. Lee J. Radiological imaging of aortic aneurysms. Korean Circulation J 2007;37:337-47. 231. Mower WR, Quiñónez WJ, Gambhir SS. Effect of intraluminal thrombus on abdominal aortic aneurysm wall stress. J Vasc Surg 2001;33(3):660-1. 232. Wolf YG, Thomas WS, Brennan FJ et al. Computed tomography scanning findings associated with rapid expansion of abdominal aortic aneurysms. J Vasc Surg 1994;20(4):529-35. 233. Vorp DA, Wang DH, Webster MW et al. Effect of intraluminal thickness and bulge diameter on the oxygen difusion in abdominal aortic aneurysm. J Biomech Eng 1998;120(5):579-83. 234. Kazi M, Thyberg J, Religa P et al. Influence of intraluminal thrombus on structural and cellular composition of abdominal aortic aneurysm. J Vasc Surg 2003;38(6):1283-90. 235. Stenbaek J, Kalin B, Swedenborg J. Growth of thrombus may be a better predictor of rupture than diameter in patients with abdominal aortic aneurysms. Eur J Endovasc Surg 2000;20(5):466-9. 236. Chaikof EL, Blanksteinjn JD, Harris PL et al. Reporting standards for endovascular aortic aneurysm repair. J Vasc Surg 2002;35(5):1048-60. 237. Schurink GW, van Baalen JM, Visser MJ et al. Thrombus within an aortic aneurysm does not reduce pressure on the aneurismal wall. J Vasc Surg 2000;31(3):501-6. 238. Scobie TK, Masters RF, Changing factors influencing abdominal aortic aneurysm repair. J Cardiovasc Surg 1982;23:309. 239. Crawford ES, Snyder DM, Graham JM. Treatment of aortic aneurysms – Updated. In: Brito CJ, Mayall RC, Pinto-Ribeiro A. (Eds.). Doenças vasculares. Anais do 24º Congresso Brasileiro de Angiologia. Rio de Janeiro: Teatral; 1983. p. 19-41. 240. Steyerberg EW, de Mol Van Otterloo JC, van Bockel JH et al. Perioperative mortality of elective abdominal aortic aneurysm surgery. A clinical prediction rule based on literature and individual patient data. Arch Intern Med 1995;155(18):1998-2004. 241. Hallin A, Bergqvist D, Holmberg L. Literature review of surgical management of abdominal aortic aneurysm. Eur J Vasc Endovasc Surg 2001;22(3):197-204.
218. Lederle FA, Johnson GR, Wilson SE et al. Rupture rage of large abdominal aortic aneurysms in patients refusing or unfit for elective repair. JAMA 2002;287(22):2968-72.
222. Ouriel K, Green RM, Donayre C et al. An evaluation of new methods of expressing aortic aneurysm size: relationship to rupture. J Vasc Surg 1992;15(1):12-8.
221. Hollier LH, Taylor LM, Ochsner J. Recommended indications for operative treatment of abdominal aortic aneurysms. Report of a subcommittee of the joint council of the society for vascular surgery and the North American chapter of the international society for cardiovascular surgery. J Vasc Surg 1992 June;15(6):1046-56.
201. Ashton HA, Buxton MJ, Day NE et al. Multicentre aneurysm screening study group. The Multicentre Aneurysm Screening Study (MASS) into the effect of abdominal aortic aneurysm screening on mortality in men: a randomized controlled trial. Lancet 2002;360(9345):1531-9.
207. Wanhainen A, Lundkvist J, Bergqvist D et al. Cost-effectiveness of different strategies for abdominal aortic aneurysm. J Vasc Surg 2005;41(5):741-51.
225. Cronenwett JL, Murphy TF, Zelenock GB et al. Actuarial analysis of variables associated with rupture of small abdominal aortic aneurysms. Surgery 1985;98(3):472-83. 226. Sterpetti AV, Cavallaro A, Cavallari N et al. Factors influencing the rupture of abdominal aortic aneurysms. Surg Gynecol Obstet 1991;173(3):175-8.
191. Davidovic LB, Lotina SI, Cinara IS et al. Chronic rupture of abdominal aortic aneurysms. Srp Arth Celok Lek 1998;126(5-6):177-82.
255. Sicard GA, Toursarkissian B. Midline versus retroperitoneal approach for abdominal aortic aneurysm surgery. In: Calligaro KD, Dougherty MJ, Hollier LH (Eds.). Diagnosis and treatment of aortic and peripheral arterial aneurysms. Philadelphia: WB Saunders; 1999. p. 135-48.
263. Honig MP, Mason RA, Giron F. Wound complications of the retroperitoneal approach of the aorta and iliac vessels. J Vasc Surg 1992;15:28-34. 264. Shepard AD, Tollefson DFJ, Reddy DJ et al. Left flank retroperitoneal exposure: a technical aid to complex aortic reconstruction. J Vasc Surg 1991;14:283-91.
273. Kouvelos G, Koutsoumpelis A, Lazaris A, Matsagkas M. Late open conversion after endovascular abdominal aortic aneurysm repair. J Vasc Surg 2015;61:1350-6. 274. Kelso RL, Lyden SP, Butler B et al. Late conversion of aortic stent grafts. J Vasc Surg 2009;49:589-95. 275. Sidawy AN, Perler BA. Rutherford’s vascular surgery and endovascular therapy, E-Book. Philadelphia: Elsevier Health Sciences; 2018. 276. Lindblad B, Almgren B, Bergqvist D et al. Abdominal aortic aneurysm with perianeurysmal fibrosis: Experience from 11 Swedish vascular centers. J Cardiovasc Surg 1991;13:231-9. 277. Fritschen VV, Malzfeld E, Clasen A et al. Inflammatory abdominal aortic aneurysm: a postoperative course of retroperitoneal fibrosis. J Vasc Surg 1999;30:1090-8. 278. Ziaja K, Sedlak L, Urbanek T et al. Inflammatory abdominal aortic aneurysm. Wiad Lek 2000;53:71-8. 279. Kashyap VS, Fang R, Fitzpatrick CM et al. Caval and ureteral obstruction secondary to an inflammatory abdominal aortic aneurysm. J Vasc Surg 2003;38(6):1416-21. 280. Tambyraja AL, Murie JA, Chalmers RT. Ruptured inflammatory abdominal aortic aneurysm: insights in clinical management and outcome. J Vasc Surg 2003;39(2):400-3. 281. Crawford JL, Stowe CL, Safi HJ et al. Inflammatory aneurysms of the aorta. J Vasc Surg 1985;2:113-24. 282. Nitecki SS, Hallett JW, Stanson AW et al. Inflammatory abdominal aortic aneurysms: a case-control study. J Vasc Surg 1996;23:860-9. 283. Sanchez R, Arroyo A, Gesto F et al. Obstructive ARF caused by an inflammatory abdominal aortic aneurysm. Am J Kidney Dis 2003;41(3):E9. 284. Moosa H, Peitzman AB, Steed DL et al. Inflammatory aneurysms of the abdominal aorta. Arch Surg 1989;124:675. 285. Giacomazzi A, Mattoso LFQ, Lauria V et al. Aneurisma inflamatório da aorta abdominal: Importância da tomografia computadorizada no seu diagnóstico. Radiol Bras 1995;28:335-8. 286. Tennant WG, Hartnell GG, Baird RN et al. Radiologic investigation of abdominal aortic aneurysm disease: Comparison of three modalities in staging and the detection of inflammatory change. J Cardiovasc Surg 1993;17:703-9. 287. Anbarasu A, Harris PL, McWilliams RG. The role of gadoliniumenhanced MR imaging in the preoperative evaluation of inflammatory aortic aneurysm. Eur Radiol 2002;12(Suppl 3):S192-5. 288. Baskerville PA, Blakeney CG, Young AE, Browse NL. The diagnosis and treatment of peri-aortic fibrosis (‘inflammatory’ aneurysms). Br J Surg 1983;70:381-5. 289. Eagleton MJ. Inflammation in abdominal aortic aneurysms: cellular infiltrate and cytokine profiles. Vascular 2012;20:278-83. 290. Bonati L, Rubini P, Japichino GG et al. Long-term outcome after inflammatory abdominal aortic aneurysm repair: case-matched study. World J Surg 2003;27(5):539-44. 291. Basar H, Basar R, Basar MM et al. The comparison of the incidence of horseshoe kidney in autopsy cases versus urologic patient population. Kajimas Folia Anat Jpn 1999;76:137-9. 292. Ferko A, Krajina A, Jon B et al. Juxtarenal aortic aneurysm associated with a horseshoe kidney. Transfemoral endoluminal repair. Arch Surg 1997;132:316-7. 293. Faggioli G, Freyrie A, Pilato A et al. Renal anomalies in aortic surgery: contemporary results. Surgery 2003;133(6):641-6. 294. Brito CJ, Silva LAM, Fonseca Filho VL et al. Abdominal aortic aneurysm in association with horseshoe kidney. Int Angiol 1991;10:112-5.
254. Abbott WM. Transperitoneal versus retroperitoneal approach for aortic surgery: which is best and when. Eighteenth annual symposium on current critical problems and new horizons in vascular surgery. Albert Einstein College of Medicine. New York: Montefiori Medical Center; 1991.
242. Kazmers A, Perkins AJ, Jacobs LA. Outcomes after abdominal aortic aneurysm repair in those > or = 80 years of age: recent Veterans Affairs experience. Ann Vasc Surg 1998;12(2):106-12.
265. Dion YM. History and perspectives in laparoscopic surgery. Acta Chir Belg 2003;104:493-8. 266. Alimi YS, Di Molfetta L, Hartung O et al. Laparoscopy-assisted abdominal aortic aneurysm endoaneurysmorraphy: early and midterm results. J Vasc Surg 2003;37(4):744-9.
268. Steenberge SP, Lyden SP, Turney EJ et al. Outcomes after partial endograft explantation. Ann Vasc Surg 2016;31:1-7. 269. Jimenez JC, Moore WS, Quinones-Baldrich WJ. Acute and chronic open conversion after endovascular aortic aneurysm repair: a 14year review. J Vasc Surg 2007;46:642-7.
270. Lipsitz EC, Ohki T, Veith FJ et al. Delayed open conversion following endovascular aortoiliac aneurysm repair: partial (or complete) endograft preservation as a useful adjunct. J Vasc Surg 2003;38:1191-8. 271. Nabi D, Murphy EH, Pak J, Zarins CK. Open surgical repair after failed endovascular aneurysm repair: is endograft removal necessary? J Vasc Surg 2009;50:714-21. 272. Terramani TT, Chaikof EL, Rayan SS et al. Secondary conversion due to failed endovascular abdominal aortic aneurysm repair. J Vasc Surg 2003;38:473-7.
247. Soisalon-Soininen SS, Salo JA, Mattila SP. Abdominal aortic aneurysm surgery in octogenarians. Vasa 1998;27:29-33.
267. Ferrari M, Adami D, Del Corso A et al. Laparoscopy-assisted abdominal aortic aneurysm repair: early and middle-term results of a consecutive series of 122 cases. J Vasc Surg 2006;43(4):695-700.
243. Jonhston KW. Multicenter prospective study of nonruptured abdominal aortic aneurysm. Part II. Variables predicting morbidity and mortality. J Vasc Surg 1989;9(3):437-47.
261. Goldstone J. Aneurysms of the aorta and iliac arteries. In: Moore WS. (Ed.). Vascular and endovascular surgery. A comprehensive review, 7th ed. Philadelphia: Saunders Elsevier; 2006. p. 488-511. 262. Cronenwett JL, Krupski WC, Rutherford RB. Abdominal aortic and iliac aneurysms. In: Rutherford RB. (Ed.). Vascular surgery, 5th ed. Philadelphia: WB Saunders; 2000. p. 1246-80.
258. Schneider JR, Gottner RJ, Golan JF. Supraceliac versus infrarenal aortic cross-clamp for repair of non-ruptured infrarenal and justarenal abdominal aortic aneurysm. Cardiovasc Surg 1997;5:279-85. 259. Siliprandi LR, Bonamigo TP. Ligadura da veia renal esquerda na cirurgia do aneurisma da aorta abdominal. Cir Vasc Ang 1991;7:9. 260. Lipsitz EC, Veith FJ, Ohki T et al. Should initial clamping for abdominal aortic aneurysm repair be proximal or distal to minimize embolization? Eur J Vasc Endovasc Surg 1999;17:413-8.
244. Graor RA. Preoperative evaluation and management of coronary and carotid artery occlusive disease in patients with abdominal aortic aneurysms. Surg Clin North Am 1989;69(4):737-43.
180 Parte VIABDÔMEN E PELVE
248. Batt M, Staccini P, Pittaluga P et al. Late survival after abdominal aortic aneurysm repair. Eur J Vasc Endovasc Surg 1999;17:338-42.
253. Sieunarine MA, Lawrence-Brown MM, Goodman MA et al. Comparison of transperitoneal and retroperitoneal approaches for infrarenal aortic surgery: early and late results. Cardiovasc Surg 1997;5:71.
256. Ferreira M, Freitas A, Coelho H, Zaniolo M. Acesso retroperitoneal para cirurgia do aneurisma da aorta abdominal. In: Bonamigo TP, Von Ristow A. (Eds.). Aneurismas. Rio de Janeiro: Di Livros; 1999. p. 91-6. 257. Crawford ES, Beckett WS, Greer MS. Justarenal infrarenal abdominal aortic aneurysm. Ann Surg 1986;203:661.
250. Johnson JN, McLoughlin GA, Wake PN et al. Comparison of extraperitoneal and transperitoneal methods of aortoiliac reconstruction: twenty-year experience. J Cardiovasc Surg 1986;27:561. 251. Sicard GA, Allen BT, Murms JJ et al. Retroperitoneal versus transperitoneal approach for repair of abdominal aortic aneurysms. Surg Clin North Am 1989;69:795-806.
252. Cambria RP, Brewster DC, Abbott WM et al. Transperitoneal versus retroperitoneal approach for aortic reconstruction. A randomized, prospective study. J Vasc Surg 1990;11:314-25.
249. Bickerstaff LK, Hollier LH, Van Peenen HJ et al. Abdominal aortic aneurysms: the changing natural history. J Vasc Surg 1984;1:6-12.
245. Huber TS, Seeger JM. Dartmouth atlas of vascular health care: impact of hospital volume, surgeon volume and training on outcome. J Vasc Surg 2001;34(4):751-6. 246. Todd GF, Voorhees AB. Survival of elderly patients following elective abdominal aortic aneurysm resection. J Cardiovasc Surg 1981;22:493.
316. Aljabri B, MacDonald PS, Satin R et al. Incidence of major venous and renal anomalies relevant to aortoiliac surgery as demonstrated by computed tomography. Ann Vasc Surg 2001;15(6):615-8.
319. Levison JA, Halpern VJ, Kline RG et al. Perioperative predictors of colonic ischemia after ruptured abdominal aortic aneurysm J Vasc Surg 1999;29:40-7.
304. Greenberg R, Green R. Complicated abdominal aortic aneurysm repair. In: Calligaro KD, Dougherty MJ, Hollier LH (Eds.). Diagnosis and treatment of aortic and peripheral arterial aneurysms. Philadelphia: WB Saunders; 1999. p. 169-81.
318. Obernosterer A, Aschauer M, Mitterhammer H et al. Congenital familial vascular anomalies: a study of patients with an anomalous inferior vena cava, and of their first-degree relatives. Angiology 2003;55(1):73-7.
321. Iliopoulos JI, Hemreck AS, Thomas JH et al. Hemodynamics of the hypogastric arterial circulation. J Vasc Surg 1989;9(5):637-41.
323. Longo WE, Lee TC, Barnett MG et al. Ischemic colitis complicating abdominal aortic aneurysm surgery in the US veteran. J Surg Res 1996;60:351-4. 324. Reid JA, Mole DJ, Johnston LC et al. Delayed paraplegia after endovascular repair of abdominal aortic aneurysm. J Vasc Surg 2003;37(6):1322-3. 325. Rockman CB, Riles TS, Landis R. Lower extremity paraparesis subsequent to endovascular management of abdominal aortic aneurysms. J Vasc Surg 2001;33(1):178-80.
307. Loftus IK, Thompson MM, Fishwick G et al. Endovascular repair of aortic aneurysms in the presence of a horseshoe kidney. J Endovasc Surg 1998;5:278-81.
295. Glen JF. Analysis of 51 patients with horseshoe kidney. N Eng J Med 1959;261:684. 296. Donati A, Bartolomeo R, Turinetto B et al. Abdominal aortic aneurysm and horseshoe kidney. J Cardiovasc Surg 1980;21:632. 297. Journal of Vascular Surgery, 2019-04-01, Volume 69, Edição 4, Páginas 1257-1267, Copyright © 2018 Society for Vascular Surgery 298. Eisendrath DN, Phifer FM, Culver HB. Horseshoe kidney. Ann Surg 1925;15:1037-41. 299. Taylor DC, Sladen JG, Maxwell T. Aortic surgery and horseshoe kidney: a challenge surgical problem. Can J Surg 1987;30:431. 300. Graves FT. Arterial anatomy of congenitally abnormal kidney. Br J Surg 1969;56:533. 301. Star DS, Foster WJ, Morris GC. Resection of abdominal aortic aneurysm in the presence of horseshoe kidney. Surgery 1981;89:387.
306. Sonneveld DJ, van Dop HR, Van Der TOL A. Resection of abdominal aortic aneurysm in a patient with left-sided inferior vena cava and horseshoe kidney. J Cardiovasc Surg 1999;40:421-4.
310. Brechtel K, Kalender G, Heller S et al. Endovascular repair of infrarenal abdominal aortic aneurysm associated with a horseshoe kidney and graft thrombosis in early follow-up. Acta Radiol 2009;50:624-8.
326. Picone AL, Green RM, Ricotta JR et al. Spinal cord ischemia following operations on the abdominal aorta. J Vasc Surg 1986;3:94. 327. Elliot JP, Szilagyi DE, Hageman JH et al. Spinal cord damage secondary to surgery of the abdominal aorta. In: Bernhard VM, Towne JB. (Eds.). Complications in vascular surgery. New York: Grune & Stratton; 1980. p. 407. 328. Sutton J, Nesbit RR. Spinal cord ischemia following surgery for aortoiliac occlusive disease. J Vasc Surg 1984;1:697. 329. Reich MP. Paraplegia following resection of an abdominal aortic aneurysm. Report of a case of atheromatous embolization to the anterior spinal artery. Vasc Surg 1968;2:23. 330. Golden GT, Sears GT, Wellons HA et al. Paraplegia complicating resection of aneurysms of the infrarenal abdominal aorta. Surgery 1973;73(1):9. 331. Dormal PA, Delberghe X, Roeland A. Infrarenal aortic aneurysm and spinal cord ischaemia. A new case and review of the literature. Acta Chir Belg 1995;95:136-8. 332. Sachdev U, Baril DT, Morrissey NJ et al. Endovascular repair of paraanastomotic aortic aneurysms. J Vasc Surg 2007;46(4):636-41.
322. Hermreck AS. Prevention and management of supraceliac aortic clamping in the difficult elective resection of abdominal aortic aneurysms. Surg Clin North Am 1989;69:869-94.
305. O’Hara PJ, Hakaim AG, Hertzer NR et al. Surgical management of aortic aneurysm and coexistent horseshoe kidney: review of a 31year experience. J Vasc Surg 1993;17:940-7.
309. Sajid MS, Ahmed N, Tibbals J, Hamilton G. Endovascular aneurysm repair in a patient with horseshoe kidney and impaired renal function. Ir J Med Sci 2006;175:71-3.
320. Welborn MB, Seeger JM. Prevention and management of sigmoid and pelvic ischemia. Semin Vasc Surg 2001;14(4):255-65.
181Capítulo 93 AneurismA s dA AortA AbdominAl
308. Teijink JA, Odink HF, Bendermacher B et al. Ruptured AAA in a patient with a horseshoe kidney: emergent treatment using the Talent acute endovascular aneurysm repair kit. J Endovasc Ther 2003;10:240-3.
311. Chan YC, Qing KX, Ting AC, Cheng SW. Endovascular infrarenal aneurysm repair in patients with horseshoe kidneys: case series and literature review. Vascular 2011;19:126-31. 312. Shindo S, Kubota K, Kojima A et al. Anomalies of inferior vena cava and left renal vein: risks in aortic surgery. Ann Vasc Surg 2000;14(4):393-6.
313. Bartle EJ, Pearce WH, Sun JH et al. Infrarenal venous anomalies and aortic surgery: avoiding vascular injury. J Vasc Surg 1987;6:590-3.
317. Ruemenapf G, Rupprecht H, Schweiger H. Preaortic iliac conference: a rare anomaly of the inferior vena cava. J Vasc Surg 1998;27:767-71.
302. Adoumie R, Hamman J. Retroperitoneal repair of an abdominal aortic aneurysm associated with a. horseshoe kidney. J Ky Med Assoc 1997;95(4):143-4. 303. Canova G, Masini R, Santoro E et al. Surgical treatment of abdominal aortic aneurysm in association with horseshoe kidney. Three case reports and review of technique. Tex Heart Inst J 1998;25:206-10.
314. Giordano JM, Trout III HH. Anomalies of the inferior vena cava. J Vasc Surg 1986;3:924-8. 315. Calligaro KD, DeLaurentis DA, Dougherty MJ. Venous anomalies encoutentered during abdominal aortic surgery. In: Calligaro KD, Dougherty MJ, Hollier LH (Eds.). Diagnosis and treatment of aortic and peripheral arterial aneurysms. Philadelphia: WB Saunders; 1999. p. 183-92.
333. Ten Bosch JA, Waasdorp EJ, de Vries JP et al. The durability of endovascular repair of para-anastomotic aneurysms after previous open aortic reconstruction. J Vasc Surg 2011;54(6):1571-8. 334. Bunt TJ. Synthetic vascular graft infections. I. Graft infections, Surgery 1983;93(6):733-46. 335. Farkas JC, Fichelle JM, Laurian C et al. Long-term follow-up of positive cultures in 500 abdominal aortic aneurysms. Arch Surg 1993;128(3):284-8. 336. Szilagyi DE, Smith RF, Elliott JP et al. Anastomotic aneurysms after vascular reconstruction: problems of incidence, etiology and treatment. Surgery 1975;78(6):800-16. 337. Adam DJ, Fitridge RA, Raptis S. Late reintervention for aortic graftrelated events and new aortoiliac diasease after open abdominal aortic aneurysm repair in an Australian population. J Vasc Surg 2006;43(4):701-6.
19. Finlayson SR, Birkmeyer JD, Fillinger MF et al. Should endovascular surgery lower the threshold for repair of abdominal aortic aneurysms? J Vasc Surg 1999;29:973-85.
20. Centers for Disease Control and Prevention NCfHS: CDC WONDER online database, compiled from Compressed Mortality File 1999-2009; 2012.
21. Brown LC, Powell JT. Risk factors for aneurysm rupture in patients kept under ultrasound surveillance. UK Small Aneurysm Trial Participants. Ann Surg 1999;230:289-96;discussion 296-287.
36. Reimerink JJ, Hoornweg LL, Vahl AC et al. Endovascular repair versus open repair of ruptured abdominal aortic aneurysms: a multicenter randomized controlled trial. Ann Surg 2013;258:248-56. 37. Investigators IT, Powell JT, Sweeting MJ et al. Endovascular or open repair strategy for ruptured abdominal aortic aneurysm: 30 day outcomes from IMPROVE randomized trial. BMJ 2014;348:f7661. Desgranges P, Kobeiter H, Castier Y et al. The Endovasculaire vs Chirurgie dans les Anevrysmes Rompus PROTOCOL trial update. J Vasc Surg 2010;51:267-70. 39. Tambyraja AL, Murie JA, Chalmers RT. Prediction of outcome after abdominal aortic aneurysm rupture. J Vasc Surg 2008;47:222-30. 40. Hardman DT, Fisher CM, Patel MI et al. Ruptured abdominal aortic aneurysms: who should be offered surgery? J Vasc Surg 1996;23:123-9. 41. Samy AK, Murray G, MacBain G. Glasgow aneurysm score. Cardiovasc Surg 1994;2:41-4. 42. Tambyraja A, Murie J, Chalmers R. Predictors of outcome after abdominal aortic aneurysm rupture: Edinburgh Ruptured Aneurysm Score. World J Surg 2007;31:2243-7. 43. Chen JC, Hildebrand HD, Salvian AJ et al. Predictors of death in nonruptured and ruptured abdominal aortic aneurysms. J Vasc Surg 1996;24:614-20;discussion 621-613. 44. Copeland GP, Jones D, Walters M. POSSUM: a scoring system for surgical audit. Br J Surg 1991;78:355-60. Robinson WP, Schanzer A, Li Y et al. Derivation and validation of a practical risk score for prediction of mortality after open repair of ruptured abdominal aortic aneurysms in a US regional cohort and comparison to existing scoring systems. J Vasc Surg 2013;57:354-61.
38.
45.
22. Sweeting MJ, Thompson SG, Brown LC et al. Meta-analysis of individual patient data to examine factors affecting growth and rupture of small abdominal aortic aneurysms. Br J Surg 2012;99:655-65. 23. Thompson JE. Early history of aortic surgery. J Vasc Surg 1998;28:746-52. 24. Ochsner A. Dr. Rudolph Matas. AMA Arch Surg 1956;72:1-19. 25. Guthrie CC. Heterotransplantation of blood vessels. Am J Physiol 1907;19:482-7. 26. Dubost C. First successful resection of an aneurysm of the abdominal aorta with restoration of the continuity by a human arterial graft. World J Surg 1982;6:256-7. 27. Cooley DA, DeBakey ME. Ruptured aneurysms of abdominal aorta; excision and homograft replacement. Postgrad Med 1954;16:334-42. 28. Blakemore AH, Voorhees AB Jr. The use of tubes constructed from Vinyon N cloth in bridging arterial defects; experimental and clinical. Ann Surg 1954;140:324-34. 29. Whittemore AD, Clowes AW, Hechtman HB et al. Aortic aneurysm repair. Reduced operative mortality associated with maintenance of optimal cardiac performance. Ann Surg 1980;192:414-21. 30. Pairolero PC. Repair of abdominal aortic aneurysms in high-risk patients. Surg Clin North Am 1989;69:755-63. 31. Stokes J, Butcher HR Jr. Abdominal aortic aneurysms. Factors influencing operative mortality and criteria of operability. Arch Surg 1973;107:297-302. 32. Laborde JC, Parodi JC, Clem MF et al. Intraluminal bypass of abdominal aortic aneurysm: feasibility study. Radiology 1992;184:185-90. 33. Marin ML, Veith FJ. Images in clinical medicine. Transfemoral repair of abdominal aortic aneurysm. N Engl J Med 1994;331:1751. 34. Yusuf SW, Whitaker SC, Chuter TA et al. Emergency endovascular repair of leaking aortic aneurysm. Lancet 1994;344:1645. 35. Hinchliffe RJ, Bruijstens L, MacSweeney ST et al. A randomized trial of endovascular and open surgery for ruptured abdominal aortic aneurysm - results of a pilot study and lessons learned for future studies. Eur J Vasc Endovasc Surg 2006;32:506-13;discussion 514-505.
12. Johansen K, Kohler TR, Nicholls SC et al. Ruptured abdominal aortic aneurysm: the Harborview experience. J Vasc Surg 1991;13:2405;discussion 245-7.
10. Dillavou ED, Muluk SC, Makaroun MS. Improving aneurysm- related outcomes: nationwide benefi ts of endovascular repair. J Vasc Surg 2006;43:446-51;discussion 451-442.
11. Starnes BW, Quiroga E, Hutter C et al. Management of ruptured abdominal aortic aneurysm in the endovascular era. J Vasc Surg 2010;51:9-17; discussion 17-8.
9. Mani K, Lees T, Beiles B et al. Treatment of abdominal aortic aneurysm in nine countries 2005-2009: a vascunet report. Eur J Vasc Endovasc Surg 2011;42:598-607.
1. Lindholt JS, Sogaard R, Laustsen J. Prognosis of ruptured abdominal aortic aneurysms in Denmark from 1994–2008. Clin Epidemiol 2012;4:111-3. 2. Sandiford P, Mosquera D, Bramley D. Trends in incidence and mortality from abdominal aortic aneurysm in New Zealand. Br J Surg 2011;98:645-51. Acosta S, Ogren M, Bengtsson H et al. Increasing incidence of ruptured abdominal aortic aneurysm: a population-based study. J Vasc Surg 2006;44:237-43. 4. Mealy K, Salman A. The true incidence of ruptured abdominal aortic aneurysms. Eur J Vasc Surg 1988;2:405-8. 5. Hoornweg LL, Storm-Versloot MN, Ubbink DT et al. Meta analysis on mortality of ruptured abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 2008;35:558-70.
6. Dillavou ED, Muluk SC, Makaroun MS. A decade of change in abdominal aortic aneurysm repair in the United States: have we improved outcomes equally between men and women? J Vasc Surg 2006;43:230-8;discussion 238. 7. Bown MJ, Sutton AJ, Bell PR et al. A meta-analysis of 50 years of ruptured abdominal aortic aneurysm repair.Br J Surg 2002;89:714-30.
8. Mani K, Bjorck M, Wanhainen A. Changes in the management of infrarenal abdominal aortic aneurysm disease in Sweden. Br J Surg 2013;100:638-44.
16. Taylor LM Jr, Porter JM. Basic data related to clinical decision-making in abdominal aortic aneurysms. Ann Vasc Surg 1987;1:502-4.
3.
ANEURISMA BIBLIOGRÁFICAS
13. Mureebe L, Egorova N, Giacovelli JK et al. National trends in the repair of ruptured abdominal aortic aneurysms. J Vasc Surg 2008;48:1101-7.
182 94Capítulo
15. Choke E, Vijaynagar B, Thompson J et al. Changing epidemiology of abdominal aortic aneurysms in England and Wales: older and more benign? Circulation 2012;125:1617-25.
14. Cowan JA Jr, Dimick JB, Henke PK et al. Epidemiology of aortic aneurysm repair in the United States from 1993 to 2003. Ann N Y Acad Sci 2006;1085:1-10.
17. Powell JT, Brown LC, Forbes JF et al. Final 12-year follow-up of surgery versus surveillance in the UK Small Aneurysm Trial. Br J Surg 2007;94:702-8.
18. Lederle FA, Wilson SE, Johnson GR et al. Immediate repair compared with surveillance of small abdominal aortic aneurysms. N Engl J Med 2002;346:1437-44.
DA AORTA ABDOMINAL ROTO REFERÊNCIAS
50. Greco G, Egorova N, Anderson PL et al. Outcomes of endovascular treatment of ruptured abdominal aortic aneurysms. J Vasc Surg 2006;43:453-9.
49.
48.
54. Coppi G, Silingardi R, Gennai S et al. A single-center experience in open and endovascular treatment of hemodynamically unstable and stable patients with ruptured abdominal aortic aneurysms. J Vasc Surg 2006;44:1140-7.
52. Bauer EP, Redaelli C, von Segesser LK et al. Ruptured abdominal aortic aneurysms: predictors for early complications and death. Surgery 1993;114:31-5.
51. Harris LM, Faggioli GL, Fiedler R et al. Ruptured abdominal aortic aneurysms: factors affecting mortality rates. J Vasc Surg 1991;14:812-8;discussion 819-20.
183Capítulo 94 AneurismA dA AortA AbdominAl roto Dimick JB, Stanley JC, Axelrod DA et al. Variation in death rate after abdominal aortic aneurysmectomy in the United States: impact of hospital volume, gender, and age. Ann Surg 2002;235:579-85. Giles KA, Pomposelli F, Hamdan A et al. Decrease in total aneurysmrelated deaths in the era of endovascular aneurysm repair. J Vasc Surg 2009;49:543-50;discussion 550-541. McPhee J, Eslami MH, Arous EJ et al. Endovascular treatment of ruptured abdominal aortic aneurysms in the United States (2001–2006): a signifi cant survival benefi t over open repair is independently associated with increased institutional volume. J Vasc Surg 2009;49:817-26. Johnston KW. Ruptured abdominal aortic aneurysm: six year follow-up results of a multicenter prospective study. Canadian Society for Vascular Surgery Aneurysm Study Group. J Vasc Surg 1994;19:888-900.
47.
62. MacKenzie EJ, Rivara FP, Jurkovich GJ et al. A national evaluation of the effect of trauma-center care on mortality. N Engl J Med 2006;354:366-78. 63. Gabbe BJ, Biostat GD, Lecky FE et al. The effect of an organized trauma system on mortality in major trauma involving serious head injury: a comparison of the United Kingdom and Victoria, Australia. Ann Surg 2011;253:138-43.
53. Mehta M, Byrne J, Darling RC 3rd et al. Endovascular repair of ruptured infrarenal abdominal aortic aneurysm is associated with lower 30-day mortality and better 5-year survival rates than open surgical repair. J Vasc Surg 2013;57:368-75.
46.
56. Visser JJ, Bosch JL, Hunink MG et al. Endovascular repair versus open surgery in patients with ruptured abdominal aortic aneurysms: clinical outcomes with 1-year follow-up. J Vasc Surg 2006;44:1148-55.
57. Loftus IM, Thompson MM. The abdominal compartment syndrome following aortic surgery. Eur J Vasc Endovasc Surg 2003;25:97-109. 58. Mehta M, Darling RC 3rd, Roddy SP et al. Factors associated with abdominal compartment syndrome complicating endovascular repair of ruptured abdominal aortic aneurysms. J Vasc Surg 2005;42:1047-51. 59. van Beek SC, Reimerink JJ, Vahl AC et al. Effect of regional cooperation on outcomes from ruptured abdominal aortic aneurysm. Br J Surg 2014;101:794-801. 60. Gabbe BJ, Simpson PM, Sutherland AM et al. Improved functional outcomes for major trauma patients in a regionalized, inclusive trauma system. Ann Surg 2012;255:1009-15.
61. Nathens AB, Brunet FP, Maier RV. Development of trauma systems and effect on outcomes after injury. Lancet 2004;363:1794-801.
55. Anain PM, Anain JM Sr, Tiso M et al. Early and midterm results of ruptured abdominal aortic aneurysms in the endovascular era in a community hospital. J Vasc Surg 2007;46:898-905.
20. Zarins CK, Crabtree T, Arko FR et al. Endovascular repair of patients surveillance of small AAA. Eur J Vasc Endov Surg 2005;29:496-503.
ANEURISMAS TÉCNICA ENDOVASCULAR BIBLIOGRÁFICAS
REFERÊNCIAS
21. Welborn III MB, Yau SY, Metral JG et al. Endovascular repair of small AAA – A paradigm shift? Vasc Endov Surg 2005;39:381-91.
15. Miahle C, Amicabile C, Bequemin JP. Endovascular treatment of infrarenal abdominal aneurysms by Stentor system: preliminary results of 79 cases. J Vasc Surg 1997;26:199-209.
22. Ouriel K, Srivasta SD, Sarac TP et al. Disparate outcome after endovascular treatment of small vs large AAA. J Vasc Surg 2003;37:1206-12.
23. Greenberg RK, Claire D, Srivasta S et al. Should patients with challenging anatomy be offered EVAR? J Vasc Surg 2003;38:990-6.
17. Chuter TAM. An endovascular system for thoracoabdominal aortic aneurysm repair. J Endovasc Ther 2001;8:23-33.
5. Dotter C. Transluminally-placed coilspring endarterial tube grafts. Long-term patency in canine popliteal artery. Invest Radiology 1969;5:329-32.
12. Chuter TAM, Green RM, Ouriel K et al. Transfemoral endovascular aortic graft placement. J Vasc Surg 1992;18:185-97.
10. Palmaz J, Richter GM, Noeldge G et al. Intraluminal stents in atherosclerotic iliac artery stenosis. Radiology 1988;168:727-31.
14. Ristow AV, Silveira PG. Tratamento do aneurisma da aorta abdominal pela técnica endovascular. In: Bonamigo TP, Ristow AV (Eds.). Aneurismas. Rio de Janeiro: DiLivros; 2000. p. 97-111.
11. Parodi JC, Palmaz J, Barone H. Transfemoral intraluminal graft implantation for abdominal aortic aneurysm. Ann Vasc Surg 1991;5:491-9.
184 95Capítulo
13. Veith FJ, Marin ML. Impact of endovascular technology on practice of vascular surgery. J Vasc Surg 1996;172:100-4.
DA AORTA ABDOMINAL –TRATAMENTO PELA
1. Ristow Av, Vescovi A, Massièrs BV, Correa MP. Aneurisma da Aorta Abdominal – Tratamento pela Técnica Endovascular. In: Brito CJ et al. (Eds). Cirurgia vascular. Rio de Janeiro: Revinter; 2013. p. 799-877.
26. Ristow, Av, Estensoro AEE, Correa MP, Presti C. Aneurismas da Aorta abdominal – diagnóstico e tratamento – Projeto Diretrizes da SBACV. Site da SBACV; 2015. 27. Veith FJ, Abbott WM, Yao JST et al. Endovascular graft committee. Guidelines for development and use of intraluminally placed endovascular prosthetic grafts in the arterial system. J Vasc Surg 1995;21:670-85. 28. Criado F. Techniques of endoluminal AAA repair – A manual. Miami: World Medical; 1997. 29. Obrand DI, Ahn SS. Training of endovascular techniques for vascular surgeons. In: Yao JST, Pearce WH (Eds.). Techniques in vascular and endovascular surgery. Stamford: Appleton & Lange; 1998. 30. Schneider PA. Endovascular skills. St Louis: QMP; 1998. 31. Nicholson A, Scott J. Training and evaluation in aorto-iliac endovascular procedures. In: Wiatt MG, Watkinson AF (Eds.). Endovascular intervention – Current controversies. Shrewsbury: Tfm; 2004. p. 55-67. 32. Lobato AC (Ed.). Cirurgia endovascular. São Paulo: ICVE-SP; 2006. 33. Chuter TAM. Anatomy of infrarenal aortic aneurysm. In: Chuter TAM, Donayre C, White RA (Eds.). Endoluminal vascular prosthesis. Boston: Little Brown; 1995. 34. Marzelle J, Miahle C, Parodi et al. Endoprothèses et anèvrismes. Traitement endoluminal des anèvrismes aortiques. Encyclop Méd Chir - Chir Vasculaire. Paris: Elsevier; 1996. 35. Dorros G, Parodi JC, Schonholz C et al. Evaluation of endovascular abdominal aortic repair: anatomical classification, procedural success, clinical assessment and data collection. J Endovasc Surg 1997;4:203-25. 36. Moritz JD, Rotermund S, Keating DP et al. Infrarenal abdominal aortic aneurysms: implications of CT evaluation of size and configuration for placement of endovascular aortic grafts. Radiology 1996;198:463-6. 37. Greenberg RK, West K, Pfaff K et al. Beyond the aortic bifurcation: branched endovascular grafts for thoracoabdominal and aortoiliac aneurysms. J Vasc Surg 2006;43:879-86. 38. Lobato AC. Sandwich technique for aortoiliac aneurysms extending to the internal iliac artery or isolated common/internal iliac artery aneurysms: a new endovascular approach to preserve pelvic circulation. J Endovasc Ther 2011;18:106-11. 39. Massière B, Ristow AV, Vescovi A et al. Management of aortoiliac aneurysms by retrograde endovascular hypogastric artery preservation. Vascular 2013;22:116-20. 40. White G, Yu W. Imaging techniques and measurements. Illinois: Baxter Heathcare Corp.; 1997. 41. Ristow Av, Bonamigo TP, Dutra CF. Seleção de pacientes para o tratamento endovascular do aneurisma da aorta abdominal. In: Bonamigo TP, Ristow AV (Eds.). Aneurismas. Rio de Janeiro: DiLivros; 2000. p. 112-9. 42. Gomes MN, Davros WJ, Keman RK. Preoperative assesment of abdominal aortic aneurysms: the value of helical and threedimensional computed tomography. J Vasc Surg 1994;20:367-76. 43. Whitaker SC. Anatomical considerations for endovascular AAA repair. In: Katzen B (Ed.). XI Intl Symp Endov Ther. Miami; 1999. 44. Armon MP, Hopkinson BR. Intraoperative imaging in endovascular aortic aneursm surgery. In: Hopkinson B et al. (Eds.). Endovascular surgery for aortic aneurysms. London: WB Saunders; 1997. Broeders IAMJ, Balm R, Blankenstejn JD et al. Preoperative sizing of grafts for transfemoral EVAR: a prospective comparative study of spyral CT angiography, arterial angiography and conventional CT imaging. J Endovasc Surg 1997;4:252-61.
24. Ristow Av, Massière B, Vescovi A. The Excluder Centervasc Registry –A preliminary report from a 10-year efficacy and durability study on EVAR. Endovascular Today 2011;Suppl:10-13.
45.
18. Ristow AV, Vescovi A, Pedron C et al. O tratamento de aneurisma de aorta justa-renal com endoprótese fenestrada reposicionável. Rev Angiol Cir Vasc RJ 2005;2:78-80.
2. Veith FJ. History, potential influence and facility requirements of transluminally placed endovascular grafts. In: Parodi JC, Veith JF, Marin ML (Eds.). Endovascular grafting techniques. Baltimore: Williams & Wilkins; 1999.
3. Seldinger S. Catheter replacement of the needle in percutaneous arteriography: a new technique. Acta Radiol 1953;39:368-76.
4. Fogarty T, Cranley J, Krause R et al. A method for extraction of arterial emboli and thrombi. Surg Ginec Obst 1963;116:241-4.
16. Browne TF, Hartley DE. Fenestrated covered suprarenal aortic stent. Eur J Vasc Endovasc Surg 1999;18:445-9.
19. Lee JT, Greenberg JI, Dalman RL. Early experience with the snorkel technique for juxtarenal aneurysms. J Vasc Surg 2012;55:935-46.
6. Gruntzig A, Hopf H. Perkutane rekanalisation chronisher arterieller verschlusse mit neuen dilatationskateter. Deutsc Med Wochenschr 1974;99:2502-51. 7. Balko A, Piasecki GS, Shah DM et al. Transfemoral placement of intraluminal poliurethan prosthesis for abdominal aortic aneurysm. J Surg Res 1986;40:305-9.
25. Verzini F, Romano L, Parlani G et al. Fourteen-year outcomes of abdominal aortic endovascular repair with the Zenith stent graft. J Vasc Surg 2017 Feb;65(2):318-29.
8. Mirich D, Wright KC, Wallace S et al. Percutaneously placed endovascular grafts for aortic aneurysms: feasibility study. Radiology 1989;170:1033-7. 9. Volodos NL, Shekhanin VE, Karpovich IP et al. Self-fixing synthetic blood vessel endoprosthetic. Vestnik Khirurgii Im Grekova 1986;137:123-5.
68. Gilling-Smith G, Brennan J, Harris PE et al. Endotension after endovascular aortic repair: definition, classification and stratergies for surveillance and intervention. J Endovasc Surg 1999;6:305-7.
46.
57. Morcos SK. Contrast media-induced nephrotoxicity – Questions and answers. Br J Radiol 1998;71:357-65.
53. Ristow Av, Massière BV, Vescovi A, Leal D. Diagnóstico por imagem para o tratamento endovascular do aneurisma da aorta abdominal. In: Presti C, Silva ES, Casella IB, Matiello MF (Eds.). Conceitos atuais em doença vascular periférica. São Paulo: SENAC; 2017. p. 79-90. 54. Peterson BG, Matsumara JS. Internal endoconduit: an innovative technique to address unfavorable ilias artery anatomy encountered during thoracic endovascular aortic repair. J Vasc Surg 2008;47:441-5.
71. Smith ST, Timaran CH, Valentine RJ et al. Percutaneous access for endovascular abdominal aortic aneurysm repair: can selection criteria be expanded? Ann Vasc Surg 2009;23:621-6.
185Capítulo 95 AneurismA s dA AortA AbdominAl – tr AtAmento Pel A téCniCA endovA sCul Ar Laan MJ, Bartels LW. Imaging for EVAR – Multislice CT. In: Wyatt MG, Watkinson AF (Eds.). Endovascular intervention – Current controversies. Shrewbury: Tfm; 2004. p. 237-46. Ristow AV (Ed.). Diagnóstico vascular por imagem. Rio de Janeiro: Revinter; 2008. p. 82. 48. Meaney JFM, Boyle GE. Contrast-enhanced magnetic resonance angiography: current indications and developments. In: Wyatt MG, Watkinson AF (Eds.). Endovascular intervention – Current controversies. Shrewbury: Tfm; 2004. p. 257-69. Prince MR, Narasimham DL, Stanley JC et al. Gadolinium enhanced magnetic resonance angiography of abdominal aortic aneurysms. J Vasc Surg 1995;21:656-69. 50. Melissano G, Civilini E, Bertoglio L. Planning & Sizing della Patologia Aortica com OsiriX. Milano: Vita Salute; 2010. 172p. 51. Parodi JC, Ferreira LM. Aneurismas da aorta abdominal – Tratamento endovascular. In: Brito CJ (Ed.). Cirurgia vascular. Rio de Janeiro: Revinter; 2002. p. 493-502. 52. Puech-Leão P. Banding of the common iliac artery: an expedient in endoluminal correction of aortoiliac aneurysms. J Vasc Surg Dec 2000;32(6):1232-38.
62. Cao P, De Rango P, Verzini F et al. Comparison of surveillance vs aortic endografting for small aneurysm repair (Caesar): results from a randomized trial. Eur J Vasc Endovasc Surg 2011;41:13-25.
64. Chuter TAM. Chuter-Gianturco bifurcated stent-graft for abdominal aortic aneurysm exclusion. In: Hopkinson B, Yusuf W, Whithaker S et al. Endovascular surgery for aortic aneurysms. London: Saunders; 1997. 65. Prinssen M. For the Dutch Randomised Endovascular Management (DREAM) Trial group. A randomized trial compering conventional and endovascular repair of AAA. N Engl J Med 2004;351:1607-18.
47.
63. Sicard GA, Zwolak RM, Sidawy MD et al. EVAR: long term outcome in patients at high risk for open surgery. J Vasc Surg 2006;44:229-35.
69. Marchiori A, Ristow AV, Guimarães MC et al. Predictive factors in the development of Type II endoleaks. J Endovasc Ther 2011;18:299. 70. Haas PC, Krajcer Z, Diethrich EB. Closure of large percutaneous access sites using the Prostar XL percutaneous vascular surgery device. J Endovasc Surg 1999;6:168-70.
49.
66. White GH, May J, Yu W et al. Endoleak as a complication of Endoluminal repair or AAA: classification, incidence, diagnosis and management. J Endov Surg 1997;4:152-68.
67. White GH, May J, Waugh RC et al. Type III and Tipe IV endoleak: toward a complete definition blod flow in the sac after endoluminal AAA repair. J Endovasc Surg 1998;5:305-9.
73. Greenberg RK. Treating large/complex aneurysms. Endov Today 2005;4:43-50. 74. Ristow Av, Vescovi A, Massière BV et al. Desafios técnicos na cirurgia endovascular do aneurisma da aorta abdominal – Problemas e soluções. In: Presti C, Simão E, Castelli V. Atualização em cirurgia vascular e endovascular. São Paulo: Elsevier; 2008. p. 73-86. 75. Massière B, Ristow Av, Pedron C et al. Push and park: uma opção técnica no ateroembolismo agudo dos membros inferiores. J Vasc Br 2006;5:229-32.
72. Bensley RP, Hurks R, Huang Z et al. Ultrasound-guided percutaneous endovascular aneurysm repair success is predicted by access vessel diameter. J Vasc Surg 2012;55:1554-61.
76. Parodi JC. Treatment of blue toe syndrome with intra-arterial injections of prostaglandin E1. In: Yao JST, Pearce WH. The ischemic extremity. Norwalk: Appleton and Lange; 1995. p. 325-31. 77. Santili SM. Iliac artery aneurysms. In: Zellenock GB (Ed.). Mastery of vascular and endovascular surgery. Philadephia: Lippincott; 2006. p. 171-6. 78. Massière BV, Ristow AV, Cury JM et al. Internal iliac artery branch stent graft for aortoiliac aneurysms using the Apolo branched device. Ann Vas Surg 2010;24:417. E15-18. 79. Melas N, Stavridis K, Saratzis A et al. Active proximal sealing in the endovascular repair of abdominal aortic aneurysms: early results with a new stent-graft. J Endovasc Ther. 2015 Apr;22(2):174-8. 80. Welborn III MB, McDaniel HB, Johnson RC et al. Clinical outcome of an extended proximal seal zone with the AFX endovascular aortic aneurysm system. J Vasc Surg 2014;60:876-84. 81. Sbaraglia P, Grattoni C, Oshoala K et al. Aorfix device for abdominal aortic aneurysm with challenging anatomy. J Cardiovasc Surg (Torino) 2014;55:61-70. 82. Malas MB, Hicks CW, Jordan WD et al. Five-year outcomes of the PYTHAGORAS U.S. clinical trial of the Aorfix endograft for endovascular aneurysm repair in patients with highly angulated aortic necks. J Vasc Surg 2017;65:1598-1607. 83. McGillicuddy EA, Fillinger M, Robinson WP et al. Lombard aorfix high angulation device, sac behavior following implantation. J Vasc Surg 2017;66;71-8. 84. Silveira PG, Galego GN, Raimondi C et al. Estudo Multicêntrico Apolo. Cirur Vasc Endovasc 1999;15:207-12. 85. Deery SE, Shean KE, Porhof et al. Three-year results of the Endurant stent graft system post approval stury. Ann Vasc Surg 2018;50:202-8. 86. De Vries JP, Ouriel K, Mehta M et al. Aneurysm treatment using the Heli-FX Aortic Securement System Global Registry ANCHOR Trial. J Vasc Surg 2014;60:1460-7. 87. Moulakakis KG, Papapetrou A, Kakisis J et al. New possibility of AAA treatment with E-Vita abdominal device. J Cardiovasc Surg (Torino) 2014;5:71-5. 88. Schoretsanitis N, Georgakarakos E, Argyriou C et al. A critical appraisal of endovascular stent-grafts in the management of abdominal aortic aneurysms. Radiol Med 2017;122:309-18. 89. Chaikof EL, Dalman RL, Eskandari MK et al. The Society for Vascular Surgery practice guidelines on the care of patients with an abdominal aortic aneurysm. J Vasc Surg 2018;67(1):2-77.e2. 90. Schneider DB. One-year U.S. results of GORE® EXCLUDER® Iliac Branched Endograft: Advantages and limitations. Presented at the 42nd Annual Symposium on Vascular and Endovascular Issues, Techniques, Horizons (VEITH Symposium). New York, NY; 2015. Nov 17-21. 91. Torsello G, Brunkwall J, Scheinert D. Cordis INCRAFT™ ultra-low profile AAA stent-graft system. J Cardiovasc Surg (Torino). 2011 Oct;52(5):661-7. 92. Pratesi G, Pratesi C, Chiesa R et al. The INNOVATION Trial: fouryear safety and effectiveness of the INCRAFT® AAA Stent-Graft System for endovascular repair. J Cardiovasc Surg (Torino) 2017 Oct;58(5):650-7. 93. Mehta M, Valdés FE, Nolte T et al. One-year outcomes from an international study of the Ovation Abdominal Styent Graft System for endovascular aneurysm repair. J Vasc Surg 2014;59:65-73. 94. de Donato G, Setacci F, Bresandola L et al. Midterm results of proximal aneurysm sealing with the Ovation stent-graft according to on-vs off-label use. J Endovasc Ther 2017;24:191-7. 95. Sobocinski J, Briffa F, Holt PJ et al. Evaluation of the Zenith lowprofile abdominal aortic aneurysm stent graft. J Vasc Surg. 2015 Oct;62(4):841-7. 96. Browne TF, Hartley DE, Purchas S et al. A fenestrated covered suprarenal aortic stent. Eur J Vasc Endov Surg 1999;18:445-9. 97. Brendan M, Stanley BM, Hartley DE et al. Fenestration in endovascular grafts for aortic aneurysm repair. J Endovas Ther 2001;8:16-24. 98. Greenberg RK, Haulon S, Lyden SP et al. Endovascular management of juxtarenal aneurysms with fenestrated endovascular grafting. J Vasc Surg 2004;39:279-87.
55. Cynamon J, Probhaker P, Twersky T. Techniques for hypogastric artery embolization. Techn Vasc Interv Radiol 2001;4:236-42. 56. Silva NB, Becker AB, Silva OB. Avaliação do risco operatório em cirurgia de aorta. In: Bonamigo TP, Ristow AV (Eds.). Aneurismas. Rio de Janeiro: Di Livros; 2000. p. 67-78.
58. Brown MJ, Norwood MG, Sayers RD. The management of abdominal aortic aneurysms in patients with concurrent renal impairment. Eur J Vasc Endovasc Surg 2005 July;30(1):1-11. 59. Pedron C, Palis AC, Ristow AV et al. Duplex assisted AAA endovascular treatment in a patient with chronic renal insufficiency. J Endov Ther. In press 2007. 60. Rezende MP, Massière BV et al. Implante de filtro de veia cava com uso de dióxido de carbono como meio de contraste: série de casos. J Vasc Bras 2012;11:18-21. 61. Ouriel K, Clair DG, Kent KC et al. Endovascular repair compared with surveillance for patients with small abdominal aortcia aneurysms –The Pivotal Trial. J Vasc Surg 2012;51:1081-7.
118. Lumsden AB, Smith III RB. Paraanastomotic aneurysms: a continuing surgical callenge. In: Calligaro KD (Ed.). Diagnosis and treatment of aortic and peripheral arterial aneurysms. Philadelphia: WB Saunders; 1999. p. 253-6.
119. Locati P, Socrate AM, Costantini E. Paranastomotic aneurysms of the abdominal aorta: a 15-year experience review. Cardiovascular Surg 2008:8:274-9.
120. Gawenda M, Zaeringer M, Brunckwal J. Open versus endovascular repair of para-anastomotic aneurysms in patients who were morphological candidates for endovascular treatment. J Endovasc Ther 2003;10:745-51.
123. Sachdev U, Baril T, Morrisey NJ et al. Endovascular repair of paraanastomotic aortic aneurysms. J Vasc Surg 2007;46:636-41.
124. Piffaretti G, Tozzi M, Lomazzi C et al. Endovaascular treatment for para-anastomotic aortic and iliac aneurysms following aortic surgery. J Cardiovasc Surg 2007;48:711-7.
108. Minion DJ. Neck, Seal and fixation. Endov Today 2009;8(Suppl) 3-6.
129. Peppelenbosch N et al. Endograft treatment of rupture abdominal aortic aneurysms using the Talent aortouniiliac system: an international multicenter study. J Vasc Surg 2006;43:1111-22.
121. Ristow AV. Traitement endovasculaire des anévrismes paraanastomotiques aortiques et iliaques. J Malad Vascul 2006;31:1S28.
117.
113. Edwards JM, Teefey SA, Zierler RE et al. Intraabdominal paraanatomotic aneurysms after aortic bypass grafting. J Vasc Surg 1992;15:344-53.
125. Verhoeven ELG, Muhs BE et al. Fenestrated and branched stentgrafting after previous surgery provides good alternative to open redo surgery. Eur J Vasc Endovasc Surg 2007;33:84-90.
126. Beck AW, Bos WTDG, Vourliotakis G et al. Fenestrated and branched endograft repair of juxtarenal aneurysms after previous open aortic reconstruction. J Vasc Surg 2009;49:1386-94.
110. Minion DJ. The use of parallel endografts for the treatment of complex aortic aneurysms. In: Oderich GS, Ricotta JJ. Modified fenestrated stent grafts: device design, modifications, implantation, and current applications. Perpect Vasc Surg Endovasc Ther 2009;21:157.
115. Odero A, Arici V, Canale S. Proximal abdominal aortic aneurysms after infrarenal aortic reconstruction. Ann Ital Chir 2004;75:211-21. 116. Curl GR, Faggioli GL, Stella A et al. Aneurysmal change at or above the proximal anastomosis after infrarenal aortic grafting. J Vasc Surg 1992;16:855-9. Coselli JS, LeMaitre SA, Buket S, Berzin E. Subsequent aortic operations in 123 patients with previous infrarenal abdominal aortic aneurysm surgery. J Vasc Surg 1995;22:59-67.
122. Ristow AV, Vescovi A, Massiére BV. The management of paraanastomotic aortic and iliac aneurysms. In: Gloviczki P et al. (Eds). Mayo clinic advances and controversies in vascular medicine, varcular surgery and vascular interventions. Torino-Itália: Minerva Medica; 2011. p. 50-8.
128. Ohki T, Veith FJ. Endovascular grafts and other image-guided catheter based adjuncts to improve the treatment of ruptured aortoiliac aneurysms. Ann Surg 2000;232:466-79.
112. Oderich GS, Ricotta JJ. Modified fenestrated stent grafts: device design, modifications, implantation, and current applications. Perspect Vasc Surg Endovasc Ther 2009;21:157.
111. Ferreira MV, Ferreira M, Katsargyris A et al. “Snare-Ride”: a bailout technique to catheterize target vessels with unfriendly anatomy in branched endovascular aortic repair. J Endovasc Ther. 2017;24:556-8.
186 Parte VIABDÔMEN E PELVE 99. Ristow Av, Vescovi A, Pedron C et al. O tratamento de aneurisma da aorta abdominal justa-renal com endoprótese fenestrada reposicionável. Rev Angiol Cir Vasc 2005;2:78-81. 100. Ristow Av, Pedron C. Correção endovascular do aneurisma da aorta justa-renal. In: Lobato AC (Ed.). Cirurgia endovascular. São Paulo: ICVE; 2006. p. 254-64. 101. Chuter TAM. An endovascular system for thoracoabdominal aortic aneurysm repair. J Endovasc Ther 2001;8:23-33. 102. Larzon T, Gruger G, Friberg Ö et al. Experiences on intentional carotid stenting in endovascular repair of aortic arch aneurysmstwo case reports. Eur J Vasc Endovasc Surg 2005;30:147. 103. Larzon T, Eliasson K, Gruber G. Top fenestrating technique in stentgrafting of aortic diseases with mid-term follow-up. J Cardiovasc Surg 2008;49:317. 104. Ohrlander T, Sonesson B, Ivancef K et al. The chimney graft: a technique for preserving or rescuing aortic branch vessels in stentgraft sealing zones. J Endovasc Ther 2008;15:427. 105. Criado FJ. A percutaneous technique for preservation of arch patency during thoracic aortic repair: retrograde catheterization and stenting. J Endovasc Ther 2007;14:54. 106. Pecoraro F, Pfammater T, Mayer D et al. Multiple periscope and chimney grafts to treat thoracoabdominal and pararenal aortic aneurysms. J Endovasc Ther 2011;18:642. 107. De Vries JPPM, Vos JA. Treatment of juxtarenal aortic aneurysms: open repair, fenestrated endografts, chimney technique or other modalities. In: De Vries JPPM (Ed.). Latest insights into AAA and endovascular repair. Torino: Minerva Medica; 2012. p. 93-104.
114. Treiman GS, Weaver FA, Cossman DV et al. Anastomotic false aneurysms of the abdominal aorta and iliac arteries. J Vasc Surg 1988;8:268-73.
130. Coutinho EEC. Aneurismas rotos da aorta abdominal. In: Ristow AV, Perissé-Moreira RS (Eds.). Urgências vasculares. Rio de Janeiro: Cultura Médica; 1983. p. 196-204. 131. Bonamigo TP, Ristow AV. Fatores preditivos de risco, intercorrências, complicações e resultados na cirurgia do aneurisma roto da aorta abdominal. In: Bonamigo TP, Ristow AV (Eds.). Aneurismas. Rio de Janeiro: DiLivros; 2000. p. 130-6. 132. Coppi G, Silingardi R, Gennai S et al. A single-center experience in open and endovascular treatment of hemodynamically unstable and stable patients with ruptured abdominal aortic aneurysms. J Vasc Surg 2006;44:1140-7. 133. Araújo AP, Toledo FV, Werneck E et al. Emboloterapia com Fogarty de oclusão no aneurisma roto de aorta abdominal. Arq Bras Med Naval 1991;52:5-19. 134. Mehta M. Endovascular aneurysm repair for ruptured andominal aortic aneurysm: the Albany Vascular Group approach. J Vasc Surg 2010;52:1706. 135. Peppelenbosch N, Yilmaz N, Marrewijk CV et al. Emergency treatment of acute symptomatic or ruptured abdominal aortic aneurism. Outcome of a prospective intent-to-treat by EVAR protocol. Eur J Vasc Endovasc Surg 2003;26:303-10. 136. Alsac JM, Desgranges P, Kobeiter H et al. Emergency endovascular repair for ruptured abdominal aortic aneurysms: feasibility and comparison of early results with conventional open repair. Eur J Vasc Endovasc Surg 2005;30:632-9. 137. Rubin BG, Sanchez LA, Choi ET et al. Endoluminal repair of rupture abdominal aortic aneurysms under local anesthesia: Initial experience. Vasc Endovasc Surg 2004;38:203-7. 138. Lachat ML, Pfammater T, Witzke HJ et al. Endovascular repair with bifurcated stent grafts under local anesthesia to improve outcome of ruptured aortoiliac aneurysms. Eur J Vasc Endovasc Surg 2011;42 (Suppl 1):86. 139. Veith FJ. RAAA Investigators. Collected world and single center experience with endovascular treatment of ruptured abdominal aortic aneurysms. Ann Surg 2009;250:818. 140. Reichart M, Geelkerken RH, Huisman AB et al. Rupture abdominal aortic aneurysm: Endovascular repair is feasible in 40% for patients. Eur J Vasc Endovasc Surg 2003;24:479-86. 141. Mehta M, Taggert J, Darling RC 3rd et al. Establishing a protocol for endovascular treatment of ruptured abdominal aortic aneurysms: outcomes of prospective analysis. 3rd ed. J Vasc Surg 2006;44:1-8. 142. Bonamigo TP. Aneurismas rotos da aorta abdominal. In: Brito CJ (Ed.). Cirurgia vascular. Rio de Janeiro: Revinter; 2002. p. 503-13. 143. Ohki T, Veith FJ, Cynamon J et al. Endovascular graft repair of ruptured aortoiliac aneurysms. J Am Coll Surg 1999 July;189(1):102-12. 144. Stannard A, Eliason JL, Rasmussen TE. Ressuscutative endovascular balloon occlusion of the aorta (REBOA) as an adjunct for hemorrhagic shock. J Trauma 2011;71:1869-72. 145. Larzon T. Aspects of endovascular treatment of abdominal aortic aneurysms. Örebro University Doctoral Dissertation: Örebro, 2012, p. 73. 146. Ristow Av, Silveira PG. Tratamento endovascular do aneurisma da aorta abdominal pela técnica endovascular. In: Bonamigo TP, Ristow AV (Eds.). Aneurismas. Rio de Janeiro: DiLivros; 2000. p. 109. 147. Grecco G, Egorova N, Anderson PL et al. Outcomes of endovascular treatment of ruptured abdominal aortic aneurysms. J Vasc Surg 2006;43:453-9. 148. Lombardi JV, Fairman RM, Golden MA et al. The utility of commercially available endografts in the treatment of contained ruptured abdominal aortic aneurysms with hemodynamic stability. J Vasc Surg 2004;40:154-60.
109. Minion DJ, Yancef A, Patterson DE et al. The endowedge and kilt techniques to achieve additinal juxtarenal seal during deployment of the Gore Excluder endoprósthesis. Ann Vasc Surg 2006;20:472-7.
127. Ristow Av, Coelho RP, Cury JM et al. Aneurismas da aorta abdominal rotos. In: Galvão-Alves J (Ed.). Emergências clínicas. Rio de Janeiro: Rubio; 2007. p. 207.
181. Sato DT, Hoff CD, Gregory RT et al. Endoleak after aortic stent graft repair: diagnosis by color duplex ultrasound scan vs computed tomography scan. J Vasc Surg 1998;28:657-63.
172.
187Capítulo 95 AneurismA s dA AortA AbdominAl – tr AtAmento Pel A téCniCA endovA sCul Ar
165. Cuypers PV, Laheij RJ, Buth J. Which factors increase the risk of conversion to open surgery following EVAR? The EUROSTAR Colaborators. Eur J Vasc Endov Surg 2000;20:183-9.
188. Gould DA, Williams RM, Edwards RD et al. Aortic side branch embolization before endovascular aneurysm repair: incidence of type II endoleak. J Vasc Interv Rad 2001;12:337-41.
193. Cho JS, Dillavou ED, Rhee RY et al. Late abdominal aortic aneurysm enlargement after endovascular repair with the Excluder device. J Vasc Surg 2004;39:1236-41. 194. Tansky WJ, Fillinger MF. Outcomes of original and low permeability Gore excluder endoprosthesis for endovascular AAA repair. J Vasc Surg 2007;42:227-35. 195. Goodney PP, Fillinger MF. The effect of endograft relining on sac expansion after EVAR with the original-permeability Gore Excluder AAA endoprosthesis. J Vasc Surg 2007;45:686-93. 196. Baum RA, Carpenter JO, Cope C et al. Aneurysm sac pressure measurement after EVAR. J Vasc Surg 2001;33:32-41. 197. Ohki T. Long term AAA sac pressure monitoring. Endov Today 2006;5:55-62. 198. Blankesteijn JD. Opinions on endoleaks and endotension. In: Veith FJ, Baum RA (Eds.). Endoleaks and endotension. New York: M Dekker; 2003. p. 255-9. 199. Gilling-Smith G. Endotensión. Téc Endov 2004;7:1070-1. 200. Hetzel G, Raithel D. Management of limb occlusions following EVAR. Téc Endov 2004;4:1202-7. 201. Millner R, Golden MA, Velazques OC et al. A new endovascular approach of acute iliac limb occlusion of bifurcated aortic stent graft with a exoskeleton. J Vasc Surg 2003;37:1329-31. 202. Lau LL, Hakaim AG, Oldenburg WA et al. Effect of suprarenal versus infrarenal aortic endograft fixation on renal function and renal artery patency: a comparative study with intermediate follow-up. J Vasc Surg 2003;37(6):1162-8. 203. Aun R, Saliture FT, Lederman A et al. Oclusão tardia das artérias renais após a correção endovascular dos aneurismas da aorta abdominal com próteses de fixação supra-renal. J Vasc Br 2005;4:143-8.
152. Powet JT, Sweeting MJ, Thomson MM et al, for the IMPROVE Trial investigators. Endovascular and open repair stratergy for ruptured abdominal aortic nweurysms: 30-day outcomes from IMPROVE randomized Trial. BMJ 2014;348-61.
182. Chisci E, Troisi N, Michelangnoli S. Use of contrast-enhanced ultrasound in follow-up of endovascular aneurysm repair. In: Donas K, Torsello G, Ouriel K (Eds.). Endovascular treatment of aortic Aneurysms. St. Louis, Elsevier; 2018. p. 15-22.
149. Visser JJ, Sambeek MRv, Hamsa TH et al. Ruptured abdominal aortic aneurysms: endovascular repair versus open surgery – Systematic review. Radiology 2007;245:122-9.
189. Engelke C, Elford J, Morgan RA et al. Internal iliac artery embolization with bilateral occlusion before endovascular aortoiliac aneurysm repair – Clinical outcome of simultaneous and sequential intervention. J Vasc Interv Radiol 2002;13:667-76. 190. Ronsivalle S, Zanchetta M, Faresin F et al. Intraoperative intrasac thombin injection to prevent type 2 endoleak after EVAR. JEVT 2007;14:176-83. 191. Baum RA, Carpenter JP, Golden MA et al. Treatment of type 2 endoleaks after endovascular repair of abdominal aortic aneurysms: comparison of transarterial and translumbar techniques. J Vasc Surg 2002;35:23-9. 192. Coppi G, Saitta G, Coppi G et al. Transealing: a novel and simple techniqu for embolization of type 2 endoleaks through direct sac Access from distal stent-graft landing zone. Eur J Vasc Endovasc Surg 2014;47;394-401.
166. Espinosa G. Tratamento endovascular dos AAA. Tese. Universidade Federal do Rio de Janeiro, 2000;77:91-92.160. 167. Elmarazi MN, Soong CV, Walker SR et al. Sigmoid isquemia and the inflammatory response following endovascular AAA repair. J Endovasc Ther 2000;7:21-30.
186. Arko FR, Rubin GD, Johnson BL et al. Type-II endoleaks following endovascular AAA repair: preoperative predictors and long term effects. J Endovasc Ther 2001;8:503-10.
155. White G. Endoleaks and endotension: definitions, classification and current concepts. In: Veith FJ, Baum RA. Endoleaks and endotension. New York: Marcel Dekker, 2003. p. 25-46.
176. May J. Distortion and structural deterioration of endovascular grafts used to repair AAA. Editorial. J Endov Surg 1999;6:1-3.
156. Lumsden AB, Alen A, Chailkof EL et al. Delayed rupture of AAA following endovascular stent grafting. Am J Surg 1995;170:174-8.
153. Crawford ES. Ruptured aortic aneurysms. Editorial. J Vasc Surg 1991:13:348-50.
173. Oderich GS, Bower TC, Cherry KJ et al. Evolution from axillofemoral to in situ prosthetic reconstruction for the trestment of aortic grafts infection at a single center. J Vasc Surg 2006;43:1166-74.
180. Fóis-Câmara A. O valor do eco-color Doppler no diagnóstico de vazamentos no TE AAA. Tese Mestrado. Rio de Janeiro: UFRJ; 2007.
150. Reimerink JJ, Hoornweg LL, Vahl AC et al. Endovascular repair versus open a repair of ruptured abdominal aortic aneurysms: a multicenter randomized control Trial. Ann Surg 2013;258:248-56.
159. Aun R. Experiência com endoprótese Zenith. Simpósio Zenith. XXI Enc Angiol e Cir Vasc RJ. Rio de Janeiro; 17 Mar 2007. 160. Hiramoto JS, Reilly LM, Chuter TAM. Long-term outcome and reinterventions after endovascular AAA repair using the Zenith stent graft. J Vasc Surg 2007;43:461-6.
177. Geller SC. Imaging guidelines for EVAR with endovascular stent grafts. J Vasc Interv Radiol 2003;14:263-4.
157. Torsello GB, Klenk E, Kasprzak B et al. Rupture of AAA previously treated bi endovascular grafting. J Vasc Surg 1998;28:184-7.
178. Rosenblit AM, Patlas M, Rosenbaum AT et al. Detection of endoleaks after EVAR: value of nonenhanced and delayed helical CT acquisitions. Radiology 2003;221:426-33.
158. Faries PL, Brener BJ, Connelly TL et al. A multicenter experience with the Talent endovascular graft for the treatment of AAA. J Vasc Surg 2002;35:1123-8.
170.
161. Ristow AV, Silveira PG. Tratamento do aneurisma da aorta abdominal pela técnica endovascular. In: Bonamigo TP, Ristow AV (Eds.). Aneurismas. Rio de Janeiro: DiLivros; 1999. p. 97-111. 162. Baker DM, Wenham PW. Renal damage. In: Hopkinson B et al. (Ed). Endovascular surgery for aortic aneurysms. London: WB Saunders; 1997. 163. Miller LE, Razavi MK, Lal BK. Suprarenal versus infrarenal stent graft fixation on renal complications after endovascular aneurysm repair. J Vasc Surg 2015;61:1340-449. 164. Briguori C, Airoldi F, D’Andrea D et al. Renal insufficiency following contrast media administration trial. Circulation 2007;115:1211-7.
174. Barbosa J. Infecção protésica – Reconstrução in situ. Ann VI Congr SPACV, Lisboa; 2006. p. 40. 175. Harris P, Brennan J, Martin J et al. Longitudinal aneurysm shrinkage following EVAR: a source of intermediate and late complications. J Endov Surg 1999;6:11-6.
187. Arko FR, Filis KA, Siedel SA et al. Intrasac flow velocities predict sealing of type II endoleaks after endovascular abdominal aortic aneurysm repair. J Vasc Surg 2003;37:8-15.
151. Desgranges P, Kobeiter H, Katsahian S et al, for the ECAR Investigators. A french randomized controlled Trial of endovascular versus open surgical repair of ruptured aortic aneurysms. Eur J Vasc Endovasc Surg 2015;50:303-10.
184. Resnikoff M, Darling III RC, Chang BB et al. Fate of the excluded AAA sac: long term follow up of 831 patients. J Vasc Surg 1996;24:851-5.
168. Stelter WJ. Endovascular grafting for AAA using modular system. In: Parodi JC, Veith FJ, Marin ML (Eds.). Endovascular grafting techniques. Baltimore: Williams & Willkins; 1999. p. 77-84.
185. Resnikoff M, Darling III RC, Chang BB et al. Fate of the excluded AAA sac: long term follow up of 831 patients. J Vasc Surg 1996;24:851-5.
171.
179. Laan MJvd, Bartels LW, Viergever MA et al. CT vs MR imaging of endoleaks after EVAR. Eur J Vasc Endovasc Surg 2006;32:361-5.
169. Fiorani P, Speziale F, Calisti A et al. Endovascular graft infection: preliminary results from an international inquiry. J Endovasc Ther 2003;10:917-27. Ristow AV. Infecção aorto-protésica. Ann VI Congr SPACV: Lisboa, 2006. p. 38-40. Cardoso MA, Frankini AD, Bonamigo TP. Use of superficial femoral vein in the treatment of infected aortoiliac prosthetic grafts. Cardiov Surg 2002;10:304-10. Ducasse E, Calisti A, Fiorani P et al. Aorto-iliac stent graft infecction –current problems and menagement. Ann Vasc Surg 2004;18:521-4.
183. Jordan Jr WD, Mehta M, Varnagy D et al. Results the ANCHOR prospective, multicenter registry of the EndoAnchors for type 1a endoleaks and endografts migration in patients with challenging anatomy. J Vasc Surg 2014;60:885-92.
154. Moore R, Nutley M, Cina CS et al. Improved survival after introduction of an emergency endovascular therapy protocol for ruptured AAA. J Vasc Surg 2007;45:443-50.
207. Zarins CK, White RA, Moll FL et al. Aneurysm rupture after endovascular repair using AneuRX stent graft. J Vasc Surg 2000;31:960-70. 208. Harris PL, Vallabhaneni SR, Desgranges P et al. Incidence and risk factors of late rupture, conversion and death after EVAR: the EUROSTAR experience. J Vasc Surg 2000;32:739-49.
209. Torella F. Effect of improved endograft design on outcome of EVAR. J Vasc Surg 2004;40:216-21.
210. May J, White GH, Stephen MS et al. Rupture of AAA: concurrent comparison of outcome of those occurring after EVAR vs without previous treatment in an 11-year single center experience. J Vasc Surg 2004;40:860-6.
211. Corriere MA, Feuer ID, Becker SY et al. Endoleak following AAA repair: implications for the duration of screening. Ann Surg 2004;239:800-7. 212. Lovegrove RE, Javid M, Magee TR et al. A meta-analysis of 21.178 patients undergoing open or endovascular repair of abdomnal aortic aneurysms. Br J Surg 2008;95:677. 213. Schermerhorn ML, O’Malley AJ, Jhaveri A et al. Endovascular vs. open repair of abdominal aortic aneurysms in the Medicare population. N Engl J Med 2008;358:464. 214. Ristow AV. A evolução e o estado da arte no tratamento de aneurismas da aorta abdominal. Experiência com 1.444 casos. Monografia. Academia Nacional de Medicina, Rio de Janeiro, Brasil; 2012. p. 149. 215. Lee WA, Carter JW, Upchurch G et al. Perioperative outcomes after open an endovascular repair of intact AAA in the USA during 2001. J Vasc Surg 2004;39:491-6. 216. Minor ME, Ellozy S, Carroccio A et al. Endovascular aortic aneurysm repair in the octogenarian: is it worthwhile? Arch Surg 2004;139:308-14. 217. Bergan JJ. Endovascular stented grafts: an independent view. In: Parodi JC, Veith FJ, Marin ML (Eds.). Endovascular grafting techniques. Baltimore: Williams & Wilkins; 1999.
204. Riambau V, Pontes C, Gracia JM et al. Conversiones de la reparación endovascular de AAA sin conversiones: experiencia de siete anos. Téc Endov 2004;7:1195-201.
188 Parte VIABDÔMEN E PELVE
205. Marone EM, Mascia D, Coppi G et al. Delayed open conversion after endovascular abdominal aortic aneurysm: a devide specific approach. Eur J vasc Endovasc Surg 2013; in press. 206. Kooning OHJ, Innen JW, Baalen JMv. Technique of the safe renoval of an aortic endograft with suprarenal fixation. J Vasc Surg 2006;43:855-7.
12. Ye W, Liu CW, Ricco JB et al. Early and late outcomes of percutaneous treatment of TransAtlantic Inter-Society Consensus class C and D aorto-iliac lesions. J Vasc Surg 2011;53:1728-37.
23. Truty MJ, Bower TC. Congenital Anomalies of the Inferior Vena Cava and Left Renal Vein: Implications during Open Abdominal Aortic Aneurysm Reconstruction. Ann Vasc Surg 2007;21:186-97.
24. Karkos CD, Bruce IA, Thomson GJ et al. Retroaortic left renal vein and its implications in abdominal aortic surgery. Ann Vasc Surg 2001;15:703-8.
28. Goldenberg SL, Gordon PB, Cooperberg PL et al. Early hydronephrosis following aortic bifurcation graft surgery: a prospective study. J Urol 1988;140:1367-9. 29. Goldstone J, Malone JM, Moore WS. Importance of the profunda femoris artery in primary and secondary arterial operations for lower extremity ischemia. Am J Surg 1978;136:215-20.
30. Radtka III J, Han D. Retroperitoneal Exposures. Operat Techniqu Gen Surg 2008;10:87-93. 31. Cambria RP, Brewster DC, Abbott WM et al. Transperitoneal versus retroperitoneal approach for aortic reconstruction: a randomized prospective study. J Vasc Surg 1990;11:314-25. 32. Twine CP, Ian FL, Williams IM. The retroperitoneal approach to the abdominal aorta in the endovascular era. J Vasc Surg 2012 Sept;56(3):834-838. 33. Sicard GA, Reilly JM. Left Retroperitoneal Approach to the Aorta and Its Branches: Part I. Ann Vasc Surg 1994;8:212-9. 34. Quick CRG, Chan CLH, Sonoda LI, Hart AJ. Midline extraperitoneal approach for elective abdominal aortic aneurysm repair. Eur J Vasc Endovasc Surg 1997 July;14(1):63-68 35. Ricco JB, Probst H, French University Surgeons Association (AURC). Long-term results of a multicenter randomized study on direct versus crossover bypass for unilateral iliac artery occlusive disease Original Research Article. J Vasc Surg 2008;47:45-54.e1. 36. Eidt J, Charlesworth D. Combined Aorto-bifemoral and Femoropopliteal Bypass in the Management of Patients with Extensive Atherosclerosis. Ann Vasc Surg 1987;1:453-60. 37. Hollinshead WH, Rosse C. Textbook of Anatomy. 4th ed. Philadelphia: Harper and Row Publishers; 1985. 38. Rutherford RB. Options in the surgical management of aortoiliac occlusive disease: a changing perspective. Cardiovasc Surg 1999;7:5-12. 39. Whittmore A, Donaldson MC, Mannick JA et al Aortoiliac occlusive disease. Philadelphia, PA: WB Saunders; 1998:483-94. 40. Honig MP, Mason RA, Giron F. Wound complications of the retroperitoneal approach to the aorta and iliac vessels. J Vasc Surg 1992;15:28-34. 41. Kirby JP, Mazuski JE. Prevention of Surgical Site Infection. Surg Clin North Am 2009;89:365-89. 42. Hall C, Allen, Barlow G. Antibiotic prophylaxis. Surgery (Oxford) 2012;30:651-8. 43. Martin P, Greenstein D, Gupta NK et al. Systemic heparinization during peripheral vascular surgery: Thromboelastographic, activated coagulation time, and heparin titration monitoring. J Cardiothorac Vasc Anesth 1994;8:150-2. 44. Szalados JE, Ouriel K, Shapiro JR. Use of the activated coagulation time and heparin dose-response curve for the determination of protamine dosage in vascular surgery. J Cardiothorac Vasc Anesth 1994;8:515-18. 45. Jacobsen W, Brauer F, Smith LL. Heparin activity monitoring during vascular surgery. Am J Surg 1978;136:141-4. Reed AB, Donaldson MC. Surgical Intervention for Lower Extremity Arterial Occlusive Disease: Aortoiliac Revascularization Operations. Comprehensive Vascular and Endovascular Surgery. 2. ed. 2009. p. 176-91.
46.
7. Brewster DC, Darling RC. Optimal methods of aortoiliac reconstruction. Surgery 1978;84:739. 8. Friedman SG, Krishnasastry KV. External iliaca ligatioin ands axilarybifemoral bypass for bue toe syndrome. Surgery 1994;115:27-30.
13. Sieunarine K, Lawrence-Brown MMD, Goodman MA. Comparison of transperitoneal and retroperitoneal approaches for infrarenal aortic surgery: early and late results. Cardiovasc Surg 1997;5:71-6.
4. Blakemore AH, Voorhees Jr AB. Use of tubes constructed from vinyon “N” cloth in bridging arterial defects: experimental and clinical. Ann Surg 1954;140:324. 5. Norgren L, Hiatt WR, Dormandy JA et al. Inter-Society Consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg 2007;45:S5–S67.
26. Davidović LB, Kostić DM, Jakovljević NS et al. Abdominal Aortic Surgery and Horseshoe Kidney. Ann Vasc Surg 2004;18:725-8.
16. Andros G, Lee L. Bypass grafts: the state of the art. Scand J Surg 2012;101:100-6.
189 96CapítuloOBSTRUÇÃO AORTOILÍACA – TRATAMENTO CIRÚRGICO REFERÊNCIAS BIBLIOGRÁFICAS
2. Bazy L, Reboul H. Technique de 1’ endarterectomie desobliterate. J Int Chir1950; 65:196. 3. Leriche R, Kunlin J. Essais de desobstruction des enteres thromboses suivant la technique de Jean Cid dos Santos. Lyon Chir 1947;42: 475.
25. Trigaux J, Vandroogenbroek S, Wispelaere J et al. Congenital Anomalies of the Inferior Vena Cava and Left Renal Vein: Evaluation with Spiral CT. J Vasc Interv Radiol 1998;9:339-45
18. Connolly JE, Price T. Endarterectomy: A Lost Art? Ann Vasc Surg 2006;20:56-62. 19. Inahara T. Eversion endarterectomy for aortoiliofemoral occlusive disease: A 16 year experience. Am J Surg 1979;138:196-204.
17. Sicard GA, Reilly JM, Rubin BG et al. Transabdominal versus retroperitoneal incision for abdominal aortic surgery: report of a prospective randomized trial. J Vasc Surg 1995; 21:174-82.
11. Jongkind V, Akkersdijk GJM, Yeung KK et al. A systematic review of endovascular treatment of extensive aortoiliac occlusive disease. J Vasc Surg 2010;52:1376-83.
20. Oertli D, Wigger P, Landmann J et al. Long-term results after open and semiclosed thrombendarterectomy for aortoiliac occlusive disease. Eur J Vasc Endovasc Surg 1996;11:432-6.
1. Thompson JE. Early history of aortic surgery. J Vasc Surg 1998;28:746-52.
15. Haimovici H, Acher E, Hollier LH (Eds.). Blackwell Science, Inc., Cambridge; 1995.
14. Moore WS, Blaisdell FW. Diagnosis and management of peripheral arterial occlusive disease. Curr Probl Surg 1973;10:1-63.
22. Nypaver TJ, Shepard AD, Reddy DJ et al. Supraceliac aortic crossclamping: Determinants of outcome in elective abdominal aortic reconstruction. J Vasc Surg 1993;17:868-76.
6. Chiu KWH, Davies PG, Nightingale PG et al. Review of direct anatomical open surgical management of atherosclerotic aorotoiliac occlusive disease. Eur J Vasc Endovasc Surg 2010;39:460-71.
9. West CA, Johnson LW, Doucet L. A contemporary experience of open aortic reconstruction in patients with chronic atherosclerotic occlusion of the abdominal aorta. J Vasc Surg 2010;52:1164-72.
10. Kashyap VS, Pavkov ML, Bena JF et al. The management of severe aortoiliac occlusive disease: endovascular therapy rivals open reconstruction. J Vasc Surg 2008;48:1451-57.
27. Henriksen LO, Mejdahl S, Petersen F et al. The incidence of ureteral obstruction secondary to aorto-femoral bypass surgery. A prospective study. Eur J Vasc Surg 1988;2:417-8
21. Rutherford RB, Cronenwett JL, Gloviczki P et al. (Eds.). Rutherford Vascular Surgery. 6th edition. Philadelphia, Pa, USA: Elsevier; 2005.
71. Szalados JE, Ouriel K, Shapiro JR. Use of the activated coagulation time and heparin dose-response curve for the determination of protamine dosage in vascular surgery. Journal of Cardiothor Vasc Anesth 1994 October; 8(5):515-518. 72. Piotrowski JL, Pearce WH, Jones DN et al. Aorto-bifemoral bypass: The operation of choice for unilateral iliac occlusion? J Vasc Surg 1988;8:211-8. 73. van der Vliet JA, Scharn DA, de Waard JW et al. Unilateral vascular reconstruction for iliac obstructive disease. Vasc Surg 1994;19:610-14.
75. Inahara T. Endarterectomy for occlusive disease of the aortoiliac and common femoral arteries. Am J Surg 1972;124:235.
65.
56. Welborn MB, Seeger JM. Prevention and management of sigmoid and pelvic ischemia associated with aortic surgery. Semin Vasc Surg 2001;14:255-65. 57. Gorecki JP, Ameli FM. Ischemic Damage to the Spinal Cord Following End-to-Side Aorto-bifemoral Bypass. Ann Vasc Surg 1993;7:569-76.
58. Goldsteins AM, Youkey JR, Pharr WF. Implantation of distal aorta: a technique for preservation of pelvic blood flow in aortofemoral reconstruction. Ann Vasc Surg 1990;4:213-6. 59. Weg T, Baird RN. Secondary aorto enteric fistulae: towards a more conservative approach. Br J Surg 1986;73:875-8. 60. Bergeron P, Espinoza H, Rudondy P et al. Secondary Aortoduodenal Fistulas: Value of Initial Axillofemoral Bypass. Ann Vasc Surg 1991;5:4-7. 61. Bergquist D, Alm D, Claes G et al. Secondary aortoenteric fistulas-an analysis of 42 cases. Eur J Vasc Surg 1987;1:11-8.
62. Scheppach W, Polzien M, Kuesters W. Aorto-bifemoral Prosthesis Penetrating Into the Duodenal Lumen. Clinical Gastroenterology and Hepatology 2011;9:A28. 63. Polterauer P, Prager MR, Holzenbein T et al. Dacron versus polytetrafluoroethylerie for Y-aortic bifurcation grafts: a six year prospective, randomized trial. Surgery 1992;111:626-33. 64. Prager MR, Polterauer P, Böhmig H et al. Collagen versus gelatincoated dacron versus stretch polytetrafluoroethylene in abdominal aortic bifurcation graft surgery: Results of a seven-year prospective, randomized multicenter trial. Surgery 2001;130:408-14. Lord RSA, Nash PA, Raj BT et al. Prospective Randomized Trial of Polytetrafluoroethylene and Dacron Aortic Prosthesis. I. Perioperative Results. Ann Vasc Surg 1988;2:248-54. 66. Youmans Jr. R, Hopkins JW, Derrick JW. Transinguinal distal profunda femoris revascularization. Am J Surg 1969;118:909-14.
48. Marrocco-Trischitta MM, Bertoglio L, Tshomba Y et al. The best treatment of juxtarenal aortic occlusion is and will be open surgery J Cardiovasc Surg (Torino) 2012;53:307-12.
51. Casali RE, Tucker E, Read RC et al. Total infrarenal aortic occlusion. Am J Surg 1977;134:809-12.
49. Spence PA, Lust RM, Chitwood Jr. WR, Iida H et al. Transfemoral balloon aortic occlusion during open cardiopulmonary resuscitation improves myocardial and cerebral blood flow. J Surg Res 1990;49:217-21.
50. Araújo AP. Controle de hemorragia abdominal grave com cateter balão fluxo-dirigível via artéria braquial: modelo experimental. 2006. Doutorado [Departamento de Cirurgia]. Universidade Federal do Rio de Janeiro, Rio de Janeiro.
47. Gupta SK, Veith FJ. Management of Juxtarenal Aortic Occlusions: Technique for Suprarenal Clamp Placement. Ann Vasc Surg 1992;6:306-12.
52. Ameli FM, Stein M, Aro L et al. End-to-end versus end-to-side proximal anastomosis in aorto-bifemoral bypass surgery: does it matter? Can J Surg 1991;34:243-6.
190 Parte VIABDÔMEN E PELVE
53. Melliere D, Labastie J, Becquemin JP, et al. Proximal anastomosis in aorto-bifemoral bypass: end-to-end or end-to-side. J Cardiovasc Surg 1990;31:77-80.
55. O’Connor SE, Walsh DB, Zwolak RM et al. Pelvic Blood Flow Following Aorto-bifemoral Bypass with Proximal End-to-Side Anastomosis. Ann Vasc Surg 1992;6:493-98.
67. Ciervo A, Dardik H, Qin F et al. The tourniquet revisited as an adjunct to lower limb revascularization. J Vasc Surg 2000;31:436-42.
76. Thomas TV. Reconstruction in unilateral iliac disease. Am J Surg 1971;122:410-13. 77. Ricco JB. Unilateral Iliac Artery Occlusive Disease: A Randomized Multicenter Trial Examining Direct Revascularization Versus Crossover Bypass. Ann Vasc Surg 1992;6:209-19. 78. Freeman NE, Leeds FH. Operations on large arteries; application of recent advances. Calif Med 1952;77:229-33. 79. Vetto RM. The treatment of unilateral iliac artery obstruction with transabdominal, subcutaneous femorofemoral graft. Surgery 1962;52:342-5. 80. Blaisdell FW. Development of femoro-femoral and axillo-femoral bypass procedures. J Vasc Surg 2011;53:540-4. 81. Perler BA, Williams GM. Does donor iliac artery percutaneous transluminal angioplasty or stent placement influence the results of femorofemoral bypass? Analysis of 70 consecutive cases with longterm follow-up. J Vasc Surg 1996;24:363-9. 82. Rutherford RB, Patt A, Pearce WH. Extra-anatomic bypass: a closer view. J Vasc Surg 1987;5:437-46. 83. Kim YW, Lee JH, Kim HG et al. Factors affecting the longterm patency of crossover femorofemoral bypass graft. Eur J Vasc Endovasc Surg 2005;30:376-80. 84. Criado E, Burnham SJ, Tinsley Jr EA et al. Femorofemoral bypass graft: Analysis of patency and factors influencing long-term outcome. J Vasc Surg 1993;18:495-505. 85. Rinckenbach S, Guelle N, Lillaz J et al. Femorofemoral Bypass as an Alternative to a Direct Aortic Approach in Daily Practice: Appraisal of its Current Indications and Midterm Results. Ann Vasc Surg 2012;26:359-64. 86. Prendiville EJ, Burke PE, Colgan MP et al. The profunda femoris: a durable outflow vessel in aortofemoral surgery. J Vasc Surg 1992:16:23-9. 87. Nakamura LY, Ferrigni RG, Stone WM et al. Urinary bladder injuries during vascular surgery. J Vasc Surg 2010;52:453-5. 88. Branchereau A, Ciosi G, Bordeaux J et al. Femorofemoral Bypass Through the Perineum for Infection Complicating Arterial Revascularization of the Lower Limb. Ann Vasc Surg 1988;2:43-9. 89. Lawrence PF, Albo D. Femoro-femoral bypass with an infrascrotal perineal approach for the patient with an infected groin wound. J Vasc Surg 1985;2:485-7. 90. Johnson HA, Mehrez IO, Vittimberga F et al. Femorofemoral CrossPerineal Infrascrotal Bypass. Ann Vasc Surg 1988;2:425. 91. Meneghetti AT, MacDonald PS, Reid JDS et al. Patency of Superficial Femoral Vein Employed as a Crossover Femoral Artery Bypass Conduit. Ann Vasc Surg 2002;16:746-50. 92. D’Addio V, Ahsan A, Timaran C et al. Femorofemoral bypass with femoral popliteal vein. J Vasc Surg 2005 July;42(1):35-39. 93. Eiberg JP, Røder J, Stahl-Madsen M et al. Fluoropolymer-coated Dacron Versus PTFE Grafts for Femorofemoral Crossover Bypass: Randomised Trial. Eur J Vasc Endovasc Surg 2006;32:431-8. 94. Melliere D, Blancas AE, Desgranges P et al. The underestimated advantages of iliofemoral endarterectomy. Ann Vasc Surg 2000;14:343–9. 95. Dos Santos JC. Sur la desobstruction des thrombus arterielles anciennes. Mem Acad Chir 1947;73:409. 96. Wylie EJ. Thromboendarterectomy for arteriosclerotic thrombosis of major arteries. Surgery 1952;23:275. 97. Ebaugh JL, Gupta N, Raffetto JD. Single-incision external iliac artery endarterectomy and patch angioplasty. Ann Vasc Surg 2011;25:1165-9. 98. van den Dungen JJAM, Boontje AH, Kropveld A. Unilateral iliofemoral occlusive disease: long-term results of the semiclosed endarterectomy with the ringstripper. J Vasc Surg 1991;14:673-7. 99. Barker WF, Cannon JA. An evaluation of endarterectomy. Arch Surg 1953;66:488-495. 100. Smeets L, DeBorst GJ, DeVries JP et al. Remote iliac artery endarterectomy: Seven-year results of a less invasive technique for iliac artery occlusive disease. J Vasc Surg 2003.38:1297. 101. Smeets L, van der Horn G, Gisbertz SS et al. Does conversion of intended remote iliac artery endarterectomy alter the early and long-term outcome? Vascular 2005;13:336-340. 102. Martin JD, Hupp JA, Peeler MO et al. Remote endarterectomy: Lessons learned after more than 100 cases. J Vasc Surg 2006;43:320-6.
68. Yao JST. The first operation on the profunda femoris artery. J Vasc Surg 2010;52:1101-2. 69. Ouriel K, DeWeese JA, Ricotta JJ et al. Revascularization of the distal profunda femoris artery in the reconstructive treatment of aortoiliac occlusive disease. J Vasc Surg 1987;6:217-20. 70. Morris Jr GC, Edward W, Cooley DA et al. Surgical importance of profunda femoris artery. Arch Surg 1961;82:32.
54. Pierce GE, Turreitine M, Iliopoules J et al. Evaluation of end-to-end vs. end-to-side proximal anastomosis in aorto-bifemoral bypass. Arch Surg 1982;117:1580-8.
74. Darling III C, Leather RP, Chang BB et al. Is the iliac artery a suitable inflow conduit for iliofemoral occlusive disease: An analysis of 514 aortoiliac reconstructions. J Vasc Surg 1993;17:15-22.
153. Davidović LB, Vasic D, Maksimovic R et al. Aorto-bifemoral grafting: factors influencing long-term results. Vascular 2004;12:171-8.
109. Forneau I, Lerut P, Sabbe S et al. The learning curve of totally laparoscopic aorto-bifemoral bypass for occlusive disease. How many cases and how safe? Eur J Vasc Endovasc Surg 2008;35:723-9.
119. Butcher Jr. HR, Jaffe BM. Treatment of aortoiliac arterial occlusive disease by endarterectomy. Ann Surg 1971;173:925-32.
127. Johnson WC, LoGerfo FW, Vollman RW et al. Is axilo-bilateral femoral graft an effective substitute for aortic-bilateral iliac/femoral graft?: an analysis of ten years experience. Surg 1977;186:123-9.
131. Martinez BD, Hertzer NR, Beven EG. Influence of distal arterial occlusive disease on prognosis following aorto-bifemoral bypass. Surgery 1980;88:795-805.
113. Tiek J, Remy P, Sabbe T et al. Laparoscopic versus open approach for aorto-bifemoral bpass for severe aorto-iliac occlusive disease - a multicenter randomised controlled trial. Eur J Vasc Endovasc Surg 2012;43:711-15. 114. Naylor AR, Ah-See AK, Engeset J. Morbidity and mortality after aortofemoral grafting for peripheral limb ischaemia. J R Coll Surg Edinb 1989;34:215-8. 115. Harrington EB, Haimov M, Schanzer H et al. Iliofemoral versus femorofemoral bypass: the case for an individualized approach. J Vasc Surg 1992;16:841-52. 116. Cham C, Myers KA, Scott DF et al. Extraperitoneal unilateral iliac artery bypass for chronic lower limb ischaemia. Aust N Z J Surg 1988;58:859-63. 117. Aguiar ET, Lederman A, Sitrangulo Jr. CJ, Puech-Leao P. Aortofemoral thromboendarterectomy. Rev Hosp Clin Fac Med São Paulo 2002;57:147-60. 118. Bowes DE, Youkey JR, Franklin DP et al. An algorithm for the surgical management of chronic abdominal aortic occlusion and occluded aortofemoral grafts. J Cardiovasc Surg (Torino) 1992;33:650-9.
107. Coggia M, Bourriez A, Javerliat I et al. Totally laparscopic aortobifemoral bypass: a new and simplified approach. Eur J Vasc Endovasc Surg 2002;24:274-5.
104. Radoux JM, Maiza D, Coffin O. Long-term outcome of 121 iliofemoral endarterectomy procedures. Ann Vasc Surg 2001;15:163-70.
122. Friedman SG, Lazzaro RS, Spier LN et al. A prospective randomized comparison of Dacron and polytetrafluoroethylene aortic bifurcation grafts. Surgery 1995;117:7-10.
110. Stadler P, Matous P, Vitasek P et al. Robot-assisted aortoiliac reconstruction: e review of 30 cases. J Vasc Surg 2006;44:915-9.
126. Jensen BV, Egeblad K. Aorto-iliac arteriosclerotic disease in young human adults. Eur J Vasc Surg 1990;4:583-6.
123. Harris PL, Bigley DJ, McSweeney L. Aortofemoral bypass and the role of concomitant femorodistal reconstruction. Br J Surg 1985;72:317-20.
133. Meister RH, Schweiger H, Lang W. Knitted double-velour Dacron prostheses in aorto-bifemoral position–long-term performance of different coating materials. Vasa 1998;27:236-9.
121. Dunn DA, Downs AR, Lye CR. Aortoiliac reconstruction for occlusive disease: comparison of end-to-end and end-to-side proximal anastomoses. Can J Surg 1982;25:382-4.
135. Mulcare RJ, Royster TS, Lynn RA et al. Long-term results of operative therapy for aortoiliac disease. Arch Surg 1978;113:601-4. 136. Ng RL, Gillies TE, Davies AH et al. Iliofemoral versus femorofemoral bypass: a 6-year audit. Br J Surg 1992;79:1011-3. 137. Oliveira M, Wilson SE, Williams R et al. Iliofemoral bypass: a 10-year review. Cardiovasc Surg 1993;1:103-6.
134. Mingoli A, Sapienza P, Feldhaus RJ et al. Aortoiliofemoral bypass graft in young adults: long-term results in a series of sixty-eight patients. Surgery 1997;121:646-53.
145. Timaran CH, Stevens SL, Freeman MB et al. Infrainguinal arterial reconstructions in patients with aortoiliac occlusive disease: the influence of iliac stenting. J Vasc Surg 2001;34:971-8.
147. Yamazaki I, Karube N, Soma T et al. Long-term outcomes using vascular grafts sealed with fragmented autologous adipose tissue for aortoiliac occlusive disease. J Artif Organs 2005;8:67-70.
120. Couch NP, Clowes AW, Whittemore AD et al. The iliac-origin arterial graft: a useful alternative for iliac occlusive disease. Surgery 1985;97:83-7.
112. Remy P, Deprez AF, D’hont Ch et al. Total laparoscopic aortobifemoral bypass. Eur J Vasc Endovasc Surg 2005;29:22-7.
149. Lee G, Yang S, Park K et al. Ten years after bypass surgery in aortoiliac occlusive disease. J Korean Surg Soc 2012; 82:365-9.
150. Vries SO, Hunink MG. Results of aortic bifurcation grafts for aortoiliac occlusive disease: a meta-analysis. J Vasc Surg 1997;26:558-69.
151. Nevelsteen A, Suy R. Graft occlusion following aortofemoral Dacron bypass. Ann Vasc Surg 1991;5:32-7.
152. van den Akker PJ, van Schilfgaarde R, Brand R et al. Long term success of aortoiliac operation for arteriosclerotic obstructive disease. Surg Gynecol Obstet 1992;174:485-96.
128. Jorgensen PE, Lundsgaard C, Jelnes R et al. Iliofemoral bypass surgery for lower limb ischaemia. A follow-up of 62 patients. Ann Chir Gynaecol 1986;75:155-9.
138. Oskam J, van den Dungen JJ, Boontje AH. Thromboendarterectomy for obstructive disease of the common iliac artery. Cardiovasc Surg 1996;4:356-9. 139. Passman MA, Taylor LM, Moneta GL et al. Comparison of axillofemoral and aortofemoral bypass for aortoiliac occlusive disease. J Vasc Surg 1996;23:263-9. 140. Perler BA, Burdick JF, Williams GM. Femoro-femoral or iliofemoral bypass for unilateral inflow reconstruction? Am J Surg 1991;161:426-30. 141. Prager MR, Hoblaj T, Nanobashvili J et al. Collagen- versus gelatinecoated Dacron versus stretch PTFE bifurcation grafts for aortoiliac occlusive disease: long-term results of a prospective, randomized multicenter trial. Surgery 2003;134:80-5. 142. Schneider JR, Besso SR, Walsh DB et al. Femorofemoral versus aortobifemoral bypass: outcome and hemodynamic results. J Vasc Surg 1994;19:43-55. 143. Sladen JG, Gilmour JL, Wong RW. Cumulative patency and actual palliation in patients with claudication after aortofemoral bypass. Prospective long-term follow-up of 100 patients. Am J Surg 1986;152:190-5. 144. Szilagyi DE, Elliott Jr. JP, Smith RF et al. A thirty-year survey of the reconstructive surgical treatment of aortoiliac occlusive disease. J Vasc Surg 1986;3:421-36.
106. Dion YM, Griselli F, Douville Y et al. Early and mid-term results of totally laparoscopic surgery for aortoiliac disease: lessons learned. Surg Laparosc Endosc Percutan Tech 2004;14:328-34.
154. Takagi H, Goto SN, Matsui M et al. A contemporary meta-analysis of Dacron versus polytetrafluoroethylene grafts for femoropopliteal bypass grafting. J Vasc Surg 2010;52:232-6.
158. Zukauskas G, Ulevicius H, Janusauskas E. An optimal inflow procedure for multi-segmental occlusive arterial disease: ilio-femoral versus aorto-bifemoral bypass. Cardiovasc Surg 1998;6:250-5.
129. Lau H, Cheng SW. Long-term outcome of aortofemoral bypass for aortoiliac occlusive disease. Ann Acad Med Singapore 2000;29:434-38. 130. Littooy FN, Steffan G, Steinam S et al. An 11-year experience with aortofemoral bypass grafting. Cardiovasc Surg 1993;1:232-8.
146. Vitale GF, Inahara T. Extraperitoneal endarterectomy for iliofemoral occlusive disease. J Vasc Surg 1990;12:409-13.
125. Jackson MR, Ali AT, Bell C et al. Aortofemoral bypass in young patients with premature atherosclerosis: is superficial femoral vein superior to Dacron? J Vasc Surg 2004;40:17-23.
132. Mason RA, Smirnov VB, Newton GB et al. Alternative procedures to aorto-bifemoral bypass grafting. J Cardiovasc Surg (Torino) 1989;30:192-7.
111. Lin J, Kolvenbach R, Schwierz E et al. Total laparoscopic aortofemoral bypass as a routine procedure for the treatment of aortoiliac occlusive disease. Vascular 2005;13:80-3.
103. Vollmar J, Laubach K. Chururgische Behandlung der arteriellen Embolie. Ring-Desobliteration der Strombahn. Münch Med Wschrift 1965;107:765-763.
105. Cau J, Ricco J, Corpataux J. Laparoscopic aortic surgery: Techniques and results. J Vasc Surg 2008;48:S37-S45.
157. Kram EB, Gupta SK, Veith FJ et al. Unilateral aortofemoral bypass: a safe and effective option for the treatment of unilateral limbthreatening ischemia. Am J Surg 1991;162:155-8.
124. Hsiang Y, Hildebrand HD. Results of vascular surgery in younger versus older patients. Am J Surg 1989;157:419-22.
191Capítulo 96 obstrução AortoilíACA – tr AtAmento CirúrgiCo
108. Coggia M, Javerliat I, Di Centa I et al. Total laparoscopic bypass for aortoiliac occlusive lesions: 93 case experience. J Vasc Surg 2004;40:899-906.
155. Gaspard DJ, Cohen JL, Gaspar MR. Aortoiliofemoral thromboendarterectomy vs bypass graft. A randomized study. Arch Surg 1972;105:898-901. 156. Urayama H, Ohtake H, Yokoi K et al. Long-term results of endarterectomy, anatomic bypass and extraanatomic bypass for aortoiliac occlusive disease. Surg Today 1998;28:151-5.
148. Ruggiero II NJ, Jaff MF. The Current Management of Aortic, Common Iliac, and External Iliac Artery Disease: Basic Data Underlying Clinical Decision Making. Ann Vasc Surg 2011;25:990-1003.
162. Tapper SS, Jenkins JM, Edwards WH et al. Juxtarenal aortic occlusion. Ann Sur 1992;215:443-50. 163. McCullough JL, Mackey WC, O’Donnell TF et al. Infrarenal aortic occlusion: a reassessment of surgical indications. Am J Surg 1983;146:178-82. 164. Starrett RW, Stoney RJ. Juxtarenal aortic occlusion. Surgery 1974;76:890-7.
159. Kalman PG, Hosang M, Johnston KW et al. Unilateral iliac disease: the role of iliofemoral bypass. J Vasc Surg 1987;6:139-43.
192 Parte VIABDÔMEN E PELVE
165. Lingush J, Criado E, Burnham SJ et al. Management of chronic atherosclerotic infrarenal aortic occlusion. J Vasc Surg 1996;24:394-405. 166. Johnson JK. Ascending thrombosis of abdominal aorta as fatal complication of Leriche’s syndrome. AMA Arch Surg 1954;69:663-8.
168. Hobson RW, Rich NM, Fedde CW. Surgical management of high aortoiliac occlusion. Am Surg 1975;5:271280. 169. Deri GP, Ballotta E. Natural history of ascending thrombosis of the abdominal aorta. Am J Surg 1983;145:652-7.
172. Andrus CH. A technique for suturing of the calcified arterial wall. Surg Gynecol Obstet 1980;151:675.
177. Cronenwett JL, Davis JT, Gooch JB et al. Aortoiliac occlusive disease in women. Surgery 1980;88:775. 178. DeLaurentis DA, Friedman P, Wolferth GC et al. Atherosclerosis and teh hypoplastic aortoiliac system. Surgery 1978;83:27.
160. Leville CD, Kashyap VS, Clair DG et al. Endovascular management of iliac artery occlusions: extending treatment to TransAtlantic InterSociety Consensus class C and D patients. J Vasc Surg 2006;43:32-9.
170. West CA, Noel AA, Bower TC, KJ et al. Factors affecting outcomes of open surgical repairs of pararenal abdominal aortic aneurysms: a 10-year experience. J Vasc Surg 2006;43:921-8.
174. Carpenter JP, Berkowitz HD. A technique for suturing anastomoses involving calcified vessels. J Vasc Surg 1992;16:494-6.
167. Bell JW. Surgical treatment of chronic occlusion of the terminal aorta. Am Surg 1972;38:481-85.
180. Brewster DC, Méier GH, Darling RC et al. Reoperation for aortofemoral limb occlusion: Optimal methods and long term results. J Vasc Surg 1987;5:363. 181. Nevelsteen A, Suy R. Graft occlusion following aortofemoral Dacron bypass. Ann Vasc Surg 1991;5:32. 182. Diehl JT, Cali RF, Hertzer NRet al. Complications of abdominal aortic reconstruction : an analysis of perioerative risk factors in 557 patients. Ann Surg 1983;197:50. 183. Castronuovo JJ, Flaningan DP. Renal failure complicating vascular surgery. In Berhnhard VM, Towne JB (Eds.). Complications in Vascular Surgery. Orlando, Grune & Stratton; 1985. p. 258-274. 184. Tollefson DFJ, Porter JM. Colon ischemia following aortic reconstruction. Ann Vasc Surg 1991;5:485-9. 185. Gloviczki P, Cross SA, Stanson AW et al. Ischemic Injury to the Spinal Cord or Lumbosacral PlexuS After Aorto:Iliac Reconstruction. Am J Surg 1991;162:131-6. 186. Bonnet P, Vandeberg C, Limet R. Treatment of Urological Complications Related to Aorto-iliac Pathology and Surgery. Eur J Vasc Endovasc Surg 2003;6:657-64. 187. Hoed PT, Veen HF. The Late Complications of Aorto-ilio-femoral Dacron Prostheses: Dilatation and Anastomotic Aneurysm Formation. Eur J Vasc Surg 1992;6:282-287. 188. Schellack J, Salam A, Abouzeid MA et al. Femoral anastomotic aneurysms: a continuing challenge. J Vasc Surg 1987;6:308. 189. Miles JR Jr, Miles DG, Johnson G Jr. Aortoiliac operations and sexual dysfunction. Arch Surg 1982;117:1177-81 190. Cormio L, Edgren J, Lepantalo M et al. Aortofemoral surgery and sexual function. Eur J Vasc Endovasc Surg 1996;11:453-457. 191. Flanigan DP, Schuler JJ, Keifer T et al. Elimination of iatrogenic impotence and improvement of sexual function after aortoiliac revascularization. Arch Surg 1982;117:544-550. 192. Baril DT, Carroccio A, Ellozy SH et al. Evolving strategies for the treatment of aortoenteric fistulas. J Vasc Surg 2006;44:250-7.
161. Liddicoat JE, Bekassy SM, Dang MH. Complete occlusion of the infrarenal abdominal aorta: management and results in 64 patients. Surgery 1975;77:467-72.
175. Melliere D, Becquemin JP, Meakins J. Technique de suture des arteres calcifies. Nouvelle Presse Medicale 1982;11:2147-8.
176. Raso AM, Varetto G, Bellan A et al. Small aorta syndrome: hypothesis or reality? Minerva cardioangiol 2001; 49:211-20.
171. Knott AW, Kalra M, Duncan AA et al. Open repair of juxtarenal aortic aneurysms (JAA) remains a safe option in the era of fenestrated endografts. J Vasc Surg 2008;47:695-701.
179. Brewster DC, Perler BA, Robison JG et al. Aortofemoral graft for multilevel occlusive disease: Predictors of success and need for distal bypass. Arch surg 1982;117:1593.
173. Ascer E, Veith FJ, Flores AS. Infrapopliteal bypasses to heavily calcified rock-like arteries: management and results. Am J Surg 1986;152:220-223.
12. Hertzer NR, Bena JF, Karafa MT. A personal experience with direct reconstruction and extra-anatomic bypass for aortoilio-femoral occlusive disease. J Vasc Surg 2007;45:527-535.
14. Littooy FN, Steffan G, Steinam S et al. An 11-year experience with aortofemoral bypass grafting. Cardiovasc Surg 1993;1:232-8.
19. Rouers A, Meurisse N, Lavigne JP et al. Potential benefits of laparoscopic aorto-bifemoral bypass surgery. Acta Chir Belg 2005;105:610-5. 20. Danczyk RC, Mitchell EL, Petersen BD et al. Outcomes of open operation for aortoiliac occlusive disease after failed endovascular therapy. Arch Surg 2012;147:841-845.
17. Erdoes LS, Bernhard VM, Berman SS. Aortofemoral graft occlusion: strategy and timing of reoperation. Cardiovasc Surg 1995;3:277-83. 18. Passman MA, Taylor LM, Moneta GL et al. Comparison of axillofemoral and aortofemoral bypass for aortoiliac occlusive disease. J Vasc Surg 1996;23:263-9.
26. Sabri SS, Choudhri A, Orgera G et al. Outcomes of covered kissing stent placement compared with bare metal stent placement in the treatment of atherosclerotic occlusive disease at the aortic bifurcation. J Vasc Interv Radiol 2010;21:995-1003. 27. Humphries MD, Armstrong E, Laird J et al. Outcomes of covered versus bare-metal balloon-expandable stents for aortoiliac occlusive disease. J Vasc Surg 2014;60:337-43.
TRATAMENTO ENDOVASCULAR REFERÊNCIAS BIBLIOGRÁFICAS
3. Wylie EJ. Thromboendarterectomy for arteriosclerotic thrombosis of major arteries. Surgery 1952;32:275-92.
1. Norgren L, Hiatt WR, Dormandy JA et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 2007;45(suppl S):S5-67.
4. de Donato G, Bosiers M, Setacci F et al. 24-Month data from the BRAVISSIMO: a large-scale prospective registry on iliac stenting for TASC A & B and TASC C & D lesions. Ann Vasc Surg 2015;29:738-750.
28. Hajibandeh S, Antoniou SA, Torella F, Antoniou GA. Covered vs. Uncovered Stents for Aortoiliac and Femoropopliteal Arterial Disease: A Systematic Review and Meta-analysis. J Endovasc Ther 2016 Jun;23(3):442-52. 29. Piazza M, Squizzato F, Spolverato G et al. Outcomes of polytetrafluoroethylene-covered stent versus bare-metal stent in the primary treatment of severe iliac artery obstructive lesions. J Vasc Surg 2015 Nov;62(5):1210-8. 30. Piazza M, Squizzato F, Dall’Antonia A et al. Editor’s Choice - Outcomes of Self Expanding PTFE Covered Stent Versus Bare Metal Stent for Chronic Iliac Artery Occlusion in Matched Cohorts Using Propensity Score Modelling. Eur J Vasc Endovasc Surg 2017 Aug;54(2):177-185. 31. Goverde PC, Grimme FA, Verbruggen PJ et al. Covered endovascular reconstruction of aortic bifurcation (CERAB) technique: a new approach in treating extensive aortoiliac occlusive disease. J Cardiovasc Surg (Torino) 2013;54:383-387. 32. Grimme FA, Goverde PC, Verbruggen PJ et al. Editor’s Choice - First results of the covered endovascular reconstruction of the aortic bifurcation (CERAB) technique for aortoiliac occlusive disease. Eur J Vasc Endovasc Surg 2015;50:638-647. 33. Taeymans K, Jebbink EG, Holewijn S et al. Three-year outcome of the covered endovascular reconstruction of the aortic bifurcation technique for aortoiliac occlusive disease. J Vasc Surg 2018 May;67(5):1438-1447. 34. Varcoe RL, Nammuni I, Lennox AF, Walsh WR. Endovascular reconstruction of the occluded aortoiliac segment using “doublebarrel” self-expanding stents and selective use of the Outback LTD catheter. J Endovasc Ther 2011;18:25-31. 35. Ye W, Liu CW, Ricco JB et al. Early and late outcomes of percutaneous treatment of TransAtlantic Inter-Society Consensus class C and D aorto-iliac lesions. J Vasc Surg 2011;53:1728-37. 36. Marin ML, Veith FJ, Cynamon J et al. Effect of polytetrafluoroethylene covering of Palmaz stents on the development of intimal hyperplasia in human iliac arteries. J Vasc Interv Radiol 1996;7:651-6. 37. Diethrich EB. Polymeric covers and coats for metallic stents: microporous PTFE and the inhibition of intimal hyperplasia. J Endovasc Surg 1995;2:266-71.
21. AbuRahma AF, Hayes JD, Flaherty SK, Peery W. Primary iliac stenting versus transluminal angioplasty with selective stenting. J Vasc Surg 2007;46:965-70. 22. Mwipatayi BP, Thomas S, Wong J et al. A comparison of covered vs. bare expandable stents for the treatment of aortoiliac occlusive disease. J Vasc Surg 2011 Dec;54(6):1561-70. 23. Bekken JA, Jongsma H, Fioole B. The use of covered stents in aortoiliac obstructions: a systematic review and meta-analysis J Cardiovasc Surg (Torino). 2018 Feb;59(1):14-25. 24. Mwipatayi BP, Sharma S, Daneshmand A et al. Durability of the balloon expandable covered versus baremetal stents in the Covered versus Balloon Expandable Stent Trial (COBEST) for the treatment of aortoiliac occlusive disease. J Vasc Surg 2016 Jul;64(1):83-94.
2. TASC Steering Committee, Jaff MR, White CJ et al. An update on methods for revascularization and expansion of the TASC lesion classification to include below-the-knee arteries: a supplement to the Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Endovasc Ther 2015;22:663-677.
16. Huber TS, Harward TR, Flynn TC et al. Operative mortality rates after elective infrarenal aortic reconstructions. J Vasc Surg 1995;22:287-93.
8. Indes JE, Pfaff MJ, Farrokhyar F et al. Clinical outcomes of 5358 patients undergoing direct open bypass or endovascular treatment for aortoiliac occlusive disease: a systematic review and metaanalysis. J Endovasc Ther 2013;20:443-455.
9. Bredahl K, Jensen LP, Schroeder TV et al. Mortality and complications after aortic bifurcated bypass procedures for chronic aortoiliac occlusive disease. J Vasc Surg 2015;62:75-82.
25. Bosiers M, Iyer V, Deloose K et al. Flemish experience using the Advanta V12 stent-graft for the treatment of iliac artery occlusive disease. J Cardiovasc Surg (Torino) 2007;48:7-12.
13. de Vries SO, Hunink MG. Results of aortic bifurcation grafts for aortoiliac occlusive disease: a meta-analysis. J Vasc Surg 1997;26:558-69.
193 97Capítulo
5. Dijkstra ML, Goverde PC, Holden A et al. Initial experience with covered endovascular reconstruction of the aortic bifurcation in conjunction with chimney grafts. J Endovasc Ther 2017;24:19-24.
7. Dorigo W, Piffaretti G, Benedetto F et al. A comparison between aortobifemoral bypass and aortoiliac kissing stents in patients with complex aortoiliac obstructive disease. J Vasc Surg 2017;65:99-107.
15. Schneider JR, Besso SR, Walsh DB et al. Femorofemoral versus aortobifemoral bypass: outcome and hemodynamic results. J Vasc Surg 1994;19:43-55.
6. Maldonado TS, Westin GG, Jazaeri O et al. Treatment of aortoiliac occlusive disease with the Endologix AFX unibody endograft. Eur J Vasc Endovasc Surg 2016;52:64-74.
10. Rutherford RB. Aortobifemoral bypass, the gold standard: technical considerations. Semin Vasc Surg 1994;7:11-16.
11. Szilagyi DE, Elliot JP, Smith RF et al. A thirty-year survey of the reconstructive surgical treatment of aortoiliac occlusive disease. J Vasc Surg 1986;3:421-436.
AORTOILÍACA
OBSTRUÇÃO –
11. Paladino C, Sampere CT, Guasch J, Sanchez Casalongue M. Hemodynamic evaluation of extra-anatomic revascularization of the aorto-iliac sector. Angiologia 1989;41:17-9.
22. Kalman PG, Hosang M, Johnston KW, Walker PM. The current role for femorofemoral bypass. J Vasc Surg 1987;6:71-6.
24. Hardy JD, Bane JW. Arterial injury and massive blood loss: a case report of management of pelvic gunshot injury with femorosubscrotal-femoral bypass and 116 units of blood. Ann Surg 1975;181:245-6. 25. Shaw R, Baue A. Management of sepsis complicating arterial reconstructive surgery. Surg 1962;53:75.
10. Ehrenfeld WK, Lord RS, Stoney RJ, Wylie EJ. Subcutaneous arterial bypass grafts in the managment of fistulae between the bowel and plastic arterial prostheses. Ann Surg 1968;168:29-35.
18. Criado E, Burnham SJ, Tinsley EA Jr. et al. Femorofemoral bypass graft: Analysis of patency and factors influencing long-term outcome. J Vasc Surg 1993;18:495-504.
26. Geier B, Barbera L, Kemen M, Mumme A. Video-assisted crossover iliofemoral obturator bypass grafting: A minimally invasive approach to extra-anatomic lower limb revascularization. J Vasc Surg 1999;29:730-3. 27. Nevelsteen A, Mees U, Deleersnijder J, Suy R. Obturator bypass: a sixteen year experience with 55 cases. Ann Vasc Surg 1987;1:558-63.
4. van Bellen B, Zorn WGW, Braga PEG. Derivações arteriais extraanatômicas do segmento aortoilíaco. Indicações e resultados. Cir Vasc Angiol 1985;1:5.
14. Livesay JJ, Atkinson JB, Baker JD et al. Late results of extra-anatomic bypass. Arch Surg 1979;114:1260-7.
194 98Capítulo DERIVAÇÕES EXTRA-ANATÔMICAS – ABDOME E PELVE: DERIVAÇÃO FEMOROFEMORAL CRUZADA
13. Brief DK, Alpert J, Parsonnet V. Crossover femoro-femoral grafts. Compromise or preference: a reappraisal. Arch Surg 1972;105:889-94.
28. Farber MA, Carlin RE, Marston WA et al. Distal thoracic aorta as inflow for teh treatment of chronic mesenteric ischemia. J Vasc Surg 2001;33(2):281-7 (discussion 287-288). 29. Oderich GS, Bower TC, Sullivan TM et al. Open versus endovascular revascularization for chronic mesenteric ischemia: risk stratified outcomes. J Vasc Surg 2009;49(6):1472-9. e1473. 30. Kihara TK, Blebea J, Anderson KM et al. Risk factors and outcomes following revascularization for chronic mesenteric ischemia. Ann Vasc Surg 1999;13:37-44. 31. Foley MI, Moneta GL, Abou-Zamzam Jr AM et al. Revascularization of the superior mesenteric artery alone for treatment of intestinal ischemia. J Vasc Surg 2000;32:37-47. 32. Cho JS, Carr JA, Jacobsen G et al. Long-term outcome after mesenteric artery reconstruction: a 37-year experience. J Vasc Surg 2002;35:453-60. 33. Ryer EJ, Oderich GS, Bower TC et al. Differences in anatomy and outcomes in patients treated with open mesenteric revascularization before and after the endovascular era. J Vasc Surg 2011;53:1611-8. e1612. 34. Davenport DL, Shivazad A, Endean ED. Short-term outcomes for open revascularization of chronic mesenteric ischemia. Ann Vasc Surg 2012;26:447-53. 35. van Petersen AS, Kolkman JJ, Beuk RJ et al. Open or percutaneous revascularization for chronic splanchnic syndrome. J Vasc Surg 2010;51:1309-16.
2. Gupta SK, Veith FJ, Kram HB, Wengerter KA. Significance and management of inflow gradients unexpectedly generated after femorofemoral, femoropopliteal, and femoroinfrapopliteal bypass grafting. J Vasc Surg 1990;12:278-83.
19. Criado E, Farber MA. Femorofemoral bypass: appropriate application based on factors affecting outcome. Sem Vasc Surg 1997;10:34-41.
23. Kretschmer G, Niederle B, Schemper M, Polterauer P. Extra-anatomic femoro-femoral crossover bypass (ff) vs. Unilateral orthotopic iliofemoral bypass (if): an attempt to compare results based on data matching. Eur J Vasc Surg 1991;5:75-82.
12. Hepp W, de Jonge K, Pallua N. Late results following extra-anatomic bypass procedures for chronic aortoiliac occlusive disease. J Cardiovasc Surg 1988;29:181-5.
8. Komori K, Okadome K, Funahashi S et al. Correlation of long-term results of extra-anatomic bypass and flow waveform analysis. Eur J Vasc Surg 1993;7:479-82. 9. End A, Staudacher M, Donath P, Schreiner W. The extra-anatomic bypass in the therapy of aortoiliacal occlusive disease. Wiener klinische Wochenschrift 1989;101:832-6.
3. Bonamigo TP, Frankini AD. Derivações extra-anatômicas no segmento aortoilíaco. In: Maffei FHA (Ed.). Doenças vasculares periféricas. Rio de Janeiro: Editora Médica e Científica Ltda; 1995. p. 477.
7. Rutherford RB, Mitchell MB. Extra-anatomic bypass. In: Rutherford RB et al. (Eds.). Vascular surgery. Philadelphia: WB Saunders; 2000. p. 981-97.
1. Vetto RM. The treatment of unilateral iliac artery obstruction with a transabdominal, subcutaneous, femorofemoral graft. Surgery 1962;52:343-5.
15. Eugene J, Goldstone J, Moore WS. Fifteen year experience with subcutaneous bypass grafts for lower extremity ischemia. Ann Surg 1977;186:177-83.
17. Schneider JR, Golan JF. The role of extraanatomic bypass in the management of bilateral aortoiliac occlusive disease. Sem Vasc Surg 1994;7:35-44.
6. Mozersky DJ, Barnes RW, Sumner DS et al. The hemodynamics of the axillary-axillary bypass. Surg Gynecol Obstetr 1972;135:925-9.
20. Chang JB. Current state of extraanatomic bypasses. Am J Surg 1986;152:202-5.
REFERÊNCIAS BIBLIOGRÁFICAS
21. Whittemore AD, Donaldson MC, Mannick JA. Aortoiliac occlusive disease. In: Moore WS (Ed.). A comprehensive review. Philadelphia: WB Saunders Co; 1998:451.
5. Brener BJ, Brief DK, Veith FJ. Extraanatomic bypasses. In: Veith FJ et al. (Eds.). Vascular surgery. Principles and practice. New York: McGraw Hill, Inc; 1994. p. 485.
16. Rutherford RB, Patt A, Pearce WH. Extra-anatomic bypass: a closer view. J Vasc Surg 1987;6:437-46.
4. Belenky A, Bartal G, Atar E et al. Ovarian varices in healthy female kidney donors: incidence, morbidity, and clinical outcome. Am J Roentgenol 2002;179:625-627.
7. Bittles MA, Hoffer EK. Gonadal vein embolization: treatment of varicocele and pelvic congestion syndrome. Semin Intervent Radiol 2008 Sep;25(3):261-70.
12. Cordts PR, Eclevea A, Buckley PJ. Pelvic congestion syndrome: Early clinical results after transcatheter ovarian vein embolization. J Vasc Surg 1998 Nov;28(5):862-8.
3. Beard RW, Kennedy RG, Gangar KF, Stones RW, Rogers V, Reginald PW, Anderson M. Bilateral oophorectomy and hysterectomy in the treatment of intractable pelvic pain associated with pelvic congestion. J Obstet Gynaecol 1991 Oct;98(10):988-92.
10. Chung MH, Huh CY. Comparison of treatment for pelvic congestion syndrome. Tohoku J Exp Med 2003;201:131-138.
13. Craig O, HobbsJT. Vulval phebography in the pelvic congestion syndrome. Clin Radiol 1974;25:517-25. 14. Cura M, Cura A. What is the significance of ovarian vein reflux detected by computed tomography in patients with pelvic pain? Clin Imaging 2009 Jul-Aug;33(4):306-10.
21. Drife JO. The pelvic pain syndrome. Br J Obstet Gynaecol 1993;100(6):508-10
24. Gandini R, Chiocchi M, Konda D, Pampana E, Fabiano S, Simonetti G. Transcatheter foam sclerotherapy of symptomatic female varicocele with sodium-tetradecyl-sulfate foam. Cardiovasc Intervent Radiol 2008 Jul Aug;31(4):778-84. 25. Ganeshan A, Upponi S, Hon LQ, Uthappa MC, Warakaulle DR, Uberoi R. Chronic pelvic pain due to pelvic congestion syndrome: the role of diagnostic and interventional radiology. Cardiovasc Intervent Radiol 2007 Nov-Dec;30(6):1105-11.
8. Black CM, Thorpe K, Venrbux A, Kim HS, Millward SF, Clark TW, Kundu S, Martin LG, Sacks D, York J, Cardella JF. Research reporting standards for endovascular treatment of pelvic venous insufficiency. J Vasc Interv Radiol 2010 Jun;21(6):796-803.
15. Dale WA, Harrus J. Cross-over vein grafts for iliac and femoral venous occlusion. Am Surg Assoc 1968 Apr;17-19.
9. Chen S, Zhang H, Shi H, Tian L, Jin W, Li M. Endovascular Stenting for Treatment of Nutcracker Syndrome: Report of 61 Cases With LongTerm Followup. J Urol 2011;186: 570-5.
26. Gloviczki P et al. The care of patients with varicose veins and associated chronic venous diseases: Clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg 2011;53:2S-48S. 27. Grabham JÁ, Barrie WW. Laparoscopic approach to pelvic congestion syndrome. Brit J Surg 1997;84(9):1264-6. 28. Gray H. Anatomy of the Human body – 1918 http://www.bartleby. com 3d – The veins of the lower extremity, abdomen and pelvis. Recuperado em 20/04/2006.
1. Ahangari A. Prevalence of chronic pelvic pain among women: an updated review. Pain Physician 2014;17:141-7.
195 99CapítuloSÍNDROME DA CONGESTÃO VENOSA PÉLVICA REFERÊNCIAS BIBLIOGRÁFICAS
16. Daniels JP et al. Effectiveness of Embolization or Sclerotherapy of Pelvic Veins for Reducing Chronic Pelvic Pain: A Systematic Review. J Vasc Interv Radiol 2016;10:1478-1486.
2. Beard RH, Highman JH, Pearce S, Reginald PW. Diagnosis of pelvic varicosities in women with chronic pelvic pain. Lancet 1984 Oct 27;2(8409):946-9.
18. Desimpelare JH, Seynaeve PC, Hager YM, Appel BJ. Pelvic congestion syndrome: demonstration and diagnosis. Abdom Imaging 1999;24(1):100-2.
23. Freedman J, Ganeshan A, Crowe PM. Pelvic congestion syndrome: the role of interventional radiology in the treatment of chronic pelvic pain. Postgrad Med J 2010 Dec;86(1022):704-10.
6. Berger A; Jaffe JW; York NT/iliac compression syndrome treated with stent placement. J Vasc Surg 1995 Mar;21(3).
29. Gulleroglu K, Gulleroglu B, Baskin E/Nutcracker Syndrome. World Nephrol 2014;3:277-281. 30. Gultasli NZ, Kurt A, Ipek A, Gumus M. The relation between pelvic varicose veins, chronic pelvic pain and lower extremity venous insufficiency in women. Dagn Interv Radiol 2006 12:34-38. 31. Hartung O, Grisoli D, Boufi M, Marani I, Hakam Z, Barthelemy P, Alimi YS. Endovascular stenting in the treatment of pelvic vein congestion caused by nutcracker syndrome: lessons learned from the first five cases. J Vasc Surg 2005 Aug;42(2):275-80. 32. Hartung O, Azghari A, Barthelemy P, Boufi M, Alimi YS. Laparoscopic transposition of the left renal vein into the inferior vena cava for nutcracker syndrome. J Vasc Surg 2010 Sep;52(3):738-41. 33. Hobbs JT. The pelvic congestion syndrome. Br J Hosp Med 1990;43(3):200-6. 34. Honjo H, Kamoi K, Naya Y, Ukimura O. Effects of acumputure for chronic pelvic pain syndrome with intrapelvic venous congestion: Preliminares results. Int J Urol 2004;11:607-12. 35. Ignacio EA, Dua R, Sarin S, Harper AS, Yim D, Mathur V, Venbrux AC. Pelvic congestion syndrome: diagnosis and treatment. Semin Intervent Radiol 2008 Dec;25(4):361-8. 36. Karaosmanoglu D, Karcaaltincaba M, Karcaaltincaba D, Akata D, Ozmen M. MDCT of the ovarian vein: normal anatomy and pathology. AJR Am J Roentgenol 2009 Jan;192(1):295-9. 37. Kennedy A; Hemingway A. Radiology of ovarian varices. Br J Hosp Med 1990;44(1):38-43. 38. Kim HS, Malhotra AD, Rowe PC, Lee JM, Venbrux AC. Embolotherapy for pelvic congestion syndrome: long-term results. J Vasc Interv Radiol 2006 Feb;17(2 Pt 1):289-97. 39. Koc Z, Ulusan S, Tokmak N, Oguzkurt L, Yildirim T. Double retroaortic left renal veins as a possible cause of pelvic congestion syndrome: imaging findings in two patients. Br J Radiol 2006 Oct;79(946):e152-5. 40. Koo S, Fan CM et al. Pelvic congestion syndrome and pelvic varicosities. Tech Vasc Interv Radiol 2014;17:90-5. 41. Kuligowska E, Deeds L, Lu K. Pelvic pain: Over-looked and underdiagnosed gynecologic conditions. Radiographics 2005;25:3-20. 42. Kwon SH, Oh JH, Ko KR, Park HC, Huh JY. Transcatheter ovarian vein embolization using coils for the treatment of pelvic congestion syndrome. Cardiovasc Intervent Radiol 2007 Jul-Aug;30(4):655-61. LePage PA, Villavicencio JL, Gomez ER. The valvular anatomy of the iliac venous system and its clinical implications. J Vasc Surg 1991;14(5):678-83.
43.
17. d’Archambeau O, Maes M, Schepper D. The pelvic congestion syndrome: Role of the nutcracker phenomenon and result of endovascular treatment. JBR-BTR 2004;87:1-8.
19. Dick EA, Burnett C, Anstee A, Hamady M, Black D, Gedroyc WM. Time Resolved imaging of contrast kinetics three-dimensional (3D) magnetic Resonance venography in patients with pelvic congestion syndrome. Br J Radiol 2010 Oct;83(994):882-7. 20. Dorobisz TA, Garcarek JS et al. Diagnosis and treatment of pelvic congestion syndrome: Single-centre experiences. Adv Clin Exp Med 2017;26:269-276.
5. Bell D, Kane PB, Liang S, Conway C, Tornos C. Vulvar varices: an uncommon entity in surgical pathology. Int J Gynecol Pathol 2007 Jan;26(1):99-101.
22. Fernandez-Samos R, Zorita A, Ortega JM, Morán C, Vazquez J, Vaquero F. Female gonadal venous insufficiency. Angiologia 1993;45(6):203-9.
11. Coakley FV, Varghess SL, Hricak H. CT and MRI of pelvic varices in women. J Comput Assist Tomogr 1999;23(3):429-34.
60. Pisco JM, Alpendre J, Santos DD, Branco J, Jorge R. Sclerotherapy of female varicocele. Acta Med Port 2003;16(1):9-12.
48.
196 Parte VIABDÔMEN E PELVE
72. Vincent K. Chronic pelvic pain in women. Postgrad Med J 2009 Jan;85(999):24-9. 73. Wang X, Zhang Y, Li C, Zhang H. Results of endovascular treatment for patients with nutcracker syndrome. J Vasc Surg 2012 Jul;56(1):142-8. Epub 2012 May 9. 74. Wozniak S, Chronic Pelvic Pain. Ann Agric Environ Med 2016;23:223-6. 75. Yi SQ, Ueno Y, Naito M, Ozaki N, Itoh M. The three most common variations of the left renal vein: a review and meta-analysis. Surg Radiol Anat. 2012 Apr 26. 76. Rudloff U, Holmes RJ, Prem JT, Faust GR. Mesoaortic compression of the left renal vein (Nutcracker syndrome): Case reports and review of literature. Ann Vasc Surg 2006 Jan;20: 120-29.
59. Pieri S, Agresti P, Morucci M, de Medici l. Percutaneous treatment of pelvic congestion syndrome. Radiol Med 2003;105(1-2):78-82.
44. Liu Y, Sun Y, Jin X. Left renocaval venous bypass with autologous great saphenous vein for nutcracker syndrome. J Vasc Surg 2012 May;55(5):1482-4.
46.
51.
62. Salehipour M, Khezri A, Rasekhi A, Zand F. Left Renal Vein transposition for treatment of the nutcracker syndrome. Arch Iranian Med 2006;9(2):161-162. 63. Shokeir T, Amr M, Abdelshaheed M. The efficacy of Implanon for the treatment of chronic pelvic pain associated with pelvic congestion: 1-year randomized controlled pilot study. Arch Gynecol Obstet 2009 Sep;280(3):437-43.
56. Nicholson T, Basile A. Pelvic congestion syndrome, who should we treat and how? Tech Vasc Interv Radiol 2006 Mar;9(1):19-23. Pandey T, Shaikh R, Viswamitra S, Jambhekar K. Use of time resolved magnetic resonance imaging in the diagnosis of pelvic congestion syndrome. J Magn Reson Imaging 2010 Sep;32(3):700-4. 58. Park SJ, Lim JW, Ko YT, Lee DH. Diagnosis of pélvica congestion syndrome using transabdominal and transvaginal sonography. Am J Roentgenol 2004;182(3):683-8.
47.
45. Lobato, Armando de Carvalho. Cirugia Endovascular. São Paulo: Instituto de cirurgia vascular e endovascular de São Paulo; 2006. Maffei, Francisco Humberto de Abreu. Doenças vasculares periféricas. 2. ed. Rio de Janeiro: Editora médica e científica Ltda; 1995. Marsh P, Holdstock JM, Bacon JL, Lopez AJ, Whiteley MS, Price BA. Coil protruding into the common femoral vein following pelvic venous embolization. Cardiovasc Intervent Radiol 2008 Mar-Apr;31(2):435-8. Meissner MH, Gibson K. Clinical outcome after treatment of pelvic congestion syndrome: Sense and nonsense. Phlebology 2015;30:73-80. Meneses L, Fava M, Diaz P, Andía M, Tejos C, Irarrazabal P, Uribe S. Embolization of Incompetent Pelvic Veins for the Treatment of Recurrent Varicose Veins in Lower Limbs and Pelvic Congestion Syndrome. Cardiovasc Intervent Radiol 2012 May 1. 50. Monedero JL. Indicaciones y tratamento del síndrome de congestión pélvica. Flebología y Linfología. Lecturas Vasculares 2010 May-Ago;5(14). Monedero JL et al. Embolization treatment of recurrent varices of pelvic origin. Phlebology 2006;21:3-21. Monedero JL, Ezpeleta SZ, Grimberg M, Correa LV, Gutiérrez JAJ. Subdiaphragmatic venous insufficiency Embolization treatment using mixed technique (coils and foam). Flebología y Linfología. Lecturas Vasculares 2004;1(45):269-275. Moore SJ, Kennedy SH. The Initial Management of Chronic Pelvic Pain. Coll Obst Gynaecol. 2012;41. 54. Moore K. Anatomia orientada para a clínica. 4. Ed. Rio de Janeiro: Guanabara Koogan S.A.; 2001. 55. Navarro H, Vinuea B, Martinez D. Sindrome de congestion pélvica: Evaluacion del dolor despues del tratamiento laparoscópico com Ligasure®. Colombia Medica Jul 2005;36(3): 153-7.
64. Scultetus AH, Villavicencio L, Gillespie DL. The pelvic venous syndrome: Analisis of our experience with 57 pacients. J Vasc Surg 2002;36:881-8. 65. Scultetus AH, Villavicencio L, Gillespie DL. The nutcracker syndrome: Its role in the pelvic venous disorders. J Vasc Surg 2001;34:812-9. 66. Soysal ME, Soysal S, Viedan K, Ozer S. A randomized controlled trial of goserelin and medroxyprogesterone acetate in the treatment of pelvic congestion. Human Reproduction 2001;16(5):931-9. 67. Stones RW. Pelvic vascular congestion – Half a century later. Clin Obstet Gynecol 2003;46(4):831-6. 68. Tu FF, Hahn D, Steege JF. Pelvic congestion syndrome-associated pelvic pain: a systematic review of diagnosis and management. Obstet Gynecol Surv 2010 May;65(5):332-40. 69. van der Vleuten CJ, van Kempen JA, Schultze-Kool LJ. Embolization to treat pelvic congestion syndrome and vulval varicose veins. Int J Gynaecol Obstet 2012 Sep;118(3):227-30. 70. Venbrux AC, Lambert DL. Embolization of the ovarian vein as a treatment for patients with chronic pelvic pain caused by pelvic venous incompetence (pelvic congestion syndrome). Curr Opin Obstet Gyncol 1999;11(4):395-9. 71. Venbrux AC, Chang AH, Kin HS, Montague BJ, Hebert JB. Pelvic congestion syndrome (pelvic venous incompetence): Impact of ovarian and intenal iliac vein emboloterapy on menstrual cycle and chronic pelvic pain. J Vasc Interv Radiol 2002;13:171-8.
57.
61. Rozenblit AM, Ricci ZJ, Tuvia J, Amis ES. Incompetent and dilatad ovarian veins: a common CT finding in asyntomatic parous women. Am J Roentgenol 2001;176(1):119-22.
53.
49.
52.
40.
6. Gray H. Anatomy of the human body. In: The veins of the lower extremity, abdomen and pelvis. 1918. Avaliable at: http://www.bartleby.com/107-173. html.
REFERÊNCIAS BIBLIOGRÁFICAS
10. Monedero JL, Zubicoa Ezpeleta S, Perrin M. Maladie veineuse chronique pelvienne non post thrombotique. Elsevier Masson SAS, Paris, Techniques chirurgicales – Chirurgie vasculaire. 2010. p. 43-175.
21. Mercado JL, Burbano OC, Marquez JA , Posada RM. Síndrome de congestión venosa pélvica – Diagnóstico y manejo endovascular. Repert Medicina y Cirurgia 2014;23(2):96-101. 22. Ahmed K, Sampath R, Kahn MS. Current trends in the diagnosis and management of renal nutcracker syndrome: a review. Eur J Vasc Endovasc Surg 2006;31:410-416. 23. Shin JI, Lee JS. ACE inhibition in nutcracker syndrome with orthostatic proteinúria: how about a hemodynamic effect? Pediatr Nephrol 2007;22:758-760. 24. Engelhorn AL, Engelhorn CA. Guia prático de ultrassonografia vascular. 3. ed. 2016;19:241-248. 25. Hilel ABS, Barros FS, Monedero JL, Perez JMG. Guia prático de ultrassonografia vascular. 3. ed. 2016;21:257-266.
46.
11. Kurklinsky AK, Rooke TW. Nutcracker phenomenon and nutcracker syndrome. Mayo Clin Proc 2010;85:552-559.
4. De Schepper A. “Nutcracker” phenomenon of the renal vein and venous pathology of the left kidney. J Belge Radiol 1972;55(5):507-511.
17. Gavrilov SG. Vulvar varicosities: diagnosis, treatment and prevention. Intl J Womwns Health 2017;9:463-475.
15. Kim AS, Greylig LA, Davis LS. Vulvar varicosities: a review. Dermatol Surg 2017 Mar;43(3):351-356. 16. Gavrilov SG, Temirbolatov MD. Varicous veins of small pélvis as a cause of vulvar varicosity and varicose veins of lower extremities. Angiol Sosud Khir 2017;23(4):171-180.
43.
8. Urban BA, Ratner LE, Fisnman EK. Three-dimensional volume-rendered CT angiography of the renal arteries and veins: normal anatomy, variants, and clinical applications. Radiographics 2001;21(2):373-376.
12. Wang L, Yi L, Yang L et al. Diagnosis and surgical treatment of nutcracker syndrome: a single center experience. Urology 2009;73:871-876.
13. Scultetus AH, Villavicencio JL, Gillespie DL. The nutcracker syndrome: its role in the pelvic disorders. J Vasc Surg 2001;34(5):812-819.
37.
1. Ananthan K, Onida S, Davies AH. Nutcracker Syndrome: An update on current diagnostic criteria and management guidelines. Eur J Vasc Endovasc Surg 2017;53:886-894.
28. Dos Santos SJ, Holdstock JM, Harrison CC et al. Ovarian vein diameter cannot be used as indicator of ovarian venous reflux. Eur J Endovas Surg 2015;49:90-94. 29. Park SJ, Lim JW, Ko YT et al. Diagnosis of pelvic congestion syndrome using transabdominal and transvaginal sonography. Am J Roentgenol 2004;182(3):683-688. 30. Gupta A, McCarthy S. Pelvic varices as a cause of pelvic pain: MRI appearance. Mag Reson Imaging 1994;12:679-681. 31. Neglen P, Raju S. Intravascular ultrasound scan evaluation of the obstructed vein. J Vasc Surg 2002;35:694-700. 32. Steenbeek MP, van der Vleuten CJM, Schultze Kool LJ, Nieboer TE. Acta Obstet Ginecol Scand 2018. 33. Beinart C, Sniderman KW, Saddekni S et al. Left renal vein hypertension: a cause of occult hematúria. Radiology 1982;145:647-650. 34. Monedero JL. Indicaciones y tratamento de síndrome de congestion pélvica. Flebologia y linfologia, lecturas vasculares 2010;5(14):841-847. 35. Binegar KN, Sheth RA, Khademhosseine A et al. Iliac vein compression syndrome: Clinical, imaging and pathologic findings. World J Radiol 2015 Nov;7(11):375-381. 36. Ahmed K, Sampath R, Kahn MS. Current trends in the diagnosis and management of renal nutcracker syndrome: a review. Eur J Vasc Endovasc Surg 2006;31:410-416. Little AF, Lavoipierre AM. Unusual clinical manifestations of the nutcracker syndrome. Austral Radiol 2002;46(2):197-200. 38. He Y, Wu Z, Chen S et al. Nutcracker syndrome – how well do we know it? Urology 2014;83:12-17. 39. Shin JI, Baek SY, Lee JS, Kim MJ. Follow-up and treatment of nutcracker syndrome. Ann Vasc Surg 2007;21:402. Venkatachalam S, Bumpus K, Kapadia SR et al. The nutcracker synfrome. Ann Vasc Surg 2011;25:1154-1164. Said SM, Gloviczki P, Kalra M et al. Renal nutcracker syndrome: surgical options. Semin Vasc Surg 2013;26:35-42. 42. Zhang H, Li M, Jin W et al. The left renal entrapment syndrome: diagnosis and treatment. Ann Vasc Surg 2007;21:198-203. Pastershank SP. Left renal vein obstruction by a superior mesenteric artery. J Can Assoc Radiol 1974;25:52-54. Reed NR, Kalra M, Bower TC et al. Left renal vein transposition for nutcracker syndrome. J Vasc Surg 2009;49:386-393. 45. Hohenfellner M, D’Elia G, Hampel C et al. Transposition of the left renal vein for treatment of the nutcracker phenomenon: long-term follow-up. Urology 2002;59:354-357. Avgerinos ED, McEnaney R, Chaer RA. Surgical ad endovascular interventions for nutcracker syndrome. Semin Vasc Surg 2013;26:170-177. Chung BI, Gill IS. Laparoscopic splenorenal venous by-pass for nutcraker syndrome. J Vasc Surg 2009;49:1319-1323. 48. Hartung O, Azghari A, Barthelemy P et al. Laparoscopic transposition of the left renal vein into the inferior vena cava for nutcracker syndrome. J Vasc Surg 2010;52:738-741. 49. Xu D, Gao Y, Chen J et al. Laparoscopic inferior mesenteric-gonadal vein by-pass for the treatment of nutcracker syndrome. J Vasc Surg 2013;57:1429-1431. 50. Bonatti J, Vetrovec G, Riga C et al. Robotic technology in cardiovascular medicine. Nat Ver Cardiol 2014;11:266-275. 51. Wang X, Zhang Y, Li C, Zhang H. Results of endovascular treatment for patients with nutcracker syndrome. J Vasc Surg 2012;56:142-148. 52. Chen Y, Mou Y, Cheng Y et al. Late stent migration into the right ventricle in a patient with nutcracker syndrome. Ann Vasc Surg 2015;29:839 e1-4. 53. Chen S, Zhang H, Shi H et al. Endovascular stenting for treatment of Nutcracker syndrome: report of 61 cases with long-term follow-up. J Urol 2011;186:570-575. 54. Leal Monedero J, Zubicoa Ezpeleta S, Perrin M. Management of left renal vein compression in patients presenting left gonadal vein reflux. Phlebology 2017 Jan.
44.
5. Chait A, Matasar KW, Fabian CE, Mellins HZ. Vascular impressions on the ureteres. Am J Roentgenol Radium Ther Nucl Med 1971;111(4):729-749.
14. Dorobisz TA, Garcarek JS, Kurcz J et al. Diagnosis and treatment of pelvic congestion syndrome: Single-center experiences. Adv Clin Exp Med 2017;26(2):269-276.
18. Labropoulos N, Apostolos K, Tassiopoulos AK et al. Veins along the course of sciatic nerve. J Vasc Surg 2009;49:690-696. 19. Jensen CFS, Ostergren P, Dupree JM et al. Varicocele and male infertility. Nat Ver Urol 2017 Sept;14(9):523-533. 20. Peixoto C, Racy Filho CB, Mancini C, Poleto MG. Cirurgia Vascular, cirurgia endovascular e angiologia. 3. ed. 2014;98:1947-1952.
SÍNDROME DE QUEBRA NOZES
2. Grant JCB. Method of Anatomy Baltimore. MD: Willians & Wilkins; 1937.
197 100Capítulo
9. Shaper KR, Jackson JE, Williams G. The nutcracker syndrome: uncommom cause of hematúria. Br J Urol 1994;74:144-146.
41.
47.
26. Kim SH, Cho SW, Kim HD et al. Nutcracker syndrome: diagnosis with Doppler US. Radiology 1996;198:93-97. 27. Cheon JE, Kim WS, Kim IO et al. Nutcracker syndrome in children with gross hematúria: Doppler ultrasound avaluation of the left renal vein. Pediatr Radiol 2006;36(7):682-686.
3. El Sadr AR, Mina E. Anatomical andsurgical aspects in the operative management of varicocele. Urol Cutaneous Ver 1950;54(5):257-262.
7. Polguj M, Topol M, Majos A. An unusual case of the left venous renal entrapment syndrome: a new type of nutcracker phenomenon? Surg Radiol Anat 2013;35:263-267.
16. Rhee RY, Gloviczki P, Luthra HS et al. Iliocaval complications of retroperitoneal fibrosis. Am J Surg 1994;168(2):179-83.
198 101Capítulo SÍNDROME DA VEIA CAVA INFERIOR REFERÊNCIAS BIBLIOGRÁFICAS
5. Hartley JW, Awrich AE, Wong J et al. Diagnosis and treatment of the inferior vena cava syndrome in advanced malignant disease. Am J Surg 1986;152(1):70-4.
14. Te Riele WW, Overtoom TTC, Van den Berg JC et al. Endovascular recanalization of chronic long-segment occlusions of the inferior vena cava: midterm results. J Endovasc Ther 2006;13(2):249-53.
7. Bergan JJ, Yao JS, Flinn WR, McCarthy WJ. Surgical treatment of venous obstruction and insufficiency. J Vasc Surg 1986;3(1):174-81.
18. O’Sullivan GJ, Semba CP, Bittner CA et al. Endovascular management of iliac vein compression (May-Thurner) syndrome. J Vasc Intervent Radiol 2000;11(7):823-36. 19. Steinberg JB, Jacocks MA. May-Thurner syndrome: a previously unreported variant. Ann Vasc Surg 1993;7(6):577-81.
27. Gloviczki P, Stanson A, Stickler G et al. Klippel-Trenaunay syndrome: the risks and benefits of vascular interventions. Surgery 1991;110(3):469-79.
2. Raju S, Hollis K, Neglen P. Obstructive lesions of the inferior vena cava: clinical features and endovenous treatment. J Vasc Surg 2006;44(4):820-7.
21. Cockett F, Thomas ML. The iliac compression syndrome. Brit J Surg 1965;52(10):816-21.
23. Bower T. Primary and secondary tumors of the inferior vena cava Handbook of venous disorders. London: Chapman & Hall; 1996. p. 529-50. 24. Bower TC, Nagorney DM, Cherry Jr KJ et al. Replacement of the inferior vena cava for malignancy: an update. J Vasc Surg 2000;31(2):270-81.
8. Erben Y, Bjarnason H, Oladottir GL et al. Endovascular recanalization for nonmalignant obstruction of the inferior vena cava. J Vasc Surg Venous Lymphat Disord 2018;6(2):173-82.
10. Raju S, Owen Jr S, Neglen P. The clinical impact of iliac venous stents in the management of chronic venous insufficiency. J Vasc Surg 2002;35(1):8-15.
20. May R, Thurner J. The cause of the predominantly sinistral occurrence of thrombosis of the pelvic veins. Angiology 1957;8(5):419-27.
22. Bower TC, Nagorney DM, Toomey BJ et al. Vena cava replacement for malignant disease: is there a role? Ann Vasc Surg 1993;7(1):51-62.
25. Neglén P, Raju S (Eds.). Proximal lower extremity chronic venous outflow obstruction: recognition and treatment. Semi Vasc Surg 2002. 26. Jackson B, Thomas ML. Post-thrombotic inferior vena caval obstruction: a review of 24 patients. Br Med J 1970;1(5687):18-22.
4. O’Donnell TF, Burnand KG, Thomas ML. The socioeconomic effects of an iliofemoral venous thrombosis. J Surg Res 1977;22(5):483-8.
15. Häusler M, Hübner D, Delhaas T, Mühler E. Long term complications of inferior vena cava thrombosis. Arc Disease in Childhood 2001;85(3):228-33.
12. Raju S, McAllister S, Neglen P. Recanalization of totally occluded iliac and adjacent venous segments. J Vasc Surg 2002;36(5):903-11.
1. Raju S. Venous insufficiency of the lower limb and stasis ulceration. Changing concepts and management. Ann Surg 1983;197(6):688.
11. Nazarian GK, Bjarnason H, Dietz Jr CA et al. Iliofemoral venous stenoses: effectiveness of treatment with metallic endovascular stents. Radiology 1996;200(1):193-9.
17. David M, Striffing V, Brenot R. Syndrome de Cockett acquis: a propos de trois cas opérés dont deux formes inhabituelles. Ann Chir 1981;35:93-8.
28. Jacob AG, Driscoll DJ, Shaughnessy WJ (Eds.). Klippel-Trenaunay syndrome: spectrum and management. Mayo Clinic Proceedings 1998. Elsevier. 29. Wang Z, Zhu Y, Wang S et al. Recognition and management of Budd-Chiari syndrome: report of one hundred cases. J Vasc Surg 1989;10(2):149-56. 30. Schanzer H, Skladany M. Complex venous reconstruction for chronic iliofemoral vein obstruction. Cardiovascular Surgery 1996;4(6):837-40. 31. Rutherford RB, Padberg Jr FT, Comerota AJ et al.Venous severity scoring: an adjunct to venous outcome assessment. J Vasc Surg 2000;31(6):1307-12. 32. Delis KT, Bjarnason H, Wennberg PW et al. Successful iliac vein and inferior vena cava stenting ameliorates venous claudication and improves venous outflow, calf muscle pump function, and clinical status in post-thrombotic syndrome. Ann Surg 2007;245(1):130. 33. Raju S. New approaches to the diagnosis and treatment of venous obstruction. J Vasc Surg 1986;4(1):42-54. 34. Yamagami T, Nakamura T, Kato T et al. Hemodynamic changes after self-expandable metallic stent therapy for vena cava syndrome. Am J Roentgenol 2002;178(3):635-9. 35. Uhl J, Verdeille S, Martin-Bouyer Y. Three-dimensional spiral CT venography for the pre-operative assessment of varicose patients. VASA Zeitschrift fur Gefasskrankheiten 2003;32(2):91-4. 36. Gloviczki P, Pairolero PC, Cherry KJ, Hallett Jr JW. Reconstruction of the vena cava and of its primary tributaries: a preliminary report. J Vasc Surg 1990;11(3):373-81. 37. Gloviczki P, Pairolero PC, Toomey BJ et al. Reconstruction of large veins for nonmalignant venous occlusive disease. J Vasc Surg 1992;16(5):750-61. 38. Bjarnason H, Kruse JR, Asinger DA et al. Iliofemoral deep venous thrombosis: safety and efficacy outcome during 5 years of catheter-directed thrombolytic therapy. J Vasc Intervent Radiol 1997;8(3):405-18. 39. AbuRahma AF, Perkins SE, Wulu JT, Ng HK. Iliofemoral deep vein thrombosis: conventional therapy versus lysis and percutaneous transluminal angioplasty and stenting. Ann Surg 2001;233(6):752. 40. Blättler W, Heller G, Largiadèr J et al. Combined regional thrombolysis and surgical thrombectomy for treatment of iliofemoral vein thrombosis. J Vasc Surg 2004;40(4):620-5. 41. Hood DB, Alexander JQ. Endovascular management of iliofemoral venous occlusive disease. Surg Clin 2004;84(5):1381-96. 42. Blättler W, Blättler IK. Relief of obstructive pelvic venous symptoms with endoluminal stenting. J Vasc Surg 1999;29(3):484-8. 43. Neglén P, Raju S. Balloon dilation and stenting of chronic iliac vein obstruction: technical aspects and early clinical outcome. J Endovasc Ther 2000;7(2):79-91. 44. de Graaf R, de Wolf M, Sailer AM et al. Iliocaval Confluence Stenting for Chronic Venous Obstructions. Cardiovasc Intervent Radiol 2015;38(5):1198-204. 45. Chick JFB, Jo A, Meadows JM et al. Endovascular Iliocaval Stent Reconstruction for Inferior Vena Cava Filter-Associated Iliocaval Thrombosis: Approach, Technical Success, Safety, and Two-Year Outcomes in 120 Patients. J Vasc Interv Radiol 2017;28(7):933-9. 46. Bjarnason H, editor Tips and tricks for stenting the inferior vena cava. Sem Vasc Surg 2013.
13. Robbins MR, Assi Z, Comerota AJ. Endovascular stenting to treat chronic long-segment inferior vena cava occlusion. J Vasc Surg 2005;41(1):136-40.
3. Tardy B, Mismetti P, Page Y et al. Symptomatic inferior vena cava filter thrombosis: clinical study of 30 consecutive cases. Eur Respirat J 1996;9(10):2012-6.
6. Warren R, Thayer TR. Transplantation of the saphenous vein for postphlebitic stasis. Surgery 1954;35(6):867-76.
9. Sebastian T, Dopheide JF, Engelberger RP et al. Outcomes of endovascular reconstruction of the inferior vena cava with selfexpanding nitinol stents. J Vasc Surg Venous Lymphat Disord 2018;6(3):312-20.
53. Yamaguchi A, Eguchi S, Iwasaki T, Asano K. The influence of arteriovenous fistulae on the patency of synthetic inferior vena caval grafts. J Cardiovasc Surg 1968;9(1):99.
199Capítulo 101 síndrome dA veiA C AvA inferior 47. Hartung O, Loundou AD, Barthelemy P et al. Endovascular management of chronic disabling ilio-caval obstructive lesions: longterm results. Eur J Vasc Endovasc Surg 2009;38(1):118-24.
62. Alimi Y, DiMauro P, Fabre D, Juhan C. Iliac vein reconstructions to treat acute and chronic venous occlusive disease. J Vasc Surg 1997;25(4):673-81. Gloviczki P, Pairolero PC. Prosthetic replacement of large veins. Atlas of venous surgery. Philadelphia: Saunders; 1992. p.191. 64. Kieffer E, Bahnini A, Koskas F. Nonthrombotic disease of the inferior vena cava: surgical management of 24 patients. Ven Disord 1991:501-16. Lalka S (Ed.). Venous bypass graft for chronic venous occlusive disease. Handbook of venous disorders Guidelines of the American Venous Forum. 1st ed. London: Chapman & Hall; 1996. 66. Kunlin J, Kunlin A, Gottlob R, Blümel G. Experimental venous surgery. Major Prob Clin Surg 1979;23:37-75.
51. Murphy EH, Johns B, Varney E, Raju S. Endovascular management of chronic total occlusions of the inferior vena cava and iliac veins. J Vasc Surg Venous Lymphat Disord2017;5(1):47-59.
57.
68. Menawat SS, Gloviczki P, Mozes G et al. Effect of a femoral arteriovenous fistula on lower extremity venous hemodynamics after femorocaval reconstruction. J Vasc Surg 1996;24(5):793-9.
59.
73. Husni E. Reconstruction of veins: the need for objectivity. J Cardiovasc Surg 1983;24(5):525-8.
74. O’Donnell TF, Mackey WC, Shepard AD, Callow AD. Clinical, hemodynamic, and anatomic follow-up of direct venous reconstruction. Arch Surg 1987;122(4):474-82.
54. Van Tricht I, De Wachter D, Tordoir J, Verdonck P. Hemodynamics and complications encountered with arteriovenous fistulas and grafts as vascular access for hemodialysis: a review. Ann Biomedic Engineering 2005;33(9):1142-57. Soyer T, Lempinen M, Cooper P et al. A new venous prosthesis. Surgery 1972;72(6):864-72. Chiu C, Terzis J, MacRae M. Replacement of superior vena cava with the spiral composite vein graft: a versatile technique. Ann Thorac Surg 1974;17(6):555-60. Wilson SE, Jabour A, Stone RT, Stanley TM. Patency of biologic and prosthetic inferior vena cava grafts with distal limb fistula. Arch Surg 1978;113(10):1174-9. Fiore A, Brown J, Cromartie R et al. Prosthetic replacement for the thoracic vena cava: an experimental study. J Thorac Cardiovasc Surg 1982;84(4):560-8. Gloviczki P, Hollier L, Dewanjee M et al. Experimental replacement of the inferior vena cava: factors affecting patency. Surgery 1984;95(6):657-66.
56.
60. Burkhart HM, Fath SW, Dalsing MC et al. Experimental repair of venous valvular insufficiency using a cryopreserved venous valve allograft aided by a distal arteriovenous fistula. J Vasc Surg 1997;26(5):817-22.
58.
50. Razavi MK, Hansch EC, Kee ST et al. Chronically occluded inferior venae cavae: endovascular treatment. Radiology 2000;214(1):133-8.
75. AbuRahma AF, Robinson PA, Boland JP. Clinical, hemodynamic, and anatomic predictors of long-term outcome of lower extremity veno venous bypasses. J Vasc Surg 1991;14(5):635-44. 76. Danza R, Navarro T, Baldizán J. Reconstructive surgery in chronic venous obstruction of the lower limbs. J Cardiovasc Surg 1991;32(1):98-103. 77. Smith D, Trimble C. Surgical management of obstructive venous disease of the lower extremity. Vascular Surgery. Philadelphia: WB Saunders Co; 1977. p. 1247-68. 78. Dale W, Harris J. Cross-over vein grafts for iliac and femoral venous occlusion. J Cardiovasc Surg 1969;10(6):458. 79. Palma E, Riss R, Del Campo F, Tobler H. Tratamiento de los trastornos post-flebiticos mediante anastomosis venosa safenofemoral contralateral. Bull Soc Surg Uruguay 1958;29:135-45. 80. Palma E. Vein transplants and grafts in surgical treatment of the postphlebitic syndrome. J Cardiovasc Surg 1960;1:94-107. 81. Lalka S. Management of chronic obstructive venous disease of the lower extremity. Vasc Surg 1995;2:1862-82. 82. Lalka SG, Lash JM, Unthank JL et al. Inadequacy of saphenous vein grafts for cross-femoral venous bypass. J Vasc Surg 1991;13(5):622-30 83. May R. The Palma operation with Gottlob’s endothelium preserving suture. Pelvic and abdominal veins: progress in diagnosis and therapy. Amsterdam: Excerpta Medica; 1981. p. 192-7. 84. Dale WA. Reconstructive venous surgery. Arch Surg 1979;114(11):1312-8. 85. Dale W, Harris J, Terry R. Polytetrafluoroethylene reconstruction of the inferior vena cava. Surgery 1984;95(5):625-30. 86. Halliday P. Femoro-femoral cross-over grafts (Palma operation): a long-term follow-up study. Surg veins 1985. 87. Gruss JD. Venous bypass for chronic venous insufficiency. Venous disorders Philadelphia: WB Saunders; 1991. p. 316-30. 88. Eklof B, Broome A, Einarsson E. Venous reconstruction in acute iliac vein obstruction using PTFE grafts. In: May R, Weber J (Eds.). Pelvic and abdominal veins 1980. p. 259. 89. Sottiurai V, Gonzales J, Cooper M. A new concept of arteriovenous fistula in venous bypass requiring no fistula interruption: Surgical technique and long-term results. Unpublished data. 2000. 90. McMurrich JP. The occurrence of congenital adhesions in the common iliac veins, and their relation to thrombosis of the femoral and iliac veins. Am J Medic Scienc (1827-1924). 1908;135(3):342. 91. Cormier JM, Fichelle JM, Vennin J et al. Atherosclerotic occlusive disease of the superior mesenteric artery: late results of reconstructive surgery. Ann Vasc Surg 1991;5(6):510-8. 92. Taheri SA, Nowakowski P, Pendergast D et al. Iliocaval compression syndrome. Phlebology 1987;2(3):173-9. 93. Trimble C, Bernstein E, Pomerantz M, Eiseman B (Eds.). A prosthetic bridging device to relieve iliac venous compression. Surgical forum 1972. 94. Rigas A, Vomvoyannis A, Tsardakas E. Iliac compression syndrome. Report of ten cases. J Cardiovasc Surg 1970;11(5):389-92. 95. Akers Jr DL, Creado B, Hewitt RL. Iliac vein compression syndrome: case report and review of the literature. J Vasc Surg 1996;24(3):477-81. 96. Reasbeck P, Reasbeck J. Iliac compression syndrome: a myth, a rarity or a condition frequently missed? New Zealand Medic J 1983;96(732):383-5. 97. Jaszczak P, Mathiesen F. The iliac compression syndrome. Acta Chirurgica Scandinavica 1978;144(3):133-6. 98. Holland-Fischer P, Grønbæk H, Astrup L et al. Budd-Chiari and inferior caval vein syndromes due to membranous obstruction of the liver veins: successful treatment with angioplasty and transcaval transjugular intrahepatic porto-systemic shunt. Scandinavian J Gastroenterol 2004;39(10):1025-8. 99. Thompson CS, Cohen MJ, Wesley JM. Endovascular treatment of obliterative hepatocavopathy with inferior vena cava occlusion and renal vein thrombosis. J Vasc Surg 2006;44(1):206-9. 100. Victor S, Jayanthi V, Kandasamy I et al. Retrohepatic cavoatrial bypass for coarctation of inferior vena cava with a polytetrafluoroethylene graft. J Thorac Cardiovasc Surg 1986;91(1):99-105. 101. Bi Y, Chen H, Ding P et al. Long-term Outcome of Recoverable stents for Budd-Chiari syndrome Complicated with Inferior Vena Cava Thrombosis. Sci Rep 2018;8(1):7393.
52. Garg N, Gloviczki P, Karimi KM et al. Factors affecting outcome of open and hybrid reconstructions for nonmalignant obstruction of iliofemoral veins and inferior vena cava. J Vasc Surg 2011;53(2):383-93.
48. Husfeldt K. Venous replacement with Gore-Tex prosthesis: experimental and first clinical results. Pelvic and abdominal veins: progress in diagnostics and therapy Amsterdam. Excerpta Medica 1981:249-58.
63.
65.
55.
67. Plate G, Hollier L, Gloviczki P et al. Overcoming failure of venous vascular prostheses. Surgery 1984;96(3):503-10.
69. Jost CJ, Gloviczki P, Cherry Jr KJ et al. Surgical reconstruction of iliofemoral veins and the inferior vena cava for nonmalignant occlusive disease. J Vasc Surg 2001;33(2):320-8.
70. Hobson RW, Wright CB. Peripheral side to side arteriovenous fistula: Hemodynamics and application in venous reconstruction. Amer J Surg 1973;126(3):411-4.
71. Gruss J, Hiemer W. Bypass procedures for venous obstruction: Palma and May-Husni bypasses, Raju perforator bypass, prosthetic bypasses, and primary and adjunctive arteriovenous fistulae. Surgical Management of Venous Diseases Baltimore, Md: Williams & Wilkins; 1997.
72. Grüss J. The saphenopopliteal bypass for chronic venous insufficiency (May-Husni operation). Surgery of the veins. Inc Orlando: Grune & Stratton; 1985. p. 255-65.
49. Juhan C, Hartung O, Alimi Y et al. Treatment of nonmalignant obstructive iliocaval lesions by stent placement: Midterm results. Ann Vasc Surg 2001;15(2):227-32.
61. Gloviczki P, Pairolero PC. Venous reconstruction for obstruction and valvular incompetence. Perspec Vasc Surg Endovasc Ther 1988;1(1):75-93.
11. Timi JRR, Abrão E. Síndrome de compressão da veia ilíaca comum esquerda. Cir Vasc Ang 1992;8(4):19-25.
17. Berger A, Jaffe JW, York TN. Iliac compression syndrome treated with stent placement. J Vasc Surg 1995;21:510-514.
1. Virchow R. Uber die erweiterung kleiner gefasse. Arch Path Anat 1851;3:427.
4. Ehrich EW, Krumbhaar EB. A frequent obstructive anomaly of the mouth of the left common iliac vein. Am Heart J 1943;26:737-749.
10. Cockett FB, Thomas ML, Negus D. Iliac vein compression. Its relation to iliofemoral thrombosis and the Post-thrombotic Syndrome. Brit Med J 1967;2:14-19.
24. Labropoulos N, Voltea N, Leon M et al. The role of venous outflow obstruction in patients with chronic venous dysfunction. Arch Surg 1997;132:46-51.
22. Guegan H, Carles J, Junes FR et al. Syndrome de Cockett par rein ectopique. Rapport de deux cas. J Chir 1992;129:257-62.
9. Negus D, Fletcher EWL, Cockett FB, Thomas ML. Compression and band formation at the mouth of the left common iliac vein. Br J Surg May 1968;55(5):369-74.
8. Cockett FB, Thomas ML. The iliac compression syndrome. Brit J Surg 1965;52:816-21.
2. McMurrich JP. The values of the iliac vein. Brit Med J 1906;2:1699.
200 102Capítulo SÍNDROME DE MAY-THURNER –TRATAMENTO ENDOVASCULAR REFERÊNCIAS BIBLIOGRÁFICAS
38.
27. Ouriel K, Green R, Greenberg RK, Clair GC. The anatomy pf deep vein thrombosis of lower extremity. J Vasc Surg 2000;31:895-900. 28. Kaltenmeier CT, Erben Y, Indes J et al. Systematic review of MayThurner syndrome with emphasis on gender differences. J Vasc Surg Venous Lymphat Disord; 2018;6(3):399-407.e4. 29. Sedhai YR, Golamari R, Salei A et al. May-Thurner Syndrome. Am J Med Sci 2018;355(5):510-514. 30. Dheer S, Joseph AE, Drooz A. Retroperitoneal hematoma caused by a ruptured pelvic varix in a patient with iliac vein compression syndrome. J Vasc Interv Radiol 2003;14:387-390. 31. Cil BE, Akpinar E, Karcaaltincaba M, Akinci D. Case 76: May-Thurner syndrome. Radiology 2004;233:361-365. 32. Alkhater M, Jockenhöfer F, Stoffels I, Dissemond J. May-Thurner syndrome: an often overlooked cause for refractory venous leg ulcers. Int Wound J 2017;14(3):578-582. 33. Taheri S, William J, Powell S et al. Iliocaval compression syndrome. Am J Surgery 1987;154:169-72. 34. Taheri S, Taheri P, Schultz R et al. Iliocaval compression syndrome. Contempor Surg 1992;40:9-15. Hurst DR, Forauer AR, Bloom JR et al. Diagnosis and endovascular treatment of iliocaval compression syndrome. J Vasc Surg 2001;34:106-13. 36. Shebel ND, Whalen CC. Diagnosis and management of iliac vein compression syndrome. J Vasc Nurs 2005;23:10-17. 37. Metzger PB, Rossi FH, Kambara AM et al. Criteria for detecting significant chronic iliac venous obstructions with duplex ultrasound. J Vasc Surg Venous and Lym Dis 2016;4:18-27. Kurtjens RL, Catarinella FS, Tee L et al. The inability of venous occlusion air plethysmography to identify patients who will benefit from stenting of deep venous obstruction. Phlebology 2017; 268355517723993. 39. Wu WLM, Tzeng WS, Wu RH et al. Comprehensive MDTC Evaluation of Patients With Suspected May-Thurner Syndrome. AJR 2012; 199:W638-645. 40. Timi JRR, Kenegusuku J, Souza PC et al. Achados radiológicos na síndrome de compressão da veia ilíaca comum esquerda. Radiol Bras 1993;26:53-55. 41. Rollo JC, Farley SM, Oskovit AZ et al. Contemporary outcomes after venography-guided treatment of patients with May-Thurner syndrome. J Vasc Surg Venous Lym Dis 2017:5(5):667-676.e1. 42. Raju S, Owen S Jr, Neglen P. The clinical impact of iliac venous stents in the management of chronic venous insufficiency. J Vasc Surg 2002;35:8-15. 43. Neglén P, Berry MA, Raju S. Endovascular surgery in the treatment of chronic primary and post-thrombotic iliac vein obstruction. Eur J Vasc Surg 2000;20:560-571. 44. Neglén P, Raju S. Balloon dilatation and stenting of chronic iliac vein obstruction: technical aspects and early outcome. J Endovasc Ther 2000;7. 45. Molloy S, Jacob S, Buckenham K et al. Arterial compression of the right common iliac vein; an unusual anatomical variant. Cardiovascular Surgery 2002;10(3):291-2. 46. Catarinella FS, Nieman FHM, Wittens CHA. An overview of the most commonly used venous quality of life and clinical outcome measurements. J Vasc Surg Venous Lymphat Disord 2015;3(3):333-40.
16. Michel C, Laffy PY, Leblanc G, Bonnet D. Traitement d’une syndrome de Cockett par mise en place percutanée d’une endoprothèse vasculaire(Gianturco). J Radiol 1994;75(5):327-330.
35.
6. May R, Thurner J. Ein Gefäbsporn in der Vena ilíaca communis sinistra als Ursache der überwiegend linksseitigen Beckenveven-thrombosen. Zeitschrift für Kreislaufforschung 1956;45:912-22.
3. McMurrich JP. The occurrence of congenital adhesions in the common iliac veins and their relation to the thrombosis of the femoral and iliac veins. Am J Med Sci 1908;135:342.
15. Calvignac JL, Giraud C, Bastide G. Syndrome de Cockett. Traitement par envelopment veineux dans une prothèse armée. Presse Med 1984;1397-98.
14. Duron JJ, Imbaud P, Dutet D, Validire J. Syndrome du Cockett: traitement par décompression veineuse par greffe osseuse rétroaortique. Ann Chir 1984;38:637-9.
19. Heniford BT, Senler SO, Olsofka JM et al. May-Thurner syndrome: management by endovascular surgical techniques. Ann Vasc Surg 1998;12:482-486.
20. Cormier JJ, Luizy F, Meli JP. Syndrome de Cockett. Explorations et indications chirurgicales. Sang Thrombose Vaisseau 1991;3:183-91.
25. Neglén P, Thrasher TL, Raju S. Venous outflow obstruction: an underestimated contributor to chronic venous disease. J Vasc Surg 2003;38:879-85. 26. Verhaeghe R. Iliac vein compression as an anatomical cause of thrombophilia: Cockett’s syndrome revisited. Thrombosis and Haemostasis 1995;74(60):1398-401.
12. Palma EC, Esperon R. Vein transplants and grafts in the surgical treatment of the postphlebitic syndrome. J Cardiovasc Surg (Torino) 1960;1:94-107.
7. May R, Thurner J. The cause of the predominantly sinistral occurrence of thrombosis of the pelvic veins. Angiology 1957;8:419-428.
13. Striffing DM, Brenot R, Barault JF, Trigalou D. Syndrome acquis de Cockett. Rapport de 3 cas traités chirurgicalement. Ann Chir 1981;35:93-98.
18. Néglen P, Raju S. Balloon dilatation and stenting of chronic iliac vein obstrution. J Endovasc Ther 2000;7:79-91.
21. David M, Striffling V, Brenot R et al. Syndrome de Cockett acquis. A propos de trois cas opérés dont deux forms inhabituelles. Ann Chir 1981;35:93-98.
23. Heijmen RH, Bollen TL, Duyndam DAC et al. Endovascular venous stenting in May-Thurner Syndrome. J Cardiovasc Surg 2001;42:83-87.
5. Di Dio LJA. Estudo anatômico de particularidades normais e patológicas da superfície interna da veia ilíaca comum esquerda: adesões, septos e válvulas. Arquivos da Biblioteca da Faculdade de Medicina da Universidade de São Paulo; 1949.
48.
52. Hartung O, Barthelémy P, Arnoux D et al. Management of pregnancy in woman with previous ilio-caval stenting. J Vasc Surg 2009;50:355-359.
71. Seager MJ, Busuttil A, Dharmarajah B, Davies AH. Editor´s Choice – A Systematic Review of Endovenous Stenting in Chronic Venous Disease Secondary to Iliac Vein Obstruction. Eur J Vasc Endovasc Surg 2016;51:100-120. 72. Birn J, Vedantham S. May-Thurner syndrome and other obstructive iliac vein lesions: meaning, myth, and mystery. Vasc Med 2015;20:74-83. 73. Park JY, Ahn JH, Jeon YS et al. Iliac vein stenting as a durable option for residual stenosis after catheter-directed thrombolysis and angioplasty of iliofemoral deep vein thrombosis secondary to May-Thurner syndrome. Phlebology 2014;29:461-70. 74. Peters M, Syed RK, Katz Morgan et al. May-Thurner syndrome: a not so uncommon cause of a common condition. Pro (Bayl Univ Med Cent) 2012 July;25(3):231-33.
51.
47.
63. de Graaf R, de Wolf M, Sailer AM et al. Iliocaval Confluence Stenting for Chronic Venous Obstructions. Cardiovasc Intervent Radiol 2015;38:1198-1204.
201Capítulo 102 síndrome de mAy-tHurner – tr AtAmento endovA sCul Ar Raju S, Neglen P. High prevalence of nonthrombotic iliac vein lesions in chronic venous disease: a permissive role in pathogenicity. J Vasc Surg 2006;44:136-44. Kibbe MR, Ujiki M, Goodwin AL et al. Iliac vein compression in an asymptomatic patient population. J Vasc Surg 2004;39:937-43. Sandri JL, Sandri GA, Santos FM et al. Tratamento atual da trombose venosa iliofemoral: tratamento combinado em um só procedimento definitivo-uma nova estratégia: protocolo de sessão única. In: Presti Calogero et al. Conceitos Atuais na Doença Vascular Periférica. São Paulo: Editora Senac São Paulo, 2017. p. 283-289. Sudheendra D, Vedantham S. Catheter-Directed Therapy Options for Iliofemoral Venous Thrombosis. Surg Clin N Am 2018;98:255-265. Patel NH, Stookey KR, Ketcham DB, Cragg AH. Endovascular management of acute extensive iliofemoral deep vein thrombosis caused by MayThurner Syndrome. J Vasc Interv Radiol 2000;11:1297-1302.
50.
53. Cheng L, Zhao H, Zhang FX. Iliac Vein Compression Syndrome in an Asymptomatic Patient Population: A Prospective Study. Chin Med J 2017;130:1269-75.
61. de Graaf R, Arnouldussen C, Wittens C. Stenting for chronic venous obstructions a new era. Phlebology 2013;28(suppl 1):117-122.
49.
57. Rossi FH, Kambara AM, Izukawa NM et al. Randomized Double Blinded Study Comparing Clinical Versus Endovascular Treatment of Iliac Vein Obstruction. J Vasc Surg Venous Lymphat Disord 2015;3:117-8.
59. Yin Minyi, Huang C, Ye K et al. The effect of stent placement for MayThurner syndrome combined with symptomatic superficial venous reflux disease. J Vasc Surg Venous and Lym Dis 2015;3:168-72.
54. Marin SP, Ascher E. www.Point/Counterpoint: Are we too quick tp treat May-Thurner Syndrome. SVS/Society for Vascular Surgery/ Official Publication. May 2, 2016. Publicado online em 2 de maio de 2016. Leitura recomendada.
60. O’Sullivan GJ, Semba CP, Bittner CA et al. Endovascular management of iliac vein compression (May-Thurner) Syndrome. JVIR 2000;11:823-836.
64. Knipp BS, Ferguson E, Williams DM et al. Factors associated with outcome after interventional treatment of symptomatic iliac vein compression syndrome. J Vasc Surg 2007;46:743-9. 65. Wen-da W, Yu Zhao, Yue-xin C. Stenting for chronic obstructive venous disease: A current comprehensive meta-analysis and systematic review. Phlebology 2016;31(6):376-389. 66. Seager MJ, Busuttil A, Dharmarajah, Davies AH. Editor´s Choice – Systematic Review of Endovenous Stenting in Chronic Venous Disease Secondary to Iliac Vein Obstruction. Eur J Vasc Endovasc Surg 2016;51:100-120. 67. Le TB, Lee TK, Park KM et al. Contralateral Deep Vein Thrombosis after Iliac Vein Stent Placement in Patients with May-Thurner Syndrome J Vasc Interv Radiol 2018;29:774-780. 68. Endovascular Stent Can Be the Treatment of Choice for Spontaneus Iliac Vein Rupture: A case Report. Vasc Endovasc Surg 2018;52(2):131-134. 69. Chen YC, Huang CL, Huang JW. Endovascular Stent Can Be The Treatment of Choice for Spontaneous Iliac Vein Rupture: A Case Report. Vasc Endovascular Surg 2018;52(2):131-134. 70. Wen-da W, Yu Z, Yue-Xin C. Stenting for chronic obstructive venous disease: A current comprehensive meta-analysis and systematic review. Phlebology 2016;31(6):376-389.
55. Mendes BC, Oderich G, Correa MP, Gloviczki P. Síndrome da Veia Cava Inferior. In: Carlos José de Brito. Cirurgia Vascular-Cirurgia Endovascular – Angiologia. Terceira Edição. Copyright© Livraria e Editora Revinter; 2014. p.1977-1996.
56. Kwak HS, HanYM, Lee YS et al. Stents in common iliac vein obstruction with acute ipsilateral deep venous thrombosis: early and late results. J Vasc Interv Radiol 2005;16:815-822.
62. de Wolf, de Graaf R, Kurstjens RLM et al. Short-Term Clinical Experience with a Dedicated Venous Nitinol Stent: Initial Results with the Sinus-Venous Stent. Eur J Vasc Endovasc Surg 2015;50:518-526.
58. van Vuuren TM, van Laaren JHH, de Geus M et al. A randomized controlled trial comparing venous stenting with conservative treatment in patients with deep venous obstruction: research protocol. BMJ Open 2017;7(9):e017233.
3.
11.
13.
2.
7.
8.
202 103Capítulo FILTROS DE VEIA CAVA REFERÊNCIAS BIBLIOGRÁFICAS
16. Cipolla J, Weger NS, Sharma R et al. Complications of vena cava filters: A comprehensive clinical review. Opus 12 Scientist 2008; 2(2):11-24.
27. Murphy E, Johnson E, Kopchok G et al. Crux®vena cava filter. Expert Rev Medic Devices 2009;6(5):477-485. 28. Stavropoulos S, Chen J, Sing R et al. Analysis of the Final DENALI Trial Data: A Prospective, Multicenter Study of the Denali Inferior Vena Cava Filter. J Vasc Intervent Radiol 2016;27(10):1531-1538. 29. Hahn D. Retrievable Filter Update: The Denali Vena Cava Filter. Sem Intervent Radiol 2015;32:379-383. 30. Looby S, Given M, Geoghegan T et al. Gunther Tulip Retrievable Inferior Vena Caval Filters: Indications, Efficacy, Retrieval, and Complications. Cardiovasc Intervent Radiol 2006;30(1):59-65. 31. Charles H, Black M, Kovacs S et al. G2 Inferior Vena Cava Filter: Retrievability and Safety. J Vasc Intervent Radiol 2009;20(8):1046-1051. 32. Sing R, Fischer P. Inferior vena cava filters. Current Opinion in Cardiol 2013;28(6):625-631. 33. Lynch F, Kekulawela S. Removal of the G2 Filter: Differences between Implantation Times Greater and Less than 180 Days. J Vasc Intervent Radiol 2009;20(9):1200-1209. 34. Huang J, Bold M, Rajebi M. Endovascular retrieval of Greenfield IVC filters 13 and 19 years post placement without major complication. J Radiol Case Reports 2017;11(6):15-25. 35. Roberts AC. Inferior Vena Cava Filters [Internet]. Endovascular Today. 2013. Available from: https://evtoday.com/2003/02/0103_061.html/ 36. Kanter B, Moser K. The Greenfield Vena Cava Filter. Chest 1988;93(1):170-175. 37. Greenfield LJ. Evolution of Venous Interruption for Pulmonary Thromboembolism. JAMA 1992;127: 622-626. 38. Scher D, Venbrux A, Okapal K et al. Retrieval of TRAPEASE and OPTEASE Inferior Vena Cava Filters with Extended Dwell Times. Sem Intervent Radiol 2015;26:1519-1525. 39. Tsui B, An T, Moon E et al. Retrospective Review of 516 Implantations of Option Inferior Vena Cava Filters at a Single Health Care System. J Vasc Intervent Radiol 2016;27(3):345-353. 40. Johnson M, Nemcek A, Benenati J et al. The Safety and Effectiveness of the Retrievable Option Inferior Vena Cava Filter: A United States Prospective Multicenter Clinical Study. J Vasc Intervent Radiol 2010;21(8):1173-1184. 41. Bruckheimer E, Judelman A, Bruckheimer S et al. In Vitro Evaluation of a Retrievable Low-Profile Nitinol Vena Cava Filter. J Vasc Intervent Radiol 2003;14(4):469-474. 42. Dake M, Murphy T, Krämer A et al. One-Year Analysis of the Prospective Multicenter SENTRY Clinical Trial: Safety and Effectiveness of the Novate Sentry Bioconvertible Inferior Vena Cava Filter. J Vasc Intervent Radiol 2018;29(10):1350-1361.e4. 43. Hohenwalter E, Stone J, O’Moore P et al. Multicenter Trial of the VenaTech Convertible Vena Cava Filter. J Vasc Intervent Radiol 2017;28(10):1353-1362. 44. Ahmed O, Hadied M, Madassery S. Retrieval of a permanent VenaTech LGM filter 18 years after implantation using a novel removal method. J Vasc Surg: Ven Lymph Disord 2018;6(4):526-529. 45. Millward SF, Peterson RA, Moher D et al. LGM (Vena Tech) Vena Caval Filter: Experience at a Single Institution. J Vasc Interv Radiol 1994; 5:351-356.
10.
15. Wu A, Helo N, Moon E et al. Strategies for prevention of iatrogenic inferior vena cava filter entrapment and dislodgement during central venous catheter placement. J Vasc Surg 2014;591(1):255-259.
23. Roehm JOF, Jr. The bird’s nest filter: A new percutaneous transcatheter inferior vena cava filter. J Vasc Surg 1984;1:498-501 24. Reed RA, Teitelbaum GP, Taylor FC et al. Use of the Bird’s Nest Filter in Oversized Inferior Venae Cavae. J Vasc Interv Radiol 1991;2:447-450
18. Inagaki E, Farber A, Eslami M et al. Improving the retrieval rate of inferior vena cava filters with a multidisciplinary team approach. J Vasc Surg: Ven Lymphat Disord 2016;4(3):276-282.
22. Li H, Jia Z, Chen X et al. Efficacy and Retrievability of Aegisy Vena Cava Filter: A Single Center Experience in 213 Patients. Ann Vasc Surg 2016;36:226-230.
19. Duszak R, Parker L, Levin D, Rao V. Placement and Removal of Inferior Vena Cava Filters: National Trends in the Medicare Population. J Am Coll Radiol 2011;8(7):483-489. 20. Hoppe H. Optional Vena Cava Filters. Deutsches Aerzteblatt Online 2009;106(24):395-402.
25. Gupta A, Wernecke T. The Celect Platinum Inferior Vena Cava Filter. Endovasc Today 2016;15(1):36-40. 26. Smouse H, Van Alstine W, Mack S, McCann-Brown J. Deployment Performance and Retrievability of the Cook Celect Vena Cava Filter. J Vasc Intervent Radiol 2009;20(3):375-383.
6.
5.
1. DeYoung E, Minocha J. Inferior Vena Cava Filters: Guidelines, Best Practice, and Expanding Indications. Sem Intervent Radiol 2016;33(2):65-70. Kearon C, Akl E, Comerota A et al. Antithrombotic Therapy for VTE Disease. Chest 2012;141(2):e419S-e496S. Kearon C, Akl E, Ornelas J et al. Antithrombotic Therapy for VTE Disease. Chest 2016;149(2):315-352. Bates S, Rajasekhar A, Middeldorp S et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy. Blood Advances 2018;2(22):3317-3359. Sobieszczyk P. Factors to Consider Regarding the Need for Inferior Vena Cava Filters. Progress in Cardiovascular Diseases 2018;60(6):622-628. Kishore S, Trost D, Madoff D et al. Inferior Vena Cava Filters and Prevention of Recurrent Pulmonary Embolism. Semin Intervent Radiol 2018;35(02):105-107. Kinney T. Update on Inferior Vena Cava Filters. J Vasc Intervent Radiol 2003;14(4):425-440. Kempczinski RF. Surgical Prophylaxis of Pulmonary Embolism. CHEST 1988;89(5):384s-388s. Ha C, Rectenwald J. Inferior Vena Cava Filters. Surg Clin N Am 2018;98(2):293-319. Espírito Santo T, Bacalhau F, Paschôa A et al. Tomographic anatomy of the vena cava and renal veins: features relevant to vena cava filter placement. J Vasc Bras 2015;14(1):10-15. Tucker WD, Burns B. Anatomy, Inferior Vena Cava. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2018 Jan-. Editorial Board. Available from: https://www.ncbi.nlm.nih.gov/ books/NBK431128/ Morosetti D, Picchi E, Calcagni A et al. Anomalous development of the inferior vena cava: Case reports of agenesis and hypoplasia. Radiol Case Repor 2018;13(4):895-903. Doe C, Ryu RK. Anatomic and technical considerations: inferior vena cava filter replacement. Semin Intervent Radiol 2016;33:88-92. 14. Kaufman J, Montgomery J. A Critical Review of Available Retrievable Inferior Vena Cava Filters and Future Directions. Semin Intervent Radiol 2016;33(02):79-87.
9.
12.
4.
17. Ni H, Win L. Retrievable Inferior Vena Cava Filters for Venous Thromboembolism. Hindawi Publishing Corporation 2013; 2013:1-8.
21. Venbrux A, Ignacio E, Sarin S et al. Venous Thromboembolic Disease: The Use of “Optional” Inferior Vena Cava Filters. Sem Intervent Radiol 2008;25(1):020-026.
46.
49.
71. Glocker R, Awonuga O, Novak Z et al. Bedside inferior vena cava filter placement by intravascular ultrasound in critically ill patients is safe and effective for an extended time. J Vasc Surg: Ven Lymph Disord 2014;2(4):377-382.
55.
57. Kim H, Song I, Jang J et al. Outcomes of retrievable inferior vena cava filters in patients with deep vein thrombosis and transient contraindication for anticoagulation. Ann Surg Treat Res 2015; 89(1):30-36.
60. Crumley K, Hyatt E, Kalva S, Shah H. Factors Affecting Inferior Vena Cava Filter Retrieval: A Review. Vasc Endovasc Surg 2018;1-6.
61. Clements W. Inferior Vena Cava Filters in the Asymptomatic Chronically Occluded Cava: To Remove or Not Remove? Cardiovasc Intervent Radiol 2018. 62. Owen RJT, Chung J. Using inferior vena cava filters to prevent pulmonary embolism. Official Publication os The College of Family Physicians of Canada 2008 Jan;54(1):49-55. 63. Goodin A, Han Q, Raissi D, Brown J. A Review of Interventions to Increase Vena Cava Filter Retrieval Rates. Ann Vasc Surg 2018;51:284-297. 64. Dowell J, Shah S, Cooper K et al. Cost-benefit analysis of establishing an inferior vena cava filter clinic. Diagn Intervent Radiol 2017;23(1):37-42. Petik B. Inferior vena cava anomalies and variations: imaging and rare clinical findings. Insights Into Imaging 2015;6(6):631-639. Caplin D, Nikolic B, Kalva S et al. Quality Improvement Guidelines for the Performance of Inferior Vena Cava Filter Placement for the Prevention of Pulmonary Embolism. J Vasc Intervent Radiol 2011;22:1499-1506. Du X, Li C, Qian A et al. Bidirectional Pull-Back Technique for Retrieval of Strut-Embedded Cylinder-Shaped Filters in Inferior Vena Cava. Med Scie Monit 2017;23:2796-2804.
48.
65.
67.
69. Abusedera M, Cho K, Williams D. Bedside intravascular ultrasoundguided inferior vena cava filter placement in medical-surgical intensive care critically-ill patients. Egypt J Radiol Nuc Medic 2015;46(3):659-664.
59. Jia Z et al. Utility of Retrievable Inferior Vena Cava Filters: A Systematic Literature Review and Analysis of the Reasons for Nonretrieval of Filters with Temporary Indications. Cardiovasc Intervent Radiol 2018;41(5):675-682.
203Capítulo 103 filtros de veiA C AvA Le Blanche A, Benazzouz A, Reynaud P et al. The VenaTech LP Permanent Caval Filter: Effectiveness and Safety in the Prevention of Pulmonary Embolism—A European Multicenter Study. J Vasc Intervent Radiol 2008;19(4):509-515. Kim H, Chang N, Lim J, Kim J. Fracture of a Tempofilter II: an Initial Case Report. Korean J Radiol 2018;12(5):626-628. Bovyn G, Ricco J, Reynaud P, Le Blanche A. Long-duration temporary vena cava filter: A prospective 104-case multicenter study. J Vasc Surg 2006;43(6):1222-1229. Guyatt G, Akl E, Crowther M, Schünemann H et al. Introduction to the Ninth Edition. Chest 2012;141(2):48S-52S. Di Gennaro T, Lettieri B, Fusco P et al. Caval filters in intensive care: a retrospective study 2014;8:2213-2219. Kennedy S, Baerlocher M. Inferior vena cava filters. Canadian Medical Association Journal 2015;187(16):1234-1234.
47.
73. Iliescu B, Haskal Z. Advanced Techniques for Removal of Retrievable Inferior Vena Cava Filters. Cardiovasc Intervent Radiol 2011;35(4):741-750. 74. Kuyumcu G, Walker T. Inferior vena cava filter retrievals, standard and novel techniques. Cardiovasc Diagn Therap 2016;6(6):642-650.
75. Guez D, Hansberry D, Eschelman D et al. Inferior Vena Cava Filter Placement and Retrieval Rates among Radiologists and Nonradiologists. J Vasc Intervent Radiol 2017;29(4):482-485.
58. Ryu R, Ghatan C. Permanent versus Retrievable Inferior Vena Cava Filters: Rethinking the “One-Filter-for-All” Approach to Mechanical Thromboembolic Prophylaxis. Sem Intervent Radiol 2016;33:75-78.
76. Grewal S, Chamarthy M, Kalva S. Complications of inferior vena cava filters. Cardiovasc Diagn Therap 2016;6(6):632-641. 77. Idakoji I, Kuo W, Deso S. Evidence-Based Evaluation of Inferior Vena Cava Filter Complications Based on Filter Type. Semin Intervent Radiol 2016;33:93-100. 78. Wang S, Siddiqui A, Rosenthal E. Long-term complications of inferior vena cava filters. J Vasc Surg: Ven Lymph Disord 2016;5(1):33-41. 79. Jia Z, Wu A, Tam M et al. Caval Penetration by Inferior Vena Cava Filters. Circulation 2015;132(10):944-952. 80. Shaheen K, Kaso A, Alraiyes A et al. Inferior vena cava filter penetration and anchor in the vertebral column. QJM 2013;106(5):461-462. 81. Parkin E, Serracino-Inglott F, Chalmers N, Smyth V. Symptomatic perforation of a retrievable inferior vena cava filter after a dwell time of 5 years. J Vasc Surg 2009;50(2):417-419. 82. Magee G, Bartley M, Plotkin A et al. Inferior Vena Cava Filter Resulting in Perforation and Massive Retroperitoneal Hematoma Presenting as Acute Onset of Lower Extremity Weakness. Ann Vasc Surg 2018;(18):1-13. 83. Johns JS, Nguyen C, Sing RF. Vena Cava Filters in Spinal Cord Injuries: Evolving Technology. J Spin Cord Medic 2006;29:183-190 84. Ahmed O, Wadhwa V. IVC Filter Use in 2018 and Beyond. Endovasc Today 2018;17(7):98-102 85. Reis PEO. Inferior Vena Cava Filters - Retrieval Program. J Vasc Endovasc Ther 2018;3:01-02 86. Kawamata K, Chiba Y, Tanaka R et al. Experience of temporary inferior vena cava filters inserted in the perinatal period to prevent pulmonary embolism in pregnant women with deep vein thrombosis. J Vasc Surg 2005;41(4):652-656. 87. Konishi H, Miyoshi T, Neki R et al. Intrapartum temporary inferior vena cava filters are rarely indicated in pregnant women with deep venous thrombosis. J Vasc Surg: Ven Lymph Disord 3(4):370-375. 88. Harris S, Velineni R, Davies A. Inferior Vena Cava Filters in Pregnancy: A Systematic Review. J Vasc Intervent Radiol 2015;20(10):1-15. 89. Valadares S, Serrano F, Torres R, Borges A. Inferior Vena Cava Filter Placement during Pregnancy: An Adjuvant Option When Medical Therapy Fails. Case Reports in Obstetr Gynecol 2013;1-3. 90. Vasireddy A, Phillips AM, Lewis D. Retrievable inferior vena cava filter use in major trauma. Ann R Coll Engl 2012;94:146-147. 91. Oliveira FAC, Amorelli CES, Campedelli FL et al. Implante profilático e temporário de filtro de veia cava inferior no trauma. J Vasc Bras 2013;12:45-48. 92. Rogers FB, Cipolle MD, Velmahos G et al. Practice management guidelines for the prevention of venous thromboembolism in trauma patients: the EAST practice management guidelines work group. J Trauma 2002;53(1):142-164. 93. Secemsky E, Carroll B, Yeh R. Inferior Vena Cava Filters and Mortality. JAMA Network Open 2018;1(3):1-3. 94. Wadhwa V, Gutta N, Trivedi P et al. In-Hospital Mortality Benefit of Inferior Vena Cava Filters in Patients With Pulmonary Embolism and Congestive Heart Failure. Am J Roentgenology 2018;211(3):672-676. 95. Bergl P. Dubious Benefit of Inferior Vena Cava Filters. Am J Medice 2018;131(7):e311-e312. 96. Decousus H. Eight-Year Follow-Up of Patients With Permanent Vena Cava Filters in the Prevention of Pulmonary Embolism. Circulation 2005;112(3):416-422. 97. Stein PD, Matta F. Vena cava filters in hospitalized patients with chronic obstructive pulmonary disease and pulmonary embolism. Thromb Haemost 2013;109:897900. 98. Decousus H, Leizorovicz A, Parent F et al. A Clinical Trial of Vena Caval Filters in the Prevention of Pulmonary Embolism in Patients with Proximal Deep-Vein Thrombosis. N Eng J Med 1998;338(7):409-416 99. Mylankal K, Fitridge R. Inferior vena cava filters: recent controversies. ANZ J Surg 2018;88(3):128-129.
53.
51.
56. Mellado M, Pijoan J, Jiménez D et al. Outcomes Associated With Inferior Vena Cava Filters Among Patients With Thromboembolic Recurrence During Anticoagulant Therapy. JACC 2016;9(23):2440-2448.
66.
52. Weinberg I, Kaufman J, Jaff M. Inferior Vena Cava Filters. JACC: Cardiovascular Interventions 2013;6(6):539-547. Rajasekhar A. Inferior vena cava filters: current best practices. J Thromb Thrombol 2015;39(3):315-327. Holly B, Funaki B, Lessne M. Inferior Vena Cava Filters. Clin Chest Medic 2018;39(3):645-650. Parris R, Carbo A. Inferior Vena Cava Filter Placement in Patients with Venous Thromboembolism without Contraindication to Anticoagulation. J Hosp Medic 2018;13(10):719-722.
50.
72. Milovanovic L, Kennedy S, Midia M. Procedural and Indwelling Complications with Inferior Vena Cava Filters: Frequency, Etiology, and Management. Sem Intervent Radiol 2015;32:34-41.
54.
68. Qin X, Lu C, Ren P et al. New method for ultrasound-guided inferior vena cava filter placement. J Vasc Surg 2018;6(4):450-456.
70. Passman M, Dattilo J, Guzman R, Naslund T. Bedside placement of inferior vena cava filters by using transabdominal duplex ultrasonography and intravascular ultrasound imaging. J Vasc Surg 2005;42(5):1027-1032.
104. Uberoi R, Tapping C, Chalmers N, Allgar V. British Society of Interventional Radiology (BSIR) Inferior Vena Cava (IVC) Filter Registry. Cardiovasc Intervent Radiol 2013;36(6):1548-1561.
204 Parte VIABDÔMEN E PELVE
101. Wood E, Malgor R, Gasparis A, Labropoulos N. Reporting the impact of inferior vena cava perforation by filters. Phlebology: J Ven Dis 2013;29(7):471-475.
107. Turner T, Saeed M, Novak E, Brown D. Association of Inferior Vena Cava Filter Placement for Venous Thromboembolic Disease and a Contraindication to Anticoagulation With 30-Day Mortality. JAMA 2018;1(3):e180452. 108. Everhart D, Vaccaro J, Worley K et al. Retrospective analysis of outcomes following inferior vena cava (IVC) filter placement in a managed care population. J Thromb Thrombol 2017;44(2):179-189.
100. Lavan O, Rimon U, Simon D et al. The use of optional inferior vena cava filters of type Optease in trauma patients - a single type of filter in a single Medical Center. Thrombosis Research 2015;135(5):873-876.
106. Mismetti P, Laporte S, Pellerin O et al. Effect of a Retrievable Inferior Vena Cava Filter Plus Anticoagulation vs Anticoagulation Alone on Risk of Recurrent Pulmonary Embolism. JAMA 2015;313(16):1627.
102. Nicholson W, Nicholson W, Tolerico P et al. Prevalence of Fracture and Fragment Embolization of Bard Retrievable Vena Cava Filters and Clinical Implications Including Cardiac Perforation and Tamponade. Arch Int Medic 2010;170(20).
103. Cohoon K, McBride J, Friese J, McPhail I. Retrievable inferior vena cava filters can be placed and removed with a high degree of success: Initial experience. Catheterizat Cardiovasc Intervent 2015;86(4):719-725.
109. Muriel A, Jiménez D, Aujesky D et al. Survival Effects of Inferior Vena Cava Filter in Patients With Acute Symptomatic Venous Thromboembolism and a Significant Bleeding Risk. J Am Coll Cardiol 2014;63(16):1675-1683.
105. Lim M, Yamada R, Guimaraes M, Greenberg C. Practice Patterns of Inferior Vena Cava Filter Placement and Factors That Predict Retrieval Rates: A Single-Center Institution and Review of the Literature. J Clin Medic Res 2018;10(10):758-764.
205
2. Royle ND. The treatment of spastic paralysis by sympathetic ramisection. Proc R Soc Med 1927;20(11):1799-804.
15. Schneider B, Richter GM, Roeren T et al. CT-guided neurolysis. Status of the technique and current results. Radiologe 1996;36(9):692-99.
18. Kramis RC, Roberts WJ, Gillette RG. Post-sympathectomy neuralgia: hypotheses on peripheral and central neuronal mechanisms. Pain 1996;64(1):1-9.
3. Burihan E. Simpatectomias. In: Goffi FS. (Ed.). Técnica cirúrgica: bases anatômicas, fisiopatológicas e técnicas da cirurgia. 4. ed. São Paulo: Atheneu; 1996. p. 205-13.
5. Yao JS, Bergan JJ. Predictability of vascular reactivity relative to sympathetic ablation. Arch Surg 1973;107:676-80.
10. 10.Straube S, Derry S, Moore RA, Cole P. Cervico-thoracic or lumbar sympathectomy for neuropathic pain and complex regional pain syndrome. Coch Database of Systemat Rev 2013;9:CD002918.
11. Pearl F. Peripheral arteries: their importance in industrial practice. Cal West Med 1937;46(1):35-38.
9. Norgren L, Hiatt WR, Dormandy JA et al. TASC II Working Group. InterSociety Consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg 2007;45 (Suppl S):S5-67.
6. Edwards EA. Operative anatomy of the lumbar simpathetic chain. Angiology 1951;2:184-86.
8. Moore WS, Hall AD. Effects of lumbar sympathectomy on skin capillary blood now in arterial oclusive disease. J Surg Res 1973;14:151-53.
16. Ruiz-Aragon J, Marquez CS. Effectiveness of lumbar sympathectomy in the treatment of occlusive peripheral vascular disease in lower limbs: systematic review. Med Clin (Barc) 2010;134:477-82.
17. Furlan AD, Lui PW, Mailis A. Chemical sympathectomy for neuropathic pain: does it work? Case report and systematic literature review. Clin J Pain 2001;17(4):327-36.
14. Link SC, el-Khoury GY, Guilford WB. Percutaneous epidural and nerve root block and percutaneous lumbar sympatholysis. Radiol Clin North Am 1998;36(3):509-21.
SIMPATECTOMIA LOMBAR BIBLIOGRÁFICAS
REFERÊNCIAS
1. Diez J. Un nuevo metodo de simpatectomia periférica para el tratamiento de las afecciones tróficas y gangrenosas de los miembros. La disociación fascicular. Bol Soc Cir Buenos Aires 1924;8:792-94.
13. Loureiro MP. Simpatectomia lombar endoscópica retroperitoneal em mulheres: efeito sobre o suor compensatório. Tese (Doutorado em Ciências) – Faculdade de Medicina, Universidade de São Paulo. São Paulo; 2007. p. 49-54.
19. Whitelaw GP, Smithwick RH. Some secondary effects of simpathectomy, with particular reference to disturbance of sexual function. N Engl J Med 1951;245:121-25. 20. Haimovici H. Criteria for completeness of sympathetic denervation. Angiology 1951;2(5):423-24. 21. Smolen AJ. Morphology of synapses in the autonomic nervous system. J Electron Microsc Tech 1988;10(2):187-204. 22. Barnes RW. Sympathectomy: quo vadis? Cardiovasc Surg 1994;2(1):9-15. 23. Zheng Zf, Liu Ys, Min X et al. Recovery of sympathetic nerve function after lumbar sympathectomy is slower in the hind limbs than in the torso. Neural Regen Res 2017;12:1177-85. 24. Sanni A, Hamid A, Dunning J. Is sympathectomy of benefit in critical leg ischaemia not amenable to revascularization? Interact Cardiovasc Thorac Surg 2005;4:478-83. 25. Karanth VKL, Karanth TK, Karanth L. Lumbar sympathectomy techniques for critical lower limb ischaemia due to nonreconstructable peripheral arterial disease. Cochrane Database of Systematic Reviews 2016;(12):CD011519. 26. Cacione DG, Moreno DH, Nakano LC, Baptista-Silva JC. Surgical sympathectomy for Buerger’s disease. JRSM Open 2017;8(8):2054270417717666. 27. Perez-Burkhardt JL, Gonzalez-Fajardo JA, Martin JF et al. Lumbar sympathectomy as isolated technique for the treatment of lower limbs chronic ischemia. J Cardiovasc Surg (Torino) 1999;40:7-13. 28. Doumas M, Faselis C, Papademetriou V. Renal sympathetic denervation in hypertension. Curr Opin Nephrol Hypertens 2011;20(6):647-53. 29. DiBona GF, Esler M. Translational medicine: the antihypertensive effect of renal denervation. Am J Physiol Regul Integr Comp Physiol 2010;298:R245-53. 30. Campese VM, Ku E, Park J. Sympathetic renal innervation and resistant hypertension. Int J Hypertens 2011;2011:814354. 31. Sanders MF, Reitsma JB, Morpey M et al. Renal safety of catheterbased renal denervation: systematic review and meta-analysis. Nephrol Dial Transplant 2017 Sep 1;32(9):1440-1447. 32. Fukuta H, Goto T, Wakami K, Ohte N. Effects of catheter-based renal denervation on heart failure with reduced ejection fraction: a systematic review and meta-analysis. Heart Fail Rev 2017 Nov;22(6):657-664. 33. Bhatt DL, Kandzari DE, O’Neill WW et al. A controlled trial of renal denervation for resistant hypertension. N Engl J Med 2014 Apr 10;370(15):1393-401. 34. Shishehbor MH, Hammad TA, Thomas G. Renal denervation: What happened, and why? Cleve Clin J Med 2017 Sep;84(9):681-686.
4. Setacci C, de Donato G, Teraa M et al. Chapter IV: treatment of critical limb ischaemia. Eur J Vasc Endovasc Surg 2011;42(Suppl 2):S43-59.
104Capítulo
7. Plecha FR, Bomberger RA, Hoffman M. A new criterion for predicting response to lumbar sympatectomy in patients with severe arteriosclerotic occlusive disease. Surgery 1980;88:375-81.
12. Noe CE, Haynsworth Jr RF. Lumbar radiofrequency sympatholysis. J Vasc Surg 1993;17(4):801-6.
206 105Capítulo
1. Reisfeld R, Berliner KI. Evidence-based review of the non surgical management of hyperhidrosis. Thorac Surg Clin 2008;18:157-66.
4. Hourlay PG, Vangertruyden F, Verduyckt F, Trimpeneers JH. Endoscopic extraperitoneal lumbar sympathectomy. Surg Endosc 1995;9(5):530-3.
5. Loureiro MP, Cury AM, Bley AG. Simpatectomia lombar retroperitoneal endoscópica. Rev Col Bras Cir 2004;31(4):274-5.
6. Rieger R, Pedevilla S. Retroperitoneoscopic lumbar sympathectomy for the treatment of plantar hyperhidrosis: technique and preliminary findings. Surg Endosc 2007;21:129-35.
3. Rieger R, Loureiro MP, Pedevilla S, Oliveira RA. Endoscopic lumbar sympathectomy following thoracic sympathectomy in patients with palmoplantar hyperhidrosis. World J Surg 2011;35(1):49-53.
LOMBAR
2. Neumayer C, Panhofer P, Zacherl J, Bischof G. Effect of endoscopic thoracic sympathetic block on plantar hyperhidrosis. Arch Surg 2005;140:676-80.
SIMPATECTOMIA POR VIDEOENDOSCOPIA BIBLIOGRÁFICAS
7. Loureiro MP, de Campos JR, Kauffman P et al. Endoscopic lumbar sympathectomy for women: effect on compensatory sweat. Clinics (São Paulo) 2008;63:189-96.
REFERÊNCIAS
Parte VII MEMBROS SUPERIORES
14. Walsham WJ. Anatomical variations: an account of a few of the more interesting abnormalities that have occurred in the dissecting-rooms during the past seven years; with remarks on their morphological significance, and their bearing on the practice of surgery. St Bartholomews Hospital Reports 1880;16:91.
209
16. Poynter CWM. Congenital anomalies of arteries and veins of the human body with bibliography. University Studies University Nebraska 1922;22:1-106.
28. Yammine K, Eric M. Patterns of the superficial veins of the cubital fossa: A meta-analysis. Phlebology 2017;32(6):403-14.
ANATOMIA
17. Campbell CC, Waters PM, Emans JB, Kasser JR, Millis MB. Neurovascular injury and displacement in type III supracondylar humerus fractures. J Pediatr Orthop 1995;15:47-52.
36. Baroni ML, Berridge DC. Anatomy of the antecubital fossa. Anaesthesia & Intensive Care Medicine 2010;11(5):200.
22. Chin KJ, Singh K. The superficial ulnar artery--a potential hazard in patients with difficult venous access. Br J Anaesth 2005;94(5):692-3.
30. Jindal K, Chan CT, Deziel C, Hirsch D, Soroka SD, Tonelli M et al Hemodialysis clinical practice guidelines for the Canadian Society of Nephrology. J Am Soc Nephrol 2006;17(3 Suppl 1):S1-27.
39.
9. Henry BM, Vikse J, Sanna B, Taterra D, Gomulska M, Pekala PA et al. Cervical Rib Prevalence and its Association with Thoracic Outlet Syndrome: A Meta-Analysis of 141 Studies with Surgical Considerations. World Neurosurg 2018;110:e965-e78.
24. Romeu-Bordas Ó, Ballesteros-Peña S. Reliability and validity of the modified Allen test: a systematic review and metanalysis. Emergencias 2017;29(2):126-35.
23. Gaudino M, Benedetto U, Fremes S, Biondi-Zoccai G, Sedrakyan A, Puskas JD et al. Radial-Artery or Saphenous-Vein Grafts in CoronaryArtery Bypass Surgery. N Engl J Med 2018.
7. Goss CM, editor. Gray Anatomia. 29. ed. Rio de Janeiro: Guanabara Koogan; 1977. 8. Leite TFO, Pires L, Cisne R, Babinski MA, Chagas CAA. Clinical discussion of the arteria lusoria: a case report. J Vasc Bras 2017;16(4):339-42.
13. Calori L. Sul variato rapporto vascolare delle due radici del nervo mediano e sulle condizioni atte a produrlo. Mem Accad Sci Instituto Bologna S 3. 1877;8:443-56.
15. Bergman RA, Thompson SA, Afifi AK, Saadeh F. Compendium of human anatomic variation: text, atlas and world literature. Baltimore: Urban & Schwarzenberg; 1988.
20. de Paula RC, Erthal R, Fernandes RMP, Babinski MA, Silva JG, Chagas CAA. Anomalous origin of the deep brachial artery (profunda brachii) observed in bilateral arms: case report. J Vasc Bras 2013;12(1):53-6.
11. Tubbs RS, Shoja MM, Loukas M, editors. Bergman’s Comprehensive Encyclopedia of Human Anatomic Variation. New Jersey: Wiley Blackwell; 2016.
APLICADA À REGIÃO DOS MEMBROS SUPERIORES REFERÊNCIAS BIBLIOGRÁFICAS
27. Ialongo C, Bernardini S. Phlebotomy, a bridge between laboratory and patient. Biochem Med (Zagreb) 2016;26(1):17-33.
2. Testut L, Jacob O. Tratado de Anatomía Topográfica con aplicaciones médicoquirúrgicas. 8. ed. Madrid: Salvat; 1952. 3. Moore KL, Dalley II AF, Agur AMR. Clinically oriented anatomy. 7. ed. Philadelphia: Lippincott Williams & Wilkins; 2014. 4. Latarjet M, Liard AR. Anatomía Humana. 4. ed. Madrid: Editorial Medica Pan-Americana; 2011.
31. Lirk P, Keller C, Colvin J, Colvin H, Rieder J, Maurer H et al. Unintentional arterial puncture during cephalic vein cannulation: case report and anatomical study. Br J Anaesth 2004;92(5):740-2. 32. Araujo RC, Pires LAS, Andrade ML, Perez MC, Filho CSL, Babinski MA. Embryological and comparative description of the cephalic vein joining the external jugular vein: a case report. Morphologie 2017. 33. Charles CM. On the arrangement of the superficial veins of the cubital fossa in american white and american negro males. Anatomical Record 1932;54(1):9-14.
37. Kumar A, Jha MS, Singla M, Gupta N, Raina P, Dubey D et al. Radiomedian cubital / radiocephalic arteriovenous fistula at elbow to prevent vascular steal syndrome associated with brachiocephalic fistula: Review of 320 cases. Indian J Urol 2007;23(3):261-4. Del Sol M, Lillo E, Lobos L, Vásquez B. Estudio de las Venas de la Fosa Cubital a través de la Tomografía Computada Helicoidal y su Aplicación Clínica. Int J Morphol 2012;30(1):64-9. Yamada K, Yamada K, Katsuda I, Hida T. Cubital Fossa Venipuncture Sites Based on Anatomical Variations and Relationships of Cutaneous Veins and Nerves. Clinical Anatomy 2008;21:307-13. Del Sol M, Vásquez B. Venas Superficiales de la Fosa Cubital. Aspectos Anátomo-Clínicos y Antropológicos. Int J Morphol 2009;27(2):527-38. Corzo Gómez EG, Díaz OLG, Mantilla MEN, Triana RJR, Díaz LJP. Distribución de los Patrones Venosos de la Fosa Cubital en una Muestra de Personas Nacidas en Bucaramanga, Colombia. Int J Morphol 2010;28(4):1011-8. 42. Tsukuda Y, Funakoshi T, Nasuhara Y, Nagano Y, Shimizu C, Iwasaki N. Venipuncture Nerve Injuries in the Upper Extremity From More Than 1 Million Procedures. J Patient Saf 2016;[Epub ahead of print]. 43. Ramos JA. Venipuncture-related lateral antebrachial cutaneous nerve injury: what to know? Braz J Anesthesiol 2014;64(2):131-3. Narayanan S, Murugan S. Bifurcation of brachial artery into a common radial-interosseous trunk and superficial ulnar artery: a rare variation. Anat Sci Int 2017. 45. Loukas M, Myers CS, Wartmann CT, Tubbs RS, Judge T, Curry B et al. The clinical anatomy of the cephalic vein in the deltopectoral triangle. Folia Morphologica 2008;67(1):72-7. Veeramani M, Vyas J, Sabnis R, Desai M. Small incision basilic vein transposition technique: A good alternative to standard method. Indian J Urol 2010;26(1):145-7.
38.
12. Adachi B, Hasebe K, Igakubu KD. Das Arteriensystem der Japaner Kyoto: Maruzen; 1928.
34. Planken RN, Duijm LE, Kessels AG, Leiner T, Kooman JP, Van Der Sande FM et al. Accessory veins and radial-cephalic arteriovenous fistula non-maturation: a prospective analysis using contrast-enhanced magnetic resonance angiography. J Vasc Access 2007;8(4):281-6.
26. Quencer KB, Arici M. Arteriovenous Fistulas and Their Characteristic Sites of Stenosis. AJR Am J Roentgenol 2015;205(4):726-34.
21. Soydan E, Akin M. Coronary angiography using the left distal radial approach - An alternative site to conventional radial coronary angiography. Anatol J Cardiol 2018.
19. Gruber W. Ueber die Arteria mediana antibrachii superficialis, Arteria ulnaris antibrachii superfcialis und Duplicitat der Arteria ulnaris. Archiv Anat Physiol 1867:668-87.
6. Gardner E, Gray DJ, O’Rahilly RR. Anatomia - Estudo Regional do Corpo Humano. 4. ed. Rio de Janeiro: Guanabara Koogan; 1978.
46.
29. Elmegarhi SS, Amarin JZ, Hadidi MT, Badran DH, Massad IM, Bani-Hani AM et al. Dorsal metacarpal veins: anatomic variation and potential clinical implications. Anat Sci Int 2018;93(2):238-43.
25. Jaschtschinski SN. Morphologie und Topography des Arcus volaris sublimis und profundus des Menschen. Anat Hefte 1897;7:161-88.
106Capítulo
18. Leite T, Pires M, Pires L, Chagas C, Oliveira AC. Giant iatrogenic pseudoaneurysm of the brachial artery: A case report. Int J Surg Case Rep 2017;37:193-5.
35. Ellis H. The antecubital fossa. Surgery (Oxford) 2010;28(Suppl 1):e1-e9.
10. Peek J, Vos CG, Unlu C, van de Pavoordt H, van den Akker PJ, de Vries JPM. Outcome of Surgical Treatment for Thoracic Outlet Syndrome: Systematic Review and Meta-Analysis. Ann Vasc Surg 2017;40:303-26.
40.
41.
44.
1. Testut L, Latarjet A. Tratado de Anatomía Humana. 9. ed. Barcelona: Salvat; 1958.
5. Warwick R, Williams PL, editors. Gray Anatomia. 35. ed. Rio de Janeiro: Guanabara Koogan; 1984.
57. Felix VB, Santos JABd, Fernandes KJdM, ral DRG, Santos CASd, Rodrigues CFdS et al. Anatomical study of the accessory axillary vein in cadavers: a contribution to the axillary surgical approach. J Vasc Bras 2016;15(4):275-9.
50. Matsushima H, Adachi T, Iwata T, Hamada T, Moriuchi H, Yamashita M et al. Analysis of the Outcomes in Central Venous Access Port Implantation Performed by Residents via the Internal Jugular Vein and Subclavian Vein. J Surg Educ 2017;74(3):443-9.
58. Reverón RR. Jean Leo Testut (1849-1925): anatomist and anthropologist. Anatomy 2014;8:36-9.
54. Pires L, Rafare AL, Peixoto BU, Pereira T, Pinheiro DMM, Siqueira MEB et al. The venous patterns of the cubital fossa in subjects from Brazil. Morphologie 2018;102(337):78-82.
48. Heil J, Miesbach W, Vogl T, Bechstein WO, Reinisch A. Deep Vein Thrombosis of the Upper Extremity. Dtsch Arztebl Int 2017;114(14):244-9.
55. Okamoto K. A study of the superficial veins in the superior extremity of live Japanese. Anat Rec 1922;23:323-31.
210 Parte VIIMEMBROS SUPERIORES
51. Strauss KW, Onia R, Van Zundert AA. Peripheral intravenous catheter use in Europe: towards the use of safety devices. Acta Anaesthesiol Scand 2008;52(6):798-804.
56. Imanishi Y, Baba K, Fukushima T, Muranaka M, Nanbu A, Iwasaki Y et al. Obui-Himo syndrome. Eur Radiol 1998;8:1248-50.
47. Cardoso AAP, Smith RL, Prates JC, Cricenti SV. Método trigonométrico para o acesso à veia basílica no terço distal do braço. Rev Col Bras Cir 2006;33(3):140-5.
49. Glavich G, Gourley J, Fong V. Paget-Schroetter syndrome with bilateral pulmonary emboli. Radiol Case Rep 2018;13(1):28-31.
52. Shenoy S. Surgical anatomy of upper arm: what is needed for AVF planning. J Vasc Access 2009;10(4):223-32.
53. Yaylak F, Ozbek O, Toker S, Algin C, Ozveren O, Erbilen E. Multiple basilic vein aneurysms concomitant with multiple hemangiomas of the upper extremity: A case report. Int J Angiol 2007;16(3):106-8.
211 107Capítulo
SUPERIORES REFER
1. Andrade MFC, Buchpiegel CA, De Luccia N. Lymph absorption and transport in acute deep venous thrombosis of the lower limbs. Lymphology 2000;33(Suppl):95-8. 2. Caplan I, Ciucci JL. Drenaje linfático superficial del miembro superior. Linfología 1995;1:33-36.
4. Drake RL, Vogl W, Mitchell AWM. Gray’s Atlas of Anatomy Philadelphia: Churchill Livingstone/Elsevier; 2008. 5. Anson BJ, McVay CB. Thoracic walls: Breast or mammary region. In: Surgical Anatomy, 6th edition, Anson, BJ, McVay, CB (Eds.). Philadelphia: Saunders; 1984. p. 357. 6. Cuadrado GA, Andrade MFC, Akamatsu FE, Jácomo AL.Anatomy of the lymphatic drainage of the upper limb and breast and its role in lymphedema prevention after breast cancer treatment. Int J Morphol 2016;34(3):1117-1122. 7. Kubik S. Anatomy of the lymphatic system. In: Foldi, Foldi, Kubik (Ed.). Textbook of lymphology. Munchen Urban & Fischer; 2003. 8. Suami H, O’Neill JK, Pan WR, Taylor GI. Superficial lymphatic system of the upper torso: preliminary radiographic results in human cadavers. Plast Reconstr Surg 2008;121(4):1231- 9. 9. Ikeda K, Ogawa Y, Komatsu H et al. Evaluation of the metastatic status of lymph nodes identified using axillary reverse mapping in breast cancer patients. World J Surg Oncol 2012;10:233.
3. Jacomo AL, Rodrigues Jr, Figueira LNT. Estudo da drenagem linfática do músculo pronador quadrado. Acta Ortop Bras 1993;1(2):60-62.
ANATOMIA DO SISTEMA DOS MEMBROS Ê NCIAS BIBLIOGRÁFICAS
LINFÁTICO
212 108Capítulo VIAS DE ACESSO AOS VASOS DOS MEMBROS SUPERIORES BIBLIOGRAFIA Gates JD, Barshes NR, Bechara C. Surgical and endovascular techniques for upper arm extremity revascularization. Uptodate 2017 May Haimovici05. H. Open surgical exposure of upper extremity arterires. In: Ascher E. Haimovici’s Vascular Surgery. 6th edition. HansenWiley-Blackwell.JT,Lambert DR. Netter Anatomia clinica. 3th edição. 2015. L’Keith M. Anatomia Orientada para a Clínica. 6. ed. Rio de Janeiro: Guanabara Koogan; 2011. Netter FH. Atlas de anatomia humana. 6. ed. Rio de Janeiro: Elsevier; 2015. Nomina anatômica. 2001. Rutherford RB. Rutherford vascular surgery. Basic vascular exposure. 8th ed. Ed. Elsevier; 2014. Wind GG, Valentine RJ. Vessels of the upper extremity. Anatomic exposure in vascular surgery. 3rd. ed. Walters Klumer: Lippincott Williams & Wilkins; 2013.
ECOCOLOR E DOS MEMBROS BIBLIOGRÁFICAS
1. Tola M, Yurdakul M, Okten S et al. Diagnosis of arterial occlusive disease of the upper extremity: comparison of color duplex sonography and angiography. J Clin Ultrasound. 2003;31(8):407-11.
9. Hirai M. Cold sensitivity of the hand in arterial occlusive disease. Surgery 1979;85(2):140-6.
5. Harris SK, Moneta GL. Noninvasive diagnosis of upper extremity arterial disease. In: Noninvasive vascular diagnosis. A pratical textbook for clinicians, 4th ed. Cham, Switzerland: Springer; 2017. p. 419-30.
2. Rollo HA, Giannini M. Doença arterial obstrutiva nos membros superiores e síndrome do desfiladeiro cervicotoracoaxilar. In: Engelhorn CA, Morais Filho D, Barros FS, Coelho NA. Guia prático de ultrassonografia vascular, 2.ed. Rio de Janeiro: DiLivros Editora Ltda; 2011. p. 123, 128. 3. Transatlantic inter-society consensus (TASC) Management of peripheral arterial disease. Epidemiology, natural history, risk factors. J Vasc Surg 2000;31(1);part 2:S5-S34.
SUPERIORES REFERÊNCIAS
4. Keck GM, Pellerito JS, Polak JF. Arterial anatomy of the extremities. In: Pellerito JS e Polak JF. Introduction to vascular ultrasonography, 6th ed. Philadelphia, PA: Elsevier Saunders; 2012. p. 231-43.
VENOSO
7. Arkkila PE. Thromboangeiitis obliterans (Buerger’s disease). Orph J Rare Dis 2006;01:14. 8. Joviliano EE, Dellalibera-Joviliano R, Dalio M et al. Etiopathogenesis, clinical diagnosis and treatment of thromboangiitis obliterans-current practice. Int J Ang 2009;18(3):119-25.
10. Degeorges R, Reynaud C, Becquemin JP. Thoracic outlet syndrome surgery: long-term functional results. Ann Vasc Surg 2004;18(5):558-5. 11. Gillard J, Perez-Cousin M, Hachulla E et al. Diagnosing thoracic outlet syndrome: contribution of provocative tests, ultrassonography, electrophysiology and helical computed tomography in 48 patients. Joint Bone Spine 2001;68:416-24.
6. Javed S, Hasan T, Ahmad S et al. Clinical characteristics of Buerger’s disease in Iran. J Col Phy Surg Pk 2008;18(8):502-5.
12. Stapleton C, Herrington L, George K. Sonographic evaluation of the subclavian artery during thoracic outlet syndrome shoulder manoeuvres. Manual Ther 2009;14:19-27. 13. Ciorlin E, de Araújo JD, de Araújo Jr JD. Síndromes compressivas neurovasculares cervicotoracoaxilares (síndrome do desfiladeiro). In: Brito CJ (Ed.). Cirurgia vascular, cirurgia endovascular, angiologia, 3.ed. Rio de Janeiro: Revinter; 2014. p. 2343-62. 14. Juliá L, Lozano P, Gomez F, Corominas C. Traumatic pseudoaneurysm of the axillary artery following anterior dislocation of the sholder. Case report. J Cardiovasc Surg (Torino) 1998;39:167-9. 15. Holm HH, Kristensen JK, Mortensen T et al. Ultrasonic diagnosis of arterial aneuryms. Scand J Thorac Cardiovasc Surg 1968;2(2):140-6. 16. Hodgkiss-HarlowKD, Bandyk DF. Interpretation of arterial duplex testing of lower-extremity arteries and interventions. Semin Vasc Surg 2013;26(2-3):95-104.
213 109Capítulo
DOPPLER ARTERIAL
13.
8. Vierhout B, Zeebregts C, Dungen J et al. Changing Profiles of Diagnostic and Treatment Options in Subclavian Artery Aneurysms. Eur J Vasc Endovasc Surg 2010;40:27-34.
1. Bozlar U, Ogur T, Norton P et al. CT Angiography of the Upper Extremity Arterial System: Part 1-Anatomy, Technique, and Use in Trauma Patients. AJR 2013;201:745-752. Silva I, Martins E. Estenose arterial subclávia bilateral: mais do que uma descida da tensão arterial – Relato de caso. Rev Port Med Geral Fam 2014;30:316-20. Ochoa V, Yeghiazarians Y. Subclavian artery stenosis: A review for the vascular medicine practitioner. Vasc Med 2011;16(1):29-34.
3.
6. Miller J, Candemil P, Loures J et al. Síndrome do roubo coronáriosubclávio: relato de caso e revisão da literatura. J Vasc Bras 2012;11(2):166-170.
2.
9. Demondion X, Herbinet P, Van Sint Jan S et al. Imaging Assessment of Thoracic Outlet Syndrome. RadioGraphics 2006;26:1735-1750.
5. Passos M, Alves L. 301Síndrome do Roubo da Subclávia. Rev Bras Ecocardiogr Imagem Cardiovasc 2012;25(4):298-301.
4. Jones C, Verde F, Johnson P et al. Nontraumatic Subclavian Artery Abnormalities: Spectrum of MDCT Findings. AJR 2016;207:434-441
214 110Capítulo ANGIOTOMOGRAFIA DOS VASOS DOS MEMBROS SUPERIORES REFERÊNCIAS BIBLIOGRÁFICAS
7. Zhan B, Zhang S, Shao Y. Operation for huge subclavian artery aneurysm: a case report. J Thorac Dis 2010;2:117-120.
10. Chen MC, Tsail WL, Tsail IC et al. Arteriovenous Fistula and Graft Evaluation in Hemodialysis Patients Using MDCT: A Primer. AJR 2010;194:838-847.
11. Lotfi U, Mostafa H. Evaluation of the Endovascular Salvage Outcome for Dysfunctional Arteriovenous Fistula for Hemodialysis According To the Site of the Lesion: 3 Years Experience. J Cardiol Cardiovasc Ther 2017;2(5):JOCCT.MS.ID.555593. 12. Junior M, Melo R, Almeida C et al. Avaliação da perviedade precoce das fístulasarteriovenosas para hemodiálise. J Vasc Bras 2011;10(2):105-109. Zhang J, Hecht E, Maldonado T et al. Time-Resolved 3D MR Angiography with Parallel Imaging for Evaluation of Hemodialysis Fistulas and Grafts: Initial Experience. AJR 2006;186:1436-1442.
9. Poretti D, Lanza E, Sconfienza LM et al. Simultaneous bilateral magnetic resonance angiography to evaluate thoracic outlet syndrome. Radiol Med 2015;120(5):407-12.
2. Razek AA, Saad E, Soliman N, Elatta HA. Assessment of vascular disorders of the upper extremity with contrast-enhanced magnetic resonance angiography: pictorial review. Jpn J Radiol 2010;28(2):87-94.
1. Wasser MN. MR Angiography of peripheral arteries: upper extremities. In: Schneider G, Prince MR, Meaney JFM, Ho VB. Magnetic resonance angiography. Techniques, indications and practical applications. Springer; 2005. p. 257-67.
5. Bode AS, Planken RN, Merkx MA et al. Feasibility of non-contrastenhanced magnetic resonance angiography for imaging upper extremity vasculature prior to vascular access creation. Eur J Vasc Endovasc Surg 2012;43(1):88-94.
3. Bannas P, François CJ, Reeder SB. Magnetic resonance angiography of the upper extremity. Magn Reson Imaging Clin N Am 2015;23(3):479-93.
14. Bossone E, Pluchinotta FR, Andreas M et al. Aortitis. Vascul Pharmacol 2016;80:1-10.
12. Leiner T, Hellinger JC, Rofsky NM. Upper extremities Vasculature. In: Rubin GD, Rofsky NM (Eds.). CT and MR angiography: Comprehensive vascular assessment. Philadelphia, PA: Lippincott Williams & Wilkins; 2009. p. 1018-117.
6. Merkx MA, Bosboom EM, Bode AS et al. Non contrast-enhanced MRA versus ultrasound blood vessel assessment to determine the choice of hemodialysis vascular access. J Vasc Access 2013;14(4):348-55.
19. Merrow AC, Gupta A, Patel MN, Adams DM. 2014 Revised Classification of Vascular Lesions from the International Society for the Study of Vascular Anomalies: Radiologic-Pathologic Update. Radiographics 2016;36(5):1494-516.
7. Raptis CA, Sridhar S, Thompson RW et al. Imaging of the Patient with Thoracic Outlet Syndrome. Radiographics 2016;36(4):984-1000.
11. Moriarty JM, Bandyk DF, Broderick DF et al. ACR Appropriateness Criteria Imaging in the Diagnosis of Thoracic Outlet Syndrome. J Am Coll Radiol 2015;12(5):438-43.
13. Barra L, Kanji T, Malette J, Pagnoux C. Vascular Imaging modalities for the diagnosis and disease activity assessment of Takayasu’s arteritis: a systematic review and meta-analysis. Autoimmun Rev 2018;17(2):175-87.
10. Aghayev A, Rybicki FJ. State-of-the-art Magnetic Resonance Imaging in Vascular Thoracic Outlet Syndrome. Magn Reson Imaging Clin N Am 2015;23(2):309-20.
8. Ersoy H, Steigner ML, Coyner KB et al. Vascular thoracic outlet syndrome: protocol design and diagnostic value of contrast-enhanced 3D MR angiography and equilibrium phase imaging on 1.5- and 3-T MRI scanners. AJR Am J Roentgenol 2012;198(5):1180-7.
4. Meaney JF, Sheehy N. MR angiography of the peripheral arteries. Magn Reson Imaging Clin N Am 2005;13(1):91-111.
16. John RA, Keshava SN, Danda D. Correlating MRI with clinical evaluation in the assessment of disease activity of Takayasu’s arteritis. Int J Rheum Dis 2017;20(7):882-6. 17. Grizzard J, Shah DJ, Klem I, Jim RJ. MR angiography of the lower extremity circulation with protocols. In: Mukherjee D, Rajagopalan (Eds.). CT and MR angiography of the peripheral circulation. Practical approach with clinical protocols. United Kingdom: Informa Healthcare; 2007. p. 283-308. 18. Flors L, Leiva-Salinas C, Maged IM et al. MR imaging of soft-tissue vascular malformations: diagnosis, classification, and therapy follow-up. Radiographics 2011;31(5):1321-40.
15. Choe YH, Han BK, Koh EM et al. Takayasu’s arteritis: assessment of disease activity with contrast-enhanced MR imaging. AJR Am J Roentgenol 2000;175(2):505-11.
215 111CapítuloANGIORRESSONÂNCIA MAGNÉTICA DOS VASOS DOS MEMBROS SUPERIORES REFERÊNCIAS BIBLIOGRÁFICAS
216 112Capítulo ANGIOGRAFIA DOS VASOS DOS MEMBROS SUPERIORES REFERÊNCIAS BIBLIOGRÁFICAS 1. Peixoto CCS, Rossi M. Trauma Vascular. Rio de Janeiro: Revinter; 2006. p. 174-88. 2. Peixoto CCS, Brito CJ. Cirurgia Endovascular e Angiologia. Rio de Janeiro: Revinter; 2008. p. 396-416. 3. Peixoto CCS, Brito CJ. Cirurgia Endovascular e Angiologia. Rio de Janeiro: Revinter; 2014. p. 527-34
TRANSRADIAL EM DOENÇA ARTERIAL
ACESSO
18. Sanghvi K, Kurian D, Coppola J. Transradial intervention of iliac and superficial femoral artery disease is feasible. J Interv Cardiol 2008;23:385-87.
2. Rao S, Stone G. Arterial access and arteriotomy site closure devices. Nat Rev Cardiol 2016;13:641-50.
1. Campeau L. Percutaneous radial artery approach for coronary angiography. Catheter Cardiovasc Diagn 1989;16:3-7.
15. Curran H, Chieffo A, Buchanan GL et al. A comparison of the femoral and radial crossover techniques for vascular access management in transcatheter aortic valve implantation: the Milan experience. Catheter Cardiovasc Interv 2014 Jan 1;83(1):156-61.
20. Rashid M, Kwok C, Pancholy S. Radial artery occlusion after transradial interventions: a systematic review and meta-analysis. J Am Heart Assoc 2016;5(1):e002686.
4. Posham R, Biederman DM, Patel RA. Transradial approach for noncoronary interventions: a single-center review of safety and feasibility in the first 1,500 cases. J Vasc Interv Radiol 2016;27:159-66.
21. Kiemeneij F, Laarman GJ, Odekerken D. A randomized comparison of percutaneous transluminal coronary angioplasty by the radial, brachial and femoral approaches: the Access Study. J Am Coll Cardiol 1997;29:1269-75.
8. Alvarez-Tostado JA, Moise MA et al. The brachial artery: a critical access for endovascular procedures. J Vasc Surg 2009;49:378-85; discussion 385. 9. Stern JR, Ellozy SH, Connolly PH et al. Utility and safety of axillary conduits during endovascular repair of thoracoabdominal aneurysms. J Vasc Surg 2017;66:705-10.
7. Coscas R, Blic RD, Capdevila C. Percutaneous radial access for peripheral transluminal angioplasty. J Vasc Surg 2015;61:463-68.
217 113Capítulo
16. Sarac TP, Altinel O, Kashyap V et al. Endovascular treatment of stenotic and occluded visceral arteries for chronic mesenteric ischemia. J Vasc Surg 2008;47:485-91.
12. Andrade PB et al. Experiência inicial com a técnica de punção distal da artéria radial esquerda em procedimentos coronários invasivos. J Transcat Intervent 2018;26(1):1-5.
19. Dattilo P, Tsai T, Rogers K. Acute and medium term outcomes of endovascular therapy of obstructive disease of diverse etiology of the common femoral artery. Catheter Cardiovasc Interv 2013;81:1013-22.
5. Aboyans V, Ricco JB, Bartelink ML. 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Eur Heart J 2018;39:763-816.
13. Jolly SS, Amlani S, Hamon M et al. Radial versus femoral access for coronary angiography or intervention and the impact on major bleeding and ischemic events: a systematic review and meta-analysis of randomized trials. Am Heart J 2009;157:132-40.
22. Grenon S, Reilly L, Ramaiah V. Technical endovascular highlights for crossing the difficult aortic bifurcation. J Vasc Surg 2011;54:893-96.
3. Gan L, Lib Q, Liuc R. Effectiveness and feasibility of transradial approaches for primary percutaneous coronary intervention in patients with acute myocardial infarction. J Nanjing Med Univ 2009;23:270-74.
17. Meertens et al. Transradial Approach for Aortoiliac and Femoropopliteal Interventions: A Systematic Review and Metaanalysis. J Endovasc Ther 2018;25(5):599-607.
6. Ruzsa Z, Tóth K, Nemes B. Transradial and transulnar access for iliac artery interventions using sheathless guiding systems: a feasibility study. Catheter Cardiovasc Interv 2016;88:923-31.
11. Barbeau GR, Arseneault F, Dugas L et al. Evaluation of the ulnopalmar arterial arches with pulse oximetry and plethysmography: comparison with the Allen’s test in 1010 patients. Am Heart J 2004;147:489-93.
10. Knowles M, Nation DA, Timaran DE et al. Upper extremity access for fenestrated endovascular aortic aneurysm repair is not associated with increased morbidity. J Vasc Surg 2015;61:80-7.
14. Cortese B, Rigattieri S, Aranzulla TC et al. Transradial versus transfemoral ancillary approach in complex structural, coronary, and peripheral interventions. Results from the multicenter ancillary registry: a study of the Italian Radial Club. Catheter Cardiovasc Interv 2018;91:97-102.
REFERÊNCIAS BIBLIOGRÁFICAS
23. Lorenzoni R, Mazzoni A, Lazzari M. Radial artery access for above the knee angioplasty: a feasibility study. EuroIntervention 2011;7:924-29.
27. Waggerhauser T, Herrmman K, Reiser M. Reconstructive endovascular treatment procedures in the area of the subclavian and its branches. Radiologe 2000;40:821-5. 28. Shane TR, Holden A, Hartley D et al. Endovascular repair of the subclavian artery aneurysm. J Vasc Surg 1996;24:304-5. 29. Yildiz AE, Peynircioglu B, Cil BE. Applications of the Amplatzer vascular plug 4. Diagn Interv Radiol 2012;18:225-30. 30. Lobato AC, Colli Jr DF, Mahfouz NH et al. Aneurismas perifericos. In: Lobato AC, Pereira AH, Von Ristow A et al Cirurgia endovascular. São Paulo: ICVE; 2010. p. 797-822. 31. Polydorou A, Henry M, Bellins I et al. Endovascular treatment of arterial aneurysms with side-branches - a simple method. Mith or reality? Hospital Chronicles 2010;5(2):88-94. 32. Haimovici H. Peripheral arterial aneurysms. In: Haimovici H. (Ed.). Vascular emergencies. New York: Appleton-Century-Crafts; 1982. p. 399-413. 33. Abbott WM, Darling RC. Axillary artery aneurysms secondary to crutch trauma. Am J Surg 1973;125:515-20. 34. Sullivan TM, Bacharach JM, Perl J et al. Endovascular management of unusual aneurysms of the axillary and subclavian arteries. J Endovasc Surg 1996;3:389. 35. Tabata S, Saito H, Takizawa M et al. Atherosclerotic aneurysm of the rigth subclavian artery: report of a case. Ann Thorac Cardiovasc Surg 2007;13:139-42. 36. Abbott WM, Darling RC. Axilary artery aneurysms secondary to crutch trauma. Am J Surg 1973;125:515-20. 37. Sullivan TM, Bacharach JM, Perl J et al. Endovascular management of unusual aneurysms of the axilary and subclavian arteries. J Endovasc Surg 1996;3:389. 38. Ko s, Han IY, Cho KH et al. Recurrent true brachial artery aneurysm. Korean J Thorac Cardiovasc Surg 2011;44:364-7. 39. Ho PK, Weiland AJ, McClinton MA et al. Aneurysms of the upper extremity. J Hand Surg Am 1987;12:39-46. 40. Cakalagaoglu C, Keser N, Alhan C. Brucella-mediated prosthetic valve endocarditis with brachial artery mycotic aneurysm. J Heart Valve Dis 1999;8:586-90. 41. Sharma AK, Gupta CK. Mycotic aneurysm of the brachial artery simulating soft tissue malignancy. Trop Doct 1993;23:93-4. 42. Lie JT, Hayes CW, Feinthch TA. Congenital brachial artery aneurysm in an infant – A case report. Angiology 1988;39:40-4. 43. Jones TR, Frusha JD, Stromeyer FW. Brachial artery aneurysm in an infant: case report and review of the literature. J Vasc Surg 1988;7:439-42. 44. Shipolini AR, Wolfe JH. Fibromuscular dysplasia and aneurysm formation in the brachial artery. Eur J Vasc Surg 1993;7:740-3. 45. Kristen R, Schmitz-Rixen T, Huber P et al. Aneurysm of the brachial artery – A rare complication of Behcet disease. Case report. Vasa 1988;17:229-32. 46. Loughlin V, Beniwal JS. Post-traumatic brachial artery aneurysm and arteriovenous fistulae. J Cardiovasc Surg 1988;29:570-1. 47. Rey C, Marache P, Watel A et al. Iatrogenic false aneurysm of the brachial artery in an infant. Eur J Pediatr 1987;146:438-9.
5. Vierhout BP, Zeebregts CJ, van den Dungen JJAM et al. Changing profiles of diagnostic and treatment options in subclavian artery aneurysms. Eur J Vasc Endovasc Surg 2010;40:27-34.
23. Myamoto S, Hadama T, Iwata E et al. Atherosclerotic aneurysm of the intrathoracic segment of the subclavian artery: a case report. Ann Thorac Cardiovasc Surg 2000;6:281-4.
22. Doughetery MJ, Calligaro KD, Savarese RP et al. Atherosclerotic aneurysm of the intrathoracic subclavian artery: a case report and review of the literature. J Vasc Surg 1995;21:521-9.
8. Nawa S, Ikeda E, Ichihara S et al. A true aneurysm of axillarysubclavian artery with cystic medionecrosis: an unusual manifestation of Marfan syndrome. Ann Vasc Surg 2003;17:562-4.
6. Chiou AC, Fantini GA. Subclavian artery aneurysm: an unusual manifestation of Takayasu’s arteritis. Cardiovasc Surg 1999;7:310-4.
21. Davidovic L, Markovic D, Pejkic S et al. Subclavian artery aneurysm. Asian J Surg 2003;26:7-11.
20. Napolitano AM, Napolitano L, Francomano F et al. Aneurysms of the subclavian artery: Clinical experience. Ann Ital Chir 1998;69:311-6.
12. Brauer RB, Naundorf M, Maurer PC. Surgical and interventional therapeutic possibilities in aneurysms of the subclavian artery. Zentralbl Chir 2000;125:2-6.
26. Austin EH, Wolfe WG. Aneurysm of aberrant subclavian artery with a review of the literature. J Vasc Surg 1985;2:571-7.
1. Argotte AF, Giron F, Bilfinger TV. Bilateral subclavian artery aneurysms with pseudocoarctation of the aorta. Case report and review of the literature. J Cardiovasc Surg 1998;39:747-50. 2. Witz M, Yahel J, Lehmann JM. Subclavian artery aneurysms. A report of 2 cases and a review of the literature. J Cardiovasc Surg 1998;39:429-32.
REFERÊNCIAS BIBLIOGRÁFICAS
25. Douglas DA, Aldeman MA, Esposito R et al. Surgical repair of a left subclavian artery aneurysm causing stenosis of a left internal mammary graft: a case report. Vasc Endovasc Surg 2005;39:281-5.
17. Ron YN, Park KB, Do YS et al. A hybrid operation in patient with complex right subclavian artery aneurysm. J Korean Surg Soc 2012;82:195-9.
3. Douglas DA, Adelman MA, Espósito R et al. Surgical repair of a left subclavian artery aneurysm causing stenosis of a left internal mammary graft–a case report. Vasc Endovasc Surg 2005;39:281-5.
10. Cakir O, Eren N, Ulku R et al. Bilateral subclavian arterial aneurysm and ruptured abdominal aorta pseudoaneurysm in Behçet’s disease. Ann Vasc Surg 2002;16:516-20.
16. Zhan B, Zhang S, Shao Y. Operation of huge subclavian artery aneurysm: a case report. J Thorac Dis 2010;2:117-20.
7. Mergan F, Naitmazi D, Dereume JP. Congenital right subclavian artery aneurysm: a case report. Acta Chir Belg 2004;104:118-89.
13. Windfuhr JP, Schubert D, Remmert S. Aneurysm of the subclavian artery. An unusual cause of dysphagia. HNO 2004;52:1097-102.
24. McCollum CH, Da Gama AD, Noon GP et al. Aneurysm of the subclavian artery. J Cardiovasc Surg (Torino) 1979;20:159-64.
18. Paiolero PC Walls JT, Payne WS et al. Subclavian-axilary artery aneurysms. Surgery 1981;90:757-63.
11. Tatebe S, Asami F, Shinohara H et al. Ruptured aneurysm of the subclavian artery in a patient with von Recklinghausen’s disease. Circ J 2005;69:503-6.
19. Halldorson A, Ramsey J, Gallagher C et al. Proximal left subclavian artery aneurisms: a case report and review of the literature. Angiology 2007;58:367-71.
15. Hohls M, Ghanem N, Wilhelm M et al. Tracheal stenosis caused by false aneurysm of the right subclavian artery. Eur J Cardiothorac Surg 2002;21:946-67.
MEMBROS SUPERIORES
4. Hobson II RW, Isreal MR, Lynch TG. Axilosubclavian arterial aneurysms. In: Bergan JJ, Yao JST. (Eds.). Aneurysms – Diagnosis and treatment. New York: Grune & Stratton; 1982. p. 435.
ANEURISMAS DE
9. Steinmetz EF, Berry P, Shames ML et al. Grape cluster aneurysm of the right subclavian artery: an unusual manifestation of fibromuscular dysplasia. Ann Vasc Surg 2003;17:296-301.
218 114Capítulo
14. Takagi H, Mori Y, Umeda Y et al. Proximal left subclavian artery aneurysm presenting hemoptysis, hoarseness, and diplopia: repair through partial cardiopulmonary bypass and perfusion of the left common carotid artery. Ann Vasc Surg 2003;17:461-3.
67. Lee BY, Kim KK, Madden JL. True aneurysm of the radial artery: report of a case with long–term follow-up. J Am Geriatr Soc 1977;25(8):376-8. 68. Shucksmith HS, Fitton JM, Glanville JN. Ununited fracture of the scaphoid complicated by aneurysm of the radial artery. Br J Surg 1969;56(12):937-8.
83. Santos LN, Esper RB, Ybarra LF, Ribeiro HB, Campos CA, Lopes Jr AC, Ribeiro EE. Pseudoaneurisma: rara complicação do acesso radial. Rev Bras Cardiol 19(3).
74. Bridge PM, Lerhaupt K, Armstrong MB. Recurrent radial artery aneurysm in a five-month-old infant. J Natl Med Assoc 2000;92(6):309-11.
52. Leon LR, Psalms SB, Labropoulos N et al. Infected upper extremity aneurysms: a review. Eur J Vasc Surg 2008;35(3):320-31.
59.
62.
79. Feres CN, Ferreira MAA. Aneurisma verdadeiro da artéria radial: relato de caso. J Vasc Bras. 2010;9:239-40.
70. Agaja SB. Matchet cut injury at the wrist as a cause of traumatic radial artery aneurysm: a case report. West Afr J Med 2002;21(1):79-81.
55.
82. Mendes CL, Rodrigues R, Marinho A, Varino J, Antunes L, Matos AA, Gonçalves O. Aneurisma micótico da artéria radial secundário a streptococos bovis. Angiol Cir Vasc 14(1).
64. Lawhorne TW, Sanders RA. Ulnar artery aneurysm complicated by distal embolization: Management with regional thrombolysis and resection. J Vasc Surg 1986;3:663-5. 65. Al-Omran M. True ulnar artery aneurysm of the hand in an 18 monthold boy: a case report. J Vasc Surg 2007;45:841-3. 66. Smith HE, Dirks M, Patterson RB. Hypothenar hammer syndrome: distal ulnar artery reconstruction with autologous inferior epigastric artery. J Vasc Surg 2004;40(6):1238-42.
219Capítulo 114 AneurismA s de membros suPeriores
56.
72. Grey AC, Vallely SR. Spontaneous false aneurysm of the radial artery in neurofibromatosis. Clin Radiol 1999;54(3):185-6.
53. Tetik O, Ozcem B, Cali AO et al. True brachial artery aneurysm. Tec Heart Inst 2010;37:618-9.
61.
49. Demircin M, Peker O, Tok M et al. False aneurysm of the brachial artery in an infant following attempted venipuncture. Turk J Pediatr 1996;38:389-91.
51. Robson II RW, Rich NM. Vascular injuries of the extremities. In: Veith FJ. (Ed.). Vascular surgery – Principles and practice, 2nd ed. New York: McGraw-Hill; 1994. p. 975-86.
58.
77. Matsagas MI, Mitsis M, Rigopoulos C et al. A large radial false aneurysm after repeated arterial punctures, causing compartment syndrome of the forearm. Intensive Care Med 2003;29(6):1032.
80. Duarte N, Ferreira MJ, Gonçalves A, González A, Marques G, Barroso P, Pinheiro I, Menezes JD. Aneurisma sacular da artéria radial: a propósito de um caso clínico. Angiol Cir Vasc 2011;7(4):94-98.
71. Singh S, Riaz M, Wilmshurst AD et al. Radial artery aneurysm in a case of neurofibromatosis. Br J Plast Surg 1998;51(7):564-5.
73. De Greef A. Mycotic aneurysm of the radial artery of the hand. A case report. S Afr Med J 1983;63(10):371-3.
78. Leitner DW, Ross JS, Neary JR. Granulomatous radial arteritis with bilateral, nontraumatic, true arterial aneurysms within the anatomic snuffbox. J Hand Surg Am 1985;10(1):131-5.
81. Santos ACB, Oliveira FM, Oliveira JG, Bolanho E, Roberti T, Mathias UUM, Costa RFB, Fernandes Jr N. Aneurisma idiopático da artéria radial na região da tabaqueira anatômica: relato de caso. J Vasc Bras 2008;7(4).
54. Chemla E, Nortley M, Morsy M. Brachial artery aneurysms associated with arteriovenous acess for hemodialysis. Semin Dial 2012;23:440-4. Memetoglu ME, Erbasan O. An unusual clinical state: true ulnar artery aneurysm in a five years old girl. Interact Cardiovasc Thorac Surgy 2012;14:675-6. Clagett GP. Upper extremity aneurysms. In: Rutherford RB. (Ed.). Vascular surgery, 5th ed. Philadelphia: WB Saunders; 2000. p. 1356-69. 57. Houshian S, Mahdi BH. Hypotenar hammer syndrome. Ugeskr Laeger 1999;161:4643-4. Jagenburg A, Goyen M, Hirschelmann R et al. Hypothenar hammer syndrome: causes, sequelae and diagnostic aspects. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 2000;172:295-300. Bakhach J, Chahidi N, Conde A. Hypothenar hammer syndrome: management of distal embolization by intraarterial fibrinolytics. Chir Main 1998;17:215-20. Torre J. Ulnar artery aneurysm with digital ischemia. Vasc Med 1999;4:143-5. Harris Jr EJ, Taylor Jr LM, Edwards JM et al. Surgical treatment of distal ulnar artery aneurysm. Am J Surg 1990;159:527-30. Muller LP, Rudig L, Kreitner KF et al. Hypothenar hammer syndrome in sports. Knee Surg Sports Traumatol Arthrosc 1996;4:167-70. 63. Ferris BL, Taylor Jr LM, Oyama K et al. Hypothenar hammer syndrome: proposed etiology. J Vasc Surg 2000;31:104-13.
48. Coen LD, Johnson BF, Moorhead PJ et al. False aneurysm of the brachial artery: an unusual complication following accidental puncture by a patient on home heamodialysis. Br J Clin Pract 1990;44:202-3.
69. Turowski GA, Amjadi N, Sterling A et al. Aneurysm of the radial artery following blunt trauma to the wrist. Ann Plast Surg 1997;38:527-30.
75. Jayle C, Corbi P, Lanquetot H et al. Radial artery aneurysm: an unusual complication of radial artery catheterization. Ann Chir 2002;127(8):631-3. 76. Coskunfirat OK, Ozgentas HE. True aneurysm of the radial artery after iatrogenic injury and successful reconstruction with an interposition vein graft. J Reconstr Microsurg 2003;19(3):143-6.
50. Yip KM, Yurianto H, Lin J. False aneurysm with median nerve palsy after iatrogenic brachial artery puncture. Postgrad Med J 1997;73:43-4.
60.
3. National Kidney Foundation Center for Guideline Development and Implementation at Tufts-New England Medical Center, Boston, MA; 2006. 4. Ravani P, Palmer SC, Oliver MJ et al. Associations between hemodialysis access type and clinical outcomes: a systematic review. J Am Soc Nephrol. 2013;24(3):465-73.
21. Cull DL. Role of prosthetic hemodialysis access following introduction of the dialysis outcome quality and Fistula First Breakthrough Initiatives. Semin Vasc Surg. 2011;24(2):89-95.
16. Oliver MJ, Rothwell DM, Fung K et al. Late creation of vascular access for hemodialysis and increased risk of sepsis. J Am Soc Nephrol. 2004;15(7):1936-42.
13. Lukowsky LR, Kheifets L, Arah OA et al Patterns and predictors of early mortality in incident hemodialysis patients: new insights. Am J Nephrol. 2012;35(6):548-58.
6. Hall RK, Myers ER, Rosas SE et al. Choice of hemodialysis access in older adults: a cost-effectiveness analysis. Clin J Am Soc Nephrol. 2017;12(6):947-54.
19. Cooper BA, Branley P, Bulfone L et al. A randomized, controlled trial of early versus late initiation of dialysis. N Engl J Med 2010;363(8):609-19.
14. International Society of Nephrology. Fistula First: National Vascular Access Improvement Initiative. (Access in: Out/18/2018). Available at: http://www.fistulafirst.org
22. Lacson E Jr, Lazarus JM, Himmelfarb J et al. Balancing fistula first with catheters last. Am J Kidney Dis. 2007;50(3):379-95.
11. United States Renal Data System: 2008 annual data report: atlas of end-stage renal disease in the United States. Bethesda, MD National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2008 12. Bradbury BD, Fissell RB, Albert JM et al. Predictors of early mortality among incident US hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Clin J Am Soc Nephrol. 2007;2(1):89-99.
15. Hammes M. When is the right time for arteriovenous fistula placement in patients with end-stage renal disease? Am J Nephrol. 2017;45(4):353-5.
7. United States Renal Data System: 2014 USRDS annual data report: Vascular access use during the first year of hemodialysis by time since initiation of ESRD treatment. Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2014. 8. Jacobs C. Renal replacement therapy by hemodialysis: an overview. Nephrol Ther. 2009;5(4):306-12.
20. Lok CE, Allon M, Moist L et al. Risk equation determining unsuccessful cannulation events and failure to maturation in arteriovenous fistulas (REDUCE FTM I). J Am Soc Nephrol. 2006;17(11):3204-12.
220 115Capítulo FÍSTULAS ARTERIOVENOSAS PARA HEMODIÁLISE REFERÊNCIAS BIBLIOGRÁFICAS
10. Mermel LA, Allon M, Bouza E et al. Clinical practice guideline for the diagnosis and management of intravascular cateter-related infection: 2009 update by the Infections Diseases Society of America. Clin Infect Dis. 2009;49(1):1-45.
26. Allon M, Lockhart ME, Lilly RZ et al. Effect of preoperative sonographic mapping on vascular access outcomes in hemodialysis patients. Kidney Int. 2001;60(5):2013-20. 27. Ilhan G, Esi E, Bozok S. The clinical utility of vascular mapping with Dopper ultrasound prior to arteriovenous fistula construction for hemodialysis access. J Vasc Access. 2013;14(1):83-8. 28. Linardi F, Bevilacqua JL, Morad JFM, Costa JA. Programa de melhoria continuada em acesso vascular para hemodiálise Continuous quality improvement in vascular access for hemodialysis. J Vasc Br. 2004;3(3):191-6. 29. Brown PW. Preoperative radiological assessment for vascular access. Eur J Vasc Endovasc Surg. 2006;31(1):64-9. 30. Guimarães AV. Access for hemodialysis in Brazil. In: Dardik A (Ed.). Vascular surgery. Switzerland: Springer Nature; 2017. p. 263-71. 31. Lazarides MK, Staramos DN, Tzilalis VD et al. Evoked thrill: a simple intraoperative maneuver predicts early patency of arteriovenous fistulas. J Vasc Surg. 1998;27(4):750-2. 32. Raza MW, Wagas K, Ayub M et al. Anatomical snuff box arteriovenous fistulas for haemodialysis. J Rawalpindi Med Col. 2014;18(1):80-2. 33. Brescia MJ, Cimino JE, Appel K, Hurwich BJ. Chronic hemodialysis using venipuncture and a surgically created arteriovenous fistula. N Engl J Med. 1966;275(20):1089-92. 34. Kinnaert P, Vereerstraeten P, Toussaint C, Van Geertruyden J. Nine years’ experience with internal arteriovenous fistulas for haemodialysis: a study of some factors influencing the results. Br J Surg. 1977;64(4):242-6. 35. Kherlakian GM, Roedersheimer LR, Arbaugh JJ et al. Comparison of autogenous fistula versus expanded polytetrafluoroethylene graft fistula for angioaccess in hemodialysis. Am J Surg. 1986;152(2):238-43. 36. Ascher E, Gade P, Hingorani A et al. Changes in the practice of angioaccess surgery: impact of dialysis outcome and quality initiative recommendations. J Vasc Surg. 2000 Jan;31(1 Pt 1):84-92.
9. Goodkin DA, Bragg-Gresham JL, Koenig KG et al. Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS). J Am Soc Nephrol. 2003;14(12):3270-7.
39. Frankini AD, Miranda Júnior F, Cardi NAM, Grubert LD. Fístulas arteriovenosas braquiocefálicas e braquiobasílicas para hemodiálises: técnicas alternativas e resultados tardios. Cir Vas Angio. 1995;67(11):58-67.
17. Pisoni RL, Zepel I, Port FK, Robinson BM. Trends in US vascular access use, patient preferences, and related practices: an update from the US DOPPS practice monitor with international comparisons. Am J Kidney Dis. 2015;65(6):905-15.
1. United States Renal Data System: 2015 USRDS Annual Data Report: Medicare Expenditures for Persons with ESRD. Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2015. 2. Sesso RC, Lopes AA, Thomé FS et al. Inquérito Brasileiro de Diálise Crônica 2016. J Bras Nefrol. 2017;39(3):261-6.
18. Miyamoto M, Kurita N, Suemitsu K, Murakami M. Fistula and survival outcomes after fistula creation among predialysis chronic kidney disease stage 5 patients. Am J Nephrol. 2017;45(4):356-364.
23. Huber TS, Ozaki CK, Flynn TC et al. Prospective validation of an algorithm to maximize native arteriovenous fistulae for chronic hemodialysis access. J Vasc Surg. 2002;36(3):452-9. 24. National Kidney Foundation. KDOQI Clinical Practice Guideline for Hemodialysis Adequacy: 2015 update. Am J Kidney Dis. 2015 Nov.;66(5):884-930. 25. Silva Jr MG, Hobson RW, Pappas PJ. A strategy for procedures: impact of preoperative noninvasive evaluation. J Vas Surg. 1998;27(2):303-7.
37. Rooijens PP, Tordoir JH, Stijnen T et al. Radiocephalic wrist arteriovenous fistula for hemodialysis: meta-analysis indicates a high primary failure rate. Eur J Vasc Endovasc Surg. 2004;28(6):583-9. 38. Cascardo S, Acchiardo AS, Beven EG. Proximal arteriovenous fistula for hemodialysis when radial arteries are unavailable. Proc Europ Dial Transplant Assoc. 1970;7:42-6.
5. Lee T, Thamer M, Zhang Y et al. Outcomes of elderly patients after predialysis vascular access creation. J Am Soc Nephrol. 2015;25(12):3133-40.
55. Hye RJ, Peden EK, O’Connor TP et al. Human type I pancreatic elastase treatment of arteriovenous fistulas in patients with chronic kidney disease. J Vasc Surg. 2014;60(2):454-61.
81. Dikow R, Schwenger V, Zeler M, Ritz E. Do AV fistulas contribute to cardiac mortality in hemodialysis patients? Semin Dial 2002;159(1):14-7. 82. Wisselink W, Money SR, Becker MO et al. Comparison of operative reconstruction and percutaneous balloon dilatation for central venous obstruction. Am J Surg. 1993;166(2):200-5. 83. Kalra M, Gloviczki P, Andrews JC i. Open surgical and endovascular treatment of superior vena cava syndrome caused by nonmalignant disease. J Vasc Surg. 2003;38(2):215-23. 84. Bornak A, Wicky S, Ris HB et al. Endovascular treatment of stenoses in the superior vena cava syndrome caused by non-tumoral lesions. Eur Radiol 2003;13(5):950-6. 85. Rizvi AZ, Kalra M, Bjarnason H et al. Benign superior vena cava syndrome: Stenting is now the first line of treatment. J Vasc Surg 2008;47(2):372-80. 86. Bolton DF, Driedger AA, Lindsay RM. Ischemic neuropathy in uremic patient caused by bovine AV shunts. J Neurol Neurosurg Psych. 1979;42(9):810-4. 87. Odland MD, Kelly PH, Ney AL et al. Management of dialysis associated steal syndrome complicating upper extremity arteriovenous fistulas. Surgery 1991;110(4):664-9. 88. Lazarides MK, Staramos DN, Panagopoulos GN et al. Indications for surgical treatment of angioaccessinduced arterial “steal.” J Am Coll Surg. 1998;187(4):422-6. 89. Goff CD, Sato DT, Bloch PH et al. Steal syndrome complicating hemodialysis access procedures: can it be predicted? Ann Vasc Surg. 2000;14(2):138-44. 90. Schanzer A, Nguyen LL, Owens CD, Schanzer H. Use of digital pressure measurements for the diagnosis of AV access-induced hand ischemia. Vasc Med 2006;11(4):227-31. 91. Schanzer H, Skadany M, Haimov M. Treatment of angioaccessinduced ischemia by revascularization. J Vasc Surg. 1992;16(6):861-6.
53. Gibson KD, Gillen DL, Caps MT et al. Vascular access survival and incidence of revisions: a comparison of prosthetic grafts, simple autogenous fistulas, and venous transposition fistulas from the United States Renal Data System Dialysis Morbidity and Mortality Study. J Vasc Surg. 2001;34(4):694-700.
67. Morris ST, McMurray JJ, Rodger RS, Jardine AG. Impaired endotheliumdependent vasodilatation in uraemia. Nephrol Dial Transplant. 2000;15(8):1194-200.
63. Laissy JP1, Menegazzo D, Debray MP et al. Failing arteriovenous hemodialysis fistulas: assessment with magnetic resonance angiography. Invest Radiol. 1999;34(3):218-24.
48. Scott EC, Glickman MH. Conduits for hemodialysis access. Semin Vasc Surg. 2007;20(3):158-63.
221Capítulo 115 fístul A s ArteriovenosA s PAr A Hemodiálise
65. Stolic R. Most important chronic complications of arteriovenous fistulas for hemodialysis. Med Princ Pract. 2013;22(3):220-8.
45. Gradman WS, Laub J, Cohen W. Femoral vein transposition for arteriovenous hemodialysis access: improved patient selection and intraoperative measures reduce postoperative ischemia. J Vasc Surg. 2005;41(2):279-84.
43. Dix FP, Khan Y, Al-Khaffaf H. The brachial artery-basilic vein arteriovenous fistula in vascular access for haemodialysis - a review paper. Eur J Vasc Endovasc Surg. 2006;31(1):70-9.
73. Huang Y, Salu K, Liu X et al. Methotrexate loaded SAE coated coronary stents reduce neointimal hyperplasia in a porcine coronary model. Heart. 2004;90(2):195-9.
44. Tordoir JHM, Keuter X, Planken N et al. Autogenous options in secondary and tertiary access for haemodialysis. Eur J Vasc Endosvasc Surg. 2006;31(1):661-6.
78. Vesely T. Use of stent grafts to repair hemodialysis graft-related pseudoaneurysms. J Vasc Interv Radiol 2005;16(10):1301-7.
62. Bay WH, Henry ML, Lazarus JM et al. Predicting hemodialysis access failure with color flow Doppler ultrasound. Am J Nephrol. 1998;18(4):296-304.
58. Hull JE, Velez JH, Martinez JP. Percutaneous proximal radial artery arteriovenous fistula creation for hemodialysis using the Ellipsys™ vascular access system. JVIR. 2014;25(3):S20.
64. Oudenhoven LF, Pattynama PM, de Roos A et al. Magnetic resonance, a new method for measuring blood flow in hemodialysis fistulae. Kidney Int. 1994;45(3):884-9.
71. Kokubo T, Uchida H, Choi ET. Integrin αvβ3 as a Target in the Prevention of Neointimal Hyperplasia. J Vasc Surg. 2007;45 Suppl A(6S):A33-8.
40. Bender MH, Bruyninckx CM, Gerlarg PG. The brachiocephalic elbow fistula: a useful alternative angioaccess for permanent hemodialysis. J Vasc Surg. 1994;20(5):808-13.
79. Haimov M, Baez A, Neff M, Slifkin R. Complication of arteriovenous fistulae for hemodialysis. Arch Surg. 1975;110(1):708-12. 80. Kerstein M, May CJ. Acute and chronic venous insufficiency in the finger. Angiology 1976;27(4):265-6.
68. Kooman JP, Wijnen JA, Draaijer P et al. Compliance and reactivity of the peripheral venous system in chronic intermittent hemodialysis. Kidney Int. 1992;41(4):1041-8. 69. Wali MA, Eid RA, Al-Homrany MA. Smooth muscle changes in the cephalic vein of renal failure patients before use as an arteriovenous fistula (AVF). J Smooth Muscle Res. 2002;38(3):75-85.
54. Nikam M, Chemla ES, Evans J et al. Prospective controlled pilot study of arteriovenous fistula placement using the novel Optiflow device. J Vasc Surg. 2015;61(4):1020-5.
56. Rajan DK, Ebner A, Desai SB et al. Percutaneous creation of an arteriovenous fistula for hemodialysis access. J Vasc Interv Radiol. 2015;26(4):484-90.
49. Kao CL, Chang JP. Fully ringed polytetrafluoroethylene graft for vascular access in hemodialysis. Asian Cardiovasc Thorac Ann. 2003;11(2):171-3.
60. Besarab A, Sullivan KL, Ross RP, Moritz MJ. Utility of intra-access pressure monitoring in detecting and correcting venous outlet stenoses prior to thrombosis. Kidney Int. 1995;47(5):1364-73.
52. Huber TS, Carter JW, Carter RL, Seeger JM. Patency of autogenous and polytetrafluoroethylene upper extremity arteriovenous hemodialysis accesses: a systematic review. J Vasc Surg. 2003;38(5):1005-11.
46. Cull JD, Cull DL, Taylor SM et al. Prosthetic thigh arteriovenous access: outcome with SVS/AAVS reporting standards. J Vasc Surg. 2004;39(2):381-6.
70. Zou Y, Dietrich H, Hu Y et al. Mouse model of venous bypass graft arteriosclerosis. Am J Pathol. 1998;153(4):1301-10.
51. Hurlbert SN, Mattos MA, Henretta JP et al. Long-term patency rates, complications and cost-effectiveness of polytetrafluoroethylene (PTFE) grafts for hemodialysis access: a prospective study that compares Impra versus Gore-tex grafts. Cardiovasc Surg 1998;6(6):652-6.
72. Stolic RV, Trajkovic GZ, Peric VM et al. The influence of atherosclerosis and plasma D-dimer concentration in patients with a functioning arteriovenous fistula for maintenance hemodialysis. Int Urol Nephrol. 2008;40(2):503-8.
59. Al Shakarchi J, Houston JG, Jones RG, Inston N. A review on the hemodialysis reliable outflow (hero) graft for haemodialysis vascular access. Eur J Vasc Endovasc Surg. 2015;50(1):108-13.
74. Saeed F, Kousar N, Sinnakirouchenan R et al. Blood loss through av fistula: a case report and literature review. Int J Nephrol. 2011;2011:350870.
47. Miller CD, Robbin ML, Barker J, Allon M. Comparison of arteriovenous grafts in the thigh and upper extremities in hemodialysis patients. J Am Soc Nephrol. 2003;14(11):2942-7.
76. Palder SB, Kirkman RL, Whittemore AD et al. Vascular access for hemodialysis. Patency rates and results of revision. Ann Surg. 1985;202(2):235-9. 77. Najibi S, Bush RL, Terramani TT et al. Covered stent exclusion of dialysis access pseudoaneuryms. J Surg Res. 2002;106(1):15-9.
41. Dagher F, Gelber, R, Ramos E. The use of basilic vein and brachial artery as an A-V fistula for long term hemodialysis. J Surg Res. 1976;20(4):373-6.
66. Ballard JL, Bunt TJ, Malone JM. Major complications of angioaccess surgery. Am J Surg. 1992;164(3):229-32.
50. Kaufman JL, Garb JL, Berman JA et al. A prospective comparison of two expanded polytetrafluoroethylene grafts for linear forearm hemodialysis access: does the manufacturer matter? J Am Coll Surg. 1997;185(1):74-9.
42. Hossny A. Brachiobasilic arteriovenous fistula: different surgical techniques and their effects on fistula patency and dialysis-related complications. J Vasc Surg. 2003;37(4):821-6.
75. Zibari GB, Rohr MS, Landreneau MD et al. Complications from permanent hemodialysis vascular access. Surgery. 1988;104(4):681-6.
61. Basseau F, Grenier N, Trillaud H et al. Volume flow measurement in hemodialysis shunts using time-domain correlation. J Ultrasound Med. 1999;18(3):177-83.
57. Novel Endovascular Access Trial (NEAT): A Study of the FLEX System for Percutaneous AV Fistula Creation in Hemodialysis Patients. 2018 (in press).
92. Minion DJ, Moore E, Endean E. Revision using distal inflow: a novel approach to dialysis-associated steal syndrome. Ann Vasc Surg. 2005;19(5):625-8. 93. Schanzer H, Eisenberg D. Management of steal syndrome resulting from dialysis access. Semin Vasc Surg 2004;17(1):45-9. 94. MacRae JM, Pandeya S, Humen DP et al. Arteriovenous fistulaassociated high-output cardiac failure: a review of Mechanisms. Am J Kidney Dis. 2004;43(5):E21-2. 95. Reis GJ, Hirsch AT, Come PC. Detection and treatment of high-output cardiac failure resulting from a large hemodialysis fistula. Cathet Cardiovasc Diagn. 1988;14(4):263-5. 96. Pandeya S, Lindsay RM. The relationship between cardiac output and access flow during hemodialysis. ASAIO J. 1999;45(3):135-8. 97. Saxena AK, Panhotra BR, Al-Mulhim AS. Vascular access related infections in hemodialysis patients. Saudi J Kidney Dis Transpl. 2005;16(1):46-71. 98. Cohen G, Haag-Weber M, Hörl WH. Immune dysfunction in uremia. Kidney Int Suppl. 1997;62:S79-82. 99. Tokars JI, Miller ER, Stein G. New national surveillance system for hemodialysis-associated infections: initial results. Am J Infect Control. 2002;30(5):288-95.
222 Parte VIIMEMBROS SUPERIORES
1. James EC, Khuri NT, Fedde CW, Gardner RJ, Tarnay TJ, Warden HE. Upper limb ischemia resulting from arterial thromboembolism. Am J Surg 1979;137(6):739-44.
2. Deguara J, Ali T, Modarai B, Burnand KG. Upper limb ischemia: 20 years experience from a single center. Vascular 2005;13(2):84-91.
REFERÊNCIAS BIBLIOGRÁFICAS
8. Dave RB, Fleischmann D. Computed tomography angiography of the upper extremities. Radiol Clin 2016;54(1):101-14.
11. Giswold ME, Landry GJ, Taylor LM, Moneta GI. Iatrogenic arterial injury is an increasingly important cause of arterial trauma. Am J Surg 2004;187:590-93.
MEMBRO SUPERIOR
OCLUSÃO DO
223 116Capítulo
13. Braga PEG, Zorn W, Bellen BV, Salgado AA. Course of the postcatheterization pulse-less arm. J Cardiovasc Surg 1984;25:236-40.
14. Righini M, Angellillo A, Gueddi S, LeGal G, Bounamewaux H. Management of severe ischemia of the hand following intra-arterial injection. Thromb Haemost 2005; 94(1):219-21.
3. Wahlberg E, Goldstone J. Acute Upper Extremity Ischemia. In: Emergency Vascular Surgery. Springer, Berlin, Heidelberg; 2017. p. 47-51.
4. Skeik N, Soo-Hoo SS, Porten BR, Graber J, Alden P, Cragg A et al Arterial embolisms and thrombosis in upper extremity ischemia. Vasc Endovasc Surg 2015;49(5-6):100-9.
5. Roddy SP, Clement Darling R. Upper extremity arterial disease: revascularization. In: Rutherford’s Vascular Surgery. Jack L Cronenwett & K Wayne Johnston (eds), 7th edition, Saunders, Philadelphia, 2010:1798-1806.
16. Patel KR, Rowe VL. Vascular trauma: Extremity. In: Rutherford’s Vascular Surgery. Jack L Cronenwett & K Wayne Johnston (eds), 7th edition, Saunders, Philadelphia; 2010. p. 2361-73.
ARTERIAL AGUDA
22. Herrick Al. The pathogenesis, diagnosis and treatment of Raynaud phenomenon. N R Reum 2012;8:469-79.
23. Fries R, Sharlat K, von Wilmowsky H, Böhm M. Sildenafil in the treatment of Raynaud’s phenomenon resistant to vasodilatory therapy. Circulation 2005;112:2980-85. 24. Gonzáles-Hernández A, Marichal-Cancino BA, Maassen van der Brink A, Villalón CM. Side effects associated with current and prospective antimigraine pharmacotherapies. Exp Opin Drug Metabol Toxicol 2018;14:25-41.
18. Williams TK, Clouse D. Current concepts in repair of extremity venous injury. J Vasc Surg (Venous and Lymphatics) 2016;4(2):238-47.
19. Comarmond C, Biard L, Lambert M, Mekinian A, Ferfar Y, Kahn J-E et al. Long-term outcomes and prognostic factors of complications in Takayasu arteritis. Circulation 2017;136:1.114-22.
10. Reigstadt A, Hellum C. Volkmann’s ischaemic contracture of the forearm. Injury 1980;12(2):148-50.
20. Koster MJ, Matteson EL, Warrington J. Recent advances in the clinical management of giant cell arteritis and Takayasy arteritis. Cur Op Rheumatol 2016;28(3):211-17. 21. Saadoun D, Lambert M, Mirault T, Resche-Rigos M, Koskas F, Cluzel P et al. Retrospective analysis of surgery versus endovascular intervention in Takayasu arteritis. A multicenter experience. Circulation 2012;125:813-19.
6. Haurani MJ, Go MR, Starr JE, Vaccaro OS, Satiani B. Analysis of upper extremity arterial duplex indications may reduce unnecessary tests. J Angiol Vasc Surg 2016;1:4-6.
17. Rozycki GS, Tremblay LN, Feliciano DV, McCleland WB. Blunt vascular trauma in the extremity: diagnosis, management and outcome. J Trauma 2002;55(5):814-24.
12. Bagga V, Palmer M, Sadasivan R, Raghuraman G. Volkmann’s contracture, persistent limb ischemia, and amputation: a complication of brachial artery catheterization for heamodynamic monitoring using PiCCo. Case Rep Crit Care 2013;2013:474358
15. Feldman DR, Vujic I, McKay D, Callcott F, Uflacker R. Crutch-induced axillary artery injury. Cardiovasc Intervent Radiol 1995;18:296-99.
9. Nagpal P, Maller V, Garg G, Hedgire S, Khandelwal A, Kalva S et al Upper extremity runoff: pearls and pitfalls in computed tomography angiography and magnetic resonance angiography. C P D Radiol 2017;46(2):115-29.
7. Shin DS, Magill DB, Johnson GE, Ingraham CR, Kogut MJ, Monroe EJ. Upper extremity catheter angiography: indications, techniques, anatomy, and classic cases. J Clin Interv Radiol 2018;2(2):87-94.
4. Martin RR, Mattox KL, Burch JM et al. Advances in treatment of vascular injuries from blunt and penetrating limb trauma. World J Surg 1992 Sept-Oct;16(5):930-37.
15. Johansen K, Watson J. Compartment syndrome: new insights. Semin Vasc Surg 1998 Dec;11(4):294-301.
5. Fowler PJ, Willis RB.Vascular compartment syndromes. Can J Surg 1975 Mar;18(2):157-61. 6. Modrall JG. Compartment syndrome. In: Rutherford RB. (Ed). Vascular surgery. 7th ed. Philadelphia: WB Saunders; 2010. p. 2412-20.
9. Mubarak SJ, Owen CA. Double incision fasciotomy of the leg for decompression in compartment syndromes. J Bone Surg 1977;59A:184-87.
2. Feliciano DV, Cruse PA, Spjut-Patrinely V et al. Fasciotomy after trauma to the extremities. Am J Surg 1988 Dec;156(6):533-36.
DO MEMBRO SUPERIOR REFERÊNCIAS
16. Belkin M, Valeri R, Hobson RW. Intraarterial urokinase increases skeletal muscle viability after acute ischemia. J Vasc Surg 1989 Jan;9(1):163-68. 17. Rollins DL, Bernhard VM, Towne JB. Fasciotomy. Arch Surg 1981;116:1474-81. 18. Lastória S, Maffei FHA. Oclusões arteriais agudas. In: Maffei FHA (Ed.). Doenças vasculares periféricas. 3. ed. Rio de Janeiro: Medsi; 2002. p. 969-97. 19. Volkmann RV. Die ischaemischen muskellahmungen und kontrakturen. Zentralbl Chir 1881;8:801. 20. Hussmann J, Kucan JO, Zamboni WA. Elevated compartment pressures after closure of a forearm burn wound with skin-stretching device. Burn 1997;23:154-56. 21. Mckenney MG, Nir I, Fee T et al. A simple device for closure of fasciotomy wounds. Am J Surg 1996;172:275-77. 22. Pitta GBB, Santos CAS, Braga FA. Fasciotomias de extremidades. In: Murilo R. (ed). Trauma vascular. Rio de Janeiro: Revinter; 2005. p. 601-10. 23. Janzing H, Broos P. Fasciotomies of the limbs: how to do it? Acta Chir Belg 1998 Aug;98(4):187-91. 24. Argenta LC; Morykwas MJ. Vacuum-assisted closure: a new method for wound control and treatment: animal studies and basic foundation. Ann Plastic Surg 1997;38(6):553-562.
1. Matsen FA. Compartmental syndrome. Clin Orthop Relat Res 1975;113:8-14.
10. Farber, Alik et al. Early fasciotomy in patients with extremity vascular injury is associated with decreased risk of adverse limb outcomes: a review of the National Trauma Data Bank. Injury 2012;43(9):1486-91.
7. Rahm M, Probe R. Extensive deep venous thrombosis resulting in compartment syndrome of thigh and leg. J Bone Joint Surg 1994 Dec;12:1854-57. 8. Granchi TS, Garcia P, Mattox KL et al. Compartment syndromes. In: Rich NM. (Ed.). Vascular trauma. 2nd ed. Philadelphia: Elservier Saunders; 2004. p.443-55.
13. Matawa MJ, Whitesides TE, Seiler JG et al. Determination of the compartment pressure threshold of muscle ischemia. In a canine model. J Trauma 1994;37(1):50-8. 14. Mabee JR, Bostwick TL. Pathophysiology and mechanisms of compartment syndrome. Orthop Rev 1993;22:175-81.
3. Patman RD. Compartmental syndromes in peripheral vascular surgery. Clin Orthop 1975 Nov-Dec;(113):103-10.
FASCIOTOMIA BIBLIOGRÁFICAS
11. Baker AC; Clouse WD. Upper extremity and junctional zone injuries. In: Rich’s Vascular Trauma. 3rd ed. 2016. p.149-67.
224 117Capítulo
25. Rush DS, Frame SB, Bell RM et al. Does open fasciotomy contribute to morbidity and mortality after acute lower extremity ischemia and revascularization? J Vasc Surg 1989;10(3):323-33. 26. Turnipseed WD, Hurschier C, Vanderby Jr R. The effects of elevated compartment pressure on tibial arteriovenous flow and relationship of mechanical and biochemical characteristics of fascia to genesis of cronic anterior compartment syndrome. J Vasc Surg 1995;21(5):116-26. 27. Beard, JD; Gaines PA; Loftus I (Ed.).Vascular and Endovascular Surgery E-Book: Companion to Specialist Surgical Practice. Elsevier Health Sciences; 2013. 28. Berman SS, Schilling JD, McIntire KE et al. Shoelace technique for delayed primary closure of fasciotomies. Am J Surg 1994 Apr;167:435-36. 29. Malinoski DJ, Slater MS, Mullins RJ. Crush injury and rhabdomyolysis. Crit Care Clin 2004;20:171-92. 30. Zager RA. Rhabdomyolysis and myohemoglobinuric acute renal failure. Kidney Int 1996;49:314-26.
12. Varma S, Hobson RW, Duran W. Metabolic and Systemic consequences of acute limb ischemia and reperfusion. In: Hallet Jr JW (Ed.). Comprehensive vascular and endovascular surgery. St Louis:Mosby, 2004. p. 235-46.
225 118Capítulo
AMPUTAÇÕES DE
BIBLIOGRAFIA De Luccia N. Incidência. In: Amputação e reconstrução na doença vascular e no pé diabético. De Luccia N. Rio de Janeiro: Revinter; 2006. p. 5-9. American Academy of Orthopaedic Surgeons. Atlas of Limb Prosthetics. St. Louis: The C.V. Mosby Company; 1981. Atkins DJ; Meyer III RH. Comprehensive Management of the upper-limb amputee. New York: Springer-Verlag; 1989. Ouelette E. Partial hand amputation: surgical management. In: Atlas of Amputations and Limb Deficiencies: surgical, prosthetic and rehabilitation principles. American Academy of Orthopaedic Surgeons; edited by Smith DG, Michael JW, Bowker JH, 3th ed. p. 197-207. De Luccia N; Marino HL. Fitting of eletronic elbow on an elbow disarticulation patient by means of a new surgical technique. Prosthet Orthot Int 2000;24:247-51. De Luccia N, Pinto MAG, Yamaoka MSO, Cunha ESC, Cunha CAP. Amputação Bilateral de Membro Superior: Aspectos da reabilitação com próteses mio-eletricas. Cir Vasc Ang 1990;6(1):7-10.
E PRÓTESES
MEMBRO SUPERIOR
Parte VIII MEMBROS INFERIORES
229
APLICADA À REGIÃO
21. Valentine J. In: Ouriel K. The posterior approach to popliteal-crural bypass. J Vasc Surg 1994;19:78-9.
REFERÊNCIAS BIBLIOGRÁFICAS
22. Dardik H, Ibrahim IM, Sprayregen S, Dardik I. Revascularization of the peroneal artery. Surg Gynecol Obstet 1976;143:946-8. 23. Karmody AM, Leather RP, Shah DM, Corson JD, Naraynsingh V. Peroneal artery bypass: A reappraisal of its value in limb salvage. J Vasc Surg 1984;1:809-16. 24. Spatelholz W. Atlas de anatomia humana. 16. ed. São Paulo: Editora Roca; 1988. 25. Stoney R, Effeney D. Vascular exposures. Philadelphia: Lippincott Raven; 1998. 26. Uflacker R. Atlas of vascular anatomy. Baltimore: Williams & Wilkins; 1997. 27. Vieira de Mello A, Nascimento Silva JLC, Portilho MA. Visualização arteriográfica pré-operatória dos arcos plantares. Radiol Bras 1984;17:138-47. 28. Azizi, M. A. A. Morfometria das fibras elásticas em colaterais varicosas do sistema de veias safenas. Rev Angiol Cir Vasc 2002;11(1). 29. Garrido MBM. A croça da veia safena magna, estudo anatômico e correlação médico-cirúrgica. Tese (Livre-docência). Rio de Janeiro. Faculdade de Medicina da Universidade Federal Fluminense; 1975. 30. Askar O. The short saphenous vein. J Cardiovasc Surg 1963;4:126-37. 31. Monteiro da Silva AJ, Meirelles ML, Costa RO. Acesso ao hiato safeno — incisão acima da prega cutânea e flexão inguinal. Rev Col Bras Cir 1974 Jan/Fev. 32. Dodd H, Cockett FB. The surgical anatomy of the veins of the lower limb. In: Dodd H, Cockett FB. (Eds.). The pathology and surgery of the veins of the lower limb. London: Churchill Livingstone; 1976. 33. Garrido M. Linfangites e Erisipelas. 2. ed. Rio de Janeiro: Revinter; 2000. 34. Schünke M. Prometheus atlas de anatomia. 4. ed. Rio de Janeiro: Guanabrara Koogan; 2019. v. 1. 35. Moore, Keith L.; Dalley, Arthur F.; AGUR, Anne M. R. Anatomia Orientada Para a Clínica. 6. ed. Rio de Janeiro: Guanabara Koogan; 2013. 36. Netter, Frank H. Atlas de Anatomia Humana. 4. ed. Rio de Janeiro: Elsevier; 2008. 37. Imagem retirada de: NETTER, Frank H. Atlas de Anatomia Humana. 5. ed. Rio de Janeiro: Elsevier; 2011. 38. Sobotta, Johannes. Atlas de anatomia humana. 22. ed. Rio de Janeiro: Guanabara Koogan; 2006.
7. Testut L, Jacob O, Billet H. Atlas de disección por regiones. Barcelona: Salvat Editores; 1975. 8. Testut L, Latarjet A. Tratado de anatomia humana. 9. ed. Barcelona: Salvat Editores; 1968. 9. Testut L, Jacob O. Tratado de anatomia topográfica com aplicações médico-cirúrgicas. Barcelona: Salvat Editores; 1975. 10. Hamilton WJ. Tratado de anatomia humana. Rio de Janeiro: Interamericana; 1982. 11. Maffei FHA. Doenças vasculares periféricas. 2. ed. Rio de Janeiro: Medsi; 1995. 12. Netter F. Atlas of human anatomy. Ciba-Geigy; 1994. 13. Netter F. The ciba collection of medical illustrations. Sistema músculoesquelético. 12th ed. Ciba-Geigy; 1990. v. 8. 14. Netter F. The ciba collection of medical illustrations. Heart. 12th ed. Ciba-Geigy; 1990. v. 5. 15. Putz R, Pabst R. Sobotta — atlas de anatomia humana. 20. ed. Rio de Janeiro: Guanabara-Koogan; 1995. 16. Rohen J, Yokochi C. Anatomia humana — atlas fotográfico de anatomia sistêmica e regional. 2. ed. São Paulo: Editora Manole; 1989. 17. Rutherford R. Atlas de cirurgia vascular. Rio de Janeiro: Interlivros; 1998. 18. Williams P, Warwick R, Dyson M, Bannister L. Gray anatomia. 37. ed. Rio de Janeiro: Guanabara-Koogan; 1995. 19. Nascimento Silva JLC. In: Ouriel K. The posterior approach to poplitealcrural bypass J Vasc Surg 1994;19:79-80. 20. Ouriel K. The posterior approach to popliteal-crural bypass. J Vasc Surg 1994;19:74-80.
119Capítulo
ANATOMIA DOS MEMBROS INFERIORES
1. Brito CJ, Silva RM. Cirurgia Vascular: Cirurgia Endovascular, Angiologia 3. ed. Revinter; 2014. 2. Azizi MAA, Azizi PCA. Compêndio de Angiologia. Patologias Vasculares 2. ed. AC Farmaceutica. Rio de janeiro; 2008 3. Baptista Netto. Manual de dissecção. 4. ed. O livro médico Ltda., 1983. 4. Berguer R, Kieffer E. Surgery of the arteries of the head. New York: Springer-Verlag; 1992. 5. Grant JCB. An Atlas of Anatomy. 6th ed. Baltimore: Williams & Wilkins; 1972. 6. Haimovici H, Ascer A, Hollier LH, Strandness Jr. E, Towne JB. Haimovici’s vascular surgery — principles and techniques. 4th ed. New York: Blackwell Science; 1996.
13. Moore, KL. O membro inferior. Anatomia Orientada para Clínica, 3.ed. Rio de Janeiro: Ed. Guanabara Koogan; 1994. p. 383-6. 14. Szilagyi DE, Whitcomb, JG, Smith, RF. Anteromedial Aproach to the popliteal Artery for Femoropopliteal Arterial Grafting. Arch Surg 1959;78(4):647-51.
19. Hoelting G, Schuermann G, Allenberg JR. Entrapment of the popliteal artery and its surgical management in a 20-year period. Br J Surg 1997 May;84:338-41. 20. Beseth BD, Moore WS. The posterior approach for repair of popliteal artery aneurysms. J Vasc Surg 2006 May;43(5):940-4. 21. Kropman RHJ, Van Santvoor HC et al. The medial versus the posterior approach in the repair of popliteal artery aneurysms: A multicenter case-matched study. J Vasc Surg 2007;46:24-30.
REFERÊNCIAS BIBLIOGRÁFICAS
15. Rutherford RB et al. Cirurgia Vascular Aberta. Considerações Básicas. Anatomia das Artérias Comumente Expostas. Cirurgia Vascular. 6. ed. –New York, USA: Elsevier Inc.; 2005. p. 658. v. 1.
24. Ouriel K. The posterior approach to popliteal-crural by-pass. J Vasc Surg 1994;19:74-80. 25. Kuma S, Morisaki K, Okazaki J, Mii S. In situ popliteal-ibial by-pass with the shor saphenous vein through a posterior approach for limb salvage. Vasc Endovasc Surg 2018 Jan;1. 26. Dardik H, Ibrahim IM, Dardik II. Femoral tibial-peroneal by-pass. The lateral approach and use of glutaraldehyde-tanned umbilical vein. Am J Surg 1977 Mar;9-12. 27. Dardik H, Elias S, Milker N et al. Medial approach to the anterior tibial artery. J Vasc Surg 1985;19(4):717-21. 28. Sladen JG, Kougger G, Raid JD. Exposure of the anterior tibial arteria by medial popliteal extension. J Vasc Surg 1994 Apr;19(4):717-21.
29. Latrémouille C, Chemia E, Diemont F et al. Posterior approach for simultaneous access to the popliteal and anterior tibial arteries: applications to distal arterial bypass. Surg Radiol Anat 2001;23(2):81-4. 30. Londoño JC, Singh V, Marinez CA. Posterior tibial artery access using transradial techniques: retrograde approach to inaccessible lower extremity lesions. Catheter Cardiovasc Interv 2012 June 1;97(7):1194-8.
16. Veith FJ, Ascer E, Gupta SK, Wengerter KR. Lateral approach to the popliteal artery. J Vasc Surg 1987;6:119-23.
17. Benzing C, Fellmer PT. Lateral Approach to the Distal Femoral Artery in Femoro-Anterior-Tibial Bypass Surgery. Eur J Vasc Endovasc Surg 2016;52:267. 18. Da Silva MS, Sobel M. Popliteal Vascular Injury during Total Knee Arthroplasty. J Surg Res 2003;109:170-4.
1. Carnevale FC. Tratado de radiologia intervencionista e cirurgia endovascular. São Paulo: Thieme Revinter Publicações LTDA; 2017. 2. Topaloc I, Marinov G. A new posterior approach for an extraanatomical arterial by-pass for lower extremity revascularization (gluteopopliteal by-pass). Eur J Vasc Surg 1993;7:454-6. 3. Papadopoulos SM, Mc Gillicuddy JE, Messina LM. Pseudoaneurysm of the inferior gluteal artery presenting as sciatic nerve compression. Neurosurgery 1989 June;24(6):926-8. 4. Rossi M. Vias de acesso mais utilizadas na cirurgia vascular. In: Brito CJ (Ed.). Cirurgia vascular. 3. ed. Rio de Janeiro: Revinter; 2014. p. 242. v. 1. 5. Nascimento Silva, JLC. Anatomia médico-cirúrgica do sistema vascular. In: Brito CJ (Ed.). Cirurgia vascular. 3. ed. Rio de Janeiro: Revinter; 2014. p. 37. v. 1. 6. Haimovici H, Ernest CB, Berguer R. Exposição cirúrgica dos vasos. In: Haimovici H (Ed.). Cirurgia vascular princípios e técnicas. 4. ed. Rio de Janeiro: Di-Livros; 2000. 7. Rossi M, Brito CJ, Cury RCP. Principais vias de acesso utilizadas no trauma vascular. In: Rossi M (Ed. Trauma vascular. Rio de Janeiro: Revinter; 2006. p. 70-1. 8. Rossi M. Dez vias de acesso. In: Rossi M (Ed.). Top ten em cirurgia vascular. Rio de Janeiro: Di-livros; 2013. p. 33-4. 9. Wind GG, Valentine RJ. Vasos do membro inferior. In: Exposições anatômicas em cirurgia vascular. 3. ed. Rio de Janeiro: Di-Livros; 2014. p. 422-6. 10. Maffei FH, Lastória S, Yoshida WB et al. In: Maffei AMH (Ed.). Doenças vasculares periféricas. 4. ed. Rio de Janeiro: Guanabara Koogan SA; 2008. p. 114-27. v. 1. 11. Merlo I, Parente JB, Komlós PP. Tratamento cirúrgico das varizes. In: Varizes e Telangectasias - Diagnóstico e Tratamento. Rio de Janeiro: Revinter; 2006. p. 233-4. 12. Rich NM, Rasmussem TE, Tai NRM. Trauma vascular na extremidade inferior. In: Rich Trauma Vascular. 3. ed. Rio de Janeiro: Elsevier; 2017. p. 169-71.
22. Ballotta E, Renon L, De Rossi A et al. Prospective randomized study on reversed saphenous vein infrapopliteal by-pass to trea limbthreaining ischemia: common femoral artery versus superficial femoral or popliteal and tibial arteries as inflow. J Vasc Surg 2004 Oct;40(4):732-40. 23. Walker CJ. Pedal access in critical limb ischemia. Cardiovasc Surg (Torino) 2014 Apr; 55(2):225-7.
31. Graham JW, Hanel KC. Veins grafts to the peroneal artery. Surgery 1981;89:264-8.
32. Lesser G, Frisch HJ, Freitag S, Venth S. Popliteoperoneal in situ bypass using the small saphenous vein enables revasculrization with low trauma. Int Surg 2011 Oct-Dec;96(4):326-30. 33. Morisaki K, Yamaoka T, Iwasa K, Ohmine T. Popliteal-peroneal artery bypass via the posterior approach: a case report. Ann Vasc Surg 2016;36:292-4. 34. Goyal A, Shah PM, Babu SC, Mateo RB. Popliteal-crural by-pass through the posterior approach with lesser saphenous vein for limb salvage. J Vasc Surg 2002;36(4):708-12. 35. Valentine RJ, Blankenship CL, Wind GG. The tibial gutter: a protected route for bypass to the distal anterior tibial artery. J Vasc Surg 1989;10:465-7. 36. Andros G, Harris RW, Salles-Cunha SX et al. Lateral plantar artery bypass grafting: definition the limits of foot revascularization. J Vasc Surg 1989;10:511-52.
230 120Capítulo VIAS DE ACESSO AOS VASOS DOS MEMBROS INFERIORES
24. Labropoulos N, Giannoukas AD, Delis K et al. Where does venous reflux start? J Vasc Surg. 1997;26(5):736-42.
25. Labropoulos N, Leon L, Kwon S et al. Study of the venous reflux progression. J Vasc Surg. 2005;41(2):291-5. 26. Labropoulos N, Tiongson J, Pryor L et al. Nonsaphenous superficial vein reflux. J Vasc Surg. 2001;34(5):872-7.
7. Caggiati A, Bergan JJ. The saphenous vein: derivation of its name and its relevant anatomy. J Vasc Surg. 2002;35(1):172-5.
ECOCOLOR E PROFUNDA BIBLIOGRÁFICAS
REFERÊNCIAS
6. Caggiati A, Bergan JJ, Gloviczki P et al. Nomenclature of the veins of the lower limb: extensions, refinements, and clinical application. J Vasc Surg. 2005;41(4):719-24.
17. van Bemmelen PS, Bedford G, Beach K, Strandness DE. Quantitative segmental evaluation of venous valvular reflux with duplex ultrasound scanning. J Vasc Surg. 1989;10(4):425-31.
18. Labropoulos N, Tiongson J, Pryor L et al. Definition of venous reflux in lower-extremity veins. J Vasc Surg. 2003;38(4):793-98.
21. Engelhorn CA, Engelhorn AL, Salles-Cunha SX. Relationship between reflux and greater saphenous vein diameter. J Vasc Technol 1997;21(3):167.
1. Coleridge-Smith P, Labropoulos N, Partsch H et al. Duplex ultrasound investigation of the veins in chronic venous disease of the lower limbs--UIP consensus document. Part I. Basic principles. Eur J Vasc Endovasc Surg. 2006;31(1):83-92.
231 121Capítulo
16. Engelhorn CA, Engelhorn AL, Cassou MF, Salles-Cunha SX. Patterns of saphenous reflux in women with primary varicose veins. J Vasc Surg. 2005;41(4):645-51.
DOPPLER NA DOENÇA VENOSA SUPERFICIAL
10. Caggiati A. Fascial relationships of the short saphenous vein. J Vasc Surg. 2001;34(2):241-6. 11. Vasdekis SN, Clarke GH, Hobbs JT, Nicolaides AN. Evaluation of noninvasive and invasive methods in the assessment of short saphenous vein termination. Br J Surg. 1989;76(9):929-32.
4. Garcia-Madrid C, Pastor Manrique JO, Gomez Blasco F, Sala Planell E. New advances in the treatment of varicose veins: endovenous radiofrequency VNUS Closure(R). Cir Esp. 2011;89(7):420-6.
22. Sandri JL, Barros FS, Pontes S et al. Diameter-reflux relationship in perforating veins of patients with varicose veins. J Vasc Surg. 1999;30(5):867-74.
14. Carandina S, Mari C, De Palma M et al. Varicose vein stripping vs haemodynamic correction (CHIVA): a long term randomised trial. Eur J Vasc Endovasc Surg. 2008;35(2):230-7.
9. Caggiati A. The “interfascial” veins of the lower limbs. Ital J Anat Embryol. 2005;110(2 Suppl 1):97-102.
3. Malgor RD, Labropoulos N. Diagnosis of venous disease with duplex ultrasound. Phlebology. 2013;28 Suppl 1:158-61.
5. Maurins U, Hoffmann BH, Losch C et al. Distribution and prevalence of reflux in the superficial and deep venous system in the general population--results from the Bonn Vein Study, Germany. J Vasc Surg. 2008;48(3):680-7.
12. Engel AF, Davies G, Keeman JN. Preoperative localisation of the saphenopopliteal junction with duplex scanning. Eur J Vasc Surg. 1991;5(5):507-9.
19. Lurie F, Comerota A, Eklof B et al. Multicenter assessment of venous reflux by duplex ultrasound. J Vasc Surg. 2012;55(2):437-45.
27. Barros FS, Zandonade E, Perez JMG, Salles-Cunha SX. Evaluation of pelvic varicose veins using color Doppler ultrasound: comparison of results obtained with ultrasound of the lower limbs, transvaginal ultrasound, and phlebography. J Vasc Br. 2010;9(2):15-23. 28. Labropoulos N, Tassiopoulos AK, Gasparis AP et al. Veins along the course of the sciatic nerve. J Vasc Surg. 2009;49(3):690-6. 29. Francheschi C, Bahnini A. Treatment of lower extremity venous insufficiency due to pelvic leak points in women. Ann Vasc Surg. 2005;19(2):284-8. 30. Perrin MR, Labropoulos N, Leon LR Jr. Presentation of the patient with recurrent varices after surgery (REVAS). J Vasc Surg. 2006;43(2):32734; discussion 334. 31. van Rij AM, Jiang P, Solomon C et al. Recurrence after varicose vein surgery: a prospective long-term clinical study with duplex ultrasound scanning and air plethysmography. J Vasc Surg. 2003;38(5):935-43.
2. Gloviczki P, Comerota AJ, Dalsing MC et al. The care of patients with varicose veins and associated chronic venous diseases: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg. 2011;53(5 Suppl):2s-48s.
8. Kachlik D, Pechacek V, Baca V, Musil V. The superficial venous system of the lower extremity: new nomenclature. Phlebology. 2010;25(3):113-23.
20. Malgor RD, Labropoulos N. Diagnosis and follow-up of varicose veins with duplex ultrasound: how and why? Phlebology. 2012;27 Suppl 1:10-15.
13. Delis KT, Knaggs AL, Khodabakhsh P. Prevalence, anatomic patterns, valvular competence, and clinical significance of the Giacomini vein. J Vasc Surg. 2004;40(6):1174-83.
32. Monedero JL, Ezpeleta SZ, Perrin M. Pelvic congestion syndrome can be treated operatively with good long-term results. Phlebology. 2012;27 Suppl 1:65-73. 33. Barros FS, Salles-Cunha SX, Vieira MM, Perez JMG. Relationship between diameter and pelvic vein reflux.; 2011; Presented at the 34th Annual Conference of the Society of Vascular Ultrasound. Chicago, IL, USA. 34. Kim HS, Malhotra AD, Rowe PC et al. Embolotherapy for pelvic congestion syndrome: long-term results. J Vasc Interv Radiol. 2006;17(2 Pt 1):289-97. 35. Ratnam LA, Marsh P, Holdstock JM et al. Pelvic vein embolisation in the management of varicose veins. Cardiovasc Intervent Radiol. 2008;31(6):1159-64. 36. De Maeseneer M, Pichot O, Cavezzi A et al. Duplex ultrasound investigation of the veins of the lower limbs after treatment for varicose veins - UIP consensus document. Eur J Vasc Endovasc Surg. 2011;42(1):89-102. 37. Blomgren L, Johansson G, Dahlberg AA et al. Recurrent varicose veins: incidence, risk factors and groin anatomy. Eur J Vasc Endovasc Surg. 2004;27(3):269-74. 38. Allegra C, Antignani PL, Carlizza A. Recurrent varicose veins following surgical treatment: our experience with five years follow-up. Eur J Vasc Endovasc Surg. 2007;33(6):751-6. 39. van Rij AM, Jones GT, Hill GB, Jiang P. Neovascularization and recurrent varicose veins: more histologic and ultrasound evidence. J Vasc Surg. 2004;40(2):296-302. 40. Geier B, Mumme A, Hummel T et al. Validity of duplex-ultrasound in identifying the cause of groin recurrence after varicose vein surgery. J Vasc Surg. 2009;49(4):968-72. 41. Egan B, Donnelly M, Bresnihan M et al. Neovascularization: an “innocent bystander” in recurrent varicose veins. J Vasc Surg. 2006;44(6):1279-84; discussion 1284. 42. Gurgel Gdo A, Castro AA, Araújo M et al. Evaluation of the venous reflux of the great saphenous vein by duplex scan after surgical
15. Kistner RL, Eklof B, Masuda EM. Diagnosis of chronic venous disease of the lower extremities: the “CEAP” classification. Mayo Clin Proc. 1996;71(4):338-45.
23. Cassou CAELEF, Zanoni CC, Gosalan CJ, Ribas E. Functional anatomic classification of saphenous vein insufficiency in the planning for varicose vein surgery based on color Doppler ultrasound. J Vasc Br. 2004;3(1):13-9.
75. Labropoulos N, Bhatti AF, Amaral S et al. Neovascularization in acute venous thrombosis. J Vasc Surg. 2005;42(3):515-8.
64. Bernardi E, Camporese G, Buller HR et al. Serial 2-point ultrasonography plus D-dimer vs whole-leg color-coded Doppler ultrasonography for diagnosing suspected symptomatic deep vein thrombosis: a randomized controlled trial. JAMA. 2008;300(14):1653-9. 65. Barros M, Pereira V, Pintol D. Controvérsias no diagnóstico e tratamento da trombose venosa profunda pela ecografia vascular. J Vasc Br. 2012;11(2):137-43. 66. Lemech LD, Sandroussi C, Makeham V et al. Is bilateral duplex scanning necessary in patients with symptoms of deep venous thrombosis? ANZ J Surg. 2004;74(10):847-51. 67. Pennell RC, Mantese VA, Westfall SG. Duplex scan for deep vein thrombosis--defining who needs an examination of the contralateral asymptomatic leg. J Vasc Surg. 2008;48(2):413-6. 68. Rubin JM, Xie H, Kim K et al. Sonographic elasticity imaging of acute and chronic deep venous thrombosis in humans. J Ultrasound Med. 2006;25(9):1179-86. 69. Barros F, Prezotti B, Pontes S. Identificação pelo eco-Doppler colorido de fístula arteriovenosa na trombose venosa profunda. J Vasc Bras. 2006;5(3):224-8. 70. Sevitt S. The mechanisms of canalisation in deep vein thrombosis. J Pathol. 1973;110(2):153-65. 71. Sevitt S. Organization of valve pocket thrombi and the anomalies of double thrombi and valve cusp involvement. Br J Surg. 1974;61(8):641-9. 72. Meissner MH, Wakefield TW, Ascher E et al. Acute venous disease: venous thrombosis and venous trauma. J Vasc Surg. 2007;46 Suppl S:25s-53s. 73. van Ramshorst B, van Bemmelen PS, Hoeneveld H et al. Thrombus regression in deep venous thrombosis. Quantification of spontaneous thrombolysis with duplex scanning. Circulation. 1992;86(2):414-9.
52. Mattos MA, Melendres G, Sumner DS et al. Prevalence and distribution of calf vein thrombosis in patients with symptomatic deep venous thrombosis: a color-flow duplex study. J Vasc Surg. 1996;24(5):738-44.
49.
48. El-Menyar A, Asim M, Jabbour G, Al-Thani H. Clinical implications of the anatomical variation of deep venous thrombosis. Phlebology. 2018;33(2):97-106. Labropoulos N, Waggoner T, Sammis W et al. The effect of venous thrombus location and extent on the development of post-thrombotic signs and symptoms. J Vasc Surg. 2008;48(2):407-12. Repella TL, Lopez O, Abraham CZ et al. Characterization of profunda femoris vein thrombosis. J Vasc Surg Venous Lymphat Disord. 2018. Labropoulos N, Webb KM, Kang SS et al. Patterns and distribution of isolated calf deep vein thrombosis. J Vasc Surg. 1999;30(5):787-91.
55. Killewich LA, Bedford GR, Beach KW, Strandness DE Jr. Diagnosis of deep venous thrombosis. A prospective study comparing duplex scanning to contrast venography. Circulation. 1989;79(4):810-14.
57. Needleman L, Cronan JJ, Lilly MP et al. Ultrasound for Lower Extremity Deep Venous Thrombosis: Multidisciplinary Recommendations From the Society of Radiologists in Ultrasound Consensus Conference. Circulation. 2018;137(14):1505-15.
58. Rollo HA, Maffei F, Yoshiba W, Fortes V. Abordagem diagnóstica dos pacientes com suspeita de trombose venosa profunda dos membros inferiores. J Vasc Bras. 2005;4(1):79-92.
86.
63. Crisp JG, Lovato LM, Jang TB. Compression ultrasonography of the lower extremity with portable vascular ultrasonography can accurately detect deep venous thrombosis in the emergency department. Ann Emerg Med. 2010;56(6):601-10.
56. Garcia R, Labropoulos N. Duplex ultrasound for the diagnosis of acute and chronic venous diseases. Surg Clin North Am. 2018;98(2):201-18.
54. Goodacre S, Sampson F, Thomas S et al. Systematic review and metaanalysis of the diagnostic accuracy of ultrasonography for deep vein thrombosis. BMC Med Imaging. 2005;5:6.
74. Yamaki T, Nozaki M. Patterns of venous insufficiency after an acute deep vein thrombosis. J Am Coll Surg. 2005;201(2):231-8.
50.
60. Jon C. Henry David Strosberg Shantanu Warhadpande B. Clinical and Ultrasound Sequelae of Nonvisualized Calf Veins on Duplex Ultrasound for Suspected Deep Vein Thrombosis. J Vasc Ultrasound 2016;40(1):26-31.
59. Rose SC, Zwiebel WJ, Nelson BD et al. Symptomatic lower extremity deep venous thrombosis: accuracy, limitations, and role of color duplex flow imaging in diagnosis. Radiology. 1990;175(3):639-44.
77. Maufus M, Elias A, Barrellier MT, Pernod G. Diagnosis of deep vein thrombosis recurrence: ultrasound criteria. Thromb Res. 2018;161:78-83. 78. Seidel AC, Cavalheri G Jr., Miranda F Jr. The role of duplex ultrasonography in the diagnosis of lower-extremity deep vein thrombosis in non-hospitalized patients. Int Angiol. 2008;27(5):377-84. 79. Sutter ME, Turnipseed SD, Diercks DB et al. Venous ultrasound testing for suspected thrombosis: incidence of significant non-thrombotic findings. J Emerg Med. 2009;36(1):55-9. 80. de Oliveira A, Franca GJ, Vidal EA et al. Duplex scan in patients with clinical suspicion of deep venous thrombosis. Cardiovasc Ultrasound. 2008;6:53. 81. Jones DW, Rezayat C, Winchester P, Karwowski JK. Adventitial cystic disease of the femoral vein in a 5-year-old boy mimicking deep venous thrombosis. J Vasc Surg. 2012;55(2):522-4. 82. Prandoni P, Kahn SR. Post-thrombotic syndrome: prevalence, prognostication and need for progress. Br J Haematol. 2009;145(3):286-95. 83. Silva Mde C. Chronic venous insufficiency of the lower limbs and its socio-economic significance. Int Angiol. 1991;10(3):152-7. 84. de Wolf MA, Wittens CH, Kahn SR. Incidence and risk factors of the post-thrombotic syndrome. Phlebology. 2012;27 Suppl 1:85-94. Scott G, Mahdi AJ, Alikhan R. Superficial vein thrombosis: a current approach to management. Br J Haematol. 2015;168(5):639-45. Frappe P, Buchmuller-Cordier A, Bertoletti L et al. Annual diagnosis rate of superficial vein thrombosis of the lower limbs: the STEPH community-based study. J Thromb Haemost. 2014;12(6):831-8.
61. Giannini M, Rollo H, Maffei F. Role of duplex scanning in the diagnosis of asymptomatic lower-extremity deep venous thrombosis. J Vasc Br 2005;4(3):290-6.
85.
62. Pandey A, Thakur B, Hogg F et al. The role of preoperative deep vein thrombosis screening in neurooncology. J Neurosurg. 2018:1-6.
76. Meissner MH, Eklof B, Smith PC et al. Secondary chronic venous disorders. J Vasc Surg. 2007;46 Suppl S:68s-83s.
232 Parte VIIIMEMBROS INFERIORES treatment of the saphenofemoral junction insufficiency. Rev Col Bras Cir. 2013;40(5):380-5. 43. Mundy L, Merlin TL, Fitridge RA, Hiller JE. Systematic review of endovenous laser treatment for varicose veins. Br J Surg. 2005;92(10):1189-94. 44. Proebstle TM, Vago B, Alm J et al. Treatment of the incompetent great saphenous vein by endovenous radiofrequency powered segmental thermal ablation: first clinical experience. J Vasc Surg. 2008;47(1):151-6. 45. White RH. The epidemiology of venous thromboembolism. Circulation. 2003;107(23 Suppl 1):I4-8. 46. Garry J, Duke A, Labropoulos N. Systematic review of the complications following isolated calf deep vein thrombosis. Br J Surg. 2016;103(7):789-96. 47. Sapp B, Craddock G, Sapp J. Patterns and distribution of deep vein thrombus in the lower extremity. J Vasc Ultrasound 2015;39(2):71-7.
53. Horner D, Hogg K, Body R. Should we be looking for and treating isolated calf vein thrombosis? Emerg Med J. 2016;33(6):431-7.
51.
8. Ventura C, Ribeiro J, Scaion RB. Ultrassonografia das artérias dos membros inferiores. In: Ventura C, Cerri GG (Eds.). Ultrassonografia vascular: correlação com angiotomografia. Rio de Janeiro: Revinter; 2012. c. 7. p. 83-95. 9. Tsunoda A, Albuquerque AF. Arterial periférico. In: Romualdo AP (Ed). Doppler sem segredos. Amsterdã: Elsevier; 2015. c. 14. p. 191-218.
12. Jager KA, Ricketts HJ, Strandness DE Jr. Duplex scanning for the evaluation of lower limb arterial disease. In Bernstein EF (Ed.). Noninvasive diagnostic techniques in vascular disease, St. Louis: Mosby; 1985. p. 619-31.
16. Leng GC et al. Accuracy and reproducibility of duplex ultrasonography in grading femoropopliteal stenoses. J Vasc Surg. 1993;17:510-17.
15. Zierler RE. Avaliação ultrassonográfica das extremidades inferiores. In: Pelerito JS, Polak JF (Eds). Introdução à ultrassonografia vascular. 6. ed. Amsterdã: Elsevier; 2014. c. 17. p. 294-306.
18. Johnson BL, Avino AJ, Bandyk DF. Duplex-monitored angioplasty of peripheral artery and infrainguinal vein graft stenosis. In: Whittemore AD (Ed.). Advances in vascular surgery. St. Louis: Mosby; 2000. v. 8. p. 83-95. 19. Gupta AK et al. Natural history of infrainguinal vein graft stenosis relative to bypass grafting technique. J Vasc Surg. 1997;25:211-25. 20. Hodgkiss-Harlow K. Avaliação ultrassonográfica durante e após intervenção carotídea e periférica. In: Pelerito JS, Polak JF (Eds.). Introdução à ultrassonografia vascular. 6. ed. Amsterdã: Elsevier; 2014. c. 18. p. 307-23. 21. Bandyk DF, Armstrong PA. Monitoração depois da angioplastia transluminal com stenting das artérias periféricas. In: Zieler RE (Ed.). Strandness – EcoDoppler nas doenças vasculares, 4.ed. Rio de Janeiro: DiLivros; 2011. c. 15. p. 217-26. 22. Mills JL et al. The origin of infrainguinal vein graft stenosis: a prospective study based on duplex surveillance. J Vasc Surg. 1995;21:16-25. 23. Bandyk DF, Hodgkiss-Harlow K. Ultrasound assesment during and after carotid and peripheral intervention. In: Pelerito JS, Polak JF (Eds.). Introduction to vascular ultrasonography. 6th ed. Amsterdã: Elsevier Saunders; 2012. p. 315. 24. Reed AB. Popliteal artery aneurysm. In: UpToDate; 2018. 25. Guzman RJ, Jo L. Femoral artery aneurysm. In: UpToDate; 2018. 26. Mehta KS, Lee JJ, Taha AA et al. Vascular applications of contrastenhanced ultrasound imaging. J Vasc Surg. 2017 July;66(1):266-74. 27. Hou XX, Chu GH, Yu Y. Prospects of contrast-enhanced ultrasonography for the diagnosis of peripheral arterial disease: a meta-analysis. J Ultrasound Med. 2018 May;37(5):1081-90.
6. Lewis BD, James ME, Welch TJ. Current applications of duplex and color Doppler ultrasound imaging: Carotid and peripheral vascular system. Mayo Clin Proc 1989;64:1147-57.
5. Thiele BL, Strandness DE Jr. Accuracy of angiographic quantification of peripheral atherosclerosis. Prog Cardiovasc Dis. 1983;26:223-36.
REFERÊNCIAS BIBLIOGRÁFICAS
11. Jager KA et al. Diagnostic value of duplex scanning in peripheral vascular disease. Vasc Med Rev. 1990;1:21-33.
7. Domingos MF. Doença aterosclerótica dos membros inferiores/Doença arterial oclusiva e aneurismática. In: Guia Prático de Ultrassonografia Vascular. 3. ed. Rio de Janeiro: DiLivros; 2015. c. 24. p. 296-319.
1. Management of peripheral arterial disease (PAD). TransAtlantic InterSociety Consensus (TASC). Int Angiol. 2000 Mar;19(1 Suppl 1):I-XXIV, 1-304. Review. 2. Fowkes FG, Rudan D, Rudan I et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet 2013;382:1329.
4. Slot HB, Strijbosch L, Greep JM. Interobserver variability in singleplane aortography. Surgery. 1981;90:497-503.
ECOCOLOR DOPPLER NA DOENÇA ARTERIAL
13. Zierler RE, Zierler BK. Duplex sonography of lower extremity arteries. Semin Ultrasound CT MR 1997;18:43.
3. Keven A, Durmaz MS. The importance of community screening of asymptomatic elderly for peripheral arterial disease by Doppler ultrasound and ankle-brachialindex. J Ultrason. 2017 Dec;17(71):235-40.
233 122Capítulo
10. Polak JF, Alessi-Chinetti JM. As artérias periféricas. In: Rumack CM (Ed.). Tratado de ultrassonografia diagnóstica. 4. ed. Amsterdã: Elsevier; 2012. c. 26. p. 998-1022.
17. Gao M, Hua Y, Zhao X et al. Optimal ultrasound criteria for grading stenosis of the superficial femoral artery. Ultrasound Med Biol. 2018 Feb;44(2):350-8.
14. Jager KA, Philips DJ, Martin RL et al. Noninvasive mapping of lower limb arterial lesions. Ultrasound Med Biol. 1985;11:515-21.
23. Dussik KT. On the possibility of using ultrasound waves as a diagnostic aid. Neurol Psychiat. 1942;174:153-68.
15. Brito CJ. Cirurgia vascular. Rio de Janeiro: Revinter; 2002. p. 25-34.
41.
2. Nasu K, Tsuchikane E, Katoh O et al. Accuracy of in vivo coronary plaque morphology assessment: a validation study of in vivo virtual histology compared with in vitro histopathology. J Am Coll Cardiol 2006;47:2405-12.
11. van Sambeek MRHM, Gussenhoven EJ, van Overhagen H et al Intravascular ultrasound in endovascular stent-grafts for peripheral aneurysm: a clinical study. J Endovasc Surg. 1998;5:106-12.
234 123Capítulo ULTRASSONOGRAFIA INTRAVASCULAR NA DOENÇA ARTERIAL PERIFÉRICA REFERÊNCIAS BIBLIOGRÁFICAS
8. Scoccianti M, Verbin CS, Kopchok GE et al. Intravascular ultrasound guidance for peripheral vascular interventions. J Endovasc Surg. 1994;1:71-80.
16. Carnevale FC. Radiologia intervencionista e cirurgia endovascular. Rio de Janeiro: Revinter; 2006. p. 31-44.
3. Nissen SE, Gurley JC, Grines CL et al. Intravascular ultrasound assessment of lumen size and wall morphology in normal subjects and patients with coronary artery disease. Circulation 1991;84:1087-99.
14. Bakal, CW. Vascular and interventional radiology. New York: Thieme; 2002. p. 16-24.
45.
22. Lee JT, White RA. Basics of Intravascular ultrasound: an essential tool for the endovascular surgeon. Semin Vasc Surg. 2004;17(2):110-8.
6. Bom N, Hoff H, Lancee CT et al. Early and recent intraluminal ultrasound devices. Int J Card Imaging. 1989;4:79-88.
13. Baum S, Pentecost MJ. Abrams’ Angiography: intervencional radiology. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 2006. p. 25-36.
17. Seldinger SI. Catheter replacement of the needle in percutaneous arteriography; a new technique. Acta radiologica 1953;39(5):368-76.
24. Benenati JF et al. Intravascular ultrasound: the role in diagnostic and therapeutic procedures. Cardiology Clinics. 1997 Feb;15(1):141-59.
26. Bom N, Lancee CT, Van Egmond FC et al. Intra-arterial ultrasonic imaging for recanalization by spark erosion. Ultrasound in Med. & Biol. 1988;14(4):257-61. 27. Lobato AC. Cirurgia endovascular. São Paulo: Instituto de Cirurgia Vascular e Endovascular de São Paulo; 2006. p. 154-75. 28. Vince DG, Davies SC. Peripheral application of intravascular ultrasound virtual histology. Semin Vasc Surg. 2004;17:119-25. 29. Nair A, Kuban BD, Tuzcu EM et al. Coronary plaque classification with intravascular ultrasound radiofrequency data analysis. Circulation 2002;106:2200-06. 30. Diethrich BE et al. Virtual Histology Intravascular Assessment of Carotid Artery Disease: The Carotid Artery Plaque Virtual Histology Evaluation (CAPITAL) Study. J Endovasc Ther 2007;14:676-86. 31. Irshad K, Reid DB, Miller PH et al. Early Clinical Experience With Color Three-Dimensional Intravascular Ultrasound in Peripheral Interventions. J Endovasc Ther 2001;8:329-38. 32. Tabara M, White R, Cavaye D, Kopchok G. In vivo human comparison of intravascular ultrasonography and angiography. J Vasc Surg. 1991;14:496-504. 33. Scoccianti M, Verbin CS et al. Intravascular ultrasound guidance during peripheral vascular interventions. J Endovasc Surg 1994;1:71-80. 34. The GUIDE Trial investigators. Impact of the vascular ultrasound on device selection and end-point assessment of intervention (absctract). J Am Coll Cardiol 1993;21:134A. 35. Gussenhoven EJ, Van der Lugt A, Pasterkamp G et al. Intravascular ultrasound predictors of outcome after peripheral balloon angioplasty. Eur J Vasc Endovasc Surg 1995;10:279-88. 36. Vogt KJ, Rasmussen JG, Just S, Schroeder TV. Prediction of outcome after femoropopliteal balloon angioplasty by intravascular ultrasound. Eur J Vasc Endovasc Surg 1997;13:563-8. 37. Vogt KJ, Schroeder VB et al. The use of intravascular ultrasound as control procedure for deployment of endovascular stented grafts. J Vasc Endovasc Surg. 1997;13:592-6. 38. Vogt KJ, Rasmussen JG, Just S, Schroeder TV. Effect and outcome of balloon angioplasty of the iliac arteries evaluated by intravascular ultrasound. Eur J Vasc Endovasc Surg. 1999;17:47-55. 39. Arko FR, Mettauer M, McCollough R et al. Use of intravascular ultrasound improves longterm clinical outcome in the endovascular management of atherosclerotic aortoiliac occlusive disease. J Vasc Surg 1998;27:614-23. 40. Navarro S, Sullivan TM, Bacharach JM. Intravascular ultrasound assessment of Iliac stent procedures. J Endovasc Ther. 2000;7:315-9. Lee SD, Arko FR, Buckley CJ. Impact of intravascular ultrasonography in the endovascular management of aortoiliac occlusive disease. J Vasc Nurs. 1998;16(3):57-61. 42. Kawasaki D, Tsujino T, Fujii K et al. Novel use of ultrasound guidance for recanalization of iliac, femoral and popliteal arteries. Catheterization and Cardiovascular Interventions 2008;71:727-33. 43. Cho JR, Kim JS et al. Subintimal angioplasty of an aortoiliac occlusion: re-entry site created using a transeptal needle under intravascular ultrasound guidance. J Endovasc Ther. 2007;14:816-22. 44. Wilson EP, White RA, Kopchok GE. Utility of intravascular ultrasound in carotid stenting. J Endovasc Surg. 1996;3:63-8. Joan MM, Moya BG, Augusti FP et al. Utility of intravascular ultrasound examination during carotid stenting. Ann Vasc Surg. 2009;23: 606-11. 46. Nair A, Kuban BD, Tuzcu EM et al. Coronary plaque classification with intravascular ultrasound radiofrequency data analysis. Circulation 2002;106:2200-6.
10. Wilson EP, White RA, Kopchok G. The utility of intravascular ultrasound in carotid stenting. J Endovasc Surg. 1996;3:63-8.
25. Bom N, Lancee CT, Van Egmond FC. An ultrasonic intracardiac scanner. Ultrasonics 1972;10:72-6.
12. White RA, Donayre CE, Kopchok G et al. Intravascular ultrasound: the ultimate tool for abdominal aortic aneurysm assessment and endovascular graft delivery. J Endovasc Surg. 1997;4:45-55.
4. Nair A, Kuban BD, Tuzcu EM et al. Coronary plaque classification with intravascular ultrasound radiofrequency data analysis. Circulation 2002;106:2200-6.
1. Prati F, Arbustini E, Labellarte A et al. Correlation between high frequency intravascular ultrasound and histomorphology in human coronary arteries. Heart 2001;85:567-70.
18. Kruger RA, Mistretta CA, Crummy AB et al. Digital k-edge subtraction radiography. Radiology 1977;125:234-5. 19. Kruger RA, Mistretta CA, Riederer SJ et al. Computerized fluoroscopy techniques for noninvasive imaging of the cardiovascular system. Radiology 1979;130(1):49-57.
9. Gussenhoven EJ, van der Lugt A, Pasterkamp G et al. Intravascular ultrasound predictors of outcome after peripheral balloon angioplasty. Eur J Vasc Endovasc Surg. 1995;10:279-88.
5. Nissen SE, Grines CL, Gurley JC et al. Application of a new phasedarray ultrasound imaging catheter in the assessment of vascular dimensions. In vivo comparison to cineangiography. Circulation 1990;81:660-6.
7. Reid DB, Douglas M, Diethrich EB. The clinical value of threedimensional intravascular ultrasound imaging. J Endovasc Surg. 1995;2:356-64.
20. TASC II (Transatlantic Intersociety Consensus II). Eur J Vasc Endovasc Surg. 2007. 21. Arthurs ZM, Bishop PD, Feiten LE et al. Evaluation of peripheral atherosclerosis: a comparative analysis of angiography and intravascular ultrasound. J Vasc Surg. 2010 Apr;51(4):933-9.
56. Fitzgerald PJ, St Goar FG, Connolly AJ et al. Intravascular ultrasound imaging of coronary arteries. Is three layers the norm? Circulation 1992; 86:154-8.
54. Tobis JM, Mallery J, Mahon D et al. Intravascular ultrasound imaging of human coronary arteries in vivo. Analysis of tissue characterization with comparison to in vitro histological specimens. Circulation 1991;83:913-26.
51. Koschyk DH, Meinertz T, Hoffman T et al. Value of intravascular ultrasound for endovascular stent-graft placement in aortic dissection and aneurysms. J Card Surg. 2003;18(5):471-7.
50. Bandyk DF, Armstrong PA. Use of intravascular ultrasound as “Quality Control” technique during carotid stent-angioplasty: are there risks to its use? J Cardiovasc Surg. (Torino) 2009;50(6):727-33.
57. Velican D, Velican C. Comparative study on age related changes and atherosclerosis involvment of the coronary arteries of male and female subjects up to 40 years of age. Atherosclerosis 1981;38:39-50.
60. Farb A, Virmani R, Atkinson JB, Kolodgie FD. Plaque morphology and pathologic changes in arteries from patients dying after coronary balloon angioplasty. J Am Coll Cardiol 1990;16:1421.
62. Kearney P, Koch L, Ge J et al. Differences in morphology of stable and unstable coronary lesions and their impact on the mechanism of angioplasty. An in vivo study with IVUS. Eur Heart J 1996;17:721-30. 63. Metz JA, Preuss P, Komiyama N et al. Discrimination between soft plaque and thrombus based on radiofrequency analysis of intravascular ultrasound. J Am Coll Cardiol 1996;27(suppl A):200A (abstract). 64. Siegel RJ, Ariani M, Fishbein MC et al. Histopathologic validation of angioscopy and intravascular ultrasound. Circulation 1991;84:109-17. 65. Di Mario C, Gorge G, Peters R et al. Clinical application and image interpretation in intracoronary ultrasound. Eur Heart J 1998;19:207-29. 66. Glagov S, Weisenberg E, Zarins CK et al. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl Med 1986;316:1371-5. 67. Ge J, Erbel R, Zamorano J et al. Coronary artery remodeling in atherosclerotic disease: an intravascular ultrasonic study in vivo. Coron Artery Dis 1993;4:981-6.
53. Nishimura RA, Edwards WD, Warner CA et al. Intravascular ultrasound imaging: in vitro validation and pathologic correlation. J Am Coll Cardiol. 1990;16:145-54.
58. Di Mario C, The SHK, Madretsma S et al. Detection and characterization of vascular lesions by intravascular ultrasound: an in vitro study correlated with histology. J Am Soc Echocardiogr. 1992;5:135-46.
52. Gussenhoven EJ, Essed CE, Lancee CT et al. Arterial wall characteristics determined by intravascular ultrasound imaging: an in vivo study. J Am Coll Cardiol. 1989;14:947-52.
59. Bartorelli AL, Potkin BN, Almagor Y et al. Plaque characterization of atherosclerotic coronary arteries by intravascular ultrasound. Echocardiography 1990;7:389-95.
55. Siegel RJ, Chae JS, Maurer G et al. Histopathologic correlation of the three-layered intravascular ultrasound appearance of normal adult human muscular arteries. Am Heart J 1993;126:872-8.
235Capítulo 123 ultr A ssonogr AfiA intr AvA sCul Ar nA doenç A ArteriAl PerifériCA 47. Irshad K, Millar S, Velu R et al. Virtual histology intravascular ultrasound in carotid interventions. J Endovasc Ther. 2007;14:198-207. 48. Timaran CH et al. Atherosclerotic plaque composition assessed by virtual histology intravascular ultrasound and cerebral embolization after carotid stenting. J Vasc Surg. 2010;52:1188-95. 49. Calvert PA, Obaid DR, West NEJ et al. B VH-IVUS findings predict major adverse cardiovascular events. The Viva Study (virtual histology intravascular ultrasound in vulnerable atherosclerosis). Heart 2011;97:A2.
61. Mintz GS, Douek P, Pichard AD et al. Target lesion calcification in coronary artery disease: an intravascular ultrasound study. J Am Coll Cardiol 1992;20:1149-55.
1. Napoli A, Anzide M, Zaccagna F et al. Peripheral Arterial Occlusive Disease: Diagnostic Performance and Effect on Therapeutic Management of 64-Section CT Angiography. Radiology 2011 Dec;261(Issue 3).
2. Norgren L, Hiatt W, Dormandy J et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Soc Vasc Surg 2007 Jan;45(1 Suppl.)S5-S67.
8. Dawson I, Hajo van Bockel J, Brand R et al. Popliteal artery aneurysms Long-term follow-up of aneurysmal disease and results of surgical treatment. J Vasc Surg 1991;13(3).
9. Bandeira R, Cacione D, Bandeira C et al. Tratamento endovascular versus tratamento aberto de aneurisma de artéria poplítea: artigo de revisão. J Vasc Bras. 2018 Jan-Mar;17(1):34-41.
13. Almeida M, Yoshida W, Melo N. Síndrome do aprisionamento da artéria poplítea. J Vasc Br 2003;2(3):211-9.
4. Cernic S, Pozzi Mucelli F, Pellegrin A et al. Comparison between 64-row CT angiography and digital subtraction angiography in the study of lower extremities: personal experience. Radiol Med 2009 Oct.;114(7):1115-29.
11. Huang Y, Gloviczki P, Noel AA et al. Early complications and long-term outcome after open surgical treatment of poplitealartery aneurysms: is exclusion with saphenous vein bypass still the gold standard? J Vasc Surg. 2007;45(4):705.
14. Papaioannou S, Tsitouridis K, Giataganas G et al. Evaluation of popliteal arteries with CT angiography in popliteal artery entrapment syndrome. Hippokratia. 2009;13:32-7.
6. Galland RB. Popliteal aneurysms: from John Hunter to the 21st century. Ann R Coll Surg Engl 2007;89:466-71.
3. Met R, Bipat S, Legemate D et al. Diagnostic performance of computed tomography angiography in peripheral arterial disease: a systematic review and meta-analysis. JAMA 2009;301(4):415-24.
236 124Capítulo ANGIOTOMOGRAFIA DOS VASOS DOS MEMBROS INFERIORES
7. Loukas M, Klaassen Z, Tubbs RS et al. Popliteal artery aneurysms: a review. Folia Morphol 2007;66(4):272-6.
12. Almeida M. Síndrome do aprisionamento poplíteo e síndrome compartimental crônica dos membros inferiores: desafios no diagnóstico e tratamento. J Vasc Bras. 2016 Out-Dez;15(4):265-7.
5. Matsumoto K, Jinzaki M, Sato K et al. Multidetector-row CT Angiography of Lower Extremities: Usefulness in the Diagnosis of and Intervention for Peripheral Arterial Disease. Ann Vasc Dis 2010;3(3):202-8.
10. Pulli R, Dorigo W, Troisi N et al. Surgical management of popliteal artery aneurysms: which factors affect outcomes? J Vasc Surg. 2006;43(3):481.
15. Gokkus K, Sagtas E, Bakalim T et al. Popliteal entrapment syndrome. A systematic review of the literature and case presentation. Muscles, Ligaments and Tendons Journal 2014;4(2):141-8.
REFERÊNCIAS BIBLIOGRÁFICAS
16. Almeida M, Yoshida W, Habberman D et al. Extrinsic compression of popliteal artery in asymptomatic athlete and non-athlete individuals. A comparative study using duplex scan (color duplex sonography). Int Angiol. 2004 Sep;23(3):218-29.
9. Edelman RR, Sheehan JJ, Dunkle E et al. Quiescent-interval single-shot unenhanced magnetic resonance angiography of peripheral vascular disease: Technical considerations and clinical feasibility. Magn Reson Med 2010;63(4):951-8.
5. Meaney JF, Sheehy N. MR angiography of the peripheral arteries. Magn Reson Imaging Clin N Am 2005;13(1):91-111.
237 125Capítulo
13. Schicchi N, Tagliati C, Agliata G et al. MRI evaluation of peripheral vascular anomalies using time-resolved imaging of contrast kinetics (TRICKS) sequence. Radiol Med 2018 Mar 22. 14. Merrow AC, Gupta A, Patel MN, Adams DM. 2014 Revised Classification of Vascular Lesions from the International Society for the Study of Vascular Anomalies: Radiologic-Pathologic Update. Radiographics 2016;36(5):1494-516.
17. Decleir P, de Foer B, de Schepper A et al MR imaging of cystic adventitial disease of the popliteal artery: 2 cases. Rofo 1997;166(2):167-9.
8. Dellegrottaglie S, Sanz J, Macaluso F et al. Technology Insight: magnetic resonance angiography for the evaluation of patients with peripheral artery disease. Nat Clin Pract Cardiovasc Med 2007;4(12):677-87.
18. Cherry KJ, Gloviczki P, Stanson AW. Persistent sciatic vein: diagnosis and treatment of a rare condition. J Vasc Surg 1996;23(3):490-7.
1. Grizzard J, Shah DJ, Klem I, Jim RJ. MR angiography of the lower extremity circulation with protocols. In: Mukherjee D, Rajagopalan (Eds.). CT and MR angiography of the peripheral circulation. Practical approach with clinical protocols. United Kingdom: Informa Healthcare; 2007. p. 283-308.
MAGNÉTICA DOS VASOS DOS MEMBROS INFERIORES
11. Wu G, Yang J, Zhang T et al. The diagnostic value of non-contrast enhanced quiescent interval single shot (QISS) magnetic resonance angiography at 3T for lower extremity peripheral arterial disease, in comparison to CT angiography. J Cardiovasc Magn Reson 2016;18(1):71. 12. Flors L, Leiva-Salinas C, Maged IM, Norton PT, Matsumoto AH, Angle JF, et al. MR imaging of soft-tissue vascular malformations: diagnosis, classification, and therapyfollow-up. Radiographics 2011;31(5):1321-40.
ANGIORRESSONÂNCIA
3. Peripheral Arterial Disease – Diagnosis and Treatment: A Systematic Review [Internet]. Swedish Council on Health Technology Assessment. Stockholm: Swedish Council on Health Technology Assessment (SBU); 2008. 4. Varga-Szemes A, Wichmann JL, Schoepf UJ et al. Accuracy of noncontrast quiescent-interval single-shot lower extremity MR angiography versus CT angiography for diagnosis of peripheral artery disease: comparison with digital subtraction angiography. JACC Cardiovasc Imaging 2017;10:1116-24.
REFERÊNCIAS BIBLIOGRÁFICAS
10. Klasen J, Blondin D, Schmitt P et al. Nonenhanced ECG-gated quiescent-interval single-shot MRA (QISS-MRA) of the lower extremities: comparison with contrast-enhanced MRA. Clin Radiol 2012;67(5):441-6.
7. Menke J, Larsen J. Meta-analysis: accuracy of contrast-enhanced magnetic resonance angiography for assessing steno-occlusions in peripheral arterial disease. Ann Intern Med 2010;153(5):325-34.
15. Ernemann U, Kramer U, Miller S et al. Current concepts in the classification, diagnosis and treatment of vascular anomalies. Eur J Radiol 2010;75(1):2-11. 16. Carneiro Júnior FCF, Carrijo ENDA, Araújo ST et al. Popliteal Artery Entrapment Syndrome: A Case Report and Review of the Literature. Am J Case Rep 2018;19:29-34.
2. Leiner T, Fleischmann D, Rofsky NM. Low extremities vasculature. In: Rubin GD, Rofsky NM (Eds.). CT and MR angiography: Comprehensive vascular assessment. Philadelphia, PA: Lippincott Williams & Wilkins; 2009. p. 922-1016.
6. Pollak AW, Norton PT, Kramer CM. Multimodality imaging of lower extremity peripheral arterial disease: current role and future directions. Circ Cardiovasc Imaging 2012;5(6):797-80.
238 126Capítulo ANGIOGRAFIA DOS VASOS DOS MEMBROS INFERIORES REFERÊNCIAS BIBLIOGRÁFICAS 1. Abrams HL. Abrams’ Angiography: Intervencional Radiology. In: Baum S, Michael J (Eds.). Pentecost. 2nd ed. Filadélfia: LWW; 2006. p. 25-36. 2. Osborn, AG. Diagnostic neuroradiology. Washington: Mosby; 1994. p. 18-32. 3. Peixoto CCS, Brito CJ. Cirurgia endovascular e angiologia. Rio de Janeiro: Revinter; 2008. p. 396-416. 4. Peixoto CCS, Rossi M. Trauma vascular. Rio de Janeiro: Revinter; 2006. p. 174-88. 5. Peixoto CCS, Brito CJ. Cirurgia endovascular e angiologia. Rio de Janeiro: Revinter; 2014. p. 527-34. 6. Rutherford RB. Vascular surgery. Colorado: Saunders; 1989. p. 25-36.
38. DeRubertis BG, Faries PL, McKinsey JF et al. Shifting paradigms in the treatment of lower extremity vascular disease-a report of 1000 percutaneous interventions. Ann Surg. 2007;246:415-24.
20. Brosi P, Dick F, Do DD et al. Revascularization for chronic critical lower limb ischemia in octogenarians is worthwhile. J Vasc Surg. 2007;46:1198-207.
36. Freitas B, Pitta GBB, Scheinert, D. Endovascular therapy for peripheral arterial disease in the femoropopliteal territory: an evolving promising scenario. Rev Bras Cardiol Invasiva 2015;23:164-5.
21. Gerhard-Herman MD, Gornik HL, Barrett C et al. 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2017 Mar 21;135(12):e686-e725. 22. Halliday A, Bax JJ. The 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in Collaboration With the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg. 2018 Mar;55(3):301-2.
15. Chae KJ, Shin JY. Is Angiosome-Targeted Angioplasty Effective for Limb Salvage and Wound Healing in Diabetic Foot?: A Meta-Analysis. PLoS ONE 2016;11(7):0159523.
3. Norgren L, Hiatt WR, Dormandy JA et al. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg. 2007;45:S5-S67(suppl).
7. Ratnam L, Raza A, Horton A et al. Outcome of aortoiliac, femoropopliteal and infrapopliteal endovascular interventions in lesions categorized by TASC classification. Clin Radiol. 2012; 67:949-54.
ANGIOSSOMAS BIBLIOGRÁFICAS
4. Trans-Atlantic Inter-Society Consensus Working Group. Management of peripheral arterial disease (PAD). J Vasc Surg. 2000;31(1 Pt 2):S1-S296. 5. Ali Rana M, Gloviczki P. Endovascular interventions for infrapopliteal arterial disease: An update. Semin Vasc Surg. 2012;25:29-34.
25. Palena LM, Garcia LF, Brigato C et al. Angiosomes: how do they affect my treatment? Tech Vasc Interv Radiol. 2014 Sep;17(3):155-69. 26. Manzi M, Cester G, Palena LM et al. Vascular imaging of the foot: The first step towards endovascular recanalization. Radiographics 2011;31:1623-36. 27. Alexandrescu V and Hubermont G. The challenging topic of diabetic foot revascularization: does the angiosome-guided angioplasty may improve outcome. J Cardiovasc Surg. (Torino) 2012; 53:3 12. 28. Alexandrescu VA, Hubermont G, Philips Y et al. Selective primary angioplasty following an angiosome model of reperfusion in the treatment of Wagner 1–4 diabetic foot lesions: practice in a multidisciplinary diabetic limb service. J Endovasc Ther. 2008;15(5):580-93.
29. Serra R, Grande R, Scarcello E, Buffone G, de Franciscis S. Angiosometargeted revascularisation in diabetic foot ulcers. Int Wound J. 2015; 12(5):555-8. 30. Varela C, Acin N, Haro J et al. The role of foot collat- eral vessels on ulcer healing and limb salvage after successful endovascular and surgical distal procedures according to an angiosome model. Vasc Endovascular Surg. 2010;44:654 60. 31. Azuma N, Uchida H, Kokubo T et al. Factors influenc- ing wound healing of critical ischaemic foot after bypass surgery: is the angiosome important in selecting bypass target artery? Eur J Vasc Endovasc Surg. 2012;43:322-8.
14. Söderstrom M, Albäck A, Biancari F et al. Angiosome-targeted infrapopliteal endovascular revascularization for treatment of diabetic foot ulcers. J Vasc Surg. 2013;57(2):427-35.
239 127Capítulo
12. Lee KM, Kim WH, Lee JH, Choi MS. Risk factors of treatment failure in diabetic foot ulcer patients. Arch Plast Surg. 2013;40(2):123-8.
1. Shammas N. Epidemiology, classification, and modifiable risk factors of peripheral arterial disease. Vasc Health Risk Manag. 2007;3:229-34.
17. Conte MS, Bandyk DF, Clowes AW et al. Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery. J Vasc Surg. 2006;43:742-751.
32. Palena LM, Brocco E, Manzi M. The clinical utility of below-the-ankle using “transmetatarsal artery access” in complex cases of CLI. Catheter Cardiovasc Interv. 2014;83:123-9. 33. European Working Group on Critical Limb Ischaemia. Second European consensus document on chronic critical leg ischaemia. Eur J Vasc Surg. 1992;6:1-32.
10. Turina M, Fry DE, Polk HC Jr. Acute hyperglycemia and the innate immune system: clinical, cellular, and molecular aspects. Crit Care Med. 2005;33(7):1624-33.
23. Taylor GI, Palmer JH. The vascular territories (angiosomes) of the body: experimental study and clinical applications. Br J Plast Surg. 1987;40(2):113-41. 24. Attinger CE, Evans KK, Bulan E et al. Angiosomes of the foot and ankle and clinical implications for limb salvage: reconstruction, incisions, and revascularization. Plast Reconstr Surg. 2006; 117(7 Suppl):261S-93S.
13. Orhan E, Özçağlayan Ö. Collateral circulation between angiosomes in the feet of diabetic patients. Vascular. 2018 Aug;26(4):432-9.
11. Peppa M, Stavroulakis P, Raptis SA. Advanced glycoxidation products and impaired diabetic wound healing. Wound Repair Regen. 2009;17(4):461-72.
19. Ortmann J, Gahl B, Diehm N et al. Survival benefits of revascularization in patients with critical limb ischemia and renal insufficiency. J Vasc Surg. 2012;56:737-45.
6. Conte MS. Diabetic revascularization: endovascular versus open bypass-Do we have the answer? Semin Vasc Surg. 2012; 25:108-14.
34. Bradbury AW, Adam DJ, Bell J et al. The Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: an intention-totreat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategy. J Vasc Surg. 2010;51(5 Suppl):5S-17S. 35. Armstrong DG, Lavery LA, Harkless LB. Validation of a diabetic wound classification system: contribution of depth, infection and vascular disease to the risk of amputation. Diabetes Care 1998;21:855-9.
REFERÊNCIAS
2. Hirsch A, Haskal Z, Hertzer N. ACC/AHA 2005 Practice guidelines of the management of patients with peripheral arterial disease. Circulation. 2006;113:e463-e654.
8. Malmstedt J, Leander K, Wahlberg E et al. Outcome after leg bypasssurgery for critical limb ischemia is poor in patients with diabetes: a population-based cohort study. Diabetes Care 2008; 31:887-92.
9. Prompers L, Huijberts M, Apelqvist J et al. High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study. Diabetologia. 2007;50(1):18-25.
16. Beaney AJ, Nunney I, Gooday C et al. Factors determining the risk of diabetes foot amputations – a retrospective analysis of a tertiary diabetes foot care service. Diabetes Res Clin Pract. 2016;114:69-74.
18. Adam DJ, Beard JD, Cleveland T et al. Bypass vs angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet. 2005;366:1925-34.
37. Kudo T, Chandra FA, Ahn SS. The effectiveness of percutaneous transluminal angioplasty for the treatment of critical limb ischemia: a 10 year experience. J Vasc Surg. 2005;41:423-35.
53. Manzi M, Palena LM, Cester G. Endovascular techniques for limb salvage in diabetics with crural and pedal disease. J Cardiovasc Surg. 2011;52:485-92.
52. Ferraresi R, Palena LM, Mauri G et al. Tips and tricks for a correct “endo approach”. J Cardiovasc Surg. 2013;54:685-711.
57. Manzi M, Fusaro M, Ceccacci T et al. Clinical results of below-theknee intervention using pedal-plantar loop technique for the revascularization of foot arteries. J Cardiovasc Surg. 2009;50:331-7.
47. Acín F, Varela C, López de Maturana I et al. Results of infrapopliteal endovascular procedures performed in diabetic patients with critical limb ischemia and tissue loss from the perspective of an angiosome-oriented revascularization strategy. Int J Vasc Med. 2014;2014:270539.
42. Graziani L, Silvestro A, Bertone et al. Vascular involvement in diabetic subjects with ischemic foot ulcer: a new morphologic categorization of disease severity. Eur J Vasc Endovasc Surg. 2007;33:453-60.
40.
240 Parte VIIIMEMBROS INFERIORES
54. Bown MJ, Bolia A, Sutton AJ. Subintimal angioplasty: Meta-analytical evidence of clinical utility. Eur J Vasc Endovasc Surg. 2009;38:323-37.
49. Kabra A, Suresh KR, Vivekanand V et al. Outcomes of angiosome and non-angiosome targeted revascularisation in critical lower limb ischemia. J Vasc Surg. 2013;57:44-9.
56. Fusaro M, Dalla Paola L, Brigato C et al. Plantar to dorsalis pedis artery subintimal angioplasty in a patient with critical foot ischemia: a novel technique in the armamentarium of the peripheral interventionist. J Cardiovasc Med (Hagerstown) 2007;8:977-80.
51. Hinchliffe RJ, Andros G, Apelqvist J et al. A systematic review of the effectiveness of revascularization of the ulcerated foot in patients with diabetes and peripheral arterial disease. Diabetes Metab Res ver. 2012;28:179-217.
58. Fusaro M, Agostoni P, Biondi-Zoccai G. “Trans-collateral” angioplasty for a challenging chronic total occlusion of the tibial vessels: a novel approach to percutaneous revascularization in critical lower limb ischemia. Catheter Cardiovasc Interv. 2008;71:268-72.
44. Sadek M, Ellozy SH, Turnbull IC et al. Improved outcomes are associated with multilevel endovascular intervention involving the tibial vessels compared with isolated tibial intervention. J Vasc Surg. 2009;49:638-43.
41.
39. Zierler RE, Jordan WD, Lal BK et al. The Society for Vascular Surgery practice guidelines on follow-up after vascular surgery arterial procedures. J Vasc Surg. 2018 July;68(1):256-84. Wolfe JH, Wyatt MG. Critical and subcritical ischaemia. Eur J Vasc Endovasc Surg. 1997;13:578-82. Aboyans V, Desormais I, Lacroix P et al. The general prognosis of patients with peripheral arterial disease differs according to the disease localization. JACC. 2010;55:898-903.
45. Attinger CE, Evans KK, Mesbahi A. Angiosomes of the foot and angiosome-dependent healing. In: Sidawy AN (Ed.). Diabetic Foot, Lower Extremity Disease and Limb Salvage. Philadelphia, PA: Lippincott Williams & Wilkins; 2006:341-50.
55. Fusaro M, Dalla Paola L, Biondi-Zoccai G. Pedal-plantar LOOP technique for a challenging below-the-knee chronic total occlusion: a novel approach to percutaneous revascularization in critical lower limb ischemia. J Invasive Cardiol 2007;19:34-7.
50. Neville R, Attinger C, Bulan E et al. Revascularization of a specific angiosome for limb sal- vage: does the target artery matter? Ann Vasc Surg. 2009;23:367–73.
46. Lida O, Nanto S, Uematsu M et al. Importance of the angiosome concept for endovascular therapy in patients with critical limb ischemia. Cathet Cardiovasc Interv. 2010;75:830-6.
59. Graziani L, Morelli LG. Combined retrograde–antegrade arterial recanalization through collateral vessels: redefinition of the technique for below-the-knee arteries. Cardiovasc Intervent Radiol. 2011;34:S78-S82. 60. Graziani L, Silvestro A, Monge L et al. Transluminal angioplasty of peroneal artery branches in diabetics: Initial technical experience. Cardiovasc Intervent Radiol. 2008;31:49-55.
61. Palena LM, Manzi M. Extreme below-the-knee interventions: Retrograde transmetatarsal or transplantar arch access for foot salvage in challenging cases of critical limb ischemia. J Endovasc Ther. 2012;19:805-11. 62. Utsunomiya M, Nakamura M, Nakanishi M et al. Impact of wound blush as an angiographic end point of endovascular therapy for patients with critical limb ischemia. J Vasc Surg. 2012;55:113-21.
43. Gray BH, Grant AA, Kalbaugh CA et al. The impact of isolated tibial disease on outcomes in the critical limb ischemic population. Ann Vasc Surg. 2010;24:349-59.
48. Lejay A, Georg Y, Tartaglia E et al. Long-term outcomes of direct and indirect below-the-knee open revascularization based on the angiosome concept on diabetic patients with critical limb ischemia. Ann Vasc Surg. 2013;pii:S0890- 5096(13)00659-6.
19. Graham LM, Zelenock GB, Whitehouse Jr WM et al. Clinical significance of arteriosclerotic femoral artery aneurysms. Arch Surg 1980;115:502. 20. Alami AA, Haddani J, Abidallah M et al. Maladie de Behçet révélée par un anévrysme fémoral bilateral. J Mal Vasc 2002;27(2):96-9.
ANEURISMAS DE BIBLIOGRÁFICAS
24. Morgan R, Belli A M. Current Treatment Methods for Postcatheterization Pseudoaneurysms. J Vasc Interv Radiol 2003;14(6):697-710.
15. Bower EB, Smullens SN, Parke WW. Clinical aspects of persistent sciatic artery. Surgery 1977;81:588-95.
27. Mallor y TH, Jaffe SL, Eberle RW. False aneurysm of the common femoral artery after total hip arthroplasty. A case report. Clin Orthop 1997;338:105-8.
241 128Capítulo
1. Kopelman D, Nitecki S, Schein M et al. Isolated iliac aneurysm. Harefuah 1993;124:340-42.
26. Fernandez GJ, Terriza MD, Cabada T et al. False aneurysm of the femoral artery as a late complication of an intertrochanteric fracture. A case report. Int Orthop 1995;19:187-89.
47.
MEMBROS INFERIORES REFERÊNCIAS
16. Sapienza P, Mingoli A, Feldhaus RJ et al. Femoral artery aneurysms: long-term follow-up and results of surgical treatment. Cardiovasc Surg 1996;4(2):181-84. 17. Levi N, Schroeder TV. Arteriosclerotic femoral artery aneurysms. A short review. J Cardiovasc Surg 1997;38(4):335-38.
21. Bordeaux J, Guys JM, Magnan PE. Multiple aneurysms in a sevenyear-old child. Ann Vasc Surg 1990;4(1):26-28. 22. Takagi H, Mizuno Y, Matsutomo M et al. Aneurysm of the femoral artery occupationally exposed to a vibratory tool for more than 10 years. J Vasc Surg 2004;39(5):1125-27.
10. Song HY, Chung G, Man YM. Nonopetative manegement of persistent sciatic artery aneurysm. J Korean Med Sci 1992;7(3):214-20.
7. Ishida K, Imamaki M, Ishida A et al. A ruptured aneurysm in persistent sciatic artery: a case report. J Vasc Surg 2005;42(3):556-58.
9. Bower EB, Smullens SN, Parke WW. Clinical aspect of persistent sciatic artery: report of two cases and review of the literature Surgery 1977;98:588-95.
3.
11. Donovan DL, Sharp Wv. Persistent sciatic artery with emphasis on embriologic development. Surgery 1984;95:363-66.
5. Wilson JS, Browser AN, Miranda A et al. Limb ischemia associated with persistent sciatic artery aneurysms. Vasc endovasc surg 2005; 39(1):97-101. 6. Kurc E, Ali Aydemir N, Sargin M et al. Traumatic aneurysm in persistent sciatic artery. Innovations (Phila) 2010;5(2):131-33.
8. Becquemin JP, Gaston A, Coulbret P et al. Aneurysm of persistent sciatic artery: Report of a case treated by endovascular occlusion and femoro-popliteal by pass. Surgery 1985;98:605-11.
2. McCready RA, Pairolero PC, Gilmore JC et al. Isolated iliac artery aneurysms. Surgery 1983;93:688. Richardson JW, Greenfield LJ. Natural history and management of iliac aneurysms. J Vasc Surg 1988;8:165-71.
12. Fung HS, Lau S, Chan MK et al. Persistent sciatic artery complicated by aneurysm formation and thrombosis. Hong Kong Med J 2008;14:492-94. 13. Samson RH, Showalter DP. Persistent sciatic arterys collateral for an occluded iliofemoral system. J Vasc Surg 2004;40:183. 14. Brantley SK, Rigdon EE, Raju S. Persistent sciatic artery: embriology, pathology, and treatment. J Vasc Surg 1993;18:242-48.
23. Gioppato S, Munhoz A, Marins M, et al. Tratamento Percutâneo de Pseudoaneurismas por Injeção de Trombina Guiada por Ultrassom. Rev Bras Cariol Invasiva 2010;18(2):165-70.
28. Ylönen K, Biancari F, Leo E et al. Predictors of development of anastomotic femoral pseudoaneurysms after aortobifemoral reconstruction for abdominal aortic aneurysm. Am J Surg 2004;187(1):83-87. 29. Hollier LH, Batson RC, Cohn I. Femoral anastomotic aneurysms. Ann Surg 1980;191(6):715-20. 30. van den Akker PJ, Brand R, van Schilfgaarde R et al. False aneurysms after prosthetic reconstructions for aortoiliac obstructive disease. Ann Surg 1989;210(5):658-66. 31. Ernst CB, Elliott JP, Ryan CJ et al. Recurrent femoral anastomotic aneurysms. A 30-year experience. Ann Surg 1988;208(4):401-9. 32. Dawson I, Sie RB, van Bockel JH. Atherosclerotic popliteal aneurysm. Br J Surg 1997;84(3):293-99. 33. Lowell RC, Gloviczki P, Hallet Jr JW et al. Popliteal artery aneurysms: The risk of nonoperative management. Ann Vasc Surg 1994;8:14. 34. Richardson JV, Mcdowell HA. Anastomotic aneurysms following arterial grafting: a 10-year experience. Ann Surg 1976;184(2):179-82. 35. Loftus WK, Isaacs JL, Spyropoulos P. Femoro artery pseudoaneurysm: ultrasound guided compression repair. Australas Radiol 1993;37:256-58. 36. Nagy Z, Gyurkovics E, Kaliszky P et al. True aneurysm of deep femoral artery. Magy Seb 2001 Aug;54(4):245-49. 37. Uzoignwe CE, Tang T, Gaunt M. Surgical repair of bilateral profunda femoral artery aneurism. Vascular 2005 May-June;13(3):184-86. 38. Lima IA, Lima IF, Bernardes MV. Isolated deep femoral artery aneurysm. Case report and literature review. J Vasc Br 2003;2(4):333-38. 39. Amer N, Grocott E, Shami S. Time for a new classification of femoral artery aneurysm? Vasa 2004;33:170-72. 40. Posner SR, Wilensky J, Dimick J et al. A true aneurysm of the profunda femoral artery: a case report and review of the English language literature. Ann Vasc Surg 2004;18:740-46. 41. Lozano F, Sánchez-Fernandez J, Gómez Alonso A. Ruptured aneurysm of the deep femoral artery. Case report and historical review. J Cardiovasc Surg 2001;42(6):821-24. 42. Toda R, Yuda T, Watanabe S et al. Surgical repair of a solitary deep femoral arterial aneurysm: report of two cases. Surg Today 2000;30(5):481-83. 43. Ganeshan A, Hawkins M, Warakaulle D et al. Endovascular therapy for a profunda femoris artery aneurysm which ruptures following intravenous trombolysis. Br J Radiol 2007;80:e147-149. 44. Paisley KE, Wells IP, Boobottom CA. Transcatheter treatment of profunda femoris aneurysm. Clin Radiol 2001;56(10);862. Lobato AC, Colli Jr DF, Mahfouz NH et al. Aneurismas periféricos. In: Lobato AC, Pereira AH, Von Ristow A et al Cirurgia Endovascular. São Paulo: ICVE, 2010. p. 797-822. 46. Duffy ST, Colgan MP, Sultan S et al. Popliteal aneurysms: a 10-year experience. Eur J Vasc Endovasc Surg 1998;16:218-22. Gaylis H. Popliteal arterial aneurysms – A review and analysis of 55 cases. S Afric Med J 1974;48:75. 48. Szilagyi DE, Schwartz RL, Reddy DJ. Popliteal arterial aneurysms. Their natural history and management. Arch Surg 1981;116:724. 49. Vermilion BD, Kimmins SA, Pace WJ et al. A review of one hundred forty-seven popliteal aneurysms with long term follow-up. Surgery 1981;90(6):1009. 50. Harder Y, Notter H, Nussbaumer P et al. Popliteal aneurysm: diagnostic workup and results of surgical treatment. World J Surg 2003;27(7):788-92. 51. Cross JE, Galland RB. Asymptomatic popliteal artery aneurysms (less than 3 cm) should be treated conservatively. Eur J Vasc Endovasc Surg 2011:41,445-49.
25. Pinto DM, Dias JO Jr, Fonseca BLC et al. Experiência inicial com o uso de adesivo tissular contendo trombina para tratamento do pseudoaneurisma femoral. J Vasc Br 2008;5(1):30-6.
45.
4. Chleboun JO, Teasdale JE. A pulsatile gluteal mass due to sciatic artery aneurysm. Aus NZJ Surg 1995;65 (12):907-10.
18. Cutler BS, Darling RC. Surgical management of arteriosclerotic femoral aneurysms. Surgery 1973;74:764.
52. Zimmermann A, Schoenberger T, Saeckl J et al. Eligibility for endovascular technique and results of the surgical approach to popliteal artery aneurysms at a single center. Ann Vasc Surg 2010;24:342-48.
60. Kp V, Yoon JR, Nha KW et al. Popliteal artery pseudoaneurysm after cystectomy of a popliteal cyst. Arthroscopy 2009;25(9):1054-57.
65. Killeen SD, O’Brien N, O’Sullivan MJ et al. Mycotic aneurysm of the popliteal artery secondary to Streptococcus pneumonia: a case report and review of the literature. J Med Case Reports 2009;3:117.
68. Belmir H, Azghari A, Mechchat A et al. Rupture of a popliteal artery pseudo-aneurysm revealing a tibial osteochondroma: case report and review of the literature. J Mal Vasc 2011;36(1):50-55.
62. Lord RV, Schwartz P. False aneurysm of the popliteal artery complicating acupuncture. Aust N Z J Surg 1996;66(9):645-47.
53. Abdul-Hussien H, Hanemaaijer R, Kleemann R et al. The pathophysiology of abdominal aortic aneurysm growth: corresponding and discordant inflammatory and proteolytic processes in abdominal aortic and popliteal artery aneurysms. J Vasc Surg 2010;51(6):1479-87.
58. Derom A. Ruptured pseudo-aneurysm of the popliteal artery after percutaneous transluminal angioplasty. Acta Chir Belg 2003;103(1):102-4.
66. Neukirch C, Bahnini A, Delcourt A et al. Popliteal aneurysm due to fibromuscular dysplasia. Ann Vasc Surg 1996;10(6):578-81.
75. Ravn H, Wanhainen A, Björck M. Surgical technique and long-term results after popliteal aneurysm repair: results from 717 legs. J Vasc Surg 2007;46:236-43.
77. Antonello M, Frigatti P, Piero B et al. Open repair versus endovascular treatment for assymptomatic popliteal artery aneurysm: results of a prospective randomized study. J Vasc Surg 2005;42:185-93.
61. Yilmaz M, Dogan OF, Guvener M et al. Pseudoaneurysm of the popliteal artery in child: an unusual complication of reconstruction of traumatic tibial fracture using Kirschner wire. Ulus Travma Acil Cerrahi Derg 2010;16(1):90-91.
71. Bradway MW, Drezner AD. Popliteal aneurysm presenting as acute thrombosis and ischemia in a middle-aged man with a history of Kawasaki disease. J Vasc Surg 1997;26(5);884-87.
79. Lovegrove RE, Javid M, Magee TR et al. Endovascular and open approches to non-thrombosed popliteal aneurysm repair: a meta analysis. Eur J Vasc Endovasc Surg 2008;36(1):96-100.
80. Rajasinghe HA, Tzilinis A, Keller T et al. Endovascular exclusion of popliteal aneurysm wiyh expanded polytetrafluoroethylene stentgrafts:nearly results. Vasc Endovasc Surg 2006;40(6):460-66.
54. Debasso R, Astrand H, Bjamgard N et al. The popliteal artery, an unusual muscular artery with wall properties similar to the aorta: implications for susceptibility to aneurysm formation? J Vasc Surg 2004;39(4):836-42.
72. Iwasaki H, Shibuya T, Ishizaka T et al. Unilateral acute lower extremity ischemia with popliteal artery aneurysm as a result of vascular type III entrapment in an elderly patient. Vascular 2010;18(2):116-20.
74. Hingorani A, Ascher E. Asymptomatic popliteal artery aneurysms (less than 3 cm). Eur J Vasc Endovasc Surg 2011;41:448.
57. Nguyen HH, Chleboun JO. False popliteal aneurysm after femoral embolectomy. Aust N Z J Surg 1995;65(5):362-64.
63. Jebara VA, Nasnas R, Achouh PE et al. Mycotic aneurysm of the popliteal artery secondary to tuberculosis. A case report and review of the literature. Tex Heart Inst J 1998;25(2):136-39.
81. Kanaoka T, Matsuura H. A true aneurysm of the posterior tibial artery: a case report. Ann Thorac Cardiovasc Surg 2004;10(5):317-18. 82. Borozan PG, Walker HS, Peterson GJ. True tibial artery aneurysms: case report and literature review. J Vasc Surg 1989;10(4):457-59. 83. Salcuni P, Azzarone M, Ugolotti U et al. An unusual case of a double location of arteriosclerotic aneurysms of the ulnar artery and anterior tibial artery. Angiologia 1991;43(1):1-6. 84. Faccena F, Alunno A, Felli MMG et al. Tibioperonal true aneurysm: case report and literature review. G Chir 2011;32(8-9):379-83. 85. Young LP, Stanley A, Menzoian JO. An anterior tibial artery aneurysm in a patient with neurofibromatosis. J Vasc Surg 2001;33(5):1114-17. 86. Hagspiel KD, Bonatti H, Sabri S et al. Metachronous bilateral posterior tibial artery aneurysms in Ehlers-Dantos Syndrome Type IV. Cardiovasc Intervent Radiol 2011;34:413-18. 87. Neary WD, Tottle AJ, Eamshaw JJ. False aneurysm of the posterior tibial artery after femoral embolectomy. Eur J Vasc Endovasc Surg 2002;23(5):460-61. 88. Sawant MR, Ireland J. Pseudo-aneurysm of the anterior tibial artery complicating high tibial osteotomy- a case report. Knee 2001;8(3):247-48. 89. Paul MA, Patka P, van Heuzen EP et al. Vascular injury from external fixation: case resports. J Trauma 1992;33(6):917-20. 90. Edwards H, Martin E, Nowygrod R. Nonoperative management of a traumatic peroneal artery false aneurysm. J Trauma 1982;22(4):323-26. 91. Skudder PA, Gelfand ML, Blumenberg RM et al. Tibial artery false aneurysm: uncommon result of blunt injury occurring during athletics. Ann Vasc Surg 1999;13(6):589-91. 92. Marron CD, McKay D, Johnson R et al. Pseudo-aneurysm of the anterior tibial artery, a rare cause of ankle swelling following a sports injury. BMC Emerg Med 2005;5:9. 93. Rooney RC, Rooney RC. Anterior tibial aneurysm following inversion injury to the ankle. J Orthop Trauma 1999;13(7):511-13. 94. Carey LC, Stremple JF. An aneurysm of the anterior tibial artery. Angiology 1967;18:117-21. 95. Manouguian S, Mlynec-Kersjes ML. Spontaneous complete rupture of a thrombotic aneurysm of the tibiofibular trunk. Pathologe 2000;21:303-6. 96. Nahrstedt U, Ruckert K. Isolated, true aneurysm of tibiofibilar trunk - a rarity among peripheral aneurysm. Vasa 1995;24(4):373-76. 97. Mõnig SP, Walter M, Sorgtz S et al. True infrapopliteal artery aneurysm: report of two cases and literature review. YMVA 1996;24(2):276-78. 98. Spronk S, den Hoed PT, Veen HF. Case report: Blue toe syndrome caused by a true crural aneurysm. J Vasc Nurs 2003;21:70-71. 99. Kars HZ, Topaktas S, Dogan K. Aneurysmal peroneal nerve compression. Neurosurgery 1992,30:930-31. 100. Papas G, Janes JM, Bernatz PE et al. Femoral aneurysms. JAMA 1964;190:489-93. 101. Yao JST, McCarthy WJ. Multiple arterial aneurysms: a seven years follow up. Contemp Surg 1987;31:73-78. 102. Borozan PG, Walker HS 3rd, Peterson GJ. True tibial artery aneurysm: case report and literature review. J Vasc Surg 1989;10(4):457-59. 103. Iwamoto K, Igawa S, Maekawa Y et al. Case of possible true aneurysm of the posterior tibial artery. Cosaka City Med J 1994;40:31-35. 104. Larena-Avellandela A, Debus ES, Daum H et al. Mycotic aneurysm affecting both lower legs of a patient with candida endocarditis. Endovasculat therapy and open vascular surgery. Ann Vasc Surg 2004;18(1):130-33.
59. Sloan K, Mofidi R, Nagy J et al. Endovascular treatment for traumatic popliteal artery pseudoaneurysms after knee arthroplasty. Vasc Endovascular Surg 2009;43(3):286-90.
69. Sadeghi-Azandaryani M, Mendl N, Rademacher A et al Pseudoaneurysm of the popliteal artery due to osteochondroma of the distal femur. Vasa 2010;39(3):274-77.
242 Parte VIIIMEMBROS INFERIORES
78. Tielliu IF, Verhoeven EL, Prins TR et al. Treatment of popliteal artery aneurysm with Hemobahn stent-graft. J Endovasc Ther 2003;10:111-16.
67. Cho YP, Kang GH, Choi SJ et al. Aneurysm of the popliteal artery in neurofibromatosis. Ann Vasc Surg 2005;19(6):900-3.
76. Huang Y, Gloviczki P, Noel AA et al. Early complications and longterm outcome after open surgical treatment of popliteal artery aneurysms: is exclusion with saphenous vein bypass still the gold standard? J Vasc Surg 2007;45(4):706-16.
64. Witjes JA, Vriesema JL, Brinkman K et al. Mycotic aneurysm of the popliteal artery as a complication of intravesical BCG therapy for superficial bladder cancer. Case report and literature review. Urol Int 2003;71(4):430-32.
56. Megalopoulos A, Siminas S, Trelopoulos G. Traumatic pseudoaneurysm of the popliteal artery after blunt trauma: case report and a review of the literature. Vasc Endovascular Surg 2007 Jan.;40(6):499-504.
73. Michaels JA, Galland RB. Management of asymptomatic popliteal aneurysms: the use of a Markov decision tree to determine the criteria for a conservative approach. Eur J Vasc Surg 1993;7(2):136-43.
55. Woolgar JD, Reddy DS, Robbs JV. Delayed presentation of traumatic popliteal artery pseudoaneurysms: a review of seven cases. Eur J Vasc Endovasc Surg 2002;23(3):255-59.
70. Kalko Y, Basaran M, Aydin U et al. The surgical treatment of arterial aneurysms in Behçet disease: a report of 16 patients. J Vasc Surg 2005;42(4):673-77.
12. Vollmar JF, Trede M, Laubach K et al. Principles of reconstructive procedures for chronic femoro-popliteal occlusions. Report on 546 operations. Ann Surg 1968;12:215.
29. Buerger L. Thromboangiitis obliterans: a study of the vascular lesions leading to presenile spontaneous gangrene. Am J Med Sci 1908;136:567-80.
30. Held L. Multiple Aneurysmen an grossen Arterien. Med Klin 1958;53:2020. 31. Vieira NV, Luz NW. Aneurismas das artérias dos membros inferiores. In: Bonamigo TP, Burihan E, Cinneli M et al. (Eds.). Doenças da aorta e seus ramos. São Paulo: Fundação Byk; 1991. p. 59-71. 32. Stuart TPA. Note on the variation in the course of the popliteal artery. J Anat 1879;13:162. 33. Hamming JJ. Intermitent claudication at an early age, due to an anomalous course of the popliteal artery. Angiology 1959;10:369-65. 34. Ristow Av, Arruda AM, Santos HB. Sindrome de compressão da artéria poplítea. Med Hoje 1979;3:80-82. 35. Donaldson MC. Hypercoagulable states in patients with peripheral vascular disease. In: Whittemore AD. (Ed.). Advances in vascular surgery. St Louis: Mosby; 1993. p. 227-42. 36. Eldrup-Jorgensen J, Flanigan DP, Brace L et al. Hypercoagulable states and lower limb ischemia in young adults. J Vasc Surg 1989;9:334-41. Atkins HJB, Key JA. A case of mixomatous tumor arising from the adventitia of the external iliac artery. B J Surg 1947;34:426-30. Brunner U, Sokia P. Chirurgische Gesichtspunkte der arteriellen Adventitiazysten. Vasa 1977;6:105-9. 39. Rubinstein ZJ, Morag B, Walden R. Persistent sciatic artery- a case report. Cardiov Interv Rad 1985;8:199-201. 40. Balaji MR, DeWeese JA. Adductor canal outlet syndrome. J Am Med Ass 1981;245:167-70. 41. Heilmann RS, Topuzlu C, Molloy M. Femoral artery injury secondary to osterochondroma of the distal femur. Am J Roentgen 1967;100:533. 42. Iwai TS, Konno K, Hiejima S et al. Fibro muscular dysplasia in the extremities. J Cardiovasc Surg 1985;26:496-501. 43. Voss EU, Volmar JF, Heyden B et al. Chirurgische Therarapie der chronischer Aortoiliacalen Arterienveschlusse. Akt Chir 1980;15:77-94. 44. Flinn WR, Harris J, Yao JST et al. Atheroembolism of cause of graft failure in femoro distal reconstruction. Surgery 1981;90:698-706. Ristow AV, Ferreira M, Cury JM. O prognóstico evolutivo de pacientes portadores de isquemia grave dos membros inferiores ao longo de três anos. Anais do XXIX Congresso da SBA-CV, Vitória/ES; 1991. Norgren L, Hiatt WR, Dormandy JA et al. Inter society consensus for the management of peripheral arterial disease – TASC II. J Vasc Surg 2007;45(1 Suppl):S-5A-67A. Palazzo JC, Ristow AV, Hastenreiter CN. Fluxometria ultrassônica nas arteriopatias dos membros inferiores. J Bras Med 1980;39:47-56. 48. Yao JST, Bergan JJ. Predictability of vascular reactivity to sympathetic ablation. Arch Surg 1973;107:676-80. 49. Leather RP, Shah DM, Karmody AM. Infra-popliteal arterial bypass for limb salvage: increased patency and utilization of the saphenous vein used “in situ “. Surgery 1981;90:1000-6. Ristow AV. A revascularização dos membros inferiores com a veia safena “in situ”. Monografia apresentada à SBACV; 1989. 51. Dawson DL, Standness DE. Duplex scanning. In: Strandness DE, van Breda A. (Eds.). Vascular Diseases. New York: Churchill Livingstone; 1994. p. 157-200. Salles-Cunha SX, Andros G. Atlas of duplex ultrasonography. Pasadena: Appleton & Davies; 1990. 53. Massariol FS, Ascer E, Salles-Cunha SX et al. Value and limitation of duplex ultrasonography as the sole imaging method of preoperative
17. Dale WA. Grafting small arteries- experience with 19 shunts below the knee. Arch Surg 1963;86:22. 18. Tyson RR, Reichle FA. Femorotibial bypass. Ann Surg 1969;170:429. 19. Brito CJ, De Biase W, Jacques H. Enxerto venoso em obstruções distais dos membros inferiores. Angiopatias 1969;9:85-88.
45.
47.
27. Fuster V. Syndromes of astherosclerosis- Am heart ass. Armonk: Futura; 1996. 28. Von Winiwarter F. uber eine eigenthumliche form von endarteritris und endophlebitis mit gangrän ds fusses. Arch Klin Chir 1879;23:201-26.
23. Ristow Av, Massière, BV, Vescovi A. Oclusões arteriais crônicas infrainguinais – Tratamento cirúrgico. In: Brito CJ (Ed.). Cirurgia Vascular. 3a ed. Rio de Janeiro: Revinter; 2013. p. 1029-88.
10. De Bakey ME, Cooley D. Surgical considerations of acquired diseases of the aorta. Ann Surg 1954;139:763-74.
14. Hall KV. The great saphenous vein used “in situ” as an arterial shunt after extirpation of the vein valves. Surgery 1962;51:492-96.
243 129CapítuloOCLUSÕES ARTERIAIS CRÔNICAS INFRAINGUINAIS –TRATAMENTO CIRÚRGICO REFERÊNCIAS BIBLIOGRÁFICAS 1. Lyons AS, Petrucelli RJ. Medicine, an Illustrated Hystory. The miracle of St. Cosmas and St. Damien. New York: Abrams; 1978. p. 291. 2. Fabricius H. De Gangrena e Sphacelo. Köln; 1593. 3. Lowe P. The whole course of Surgery. London; 1597, cap. V. 4. Tiedemann F. Von de verengung und schliessung der pulsadern. In: Krakheiten. Heidelberg: Groos; 1843. 5. Leriche R. Des oblitérations artérielles hautes (obliteration de la terminaison de l’aorte) come causes des insuffisances circulatoires des membres inferieures. Bull Soc Chir (Paris) 1923;49:1404. 6. Diez J. Le traitement de la thrombo-angéite oblitérante des membres inferieures par la resection du sympathique lombaire. Soc Cir Bs Aires 1924;8:792. 7. Jeger E. Die chirurgie der blutgefässe und des herzens. Berlin: Hirschwald; 1913. 8. Dos Santos JC. Sur la desobstruction des thromboses arterielles anciennes. Mém Acad Chir 1947;73:409-16. 9. Kunlin J. Le traitment de l’artérite obliterative par la gréffe veineuse Arch Mal Coeur 1949;43:371.
22. Vollmar J. Femoro-popliteal Arterien Verschlusse. In: Vollmar JF. Rekonstruktive chirurgie der arterien. 4th ed. Stuttgart: Thieme; 1996. p. 242-83.
50.
11. Cannon JA, Baker WF. Successful management of obstructive femoral arteriosclerosis by endarterectomy. Surgery 1955;38:48-53.
52.
37.
38.
24. Bonamigo TP, Ristow Av. Doença arterial oclusiva infrainguinal. In: Castro I (Ed.). Cardiologia: princípios e prática. Porto Alegre: Artmed; 1999. p. 992-1015. 25. Lanz TV, Wachsmuth W. Praktische anatomie- Bein un statik. Berlin: Springer; 1938. 26. Grigg MS, Wolfe JHN. Combination reversed and unreversed upper arm veins for femoro-distal grafting. J Surg 1988;2:49-52.
15. Ortner AB, Berg AF, Lebendiger A. Limb salvage through small vessel surgery. Arch Surg 1961;83:102.
16. McCaughan JJ. Successful arterial grafts to the anterior tibial, posterior tibial and peroneal arteries. Angiology 1961;12:91.
20. Reis JMM, Mansano A, Pazzinatto AC et al. Última opção ante a amputação iminente: revascularização por enxerto femoropoplíteo. J Bras Med 1976;30:65-69. 21. Leather RP, Powers SR, Karmody AM. A reapraisal of the in situ saphenous vein bypass. Surgery 1979;90:1000.
46.
13. Voorhees AB, Jaretzki AH, Blakemore A. The use of tubes constructed from Vinion-N cloth for bridging arterial defects. Ann Surg 1952;135:332.
76. Wolfe JHN, Tyrrell MR. Improving the patency of prosthetic grafts with vein cuffs. Sem Vasc Surg 1995;8:246-52. 77. Frankini AD, Pezzella MV. Foot revascularization in patients with critical limb ischemia. Bras Vasc J 2002;1:81-88.
72. Yang PM, Wengerter KR, Veith FJ et al. Value and limitations of secondary femoro-popliteal bypasses with PTFe. J Vasc Surg 1991;14:292-98. 73. Poletti LF, Matsura JH, Dattilo JB et al. Should veins be saved for future operations? A 15 year rewiew of infrainguinal bypasses and the subsequent need for autogenous vein. Ann Vasc Surg 1998;12:143-47. 74. Nascimento Silva JLC. Revascularização estadiada dos membros inferiores através da veia safena parva - uma segunda chance? Rev Angiol Cir Vasc 1992;1:6-18. 75. Miller JH, Foreman RK, Ferguson L et al. Interposition vein cuff for anastomosis of prosthesis to small arteries. Austr N Zeal J Surg 1984;54:283-87.
57. Leers AS, Reifsnyder T, Delmonte R et al. Realistic expectations for pedal bypass grafts in patients with end stage renal disease. J Vasc Surg 1998;28:976-83. 58. Rutherford RB, Flanigan PD, Gupta SK et al. Suggested standards for reports dealing with lower extremity ischemia. J Vasc Surg 1986;4:80.
68. Karmody AM, Leather RP. The saphenous vein used ‘in situ” for infrainguinal bypass. In: Bergan JJ. Arterial surgery. Edinborough: Churchill Livingstone; 1984. 69. Vieira de Mello A, Santos CMT, Oliveira BC et al. Distal revascularization of lower extremities: a 13-year experience. Bras Vasc J 2002;1:69-80.
54. Salles-Cunha SX, Beebe HG, Andros G. Peroperative assessment of alternative veins. Sem Vasc Surg 1995;8:172-78. Veith JF, Ascer E, Gupta SK et al. Tibio-tibial vein bypass grafts: a new operation for limb salvage. J Vasc Surg 1985;2:552-56.
78. Barbato HA, Malheiros FD, Puech Leão P et al. Estudo comparativo da eficiência de dois valvulótomos. Cir Vasc Angiol 1994;10:130-32. 79. Kakkar VV. The cephalic vein as a peripheral arterial graft. Surg Ginec Obst 1969;128:555-56. 80. Schulman ML, Badhey MR, Yatio J et al. An 11–year experience with deep leg veins as femoro-popliteal bypass grafts. Arch Surg 1986;121:1010-15.
97. Ernst E. Chelation therapy for peripheral arterial occlusive disease: a systematic rewiew. Circulation 1997;96:1031-33.
67. Chevalier JM, Enon B, Pillet J. Destruction des valves de la saphéne interne dans la téchnique du pontage femoro-jambier “in situ”. La Nouv Pres Med 1980;9:39-42.
62. De Luccia N. Amputação e reconstrução nas doenças vasculares e no pé diabético. Rio de Janeiro: Revinter; 2006. 248p. 63. Andros G, Harris RW, Dulawa L et al. Baloon angioplasty of iliac, femoral and infrainguinal arteries: percutaneous and intraoperative strategies and techniques. In: Bergan JJ, Yao JST. Techniques in arterial surgery. Philadelphia: Saunders; 1990. 64. Leeds FH, Gilfillan RS. Revascularization of the ischemic limb: importance of the profound femoris artery. Surgery 1961;82:25-31. 65. Martin P, Frawley JE, Barabas AO et al. On the surgery of atherosclerosis of the profound femoris artery. Surgery 1972;71:182-89. 66. Stern JR, Bernhard M. In patients with profound artery disease, is open revascularization superior to endovascular repair for improving rest pain? In Skelly CL & Millner R(Eds.). Difficult decisions in vascular surgery. Cham, Suiça: Springer; 2017. p. 185-97.
56. Taylor LM, Edwards JM, Porter JM. Present status of reversed vein bypass grafting: five-year results of a modern series. J Vasc Surg 1990;11:193-205.
81. Sladden JG, Downs AR. Superficial femoral vein. Sem Vasc Surg 1995;8:209-15. 82. Mohler III ER. Lipid therapy. Endovascular Today 2005;4:55-56.
98. Cohen LB, Rubinstein C, Cronenwett J. Lower limb reconstruction with combined distal vascular bypass surgery and microsurgical free tissue transfer. Adv Vasc Surg 1995;3:201-22. 99. Trédivic P, Marzelle J, Cormier J et al. Lambeaux de sauvetage de membre inférieur. Encyclopédie Médicale et Chirurgicales. Paris: Elsevier; 1996. p. 1-3. 100. Taylor GI, Palmer JH. The vascular territories (angiossomes) of the body: Experimental study and clinical applications. BR J Plast Surg 1987;40:113-41. 101. Attinger C, Cooper P, Blume P et al. The safest incisions and amputations applying the angiossome principles and using Doppler to access the arterial-arterial connections of the foot and ankle. Foot Ankle Clin N Am 2001;6:745-99. 102. Romiti M. Albers M, Brochado-Neto FC et al. Meta-Analysis IF infrapopliteal angioplasty for chronic lims ischemia. J Vasc Surg 2008;47:975-81. 103. Alexandrescu V, Söderström M, Venermo M. Angiosome theory: fact or fiction? Scand J Surg 2012;101:125-31. 104. Attinger CE, Cooper P, Blume P. Vascular anatomy of the foot and ankle. Oper Tech Plast Reconstr Surg 1997;4:183-98. 105. Taylor G, Pan W. Angiossomes of the leg: anatomic study and clinical implications. Plast Reconstr Surg 1998;102:599-616. 106. Gutiérrez RFS. El modelo angiosoma en la estrategia de revascularización de la isquemia critica. Angiologia 2012;64:173-82. 107. Pomposelli FB, Arora S, Gibbons GW et al. Lower extremity arterial reconstruction in the very elderly. J Vasc Surg 1998;28:215-25. 108. Raviolla CA, Nichter LS, Baker JB et al. Cost of treating advanced leg ischemia: bypass graft vs. primary amputation. Arch Surg 1988;123:495-96. 109. Tirrell MR, Grigg MJ, Wolfe JHN. Is arterial reconstruction to the ankle worthwhile in the abscence of autogenous vein? Eur J Vasc Surg 1989;3:429-34. 110. Deterling RA. Is there a place for peripheral nerve crisching? J Cardiovasc Surg 1962;3:329. 111. Thomaz JB, Herdy CDC, Monteiro GM. Neurotripsia. Rev Bras Med 1985;59:249-54.
244 Parte VIIIMEMBROS INFERIORES evaluation for popliteal and infrapopliteal bypasses. Ann Vasc Surg 1999;13:1-10.
83. Hölzenbein TJ, Pomposelli FB, Miller A et al. Results of a policy used as the first alternative to an unavailable ipsilateral greater saphenous vein for infrainguinal bypass. J Vasc Surg 1996;23:130-40. 84. Robison JG, Ross JP, Brothers TE et al. Distal wound complications following pedal bypass. Analisis of risk factors. Ann Vasc Surg 1995;9:53-59. 85. Alves E. Importância cirúrgica da artéria fibular na manutenção da viabilidade do membro inferior. Tese. Rio de Janeiro, PUC; 1993. 86. Ouriel K, Fiore GM, Geary JE. Limb threatening ischemia in the medically compromised patient: Amputation or revascularization? Surgery 1988;104:167-72. 87. Darling RC, Chang B, Shah DM et al. Choice of peroneal or dorsalis pedis artery bypass for limb salvage. Sem Vasc Surg 1997;10:17-22. 88. Treiman GS. Tourniquet occlusion technique for tibial artery reconstruction. Sem Vasc Surg 2000;13:40-43. 89. Swedeborg J, Nydahl S, Egberg N. Low molecular mass heparin instead of unfractioned heparin during infrainguinal bypass surgery. Eur J Vasc Endovasc Surg 1996;11:59-64. 90. Kretschmer G, Herbst F, Prager M et al. A decade of oral antiagulant treatment to maintain autologous vein grafts for femoropopliteal atherosclerosis. Arch Surg 1992;127:1112-15. 91. Arfvidson B, Lundgren F, Drott C et al. Influence of coumadine treatment on patency and limb salvage after peripheral arterial reconstructive surgery. Am J Surg 1990;159:550-60. 92. Antiplatelet Trialists Collaboration. Secondary prevention of vascular disease by prolonged antiplatelet treatment. BMJ 1988;296:320-31. 93. Caprie Steering Committee. A randomized, blinded, trial of clopidogrel versus aspirin in patients at risk of ischemic events. Lancet 1996;438:1329-39. 94. Hensler M, Vasehus J, Madsen P. Acetylsalicylic acid treatment after peripheral vascular surgery. U Laeger 1994;156:1278-85.
55.
70. Abbott WM, Green RM, Matsumoto T et al. Prosthetic above-knee bypass grafting: results of a multicenter randomized prospective trial. J Vasc Surg 1977;25:19. 71. Moore WS. Choice of graft material for femoro-popliteal bypass: the case for preferential use of PTFe. In: Veith FJ. (Ed.). Current critical problems in vascular surgery. New York: Quality Med; 1991.
59. Albers MTV, Luccia ND, Aun R et al. O aproveitamento máximo de veias autógenas na cirurgia de reconstrução arterial infrainguinal. Cir Vasc Angiol 1989;5:17-22. 60. Dardik H. Arterial reconstruction in the lower extremity. New York: McGraw & Hill; 1986. 61. Vieira de Mello A, Santos CMT. Manejo do paciente com isquemia crítica. In: Bonamigo TP, Burihan E, Cinneli M et al. (Eds.). Doenças da aorta e seus ramos. São Paulo: Fundação Byk; 1991. p. 405-15.
95. Second European Consensus. European Working Group on Critical Ischemia. Circulation 1991;84:1-26. 96. Eberhardt RT. Pharmacotherapy for intermittent claudication. In: Cofman JD, Eberhardt RT (Eds.). Peripheral arterial disease. Totowa: Humana; 2003. p. 173-87.
116. Matsui IK, Menezes FH, Silveira SAF et al. Derivações arteriais com veia safena interna autógena varicosa: seguimento com duplex. Cir Vasc Angiol 1994;10:126-29.
129. Harris PL, Bakran A, Enabi L et al. PTFe grafts for femoro-crural grafts- improved results with combined adjuvant venous cuff and arteriovenous fistula. Eur J Vasc Endovas Surg 1993;7:528-33.
112. Cury JM, Ristow Av. Síndrome Compartimental. In: Rossi M (Ed.). Trauma Vascular. Rio de Janeiro, Revinter; 2006. p. 617-27.
132. Santos CMT. Durabilidade das revascularizações infrainguinais com safena in situ. Rev Angio Cir Vasc 1995;4:46-58.
135. Elliot BM, Robison JG, Brithers TE et al. Limitations of peroneal artery bypass grafting for limb salvage. J Vasc Surg 1993;18:881-88.
136. Jacobs M, Legemate D, Balm R. Bypass to the arteries of the ankle and foot. Crit Ischemia 1998;8:7-14. 137. Pomposelli FB, Marcaccio EJ, Gibbons GW et al. Dorsalis pedis arterial bypass: durable limb salvage for foot ischemia in patients with diabetes mellitus. J Vasc Surg 1995;21:375-84.
133. Glowiczki P, Bower TC, Toomey BJ et al. Microscope aided pedal bypass is an effective and low risk operation to salvage the ischemic foot. Am J Surg 1994;168:76-84. 134. Shah DM, Darling RC III, Chang BB et al. Is long vein bypass from groin to ankle a durable procedure? An analysis of a ten-year experience. J Vasc Surg 1992;15:402-7.
138. Ristow AV, Cury JM, Pedron C et al. Obstruções arteriais crônicas infrainguinais. In: Brito CJ (Ed.). Tratamento cirúrgico. Rio de Janeiro: Revinter; 2002. p. 589-645. 139. Walsh DB. Management of the thrombosed infrainguinal vein graft. Advances in Vasc Surg 1998;6:181-9. 140. Wensing PJ, Scholten FG, Buijs PC et al. Arterial tortuosity in the femoropopliteal region during knee flexion: a magnetic resonance angiographic study. J Anat 1995 Aug;187 (Pt 1):133-9. 141. 141. Moore JE, Scott EA, Moreno MR. The Mechanical Environment of Peripheral Arteries. Endov Today 2011;10:68-72. 142. MacTaggart J, Poulson W, Seas A et al. Stent Design Affects Femoropopliteal Artery Deformation. Ann Surg 2018, Mar 23. 143. Bishop PD1, Feiten LE, Ouriel K et al. Arterial calcification increases in distal arteries in patients with PAD. Ann Vasc Surg 2008;22:799-805. 144. Scholten FG1, Warnars GA, Mali WP, van Leeuwen MS. Femoropopliteal occlusions and the adductor canal hiatus, Duplex study. Eur J Vasc Surg 1993;7:630:3.
122. Schweiger H, Klein P, Lang W. Tibial bypass grafting for limb salvage with ringed PTFe: results of primary and secondary procedures. J Vasc Surg 1993;18:867-74.
128. Ascer E, Veith FJ, White-Flores AS et al. Components of outflow resistance and their correlation with graft patency in lower extremity arterial reconstruction. J Vasc Surg 1984;5:817-28.
126. Raptis S, Miller JH. Influence of a vein cuff on PTFe grafts for primary femoro-popliteal bypass. Br J Surg 1995;82:487-91.
130. Syrek JR, Calligaro KD, Dougherty MJ et al. Do distal arteriovenous fistulae improve patency rates of prosthetic infrapopliteal arterial bypasses? Ann Vasc Surg 1997;12:148-52.
245Capítulo 129 oClusões ArteriAis CrôniCA s infr AinguinAis – tr AtAmento CirúrgiCo
121. Veith FJ, Gupta SK, Ascer E et al. Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded PTFe grafts for infrainguinal arterial reconstructions. J Vasc Surg 1986;3:104-14.
115. Bandik DF, Schmitt DD, Seabrook GR et al. Monitoring functional patency if in situ saphenous vein bypasses: the impact of a surveillance protocol and elective revision. J Vasc Surg 1989;9:284-96.
125. Stonebridge PA, Preescott RJ, Ruckley CV. Randomised trial comparing infrainguinal PTFe bypass grafting with and without vein interposition cuff at the distal anastomosis. The Joint Vascular research group. J Vasc Surg 1997;26:543-50.
117. Virgini CE, Porto CL, Camelier AM et al. Comportamento biológico das derivações com veia safena in situ. Resultados preliminares da vigilância com o duplex-scan. Rev Angiol Cir Vasc 1998;7:130-38.
118. Ristow AV, Burihan E, Cinelli M et al. Complicações precoces e tardias nas restaurações arteriais dos membros inferiores. In: Bonamigo TP, Burihan E, Cinneli M et al. (Eds.). Doenças da aorta e seus ramos. São Paulo: Fundação Byk; 1991. p. 383-96.
119. Bernhard VM, Towne JB (Eds.). Complications in vascular surgery. St Louis: QMP; 1991. 120. Trout HH, Giordano JM, De Palma RG. Reoperative vascular surgery New York: Marcel Dekker; 1987.
123. Morasch MD, Course NF, Colgan MP et al. Lower extremity bypass for critical ischemia using a synthetic conduit and adjuvant vein cuff. Ann Vasc Surg 1997;11:242-46.
113. Fredenucci P. Oxigéniotherapie hyperbare et artériopathies. J Mal Vasc 1985;10:166-72. 114. Szylagyi DE, Elliot JP, Hageman JH et al. Biologic fate of autogenous vein implants as arterial substitutes: clinical, angiographic and hystopathologic observation on femoropopliteal operations for atherosclerosis. Ann Surg 1973;178:232-46.
124. Jakobsen HL, Baekgaard N, Christofferson JK. Bellow-knee popliteal and distal bypass with PTFe and vein cuff. Eur J Vasc Endovas Surg 1998;15:327-30.
127. Panayotopoulos YP, Taylor PR. A paper for debate: vein vs. PTFe for critical limb ischemia- an unfair comparison? Eur J Vasc Edovasc Surg 1997;14:191-94.
131. Leather RP, Chang BB, Darling RC III et al. The in situ saphenous vein bypass: a 15-year experience. Adv Vasc Surg 1994;2:9-24.
7. Haimovici H, Ascer E, Hollier LH et al. (Eds). Haimovici’s vascular surgery. Principles and Techniques, 4. ed. Oxford: Blackwell Science; 1999. v.1, 2. 8. Garrett HE Jr, Richardson JW, Howard HS, Garrett HE. Retroperitoneal lymphocele after abdominal aortic surgery. J Vasc Surg. 1989 Sep.;10(3):245-53.
11. Bosanquet DC, Glasbey JC, Williams IM, Twine CP. Systematic review and meta-analysis of direct versus indirect angiosomal revascularisation of infrapopliteal arteries. Eur J Vasc Endovasc Surg. 2014 July;48(1):88-97.
4. Bunte MC, Shishehbor MH. Angiosome-Guided Intervention in Critical Limb Ischemia. Interv Cardiol Clin. 2017 Apr;6(2):271-7.
14. Norgren L, Hiatt WR, Dormandy JA et al. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg. 2007;45(1):S5-S67.
20. Popplewell MA, Davies H, Jarrett H et al. Bypass versus angioplasty in severe ischaemia of the leg - 2 (BASIL-2) trial: study protocol for a randomized controlled trial. Trials 2016;17:11.
21. Dormandy JA, Rutherford B. Management of peripheral arterial disease (PAD). J Vasc Surg. 2000;31:S1-S296.
12. Aboyans V, Ricco JB, Bartelink ML et al. 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Kardiol Pol. 2017;75(11):1065-160.
13. Mills JL Sr, Conte MS, Armstrong DG et al. The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: risk stratification based on wound, ischemia, and foot infection (WIfI). J Vasc Surg. 2014;59(1):220-34.e1-2.
19. Menard MT, Farber A. The BEST-CLI trial: a multidisciplinary effort to assess whether surgical or endovascular therapy is better for patients with critical limb ischemia. Semin Vasc Surg. 2014;27:82-4.
22. Johnston KW. Femoral and popliteal arteries: reanalysis of results of balloon angioplasty. Radiology 1992;183:767-71. 23. Minar E, Pokrajac B, Maca T et al. Endovascular brachytherapy for prophylaxis of restenosis after femoropopliteal angioplasty: results of a prospective randomized study. Circulation 2000;102:2694-9.
246 130Capítulo OCLUSÃO ARTERIAL INFRAINGUINAL –
TRATAMENTO ENDOVASCULAR REFERÊNCIAS BIBLIOGRÁFICAS
25. Cejna M, Turnher S, Illiasch H et al. PTA versus Palmaz stent in femoropopliteal artery obstructions: a multicentre prospective randomized study. J Vasc Interv Radiol 2001;12:23-31. 26. Vroegindeweij D, Vos LD, Tielbeek AV et al. Balloon angioplasty combined with primary stenting versus balloon angioplasty alone in femoropopliteal obstructions: a comparative randomized study. Cardiovasc Intervent Radiol 1997;20:420-5. 27. Grimm J, Muller-Hulsbeck S, Jahnke T et al. Randomized study to compare PTA alone versus Palmaz stent placement for femoropopliteal lesions. J Vasc Interv Radiol 2001;12:935-42. 28. Zdanowski Z, Albrechtsson U, Lundin A et al. Percutaneous transluminal angioplasty with or without stenting for femoropopliteal occlusions? A randomized controlled study. Int Angiol. 1999;18:251-5. 29. Becquemin JP, Favre JP, Marzelle J et al. Systematic versus selective stent placement after superficial femoral artery balloon angioplasty: a multicenter prospective randomized study. J Vasc Surg. 2003;37:487-94. 30. Schillinger M, Sabeti S, Loewe C et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med. 2006;354:1879-88. 31. Schillinger M, Sabeti S, Dick P et al. Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting. Circulation 2007;115(21):2745-9. 32. Laird J, Katzen BT, Scheinert D et al. RESILIENT Investigators. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelvemonth results from the RESILIENT randomized trial. Circ Cardiovasc Interv. 2010;3:267-76. 33. Laird JR, Katzen BT, Scheinert D et al. Nitinol stent implantation vs. balloon angioplasty for lesions in the superficial femoral and proximal popliteal arteries of patients with claudication: three-year follow-up from the RESILIENT randomized trial. J Endovasc Ther. 2012;1:1-9. 34. Kröger K, Santosa F, Goyen M. Biomechanical incompatibility of popliteal stent placement. J Endovasc Ther. 2004;11:686-94. 35. Hoffmann U, Vetter J, Rainoni L et al. Popliteal artery compression and force of active plantar flexion in young healthy volunteers. J Vasc Surg. 1997;26:281-7. 36. Scheinert D, Werner M, Scheinert S et al. Treatment of complex atherosclerotic popliteal artery disease with a new self-expanding interwoven nitinol stent: 12-month results of the Leipzig SUPERA popliteal artery stent registry. JACC Cardiovascular Interventions 2013;6(1):65-71. 37. Morice MC, Serruys PW, Sousa JE et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med. 2002;346(23):1773–80.
3. Romiti M, Albers M, Brochado-Neto FC et al. Meta-analysis of infrapopliteal angioplasty for chronic critical limb ischemia. J Vasc Surg. 2008 May;47(5):975-981.
2. Conrad MC. Functional anatomy of the circulation to the lower extremities. Chicago: Yearbook Medical Publishers Inc; 1971:1.
17. Bradbury AW et al. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: An intention-to-treat analysis of amputation free and overall survival in patients randomized to a bypass surgeryfirst or a balloon angioplasty-first revascularization strategy. J Vasc Surg. 2010;51:5S-17S.
9. Taylor GI, Pan WR. Angiosomes of the leg: anatomic study and clinical implications. Plast Reconstr Surg. 1998 Sep;102(3):599-616; discussion 617-8. 10. Taylor GI, Palmer JH. The vascular territories (angiosomes) of the body: experimental study and clinical applications. Br J Plast Surg. 1987 Mar;40(2):113-41.
24. Capek P, McLean GK, Berkowitz HD. Femoropopliteal angioplasty: factors influencing long-term success. Circulation 1991;83:Suppl 2:I70-I80.
15. Klinkert P, Post PN, Breslau PJ, van Bockel JH. Saphenous vein versus PTFE for above-knee femoropopliteal bypass. A review of the literature. Eur J Vasc Endovasc Surg. 2004;27:357-62.
16. Adam DJ et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomized controlled trial. Lancet 2005;366:1925-34.
38. Duda SH, Bosiers M, Lammer J et al. Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial. J Endovasc Ther. 2006;13:701-10.
5. Gardner E, O’Hahilly R, Gray DJ. Anatomia - Estudo Regional do Corpo Humano. 4.ed. Rio de Janeiro: Editora Guanabara; 1975. 6. Cronenwett JL, Johnston KW. Rutherford’s vascular surgery, 8.ed. Rio de Janeiro: Editora Guanabara; 2016.
18. Bradbury AW et al. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: Analysis of amputation free and overall survival by treatment received. J Vasc Surg. 2010;51:18S-31S.
1. Antonopoulos AG, Thomopoulos M, Trikas A. The role of the angiosome model in percutaneous intravascular and surgical reperfusion treatment of peripheral artery disease of the lower limbs. Hellenic J Cardiol. 2014 Jan-Feb;55(1):52-7.
44. Scheller B, Speck U, Bohm M. Prevention of restenosis: is angioplasty the answer? Heart. 2007;93:539-41.
45. Rosenfield K, Jaff MR, White CJ et al. Trial of a paclitaxelcoated balloon for femoropopliteal artery disease. N Engl J Med. 2015;373(2):145-53.
53. Albers M, Romiti M, Brochado-Neto FC et al. Meta-analysis of popliteal-to-distal vein bypass grafts for critical ischemia. J Vasc Surg. 2006;43:498-503.
49. Saxon RR, Chervu A, Jones PA et al. Heparin-bonded, expanded polytetrafluoroethylene-lined stent graft in the treatment of femoropopliteal artery disease: 1-year results of the VIPER (Viabahn Endoprosthesis with Heparin Bioactive Surface in the Treatment of Superficial Femoral Artery Obstructive Disease) trial. J Vasc Interv Radiol 2013;24(2):165-73.
50. Lammer J, Zeller T, Hausegger KA et al. Sustained benefit at 2 years for covered stents versus bare-metal stents in long SFA lesions: the VIASTAR trial. Cardiovasc Intervent Radiol. 2015;38(1):25-32.
76. Dave RM, Patlola R, Kollmeyer K et al. Excimer laser recanalization of femoropopliteal lesions and 1-year patency: results of the CELLO registry. J Endovasc Ther. 2009;16(6):665-75. 77. Lawrence JB, Prevosti LG, Kramer WS et al. Pulsed laser and thermal ablation of atherosclerotic plaque: morphometrically defined surface thrombogenicity in studies using an annular perfusion chamber. J Am Coll Cardiol. 1992;19:1091-100. 78. Ramaiah V, Gammon R, Kiesz S et al. Midterm outcomes from the TALON Registry: treating peripherals with SilverHawk: outcomes collection. J Endovasc Ther. 2006;13:592-602. 79. McKinsey JF, Goldstein L, Khan HU et al. Novel treatment of patients with lower extremity ischemia: use of percutaneous atherectomy. Ann Surg. 2008:248:519-28. 80. Zeller T, Rastan A, Sebastian S et al. Long-term results after directional atherectomy of femoropopliteal lesions. J Am Coll Cardiol 2006;48:1573-8. 81. Kim D, Gianturco LE, Porter DH et al. Peripheral directional atherectomy: 4-year experience. Radiology. 1992;183:773-8. 82. Zeller T, Krankenberg H, Rastan A et al. Percutaneously rotational and aspiration atherectomy in infrainguinal peripheral arterial occlusive disease: a multicenter pilot study. J Endovasc Ther. 2007;14:357-64. 83. Zeller T, Krankenberg H, Steinkamp HJ et al. Percutaneous rotational and aspiration atherectomy in infrainguinal peripheral arterial
70. Peeters PJ, Bosiers M, Scheinert D, Gershony G. Role of the AngioSculpt Scoring Balloon Catheter for the Treatment of Femoropopliteal Disease: One Year Results from the MASCOT Trial. Cardiovascular Revascularization Medicine Oct 2010;11(4):272-3. 71. Schneider PA, Laird JR, Tepe G et al. Treatment effect of drug-coated balloons is durable to 3 years in the femoropopliteal arteries: longterm results of the IN.PACT SFA Randomized Trial. Circ Cardiovasc Interv. 2018;11(1):e005891.
43. Hwang CW, Wu D, Edelman ER. Physiological transport forces govern drug distribution for stentbased delivery. Circulation. 2001;104:600-5.
59. Donas KP, Torsello G, Schwindt A et al. Below knee bare nitinol stent placement in high-risk patients with critical limb ischemia is still durable after 24 months of follow-up. J Vasc Surg. 2010;52(2):356-61.
60. Spreen MI, Martens JM, Hansen BE et al. Percutaneous transluminal angioplasty and drug-eluting stents for infra- popliteal lesions in critical limb ischemia (PADI) trial. Circ Cardiovasc Interv. 2016;9:e002376.
42. Laird JR, Yeo KK. The treatment of femoropopliteal in-stent restenosis: back to the future. J Am Coll Cardiol. 2012;59:24-5.
247Capítulo 130 oClusão ArteriAl infr AinguinAl – tr AtAmento endovA sCul Ar Dake MD, Ansel GM, Jaff MR et al. Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelvemonth Zilver PTX randomized study results. Circ Cardiovasc Interv. 2011;4:495-504. Rogers JH, Laird JR. Overview of new technologies for lower extremity revascularization. Circulation 2007;116(18):2072-85. Scheinert D, Scheinert S, Sax J et al. Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J Am Coll Cardiol. 2005;45:312-5.
48. Geraghty PJ, Mewissen MW, Jaff MR et al. Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive disease. J Vasc Surg 2013;58(2):386-95.
52. Camm AJ, Lüscher TF, Maurer G, Serruys PW. ESC CardioMed (DRAFT), 3rd ed. Oxford University Press, 2018 Mar. Published online DOI: 9780198784906.
74. Dake MD, Ansel GM, Jaff MR et al. Durable clinical effectiveness with paclitaxel-eluting stents in the femoropopliteal artery: 5-year results of the Zilver PTX randomized trial. Circulation. 2016;133(15):1472-83.
75. Bunting TA, Garcia LA. Peripheral atherectomy: a critical review. J Interv Cardiol. 2007;20:417-24.
47.
72. Zeller T, Gaines PA, Ansel GM, Caro CG. Helical centerline stent improves patency: two-year results from the randomized mimics trial. Circulation Cardiovascular Interventions 2016;9(6):e002930.
54. Siablis D, Karnabatidis D, Katsanos K et al. Infrapopliteal application of sirolimus-eluting versus bare metal stents for critical limb ischemia: analysis of long-term angiographic and clinical outcome. J Vasc Interv Radiol. 2009;20:1141-50.
39.
58. Cassese S, Ndrepepa G, Liistro F et al. Drug-coated balloons for revascularization of infrapopliteal arteries: a meta-analysis of randomized trials. JACC Cardiovascular Interventions. 2016;9(10):1072-80.
57. Zeller T, Baumgartner I, Scheinert D et al. Drug-eluting balloon versus standard balloon angioplasty for infrapopliteal revascularization in critical limb ischemia: 12-month results from the IN.PACT DEEP randomized trial. J Am Coll Cardiol. 2014;64:1568-76.
41.
56. Laird JR, Armstrong EJ. Drug-coated balloons for infrapopliteal disease: digging deep to understand the impact of a negative trial. J Am Coll Cardiol. 2014;64:1577–9.
51. Ohki T, Kichikawa K, Yokoi H et al. Outcomes of the Japanese multicenter Viabahn trial of endovascular stent grafting for superficial femoral artery lesions. J Vasc Surg. 2017 July;66(1):130-42.
55. Baumann F, Fust J, Engelberger RP et al. Early recoil after balloon angioplasty of tibial artery obstructions in patients with critical limb ischemia. J Endovasc Ther. 2014;21:44-51.
61. Fusaro M, Cassese S, Ndrepepa G et al. Drug-eluting stents for revascularization of infrapopliteal arteries: updated meta- analysis of randomized trials. JACC Cardiovasc Interv. 2013;6:1284-93.
46. Tepe G, Laird J, Schneider P et al. Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial. Circulation. 2015;131(5):495-502. Jongsma H, van Mierlo-van den Broek P, Imani F et al. Randomized comparison of femoropopliteal artery drug-eluting balloons and drug-eluting stents (FOREST trial): study protocol for a randomized controlled trial. J Vasc Surg 2017;66(4):1293-8.
40.
62. Katsanos K, Spiliopoulos S, Diamantopoulos A et al. Wound healing outcomes and health-related quality-of-life changes in the ACHILLES trial: 1-year results from a prospective randomized controlled trial of infrapopliteal balloon angioplasty versus sirolimus-eluting stenting in patients with ischemic peripheral arterial disease. JACC Cardiovasc Interv. 2016;9:259-67.
63. Thomas SD, McDonald RR, Varcoe RL. Vasculitis resulting from a superficial femoral artery angioplasty with a paclitaxel-eluting balloon. J Vasc Surg. 2014;59(2):520-3. 64. Antoniou GA, Chalmers N, Kanesalingham K et al. Metaanalysis of outcomes of endovascular treatment of infrapopliteal occlusive disease with drug-eluting stents. J Endovasc Ther. 2013;20(2):131-44. 65. Zhang J, Xu X, Kong J et al. Systematic Review and Meta-Analysis of Drug-Eluting Balloon and Stent for Infrapopliteal Artery Revascularization. Vasc Endovascular Surg. 2017 Feb;51(2):72-83. 66. Albiero R. Cutting balloon versus conventional balloon angioplasty for the treatment of coronary artery disease. Business Briefing: European Cardiology; 2005. p. 48-52. 67. Cotroneo AR, Pascali D, Iezzi R. Cutting balloon versus conventional balloon angioplasty in short femoropopliteal arterial stenoses. J Endovasc Ther. 2008;15:283-91. 68. Gershony G, Virmani R, Lotan C et al. A novel angioplasty catheter for the treatment of complex CAD: AngioSculpt. Am J Cardiol. 2003;92suppl 1:166L. 69. Scheinert D, Graziani L, Peeters P et al. Results of the multi-center first-in-man study of a novel scoring balloon catheter for the treatment of infra-popliteal peripheral arterial disease. Cathet Cardiovasc Interv. 2007;70:1034-9.
73. Garcia L, Jaff MR, Metzger C et al. Wire-interwoven nitinol stent outcome in the superficial femoral and proximal popliteal arteries: twelve-month results of the SUPERB trial. Circ Cardiovasc Interv. 2015;8(5):e000937.
90.
248 Parte VIIIMEMBROS INFERIORES occlusive disease: a multicenter study. Am J Cardiol. 2008;102(supp 1):38i-39i. 84. Heuser RR. Treatment of lower extremity vascular disease: the Diamondback 360¼ Orbital Atherectomy System. Expert Review of Medical Devices. 2008;5:279-86. 85. Niazi K, Safian R, Heuser R et al. Final study results of 124 patients demonstrate safety and acute procedural effectiveness of orbital atherectomy for peripheral vascular stenosis. Am J Cardiol 2008;102(supp 1):229i. 86. Kamper L & Haage P. Perkutane Zugänge zur endovaskulären PAVKTherapie. Der Radiologe. 2016;56(3):223-32. 87. Ye M, Zhang H, Huang X. Retrograde popliteal approach for challenging occlusions of the femoral-popliteal arteries. J Vasc Surg 2013;58(1):84-9.
100. Venkatachalam S, Bunte M, Monteleone P et al. Combined antegraderetrograde intervention to improve chronic total occlusion recanalization in high-risk critical limb ischemia. Ann Vasc Surg. 2014;28:1439-48. 101. Mustapha JA, Saab F, McGoff T et al. Tibio-pedal arterial minimally invasive retrograde revascularization in patients with advanced peripheral vascular disease: theTAMI technique, original case series. Catheter Cardiovasc Interv. 2014;83:987-94. 102. Morgan R, Belli AM. Current Treatment Methods for Postcatheterization Pseudoaneurysms. J Vasc Interv Radiol 2003;14:697-710. 103. Katzenschlager R, Ugurluoglu A, Ahmadi A et al. Incidence of pseudoaneurysm after diagnostic and therapeutic angiography. Radiology. 1995 May;195:463-6. 104. Ahmad F, Turner SA , Torrie P, Gibson M. Iatrogenic femoral artery pseudoaneurysms - A review of current methods of diagnosis and treatment. Clinical Radiology. 2008;63:1310-6. 105. Gabriel M, Pawlaczyk K, Waliszewski K et al. Location of femoral artery puncture site and the risk of postcatheterization pseudoaneurysm formation. Int J Cardiol. 2007;120:167-71. 106. Lanziotti L. Doença obstrutiva aterosclerótica suprapatelar. In: Belczac SQ. Cirurgia endovascular e angiorradiologia. Rio de Janeiro: Rubio; 2016. p. 224-32. 107. Sambol EB, Mckinsey JF. Local Complications: Endovascular. In: Cronenwett JL, Johnston KW. Rutherford’s vascular surgery, 8th ed. Philadelphia: Elsevier; 2014. 704-22. 108. Ravin RA, Faries PL. Infrainguinal disease: endovascular treatment. In: Cronenwett JL, Johnston KW. Rutherford’s vascular surgery, 8th ed. Philadelphia: Elsevier; 2014. p. 1782-800. 109. Stegman BM, Shishehbor MH. Commentary: optimal revascularization for critical limb ischemia: one approach doesn’t always fit all. J Endovasc Ther. 2015;22:482-4. 110. Farber A. Endovascular treatment for claudication still awaits longterm results. J Vasc Surg. 2017;66(1):1. 111. Shishehbor MH, White CJ, Gray BH et al. Critical limb ischemia: an expert statement. J Am Coll Cardiol. 2016 Nov. 1;68(18):2002-15.
88. Affonso BB, Domingos FUG, da Motta Leal Filho JM et al. Retrograde proximal anterior tibial artery access for treating femoropopliteal segment occlusion: a novel approach. Ann Vasc Surg. 2016;33:237-44. 89. Hendricks NJ & Sabri SS. Subintimal arterial flossing with antegraderetrograde intervention (SAFARI) and retrograde access for critical limb ischemia. Tech Vasc Intervent Radiol 2014;17(3):203-10. Mustapha JA, Diaz-Sandoval LJ, Saab F. Innovations in the endovascular management of critical limb ischemia: retrograde tibiopedal access and advanced percutaneous techniques. Curr Cardiol Rep. 2017 Aug.;19(8):68. 91. Ambler GK, Radwan R, Hayes PD et al. Atherectomy for peripheral arterial disease. Cochrane Database Syst Rev. 2014;(3):CD006680. 92. McCaslin JE, Andras A, Stansby G. Cryoplasty for peripheral arterial disease. Cochrane Database Syst Rev. 2013;(8):CD005507. 93. Shammas NW, Coiner D, Shammas G et al. Percutaneous lower extremity arterial interventions using primary balloon angioplasty versus cryoplasty: a randomized pilot trial. Cardiovasc Revasc Med. 2012;13:172–6. 94. Katsanos K, Spiliopoulos S, Reppas L, Karnabatidis D. Debulking Atherectomy in the Peripheral Arteries: Is There a Role and What is the Evidence? Cardiovasc Intervent Radiol. 2017 July;40(7):964-977. 95. Mustapha JA, Diaz-Sandoval LJ, Saab F. Tibioperoneal CTOs in patients with critical limb ischemia. Using cap analysis to design and implement crossing strategies. Endovascular Today. 2014 May;13(5):42–54. 96. Ruzsa Z, Nemes B, Bansaghi Z et al. Transpedal access after failed anterograde recanalization of complex below-the-knee and femoropoliteal occlusions in critical limb ischemia. Catheter Cardiovasc Interv. 2014;83:997-1007. 97. Ozawa N. A new understanding of chronic total occlusion from a novel PCI technique that involves a retrograde approach to the right coronary artery via a septal branch and passing of the guidewire to a guiding catheter on the other side of the lesion. Catheter Cardiovasc Interv. 2006;68:907-13. 98. Montero-Baker M, Schmidt A, Bräunlich S et al. Retrograde approach for complex popliteal and tibioperoneal occlusions. J Endovasc Ther. 2008;15:594-60. 99. Goltz JP, Planert M, Horn M et al. Retrograde transpedal access for revascularization of below-the-knee arteries in patients with critical limb ischemia after an unsuccessful antegrade transfemoral approach. Rofo. 2016 Oct;188(10):940-8.
24. Zierler RE, Jordan WD, Lal BK et al. The Society for Vascular Surgery practice guidelines on follow-up after vascular surgery arterial procedures. J Vasc Surg 2018 Jul;68(1):256-284. 25. Kudo T, Chandra FA, Kwun WH et al. Changing pattern of surgical revascularization for critical limb ischemia over 12 years: endovascular versus open bypass surgery. J Vasc Surg 2006;44:304-313.
22. Gerhard-Herman MD, Gornik HL, Barrett C et al. 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 2017 Mar 21;135(12):e686-e725. 23. Halliday A, Bax JJ. The 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in Collaboration With the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg 2018 Mar;55(3):301-302.
6. Conte MS. Diabetic revascularization: Endovascular versus open bypass-Do we have the answer? Semin Vasc Surg 2012;25:108-114.
11. Bradbury AW, Adam DJ, Bell J et al. The Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: an intention-totreat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategy. J Vasc Surg 2010;51(5 Suppl):5S-17S.
4. TransAtlantic Inter-Society Consensus Working Group. Management of peripheral arterial disease (PAD). J Vasc Surg 2000;31(1 Pt 2):S1-S296.
16. Romiti M, Albers M, Brochado-Neto FC et al. Meta-analysis of infrapopliteal angioplasty for chronic critical limb ischemia. J Vasc Surg 2008;47: 975-981.
12. Rogers LC, Andros G, Caporusso J et al. Toe and flow: essential components and structure of the amputation prevention team. J Vasc Surg 2010;52:23S-27S(suppl).
9. Ihnat DM, Mills JL. Current assessment of endovascular therapy for infrainguinal arterial occlusive disease in patients with diabetes. J Vasc Surg 2010;52:92S-95S. 10. Criqui MH. Peripheral arterial disease–epidemiological aspects. Vasc Med 2001;6(3 Suppl):3-7.
20. Kudo T, Chandra FA, Ahn SS. The effectiveness of percutaneous transluminal angioplasty for the treatment of critical limb ischemia: a 10 year experience. J Vasc Surg 2005;41:423-435.
29. Sadek M, Ellozy SH, Turnbull IC et al. Improved outcomes are associated with multilevel endovascular intervention involving the tibial vessels compared with isolated tibial intervention. J Vasc Surg 2009;49:638-643;discussion 643-644. 30. Adam DJ, Beard JD, Cleveland T et al. Bypass versus angioplasty insevere ischemia of the leg (BASIL): multicenter, randomized controlled trial. Lancet 2005;366:1925-1934.
13. Piorkowski M, Freitas B, Steiner S et al. 12 month experience with the GORE® TIGRIS® Vascular Stent in the superficial femoral and popliteal arteries. J Cardiovasc Surg 2014;1827-191X: ahead of print.
26. Freitas B, Steiner S, Bausback Y et al. Single Center Experience with Vascular Closure Closure Devices in real-world endovascular Peripheral Interventions. J Cardiovasc Surg 2016;58:1827-191x. 27. Giles K, Pomposelli F, Spence T. Infrapopliteal angioplasty for critical limb ischemia: relation of TransAtlantic InterSociety Consensus class to outcome in 176 limbs. J Vasc Surg 2008;48:128-136.
8. Malmstedt J, Leander K, Wahlberg E et al. Outcome after leg bypasss surgery for critical limb ischemia is poor in patients with diabetes: a population-based cohort study. Diabetes Care 2008;31:887-892.
17. Vogel TR, Dombrovskiy VY, Carson JL et al. In-hospital and 30-day outcomes after tibioperoneal interventions in the US medicare population with critical limb ischemia. J Vasc Surg 2011;54:109-115.
3. Norgren L, Hiatt WR, Dormandy JA et al. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg 2007;45:S5-S67(suppl).
14. Schanzer A, Conte MS. Critical limb ischemia. Curr Treat Options Cardiovasc Med 2010;12:214-229.
249 131CapítuloREVASCULARIZAÇÃO ULTRADISTAL –TRATAMENTO ENDOVASCULAR REFERÊNCIAS BIBLIOGRÁFICAS
28. Soderstrom MI, Arvela EM, Korhonen M et al. Infrapopliteal percutaneous transluminal angioplasty versus bypass surgery as firstline strategies in critical leg ischemia: a propensity score analysis. Ann Surg 2010;252(5):765-73.
18. Freitas B, Steiner S, Bausback Y et al. Rotarex Mechanical Debulking In Acute And Subacute Arterial Lesions: Single-Center Experience With 525 Patients. Angiology (Roslyn, N.Y.) 2016;67:502-510.
5. Ali Rana M, Gloviczki P. Endovascular interventions for infrapopliteal arterial disease: An update. Semin Vasc Surg 2012;25:29-34.
1. Shammas N. Epidemiology, classification, and modifiable risk factors of peripheral arterial disease. Vasc Health Risk Manag 2007;3:229-234. 2. Hirsch A, Haskal Z, Hertzer N. ACC/AHA 2005 Practice guidelines of the management of patients with peripheral arterial disease. Circulation 2006;113:e463-e654.
19. Freitas B, Pitta GBB, Scheinert D. Endovascular Therapy for Peripheral Arterial Disease in the Femoropopliteal Territory: An Evolving Promising Scenario. Rev Bras Cardiol Invasiva (English Edition) 2015;23:164-165.
21. DeRubertis BG, Faries PL, McKinsey JF et al. Shifting paradigms in the treatment of lower extremity vascular disease-a report of 1000 percutaneous interventions. Ann Surg 2007;246:415-424.
31. Gray BH, Grant AA, Kalbaugh CA et al. The impact of isolated tibial disease on outcomes in the critical limb ischemic population. Ann Vasc Surg 2010;24:349-59. 32. Schanzer A, Mega J, Meadows J et al. Risk stratification in critical limb ischemia: derivation and validation of a model to predict amputationfree survival using multicenter surgical outcomes data. J Vasc Surg 2008;48:1464-71. 33. Schillinger M, Sabeti S, Loewe C et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. New Engl J Med 2006;354:1879-88. 34. Taylor SM, Kalbaugh CA, Blackhurst DW et al. A comparison of percutaneous transluminal angioplasty versus amputation for critical limb ischemia in patients unsuitable for open surgery. J Vasc Surg 2007;45:304-310. 35. Nylaende M, Abdelnoor M, Stranden E et al. The Oslo Balloon Angioplasty versus Conservative Treatment study (OBACT): the 2-years results of a single centre, prospective, randomized study in patients with intermittent claudication. Eur J Vasc Endovasc Surg 2007;33:3-12.
15. Zeller T, Frank U, Bürgelin K et al. Initial clinical experience with percutaneous atherectomy in the infragenicular arteries. J Endovasc Ther 2003;10:987-93.
36. Hirsch AT, Haskal ZJ, Hertzer NR et al. ACC/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients with Peripheral Arterial Disease); endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation, National Heart, Lung, and Blood Institute;
7. Ratnam L, Raza A, Horton A et al. Outcome of aortoiliac, femoropopliteal and infrapopliteal endovascular interventions in lesions categorized by TASC classification. Clin Radiol 2012;67:949-954.
42. Deutschmann HA, Schoellnast H, Temmel W et al. Endoluminal therapy in patients with peripheral arterial disease: prospective assessment of quality of life in 190 patients. AJR Am J Roentgenol 2007;188:169-175.
43. White CJ, Gray WA. Endovascular therapies for peripheral arterial disease: an evidence-based review. Circulation 2007;116:2203-2215.
50. Kawarada O, Yokoi I. Retrograde 3-French popliteal approach in supine position after failed antegrade angioplasty for chronic superficial femoral artery occlusion. J Endovasc Ther 2010;17(2):255-258.
54. Rogers RK, Tsai T, Cassety IP. Novel application of the “CART” technique for endovascular treatment of external iliac artery occlusion. Catheter Cardiovasc Interv 2010;75(5):673-678.
47.
51. Fannelli F, Lucatelli P, Allegrini M et al. Retrograde popliteal accessin the supine patient for recanalization of the superficial femoral artery: initial results. J Endovasc Ther 2011;18(4):503-509.
45.
48. Scheinert D, Braunlich S, Scheinert S et al. Initial clinical experience with an IVUS-guided transmembrane puncture device to facilitate recanalization of total femoral artery occclusions. Eurointervention 2005;1:115-119.
52. Montero-Baker M, Schmidt A, Braunlich S et al. Retrograde approach for complex popliteal and tibioperoneal occlusions. J Endovasc Ther 2008;15(5):594-604.
53. Palena LM, Diaz-Sandoval LJ, Raja LM et al. Precise Retrograde Supera Stenting of the Ostium (PRESTO) of the Superficial Femoral Artery for Complex Femoropopliteal Occlusions: The PRESTO Technique. J Endovasc Ther 2018 Oct;25(5):588-591.
LEITURAS SUGERIDAS Airoldi F, Vitiello R, Llosa S. Retrograde recanalization of the anteriortibial artery following surgical vessel exposure: a combined approach for single remaining infragenicular vessel. J Vasc Interv Radiol Becker2010;21:949-950.F,Robert-Ebadi H, Ricco JB et al. Chapter I: definitions, epidemiology, clinical presentation and prognosis. Eur J Vasc Endovasc Surg 2011;42:S4-S12(suppl 2). Brodmann M, Froehlich H, Dorr A. Percutaneous transluminal angioplasty versus primary stenting in infrapopliteal arteries in critical limb ischemia. Vasa 2011;40:482-490. Fernandez N, McEnaney R, Marone L. Predictors of failure and success of tibial interventions for critical limb ischemia. J Vasc Surg Fernandez2010;52:834-842.N,McEnaney R, Marone LK et al. Multilevel versus isolated endovascular tibial interventions for critical limb ischemia. J Vasc Surg Dattilo2011;54(3):722-9.PB,CasserlyIP. Critical Limb Ischemia: Endovascular Strategies for Limb Salvage. Prog Cardiovasc Diseases 2011;54:47–60. Schmidt A, Ulrich M, Winker B. Angiographic patency and clinical outcome after balloon-angioplasty for extensive infrapopliteal arterial disease. Catheter Cardiovasc Interv 2010;76:1047-1054. Soderstrom M, Albäck A, Biancari F et al. Angiosome-targeted infrapopliteal endovascular revascularization for treatment of diabetic foot ulcers. J Vasc Surg 2013;57(2):427-35. Varu VN, Hogg ME, Kibbe MR. Critical Limb Ischemia. J Vasc Surg 2010;51:230-241. Review. Yeh K, Tsai Y, Huang H. Dual vascular access for critical limb ischemia: immediate and follow-up results. Catheter Cardiovasc Interv 2011;77:296-302.
37. Mitchell DC, Murray A, Wood RF, Grasty M et al. Laser-assisted angioplasty for arterial occlusion of the lower limb: initial results and follow-up. Br J Surg 1992;79:81-5. Rooke TW, Hirsch AT, Misra S. 2011 ACCF/AHA Focused update of the guideline for the management of patients with peripheral arterial disease (updating the 2005 guideline). J Vasc Surg 2011;54:e32-58. Lipsky BA, Peters EJ, Berendt AR et al. Specific guidelines for the treatment of diabetic foot infections 2011. Diabetes Metab Res Rev 2012;28:234-235(suppl 1). 40. Rastan A, Tepe G, Krankenberg H. Sirolimus-eluting stents vs. baremetal stents for treatment of focal lesions in infrapopliteal arteries: a double blind, multicenter, randomized clinical trial. Eur Heart J 2011;32:2274-2281.
49. Noory E, Rastan A, Schwarzwalder U et al. Retrograde transpopliteal recanalization of chronic superficial femoral artery occlusion after failed antegrade subintimal angioplasty. J Endovasc Ther 2009;16(5):619-623.
55. Werner M, Piorkowski M, Schmidt A. Techniques and outcome of retrograde crural artery revascularization. J Cardiovasc Surg (Torino) 2013;54(1 Suppl 1):151-8. Review.
39.
41. Rogers JH, Laird JR. Overview of new technologies for lower extremity revascularization. Circulation 2007;116:2072-2085.
44. Golledge J, Askew C, Leicht A et al. Outcome assessment for intermittent claudication. Eur J Vasc Endovasc Surg 2006;31:44-45. Krankenberg H, Schluter M, Steinkamp HJ et al. Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the Femoral Artery Stenting Trial (FAST). Circulation 2007;116:285-292. Rueda CA, Nehler MR, Perry DJ et al. Patterns of artery disease in 450 patients undergoing revascularization for critical limb ischemia: implications for clinical trial design. J Vasc Surg 2008;47:995-1000. Bausback Y, Botsios S, Flux J et al. Outback catheter for femoropopliteal occlusions. Immediate and long term results. J Endovasc Ther 2011;18(1):13-21.
38.
250 Parte VIIIMEMBROS INFERIORES Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation 2006;113:e463-e654.
46.
3. Kunlin J. Le traitement de l’ischaemie artéritique par la greffe veineuse longue. Rev Chir Orthop 1951;70:206.
REFERÊNCIAS BIBLIOGRÁFICAS
15. Albers MTV. Revascularização das artérias de perna com veia safena não invertida. Faculdade de Medicina da Universidade de São Paulo. Tese de Livre-Docência, 1986 16. Belkin M, Donaldson MC, Mannick JÁ, Whittemore AD. Infrainguinal arterial reconstrution with no reversed great saphenous vein. J Vasc Surg 1996;24:957-62.
10. Johnson Jr G. Valve excision in autogenous vein grafts. Surg Ginec Obstet 1996;123:845-6. 11. Scheinin TM, Linna MI, Inberg MV. Eversion-valvulotomy of unreversed femoro popliteal venous autografts. J Cardiovasc Surg 1969;10:12-5.
2. Nicholas GG, Barker CF, Berkowitz HD, Roberts B. Reconstrutive surgery distal to the popliteal trifurcation. Arch Surg 1973;107:652-6.
1. Cronenwett JL, Warner KG, Zelenock GB et al. Intermittent claudication. Current results of nonoperative management. Arch Surg 1984;119:430-5.
12. Leather RP, Shah DM, Karmody AM. Infrapopliteal arterial by-pass for limb salvage: Increased patency and utilization of the saphenous vein used” in situ”. Surgery 1981;90:1000-8.
18. Abou-Zamzam AM Jr, Lee RW, Moneta GL et al. Functional outcome after infrainguinal bypass for limb salvage. J Vasc Surg 1997;25:287-297 19. Ascer E, Veith FJ, Gupta SK et al. Six year experience with expanded polytetrafluoroethylene arterial grafts for limb salvage. J Cardiovasc Surg 1985;26. 20. Whittemore AD, Kent KC, Donaldson MC et al. What is the proper role of politetrafluoroethylene grafts in infrainguinal reconstruction? J Vasc Surg 1989:10:299-305.
17. Taylor JR, Edwards JE, Porter JM. Present status of reversed vein bypass grafting: five-year results of a modern series. J Vasc Surg 1990;11:193-206.
251
SUBSTITUTIVOS NA REVASCULARIZAÇÃO INFRAPATELAR
21. Flinn WR, Rohrer MY, Bergan JJ. Improved long-term patency of infragenicular polytetrafluoroethylene grafts. J Vasc Surg 1988;7:685-90.
25. Clayson KR, Dale WA. Arm veins for peripheral arterial reconstruction. Arch Surg 1976;111:1276-80 26. Whittemore AD, Clowes AW, Couch NP, Mannicck JA. Secondary femoropopliteal reconstruction. Ann Surg 1981;193:35-42. 27. Graham JW, Lusby RJ. Infrapopliteal bypass grafting: use of upper limb alone and in autogenous composite grafts. Surgery 1982;91:646-9. 28. Schulman ML, Badhey MR. Late results and angiographic evaluation of experience with deep leg veins as femoropopliteal bypass grafts. Surgery 1082;92:1032-41. 29. Harris RH, Andros G, Dulawa LB et al. Sucessful long-term limb salvage using cephalic vein bypass grafts. Ann Surg 1984;200:785-92. 30. Bergan JS, Veith FJ, Bernhard VM et al. Randomization of autogenous vein and polytetrafluoroethylene grafts in femoral-distal reconstruction. Surgery 1982;92:91-30. 31. Salles-Cunha SK, Andros G, Harris RW et al. Preoperative noninvasive assessment of arm veins to be used as by-pass grafts in the lower extremities. J Vasc Surg 1986;3:813-6. 32. Harris RH, Andros G, Dulawa LB et al. Totally autogenous venovenous composite bypass grafts. Arch Surg 1986;121:1128-32 33. Logerfo FW, Paniszyn CW, Menzoian JO. A new arm vein graft for distal bypasses. J Vasc Surg 1987;5:889-91. 34. Holzenbein TJ, Pomposelli FB Jr, Miller A et al. The upper arm basiliccephalic loop for distal bypass grafting: technical considerations and follow-up. J Vasc Surg 1995;21:586-594. 35. Holzenbein TJ, Pomposelli FB Jr, Logerfo FW et al. Results of a policy with arm veins used as the first alternative to an unavailable ipsilateral greater saphenous vein for infrainguinal bypass. J Vasc Surg 1996;23:130-140. 36. Edwards JE, Taylor LM Jr, Porter JM. Treatment of failed lower extremity bypass grafts with new autogenous vein bypass grafting. J Vasc Surg 1990;11:136-45. 37. Gentile AT, Lee RW, Moneta GL et al. Results of bypass to popliteal and tibial arteries with alternative sources of autógenous vein. J Vasc Surg 1996;23:272-80. 38. Chew DKW, Owens CD, Belkin M et al. Bypass in the absence of ipsilateral greater saphenous vein: Safety and superiority of the contralateral greater saphenous vein. J Vasc Surg 2002;35:1085-92. Campbell DR, Hoar CS Jr, Gibons GW. The use of arm veins in femoral-popliteal bypass. Ann Surg 1979;190:740-42. 40. Londrey GL, Bosher LP, Brow PW et al. Infrainguinal reconstruction with arm vein, lesser saphenous vein, and remnants of great saphenous veins: a report of 257 cases. J Vasc Surg 1994;20:451-7. Vauclair F, Haller C, Marques-Vidal P et al. Infrainguinal by-pass for peripheral arterial occlusive disease: When arms save legs. Eur J Vasc Endovasc Surg 2012;43:48-53. Brochado-Neto FC, Albers M, Pereira CAB et al. Prospective comparison of arm veins and greater saphenous veins as infrageniculate bypass grafts. Eur J Vasc Endovasc 2001;22:146-51. 43. Mills NL, Ochsner JL. Valvulotomy of valves in the saphenous vein in the saphenous vein grafts before coronary bypass. J Thorac Surg 1976;71:878-9. 44. Tinder CN, Chavanpun JP, Bandik DF et al. Efficacy of duplex ultrasound surveillance after inguinal vein bypass may be enhanced by identification of characteristics predictive of graft stenosis development. J Vasc Surg 2008;48:613-8. 45. Andros G, Salles-Cunha SK, Harris RW et al. Arm veins for arterial revascularization of the leg: arteriographic and clinical observations. J Vasc Surg 1986;4:416-27. 46. Brochado-Neto FC, Sandri GA, Kalaf MJ et al. Arm vein as a alternative autogenous conduit for infragenicular bypass in the
39.
132Capítulo
41.
42.
4. Deweese JA, ROB CG. Autogenous venous grafts ten years later. Surgery 1977;82:775-84. 5. Szilagyi DE, Hageman JH, Smith RF et al. Autogenous vein grafting in femoro-popliteal atherosclerosis: the limits of its effectiveness. Surgery 1979;86:836-51.
8. Tyson RR, Reichle FA. Femorotibial by-pass for salvage of the ischemic lower extremity. Surg Gynec Obstet 1972;134:771-6.
13. Edwards WS, Holdefer WF, Mohtashemi M. The importance of proper caliber of lumen in femoro-popliteal artery reconstruction. Surg Ginec Obst 1966;122:37-40.
ALTERNATIVOS
14. Campbell SJ, Flanigan DP, Goodreau JJ. Expanded microporous polytetrafluoroethylene as a vascular substitute. A two-year follow-up. Surgery 1979;85:177-83
23. Kakkar VV. The cephalic vein as a peripheral vascular graft. Surg Gynecol Obstet 1969;128:551-556.
6. Palma EC, apud Dale WA. Grafting small arteries. Arch Surg 1963;86:36-47.
22. Quiñones-Baldrich WJ, Busuttil RW, Baker JD, et al. Is the preferencial use of politetrafluoroethylene grafts for femoropopliteal bypass justified? J Vasc Surg 1988;8:219-28.
9. Hall KV. The great saphenous vein in situ as an arterial shunt after vein valve extirpation. Acta Chir Scand 1964;128:365-86.
7. McCaughan JR JJ. Successful arterial grafts to the anterior tibial, posterior tibial (below the peroneal), and peroneal arteries. Angiology 1961;12:91-4.
24. Vellar IDA, Doyle JC. The use of the cephalic veins as peripheral vascular graft. Aust N J Surg 1970;40:52-7.
52. De Luccia N, Sassaki P, Durazzo A et al. Limb salvage using bypass to the perigeniculate arteries. Eur J Vasc Endovasc Surg 2011;42:374-8.
47. Sesto ME, Sullivan TM, Hertzer NR et al. Cephalic vein grafts for lower extremity revascularization. J Vasc Surg 1992;15:543-9.
69. Delis KT, Swan M, Crane JS, Cheshire NJ. The Giacomini vein as an autologous conduit in infrainguinal arterial reconstruction. J Vasc Surg 2004;40(3):578-81.
57. Pascarela L, Murcebe L, Cox MW, McCann RI. Spliced Arm Grafts for Critical Lower Limb Ischemia. J Vasc Surg 2012;56:1826.
70. Weaver FA, Barlow CR, Edwards WH et al. The lesser saphenous vein: autogenous tissue for lower extremity revascularization. J Vasc Surg 1987;5(5):687-92.
50. Varcoe RL, Chee P, Subramaniam P et al. Arm vein as a last autogenous option for infrainguinal bypass surgery: It is Worth the Effort. Eur J Vasc Endovasc Surg 2007;33:737-741.
65. Nunes AA, Veith FJ, Collier P et al. Direct approaches to the distal portions of the profunda femoris artery for limb salvage bypasses. J Vasc Surg 1988;8:576-8.
73. Schanzer H, Chiang K, Mabrouk M, Peirce EC 2nd. Use of lower extremity deep veins as arterial substitutes: functional status of the donor leg. J Vasc Surg 1991;14(5):624-7.
48. Devine C, McCollum C. North West Femoro-Popliteal Trail P. Heparin-blonded Dacron or polytetrafluoroethylene for femoropopliteal by-pass: five-year results of a prospective randomized multicenter clinical trial. J Vasc Surg 2004;40:924-31.
76. Schulman ML, Badhey MR, Yatco R. Superficial femoral-popliteal veins and reversed saphenous veins as primary femoropopliteal bypass grafts: a randomized comparative study. J Vasc Surg 1987;6(1):1-10. 77. Veith FJ, Gupta SK, Ascer E et al. Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial reconstructions. J Vasc Surg 1986;3(1):104-14.
51. Latour B, Nourissat G, Duprey A et al. Bypass to the perigeniculate colateral arteries: mid-term results. Eur J Vasc Endovasc Surg 2008;35: 473-9.
49. Faries PL, Arora S, Pomposelli Jr FB et al. The use of arm vein in lower-extremity revascularization: results of 520 procedures performed in eigth years. J Vasc Surg 2000;31:50-9.
75. Schulman ML, Badhey MR, Yatco R, Pillari G. A saphenous alternative: preferential use of superficial femoral and popliteal veins as femoropopliteal bypass grafts. Am J Surg 1986;152(2):231-7.
55. Arvela E, Venermo M, Söderströn M et al. Outcome of infrainguinal single-segment great saphenous vein bypass for critical limb ischemia is superior to alternative autologus vein bypass, especially in patients with high operative risk. Ann Vasc Surg 2012;26:396-403.
63. Darling RC 3rd, Shah DM, Change BB et al. Can the deep femoral artery be used reliably as an inflow source for infrainguinal reconstruction? Long-term results in 563 procedures. J Vasc Surg 1994;20(6):889-95.
78. Edwards JE, Taylor LM Jr, Porter JM. Treatment of failed lower extremity bypass grafts with new autogenous vein bypass grafting J Vasc Surg 1990; 11(1):136-45.
252 Parte VIIIMEMBROS INFERIORES treatment of critical limb ischaemia: A 15 year experience. Eur J Vasc Endovasc Surg 2014;47:609-14.
62. Mills JL, Taylor SM, Fujitani RM. The role of the deep femoral artery as an inflow site for infrainguinal revascularization. J Vasc Surg 1993;18(3):416-23.
64. Brochado-Neto FC, Casella IB, Matielo MF et al. Artéria femoral profunda: uma opção como origem de fluxo para derivações infrageniculares. J Vasc Bras 2008;7(3):193-202.
66. Brochado-Neto FC, Albers MTV, Romiti M. Distal zone of the deep femoral artery as the inflow site in femorodistal bypass grafting. Eur J Vasc Endovasc Surg 2006;31:407-09.
94. Hartranft CA, Noland S, Kulwicki A et al. Cryopreserved saphenous vein graft in infrainguinal bypass. J Vasc Surg 2014;60(5):1291-96. 95. O’Banion LA, Wu B, Eichler CM et al. Cryopreserved saphenous vein as a last-ditch conduit for limb salvage. J Vasc Surg 2017;66(3):844-849. 96. Chang CK, Scali ST, Feezor RJ et al. Defining utility and predicting outcome of cadaveric lower extremity bypass grafts in patients with critical limb ischemia. J Vasc Surg 2014;60(6):1554-64. 97. Wang SK, Gutwein AR, Drucker NA et al. Cryopreserved Homografts in Infected Infrainguinal Fields Are Associated with Frequent Reinterventions and Poor Amputation-Free Survival. Ann Vasc Surg 2018;49:24-29. 98. Gonzalez J, Dufek JH, Kahn DR. Preservation and long-term patency of venous grafts. Surg Forum 1977;28:217-9.
58. McPhee JT, Barshes NR, Ozaki K et al. Optimal conduit choice in the absence of single-segment great saphenous vein for below-knee popliteal. J Vasc Surg 2012;55:1008-14. 59. Gröschel DHM, Strain BA. Arterial graft infections from a microbiologist’s view. In: Calligaro KD, Veith FJ (Eds.). Management of infected arterial grafts. St Louis: Quality Medical Publishing; 1994. p. 3-15. 60. Arvela E, Söderströn M, Albäck A et al. Arm conduit vs. prosthetic graft in infrainguinal revascularization for critical leg ischemia. J Vasc Surg 2010;52:616-23. 61. Robinson DR, Varcoe RL, Chee W et al. Long-term follow-up of last autogenous option arm vein bypass. ANZ J Surg 2013 ;83(10):769-73.
71. Chang BB, Paty PS, Shah DM, Leather RP. The lesser saphenous vein: an underappreciated source of autogenous vein. J Vasc Surg 1992;15(1):152-7. 72. Clagett GP, Bowers BL, Lopez-Viego MA et al. Creation of a neoaortoiliac system from lower extremity deep and superficial veins. Ann Surg 1993;218(3):239-49.
53. Hughes K, Domenig CM, Hamdan AD et al. Bypass to plantar and tarsal arteries: An acceptable approach to limb salvage. J Vasc Surg 2004;40:1149-57.
82. Presti C. Endarterectomia de eversão associada a enxertos de veia em restaurações arteriais infrainguinais. Tese de doutorado, 1994, Faculdade de Medicina da Universidade de São Paulo. 83. Taylor SM, Langan EM 3rd, Snyder BA, Crane MM. Superficial femoral artery eversion endarterectomy: a useful adjunct for infrainguinal bypass in the presence of limited autogenous vein. J Vasc Surg 1997 Sep;26(3):439-46. 84. Julian OC, Dye WS. Treatment of peripheral vascular disease. Surg Clin North Am 1952;32;263-85. 85. Inahara T. The surgical treatment of aortoiliac atherosclerosis. Surgery 1965;58:960-8. 86. Harrison HJ, Jordon WD, Perez AR. Eversion thromboendarterectomy. Surgery 1967;61:26-30. 87. Presti C, Puech-Leão P, Albers M. Superficial femoral eversion endarterectomy combined with a vein segment as a composite artery-vein bypass graft for infrainguinal arterial reconstruction. J Vasc Surg 1999;29(3):413-21. 88. Stonebridge PA, Prescott RJ, Ruckley CV. Randomized trial comparing infrainguinal polytetrafluoroethylene bypass grafting with and without vein interposition cuff at the distal anastomosis. The Joint Vascular Research Group. J Vasc Surg 1997;26(4):543-50. 89. Morris GE, Raptis S, Miller JH, Faris IB. Femorocrural grafting and regrafting: does polytetrafluoroethylene have a role? Eur J Vasc Surg 1993;7(3):329-34. 90. Taylor RS, Loh A, McFarland RJ et al. Improved technique for polytetrafluoroethylene bypass grafting: long-term results using anastomotic vein patches. Br J Surg 1992;79(4):348-54.
92. Ziza V, Canaud L, Gandet T et al. Outcomes of cold-stored venous allograft for below-knee bypasses in patients with critical limb ischemia. J Vasc Surg 2015;62(4):974-83. 93. Zehr BP, Niblick CJ, Downey H, Ladowski JS. Limb salvage with CryoVein cadaver saphenous vein allografts used for peripheral arterial bypass: role of blood compatibility. Ann Vasc Surg 2011;25(2):177-81.
79. Donaldson MC, Whittemore AD, Mannick JA. Further experience with an all-autogenous tissue policy for infrainguinal reconstruction. J Vasc Surg 1993;18(1):41-8. 80. Albers MTV, Aun R, Wolosker M, Langer B. Substituição arterial com enxertos mistos autógenos: artéria femoral endarterectomizada por eversão e veia safena magna. Rev Paul Med 1979;94:74-6. 81. Albers MTV, Langer B, Aun R et al. Artérias endarterectomizadas como substitutos vasculares na cirurgia reconstrutora aorto-ílíaca e fêmoro-poplítea. Rev Hosp Clin Fac Med (São Paulo)1984;39:6-11.
67. Pomposelli FB, Kansal N, Hamdan AD et al. A decade of experience with dorsalispedis artery bypass: analysis of outcome in more than 1000 cases. J Vasc Surg 2003;37:307-14. 68. Brochado Neto FC, Cury MVM, Costa VS et al. Inframaleolar Bypass Grafts for Limb Salvage. Eur J Vasc Endovasc Surg 2010;40:747-53.
91. Rossi G, Munteanu FD, Padula G et al. Nonanastomotic aneurysms in venous homologous grafts and bovine heterografts in femoropopliteal bypasses. Am J Surg 1976;132(3):358-62.
74. Schulman ML, Badhey MR. Deep veins of the leg as femoropopliteal bypass grafts. Arch Surg 1981;116(9):1141-5.
56. Chalmers RT, Hoballah JJ, Kresowik TF et al. The impact of color duplex surveillance on the outcome of lower limb bypass with segments of arm veins. J Vasc Surg 1984;19:279-88.
54. Brochado-Neto FC, Cury MVM, Bonadiman SST et al. Vein bypasses to branches of pedal arteries. J Vasc Surg 2012;55:746-52.
102. Anibueze C, Sankaran V, Sadat U et al. Neoaortic Xenoprosthetic Grafts for Treatment of Mycotic Aneurysms and Infected Aortic Grafts. Ann Vasc Surg 2017;44:419.e1-419.e12.
104. Ascer E, Gennaro M, Pollina RM et al. Complementary distal arteriovenous fistula and deep vein interposition: a five-year experience with a new technique to improve infrapopliteal prosthetic bypass patency. J Vasc Surg 1996;24(1):134-43.
100. Tolva V, Bertoni GB, Trimarchi S et al. Unreliability of depopulated bovine ureteric xenograft for infra inguinal bypass surgery: midterm results from two vascular centers. Eur J Vasc Endovasc Surg 2007;33(2):214-6.
103. Neufang A, Dorweiler B, Espinola-Klein C et al. Outcomes of complex femorodistal sequential autologous vein and biologic prosthesis composite bypass grafts. J Vasc Surg 2014;60(6):1543-53.
101. Wagner WH, Levin PM, Treiman RL et al. Early results of infrainguinal arterial reconstruction with a modified biological conduit. Ann Vasc Surg 1992;6(4):325-33.
107. Johnson WC, Williford WO. Department of Veterans Affairs Cooperative Study #362.Benefits, morbidity, and mortality associated with long-term administration of oral anticoagulant therapy to patients with peripheral arterial bypass procedures: a prospective randomized study. J Vasc Surg 2002;35(3):413-21.
99. Sacilotto R. Utilização da Veia safena homóloga fixada com gluteraldeído em revascularizações infra-geniculares para salvamento de membros. Tese de doutorado apresentada na Faculdade de Medicina da Universidade de São Paulo 1994.
106. Dardik H, Sussman B, Ibrahim IM et al. Distal arteriovenous fistula as an adjunct to maintaining arterial and graft patency for limb salvage. Surgery 1983;94(3):478-86.
108. Tyrrell MR, Wolfe JH. New prosthetic venous collar anastomotic technique: combining the best of other procedures. Br J Surg 1991;78(8):1016-7. 109. Lundgren F, Bergquist D, Norgren et al. SCAMICOS collaborators. PTFE bypass to below-knee arteries: distal vein collar or not? A prospective randomised multicenter study. Eur J Vasc Endovasc Surg 2010;39(6):747-54. 110. Branco BC, Kougias P, Braun JD et al. Distal vein patch use and limb events after infragenicular prosthetic bypasses. J Vasc Surg 2018;68(1):145-152. 111. Khalil AA, Boyd A, Griffiths G. Interposition vein cuff for infragenicular prosthetic bypass graft. Cochrane Database Syst Rev 2012;(9):CD007921. 112. Dardik H, Berry SM, Dardik A et al. Infrapopliteal prosthetic graft patency by use of the distal adjunctive arteriovenous fistula. J Vasc Surg 1991;13(5):685-91.
253Capítulo 132 substitutivos AlternAtivos nA revA sCul Ariz Ação infr APAtel Ar
105. Miller JH, Foreman RK, Ferguson L, Faris I. Interposition vein cuff for anastomosis of prosthesis to small artery. Aust N Z J Surg 1984;54(3):283-5.
49.
2.
1. Sinha S, Houghton J, Holt PJ et al. Popliteal entrapment syndrome. J Vasc Surg. 2012;55:252-62.e30. Gokkus K, Sagtas E, Bakalim T et al. Popliteal entrapment syndrome. A systematic review of the literature and case presentation. Muscles Ligaments Tendons J. 2014;4: 141-8. Stuart TPA. Note on a variation in the course of the popliteal artery. J Anat Physiol. 1879;13(Pt 2):162-5. Hamming JJ. Intermittent claudication at an early age, due to anomalous course of the popliteal artery. Angiology. 1959;10:369-70. 5. Love JW, Whelan TJ. Popliteal artery entrapment syndrome. Am J Surg. 1965;109:620-4. Inada K, Okabe K, Okada K et al. Circulation disturbances due to variation in the course of the popliteal artery. Surg Diag Treat. 1972;14:743-8. 7. Gaylis H, Rosenberg B. Popliteal artery entrapment syndrome. S Afr Med J. 1972;46:1071. 8. Connell J. Popliteal vein entrapment. Br J Surg. 1978;65:351.
14. Persky JM, Kempczinski RF, Fowl RJ. Entrapment of the popliteal artery. Surg Gynecol Obstet. 1991;173:84-90.
6.
10. Ristow AVB, Arruda AM, Baptista H. Síndrome de compressão da artéria poplítea. Med Hoje. 1979;5:80-2. 11. Senior HD. The development of the arteries of the human lower extremities. Am J Anat. 1919;25:55-95.
16. Insua JA, Young JR, Humphies AW. Popliteal artery entrapment syndrome. Arch Surg. 1970;101:771-5.
28. Abou-Zamzam Jr AM, Edwards JM, Porter JM. Popliteal entrapment syndromes. In: Moore WS (Ed.). Vascular surgery: a comprehensive review. Philadelphia: WB Saunders; 1998. p. 133. 29. Bernhein JW, Hanson J, Faries P et al. Acute lower extremity ischemia in a 7-year-old boy: an unusual case of popliteal entrapment syndrome. J Vasc Surg. 2004;39(6):1340-3. 30. Carter AE, Eban RA. A case of bilateral developmental abnormality of the popliteal arteries and gastrocnemius muscles. Br J Surg. 1964;51:518-22. 31. Darling RC, Buckley SJ, Abbott WM et al. Intermittent claudication in young athletes: popliteal artery entrapment syndrome. J Trauma. 1974;15:543-52. 32. Schurmann G, Mattfeld T. The popliteal artery entrapment. Eur J Vasc Surg. 1990;4:223-31. 33. Fong H, Downs AR. Popliteal artery entrapment syndrome with digital embolization – a report of two cases. J Cardiovasc Surg. 1989;30:85-8. 34. Leon M, Volteas N, Labropoulos N et al. Popliteal vein entrapment in the normal population. Eur J Vasc Surg. 1992;6:623-7. 35. Raju S, Neglen P. Popliteal vein entrapment: a benign venographic feature or a pathologic entity? J Vasc Surg. 2000;31:631-41. 36. Di Marzo L, Cisternino S, Sapienza P et al. La síndrome da intrappolamento dela vena poplítea: risultati del tratamento chirurgico. Ann Ital Chir. 1996;67(4):515-20. 37. Hoffmann U, Vetter J, Rainoni L et al. Popliteal artery compression and force of active plantar flexion in young healthy volunteers. J Vasc Surg. 1997;26:281-7. 38. Fowl RJ, Kempckinski RF. Management of chronic ischemia of the lower extremities. In: Rhuterford RB (Ed.). Popliteal artery entrapment. Philadelphia: WB Saunders; 2000. p. 1087-93. 39. MacSweeney STR, Cuming R, Greenhalgh RM. Colour Doppler ultrasonographic imaging in the diagnosis of popliteal artery entrapment syndrome. Br J Surg. 1994;81:822-3. 40. Mintz AJ, Weinberg I. Nonatherosclerotic PAD: approach to exertional pain in the lower extremities. Curr Cardiol Rep. 2015;17:66. 41. Altintas U, Helgstrand UV, Hansen MA et al. Popliteal artery entrapment syndrome: ultrasound imaging, intraoperative findings, and clinical outcome. Vasc Endovascular Surg. 2013;47:513-8. 42. Beregi JP, Djabbari M, Desmoucelle F et al. Popliteal vascular disease: evaluation with spiral CT angiography. Radiology. 1997;203(2):477-83. 43. Rizzo RJ, Flinn WR, Yao JST et al. Computed tomography for evaluation of arterial disease in the popliteal fossa. J Vasc Surg. 1990;11:112-9. 44. Takase K, Imakita S, Kuribayashi S et al. Popliteal artery entrapment syndrome: aberrant origin of gastrocnemius muscle shown by 3D CT. J Comput Assist Tomogr. 1997;21(4):523-8. Muller N, Morris DC, Nichols DM. Popliteal artery entrapment demonstrated by CT. Radiology. 1984;151:157-8. 46. Fujiwara H, Sugano T, Fujii N. Popliteal artery entrapment syndrome: accurate morphological diagnosis utilizing MRI. J Cardiovasc Surg. 1992;33:160-2. Roberts AC, Kaufmann JA, Geller SC. Popliteal artery entrapment syndrome. In: Strandness Jr DE, Van Breda A (Eds.). Vascular diseases: surgical and interventional therapy. New York: Churchill Livingstone; 1994. p. 226. v. 1. 48. Chernoff DM, Walker AT, Khorasani R et al. Asyntomatic functional popliteal artery entrapment: demonstration at MR imaging. Radiology 1995;195:176-80. Atilla S, Akpek ET, Yucel C et al. MR imaging and MR angiography in popliteal artery entrapment syndrome. Eur Radiol. 1998;8(6):1025-9.
4.
17. Bouthoutsos J, Daskalakis E. Muscular abnormalities affecting the popliteal vessels. Br J Surg. 1981;68:501-6. 18. Forbes TL, Kayssi A. Rutherford’s vascular surgery and endovascular therapy: nonatheromatous popliteal artery disease. 9th ed. Philadelphia: Elsevier; 2019. p. 1891-905. v. 2. 19. Rignault DP, Pailler JL, Lunel F. The “functional” popliteal artery entrapment syndrome. Int Angiol. 1985;3:341-3. 20. Levien LJ. Popliteal artery thrombosis caused by popliteal entrapment syndrome. In: Greenhalgh RM, Powel JT. (Eds.). Inflammatory and trombotic problems in vascular surgery. London: WB Saunders; 1997. p. 159-68. 21. Turnipseed WD, Pozniac M. Popliteal entrapment as a result of neurovascular compression by the soleus and plantaris muscles. J Vasc Surg. 1992;15:285. 22. Baker WH, Stoney RJ. Acquired popliteal entrapment syndrome. Arch Surg. 1992;15:285. 23. Brener BJ, Alpert J, Brief DK et al. Iatrogenic entrapment of femoropopliteal saphenous vein bypass grafts by the gastrocnemius muscle. Surgery. 1975;78:668-74. 24. Van Damme H, Ballaux JM, Deseune JP. Femoro-popliteal venous graft entrapment. Cardiovasc Surg. 1988;29:50-5. 25. Goldstone J, Krupski WC. Iatrogenic popliteal entrapment syndrome. Perspec Vasc Surg. 1992;5(1):99-103. 26. Hamming JJ, Vink U. Obstruction on the popliteal artery at an early age. J Cardiovasc Surg. 1965;5:516-24. 27. Gibson MHL, Mills JG, Johnson GE et al. Popliteal entrapment syndrome. Ann Surg. 1977;185:341-8.
47.
13. Lambert AW, Wilkins DC. Popliteal artery entrapment syndrome (Review). Br J Surg. 1999;86(11):1365-70.
9. Ximenes JOC. Síndrome de enlaçamento da artéria poplítea: relato de um caso e revisão da literatura. Rev Col Bras Cirur. 1975;2:74-7.
15. Rich NM, Collins GJ, McDonald PT et al. Popliteal vascular entrapment. Arch Surg. 1979;114:1377.
254 133Capítulo DOENÇAS DA ARTÉRIA POPLÍTEA NÃO ATEROMATOSAS REFERÊNCIAS BIBLIOGRÁFICAS
12. Levien LJ, Veller MG. Popliteal artery entrapment syndrome: more common than previously recognized. J Vasc Surg. 1999;30:587-98.
45.
3.
51. Greenwood LH, Yrizanny JM, Hallett JW. Popliteal artery entrapment: importance of the stress runoff for diagnosis. J Cardiovasc Interv Radiol 1986;9:93-9.
67.
65. Ring Jr DH, Haines GA, Miller DL. Popliteal artery entrapment syndrome: arteriographic findings and thrombolytic therapy. J Vasc Interv Radiol. 1999;10(6):713-21.
53. Lysens RJ, Renson LM, Ostyn MS et al. Intermittent claudication in young athletes: popliteal artery entrapment syndrome. Am J Sports Med. 1983;11(3):177-9.
63.
50. Forster BB, Houston JG, Machan LS et al. Comparasion of twodimension time-of-fligth dynamic magnetic resonance angiography with digital subtraction angiography in popliteal artery entrapment syndrome. Can Assoc Radiol J. 1997;48(1):11-8.
66. Igari K, Sugano N, Kudo T et al. Surgical treatment for popliteal artery entrapment syndrome. Avd 2014;7:28-33. Yamamoto S, Hoshina K, Hosaka A et al. Long-term outcomes of surgical treatment in patients with popliteal artery entrapment syndrome. Vascular 2015;23:449-54. 68. Kim SY, Min SK, Ahn S et al. Long-term outcomes after revascularization for advanced popliteal artery entrapment syndrome with segmental arterial occlusion. J Vasc Surg. 2012;55:90-7.
255Capítulo 133 doenç A s dA ArtériA PoPlíte A não AteromAtosA s
60.
69. Ozkan U, Ozen M, and Ozkoc G. Endovascular treatment of popliteal artery entrapment syndrome: technical aspects and results of endovascular treatment with surgical release of popliteal artery. Vasc Dis Manag 2015;12:77-83.
61.
98. Flanigan DP, Burnham SJ, Goodreau JJ et al. Summary of cases of adventitial cystic disease of the popliteal artery. Ann Surg. 1979;189:165-75. 99. Haid SP, Conn Jr J, Bergan JJ. Cystic adventitial disease of the popliteal artery. Arch Surg. 1970;101:765. 100. di Marzo L, Rocca CD, d’Amati G et al. Cystic adventitial degeneration of the popliteal artery: Lectin – histochemical study. Eur J Vasc Surg. 1994;8:16. 101. Jay GD, Ross FL, Mason RA, Giron F. Clinical and chemical characterisation of an adventitial popliteal cyst. J Vasc Surg. 1989;3:448. 102. Berger MF, Weber EE. MR imaging of recurrente cystic adventitial disease of the popliteal artery. J Vasc Interv Radiol. 1993;4:695-7. 103. Ejrup B, Hiertonn T. Intermittent claudication: three cases treated by free vein graft. Acta Chir Scand. 1954;108:217. 104. Hiertonn T, Lindberg K, Rob C. Cystic degeneration of the popliteal artery. Br J Surg. 1957;44:348. 105. Rich NM. Popliteal entrapment and adventitial cystic disease. Surg Cl N Am. 1982;62:449. 106. Harris JD, Jepson RP. Cystic degeneration of the popliteal artery. Austr NZJ Surg. 1965;34:265. Citado por Flanigan. 107. Rollo HA, Gama JCFD, Lastória S et al. Cisto de adventícia em artéria poplítea. Relato de dois casos. Rev Ass Med Brasil. 1982;28:79-81. 108. Miranda Jr F, Francisco Jr J, Burihan E. Cisto de artéria poplítea. Rev Bras Cir. 1982;72:221. 109. Hiertonn T, Lindberg K. Cystic adventitial degeneration of the popliteal artery. Acta Chir Scand. 1957;113:72-7.
71. Rich NM, Gomez ER, Collins PS et al. Popliteal vascular entrapment: a review and update. In: Veith FJ (Ed.). Current critical problems in vascular surgery. St Louis: Quality Medical; 1991. p. 86-93. v. 3. 72. Levien LJ, Veller MG. Popliteal artery entrapment syndrome: more common than previously recognized. J Vasc Surg. 1999;30:587-8.
54. Turnipseed WD. Popliteal entrapment and chronic compartment syndrome: unusual causes for claudication in young adults. In: Haimovici H, Ascer E, Hollier LH et al. (Eds.). Vascular surgery. 4th ed. Cambridge, MA: Blackwell Science; 1996.
70. Rosset E, Hartung O, Brunet C et al. Popliteal artery entrapment syndrome: anatomic and embryologic bases, diagnostic and therapeutic considerations following a series of 15 cases with a review of literature. Surg Radiol Anat. 1995;17:161.
59.
52. Servello M. Clinical syndrome of anomalous position of popliteal artery. Circulation. 1962;26:885-90.
58. Mc Donald PT, Easterbrook JA, Rich NM et al. Popliteal artery entrapment syndrome. Clinical noninvasive and angiographic diagnosis. Am J Surg. 1980;139:318-25. Samson HR, Showalter DP. Regarding “Popliteal entrapment: more common than previously recognezid”. J Vasc Surg. 2000;31(5):1077. Verhoeven ELG, Lucarotti ME, Campbell WB. Vanishing popliteal entrapment. Eur J Vasc Endovasc Surg. 1995;9:244-6. Di Marzo L, Cavallaro A, Sciacca V et al. Surgical treatment of popliteal artery entrapment syndrome: a ten year experience. Eur J Vasc Surg. 1991;5:59-64. 62. Porcellini M, Selvetella L, Bernardo B et al. Popliteal artery entrapment syndrome: diagnosis and management. G-Chir 1997;18(4):182-6. Steurer J, Hoffmann U, Schneider E et al. A new therapeutic approach to popliteal artery entrapment syndrome (PAES). Eur Vasc Surg. 1995;10(2):243-7. 64. Lambert AW, Wilkins DC. Popliteal artery entrapment syndrome: collaborative experience of the Joint Vascular Research Group. Br J Surg. 1998;85(10):1367-8.
55. Ikeda M, Iwase T, Ashida K et al. Popliteal artery entrapment syndrome – report of a case and study of 18 cases in Japan. Am J Surg. 1981;141:726-30. 56. Vieira GNR. Síndrome de aprisionamento da artéria poplítea. In: Britto CJ. Cirurgia vascular. Rio de Janeiro: Revinter; 2002. v. 2. 57. Cummings RJ, Webb HW, Lovell WW et al. The popliteal artery entrapment syndrome in children. J Pediatr Orthop. 1992;12:539-41.
73. Marzo L, Cavallaro A, Mingoli A et al. Popliteal artery entrapment syndrome: the role of early diagnosis and treatment. Surgery 1997;122:26-31. 74. Lewis GJT, Douglas DM, Reid W et al. Cystic adventitial disease of the popliteal artery. Br Med J 1967;3:411. 75. Levien LJ, Bergan JJ. Adventitial cystic disease of the popliteal artery. In: Rutherford RB (Ed.). Vascular surgery. Philadelphia: WB Saunders; 2000. p. 1079-86. 76. De Laurentis DA, Wolferth CCJr, Wolf FM et al. Mucinous adventitial cysts of the popliteal artery in an 11 year old girl. Surgery 1973;74:456. 77. Colombier D, Elias A, Rousseau H et al. Kyste adventiciel: intérêt du scanner dans la stratégie diagnostique et thérapeutique. J Mal Vasc. 1997;22:181-6. 78. Chafké N, Beaufigeau M, Geny B et al. Les localisations extrapoplitées des kystes adventitiels. Revue de la littérature. J Mal Vasc. 1997;22:79-85. 79. Eastcott HHG. Cystic myxomatous degeneration of popliteal artery. Br Med J. 1963;2:1270. 80. Jaquet GH, Meyer-Burgdorff G. Arterielle durchblutungsstorung infolge cystischer degeneration der adventitia. Der Chirurg. 1960;31:481. Citado por Flanigan. 81. Ishikawa K, Mishima Y, Kobayashi S. Cystic adventitial disease of the popliteal artery. Angiology. 1961;12:357-66. 82. Taylor H, Taylor RS, Ramsay CA. Cyst of popliteal artery. Br Med J. 1967;4:109. 83. Linquette M, Mesmacque R, Beghin B et al. Dégénerescence kystique de l’adventice de l’artère poplitée. Sem Hop Paris. 1967;43:3005-13. citado por Levien e Bergan. 84. Shute K, Rothnie NG. The aetiology of cystic arterial disease. Br J Surg. 1973;60:397-400. Citado por Ishikawa. 85. Devereux D, Forrest H, McLeod T, Ahweng A. The monarterial origin of cystic adventitial disease of the popliteal artery in two patients. Surg. 1980;88:723. 86. Leaf G. Amino-acid analysis of protein present in a popliteal artery cyst. Br Med J. 1967;3:415. 87. Leu HJ. Pathogenese und histologie der zystischen adventitia degeneration peripherer blutfegasse. Vasa. 1977;6:94. 88. Alder VW, Zwicker H. The diagnosis of cystic degeneration of the adventitia. Roefo 1977;126:331. 89. Levien LJ, Benn CA. Adventicial cystic disease: an unifying hipothesis. J Vasc Surg. 1998;28:193-205. 90. Endo M, Tamura S, Minakuchi S et al. Isolation and identification of proteohyaluronic acid from a cyst of cystic mucoid degeneration. Clin Chim Acta. 1973;47:417-24. Citado por Levien e Benn. 91. Begg MW, Scott JE. Hyaluronic acid and protein in simple ganglia and Heberden’s nodes. Ann Rheum Dis. 1966;25:145-8. Citado por Levien e Benn. 92. Sakamoto H, Nishimura A, Nakanishi Y et al. Bilateral cystic adventitial disease of the popliteal artery. Myakkan Gaku. J Jap Coll Angiol 1976;16:607-8. Citado por Ishikawa. 93. Lassonde J, Laurendeau F. Cystic adventitial disease of the popliteal artery. Am Surg. 1982;48:341. 94. Schroe H, Van Opstal C, De Leersnijder J et al. Baker’s cyst connected to popliteal artery cist. Ann Vasc Surg. 1988;2:385. 95. Hunt BP, Harrington MG, Goode JJ, Galloway JM. Cystic adventitial disease of the popliteal artery. Br J Surg. 1980;67:811. 96. Tsilimparis N, Hanack U, Yousefi S, Alevizakos P, Ruckert R. Cystic adventitial disease of the popliteal artery: an argument for the developmental theory. J Vasc Surg. 2007;45:1249-52. 97. Spinner RJ, Desy NM, Agarwal G et al. Evidence to support that adventitial cysts, analogous to intraneural ganglion cysts, are also joint-connected. Clinical Anatomy. 2013;26(2):267-81.
132. de Oliveira JCP, Barreto FTR, de Abreu DDB. “Doença cística adventicial da artéria poplítea: relato de caso.” J Vasc Bras. 2018;17.1:55.
113.
256 Parte VIIIMEMBROS INFERIORES
130. Brito CJD. Cirurgia vascular: cirurgia endovascular, angiologia, 3.ed. Silva RM et al. (Coeds.). Rio de Janeiro: Revinter; 2014. p. 1132-46. 131. Miller A, Salenius J-P, Sacks BA et al. Noninvasive vascular imaging in the diagnosis and treatment of adventitial cystic disease of the popliteal artery. J Vasc Surg. 1997;26(4):715-20.
133. Kauffman P et al. Doença cística adventicial da artéria poplítea: causa infrequente de claudicação intermitente. Einstein 2014;12(4):358-60.
118.
134. Owen ERTC, Speechly-Dick EM, Kour NW et al. Cystic adventitial disease of the popliteal artery - a case of spontaneous resolution. Eur J Vasc Surg. 1990;4:319-21.
138. Pursell R, Torrie EP, Gibson M, Galland RB. Spontaneous and permanent resolution of cystic adventitial disease of the popliteal artery. J R Soc Med 2004;97(2):77-8.
124. Jasinski RW, Masselink BA, Partridge RW et al. Adventitial cystic disease of the popliteal artery. Radiology. 1987;163:153-5.
110. Cassar K, Engeset J. Cystic adventitial disease: a trap for the unwary. Eur J Vasc Endovasc Surg. 2005;29:93-6. Tsolakis IA, Walvatne CS, Caldwell MD. Cystic adventitial disease of the popliteal artery: diagnosis and treatment. Eur J Vasc Endovas Surg. 1998;15:188-94. 112. Hart Hansen JP. Cystic mucoid degeneration of the popliteal artery. Acta Chir Scand. 1966;131:171. Citado por Flanigan. Parkes A. Intraneural ganglion of the lateral popliteal nerve. J Bone Joint Surg. 1961;43B:784. Citado por Flanigan. Stapff J, Zoller WG, Spengel FA. Image-directed Doppler ultrasound findings in adventitial cystic disease of the popliteal artery. J Clin Ultrasound 1989;17:689-91. 115. Baron O, Julia P, Sintes V et al. Une cause rare de claudication chez le sujet jeune: la dégénérescence kystique adventicielle de l’artère poplitée. J Mal Vasc. 1993;18:68-9.
139. McAnespey D, Rosen RC, Cohen JM et al. Adventitial cystic disease. J Foot Surg. (United States) 1991;30:160-4.
114.
142. Simon R. Dégénerescence colloide de l’adventice de l’artère poplitée traitée par prothese em dacron. Mem Acad Chir. 1963;89:849. 143. Mentha C. Dégénerescence kystique adventicielle ou mucoide de l’artère poplitée. J Chir. 1965;89:173-80.
127. Maged I, Turba U, Housseini A et al. High spatial resolution magnetic resonance imaging of cystic adventicial disease of the popliteal artery. J Vasc Surg. 2010;51:471-4.
147. Sieunarine K, Lawrence-Brown M, Kelsey P. Adventitial cystic disease of the popliteal artery: early recurrence after CT – guided percutaneous aspiration. J Cardiovasc Surg. 1991; 32:702-4.
121.
137. Soury P, Rivière J, Watelet J et al. Regression spontanee d’un kyste sous-adventiciel de l’artère poplitée. J Mal Vasc. 1995;20(4):323-5.
140. Ohta T, Kato R, Sugimoto I, Tsuchioka H. Recurrence of cystic adventitial disease in an interposed vein graft. Surgery 1994;116:587-92.
129. Ishikawa K. Cystic adventitial disease of the popliteal artery and of other stem vessels in the extremities. Jpn J Surg 1987;17:221-9.
148. Samson RH, Willis PD. Popliteal artery occlusion caused by cystic adventitial disease: successful treatment by urokinase followed by nonresectional cystotomy. J Vasc Surg. 1990;12:591-3.
151. Hiertonn T, Karacagil S, Bergqvist D. Long-term follow-up of autologous vein grafts. 40 year after reconstrution for cystic adventitial disease. Vasa 1995;24(3):250-2.
120. Vos LD, Tielbeek AV, Vroegindeweij D, van-den-Bosch HC. Cystic adventitial disease of the popliteal artery demonstrated with intravascular US. J Vasc Interv Radiol. 1996;7(4):583-6. Sakamoto M, Kubota Y, Hirohashi S et al. Adventitial cystic disease of the popliteal artery demonstrated by intravascular ultrasonography. J Ultrasound Med. 2000;19(10):713-7.
150. Wali MA, Dewan M, Renno WM, Ezzedin-M. Mucoid degeneration of the brachial artery: case report and a review of literature. J R Coll Surg Edinb 1999;44(2):126-9.
152. Maged IM, Kron IL, Hagspiel KD. Recurrent cystic adventitial disease of the popliteal artery: successful treatment with percutaneous transluminal angioplasty. Vasc Endovascular Surg. 2009;43(4):399-402.
135. Furunaga A, Zempo N, Akiyama N et al. Cystic disease of right popliteal artery with spontaneous resolution. J Jap Surg Soc. 1992;93(Suppl 12):1501-03.
141. Tytgat H, Derom F, Galinsky A. Dégénerescence kystique de l’artére poplitée traitée par greffe em nylon. Acta Chir Belg. 1958;57:188.
123.
116. Bunker SR, Lauten GJ, Hutton JrJE. Cystic adventitial disease of the popliteal artery. ARJ 1981;136:1209-12. Rivière J, Soury P, Poli P et al. Intérêt des examens complémentaires peropératoires dans le traitement de la dégénerescence kystique adventicielle de l’artère poplitée. J Mal Vasc. 1994;19:251-2. Chen JW, Thomson IA. Adventitial cystic disease of the popliteal artery - a case for intraoperative duplex scanning. Eur J Vasc Endovasc Surg. 1998;16(6):537-9.
111.
126. Kauffman P et al. Doença cística adventicial da artéria poplítea: causa infrequente de claudicação intermitente. Einstein 2014;12(3):358-60.
128. Loffroy R, Rao P, Krausé D, Steinmetz E. Use of 3.0 – Tesla high spacial resolution magnetic resonance imaging for diagnosis and treatment of cystic adventitial disease of the popliteal artery. Ann Vasc Surg. 2011;25:385.e5-385.e10.
117.
119. Koppensteiner R, Katzenschlager R, Ahmadi A et al. Demonstration of cystic adventitial disease by intravascular ultrasound imaging. J Vasc Surg. 1996;23(3):534-36.
144. Fox RL, Kahn M, Adler J et al. Adventitial cystic disease of the popliteal artery: failure of percutaneous transluminal angioplasty as a therapeutic modality. J Vasc Surg. 1985;2:464-7.
149. Do DD, Braunschweig M, Baumgartner I et al. Adventitial cystic disease of the popliteal artery: percutaneous US – guided aspiration. Radiology 1997;203(3):743-6.
153. Baxter AR, Garg K, Lamparello PJ et al. Cystic adventitial disease of the popliteal artery: is there a consensus in management? Vascular 2011(19);3:163-6.
154. Del Canto Peruyera P, Vazquez MJ, Velasco MB et al. Cystic adventitial disease of the popliteal artery: Two case reports and a review of the literature. Vascular 2015;23:204-10.
155. Flessenkaemper I, Muller KM. Early recurrence of cystic adventitial disease in a vein graft after complete resection of the popliteal artery. Vasa 2014;43:69-72.
122. Foster MT, Collins JT, Morgan JP. Intravascular ultrasound diagnosis of cystic adventitial degeneration of the popliteal artery: a case report. Catheter Cardiovasc Interv. 2001;53(4):527-9. Fitzjohn TP, White FE, Loose HW, Proud G. Computed tomography and sonography of cystic adventitial disease. Br J Radiol. 1986;59:933-5.
146. Wilbur AC, Spigos DG. Adventitital cyst of the popliteal artery: CT – guided percutaneous aspiration. J Comput Assist Tomog 1986;10:161-3.
145. Khoury M. Failed angioplasty of a popliteal artery stenosis secondary to cystic adventitial disease. Vasc Endovasc Surg. 2004;38(3):277-80.
125. Deutsch AL, Hyde J, Miller SM et al. Cystic adventitial degeneration of the popliteal artery: CT demonstration and directed percutaneous therapy. AJR 1985;145:117-8.
136. Lossef SV, Rajan S, Calcagno D et al. Spontaneous rupture of an adventitial cyst of the popliteal artery: confirmation with MR imaging. J Vasc Interv Radiol. 1992;3:95-7.
6. Girolami B, Bernardi E, Prins MH et al. Treatment of intermittent claudication with physical training, smoking cessation, pentoxifylline, or nafronyl: a meta-analysis. Arch Intern Med. 1999;159:337-45.
13. Cimminiello C. PAD: epidemiology and pathophysiology. Thromb Res. 2002;106:V295-301.
REFERÊNCIAS
DOS MEMBROS INFERIORES BIBLIOGRÁFICAS
19. Gage FH. Mammalian neural stem cells. Science. 2000;287:1433-8.
22. Olic D, Kajstura J, Chimenti S et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001;410:701-5.
17. Thomas ED, Lochte Jr H, Cannon JH et al. Supralethal whole body irradiation and isologous marrow transplantation in man. J Clin Invest. 1959;38 (10 pt 1-2):1709-16. J Clin Invest. 1959;38(10 pt 1-2):1709-16.
20. Planat-Bernard V, Silvestre IS, Cousin B et al. Plasticity of human adipose Lineage Cells toward endothelial cells: Phisiological and therapeutic perspectives. Circulation 2004;109:656-63.
2. Araújo JD. Técnicas cirúrgicas básicas na reconstrução vascular. Cirurgia Vascular – Carlos José de Brito. Rio de Janeiro: Revinter; 2002. v. I. p. 134-51.
5. Quick CRG, Cotton LT. The measured effect of stopping smoking on intermittent claudication. Br J Surg. 1982;69(Suppl.):S24-S26.
7. de Godoy JM, de Godoy MF, Batigalia F et al. Lower-extremity amputation: 6-year follow-up study in Brazil. J Orthop Surg. (Hong Kong). 2005 Aug.;13(2):164-6.
21. Pittenger MF, Mackay AM, Beck SC et al. Multilineage potencial of adult human mesenchymal stem cells. Science 1999;284:143-7.
16. Hirsch AT. Critical limb ischemia and stem cell reserearch (Anchoring Hope With Informed Adverse Event Reporting). Circulation 2006;114:2581-83.
8. Tseng CH, Tai TY, Chong CK et al. Mortality in diabetic patients after lower extremity amputations. J Formos Med Assoc. 1994 Oct.;93(10):842-8.
1. Klinkert P, Post PN, Breslau PJ, van Bockel JH. Saphenous vein versus PTFE for above-knee femoropopliteal bypass. A review of the literature. Eur J Vasc Endovasc Surg. 2004 Apr.;27(4):357-62.
257 134CapítuloTERAPIA CELULAR NA ISQUEMIA CRÍTICA
3. Becquemin JP, Cavillon A, Allaire E et al. Iliac and femoropopliteal lesions: Evaluation of ballon angioplasty and classical surgery. J Endovasc Surg. 1995;2(1):42-50.
41.
10. Inderbitzi R, Buettiker M, Enzler M. The long-term mobility and mortality of patients with peripheral arterial disease following bilateral amputation. Eur J Vasc Endovasc Surg. 2003 July; 26(1):59-64.
39.
23. Shi BQ, Raffi S, Wu MHD et al. Evidence for circulating bone marrowderived endothelial cells. Blood 1998;92:362-7.
4. Franz RW, Parks A, Shah KJ et al. Use of autologous bone morrow mononuclear cell implantation therapy as a limb salvage procedure in patients with severe peripheral arterial disease. J Vasc Surg. 2009;50:1378-90.
11. Rutherford RB, Baker JD, Ernst C et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg. 1997;26:517-38.
18. Alison M, Sarraf C. Hepatic stem cells. J Hepatol. 1998;29:676-82.
9. Fusetti C, Senechaud C, Merlini M. [Quality of life of vascular disease patients following amputation]. Ann Chir. 2001 June;126(5):434-9.
14. Bloor K. Natural history of arteriosclerosis of the lower extremities. Ann R Coll Surg Engl. 1961;28:36-51.
24. Reys M, Lund T, Lenvik T et al. Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood 2001;98:2615-25.
25. Lu D, Chen B, Liang Z et al. Comparison of bone marrow mesenchymal stem cells with bone marrow-derived mononuclear cells for treatment of diabetic critical limb ischemia and foot ulcer a double-blind, randomized, controlled trial. Diabetes Res Clin Pract. 2011;92:26-36. 26. Powell RJ, Camerota AJ, Berceli Sa et al. Interim analysis results from the RESTORE-CLI, a randomized, double-blind multicenter plase II trial comparing expanded autologous bone marrow-derived tissue repair cells and placebo in patients with critical limb ischemia. J Vasc Surg. 2011;54:1032-41. 27. Yoon YS, Wecker A, Heyd L et al. Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction. J Clin Invest 2005;115:326-38. 28. Asahara T, Masuda H, Takahashi T et al. Bone marrow origin of endotelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res. 1999;85:221-8. 29. Minamino T, Miyauchi H, Yoshida T et al. Endothelial Cell senescence in human atherosclerosis role of telomere in endothelial dysfunction. Circulation 2002;105:1541-4. 30. Rauscher FM, Goldschmidt-Clermont PJ, Davis BH et al. Aging progenitor cell exhaustion, and atherosclerosis. Circulation. 2003;108:457-63. 31. Shimada T, Takeshita Y, Murohara T et al. Angiogenesis and vasculogenesis are impaired in the precocious-aging klotho mouse. Circulation. 2004;110(9):1148-55. 32. Sata M. Circulating vascular progenitor cells contribute to vascular repair, remodeling, and lesion formation. Trends Cardiovasc Med 2003;13(6):249-53. 33. Gulati R, Jevremovic D, Peterson TE et al. Autologous culturemodified mononuclear cells confer vascular protection after arterial injury. Circulation 2003;108:1520-6. 34. Fujiyama S, Amano K, Uehira K et al. Bone marrow monocyte lineage cells adhere on injured endothelium in a monocyte chemoattractant protein-1-dependent manner and accelerate reendothelialization as endothelial progenitor cells. Cir Res. 2003;93(10):980-9. 35. Sata M, SaiuraA, Kunisato A et al. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med. 2002 Apr;8(4):403-9. 36. Boisvert WA, Spangenberg J, Curtiss LK. Treatment of severe hypercholesterolemia in apolipoprotein e-deficient mice by bone marrow transplantation. J Clin Invest. 1995;96:1118-24. 37. Rehman J, Li Jingling, Parvathaneni L et al. Exercise acutely increases circulating endothelial progenitor cells and monocyte-macrophagederived angiogenic cells. J Am Coll Cardiol. 2004;43:2314-8. 38. Dimmeler S, Aicher A, Vasa M et al. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-Kinase/Akt pathway. J Clin Invest. 2001;108:391-7. Vasa M, Fichtlscherer S, Adler K et al. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation. 2001;103:2885-90. 40. Hill JM, Zalos G, Halcox JPJ et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med. 2003;348:593-600. Waltenberger J, Lange J, Kranz A. Vascular endothelial growth factora-induced chemotaxis of monocytes is attenuated in patients with diabetes mellitus. A Potencial predictor for the individual capacity to develop collaterals. Circulation. 2000;102:185-90.
15. Pecoraro RE, Reiber GE, Burgess EM. Pathways to diabetic limbs amputation. Basis for prevention. Diabetes Care. 1990;13:513-21.
12. Consensus TI. Management of peripheral arterial disease: epidemiology, natural history, risk factors. J Vasc Surg. 2000;31(1, part 2):S5-34.
74. Peichev M, Naiyer AJ, Pereira D et al. Expression of VEGFR-2 and AC133 by circulating human CD 34 cells identifies a population of functional endothelial precursors. Blood In press. J Clin Invest. 2000;105(1):17-9. 75. Araújo JD, Araújo Filho JD, Ciorlin E et al. A terapia celular no tratamento da isquemia crítica dos membros inferiores. J Vasc Br. 2005;4(4):357-65. 76. Shrireman PK. The chemokine system in arteriogenesis and hind limb ischemia. J Vasc Surg. 2007;45:48A-56A. 77. Templin C, Zweigerdt R, Scgwanke K et al. Transplantation and tracking of human-induced pluripotent stem cells in a pig model of myocardial infarction. Assessment of cell survival, engraftment, and distribution by hybrid single photon emission computed tomography/computed tomography of sodium iodide symporter transgene expression. Circulation. 2012;126;430-9.
65. Herttuala SY, Alitalo K. Gene transfer as a tool to induce therapeutic vascular growth. Nature Medicine. 2003:9;694-701. 66. Comerota AJ, Throm RC, Miller KA et al. Naked plasmid DNA encoding fibroblast growth factor type 1 for the treatment of endstage unreconstructible lower extremity ischemia: Preliminary results of a plase I trial. J Vasc Surg. 2002;35:930-6.
50.
67. Raffi S, Heissig B, Hattori K. Efficient mobilization and recruitment of marrow-derived endothelial and hematopoietic stem cells by adenoviral vectors expressing angiogenic factors. Gene Ther. 2002;9(10):631-41.
43. Mancuso P, Burlini A, Pruneri G et al. Resting and activated endothelial cells are increased in the peripheral blood of cancer patient. Blood 2001;97(11):3658-61.
60. Higashi Y, Kimura M, Hara K et al. Autologous bone-marrow mononuclear cell implantation improves endothelium-dependent vasodilation in patients with limb ischemia. Circulation 2004;109(10):1215-8.
52. Stump MM, Jordan GL Jr, DeBakey ME, Halpert B. Endothelium grown from circulating blood on isolated intravascular Dacron hub. Am J Pathol. 1993;43:361.
61. Dong Y, Waeckel L, Ebrahemian TG et al. Increase in vascular permeability and vasodilatation an critical for proangiogenic effects of item cell therapy. Circulation 2006;114:328-38.
48.
78. Li TS, Masayuki K, Ueda K et al. Identification of risk factors related to poor angiogenic potency of bone marrow cells from different patients. Circulation. 2009;120(suppl 1):S255-S261. 79. Yamanaka S. Induced pluripotent stem cells: past, present, and future. J Stem. 2012 June 14;10(6):678-84. 80. Gurdon JB. The developmental capacity of nuclei t Taken from intestinal epithelium cells of feeding tadpoles. J Embryol Exp Morphol. 1962;10:622-40. 81. Malek A, Bersinger NA. Human placental stem cells biomedical potential and clinical relevance. J Stem Cells. 2011:6(2):75-92. 82. Yuyama ET, Matsubara H, Murohara T et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomized controlled trial. Lancet 2002;360:427-35. 83. Al-Khaldi A, Al-Sabti H, Galipeau J, Lachapelle K. Therapeutic angiogenesis using autologous bone marrow stromal cells: improved blood flow in a chronic limb ischemia model. Ann Thorac Surg. 2003;75:204-9. 84. Li TS, Hamano K, Suzuki K et al. Improved angiogenic potency by implantation of ex vivo hypoxia prestimulated bone marrow cells in rats. Am J Physiol Heart Circ Physiol. 2002;283(2): H468-H473. 85. Shintani S, Murohara T, Ikeda H et al. Augmentation of postnatal neovascularization with autologous bone marrow transplantation. Circulation. 2001;103:897903. 86. Silvestre JS, Mallat Z, Duriez M et al. Antiangiogenic effect of interleukin-10 in ischemia-induced angiogenesis in mice hindlimb. Cir Res. 2000;87(6):448-52. 87. Kawamura A, Horie T, Tsuda I et al. Prevention of limb amputation in patients with limbs ulcers by autologous peripheral blood mononuclear cell implantation. Ther Apher Dial. 2005;9(1):59-63. 88. Huang PP, Li SZ, Han MZ et al. Autologous transplantation of peripheral blood stem cells as an effective therapeutic approach for severe arteriosclerosis obliterans of lower extremities. Thromb Haesmost. 2004;91(3):606-9. 89. Yang XF, Wu YX, Wang HM et al. Autologous peripheral blood stem cells transplantation in treatment of 62 cases of lower extremity ischemic disorder. Zhonghnua Nei Ke Za Zhi 2005;44(2):95-8. 90. Ramirez PH, Balea ED, Padron CH. Trasplante de celulas madre autólogas en el miembro inferior isquémico de un paciente con arteriosclerosis obliterante crítica. Rev Cubana Hematol Inmunol Hemoter. 2005;21:33-8. 91. Nizankowski R, Petriczec T, Skotnicki A, Szczeklik A. The treatment of advanced chronic lower limb ischaemia with marrow stem cell
49.
42. Yamamoto K, Kondo T, Suzuti S et al. Molecular evaluation of endothelial progenitor cells in patients with ischemic limbs. Arterioscler Thromb Vasc Biol. 2004;24:e192-e196.
258 Parte VIIIMEMBROS INFERIORES
55. Schaper W, Secholz D. Factors regulating arteriogenesis. Thromb Vasc Biol. 2003;23:1143-51. 56. Simons M. Angiogenesis. Where do we Stand Now? Circulation. 2005;111:1556-66.
63. Smith Jr RS, Lin KF, Agata J et al. Human endotelial nitric oxide sintais gene delivery promotes angiogenesis in a rat model of hindlimb ischemia. Arterioscler Tromb Vasc Biol. 2002;22:1279-85.
62. Duorak HF. Vascular permeability factor/vascular endotelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis an therapy. J Clin Oncol 2002;4:368-80.
58.
69. Asahara T, Bauters C, Zheng LP et al. Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. Circulation 1995; 92(9 suppl): II365-71.
44. Davidoff AM, Ng CY, Brown P et al. Bone marrow-derived cells contribute to tumor neovasculature and, when modified to express an angiogenesis inhibitor, can restrict tumor growth in mice. Clin Cancer Res. 2001;7(9):2870-9.
47. Shalaby F, Rossant J, Yamaguchi TP et al. Failure of blood-island formation and vasculogenesis in FLK-1 deficient nice. Nature 1995;376:62-6. Shalaby F, Ho J, Stranford WL et al. A requirement for flk-1 in primitive and definitive hematopoiesis and vasculogenesis. Cell 1990;89:981-90. Nishikawa SI, Nishikawa S, Hirashima M et al. Progressive lineage analysis by cell sorting and culture identifies FLK + VE cadherin + cells at a diverging point of endothelial and hematopoietic lineages. Development 1998;125:1747-57. Ribatti D, Vacca A, Nico B. Cross-talk between hematopoiesis and angiogenesis signaling pathways. Curr Mol Med. 2002;2:537-47. Asahara T, MuroharaT, Sullivan A et al. Isolation of putative progenitor endotelial cells for angiogenesis. Science 1997;275(5302):964-7.
51.
54. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med. 2000 Apr.;6(4):389-95.
57. Wang JS, Shum Tim D, Galipeau J et al. Marrow stromal cells for cellular cardiomyoplasty feasibility and potential clinical advantages. J Thorac Cardiovasc Surg. 2000;120:999-1005. Iba O, Matsubara H, Nozawa Y et al. Angiogenesis by implantation of peripheral blood mononuclear cells and platelets into ischemic limbs. Circulation 2002;106:2019-25. 59. Rehman J, Li Jingling, Orschell CM, March KL. Peripheral Blood “Endothelial Progenitor Cells” Are Derived From Monocyte/ Macrophages and Secrete Angiogenic Growth Factors. Circulation. 2003;107:1164-9.
45. Ribatti D, Vacca A, Roncali L, Dammacco F. Hematopoiesis and angiogenesis: a link between two apparently independent processes. J Haemother Stem Cell Res. 2000;9(1):13-9.
64. Tepper OM, Galiano RD, Capla JM et al. Human endotelial progenitor cells from type II diabetics exhibit impaired proliferation adhesion, and incorporation in intravascular structures. Circulation 2002;106:2781-6.
53. Frazier OH, Baldwin RT, Eskin SG, Duncan JM. Immunochemical identification of human endothelial cells on the lining of a ventricular assist device. Texas Heart Inst J. 1993;2:78.
68. Takahashi T, Kalka C, Masuda H et al. Ischemia and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med. 1999;5(4):434-8.
70. Hattori K, Dias S, Heissig B et al. Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells. J Exp Med. 2001;193:1005-14.
71. Iwaguro H, Yamaguchi J, Kalka C et al. Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration. Circulation. 2002;105:732-8. 72. Gross P, Herbrig K. Role of endothelial progenitor cells in cardiovascular pathology. Annales Academiae Medicae Bialostocenis 2004;49:174-7. 73. Rafii S. Circulating endothelial precursors: mystery, reality, and promise. J Clin Invest. 2000:105(1):17-9.
46. Eichmann A, Corbel C, Nataf V et al. Ligand-dependent development of the endothelial and hemopoietic lineages from embryonic mesodermal cells expressing vascular endothelial growth factor receptor-2. Proc Natl. Acad Sci. USA 1997;94:5141-6.
98. Rigato M, Monami M, Fadini GP. Autologous cell therapy for peripheral arterial disease: systematic review and meta-analysis of randomized, nonrandomized, and noncontrolled studies. Circ Res. 2017;120(8):1326–40. 99. Madaric J, Klepanec A, Valachovicova M et al. Characteristics of responders to autologous bone marrow cell therapy for nooption critical limb ischemia. Stem Cell Res Ther [Internet]. Stem Cell Research & Therapy. 2016;7(1):116. Available s13287-016-0379-z.http://stemcellres.biomedcentral.com/articles/10.1186/from: 100. Guo J, Guo L, Cui S. Autologous bone marrow-derived mononuclear cell therapy in Chinese patients with critical limb ischemia due to thromboangiitis obliterans: 10-year results. Stem Cell Res Ther [Internet]. Stem Cell Research & Therapy. 2018;9(1):43. Available from: s13287-018-0784-6https://stemcellres.biomedcentral.com/articles/10.1186/
259Capítulo 134 ter APiA Celul Ar nA isquemiA CrítiCA dos membros inferiores autotransplantation. Kardiol Pol. 2005 Oct.;63(4):351-60;discussion 361. 92. Durdu S, Akar AR, Arat MA et al. Autologous bone marrow mononuclear cell implantation for patients with Rutherford grade IIIII thromboangiitis obliterans. J Vasc Surg. 2006;44:732-9.
94. Silvestre JS, Gojova A, Brun V et al. Transplantation of bone marrow derived mononuclear cells in ischemic apolipoprotein E-Knockout mice accelerates atherosclerosis without altering plaque composition. Circulation 2003;108:2839-42.
93. Takeshita S, Nonogi H, Nakatami T et al. Unblinded pilot study of autologous transplantation of bone marrow mononuclear cells in patients with thromboangiitis obliterans. Circulation. 2006;114:2679-84.
95. Lawall H, Bramlage P, Amann B. Treatment of peripheral arterial disease using stem and progenitor cell therapy. J Vasc Surg. 2011;53:445-53.
96. Araujo JD, Araújo filho JD, Ciorlin E et al. Células-tronco de medula óssea em isquemia crítica de membros. Rev Bras Hematolol Hemoster. 2009;31(supl.1):128-39.
97. U.S. National Institutes of Health. (Atualizada em dezembro de 2006, acesso em dezembro 2006). Disponível em: http://www.clinical trials.gov.
15. Karapolat S, Dag O, Abanoz M, Aslan M. Arterial embolectomy: a retrospective evaluation of 730 cases over 20 years. Surg Today 2006;36:416-9.
10. Haimovici H. Metabolic complications of acute arterial occlusions and related conditions (myonephropatic-metabolic syndrome). New York: Futura Publishing Co; 1988. 11. Abbott WM, Maloney RD, McGabe CC. Arterial embolism, a 44-yaear perspective. Am J Surg 1982;143:460-9.
1. Harvey W. Anatomical studies of the motion of the heart and blood, 1628. Modern English translation with annotations by CD. Springfield, IL: Charles C. Thomas, Publisher; 1941. 2. Barker WF. A history of vascular surgery. In: Moore WS: Vascular Surgery – A Comprehensive Review. Philadelphia: WB Saunders; 1991. 3. Carrel A. The surgery of blood vessels etc. Johns Hopkins Hosp Bull 1907;18:18-28. 4. Fann JI, Sarris GE, Mirchell RS et al. Treatment of patients with aortic dissection presenting with peripheral vascular complications. Ann Surg 1990;212:705-13. 5. Fogarty TJ, Daily PO, Shumway NE et al. Experience with balloon catheter technic for arterial embolectomy. Am J Surg 1971;122:231-6.
17. Kvilekval KH, Yunis JP, Mason RA, Giron F. After the blue toe: prognosis of noncardiac arterial embolization in the lower extremities. J Vasc Surg. 1993;17(2):328-34.
18. Becquemin JP, Kovarsky S. Arterial emboli of the lower limbs: analysis of risk factors for mortality and amputation. Ann Vasc Surg. 1995;9 Suppl:S32-38.
16. Connett MC, Murray DH Jr, Wenneker WW. Peripheral arterial emboli. Am J Surg. 1984;148(1):14-9.
12. Blaisdell FW, Steele M, Allen RE. Management of acute lower extremity arterial ischemia due to embolism and thrombosis. Surgery 1978;84:822-30.
24. Vargas AP, Couto M, Mourad JJA et al. Obstrução aguda de aorta por êmbolo de schwanoma maligno. Cir Vasc Angiol. 1999;9:19-22.
25. Katz S, Andros G, Kohl R et al. Arterial emboli of venous origin. Surg Gynecol Obstet. 1992;174:17-22.
39.
14. Gassage JA, Ali T, Chambers J, Burnand KG. Peripheral arterial embolism: prevalence, outcome and the role of echocardiography in the management. Vasc Endovasc Surg. 2006;40:280-6.
13. Tawes RL Jr., Harris EJ, Brown HJ. Arterial thromboembolism. A 20year perspective. Arch Surg 1985;120:595-9.
22. Prioleau PG, Katzenstein AA. Major peripheral arterial occlusion due to malignant tumor embolism. Histologic recognition and surgical management. Cancer 1978;42:2009-12.
21. Machleder HI, Atkliff H, Lois JF, Holburt E. Aortic mural thrombus: An occult source thromboembolism. J Vasc Surg 1986;4:473-8.
6. Dos Santos R, Lamas A, Caldas J. L’artériographie des members, de l’aorte et de ses branches abdominales. Bull Mem Soc Nat Chir 1929;55:587-601. 7. Dos Santos JC. Sur la désobstruction des thromboses artérielles anciennes. Mém Acad Chir 1947;73:409-11.
19. Reber PU, Patel AG, Stauffer E et al. Mural aortic thrombi: An important cause of peripheral embolization. J Vasc Surg. 1999;30(6):1084-9.
260 135Capítulo OBSTRUÇÃO ARTERIAL AGUDA DOS MEMBROS INFERIORES REFERÊNCIAS BIBLIOGRÁFICAS
20. Kempczinski RF. Lower extremity arterial emboli from ulcerating atherosclerotic plaques. JAMA 1979;241:807-12.
26. Keen RR, Yao JST, Aneurysms and embolization: Detection and management. In: YAO JST, Pearce WH (Eds.). Aneurysms: New Findings and Treatment. Norwalk, CT: Appleton & Lange; 1994. p. 305-22. 27. Mozersky DJ, Summer DS, Strandness DE. Disease progression after femoropopliteal surgical procedures. Surg Gynecol Obstet. 1972;135:700-10. 28. Nypaver TJ, Whyte BR, Endean ED. Nontraumatic lower extremity acute arterial ischemia. Am J Surg. 1998;176:147-52. 29. Szilagyi DE, Elliott JP, Hageman JH et al. Biologic fate of autogenous vein implants as arterial substitutes: Clinical, angiographic and hystopathologic observations in femoro-popliteal operations for atherosclerosis. Ann Surg. 1973;178:232-43. 30. Vinard E, Eloy R, Descotes J et al. Dacron vascular prosthesis in man: Mechanical performance, lesions, and molecular stability. Presse Méd 1990;19:709-14. 31. Kitts D, Bongard FS, Klein SR. Septic embolism complicating infective endocarditis. J Vasc Surg 1991;14:480-7. 32. Gardiner GA Jr., Meyerovitz MF, Stokes KR et al. Complications of transluminal angioplasty. Radiology 1986;159:201-8. 33. Miranda Jr. F, Perez MCJ, Nakano LCU et al. Embolia arterial de membro superior por mercúrio metálico. Relato de dois casos. Cir Vasc Angiol. 1999;15:153-5. 34. Shannon JJ, Ngia MV, Stanton PE Jr., Dimler M. Peripheral arterial missile embolization: a case report and 22-year literature review. J Vasc Surg. 1987;5:773-8. 35. Bouhoustsos J, Daskalakis E. Muscular abnormalities affecting the popliteal vessels. Br J Surg. 1981;68:501-11. 36. Flanigan DP, Burnham SJ, Goodreau JJ et al. Summary of cases advential cystic disease of the popliteal artery. Ann Surg. 1979;189:165-71. 37. Stallworth JM, Braun AG, Burges GE et al. Cystic advential disease of the popliteal artery. Am Surg. 1985;51:455-66. 38. DeFrang RD, Edwards JM, Moneta GL et al. Repeat leg bypass after multiple prior bypass failures. J Vasc Surg. 1994;19:268-77. Braga PEG, Salgado AA, Zorn WGW, van Bellen B. Course of the postcatheterization pulseless arm. J Cardiovasc Surg. 1984;25:236-40. 40. Couto M, Mourad J, Duarte R et al. Trauma vascular iatrogênico. Cir Vasc Angiol. 1993;9:26. 41. Eldrup-Jorgensen J, Flanigan DP, Brace L et al. Hypercoagulable states and lower limb ischemia in young adults. J Vasc Surg. 1989;9:334-41. 42. Cocler BS, Owen J, Jesty J et al. Deficiency of plasma protein S, protein C, or antithrombin III and arterial thrombosis. Arteriosclerosis. 1987;7:456-60. 43. Wiesel ML, Borg JY, Grunebaum L et al. Influence of protein S deficiency on the arterial thrombosis risk. Presse Med. 1991;20:1023-332. 44. Bell PRF, Charlesworth D, DePalma RG. The definition of critical ischaemia of a limb. Brit J Surg. 1982;69:52-5. 45. Rutherford RB, Flanigan DP, Gupta SK et al. Suggested standards for reports dealing with lower extremity ischemia. J Vasc Surg. 1986;4:80-94. 46. Norgren L, Hiatt WR, Dormandy JA et al. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg. 2007;45 (Suppl):S5-S67. 47. Bergan JJ et al. Nontraumatic mesenteric ischemia. J Vasc Surg. 1987;5:903-9.
8. Sherry S. History and development of thrombolytic therapy in Camerota AJ (ED.): Thrombolytic Therapy. Orlando: Grune & Stratton; 1988. p. 1-15. 9. Blebea J, Kempczinski RF. Acute limb ischemia. In: Dean RH, Yao JST, Brewster DC (Eds.). Current Diagnosis and Treatment in Vascular Surgery. New Jersey: Prentice Hall Int. Inc; 1995. p. 282-96.
23. Shafer AI, Kroll MH. Nonatheromatous arterial thrombosis. Ann Rev Méd 1993;44:155-60.
57. Blackshear JL, Oldenburg WA, Cohen MD. Making the diagnosis when the patient has “blue toes”. Geriatrics 1994;49:43-5.
58. Parodi JC. Treatment of blue toe syndrome with intra-arterial injections of prostaglandin E. In: Yao JST, Pearce WH (Eds.). The Ischemic Extremity Advances and Treatment. Norwalk, CT: Appleton & Lange; 1995. p. 325.
85.
64. Weaver FA, Comerota AJ, Youngblood M. Surgical revascularization versus throbolysis for nonembolic lower extremity native artery occlusions: results of a prospective randomized trial. The STILE investigators. J Vasc Surg. 1996;24:513-21.
49.
50.
48.
54. Fogarty TJ, Cranley JJ, Krause RJ et al. A method of extraction of arterial emboli and thrombi. Surg Gynecol Obstet. 1963;116:241-4.
261Capítulo 135 obstrução ArteriAl AgudA dos membros inferiores Haimovici H. Ischemic forms of venous thrombosis: Phlegmasia cerulea dolens and venous gangrene. Springfield, Il: Charles C. Thomas; 1971. Raby N, Giles J, Walters H. Aortic dissection presenting as acute leg ischemia. Clin Radiol 1990;42:116-7. Campbell WB. Current management of acute leg ischemia: results of an audit by the Vascular Surgical Society of Great Britiain and Ireland. Br J Surg. 1998;85:1498-503. Clason AE, Stonebridge PA, Duncan AJ et al. Morbidity and mortality in acute lower limb ischemia: a 5-year review. Eur J Vasc Surg. 1989;3:339-43. 52. Berridge DC, Hopkinson BR, Makin GS. Acute lowe r limb arterial ischemia: a role for continuous oxygen inhalation. Br J Surg. 1989;76:1021-3.
55. STILE investigators. Results of a prospective randomized trial evaluating surgery versus thrombolysis for ischemia of the lower extremity. The STILE Trial. Ann Surg. 1994;220:251-68.
56. Karlström L, Bergqvist D. Effects of vascular surgery on amputation rates and mortality. Eur J Vasc Endovasc Surg. 1997;14:273-83.
60. Rajan DK, Patel NH, Valji K et al. Quality improvement guidelines for percutaneous management of acute limb ischemia. J Vasc Interv Radiol 2009 July;20(7Suppl):208-18.
70. Ernst S, Fischbach R, Brochhagen HG et al. Transbrachial thrombolysis, PTA and stenting in the lower extremities. Cardiovasc Interv Radiol 2003;26:516-21.
79. Kasirajan K, Gray B, Beavers F. Rheolytic thrombectomy in the treatment of acute life-threatening ischemia: immediate results and six month follow-up of the multi-center Angiojet registry. J Vasc Interv Radiol. 2001;12:413-21.
63. Ouriel K, Shortell Ck, DeWeese JA et al. A comparison of thrombolytic therapy with operative revascularization in the treatment of acute peripheral arterial ischemia. J Vasc Surg. 1994;19:1021-30.
73. Norgren L, Hiatt WR, Dormandy JA et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg. 2007 Jan;45(Suppl S):55-67. 74. Kessel DO, Berridge DC, Robertson I. Infusion techniques for peripheral arterial thrombolysis. Cochrane Database of Systematic Reviews. In: The Cochrane Library, issue 3, Art. No. CD000985. 75. Parent FN, Piotrowski JJ, Bernhard VM et al. Outcome of intraarterial urokinase for acute vascular occlusion. J Cardiovasc Surg. 1991;32:680-90. 76. Antithrombotic Trialist’s Collaboration meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction and stroke in high risk patients. BMJ 2002;324:71-6.
80. Sarac TP, Hilleman D, Arko FR et al. Clinical and economic evaluation of the Trellis thrombectomy device for arterial occlusions. Preliminary results. J Vasc Surg. 2004;39:556-9.
59. Hirsch AT, Haskal ZJ, Hertzer NR et al. Vascular Disease Foundation Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Endorsed by the American Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients with Peripheral Artery Disease); Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/ AHA Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Collaborative Report from the American Association for Vascular Surgery/Society for Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic): ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease. Circulation. 2006;113:463-54.
71. Shilling JD, Pond GD, Nulcahy Hunter GC et al. Catheter directed urokinase thrombolysis: an adjunct to PTA/surgery for managemet of lower extremity thromboembolic disease. Angiology 1994;45:851-60. 72. Working Party on Thrombolysis in the Management of Limb Ischemia. Thrombolysis in the management of lower limb peripheral arterial occlusion – a consensus document. J Vasc Interv Radiol. 2003 Sep;14(9Pt2):S337-49.
61. Barr H, Lancashire MJR, Torrie EPH, Galland RB. Intra-arterial thrombolytic therapy in the management of acute and chronic lim ischaemia. Br J Surg. 1991;78:284-7. 62. Comerota AJ, Weaver FA, Hosking JD. Results of a prospective randomized trial of surgery versus thrombolysis for occluded lower exteremitiy by-pass grafts. Am J Surg. 1996;172:105-12.
51.
77. Ouriel K, Castaneda F, Mcnamara T, Swischuk J. Reteplase monotherapy and reteplase/abciximab combination therapy in peripheral arterial occlusive disease. Results from the RELAX Trial. J Vasc Interv Radiol. 2004;15:229-38. 78. Kasirajan K, Haskal ZJ, Ouriel K. The use of mechanical thrombectomy devices in the management of acute peripheral arterial occlusive disease. J Vasc Interv Radiol. 2001;12(4):405-11.
81. Zeller T, Frank U, Bergerlink K et al. Early experience with a rotational thrombectomy device for treatment of acute and subacute arterial occlusions. J Endovasc Ther. 2003;10:322-31. 82. Hagino RT, Fujitani RM, Dawson DL et al. Does infrapopliteal arterial runoff predict success for popliteal artery aneurysmorrrhaphy? Am J Surg 1994;168:652-8. 83. Ljungman C, Adami NO, Bergqvist D et al. Risk factors for early lower limb loss after embolectomy for acute arterial occlusions: A population based case control study. Br J Surg. 1991;78:1482-5. 84. Comerota AJ. Intraoperative, intra-arterial thrombolytic therapy. In: Perler BA, Becker GJ (Eds.). Vascular intervention: a clinical approach. New York, NY: Thieme Medical Publishers, Inc; 1998. p. 325-30. Comerota AJ, Rao AK, Throm RC et al. A prospective, randomized, blinded and placebo-controlled trial of intraoperative, intra-arterial uroquinase infusion during lower extremity revascularization: regional and systemic effects. Ann Surg. 1993;218(4):534.
65. Ouriel K, Veith FJ, Sasahara AA. A comparison of recombinant urokinase with vascular surgery as initial treatment for acute arterial occlusion of the legs. Thrombolysis or Peripheral Arterial surgery (TOPAS) Investigators. N Eng J Med 1998;338:1105-111.
66. Ouriel K, Veith FJ, Sasahara AA. Thrombolysis or peripheral arterial surgery. Phase I results TOPAS investigators. J Vasc Surg. 1996;23:64-73. 67. Kandarpa K, Goldhaber SZ, Myerovitz MF. Pulse spray thrombolysis: the careful analysis. Radiology 1994;193:320-24. 68. Kandarpa K, Chopra OS, Arung JE. Intra-arterial throbolysis of lower extremity occlusion: prospective randomized comparison of forced periodic infusion and conventional slow continuous infusion. Radiology 1993;188:861-7. 69. Kalinowski M, Wagner HJ. Adjunctive techniques in percutaneous mechanical thrombectomy. Tech Vasc Interv Radiol. 2003;6:6-13.
53. Mackay CA, Razik W, Simms MN. Local anaesthetic for lower limb revascularization in high risk patients. Br J Surg. 1997;84:1096-98.
15. Dabby D, Greif F, Yaniv M et al. Thromboxane A2 in postischemic acute compartmental syndrome. Arch Surg 1998 Sept.;133(9):953-6.
5. Fowler PJ, Willis RB. Vascular compartment syndromes. Can J Surg 1975 Mar;18(2):157-61. 6. Modrall JG. Compartment syndrome. In: Rutherford RB (Ed.). Vascular surgery., 7th ed. Philadelphia: WB Saunders; 2010. p. 2412-20.
10. Granchi TS, Garcia P, Mattox KL et al. Compartment syndromes. In: Rich NM. (Ed.). Vascular trauma, 2nd ed. Philadelphia: Elservier Saunders; 2004. p. 443-55.
13. Velmahos GC, Toutouzas KG. Vascular trauma and compartment syndromes: complex and challenging injuries, Part II. Surg Clin North Am 2002;82(1):125-41.
26. Razuk A, Porciúncula M, Caffaro RA. Esmagamento de membros. In: Murilo R. (Ed.). Trauma vascular. Rio de Janeiro: Revinter; 2005;423-33. 27. Ernst CB, Brennaman BH, Haimovici H. Fasciotomy. In: Haimovici H. (Ed.). Haimovici’s vascular surgery, 4th ed. USA: Blackwell Science; 1996. p. 1290-8. 28. Percival TJ, Rasmussen TE. Reperfusion strategies in the management of extremity vascular injury with ischaemia. Br J Surg 2012;99(S1):66-74. 29. Amyot S-L et al. Myoglobin clearance and removal during continuous venovenous hemofiltration. Inten Care Med 1999;25(10):1169-72. 30. Mubarak SJ, Hargens AR, Owen CA et al. The wick catheter technique for measurement of intramuscular preassure. J Bone Joint Surg 1976 Oct.;58-A(7):1016-20. 31. Shah DM, Bock EM, Darling III RC et al. Beneficial effects of hypertonic mannitol in acute ischemia- reperfusion injuries in humans. Card Vasc Surg 1996 Fev.;4(1):97-100. 32. Johansen K, Watson J. Compartment syndrome: new insights. Semin Vasc Surg 1998 Dec.;11(4)294-301. 33. Rorabeck CH, Castle GSP, Hardie R et al. Compartment pressure measurements: An experimental investigation using the slit catheter. J Trauma 1981;21(6):446-9. 34. Filho JMC, Ristow AV. Síndrome compartimental. In: Murilo R. (Ed.). Trauma Vascular. Rio Janeiro: Revinter; 2005. p. 617-27. 35. Matawa MJ, Whitesides TE, Seiler JG et al. Determination of the compartment pressure threshold of muscle ischemia. in a canine model. J Trauma 1994;37(1):50-8. 36. Mabee JR, Bostwick TL. Pathophysiology and mechanisms of compartment syndrome. Orthop Rev 1993;22:175-81. 37. Rollins DL, Bernhard VM, Towne JB. Fasciotomy. Arch Surg 1981;116:1474-81. 38. Lastória S, Maffei FHA. Oclusões arteriais agudas. In: Maffei FHA. (Ed.). Doenças vasculares periféricas. 3. ed. Rio de Janeiro: Medsi; 2002. p. 969-97. 39. Pitta GBB, Santos CAS, Braga FA. Fasciotomias de extremidades. In: Murilo R. (ed). Trauma vascular. Rio de Janeiro: Revinter; 2005. p. 601-10. 40. Janzing H, Broos P. Fasciotomies of the limbs: how to do it? Acta Chir Belg 1998 Aug.;98(4):187-91. 41. Argenta LC, Morykwas MJ. Vacuum-assisted closure: a new method for wound control and treatment: animal studies and basic foundation. Ann Plastic Surg 1997;38(6):553-62. 42. Rush DS, Frame SB, Bell RM et al. Does open fasciotomy contribute to morbidity and mortality after acute lower extremity ischemia and revascularization? J Vasc Surg 1989;10(3):323-33. 43. Turnipseed WD, Hurschier C, Vanderby Jr R. The effects of elevated compartment pressure on tibial arteriovenous flow and relationship of mechanical and biochemical characteristics of fascia to genesis of cronic anterior compartment syndrome. J Vasc Surg 1995;21(5):116-26. 44. Volkmann RV. Die ischaemischen muskellahmungen und kontrakturen. Zentralbl Chir 1881;8:801. Beard JD, Gaines PA, Loftus Ian (Eds.). Vascular and Endovascular Surgery E-Book: Companion to Specialist Surgical Practice. Elsevier Health Sciences; 2013. 46. Berman SS, Schilling JD, McIntire KE et al. Shoelace technique for delayed primary closure of fasciotomies. Am J Surg 1994 Apr.;167:435-6. 47. Malinoski DJ, Slater MS, Mullins RJ. Crush injury and rhabdomyolysis. Crit Care Clin 2004;20:171-92. 48. Zager RA. Rhabdomyolysis and myohemoglobinuric acute renal failure. Kidney Int 1996;49:314-26.
24. Frykberg ER. Vascular trauma: history, general principles and extremity injuries. In: Callow AD, Ernst CB. (Ed.). Vascular surgery. Stanford: Appleton & Lange; 1995. p. 985-1037. 25. Mckenney MG, Nir I, Fee T et al. A simple device for closure of fasciotomy wounds. Am J Surg 1996;172:275-7.
22. Blaisdell FW. The pathophysiology of skeletal muscle ischemia and the reperfusion syndrome: a review. Cardiovasc Surg 2002;10:620-30. 23. Sise MJ. Diagnosis of vascular injury. In: Rasmudssen T, Tai NRM. Rich’s vascular trauma. 3rd ed. Philadelphia: Elsevier; 2016. p. 35-43. v. 1. c. 5.
14. Templeman D, Lange R, Harms B. Lower extremity compartment syndrome associated with use of pneumatic antishock garments. J Trauma 1987;27(1):79-81.
4. Martin RR, Mattox KL, Burch JM et al. Advances in treatment of vascular injuries from blunt and penetrating limb trauma. World J Surg 1992 Sept.-Oct.;16(5):930-7.
1. Matsen FA. Compartmental syndrome. Clin Orthop Relat Res 1975;113:8-14.
2. Feliciano DV, Cruse PA, Spjut-Patrinely V et al. Fasciotomy after trauma to the extremities. Am J Surg 1988 Dec.;156(6):533-6.
20. Belkin M, Valeri R, Hobson RW. Intraarterial urokinase increases skeletal muscle viability after acute ischemia. J Vasc Surg 1989 Jan.;9(1):163-8.
3. Patman RD. Compartmental syndromes in peripheral vascular surgery. Clin Orthop 1975 Nov.-Dec.;(113):103-10.
7. Rahm M, Probe R. Extensive deep venous thrombosis resulting in compartment syndrome of thigh and leg. J Bone Joint Surg 1994 Dec.;12:1854-7. 8. Mubarak SJ, Owen CA. Double incision fasciotomy of the leg for decompression in compartment syndromes. J Bone Surg 1977;59A:184-7.
11. Duran WN, Takenaka H, Hobson RW. Microvascular pathophysiology of skeletal muscle ischemia-reperfusion. Semin Vasc Surg 1998 Sept.;11(3):203-14.
12. Rasmussen TE, Tai NRM. Rich trauma vascular. Elsevier Brasil; 2017.
REFERÊNCIAS BIBLIOGRÁFICAS
18. Wright JG, Araki CT, Belkin M et al. Postischemic hypothermia diminishes skeletal reperfusion edema. J Surg Res 1989 Nov.;47(5):389-96.
19. Hayes PG, Liauw S, Smith A et al. Exogenous magnesium chlorideadenosine triphosphate administration during reperfusion reduces the extent of necrosis in previously ischemic skeletal muscle. J Vasc Surg 1990 Mar;11(3):441-7.
21. Crawford RD, Watkins MT. Ischemia-reperfusion. In: Rutherford RB. (Ed.). Vascular surgery. 7th ed. Philadelphia: WB Saunders; 2010. p. 89-100.
45.
262 136Capítulo FASCIOTOMIAS – INDICAÇÕES E TÉCNICAS
17. Varma S, Hobson RW, Duran W. Metabolic and systemic consequences of acute limb ischemia and reperfusion. In: Hallet Jr JW. (Ed.). Comprehensive vascular and endovascular surgery. St Louis: Mosby; 2004. p. 235-46.
9. Farber A et al. Early fasciotomy in patients with extremity vascular injury is associated with decreased risk of adverse limb outcomes: a review of the National Trauma Data Bank. Injury 2012;43(9):1486-91.
16. Belkin N, LaMorte W, Wright G et al. The role of leucocytes in pathophysiology of skeletal ischemic injury. J Vasc Surg 1989 July;10(1):14-8.
3. Coleridge-Smith PD. The management of chronic venous disorders of the leg: an evidence-based report of an international task force. Phlebology 1999;(Suppl. 1):66-105.
13. Coleridge-Smith PD et al. The management of chronic venous disorders of the leg: an evidence-based report of an international task force. Phlebology 1999;14(supplement 1):1-65.
16. Vasquez MA, Rabe E, McLafferty RB et al. Revision of the venous clinical severity score: venous outcomes consensus statement: special communication of the American Venous Forum Ad Hoc Outcomes Working Group. J Vasc Surg 2010;52:1387-96. Sumner DS, van Bemmelem PS. Hemodynamics of the venous system: Calf pump and valve function. IN: Raju S, Villavicencio JL. Surgical management of venous disease. Williams & Wilkins; 1997;16-59. Cornu-Thenard A, Boivin P, Baud J et al. Importance of the familial factor in varicose disease: clinical study of 134 families. J Dermatol Surg Oncol 1994;20:318-26. 19. Crawford JM, Lal BK, Durán WN, Pappas PJ. Pathophysiology of venous ulceration. J Vasc Surg Venous and Lym Dis 2017;5:596-605.
15.
17.
6. Rabe E, Guex JJ, Puskas A et al. Epidemiology of chronic venous disorders in geographically diverse populations: results from the Vein Consult Program. Int Angiol 2012;31:105e15.
18.
263 137Capítulo
2. Wittens C, Davies AH, Baekgaard N et al. Management of chronic venous disease — clinical practice guidelines for the European Society for Vascular Surgery. Eur J Vasc Endovasc Surg 2015;51(4):609.
7. Lohr JM et al. Increasing awareness about venous disease: the American Venous Forum expands the national venous screening program. J Vasc Surg 2008;48:394-9.
23. Skull KC, Nicolaides NA, Fernandes e Fernandes J et al. Significance of popliteal reflux in relation to ambulatory venous pressure and ulceration. Arch Surg 1974;114:1304. 24. Labropoulos N, Leon M, Nicolaides NA et al. Venous reflux in patients with previous deep venous thrombosis: correlation with ulceration and other symptoms. J Vasc Surg 1994;20:20.
25. Hanrahan LM, Araki CT, Rodriguez AA et al. Distribution of valvular incompetence in patients with venous stasis ulceration. J Vasc Surg 1991;13:805. 26. Myers KA, Ziegenbein RW, Zeng GH, Mathews PG. Duplex ultrasonography scanning for chronic venous disease: paterns of venous reflux. J Vasc Surg 1995;21:605. 27. Burnand KG, O’Donnell TF, Lea Thomas M, Browse NL. The relationship between the number of capillaries in the skin of the venous ulcer bearing area of the lower leg and the fall in foot vein pressure during exercise. Br J Surg 1981;68:297. 28. Fagrell B. Microcirculatory disurbances – the final cause for venous ulcers. VASA 1982;11:101-103. 29. Pappas PJ, DeFouw DO, Venezio LM et al. Morphometric assessment of the dermal microcirculation in patients with chronic venous insufficiency. J Vasc Surg. 1997;26(5):784-95. 30. Mansilha A, Sousa J. Pathophysiological Mechanisms of Chronic Venous Disease and Implications for Venoactive Drug Therapy. Int J Mol Sc. 2018;19:1669. 31. Perrin M, Ramelet AA. Pharmacological treatment of primary chronic venous disease: rationale, results and unanswered questions. Eur J Vasc Endovasc Surg 2011;41:117e125. 32. Ono T, Bergan JJ, Schmid-Schönbein GN, Takase S. Monocyte infiltration intovenous valves. J Vasc Surg 1998; 27:158e66. 33. Raffetto JD, Khalil RA. Mechanisms of varicose vein formation: valve dysfunction and wall dilation. Phlebology 2008;23:85e98. 34. Bergan JJ, Pascarella L, Schmid-Schönbein G. Pathogenesis of primary chronic venous disease: insights from animal models of venous hypertension. J Vasc Surg 2008;47:183e92. 35. Schmid-Schonbein GW, Takase S, Bergan JJ. New advances in the understanding of the pathophysiology of chronic venous insufficiency. Angiology. 2001;52 Suppl1:S27-34. 36. Burnand KG, WhimsterI, Naidoo A, Brose NL. Pericapillary fibrin in the ulcer bearing skin of the leg. Br Med J 1982;285:1071. 37. Herrick SE, Sloan P, McGurk M et al. Sequential changes in histologic pattern and extracellular matrix deposition during the healing of chronic venous ulcers. Am J Pathol. 1992;141(5):1085-95. Bishop JE. Regulation of cardiovascular collagen deposition by mechanical forces. Mol Med Today. 1998;4(2):69-75. 39. Pappas PJ, Brajesh KL, Cerveira JJ, Duran WN. The pathophysiology of chronic venous insufficiency. In: Rutherford RB et al. Vascular surgery, 6th ed. Philadelphia, Pennsylvania, USA: Elservier Saunders; 2005. p. 2220-9. 40. Allen AJ, Wright DII, McCollum CN, Tooke JE. Impaired postural vasoconstriction: a contributory cause for edema in patients with chronic venous insufficiency. Phlebology 1988;3:163-8. 41. Scurr JH, Coleridge–Smith PD. The microcirculation in venous disease. Angiology 1994;45:537-41. 42. Cheatte TR, Chittenden SJ, Shami SK. Peripheral neuropathy of the lower limb. In: Coleridge-Smith PD. Microcirculation in venous disease. Landes Bioscience 1998;84-115. 43. Moyses C, Cederholm-Williams AS, Michel CC. Haemoconcentration and accumulation of white cells in the feet during venous stasis. Int J Microcirc Exp 1987;5:311-20.
REFERÊNCIAS BIBLIOGRÁFICAS
20. Ng MY, Andrew T, Spector TD, Jeffery S. Lymphoedema Consortium. Linkage to FOXC2 region of chromosome 16 for varicose veins in otherwise healthy, unselected sibling pairs. J Med Genet 2005;42:235-9. 21. Serra R, Buffone G, de Franciscis A et al. A genetic study of chronic venous insufficiency. Ann Vasc Surg 2012;26:636-42.
10. Scuderi A, Raskin B, Al Assal F et al. The incidence of venous disease in Brazil based on the CEAP classification. Int Angiol. 2002;21(4):316-21.
22. Munger S, Geng X, Srinivasan RS et al. Segregated FOXC2, NFATc1 and Connexin expression at normal developing venous valves, and Connexin-specific differences in the valve phenotypes of Cx37, Cx43, and Cx47 knockout mice. Dev Biol 2016;412:173-90.
38.
4. Brand FN, Dannenberg AL, Abbott RD, Kannel WB. The epidemiology of varicose veins: the Framingham study. Am J Prev Med 1988;4:96-101.
11. Rabe E, Guex JJ, Puskas A Et al. Epidemiology of chronic venous disorders in geographically diverse populations: results from the Vein Consult Program. Int Angiol 2012;31(2):105-15.
5. Widmer LK. Peripheral venous disorders. Prevalence and sociomedical importance. Observations in 4529 apparently healthy persons, Basle III study. Hans Huber (Bern) 1978;1-90.
14. Eklöf B, Rutherford RB, Bergan JJ et al. Revision of the CEAP classification for chronic venous disorders: Consensus statement. J Vasc Surg 2004;40:1248-52. DynaMed Plus: EBSCO Information Services. 1995. Record No. 116699, Varicose veins; [updated 2018 Mar 30]. Available from dynamed.com/login.aspx?direct=true&site=DynaMed&id=116699.http://www.
INSUFICIÊNCIA VENOSA CRÔNICA
12. Santos MERC Venous Disease: Brazilian Overview. In: Dardik A. Vascular Surgery: A Global Perspective. Switzerland: Springer International Publishing; 2017. p. 217-22.
1. Eklof B, Perrin M, Delis KT et al. Updated terminology of chronic venous disorders: The VEIN-TERM transatlantic interdisciplinary consensus document. J Vasc Surg 2009;49:498-501.
8. Gloviczki P, Comerota AJ, Dalsing MC et al. The care of patients with varicose veins and associated chronic venous diseases: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg 2011 May;53(5 Suppl):2S-48S.
9. Maffei FHA, Magaldi C, Pinho SZ, et al. Varicose veins and chronic venous insufficiency in Brazil: prevalence among 1755 inhabitants of a country town. Int J Epidemiol 1986;15:210-7.
46. Raffetto JD, Marston WA. Venous Ulcer: What is new? Plast Reconstr Surg 2011;127:279S-288S.
264 Parte VIIIMEMBROS INFERIORES
47. Meissner MH, Gloviczki P, Bergan J et al. Primaru Chronic Venous Disorder. J Vasc Surg 2007;46:54S-67S.
48. Raffetto JD, Khalil RA. Matrix metalloproteinases in venous tissue remodeling and varicose vein formation. Curr Vasc Pharmacol. 2008;6:158-72.
51. Coleridge-Smith PD, Thomas P, Scurr JH, Dormandy JA Causes of venous ulceration: a new hypothesis. Br Med J 1988;296:1726-7.
52. Simka M. Cellular and molecular mechanisms of venous leg ulcers development—the “puzzle” theory. Int Angiol 2010;29:1-1.
49. Cook H, Stephens P, Davies KJ, Thomas DW. Defective extracellular matrix reorganization by chronic wound fibroblasts is associated with alterations in TIMP-1, TIMP-2, and MMP-2 activity. J Invest Dermatol. 2000;115:225-33.
45. Scott HJ, Coleridge-Smith PD, Scurr JH. Histological study of white blood cells and their association with lipodermatosclerosis and venous ulceration. Br Med J 1991;78:1.
50. Bollinger A, Speiser B, Haselbach P, Jager K. Microangiopathy of mild and severe chronic venous incompetence (CVI) studied by fluoresceine videomicroscopy. American Symposium on Venous Diseases. Washington DC; 1987. Abstract 0241-5.
44. Thomas PRs, Nash GB, Dormandy JA. White cell accumulation in the dependent leg of patients with venous hypertension: a possible mechanism for trophic changes in the skin. Br Med J 1988;296:1693-5.
CONCEITOS
INFERIORES
BIBLIOGRAFIA Abramson JH, Hopp C, Epstein LM. The epidemiology of varicose veins: A survey in western Jerusalem. J Epidemiol Community Health Abu-Own1981;35:213-7.A,Scurr JH, Coleridge Smith PD. Saphenous vein reflux without incompetence at the saphenofemoral junction. Br J Surg Ackroyd1994;81:1452-4.JS,Pattison M, Browse NL. A study of the mechanical properties of fresh and preserved human femoral vein wall and valve cusps. Br J Surg 1985;72:117-19. Adams F. The genuine works of Hippocrates. Baltimore: The Williams & Wilkins Company; 1946. Aguiar NEA, Barreto H. Metodização de uma prova para diagnóstico das insuficiências venosas nos membros inferiores. Rev Bras Cir Aharinejad1955;30:437-44.S,Nedwed S, Michlits W, Dunn R, Abraham D, Vernadakis A et al. Valvular density alone cannot account for sites of chronic venous insufficiency and ulceration in the lower extremity. Microcirculation 2001;8:347e354. Al Assal F. Varizes dos membros inferiores. Arq Cir Clin Exp Alexander1951;14:23-43.CJ.Chair-Sitting and varicose veins. Lancet 1972;15:822-3. Alexander CJ. The epidemiology of varicose veins. Med J Aust Andreotti1972;1:215-8.L,Cammelli D. Connective tissue in varicose veins. Angiology Arenander1979;30:798-805.E.Hemodynamic effects of varicose veins and results of radical surgery. Acta Chir Scand suppl 1960;260:1-76. Arnoldi CC. The aetiology of primary varicose veins. Dan Med Bull Arnoldi1957;4:102-7.CC.Theheredity of venous insufficiency. Dan Med Bull Arruda1958;5:169-76.S.Varizesdos membros inferiores: Diagnóstico e tratamento. Rev Roche 1957;17:74-84. Ascher E, Jacob T, Hingorani A et al. Expression of molecular mediators of apoptosis and their role in the pathogenesis of lower-extremity varicose veins. J Vasc Surg 2001;33:1080-1086. Ascher E, Jacob T, Hingorani A. Programmed cell death (Apoptosis) and its role in the pathogenesis of lower extremity varicose veins. Ann Vasc Surg 2000;14:24-30. Askar O, Emara A. Varicose veins and occupation. J Egypt Med Ass Atenas1970;53:341-50.JG.Theefficacy of aminaphtone in patients suffering from chronic venous insufficiency. Annals Exp and Clin Med 1995;2:81-5. Baker DM, Turnbull NB, Pearson JCG et al. How successful is varicose veins surgery? A patient outcome study following varicose vein surgery using the SF-36 Health Assessment Questionnaire. Eur J Vasc Endovasc Surg 1995;9:299-304. Baron HC, Cassaro S. The role of arteriovenous shunts in the pathogenesis of varicose veins. J Vasc Surg 1986;4:124-28. Barwin BN, Roddie IC. Venous distensibility during pregnancy determined by graded venous congestion. Am J Obstet Gynecol 1976;125:921-3. Basmajian JV. The distribuition of valves in the femoral, external iliac and common femoral veins and their relation ship to varicose veins. Surg Gynecol Obstet 1952;95:537. Baud JM, Lemasle P. Explorations actuellement utiles pour l’indication du traitement des varices des membres inférieurs. Ann Chir Beaglehole1997;51:729-34.R.Epidemiology of varicose veins. World J Surg Belcaro1986;10:898-902.G,Christopoulos D, Nicolaides AN. Lower Extremity venous hemodynamics. Ann Vasc Surg 1991;5:305-10. Benabou J, Molnar L, Cardoso F et al. Varizes recidivadas: Estudo comparativo entre mapeamento duplex e flebografia ascendente na detecção de coto residual de veia safena magna com refluxo {Abstract}. Cir Vasc Angiol 1993;9:33a. Benabou JE, Molnar LJ, Cardoso Neto F et al. Avaliação por mapeamento duplex da junção safenofemoral em pacientes portadores de varizes recidivantes, submetidos à prévia cirurgia radical de varizes. Cir Vasc Angiol 1996;12:36s-9s. Bergan JJ, Weiss RA, Goldman MP. Extensive tissue necrosis following high-concentration sclerotherapy for varicose veins. Derm Surg Bergan2000;26:535-42.JJ.Aunifying concept of primary venous insufficiency. Dermatol Surg Bergqvist1998;24:425-28.D,Jaroszewsky H. Deep vein thrombosis in patients with superficial thrombophlebitis of the leg. B M J 1986;292:658-59.
Bettmann OL. A pictorial history of medicine. 1979. Biagi G, Lapilli A, Zendron R et al. Prostanoid production in varicose veins: evidence for decreased prostacyclin with increased thromboxane A2 and prostaglandin E2 formation. Angiology 1988;39:1036-42. Birger I. La maladie variqueuse considérée comme une entité clinique héréditaire. Phlébologie 1967;20:269-71. Blalock A. Oxygen content of blood in patients with varicose veins. Arch Surg 1929;19:898-905. Bobek K, Cajzl L, Cepelak V et al. Étude de la fréquence des maladies phlébologiques et de l’influence de quelques facteurs étiologiques. Phlébologie 1966;19:217-30. Bonardi O. Le vene varicose. Min Med 2012;72:122-25. Bracey DW. Simple device for location of perforating veins. Br Med J Bradbury1958;2:101-4.AW,Stonebridge PA, Callam MJ et al. Recurrent varicose veins: Assessment of the saphenofemoral junction. Br J Surg 1994;81:373-5. Brand FN, Dannenberg AL, Abbott RD et al. The epidemiology of varicose veins: the Framingham study. Am J Prev Med 1988;4:96-101. Brito CJ, Fonseca Filho VI, Salles SN et al. Comparação dos métodos diagnósticos na detecção da insuficiência valvular safeno femoral {Abstract}. Cir Vasc Angiol 1993;9:12a. Brodribb AJM, Humphreys DM. Diverticular disease: three studies. Part I –Relation to other disorders and fibre intake. Br Med J 1976;1:424-30. Bueno Neto J, Puech Leão LE, Toledo OM et al. Varizes: Problema de cirurgia estética. Rev Assoc Med Brasil 1959;5:41-6. Bueno Neto J, Toledo OM, Wolosker M et al. Resultados da cirurgia radical nas varizes dos membros inferiores. Rev Paul Med 1960;57:151-56. Bueno Neto J, Zupo M. Varizes dos membros inferiores. Rev Med Burihan1956;40:18-49.E.Estudo anatômico da veia safena parva: Tipos de terminação. Rev Bras Cardiovasc 1974;10:89-99. Burkitt DP. Varicose veins, deep vein thrombosis, and haemorrhoids: epidemiology and suggested aetiology. Br Med J 1972;2:556-61. Burkitt DP. Varicose veins. Arch Surg 1976;111:1327-32. Burnand KG, O’Donnell Jr F, Thomas ML et al. The relative importance of incompetent communicating veins in the production of varicose veins and venous ulcers. Surgery 1977;82:9-14. Caggiati A, Phillips M, Lametschwandtner A, Allegra C. Valves in small veins and venules. Eur J Vasc Endovasc Surg 2006;32:447-52. Caggiati A, Rosi C, Heyn R. Age-related variations of varicose veins anatomy. J Vasc Surg 2006;44:1291-95. Callam MJ. Epidemiology of varicose veins. Br J Surg 1994;81:167-73. Campbell WB. Varicose veins: an increasing burden for the NHS. Brit Med J Carpentier1990;300:763-64.PH,Maricq HR, Biro C et al. Prevalence, risk factors, and clinical patterns of chronic venous disorders of lower limbs: a populationbased study in France. J Vasc Surg 2004;40:650-9.
265 138Capítulo
VARIZES DE MEMBROS –
Castro-Ferreira R, Cardoso R, Leite-Moreira A, Mansilha A.The Role of Endothelial Dysfunction and Inflammation in Chronic Venous Disease. Ann Vasc Surg 2018 Jan;46:380-93. Cheatle TR, Sarin S, Smith C et al. The pathogenesis of skin damage in venous disease: a review. Eur J Vasc Surg 1991;5:115-23. Clark JH. The elasticity of veins. Am J Physiol 1933;105:418-27. Clarke H, Smith SRG, Vasdekis SN et al. Role of venous elasticity in the development of varicose veins. Br J Surg 1989;76:577-80. Clyne CAC. Ramsden WH, Chant ADB, Webster JHH. Oxygen tension on the skin of the gaiter area of limbs with venous disease. Br J Surg Correia1985;72:644-47.NetoA.Tratamento cirúrgico das varizes dos membros inferiores e das úlceras varicosas rebeldes. Rev Cir S Paulo 1935;2:29-47. Coursley G, Ivins JC, Arker NW. Congenital arteriovenous fistulas in the extremities. Angiology 1956;7:201-17. Crane C. The surgery of varicose veins. Surg Clin North Am Criado1979;59:737-48.E,FarberMA, Marston WA et al. The role of air plethysmography in the diagnosis of chronic venous insufficiency. J Vasc Surg Da1998;27:660-70.SilvaA,Widmer LK, Martin H et al. Varicose veins and chronic venous insufficiency. Prevalence and risk factors in 4376 subjects of the Basle study II. Vasa 1974; 3:118-25. Darke SG, Vetrivel S, Foy DMA et al. A comparison of duplex scanning and continuous wave doppler in the assessment of primary and uncomplicated varicose veins. Eur J Vasc Endovasc Surg Degni1997;14:457-61.M,KardoshCB, Bolanho E. Estudo de 67 pacientes com síndrome pós-flebítica e flebite mural crônica tratados com aminaftone. Rev Bras Med 1984;41:174-80. Dixon PM. Duplex ultrasound in the pre-operative assessment of varicose veins. Australas Radiol 1996;40:416-21. Dodd H. The cause, prevention, and arrest of varicose veins. Lancet Dortu1964;2:809-11.JA.Lesreflux veineux superficiels dans les regions inguino-crurales et inguino-femorales autres que la jonction saphéno-fémoral. Cir Vasc Angiol 1996;12:-12s. Dunn RM, Fudem GM, Walton RL, Anderson Jr FA, Malhotra R. Free flap valvular transplantation for refractory venous ulceration. J Vasc Surg Duque1994;19:525e531.F,BernardiniEMT. Varizes essenciais. Angiopatias 1963;3:96-106. Edwards EA, Edwards JE. The effect of thrombophlebitis on the venous valve. Surg Gynecol Obst 1937;65:310-20. Edwards EA. The treatment of varicose veins. Surg Gynecol Obst Eger1934;59:916-28.SA,CasperSL.Etiology of varicose veins from an anatomic aspect, based on a dissection of thirty-eight adult cadavers. JAMA Eiriksson1943;123:148-49.E,DahnI.Plethysmographic studies of venous distensibility in patients with varicose veins. Acta Chirurgica Scand 1968;398:19-26. Engel AF, Davies G, Keeman JN. Preoperative localisation of the saphenopopliteal junction with duplex scanning. Eur J Vasc Surg Engelhorn1991;5:507-9.CA,Picheth FS, Castro Jr N et al. Estudo do sistema venoso superficial com o duplex scan a cores. Cir Vasc Angiol 1996;12:12s-4s. Evangelista SSM, Fonseca FP, Caldeira EL et al Recentes avanços em cirurgia de varizes tronculares primárias dos MMII: uma nova visão. Cir Vasc Angiol 1999; edição especial:10-5. Evangelista SSM, Fonseca FP, Sarquis AL. Métodos não-invasivos de diagnóstico na avaliação dos pacientes com varizes primárias dos membros inferiores [Abstract]. Cir Vasc Angiol 1993;9:33a. Fegan WG, Kline AL. The cause of varicosity in superficial veins of the lower limb. Br J Surg 1972;59:798-801. Fegan WG, Lambe R, Henry M. Steroid hormones and varicose veins. Lancet 1967;1:1070-1. Fegan WG. Continuous compression technique of injecting varicose veins. Lancet 1963;2:109-12. Fiebig A, Krusche P, Wolf A. Heritability of chronic venous disease. Hum Genet 2010; 127:669-74. Filis K, Kavantzas N, Isopoulos T et al. Increased vein wall apoptosis in varicose vein disease is related to venous hypertension. Eur J Vasc Endovasc Surg 2011;41:533-39. Fischer H. Socio-epidemiological study on distribution of venous disorders among a residential population. Int Angiol 1984;3:89-90. Folse R. The influence of femoral vein dynamics on the development of varicose veins. Surgery 1970;68:974-79. Fowkes FG, Evans CJ, Lee AJ. Prevalence and risk factors of chronic venous insufficiency. Angiology 2001;52:S5-15.
Francisco Jr J, Pitta GBB, Miranda Jr F et al. O uso da flebografia descendente no estudo da estase venosa crônica. Radiol Bras Franco1989;22:71-74.G.Écho-doppler couleur et exploration veineuse superficielle. Phlébologie 1994;47:63-75. Fried PH, Perilstein PK, Wagner FB. Saphenous Varicosities vs. Angiectids: Consideration of so-called varicose vein of the lower extremities complicating pregnancy. Obstet Gynecol 1953;2:418-26. Fuchs JCA, Mitchener JS, Hagen P. Postoperative changes in autologous vein grafts. Ann Surg 1978;188:1-15. Gandhi RH, Irizarry E, Nackman GB et al. Analysis of the connective tissue matrix and proteolytic activity of primary varicose veins. J Vasc Surg Garrido1993;18:814-20.M,Canongia PM, Fonseca Filho VL et al. Varizes dos membros inferiores. Rev Angiol Cir Vasc 1996;5:149-62. Garrido M. Varizes tronculares primárias dos membros inferiores (MMII): Considerações anatômicas. Cir Vasc Angiol 1996;12:5s-8s. Garrido MBM. Patologia e diagnóstico de varizes dos membros inferiores. In: Maffei FHA, ed. Doenças Vasculares Periféricas. Rio de Janeiro: Medsi; 1987. p. 618-9. Georgiev M. The preoperative duplex examination. Dermatol Surg Gius1998;24:433-40.JA.Arteriovenous anastomoses and varicose veins. Observations with the operation microscope. Arch Surg 1960;81:299-310. Gloviczki P, Comerota AJ, Dalsing MC et al. The care of patients with varicose veins and associated chronic venous diseases: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg 2011;53:2S-48S. Gloviczki P. Classification and reporting standards for venous disease. Mayo Clin Proc 1996;71:422-23. Goldman MP. Escleroterapia: tratamento das veias varicosas e telangiectasias dos membros inferiores. Rio de Janeiro: Interlivros; Goldman1998. MP. Sclerotherapy. Treatment of Varicose and Telangiectatic Leg Veins. Saint Louis: Mosby;1995. Goldman MP. Treatment of Varicose and Telangiectatic Leg Veins. Saint Louis: Mosby; 1995. Goodrich SM, Wood JE. Peripheral venous distensibility and velocity of venous blood flow during pregnancy or during oral contraceptive therapy. Am J Obstet Gynecol 1964;90:740-44. Guberan E, Widmer LK, Glaus L et al. Causative factors of varicose veins: myths and facts. An epidemiological study of 610 women. Vasa Guberan1973;2:115-20.E,Widmer LK, Glaus L et al. Gendre F. Causative factors of varicose veins: myths and facts. An epidemiological study of 610 women. International Angiology 1973;2:115-20. Guex JJ. Thrombotic complications of varicose veins. A literature review of the role of superficial venous thrombosis. Dermatol Surg Guimarães1996;22:378-82.PCM,Orlando JL, Molnar L et al. Estudo comparativo entre a flebografia descendente e o mapeamento dúplex na avaliação do refluxo venoso dos membros inferiores [Abstract] . Cir Vasc Angiol Gundersen1993;9:33a.J,Hauge M. Hereditary factors in venous insufficiency. Angiology 1969;20:346-55. Haardt B. Comparaison histochimique des profils enzymatiques de veines saines et de veines variqueuses. Phlébologie 1986;39:921-31. Haeger KH, Bergman L. Skin temperature of normal and varicose legs and some reflections on the etiology of varicose veins. Angiology Haimovici1963;14:473-79.H,Steinman C, Caplan LH. Role of arteriovenous anastomoses in vascular diseases of the lower extremity. Ann Surg Haimovici1966;164:990-1002.H.Abnormal arteriovenous shunts associated with chronic venous insufficiency. J Cardiovasc Surg 1976;17:473-82. Haimovici H. Arteriovenous shunting in varicose veins. Its diagnosis by Doppler ultrasound flow detector. J Vasc Surg 1985;2:684-91. Haimovici H. Role of precapillary arteriovenous shunting in the pathogenesis of varicose veins and its therapeutic implications. Surgery Hanrahan1987;101:515-22.LM,Araki CT, Rodriguez AA et al. Distribution of valvular incompetence in patients with venous stasis ulceration. J Vasc Surg Hauge1991;13:805-12.M,Gundersen J. Genetics of varicose veins of the lower extremities. Human Heredity 1969;19:573-80. Heyerdale WW, Anderson EM. Diagnosis and occurrence of communicating veins in treatment. Proc Staff Meet Mayo Clin 1942;17:221-2.
266 Parte VIIIMEMBROS INFERIORES
267Capítulo 138 vArizes de membros inferiores – ConCeitos
Lowell RC, Gloviczki P, Miller VM. In vitro evaluation of endothelial and smooth muscle function of primary varicose veins. J Vasc Surg Luccas1992;16:679-86.GC,Kauffman P, Lane JC. Método de avaliação do estado funcional da veia safena interna. Cir Vasc Angiol 1985;1:22-8. Luccas GC, Lane JC. Método de detecção de insuficiência da veia safena interna. Rev Paul Med 1984;102:277-8. Luccas GC, Nagase Y, Menezes FH et al. Cirurgia de varizes dos membros inferiores: Avaliação pré-operatória do sistema venoso com duplex [Abstract] . Cir Vasc Ang 1995;11:36a. Luccas GC, Nagase Y, Menezes FH et al. Cirurgia de varizes dos membros inferiores: Avaliação pré-operatória do sistema venoso com mapeamento dúplex. Cir Vasc Angiol 1996;12:15-20. Luccas GC, Nagase Y, Menezes FH et al. Fleboextração parcial proximal da veia safena interna no tratamento das varizes primárias dos membros inferiores. Cir Vasc Angiol 1993;9:6-10. Luccas GC, Parente JBHF, Nagase Y et al. Preservação da veia safena magna em cirurgia de varizes: Resultados tardios. Cir Vasc Angiol Ludbrook1995;11:15-8.J,Beale G. Femoral venous valves in relation to varicose veins. Lancet Ludbrook1962;1:79-81.J.Obesityand varicose veins. Surg Gynecol Obstet 1964;4. Ludbrook J. Valvular defect in primary varicose veins: cause or effect? Lancet 1962;2:1289-92. Maffei FHA, Magaldi C, Pinho SZ et al. Varicose veins and chronic venous insufficiency in Brazil: prevalence among 1755 inhabitants of a country town. Int J Epidemiol 1986;15:210-17. Magnusson M, Kälebo P, Lukes P et al. Colour doppler ultrasound in diagnosing venous insufficiency: A comparison to descending phlebography. Eur J Vasc Surg 1995;9:437-43. Mahorner HR, Ochsner A. A new test for evaluating circulation in the venous system of the lower extremity affected by varicosities. Arch Surg Malhotra1936;33:479-92.S.L.Anepidemiological study of varicose veins in Indian railroad workers from the south and north of India, with special reference to the causation and prevention of varicose veins. Int J Epidemiol Marmasse1972;1:177-83.J.Critique de la notion d’hérédité variqueuse. Phlébologie Marston1967;20:267-8.WA.Evaluation of varicose veins: what do the clinical signs and symptoms reveal about the underlying disease and need for intervention? Semin Vasc Surg 2010;23:78-84. Masuda EM, Kistner R. Prospective comparison of duplex scanning and descending venography in the assessment of venous insufficiency. Am J Surg Matousek1992;164:254-9.V,PrerovskyI. A contribution to the problem of inheritance of primary varicose veins. Human Heredity 1974;24:225-35. Mayall RC, Naveira J. Varizes: Estudo estatístico. Vida Médica 1957;24:5-8. Mayall RC. Reavaliação da patologia varicosa. Clin Geral 1975;9:27-48. McCausland AM, Holmes F, Trotter AD. Venous distensibility during the menstrual cycle. Am J Obstet Gynecol 1963;86:640-5. McCausland AM, Hyman C, Winsor T et al. Venous distensibility during pregnancy. Am J Obstet Gynecol 1961;81:472-9. McEwan AJ, McArdle CS. Effect of hydroxyethlrutosides on blood oxygen levels and venous insufficiency symptoms in varicose veins. Brit Med J McLennan1971;138-41.CE.Antecubital and femoral venous pressures in normal and toxemic pregnancy. Am J Obstet Gynecol 1943;45:74. McMullin GM, Coleridge Smith PD. An evaluation of doppler ultrasound and photoplethysmography in the investigation of venous insufficiency. Aust N Z J Surg 1992;62:270-5. McMullin GM, Coleridge Smith, Scurr JH. A study of tourniquets in the investigation of venous insufficiency. Phlebology 1991;6:133-9. McPheeters HO. The value of estrogen therapy in the treatment of varicose veins complicating pregnancy. Lancet 1949;69:2-4. Medeiros A, Pinto-Ribeiro A. Varizes essenciais. Angiopatias Meissner1964;4:134-61.MH,Gloviczki P, Bergan J et al. Primary chronic venous disorders. J Vasc Surg 2007;46:54S-67S. Mekky S, Schilling RSF, Walford J. Varicose veins in women cotton workers. An epidemiological study in England and Egypt. Br Med J Melet1969;2:591-5.JJ.Laplace de l’alimentation parmi les facteurs de risque des maladies veineuses. Phlébologie 1981;34:469-88. Mellière D. Le traitement personnalisé des varices en fonction de la clinique, de l’échodoppler et de la necessité de preserver les veines grandes saphènes chaque fois que possible. Cir Vasc Angiol 1996;12:15s-8s.
Hirai M, Naiki K, Nakeyama R. Prevalence and risk factors of varicose veins in japanese women. Angiology 1990;3:228-32. Hoare MC, Nicolaides AN, Miles CR et al. The role of primary varicose veins in venous ulceration. Surgery 1982;92:450-3. Homans J. The operative treatment of varicose veins and ulcers based upon a classification of these lesions. Surg Gynecol Obstet Howell1916;22:143-58.RG,BurtonJL. Decreased fertility in men with venous stasis of the legs. Lancet 1982;18:630-631 Hu MH, Wu KW, Jian YM et al. Vascular compression syndrome of sciatic nerve caused by gluteal varicosities. Ann Vasc Surg 2010;24:1134.e1-4. Ikard RW, Ueland K, Folse R. Lower limb venous dynamics in pregnant women. Surg Gynecol Obstet 1971;132:483-8. Isaacs MN. Symptomatology of vein disease. Dermatol Surg Jawien1995;21:321-3.A.Theinfluence of environmental factors in chronic venous insufficiency. Angiology 2003;54:S19-31. Jeanneret C, Baldi T, Hailemariam S et al. Selective loss of extracellular matrix proteins is linked to biophysical properties of varicose veins assessed by ultrasonography. Br J Surg 2007;94:449-56. Kanter A, Gardner M, Isaacs M. Identification of arteriovenous anastomoses by duplex ultrasound. Dermatol Surg 1995;21:885-89. Kanter AH. The effect of sclerotherapy on restless legs syndrome. Dermatol Surg 1995;21:328-32. Katsomouris AN, Kardoulas DG, Gourtsoyiannis N. The nature of lower extremity venous insufficiency in patients with primary varicose veins. Eur J Vasc Surg 1994;8:464-71. Kendler M, Blendinger Ch, Haas E. Elevated serum estradiol/testosterone ratio in men with primary varicose veins compared with a healthy control group. Angiology 2009 Jun-Jul;60(3):283-9. Kendler M, Kratzsch J, Wetzig T, Simon JC. Sex steroid hormones are not altered in great saphenous veins after varicose vein treatment in male patients. Phlebology 2014 Jun;29(5):310-7. Kendler M, Makrantonaki E, Tzellos T, Kratzsch J, Anderegg U, Wetzig T et al. Elevated sex steroid hormones in great saphenous veins in men. J Vasc Surg 2010 Mar;51(3):639-46. Erratum in: J Vasc Surg. 2010 Aug;52(2):538. Tzellos, Thrasivoulos [added]. Kerr MG, Scott DB, Samuel E. Studies of the inferior vena cava in late pregnancy. Br Med J 1964;1:532-3. Khan AF, Chaudhri R, Ashraf MA, Mazaffar MS, Zawar-ul-Imam S, Tanveer M. Prevalence and presentation of chronic venous disease in Pakistan: a multicentre study. Phlebology 2013 Mar;28(2):74-9. King ESJ. The genesis of varicose veins. Aust NZ J Surg 1950;20:126-33. Kirsch D, Dienes HP, Küchle R. Changes in the extracellular matrix of the vein wall--the cause of primary varicosis? Vasa 2000;29:173-77. Kirsch D, Wahl W, Böttger T. Primary varicose veins-changes in the venous wall and elastic behavior. Chirurg 2000;71:300-305. Kistner RL, Ferris EB, Randhawa G et al. A method of performing descending venography. J Vasc Surg 1986;4:464-8. Kitslaar PJEHM, Rutgers PH. Varicose veins and the vascular surgeon: from nuisance 8o challenge. Eur J Vasc Surg 1993;7:109-12. Kowalewski R, Sobolewski K, Wolanska M et al. Matrix metalloproteinases in the vein wall. Int Angiol 2004;23:164-69. Kühnl A, Söllner H, Eckstein HH. Epidemiology and inpatient treatment of vascular diseases in Germany: English Version. Gefasschirurgie 2016;21:14-23. Epub 2015 Oct 23. Labropoulos N, Kang SS, Mansour MA. Primary superficial vein reflux with competent saphenous trunk. Eur J Vasc Endovasc Surg Labropoulos1999;18:201-06.N,Leon L, Kwon S. Study of the venous reflux progression. J Vasc Surg 2005;41:291-295. Labropoulos N, Touloupakis E, Giannoukas AD et al. Recurrent varicose veins: Investigation of the pattern and extent of reflux with color flow duplex scanning. Surgery 1996;119:406-9. Laing W. Chronic Venous Diseases of the Leg. UK: Office of Health Economics; 1992. p.1-44. Lake M, Pratt GH, Wright IS. Arteriosclerosis and varicose veins: occupational activities and other factors. JAMA 1942;119:696-701. Lane JC. O ultra-som no exame do sistema venoso profundo. Rev Paul Med Leu1974;84:128-30.HJ.Héréditéde la varicose: Relations entre le poids corporel et la varicose et rapports entre le poids corporel, la varicose et la gonarthrose. Phlébologie 1967;20:235-9. Licalzi LK, Stansel HC. Failure of autogenous reversed saphenous vein femoropopliteal grafting: Pathophysiology and prevention. Surgery Lim1982;91:352-58.CS,DaviesAH.Pathogenesis of primary varicose veins. Br J Surg 2009;96:1231-42.
268 Parte VIIIMEMBROS INFERIORES
Mellor RH, Brice G, Stanton AW et al. Mutations in FOXC2 are strongly associated with primary valve failure in veins of the lower limb. Circulation 2007;115:1912-20. Menezes RE, Sales EA. Estudo da pressão venosa dos membros inferiores através do Doppler ultra-som. Cir Vasc Angiol 1989;5:17-9. Moneta GL, Bedford G, Beach K et al. Duplex ultrasound assessment of venous diameters, peak velocities, and flow patterns. J Vasc Surg Monteiro1998;8:286-91.daSilva AJ, Vieira de Mello A, Bernardini E et al. Varizes essenciais dos membros inferiores. Ars Curandi 1983;16:87-106. Morais Filho D, Palma O, Silvestre JMS et al. Contribuição do exame nãoinvasivo (dupplex-ultrassom) ao diagnóstico pré-operatório das varizes primárias [Abstract] . Cir Vasc Ang 1995;11:36a. Moreira RCR, Miayamoto M, El-Hosni Jr. RA et al. O papel da fleboscopia por transiluminação no planejamento de cirurgias estéticas de varizes. J Vasc Bras 2009;8:313-17. Mullane DJ. Varicose veins of pregnancy. Am J Obstet Gynecol Mungioli1952;63:621-6.LE,Nunes P. Varizes dos membros pélvicos e as doenças profissionais. Rev Bras Cardiovasc 1966;2:249-54. Murphy MA, Hands L. Is arteriovenous shunting involved in the development of varicosities? A study of the intraluminal pressure and oxygen content in varicose veins. Phlebology 2008;23:137-41. Nabatoff RA. Simple palpation to detect valvular incompetence in patients with varicose veins. JAMA 1955;159:27-8. Nabatoff RA. Varicose veins of pregnancy. JAMA 1960;174:1712-6. Naoum JJ, Hunter GC, Woodside KJ et al. Current advances in the pathogenesis of varicose veins. J Surg Res 2007;141:311-16. Neglen P, Raju S. A comparison between descending phlebography and duplex doppler investigation in the evaluation of reflux in chronic venous insufficiency: A challenge to phlebography as the “gold standard”. J Vasc Surg 1992;16:687-93. Nicholson BB. Varicose vein. Etiology and treatment; a clinical and histologic study. Arch Surg 1927;15:351-72. Nicolaides A, Hoare M, Miles C et al. The value of ambulatory venous pressure in the assessment of venous insufficiency. Vasc Diag Ther Nicolaides1981;3:41-5.AN,Renton SC. Duplex scanning: The second sight of the vascular surgeon. Eur J Vasc Surg 1990;4:445-7. Nicolaides AN. Chronic venous disease and the leukocyte-endothelium interaction: from symptoms to ulceration. Angiology 2005;56:S11-19. Norris CS, Beyrau A, Barnes RW. Quantitative photoplethysmography in chronic venous insufficiency: A new method of noninvasive estimation of ambulatory venous pressure. Surgery 1983;94:758-64. Nylander G. Haemodynamics of the pelvic veins in incompetence of the femoral vein. Acta Radiol 1961;56:369-76. Oklu R, Habito R, Mayr M. Pathogenesis of varicose veins. J Vasc Interv Radiol 2012;23:33-39. Ono T, Bergan JJ, Schmid-Schönbein GW et al. Monocyte infiltration into venous valves. J Vasc Surg 1998;27:158-66. Ottley C. Heredity and varicose veins. Br Med J 1934;1:528. Özcan S, Tezcan O, Kurt T, Türköne H, Karahan O, Çalişkan AT et al. Serum estradiol/free testosterone ratio can be important predictor for varicose vein recurrence in men. Int Angiol 2015 Dec;34(6):576-81. Paiva HD, Varela CM, Bonamigo TP. Varizes dos membros inferiores. Pesquisa Médica 1973;9:459-73. Pascarella L, Schmid-Schönbein GW, Bergan JJ. An animal model of venous hypertension: the role of inflammation in venous valve failure. J Vasc Surg Peixoto2005;41:303-11.LHWP,BragaPEG, Zorn WGW et al. Estase venosa e gravidez: Um estudo prospectivo fotopletismográfico. Cir Vasc Ang 1990;6:15-9. Perthes G. Ueber die Operation der Unterschenkelvaricen nach Trendelenburg. Deutsch Med Wchnsch 1895;21:253-7. Pinto-Ribeiro A. Painel de angiologia. Sintomatologia da doença varicosa. Med de Hoje 1979;51:697-99. Pinto-Ribeiro A. Varizes dos membros inferiores. In: Maffei FHA. Doenças Vasculares Periféricas. Rio de Janeiro: MEDSI; 1987. p. 583-92. Pinto-Ribeiro A. Varizes essenciais: Considerações sobre 5.000 casos. Rev Bras Clin Terap 1977;6:117-26. Pinto-Ribeiro A. Varizes essenciais: Incidência familiar em 10.000 varicosos. F Méd 1980;80:651-4. Pistorius MA. Chronic venous insufficiency: the genetic influence. Angiology 2003;54:S5-12. Pittaluga P, Chastanet S, Rea B et al. Classification of saphenous refluxes: implications for treatment. Phlebology 2008;23:2-9. Piulachs P, Vidal-Barraquer F. Pathogenic study of varicose veins. Angiology 1953;4:59-100. Potério-Filho J, Silveira SA, Potério GM, Fecuri RJ, de Almeida FH, Menezes FHM. The effect of walking with high-heeled shoes on the leg venous pressure. Angiology 2006 Aug-Sep;57(4):424-30. Powell CC, Roher MJ, Barnard MR et al. Chronic venous insufficiency is associatedwith increased platelet and monocyte activation and aggregation. J Vasc Surg 1999;30:844-51. Powell T, Lynn RB. The valves of the external iliac, femoral, and upper third of the popliteal veins. Surg Gynecol Obstet 1951;92:453-55. Pratt GH. Arterial varices. A syndrome. Am J Surg 1949;77:456-66. Pratt GH. Test for incompetent communicating branches in the surgical treatment of varicose veins. JAMA 1941;17:100-1. Psaila JV, Melhuish J. Viscoelastic properties and collagen content of the long saphenous vein in normal and varicose veins. Br J Surg Puech1989;76:37-40.LeãoLE,Almeida CG. Um método para a obtenção de flebogramas dos membros inferiores: Sua aplicação ao estudo das seqüelas pósflebíticas. Rev Med Cir S Paulo 1951;11:51-7. Puech Leão LE, Toledo OM, Moraes IN et al. Cirurgia radical das varizes dos membros inferiores. Rev Paul Med 1958;53:303-12. Puech-Leão LE. A fisiopatologia da síndrome pós-flebítica vista através da flebografia dinâmica. Rev Paul Med 1958;52:111-20. Puech-Leão LE. Varizes essenciais e pós-trombóticas dos membros inferiores. Rev Paul Med 1956;48:409-10. Quill RD, Fegan WG. Reversibility of femorosaphenous reflux. Brit J Surg Raffetto1971;55:389-95.JD,KhalilRA. Mechanisms of varicose vein formation: valve dysfunction and wall dilation. Phlebology 2008;23:85-98. Reagan B, Folse R. Lower limb venous dynamics in normal persons and children of patients with varicose veins. Surg Gynecol Obstet Ristow1971;132:14-18.AVB,Arruda AM, Albuquerque JT et al. Varizes primárias: Dez anos de experiência com o tratamento cirúrgico. Rev Ass Med Brasil Ristow1979;25:216-18.AVB.ODoppler ultra-som na propedêutica da estase venosa dos membros. Folha Med 1983;86:119-23. Rizzo JL, Baker LA, Boyajian RA et al. Accuracy of B-mode ultrasound vein mapping for vessel size. J Vasc Technol 1993;17:287-9. Rollo HA, Lastória S, Yoshida WB et al. Cirurgia de varizes com preservação da veia safena magna: Avaliação pré e pós-operatória pelo mapeamento dúplex. Resultados preliminares. Cir Vasc Angiol Rose1996;12:63s-8s.SS,AhmedA. Some thoughts on the aetiology of varicose veins. J Cardiovasc Surg 1986; 27:534-43. Sadick NS. Predisposing factors of varicose and telangiectatic leg veins. J Dermatol Surg Oncol 1992;18:6. Saharay M, Shields DA, Porter JB et al. Leukocyte activity in the microcirculation of the leg in patients with chronic venous disease. J Vasc Surg 1997;26:265-73. Salaman RA, Fligelstone LJ, Wright IA et al. Hand-held bi-directional doppler versus colour duplex scanning in the pre-operative assessment of varicose veins. J Vasc Invest 1995;1:183-6. Sandström B, Bjerle P. Calf blood flow and venous capacity during late pregnancy in women with varices. Acta Obstet Gynec Scand Sansilvestri-Morel1974;53:355-8. P, Rupin A, Badier-Commander C. Chronic venous insufficiency: dysregulation of collagen synthesis. Angiology Sansilvestri-Morel2012;54:S13-8. P, Rupin A, Jaisson S. Synthesis of collagen is dysregulated in cultured fibroblasts derived from skin of subjects with varicose veins as it is in venous smooth muscle cells. Circulation Sansilvestri-Morel2002;106:479-83.P, Rupin A, Jullien ND. Decreased production of collagen Type III in cultured smooth muscle cells from varicose vein patients is due to a degradation by MMPs: possible implication of MMP-3. J Vasc Res 2005;42:388-98. Sarquis AL. Avaliação pré e pós-operatório no tratamento cirúrgico conservador de varizes tronculares com o duplex scan a cores. Cir Vasc Angiol 1996;12:9s-11s. Schalin L. Arteriovenous communications in varicose veins localized by thermography and identified by operative microscopy. Acta Chir Scand Schina1981;147:409-20.MJ,Neumyer MM, Healy DA et al. Influence of age on venous physiologic parameters. J Vasc Surg 1993;18:749-52. Schultheiss R, Billeter M, Bollinger A et al. Comparison between clinical examination, cw-doppler ultrasound and colour-duplex sonography in the diagnosis of incompetent perforating veins. Eur J Vasc Endovasc Surg 1997;13:122-6.
269Capítulo 138 vArizes de membros inferiores – ConCeitos
Serra R, Gallelli L, Butrico L, Buffone G, Caliò FG, De Caridi G et al. From varices to venous ulceration: the story of chronic venous disease described by metalloproteinases. Int Wound J 2017 Feb;14(1):233-40. Silveira PRM. Estudo estrutural da veia safena magna normal e varicosa 1992. São Paulo, Tese (Doutoramento à Escola Paulista de Medicina). Ref Type: Thesis/Dissertation. Silvestre JMS. A flebografia nas recidivas em pacientes submetidos a tratamento cirúrgico de varizes tronculares primárias dos membros inferiores. Cir Vasc Angiol 1996;12:40s-3s. Simovart HE, Arend A, Lieberg J et al. Associations of NF-kappaB and bax with apoptosis in varicose veins of women of different age groups. Int J Vasc Med 2011; Epub 2011 Nov 1. Skudder PA, Farrington DT, Weld E et al. Venous dysfunction of late pregnancy persists after delivery. J Cardiovasc Surg 1990;31:748-52. Smith JJ, Garratt AM, Guest M et al. Evaluating and imporving healthrelated quality of live in patients with varicose veins. Phlebology Stanhope1999;30:710-9.JM.Varicose veins in a population of Lowland New Guinea. Int J Epidemiol 1975;4:221-5. Steiner CA, Palmer LH. A simplification of the diagnosis of varicose veins. Ann Surg Struckmann1948;127:362-71.JR,MeilandH,Bagi P et al. Venous muscle pump function during pregnancy. Acta Obstet Gynecol Scand 1990;69:209-15. Summers JE. Highlights in the treatment of varicose veins and ulcers. Am J Surg Sumner1953;87:443-65.DS.Hemodynamics and pathophysiology of venous disease. In: Rutherford RB, ed. Vascular Surgery. Philadelphia: W.B. Saunders Company; 1995. p. 1673-95. Sumner DS. Venous dynamics – varicosities. Clin Obstet Gynecol Svejcar1981;24:743-61.J,Prerovsky I, Lihhart J et al. Content of collagen, elastin, and hexosamine in primary varicose veins. Clin Sci 1963;24:325-30. Szilagyi DE, Elliott JP, Hageman JH et al. Biologic fate of autogenous vein implants as arterial substitutes: Clinical, Angiographic and Histopathologic observations in femoro-popliteal operations for atherosclerosis. Ann Surg 1973;178:232-46. Takase S, Schmid-Schönbein GW, Bergan JJ. Leukocyte activation in patients with venous insufficiency. J Vasc Surg 1999;30:148-56. Tanyol H, Menduke H. Alcohol as a possible etiologic agent in varicose veins. A study of drinking habits in 136 patients with varicose veins and in 70 control patients. Angiology 1961;12:382-4. Tedeschi Filho W1, Dezzotti NR, Joviliano EE, Moriya T, Piccinato CE. Influence of high-heeled shoes on venous function in young women. J Vasc Surg 2012 Oct;56(4):1039-44. Thibaultp, Bray A, Wlodarczyk J et al. Cosmetic leg veins: evaluation using duplex venous imaging. J Dermatol Surg Oncol 1990;16:612-18. Thomaz JB. Varizes e telangiectasias: possíveis fatores etiológicos ou predisponentes. Ars Cvrandi 1978;11:42-8. Timi JRR, Tomitan E, Bley A et al. Incidência de varizes na gestação [Abstract] . Cir Vasc Angiol 1995;11:22a. Toledo OM, Bueno Neto J, Puech Leão LE et al. Atualização do tratamento das varizes dos membros inferiores. Seara Med 1955;10:111-9. Toledo OM. A prova de Trendelenburg na propedêutica das varizes. Rev Hosp Clin Fac Med S Paulo 1953;8:155-73. Toledo OM. Evolução e estado atual do tratamento das varizes dos membros inferiores. Rev Paul Med 1954;45:283-89.
Toledo OM. Tratamento cirúrgico das varizes dos membros inferiores. Rev Med Cir S Paulo 1953;13:17-66. Tournay R. “Ne fait pas de varices qui veut” . Phlébologie 1967;20:205-11. Trendelenburg F. Ueber die Unterbindung der Vena Saphena Magna bei Unterschenkelvaricen. Beitr Z Klin Chir 1891;7:195-211. Tretbar LL. Treatment of small bleeding varicose veins with injection sclerotherapy. Bleeding blue blebs. Dermatol Surg 1996;22:78-80. Troisier J, Bayon LE. Étude génétique des varices. Ann Médecine 1937; Van41:30-41.Bemmelen PS, Bedford G, Beach K et al. Quantitative segmental evaluation of venous valvular reflux with duplex ultrasound scanning. J Vasc Surg 1989;10:425-31. Van Bemmelen PS, Van Ramshorst B, Eikelboom BC. Photoplethysmography reexamined: Lack of correlation with duplex scanning. Surgery 1992;112:544-8. van den Bremer J, Moll FL. Historical overview of varicose vein surgery. Ann Vasc Surg 2010;24:426-32. Vasdekis SN, Clarke GH, Hobbs JT et al. Evaluation of non-invasive and invasive methods in the assessment of short saphenous vein termination. Br J Surg 1989;76:929-32. Vasdekis SN, Clarke GH, Nicolaides AN. Quantification of venous reflux by means of duplex scanning. J Vasc Surg 1989;10:670-7. Vin F, Allaert FA, Levardon M. Influence of estrogens and progesterone on the venous system of the lower limbs in women. J Dermatol Surg Oncol Vincent1992;18:888-92.JR,JonesGT, Hill GB, van Rij AM. Failure of microvenous valves in small superficial veins is a key to the skin changes of venous insufficiency. J Vasc Surg 2011;54(6 Suppl):62S-9S.e1-3. Waibel P. Operative treatment of varicose veins. Prog Surg 1973;11:1-36. Watts GT. Varicose veins are caused by defective valves in the veins. Lancet Weingarten1986;2:31-2.MS,Czeredarczuk M, Scovell S et al. A correlation of air plethysmography and color-flow-assisted duplex scanning in the quantification of chronic venous insufficiency. J Vasc Surg Welkie1996;24:750-4.JF,Comerota AJ, Kerr RP et al. The hemodynamics of venous ulceration. Ann Vasc Surg 1992;6:1-4. Welkie JF, Kerr RP, Katz ML et al. Can noninvasive venous volume determinations accurately predict ambulatory venous pressure? J Vasc Technology 1991;15:186-90. Wesener G. Les varices, maladie héréditaire. Phlébologie 1967; 20:255-65. Wright DJ, Shepard AD, McPharlin M et al. Pitfalls in lower extremity venous duplex scanning. J Vasc Surg 1990;11:675-9. Wright HP, Osborn SB, Edmonds DG. Changes in the rate of flow of venous blood in the leg during pregnancy, measured with radioactive sodium. Surg Gynecol Obstet 1950;90:481-4. Yetkin E, Ileri M. Dilating venous disease: Pathophysiology and a systematic aspect to different vascular territories. Med Hypotheses 2016 ZimmetJun;91:73-76.SE.Venous leg ulcers: Modern evaluation and management. Dermatol Surg 1999;25:236-41. Zorn WGW, Van Bellen B, Godoy IB. Estudo da junção safeno-femural pelo Doppler-ultrassom [Abstract] . Rev Argent Angiol 1973;12:45a. Zsotér T, Cronin RFP. Venous distensibility in patients with varicose veins. Can Med Assoc J 1966;4:1293-97. Zsotér T, Moore S, Keon W. Venous distensibility in patients with varicosities: in vitro studies. J Applied Physiol 1967;22:505-08.
10. Tsukanov YT, Nikolainchuk AI. Orthotatic-loading-induced transient venous refluxes (day orthostatic loading test), and remedial effect of micronized purified flavonoid fraction in patients with telangiectasia and reticular vein. Int Angiol 2017;36(2):189-96.
16. Laurent R, Gilly R, Frileux C. Clinical evaluation of a venotropic drug in man. Int Angiol 1988;7:39-43.
8. Gloviczki P, Comerota AJ, Dalsing MC et al. The cares of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg 2011;53:2S-64S. 9. Bush R, Comerota A, Meissner M et al. Recomendations for the medical management of chronic venous desease: The role of Micronized Purified Flavnoid Fraction (MPFF). Phlebology 2017;32(Suppl 1):3s-19s.
28. Weiss RA, Weiss MA. Resolution of pain associated with varicose and telangiectatic leg veins after compression sclerotherapy. J Dermatol Surg Oncol 1990;16:333-36. 29. Kauvar AN. The role of lasers in the treatment of leg veins. Semin Cutan Med Surg 2000;19:245-52. 30. Norris MJ, Carlin MC, Ratz JL. Treatment of essential telangiectasia, effects of increasing concentrations of polidocanol. J Am Acad Dermatol 1989;20:643-49. 31. Puissegur Lupo ML. Sclerotherapy, review of results and complications in 200 patients. J Dermatol Surg Oncol 1989;15:214-19. 32. Coleridge Smith PD. The management of chronic venous disorders of the leg, an evidence-based report of an international task force. Phlebology 1999;(Suppl 1):66-105. 33. Villavicencio JL, Lohr J, Pfeifer JR et al. Getting a leg up on varicose veins treatment choices. Ad Hoc Committee on Sclerotherapy. The American Venous Forum. Federal Trade Comission brochure; 1999. 34. Wiek K, Vanscheidt W, Ishkhanian S et al. Selective photothermolysis of superficial varicose veins telangiectasias of the lower extremity. Hautarzt 1996;47:258-63. 35. Imhoff E, Stemmer R. Classification and mechanism of action of sclerosing agents. Phlebologie 1969;22:145-48. 36. Carlin MC, Ratz JL. Treatment of telangiectasia, comparison of sclerosing agents. J Dermatol Surg Oncol 1987;13:1181-84. 37. Pinto-Ribeiro A. Escleroterapia de varizes. In: Maffei FHA. (Ed.). Doenças vasculares periféricas. Rio de Janeiro: Medsi; 1987. p. 636-47. 38. Pinto-Ribeiro A. Varizes, cirurgia ou escleroterapia, eis a questão. Rev Bras Cardiovasc 1977;12:133. 39. Puech-Leão LE. Bases racionais para o tratamento das varizes dos membros inferiores. Med Cirur Farmácia 1945;105:42-48. 40. Medeiros A, Pinto-Ribeiro A. Tratamento esclerosante das varizes essenciais. Folha Médica 1966;52:537-44. 41. Tollins SH. Treatment of varicose veins, an update. Am J Surg 1983;145:248-52. 42. Baccaglini U, Spreafico G, Castoro C et al. Sclerotherapy of varicose veins of the lower limbs. Consensus paper. Dermatol Surg 1996;22:883-89. 43. Galland RB, Magee TR, Lewis MH. A survey of current attitudes of british and irish vascular surgeons to venous sclerotherapy. Eur J Vasc Endovasc Surg 1998;16:43-46. 44. Martino Neumann HA. Commentary - The Australian polidocanol (aethoxysklerol) study. Results at 2 years. Dermatol Surg 1995;21:337-38. 45. Conrad P, Malouf MB, Stacey DS. The Australian polidocanol (aethoxysklerol) study. Results at 2 years. Dermatol Surg 1995;21:334-36. 46. Weiss MA, Weiss RA. Sclerotherapy in the US. Past, present, future. Dermatol Surg 1995;21:393-65.
2. Reporting standards in venous disease. Prepared by the Subcommittee on Reporting Standards in Venous Disease, Ad Hoc Committee on Reporting Standards, Society for Vascular Surgery/ North American Chapter, International Society for Cardiovascular Surgery. J Vasc Surg 1988 Aug;8(2):172-81.
15. Guilhou JJ, Dereure O, Marzin L et al. Efficacy of Daflon 500 mg in venous leg ulcer healing, a double-blind, randomized, controlled vesus placebo trial in 107 patients. Angiology 1997;48:77-85.
1. Goldman MP. (Ed.) Sclerotherapy. Treatment of varicose and telangiectatic leg veins. Saint Louis: Mosby; 1995.
6. Batista WC, Matsudo VKR. Patologia venosa periférica e atividades físico-desportivas, uma revisão da literatura. Cir Vasc Ang 1987;3:9-14.76. 7. Monteiro da Silva, AJ, Vieira de Mello A, Bernardini E et al. Varizes essenciais dos membros inferiores. Ars Curandi 1983;16:87-106.
21. Venocur triplex. Experiência clínica e laboratorial. Uma revisão. Monografia Knoll, 1-17. 22. Pinto-Ribeiro A, Medeiros A. Sobre a efetividade dos chamados medicamentos flebotrópicos. Angiopatias 1970;10:161-67.
25. Dissemond J, Storck M, Kroger K et al. Indikationen und Kontraindikationen der modernen Kompressionstherapie. Wien Med Wochenschr. Published online 20 oct 2017. 26. Bachoo P. Interventions for uncomplicated varicose veins. Phlebology 2009;24:3-12. 27. Luccas GC, Menezes FH, Lane JC. Bota de tecido e velcro para tratamento de úlcera de estase venosa. Comparação entre curativo simples e curativo hidroativo. Cir Vasc Angiol 1996;12:53-56.
5. Brito CJ, Duarte Jr WP, Fernandes DC. Varizes dos membros inferiores. Ars Curandi 1974;7:4.
12. Degni M, Kardosh CB, Bolanho E. Estudo de 67 pacientes com síndrome pós-flebítica e flebite mural crônica tratados com aminaftone. Rev Bras Méd 1984;41:174-80.
13. Atenas JG. The efficacy of aminaphtone in patients suffering from chronic venous insufficiency. Ann Exp Clin Med 1995;2:81-85.
3. Beebe HG, Bergan JJ, Bergqvist D et al. Classification and grading of chronic venous disease in the lower limbs. A consensus statement: February 22-26, 1994, Maui, Hawaii. Dermatol Surg 1995;21:642-46.
4. Vasquez MA, Rabe E, McLafferty RB et al. Revision of the venous clinical severity score: Venous outcomes consensus statement: special communication of the American Venous Forum Ad Hoc Outcomes Working Group. J Vasc Surg 2010;52:1387-96.
17. Mayall RC, Mayall ACDG, Jannuzzi JCM et al. Aminaftone na síndrome pós-flebítica. Rev Bras Med 1984;41:118-24.
23. Rohan CP-Y, Badel P, Lun B et al. Biomechanic response of varicose veins to elastic compression: A numerical study. J Biomechan 2013;46:599-603. 24. De Carvalho MR, De Andrade IS, De Abreu AM et al. All about compression: A literature review. J Vasc Nurs 2016;34(2):47-53.
11. Eberhardt RT, Raffetto JD. Chronic venous insufficiency. Contemporary Reviews in Cardiovascular Medicine 2014;130:330-46.
18. Muraco B, Miyake H, Kauffman P et al. Terapêutica sintomática das varizes dos membros inferiores - Uso do medicamento CIBA21´401-Ba. Folha Médica 1969;59:123-31. 19. Ristow AVB, Hastenreiter CN, Ristow AVB et al. O emprego da diosmina na insuficiências venosa crônica. Folha Médica 1981;82:575-79. 20. Salviano PA. Atualização bibliográfica de associação medicamentosa flebotrópica utilizada no tratamento das varizes e hemorróidas. Rev Bras Méd 1993;50:692-95.
14. Blume J, Langnbahn H, Champvallins M. Quantification of edema using the volumeter technique, therapeutic application of Daflon 500 mg in chronic venous insufficiency. Phlebology 1992;7:37-40.
270 139Capítulo VARIZES DE MEMBROS INFERIORES – TRATAMENTO REFERÊNCIAS BIBLIOGRÁFICAS
47. Boné C. Tratamiento endoluminal de las varices com laser diodo. Estudio preliminar. Rev Patol Vasc Clin Exp Ophthalmol 1999;5:35-46.
63. Tretbar LL. Treatment of small bleeding varicose veins with injection sclerotherapy. Bleeding blue blebs. Dermatol Surg 1996;22:78-80. 64. Ninia JG. Treatment of vulvar varicosities by injection-compression sclerotherapy. Dermatol Surg 1997;23:573-75.
70. Rutgers PH, Kistlaar PJEHM. Randomized trial of stripping versus high ligation combined with scleroterapy in the treatment of the incompetent greater saphenous vein. Am J Surg 1994;168:311-15.
48. Navarro L, Min RJ, Boné C. Endovenous laser a new minimally invasive method of treatment for varicose veins - preliminary observations using an 810 nm Diode laser. Dermatol Surg 2001;27:117-22.
67. van der Velden SK, Biemans AA, De Maeseneer MG et al. Fiveyear results of a randomized clinical trial of conventional surgery, endovenous laaser ablation and ultrasound-guided foam sclerotherapy in patients with great saphenous varicose veins. Br J Surg 2015 Sep;102 (10):1184-94.
65. Liu X, Jia X, Guo W, Xiong J, Zhang H, Liu M et al. Ultrasound-guided foam sclerotherapy of the great sapenhous vein with saphenofemoral ligation compared to standard stripping: a prospective clinical study. Int Angiol 2011 Aug;30(4):321-6.
51. Barrett JM, Allen B, Ockelford A et al. Microfoam ultrasoundguided sclerotherapy of varicose veins in 100 legs. Dermatol Surg 2004;30:6-12.
57. Milleret R, Lepivert P. Cryosclérose des troncs saphéniens dans le reflux variqueux de l´obèse et du vieillard. Phlébologie 1981;34:601-5. 58. Min RJ, Navarro L. Transcatheter duplex ultrasound-guided sclerotherapy for treatment of saphenous vein reflux preliminary report. Dermatol Surg 2000;26:410-14. 59. Vin F, Chleir F, Allaert FA. An ambulatory treatment of varicose veins associating surgical section and sclerotherapy of large saphenous veins (3s technique). Preliminary study with results at one year. Dermatol Surg 1996;22:65-70. 60. Weiss RA, Sadick NS, Goldman MP et al. Post-sclerotherapy compression controlled study of duration of compression and its effects on clinical outcome. Dermatol Surg 1999;25:105-8.
66. Rasmussen L, Lawaetz M, Serup J et al. Randomized clinical trial comparing endovenous laser ablation, radiofrequency ablation, foram sclerotherapy, and surgical stripping for great saphenous varicose veins with 3-year floolw-up. J Vasc_Surg Venous Lymphat Disord 2013 Oct;1(4):349-56.
62. Wright DD, Gibson KD, Barclay J et al. High prevalence of rightto-left shunt in patients with symptomatic great saphenous incompetence and varicose veins. J Vasc Surg 2010;51:104-7.
55. Bergan JJ, Pascarella L, Mekenas L. Venous disorders treatment with sclerosant foam. J Cardiovasc Surg (Torino) 2006;47:9-18.
56. Cornu-Thenard A, Cottreau H, Weiss RA. Sclerotherapy. Continous wave Doppler-guided injections. Dermatol Surg 1995;21:867-70.
72. Mayo CH. The surgical treatment of varicose veins. St Paul Med J 1904;6:695-99. 73. Keller WL. A new method of extirpating the internal saphenous and similar veins in varicose conditions a preliminary report. NY Med J 1905;82:385-86. 74. Babcock WW. A new operation for the extirpation of varicose veins of the leg. NY Med J 1907;86:153-56. 75. Correia Neto A. Tratamento cirúrgico das varizes dos membros inferiores e das úlceras varicosas rebeldes. Rev Cir S Paulo 1935;2:29-47. 76. Puech-Leão LE. Bases racionais para o tratamento das varizes dos membros inferiores. Med Cirurg Farm 1945;105:42-48. 77. Toledo OM, Bueno Neto J, Puech Leão LE et al. Atualização do tratamento das varizes dos membros inferiores. Seara Méd 1955;10:111-19. 78. Puech Leão LE, Toledo OM, Moraes IN et al. Cirurgia radical das varizes dos membros inferiores. Rev Paul Méd 1958;53:303-12. 79. Myers TT. Management of varicose veins with special reference to the stripping operation. Surg Clin North Am 1955;35:1147-73. 80. Bueno Neto J, Toledo OM, Wolosker M et al. Resultados da cirurgia radical nas varizes dos membros inferiores. Rev Paul Méd 1960;57:151-56. 81. Agrifoglio G, Edwards EA. Results of surgical treatment of varicose veins. One to fourteen-year follow-up study of 416 patients. JAMA 1961;178:906-11. 82. Medina AL, Costa PSG, Côrtes JCB. Conduta cirúrgica nas varizes essenciais dos membros inferiores. Angiopatias 1965;5:74-84. 83. Haeger K. Five-year results of radical surgery for superficial varices with or without coexistent perforator insufficiency. Acta Chir Scand 1966;131:38-49. 84. Wolosker M, Bueno Neto J, Gabriele J et al. Bases anatômicas para o planejamento cirúrgico das varizes dos membros inferiores. Rev Hosp Clín Fac Med São Paulo 1968;23:295-304. 85. Nabatoff RA. Reasons for major recurrence following operations for varicose veins. Surg Gynec Obstet 1969;128:275-78. 86. Larson RH, Lofgren EP, Myers TT et al. Long-term results after vein surgery. Study of 1000 cases after 10 years. Mayo Clin Proc 1974;49:114-17. 87. Rivlin S. The surgical cure of primary varicose veins. Br J Surg 1975;62:913-17. 88. Rintoul RF, MacPherson AIS. Long-term follow-up of operation for varicose veins. A prospective study. J R Coll Surg Edimb 1975;20:195-99. 89. Puech-Leão LE, Miyake H. Aspectos técnicos do tratamento cirúrgico das varizes. Rev Hosp Clin Fac Med S Paulo 1979;34:133-35. 90. Ristow AVB, Arruda AM, Albuquerque JT, Medina AL. Varizes primárias. Dez anos de experiência com o tratamento cirúrgico. Rev Ass Med Brasil 1979;25:216-18. 91. Samuels PB. Technique of varicose vein surgery. Am J Surg 1981;142:239-44. 92. Corbett CRR, Runcie IJ, Thomas ML, Jamieson CW. Reasons to strip the long saphenous vein. Phlébologie 1988;41:766-69. 93. Kunlin J. Le traitement de l’arterite obliterante par la greffe veineuse. Arch des Mal du Coeur et des Vais 1949;43:371-73. 94. Muller R. Traitment des varices par le phlébectomie ambulatoire. Phlebologie 1966;19:277-79. 95. Kafejian O, Oliveira GAC, Takayanagi T. Inovações técnicas na cirurgia de varizes visando a resultados estéticos. Rev Ass Med Bras 1976;22:296-97. 96. Luccas GC, Lane JC. Método de detecção de insuficiência da veia safena interna. Rev Paul Med 1984;102:277-78. 97. Large J. Doppler testing as an important conservation measure in the treatment of varicose veins. Aust N Z J Surg 1984;54(22):8357-59. 98. Koyano K, Sakagushi S. Selective stripping operation based on doppler ultrasonic findings for primary varicose veins of the lower extremities. Surgery 1988;103:615-19. 99. Luccas GC, Kauffman P, Lane JC. Método de avaliação do estado funcional da veia safena interna. Cir Vasc Angiol 1985;1:22-28. 100. Marston WA. Evaluation of varicose veins: what do the clinical signs and symptoms reveal about the underlying disease and need for intervention? Semin Vasc Surg 2010;23:78-84. 101. Barwell JR, Davies CE, Deacon J et al. Comparison of surgery and compression with compression alone in chronic ulceration (ESCHAR study): Randomized controlled trial. Lancet 2004;363:1854-59. 102. Viarengo LMA, Poterio Filho J, Poterio GMB et al. Venous laser treatment for varicose veins in patients with active ulcers.
50. Cabrera J, Redondo P, Becerra, A et al. Ultrasound-guided injection of polidocanol microfoam in the management of venous leg ulcers. Arch Dermatol 2004;140:667-73.
61. Tazelaar DJ, Neumann HAM, Roos KP. Long cotton wool rolls as compression enhancers in macrosclerotherapy for varicose veins. Dermatol Surg 1999;25:38-40.
271Capítulo 139 vArizes de membros inferiores – tr AtAmento
54. Alos J, Carreno P, Lopez et al. Efficacy and safety of sclerotherapy using polidocanol foam a controlled clinical trial. Eur J Vasc Endovasc Surg 2006;31:101-7.
68. McMullin GM, Coleridge Smith PD, Scurr JH. Objective assessment of high ligation without stripping the long saphenous vein. Br J Surg 1991;78:1139-42. 69. Neglen P, Einarsson E, Eklot B. The functionallong term value of different types of treatment for saphenous vein incompetence. J Cadiovasc Surg (Torino) 1993;34:295-301.
52. Barrett JM, Allen B, Ockelford A et al. Microfoam ultrasound-guided sclerotherapy treatment for varicose veins in a subgroup with diameters at the junction of 10 mm or greater compared with a subgroup of less than 10 mm. Dermatol Surg 2004;30:1386-90.
71. Kómlos PP, Capp E, Merlo I et al. Procedimento combinado para varizes, microvarizes e telangiectasias. In: Merlo I, Parente JBH, Kómlos PP. (Eds.). Varizes e telangiectasias – Diagnóstico e tratamento. Rio de Janeiro: Revinter; 2006. p. 249-54.
53. Coleridge Smith PD. Saphenous ablation sclerosant or sclerofoam? Semin Vasc Surg 2005;18:19-24.
49. Cabrera J, Cabrera Jr J, Garcia-Olmedo MA. Sclerosants in microfoam. A new approach in angiology. Int Angiol 2001;20:322-29.
105. Labropoulos N, Leon L, Kwon S. Study of the venous reflux progression. J Vasc Surg 2005;41:291-95.
117. Bradbury AW, Stonebridge PA, Callam MJ et al. Recurrent varicose veins. Assessment of the saphenofemoral junction. Br J Surg 1994;81:373-75.
120.
125. Struckmann JR. Assessment of venous muscle pump function by ambulatory calf volume strain gauge plethysmography after surgical treatment of varicose veins. A prospective study of 21 patients. Surgery 1987;101:347-53.
118. Benabou JE, Molnar LJ, Cardoso Neto F et al. Avaliação por mapeamento dúplex da junção safenofemoral em pacientes portadores de varizes recidivantes, submetidos a prévia cirurgia radical de varizes. Cir Vasc Angiol 1996;12:36s-9s.
151. Ricci A, Laurora G, Cesarone MR, et al. Plicatura della giunzione safeno-femorale. Minerva Chir 1991;46:1123-26. 152. Schanzer H, Skladany M. Varicose vein surgery with preservation of the saphenous vein. A comparison between high ligation-avulsion versus saphenofemoral banding valvuloplasty-avulsion. J Vasc Surg 1994;20:684-87.
104. Labropoulos N, Kang SS, Mansour MA. Primary superficial vein reflux with competent saphenous trunk. Eur J Vasc Endovasc Surg 1999;18:201-6.
106. Marston W A, Brabham VW, Mendes R et al. The importance of deep venous reflux velocity as a determinant of outcome in patiens with combined superficial and deep venous reflux treated with endovenous saphenus ablation. J Vasc Surg 2008;48(2):400-406.
128. Evangelista SSM. O valor da pletismografia no pré e pós-operatório das varizes tronculares dos MMIIs. Cir Vasc Angiol 1996;12:59-62.
111.
116. Georgiev M. The preoperative dúplex examination. Dermatol Surg 1998;24:433-40.
127. Sánchez JAA, Gómez MEV, Griñán MAM et al. La pletismografía en el estudio y seguimiento de los operados de varices. Angiologia 1988;4:145-48.
153. Zamboni P, Marcellino MG, Murgia AP et al. Effetti clinici ed emodinamici della plastica esterna delle valvole del giunto safenofemorale. Minerva Chir 1995;50:463-68. 154. Zamboni P, Feo C, Marcellino MG et al. Angiovideo-assisted hemodynamic correction of varicose veins. Int Angiol 1995;14:202-8.
Measurement of intravenous and perivenous temperatures during the procedure. Dermatol Surg 2007;33:1234-42.
148. Engelhorn CA, Engelhorn AL, Cassou MF et al. Classificação antomofuncional da insuficiência das veias safenas baseada no eco-Doppler colorido, dirigida para o planejamento da cirurgia de varizes. J Vasc Br 2004;3:13-19.
124. Barel EV. Estudo Quantitativo do Refluxo da Veia Safena Interna pelo Duplex em Pacientes com Varizes dos Membros Inferiores. Tese de Doutorado, Faculdade de Ciências Médicas da Universidade Estadual de Campinas, 2002.
107. Caggiati A, Rosi C, Heyn R. Age-related variations of varicose veins anatomy. J Vasc Surg 2006;44:1291-95.
113.
135. Goren G, Yellin AE. Minimally invasive surgery for primary varicose veins. limited invaginated axial stripping and tributary (hook) stab avulsion. Ann Vasc Surg 1995;9:401-14. 136. Sadick NS, Schanzer H. Combined high ligation and stab avulsion for varicose veins in an outpatient setting. Dermatol Surg 1998;24:475-79. 137. Cox SJ, Wellwood JM, Martin A. Saphenous nerve injury caused by stripping of the long saphenous vein. BMJ 1974;1:415-17. 138. Wellwood JM, Cox SJ, Martin A et al. Sensory changes following stripping of the long saphenous vein. J Cardiovasc Surg 1975;16:123-24. 139. Garrido M, Assaf SA, Lucas VS et al. O nervo safeno e sua importância na fleboextração da veia safena magna. Rev Bras Cardiovasc 1979;15:81-89. 140. Ramasastry SS, Dick GO, Futrell JW. Anatomy of the saphenous nerve relevance to saphenous vein stripping. Am Surg 1987;53:274-77. 141. Garrido M. Varizes tronculares primárias dos membros inferiores (MMII). Considerações anatômicas. Cir Vasc Angiol 1996;12:5-8. 142. Goren G, Yellin AE. Invaginated axial saphenectomy by a semirigid stripper. Perforate-invaginate stripping. J Vasc Surg 1994;20:970-77. Van Bellen B, Gross WS, Verta Jr MJ et al. Lymphatic disruption in varicose vein surgery. Surgery 1977;82:257-59. 144. Brito CJM, Silva Filho WB, Duarte Jr WP. Cirurgia das varizes. J Bras Med 1972;23:30-37. 145. 144.Cappelli M, Molino-Lova R, Giangrandi I, Ermini S, Gianesini S. Ligation of the saphenofemoral junction tributaries as risk factor for groin recurrence. J Vasc Surg Venous Lymphat Disord 2018 Mar;6(2):224-229 146. Casoni P, Lefebvre-Vilardebo M, Villa F et al. Great saphenous vein surgery without high ligation of the saphenofemoral junction. J Vasc Surg 2013;58(1):173-8. 147. Mariani F, Mancini S, Bucslossi M et al. Selective high ligation of the sapheno-femoral junction decreases the neovascularization and the recurrent varicose veins in the operated groin. Int Angiol 2015; 34(3):250-6.
130. Katz ML, Comerota AJ, Kerr RP. Air plethysmograph (APGTM). A new technique to evaluate patients with chronic venous insufficiency. J Vasc Tech 1991;15:23-27. 131. Gillespie DL, Cordts PR, Hartono C et al. The role of air plethysmograph in monitoring results of venous surgery. J Vasc Surg 1992;16:674-78. 132. Owens LV, Farber MA, Young ML et al. The value of air plethysmograph in predicting clinical outcome after surgical treatment of chronic venous insufficiency. J Vasc Surg 2000;32:961-68. 133. Bishop CCR, Jarrett PEM. Outpatient varicose vein surgery under local anaesthesia. Br J Surg 1986;73:821-22. 134. Ivo CS, Fonseca FP, Caldeira EL. Solução anestésica alcalinizada e diluída para uso em cirurgia ambulatorial de varizes dos membros inferiores. Cir Vasc Angiol 1994;10:14-18.
119. Labropoulos N, Touloupakis E, Giannoukas AD et al. Recurrent varicose veins. Investigation of the pattern and extent of reflux with color flow dúplex scanning. Surgery 1996;119:406-9. Van Bemmelen PS, Bedford G, Beach K et al. Quantitative segmental evaluation of venous valvular reflux with duplex ultrasound scanning. J Vasc Surg 1989;10:425-31. Vasdekis SN, Clarke GH, Nicolaides AN. Quantification of venous reflux by means of dúplex scanning. J Vasc Surg 1989;10:670-77. Luccas GC, Nagase Y, Menezes FH et al. Avaliação quantitativa do refluxo na veia safena interna com dúplex. Aplicação no planejamento cirúrgico das varizes primárias dos membros inferiores. Cir Vasc Angiol 1999;15:s-27.
108. Hoare MC, Royle JP. Doppler ultrasound detection of saphenofemoral and saphenopopliteal incompetence and operative venography to ensure precise saphenopopliteal ligation. Aust N Z J Surg 1984;54:49-52. 109. Campbell WB, Niblett PG, Ridler BMF et al. Hand-held doppler as a screening test in primary varicose veins. Br J Surg 1997;84:1541-43.
112.
115.
121.
149. Brito CJM, Silva RM, Araújo EL et al. Fleboextração seletiva da safena interna. In: 28º Congresso da sociedade brasileira de angiologia e cirurgia vascular, São Paulo, 1989; Temas Livres Especiais:121. 150. Rollo HA, Lastória S, Yoshida WB et al. Cirurgia de varizes com preservação da veia safena magna. Avaliação pré e pós-operatória pelo mapeamento dúplex. Resultados preliminares. Cir Vasc Angiol 1996;12:63s-8s.
110. Luccas GC. Método de avaliação do estado funcional da veia safena interna com o efeito Doppler do ultrassom. Tese de doutorado, Faculdade de Medicina da Universidade de São Paulo; 1985. Vasdekis SN, Clarke GH, Hobbs JT et al. Evaluation of non-invasive and invasive methods in the assessment of short saphenous vein termination. Br J Surg 1989;76:929-32. Luccas GC, Nagase Y, Menezes FH et al. Cirurgia de varizes dos membros inferiores. Avaliação pré-operatória do sistema venoso com mapeamento dúplex. Cir Vasc Angiol 1996;12:15-20. Caldeira EL, Martins FLA, Ivo CS et al. Tratamento das varizes relacionadas às veias pudendas externas. Cir Vasc Angiol 1996;12:23-25. 114. Engelhorn CA, Picheth FS, Castro Jr N et al. Estudo do sistema venoso superficial com o dúplex scan a cores. Cir Vasc Angiol 1996;12:12s-4s. Sarquis AL. Avaliação pré e pós-operatório no tratamento cirúrgico conservador de varizes tronculares com o dúplex scan a cores. Cir Vasc Angiol 1996;12:9s-11s.
143.
126. Christopoulos D, Nicolaides AN, Galloway JMD et al. Objective noninvasive evaluation of venous surgical results. J Vasc Surg 1988;8:683-87.
129. Padberg Jr FT, Pappas PJ, Araki CT et al. Hemodynamic and clinical improvement after superficial vein ablation in primary combined venous insufficiency with ulceration. J Vasc Surg 1996;24:711-18.
103. Pittaluga P, Chastanet S, Rea B et al. Classification of saphenous refluxes: implications for treatment. Phlebology 2008;23:2-9.
272 Parte VIIIMEMBROS INFERIORES
122.
123. Silveira SAF. Determinação do fluxo arterial com o auxílio da pneumopletismografia e da ultrassonografia dúplex. Estudo experimental e em voluntários. Tese de Mestrado, Faculdade de Ciências Médicas da Universidade Estadual de Campinas, 1999.
166. Pelli P, Nicoletti G, Beccaria G et al. La malattia varicosa nella patogenesi delle recidive dopo trattamento chirurgico delle varici essenziali. Minerva Chir 1988;43:1941-45.
204. Pittaluga P, Chastanet S. Treatment of varicose veins by ASVAL: Results at 10 years. Ann Vasc Surg 2017;38:e10.
165. Haimovici H. Role of precapillary arteriovenous shunting in the pathogenesis of varicose veins and its therapeutic implications. Surgery 1987;101:515-22.
201. Yamaki T, Nozaki M, Sakurai H et al. Great saphenous vein sparing surgery by angioscopic valvuloplasty combined with axial transposition of a competent tributary vein-5-year follow-up. Eur J Vasc Endovasc Surg 2009;37:103-8. 202. Pittaluga P, Chastanet S, Locret T et al. The effect of isolated phlebectomy on reflux and diameter of the great saphenous vein: a prospective study. Eur J Vasc Endovasc Surg 2010;40:122-28. 203. Chalstanet S, Pittaluga P. Influence of the competence of the sapheno-femoral junction on the mode of treatment of varicose veins by surgery. Phlebology 2014;29:61-5.
179. Hammarsten J, Pedersen P, Cederlung CG et al. Long saphenous vein saving surgery for varicose veins. A long-term follow-up. Eur J Vasc Surg 1990;4:361-64.
184. Fonseca FP, Evangelista SSM, Sarquis AL. O tratamento cirúrgico ambulatorial e com anestesia local das varizes tronculares primárias dos membros inferiores, com preservação das safenas. Avaliação pré e pós-operatória com o dúplex scan e com a fotopletismografia. Cir Vasc Angiol 1996;12:19-22. 185. Mellière D. Le traitement personnalisé des varices en fonction de la clinique, de l’échodoppler et de la necessité de preserver les veines grandes saphènes chaque fois que possible. Cir Vasc Angiol 1996;12:15s-8s.
181. Friedell ML, Samson RH, Cohen MJ et al. High ligation of the greater saphenous vein for treatment of lower extremity varicosities the fate of the vein and therapeutic results. Ann Vasc Surg 1992;6:5-8.
176. Labropoulos N, Kokkosis AA, Spentzouris G et al. The distribution and significance of varicosities in the saphenous trunks. J Vasc Surg 2010;5:96-103.
162. Vigoni M. Une conception personnelle des facteurs qui conditionnent la récidive des varices essentielles après leur traitment. Phlébologie 1982;35:523-28.
180. Rutherford RB, Sawyer JD, Jones DN. The fate of residual saphenous vein after partial removal or ligation. J Vasc Surg 1990;12:422-28.
186. Campanello M, Hammarsten J, Forsberg C et al. Standard stripping versus long saphenous vein-saving surgery for primary varicose veins a prospective, randomized study with the patients as their own controls. Phlebology 1996;11:45-49. 187. Jakobsen BH. The value of different forms of treatment for varicose veins. Br J Surg 1979;66:182-84.
173. Bergan JJ. Saphenous vein stripping and quality of outcome. Br J Surg 1996;83:1025-27.
178. Schobinger RA. Conservative varicose vein surgery a modern necessity. Helv chir Acta 1985;52:7-9.
183. Fligelstone L, Salaman RA, Oshodi TO et al. Flush saphenofemoral ligation and multiple stab phlebectomy preserve a useful greater saphenous vein four years after surgery. J Vasc Surg 1995;22:588-92.
208. Viarengo LMA, Meirelles GV, Poterio Filho J. Tratamento de varizes com LASER endovenoso. Estudo prospectivo com acompanhamento de 39 meses. J Vasc Bras 2006;5:184-93. 209. Milosek RK, Wozniak W, Gruszecki L, Stapa RZ. The use of a novel method of endovenous steam ablation in treatment of great
182. Fligelstone L, Carolan G, Pugh N et al. An assessment of the long saphenous vein for potential use as a vascular conduit after varicose vein surgery. J Vasc Surg 1993;18:836-40.
160. Miyake H, Wolosker M, Bueno Neto J et al. Cirurgia radical de varizes sem sangramento. Rev Ass Med Bras 1970;16:419-22.
171.
195. Stonebridge PA, Chalmers N, Beggs I et al. Recurrent varicose veins. A varicographic analysis leading to a new practical classification. Br J Surg 1995;82:60-62. 196. Franceschi C. La cure hémodynamique de l’insuffisance veineuse en ambulatoire (CHIVA). J Mal Vasc 1992;17:291-300.
155. Navarro TP, Nunes TA, Ribeiro AL et al. Is total abolishment of great saphenous reflux in the invasive treatment of superficial chronic venous insufficiency always necessary? Int Angiol 2009;28:4-11.
156. Pittaluga P, Chastanet S, Locret T et al. The effect of isolated phlebectomy on reflux and diameter of the great saphenous vein: a prospective study. Eur J Vasc Endovasc Surg 2010;40:122-28.
158. Linton RR. The communicating veins of the lower leg and the operative technic for their ligation. Ann Surg 1938;107:582-93.
273Capítulo 139 vArizes de membros inferiores – tr AtAmento
167. Garrido M, Coelho N. Recidiva varicosa em pacientes submetidos a safenectomia há mais de 15 anos. Cir Vasc Angiol 1996;12:46-50.
161. Schalin L. Arteriovenous communications in varicose veins localized by thermography and identified by operative microscopy. Acta Chir Scand 1981;147:409-20.
168. Luccas GC. Recidiva das varizes primárias tratadas cirurgicamente de acordo com a avaliação pré-operatória das veias safenas com o ultrassom (Doppler). Tese de Livre Docência. Faculdade de Ciências Médicas da Universidade Estadual de Campinas, 1992. 169. Luccas GC, Parente JBHF, Nagase Y et al. Preservação da veia safena magna em cirurgia de varizes. Resultados tardios. Cir Vasc Angiol 1995;11:15-18.
174. Dwerryhouse S, Davies B, Harradine K et al. Stripping the long saphenous vein reduces the rate of reoperation for recurrent varicose veins. Five year results of a randomized trial. J Vasc Surg 1999;29:589-92.
157. Luz N, Vieira G, Bertoncini R et al. Estudo flebográfico das varizes do nervo sural. Cir Vasc Angiol 1996;12:67-70.
163. Rose SS, Ahmed A. Some thoughts on the aetiology of varicose veins. J Cardiovasc Surg 1986;27:534-43.
175. Luccas GC, Nagase Y, Menezes FH et al. Fleboextração parcial proximal da veia safena interna no tratamento das varizes primárias dos membros inferiores. Cir Vasc Angiol 1993;9:6-10.
170. Holme JB, Holme K, Sorensen LS. The anatomic relationship between the long saphenous vein and the saphenous nerve. Relevance for radical varicose vein surgery. Acta Chir Scand 1988;154:631-33. Sarin S, Scurr JH, Coleridge Smith PD. Assessment of stripping the long saphenous vein in the treatment of primary varicose veins. Br J Surg 1992;79:889-93. Sarin S, Scurr JH, Coleridge Smith PD. Stripping of the long saphenous vein in the treatment of primary varicose veins. Br J Surg 1994;81:1455-58.
164. Baron HC, Casssaro S. The role of arteriovenous shunts in the pathogenesis of varicose veins. J Vasc Surg 1986;4:124-28.
177. Large J. Surgical treatment of saphenous varices, with preservation of the main great saphenous trunk. J Vasc Surg 1985;2:886-91.
188. Munn SR, Morton JB, Macbeth WAAG et al. To strip or not to strip the long saphenous vein? A varicose veins trial. Br J Surg 1981;68:426-28. 189. Gloviczki P, Comerota AJ, Dalsing MC et al. The care of patients with varicose veins and associated chronic venous diseases: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg 2011;53(5 Suppl):2S-48S. 190. Pitta GBB. Preservação da veia safena magna na cirurgia das varizes tronculares primárias. Tese de doutorado, Escola Paulista de Medicina - Universidade Federal de São Paulo, 1998. 191. Matsui IA, Menezes FH, Silveira SAF et al. Derivações arteriais com veia safena interna autógena varicosa acompanhamento com dúplex. Cir Vasc Angiol 1994;10:126-29. 192. Starnes HF, Vallance R, Hamilton DNH. Recurrent varicose veins a radiological approach to investigation. Clin Radiol 1984;35:95-99. 193. Silvestre JMS, Francisco Jr. J, Miranda Jr. F et al. Valor propedêutico do exame clínico e da flebografia no diagnóstico das varizes recidivadas de membros inferiores. Cir Vasc Angiol 1987;3:15-20.
159. Felder DA. The phlebografic diagnosis and treatment of the postphlebitic syndrome. Radiology 1953;61:208.
197. Zamboni P, Marcellino MG, Feo C et al. When CHIVA treatment could be video guided. Dermatol Surg 1995;21:621-25.
198. Franco G. L. Écolo-Phlébologie ou le mythe de CHIVA. Phlébologie 1990;43:173-81. 199. Franco G. Cure hémodynamique de l’insuffisance veineuse (CHIVA), revolution ou regression. Cir Vasc Angiol 1996;12:28-32.
200. Lane RJ, Cuzzilla ML, Coroneos JC et al. Recurrence rates following external valvular stenting of the saphenofemoral junction: a comparison with simultaneous contralateral stripping of the great saphenous vein. Eur J Vasc Endovasc Surg 2007;34:595-603.
205. Milleret R, Huot L, Nicolini P, Creton D et al. Great saphenous vein ablation with steam injection: results of a multicentre study. Eur J Vasc Endovasc Surg 2013 Apr;45(4):391-6. 206. Rasmussen L, Lawaetz M, Serup J et al. Randomized clinical trial comparing endovenous laser ablation, radiofrequency ablation, foram sclerotherapy, and surgical stripping for great saphenous varicose veins with 3-year floolw-up. J Vasc Surg Venous Lymphat Disord 2013 Oct; 1(4):349-56. 207. Ahadiat O, Higgins S, Ly A et al. Review of endovenous thermal ablation of the great saphenous vein: Endovenous Laser therapy versus radiofrequency ablation. Dermatol Surg 2018;44(5):679-88.
194. Loveday EJ, Thomas ML. The distribution of recurrent varicose veins a phlebographic study. Clin Radiol 1991;43:47-51.
172.
213. Manfrini S, Gasbarro V, Danielsson G et al. Endovenous management of saphenous vein reflux. J Vasc Surg 2000;32:330-42.
214. Medeiros CAF. Estudo comparativo entre o laser endovenoso e a fleboextração convencional da veia safena interna em pacientes com varizes primárias. Tese de Mestrado, Faculdade de Ciências Médicas da Universidade Estadual de Campinas, 2005. 215. Medeiros CAF, Luccas GC. Comparison of endovenous treatment with an 810 nm laser versus conventional stripping of the great saphenous vein in patients with primary varicose veins. Dermatol Surg 2005;31:1685-94.
216. Van den Bos R, Arends L, Kockaert M et al. Endovenous therapies of lower extremity varicosities: a meta-analysis. J Vasc Surg 2009;49:230-39. 217. Murad MH, Coto-Yglesias F, Zumaeta-Garcia M et al. A systematic review and meta-analysis of the treatments of varicose veins. J Vasc Surg 2011;53(5 Suppl):49S-65S.
225. Keith Jr LM, Smead WL. Saphenous vein stripping and its complications. Surg Clin North Am 1983;63:1303-12. 226. Miyake RK, Cherri J, Moriya T et al. Lesão inadvertida da artéria femoral superficial durante safenectomia. Cir Vasc Angiol 1990;6:17-9.
227. Mellière D. Complications graves des traitements des varices des membres inferieurs. Cir Vasc Angiol 1996;12:57-8.
230. Ginanneschi F, Filippou G, Frediani B et al Injury of cutaneous branches of the femoral nerve following varicose vein surgery. Pub 08 Jan 2013. 231. Hutinel B, Maraval M. Télangiectasies post-stripping. Phlébologie 1985;38:665-67. 232. Guex JJ. Thrombotic complications of varicose veins. A literature review of the role of superficial venous thrombosis. Dermatol Surg 1996;22:378-82. 233. Husni EA,Williams WA. Superficial thrombophlebitis of lower limbs. Surgery 1982;91:70-74. 234. Bergqvist D, Jaroszewsky H. Deep vein thrombosis in patients with superficial thrombophlebitis of the leg. BMJ 1986;292:658-59. 235. Raffetto JD, Eberhardt RT. Benefit of anticoagulation for the treatment of lower extremity superficial venous thrombosis. J Vasc Surg 2015; 3(2):236-41. 236. Scott G, Mahdi AJ, Alikhan R, Superficial vein thrombosis: a current approach to management. Br J Haematol 2015; 168(5):639-45. 237. Wolinsky CD, Waldorf H. Chronic venous disease. Med Clin North Am 2009;93:1333-46. 238. Viarengo LMA, Meirelles GV, Poterio Filho J. Tratamento de varizes com LASER endovenoso. Estudo prospectivo com acompanhamento de 39 meses. J Vasc Bras 2006;5:184-93. 239. Néglen P, Raju S. Balloon dilatation and stenting of chronic iliac vein obstruction. Technical aspects and early clinical outcome. J Endovasc Ther 2000;4:79-91. 240. Gloviczki P, Bergan JJ, Rhodes JM et al. Mid-term results of endoscopic perforator vein interruption for chronic venous insufficiency lessons learned from the North American subfascial endoscopic perforator surgery registry. North American Study Group. J Vasc Surg 1999;29:489-502. 241. TenBrook Jr. JA, Iafrati MD, O’Donell Jr. TF et al. Systematic review of outcomes after surgical management of venous disease incorporating subfascial endoscopic perforator surgery. J Vasc Surg 2004;39:583-89. 242. Kostas T, Loannou CV, Touloupakis E et al. Recurrent varicose veins after surgery: a new appraisal of a common and complex problem in vascular surgery. Eur J Vasc Endovasc Surg 2004; 27:275-82. 243. Ostler AE, Holdstock JM, Harrison CC et al. Strip-tract revascularization as a source of recurrent venous reflux following high saphenous tie and stripping: results at 5-8 years after surgery. Phlebology 2015;30(8):569-572. 244. Perrin MR, Labropoulos N, Leon L R. Presentation of the patient with recurrent varices after surgery (REVAS) from the American venous Forum; 2006. 327-34.
210. Proebstle T, Alm J, Gockeritz O et al
218. Nootheti PK, Cadag KM, Goldman MP. Review of intravascular approaches to the treatment of varicose veins. Dermatol Surg 2007;33:1149-57.
228. Kim R et al. Anatomic variations of lower extremity venou system in varicose vein patients: demonstration by three-dimensional CT venography. Acta Radiol 2017 May;58(5) 542-49.
229. Miloni M, Di Minno MN, Maietta P et al. Great saphenous vein stripping and nerve injury: the role of stripping direction. Int Angiol 2015;34(3):238-42.
220. Nabatoff RA. The short saphenous vein. Surg Gynec Obstet 1979;149:49-53. 221. Perrin M, LePretre M, Becker F. La place de la saphène externe dans la chirurgie itérative des varices essentielles des membres inférieurs. Phlébologie 1980;33:321-27. 222. Corcos L, Peruzzi G, Romeo V et al. Papel de la safena externa en las varices primitivas y secundarias de los miembros inferiores. Angiologia 1985;37:124-35. 223. Elbaz C. La chirurgie de la saphène externe. Phlébologie 1985;38:475-83. 224. Santos MERC. O tratamento cirúrgico das varizes causadas por refluxo da safena parva. Cir Vasc Angiol 1996;12:51-2.
One year follow up of the European Multicenter Study on cyanoacrylate embolization of incompetent great saphenous veins. International Union of Phlebology World Meeting, September 8-13, 2013, Boston, MA, USA.
212. Pan Y, Zhao J, Mei J, Shao M, Zhang J. Comparison of endovenous laser ablation and high ligateion and stripping for varicose vein treatment: a meta-analysis. Phlebology 2014 Mar:29(2):109-19.
274 Parte VIIIMEMBROS INFERIORES saphenous vein insufficiency: own experiences. Phlebology 2014 Feb;29(1):58-65.
219. Dodd H. Varicosity of the external and pseudo-varicosity of the short (external) saphenous vein. Br J Surg 1959;46:520-30.
211. Witte ME, Zeebregts CJ, de Borst GJ, Reijnen MMPJ, Boersma D. Mechanochemical endovenous ablation of sapnehous veins using the ClariVein: A systematic review. Phlebology 2017 Dec;32(10):649-657.
11. Merlo I, Parente JBH, Komlós PP et al. Tratamento cirúrgico das varizes. In: Merlo I, Parente JBH, Komlós PP. (Eds.). Varizes e telangiectasias diagnóstico e tratamento. Rio de Janeiro: Revinter; 2006. p. 224-42.
12. Komlós PP, Capp E, Merlo I et al. Procedimento combinado para varizes, microvarizes e telangiectasias. In: Merlo I, Parente JBH, Komlós PP. (Eds.). Varizes e telangiectasias diagnóstico e tratamento Rio de Janeiro: Revinter; 2006. p. 249-54.
15. Ivo CS, Fonseca FP, Caldeira EL. Solução anestésica alcalinizada e diluída para uso em cirurgia ambulatorial de varizes de membros inferiores. Cirurgia vascular & angiologia. Rev Sociedade Bras Angiol Cir Vasc 1994;10(1):14-18.
13. Hudson BF, Ogden J, Whiteley MS. A thematic analysis of experiences of varicose veins and minimally invasive surgery under local anaesthesia. J Clin Nurs 2015 Jun;24(11-12):1502-12.
19. Pereira RIC. Farmacologia dos anestésicos locais. In: Auler Jr JOC, Vane LA. (Eds.). SAESP atualização em anestesiologia. Rio de Janeiro: Atheneu; 1992. p. 77-91, vol 1. 20. Richie JM, Greene NM. Anestésicos locais. In: Goodman, Gilman. As bases farmacológicas da terapêutica. 6. ed. Rio de Janeiro: Guanabara Koogan; 1983. p. 268-85. 21. Ackerman III WE, Ware TR, Juneja M. The air-liquid interface and the pH and PCO2 of alcalinized local anaesthetic solutions. Canadian J Anaesth 1992;39:387-89. 22. Miyake RK., et al. Vein Imaging: A new method of near infrared imaging, where a processed image is projected onto the skin for the enhancement of vein treatment. Dermatol Surg., v. 32, p. 1031-38, 2006. 23. Medeiros Neto LP, Nicolau RA. Aplicação da luz infravermelhapróxima (NIR)na visualização de vasos sanguíneo. XVI Encontro Latino Americano de Iniciação Científica e XII Encontro Latino Americano de Pós-Graduação – Universidade do Vale do Paraíba UNIVAP 2012. p. 1-6. arquivos/1108_1021_01.pdf.http://www.inicepg.univap.br/cd/INIC_2012/anais/ 24. Fonseca FP. Varizes de membros inferiores. In: Fonseca FP, Savassi Rocha PR. (Eds.). Cirurgia ambulatorial. Rio de Janeiro: Guanabara Koogan; 1999. p. 511-36. 25. Ivo CS, Pedroza AA, Sarquis AL et al. Linhas de referência para marcação de varizes de MMII baseadas em achados de Duplex Scan. Cir Vasc Angiol 1995 Set.;11(3)(Suppl 1):50. 26. D’assumpção EA. Incisões, suturas, retalhos, z-plastias e enxertos. In: Fonseca FP, Savassi Rocha PR. (Ed.). Cirurgia ambulatorial. Rio de Janeiro: Guanabara Koogan; 1999. p. 70-89. 27. Garrido MBM. Anatomia médico-cirúrgica do sistema venoso dos membros inferiores. In: Maffei FHA. Doenças vasculares periféricas. 2. ed. Rio de Janeiro: Medsi; 1995. p. 745-70. 28. Garrido MBM. Varizes tronculares primárias dos membros inferiores. Considerações anatômicas. Cir Vasc Angiol 1996;12:5s-8s. 29. Komlós PP. Tratamento das varizes dos membros inferiores. In: Bonamigo TP, Frankini AD, Komlós PP et al Angiologia e cirurgia vascular: guia prático. Porto Alegre: Assessoria; 1994. p. 97-106. 30. Merlo I. Cirurgia de varizes. Técnica para pacientes que buscam exclusivamente o resultado estético. Rev Angiol Cir Vasc Regional do RJ da SBACV 1993 Jan/Mar;2(1):177-86. 31. Brito CJ. Repensando a fleboextração na cirurgia de varizes. Boletim da SBACV 1988;2(3):3.JM. 32. Brito CJ, De Biase Filho W, Duarte Jr WP. Cirurgia de varizes. JBM 1972;23:30. 33. Brito CJ, Duarte Jr WP, Fernandes DC. Varizes dos membros inferiores. Ars Curandi 1974;7(1). 34. Boné C. Tratamento endoluminal de las varices com laser de diodo. Estudo preliminar. Rev Patol Vasc 1999;5:35-46. 35. Navarro L, Min RJ, Boné C. Endovenous laser: a new minimally invasive method of treatment for varicose veins-preliminary observations using an 810 nm diode laser. Dermatol Surg 2001;27(2):117-22. 36. Merchant RF, Desalma RG, Kabnick LS. Endovascular obliteration of saphenous reflux, multicenter study. J Vasc Surg 2002;35:1190-96. 37. Medeiros CAF. Tratamento cirúrgico endovascular com laser. In: Merlo I, Parente JBH, Komlós PP. (Eds.). Varizes e telangiectasias diagnóstico e tratamento. Rio de Janeiro: Revinter; 2006. p. 288-95. 38. Carmelino C. Ablação endovascular no tratmento cirurgico com Laser 1470 nm. In: Merlo I e Cols (Eds). Varizes e Telangiectasias II, Laser Espuma e Radiofrequência. DiLivros; 2014. p. 49-57. 39. Bergan JJ. Sclerotherapy: technique and application. In: Rutherford RB. Vascular surgery. 4th ed. Philadelphia: WB Saunders; 1995. p. 182836, vol. 2. 40. Rivitti S. Dermatologia. São Paulo: Artes Médicas; 1998. 41. Braun-Falco O, Plewig G, Wolff HH et al Dermatology. 3. ed. Berlin: Springer-Verlag; 1991.
14. Voigt R. Preparados para inyección e infusión. In: Rudolf Voigt. Tratado de tecnologia farmacêutica. Zaragoza: Acribia; 1979. p. 415-63.
8. Viarengo LMA, Mancini MW, Viarengo G. Cirurgia ambulatorial de varizes com endolaser. In: Merlo I, Bastos FR,Parente JBH, Ferreira JhG, Figueiredo M, Murilo R. (Eds.). Varizes e telangiectasias II– laser, espuma e radiofrequência. Rio de Janeiro: DiLivros; 2014. p. 177-196.
17. Borba SRC. Anestésicos locais. In: Manica JT. Anestesiologia princípios e técnicas. Porto Alegre: Artes Médicas; 1992. p. 188-98.
REFERÊNCIAS BIBLIOGRÁFICAS
1. Miyake H, Puech-Leão LE. Tratamento cirúrgico das varizes de membros inferiores. In: Maffei FHA. Doenças vasculares periféricas. 2. ed. Rio de Janeiro: Medsi; 1995. p. 975-84. 2. Dittimar JJ, Costa ER, Gomes CC. Nossa experiência com microcirurgia de varizes dos mmii com agulha de crochê. XXII Congresso Bras. de Angiol. Impressa Universitária UFMG; 1977. p. 112. 3. Kafejian O, Oliveira GAC, Takayanagi T. Inovações técnicas na cirurgia de varizes visando a resultados estéticos. Rev Ass Med Brasil 1976;22:296-97. 4. Ivo CS, Caldeira EL. Cirurgia das pequenas varizes de membros inferiores com a técnica de incisões puntiformes. Revista de Angiologia e Cirurgia Vascular Regional do RJ da SBACV 1993 Jan/Mar;2(1):200-3. 5. Roizen MF. Cost-effective laboratory preoperative testing. JAMA 1994;271:319. 6. Thomaz JB. Varizes dos membros inferiores: medidas terapêuticas. In: Thomaz JB. Angiologia e cirurgia vascular – Tópicos atuais. Rio de Janeiro: Revinter; 2000. p. 107-24. 7. Resolução do Conselho Federal de Medicina no.1886/2008, publicada no DOU de 21 de novembro de 2008seção I, p. 271, disponível http://www.portalmedico.org.br/resolucoes/cfm/2008/1886_2008.em:
16. Bromage PR. Farmacologia. In: Bromage PR. Analgesia epidural. São Paulo: Manole; 1980. p. 63-113.
275 140CapítuloVARIZES DE MEMBROS INFERIORES – ASPECTOS ESTÉTICOS DO TRATAMENTO CIRÚRGICO
10. Vloka JD, Hadzic A, Mulcare R et al. Femoral and genitofemoral nerve blocks versus spinal anesthesia for outpatients undergoing long saphenous vein stripping surgery. Anesth-Analg 1997 Apr.;84(4):749-52.
18. Kennedy RL, Knapp RB. Anestésicos locais. In: Craig CR, Stitzes RD. Farmacologia moderna. São Paulo: Roca; 1986. p. 431-40a.
9. Gouveia Ma, Labrunie GM. Complicações da anestesia regional. Rev Bras Anest RJ 1991;41:29-38
17. Do DV, Kelley LC. Tumescent Anesthesia: Evolution and Current Uses. Adv Dermatol. 2007 Jan;23:33-46.
16. Yilmaz S, Ceken K, Alimoglu E, Sindel T. US-guided femoral and sciatic nerve blocks for analgesia during endovenous laser ablation. Cardiovasc Intervent Radiol 2013 Feb;36(1):150-7
35. Marsh P, Price BA, Holdstock J, Harrison C, Whiteley MS. Deep Vein Thrombosis (DVT) after Venous Thermoablation Techniques: Rates of Endovenous Heat-induced Thrombosis (EHIT) and Classical DVT after Radiofrequency and Endovenous Laser Ablation in a Single Centre. Eur J Vasc Endovasc Surg 2010 Oct;40(4):521-7.
12. Van der Velden S, Shadid N, Nelemans P, Sommer A. How specific are venous symptoms for diagnosis of chronic venous disease? Phlebology: J Venous Disease 2014 Jan 3. [Epub ahead of print]
22. Pichot O, De Maeseneer M. Treatment of Varicose Veins: Does Each Technique Have a Formal Indication? Perspect Vasc Surg Endovasc Ther 2012 Mar 30;23(4):250-4. 23. Gad MA, Saber A, Hokkam EN. Assessment of causes and patterns of recurrent varicose veins after surgery. North Am J Med Sci 2012 Jan;4(1):45-8. 24. Brake M, Lim CS, Shepherd AC, Shalhoub J, Davies AH. Pathogenesis and etiology of recurrent varicose veins. J Vasc Surg 2013 Mar;57(3):860-8. 25. Sharma AK, Drumsta D, Lee DE. Duplex Ultrasonography in the Management of Varicose Veins. Ultrasound Clinics. Elsevier Inc 2013 Apr 1;8(2):227-35. 26. Bush RG, Bush P, Flanagan J, Fritz R, Gueldner T, Koziarski J et al. Factors Associated with Recurrence of Varicose Veins after Thermal Ablation: Results of The Recurrent Veins after Thermal Ablation Study. Scientific World J. 2014;2014(4):1-7. 27. Theivacumar NS, Dellagrammaticas D, Darwood RJ, Mavor AID, Gough MJ. Fate of the Great Saphenous Vein Following Endovenous Laser Ablation: Does Re-canalisation Mean Recurrence? Eur J Vasc Endovasc Surg 2008 Aug;36(2):211-5. 28. Knipp BS, Blackburn SA, Bloom JR, Fellows E, LaForge W, Pfeifer JR et al. Endovenous laser ablation: Venous outcomes and thrombotic complications are independent of the presence of deep venous insufficiency. J Vasc Surg 2008 Dec;48(6):1538-45. 29. Mozafar M, Atqiaee K, Haghighatkhah H, Taheri MS, Tabatabaey A, Lotfollahzadeh S. Endovenous laser ablation of the great saphenous vein versus high ligation: long-term results. Lasers Med Sci 2013 Aug 14;29(2):765-71. 30. Theivacumar NS, Gough MJ. Arterio-venous fistula following endovenous laser ablation for varicose veins. Eur J Vasc Endovasc Surg 2009;38:234-6 31. Vaz C, Matos A, Oliveira J, Nogueira C, Almeida R, Mendonc M. Iatrogenic arteriovenous fistula following endovenous laser therapy of the short saphenous vein. Ann Vasc Surg 2009;23:412. 32. Ziporin Sj, Ifune CK, MacConmara MP, Geraghty PJ, Choi ET. A case of external iliac arteriovenous fistula and high-output cardiac failure after endovenous laser treatment of great saphenous vein. J Vasc Surg 2010;51:715-9.
13. Kröger K, Ose C, Rudofsky G, Roesener J, Hirche H. Symptoms in individuals with small cutaneous veins. Vasc Med 2002;7(1):13-7.
37. Korepta LM, Watson JJ, Mansour MA, Chambers CM, Cuff RF, Slaikeu JD et al. Outcomes of a single-center experience with classification
21. Kelleher D, Lane TRA, Franklin IJ, Davies AH. Treatment options, clinical outcome (quality of life) and cost benefit (qualityadjusted life year) in varicose vein treatment. Phlebology 2012 Feb 6;27(Supplement 1):16-22.
7. Neglén P, Egger JF 3rd, Olivier J, Raju S. Hemodynamic and clinical impact of ultrasound-derived venous reflux parameters. J Vasc Surg 2004 Aug;40(2):303-10.
11. Marston WA. Evaluation of Varicose Veins: What do the Clinical Signs and Symptoms Reveal about the Underlying Disease and Need for Intervention? Semin Vasc Surg 2010 Jun;23(2):78-84.
15. Wittens, CDAH et al. Editor’s choice–management of chronic venous disease: clinical practice guidelines of the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg 2015;49(6):678-737.
3. Keller WL. A new method of extirpating the internal saphenous and similar veins in varicose conditions: a preliminary report. NY Med J 1905;82:385-6.
18. Proebstle TM, Moehler T, Gül D, Herdemann S. Endovenous treatment of the great saphenous vein using a 1,320 nm Nd:YAG laser causes fewer side effects than using a 940 nm diode laser. Dermatol Surg 2005 Dec;31(12):1678-83.
19. Nejm Jr. CS, Timi JR, de Araújo Jr. WB, Caron FC. Endovenous laser ablation of the great saphenous vein – Varying energy may not affect outcome. Phlebology 2015;32(1):13-18.
20. Proebstle TM, Moehler T, Herdemann S. Reduced recanalization rates of the great saphenous vein after endovenous laser treatment with increased energy dosing: definition of a threshold for the endovenous fluence equivalent. J Vasc Surg 2006 Oct;44(4):834-9.
33. Scurr JRH, Martin J, How TV, Gambardella I, Brennan JA. Retained Laser Fibre Following Endovenous Laser Ablation. EJVES Extra 2007 Feb;13(2):30-2. 34. Dunst KM, Huemer GM, Wayand W, Shamiyeh A. Diffuse phlegmonous phlebitis after endovenous laser treatment of the greater saphenous vein. J Vasc Surg 2006 May;43(5):1056-8.
10. Rabe E, Pannier F. Clinical, aetiological, anatomical and pathological classification (CEAP): gold standard and limits. Phlebology 2012 Mar;27(Supplement 1):114-8.
6. Navarro TP, Delis KT, Ribeiro AP. Clinical and hemodynamic significance of the greater saphenous vein diameter in chronic venous insufficiency. Arch Surg 2002 Nov;137(11):1233-7.
276 141Capítulo VARIZES DE MEMBROS INFERIORES –TRATAMENTO COM ENDOLASER REFERÊNCIAS BIBLIOGRÁFICAS
1. Evans CJ, Fowkes FG, Ruckley CV, Lee AJ. Prevalence of varicose veins and chronic venous insufficiency in men and women in the general population: Edinburgh Vein Study. J Epidemiol Community Health 1999 Mar;53(3):149-53.
8. Magnusson MB, Nelzén O, Risberg B, Sivertsson R. A colour Doppler ultrasound study of venous reflux in patients with chronic leg ulcers. Eur J Vasc Endovasc Surg 2001 Apr;21(4):353-60.
4. Babcock WW. A new operation for the extirpation of varicose veins of the leg. NY Med J 1907;86:153-6.
5. Navarro LL, Min RJR, Boné CC. Endovenous laser: a new minimally invasive method of treatment for varicose veins- preliminary observations using an 810 nm diode laser. Dermatologic Surgery 2001 Feb 1;27(2):117-22.
14. Gloviczki P, Comerota AJ, Dalsing MC, Eklof BG, Gillespie DL, Gloviczki ML et al. The care of patients with varicose veins and associated chronic venous diseases: Clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg 2011 May;53(Supplement 16):2S-48S.
9. Antignani PL, Cornu-Thenard A, Allegra C, Carpentier PH, Partsch H, Uhl JF. Results of a Questionnaire Regarding Improvement of “C” in the CEAP Classification. Eur J Vasc Endovasc Surg 2004 Aug;28(2):177-81.
36. Van Den Boss RR, Neumann M, De Roos KP et al. Endovenous laser ablation induced complications: review of literature and new cases. Dermatol Surg 2009: 35:1206-14.
2. Maffei FH, Magaldi C, Pinho SZ, Lastoria S, Pinho W, Yoshida WB et al. Varicose veins and chronic venous insufficiency in Brazil: prevalence among 1755 inhabitants of a country town. Int J Epidemiol 1986 Jun;15(2):210-7.
44.
61. Tellings SS, Ceulen RPM, Sommer A. Surgery and endovenous techniques for the treatment of small saphenous varicose veins: a review of the literature. Phlebology 2011 Jul 26;26(5):179-84.
67. Zerweck C, Hodenberg von E, Knittel M, Zeller T, Schwarz T. Endovenous laser ablation of varicose perforating veins with the 1470-nm diode laser using the radial fibre slim. Phlebology 2012 Nov 15. 68. Ozkan U. Endovenous laser ablation of incompetent perforator veins: a new technique in treatment of chronic venous disease. Cardiovasc Intervent Radiol 2009;32:1067-70. 69. Myers KA, Clough A, Tilli H. Endovenous laser ablation for major varicose tributaries. Phlebology 2013;28:180-183. 70. Kim HK, Kim HJ, Shim JH, Baek M-J, Sohn Y-S, Choi YH. Endovenous Lasering Versus Ambulatory Phlebectomy of Varicose Tributaries in Conjunction with Endovenous Laser Treatment of the Great or Small Saphenous Vein. Ann Vasc Surg 2009;23(2):207-11.
72. Heger M, van Golen RF, Broekgaarden M, van den Bos RR, Neumann HAM, van Gulik TM, van Gemert MJC. Endovascular laser–tissue interactions and biological responses in relation to endovenous laser therapy. Lasers Med Sci 2014;29:405-422. 73. Vuylsteke ME, Mordon SR. Endovenous Laser Ablation: A Review of Mechanisms of Action. Ann Vasc Surg 2012 Apr 1;26(3):424-33. 74. Poluektova AA, Malskat WSJ, Gemert MJC, Vuylsteke ME, Bruijninckx CMA, Neumann HAM et al. Some controversies in endovenous laser ablation of varicose veins addressed by optical–thermal mathematical modeling. Lasers Med Sci 2013 Oct 9;29(2):441-52. 75. Proebstle TM, Sandhofer M, Kargli A, Gül D, Rother W, Knop J, Lehr HA. Thermal damage of the inner vein wall during endovenous laser treatment: key role of energy absorption by intravascular blood. Dermatol Surg 2002;28:596-600. 76. van der Geld CWM, van den Bos RR, van Ruijven PWM, Nijsten T, Neumann HAM, van Gemert MJC. The heat-pipe resembling action of boiling bubbles in endovenous laser ablation. Lasers Med Sci 2010 Jul 20;25(6):907-9. 77. Amzayyb M, van den Bos RR, Kodach VM, de Bruin DM, Nijsten T, Neumann HAM et al. Carbonized blood deposited on fibres during 810, 940 and 1,470 nm endovenous laser ablation: thickness and absorption by optical coherence tomography. Lasers Med Sci 2010 May;25(3):439-47. 78. Disselhoff BCVM, Rem AI, Verdaasdonk RM, Kinderen Der DJ, Moll FL. Endovenous laser ablation: an experimental study on the mechanism of action. Phlebology 2008 Apr 1;23(2):69-76. 79. Heger M, Golen RF, Broekgaarden M, Bos RR, Neumann HAM, Gulik TM et al. Endovascular laser–tissue interactions and biological responses in relation to endovenous laser therapy. Lasers Med Sci 2013 Nov 15;29(2):405-22. 80. Almeida J, Mackay E, Javier J, Mauriello J, Raines J. Saphenous Laser Ablation at 1470 nm Targets the Vein Wall, Not Blood. Vasc Endovasc Surg 2009 May 21;43(5):467-72. 81. Kabnick LS. Outcome of different endovenous laser wavelengths for great saphenous vein ablation. J Vasc Surg 2006 Jan;43(1):88-88. 82. Proebstle TM, Moehler T, Gui D, Herdermann S. Endovenous treatment of great saphenous vein using 1320nm Nd:YAG laser causes fewer side effects than using a 940nm diode laser. Dermatol Surg 2005;31:1678-83.
45.
277Capítulo 141 VARIZES DE MEMBROS INFERIORES – TRATAMENTO COM ENDOLASER and treatment of endothermal heat-induced thrombosis after endovenous ablation. J Vasc Surg: 2017; 5(3):332-38.
46.
42. de Araujo WJB, Timi JRR, Erzinger FL, Caron FC. Trombose induzida pelo calor endovenoso: relato de dois casos tratados com rivaroxabana e revisão da literatura. J Vasc Bras 2016);15(2):147-52. Huisman L, Bruins R, van den Berg M, Hissink R. Endovenous laser ablation of the small saphenous vein: prospective analysis of 150 patients, a cohort study. Eur J Vasc Endovasc Surg 2009;38:199-202. Chang C, Chua J. Endovenous laser photocoagulation for varicose veins. Lasers Surg Med 2002;31:257-62. Lawrence PF, Alktaifi A, Rigberg D, DeRubertis B, Gelabert H, Jimenez JC. Endovenous ablation of incompetent perforating veins is effective treatment for recalcitrant venous ulcers. J Vasc Surg 2011 Sep;54(3):737-42. Kabnick L. Complications of endovenous therapies: statistics and treatment. Vascular 2006;14:31. 47. Dexter D, Kabnick L, Berland T, Jacobowitz G, Lamparello P, Maldonado T et al. Complications of endovenous lasers. Phlebology 2012 Mar;27(Supplement 1):40-5. 48. de Araujo WJB, Guimarães AC, Moreira RH. Fístula arteriovenosa após termoablação com laser endovenoso 1470 nm: relato de caso. J Vasc Bras 2016;15(3):254-58. Navarro L, Navarro N, Boné-Salat C, Fructuoso-Gomez J, Min RJ. Endovascular laser device and treatment of varicose veins. United States Patent (2002), US 6,398,777 B1; patent filed in 1999, date of patent: June 4. 50. Darwood RJ, Gough MJ. Endovenous laser treatment for uncomplicated varicose veins. Phlebology 2009;24(Supplement 1):50-61. Samuel N, Carradice D, Wallace T, Smith G, Khan J, Chetter I. Endovenous laser therapy: Evolution of practice. Int J Surg. 2011;9(7):554-5.
57. Soo J. Rhee et al. Factors Influencing the Incidence of Endovenous Heat-Induced Thrombosis (EHIT). Vasc Endovasc Surg 2013;47(3):207-12.
58. McMaster S. Is routine scanning for deep-vein thrombosis necessary following endovenous laser ablation and ultrasoundguided sclerotherapy? A statistical perspective in Australian Phlebology practice. Phlebology 2011 Mar 2;26(2):49-51.
63. Doganci S, Yildirim V, Demirkilic U. Does Puncture Site Affect the Rate of Nerve Injuries Following Endovenous Laser Ablation of the Small Saphenous Veins? Eur J Vasc Endovasc Surg. 2011 Mar 1;41(3):400-5. 64. Janne d’Othée B, Walker TG, Kalva SP, Ganguli S, Davison B. Endovenous Laser Ablation of the Small Saphenous Vein Sparing the Saphenopopliteal Junction. CardioVasc Intervent Radiol 2010 Jan 20;33(4):766-71. 65. Uchino IJ. Endovenous laser closure of the perforating vein of the leg. Phlebology 2007 Mar 31;22(2):80-2. 66. Proebstle TM, Herdemann S. Early results and feasibility of incompetent perforator vein ablation by endovenous laser treatment. Dermatol Surg 2007;33:162-8.
71. Neumann HAM, Gemert MJC. Ins and outs of endovenous laser ablation: afterthoughts. Lasers Med Sci 2014 Jan 8;29(2):513-8.
59. Jones RTC, Kabnick LS. Perioperative Duplex Ultrasound Following Endothermal Ablation of the Saphenous Vein: Is it Worthless? J Invasive Cardiol 2014;26(10):548-50.
52. Mariani F, Marone EM, Gasbarro V, Bucalossi M, Spelta S, Amsler F et al. Multicenter randomized trial comparing compression with elastic stocking versus bandage after surgery for varicose veins. YMVA Elsevier Inc 2011 Jan 1;53(1):115-22. Biswas S, Clark A, Shields DA. Randomised Clinical Trial of the Duration of Compression Therapy after Varicose Vein Surgery. Eur J Vasc Endovasc Surg 2007 May;33(5):631-7.
56. Marsh P, Price BA, Holdstock J, Harrison C, Whiteley MS. Deep Vein Thrombosis (DVT) after Venous Thermoablation Techniques: Rates of Endovenous Heat-induced Thrombosis (EHIT) and Classical DVT after Radiofrequency and Endovenous Laser Ablation in a Single Centre. Eur J Vasc Endovasc Surg 2010 Oct;40(4):521-7.
39. Uthoff H, Holtz D, Broz P, Staub D, Spinedi L. Rivaroxaban for thrombosis prophylaxis in endovenous laser ablation with and without phlebectomy. J Vasc Surg 2017. 40. Soo J. Rhee et al. Factors Influencing the Incidence of Endovenous Heat-Induced Thrombosis (EHIT). Vasc Endovasc Surg 2013;47(3):207-12.
51.
43.
54. Huang TW, Chen SL, Bai CH, Wu CH, Tam KW. The Optimal Duration of Compression Therapy Following Varicose Vein Surgery: A Meta-analysis of Randomized Controlled Trials. Eur J Vasc Endovasc Surg. 2013 Apr 1;45(4):397-402.
62. Samuel N, Carradice D, Wallace T, Mekako A, Hatfield J, Chetter I. Randomized Clinical Trial of Endovenous Laser Ablation Versus Conventional Surgery for Small Saphenous Varicose Veins. Ann Surg 2013 Mar;257(3):419-26.
38. Sufian S, Arnez A, Labropoulos N, Lakhanpal S. Incidence, progression, and risk factors for endovenous heat-induced thrombosis after radiofrequency ablation. J Vasc Surg 2013, vol 1(2):159-64.
41. Kabnick L et al. Endovenous heat induced thrombosis (EHIT) at the superficial deep venous junction: a new post-treatment clinical entity, classification and potential treatment strategies. 18th Anual Meeting of the American Venous Forum, Miami, FL; 2006.
49.
53.
60. Kontothanassis D, Di Mitri R, Ruffino SF, Zambrini E, Camporese G, Gerard JL et al. Endovenous laser treatment of the small saphenous vein. Journal of Vascular Surgery. Soc Vasc Surg 2009 Apr 1;49(4):973-979.e1.
55. Bakker NA, Schieven LW, Bruins RMG, van den Berg M, Hissink RJ. Compression Stockings after Endovenous Laser Ablation of the Great Saphenous Vein: A Prospective Randomized Controlled Trial. Eur J Vasc Endovasc Surg. 2013 Nov 1;46(5):588-92.
87. Van den Bussche D, Moreels N, De Letter J et al. Endovenous laser treatment for primary varicose veins. Acta Chir Belg 2006;106:32-35. 88. Mendoza E, Blättler W, Amsler F. Great saphenous vein diameter at the saphenofemoral junction and proximal thigh as parameters of venous disease class. Eur J Vasc Endovasc Surg 2013;45:76-83.
278 Parte VIIIMEMBROS INFERIORES
83. Doganci S, Demirkilic U. Comparison of 980 nm Laser and Baretip Fibre with 1470 nm Laser and Radial Fibre in the Treatment of Great Saphenous Vein Varicosities: A Prospective Randomised Clinical Trial. Eur J Vasc Endovasc Surg. 2010 Aug 1;40(2):254-9.
85. Bueno KA, Albernaz DTS, Albernaz LFL, Zignani FRM. Endolaser venoso: estudo série de casos. J Vasc Bras 2012;11(4):286-88. 86. Erzinger FL, de Araujo WJB, Junior CSN, Caron FC, Timi JRR. Estudo comparativo da termoablação da veia safena magna na coxa, com e sem tumescência. J Vasc Bras 2016;15(3):217-23.
89. Starodubtsev V, Lukyanenko M, Karpenko A, Ignatenko P. Endovenous laser ablation in patients with wide diameter of the proximal segment of the great saphenous vein: Comparison of methods. Phlebology 2014, published online Oct 10. 90. Atasoy MM. Efficacy and Safety of Endovenous Laser Ablation in Very Large and Tortuous Great Saphenous Veins. J Vasc Interv Radiol 2015 Jun 8 (article in press). 91. Timperman PE. Prospective evaluation of higher energy great saphenous vein endovenous laser treatment. J Vasc Interv Radiol 2005 Jun;16(6):791-4.
92. Prince EA, Ahn SH, Dubel GJ, Soares GM. An Investigation of the Relationship between Energy Density and Endovenous Laser Ablation Success: Does Energy Density Matter? J Vasc Interv Radiol 2008 Oct;19(10):1449-53.
98. Atasoy MM, Gumus B, Caymaz I, Oguzturk L. Targeted endovenous treatment of Giacomini vein insufficiency-associated varicose disease: considering the reflux patterns. Diagn Interv Radiol 2014 Oct 31;20(6):481-6.
84. Malskat WSJ, Poluektova AA, Geld CWM, Neumann HAM, Weiss RA, Bruijninckx CMA et al. Endovenous laser ablation (EVLA): a review of mechanisms, modeling outcomes, and issues for debate. Lasers Med Sci 2013 Dec 24;29(2):393-403.
93. Vuylsteke M, Liekens K, Moons P, Mordon S. Endovenous Laser Treatment of Saphenous Vein Reflux: How Much Energy Do We Need to Prevent Recanalizations? Vasc Endovasc Surg 2008 May 1;42(2):141-9. 94. Viarengo LMA, Viarengo G, Martins AM, Mancini MW, Lopes LA. Resultados de médio e longo prazo do tratamento endovenoso de varizes com laser de diodo em 1940 nm: análise crítica e considerações técnicas. J Vasc Bras 2017 Jan-Mar;16(1):23-30.
99. der Kinderen DJ, Disselhoff BC, Koten JW et al. Histopathologic studies of the below-the-knee great saphenous vein after endovenous laser ablation. Dermatol Surg 2009 Dec.;35(12):1985-8. 100. Theivacumar NS, Darwood RJ, Dellagrammaticas D et al. The clinical significance of below-knee great saphenous vein reflux following endovenous laser ablation of above-knee great saphenous vein. Phlebology 2009 Feb;24(1):17-20.
101. Theivacumar NS, Dellagrammaticas D, Mayor Al, Gough MJ. Endovenous laser ablation: does standard above-knee great saphenous vein ablation provide optimum results in patients with both above- and below-knee reflux? A randomized controlled trial. J Vasc Surg 2008 July;48(1):173-8.
102. de Araujo WJB, Timi JRR, Junior N, Seme C, Erzinger FL, Caron FC. Persistent below-knee great saphenous vein reflux after aboveknee endovenous laser ablation with 1470-nm laser: a prospective study. J Vasc Bras 2016 Apr-June;15(2):113-119. 103. Gifford SM, Kalra M, Gloviczki P et al. Reflux in the below-knee great saphenous vein can be safely treated with endovenous ablation. J Vasc Surg Venous Lymphat Disord 2014;2(4):397-402. 104. de Araujo WJB, Timi JRR, Erzinger FL, Caron FC, Cambrussi AK. Development of an ex vivo model of endovenous laser ablation of the great saphenous vein in a pilot study. Acta Cir Bras 2016;31(3):161-167. 105. de Araujo WJB et al. Comparison of the effects of endovenous laser ablation at 1470 nm versus 1940 nm and different energy densities. Phlebology 2019 Apr;34(3):162-170.
97. Park SW, Lee SA, Hwang JJ, Yun IJ, Kim JS, Chang S-H et al. Early Results of Endovenous Ablation with a 980-nm Diode Laser for an Incompetent Vein of Giacomini. Korean J Radiol 2011;12(4):481-6.
95. Delis KT, Knaggs AL, Khodabakhsh P. Prevalence, anatomic patterns, valvular competence, and clinical significance of the Giacomini vein. J Vasc Surg 2004 Dec;40(6):1174-83. 96. Theivacumar NS, Dellagrammaticas D, Mavor AID, Gough MJ. Endovenous Laser Ablation (EVLA) of Great Saphenous Vein to Abolish “Paradoxical Reflux” in the Giacomini Vein: A Short Report. Eur J Vasc Endovasc Surg 2007 Aug;34(2):229-31.
4. Mackay DC, Summerton DJ, Walker AJ. The early morbidity of varicose vein surgery. J R Nav Med Serv 1995;81(1):42-6.
REFERÊNCIAS
17. Lurie F, Creton D, Eklof B et al. Prospective randomized study of endovenous radiofrequency obliteration (closure) versus ligation and vein stripping (EVOLVeS): two-year follow-up. Eur J Vasc Endovasc Surg 2005;29(1):67-73.
5. Eklöf B, Rutherford RB, Bergan JJ et al. Revision of the CEAP classification for chronic venous disorders: consensus statement. J Vasc Surg 2004;40(6):1248-52.
12. Angelescu H. Varicose vein surgery without stripping. Phlebologie 1969;22(4):395-400. 13. Fonseca FP, Sarquis AL, Evangelista SSM. Surgery for primary troncular varicose without stripping the saphenous vein – pre and postoperative evaluation by duplex scan and photoplethysmography. Phlebology 1995;1 Suppl:419-21.
6. Depalma RG, Kowallek DL, Barcia TC et al. Target selection for surgical intervention in severe chronic venous insufficiency: comparison of duplex scanning and phlebography. J Vasc Surg 2000;32(5):913-20.
16. Lurie F, Creton D, Eklof B et al. Prospective randomized study of endovenous radiofrequency obliteration (closure procedure) versus ligation and stripping in a selected patient population (EVOLVeS Study). J Vasc Surg 2003;38(2):207-14.
18. Rautio T, Ohinmaa A, Perälä J et al. Endovenous obliteration versus conventional stripping operation in the treatment of primary varicose veins: a randomized controlled trial with comparison of the costs. J Vasc Surg 2002;35(5):958-65.
7. Nicolini P, Closure Group. Treatment of primary varicose veins by endovenous obliteration with the VNUS closure system: results of a prospective multicentre study. Eur J Vasc Endovasc Surg 2005;29(4):433-9.
9. Fischer R, Linde N, Duff C et al. Late recurrent saphenofemoral junction reflux after ligation and stripping of the greater saphenous vein. J Vasc Surg 2001;34(2):236-40.
20. Merchant RF, Pichot O, Closure Study Group. Long-term outcomes of endovenous radiofrequency obliteration of saphenous reflux as a treatment for superficial venous insufficiency. J Vasc Surg 2005;42(3):502-9.
19. Merchant RF, Pichot O, Myers KA. Four-year follow-up on endovascular radiofrequency obliteration of great saphenous reflux. Dermatol Surg 2005;31(2):129-34.
14. Chandler JG, Pichot O, Sessa C et al. Defining the role of extended saphenofemoral junction ligation: a prospective comparative study. J Vasc Surg 2000;32(5):941-53.
1. Maffei FHA. Varizes dos membros inferiores: epidemiologia, etiopatogenia e fisiopatologia. In: Maffei FHA, Lastória S, Yoshida WB, Rollo HA (editores). Doenças vasculares periféricas. 4. ed. Rio de Janeiro: Medsi; 1995. p. 939-49.
11. Campanello M, Hammarsten J, Forsberg C et al. Standard stripping versus long saphenous vein-saving surgery for primary varicose veins: a prospective randomized study with the patients as their own controls. Phlebology 1996;11:45-9.
10. Hinchliffe RJ, Ubhi J, Beech A et al. A prospective randomized controlled trial of VNUS closure versus surgery for the treatment of recurrent long saphenous varicose veins. Eur J Vasc Endovasc Surg 2006;31(2):212-8.
2. Van Rij AM, Jones GT, Hill GB et al. Neovascularization and recurrent varicose veins: more histologic and ultrasound evidence. J Vasc Surg 2004;40(2):296-302.
142CapítuloVARIZES DE MEMBROS INFERIORES
8. Glass GM. Neovascularisation in recurrence of the varicose great saphenous vein following transaction. Phlebology 1987;2:81-92.
15. Chandler J, Pichot O, Sessa C et al. Treatment of Primary Venous Insufficiency by Endovenous Saphenous-Vein Obliteration. Vasc Surg 2000;34:201-14.
279 –TRATAMENTO POR RADIOFREQUÊNCIA BIBLIOGRÁFICAS
3. Jones L, Braithwaite BD, Selwyn D et al. Neovascularization is the principal cause of varicose vein recurrence: results of a randomized trial of stripping the long saphenous vein. Eur J Vasc Endovasc Surg 1996;12(4):442-5.
DE VARIZES
47.
49.
ESCLEROTERAPIA –SUBSTÂNCIAS ESCLEROSANTES BIBLIOGRÁFICAS
15. Cabrera Garrido JR, Cabrera Garcia-Olmedo JR, Garcia-Olmedo Domingues MA. Elargissement des limites de la sclérothérapie: nouveaux produits sclérosants. Phlebologie 1997;50(2):181.
13. Andrade JA. Escleroterapia de varizes de grossos calibers –“Macroescleroterapia”. In: Merlo I, Parente JBH, Komlós PP, (Eds.) Varizes e telangiectasias. Rio de Janeiro: Revinter; 2006. p. 201.
50.
1. Schwartz L, Maxwell H. Sclerotherapy for lower limb telangiectasias. Cochrane Database Syst Rev 2011 Dec 7;(12). 2. Goldman MP. Escleroterapia. Tratamento das veias varicosas e telangiectasias dos membros inferiores. Rio de Janeiro: Interlivros; 1994. 3. Tournay R. La sclerose des varices. Paris: L’Expansion Scientifique Française; 1980. 4. Pinto-Ribeiro A. Escleroterapia de varizes. In: Maffei FHA, et al. (ed.) Doenças vasculares periféricas. Rio de Janeiro: Medisi; 1987. p. 636-47. 5. Rynd F. Neuralgia: introduction of fluid to the nerve. Dublin Med Press 1845;13:167. 6. Garrison FH. An introduction of the history of medicine. Philadelphia: Saunders; 1929. 7. Orbach EJ. A new approach to the sclerotherapy of varicose veins. Angiology 1950;1:302. Fegan WG. Continuous compression technique of injecting varicose veins. Lancet 1963;2:109-12. 9. Hobbs JT. The treatment of varicose veins: a random trial of injection/ compression versus surgery. Br J Surg 1974;55:777. 10. Pinto-Ribeiro A. Varizes essencias. Escleroterapia versus cirurgia. Angiopatias (Bras) 1961;2:1. 11. Medeiros A, Pinto-Ribeiro A. Varizes essenciais. JBM 1964;8(7):797-815.
29. Pfeifer JR. Injection compression sclerotherapy of spider telangiectasia and small varicose veins. In: Goldman MP, Bergan JJ, (eds.). Ambulatory treatment of venous disease. St. Louis: Mosby-Year Book; 1996. 30. Weiss MA, Weiss RA. Sclerotherapeutic agents available in the United States and elsewere. In: Goldman MP, Bergan JJ, (eds.). Ambulatory treatment of venous disease. St Louis: Mosby-Year Book; 1996. 31. Hoff IM, Stemer R. Classification and mechanism of action of sclerosing agents. Soc Franc Phebol 1969;22:143. 32. Rotter SM, Weiss RA. Human saphenous vein in vitro model for studying action of sclerosing. J Dermatol Surg Oncol 1993;19:59-62. 33. Foote RR. Severe reaction to monoethanolamine oleate. Lancet 1944;2:390-91. 34. Hughes Jr RW et al. Endoscopic variceal sclerosis: a one year experience. Gastrointest Endosc 1982;28:62-68. 35. Reid RG, Rothnie NG. Treatment of varicose vein by compression sclerotherapy. Br J Surg 1968;55:889-95. 36. Ribeiro MC, Grossmann MCS, Amaral MBF, de Castro WH, Navarro TP, Procopio RJ, Silva TA, de Nazaré Alves de Oliveira Kato C, Mesquita RA. Effectiveness and safety of foam sclerotherapy with 5% ethanolamine oleate in the treatment of low-flow venous malformations in the head and neck region: a case series. Int J Oral Maxillofac Surg 2018 Jul;47(7):900-907. 37. Melo JMS, (Ed.). Dicionário de especilidades farmacêuticas. Rio de Janeiro: Publicações Científicas; 1997/1998. 38. Carlin MC, Ratz JL. Treatment of telangiectasia: comparison of sclerosing agents. J Dermatol Surg Oncol 1987;13:1181. 39. Todd 3rd, KL, et al. The VANISH-2 study: a randomized, blinded, multicenter study to evaluate the efficacy and safety of polidocanol endovenous microfoam 0.5% and 1.0% compared with placebo for the treatment of saphenofemoral junction incompetence. Phlebology 2014;29:608. 40. Amblard P. Our expirience with aethoxysklerol. Phlebologie 1977;30:213. 41. Hoffer AE. Aethoxysklerol (Kreussler) in the treatment of varices. Minn Cardioang 1972;20:601-4. 42. Lindemayr H, Santler R. The fibrinolytic activity of the vein wall. Phlebologie 1977;30:151. 43. Jausion H et al. Une methode simple de phlebosclerose: la cure des varices par le injections de glycerine diluée. Bul Soc Franc Dermatol Syph 1931;38:171. 44. Stemmer R, et al. Etude physique del injection sclerosante. Phebologie 1969;22:149. 45. Abrahão GJ. Glicerina cromada. Rev Ang Cir Vasc 1996;5(1):17-20. Bastos FR, Lima A, Assunção AC. Escleroterapia de varizes com espuma. Revisão. Rev Med MG 2009;19(1):38-43 Bastos FR. Técnica da esclelroterapia com espuma. In: Merlo I et al., (Ed.) Varizes e telabngiectasias II-Laser, espuma e radiofrequencia. Rio de Janeiro: Di Livros; 2014. p. 79-90 Hanisch F, Muller T, Krivokuca M et al. Stroke following variceal sclerotherapy. Eur J Med Res 2004;9:282. Forlee MV, Grouden M, Moore DJ et al. Stroke after varicose vein foam injection sclerotherapy. J Vasc Surg 2006;43:162. David ME, Shunji K. Microvascular embolization following polidocanol microfoam sclerosant administration. Derm Surg 2005;31(6):636-43. Horton SC, Bunch TJ. Patent foramen ovale and stroke. Mayo Clin Proc 2004;79:79-88. Silva MAM, Burihan MC, Barros OC, Nasser F, Ingrund JC, Neser A. Resultados do tratamento da insuficiência venosa crônica grave com espuma de polidocanol guiada por ultrassom. J Vasc Bras 2012;11(3):206-11.
51.
52.
14. Barrett JM, Allen B, Ockelford A et al. Microfoam ultrasound-guided sclerotherapy of varicose veins in 100 legs. Dermatol Surg 2004;30:6.
280 143Capítulo
28. Green D. Compression sclerotherapy techniques. Dermatol Clin 1989;7:137.
8.
19. Duffy DM. Small vessel sclerotherapy: an overview. Adv Dermatol 1988;3:221-42. 20. Faria JL, Moraes IN. Histopathology of the telangiectasia associated with varicose veins. Dermatologica 1963;127:321-24. 21. Goldman MP, Bennett RG. Treatment of telangiectasia: a review. J Am Acad Dermatol 1987;17:167-82. 22. Wokalek H et al. Morphology and localization of sunburst varicosities: an eletron microscopic and morphometric study. J Dermatol Surg Oncol 1989;15:149-54. 23. Somjen GM. Duplex anatomy of telangiectasias as a guide to treatment. In: Goldman MP, Bergan JJ. (Eds.). Ambulatory treatment of venous disease. St Louis: Moby-Year Book; 1996. p. 29-35. 24. Merlen JF. Telangiectasies rouges, telangiectasies bleues. Phlebologie 1970;23:167. 25. Redisch W, Pelzer RH. Localized vascular dilatations of human skin: capillary microscopy and related studies. Am Heart J 1949;37:106. 26. Dodd H, Cockett FB. The patology and surgery of the veins of the lower limb. 2nd ed. London: Churchill Livingstone; 1976.
48.
16. Cabrera J, Cabrera Jr J, Garcia-Olmedo MA. Sclerosants in microfoam. A new approach in angiology. Int Angiol 2001;20(4):322. 17. Tessari L, Cavezzi A, Frulinni A. Preliminary experience with a new sclerosing foam in the treatment of varicose veins. Derm Surg 2001;27:58. 18. Tessari L. Nouvelle technique d’obtention de la scleromousse. Phlebologie 2000;53:129.
46.
12. Tazelaar RJ, Neumann HAM. Macroscleroterapy and compression. In: Goldman MP, Bergan JJ, (ed.) Ambulatory treatment of venous disease St Louis: Mosby-Year Book; 1996.
27. Widmer LK. Peripheral venous disorders. Prevalence and sociomedical importance. Observations in 4,529 apparently healthy persons. Basle Study III, H. Huber, Bern. 1978. (Cited in Winkel, 1981, op sit).
REFERÊNCIAS
76. Merlo I, Duque AC. Varizes dos membros inferiores. Tratamento cirúrgico com ênfase no resultado estético. Arq Bras Med 1986;60(3):233-36. 77. Komlós PP, Frankini AD, Komlós F. Técnicas quirurgicas com anestesia local en varices de los miembros inferiores. Patologia Vasc 1997;111(3):65-73. 78. Miyake H, Puech-Leão LE. Tratamento cirúrgico das varizes dos membros inferiores. In: Maffei FHA, et al., (Eds.). Doenças vasculares periféricas. 2. ed. Rio de Janeiro: Medsi; 1995. 79. Bergan JJ. Management of external hemorrhage from varicose veins. Vasc Surg 1997;31:413-18. 80. Hobbs J. Compression sclerotherapy of varicose veins. In: Bergan JJ, Yao JST, (eds.) Venous problems. Chicago: Year-Book Medical; 1976. 81. Abenhaim L, et al. The venous forum of the Royal Society of Medicine and Societas Phlebologica Scandinavica. Phlebology 1999;14(Suppl1):35-42. 82. Jakobsen BH. The value of different forms of treatment for varicos veins. Brit J Surg 1979;66:182. 83. Orbach EJ. Sclerotherapy of varicose veins. Utilization of an intravenous air block. Am J Surg 1944;66:362. 84. Sadick N. Sclerotherapy of the telangiectatic. In: Goldman MP, Bergan JJ, (eds.). Ambulatory treatment of venous diseas. St Louis: Mosby-Year Book; 1996. 85. Pinto-Ribeiro A. La téchnique du cinquième doigt dans la sclérose des varices. Rev Bras Cardiov 1977;13:115. 86. Miyake H. Necroses cutâneas provocadas por injeções esclerosantes utilizadas no tratamento de microvarizes e telangiectasias. Estudo experimental. Tese. São Paulo, 1972. 87. Chatard H. Discussion de la question de J-C Allart: pigmentations post-scleroterapiques. Phlebologie 1976;29:211-6. 88. Goldman MP. Sclerotherapy of superficial venules and telangiectasias of the lower extremities. Dermatol Clin 1987;5:369. 89. Norris MJ, et al. Treatment of essencial telangiectasia: effects of incresing concentrations of polidocanol. J Am Dermatol 1989;20:643. 90. Shing Y, et al. Angiogenesis is stimulated by tumor-derived endotelial cell growth factor. J Cell Biochem 1985;29:275. 91. Sadick NS, Niedt GW. A study of strogen and progesterone receptors in spider telangiectasias of the lower extremities. J Dermatol Surg Oncol 1990;16:620. 92. Sapin G. A propos d’un cas de trombose profunde sur 300.000 injections sclérosants (ou soit-disant telles). Phlébologie 1966;4:321. 93. Alderman DB. Therapy for essential cutaneos telangiectasias. Posgrad Med 1977;61:91. 94. Pinto-Ribeiro A. Varizes essenciais. Estudo de 5.000 casos. Tese. UFRJ. Rio de Janeiro, 1970.
75. Vin F, Schadeck M. Macroesclerotherapy and duplex technology. In: Goldman MP, Bergan JJ. (eds.). Ambulatory treatment of venous disease. St Louis: Mosby-Year Book; 1996.
53. Breu FX, Guggenbichier S. European consensus meeting on foam scleroterapy, 2003 Apr, 4-6,Tegernsee, Germany. Dermat Surg 2004;30(5):709. 54. Francischelli Neto M. Crioescleroterapia. In: Merlo I, Parente JBH, Komlós PP. (eds.). Varizes e telangiectasias. Rio de Janeiro: Revinter; 2006. p. 184. 55. Francichelli Neto M. Estudo comparativo entre escleroterapia convencional e escleroterapia com esclerosante a baixa temperatura no tratamento das telangiectasias dos membros inferiores. Tese Doutorado. Faculdade de Ciências Médicas da Universidade Estadural de Campinas, 2002. 293p. 56. Munia MA, Wolosker N, Munia CG, Chao WS, Pueche-Leão P. Comparison of lasers versus scleroterapy in the treatment of lower extremity telangiectases: a prospective study. Dermatol Surg 2012 April;38(4):635-9
58. Duffy DM. Remodelacion vascular/neovasculacion inducida por escleroterapia. Phlebology Digest 1998;4:6-11. 59. Ayres Jr S et al. Generalized telangiectasias and sinus infection: report of a case with cure by treatment of chronic sunisitis. Arch Derm Syph 1931;26:56. 60. Noe JM et al. Pos rhinoplasty “red nose”: differential diagnosis and treatment by laser. Plast Reconstr Surg 1981;67:661. 61. Miyake H. Tratamento estético das microvarizes. Aula proferida durante o 29º Congresso Brasileiro de Angiologia e Cirurgia Vascular. Vitória, 1991. 62. Miyake H. Estado atual da escleroterapia de varizes. In: Maffei FHA et al., (eds.). Doenças vasculares periféricas. 2. ed. Rio de Janeiro: Medsi; 1995. p. 975. 63. Merlo I. Cirurgia de varizes. Técnica para pacientes que buscam exclusivamente o resultado estético. Rev Angiol Cir Vasc 1993;2(1):177. 64. Salles-Cunha S. Modern and new non-invasive technique for the diagnosis of acute and chronic venous disease. Aula proferida no 4º Panamerican Congress on Vascular Surgery. Rio de Janeiro, 1996. 65. Goldman MP, Zaleski-Larsen L. Pathophysiology of telangiectasias. In: Goldman MP, Weiss RA, et al., (eds). Treatment of varicose and telangiectatic leg veins. Scleroterapy. 6th ed. Amsterdam: Elsevier; 2017. p. 81-99. 66. Curri GB, Lo Brutto ME. Influenza dei mucopolisaccaridi e dei loro constituenti sulla neofarmazione vascolare. Riv Pat Clin Sper 1967;8:379. 67. Jensen EV et al. Receptors reconsidered: a 20-years perspective. Rec Prog Hom Res 1982;38:1. 68. Davis LT, Duffy DM. Determination of incidence and risk factors for post-scleroterapy telangiectaic matting of the lower extremity: a retrospective analysis. J Dermatol Surg Oncol 1990;16:327-30. 69. Colburn P. Estrogen binding sites in endothelial cell cultures. Science 1978;201:817. 70. O’Brian JP. Solar and radiant demage to elastic tissue as a internal vascular disease. Aust J Dermatol 1980;21:1.
72. Ryan TJ, Kurban AK. New vessel growth in the adult skin. Br J Dermatol 1970;82(Suppl):92. 73. Folkman J, Klagsburn M. Angiogenic factors. Science 1987;235:442. 74. Fallon Jr T et al. Telangiectasias of the anterior chest in homosexual men. Ann Intern Med 1986;105:679.
281Capítulo 143 esCleroter APiA de vArizes – substânCiA s esClerosAntes
57. Parente JBH, Murilo R, Merlo I. Tratamento combinado com laser e escleroterapia nas telangiectasias. In: Merlo I, Bastos FR, Parente JBH, Figueiredo M, Murilo R, (eds.). Varizes e telangiectasias II - laser, espuma e radiofrequência.Rio de Janeiro: DiLivros; 2014. p. 43-48
71. Kumaraki M et al. Biologic changes due to long wave ultraviolet irradiation on human skin. J Invest Dermatol 1977;69:392.
2. Tatsioni A, Balk E, O´Donnell TF Jr, Lau J. Usual care in the management of chronic wounds: a review of the recent literature. J Am Coll Surg 2007;205:617-24 McLaferty RB, Passman MA, Caprini JA, Rooke TW, Markwell SA, Lohr JM, et al. Increasing awareness about venous disease: The American Venous Forum expands the National Venous Screening Program. J Vasc Surg 2008;48:394-9.
22. Portal.anvisa.gov.br>consultas-produtos. 23. Bastos FR, Pinotti M.Escleroterapia com espuma. Belo Horizonte: Folium; 2012. iBook, apple.com.
24. Rabe E, Pannier-Fisher F, Gerlach H, et al. Guidelines for sclerotherapy of varicose veins. Dermatol Surg 2004; 30: 687-93.
1. Maffei FHA, Magaldi C, Pinho SZ, Lastoria S, Pinho W, Yoshida WB, Rollo HA. Varicose veins and chronic venous insufficiency in Brazil: prevalence among 1755 inhabitants of a country town. Int J Epidemiol 1986;15:210-7.
5. www.club-mousse.com 2007. Référentiel de traitement endovasculaire des varices par injection écho-guiadée de mousse fibrosante. Le Consensus de Grenoble version 2011.
282 144Capítulo TERAPIA COM ESPUMA NAS VARIZES DOS MEMBROS INFERIORES REFERÊNCIAS BIBLIOGRÁFICAS
7. O’Donnell Jr TF, Passman MA, Marston WA, Ennis WJ, Dalsing M, Kistner RL, Laurie F, Henke PK, Gloviczki ML, Eklöf BG, Stoughton J, Raju S, Shortell CK, Raffetto JD, Partsch H, Pounds LC, Cummings ME, Gillespie DL, McLafferty RB, Hassan Murad M, Wakefield TW, Gloviczki P. Management of leg ulcers: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg 2014;60:3S-59S.
17. Bergan J, Cheng V. Foam sclerotherapy: a textbook. Royal Society of Medicine. Elsevier; 2008.
25. Vin F, Benigni JP. Compression therapy: International consensus document guidelines according to scientific evidence. International Angiology 2004;23:317-45. 26. Ouvry P, Allaert FA, Desnos P and Hamel-Desnos C. Efficacy of polidocanol foam versus liquid in sclerotherapy of the great saphenous vein: a multicenter randomised controlled trial with a 2-year follow-up. Eur J Vasc Surg 2008;36:366-70. 27. Alòs J, Carreno P, Lopez JA, et al. Efficacy and safety of sclerotherapy using polidocanol foam: a controlled clinical trial. Eur J Vasc Endovasc Surg 2006;31:101-7. 28. Chen CH, Chiu CS, Yang CH. Ultrasound-guided foam sclerotherapy for treating incompetent great saphenous veins – results of 5 years of analysis and morphologic evolvement study. Dermatol Surg 2012;38:851-7. 29. Gillet JL, Guedes JM, Guex JJ, Hamel-Desnos C, Schadeck M, Lauseker M, Allaert FA. Side-effects and complications of foam sclerotherapy of the great and small saphenous veins: a controlled multicentre prospective study including 1025 patients. Phlebology 2009;24(3):131-38. 30. Guex JJ. Ultrasound guided sclerotherapy for perforating veins. Hawaii Med J 2000;59:261-2. 15. 31. Masuda EM, Kessler DM, Lurie F, Puggioni A, Kistner RL, Eklof B. The effect of ultrasound guided sclerotherapy of incompetent perforator veins on venous clinical severity scores. J Vasc Surg 2006;43:551-6. 32. Kakkos SK, Bountouroglou DG, Azzam M, Kalodiki E, Daskalopoulos M, Geroulakos G. Effectiveness and safety of ultrasound-guided foam sclerotherapy for recurrent varicose veins: immediate results. J Endovasc Ther 2006;13:357-64. 23. 33. Darvall KA, Bate GR, Adam DJ, Silverman SH, Bradbury AW. Duplex ultrasound outcomes following ultrasound guided foam sclerotherapy of symptomatic recurrent great saphenous varicose veins. Eur J Vasc Endovasc Surg 2011;42:107-14. 34. Stücker M, Reich S, Hermes N, et al. Safety and efficiency of perilesional sclerotherapy in leg ulcer pacientes with post-thrombotic syndrome and/or oral anticoagulation with phenprocoumarinun. JDDG 2006;4:734-8. 35. Hertzman PA, Owens R. Rapid healing of chronic venous ulcers following ultrasound- guided foam sclerotherapy. Phlebology 2007;22:34-9. 36. Obermayer A, Garzon K. Identifying the source of superficial reflux in venous leg ulcers using duplex ultrasound. J Vasc Surg 2010;52:1255-61. 37. Hamel-Desnos C, Ouvry P, Benigni JP, Boitelle G, Schadeck M, Desnos P, Allaert FA. Comparison of 1% and 3% polidocanol foam in ultrasound guided sclerotherapy of the great safenous vein: a randomised, double-blind trial with two year-follow-up. The 3/1 study. Eur J Vasc Endovasc Surg 2007;34:723-29. 38. Coleridge-Smith P. Chronic venous disease treated by ultrasound guided foam sclerotherapy. Eur J Vasc Surg 2006;32:577-83. 39. Laurie F, Camerota A, Eklöf B, Kistner RL, Laborpoulos N, Lohr J, Marston W, Meissner M, Moneta G, Neglén P, Neuhardt D, Padberg Jr F, Welsh HJ. Multicenter assesment of venous reflux by duplex ultrasound. J Vasc Surg 2011;55(2):437-45.
6. Rabe E, Breu FX, Cavezzi A, Coleridge Smith P, Frullini A, Gillet JL, Guex JJ, Hamel-Desnos C, Kern P, Partsch H, Ramelet AA, Tessari L, Pannier F. European guidelines for sclerotherapy in chronic venous disorders. Phlebology 2014;29(6):338-54.
4. Criqui MH, Jamosmos M, Fronek A, et al. Chronic venous disease in an ethnically diverse population. Am J Epidemiol 2003;158:448-56.
8. Presti C, Miranda F, Merlo I, Moraes MRS, Kikushi R, Campos Jr W, Moura MRL. Insuficiência venosa crônica: diagnóstico e tratamento. Projeto Diretrizes – S.B.A.C.V. 2015;34p. 9. Orbach EJ, Petegretti AK. The thrombogenic property of a foam of a synthetic anionic detergent (sodium tetradecil sulfato). Angiology 1950;1:237.
3.
10. Orbach EJ. Contribution to the therapy of the varicose complex. J Int Coll Surg 1950;13:7765-7. 11. Cabrera Garrido JR, Cabrera Garcia-Olmedo JR, Garcia-Olmedo DMA. Elargissement des limites de la schlérothérapie: noveaux produits sclérosants. Phlébologie 1997;50:181-8.
12. Monfreux A. Traitement sclérosant des troncs saphéniens et leur collatérales de gros calibre par le méthode MUS. Phébologie 1997;50:351-3. 13. Tessari L, Cavezzi A, Frulinni A. Preliminary experience with a new sclerosing foam in the treatment of varicose veins. Dermatol Surg 2001;27:58-60. 14. Hamel-Desnos C, Desnos P, Wollmann JC, Ouvry P, Mako S, Allaert FA. Evaluation of the efficacy of polidocanol in the form of foam compared with liquid form in sclerotherapy of the greater saphenous vein: initial results. Dermatol Surg 2003;29(12):1170-5.
18. Meissner MH, Gloviczki P, Bergan J, Kistner RL, Morrison N, Pannier F, Pappas PJ, Rabe E, Raju S, Villavicencio JL. Primary chronic venous disorders. J Vasc Surg 2007;46:54S-67S.
19. Bradbury AW, Bate G, Pang K, Darval KA, Adam DJ. Ultrasound-guided foam sclerotherapy is a safe and clinically effective treatment for superficial venous reflux. J Vasc Surg 2010;52:939-45.
20. Parsi K, Connor DE, Exner T, Herbert A, Ma DDF, Joseph JE. The lytic effects of detergent sclerosants on erythrocytes, platelets, endothelial cells and microparticles are attenuated by albumin and other plasma components in vitro. Eur J Vasc Endovasc Surg 2008; 36(2): 216-23.
21. http://www.aethoxysklerol-internacional.com/50-years-of-aethoxysklerol-health-legs.
15. Gobin JP, Benigni JP. La sclérothérapie. Paris: Eska; 2007. 16. Breu FX, Guggenbichler S, Wollmann JC. Second European Consensus Meeting on Foam Sclerotherapy. Tergernsee, Germany: Vasa; 2008. p. 3790-5.
44.
52. Guex JJ, Allaert FA, Gillet JL, et al. Immediate and midterm complications of sclerotherapy:report of a prospective multicenter registry of 12,173 sclerotherapy sessions. Dermatol Surg 2005;31:123-8.
47.
45.
53. Jia X, Mowatt G, Burr JM, et al. Systematic review of foam sclerotherapy for varicose veins. Br J Surg 2007;94:925-36.
40.
49.
42.
283Capítulo 144 ter APiA Com esPumA nA s vArizes dos membros inferiores Perrin M. Rationale for surgery in the treatment of venous ulcer of the leg. Phlebolimphol 2004;45:276-80. Danielsson G, Arfvidsson B, Eklöf B, Kistner RL, Masuda EM, Satoc DT. Reflux from thigh to calf, the major pathology in chronic venous ulcer disease: surgery indicated in the majority of pacientes. Eur J Vasc Endovasc Surg 2004;38:209-19. Beckitt, et al. Air versus phisiological gas for ultrasound guided foam sclerotherapy treatment of varicose veins. European J Vasc Endovasc Surg 2011;1:5. De Roos KP, Groen L, Leenders AC. Foam sclerotherapy: investigating the need for sterile air. Dermatol Surg 2011;37:1119-24. Bastos FR, Lima A, Assumpção AC. Escleroterapia de varizes com espuma. Revisão. Rev Med MG 2009;19(1):38-43. Partsch H, Mosti G, Uhl JF. Unexpected venous diameter reduction by compression stocking of deep, but not of superficial veins. Veins and Lymphatics 2012;1:e3. Ragg JC. Eccentric compression of large varicose veins after foam sclerotherapy using a novel silicone gel pad. Phlebologie 2014;43;250-6. Ragg JC. Film compression bandage: a new modality to improve sclerotherapy of superficial varicosities. Veins and Lymphatics 2017;6:6635 Figueiredo M, Araújo SP, Penha-Silva N. Escleroterapia com microespuma em varizes tronculares primárias. J Vasc Bras 2006;v5:3. Silva MAM, Burihan MC, Barros OC, Nesser F, Ingrund JC, Neser A. Resultados do tratamento da insuficiência venosa crônica grave com espuma de polidocanol guiada por ultrassom. J Vasc Bras 2012;11:3. Campos Jr W, Torres IO, da Silva ES, Casella IB, Puech-Leão P. A prospective randomised study comparing polidocanol foam sclerotherapy with surgical treatment of patients with primary chronic venous insufficiency and ulcer. Ann Vasc Surg 2015;27(6):1128-35.
46.
48.
51. Gohel MS, Heatley F, Liu X, Bradbury A, Bulbulia R, Cullum N, Epstein DM, Nyamekye I, Poskitt KR, Renton S, Warwick J, Davies AH for the EVRA Trial Investigators. A randomized trial of early endovenous ablation in venous ulceration. N Engl J Med 2018; 378:2105-14.
41.
54. Tiossi SR, Taira SA, Martins MJ, Morais JDF, Palomo AT, Tanaka CM, Matielo MF, Nakamura ET, Godoy MR, Pecego CS, Sacilotto R. Análise do tratamento ambulatorial das varizes na insuficiência venosa crônica avançada através da escleroterapia com espuma guiada por eco-Doppler. Poster dos anais do XVI Encontro São Paulo de Cirurgia Vascular e Endovascular, 2018. 55. Raymond-Martimbeau P. Transiente adverse events positively associated with patent foramen ovale after ultrasound-guided foam sclerotherapy. Phlebology 2009;24:1114-9.
56. Frulini A, Felice F, Burchielli S, Di Stefano R.Neurological complications of foam sclerotherapy: fears and reality. Phlebology 2011;26:277-79. 57. Sarvananthan T, Shepherd AC, Willenberg T, Davies AH.Neurological complications of scleroherapy for varicose veins. J Vasc Surg 2012;55(1):243-51.
58. Kulkarni SR, Messenger DE, Slim FJA, Emerson LG, Balbulia RA, Whyman MR, Poskitt KR. The incidence and characterization of deep vein trhombosis following ultrasound-guided foam sclerotherapy in 1000 legs with superficial venous reflux. J Vasc Surg; Venous and Lymphatic Disorders 2013;1:231-8.
43.
50.
28. Cavezzi A, Mosti G, Campana F, Tessari L, Bastiani L, Urso SU. Corrigendum to “catheter foam sclerotherapy of the great saphenous vein, with perisaphenous tumescence infiltration and saphenous irrigation” [Eur J Vasc Endovasc Surg (2017) 629–635] (S1078588417305002) (10.1016/j.ejvs.2017.08.004). Eur J Vasc 2018;55(5):745. 29. Barwell JR, Davies CE, Deacon J, Harvey K, Minor J, Sassano A, et al. Comparison of surgery and compression with compression alone in chronic venous ulceration (ESCHAR study): randomised controlled trial. Lancet 2004 Jun 5;363(9424):1854-9. 30. Gohel MS, Barwell JR, Taylor M, Chant T, Foy C, Earnshaw JJ, et al Long term results of compression therapy alone versus compression plus surgery in chronic venous ulceration (ESCHAR): randomised controlled trial. BMJ 2007 Jul 14;335(7610):83. 31. Kulkarni SR, Slim FJA, Emerson LG, Davies C, Bulbulia RA, Whyman MR, et al. Effect of foam sclerotherapy on healing and long-term recurrence in chronic venous leg ulcers. Phlebol J Venous Dis 2013 Apr 6;28(3):140-6. 32. IBGE Censo 2010 [Internet]. [cited 2018 Jul 8]. Available from: https:// censo2010.ibge.gov.br/sinopse/index.php?dados=12. 33. Agência Nacional de Saúde Suplementar. Caderno de Informação da Saúde Suplementar. Rio de Janeiro; 2017. 34. Ricardo Barros. Portaria n0 709, de 9 de março de 2017. Brasília: Ministério da Saúde; 2017. p. 1-3. 35. Ministério da Saúde B. DATASUS [Internet]. [cited 2018 Jul 8]. Available from: http://www2.datasus.gov.br/DATASUS/index.php?area=02.
12. Cavezzi A, Mosti G, Campana F, Tessari L, Bastiani L, Urso SU. Catheter foam sclerotherapy of the great saphenous vein, with perisaphenous tumescence infiltration and saphenous irrigation. Eur J Vasc Endovasc Surg Elsevier Ltd 2017;1-7.
17. Gohel MS, Heatley F, Liu X, Bradbury A, Bulbulia R, Cullum N, et al. A randomized trial of early endovenous ablation in venous ulceration. N Engl J Med 2018 May 31;378(22):2105-14.
26. Gonzalez-Zeh R, Armisen R, Barahona S. Endovenous laser and echoguided foam ablation in great saphenous vein reflux: one-year follow-up results. J Vasc Surg 2008 Oct;48(4):940–6. 27. Smith PC. Chronic venous disease treated by ultrasound guided foam sclerotherapy. Eur J Vasc Endovasc Surg 2006 Nov;32(5):577-83.
10. Rabe E, Breu F, Cavezzi A, Smith PC, Frullini A, Gillet J, et al. European guidelines for sclerotherapy in chronic venous disorders. Phlebol J Venous Dis 2014 Jul 6;29(6):338-54.
284 145Capítulo TERAPIA COM ESPUMA NAS VARIZES DE MEMBROS INFERIORES CEAP 5 E 6 REFERÊNCIAS BIBLIOGRÁFICAS
4. Mendoza E, Blättler W, Amsler F. Great saphenous vein diameter at the saphenofemoral junction and proximal thigh as parameters of venous disease class. Eur J Vasc Endovasc Surg 2013 Jan;45(1):76-83.
20. Brittenden J, Cotton SC, Elders A, Ramsay CR, Norrie J, Burr J, et al A randomized trial comparing treatments for varicose veins. N Engl J Med 2014 Sep 25;371(13):1218-27. 21. Rasmussen LH, Lawaetz M, Bjoern L, Vennits B, Blemings A, Eklof B. Randomized clinical trial comparing endovenous laser ablation, radiofrequency ablation, foam sclerotherapy and surgical stripping for great saphenous varicose veins. Br J Surg 2011 Aug;98(8):1079-87.
1. Jantet G. Chronic venous insufficiency: worldwide results of the RELIEF study. Angiology 2002 May 2;53(3):245-56.
6. Cameron E, Chen T, Connor DE, Behnia M, Parsi K. Sclerosant foam structure and stability is strongly influenced by liquid air fraction. Eur J Vasc Endovasc Surg 2013 Oct;46(4):488-94.
5. Breu FX, Guggenbichler S, Wollmann JC. 2nd European Consensus Meeting on Foam Sclerotherapy 2006, Tegernsee, Germany: Vasa; 2008 Feb;37 Suppl 71:1-29.
16. Campos W, Torres IO, Da Silva ES, Casella IB, Puech-Leão P. A prospective randomized study comparing polidocanol foam sclerotherapy with surgical treatment of patients with primary chronic venous insufficiency and ulcer. Ann Vasc Surg 2015;29(6):1128-35.
18. Alden PB, Lips EM, Zimmerman KP, Garberich RF, Rizvi AZ, Tretinyak AS, et al. Chronic venous ulcer: minimally invasive treatment of superficial axial and perforator vein reflux speeds healing and reduces recurrence. Ann Vasc Surg 2013 Jan;27(1):75-83.
19. Lloret P, Redondo P, Cabrera J, Sierra A. Treatment of venous leg ulcers with ultrasound-guided foam sclerotherapy: healing, longterm recurrence and quality of life evaluation. Wound Repair Regen 2015;23(3):369-78.
25. Myers KA, Jolley D, Clough A, Kirwan J. Outcome of ultrasound-guided sclerotherapy for varicose veins: medium-term results assessed by ultrasound surveillance. Eur J Vasc Endovasc Surg 2007 Jan;33(1):116-21.
7. Troianos CA, Hartman GS, Glas KE, Skubas NJ, Eberhardt RT, Walker JD, et al. Guidelines for performing ultrasound guided vascular cannulation: recommendations of the American Society of Echocardiography and the Society of Cardiovascular Anesthesiologists. J Am Soc Echocardiogr 2011 Dec;24(12):1291-318.
3. Cabrera J, Redondo P. Foam Treatment of venous leg ulcers: the initial experience. Venous ulcers. Academic Press 2007 Jan 1;199-213.
14. Pang KH, Bate GR, Darvall KAL, Adam DJ, Bradbury AW. Healing and recurrence rates following ultrasound-guided foam sclerotherapy of superficial venous reflux in patients with chronic venous ulceration. Eur J Vasc Endovasc Surg 2010;40(6):790-5.
22. Grover G, Tanase A, Elstone A, Ashley S. Chronic venous leg ulcers: effects of foam sclerotherapy on healing and recurrence. Phlebology 2016;31(1):34-41. 23. Kulkarni SR, Slim FJA, Emerson LG, Davies C, Bulbulia RA, Whyman MR, et al. Effect of foam sclerotherapy on healing and long-term recurrence in chronic venous leg ulcers. Phlebol J Venous Dis 2013 Apr 6;28(3):140-6. 24. Shadid N, Nelemans P, Lawson J, Sommer A. Predictors of recurrence of great saphenous vein reflux following treatment with ultrasoundguided foamsclerotherapy. Phlebology 2015;30(3):194–9.
11. Yamaki T, Hamahata A, Soejima K, Kono T, Nozaki M, Sakurai H. Prospective randomised comparative study of visual foam sclerotherapy alone or in combination with ultrasound-guided foam sclerotherapy for treatment of superficial venous insufficiency: preliminary report. Eur J Vasc Endovasc Surg 2012 Mar;43(3):343-7.
13. Devereux N, Recke AL, Westermann L, Recke A, Kahle B. Catheterdirected foam sclerotherapy of great saphenous veins in combination with pre-treatment reduction of the diameter employing the principals of perivenous tumescent local anesthesia. Eur J Vasc Endovasc Surg WB Saunders 2014 Feb 1;47(2):187-95.
2. Cesarone MR, Belcaro G, Nicolaides AN, Laurora G, De Sanctis MT, Incandela L, et al. Epidemiology and costs of venous diseases in central Italy. The San Valentino venous disease project. Angiology 1997 Jul 2;48(7):583-93.
8. Masuda EM, Kessler DM, Lurie F, Puggioni A, Kistner RL, Eklof B. The effect of ultrasound-guided sclerotherapy of incompetent perforator veins on venous clinical severity and disability scores. J Vasc Surg 2006 Mar;43(3):551-6; discussion 556-7.
9. Kiguchi MM, Hager ES, Winger DG, Hirsch SA, Chaer RA, Dillavou ED. Factors that influence perforator thrombosis and predict healing: perforator sclerotherapy for venous ulceration without axial reflux. J Vasc Surg 2014 Jan 6;59(5):1368-76.
15. Howard JK, Slim FJA, Wakely MC, Emerson LG, Davies CE, Kulkarni SR, et al. Recanalisation and ulcer recurrence rates following ultrasoundguided foam sclerotherapy. Phlebology 2016;31(7):506-13.
36. National Clinical Guideline Centre. Varicose veins in the legs. The diagnosis and management of varicose veins. 2013. 37. NICE. Surveillance report 2016 – Varicose veins in the legs (2013) NICE guideline CG168. 2016.
27. Beasley KL, Weiss RA, Weiss MA et al. Treatment of post-sclerotherapy hyperpigmentation with a novel Q-switched combination 532/1064nm Nd:YAG laser. Lasers Med Surg 2004;16:15
7. Goldman MP, Kaplan RP, Duffy DM. Postsclerotherapy hyperpigmentation: a histologic evaluation. J Dermatol Surg Oncol 1982;13(5):547-50.
6. Scott C, Seiger E. Postsclerotherapy pigmentation. Is sérum ferritin level an accurate indicator? Dermatol Surg 1997;23(4):281-2.
2. Palm MD, Guiha IC, Goldman MP. Foam sclerotherapy for reticular veins and nontruncal varicose veins of the legs: a retrospective review of outcomes and adverse effects. Dermatol Surg 2010;36 (Suppl 2):1026-33.
8. Caggiati A, Rosi C et al. Skin iron deposition characterises lipodermatosclerosis and leg ulcer. Eur J Vasc Endovasc Surg 2010;40(6):777-82.
15. Anderson RR, Parish JA. Selective photodermolysis: precise microsurgery by selective absorption of pulsed radiation. Science 1983;220(4596):524-7.
16. Scultetus AH, Vilavicencio J et al. Microthrombectomy reduces postsclerotherapy pigmentation: multicenter randomized trial. J Vasc Surg 2003;38(5):896-903.
28. Babilas P, Schreml S et al. Intense Pulsed Light (IPL):a review. Lasers Surg Med 2010;42(2):93-104.
285 146CapítuloMANCHAS HIPERCRÔMICAS APÓS CIRURGIA DE VARIZES E ESCLEROTERAPIA REFERÊNCIAS BIBLIOGRÁFICAS
4. Ackerman Z, Seidenbaum M et al. Overload of iron in the skin of patients with varicose ulcers. Possible contributing role of iron accumulation in progress of the disease. Arch Dermatol 1988;124(9):1376-8.
5. Thibault PK, Wlodarczyk J. Correlation of sérum ferritin levels and postsclerotherapy pigmentation. A prospective study. J Dermatol Surg Oncol 1994;20(10):684-6.
9. Bisset DL, Chatterjee R, Hannon DP. Chronic ultravioleta radiation induced increase in skin iron and the photoprotective effect of topically applied iron chelators. Photochem Photobiol 1991;54(2):215-23.
3. Goldman, MP. Complications and adverse sequelae os sclerotherapy. 5th ed. Rio de Janeiro: Elsevier; 2011. p. 180-237.
14. Verveková L, Jedlièka V, Wechsler J et al. Analysis of surgical procedures on the vena saphena magna in the Czech Republic and an effect of Detralex during its stripping. Rozhl Chir 2005;84:410-16.
22. Górski G, Szopinski P et al. Liposomal heparina spray: a new formula in adjunctive treatment of superficial venous thrombosis. Angiology 2005;56(1):9-17. 23. Weiss RA, SadickNS et al. Post-sclerotherapy compression: controlled comparative study of duration of compression and its effects on clinical outcome. Dermatol Surg 1999;25(2):105-8. 24. Myers HL. Topical chelation therapy for varicose pigmentation. Angiology 1966;17(1):66-8. 25. Lopez L, Dilley RB et al. Cutaneous hyperpigmentation following venous sclerotherapy treated with deferoxamine mesylate. Dermatol Surg 2001;27(9):795-8. 26. Chaudhuri RK. Emblica cascading antioxidant: a novel natural skin care ingredient. Skin Pharmacol ApplSkin Physiol 2002;15(5):374-80.
13. Jia X, Mowatt G et al. Systematic review of foam sclerotherapy for varicose veins. Br J Surg 2007;94(8):925-36.
17. Bergan JJ, Pascarella L et al. Pathogenesis of primary chronic venous disease: Insights from animal models of venous hypertension. J Vasc Surg 2008;47(1):183-92. 18. Francoise P. Benefit of Daflon 500mg in combination with sclerotherapy of telangiectasias of the lower limbs: results from SYNERGYand SATISFY surveys. Phlebolymphology 2011;119:18-87.
12. Bruken A, Rabe E, Pannier F. Changes in venous function after foam sclerotherapy of varicose veins. Phebology 2009;24(4):145-50.
21. Cesarone MR, Belcaro G. Topical heparina: new observations. Angiology 2007;58(Suppl 1):16S-20S.
1. Beebe HG, Bergan JJ, Bergqvist D et al. Classification and grading of chronic venous disease in the lower limbs: a consensus statement. Vasc Surg 1996;30:5-11.
19. Savuevy VS, Pokrovsky AV et al. Stripping of the great saphenous vein under micronized purified flavonoid fraction (MPFF) protection. Phlebolymphology 2008;15:45-51. 20. Plesca-Manea L, Pârvu AE et al. Effect of Melilotus officinalis on accute inflammation. Phytother Res 2002;16(4):316-9.
10. Nordlund JJ. Postinflammatory hyperpigmentation. Dermatol Clin 1988;6(2):185-92.
11. Briganti S, Camera E, Picardo M. Chemical and instrumental approaches to treat hyperpigmentation. Pigment Cell Res 2003;16(2):101-10.
16. Czuprynska J, Patel JP, Arya R. Current challenges and future prospects in oral anticoagulant therapy. Br J Haematol 2017 Sep;178(6):838-851. 17. Gómez-Outes A, Suárez-Gea ML, Lecumberri R, Terleira-Fernández AI, Vargas-Castrillón E. Direct-acting oral anticoagulants: pharmacology, indications, management, and future perspectives. Eur J Haematol 2015 Nov;95(5):389-404.
4. Baglin T, Luddington R, Brown K, Baglin C. Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study. Lancet 2003;362(9383):523-6.
REFERÊNCIAS BIBLIOGRÁFICAS
1. Rosendaal FR. Venous thrombosis: a multicausal disease. Lancet 1999;353:1167-73.
10. Kearon C, Ginsberg JS, Kovacs MJ, et al. Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism. N Engl J Med 2003;349(7):631-9.
11. Finazzi G, Marchioli R, Brancaccio V, et al. A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS)1. J Thromb Haemost 2005;3(5):848-53.
TROMBOFILIAS
9. Cohn DM, Rochani S, Middeldorp S. Thrombophilia and venous thromboembolism: implications for testing. Semin Throm Hemost 2007;33:573-81.
18. van der Hulle T, Kooiman J, den Exter PL, Dekkers OM, Klok FA, Huisman MV. Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta-analysis. J Thromb Haemost 2014;12(3):320-8.
7. Middeldorp S, Levi M. Thrombophilia: an update. Semin Thromb Hemost 2007;33:563-72.
2. Pruthi RK. Optimal utilization of thrombophilia testing. Int J Lab Hematol 2017;39 Suppl 1:104-10. 3. Bauer KA. The thrombophilias: well-defined risk factors with uncertain therapeutic implications. Ann Intern Med 2001;135(5):367-73.
5. Christiansen SC, Cannegieter SC, Koster T, Vandenbroucke JP, Rosendaal FR. Thrombophilia, clinical factors, and recurrent venous thrombotic events. JAMA 2005;293(19):2352-61.
6. Ho WK, Hankey GJ, Quinlan DJ, Eikelboom JW. Risk of recurrent venous thromboembolism in patients with common thrombophilia: a systematic review. Arch Intern Med 2006;166(7):729-36.
12. Keijzer MB, Blom HJ, Bos GM, Willems HP, Gerrits WB, Rosendaal FR. Interaction between hyperhomocysteinemia, mutated methylenetetrahydrofolatereductase (MTHFR) and inherited thrombophilic factors in recurrent venous thrombosis. Thromb Haemost 2002;88(5):723-8. 13. Simioni P, Sanson BJ, Prandoni P, et al. Incidence of venous thromboembolism in families with inherited thrombophilia. Thromb Haemost 1999;81(2):198-202. 14. Wu O, Robertson L, Twaddle S, et al. Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study. Health Technol Assess 2006;10(11):110. 15. Bank I, Scavenius MP, Büller HR, Middeldorp S. Social aspects of genetic testing for factor V Leiden mutation in healthy individuals and their importance for daily practice. Thromb Res 2004;113(1):7-12.
8. Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Eisenberg PR,Miletich JP. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med 1995;332:912-7.
19. Heit JA. Predicting the risk of venous thromboembolism recurrence. Am J Hematol 2012;87:S63-S67. 20. Prins MH, Lensing AWA, Prandoni P, Wells PS, Verhamme P, Beyer-Westendorf J, Bauersachs R, Bounameaux H, Brighton TA, Cohen AT, Davidson BL, Decousus H, Kakkar AK, van Bellen B, Pap AF, Homering M, Tamm M, Weitz JI. Risk o f recurrent venous thromboembolism according to baseline risk factor profiles. Blood Adv 2018;10;2(7):788-96.
286 147Capítulo
4. Kalodiki E. Superficial vein thrombosis: a consensus statement. Int Angiol 2012;31:203-16. 5. Litzendorf M. Superficial venous thrombosis: disease progression and evolving treatment approaches. Vasc Health Risk Manag 2011;7:569-75.
3. Sobreira ML et al. Tromboflebite superficial: epidemiologia, fisiopatologia, diagnóstico e tratamento. J Vasc Br 2008;7(2):131-43.
TROMBOSE VENOSA SUPERFICIAL BIBLIOGRÁFICAS
21. Blattler W et al. Superficial vein thrombophlebitis: serious concern on much ado about little? Vasa 2008;37(1):31-8. 22. Lozano FS, Almazan A. Low-molecular-weight heparin versus saphenofemoral disconnection for the treatment of above-knee greater saphenous thrombophlebitis: a prospective study. Vasc Endovasc Surg 37(6):415-20.
14. Kearon C, Akl EA, Comerota AJ, Prandoni P, Bounameaux H, Goldhaber S, Nelson M, Wells PS, Gould MK, Dentali F, Crowther M, Kahn SR. American College of Chest Physicians. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. 9th ed. Chest 2012;141(2):425S.
10. Sobreira ML. Prevalência de trombose venosa profunda e embolia pulmonar em tromboflebite superficial de membros inferiores: estudo prospectivo de 60 casos. J Vasc Br 2010;9(1):90-1.
19. Heit JA, Siverstein MD, Mohr DN, et al. Risk factors for deep vein thrombosis and pulmonary embolism. Arch Intern Med 2000;160(6):809-15. 20. Sullivan V et al. Ligation versus anticoagulation: treatment of aboveknee superficial thrombophlebitis not involving the deep venous system. L Am Coll Surg 2011;193:556-62.
1. Décousus H et al. Recent findings in the epidemiology, diagnosis and treatment of superficial-vein thrombosis. Thrombosis Research 2011;127:S81-S85.
7. Scovell SD, Ergul EA, Conrad MF. Medical management of acute superficial vein thrombosis of saphenous vein. J Vasc Surg 2017 Oct 30. 8. van Langevelde K. Increased risk of venous thrombosis in persons with clinically diagnosed superficial vein thrombosis: results from MEGA study. Blood 2011;118:4239-41.
6. Décousus H. Superficial vein thrombosis: risk factors, diagnosis and treatment. Curr Opini Pulm Med 2003;9:393.
15. Husni EA, Williams WA. Superficial thrombophlebitis of lower limbs, Surgery 1982;91:70-74. 16. Lofgren EP, et al. The surgical treatment of superficial thrombophlebitis. Surgery 1981;90:49-54. 17. Kitchens CS, et al. How I treat superficial venous thrombosis. Blood 2011;117(1):39-44.
23. Superficial thrombophlebitis treated by enoxaparin study group. A pilot randomized double-blind comparison of a low-molecularweight heparina, a nonsteroidal anti-inflamatory agent, and placebo in the treatment of superficial vein thrombosis. Arch Intern Med 2003;163(14):1657-63.
18. Leon L, Giannoukas AD, Dodd D, et al. Clinical significance of superficial vein thrombosis. Eur J Vasc Endovasc Surg 2005;29(1):10-7.
24. Silvestre MA, Quashié C, Genty C, Rolland C, Queré I, Bosson JL; Optimev investigators. Clinical presentation and mortality in pulmonary embolism: the Optimev Study. J Mal Vasc 2010;35(4):242-249.
13. Kearon C, Kahn SR, Agnelli G, Goldhaber S, Raskob GE, Comerota AJ. American College of Chest Physicians. Antitrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. 8th ed. Chest 2008;133(S6):454S-545S.
2. Wichers IM et al. Treatment of superficial vein thrombosis to prevent deep vein thrombosis and pulmonary embolism: a systematic review. Haematologica 2005;90:672-7.
9. Sobreira ML, Rogatto SR, dos Santos RM, Santos IT, Ferrari IC, Yoshida WB. An unexpectedly high rate of thrombophilia disorders in patients with superficial vein thrombosis of the lower extremities. Ann Vasc Surg 2017;43:272-7.
12. Di Nisio M, Wichers IM, Middeldorp. Treatment for superficial thrombophlebitis of the leg. Cochrane Database Syst Rev 2007:CD004982.
REFERÊNCIAS
11. Décousus H, et al. Superficial venous thrombosis and venous thromboembolism: a large, prospective epidemiologic study. Ann Intern Med 2010;152:218-24.
287 148Capítulo
8. Brandjes DP, Büller HR, Heijböer H et al. Randomised trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosis. Lancet 1997;349:759-62.
30. Anderson FA Jr, Wheeler HB, Goldberg RJ et al. The prevalence of risk factors for venous thromboembolism among hospital patients. Arch Intern Med 1992;152(8):1660-4.
19. Poort S, Rosendaal FR, Reistima PH et al. A common genetic variation in the 3’– untranslated region of the protrombin gen associated with elevated plasma protrombin levels and increase in venous thrombosis. Blood 1996;88:3698-703.
7. Lindblad B, Stemby NH, Bergqvist D. Incidence of venous thromboembolism verified by necropsy over 30 years. BMJ 1991;302(6778):709-11.
6. Maffei FHA, Falleiros ATS, Venezian LA, Franco MF. Contribuição ao estudo da incidência e anatomia patológica do tromboembolismo venoso em autopsias. Rev Ass Med Bras 1980;26:7-10.
23. Heit JA, Silverstein MD, Mohr DN et al. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based casecontrol study. Arch Intern Med 2000;160(6):809-15.
288 149Capítulo
17. Broekmans AW. Hereditary protein S deficiency and venous thromboembolism. Thromb Haemost 1985;53:273-7.
12. Thomas D. Venous thrombogenesis. Br Med Bull 1994;50(4):803-12.
29. Engbers MJ, van Hylckama Vlieg A, Rosendaal FR. Venous thrombosis in the elderly: incidence, risk factors and risk groups. J Thromb Haemost 2010;8:2105-12.
13. Aronson DL, Thomas DP. Experimental studies on venous thrombosis: effect of coagulants, procoagulants and vessel contusion. Thromb Haemost 1985;54(4):866-70.
21. Kakkar VV, Flanc C, Howe CT, Clark MB. Natural history of postoperative deep vein thrombosis. Lancet 1969;2:230-2.
16. Griffin JH, Evatt B, Zimmerman TS. Deficiency of protein C in congenital thrombotic disease. J Clin Invest 1981;68:1370-3.
26. Samama MM. An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study. Arch Intern Med 2000;160(22):3415-20. 27. Lindblad B, Sternby N, Bergqvist D. Incidence of venous thromboembolism verified by necropsy over 30 years. BMJ 1991;302:709-11.
PROFUNDA REFERÊNCIAS
25. Goldhaber, SZ. Prevention of recurrent idiopathic venous thromboembolism. Circulation 2004 Dec 14;110(24 Suppl 1):IV20-4.
20. Warwick D. Prevention of venous thromboembolism in total knee and hip replacement. Circulation 2012;125(17):2151-5.
28. Warlow C, Ogston D, Douglas AS. Deep venous thrombosis of the legs after stroke. Part I: incidence and predisposing factors. Br Med J 1976;1(6019):1178-81.
10. Thomas DP, Merton RE, Hockley DJ. The effect of stasis on venous endothelium: an ultrastructural study. Br J Haematol 1983;55(1):113-22.
35. Bloemenkamp KW, Rosendaal FR, Helmerhorst FM et al Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a thirdgeneration progestagen. Lancet 1995;346(8990):1593-6. 36. Rosendaal FR, Vessey M, Rumley A et al. Hormonal replacement therapy, prothrombotic mutations and the risk of venous thrombosis. Br J Haematol 2002;116(4):851-4. 37. Herrington DM, Vittinghoff E, Howard TD et al. Factor V Leiden, hormone replacement therapy, and risk of venous thromboembolic events in women with coronary disease. Arterioscler Thromb Vasc Biol 2002;22(6):1012-7. 38. Marik PE, Plante LA. Venous thromboembolic disease and pregnancy. N Engl J Med 2008;359(19):2025-33. 39. Konstantinides S. Clinical practice: Acute pulmonary embolism. N Engl J Med 2008;359(26):2804-13. 40. Cogo A, Bernardi E, Prandoni P. Acquired risk factors for deepvein thrombosis in symptomatic outpatients. Arch Inten Med 1994;154(2):164-68. 41. White RH, Zhou H, Gage BF. Effect of age on the incidence of venous thromboembolism after major surgery. J Thromb Haemost 2004;2:1327-33. 42. Borch KH, Braekkan SK, Mathiesen EB et al. Abdominal obesity is essential for the risk of venous thromboembolism in the metabolic syndrome: the Tromso study. J Thromb Haemost 2009;7:739-45. 43. Turpie AG, Levine MN, Hirsch J et al. A randomized controlled trial of a low molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery. N Engl J Med 1986;315(15):925-9. 44. Clagett GP, Anderson FA, Heit J et al. Prevention of venous thromboembolism. Chest 1995;108(4 Suppl):312S-34S. 45. Scurr JH. How long after surgery does the risk of thromboembolism persist? Acta Chir Scand Suppl 1990;556:22-4.
11. Thomas DP, Merton RE, Wood RD, Hockley DJ. The relationship between vessel wall injury and venous thrombosis: an experimental study. Br J Haematol 1985;59(3):449-57.
22. Rosendaal FR. Thrombosis in the young: epidemiology and risk factors. A focus on venous thrombosis. Thromb Haemost 1977;78(1):1-6.
14. Franco RF. Fisiologia da coagulação, anticoagulação e fibrinólise. Medicina 2001;34:229-37. 15. Egeberg O. Inherited antithrombin deficiency causing thrombophilia. Thromb Diath Haemorrh 1965;13:516-30.
1. Maffei FHA. Epidemiologia do tromboembolismo venoso no Brasil. Anais do XXXII Congresso Brasileiro de Angiologia e Cirurgia Vascular 1987;283. 2. Nordström M, Lindblad B, Bergqvist D, Kjellström T. A prospective study of the incidence of deep venous thrombosis within a defined urban population. J Intern Med 1992;232:155-60.
9. The management of chronic venous disorders of the leg: an evidence-based report of an international task force. Phlebology 1999;14(Suppl 1):1-65.
3. Criado E, Burnham CB. Predictive value of clinical criteria for the diagnosis of deep vein thrombosis. Surgery 1997;22(3):578-83.
5. Wells PS, Borah BJ, Sengupta N. Analysis of venous thromboprophylaxis duration and outcomes in orthopedic patients. Am J Manag Care 2010;16(11):857-63.
31. Prandoni P, Lensing AW, Cogo A et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med 1996;125:1-7. 32. Noboda S, Le Gal G, Lakut K et al. Family history as a risk factor for venous thromboembolism. Thrombosis Research 2008;122:624-29. 33. Bezemer ID, van der Meer FJ, Elkenboom JC et al. The value of family history as a risk indicator for venous thrombosis. Arch Intern Med 2009;169(6):610-15. 34. Gomes MP, Deitcher SR. Risk of venous thromboembolic disease associated with hormonal contraceptives and hormone replacement therapy: a clinical review. Arch Intern Med 2004;164(18):1965-76.
24. Sinescu C, Hostiuc M, Bartos D. Idiopathic venous thromboembolism and thrombophilia. J Med Life 2011 Feb 15;4(1):57-62.
4. Hoog K, Wells PS, Gandara E. The diagnosis of venous thromboembolism. Semin Thromb Hemost 2012;38(7):691-701.
18. Dahlbäck B, Carlsson M, Svensson P. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: Prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 1993;90:1004-8.
TROMBOSE VENOSA BIBLIOGRÁFICAS
69.
60. Prandoni P, Lensing AW, BBuller HR et al. Deep-vein thrombosis and the incidence of subsequent symptomatic cancer. N Engj J Med 1992;327(16):1128-33.
47. Turpie AG, Levine MN, Hirsch J et al. A randomized controlled trial of a low molecular weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery. N Engl J Med 1986;315:925-9.
67. Emerson PA Marks P. Preventing thromboembolism after myocardial infarctation: effect of low-dose heparin or smoking. Br Med J 1977;1(6052):18-20. Samama MM, Cohen AT, Darmon JY et al. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. N Engl J Med 1999;341(11):793-800. TapsonVF, Carrol BA, Davidson BL et al. The diagnostic approach to acute venous thromboembolism. Clinical practice guideline. American Thoracic Society. Am J Respir Crit Care Med 1999;160(3):1046-66.
50. Geerts WH, Jay RM, Code KI et al. A comparison of low-molecularweight heparin against venous thromboembolism after major trauma. N Eng J Med 1996;335:701-7.
75. Wautrecht JC, Galle C, Motte S et al. The role of ABO blood groups in the incidence of deep vein thrombosis. Thromb Haemost 1998;79(3):688-9. 76. Blann AD, Daly RJ, Amiral J. The influence of age, gender and ABO blood group on soluble endothelial cell markers and adhesion molecules. Br J Haematol 1996;96(2):498-500. 77. Landgraf H, Vanselow B, Schulte-Huermann et al. Economy class syndrome: rheology, fluid balance and lower leg edema during a simulated 12-h long distance flight. Aviat Space Environ Med 1994;65(10):930-5. 78. Lapostolle F, Surget V, Borron SW et al. Severe pulmonar embolism associated with air travel. N Engl J Med 2001;345(11):799. 79. Griffin JH, Evatt B, Zimmerman TS. Deficiency of protein C in congenital thrombotic disease. J Clin Invest 1981;68:1370-73. 80. Comp PC Esmon CT. Recurrent venous thromboembolism in patients with a partial deficiency of protein S. N Engl J Med 1984;311:1525-28. 81. Hillarp A, Zöller B, Svensson PJ et al. The 20210A allele of the prothrombin gene is a common risk factor among Swedish population with verified deep venous thrombosis. Thromb Haemost 1997;78:990-92. 82. Connors, JM. Thrombophilia Testing and Venous Thrombosis. N Engl J Med 2017;377:1177-87. 83. Paschôa AF, Guillaumon AT. Impact of screening on thrombophilia for patients with venous thrombosis. Int Angiol 2006;25(1):52-9. 84. Lijfering WM; Middeldorp S; Veeger NJ et al. Risk of recurrent venous thrombosis in homozygous carriers and double heterozygous carriers of factor V Leiden and prothrombin G20210A. Circulation 2010;121:1706-12.
62. Monreal M, Lafoz E, Casals A et al. Occult cancer in patients with venous thrombosis. A systematic approach. Cancer 1991;67:541-5. 63. Meis E, Levy RA. Câncer e trombose: uma revisão da literatura. Rev Bras Cancerol 2007;53(2):183-93.
86. Garcia D, Akl EA, Carr R, Kearon C. Antiphospholipid antibodies and the risk of recurrence after a first episode of venous thromboembolism: a systematic review. Blood 2013;122:817-24.
52. Zahn HR, Skinner JA, Porteous MJ. The preoperative prevalence of deep venous thrombosis in patients with femoral neck fractures and delayed operation. Injury 1999;30(9):605-7.
68.
49. Caprini JA, Arcelus JI, Motykie G. The influence of oral anticoagulant therapy on deep vein thrombosis rates four weeks after total hip replacement. J Vasc Surg 1999;30:813-20.
61. Bastounis EA, Karayiannakis AJ, Makri GG et al. The incidence of occult cancer in patients with deep venous thrombosis: a prospective study. J Intern Med 2001;135:367-73.
289Capítulo 149 trombose venosA ProfundA
70. Anderson FA Jr. Wheeler HB, Goldberg RJ et al. A population- based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT study. Arch Intern Med 1991;151(5):933-38.
48. Geerts WH, Pineo GF, Heit JA et al. The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy: Prevention of Venous Thromboembolism. Chest 2004;126:338S-400S.
58. Zangari M, Anaissie E, Barlogie B et al. Increased risk of deepvein thrombosis in patients with multiple myeloma receiving thalidomide and chemotherapy. Blood 2001;98(5):1614-15.
46. White RH, Romano PS, Zhou H. Incidence and time course of thromboembolic outcomes following total hip or knee arthroplasty. Arch Intern Med 1998;158(14):1525-31.
56. Sorensen HT, Mellemkjaer L, Steffensen FH et al. The risk of a diagnosis of cancer after a primary deep venous thrombosis or pulmonary embolism. N Engl J Med 1998;338(17):1169-73.
72. Enga KF, Brækkan SK, Hansen-Krone IJ et al Cigarette smoking and the risk of venous thromboembolism. The Tromsø study. J Thromb Haemost 2012;10(10):2068-74.
73. Holst AG, Jensen G, Prescott E. Risk factors for venous thromboembolism: results from the Copenhagen City Heart Study. Circulation 2010;121(17):1896-1903.
85. Christiansen SC, Cannegieter SC, Koster T, Vandenbroucke JP, Rosendaal FR. Thrombophilia, clinical factors, and recurrent venous thrombotic events. JAMA 2005;293:2352-61.
55. Thodiyil PA, Kakkar AK. Variation in relative risk of venous thromboembolism in different cancers. Thromb Haemost 2002;87(6):1076-77.
51. Hill SL, Berry RE, Ruiz AJ. Deep venous thrombosis in trauma patients. Am Surg 1994; 60(6):405-8.
57. Svendsen HT, Karwinski B. Prevalence of pulmonary embolism at necropsy in patients with cancer. J Clin Pathol 1989;42(8):805-9.
53. Khorana AA. Cancer-associated thrombosis: update and controversies. Hematology Am Soc Hematol Educ Program 2012;2012:626-30.
74. Jick H Slone D, Westerholm B et al. Venous thromboembolism disease and ABO blood type. A cooperative study. Lancet 1969;1(7594):539-42.
71. Douketis JD, Foster GA, Crowter MA et al. Clinical risk factors and timing of recurrent venous thromboembolism during the initial 3 months of anticoagulant therapy. Arch Intern Med 2000;160(22):3431-36.
87. Kahn SR. The clinical diagnosis of deep venous thrombosis: integrating incidence, risk factors, and symptoms and signs. Arch Int Med 1998;158:2315-23. 88. Wells PS, Anderson DR, Bormanis J et al. Value of assessment of pretest probability of deep-vein thrombosis in clinical management. Lancet 1997;350:1795-8. 89. Delluc A, Le Pape F, Le Bras A et al. Validation of a clinical prediction rule for the diagnosis of deep vein thrombosis of the lower limbs in primary care. Rev Med Interne 2012;33(5):244-9. 90. Shrey Modi, Ryan Deisler, Karen Gozel, Patty Reicks, Eric Irwin, Melissa Brunsvold et al. Wells criteria for DVT is a reliable clinical tool to assess the risk of deep venous thrombosis in trauma patients. World J Emerg Surg 2016;11:24. 91. Bates SM; D-dimer assays in diagnosis and management of thrombotic and bleeding disorders. Semin Thromb Hemost 2012;38(7):673-82. 92. Hogg K, Wells PS, Gandara E. The diagnosis of venous thromboembolism. Semin Thromb Hemost 2012;38(7):691-701. 93. Sidhu PS, Alikhan R, Amar T et al. Lower limb contrast venography: a modified technique for use in thromboprophylaxis clinical trials for the accurate evaluation of deep vein thrombosis. Br J Radiol 2007;80(959):859-65. 94. Fikrle A, Suchý M, Slípková D et al. Use of radionuclides in the diagnosis of thromboembolism of venous origin: its potential and limitations. A review. Cor Vasa 1990;32(2):166-74. 95. Sarin S, Shields DA, Scurr JH, Coleridge Smith PD. Photoplethysmography: a valuable noninvasive tool in the assessment of venous dysfunction? J Vasc Surg 1992;116:154-162. 96. 96. Johnston KW, Maruzzo BC, Kassam M, Cobbold RES. Methods for obtaining, processing and quantifying Doppler blood velocity waveforms. In: Nicolaides N, Yao JST. (Ed.). Investigation of Vascular Disorders. New York: Churchill Livingstone; 1981. p. 291.
64. S Noble. Epidemiology and pathophysiology of cancer associated thrombosis. Brit J Cancer 2010;102:S2-S9. Kahn SR, Lim W, Dunn AS et al. Prevention of VTE in nonsurgical patients: 9ª ACCP. Chest 2012;141(2):195S-226S. 66. Aupeix K, Toti F, Satta N et al. induce membrane procoagulant activity in monocyte THP-1 cells. Biochem J 1996;314:1027-33.
65.
54. Levitan N, Dowlati A, Remick SC et al. Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data. Medicine (Baltimore)1999;78(5):285-91.
59. Caskill-Stevens W, Wilson j, Bryant J et al. Contralateral breast cancer and thromboembolic events in African American women treated with tamoxifen. J Natl Cancer Inst 2004;96(23):1762-69.
122. Eppsteiner RW, Shin JJ, Johnson J, van Dam RM. Mechanical compression versus subcutaneous heparin therapy in post-operative and posttrauma patients: a systematic review and meta-analysis. World J Surg 2010;34(1):10-19.
127. Dennis M, Sandercock PA, Reid J et al. CLOTS Trials Collaboration. Effectiveness of thigh-length graduated com- pression stockings to reduce the risk of deep vein thrombosis after stroke (CLOTS trial 1): a multicentre, randomised controlled trial. Lancet 2009;373(9679):1958-65.
100. Puls R, Hosten N, Bück JS et al. Signal-enhanced color Doppler sonography of deep venous thrombosis in the lower limbs and pelvis. J Ultrasound Med 1999;18(3):185-90. 101. Kakkar VV et al. Efficacy of low doses of heparine in prevention of deep vein thrombosis after major surgery. A double blind, randomized trial. Lancet 1972;2:101-106.
129. CLOTS (Clots in Legs Or Stockings after Stroke) Trial Collaboration. Thigh-length versus below-knee stockings for deep venous thrombosis prophylaxis after stroke: a randomized trial. Ann Intern Med 2010;153(9):553-62.
107. Cook D, Meade M, Guyatt G et al. Dalteparin versus unfractioned heparin in critically ill patients: PROTECT study. N Engl J Med 2011;364(14):1305-14.
116. Kakkar AK, Brenner B, Dahl OE et al; RECORD2 Investigators. Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial. Lancet 2008; 372(9632):31-39.
112. Eriksson BI, Dahl OE, Rosencher N et al. Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial. Lancet 2007;370(9591):949-56.
120. Pulmonary Embolism Prevention (PEP) trial Collaborative Group. Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial. Lancet 2000;355(9212):1295-1302.
109. Harneberg J, Wehling M. Current and future prospects for anticoagulant therapy: inhibitors of factor Xa and factor IIa. Semin Thromb Hemost 2008;34(1):39-57.
128. Muir KW, Watt A, Baxter G, Grosset DG, Lees KR. Randomized trial of graded compression stockings for prevention of deep-vein thrombosis after acute stroke. QJM 2000;93(6):359-64.
136. Havig, O. Deep vein thrombosis and pulmonary embolism. An autopsy study with multiple regression analysis of possible risk factors. Acta Chir Scand Suppl 1977;478:1. 137. Galanaud JP, Sevestre-Pietri MA, Bosson JL, Laroche JP, Righini M, Brisot D et al. Comparative study on risk factors and early outcome of symptomatic distal versus proximal deep vein thrombosis: results from the OPTIMEV study. Thromb Haemost 2009;102(3):493. 138. Kearon C, Akl EA, Comerota AJ, Prandoni P, Bounameaux H, Goldhaber SZ et al. Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012;141(2 Suppl):e419S. 139. Carrier M, Le Gal G, Wells PS, Rodger MA. Systematic review: case-fatality rates of recurrent venous thromboembolism
133. Holst J, Lindblad B, Bergqvist D, Garre K, Nielsen H, Hedner U et al. Protamine neutralization of intravenous and subcutaneous lowmolecular-weight heparin (tinzaparin, logiparin). An experimental investigation in healthy volunteers. Blood Coagul Fibrinolysis 1994;5:795-803. 134. Brandjes DPM, Heijboer H, Büller HR, de Rijk M, Jagt H, Cate JW. Acenocoumarol and heparin compared with acenocoumarol alone in the initial treatment of proximal-vein thrombosis. N Engl J Med 1992;327(21):1485-89.
124. Benkö T, Cooke EA, McNally MA, Mollan RA. Graduated compression stockings: knee length or thigh length. Clin Orthop Relat Res 2001;383(383):197-203.
97. Molnár LJ. Imagem ultra-sonográfica no diagnóstico das doenças venosas. In: Maffei FHA. Doença Vasculares Periféricas 2. ed. São Paulo: Medsi; 1995. p. 795-906. 98. Talbot SR. Use of real-time imaging in identifying deep venous obstruction: a preliminary report. Bruit 1982;6:41. 99. Barloon TJ, Bergus GR, Seabold JE. Diagnostic Imaging of lower limb deep venous thrombosis. [serial on line]. Available from: htmlwww.radiology.iuiowa.edu/Personnel/DiagRadMDS/BarloonThomas.http://13.
117. Lassen MR, Ageno W, Borris LC et al. RECORD3 Investigators. Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty. N Engl J Med 2008;358(26):2776-86.
115. Eriksson BI, Borris LC, Friedman RJ et al; RECORD1 Study Group. Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty. N Engl J Med 2008;358(26):2765-75.
130. Elliot CG, Dudney TM, Egger M. Calf-thigh sequential pneumatic compression compared with plantar venous pneumatic compression to prevent deep-vein thrombosis after non-lower extremity trauma. J Trauma 1999;47(1):25-32.
106. Turpie AG, Bauer KA, Eriksson BI et al. Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta- analysis of 4 randomized double-blind studies. Arch Intern Med 2002;162(16):1833-40.
118. Turpie AGG, Bauer KA, Davidson B et al. Once-daily oral rivaroxaban compared with subcutaneous Enoxaparin every 12 hours for thromboprophylaxis after total knee replacement RECORD 4. Blood (American Society of Hematology Annual Meeting Abstract No 35).
135. Browse NL, Thomas ML. Source of non-lethal pulmonary emboli. Lancet 1974;1(7851):258.
132. Cornwell EE III, Chang D, Velmahos G et al. Compliance with sequential compression device prophylaxis in at-risk trauma patients: a prospective analysis. Am Surg 2002; 68(5):470-73.
131. Comerota AJ, Katz ML, White JV. Why does prophylaxis with external pneumatic compression for deep vein thrombosis fail? Am J Surg 1992;164(3):265-68.
114. Eriksson BI, Borris L, Dahl OE et al. Oral, direct Factor Xa inhibition with BAY 59-7939 for the prevention of venous thromboembolism after total hip replacement. J Thromb Haemost 2006;4(1):121-28.
113. RE-MOBILIZE Writing Committee. Ginsberg JS, Davidson BL et al. The oral thrombin inhibitor dabigatran etexilate vs the North American enoxaparin regimen for prevention of venous thromboembolism after knee arthroplasty surgery. J Arthroplasty 2009;24(1):1-9.
119. Li XM, Sun SG, Zhang WD. Apixaban versus enoxaparin for thromboprophylaxis after total hip or knee arthroplasty: a meta-analyses of randomized controlled trials. Chin Med J 2012;125(13):2339-45.
111. Erikkson BI, Dahl OE, Rosencher N et al. Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial. J Thromb Haemost 2007;5(11):2178-85.
110. Al Hajri L, Jabbari S, AlEmad H, AlMahri K, AlMahri M, AlKitbi N. The Efficacy and Safety of Edoxaban for VTE Prophylaxis PostOrthopedic Surgery: A Systematic Review. J Cardiovasc Pharmacol Ther. 2017 May;22(3):230-238.
108. Junqueira DR, Perini E, Penholati RR et al. Unfractioned heparin versus low molecular weight heparin for avoiding heparin-induced thrombocytopenia in postoperative patients. Cochrane Database Syst Rev 2012;12;9 CD007557.
290 Parte VIIIMEMBROS INFERIORES
123. Falck-Ytter Y, Francis CW, Johanson NA et al. Prevention of VTE in orthopedic surgery patients: antithrombotic therapy and prevention of thromboembolism, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141(2) (suppl):e278S-e325S.
103. Barbar S, Noventa F, Rossetto V et al. A risk assessment model for the identification of hospitalized medical patients at risk of venous thromboembolism: the Padua Prediction Score. J Throm Haemost 2010;8(11):2450-7.
102. Caprini JA, Arcelus JI, Hasty JH, Tamhane AC, Fabrega F. Clinical assessment of venous thromboembolic risk in surgical patients Semin Thromb Hemost 1991;17 Suppl 3:304-12.
104. Khorana AA, Kuderer NM, Culakova E, Lyman GH, Francis CW. Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood 2008;111:4902-7. 105. Cella CA, Di Minno G, Carlomagno C, Arcopinto M, Cerbone AM, Matano E et al. Preventing Venous Thromboembolism in Ambulatory Cancer Patients: The ONKOTEV Study. Oncologist 2017 May;22(5):601-8.
121. Antiplatelet Trialists’Collaboration. Collaborative overview of randomised trials of antiplatelet therapy—I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994;308(6921):81-106.
125. Amaragirl SV, Lees TA. Elastic compression stockings for prevention of deep vein thrombosis. Cochrane Database Syst Rev 2000;(3):CD001484. 126. Kierkegaard A, Norgren L. Graduated compression stockings in the prevention of deep vein thrombosis in patients with acute myocardial infarction. Eur Heart J 1993;14(10):1365-68.
153. Boccalon H, Elias A, Chalé JJ, Cadène A, Gabriel S. Clinical outcome and cost of hospital vs home treatment of proximal deep vein thrombosis with a low-molecular-weight heparin: the Vascular Midi-Pyrenees study. Arch Intern Med 2000;160(12):1769-73.
149. van Bellen B, Bamber L, Carvalho FC de, Prins M, Wang M, Lensing AWA. Reduction in the length of stay with rivaroxaban as a singledrug regimen for the treatment of deep vein thrombosis and pulmonary embolism. Curr Med Res Opin 2014;30:829-37.
169. Lee AYY, Levine MN, Baker RI et al. the Randomized Comparison of Low-Molecular-Weight Heparin versus Oral Anticoagulant Therapy for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer (CLOT) Investigators. Low-MolecularWeight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer. N Engl J Med 2003;349:146-53. 170. Akl EA, Kahale L, Barba M et al. Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer. Cochrane Database Syst Rev 7 (2014) CD006650. 171. van Doormaal FF, Raskob GE, Davidson BL, Decousus H, Gallus A, Lensing AW et al. Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials. Thromb Haemost 2009;101(4):762. 172. The HOKUSAI-VTE Cancer Investigators. Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism. N Engl J Med 2018;378(7):615-24.
173. Verso M, Franco L, Giustozzi M, Becattini C, Agnelli G. Treatment of venous thromboembolism in patients with cancer: What news from clinical trials? Thromb Res 2018 Apr;164 Suppl 1:S168-S171.
174. Direct Oral anticoagulants (DOACs) versus LMWH+/− warfarin for VTE in cancer (CANVAS), https://clinicaltrials.gov./ct2/show/record/ NCT02744092.
166. Hutten BA, Prins MH, Gent M, Ginsberg J, Tijssen JG, Büller HR. Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio: a retrospective analysis. J Clin Oncol 2000;18(17):3078.
142. Schwarz T, Buschmann L, Beyer J, Halbritter K, Rastan A, Schellong S. Therapy of isolated calf muscle vein thrombosis: a randomized, controlled study. J Vasc Surg 2010;52(5):1246. Epub 2010 Jul 13.
144. Gallus AS, Baker RI, Chong BH et al. Consensus guidelines for warfarin therapy. Recommendations from the Australasian Society of Thrombosis and Haemostasis. Med J Aust 2000;172:600-5.
291Capítulo 149 trombose venosA ProfundA and major bleeding events among patients treated for venous thromboembolism. Ann Intern Med 2010;152(9):578.
152. O’Shaughnessy D, Miles J, Wimperis J. UK patients with deepvein thrombosis can be safely treated as out-patients. QJM 2000;93(10):663.
148. McBane Ii R, Loprinzi CL, Ashrani A, Perez-Botero J, Leon Ferre RA, Henkin S et al. Apixaban and dalteparin in active malignancy associated venous thromboembolism. The ADAM VTE Trial. Thromb Haemost 2017 Oct 5;117(10):1952-61.
145. Kearon C, Akl EA, Ornelas J et al. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest 2016;149(2):315-52.
154. Chong BH, Brighton TA, Baker RI, Thurlow P, Lee CH; ASTH DVT Study Group. Once-daily enoxaparin in the outpatient setting versus unfractionated heparin in hospital for the treatment of symptomatic deep-vein thrombosis. J Thromb Thrombolysis 2005;19(3):173-81.
175. McBane R, Loprinzi Cl, Ashrani A et al. Apixaban and dalteparin in active malignancy associated venous thromboembolism. The ADAM VTE trial. Thromb Haemost 117 (2017) 1952-61. 176. Direct Oral anticoagulants (DOACs) versus LMWH+/− warfarin for VTE in cancer (CANVAS), https://clinicaltrials.gov./ct2/show/record/ NCT02744092. 177. Kearon C, Akl EA, Ornelas J, Blaivas A, Jimenez D, Bounameaux H et al. Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report. Chest 2016;149(2):315. 178. Fried LP, Tangen CM, Walston J et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001;56(3):M146-M156. 179. Xue, Qian-Li. The Frailty Syndrome: Definition and Natural History. Clin Geriatr Med 2011 Feb;27(1):1-15. 180. Pilotto A, Gallina P, Copetti M on behalf of MPIAGE Project Investigators. Warfarin treatment and allcause mortality in community-dwelling older patients with atrial fibrillation: a retrospective observational study. J Am Geriatr Soc 2016;64:1416-24. 181. Bo M, Puma FL, Badinella MM. Effects of oral anticoagulant therapy in older medical in-patients with atrial fibrillation: a prospective cohort observational study. Aging Clin Exp Res 2016. 182. McGrath ER, Go AS, Chang Y. Use of oral anticoagulant therapy in older adults with atrial fibrillation after acute ischemic stroke. J Am Geriatr Soc 2017;65:241-8. 183. H Heidbuchel, P Verhamme, M Alings. Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin
159. Spyropoulos AC, Hurley JS, Ciesla GN, de Lissovoy G. Management of acute proximal deep vein thrombosis: phar- macoeconomic evaluation of outpatient treatment withenoxaparin vs inpatient treatment with unfractionated heparin. Chest 2002;122(1):108-14.
165. Lecumberri R, Marques M, Panizo E, Alfonso A, Garcia-Mouriz A, Gil-Bazo I et al. High incidence of venous thromboembolism despite electronic alerts for thromboprophylaxis in hospitalised cancer patients. Thromb Haemost 2013;110:184-90.
140. Barritt DW, Jordan SC. Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial. Lancet 1960;1(7138):1309.
151. Levine M, Gent M, Hirsh J, Leclerc J, Anderson D, Weitz J et al. A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis. N Engl J Med 1996;334(11):677.
164. Suter TM, Ewer MS. Cancer drugs and the heart: importance and management. Eur Heart J 2013;34(15):1102-11.
150. Koopman MM, Prandoni P, Piovella F, Ockelford PA, Brandjes DP, van der Meer J et al. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group. N Engl J Med 1996;334(11):682.
161. Douketis JD. Treatment of deep vein thrombosis: what factors determine appropriate treatment? Can Fam Physician 2005;51:217.
157. Levine M, Gent M, Hirsh J et al. A comparison of low- molecularweight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis. N Engl J Med 1996;334(11):677-81.
156. Koopman MMW, Prandoni P, Piovella F et al. The Tasman Study Group. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. N Engl J Med 1996;334(11):682-87.
147. Young A, Phillips J, Hancocks H, Hill C, Joshi N, Marshall A et al. OC11 - Anticoagulation therapy in selected cancer patients at risk of recurrence of venous thromboembolism. Thromb Res 2016 Apr;140 Suppl 1:S172-3.
162. Lim HY, Nandurkar H, Ho P. Direct Oral Anticoagulants and the Paradigm Shift in the Management of Venous Thromboembolism. Semin Thromb Hemost 2018 Apr;44(3):261-66.
160. Tillman DJ, Charland SL, Witt DM. Effectiveness and economic impact associated with a program for outpatient management of acute deep vein thrombosis in a group model health maintenance organization. Arch Intern Med 2000;160(19):2926-32.
155. Daskalopoulos ME, Daskalopoulou SS, Tzortzis E et al. Long-term treatment of deep venous thrombosis with a low molecular weight heparin (tinzaparin): a prospective randomized trial. Eur J Vasc Endovasc Surg 2005;29(6):638-50.
163. Rickles FR. Mechanisms of cancer-induced thrombosis in cancer. Pathophysiol Haemost Thromb 2006;35:103-10.
158. Bäckman K, Carlsson P, Kentson M, Hansen S, Engquist L, Hallert C. Deep venous thrombosis: a new task for primary health care. A randomised economic study of outpatient and inpatient treatment. Scand J Prim Health Care 2004;22(1):44-9.
167. Lyman GH, Khorana AA, Kuderer NM, Lee AY, Arcelus JI, Balaban EP et al. Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 2013;31(17):2189. Epub 2013 May 13 168. Streiff MB, Holmstrom B, Ashrani A, Bockenstedt PL, Chesney C, Eby C et al. Cancer-Associated Venous Thromboembolic Disease, Version 1.2015. J Natl Compr Canc Netw 2015;13(9):1079.
146. Lagerstedt CI, Olsson CG, Fagher BO et al. Need for long-term anticoagulant treatment in symptomatic calf-vein thrombosis. Lancet 1985;2:515-8.
141. Masuda EM, Kistner RL. The case for managing calf vein thrombi with duplex surveillance and selective anticoagulation. Dis Mon 2010 Oct;56(10):601-13.
143. Macdonald PS, Kahn SR, Miller N, Obrand D. Short-term natural history of isolated gastrocnemius and soleal vein thrombosis. J Vasc Surg 2003;37(3):523.
213. Eldor A. Unexplored territories in the nonsurgical patient: a look at pregnancy. Semin Hematol 2001;38(2 Suppl 5):39-48.
201. Scholten DJ, Hoedema RM, Scholten SE. A comparison of two different prophylactic dose regimens of low molecular weight heparin in bariatric surgery. Obes Surg 2002;12:19-24. 202. Michota F, Merli G. Anticoagulation in special patient populations: are special dosing considerations required? Cleve Clin J Med 2005 Apr;72 Suppl 1:S37-42.
214. Greer IA. Epidemiology, risk factors and prophylaxis of venous thromboembolism in obstetrics and gynaecology. Baillieres Clin Obstet Gynaecol 1997;11:403-30.
218. de Oliveira ALML, Marques MA, von Ristow A, Paschoa AF. Tromboembolismo venoso na gestação. J Vasc Bras 2016;15(4):293-301.
292 Parte VIIIMEMBROS INFERIORES K antagonist anticoagulants in patients with non-valvular atrial fibrillation. Europace 2015;17:1467-507.
206. The AMPLIFY Investigators. Oral Apixaban for the Treatment of Acute Venous Thromboembolism. N Engl J Med 2013;369(9):799-808. 207. The HOKUSAI-VTE Investigators. Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism. N Engl J Med 2013 Oct 10;369(15):1406-15. 208. Bauersachs R, Berkowitz SD, Brenner B, Buller HR, Decousus H, Gallus AS et al. Oral rivaroxaban for symptomatic venous thromboembolism. New Engl J Med 2010;363(26):2499-2510. 209. The ROCKET AF Investigators. Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation. N Engl J Med 2011;365:883-91.
192. Spinler SA, Inverso SM, Cohen M et al. Safety and efficacy of unfractionated heparin versus enoxaparin in patients who are obese and patients with severe renal impairment: analysis from the ESSENCE and TIMI 11B studies. Am Heart J 2003;146:33-41.
203. Shepherd MF, Rosborough TK, Schwartz ML. Heparin thromboprophylaxis in gastric bypass surgery. Obes Surg 2003;13:249-53.
215. Koonin L, Atrash H, Lawson H et al. Maternal mortality surveillance, United States, 1979-1986. MMWR CDC Surveill Summ1991;40:1-13. 216. Stirling Y, Woolf L, North W et al. Hemostasis in normal pregnancy. Thromb Haemost 1984;52:176-82. 217. Bates SM, Greer IA, Hirsh J, Ginsberg JS. Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126(3 Suppl):627S-644S.
187. Lutz J, Menke J, Sollinger D et al. Haemostasis in chronic kidney disease. Nephrol Dial Transplant 2014;29:29-40. 188. Pavord S, Myers B. Bleeding and thrombotic complications of kidney disease. Blood Rev 2011;25:271-78. 189. Wattanakit K, Cushman M. Chronic kidney disease and venous thromboembolism: epidemiology and mechanisms. Curr Opin Pulm Med 2009;15:408-12. 190. Boccardo P, Remuzzi G, Galbusera M. Platelet dysfunction in renal failure. Semin Thromb Hemost 2004;30:579-89. 191. Wattanakit K, Cushman M, Stehman-Breen C et al. Chronic kidney disease increases risk for venous thromboembolism. J Am Soc Nephrol 2008;19:135-40.
210. Ezekowitz ME, Parise H, Connolly SJ, Brueckmann M, Kleine E, Clemens A, Parvataneni R, Yusuf S, Wallentin L. The use of dabigatran according to body mass index: the RE-LY experience. Eur Heart J 2014;35:1111.
225. Watson LI, Armon MP. Thrombolysis for acute deep vein thrombosis. Cochrane Database Syst Rev 2004;(4):CD002783. 226. Laiho MK, Oinonen A, Sugano N et al. Preservation of venous valve function after catheter-directed and systemic thrombolysis for deep venous thrombosis. Eur J Vasc Endovasc Surg 2004;28(4):391-96.
200. Priglinger U, Delle Karth G, Geppert A et al. Prophylactic anticoagulation with enoxaparin: is the subcutaneous route appropriate in the critically ill? Crit Care Med 2003;31:1405-9.
219. American College of Obstetricians and Gynecologists Women’s Health Care Physicians. ACOG Practice Bulletin No. 138: Inherited thrombophilias in pregnancy. Obstet Gynecol 2013 Sep;122(3):706-17. 220. Connors JM. Thrombophilia Testing and Venous Thrombosis. N Engl J Med 2017;377:1177-87. 221. Ginsberg JS, Crowther MA. Direct oral anticoagulants (DOACs) and pregnancy: A plea for better information. Thromb Haemost 2016;116(4). 222. Kahn SR, Shrier I, Julian JA et al. Determinants and time course of the postthrombotic syndrome after acute deep venous thrombosis. Ann Intern Med 2008;149(10):698-707. 223. Sharifi M, Mehdipour M, Bay C, Smith G, Sharifi J. Endovenous therapy for deep venous thrombosis: the TORPEDO trial. Catheter Cardiovasc Interv 2010;76(3):316-25. 224. Vedantham S et al. Pharmacomechanical Catheter-Directed Thrombolysis for Deep-Vein Thrombosis. N Engl J Med 2017;377(23):2240-2252.
227. Karp RB, Wylie EJ. Recurrent thrombosis after iliofemoral venous thrombectomy. Surg Forum 1966;17:147. 228. Lansing AM, Davis WM. Five-year follow-up study of ilio-femoral venous thrombectomy. Ann Surg 1968;168(4):620-28. 229. Plate G, Akesson H, Einarsson E et al. Long-term results of venous thrombectomy combined with a temporary arterio-venous fistula. Eur J Vasc Surg 1990;4(5):483-489. 230. Plate G, Einarsson E, Ohlin P et al. Thrombectomy with temporary arteriovenous fistula: the treatment of choice in acute iliofemoral venous thrombosis. J Vasc Surg 1984;1(6):867-76. 231. Plate G, Eklöf B, Norgren L, Ohlin P, Dahlström JA. Venous thrombectomy for iliofemoral vein thrombosis— 10-year results of a prospective randomised study. Eur J Vasc Endovasc Surg 1997;14(5):367-74. 232. White RH, Brunson A, Romano PS, Li Z, Wun T. Outcomes After Vena Cava Filter Use in Noncancer Patients With Acute Venous Thromboembolism: A Population-Based Study. Circulation 2016 May;133(21):2018-29. Epub 2016 Apr 5. 233. Uppal B, Flinn WR, Benjamin ME. The bedside insertion of inferior vena cava filters using ultrasound guidance. Perspect Vasc Surg Endovasc Ther 2007 Mar;19(1):78-84. 234. do Espírito Santo TM, Bacalhau F, Paschôa AF, van Bellen B, Austin I, Raci D. Tomographic anatomy of the vena cava and renal veins: features relevant to vena cava filter placement. J Vasc Bras. [Internet]. 2015 Mar [cited 2018 June 20];14(1):10-15. Available from: php?script=sci_arttext&pid=S1677-54492015000100010&lng=enhttp://www.scielo.br/scielo.
184. IG Zarraga, J. Kron Oral anticoagulation in elderly adults with atrial fibrillation: integrating new new options with old concepts. J Am Geriatr Soc 2013;61:143-50. 185. F Andreotti, B Rocca, S Husted. Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis. Eur Heart J 2015. 186. Romão Junior JE. Doença Renal Crônica: Definição, Epidemiologia e Classificação. Braz J Nephrol (J Bras Nefrol) 2004;26(3 Suppl 1):1-3.
211. The AMPLIFY Investigators. Oral Apixaban for the Treatment of Acute Venous Thromboembolism. N Engl J Med 2013;369(9):799-808. 212. Moore KT, Kröll D. Influences of Obesity and Bariatric Surgery on the Clinical and Pharmacologic Profile of Rivaroxaban. Am J Med 2017 Sep;130(9):1024-32.
235. Streiff MB. Vena caval filters: a comprehensive review. Blood 2000;95(12):3669. 236. Becker DM, Philbrick JT, Selby JB. Inferior vena cava filters. Indications, safety, effectiveness. Arch Intern Med 1992;152(10):1985.
195. Castellucci LA, Shaw J, Giulivi A, Edwards C, Carrier M, Patel R. Determining the safety of enoxaparin prophylaxis in critically ill patients with severe renal insufficiency - The PACER pilot study. Thromb Res 2016 Aug;144:69-71. 196. Hughes S, Szeki I, Nash MJ. Anticoagulation in chronic kidney disease patients—the practical aspects. Clin Kidney J 2014 Oct;7(5):442-9.
197. Limdi NA, Limdi MA, Cavallari L et al. Warfarin dosing in patients with impaired kidney function. Am J Kidney Dis 2010;56:823-31.
193. Thorevska N, Amoateng-Adjepong Y, Sabahi R et al. Anticoagulation in hospitalized patients with renal insufficiency: a comparison of bleeding rates with unfractionated heparin vs enoxaparin. Chest 2004;125:856-63.
194. Chan KE, Thadhani RI, Maddux FW. No difference in bleeding risk between subcutaneous enoxaparin and heparin for thromboprophylaxis in end-stage renal disease. Kidney International 2013;84:555-61.
198. Brodsky SV, Nadasdy T, Rovin BH et al. Warfarin-related nephropathy occurs in patients with and without chronic kidney disease and is associated with an increased mortality rate. Kidney Int 2011;80:181-89.
199. Frederiksen SG, Hedenbro JL, Norgren L. Enoxaparin effect depends on body-weight and current doses may be inadequate in obese patients. Br J Surg 2003;90:547-48.
204. Montalescot G, Polle V, Collet JP et al. Low molecular weight heparin after mechanical heart valve replacement. Circulation 2000;101:1083-86.
205. Venclauskas L, Maleckas A, Arcelus JI. ESA VTE Guidelines Task Force. European guidelines on perioperative venous thromboembolism prophylaxis: Surgery in the obese patient. Eur J Anaesthesiol 2018 Feb;35(2):147-53.
293Capítulo 149 trombose venosA ProfundA 237. Muriel A, Jiménez D, Aujesky D, Bertoletti L, Decousus H, Laporte S et al. Survival effects of inferior vena cava filter in patients with acute symptomatic venous thromboembolism and a significant bleeding risk. J Am Coll Cardiol 2014;63(16):1675. Epub 2014 Feb 25. 238. Stein PD, Matta F. Vena cava filters in unstable elderly patients with acute pulmonary embolism. Am J Med 2014 Mar;127(3):222-5. Epub 2013 Nov 23. 239. Decousus H, Leizorovicz A, Parent F, Page Y, Tardy B, Girard P et al A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prévention du Risque d’Embolie Pulmonaire par Interruption Cave Study Group. N Engl J Med 1998;338(7):409. 240. PREPIC Study Group. Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC (Prevention du Risque d’Embolie Pulmonaire par Interruption Cave) randomized study. Circulation 2005;112(3):416. 241. Segal JB, Streiff MB, Hofmann LV, Thornton K, Bass EB. Management of venous thromboembolism: a systematic review for a practice guideline. Ann Intern Med 2007;146(3):211. Epub 2007 Jan 29. 242. Snow V, Qaseem A, Barry P, Hornbake ER, Rodnick JE, Tobolic T et al. Management of venous thromboembolism: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians. Ann Intern Med 2007;146(3):204. Epub 2007 Jan 29. 243. Prandoni P, Lensing AW, Prins MH, Frulla M, Marchiori A, Bernardi E et al. Below-knee elastic compression stockings to prevent the postthrombotic syndrome: a randomized, controlled trial. Ann Intern Med 2004;141(4):249. 244. Brandjes DP, Büller HR, Heijboer H, Huisman MV, de Rijk M, Jagt H, ten Cate JW . Randomised trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosis. Lancet 1997;349(9054):759.
249. Schulman S, Granqvist S, Holmström M et al. The Duration of Anticoagulation Trial Study Group. The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. N Engl J Med 1997;336(6):393-98.
250. Kearon C, Gent M, Hirsh J et al. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. N Engl J Med 1999;340(12):901-7.
245. Ginsberg JS, Hirsh J, Julian J, Vander M, Magier D, MacKinnon B, Gent M . Prevention and treatment of postphlebitic syndrome: results of a 3-part study. Arch Intern Med 2001;161(17):2105. 246. Aschwanden M, Jeanneret C, Koller MT, Thalhammer C, Bucher HC, Jaeger KA. Effect of prolonged treatment with compression stockings to prevent post-thrombotic sequelae: a randomized controlled trial. J Vasc Surg 2008;47(5):1015.
254. van Es N, Coppens M, Schulman S, Middeldorp S, Büller HR. Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials. Blood 2014:124(12):1968-75. 255. Agnelli G et al. Apixaban for extended treatment of venous thromboembolism. N Engl J Med 2013;368(8):699-708. 256. Schulman S, Kearon C, Kakkar AK, Schellong S, Eriksson H, Baanstra D et al. RE-MEDY Trial Investigators; RE-SONATE Trial Investigators. Extended use of dabigatran, warfarin, or placebo in venous thromboembolism. N Engl J Med 2013;368:709-18. 257. Schulman S, Eriksson H, Goldhaber SZ, Kakkar AKL, Kearon C, Kvamme AM et al. Dabigatran or warfarin for extended maintenance therapy of venous thromboembolism. ISTH 2011; July 28. J Thromb Haemost 2011;9 (Suppl 2):731; Abstract O-TH-033. 258. Eichinger S, Heinze G, Jandeck LM, Kyrle PA. Risk assessment of recurrence in patients with unprovoked deep vein thrombosis or pulmonary embolism: the Vienna prediction model. Circulation 2010 Apr 13;121(14):1630-6. 259. Mackman N. New insights into the mechanisms of venous thrombosis. J Clin Invest 2012;122(7):2331-6.
252. Baglin T, Douketis J, Tosetto A et al. Does the clinical presentation and extent of venous thrombosis predict likelihood and type of recurrence? A patient-level meta-analysis. J Thromb Haemost 2010 Nov;8(11):2436-42. 253. Prandoni P, Prins MH, Lensing AW et al. Residual thrombosis on ultrasonography to guide the duration of anticoagulation in patients with deep venous thrombosis: a randomized trial. Ann Intern Med 2009;150(9):577-85.
251. Farraj RS. Anticoagulation period in idiopathic venous thromboembolism. How long is enough? Saudi Med J 2004;25(7):848-51.
247. Prandoni P, Noventa F, Ghirarduzzi A et al. The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients. Haematologica 2007 Feb;92(2):199-205.
248. Baglin T, Luddington R, Brown K et al. Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study. Lancet 2003;362(9383):523-26.
3.
6.
1. Jacomo AL, Caplan I. Estudio y investigación del drenaje linfático cutâneo antero-externo de la region tibial anterior. I Congreso de la sociedade de Ciencias morpologicas de La Plata, La Plata, Argentina; 1991. Tourani SS, Taylor GI, Ashton MW. Understanding the threedimensional anatomy of the superficial lymphatics of the limbs. Plast Reconstr Surg 2014;134:1065. Jacomo AL, Rodrigues Jr. AJ, Figueira LNT. Drenagem linfática superficial da pele da região plantar. Acta Ortop Bras 1994;2:35-7. Foldi M, Foldi E. Textbook of lymphology. Boulder: Klose Training & Consulting LLC; 2003. Jacomo AL et al. Estudo da drenagem linfática do músculo vasto lateral da coxa, no homem. Acta Ortop Bras 1993;1(1):12-4. Caplan I. The lymphatic system of the big toe. Folia Angiol 1978;26:241-5.
2.
294 150Capítulo ANATOMIA DO SISTEMA LINFÁTICO DOS MEMBROS INFERIORES REFERÊNCIAS BIBLIOGRÁFICAS
4.
5.
17. Ciucci JL et al 3º Consenso Latinoamericano para el tratamiento del linfedema. B. Aires: Nayarit; 2007. 18. Guedes Neto HJ et al 4º Consenso Latino Americano para tratamento do linfedema. São Paulo: Servier – Sigvaris; 2011. 19. Guedes Neto HJ, Belczak CEQ. Linfologia, diagnóstico, clínica e tratamento. São Caetano do Sul: Yendis; 2009. 20. Ciucci JL et al. 5º Consenso Latinoamericano para el tratamiento del linfedema. B. Aires: Nayarit; 2014. 21. Ciucci JL et al 6º Consenso Latinoamericano para el tratamiento del linfedema. B. Aires: Nayarit; 2017.
8. Guedes Neto HJ. Surgical treatment of peno-scrotal lymphedema. In: Proceedings of 15th International Congress of Lymphology. Recife, São Paulo, Brazil, 1995. p. 354-58.
295
7. Guedes Neto HJ. Post mastectomy lymphedema: an epidemiological study. In: Proceedings of the 15th International Congress of Lymphology. Recife, São Paulo, Brazil, 1995. p. 285-88.
9. Guedes Neto HJ. Surgical treatment of penile-scrotal lymphedema. Lymphology 1997;29(3):132-3.
15. Perez MCJ. Compressão pneumática intermitente sequencial no linfedema de membros inferiores: avaliação linfocintilográfica com Dextran marcado com Tecnécio-99 m. Tese Doutorado. EPM, São Paulo, 1996.
16. Witte CL, Clodius L, Pecking A. The diagnosis and treatment of peripheral lymphedema consensus document. Lymphology 1995;28(4):113-17.
1. Cordeiro AK, Baracat FF. Linfologia. São Paulo: Fundo Editorial BykProcienx; 1983. 2. Bouabci AS, Wolosker M. Linfopatias. In: Zerbini EJ. Clínica cirúrgica Alípio Correa Netto. São Paulo: Sarvier; 1974. p. 157-29.
10. Guedes Neto HJ. Arm edema after treatment for breast cancer. Lymphology 1997;30(1):35-36.
14. Gomes SCN. Linfocintilografia superficial de membros inferiores com Dextran-500 e Tecnécio-99 m. Tese Mestrado, Recife, 1990.
13. Maffei FHA et al Doenças vasculares periféricas. São Paulo: Medsi; 2002.
151Capítulo
REFERÊNCIAS BIBLIOGRÁFICAS
In: Proceedings of the 14th International Congress of Lymphology Washington, DC, USA, 1993. p. 821-24.
12. Degni M, Nunes P. Linfedema. In: Maffei FHA. Doenças vasculares periféricas. 2. ed. Rio de Janeiro: Medsi; 1995. p. 1083-110.
LINFEDEMAS – TRATAMENTO NÃO CIRÚRGICO
3. Andrade MFC. Avaliação da absorção e transporte linfáticos em pacientes com trombose venosa profunda aguda de membro inferior através da linfocintilografia. Tese Doutorado. USP; 1998. 4. Garrido M, Ribeiro AP. Linfangites e erisipelas. São Paulo: Revinter; 2000. p. 9-14; 53-57. 5. Ciucci JL et al. 1º Consenso Latinoamericano para el tratamiento del linfedema. B. Aires: Nayarit; 2003. 6. Ciucci JL et al 2º Consenso Latinoamericano para el tratamiento del linfedema. B. Aires: Nayarit; 2005.
11. Guedes Neto HJ. Surgical treatment of peno-scrotal lymphedema.
9. Moreno CH, Rodrigues A, Guedes Neto HJ, Helene Júnior A, Malheiros CA. Lymphoscintigraphy: Evaluation of the lymphatic system. In: Shiffman MA, Di Giuseppe A.(Org). Body Countouring. New York: Springer; 2010. p. 337-45. 10. Guedes Neto HJ. Post Mastectomy lymphedema: na epidemio logical Study. In: Proceedings of the 15th International Congres of Lymphology Recife, São Paulo, 1995. p. 285-88. 11. Guedes Neto HJ. Arm Edema after treatment for breast cancer. Lymphology 1997;30:35-36.
2. Silva W. Elefantíase dos membros inferiores. Contribuição ao tratamento cirúrgico. Tese para Concurso de Professor Titular da Disciplina de Cirurgia Vascular da UFPE, Recife, 1985. 3. Marques R, Silva W, Negreiros L et al. Tratamento cirúrgico do linfedema crônico progressivo: técnica simplificada da operação de Charles. 18º Congresso Brasileiro de Angiologia. Olinda, Pernambuco, 1971, Tema livre nº 46. 4. Silva W. Tratamento cirúrgico do linfedema. In: Pitta GBB, Castro AA, Burihan E. (Ed.). Angiologia e cirurgia vascular: guia ilustrado. Maceió: UNCISAL/ECMAL & LAVA, 2003. Disponível em: http://www.lava.med. br/livro.
8. Moreno CH, Guedes Neto HJ, Helene Júnior A, Malheiros CA.Thighplasty.In: Shiffman MA, Di Giuseppe A. (Org). Body Countouring. New York: Springer; 2010. p. 827-35.
6. Ciucci JL et al 1º Consenso Latino Americano para el tratamiento del linfedema. Buenos Aires: Nayarit; 2003.
12. Ciucci JL et al 2º Consenso Latino Americano para el tratamiento del linfedema. Buenos Aires: Nayarit; 2005. 13. Ciucci JL et al 3º Consenso Latino Americano para el tratamiento del linfedema. Buenos Aires: Nayarit; 2008. 14. Guedes Neto HJ et al. 4º Consenso Latino Americano para tratamento do linfedema. São Paulo: Servier-Sigvaris; 2011.
5. Bouabci AS. A cirurgia de Thompson no tratamento dos linfedemas dos membros inferiores. Rev Hosp Clin Méd SP 1984;39:40-3.
296 152Capítulo LINFEDEMA – TRATAMENTO POR CIRURGIAS DE RESSECÇÃO REFERÊNCIAS BIBLIOGRÁFICAS
7. Moreno CH, Guedes Neto HJ, Helen Júnior A, Malheiros CA. Thighplasty After Bariatric Surgery:Evaluation of lymphatic drainage in lower Extremities. Obesity Surgery Jcr 2008;18:1160-64.
1. Guedes Neto HJ. Linfedemas – Classificação, etiologia, quadro clínico e tratamento não cirúrgico. In: Brito CJ et al Cirurgia vascular. Rio de Janeiro: Revinter; 2002. p. 1233-34, vol. 2.
10. Blackberg A, Trell K, Rasmussen M. Erysipelas, a large retrospective study of aetiology and clinical presentation. BMC Infectious Disease 2015;15:402-7.
297 153Capítulo
21. Levin ASS, Dias MBGS, Oliveira MS, Lobo RD. Guia de utilização de anti-infecciosos e recomendações para a prevenção de infecções relacionadas à assistência à saúde. 6. ed, São Paulo: Faculdade de Medicina da Universidade de São Paulo (FMUSP), 2015-2017. 22. Lowy FD. Methicillin-resistant Staphylococcus aureus (MRSA) in adults: Treatment of skin and soft tissue infections - Up ToDate 2018. Disponível em: http://www.uptodate.com/online.
5. Moore DL. A bite in the playroom: Managing human bites in child care settings. Paediatr Child Health 2008;13(6):515-19.
LINFANGITES BIBLIOGRÁFICAS Spelman D. Lymphangitis UpToDate. 2018. Disponível em: HTTP:// www.uptodate.com/online.
1.
15. Raff AB, Kroshinsky D. Cellulitis A Review. JAMA 2016;316(3):325-37.
16. Maxwell-Scott, Kandil H. Diagnosis and management of cellulites and erysipelas. Br J Hosp Med 2015;76(8):C114-117.
11. Inghammar M, Rasmussen M, Linder A. Recurrent erysipelas – risk factors and clinical presentation. BMC Infectious Disease 2014;14:270-5. 12. Gontijo B, Bittencourt FV, Lourenço LFS. Manifestações cutâneas decorrentes do uso de drogas ilícitas. An Bras Dermatol 2006;81(4):307-17.
18. Chaudhry AA, Baker KS, Gould ES, Gupta R. Necrotizing fasciitis and its mimics: What radiologists need to know. Am J Roentg 2015;204(1):128-39.
2. Cohen BE, Nagler AR, Pomeranz MK. Nonbacterial causes of lymphangitis with streaking. JABFM 2016; 29(6):808-12. Caetano M, Amorim A. Erisipela. Acta Med Port 2005;18:385-94.
19. Baron EL. Cellulitis and skin abscess in adults: Treatment. Up ToDate 2018. Disponível em: http://www.uptodate.com/online.
23. Esposito S, Basseti M, Concia E, De Simone G, De Rosa FG, Grossi P et al. Diagnosis and management of skin and soft-tissue infections (SSTI). A literature review and consensus statement: an update. J Chemother 2017;29:1-18. 24. Sjoblom AC, Eriksson B, Jorup-Ronstrom C, Karkkonen K, Lindqvist M. Antibiotic prophylaxis in recurrent erysipelas. Infection 1993;21:390-3. 25. Oh CC, Ko HCH, Lee HY, Safdar N, Maki DG, Chelebicki MP. Antibiotic prophylaxis for preventing recurrent cellulitis: A systematic review and meta-analysis. J Infect 2014;69:26-34. 26. Dalal A, Eskin-Schwartz M, Mimouni D, Ray S, Days W, Hodak E et al Interventions for the prevention of recurrent erysipelas and cellulitis (Review). In: Cochrane Library, 2017 (issue 6). Oxford: Update Software Ltd. Disponível em: http://www.cochrane.library.com. Chichester, UK: John Wiley & Sons, Ltd. 27. Thomas KS, Crook AM, Nunn AJ, Foster KA, Mason JM, Chalmers JR et al. Penicillin to Prevent Recurrent Leg Cellulitis. N Engl J Med 2013;368:1695-1703. 28. Oh CC. Cellulitis and erysipelas: prevention. Clinical Evidence 2015;11:1708-15. 29. Rob F, Hercogová J. Benzathine penicillin G once-every-3-week prophylaxis for recurrent erysipelas a retrospective study of 132 patients. J Dermatological Treatment 2018;29(1):39-43. 30. U.K Dermatology Clinical Trials Network’s PATCH Trial Team. Prophylactic antibiotics for the prevention of cellulitis (erysipelas) of the leg: results of the U.K. Dermatology Clinical Trials Network’s PATCH II trial. BJD 2012;166:169-78. 31. Borschitz T, Schlicht S, Siegel E, Hanke E, von Stebut E. Improvement of a Clinical Score for Necrotizing Fasciitis: ‘Pain Out of Proportion’ and High CRP Levels Aid the Diagnosis. PLOS ONE 2015:1-13.
8. Klion AD. Lymphatic filariasis: Epidemiology, clinical manifestations, and diagnosis. UpToDate. 2018. Disponível em: http://www.uptodate. com/online.
20. Sartelli M, Malangoni MA, May AK, Viali P, Kao LS, Catena F et al. World Society of Emergengy Surgery (WSES) guidelines for management of skin and soft tissue infections. World J Emerg Surg 2014;9:57-74.
6. Koslowska D, Mysliwiec H, Kiluk P, Baran A, Milewska AJ, FlisiaK I. Clinical and Epidemiological assessement of patients hospitalized for primary and recurrent erysipelas. Przegl Epidemiol 2016;70(4):575-84.
3.
E ERISIPELAS REFERÊNCIAS
9. Almeida CC. Linfocintigrafia dos membros inferiores em portadores de Febre Chikungunya. Tese de Mestrado. Centro de Ciências da Saúde; Universidade Federal de Pernambuco. 2017.
17. Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJC, Gorbach SL et al. Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America. CID 2014;59:147-59.
7. Pires CA, Santos MAL, Oliveira BA, Souza CR, Belarmino LMN, Martins MF. Infecções bacterianas primárias da pele: perfil dos casos atendidos em um serviço de dermatologia na região amazônica, Brasil. Rev Pan-Amaz Saúde 2015;6(2):45-50.
4. Spelman D, Baddour LM. Cellulitis and skin abscess: Clinical manifestations and diagnosis. Up ToDate 2018. Disponível em: http:// www.uptodate.com/online.
13. Linke M, Booken N. Risk factors associated with a reduced response in the treatment of erysipelas. JDDG 2015;13(3):217-25. 14. Inghammar M, Rasmussen M, Linder A. Recurrent erysipelas – risk factors and clinical presentation. BMC infectious disease 2014;270-5.
298 154Capítulo PÉ DIABÉTICO – UMA VISÃO GERAL
2. Fox CS, Pencina MJ, Meigs JB et al. Trends in the incidence of type 2 diabetes mellitus from the 1970s to the 1990s: the Framingham Heart Study. Circulation 2006;113:2914-18.
6. Ramachandran A, Snehalatha C, Baskar AD et al. Temporal changes in prevalence of diabetes and impaired glucose tolerance associated with lifestyle transition occurring in the rural population in India. Diabetologia 2004;47:860-5.
17. De vivo S, Palmer-Kazen U, Kalin B, Wahlberg E. Risk factors for poor collateral development in claudication. Vasc Endovascular Surg 2005;39:519-524.
7. Zuo H, Shi Z, Hussain A. Prevalence, trends and risk factors for the diabetes epidemic in China: a systematic review and meta-analysis. Diabetes Res Clin Pract 2014;104:63-72
4. Echouffo-Tcheugui JB, Dzudie A, Epacka ME et al. Prevalence and determinants of undiagnosed diabetes in an urban sub-Saharan African population. Primary Care Diabet 2012;6:229-34.
REFERÊNCIAS BIBLIOGRÁFICAS
25. Taddei S, Virdis A, Mattei P et al. Effect of insulin on acetylcholineinduced vasodilation in normotensive subjects and patients with essential hypertension. Circulation 1995;92:2911-8. 26. Williams SB, Cusco JA, Roddy M et al. Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus. J Am Coll Cardiol 1996;27:567-74.
19. Goldenberg S, Alex M, Joshi RA, Blumenthal HT. Nonatheromatous peripheral vascular disease of the lower extremity in diabetes mellitus. Diabetes 1959; 8:261-273.
22. Akbari CM, Lo Gerfo FW. Diabetes and peripheral vascular disease. J Vasc Surg 1999;30:373-84. 23. Jörneskog G, Brismar K, Fagrell B. Skin capillary circulation is more impaired in toes of diabetic than non-diabetic patients with peripheral vascular disease. Diabetic Medicine 1995;12:36-41.
13. Wattanakit K, Folsom AR, Selvin E et al. Risk factors for peripheral arterial disease incidence in persons with diabetes: the Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis 2005;180:389-397.
8. American Diabetes Association (ADA). Economic costs of diabetes in the U.S. 2007. Diabetes Care 2008;31:596-615. 9. Driver VR, Fabbi M, Lavery LA, Gibbons G. The costs of diabetic foot: the economic case for the limb salvage team. J Vasc Surg 2010;52:17S-22S.
10. Bild DE, Selby JV, Sinnock P et al. Lower-extremity amputation in people with diabetes mellitus. Epidemiology and prevention. Diabetes Care 1989;12:24-31.
15. Soor GS, Vukin I, Leong SW et al. Peripheral vascular disease: who gets it and why? A histomorphological analysis of 261 arterial segments from 58 cases. Pathology 2008;40:385-391.
11. Iversen MM, Tell GS, Riise T et al. History of foot ulcer increases mortality among individuals with diabetes: ten-year follow-up of the Nord-Trondelag Health Study, Norway. Diabetes Care 2009;32:2193-199.
21. Parving HH, Viberti GC, Keen H et al. Hemodynamic factors in the genesis of diabetic microangiopathy. Metabolism 1983;32:943-9.
12. Gibbons GW, Shaw PM. Diabetic vascular disease: characteristics of vascular disease unique to the diabetic patient. Semin Vasc Surg 2012;25:89-92.
27. Timimi FK, Ting HH, Haley EA et al. Vitamin C improves endotheliumdependent vasodilation in patients with insulin-dependent diabetes mellitus. J Am Coll Cardiol 1998;31:552-7. 28. Clarkson P, Celermajer DS, Donald AE et al. Impaired vascular reactivity in insulin-dependent diabetes mellitus is related to disease duration and low density lipoprotein cholesterol levels. J Am Coll Cardiol 1996;28:573-9. 29. Ohara Y, Peterson TE, Harrison DG. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest 1993;91:2546-51. 30. Wautier JL, Zoukourian C, Chappey O. Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats. J Clin Invest 1996;97:238-43. 31. Ballard JL, Eke CC, Bunt TJ, Killeen JD. A prospective evaluation of transcutaneous oxygen measurements in the management of diabetic foot problems. J Vasc Surg 1995;22:485-92. 32. Pfeifer MA, Schumer MP. Clinical trials of diabetic neuropathy: past, present, and future. Diabetes 1995;44:1355-61. 33. Ward JD. Diabetic neuropathies. Current concepts in prevention and treatment. Drugs 1986;32:279-89. 34. Veves A, Akbari CM, Primavera J et al. Endothelial dysfunction and the expression of endothelial nitric oxide synthetase in diabetic neuropathy, vascular disease, and foot ulceration. Diabetes 1998;47:457-63. 35. Parkhouse N, Lequeen PM. Impaired neurogenic vascular response in patients with diabetes and neuropathic foot lesions. N Engl J Med 1998;318:1306-9. 36. Duksal T, Tiftikcioglu BI, Bilgin S et al. Role of inflammation in sensory neuropathy in prediabetes or diabetes. Acta Neurol Scand 2016;133(5):384-90. 37. Peters EJ, Lavery LA, Armstrong DG. Diabetic lower extremity infection: influence of physical, psychological, and social factors. J Diabetes Complications 2005;19:107-12. 38. Hobizal KB, Wukich DK. Diabetic foot infections: current concept review. Diabetic Foot & Ankle 2012;3:18409. 39. Lavery LA, Armstrong DG, Wunderlich RP et al. Risk factors for foot infections in individuals with diabetes. Diabetes Care 2006;29:1288-93. 40. Zilliox L, Peltier AC, Wren PA et al. Assessing autonomic dysfunction in early diabetic neuropathy: the Survey of Autonomic Symptoms. Neurology 2011;76:1099-1105. 41. Rogers LC, Frykberg RG, Armstrong DG et al. The Charcot Foot in Diabetes. Diabetes Care 2011;34:2123-2129. 42. Butalia S, Palda VA, Sargeant RJ et al. Does this patient with diabetes have osteomyelitis of the lower extremity? JAMA 2008 20;299:806-13.
24. Vane JR, Anggard EE, Botting RM. Regulatory functions of the vascular endothelium. N Eng J Med 1990;323:27-36.
3. Monesi L, Baviera M, Marzona I et al. Prevalence, incidence and mortality of diagnosed diabetes: evidence from an Italian populationbased study. Diabet Med 2012;29:385-92.
14. Brownrigg JR, Schaper NC, Hinchliffe RJ. Diagnosis and assessment of peripheral arterial disease in the diabetic foot. Diabet Med 2015;32:738-47.
5. Gao WG, Dong YH, Pang ZC et al. Increasing trend in the prevalence of Type 2 diabetes and pre-diabetes in the Chinese rural and urban population in Qingdao, China. Diabet Med 2009;26: 1220-27.
16. Forsythe RO, Brownrigg J, Hinchliffe RJ. Peripheral arterial disease and revascularization of the diabetic foot. Diabetes Obes Metab 2015;17:435-44.
18. Akbari CM, Gibbons GW, Habershaw GM et al. The effect of arterial reconstruction on the natural history of diabetic neuropathy. Arch Surg 1997;132:148-52.
20. Williamson JR, Titlon RG, Chang K, Kilo C. Basement membrane abnormalities in diabetes mellitus: relationship to clinical microangiopathy. Diabetes Metab Rev 1988;4:339-70.
1. Kauffman P, Martinez RIR. Pé diabético. In: Puech-Leão P, Kauffman P. Interfaces da Angiologia e Cirurgia Vascular. São Paulo: Roca; 2002. p.389-402.
51. Williams DT, Harding KG, Price P. An evaluation of the efficacy of methods used in screening for lower-limb arterial disease in diabetes. Diabetes Care 2005;28:2206-2210.
43. Rajbhandari SM, Sutton M, Davies C et al. ‘Sausage toe’: a reliable sign of underlying osteomyelitis. Diabet Med 2000;17:74-77.
50. Mills JL. Lower limb ischaemia in patients with diabetic foot ulcers and gangrene: recognition, anatomic patterns and revascularization strategies. Diabetes Metab Res Rev 2016;32(Suppl 1):239-45.
67. Ziegler D, Low PA, Litchy WJ et al. Efficacy and safety of antioxidant treatment with “-lipoic acid over 4 years in diabetic polyneuropathy: the NATHAN 1 trial. Diabetes Care 2011;34:2054-60. 68. Suh KS, Oh SJ, Woo JT et al. Effect of cilostazol on the neuropathies of streptozotocin-induced diabetic rats. Korean J Intern Med 1999;14:34-40. 69. Asal NJ, Wojciak KA. Effect of cilostazol in treating diabetes-associated microvascular complications. Endocrine 2017;56:240-44. 70. Sindrup SH, Jensen TS. Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action. Pain 1999;83:389-400. 71. Apfel SC. Neurotrophic factors in the therapy of diabetic neuropathy. Am J Med 1999;107:34S-43S. 72. Young RJ, Ewing DJ, Clarke BF. Chronic and remitting painful diabetic polyneuropathy. Correlations with clinical features and subsequent changes in neurophysiology. Diabetes Care 1988;11:34-40.
52. Graziani L, Silvestro A, Bertone V et al. Vascular involvement in diabetic subjects with ischemic foot ulcer: a new morphologic categorization of disease severity. Eur J Vasc Endovasc Surg 2007;33:453-60.
47. Lavery LA, Armstrong DG, Murdoch DP et al. Validation of the Infectious Diseases Society of America’s diabetic foot infection classification system. Clin Infect Dis 2007;44:562-5.
44. Bell PRF, Charlesworth D, Depalma RG et al. The definition of critical ischemia of a limb. Working Party of the International Vascular Symposium. Br J Surg 1982;69(Suppl):S2.
49. Hingorani A, Lamuraglia GM, Henke P et al. The management of diabetic foot: A clinical practice guideline by the Society for Vascular Surgery in collaboration with the American Podiatric Medical Association and the Society for Vascular Medicine. J Vasc Surg 2016;63(2 Suppl):3S-21S.
45. Mills JL SR, Conte MS, Armstrong DG et al. Society for Vascular Surgery Lower Extremity Guidelines Committee. The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: risk stratification based on wound, ischemia, and foot infection (WIfI). J Vasc Surg 2014;59:220-34.e1-2.
54. Dumville JC, O’Meara S, Bell-Syer SEM. Dressings for treating foot ulcers in people with diabetes: an overview of systematic reviews. Cochrane Database Syst Rev 2013;4(CD010471).
48. Zhan LX, Branco BC, Armstrong DG et al. The Society for Vascular Surgery lower extremity threatened limb classification system based on Wound, Ischemia, and foot Infection (WIfI) correlates with risk of major amputation and time to wound healing. J Vasc Surg 2015;61:939-44.
55. Hasan R, Firwana B, Elraiyah T et al. A systematic review and metaanalysis of glycemic control for the prevention of diabetic foot syndrome. J Vasc Surg 2016;63(2 Suppl):22S-28S.e1-2.
58. Elraiyah T, Domecq JP, Prutsky G et al. A systematic review and metaanalysis of débridement methods for chronic diabetic foot ulcers. J Vasc Surg 2016 Feb;63(2 Suppl):37S-45S.e1-2.
64. Müller-Stich BP, Billeter AT, Fleming T et al. Nitrosative stress but not glycemic parameters correlate with improved neuropathy in nonseverely obese diabetic patients after Roux-Y gastric bypass. Surg Obes Relat Dis 2015;11:847-54. 65. Navigator Study Group, McMurray JJ, Holman RR, Haffner SM et al Effect of valsartan on the incidence of diabetes and cardiovascular events. N Engl J Med 2010;362:1477-90. 66. Callaghan BC, Cheng HT, Stables CL et al. Diabetic neuropathy: clinical manifestations and current treatments. Lancet Neurol 2012;11:521-34.
46. Mills JL SR. Update and validation of the Society for Vascular Surgery wound, ischemia, and foot infection threatened limb classification system. Semin Vasc Surg 2014;27:16-22.
53. Aboyans V, Ricco JB, Bartelink MEL et al. 2017 ESCGuidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries Endorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J 2018;39:763-816.
59. Kranke P, Bennett M, Roeckl-Wiedmann I, Debus S. Hyperbaric oxygen therapy for chronic wounds. Cochrane Database Syst Rev 2004;(2):CD004123 60. Kranke P, Bennett MH, Martyn-St James M et al. Hyperbaric oxygen therapy for chronic wounds. Cochrane Database Syst Rev 2015;24(6):CD004123. 61. Lipsky BA, Berendt AR, Cornia PB et al. 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis 2012;54:132-73.
62. Boulton AJ, Vinik AI, Arezzo JC et al. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care 2005;28:956-62. 63. Callaghan BC, Little AA, Feldman EL, Hughes RA. Enhanced glucose control for preventing and treating diabetic neuropathy. Cochrane Database Syst Rev 2012;CD007543.
299Capítulo 154 Pé diAbétiCo – umA visão ger Al
73. Lunn MP, Hughes RA, Wiffen PJ. Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia. Cochrane Database Syst Rev 2014;CD007115. 74. Rowbotham MC, Goli V, Kunz NR, Lei D. Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study. Pain 2004;110:697-706. 75. Gallagher HC, Gallagher RM, Butler M et al. Venlafaxine for neuropathic pain in adults. Cochrane Database Syst Rev 2015;CD011091. 76. Freeman R, Durso-Decruz E, Emir B. Efficacy, safety, and tolerability of pregabalin treatment for painful diabetic peripheral neuropathy: findings from seven randomized, controlled trials across a range of doses. Diabetes care 2008;31:1448-54. 77. Wiffen PJ, Derry S, Lunn MP, Moore RA. Topiramate for neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev 2013;CD008314. 78. Ziegler D, Ametov A, Barinov A et al. Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial. Diabetes Care 2006;29:2365-70. 79. Sindrup SH, Andersen G, Madsen C et al. Tramadol relieves pain and allodynia in polyneuropathy: a randomised, double-blind, controlled trial. Pain 1999;83:85-90. 80. Gaskell H, Derry S, Stannard C, Moore RA. Oxycodone for neuropathic pain in adults. Cochrane Database Syst Rev 2016;7:CD010692. 81. Bril V, England J, Franklin GM et al. Evidence-based guideline: Treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology 2011;76:1758-65. 82. Barbano RL, Herrmann DN, Hart-Gouleau S et al. Effectiveness, tolerability, and impact on quality of life of the 5% lidocaine patch in diabetic polyneuropathy. Arch Neurol 2004;61:914-8. 83. Dubinsky RM, Miyasaki J. Assessment: efficacy of transcutaneous electric nerve stimulation in the treatment of pain in neurologic disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2010;74:173-6. 84. Bennet AM, Brismar K, Hallqvist J et al. The risk of myocardial infarction is enhanced by a synergistic interaction between serum insulin and smoking. Eur J Endocrinol 2002;147:641-47. 85. Hageman D, Fokkenrood HJ, Gommans LN et al. Supervised exercise therapy versus home-based exercise therapy versus walking advice for intermittent claudication. Cochrane Database Syst Rev 2018 Apr 6;4:CD005263. 86. Lauret GJ1, Fakhry F, Fokkenrood HJ et al. Modes of exercise training for intermittent claudication. Cochrane Database Syst Rev 2014 Jul 4;(7):CD009638. 87. Berger JS, Krantz MJ, Kittelson JM et al. Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials. JAMA 2009;301:1909-19.
56. British Medical Association and Royal Pharmaceutical Society of Great Britain. British National Formulary Appendix 8: Wound management products and elastic hosiery. http://www.bnf.org.uk/bnf/bnf/current Sept 2010;60. 57. Yazbek G. Atualização do tratamento tópico das úlceras microangiopáticas de origem diabética. In: Presti, Calógero. Conceitos Atuais na Doença Vascular Periférica. São Paulo: Editora Senac; 2017. p. 367-375.
89. Cacoub PP, Bhatt DL, Steg PG et al. Patients with peripheral arterial disease in the CHARISMA trial. Eur Heart J 2009;30:192-201.
101. Rewale V, Prabhakar KR, Chitale AM. Pentoxifylline: a new armamentarium in diabetic foot ulcers. J Clin Diagn Res 2014;8:84-6. 102. Ruffolo AJ, Romano M, Ciapponi A. Prostanoids for critical limb ischaemia. Cochrane Database Syst Rev 2010;CD006544. 103. Prompers L, Huijberts M, Apelqvist J et al. Delivery of care to diabetic patients with foot ulcers in daily practice: results of the Eurodiale study, a prospective cohort study. Diabet Med 2008;25:700-7.
300 Parte VIIIMEMBROS INFERIORES
93. Braga MF, Leiter LA. Role of renin-angiotensin system blockade in patients with diabetes mellitus. Am J Cardiol 2009;104:835-9.
90. Armstrong EJ, Anderson DR, Yeo KK et al. Association of dualantiplatelet therapy with reduced major adverse cardiovascular events in patients with symptomatic peripheral arterial disease. J Vasc Surg 2015;62:157-65.
88. Caprie Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996;348:1329-39.
100. Moher D, Pham B, Ausejo M et al. Pharmacological management of intermittent claudication: a meta-analysis of randomised trials. Drugs 2000;59:1057-70.
92. Hershon KS. Mechanistic and clinical aspects of renin-angiotensinaldosterone system blockade in the prevention of diabetes mellitus and cardiovascular disease. Endocr Pract 2011;17:430-40.
91. Warfarin Antiplatelet Vascular Evaluation Trial Investigators, Anand S, Yusuf S, Xie C et al. Oral anticoagulant and antiplatelet therapy and peripheral arterial disease. N Engl J Med 2007;19;357:217-27.
94. Gerstein HC. Reduction of cardiovascular events and microvascular complications in diabetes with ACE inhibitor treatment: HOPE and MICRO-HOPE. Diabetes Metab Res Rev 2002;18 Suppl 3:S82-5. 95. Shahin Y, Cockcroft JR, Chetter IC. Randomized clinical trial of angiotensin-converting enzyme inhibitor, ramipril, in patients with intermittent claudication. Br J Surg 2013;100:1154-63. 96. Kumbhani DJ, Steg PG, Cannon CP et al. Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registry. Eur Heart J 2014;35:2864-72. 97. Bedenis R, Stewart M, Cleanthis M et al. Cilostazol for intermittent claudication. Cochrane Database Syst Rev 2014 Oct 31;(10):CD003748. 98. Norgren WR, Hiatt JA, Dormandy MR et al. Fowkes on Behalf of the TASC II Working Group. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 2007;45:(Suppl.) S5-S67. 99. Brasileiro JL, Inoye CM, Aydos RD et al. Ischemia and reperfusion of rat small intestine using pentoxyfilline and prostaglandin E1. Acta Cirúrgica Brasileira 2013;28:767-73.
104. Lipsky BA, Aragón-Sánchez J, Diggle M et al. IWGDF guidance on the diagnosis and management of foot infections in persons with diabetes. Diabetes Metab Res Rev 2016;32 (Suppl 1):45-74. 105. Perim MC, Borges JDA C, Celeste SR et al. Aerobic bacterial profile and antibiotic resistance in patients with diabetic foot infections. Rev Soc Bras Med Trop 2015;48(5):546-54. 106. Fernandes FF, Pimenta FC, Fernandes Fernando DF. Isolamento e perfil de suscetibilidade de bactérias de pé diabético e úlcera de estase venosa de pacientes admitidos no pronto-socorro do principal hospital universitário do estado de Goiás, Brasil. J Vasc Bras 2007;6:211-217. 107. Carvalho CB, Neto RM, Aragão LP et al. Diabetic foot infection. Bacteriologic analysis of 141 patients. Arq Bras Endocrinol Metabol 2004;48:398-405.
24. Ctercteko GC, Dhanendran M, Hutton WC, Le Quesne LP. Vertical forces acting on the feet of diabetic patients with neuropathic ulceration. Br J Surg 1981;68:608-14. 25. Downs DM, Jacobs RL. Treatment of resistant ulcers on the plantar surface of the great toe in diabetics. J Bone Joint Surg Am 1982;64:930-3. 26. Johnson JE1, Anderson SA. One stage resection and pin stabilization of first metatarsophalangeal joint for chronic plantar ulcer with osteomyelitis Foot Ankle Int 2010 Nov;31(11):973-9. 27. Rosenblum BI, Giurini JM, Chrzan JS, Habershaw GM. Preventing loss of the great toe with the hallux interphalangeal joint arthroplasty. J Foot Ankle Surg 1994;33:557-60. 28. Laborde JM: Neuropathic toe ulcers treated with toe flexor tenotomies. Foot Ankle Int 2007;28:1160-4. 29. Tamir E, McLaren AM, Gadgil A, Daniels TR. Outpatient percutaneous flexor tenotomies for management of diabetic claw toe deformities with ulcers: A preliminary report. Can J Surg 2008;51:41-4. 30. Schepers T, Berendsen HA, Oei IH, Koning J. Functional outcome and patient satisfaction after flexor tenotomy for plantar ulcers of the toes. J Foot Ankle Surg 2010;49:119-22. 31. Kearney TP, Hunt NA, Lavery LA. Safety and effectiveness of flexor tenotomies to heal toe ulcers in persons with diabetes. Diabetes Res Clin Pract 2010;89:224-6. 32. van Netten JJ, Bril A, van Baal JG. The effect of flexor tenotomy on healing and prevention of neuropathic diabetic foot ulcers on the distal end of the toe. J Foot and Ankle Res 2013;6:3. 33. Bonanno DR, Gillies EJ. Flexor Tenotomy Improves Healing and Prevention of Diabetes-Related Toe Ulcers: A Systematic Review. J Foot Ankle Surg 2017;56(3):600-604. 34. Jacobs RL. Hoffman procedure in the ulcerated diabetic neuropathic foot. Foot Ankle 1982;3:142-9. 35. Icks A, Haastert B, Trautner C et al. Incidence of lower-limb amputations in the diabetic compared to thenon-diabetic population. findings from nationwide insurance data, Germany, 2005-2007. Exp Clin Endocrinol Diabetes 2009;117:500-4. 36. Agarwal AK, Goel MK, Srivastava RK, Rastogi S. A clinical study of amputations of the lower limb. Prosthet Orthot Int 1980;4:162-4. 37. Boffeli TJ, Reinking R. Plantar rotational flap technique for panmetatarsal head resection and transmetatarsal amputation: a revision approach for second metatarsal head transfer ulcers in patients with previous partial first ray amputation. J Foot Ankle Surg 2014;53:96-100. 38. Jeffcoate WJ. Theories concerning the pathogenes is of the acute Charcot foot suggest future therapy. Curr Diab Rep 2005;5:430-5. 39. Rosenblum BI, Giurini JM, Miller LB et al. Neuropathic ulcerations plantar to the lateral column in patients with Charcot foot deformity: a flexible approach to limb salvage. J Foot Ankle Surg 1997;36:360-3. 40. Frykberg RG. Charcot Arthropathy in the Diabetic Foot. Foot Ankle Spec 2012;4:262-71. 41. Ferreira RC, Gonçalez DH, Fonseca Filho JM et al. Midfoot Charcot arthropathy in diabetic patients: complication of an epidemic disease. Rev Bras Ortop 2012;47:616-25.
REFERÊNCIAS
1. Reiber GE, Boyko EJ, Smith DG. Lower Extremity Foot Ulcers and Amputations in Diabetes. In: Harris MI, Cowie CC, Stern MP et al. (Eds.). Diabetes in America. 2nd ed. Washington, DC: U.S. Government Printing Office; 1995.
301
3. Rezende KF, Ferraz MB, Malerbi D A et al. Direct costs and outcomes for in patients with diabetes mellitus and foot ulcers in a developing country: The experience of the public health system of Brazil. Diabetes and Metabolic Syndrome: Clinical Research and Reviews 2009;3:228-232.
2. Shahbazian H, Yazdanpanah L, Latif SM. Risk assessment of patients with diabetes for foot ulcers according to risk classification consensus of international working group on diabetic foot (IWGDF). Pak J Med Sci 2013;29:730-4.
4. Bosi PL, Carvalho AM, Contrera D et al. Prevalência de diabetes melito e tolerância à glicose diminuída na população urbana de 30 a 79 anos da cidade de São Carlos, São Paulo. Arq Bras Endocrinol Metabol 2009;53:726-32.
10. Armstrong DG, Lipsky B A. Diabetic foot infections: stepwise medical and surgical management. Int Wound J 2004;1:123-32. 11. Edmonds ME, Blundell MP, Morris ME et al. Improved survival of the diabetic foot: the role of a specialized foot clinic. Q J Med 1986;60:763-71.
7. Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA 2005;293:217-228.
12. Thomson F, Veves A, Ashe H, Knowles E. A team approach to diabetic foot care? The Manchester experience. Foot 1991;2(1):75-82.
14. Dias E. Angiossomas do pé e do tornozelo – implicações no tratamento da isquemia crítica dos membros inferiores. Angiologia e Cirurgia Vascular 2011;7:7-10.
5. Torquato MT, Montenegro Júnior RM, Viana LA et al. Prevalence of diabetes mellitus and impaired glucose tolerance in the urban population aged 30-69 years in Ribeirão Preto (São Paulo), Brazil. São Paulo Med J 2003;121:224-30.
155Capítulo
15. Alexandrescu V, Hubermont G. Primary infragenicular angioplasty for diabetic neuroischemic foot ulcers following the angiosome distribution: a new paradigm for the vascular interventionist? Diabetes Metab Syndr Obes 2011;4:327-36.
16. Alexandrescu VA, Hubermont G, Philips Y et al. Selective primary angioplasty following an angiosome model of reperfusion in the treatment of Wagner 1-4 diabetic foot lesions: practice in a multidisciplinary diabetic limb service. J Endovasc Ther 2008;15:580-93.
13. Gibbons GW. Vascular evaluation and long-term results of distal bypass surgery in patients with diabetes. Clin Podiatr Med Surg 1995;12:129-40.
17. Grodinsky M. Foot Infections of Peridigital Origin: Routes of Spread and Methods of Treatment. Ann Surg 1931;94:274-85.
TRATAMENTO CIRÚRGICO DO PÉ DIABÉTICO BIBLIOGRÁFICAS
8. Frykberg RG, Armstrong DG, Giurini J et al. Diabetic foot disorders: a clinical practice guideline. American College of Foot and Ankle Surgeons. J Foot Ankle Surg 2000;39(5suppl):S1-S60.
18. Loeffler RD, Ballard A. Plantar fascial spaces of the foot and a proposed surgical approach. Foot Ankle 1980;1:11-14.
19. Attinger C, Cooper P, Blume P. Vascular anatomy of the foot and ankle. Op Tech Plast Reconstr Surg 1997;4:183-98.
20. Quiñones-Baldrich WJ, Colburn MD, Ahn SS et al. Very distal bypass for salvage of the severely ischemic extremity. Am J Surg 1993;166:117-23.
6. Boulton AJ. The pathway to foot ulceration in diabetes. Med Clin North Am 2013;97:775-790.
21. Ascer E, Veith FJ, Gupta SK. Bypasses to plantar arteries and other tibial branches: an extended approach to limb salvage. J Vasc Surg 1988;8:434-41.s 22. Bergamini TM, George SM, Massey HT et al. Pedal or peroneal bypass: which is better when both are patent? J Vasc Surg 1994;20:347-55. 23. Cavanagh PR, Rodgers MM, Iiboshi A. Pressure distribution under symptom-free feet during barefoot standing. Foot Ankle 1987;7:262-76.
9. Eldor R, Raz I, Ben Yehuda A, Boulton AJ. New and experimental approaches to treatment of diabetic foot ulcers: a comprehensive review of emerging treatment strategies. Diabet Med 2004;21:1161-1173.
54. Logerfo FW. Vascular disease, matrix abnormalities, and neuropathy: implications for limb salvage in diabetes mellitus. J Vasc Surg 1987;5:793-6.
48.
49.
53. Wu JT, Wong M, Lo ZJ et al. A Series of 210 Peripheral Arterial Disease Below-Knee Amputations and Predictors for Subsequent Above-Knee Amputations. Ann Vasc Dis 2017;10;217-22.
72. Pomposelli FB, Kansal N, Hamdan A et al. A decade of experience with dorsalis pedis artery bypass: analysis of outcome in more than 1000 cases. J Vasc Surg 2003;37:307-14.
45.
46.
42. Fosse S, Jacqueminet S, Van GH, Grimaldi A. Complications, incidence and characteristics of lower limb amputations in people with diabetes. Diabet Med 2009;26:391-6. Cooper PS. Application of external fixators for management of Charcot deformities of the foot and ankle. Foot Ankle Clin 2002;7:207-54. 44. Akkurt MO, Demirkale I, Öznur A. Partial calcanectomy and Ilizarov external fixation may reduce amputation need in severe diabetic calcaneal ulcers. Diabet Foot Ankle 2017;8:1264699. Tan JS, Friedman NM, Hazelton-Miller C et al. Can aggressive treatment of diabetic foot infections reduce the need for aboveankle amputation? Clin Infect Dis 1996;23:286-91. Bradley RV. Debridement and Amputations. In: Levin ME, O’Neal LW (Ed.). The diabetic foot. Saint Louis: C.V. Mosby Company; 1973. Sheahan MG, Hamdan AD, Veraldi JR et al. Lower extremity minor amputations: the roles of diabetes mellitus and timing of revascularization. J Vasc Surg 2005;42:476-80. Armstrong DG, Lavery LA. Diabetic Foot Study Consortium. Negative pressure wound therapy after partial diabetic foot amputation: a multicenter, randomised controlled trial. Lancet 2005;366:1704-10. Blume PA, Walters J, Payne W et al. Comparison of negative pressure wound therapy using vacuum-assisted closure with advanced most wound therapy in the treatment of diabetic foot ulcers: a multicenter randomized controlled trial. Diabetes Care 2008;31:631-6.
52. Toursarkissian B, Shireman PK, Harrison A et al. Major lowerextremity amputation: contemporary experience in a single Veterans Affairs institution. Ann Vasc Surg 2002;16:601-7.
69. Buchbinder D, Pasch AR, Rollins DL et al. Results of arterial reconstruction of the foot. Arch Surg 1986;121:673-7.
43.
58. Tannembaum GA, Pomposelli FB, Marcaccio EJ et al. Safety of vein bypass grafting to the dorsal pedal artery in diabetic patients with foot infections. J Vasc Surg 1992;15:982-8. 59. Kalish J, Hamdan A. Management of diabetic foot problems. J Vasc Surg 2010;51:476-86. 60. Treiman GS, Oderich GS, Ashrafi A, Schneider PA. Management of ischemic heel ulceration and gangrene: An evaluation of factors associated with successful healing. J Vasc Surg 2000;31:1110-8. 61. Berceli SA, Chan AK, Pomposelli FB Jr et al. Efficacy of dorsal pedal artery bypass in limb salvage for ischemic heel ulcers. J Vasc Surg 1999;30:499-508. 62. Cook J, Cook E, Landsman AS et al. A retrospective assessment of partial calcanectomies and factors influencing postoperative course. J Foot Ankle Surg 2007;46:248-55. 63. Khanolkar MP, Bain SC, Stephens JW. The diabetic foot. QJM 2008;101:685-95. 64. Faglia E, Clerici G, Clerissi J et al. Long-term prognosis of diabetic patients with critical limb ischemia: a population-based cohort study. Diabetes Care 2009;32:822-7. 65. McCaughan Jr JJ. Bypass graft to the posterior tibial artery at the ankle. Case reports. Ann Surg 1966;32:126-30. 66. Harjola P, Tala P. Long femoro-maleolar bypass grafting in advanced femoro-popliteal arterial occlusion. J Cardiovasc Surg 1969;10:229-32. 67. Baird RJ, Tutassaura H, Miyagishima RT. Saphenous vein bypass grafts to the arteries of the ankle and foot. Ann Surg 1994;20:347-56. 68. Andros G, Harris RW, Salles-Cunha SX et al. Bypass grafts to the ankle and the foot. J Vasc Surg 1988;7:785-94.
50. Guffanti A. Negative pressure wound therapy in the treatment of diabetic foot ulcers: a systematic review of the literature. J Wound Ostomy Continence Nurs 2014;41:233-7.
51. Nehler MR, Coll JR, Hiatt WR et al. Functional outcome in a contemporary series of major lower extremity amputations. J Vasc Surg 2003;38:7-14.
70. Foster RP, Yonke BP. Extremity salvage: vein bypass to the ankle level and beyond. J Vasc Surg 1971;5:12-20.
71. Harris HW, Rapp JH, Reilly LM et al. Saphenous vein bypass to pedal arteries. Arch Surg 1989;124:1232-6.
73. Conte MS, Bandyk DF, Clowes AW et al. Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery. J Vasc Surg 2006;43:742-751. 74. Black JH III, LaMuraglia GM, Kwolek CJ et al. Contemporary results of angioplasty based infrainguinal percutaneous interventions. J Vasc Surg 2005;42:932-9.
75. Bosiers M, Hart JP, Deloose K et al. Endovascular therapy as the primary approach for limb salvage in patients with critical limb ischemia: experience with 443 infrapopliteal procedures. Vascular 2006;14:63-9. 76. Giles KA, Pomposelli FB, Hamdan AD et al. Infrapopliteal angioplasty for critical limb ischemia: relation of TransAtlantic InterSociety Consensus class to outcome in 176 limbs. J Vasc Surg 2008;48(1):128-36. 77. Morgenstern BR, Getrajdman GI, Laffey KJ et al. Total occlusions of the femoropopliteal artery: high technical success rate of conventional balloon angioplasty. Radiology 1989;172:937-40. 78. Mellière D, Berrahal D, D’Audiffret A et al. Percutaneous transluminal angioplasty in patients with ischemic tissue necrosis is worthwhile. Cardiovasc Surg 2001;9:122-126. 79. Conrad MF, Cambria RP, Stone DH et al. Intermediate results of percutaneous endovascular therapy of femoropopliteal occlusive disease: a contemporary series. J Vasc Surg 2006;44:762-769. 80. Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD). TASC Working Group. 3.TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg 2000;31:S1-S296. 81. Bodewes TCF, Darling JD, Deery SE et al. Patient selection and perioperative outcomes of bypass and endovascular intervention as first revascularization strategy for infrainguinal arterial disease. J Vasc Surg 2014;59:708-19. 82. Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD). TASC Working Group. 3.TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg 2000;31:S1-S296. 83. Neville RF, Attringer CE, Bulan EJ et al. Revascularization of a specific angiosome for limb salvage: does the target artery matter? Ann Vasc Surg 2009;23:367-73. 84. Brownrigg JRW, Apelqvist J, Bakker K et al. Evidence-based Management of PAD & the Diabetic Foot. Eur J Vasc Endovasc Surg 2013;45:673-81. 85. Gerhard-Herman MD, Gornik HL, Barrett C et al. 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 2017;21;135:e726-e779. 86. Hamdan AD, Rayan SS, Hook SC et al. Bypasses to tibial vessels using polytetrafluoroethylene as the solo conduit in a predominantly diabetic population. Vasc Endovascular Surg 2002;36:59-63. 87. Domenig CM, Hamdan AD, Holzenbein TJ et al. Timing of pedal bypass failure and its impact on the need for amputation. Ann Vasc Surg 2005;19:56-62. 88. Brochado Neto FC, Cury MVM, Costa VS et al. Inframaleolar bypass grafts for limb salvage. Eur J Vasc Endovasc Surg 2010;40:747-53. 89. Taylor Jr LM, Chitwood RW, Dalman RL et al. Antiphospholipid antibodies in vascular surgery patients, Ann Surg 1994;220:544-51. 90. Rutherford R, Jones DN, Bergentz SE et al. Factors affecting the patency of infrainguinal bypass. J Vasc Surg 1988;8:236-46. 91. Schanzer A, Hevelone N, Owens CD et al. Technical factors affecting autogenous vein graft failure: observations from a large multicenter trial. J Vasc Surg 2007;46:1180-90. 92. Casella IB, Brochado-Neto FC, Sandri GA et al. Outcome analysis of infrapopliteal percutaneous transluminal angioplasty and bypass graft surgery with nonreversed saphenous vein for individuals with critical limb ischemia. Vasc Endovasc Surg 2010;44:625-32. 93. Harris RW, Andros G, Dulawa LB et al. Successful long-term limb salvage using cephalic vein bypass grafts. Ann Surg 1984;200:785-92.
56. Pomposelli F, Jepsen SJ, Gibons GW et al. Efficacy of the dorsal pedal bypass for limb salvage in diabetic patients: short- term observations. J Vasc Surg 1990;11:745-51. 57. Walker WB. Peripheral arterial surgery in the diabetic. In: Levin ME, O’Neal LW (Ed.). The Diabetic Foot. Saint Louis: C.V. Mosby Company; 1973. p. 156-81.
55. Ciavarella A, Silletti A, Mustacchio A et al. Angiographic evaluation of the anatomic pattern of arterial obstructions in diabetic patients with critical limb ischemia. Diabet Metab 1993;19:586-9.
302 Parte VIIIMEMBROS INFERIORES
47.
118. Moos JM, Ham SW, Han SM et al. Safety of carbon dioxide digital subtraction angiography. Arch Surg 2011;146:1428-32.
115. Feiring AJ, Wesolowski AA, Lade S. Primary stent-supported angioplasty for treatment of below-knee critical limb ischemia and severe claudication: early and one-year outcomes. J Am Coll Cardiol 2004;44:2307-14. 116. Schneider PA, Caps MT, Ogawa DY, Hayman ES. Intraoperative superficial femoral artery balloon angioplasty and popliteal to distal bypass graft: an option for combined open and endovascular treatment of diabetic gangrene. J Vasc Surg 2001;33:955-62.
94. Andros G, Harris RW, Salles-Cunha SX et al. Lateral plantar artery bypass grafting: defining the limits of foot revascularization. J Vasc Surg 1989;10:511-9. 95. Friedman SG, Krishnasastry KV, Doscher W, Deckoff SL. Lower extremity revascularization via the lateral plantar artery. Am Surg 1990;56:721-5. 96. Gloviczki P, Morris SM, Bower TC et al. Microvascular pedal bypass for salvage of the severely ischemic limb. Mayo Clin Proc 1991;66:243-53. 97. Hughes K, Domenig CM, Hamdan AD et al. Bypass to plantar and tarsal arteries: an acceptable approach to limb salvage. J Vasc Surg 2004;40:1149-57. 98. Brochado-Neto FC, Cury MV, Bonadiman SS et al. Vein bypasses to branches of pedal arteries. J Vasc Surg 2012;55:746-52. 99. Saarinen E, Kauhanen P, Söderström M et al. Long-term Results of Inframaleolar Bypass for Critical Limb Ischaemia. Eur J Vasc Endovasc Surg 2016; 52: 815-822. 100. Barral X, Salari GR, Tourarkissian B et al. Bypass to the perigeniculate collateral vessels. A useful technique for limb salvage: preliminary report on 20 patients. J Vasc Surg 1998;27:928-35. 101. Latour B, Nourissat G, Duprey A et al. Bypass to the perigeniculate collateral arteries: mid-term results. Eur J Vasc Endovasc Surg 2008;35:473-9. 102. Brochado-Neto FC, Gonzalez J, Cinelli Jr M, Albers M. Bypass to the genicular arteries for revascularization of the lower limb. Eur J Vasc Endovasc Surg 2000;20:545-9.
119. Lantis JC 2nd, Conte MS, Belkin M et al. Infrainguinal bypass grafting in patients with end-stage renal disease: improving outcomes?
127. Toursarkissian B, Shireman PK, Harrison A et al. Major lowerextremity amputation: contemporary experience in a single Veterans Affairs institution. Am Surg 2002;68:606-10.
108. Adam DJ, Beard JD, Cleveland T et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicenter, randomised controlled trial. Lancet 2005;366:1925-34.
103. De Luccia N, Appolonio F, Espirito Santo FR. Arm vein bypass from distal deep femoral to superior genicular artery for limb salvage. J Vasc Surg 2009;50:1196-7. 104. Norgren L et al. Inter-society consensus for the management of peripheral arterial disease (TASC II). Eur J Vasc Endovasc Surg 2007;33:S1-S70.
J Vasc Surg 2001;33:1171-8.
124. Graziani L, Silvestro A, Bertone V et al. Percutaneous transluminal angioplasty is feasible and effective in patients on chronic dialysis with severe peripheral artery disease. Nephrol Dial Transplant 2007;22:1144-9.
106. Bradbury A, Wilmink T, Lee AJ et al. Bypass versus angioplasty to treat severe limb ischemia: factors that affect treatment preferences of UK surgeons and interventional radiologists. J Vasc Surg 2004;39:1026-32. 107. DeRubertis BG, Pierce M, Ryer EJ et al. Reduced primary patency rate in diabetic patients after percutaneous intervention results from more frequent presentation with limb-threatening ischemia. J Vasc Surg 2008;47:101-8.
126. Nehler MR, Coll JR, Hiatt WR et al. Functional outcome in a contemporary series of major lower extremity amputations. J Vasc Surg 2003;38:7-14.
109. Beard JD. Which is the best revascularization for critical limb ischemia: Endovascular or open surgery? J Vasc Surg 2008;48(6 Suppl):11S-16S. 110. Bradbury AW, Adam DJ, Bell J et al. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: An intention-totreat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategy. J Vasc Surg 2010;51(5 Suppl):5S-17S.
111. Surowiec SM, Davies MG, Eberly SW et al. Percutaneous angioplasty and stenting of the superficial femoral artery. J Vasc Surg 2005;41:269-78. 112. Ryer EJ, Trocciola SM, DeRubertis B et al. Analysis of outcomes following failed endovascular treatment of chronic limb ischemia. Ann Vasc Surg 2006;20:440-6. 113. Donas KP, Schwindt A, Schönefeld T et al. Below-knee bare nitinol stent placement in high-risk patients with critical limb ischaemia and unlimited supragenicular inflow as treatment of choice. Eur J Vasc Endovasc Surg 2009;37:688-93.
117. Back MR, Caridi JG, Hawkins IF Jr, Seeger JM. Angiography with carbon dioxide (CO2). Surg Clin North Am 1998;78:575-91.
114. Karnabatidis D, Katsanos K, Spiliopoulos S et al. Incidence, anatomical location, and clinical significance of compressions and fractures in infrapopliteal balloon-expandable metal stents. J Endovasc Ther 2009;16:15-22.
120. Ramdev P, Rayan SS, Sheahan M et al. A decade experience with infrainguinal revascularization in a dialysis-dependent patient population. J Vasc Surg 2002;36:969-74.
121. Korn P, Hoenig SJ, Skillman JJ, Kent KC. Is lower extremity revascularization worthwhile in patients with end-stage renal disease? Surgery 2000;128:472-9.
303Capítulo 155 tr AtAmento CirúrgiCo do Pé diAbétiCo
105. De Luccia N, Sassaki P, Durazzo A et al. Limb salvage using bypass to the perigeniculate arteries. Eur J Vasc Endovasc Surg 2011;42:374-8.
125. Abou-Zamzam AM Jr, Gomez NR, Molkara A et al. A prospective analysis of critical limb ischemia: factors leading to major primary amputation versus revascularization. Ann Vasc Surg 2007;21:458-63.
122. Johnson BL, Glickman MH, Bandyk DF, Esses GE. Failure of foot salvage in patients with end-stage renal disease after surgical revascularization. J Vasc Surg 1995;22:280-5.
123. Aulivola B, Gargiulo M, Bessoni M et al. Infrapopliteal angioplasty for limb salvage in the setting of renal failure: do results justify its use? Ann Vasc Surg 2005;19:762-8.
15. Burgess EM, Romano RL, Zettl JH. The management of lower extremity amputation. US Government Printing Office, Washington DC; 1969. 16. Andrade MFC, De Luccia N, Lobato A et al Desarticulação coxofemoral por doença vascular periférica. Anais do XXIX Congresso da Sociedade Brasileira de Angiologia e Cirurgia Vascular; p. 82.
13. De Luccia N. Desarticulação do joelho como nível de amputação na doença vascular periférica. Tese Doutorado, Faculdade de Medicina da Universidade de São Paulo, 1985. 14. De Luccia N. Desarticulação do joelho. In: De Luccia N. Amputação e reconstrução na doença vascular e no pé diabético. Rio de Janeiro: Revinter; 2006. p. 177-191.
REFERÊNCIAS BIBLIOGRÁFICAS
17. Sugarbaker PH, Chretien PB. A surgical technique for hip disarticulation. Surgery 1981:90:546.
304 156Capítulo ASPECTOS DA TÉCNICA OPERATÓRIA DAS
1. Bowker J H. Terminology in acquired limb loss. In: Smith DG, Michael JW, Bowker JH (Eds.). Atlas of Amputations and Limb Deficiencies: surgical, prosthetic and rehabilitation principles/American Academy of Orthopaedic Surgeons. 3rd ed., 2004. p. 945.
MAIORES
5. Bickel WH. Amputation below the knee in occlusive arterial disease. Surg Clin North Am 1943;23:982-994.
3. Wagner WF. Syme’s amputation done in two stages for diabetics, dysvascular gangrene and infection. New York: Presented at the ISPO World Congress; 1977. 4. Francis H, Roberts JR, Clagett GP et al. The Syme amputation: success in elderly diabetic patients with palpable ankle pulses. J Vasc Surg 1990;12,3:237-240.
9. Adams F. The genuine works of Hippocrates. New York: William Wood Company; 1886. 10. Velpeau A. Mémoire sur l’amputation de la jambe dans l’articulation du génou, et description dún nouveau procedé pour pratiquer cette operation. Arch Gen Med 1830;24:44-60. 11. Batch JW, Spittler AW, McFaddin JG. Advantages of the knee disarticulation over amputations through the tigh. J Bone Joint Surg 1954;36-A:921-930. 12. Baumbartner RF. Knee disarticulation versus above knee amputation. Prost Orthot Int 1979;3:15-19.
2. Syme J. Amputation at the ankle joint, Edinburgh Monthly. J Med Sci 1843;2:93.
6. Burgess EM. The below knee amputation. Bull Prosthet Res 1968;10:19-25. 7. Moore WS, Hall AD, Lim RC. Below knee amputation for ischaemic gangrene. Comparative results of conventional operation and immediate postoperative fitting technique. Am J Surg 1972;124:127-134.
8. Sanders RJ, Augspurger R. Skin flap measurement for below-knee amputation. Surg Gyn Obs 1977;145:740-742.
AMPUTAÇÕES DE MEMBROS INFERIORES
305 157Capítulo
PÓS-AMPUTAÇÃO
REFERÊNCIAS BIBLIOGRÁFICAS
1. De Frang RD, Taylor LM, Porter JM. Amputations. In: Porter JM, Taylor LM. Basic data underlying clinical decision making in vascular surgery. Quality Medical Publishing Inc; 1994. 2. Baumbartner R, Botta P. Amputation und Prothesenversorgung der unteren Extremität. Ferdinand Enke Verlag; 1989. 3. Söderberg B, Anders W, Schaarschuch R, Persson BM. The use of prostheses in relation to level of partial foot amputation. In: Partial foot amputations: guideline to prosthetic and surgical techniques Helsinborg: Centre for Partial Foot Amputees; 2001. p. 74-5. 4. De Luccia N. Amputação e reconstrução na doença vascular e no pé diabético. Rio de Janeiro: Revinter; 2006. p. 109. 5. Bowker JH, San Giovanni TP. Amputations and disarticulation. In: Myerson MS. Foot and ankle disorders. Saunders Co; 2000 6. Chang BB, Bock DE, Jacobs RL, Darling, RC, Leather,RP, Shah DM, et al. Increased limb salvage by the use of unconventional foot amputations. J Vasc Surg 1994;19(2). 7. Pedersen H. The problem of the geriatric amputee. Artificial Limbs 1968 Autumn;12(2):i-iii.
REABILITAÇÃO
Parte IX DOENÇAS MISTAS
43.
19. Sigmund G, Hettinger M, Block T et al. Evaluation of renal artery stenosis: Comparison of angiography and invasive blood pressure measurement and doppler ultrasound. ROFO Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 2000;172:615.
6. Espinoza JL, Ai S, Matsumura I. New Insights on the Pathogenesis of Takayasu Arteritis: Revisiting the Microbial Theory. Pathogens 2018 Sep 6;7(3):73. 7. Guillevin L, Pagnoux C. Urgence Médicales e complications grave des vascularites. Réanimation 2005 14;569-575. 8. Kerr GS, Mallahan CW, Giordano J et al. Takayasu’s Arteritis. Ann Intern Med 1994;120-919. 9. Johnston SL, Lock RJ, Gompels MM. Takayasu arteritis: a review. J Clin Pathol 2002;55:481-486. 10. Hoffman GS. Takayasu arteritis: lessons from the American Nation Institute of Health Experience. Int J Cardiol 1996;54(Suppl):83. Rizzi R, Bruno S, Stellacci C, Dammacco R. Takayasu’s arteritis: a cellmediated large-vessel vasculitis. Int J Clin Lab Res 1999;29(1):8-13.
11.
REFERÊNCIAS
309
42.
2. Lightfoot RW Jr. Vasculitides Overview of the inflamatory vascular diseases. In: Klippel JH, Dieppe PA. Rheumatology. Londres: Mosby; 1998. 3. Newport MJ, Finan C. Genome-wide association studies and susceptibility to infectious diseases. Brief Funct Genomics 2011 March 1;10(2):98-107. 4. Bozza A, Levy R. Vasculites primárias. In: Maffei FHA, Lastória S, Yoshida WB, Rollo HA. (Ed.). Doenças vasculares periféricas. 3. ed. Rio de Janeiro: MEDSI; 2002. p. 1761-78. 5. Merkel PA. Overview of vasculitis. In: Creager MA, Dzau VJ, Loscalzo J. Vascular medicine: a companion to Braunwald’s heart disease. 1st ed. Philadelphia: Saunders Elsevier; 2006. p. 607-622.
46.
23. Miyata T, Sato O, Koyama H et al. Long-term survival after surgical treatment of patients with Takayasu’s arteritis. Circulation 2003;108:1474-1480.
24. Kalra M, Cherry KJ. Supra aortic great vessels: surgical and percutaneous approach. In: Lanzer P, Topol E. Pan vascular medicine New York: Springer-Verlag; 2002. cap. 99. p. 1575-1595.
45.
17. Park JH, Chung JW, Im JG et al. Takayasu’s Arteritis - Evaluation of mural changes in the aorta and pulmonary artery with CT angiography. Radiology 1995;196:89-93.
1. Jennette C et al. Nomenclature of systemic vasculitis. Proposal of an International Consensus Conference. Arthritis Rheum 1994;37:187.
26. Stoodley MA, Thompson RC, Mitchell RS et al. Neurosurgical and neuroendovascular management of Takayasu’s arteritis. Neurosurgery 2000;46:841-851. 27. DeBakey ME, Crawford ES, Morris JC, Cooley DA. Surgical Considerations of Occlusive Diseases of the innominate, carotid, subclavia and vertebral arteries. Ann Surg 1961;154:698-725. 28. Buttgereit F, Dejaco C, Matteson EL, Dasgupta B. Polymyalgia Rheumatica and Giant Cell Arteritis: A Systematic Review. JAMA 2016;315(22):2442-2458. 29. Prior JA, Ranjbar H, Belcher J et al. Diagnostic delay for giant cell arteritis - a systematic review and meta-analysis. BMC Med 2017;15(1):120. 30. Cid MA, Merkel PA. Giant Cell Arteritis. In: Creager MA, Dzau VJ, Loscalzo J. Vascular medicine: a companion to Braunwald’s heart disease. Philadelphia: Saunders Elsevier; 2006. p. 629-640. 31. Alesting K, Barr J. Giant-cell arteritis: a biopsy study of polymialgia rheumatic including one case of Takayasu’s disease. Lancet 1963;1:1228. 32. Restuccia G, Boiardi L, Cavazza A et al. Long-term remission in biopsy proven giant cell arteritis: a retrospective cohort study. J Autoimmun 2017;77:39-44. 33. Hamrin B. Polymyalgia arteritica. Acta Med Scand Suppl 1972;533:1-131. 34. Weyand CM, Goronzy JJ. Arterial wall injury in giant cell arteritis. Arthritis Rheum 1999;42:844-53. 35. Kussmaul A, Maier R. Über eine bisher micht beschreibene eigen thümliche arterienerkrankung (periarteritis nodosa), die mit Morbus Brightii und rapid fortschreitender allgemeiner Muskellähmung einhergeht. Dtsch Arch Klin Med 1866;1:484-517. 36. Bozza A, Levy R. Vasculites. In: Pitta GBB, Castro AA, Burihan E. (Eds.). Angiologia e cirurgia vascular: guia ilustrado. Maceió: UNCISAL/ECMAL & LAVA; 2003. Disponível em: URL: http://www.lava.med.br/livro 37. Churg A, Churg J. Systemic vasculitides. New York/Tokyo: lgaku-Shoin, Tokyo, 1991. 38. Savage COS, Winearls CG, Evans DJ et al. Microscopic polyarteritis: presentation, pathology and prognosis. Q J Med 1985;56:467-83. 39. Kawasaki T. Acute febrile mucocutaneous syndrome with lymph node involvement with specific desquamation of the fingers toes in children. Arerugi 1967;16:178-222. 40. Kawasaki T. Kawasaki disease. In: Klippel J, Dieppe P. (Ed.). Rheumathology. London: Mosby; 1998. 41. Newburg JW et al. The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med 1986;315:341-347. Nonoyama S. Immunological abnormalities and endothelial cell in Kawasaki disease. Immunological Acta Paediatr J 1991;33(6):752-5. Walton EW. Giant-cell granuloma of the respiratory tract (Wegener’s granulomatosis). Br Med J 1958;2:265. 44. Churg J, Churg A. Idiopathic and secondary vasculitis: a review. Mod Pathol 1989;2:144-60. Jayne D, Rasmussen N, Andrassy K, et al. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med 2003;349:36. Langford CA. Treatment of ANCA-associated vasculitis. N Engl J Med 2003;349:3
20. Bletry O, Piette AM. Takayasu’s arteritis: towards less invasive management. Rev Med Interne 1998;19(12):867-9.
25. Mathias K, Jager H, Gissler HM. Endoluminal treatment of internal carotid artery stenosis. World Surg 2001;25:328-336.
BIBLIOGRÁFICAS
14. Numano F, Kobayashi Y. Takayasu arteritis— beyond pulselessness. Intern Med 1999;38(3):226-32.
13. Uthman IW, Bizri AR, Hajj Ali RA et al. Takayasu’s arteritis presenting as fever of unknown origin: report of two cases and literature review. Semin Arthritis Rheum 1999;28(4):280-5.
16. Gotway MB, Araoz PA, Macedo TA et al. Imaging Findings in Takayasu’s Arteritis. AJR 2005;184:1945-1950.
18. Sueyoshi E, Sakamoto I, Uetani M. MRI of Takayasu’s arteritis: typical appearances and complications. AJR 2006;187:W569-W575.
15. Pan LL, Du J, Gao N et al. IL-9-producing Th9 cells may participate in pathogenesis of Takayasu’s arteritis. Clin Rheumatol 2016;35:3031-3036.
21. Nakaoka Y, Isobe M, Takei S, Tanaka Y, Ishii T, Yokota S et al. Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis: results from a randomised, double-blind, placebocontrolled, phase 3 trial in Japan (the TAKT study). Ann Rheum Dis 2018;77:348-354.
158Capítulo
22. Hoffman GS, Ahmed AE. Surrogate Markers of disease activity in patients with Takayasu arteritis. A preliminary report from the International Network for the Study of the Systemic Vasculitides (INSSYS). Int J Cardiol 1998;66:S191-S194.
VASCULITES
12. Maksimowicz-McKinnon K, Hoffman G. Takayasu’s Arteritis. In: Creager MA, Dzau VJ, Loscalzo J. Vascular medicine: a companion to Braunwald’s heart disease. Philadelphia: Saunders Elsevier; 2006. p. 623-628.
52. Fauci AS, Haynes BF, Katz P. The spectrum of vasculitis: clinical, pathological, immunologic, and therapeutic considerations. Ann Intern Med 1978;89:660-76.
59. International Study Group for Behçet’s Disease. Lancet 1990;335:1078-80. 60. Kavanaugh A, Oppenheimer-Marks N. The role of vascular endothelium in the pathogenesis of vasculites. In: LeRoy EC. (Ed.). The biologic basis of systemic vasculitis. New York: Dekker, 1992. p. 65-92.
57. Okada AA, Goto H, Ohno S, Mochizuki M. Ocular Behçet’s Disease Research Group of Japan FT. Multicenter Study of Infliximab for Refractory Uveoretinitis in Behçet Disease. Arch Ophthalmol 2012;130(5):592-598.
53. James DC, Thomson A. Recognition of the diverse cardiovascular manifestations Behçet’s disease. Am Heart J 1982;30:457-8.
Parte IX310 DOENÇAS MISTAS 47. Lhote F. Vascularite, périartérite nouese, syndrome de Churg et Strauss. Encycl Méd Chir (Editions Scientifiques et Médicales Elsevier SAS, Paris, tous droits réservés), AKOS Encyclopédie Pratique de Médecine, 5-0320. Angéiologie 2000;19(1830):7. 48. Marques CC, Fernandes EL, Miquelin GM, Colferai MM. Cutaneous manifestations of Churg-Strauss syndrome: key to diagnosis. An Bras Dermatol 2017;92(5 Suppl 1):56-8. 49. Egan CA, O’Reilly MA, Meadows KP, Zone JJ. Relapsing HenochSchönlein purpura associated with Pseudomonas aeruginosa pyelonephritis. J Am Acad Dermatol 2000;42(2 Pt 2):381-3. 50. Hachulla E. Purpuras vasculaires. Encycl Méd Chir (Elsevier, Paris). Angéiologie 1997;19(2560):7. 51. Wechsler B, Du Boutin LTH. Maladie de Behçet. Encycl Méd Chir (Elsevier, Paris) Appareil Locomoteur, IV-98, 14-206-B-10. Angeologie 1999;19(1920):6.
62. Gower RG, Saysker WF, Komler FP et al. Small-vessel vasculitis caused by hepatitis B virus immune complexes. J Allergy Clin lmmunol 1978;62:222-8. 63. Agnello V, Churg RT, Kaplan LM. A role for hepatitis C virus infection in type II mixed crioglobulinemia. N Engl J Med 1992;327:1490-95. 64. Millian G. Les atrophies cutâneos syphilitiques. Bull Soc Franç Dermatol Syph 1929;36:865. 65. Gougerot H, Burnier R. Capillarite obliterante necrosante fixée. Bull Soc Franç Dermatol Syph 1935;42:586. 66. Duperrat B. Précis de Dermatologie. Paris: Masson & Cie., 1959. 67. Winkelmann RK. Livedoid vasculitis (segmental hyalizing vasculitis). JAPJ Dermatol 1972;82:84. 68. Wolff K, Winkelmann RK. VascuIites. Major Problems in Dermatology. Philadelphia: WB Saunders; 1980. v.10. 69. Winiwarter von F. Ueber eine eigenthumliche form von Endarteriitis und Endophlebitis mit Gangran des Fusses. Archklin Chir 1879;23:202-6. 70. Buerger L. Thromboangiitis obliterans: a study of the vascular lesions leading to presenile spontaneous gangrene. Am J Med Sci 1908;136:567-80. 71. Buerger L. The circulatory disturbances of the extremities. Philadelphia: WB Saunders; 1924. 72. Janini JBM. Tromboangeíte obliterante. Aspectos histopatológicos. Tese para Concurso de Livre- Docência. Faculdade de Medicina da UFRJ; 1967. 73. Olin JW. Thromboangiitis obliterans (Buerger’s disease). In: Creager MA, Dzau VJ, Loscalzo J. Vascular Medicine: a companion to Braunwald’s heart disease. Philadelphia: Saunders Elsevier; 2006. p. 641-56. 74. Duque FLV, Duque AC. Angiopatias funcionais. In: Brito CJ. Cirurgia vascular. Rio de Janeiro: Revinter; 2002. v. 2. p. 1359-77. 75. Duque FLV. Síndrome de Raynaud – colagenoses. Comunicação ao VIII Congresso Brasileiro de Angiologia, Belo Horizonte; 1961.
54. Kashara Y, Tanaka S, Nishino M et al. Intestinal involvement in Beçhet’s disease: Review of 136 surgical cases in Japanese literature. Dis Col Rect 1981;24:103-6.
56. Bouche P, Léger JM, Travers MA et al. Peripheral neuropathy in systemic vasculitis: clinical and electrophysiologic study of 22 patients. Neurology (NY) 1986;36:1598-1602.
58. Bozza A, Vasques C, Portella A et al. Syndrome de Behçet. A propos d’un cas. Journal des Maladies Vasculaires1995:20(Suppl. A):48.
55. Wechsler B, Godeau P. Manifestations arterielles de la maladie de Behçet. In: Rouffy J, Natali. (Eds.). Arteriopathies peripheriques non atheromateuses. Paris: Masson, 1990.
61. Calabrese LH, Yen-Lierberman B, Estes M et al. Systemic vasculitis in association with human infection. Arthritis Rheum 1989;32:569-76.
FUNCIONAIS REFERÊNCIAS
2. Schafer E, Malik KU. Endogenous autacoids in blood vessel function. In: Bevan JA et al. (Ed.). Vascular neuroeffector Mechanisms. Cap 8. New York: Raven Press; 1980. 3. Burnstock G. Do some nerve cells release more than one transmitter? Neuroscience 1976;1:239. 4. Clement DL, Shepherd JT. Vascular disease in the limbs. St.Louis: Mosby Yearbook; 1993. 5. Strendell T, Shepherd JT. The effect in humans of increased sympathetic activity on the blood flow to active muscles. Acta Med Scandinavia 1967;472(suppl.):146.
18. Lieberman EH, Gerhard MD, Uehata A et al. Estrogen improves endothelium-dependent flow-mediated vasodilatation in postmenopausal women. Ann Intern Med 1994;121:936-41.
19. Celermajer DS, Sorensen K, Georgakopoulos D et al. Cigarrete smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation 1993;88:2149-55.
20. Carvalho NHC, Scivoletto Fortes ZB, Nigro D. The role of endothelium in vascular reactivity. Brazilian J Med Biol Res 1989;22:533-45.
24. Duque FLV, Chagas CAA. Acidente por injeção medicamentosa no músculo deltoide: lesões locais e à distância, revisão de 32 casos. J Vasc Bras 2009;8(3):238-246. 25. Duque LFV, Bernardini E. Arterite cutis medicamentosa. Progresso n Angiology. Proc. Of the 8th International Congress Brazilian of Angiology 1974;3:1077-81. 26. Milles-Lettlle I, Fergusson DA. The incidence of the hypothenar hammer syndrome. Arch Surg 1972;105:684. 27. Hyvarinen J, Pyykko I, Sunberg S. Vibration frequencies and amplitudes in the aetiology of traumatic vasoespastic disease. Lancet 1993;1:791. 28. Harris EJ et al. Surgical treatment of distal ulnar artery aneurism. Am J Surg 1990;159:527. 29. Mosquera D, Goldman DR. An unusual variant of the hypothenar hammer syndrome. Br J Med 1988;45:568. 30. Neuler MR et al. Upper extremity arterial bypass distal to the wrist. J Vasc Surg 1992;16:633. 31. Duque LFV. Síndrome de Raynaud; estudo de 134 casos. Conferência nas Comemorações do Centenário da Publicação de Maurice Raynaud. São Paulo; 1962. 32. Kayser C et al. Fenômeno de Raynaud. Rev Bras Reumatol 2009;49:1-14. 33. LeRoy EC, Medsger TA Jr. Raynaud’s phenomenon: a proposal for classification. Clin Exp Rheumatol 1992;10:485-8. 34. Barros SMVA, Duque LFV. Comprometimento arterial troncular na esclerodermia sistêmica progressiva. XXII Congresso Brasileiro de Angiologia e Cirurgia Vascular; 1977. 35. Kutilek S, Nemec V, Bockayova E. Níveis séricos elevados de homocisteína em pacientes pediátricos com fenômeno de Raynaud primário. Rev Bras de Reumatol 2012;52(1):128-130. 36. Souza EJR, Kayser C. Capilaroscopia periungueal: relevância para a prática reumatológica. Rev Bras Reumatol 2015;31(3):264-71. 37. Lonzetti LS et al. Necrose digital em paciente com lúpus eritematoso sistêmico e esclerose sistêmica tratada com inibidores da fosfodiesterase. Rev Bras Reumatol 2008:48(5):306-8. 38. Korn JH, Mayes M, Matucci Cerinic M et al. Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist. Arthritis Rheum 2004;50:3985-93. 39. Selenko-Gebauer N, Duschek N, Minimair G et al. Successful treatment of patients with severe secondary Raynaud’s phenomenon with the endothelin receptor antagonist bosentan. Rheumatology 2006;45(S3):45-8. 40. Mariz HA, Corrêa MJU, Kayser C. Bosentana no tratamento de úlceras de extremidades refratárias na esclerose sistêmica. Rev Bras Reumatol 2009:49(3):254-64. 41. Fries R, Shariat K, von Wilmowsky H, Böhm M. Sildenafil in the treatment of Raynaud’s phenomenon resistant to vasodilatory therapy. Circulation 2005:112:2980-5. 42. Azevedo MNL, Bernardine EMT et al. Bloqueio do receptor do leucotrieno CysLT1 em pacientes com fenômeno de Raynaud: evidência capilaroscópica do papel do leucotrieno. Ver Bras Reumatol 2012;52 (1):30-2. 43. Smith CR, Rodeheffer RJ. Treatment of Raynaud’s phenomenon with calcium channel blockers. Am J Med 1985;78(Suppl.2B):39. 44. Merskey H, Bogduk N. Classification of Chronic Pain: Descriptions of Chronic Pain Syndromes and Definitions of Pain Terms. 2nd ed. Seattle: IASP Press; 1994. p. 40-2. 45. Woolf CJ, Salter MW. Neuronal plasticity: increasing the gain in pain. Science 2000;288:1765-9.
11. Toda N, Okamura T. Role of nitric oxide in neurally-induced cerebroarterial relaxation. J Pharmacol Exp Ther 1991;258:1027.
7. Joyner MJ, Duprez D, Shepherd JT. Control of human limb blood vessels and limphatics. In: Clement DL, Shepherd JT. Vascular Diseases in the Limbs. St.Louis: Mosby Yearbook;1993.
13. Zimmerman BG, Gomer SK, Liao JC. Action of angiotensina on vascular adrenergic nerve endings. Fed Proc 1972;31:1344-50.
311 159Capítulo
14. Rubany IGM. Cardiovascular Significance of Endothelium-Derived VasoActive Factors. Mount Kisko, NY: Futura Publishing Company; 1991.
22. Clarkson P, Celermajer DS, Donald AE et al. Impaired vascular reactivity in insulin-dependent diabetes melito is related to disease duration and low density lipoprotein cholesterol levels. J Am Coll Cardiol 1996;28:573-9.
21. Izzo MR, Feldman MD, Wu C et al. Plasma hemocysteine levels predict brachial artery vasoreactivity in patients with coronary artery disease. J Am Coll Cardiol 1996;27:412A.
6. Shepherd JT. Physiology of the circulation in humans limbs in health and disease. Philadelphia: WB Saunders; 1963.
16. Yeung AC, Vekshtein VI, Krantz DS et al. The effect of atherosclerosis on the vasomotor response of coronary arteries to mental stress. N Engl J Med 1991;325:1551-56.
17. Sorensen K, Celermajer DS, Robinson J et al. Impairment of endothelium-dependent flow-mediated dilation is an early event in children with familial hypercholesterolemia and is related to the Lp(a) level. J Clin Invest 1994;93:50-55.
8. Bredt DS, Hwang PM, Snyder SH. Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature 1990;347:768. 9. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980;288:373. 10. Moncada S, Palmer RMJ, Higgins EA. Nitric oxide: Physiology, pathophysiology and pharmacology. Pharmacol Rev 1991;43:109.
12. Wenzel RR, Noll G, Luscher TF. Endothelin receptor antagonists inhibit endothelin in human skin microcirculation. Hypertension 1994;23:581-86.
1. Zvonimir SK, Shepherd JT. Principles of vascular regulation. In Clement DL, Shepherd JT. Vascular Diseases in The Limbs. St. Louis: Mosby Yearbook; 1993.
23. Duque FLV. Embolia cutis medicamentosa (apresentação de seis casos no membro superior, com lesão de mão). I Congresso LatinoAmericano de Angiologia. Buenos Aires;1952.
ANGIOPATIAS BIBLIOGRÁFICAS
15. Fitzgerald CA, Pedersen AK, Patrono C. Analysis of prostacyclin and thromboxane biosinthesis in cardiovascular diseases. Circulation 1983;67:1174-77.
55.
61. Bristow MR. Mechanism of action of beta-blocking agents in heart failure. Am J Cardiol 1997;80:26-40. 62. Batlouni M, Albuquerque DC. Bloqueadores beta-adrenérgicos na insuficiência cardíaca. Arq Brás Cardiol 2000;75:339-60.
60. Duprez D, De Buyzere M, De Baker T et al. Impaired microcirculation in moderate essential hypertension. J Hypertens 1992;10:251-54.
63. Duprez DA. Secondary vasoespastic disorders. In: Clement DL, Shepher JI. Vascular Diseases in the Limbs. St. Louis Mosby Yearbook; 1993. p. 169. 64. Spittel Jr JA. Vascular syndromes related to environmental temperature. In: Juergens, Spittel, Fairbairn II (Eds.). Peripheral Vascular Diseases. Philadelphia: WB Saunders; 1980. 65. Kappert A. In: Mello NA. Angiologia. Rio de Janeiro: GuanabaraKoogan; 1998. 66. Martorell F. Angiologia. Barcelona: Salvat editores, 1967. 67. Allen EV, Barker NW, Hines EA. Peripheral Vascular Diseases. 3rd ed. Philadelphia: WB Saunders; 1962. 68. Michiels JJ, Abels J, Steketee J et al. Erythromelalgia caused by plateletmediated arteriolar inflammation and thrombosis. Ann Intern Med 1985;102:466-71. 69. Cohen JS. Erythromelalgia: New theories and new therapies. J Am Acad Dermatol 2000; 43:841-47. 70. Rauck RL, Naveira F, Speight KL, Smith BP. Refractory idiopathic erythromelalgia. Anesth Anal 1996;82:1097-101. 71. Mello NA. Síndrome de Raynaud. Estudo do fator etiológico. VIII Congresso International de Angiologia e XIX Congresso Brasileiro de Angiologia; 1972. 72. Stone JD, Rivey MP, Allington DR. Nitroprusside treatment of erythromelalgia in a adolescent female. Ann Pharmacother 1997;31:590-2. 73. Wen-Hui Wang, MD et al. Chemical Lumbar Sympathectomy in the treatment of recalcitrante erythromelalgia. J Vasc Surg 2018;68:1897-1905. 74. Goldman MD, Ausiello D. Cecil – Tratado de Medicina Interna. 22. ed. Rio de Janeiro: Elsevier; 2005.
Parte IX312 DOENÇAS MISTAS 46. Baluk P. Neurogenic inflammation in skin and airways. J Investig Dermatol Symp Proc 1997;2:76-81. 47. Hilker AW. The shoulder-hand syndrome: A complication of coronary artery disease. Ann of Int Med 1949;31:303-11. 48. Stanton-Hicks M, Janig W, Hassenbusch S et al. Reflex sympathetic dystrophy: Changing concepts and taxonomy. Pain 1995;63:127-33. 49. Wasner G, Heckmann K, Maier C, Baron R. Vascular abnormalities in acute reflex sympathetic dystrophy (CRPSI); complete inhibition of sympathetic nerve activity with recovery. Arch Neurol 1999;56:613-20. 50. Kemler MA, Barendse GAM, van Kleefm, de VET HCV et al. Spinal cord stimulation in patients with chronic reflex sympathetic dystrophy. New Engl J Med 2000;343:618-24. 51. Van Hilten BJ, van de Beek W-JT, Hoff JI et al. Intrathecal Baclofen for the treatment of dystonia in patients with reflex sympathetic dystrophy. New Engl J Med 2000;343:625-30.
54. Silva SBG and Miot HÁ. Case for diagnosis. Na Bras Ddermatol 2012 Apr;87(2):319-321. Barker NW, Hines EA JR, Craig WMcK. Livedo reticularis: A peripheral arteriolar disease. Am Heart J 1941;21:592. 56. Mello NA. Angiologia. Rio de Janeiro: Guanabara-Koogan, 1998. 57. Jacobs MJ, Breslau PJ, Slaaf DW et al. Nomenclature of Raynaud’s phenomenon: A Capillary microscopic and hemorheologic study. Surgery 1987;101:136-45.
59. Hines EA Jr., Farber EM. Ulcer of the leg due to arteriolosclerose and ischemy, occurring in the presence of hypertensive disease (hypertensive-ischemic ulcers). A preliminary report. Proc Staff Meet Mayo Clinic 1946;21:337-46.
53.
52. Minami HSC, Costa MD, Antônio SF, Chahade WH. Distrofia simpática reflexa pós herpes zóster. Rev Bras Reumatol 2004:44(4):301-4. Coffman JD, Eberhardt RT. Cutaneous Changes in Peripheral Vascular Disease. In: Freedberg IM; Eisen AZ; Wolf K et al Fitzpatrick’s Dermatology in General Medicine. McGraw-Hill; 2003. cap. 167.
58. Marttortell F. Las úlceras supramaleolares por arteriolitis de las grandes hipertensos. Acta de lás Reuniones Científicas del Cuerpo Facultativo del Instituto Policlínico de Barcelona 1945;1:6-9.
11. Boon LM, Enjolras O, Mulliken JB. Congenital hemangioma: evidence of acelered involution. J Pediatr 1996;128:329-35.
7. Dubois JM, Patriquim HB, Garel L et al. Soft-tissue hemangiomas in infants and children: diagnosis using Doppler sonography. Am J Roentgenol 1998;171:247-52.
8. Solman L et al. Oral propranolol in the treatment of proliferating infantile haemangiomas: British Society for Paediatric Dermatology consensus guidelines. Br J Dermatol. 2018 Sep;179(3):582-9.
9. Adams DM, Ricci KW. Infantile hemangiomas in the head and neck region. Otolaryngol Clin North Am. 2018 Feb;51(1):77-87.
REFERÊNCIAS BIBLIOGRÁFICAS
10. Furuta S, Sato H, Tsuji S et al. Effective treatment for infantile hemangioma with long-pulsed dye laser with oral propranolol medication: a preliminaty report. Pediatr Surg Int 2016;32(9):857-62.
5. Enjolras O, Riche MC, Merland JJ, Escande JP. Management: a review of 25 cases. Pediatrics 1990;85:491-8.
6. Donnelly LF, Adams DM, Bisset GS 3rd. Vascular malformations and hemangiomas: a practical approach in a multidisciplinary clinic. AJR Am J Roentgenol 2000;174(3):597-608.
12. Berenguer B, Mulliken JB, Enjolras O et al. Rapidly involuting congenital hemangioma: clinical and histopathologic features. Pediatr Dev Pathol 2003;6:495-510.
13. Enjolras O, Mulliken JB, Boon LM et al. Noninvoluting congenital hemangioma: a rare cutâneos vascular anomaly. Plast Reconstr Surg 2001;107:1647-54.
14. Sakar M, Mulliken JB, Kozakewich HP et al. Thrombocytopenic coagulopathy Kasabach Merritt phenomenon is associated with Kaposiform hemangioendothelioma and not with common infantile hemangioma. Plast Reconstr Surg 1997;100:1377-86.
313 160Capítulo
4. Mulliken JB. Classification of Vascular Birthmarks. In: Mulliken JB, Young AE (Eds.). Vascular Birthmarks: hemangiomas and vascular malformations. Philadelphia: Saunders; 1988. v. 2. p. 24-37.
3. Silva Filho TJ, Oliveira DHIP, Moura IS. Importance of GLUT1 in differential diagnosis of vascular anomalies. J Vasc Bras 2015;14(2).
1. Mulliken JB, Glowaki J. Tumores Vasculares - Diagnóstico e Tratamento. Hemangioma and vascular malformation in infants and children: A classification based on endothelial characteristics. Plast Reconstr Sug 1982;69(3):412-20.
15. O’Rafferty C, O’Regan GM, Irvine AD, Smith OP. Recent advances in the pathobiology and management of Kasabach-Merritt phenomeno. Br J Haematol. 2015 Oct;171(1):38-51. 16. Lewis D, Vaidya R. Kasabach Merritt Syndrome. StatPearls (Internet). Treasure Island (FL): StatPearls Publishing; 2019 Jan-2019 Mar 13. 17. Silva CMD, Schettini APM, Santos M, Chirano CAR. Tufted angioma. An Bras Dermatol 2017 Sep-Oct;92(5):742-3. 18. Campos HGA, Curado JH. Anomalias vasculares, doenças vasculares periféricas, 5.ed. Grupo GEN. c. 168. 19. Lei HZ, Sun B, Ma YC et al. Retrospective study on the outcomes of infantile tufted angioma complicated by Kasabach-Merritt Phenomenon. Clin Chim Acta 2018 Nov;486:199-204. 20. Vaseenon T, Saengsin J, Pattamapaspong N et al. Spindle Cell Hemangioma of the Midfoot: A Case Report. J Orthop Case Rep 2017 Sep-Oct;7(5):75-9. 21. PDQ Pediatric Treatment Editorial Board. PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US) 2002-2018 Jan 26. Childhood Vascular Tumors Treatment (PDQ®): Health Professional Version. 22. Jones EW, Orkin M. A benign progressive hemangioma, not to be confused with Kaposi’s sarcoma or low-grade angiosarcoma. J Am Acad Dermatol 1989;20:214-25. 23. Requena L, Sangueza OP. Cutaneous vascular proliferation. Part II. Hiperplasias and benign neoplasms. J Am Acad Dermatol 1997;37:887-919.
TUMORES VASCULARES
2. North PE, Waner M, Mizeracki A, Mimi MC Jr. GLUT1: a newly discovered immunohistochemical marker for juvenile e hemangiomas. Hum Pathol 2000;31(1):11-22.
10. Ngai C, Ding DY, Rapp TB. Maffucci syndrome. Bull Hosp Joint Dis 2015;73(4):282-285.
MALFORMAÇÃO BIBLIOGRÁFICAS
314 161Capítulo
17. Marsh DJ, Trahair TN, Martin JL et al. Rapamycin treatment for a child with germline PTEN mutation. Nat Clin Pract Oncol 2008;5(6):357-361.
3. Boccara O, Maruani A, Léauté-Labrèze C. Benign aggressive vascular anomalies in children. Bull Cancer 2018;105(6):610-625.
VASCULAR REFERÊNCIAS
2. Mulliken J, Glowacki J. Classification of pediatric vascular lesions. Plast Reconstr Surg 1982;70:120-121.
8. Fishman SJ, Smithers CJ, Folkman J et al. Blue rubber bleb nevus syndrome: Surgical eradication of gastrointestinal bleeding. Ann Surg 2005;241(3):523-528.
6. Waelchli R, Aylett SE, Robinson K et al. New vascular classification of port-wine stains: Improving prediction of Sturge-Weber risk. Br J Dermatol 2014;171(4):861-867. 7. Bloom J, Upton J. CLOVES syndrome. J Hand Surg Am 2013;38(12):2508-2512.
1. Mulliken J, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg 1982;69:412-422.
15. Orlando JL, Mendes Pereira Caldas JG, Do Amaral Campos HG et al Ethanol sclerotherapy of superficial venous malformation: A new procedure. Dermatology 2010;220(4):376-380.
12. Ardillon L, Lambert C, Eeckhoudt S et al. Dabigatran etexilate versus low-molecular weight heparin to control consumptive coagulopathy secondary to diffuse venous vascular malformations. Blood Coagul Fibrinolysis 2016;27(2):216-219.
4. Lee B, Baumgartner I, Berlien P et al. Diagnosis and Treatment of Venous Malformations. Consensus Document of the International Union of Phlebology (IUP): updated 2013. Int Angiol 2015;34(2):97-149. 5. Cohen MM. Proteus syndrome review: molecular, clinical, and pathologic features. Clin Genet 2013;(1):111-119.
13. Mulligan P, Prajapati H, Martin L, Patel T. Vascular anomalies: classification , imaging characteristics and implications for interventional radiology treatment approaches. BJR 2014;87:1-18.
9. Nahm WK, Moise S, Eichenfield LF et al. Venous malformations in blue rubber bleb nevus syndrome: variable onset of presentation. J Am Acad Dermatol 2004;50(5):101-106.
14. Horbach SER, Rigter IM, Smitt JHS et al. Intralesional bleomycin injections for vascular malformations: A systematic review and metaanalysis. Plast Reconstr Surg 2016;137(1):244-256.
11. Laroche JP, Becker F, Khau-Van-Kien A et al. Standards de qualité pour la pratique de l’examen écho-doppler dans l’étude des malformations et tumeurs vasculaires. Rapport de la Société française de médecine vasculaire (SFMV). J Mal Vasc 2013;38(1):29-42.
16. de Moraes Silva MA, Ferreira RG, de Jesus-Silva SG et al. Effect of polidocanol foam administration into rat peripheral veins on pulmonary parenchyma. Phlebology 2018;33(2):122-127.
13. Ali S, Mitchell SE. Outcomes of Venous Malformation Sclerotherapy: A Review of Study Methodology and Long-Term Results. Semin Intervent Radiol 2017;34:288-293.
22. Agid R, Burvin R, Gomori JM. Sclerotherapy for venous malformations using a “negative subtraction” technique. Neuroradiology 2006;48(2):127-129.
4. Burrows PE. Endovascular treatment of slow-flow vascular malformations. Tech Vassc Interv Radiol 2013;16(1):12-21.
31. Thomas DM, Wieck MM, Grant CN et al. Doxycycline Sclerotherapy Is Superior in the Treatment of Pediatric Lymphatic Malformations. J Vasc Interv Radiol 2016;27:1846-1856 32. Burrows PE, Mitri RK, Alomari A et al. Percutaneous sclerotherapy of lymphatic malformations with doxycycline. Lymphat Res Biol 2008;6:209-216. 33. Adams MT, Saltzman B, Perkins JA. Head and neck lymphatic malformation treatment: a systematic review. Otolaryngol Head Neck Surg 2012;147:627-639. 34. Shergill A, John P, Amaral JG. Doxycycline sclerotherapy in children with lymphatic malformations: outcomes, complications and clinical efficacy. Pediatr Radiol 2012;42:1080-1088. 35. Conway AM, QatoK, Drury J et al. Embolization techniques for high flow arteriovenous malformations with a dominant outflow vein. J Vasc Surg 2015;3(2):178-183. 36. Dunham GM, Ingraham CR, Maki JH et al. Finding the Nidus: Detection and Workup of Non-Central Nervous System Arteriovenous Malformations. Radiographics 2016;36:891-903. 37. Colletti G, Valassina D, Bertossi D et al. Contemporary Management of Vascular Malformations. J Oral Maxillofac Surg 2014;72:510-528. 38. Giurazza F, Corvino F, Cangiano G et al. Transarterial embolization of peripheral high-flow arteriovenous malformation with ethylene vinyl alcohol copolymer (Onyx): single-center 10-year experience. Radiol Med 2018. 39. Rosen RJ, Nassiri N, Drury J. Interventional Management of High-Flow Vascular Malformations. Tech Vasc Interventional Rad 2013;16:22-38. 40. Houdart E, Gobin YP, Casasco A et al. A proposed angiographic classification of intracranial anteriovenous fistulae and malformations. Neuroradiology 1993;35:381-385. Cho SK, Do YS, Shin SW et al. Arteriovenous malformations of the body and extremities: analysis of therapeutic outcomes and approaches according to a modified angiographic classification J Endovasc Ther 2006;13:527-538. 42. Lam K, Pillai A, Reddick M. Peripheral arteriovenous malformations: classification and endovascular treatment. Applied radiology 2017;15-22. 43. Yee DC, Yakes WF. Dominant outflow-vein occlusion of high-flow malformations (abstract). Presented at the 28th Annual Meeting of the Society of Interventional Radiology, March 2003, Salt Lake City, Utah, USA. Wohlgemuth WA, Muller-Wille R, Teuxch VI et al. The retrograde transvenous push-through method: a novel treatment of peripheral arteriovenous malformations with dominant venous outflow. Cardiovasc Intervent Radiol 2015;38:623-63.
VASCULAR –TRATAMENTO ENDOVASCULAR
20. Songsaeng D, Churojana A, Khumthong R et al. Comparative outcome for sclerotherapy of head and neck venous vascular malformation between alcohol and bleomycin. J Med Assoc Thai 2015;98:408-413.
10. Brassel F, Meila D. Evolution of embolic agents in interventional neuroradiology. Clin Neuroradiol 2015;2(2):333-339.
17. Tessari L, Cavezzi A, Frullini A. Preliminary experience with a new sclerosing foam in the treatment of varicose veins. Dermatol Surg 2001;27:58-60.
7. Sadick M, Wohlgemuth WA, Huelse R et al. Interdisciplinary Management of Head and Neck Vascular Anomalies: Clinical Presentation, Diagnostic Findings and Minimalinvasive Therapies. Eur J Radiol Open 2017;4:63-68.
15. Orlando JL, Caldas JG, Campos HG et al. Ethanol sclerotherapy of head and neck venous malformations. Einstein (São Paulo) 2014;12:181-186.
26. Alomari AI, Karian VE, Lord DJ et al. Percutaneous sclerotherapy for lymphatic malformations: a retrospective analysis of patient evaluated improvement. J Vasc Interv Radiol 2006;17:1639-1648. 27. Ogita S, Tsuto T, Tokiwa K et al. Intracystic injection of OK-432: a new sclerosing therapy for cystic hygroma in children. Br J Surg 1987;74(8):690-1. 28. Yang Y, Sun M, Ma Q et al. Bleomycin A5 sclerotherapy for cervicofacial lymphatic malformations J Vasc Surg 2011;53:150-5. 29. Baskin D, Tander B, Bankaoglu M. Local bleomycin injection in the treatment of lymphangioma. Eur J Pediatr Surg 2005:15(6);385-6. 30. Kumar V, Kumar P, Pandey A et al. Intralesional bleomycin in lynphangioma: an effective and safe non-operative modality of treatment. J Cutan Aesthet Surg 2012;5(2);133-136.
3. Sadick M, Müller-Wille R, Wildgruber M, Wohlgemuth WA. Vascular Anomalies (Part I): Classification and Diagnostics of Vascular Anomalies. Rofo 2018 Sep;190(9):825-835.
18. Yamaki T, Nozaki M, Sakurai H et al. Prospective randomized efficacy of ultrasound-guided foam sclerotherapy compared with ultrasoundguided liquid sclerotherapy in the treatment of symptomatic venous malformations. J Vasc Surg 2008;47:578-584.
11. Spence J, Krings T, TerBrugge KG et al. Percutaneous treatment of facial venous malformations: a matched comparison of alcohol and bleomycin sclerotherapy. Head Neck 2011;33:125-130.
16. Bisdorff A, Mazighi M, Saint-Maurice JP et al. Ethanol threshold doses for systemic complications during sclerotherapy of superficial venous malformations: a retrospective study. Neuroradiology 2011;53:891-894.
21. Puig S, Aref H, Chigot V et al. Classification of venous malformations in children and implications for sclerotherapy. Pediatr Radiol 2003;33:99-103.
19. Zhang J, Li HB, Zhou SY et al. Comparison between absolute ethanol and bleomycin for the treatment of venous malformation in children. Exp Ther Med 2013;6:305-309.
8. Ali S, Weiss CR, Sinha A et al. The treatment of venous malformations with percutaneous sclerotherapy at a single academic medical center. Phlebology 2016;31(9):603-609. 9. Eckmann DM. Polidocanol for Endovenous Microfoam Sclerosant Therapy. Expert Opin Investig Drug 2009;18(12):1919-1927.
1. Wassef M, Blei F, Adams D et al. Vascular Anomalies Classification: Recommendations From the International Society for the Study of Vascular Anomalies. Pediatrics 2015;136:203-214. 2. Müller-Wille R, Wildgruber M, Sadick M, Wohlgemuth WA. Vascular Anomalies (Part II): Interventional Therapy of Peripheral Vascular Malformations. Rofo 2018;190:e927-e937.
44.
5. Green D. Mechanism of action of sclerotherapy. Semin Dermatol 1993;12:88-97.
23. Berber O, Holt P, Hinchliffe R et al. Endovenous therapy for the treatment of congenital venous malformations. Ann Vasc Surg 2010;24:415-417.
24. Bhatnagar A, Upadhyaya VD, Kumar B et al. Aqueous intralesional bleomycin sclerotherapy in lymphatic malformation: Our experience with children in adult. Natl J Maxillofac Surg 2017;8(2):130-135.
25. Wassef M, Blei F, Adams D et al. Vascular anomalies classification: recommendations from the international society for the study of vascular anomalies. Pediatrics 2015;136:e203-e214.
6. Grieb D, Meila D, Greling B et al. Craniofacial venous malformations treated by percutaneous sclerotherapy using polidocanol: a singlecenter experience. Acta Radiol 2018;0(0):1-9.
14. Steiner F, FitzJohn T, Tan ST. Ethanol sclerotherapy for venous malformation. ANZ J Surg 2016;86:790-795.
41.
MALFORMAÇÃO REFERÊNCIAS BIBLIOGRÁFICAS
315 162Capítulo
12. Horbach SE, Lokhorst M, Saeed P et al. Sclerotherapy for low-flow vascular malformations of the head and neck: a systematic review of sclerosing agents. J Plast Reconstr Aesthet Surg 2016;69:295-304.
54. Park HS, Do YS, Park KB et al. Ethanol embolotherapy of hand arteriovenous malformations. J Vasc Surg 2011;53:725-31.
46. Chen WL, Ye JT, Xu LF et al. A multidisciplinar approach to treating maxillofacial arteriovenous malformations in children. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009;108(1):41-47.
45. Do YS, Kim YW, Park K et al. Endovascular treatment combined with emboloscleorotherapy for pelvic arteriovenous malformations. J Vasc Surg 2012;55:465-71.
47. Yakes W, Huguenot M, Yakes A et al. Percutaneous embolization of arteriovenous malformations at the plantar aspect of the foot. J Vasc Surg 2016;64:1478-82.
52. Vollherbst DF, Sommer CM, Ulfert C et al. Liquid Embolic Agents for Endovascular Embolization Evaluation of an Established (Onyx) and a Novel (PHIL) Embolic Agent in an In Vitro AVM Model. AJNR Am J Neuroradil 2017;38(7):1377-82.
49. Hwang JH, DO YS, Park KB. Embolization of congenital renal arteriovenous malformations using ethanol and coil depending on angiographic types. J Vasc Interv Radiol 2017;26:64-70.
55. Kilani MS, Lepennec V, Petit P et al. Embolization of peripheral highflow arteriovenous malformations with Onyx. Diagn Interv Imag 2017;98:217-226. 56. Massoud TF, Hademenos GJ. Transvenous retrograde nidus sclerotherapy under controlled hypotension (TRENSH): a newly proposed treatment for brain arteriovenous malformations – concepts and rationale. Neurosurgery 1999;45:351-365. 57. Chen CJ, Norat P, Ding D et al. Transvenous embolization of brain arteriovenous malformations: a review of techniques, indications and outcomes. Neurosurg Focus 2018;45(1):1-7.
51. van der Linden E, van Baalen JM, Pattynama PM. Retrograde transvenous etanol embolization of high-flow peripheral arteriovenous malformations. Cardiovasc Interv Radiol 2012;35(4):820-825.
58. Kuhara A, Tanaka N, Koganemaru M et al. A retrograde transvenous embolization technique with balloon-assisted arterial aspiration for a peripheral arteriovenous malformation with a venous pouch. Cardiovasc Intervent Radiol 2017;40(5):788-792. 59. Kishino M, Miyasaka N, Takeguchi Y et al. Retrograde transvenous obliteration for uterine arteriovenous malformation. Obstet Gynecol 2014;123(2):427-30. 60. Nassiri N, Thomas J, Rahimi S. Fibrodysplastic implications for transvenous embolization of a high-flow pelvic arteriovenous malformation in Osler-Weber-Rendu syndrome. J Vasc Surg Cases 2015;1(1):16-19.
53. Kitagawa A, Yamamoto T, Matsunaga N et al. Polidocanol sclerotherapy combined with transarterial embolization using n-Butyl Cyanoacrylate for extracranial arteriovenous malformations. Cardiovasc Intervent Radiol 2018;41:856-866.
48. Su L, Wang D, Han Y et al. Absolute ethanol embolization of infiltrating-diffuse extracranial arteriovenous malformations in the head and neck. Eur J Vasc Endovasc Surg 2015;50:114-121.
50. Yakes WF, Rossi P, Odink H. How I do it. Arteriovenous malformation management. Cardiovasc Intervent Radiol 1996;19:65-71.
Parte IX316 DOENÇAS MISTAS
9. WOCN - Wound, Ostomy, and Continence Nurses Society. Guideline for management of wounds in patients with lower-extremity venous disease, 2005. (WOCN clinical practice guideline; no. 4). 10. Frank C, Bayoumi I, Westendorp C. Approach to infected skin ulcers. Can Fam Physician 2005 October 10;51(10):1352-1359.
1. Nelzen O, Berqvist D, Lindhagen A et al. Chronic Leg Ulcers: An underestimated problem in primary health care among elderly patients. J Epidemiol Community Health 1991;45(3):184-187. 2. Mekkes A JR, Loots MAM, Van der Wal AC, Bos JD. Causes, investigation and treatment of leg ulceration. Br J Dermatol 2003;148(3):388-401.
317
4. Dissemond J, Körber A, Grabbe S. Differential diagnosis of leg ulcers. JDDG 2006 Aug;4(8):627.
8. Scottish Intercollegiate Guidelines Network Management of chronic venous leg ulcers. 2010 August. www.sign.ac.uk.
163CapítuloÚLCERAS DE PERNA – DIAGNÓSTICO DIFERENCIAL REFERÊNCIAS BIBLIOGRÁFICAS
14. Coleridge-Smith PD, Thomas P, Scurr JH et al. Causes of venous ulceration: a new hypothesis. Br Med J 1988;296:1726-1727
17. Cruz MJ, Baudrier T, Azevedo F. Uncommon causes of leg ulcers: Investigative approach and therapeutics. Dermatol Online J 2011:17(9):6. 18. Shanmugam VK, Angra D, Rahimi H, MCNish S. Vasculitic and autoimmune wounds. J Vasc Surg Venous Lymphat Disord 2017;5(2):280-292. 19. Perry HO, Winkelmann RK. Bullous pyoderma gangrenosum and leukaemia. Arch Dermatol 1972;106:901-905. 20. Rasmussen I. Pyoderma gangrenosum treated with clofazimine. Acta Derm Venereol 1983;63:552-553. 21. Minelli L, Nonino AB, Salmazo JC et al Diabetes mellitus e afecções cutâneas. An Bras Dermatol 2003 Dez;78(6):735-747. 22. Guzman UV, Verde E, Vinuesa SG et al. Calcifilaxis: complicación grave del síndrome cardio-metabólico en pacientes con enfermedad renal crónica terminal (ERCT). Nefrologia 2008;28(1):32-36. 23. Gontijo Jr OM. Impetigo e Ectima. In: Machado-Pinto J (Ed.). Doenças Infecciosas com Manifestações Dermatológicas. Rio de Janeiro: MEDSI; 1994. p. 243-245. 24. Silveira JCB. Tuberculose e Micobacterioses. In: Machado-Pinto J (Ed.). Doenças Infecciosas com Manifestações Dermatológicas. Rio de Janeiro: MEDSI; 1994. p. 301-311. 25. Araújo MG, Machado-Pinto J, Pederneiras E. Hanseníase. In: MachadoPinto J (Ed.). Doenças Infecciosas com Manifestações Dermatológicas. Rio de Janeiro: MEDSI; 1994. p. 247-264. 26. Rivitti EA. Sífilis. In: Machado-Pinto J (Ed.). Doenças Infecciosas com Manifestações Dermatológicas. Rio de Janeiro: MEDSI; 1994. p. 499-51. 27. Robinson DC, Adrians B, Hay RJ, Yesudian P. The clinical and epidemiological features of tropical ulcer (tropical phagedenic ulcer). Int J Dermatol 1988;1:49-53. 28. Furtado TA. Leishmaniose Tegumentar Americana. In: Machado-Pinto J (Ed). Doenças Infecciosas com Manifestações Dermatológicas. Rio de Janeiro: MEDSI; 1994. p. 319-388. 29. Campbell I. Esporotricose, In: Talhari S, Neves RG (Eds.) Dermatologia Tropical. Soriak Comércio e Promoções AS, São Paulo; 1997. p. 167-183. 30. Eckmann J, Platt A. Sickel cell information center guidelines. www. cc.emory.edu/PEDS/SICKLE/legulcr.htm,october 2000.
3. Ryan TJ, Burnand K. Diseases of the Veins and Arteries – Leg Ulcers. In: Champion RH, Burton JL, Ebling FGJ (Eds.). Rook/Wilkinson/Ebling Textbook of Dermatology. Oxford: Blackwell; 1992. p. 1963-2013.
6. Nelzen O, Berqvist D, Lindbagen A. Venous and non –venous leg ulcers: clinical history and appearence in a population study. Br J Surg 1994;81:182-187.
15. Kirsner RS, Pardes JB, Eaglstein WH et al. The clinical spectrum of lipodermatosclerosis. J Am Acad Dermatol 1993;28:623-627. 16. Barnhill RL, Busam KJ. Vascular Diseases. In: Elder D, Elenitsas R, Jaworsky C, Johnson Jr B (Eds.). Lever’s Histopathology of the Skin. 8th ed, Lippincott-Raven Publishers, Philadelphia; 1997. p. 185-208.
11. Huovinen S, Malanin G, Helander I et al. Fine needle aspiration biopsy, curettage and swab samples in bacteriologic analysis of leg ulcers (letter). Arch Dermatol 1992;128(6):856-7.
5. Baker SR, Stacey MC, Singh G et al. Aetiology of chronic leg ulcers. Eur J Vasc Surg 1992;6:245-251.
12. Philips TJ, Dover JS. Leg Ulcers. J Am Acad Dermatol 1991;25:965-987. 13. Hanrahan LM, Araki CT, Rodriguez AA et al. Distribution of valvular incompetence in patients with venous stasis ulceration. J Vasc Surg 1991;13:805-811.
7. Moffatt CJ, Oldroyd MI, Greenlagh RM, Franks PJ. Palpating ankle pulses is insufficient in detecting arterial insufficiency in patients with leg ulceration. Phlebology 1994;9:170-172.
Parte X TRAUMA VASCULAR
3.
50.
1.
5.
40.
19. Jahnke EJ, Seeley SF. Acute vascular injuries in the Korean War: an analysis of 77 consecutive cases. Ann Surg 1953;138:158-77.
27. Vollmar J. Surgical experience with 197 traumatic arterial lesions (1953-1966). In: Hiertonn T, Rybeck B. (Eds.). Traumatic arterial lesions. Stockholm, Sweden: Forsvarets Forskningsanstalt; 1968.
43.
4.
20. Hughes CW. Acute vascular trauma in Korean War casualties: an analysis of 180 cases. Surg Gynecol Obstet 1954;99:91-100. 21. Hughes CW. Arterial repair during the Korean War. Ann Surg 1958;147:555-61.
8.
15.
9.
28. Mattox KL, Feliciano DV, Burch J et al. Five Thousand seven hundred sixty cardiovascular injuries in 4.459 patients: epidemiologic evolution 1958 to 1987. Ann Surg 1989;209:698-705.
16. Bernheim BM. Blood-vessel surgery in the war. Surg Gynecol Obstet 1920;30:564-7.
321 164Capítulo
29. Oller DW, Rutledge R, Clancy T et al. Vascular injuries in a rural state: a review of 978 patients from a state trauma registry. J Trauma 1992;32:740-6.
22. Ferguson IA, Byrd WM, McAfee DK. Experiences in the management of arterial injuries. Ann Surg 1961;153:980-6.
30. Perry MO, Thal ER, Shires GT. Management of arterial injuries. Ann Surg 1971;173:403-8. 31. Seldinger SI. Catheter replacement of the needle in percutaneous arteriography. Acta Radiol 1953;39:368-76. 32. Araujo GR, Mathias SB, Junior GF. Dados epidemiológicos. In: Rossi M. (Ed.). Trauma vascular. Rio de Janeiro: Revinter; 2006. p. 74-82. 33. Beebe GW, DeBakey ME. Battle casualties: incidence, mortality, and logistic considerations. Springfield, IL: Charles C. Thomas, 1952. 34. Makins GW. Gunshot injuries to the blood vessels. Bristol: John Wright and Sons, 1919. 35. Morris GC, Beall AC, Roof WR, et al. Surgical experience with 220 acute arterial injuries in civilian practice. Am J Surg 1960;99:775-81. 36. Treiman RL, Doty D, Gaspar MR. Acute vascular trauma: a fifteen year study. Am J Surg 1966;111:469-37. 37. Robbs JV, Baker LW. Major arterial trauma: review of experience with 267 injuries. Br J Surg 1978;65:532-8. 38. Rich NM. Vietnam missile wounds evaluated in 750 patients. Mil Méd 1968;133:9-15. 39. White JM, Stannard A, Bukhardt GE et al. United States Army Institute of Surgical Research. Ann Surg 2011;253(6):1184-9. Nickolay PM, Joseph JD, Daniel S et al. Anatomic distribuition and mortality of arterial injury in the wars in Afghanistan and Iraq with comparison to civilian benchmark. J Vasc Surg 2012 Sept;56(3):728-36. 41. Smith RF, Szilagyi DE, Pfeifer JR. Arterial trauma. Arch Surg 1963;86:825-35. 42. Dillard BM, Nelson DL, Norman HG. Review of 85 major traumatic arterial injuries. Surgery 1968;63:391-5. Drapanas T, Hewitt RL, Weichert RF et al. Civilian vascular injuries: a critical appraisal of three decades of management. Ann Surg 1970;172:351-60. 44. Moore CH, Wolma FJ, Brown RW et al. Vascular trauma: a review of 250 cases. Am J Surg 1971;122:576-8. Cheel RC, Pope JC, Smith HF et al. Diagnosis and management of major vascular injuries: a review of 200 operative cases. Am Surg 1975;41:755-60. 46. Kelly GL, Eiseman B. Civilian vascular injuries. J Trauma 1975;15:507-14. 47. Hardy JD, Raju S, Neely WA et al. Aortic and other arterial injuries. Ann Surg 1975;181:640-53. 48. Bole PV, Purdy RT, Munda RT et al. Civilian arterial injuries. Ann Surg 1976;183:13-23. 49. Patman RD, Poulos E, Shires GT. The management of civilian arterial injuries. Surg Gynecol Obstet 1964;118:725-38. Sirinek KR, Gaskill HV, Dittman WI, et al. Exclusion angiography for patients with possible vascular injuries of the extremites – A better use of trauma center resources. Surgery 1983;94:598-603. 51. Saide R, Jacobsen DC, Bloch JH et al. Management of peripheral vascular trauma. Am Surg 1981;47:429-38. 52. Spencer AD. The reliability of signs of peripheral vascular injury. Surg Gynecol Obstet 1962;114:490-4. Waiselfisz JJ. Novos padrões da violência homicida no Brasil Mapa da Violência. Instituto Sangari. São Paulo, 2016. 54. Babu SC, Piccorelli GO, Shah PM et al. Incidence and results of arterial complications among 16.350 patients undergoing cardiac catherization. J Vasc Surg 1989;10:113-6. 55. Kresowik TF, Khoury MD, Miller BV et al. A prospective study of the incidence and natural history of femoral vascular complications after percutaneous transluminal coronary angioplasty. J Vasc Surg 1991;13:328-36. 56. Ricci MA, Travisani GT, Pilcher DB. Vascular complications of cardiac catherization. Am J Surg 1994;167(4):375-8.
26. Silva AJM. Fundamentos históricos da traumatologia vascular. In: Rossi. (Ed.). Trauma vascular. Rio de Janeiro: Revinter; 2006. p. 3-21.
45.
53.
10.
17. Makins GH. Injuries to the blood vessels. In: Official history of the great war medical services: surgery of the war. London, England: His Majesty’s Stationery Office; 1922. p. 170-296. v. 2.
TRAUMA BIBLIOGRÁFICAS Zaluar A. A guerra privatizada da juventude. Folha de São Paulo; 18 Maio 1997 2. Souza ER, Assis SE. Mortalidade por violência em crianças e adolescentes do município do Rio de Janeiro. J Bras Psiq 1996;45(2):85-94. Dale WA. The beginnings of vascular surgery. Surgery 1974;76:849-66. Schwartz AM. The historical development of methods of hemostasis. Surgery 1958;44:604-15. Rich NM, Spencer FC. Vascular trauma. Philadelphia: WB Saunders; 1978. 6. Esmarch F. The surgeon’s handbook of the treatment of the wounded in war. New York, NY: LW Schmidt; 1878. 7. Hunter JL. Hunter’s operation for the cure of aneurysm (1786). Br J surg 1929;17:193-200. Rob CG. A history of arterial surgery. Arch Surg 1972;105:821-40. Dorfler J. Über arteriennaht. Beitr Klin Chir 1899;25:781-802. Murphy JB. Resection of arteries and veins injured in continuity –end-to-end suture – experimental and clinical research. Med Rec 1897;51:73-88. 11. Carrel A. Results of transplantation of blood vessels, organs and limbs. JAMA 1908;51:1662-75. 12. Guthrie CC. Blood Vessel surgery. London, England: Edward Arnold; 1912. 13. Goyanes J. Nuevos trabajos de chirurgia vascular: substitution plastia de lãs artérias por les venas, o arterioplastica venosa, aplicado, como nuevo método, al traitamiento de los aneurysmas. El Siglo Méd 1906;53:561-80. 14. Lexer E. Die ideale operation dês arteriellen und des arteriellvenosen aneurysma. Arch Klin Chir 1907;83:459-70. Soubbotitch V. Military experiences of traumatic aneurysms. Lancet 1913;2:720-1.
25. Lloyd JT. Traumatic peripheral aneurysms. Am J Surg 1957;93:755-64.
23. Spencer FC, Grewe RF. The management of arterial injuries in battle casualties. Ann Surg 1955;141:304-13. 24. Rich NM, Baugh JH, Hughes CW. Acute arterial injuries in Vietnam: 1.000 cases. J Trauma 1970;10:359-69.
VASCULAR REFERÊNCIAS
18. DeBakey ME, Simeone FA. Battle injuries of the arteries in Word War II: an analysis of 2, 471 cases. Ann Surg 1946;123:534-79.
77.
83. Lindsey D. The idolatry of velocity, or lies, damn lies, and ballistics. J Trauma 1980;20:1068-9. 84. Swan KG, Swan RC, Levine MG et al. The US M-16 rifle versus the Russian AK-47 rifle. Ann Surg 1983;49:472-9. 85. Fackler ML, Malinowski JA. The wound profile: a visual method for quantifying gunshot wound components. J Trauma 1985;25(6):522-9. 86. Fackler ML. Ballistic injury. Am Emerg Med 1986;15:1451-5.
60. Catálogo: Stopping Power e Munições. Edição Especial. Armas, técnicas e táticas para o serviço policial. Magnum; 1991. p. 52-59. cap. 7. 61. Amato JJ. Wound ballistics and the mechanisms of vascular injuries. In: Flanigan DP. (Ed.). Civilian vascular trauma. Philadelphia: Lea & Febiger; 1992. p. 11-35. 62. Suarez FA, Canetti MD. Atendimento pré-hospitalar à vítima de traumatismo vascular. In: Rossi M. (Ed.). Trauma vascular. Rio de Janeiro: Revinter; 2006. p. 337-545. 63. Morton JH, Southgate WA, Deweese JA. Arterial injuries of the extremities. Surg Gynecol Obstet 1996;123:611-26. 64. Mccready RA. Upper extremity vascular injuries. Surg Clin North Am 1988;68:725-40. 65. Mullins RJ, Lucas CE, Ledzerwood AM. The natural history following venous ligation for civilian injuries. J Trauma 1980;20:737-43. 66. Coupland RM. The Red Cross wound classification. Geneva: International Committee of the Red Cross; 1991. 67. Dennis JW, Frykberg ER, Veldenz HC et al. Validation of monoperation vascular injuries and accuracy of physical examination in penetrating extremity. Trauma, 5-10 year follow-up. J Trauma 1998;44(2):243-52. 68. Dufove D, Kromann JS, Owen SM et al. Surgery of the victims of war Geneva: International Committee of the Red Cross; 1988. 69. Advanced Trauma Life Support. Resource Document 3: Kinematics of trauma. Chicago: American College of Surgeons; 1997. 70. King M. (Ed.). Primary surgery. Trauma. Oxford: Oxford Medical; 2006. v. 2. 71. Milne JS, Hargarten SW. Handgun safety features: a review for physicians. J Trauma 1999;47:145-50. 72. Bradford B. Vascular injuries in war. Surg Gynec & Obst 1946;83:667. 73. Miller HH, Welch CS. Quantitative studies of the time factor in arterial injuries. Ann Surg 1949;130:428-38. 74. Swan KG. Missile injuries: wound ballistics and principles of management. Milit Med 1987;152:29-34. 75. Rybec B. Missile wounding and hemodynamic effects of energy absorption. Acta Chir Scand 1947;(Suppl 450):5332. 76. Amato JJ, Rich NM, Billy LJ et al. High-velocity arterial injury: a study of the mechanism of injury. J Trauma 1971;11:412-6. Amato JJ, Rich NM. Tempory cavity effects in blood vessel injury by high velocity missiles. J Cardiovasc Surg 1972;13:147-55. 78. Belkin M. Wound ballistics. Prog Surg 1978;16:7-24. 79. Hopkinson DAW, Watts JC. Studies in experimental missile injuries of skeletal muscle. Proc R Soc Med 1963;5:461-8. 80. Kocher T. Ueber die Sprengwirkung der Modernen. Kleingewehrgeschosse. Correspondenz-Blatt fuer Schweitzer Aerzte 1987;5:3-7, 29-33, 69-74. 81. Kocher T. Ueber Schusswunden. Experimentalle Undterschunaen ueber die Wirkungsweise der Modernen Klein-ewehr-eschosse. Leipzig: Verlag von FCW Vogel; 1880. 82. Fackler ML. Physics of penetrating trauma. In: McSwain Jr NE, Kerstein MD (Eds.). Evaluation and management of trauma. Norwalk: Conn, Appleton, Century; 1987. p. 25-41. c. 2.
106. Marangoni DV, Santos M. Antibioticoterapia no trauma vascular. In: Rossi M (Ed.). Trauma vascular. Rio de Janeiro: Revinter; 2006. p. 590-7.
104. Peixoto CLS, Martins Jr HS, Ristow von A. Arteriografia no trauma vascular. In: Rossi M (Ed.). Trauma vascular. Rio de Janeiro: Revinter; 2006. p. 174-88.
57. Katzenschlager R, Ururluoglu A, Ahmadi A et al. Incidence of pseudoaneurysm after diagnostic and therapeutic angiography. Radiology 1995;195:463-6. Champault G, Cazacu F, Taffinder N. Serious trocar accidents in laparoscopic surgery: a French survey of 103.852 operations. Surg Laparosc Endosc 1996;6:367-70. 59. Papadoulas S, Konstatinou D, Kourea HP et al. Vascular injury complicating lumbar disc surgery. A systematic review. Eur J Vasc Endovasc Surg 2002;24:189-95.
58.
322 Parte XTRAUMA VASCULAR
87. Harvey EN, Korr IM, Oster G et al. Secondary damage in wounding due to pressure changes accompanying the passage of high velocity missiles. Surgery 1946;21:218-39. 88. Owen-Smith MS. High velocity missile wounds. London: Edward Arnold; 1981. p. 21-32. 89. Whelan Jr TJ. Missile-caused wounds. In: Emergency War Surgery – NATO Handbook. 1st US Revision. Washington, DC: Government Printing Office; 1975, cap. 2. 90. Russotti GM, Sim FH. Missile wounds of the extremities: a current concepts review. Orthopedics 1985;8:1106-16. 91. Fackler ML, Surinchak JS, Malinowski JA et al. Bullet fragmentation: a major cause of tissue disruption. J Trauma 1984;24:35-9. 92. Harvey EN. Studies on wound ballistics. In: Andrus CE, Bronk DW, Corden Jr GA et al (Eds.). Advances in military medicine. Boston: Little, Brown; 1948. c. 18. 93. Swan KG, Swan RC. Gunshot wounds: pathophysiology and management. Littleton, Mass: PSG; 1980. 94. Massari Armor. Tabela de resistência balística: Catálogo. Rio de Janeiro: Guanabara; 1999. 95. Haschek E, Lindenthal OT. A contribution to the practical use of the photography according to Roentgen. Wein Klin Wochenschr 1986;9:63-4. 96. Azevedo FS, Laburemie EM. Arteriografia. In: Brito CJ (Ed.). Cirurgia vascular. Rio de Janeiro: Revinter; 2002. p. 347-59. 97. Dos Santos R, Lamas AC, Caldas JP. Arteriografia da aorta dos vasos abdominais. Méd Comtemp 1929;47:93. 98. Francis H. Vascular proximity: is it valid indication for arteriography in asymptomatic patients? J Trauma 1991;31:512-4. 99. Ben-Menachem Y. Angiography in diagnosis of vascular trauma. In: Taveras JM (Ed.). Radiology. Philadelphia: JB Lippincott; 1988. p. 1243-6. v. 2. 100. Flint LM, Snyder WH, Perry MO et al. Management of major vascular injuries in the base of the neck. An 11-year experience with 146 cases. Arch Surg 1973 Apr.;106(4):407-13. 101. Jacobson B, Schlossman D. Thromboembolism of the leg following percutaneous catherization of the femoral artery for angiography, predisposing factors. Acta Radiol Diagn 1969;8:109-18. 102. Reid JDS, Weigelt JA, Thal ER et al. Assessment of proximity of a wound to major vascular structures as an indication for arteriography. Arch Surg 1988;128:942. 103. Reid KR. Arteriography and intervention in extremity trauma. Sem Intervent Radiol 1997;14(2):193-204.
105. Frykberg ER, Dennis JW, Bishop K et al. The reliability of physical examination in the evaluation of penetrating extremity trauma for vascular injury: results at one year. J Trauma 1991;31:502-11.
14. Al Wahbi A, Aldakhil S, Al Turki S, El Kayali A, Al Kohlani H, Al Showmer A. Risk factors for amputation in extremity vascular injuries in Saudi Arabia. Vasc Health Risk Manag. 2016;12:229-32.
12. Natsuhara KM, Yeranosian MG, Cohen JR, Wang JC, McAllister DR, Petrigliano FA. What is the frequency of vascular injury after knee dislocation? Clin Orthop Relat Res. 2014;472(9):2615-20.
15. Farber A, Tan TW, Hamburg NM, Kalish JA, Joglar F, Onigman T, et al. Early fasciotomy in patients with extremity vascular injury is associated with decreased risk of adverse limb outcomes: a review of the National Trauma Data Bank. Injury 2012;43(9):1486-91.
EPIDEMIOLOGIA DO TRAUMA
REFERÊNCIAS BIBLIOGRÁFICAS
165Capítulo
3. Allison ND, Anderson CM, Shah SK, Lally KP, Hayes-Jordan A, Tsao KJ, et al. Outcomes of truncal vascular injuries in children. J Ped Surg. 2009;44(10):1958-64.
6. Liang M, Rong J, Sun J, Yao T, Xuan F, Zhao L, et al. A mobile minimally invasive interventional shelter: a new answer to on-spot emergency treatment of large arterial injuries? Scand J Trauma, Resusc Emerg Med. 2015;23:63.
9. Shireman PK, Rasmussen TE, Jaramillo CA, Pugh MJ. VA Vascular Injury Study (VAVIS): VA-DoD extremity injury outcomes collaboration. BMC Surgery 2015;15:13.
323
2. Montorfano MA, Montorfano LM, Perez Quirante F, Rodriguez F, Vera L, Neri L. The FAST D protocol: a simple method to rule out traumatic vascular injuries of the lower extremities. Crit Ultrasound J. 2017;9(1):8.
13. Khan FH, Yousuf KM, Bagwani AR. Vascular injuries of the extremities are a major challenge in a third world country. J Trauma Manag Outcomes 2015;9:5.
17. Karaolanis G, Maltezos K, Bakoyiannis C, Georgopoulos S. Contemporary strategies in the management of civilian neck zone II vascular trauma. Frontiers in Surgery 2017;4:56.
10. Weinberg DS, Scarcella NR, Napora JK, Vallier HA. Can vascular injury be appropriately assessed with physical examination after knee dislocation? Clin Orthop Relat Res. 2016;474(6):1453-8.
18. Costa-Val R, Campos-Christo SF, Abrantes WL, Campos-Christo MB, Marques MC, Miguel EV. Reflexões sobre o trauma cardiovascular civil a partir de um estudo prospectivo de 1000 casos atendidos em um centro de trauma de nível I. Rev Col Bras Cir 2008;35(3):162-7.
11. Medina O, Arom GA, Yeranosian MG, Petrigliano FA, McAllister DR. Vascular and nerve injury after knee dislocation: a systematic review. Clin Orthop Relat Res 2014;472(9):2621-9.
5. Ramdass MJ, Harnarayan P. A decade of major vascular trauma: lessons learned from gang and civilian warfare. Ann R Coll Surg Engl. 2017;99(1):70-5.
7. Jr Amd OG, Rodrigues ADV, Braga FB, Andrade MCD, Abib SDCV. Vascular trauma in the Amazon Region: a two years cases review from a single Institution. Health 2014;6:517-30.
16. Yan H, Zhao B, Kolkin J, Li Z, Chen X, Chu T, et al. The management of lower extremity multilevel arterial injuries: a 10-year experience. PloS One 2015;10(3):e0121769.
4. Giannakopoulos TG, Avgerinos ED. Management of peripheral and truncal venous injuries. Front Surg. 2017;4:46.
8. Goes Junior AM, Rodrigues AD, Braga FB, de Andrade MC, Abib S de C. Vascular trauma in the Amazon - the challenge of great distances. Rev Col Bras Cir 2015;42(4):244-52.
1. Pereira BM, Chiara O, Ramponi F, Weber DG, Cimbanassi S, De Simone B, et al. WSES position paper on vascular emergency surgery. WJES. 2015;10:49.
19. Costa CA, Souza JE, Araujo AO, Melo FA, Costa IN, Klein PH. Pediatric vascular trauma in Manaus, Amazon - Brazil. Rev Col Bras Cir 2016;43(5):320-6.
11. Lipowsky HH, The endothelial glycocalyx as a barrier to leukocyte adhesion and its mediation by extracellular proteases Ann Biomed Eng 2012;40(4):840-8.
6.
8.
9. Song JW, Goligorsky MS. Perioperative implication of the endothelial glycocalyx Korean J Anesthesiol 2018;71(2):92-102.
16. Busl KM, Greer DM. Hypoxic-ischemic brain injury: pathophysiology, neuropathology and mechanisms. Neuro Rehab 2010;26(1):5-13.
18. Eltzschig HK, Collard CD. Vascular ischaemia and reperfusion injury. Br Med Bull 2004;70:71-86.
19. Gifford SM, et al. Early versus delayed restoration of flow with temporary vascular shunt reduces circulating markers of injury in a porcine model J Trauma 2009;67(2):259-65.
324 166Capítulo FISIOPATOLOGIA DO TRAUMA REFERÊNCIAS BIBLIOGRÁFICAS
13. Collard CD, et al. Complement activation following oxidative stress. Mol Immunol 1999;36(13-14):941-8.
2.
24. Zhao ZQ, et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning Am J Physiol Heart Circ Physiol 2003;285(2):H579-88.
12. Reffelmann T, et al. No-reflow phenomenon persists long-term after ischemia/reperfusion in the rat and predicts infarct expansion Circulation 2003;108(23):2911-7.
1. Ruggeri ZM, and Mendolicchio GL, Adhesion mechanisms in platelet function. Circ Res 2007;100(12):1673-85. Ruggeri ZM, The role of von Willebrand factor in thrombus formation Thromb Res 2007;120 Suppl 1:S5-9. Siedlecki CA, et al. Shear-dependent changes in the three-dimensional structure of human von Willebrand factor. Blood 1996;88(8):2939-50. Gale AJ, Continuing education course #2: current understanding of hemostasis Toxicol Pathol 2011;39(1):273-80. Dahlback B. Blood coagulation Lancet 2000;355(9215):1627-32. Green D. Coagulation cascade. Hemodial Int 2006;10 Suppl 2:S2-4. Hoffman M. Remodeling the blood coagulation cascade J Thromb Thrombolysis 2003;16(1-2):17-20. Varadarajan R, et al. Nitric oxide in early ischaemia reperfusion injury during human orthotopic liver transplantation Transplantation 2004;78(2):250-6.
10. van Golen RF, van Gulik TM, Heger M. Mechanistic overview of reactive species-induced degradation of the endothelial glycocalyx during hepatic ischemia/reperfusion injury. Free Radic Biol Med 2012;52(8):1382-402.
4.
5.
20. Hancock HM, et al. Hemorrhagic shock worsens neuromuscular recovery in a porcine model of hind limb vascular injury and ischemia-reperfusion. J Vasc Surg 2011;53(4):1052-62; discussion 1062. 21. Irving GA, Noakes TD. The protective role of local hypothermia in tourniquet-induced ischaemia of muscle J Bone Joint Surg Br 1985;67(2):297-301.
23. Mowlavi A, et al. Local hypothermia during early reperfusion protects skeletal muscle from ischemia-reperfusion injury. Plast Reconstr Surg 2003;111(1):242-50.
3.
27. Xue F, et al. Postconditioning the human heart in percutaneous coronary intervention. Clin Cardiol 2010;33(7):439-44. 28. Marzi I, et al. Value of superoxide dismutase for prevention of multiple organ failure after multiple trauma J Trauma 1993;35(1):110-9; discussion 119-20. 29. Fitch JC, et al. Pharmacology and biological efficacy of a recombinant, humanized, single-chain antibody C5 complement inhibitor in patients undergoing coronary artery bypass graft surgery with cardiopulmonary bypass. Circulation 1999;100(25):2499-506.
17. Malan E, Tattoni G. Physio- and anatomo-pathology of acute ischemia of the extremities J Cardiovasc Surg (Torino) 1963;4:212-25.
15. Li C, Jackson RM. Reactive species mechanisms of cellular hypoxiareoxygenation injury Am J Physiol Cell Physiol 2002;282(2):C227-41.
14. Kaminski KA, et al. Oxidative stress and neutrophil activationthe two keystones of ischemia/reperfusion injury. Int J Cardiol 2002;86(1):41-59.
25. Zhao ZQ, Vinten-Johansen J. Postconditioning: reduction of reperfusion-induced injury. Cardiovasc Res 2006;70(2):200-11. 26. Gyurkovics E, et al. Postconditioning of the lower limb - protection against the reperfusion syndrome J Surg Res 2011;169(1):139-47.
7.
22. Osterman AL, et al. Muscle ischemia and hypothermia: a bioenergetic study using 31phosphorus nuclear magnetic resonance spectroscopy J Trauma 1984;24(9):811-7.
REFERÊNCIAS BIBLIOGRÁFICAS
42.
1. Wood CS. A short history of blood transfusion. Transfusion 1967;7(4):299-300.
19. Shires T, Coln D, Carrico J et al. Fluid therapy in hemorrhagic shock. Arch Surg 1964;88:688-93.
10. Pye-Smith RJ. Sheffield public hospital and dispensary: five cases of intravenous injection of saline fluid for hæmorrhage and collapse. Lancet 1892;139(3582):913-5
24. Westphal RG. Rational alternatives to the use of whole blood. Ann Intern Med 1972;76(6):987-90. 25. Holcomb JB. Fluid resuscitation in modern combat casualty care: lessons learned from Somalia [review]. J Trauma 2003;54(5 Suppl):S46-51.
325 167CapítuloSISTEMA DE ATENDIMENTO NO TRAUMA VASCULAR
13. Beecher HK. Preparation of battle casualties for surgery. Ann Surg 1945;121(6):769-92.
17. Fogelman MJ, Wilson BJ. A different concept of volume replacement in traumatic hypovolemia observations on injured man and animal. Am J Surg 1960;99(5):694-701.
14. Beecher HK. Early care of the seriously wounded man. J Am Med Assoc 1951;145(4):193-200.
33. Brohl K, Cohen MJ, Davenport RA. Acute coagulopathy of trauma: mechanism, identification and effect. Curr Opin Crit Care 2007;13:680-5. 34. Bickell WH, Wall MJ, Pepe PE et al. Immediate versus delayed fluid resuscitation for hypotensive patients with penetrating torso injuries. N Engl J Med 1994;331(17):1105-9. 35. Hampton DA, Fabricant LJ, Differding J et al. Pre-hospital intravenous fluid is associated with increased survival in trauma patients. J Trauma Acute Care Surg 2013;75(1):s9-15. 36. MacLeod JB, Lynn M, McKenney MG, et al. Early coagulopathy predicts mortality in trauma. J Trauma 2003;55(1):39-44. 37. Brohi K, Singh J, Heron M et al. Acute traumatic coagulopathy. J Trauma 2003;54:1127-30. 38. Gunter OL Jr, Au BK, Isbell JM et al. Optimizing outcomes in damage control resuscitation: identifying blood product ratios associated with improved survival. J Trauma 2008;65(3):527-34. Pidcoke HF, Aden JK, Mora AG et al. Ten-year analysis of transfusion in Operation Iraqi Freedom and Operation Enduring Freedom: increased plasma and platelet use correlates with improved survival. J Trauma Acute Care Surg 2012;73(6):S445-52. 40. Myburgh JA, Mythen MG. Resuscitation fluids. N Engl J Med 2013;369(13):1243-51. Dutton RP. Management of traumatic haemorrhage—the US perspective. Ansethesia 2015;70(1):108-13. Borgman MA, Spinella PC, Perkins JG et al. The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital. J Trauma 2007;63(4):805-13. Duchesne JC, Hunt JP, Wahl G et al. Review of current blood transfusions strategies in a mature level I trauma center: were we wrong for the last 60 years. J Trauma 2008;65:272-6 [discussion: 276-8]. Teixeira PG, Inaba K, Shulman I et al. Impact of plasma transfusion in massively transfused trauma patients. J Trauma 2009;66(3):693-7.
32. Bickell WH, Wall MJ, Pepe PE, et al. Immediate versus delayed fluid resuscitation for hypotensive patients with penetrating torso injuries. N Engl J Med 1994;331(17):1105-9.
39.
2. Blundell J. Some account of a case of obstinate vomiting, in which an attempt was made to prolong life by the injection of blood into the veins. Med Chir Trans 1819;10(Pt 2):296-311.
27. Shackford SR, Virgilio RW, Peters RM. Whole blood versus packed-cell transfusions: a physiologic comparison. Ann Surg 1981;193(3):337-40.
7. Marino P. The ICU book. 4th ed. Philadelphia: Wolters Kluwer Health; 2014. p. 217-34.
6. Malbrain ML, Van Regenmortel N, Owczuk R. It is time to consider the four D’s of fluid resuscitation. Anaesthesiol Intensive Ther 2015;47:s1-5.
12. Hess JR, Thomas MJ. Blood use in war and disaster: lessons from the past century. Transfusion 2003;43(11):1622-33.
21. Balogh Z, McKinley BA, Cocanour CS et al. Supranormal trauma resuscitation causes more cases of abdominal compartment syndrome. Arch Surg 2003;138:637-42.
46. Sperry JL, Ochoa JB, Gunn SR et al. Inflammation the Host Response to Injury Investigators. An FFP: PRBC transfusion ratio >1:1.5 is associated with a lower risk of mortality after massive transfusion. J Trauma 2008;65:986.
45. Brown LM, Aro SO, Cohen MJ et al. A high fresh frozen plasma: packed red blood cell transfusion ratio decreases mortality in all massively transfused trauma patients regardless of admission international normalized ratio. J Trauma 2011;71(2 Suppl 3):S358-63.
15. Beecher HK. Resuscitation, and anesthesia for wounded men, the management of traumatic shock. Springfield (IL): Charles C. Thomas; 1949. 16. Shires T, Jackson DE. Postoperative salt tolerance. Arch Surg 1962;84:703-6.
8. Jennings CE. The intra-venous injection of fluid for severe hæmorrhage. Lancet 1882;120(3081):436-7. 9. Jennings CE. The intra-venous injection of fluid for severe hæmorrhage. Lancet 1883;121(3102):228-9.
4. Spinella PC. Warm fresh whole blood transfusion for severe hemorrhage: US military and potential civilian applications. Crit Care Med 2008;36(7):S340-5.
28. Counts RB, Haisch C, Simon TL et al. Hemostasis in massively transfused trauma patients. Ann Surg 1979;190(1):91-9.
47. Rowell SE, Barbosa RR, Diggs BS et al. Effect of high product ratio massive transfusion on mortality in blunt and penetrating trauma patients. J Trauma 2011;71(2 Suppl 3):S353-7.
11. Fraser J, Cowell EM. Clinical study of blood pressure in wound conditions. JAMA 1918;70(8):520-35.
18. Wolfman EF, Neill SA, Heaps DK et al. Donor blood and isotonic salt solution. Effect on survival after hemorrhagic shock and operation. Arch Surg 1963;86:869-73.
26. McSwain NE, Champion HR, Fabian TC et al. State of the art of fluid resuscitation 2010: prehospital and immediate transition to the hospital. J Trauma 2011;70(5):S2-10.
23. Cotton BA, Guy JS, Morris JA Jr et al. The cellular, metabolic, and systemic consequences of aggressive fluid resuscitation strategies. Shock 2006;26:115-21.
41.
5. Kobayashi L, Costantini TW, Coimbra R. Hypovolemic shock. Surg Clin North Am 2012;92:1403-23.
3. Schmidt PJ. Transfusion in America in the eighteenth and nineteenth centuries. N Engl J Med 1968;279(24):1319-20.
20. McClelland RN, Shires GT, Baxter CR et al. Balanced salt solution in the treatment of hemorrhagic shock. JAMA 1967;199:830-4.
43.
44.
29. Carrico CJ, Canizaro PC, Shires GT. Fluid resuscitation following injury: rationale for the use of balanced salt solutions. Crit Care Med 1976;4(2):46-54. 30. Gattinoni L, Brazzi L, Pelosi P et al. A trial of goal-oriented hemodynamic therapy in critically ill patients. N Engl J Med 1995;333(16):1025-32. 31. Velmahos GC, Demetriades D, Shoemaker WC et al. Endpoints of resuscitation of critically injured patients: normal or supranormal?: a prospective randomized trial. Ann Surg. 2000;232(3):409-18.
22. Brandstrup B, Tønnesen H, Beier-Holgersen R et al. Effects of intravenous fluid restriction on postoperative complications: comparison of two perioperative fluid regimens: a randomized assessor-blinded multicenter trial. Ann Surg 2003;238(5):641.
88. Bulger E, Snyder D, Schoelles K et al. An evidence-based prehospital guideline for external hemorrhage control: American College of Surgeons Committee on Trauma. Prehosp Emerg Care 2014;18(2):163-73. 89. Theodoridis CA, Kafka KE, Perez AM, Curlee JB, Yperman PC, Oppermann N, Holmstroem E, Niegsch DD, Mannino A, Ramundo N. Evaluation and testing of junctional tourniquets by special operation forces personnel: a comparison of the combat ready clamp and the junctional emergency treatment tool. J Spec Oper Med 2016;16(1):44-50. 90. Granville-Chapman J, Jacobs N, Midwinter M. Pre-hospital haemostatic dressing: a systematic review. Injury 2011;42(5):447-59.
73. Cotton BA, Minei KM, Radwan ZA et al. Admission rapid thrombelastography predicts development of pulmonary embolism in trauma patients. J Trauma Acute Care Surg 2012;72(6):1470-5.
55.
52. Snyder CW, Weinberg JA, McGwin G Jr et al. The relationship of blood product ratio to mortality: survival benefit or survival bias. J Trauma 2009;66(2):358-62.
76. Gruen RL, Brohi K, Schreiber M, Balogh ZJ, Pitt V, Narayan M, Maier RV. Haemorrhage control in severely injured patients. Lancet 2012;380:1099-1108.
75. Lockey DJ, Weaver AE, Davies GE: Practical translation of hemorrhage control techniques to the civilian trauma scene. Transfusion 2013;53(Suppl 1):17S-22S.
69. Schreiber MA, Meier EN, Tisherman SA, et al. A controlled resuscitation strategy is feasible and safe in hypotensive trauma patients: results of a prospective randomized pilot trial. J Trauma Acute Care Surg 2015;78(4):687. 70. Sondeen JL, Coppes VG, Holcomb JB. Blood pressure at which rebleeding occurs after resuscitation in swine with aortic injury. J Trauma 2003;54(5 Suppl):S110-7.
77. Jacobs LM, Burns KJ, Langer G, Kiewiet de Jonge C. The Hartford Consensus: a national survey of the public regarding bleeding control. J Am Col Surg 2016;222(5):948-955.
326 Parte XTRAUMA VASCULAR
68. Wall MJ Jr, Granchi TS, Liscum K et al. Delayed versus immediate fluid resuscitation in patients with penetrating trauma: subgroup analysis. J Trauma 1995;39:173.
66. Repine TB, Perkins JG, Kauvar DS et al. The use of fresh whole blood in massive transfusion. J Trauma 2006;60(6 suppl):S59-69.
72. Spinella PC, Holcomb JB. Resuscitation and transfusion principles for traumatic hemorrhagic shock. Blood Rev 2009;23(6):231-40.
74. Holcomb JB, Minei KM, Scerbo ML et al. Admission rapid thrombelastography can replace conventional coagulation tests in the emergency department: experience with 1974 consecutive trauma patients. Ann Surg 2012;256(3):476-86.
63. Golan M, Modan M, Lavee J et al. Transfusion of fresh whole blood stored (4 degrees C) for short period fails to improve platelet aggregation on extracelular matrix and clinical hemostasis after cardiopulmonary bypass. J Thorac Cardiovasc Surg 1990;99(2):354-60. 64. Cotton BA, Podbielski J, Camp E, et al. A randomized controlled pilot trial of modified whole blood versus componente therapy in severely injured patients requiring large volume transfusions. Ann Surg 2013;258(4):527-32 [discussion: 532-3].
48. Pati S, Matijevic N, Doursout MF et al. Protective effects of fresh frozen plasma on vascular endothelial permeability, coagulation, and resuscitation after hemorrhagic shock are time dependent and diminish between days 0 and 5 after thaw. J Trauma 2010;69(Suppl 1):S55-63.
86. Duchesne JC, Pereira BM, Fraga GP. Damage control resuscitation Trauma Surgery, Vol 1, In Di Saverio S, Tugnoli G, Catena F, et al. Springer; 2014. 87. Sharpe D, Barneby E, Russell R. New approaches to the management of traumatic external hemorrhage. J Trauma 2011;13:47-55.
58. Moore HB, Moore EE, Chapman MP et al. Plasma-first resuscitation to treat haemorrhagic shock during emergency ground transportation in an urban area: a randomised trial. Lancet. 2018;392:283-391 59. Spinella PC, Pidcoke HF, Strandenes G et al. Whole blood for hemostatic resuscitation of major bleeding. Transfusion 2016;56(S2):S190-202. 60. Holcomb JB. Damage control resuscitation [review]. J Trauma 2007;62(6Suppl):S36-7. Spinella PC, Perkins JG, Grathwohl KW et al. Warm fresh whole blood is independently associated with improved survival for patients with combat-related traumatic injuries. J Trauma 2009;66(4 Suppl):S69-76. 62. Holcomb JB, Spinella PC. Optimal use of blood in trauma patients. Biologicals 2010;38(1):72-7.
54. Oyeniyi BT, Fox EE, Scerbo M et al. Trends in 1029 trauma deaths at a level 1 trauma center: Impact of a bleeding control bundle of care. Injury 2017;48(1):5-12. Holcomb JB, Tilley BC, Baraniuk S et al. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. JAMA 2015;313(5):471-82.
53. Holcomb JB, del Junco DJ, Fox EE et al. The prospective, observational, multicenter, major trauma transfusion (PROMMTT) study: comparative effectiveness of a time-varying treatment with competing risks. JAMA Surg 2013;148(2):127-36.
57.
65. Kauvar DS, Holcomb JB, Norris GC et al. Fresh whole blood transfusion: a controversial military practice. J Trauma 2006;61(1):181-4.
51. Cardenas JC, Cap AP, Swartz MD et al. Plasma resuscitation promotes coagulation homeostasis following shock-induced hypercoagulability. Shock 2016;45(2):166-73.
61.
78. Fox N, Rajani RR, Bokhari F, Chiu WC, Kerwin A, Seamon MJ, Skarupa D, Frykberg E, Eastern Association for the Surgery of T: Evaluation and management of penetrating lower extremity arterial trauma: an Eastern Association for the Surgery of Trauma practice management guideline. J Trauma Acute Care Surg 2012;73:S315-320. 79. Sadek S, Lockey DJ, Lendrum RA, Perkins Z, Price J, Davies GE. Resuscitative endovascular balloon occlusion of the aorta (REBOA) in the pre-hospital setting: an additional resuscitation option for uncontrolled catastrophic haemorrhage. Resuscitation 2016 Oct;107:135-8. 80. Reva VA, Hörer TM, Makhnovskiy AI, Sokhranov MV, Samokhvalov IM, DuBose JJ. Field and en route resuscitative endovascular occlusion of the aorta: a feasible military reality? J Trauma Acute Care Surg 2017 Jul;83(1 Suppl 1):S170-S176. 81. Baraniuk S, Tilley BC, del Junco DJ et al. Pragmatic Randomized Optimal Platelet and Plasma Ratios (PROPPR) Trial: design, rationale and implementation. Injury 2014 Sep;45(9):1287-95. 82. Brenner ML, Moore LJ, DuBose JJ, Tyson GH, McNutt MK, Albarado RP, Holcomb JB, Scalea TM, Rasmussen TE: a clinical series of resuscitative endovascular balloon occlusion of the aorta for hemorrhage control and resuscitation. J Trauma Acute Care Surg 2013;75:506-11. 83. Curry N, Foley C, Wong H et al. Early fibrinogen concentrate therapy for major haemorrhage in trauma (E-FIT 1): results from a UK multicentre, randomised, double blind, placebo-controlled pilot trial. Crit Care 2018 Jun 18;22(1):164. 84. Sorensen B, Tang M, Larsen OH, Laursen PN, Fenger-Eriksen C, Rea CJ. The role of fibrinogen: a new paradigm in the treatment of coagulopathic bleeding. Thromb Res 2011;128(Suppl 1):S13-16. 85. CRASH-2 Trial Collaborators. Improving the evidence base for trauma care: progress in the international CRASH-2 trial. PLoS Clin Trials 2006 Oct 27;1(6):e30.
50. Sillesen M, Johansson PI, Rasmussen LS et al. Fresh frozen plasma resuscitation attenuates platelet dysfunction compared with normal saline in a large animal model of multisystem trauma. J Trauma Acute Care Surg 2014;76(4):998-1007.
49. Watson JJ, Pati S, Schreiber MA. Plasma transfusion: history, current realities, and novel improvements. Shock 2016;46(5):468-79.
71. Plotkin AJ, Wade CE, Jenkins DH et al. A reduction in clot formation rate and strength assessed by thrombelastography is indicative of transfusion requirements in patients with penetrating injuries. J Trauma 2008;64(2 Suppl):S64-8.
56. Fox EE, Holcomb JB, Wade CE et al. Earlier endpoints are required for hemorrhagic shock trials among severely injured patients. Shock 2017;47(5):567-73. Sperry JL, Guyette FX, Brown JB et al. Prehospital plasma during air medical transport in trauma patients at risk for hemorrhagic shock. N Engl Med 2018;379(4):315-326
67. Bickell WH, Wall MJ Jr, Pepe PE et al. Immediate versus delayed fluid resuscitation for hypotensive patients with penetrating torso injuries. N Engl J Med 1994;331(17):1105-9.
1. Stone HH, Strom PR, Mullins RJ. Management of the major coagulopathy with onset during laparotomy. Ann Surg Lippincott, Williams, and Wilkins 1983 May;197(5):532-5.
18. Blackbourne LH, Butler FK. Damage control: prehospital care of the patient with vascular injury. In: Rich’s vascular trauma. 3th ed. Elsevier; 2016. p. 183-97.
4. Moore EE. Thomas G. Orr Memorial Lecture. Staged laparotomy for the hypothermia, acidosis, and coagulopathy syndrome. Am J Surg 1996; 172:405-10.
24. White JM, Cannon JW, Stannard A, Markov NP, Spencer JR, Rasmussen TE. Endovascular balloon occlusion of the aorta is superior to resuscitative thoracotomy with aortic clamping in a porcine model of hemorrhagic shock. Surgery 2011 Sep;150(3):400-9.
2. Rotondo MF, Schwab CW, McGonigal MD, Phillips GR, Fruchterman TM, Kauder DR, et al. “Damage control”: an approach for improved survival in exsanguinating penetrating abdominal injury. J Trauma 1993 Sep;35(3):375-82-discussion382-3.
28. Roberts DJ, Bobrovitz N, Zygun DA, Ball CG, Kirkpatrick AW, Faris PD, et al. Indications for use of damage control surgery in civilian trauma patients: a content analysis and expert appropriateness rating study. Ann Surg 2016 May;263(5):1018-27.
10. Kotwal RS, Montgomery HR, Kotwal BM, Champion HR, Butler FK, Mabry RL, et al. Eliminating preventable death on the battlefield. Arch Surg 2011 Dec;146(12):1350-8.
16. Rhee P, Brown C, Martin M, Salim A, Plurad D, Green D, et al. QuikClot use in trauma for hemorrhage control: case series of 103 documented uses. J Trauma 2008 Apr;64(4):1093-9.
29. Schreiber MA, Perkins J, Kiraly L, Underwood S, Wade C, Holcomb JB. Early predictors of massive transfusion in combat casualties. J Am Coll Surg 2007 Oct;205(4):541-5.
27. Cosgriff N, Moore EE, Sauaia A, Kenny-Moynihan M, Burch JM, Galloway B. Predicting life-threatening coagulopathy in the massively transfused trauma patient: hypothermia and acidoses revisited. J Trauma 1997 May;42(5):857-61-discussion 861-2.
12. King DR, Larentzakis A, Ramly EP, Boston Trauma Collaborative. Tourniquet use at the Boston Marathon bombing: Lost in translation. J Trauma Acute Care Surg 2015 Mar;78(3):594-9.
15. Teixeira PGR, Brown CVR, Emigh B, Long M, Foreman M, Eastridge B, et al. Civilian prehospital tourniquet use is associated with improved survival in patients with peripheral vascular injury. J Am Coll Surg 2018 May;226(5):769-776.e1.
11. Department of Defense Joint Trauma System. Tactical Combat Casualty Care Guidelines [Internet]. 2012 [cited 2017 Aug 23]. pp. 1-14. Available from: Course_Materials/TCCC-Guidelines-120917.pdfhttp://www.health.mil/Libraries/120917_TCCC_
20. Meusnier J-G, Dewar C, Mavrovi E, Caremil F, Wey P-F, Martinez J-Y. Evaluation of two junctional tourniquets used on the battlefield: Combat Ready Clamp® versus SAM® Junctional Tourniquet. J Spec Oper Med 2016;16(3):41-6.
9. Kragh JF, Walters TJ, Baer DG, Fox CJ, Wade CE, Salinas J, et al. Survival with emergency tourniquet use to stop bleeding in major limb trauma. Ann Surg 2009 Jan;249(1):1-7.
22. Klotz JK, Leo M, Andersen BL, Nkodo AA, Garcia G, Wichern AM, et al
35. Taller J, Kamdar JP, Greene JA, Morgan RA, Blankenship CL, Dabrowski P, et al. Temporary vascular shunts as initial treatment of proximal extremity vascular injuries during combat operations: the new standard of care at Echelon II facilities? J Trauma 2008 Sep;65(3):595-603. 36. Gifford SM, Aidinian G, Clouse WD, Fox CJ, Porras CA, Jones WT, et al. Effect of temporary shunting on extremity vascular injury: an
6. Chovanes J, Cannon JW, Nunez TC. The evolution of damage control surgery. Surg Clin North Am 2012 Aug;92(4):859-75-vii-viii.
14. Inaba K, Siboni S, Resnick S, Zhu J, Wong MD, Haltmeier T, et al. Tourniquet use for civilian extremity trauma. J Trauma Acute Care Surg 2015 Aug;79(2):232-7-quiz332-3.
13. Jacobs LM, Burns KJ, Pons PT, Gestring ML. Initial steps in training the public about bleeding control: surgeon participation and evaluation. J Am Coll Surg 2017 Jun;224(6):1084-90.
7. Eastridge BJ, Hardin M, Cantrell J, Oetjen-Gerdes L, Zubko T, Mallak C, et al. Died of wounds on the battlefield: causation and implications for improving combat casualty care. J Trauma 2011 Jul;71(1 Suppl):S4-8.
First case report of SAM(r) Junctional tourniquet use in Afghanistan to control inguinal hemorrhage on the battlefield. J Spec Oper Med 2014;14(2):1-5. 23. Kheirabadi BS, Terrazas IB, Miranda N, Estep JS, Corona BT, Kragh JF, et al. Long-term effects of Combat Ready Clamp application to control junctional hemorrhage in swine. J Trauma Acute Care Surg 2014 Sep;77(3 Suppl 2):S101-8.
30. Aucar JA, Hirshberg A. Damage control for vascular injuries. Surg Clin North Am 1997 Aug;77(4):853-62.
327 168CapítuloCONTROLE DO DANO NO TRAUMA VASCULAR REFERÊNCIAS BIBLIOGRÁFICAS
31. White JM, Stannard A, Burkhardt GE, Eastridge BJ, Blackbourne LH, Rasmussen TE. The epidemiology of vascular injury in the wars in Iraq and Afghanistan. Ann Surg 2011 Jun;253(6):1184-9. 32. Scott DJ, Rasmussen TE. 17 - surgical damage control and temporary vascular shunts. In: Rich’s vascular trauma. 3th ed. Elsevier; 2016. p. 198-205. 33. Rasmussen TE, Clouse WD, Jenkins DH, Peck MA, Eliason JL, Smith DL. The use of temporary vascular shunts as a damage control adjunct in the management of wartime vascular injury. J Trauma 2006 Jul;61(1):8-12-discussion 12-5.
21. Kragh JF, Lunati MP, Kharod CU, Cunningham CW, Bailey JA, Stockinger ZT, et al. Assessment of groin application of junctional tourniquets in a Manikin Model. Prehosp Disaster Med 2016 Aug;31(4):358-63.
17. Kheirabadi BS, Scherer MR, Estep JS, Dubick MA, Holcomb JB. Determination of efficacy of new hemostatic dressings in a model of extremity arterial hemorrhage in swine. J Trauma 2009 Sep;67(3):450-9-discussion 459-60.
19. Ran Y, Hadad E, Daher S, Ganor O, Kohn J, Yegorov Y, et al. QuikClot Combat Gauze use for hemorrhage control in military trauma: January 2009 Israel Defense Force experience in the Gaza Strip-a preliminary report of 14 cases. Prehosp Disaster Med 2010 Nov;25(6):584-8.
34. Chambers LW, Green DJ, Sample K, Gillingham BL, Rhee P, Brown C, et al. Tactical surgical intervention with temporary shunting of peripheral vascular trauma sustained during Operation Iraqi Freedom: one unit’s experience. J Trauma 2006 Oct;61(4):824-30.
25. Brenner M, Inaba K, Aiolfi A, DuBose J, Fabian T, Bee T, et al. Resuscitative endovascular balloon occlusion of the aorta and resuscitative thoracotomy in select patients with hemorrhagic shock: early results from the American Association for the Surgery of Trauma Aortic Occlusion in Resuscitation for Trauma and Acute Care Surgery Registry. J Am Coll Surg 2018 Feb 6. 26. Sadek S, Lockey DJ, Lendrum RA, Perkins Z, Price J, Davies GE. Resuscitative endovascular balloon occlusion of the aorta (REBOA) in the pre-hospital setting: an additional resuscitation option for uncontrolled catastrophic haemorrhage. Resuscitation 2016 Oct;107:135-8.
8. Stannard A, Morrison JJ, Scott DJ, Ivatury RA, Ross JD, Rasmussen TE. The epidemiology of noncompressible torso hemorrhage in the wars in Iraq and Afghanistan. J Trauma Acute Care Surg 2013 Mar;74(3):830-4.
5. Shapiro MB, Jenkins DH, Schwab CW, Rotondo MF. Damage control: collective review. J Trauma 2000 Nov;49(5):969-78.
3. Hess JR, Holcomb JB, Hoyt DB. Damage control resuscitation: the need for specific blood products to treat the coagulopathy of trauma. Transfusion 2006 May;46(5):685-6.
41. Beecher HK. Preparation of battle casualties for surgery. Ann Surg 1945 Jun;121(6):769-92.
56. Fox CJ, Perkins JG, Kragh JF, Singh NN, Patel B, Ficke JR. Popliteal artery repair in massively transfused military trauma casualties: a pursuit to save life and limb. J Trauma 2010 Jul;69 Suppl 1(Supplement):S123-34. 57. Dua A, Patel B, Kragh JF, Holcomb JB, Fox CJ. Long-term follow-up and amputation-free survival in 497 casualties with combat-related vascular injuries and damage-control resuscitation. J Trauma Acute Care Surg 2012 Dec;73(6):1517-24.
J Trauma 2008 Feb;64(2 Suppl):S99-106-discussion S106-7.
39. Maher Z, Frank B, Saillant N, Goldenberg A, Dauer E, Hazelton JP, et al
51. CRASH-2 trial collaborators, Shakur H, Roberts I, Bautista R, Caballero J, Coats T, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet 2010 Jul 3;376(9734):23-32.
45. Ley EJ, Clond MA, Srour MK, Barnajian M, Mirocha J, Margulies DR, et al. Emergency department crystalloid resuscitation of 1.5 L or more is associated with increased mortality in elderly and nonelderly trauma patients. J Trauma 2011 Feb;70(2):398-400.
328 Parte XTRAUMA VASCULAR outcome analysis from the Global War on Terror vascular injury initiative. J Vasc Surg 2009 Sep;50(3):549-55-discussion 555-6.
44. Morrison CA, Carrick MM, Norman MA, Scott BG, Welsh FJ, Tsai P, et al. Hypotensive resuscitation strategy reduces transfusion requirements and severe postoperative coagulopathy in trauma patients with hemorrhagic shock: preliminary results of a randomized controlled trial. J Trauma 2011 Mar;70(3):652-63.
46. Cotton BA, Reddy N, Hatch QM, LeFebvre E, Wade CE, Kozar RA, et al. Damage control resuscitation is associated with a reduction in resuscitation volumes and improvement in survival in 390 damage control laparotomy patients. Ann Surg 2011 Oct;254(4):598-605.
52. CRASH-2 collaborators, Roberts I, Shakur H, Afolabi A, Brohi K, Coats T, et al. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet 2011 Mar 26;377(9771):1096101-1101.e1-2.
43. Cannon JW, Khan MA, Raja AS, Cohen MJ, Como JJ, Cotton BA, et al. Damage control resuscitation in patients with severe traumatic hemorrhage: a practice management guideline from the Eastern Association for the Surgery of Trauma. J Trauma Acute Care Surg 2017;82:605-17.
60. Kurtoglu M, Yanar H, Taviloglu K, Sivrikoz E, Plevin R, Aksoy M. Serious lower extremity venous injury management with ligation: prospective overview of 63 patients. Am Surg 2007 Oct;73(10):1039-43. 61. Ritenour AE, Dorlac WC, Fang R, Woods T, Jenkins DH, Flaherty SF, et al. Complications after fasciotomy revision and delayed compartment release in combat patients. J Trauma 2008 Feb;64(2 Suppl):S153-61discussion S161-2.
Systemic intraoperative anticoagulation during arterial injury repair: implications for patency and bleeding. J Trauma Acute Care Surg 2017 Apr;82(4):680-6.
49. Kalkwarf KJ, Cotton BA. Resuscitation for hypovolemic shock. Surg Clin North Am 2017 Dec;97(6):1307-21.
58. Langan NR, Eckert M, Martin MJ. Changing patterns of in-hospital deaths following implementation of damage control resuscitation practices in US Forward Military Treatment Facilities. JAMA Surg. American Medical Association 2014 Sep 1;149(9):904-9. 59. Quan RW, Gillespie DL, Stuart RP, Chang AS, Whittaker DR, Fox CJ. The effect of vein repair on the risk of venous thromboembolic events: a review of more than 100 traumatic military venous injuries. J Vasc Surg 2008 Mar;47(3):571-7.
40. Granchi T, Schmittling Z, Vasquez J, Schreiber M, Wall M. Prolonged use of intraluminal arterial shunts without systemic anticoagulation. AJS 2000 Dec;180(6):493-6-discussion 496-7.
53. Morrison JJ, Dubose JJ, Rasmussen TE, Midwinter MJ. Military application of tranexamic acid in trauma emergency resuscitation (MATTERs) study. Arch Surg American Medical Association 2012 Feb;147(2):113-9.
42. Fox CJ, Gillespie DL, Cox ED, Mehta SG, Kragh JF, Salinas J, et al. The effectiveness of a damage control resuscitation strategy for vascular injury in a combat support hospital: results of a case control study.
54. Johnston LR, Rodriguez CJ, Elster EA, Bradley MJ. Evaluation of military use of tranexamic acid and associated thromboembolic events. JAMA Surg 2017 Oct 25. 55. Hauser CJ, Boffard K, Dutton R, Bernard GR, Croce MA, Holcomb JB, et al. Results of the CONTROL trial: efficacy and safety of recombinant activated Factor VII in the management of refractory traumatic hemorrhage. J Trauma 2010 Sep;69(3):489-500.
48. Holcomb JB, Tilley BC, Baraniuk S, Fox EE, Wade CE, Podbielski JM, et al. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. JAMA 2015 Feb 3;313(5):471-82.
37. Subramanian A, Vercruysse G, Dente C, Wyrzykowski A, King E, Feliciano DV. A decade’s experience with temporary intravascular shunts at a civilian level I trauma center. J Trauma 2008 Aug;65(2):316-24-discussion 324-6.
50. Spinella PC, Perkins JG, Grathwohl KW, Beekley AC, Holcomb JB. Warm fresh whole blood is independently associated with improved survival for patients with combat-related traumatic injuries. J Trauma 2009 Apr;66(4 Suppl):S69-76.
47. Borgman MA, Spinella PC, Perkins JG, Grathwohl KW, Repine T, Beekley AC, et al. The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital. J Trauma 2007 Oct;63(4):805-13.
38. Mathew S, Smith BP, Cannon JW, Reilly PM, Schwab CW, Seamon MJ. Temporary arterial shunts in damage control: experience and outcomes. J Trauma Acute Care Surg 2017 Mar;82(3):512-7.
19. Weber MA, Fox CJ, Adams E, et al. Upper extremity arterial combat injury management. Perspect Vasc Surg Endovasc Ther 2006;18(2):141-5.
4. Fox CJ, Gillespie DL, Weber MA, et al. Delayed evaluation of combatrelated penetrating neck trauma. J Vasc Surg 2006;44(1):86-93.
10. White JM, Stannard A, Burkhardt GE, Eastridge BJ, Blackbourne LH, Rasmussen TE. The epidemiology of vascular injury in the wars in Iraq and Afghanistan. Ann Surg 2011 Jun;253(6):1184-9.
1. Eastridge BJ, Jenkins D, Flaherty S, Schiller H, Holcomb JB. Trauma system development in a theater of war: experiences from Operation Iraqi Freedom and Operation Enduring Freedom. J Trauma 2006;61(6):1366-72.
6. Fox CJ, Gillespie DL, O’Donnell SD, et al. Contemporary management of wartime vascular trauma. J Vasc Surg 2005;41(4):638-44.
24. Kragh JF, Jr., Walters TJ, Baer DG, et al. Practical use of emergency tourniquets to stop bleeding in major limb trauma. J Trauma 2008;64(2 Suppl):S38-S49. 25. Kragh JF Jr, Walters TJ, Baer DG, et al. Survival with emergency tourniquet use to stop bleeding in major limb trauma. Ann Surg 2009;249(1):1-7.
11. Patel JA, White JM, White PW, Rich NM, Rasmussen TE. A contemporary, 7-year analysis of vascular injury from the war in Afghanistan. J Vasc Surg 2018 Jun 11 [Epub ahead of print]
39. Rasmussen TE, Clouse WD, Jenkins DH, Peck MA, Eliason JL, Smith DL. The use of temporary vascular shunts as a damage control adjunct in the management of wartime vascular injury. J Trauma 2006;61(1):8-12. 40. Chambers LW, Green DJ, Sample K, et al. Tactical surgical intervention with temporary shunting of peripheral vascular trauma sustained during Operation Iraqi Freedom: one unit’s experience. J Trauma 2006;61(4):824-30. 41. Gifford SM, Aidinian G, Clouse WD, et al. Effect of temporary shunting on extremity vascular injury: an outcome analysis from
18. Clouse WD, Rasmussen TE, Perlstein J, et al. Upper extremity vascular injury: a current in-theater wartime report from Operation Iraqi Freedom. Ann Vasc Surg 2006; 20(4):429-34.
GUERRAS RECENTES
15. Hughes CW. Arterial repair during the Korean War. Ann Surg 1958; 147(4):555-61.
13. Holcomb JB, McMullin NR, Pearse L, et al. Causes of death in US Special Operations Forces in the Global War on Terrorism 2001-2004. Ann Surg 2007;245(6):986-91.
26. Fox CJ, Mehta SG, Cox ED, Kragh JF, Jr., Salinas J, Holcomb JB. Effect of recombinant factor VIIa as an adjunctive therapy in damage control for wartime vascular injuries: a case control study. J Trauma 2009;66(4 Suppl):S112-S119. 27. Alam HB, Rhee P. New developments in fluid resuscitation. Surg Clin North Am 2007;87(1):55-72, vi. 28. Stansbury LG, Lalliss SJ, Branstetter JG, Bagg MR, Holcomb JB. Amputations in U.S. military personnel in the current conflicts in Afghanistan and Iraq. J Orthop Trauma 2008;22(1):43-46. 29. Fox CJ, Gillespie DL, Cox ED, et al. The effectiveness of a damage control resuscitation strategy for vascular injury in a combat support hospital: results of a case control study. J Trauma 2008;64(2 Suppl):S99-106. 30. Borgman MA, Spinella PC, Perkins J, et al. The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital. J Trauma 2007;63(4):805-13. 31. Central Command Clincal Practice Guidelines. Damage Control Resuscitation for Level IIb-III [document on the Internet]: US Department of Defense. Available from: https://jpta.fhp.osd.mil. 2006. Holcomb JB, Stansbury LG, Champion HR, Wade C, Bellamy RF. Understanding combat casualty care statistics. J Trauma 2006;60(2):397-401. 32. Holcomb JB, Jenkins D, Rhee P, et al. Damage control resuscitation: directly addressing the early coagulopathy of trauma. J Trauma 2007;62(2):307-10. 33. Schreiber MA, Perkins J, Kiraly L, Underwood S, Wade C, Holcomb JB. Early predictors of massive transfusion in combat casualties. J Am Coll Surg 2007;205(4):541-5. 34. Stinger HK, Spinella PC, Perkins JG, et al. The ratio of fibrinogen to red cells transfused affects survival in casualties receiving massive transfusions at an army combat support hospital. J Trauma 2008;64(2 Suppl):S79-S85. 35. Holcomb JB, Wade CE, Michalek JE, et al. Increased plasma and platelet to red blood cell ratios improves outcome in 466 massively transfused civilian trauma patients. Ann Surg 2008;248(3):447-58. 36. McLaughlin DF, Niles SE, Salinas J, et al. A predictive model for massive transfusion in combat casualty patients. J Trauma 2008;64(2 Suppl):S57-S63. 37. Spinella PC, Perkins JG, Grathwohl KW, Beekley AC, Holcomb JB. Warm fresh whole blood is independently associated with improved survival for patients with combat-related traumatic injuries. J Trauma 2009;66(4 Suppl):S69-S76. 38. Perkins JG, Andrew CP, Spinella PC, et al. An evaluation of the impact of apheresis platelets used in the setting of massively transfused trauma patients. J Trauma 2009;66(4 Suppl):S77-S84.
5. Beekley AC. United States military surgical response to modern largescale conflicts: the ongoing evolution of a trauma system. Surg Clin North Am 2006;86(3):689-709.
2. Beekley AC, Starnes BW, Sebesta JA. Lessons learned from modern military surgery. Surg Clin North Am 2007;87(1):157-84, vii.
22. Wenke JC, Walters TJ, Greydanus DJ, Pusateri AE, Convertino VA. Physiological evaluation of the U.S. Army one-handed tourniquet. Mil Med 2005;170(9):776-81.
16. Fox CJ, Starnes BW. Vascular surgery on the modern battlefield. Surg Clin North Am 2007;87(5):1193-211, xi.
20. Fox CJ, Gillespie DL, Cox ED, et al. Damage control resuscitation for vascular surgery in a combat support hospital. J Trauma 2008;65(1):1-9. 21. Ritenour A, Dorlac W, Fang R, et al. Complications after fasciotomy revision and delayed compartment release in combat patients. J Trauma 2008;64(2 Suppl):S153-S162.
REFERÊNCIAS BIBLIOGRÁFICAS
3. Sebesta J. Special lessons learned from Iraq. Surg Clin North Am 2006; 86(3):711-26.
7. Rasmussen TE, Clouse WD, Jenkins DH, Peck MA, Eliason JL, Smith DL. Echelons of care and the management of wartime vascular injury: a report from the 332nd EMDG/Air Force Theater Hospital, Balad Air Base, Iraq. Perspect Vasc Surg Endovasc Ther 2006;18(2):91-9.
329 169Capítulo
VASCULAR
TRAUMA DURANTE AS
17. Woodward EB, Clouse WD, Eliason JL et al. Penetrating femoropopliteal injury during modern warfare: experience of the Balad Vascular Registry. J Vasc Surg 2008; 47(6):1259-64.
12. Clouse WD, Rasmussen TE, Peck MA et al. In-theater management of vascular injury: 2 years of the Balad Vascular Registry. J Am Coll Surg 2007;204(4):625-32.
23. Walters TJ, Mabry RL. Issues related to the use of tourniquets on the battlefield. Mil Med 2005;170(9):770-5.
14. DeBakey ME, Simeone MC. Battle injuries of the arteries in World War II: an analysis of 2,471 cases. Ann Surg 1946;123(4):534-79.
8. Taller J, Kamdar JP, Greene JA et al. Temporary vascular shunts as initial treatment of proximal extremity vascular injuries during combat operations: the new standard of care at echelon II facilities? J Trauma 2008;65(1):595-603. 9. Rich NM, Baugh JH, Hughes CW. Acute arterial injuries in Vietnam: 1,000 cases. J Trauma 1970;10(5):359-69.
52. Aidinian G, Fox CJ, Rasmussen TE, Gillespie DL. Varied presentations of missile emboli in military combat. J Vasc Surg 2009. 53. Rasmussen TE, Clouse WD, Peck MA, et al. Development and implementation of endovascular capabilities in wartime. J Trauma 2008;64:1169-76.
59. Leininger BE, Rasmussen TE, Smith DL, Jenkins DH, Coppola C. Experience with wound VAC and delayed primary closure of contaminated soft tissue injuries in Iraq. J Trauma 2006;61(1):1207-11.
45. Brigham RA, Eddleman WL, Clagett GP, Rich NM. Isolated venous injury produced by penetrating trauma to the lower extremity. J Trauma 1983;23(3):255-7.
63. Johnson ON, III, Gillespie DL, Aidinian G, White PW, Adams E, Fox CJ. The use of retrievable inferior vena cava filters in severely injured military trauma patients. J Vasc Surg 2009;49(2):410-16.
69. Williams TK, Neff LP, Johnson MA, Ferencz SA, Davidson AJ, Russo RM, Rasmussen TE. Extending resuscitative endovascular balloon occlusion of the aorta: endovascular variable aortic control in a lethal model of hemorrhagic shock. J Trauma Acute Care Surg 2016 Aug;81(2):294-301.
48. White R, Krajcer Z, Johnson M, Williams D, Bacharach M, O’Malley E. Results of a multicenter trial for the treatment of traumatic vascular injury with a covered stent. J Trauma 2006; 60(6):1189-95.
56. Rich NM, Baugh JH, Hughes CW. Popliteal artery injuries in Vietnam. Am J Surg 1969;118(4):531-34.
70. Fisher AD, Teeter WA, Cordova CB, Brenner ML, Szczepanski MP, Miles EA, Galante JM, DuBose JJ, Rasmussen TE. The Role I Resuscitation Team and Resuscitative Endovascular Balloon Occlusion of the Aorta. J Spec Oper Med 2017 Summer;17(2):65-73.
49. Starnes BW, Arthurs ZM. Endovascular management of vascular trauma. Perspect Vasc Surg Endovasc Ther 2006;18(2):114-29.
50. Lin PH, Bush RL, Zhou W, Peden EK, Lumsden AB. Endovascular treatment of traumatic thoracic aortic injury - should this be the new standard of treatment? J Vasc Surg 2006;43 Suppl A:22A-29A.
68. DuBose JJ, Scalea TM, Brenner M, Skiada D, Inaba K, Cannon J, Moore L, Holcomb J, Turay D, Arbabi CN, Kirkpatrick A, Xiao J, Skarupa D, Poulin N. AAST AORTA Study Group. The AAST prospective Aortic Occlusion for Resuscitation in Trauma and Acute Care Surgery (AORTA) registry: data on contemporary utilization and outcomes of aortic occlusion and resuscitative balloon occlusion of the aorta (REBOA). J Trauma Acute Care Surg 2016 Sep;81(3):409-19.
65. Harvin JA, et al. Mortality following emergent trauma laparotomy: a multicenter, retrospective study. J Trauma Acute Car Surg [Publish Ahead of Print]. 2017;83(3):464-468. 66. Burkhardt GE, Rasmussen TE, Propper BW, et al. A national survey of evolving management patterns for vascular injury. J Surg Ed 2009;66(5):239-47.
54. Cox MW, Whittaker DR, Martinez C, Fox CJ, Feuerstein IM, Gillespie DL. Traumatic pseudoaneurysms of the head and neck: early endovascular intervention. J Vasc Surg 2007;46(6):1227-33.
62. Aidinian G, Fox CJ, White PW, Cox M, Adams ED, Gillespie DL. Intravascular ultrasound - guided inferior vena cava filter placement in the military multitrauma patients: a single-center experience. Vasc Endovascular Surg 2009;43(5):497-501.
42. Rich NM, Hughes CW. The fate of prosthetic material used to repair vascular injuries in contaminated wounds. J Trauma 1972;12(6):459-67.
46. Quan RW, Adams ED, Cox MW, et al. The management of trauma venous injury: civilian and wartime experiences. Perspect Vasc Surg Endovasc Ther 2006;18(2):149-56.
51. Starnes BW, Beekley AC, Sebesta JA, Andersen CA, Rush RM, Jr. Extremity vascular injuries on the battlefield: tips for surgeons deploying to war. J Trauma 2006;60(2):432-42.
47. Quan RW, Gillespie DL, Stuart RP, Chang AS, Whittaker DR, Fox CJ. The effect of vein repair on the risk of venous thromboembolic events: a review of more than 100 traumatic military venous injuries. J Vasc Surg 2008;47(3):571-7.
55. White PW, Gillespie DL, Feuerstein IM, et al. Sixty-four slice multidetector computed tomographic angiography in the evaluation of vascular trauma. J Trauma 2010; 68(1):96-102.
44. Vertrees A, Fox CJ, Quan RW, Cox MW, Adams ED, Gillespie DL. The use of prosthetic grafts in complex military vascular trauma: a limb salvage strategy for patients with severely limited autologous conduit. J Trauma 2009;66(4):980-3.
58. Perkins ZB, Yet B, Glasgow S, Marsh DWR, Tai NRM, Rasmussen TE. Long-term, patient-centered outcomes of lower-extremity vascular trauma. J Trauma Acute Care Surg 2018 Jul;85(1S Suppl 2):S104-S111.
64. Simon TE, Walker PF, Daab LJ, White JM, White PW. A quality improvement project to improve inferior vena cava filter retrieval. J Vasc Surg Venous Lymphat Disord 2017 Jan;5(1):42-46.
71. Manley JD, Mitchell BJ, DuBose JJ, Rasmussen TE. A modern case series of Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) in an Out-of-Hospital, Combat Casualty Care Setting. J Spec Oper Med 2017 Spring;17(1):1-8.
67. White JM, Cannon JW, Stannard A, Markov NP, Spencer JR, Rasmussen TE. Endovascular balloon occlusion of the aorta is superior to resuscitative thoracotomy with aortic clamping in a porcine model of hemorrhagic shock. Surgery 2011 Sep;150(3):400-9.
61. Sabino J, Polfer E, Tintle S, Jessie E, Fleming M, Martin B, Shashikant M, Valerio IL. A decade of conflict: flap coverage options and outcomes in traumatic war-related extremity reconstruction. Plast Reconstr Surg 2015 Mar;135(3):895-902.
57. Fox CJ, Perkins JG, Kragh JF, Jr., Singh NN, Patel B, Ficke JR. Popliteal artery repair in massively transfused military trauma casualties: a pursuit to save life and limb. J Trauma 2010;69(1 Suppl):S123-S134.
330 Parte XTRAUMA VASCULAR the Global War on Terror vascular injury initiative. J Vasc Surg 2009;50(3):549-55.
60. Peck MA, Clouse WD, Cox MW, et al. The complete management of extremity vascular injury in a local population: a wartime report from the 332nd Expeditionary Medical Group / Air Force Theater Hospital, Balad Air Base, Iraq. J Vasc Surg 2007;45(1):1197-204.
43. Rich NM, Baugh JH, Hughes CW. Significance of complications associated with vascular repairs performed in Vietnam. Arch Surg 1970;100(6):646-51.
21. Demetriades D, Theodorou D, Cornwell E 3rd, Weaver F, Yellin A, Velmahos G et al. Penetrating injuries of the neck in patients in stable condition. Physical examination, angiography, or color flow Doppler imaging. Arch Surg 1995 Sep;130(9):971-5.
13. Rao PM, Ivatury RR, Sharma P, Vinzons AT, Nassoura Z, Stahl WM. Cervical vascular injuries: a trauma center experience. Surgery 1993 Sep;114(3):527-31.
16. Modrall JG, Weaver FA, Yellin AE. Diagnosis and management of penetrating vascular trauma and the injured extremity. Emerg Med Clin North Am 1998 Feb;16(1):129-44.
39.
4. Ristow AV. Traumatismos vasculares dos troncos supra-aórticos. Anais do XXXII Congresso Brasileiro de Angiologia e Cirurgia VascularSBACV, Curitiba; 1997. p. 249-52.
REFERÊNCIAS BIBLIOGRÁFICAS
28. Morales-Uribe C, Ramírez A, Suarez-Poveda T, Ortiz M, Sanabria A. Diagnostic performance of CT angiography in neck vessel trauma: systematic review and meta-analysis. Emergency Radiology 2016 Oct;23(5):421-31. 29. Madsen AS, Kong VY, Oosthuizen GV, Bruce JL, Laing GL, Clarke DL. Computed tomography angiography is the definitive vascular imaging modality for penetrating neck injury: a South African experience.
6. Nason RW, Assuras GN, Gray PR, Lipschitz J, Burns CM. Penetrating neck injuries: analysis of experience from a Canadian trauma centre. Can J Surg 2001 Apr;44(2):122-6.
18. American College of Surgeons - Committee on Trauma. Advanced Life Trauma Support for Doctors (ATLS). 7th ed. 2007. 19. Feliciano DV, Burch JM, Mattox KL, Bitondo CG, Fields G. Balloon catheter tamponade in cardiovascular wounds. Am J Surg 1990 Dec;160(6):583-7.
22. Ginzburg E, Montalvo B, LeBlang S, Nunez D, Martin L. The use of duplex ultrasonography in penetrating neck trauma. Arch Surg 1996 Jul;131(7):691-3.
Scand J Surg 2018 Mar;107(1):23-30. 30. Miller PR, Fabian TC, Croce MA, Cagiannos C, Williams JS, Vang M, et al. Prospective screening for blunt cerebrovascular injuries: analysis of diagnostic modalities and outcomes. Ann Surg 2002 Sep;236(3):38693; discussion 393-5. 31. Aerts N, Gioscia J, Gudde H, Paiva H. Arteriografia retrógrada no diagnóstico de trauma vascular do segmento subclávio-axilar. Rev Angiol Cir Vasc 1988;4:23-5. 32. Aerts NR, Poli de Figueiredo LF, Burihan E. Emergency room retrograde transbrachial arteriography for the management of axillosubclavian vascular injuries. J Trauma 2003 Jul;55(1):69-73. 33. Sturm JT, Cicero JJ. The clinical diagnosis of ruptured subclavian artery following blunt thoracic trauma. Ann Emerg Med 1983 Jan;12(1):17-9. 34. Gonzalez RP, Falimirski ME. The role of angiography in periclavicular penetrating trauma. Am Surg 1999 Aug;65(8):711-13; discussion 714. 35. Thal ER, Snyder WH 3rd, Hays RJ, Perry MO. Management of carotid artery injuries. Surgery. 1974 Dec;76(6):955-62.
23. Rich NM. Management of venous trauma. Surg Clin North Am 1988 Aug;68(4):809-21.
27. Inaba K, Branco BC, Menaker J, Scalea TM, Crane S, DuBose JJ et al Evaluation of multidetector computed tomography for penetrating neck injury: a prospective multicenter study. J Trauma Acute Care Surg 2012 Mar;72(3):576-83; discussion 583-4; quiz 803-4.
TRAUMA DOS VASOS
15. Colombo F, Sansonna F, Baticci F, Boniardi M, Di Lernia S, Ferrari GC, et al. [Penetrating injuries of the neck: review of 16 operated cases]. Ann Ital Chir 2003 Apr;74(2):141-8.
36. Ramadan F, Rutledge R, Oller D, Howell P, Baker C, Keagy B. Carotid artery trauma: a review of contemporary trauma center experiences. J Vasc Surg 1995 Jan;21(1):46-55; discussion 55-6. 37. Lim LT, Saletta JD, Flanigan DP. Subclavian and innominate artery trauma. A five-year experience with 17 patients. Surgery 1979 Dec;86(6):890-7. 38. Thomas GI, Anderson KN, Hain RF, Merendino KA. The significance of anomalous vertebral-basilar artery communications in operations on the heart and great vessels: an illustrative case with review of the literature. Surgery 1959 Oct;46:747-57. Hawthorn IE, Rochester J, Beard JD. Treatment of combined brachial plexus and subclavian artery trauma. Injury 1993 Jul;24(6):377-9. 40. Fogelman MJ, Stewart RD. Penetrating wounds of the neck. Am J Surg 1956 Apr;91(4):581-93; discussion, 593-6. 41. Rao PM, Bhatti MF, Gaudino J, Ivatury RR, Agarwal N, Nallathambi MN et al. Penetrating injuries of the neck: criteria for exploration. J Trauma 1983 Jan;23(1):47-9. 42. Golueke PJ, Goldstein AS, Sclafani SJ, Mitchell WG, Shaftan GW. Routine versus selective exploration of penetrating neck injuries: a randomized prospective study. J Trauma 1984 Dec;24(12):1010-4. 43. Noyes LD, McSwain NE Jr, Markowitz IP. Panendoscopy with arteriography versus mandatory exploration of penetrating wounds of the neck. Ann Surg 1986 Jul;204(1):21-31.
20. Monson DO, Saletta JD, Freeark RJ. Carotid vertebral trauma. J Trauma 1969 Dec;9(12):987-99.
14. Bishara RA, Pasch AR, Douglas DD, Schuler JJ, Lim LT, Flanigan DP. The necessity of mandatory exploration of penetrating zone II neck injuries. Surgery 1986 Oct;100(4):655-60.
17. Mattox KL, Brundage SI, Hirschberg A. Traumatismo vascular. In: Sabiston - tratado de cirurgia. Guanabara Koogan; 2003. p. 1541-58.
24. Patterson BO, Holt PJ, Cleanthis M, Tai N, Carrell T, Loosemore TM. Imaging vascular trauma. Br J Surg 2012 Apr;99(4):494-505.
8. Laverick MD, D’Sa AA, Kirk SJ, Mollan RA. Management of blunt injuries of the axillary artery and the neck of the humerus: case report. J Trauma 1990 Mar;30(3):360-1. 9. Feliciano DV. Management of penetrating injuries to carotid artery. World J Surg 2001 Aug;25(8):1028-35.
CERVICAIS
7. Mattox KL, Feliciano DV, Burch J, Beall AC Jr, Jordan GL Jr, De Bakey ME. Five thousand seven hundred sixty cardiovascular injuries in 4459 patients. Epidemiologic evolution 1958 to 1987. Ann Surg 1989 Jun;209(6):698-705; discussion 706-7.
10. Inamasu J, Guiot BH. Vertebral artery injury after blunt cervical trauma: an update. Surg Neurol 2006 Mar;65(3):238-245; discussion 245-6. 11. Ristow AV, Cury Filho JM, Gress MHT, Peixoto CCS. Trauma das artérias carótidas e vertebrais. In: Trauma vascular. Rio de Janeiro: Revinter; 2006. p. 261-80.
331 170Capítulo
5. Perisse-Moreira RS, Ristow AV, Palazzo JC. Traumatismos vasculares das regiões cérvico-torácica e cervical. In: Urgências Vasculares Medsi; 1983. p. 76-100.
1. Friedman SG. História da cirurgia vascular. Rio de Janeiro: Revinter; 2005. 2. Demetríades D, Asensio JA, Velmahos G, Thal E. Problemas complexos no traumatismo cervical penetrante. In: Problemas Complexos e Desafiadores na Cirurgia Traumatológica. Interlivros; 1996. p. 663-86.
25. Eastman AL, Chason DP, Perez CL, McAnulty AL, Minei JP. Computed tomographic angiography for the diagnosis of blunt cervical vascular injury: is it ready for primetime? J Trauma 2006 May;60(5):925-9; discussion 929. 26. Mazolewski PJ, Curry JD, Browder T, Fildes J. Computed tomographic scan can be used for surgical decision making in zone II penetrating neck injuries. J Trauma 2001 Aug;51(2):315-9.
12. Hirschberg A, Hirschberg A. Traumatismo vascular. In: Haimovicicirurgia vascular. Rio de Janeiro: Revinter; 2006. p. 411-26.
3. Pearce WH, Whitehall TA. Lesões das artérias carótidas e vertebrais. In: Traumatismo Vascular. Rio de Janeiro: Interlivros; 1996. p. 735-54.
48. Meyer JP, Barrett JA, Schuler JJ, Flanigan DP. Mandatory vs selective exploration for penetrating neck trauma. A prospective assessment. Arch Surg 1987 May;122(5):592-7.
332 Parte XTRAUMA VASCULAR 44. Woo K, Magner DP, Wilson MT, Margulies DR. CT angiography in penetrating neck trauma reduces the need for operative neck exploration. Am Surg 2005 Sep;71(9):754-8. 45. McGovern PJ Jr, Swan KG. Management of bilateral internal jugular venous injuries. Injury 1985 Jan;16(4):259-60. 46. Ledgerwood AM, Mullins RJ, Lucas CE. Primary repair vs ligation for carotid artery injuries. Arch Surg 1980 Apr;115(4):488-93. 47. Kuehne JP, Weaver FA, Papanicolaou G, Yellin AE. Penetrating trauma of the internal carotid artery. Arch Surg 1996 Sep;131(9):942-7; discussion 947-8.
The management of arterial injuries caused by penetration of zone III of the neck. J Trauma 1985 Sep;25(9):871-81.
61. Ballard JL, Bunt TJ, Fitzpatrick B, Malone JM. Bilateral traumatic internal carotid artery dissections: case report. J Vasc Surg 1992 Feb;15(2):431-5.
59. Cogbill TH, Moore EE, Meissner M, Fischer RP, Hoyt DB, Morris JA et al. The spectrum of blunt injury to the carotid artery: a multicenter perspective. J Trauma 1994 Sep;37(3):473-9.
51. Teehan EP, Padberg FT Jr, Thompson PN, Lee BC, Silva M Jr, Jamil Z et al. Carotid arterial trauma: assessment with the Glasgow Coma Scale (GCS) as a guide to surgical management. Cardiovasc Surg 1997 Apr;5(2):196-200.
50. Pinto D, Bez L, Costa-Val E, Christo S, Miguel E. Tratamento do trauma penetrante das artérias carótidas no Hospital João XXIII. Comparação entre ligadura e reconstrução arterial. J Vasc Br 2004;3:247-52.
56. Fabian TC, Patton JH Jr, Croce MA, Minard G, Kudsk KA, Pritchard FE. Blunt carotid injury. Importance of early diagnosis and anticoagulant therapy. Ann Surg 1996 May;223(5):513-22; discussion 522-5.
63. George E, Khandelwal A, Potter C, Sodickson A, Mukundan S, Nunez D, et al. Blunt traumatic vascular injuries of the head and neck in the ED. Emerg Radiol 2018 Aug 10. 64. Scott WW, Sharp S, Figueroa SA, Eastman AL, Hatchette CV, Madden CJ et al. Clinical and radiographic outcomes following traumatic Grade 3 and 4 carotid artery injuries: a 10-year retrospective analysis from a Level 1 trauma center. The Parkland Carotid and Vertebral Artery Injury Survey. J Neurosurg 2015 Mar;610-5. 65. Brown MF, Graham JM, Feliciano DV, Mattox KL, Beall AC Jr, DeBakey ME. Carotid artery injuries. Am J Surg 1982 Dec;144(6):748-53. 66. Miller PR, Fabian TC, Bee TK, Timmons S, Chamsuddin A, Finkle R, et al. Blunt cerebrovascular injuries: diagnosis and treatment. J Trauma 2001 Aug;51(2):279-85; discussion 285-6. 67. Reid JD, Weigelt JA. Forty-three cases of vertebral artery trauma. J Trauma 1988 Jul;28(7):1007-12. 68. Maras D, Lioupis C, Magoufis G, Tsamopoulos N, Moulakakis K, Andrikopoulos V. Covered stent-graft treatment of traumatic internal carotid artery pseudoaneurysms: a review. Cardiovasc Intervent Radiol 2006 Dec;29(6):958-68. 69. DuBose J, Recinos G, Teixeira PGR, Inaba K, Demetriades D. Endovascular stenting for the treatment of traumatic internal carotid injuries: expanding experience. J Trauma 2008 Dec;65(6):1561-6. 70. DuBose JJ, Rajani R, Gilani R, Arthurs ZA, Morrison JJ, Clouse WD, et al. Endovascular management of axillo-subclavian arterial injury: a review of published experience. Injury 2012 Nov;43(11):1785-92. 71. Pikwer A, Acosta S, Kölbel T, Malina M, Sonesson B, Akeson J. Management of inadvertent arterial catheterisation associated with central venous access procedures. Eur J Vasc Endovasc Surg 2009 Dec;38(6):707-14. 72. Du Toit DF, Coolen D, Lambrechts A, de V Odendaal J, Warren BL. The endovascular management of penetrating carotid artery injuries: long-term follow-up. Eur J Vasc Endovasc Surg 2009 Sep;38(3):267-72. 73. Gray K, Beckord B, Moazzez A, Plurad D, Bowens N, Kim D. A comparative analysis of open versus endovascular techniques for management of non-aortic cervicothoracic arterial injuries. Am Surg 2017 Oct 1;83(10):1054-8.
62. Ringer AJ, Matern E, Parikh S, Levine NB. Screening for blunt cerebrovascular injury: selection criteria for use of angiography. J Neurosurg 2010 May;112(5):1146-9.
52. Symbas PN, Hatcher CR Jr, Vlasis SE. Esophageal gunshot injuries. Ann Surg 1980 Jun;191(6):703-7.
58. Davis JW, Holbrook TL, Hoyt DB, Mackersie RC, Field TO Jr, Shackford SR. Blunt carotid artery dissection: incidence, associated injuries, screening, and treatment. J Trauma 1990 Dec;30(12):1514-7.
60. Kerwin AJ, Bynoe RP, Murray J, Hudson ER, Close TP, Gifford RR, et al
49. Richardson R, Obeid FN, Richardson JD, Hoyt DB, Wisner DH, Gomez GA, et al. Neurologic consequences of cerebrovascular injury. J Trauma 1992 Jun;32(6):755-8; discussion 758-60.
54. Sclafani SJ, Panetta T, Goldstein AS, Phillips TF, Hotson G, Loh J, et al
57. Parikh AA, Luchette FA, Valente JF, Johnson RC, Anderson GL, Blebea J et al. Blunt carotid artery injuries. J Am Coll Surg 1997 Jul;185(1):80-6.
53. Glatterer MS Jr, Toon RS, Ellestad C, McFee AS, Rogers W, Mack JW et al. Management of blunt and penetrating external esophageal trauma. J Trauma 1985 Aug;25(8):784-92.
55. Hatzitheofilou C, Demetriades D, Melissas J, Stewart M, Franklin J. Surgical approaches to vertebral artery injuries. Br J Surg 1988 Mar;75(3):234-7.
Liberalized screening for blunt carotid and vertebral artery injuries is justified. J Trauma 2001 Aug;51(2):308-14.
2. Chen FH, Shim WH, Chang BC. False aneurysms at both ends of a descending thoracic aortic stent-graft: complication after endovascular repair of a penetrating atherosclerotic ulcer. J Endovasc Ther 2003;10:249-53.
41.
39. Brandt M, Hussel K, Walluscheck KP et al. Stent-graft repair versus open surgery for the descending aorta: a case-control study. J Endovasc Ther 2004;11:535-8. 40. Andrassy J, Weidenhagen R, Meimarakis G et al. Stent versus open surgery for acute and chronic traumatic injury of the thoracic aorta: a single-center experience. J Trauma 2006;60:765-71. Ott MC, Stewart TC, Lawlor DK et al. Management of blunt thoracic aortic injuries: endovascular stents versus open repair. J Trauma 2004;56:565-70. 42. Peterson BG, Matsumura JS, Morasch MD et al. Percutaneous endovascular repair of blunt thoracic aortic transection. J Trauma 2005;59:1062-5. 43. Hoornweg LL, Dinkelman MK, Goslings JC et al. Endovascular management of traumatic ruptures of the thoracic aorta: a retrospective multicenter analysis of 28 cases in The Netherlands. J Vasc Surg 2006;43:1096-102. 44. Borsa JJ, Hoffer EK, Karmy-Jones R et al. Angiographic description of blunt traumatic injuries to the thoracic aorta with specific relevance to endograft repair. J Endovasc Ther 2002;9(Suppl 2):II84-91.
12. Katyal D, McLellan BA, Brenneman FD et al. Lateral impact motor vehicle collisions: significant cause of blunt traumatic rupture of the thoracic aorta. J Trauma 1997;42:769-72.
19. Wong H, Gotway MB, Sasson AD et al. Periaortic hematoma at diaphragmatic crura at helical CT: sign of blunt aortic injury in patients with mediastinal hematoma. Radiology 2004;231:185-9.
9. Cohen AM, Crass JR, Thomas HA et al. CT evidence for the “osseous pinch” mechanism of traumatic aortic injury. AJR Am J Roentgenol 1992;159:271-74.
AORTA TORÁCICA REFERÊNCIAS
21. Dyer DS, Moore EE, Mestek MF et al. Can chest CT be used to exclude aortic injury? Radiology 1999;213:195-202.
15. Mirvis SE, Bidwell JK, Buddemeyer EU et al. Value of chest radiography in excluding traumatic aortic rupture. Radiology 1987;163:487-93.
13. Cook J, Salerno C, Krishnadasan B et al. The effect of changing presentation and management on the outcome of blunt rupture of the thoracic aorta. J Thorac Cardiovasc Surg 2006;131:594-600.
25. Saletta S, Lederman E, Fein S et al. Transesophageal echocardiography for the initial evaluation of the widened mediastinum in trauma patients. J Trauma 1995;39:137-42. 26. Hudson HM, Woodson J, Hirsch E. The management of traumatic aortic tear in the multiply-injured patient. Ann Vasc Surg 1991;5:445-8. 27. Hunt JP, Baker CC, Lentz CW et al. Thoracic aorta injuries: management and outcome of 144 patients. J Trauma 1996;40:547-55.
20. Mirvis SE, Shanmuganathan K, Buell J et al. Use of spiral computed tomography for the assessment of blunt trauma patients with potential aortic injury. J Trauma 1998;45:922-30.
10. Javadpour H, O’Toole JJ, McEniff JN et al. Traumatic aortic transection: evidence for the osseous pinch mechanism. Ann Thorac Surg 2002;73:951-53.
14. Fishman JE. Imaging of blunt aortic and great vessel trauma. J Thorac Imaging 2000;15:97-103.
5. Burkhart HM, Gomez GA, Jacobson LE et al. Fatal blunt aortic injuries: a review of 242 autopsy cases. J Trauma 2001;50:113-5.
16. Patel NH, Stephens Jr KE, Mirvis SE et al. Imaging of acute thoracic aortic injury due to blunt trauma: a review. Radiology 1998;209:335-48.
28. Karmy-Jones R, Jurkovich GJ. Blunt chest trauma. Curr Probl Surg 2004;41:211-380. 29. Karmy-Jones R, Carter YM, Nathens A et al. Impact of presenting physiology and associated injuries on outcome following traumatic rupture of the thoracic aorta. Am Surg 2001;67:61-6. 30. von Oppell UO, Dunne TT, De Groot MK et al. Traumatic aortic rupture: twenty-year metaanalysis of mortality and risk of paraplegia. Ann Thorac Surg 1994;58:585-93. 31. Akins CW, Buckley MJ, Daggett W et al. Acute traumatic disruption of the thoracic aorta: a ten-year experience. Ann Thorac Surg 1981;31:305-9. 32. Galli R, Pacini D, Di Bartolomeo R et al. Surgical indications and timing of repair of traumatic ruptures of the thoracic aorta. Ann Thorac Surg 1998;65:461-64. 33. Pate JW, Fabian TC, Walker W. Traumatic rupture of the aortic isthmus: an emergency? World J Surg 1995;19:119-26. Maggisano R, Nathens A, Alexandrova NA et al. Traumatic rupture of the thoracic aorta: should one always operate immediately? Ann Vasc Surg 1995;9:44-52. 35. Carter YM, Karmy-Jones R, Aldea GS. Delayed surgical management of a traumatic aortic arch injury. Ann Thorac Surg 2002;73:294-6. 36. Mattox KL, Wall Jr MJ. Historical review of blunt injury to the thoracic aorta. Chest Surg Clin N Am 2000;10:167-82.
34.
23. Bruckner BA, DiBardino DJ, Cumbie TC et al. Critical evaluation of chest computed tomography scans for blunt descending thoracic aortic injury. Ann Thorac Surg 2006;81:1339-46.
17. Cook AD, Klein JS, Rogers FB et al. Chest radiographs of limited utility in the diagnosis of blunt traumatic aortic laceration. J Trauma 2001;50:843-47.
333 171Capítulo
1. Tambyraja AL, Scollay JM, Beard D et al. Aortic trauma in Scotland – a population based study. Eur J Vasc Endovasc Surg 2006 Dec;32(6):686-89.
11. Blackmore CC, Zweibel A, Mann FA. Determining risk of traumatic aortic injury: how to optimize imaging strategy. AJR Am J Roentgenol 2000;174:343-7.
6. Balci AE, Kazez A, Eren S et al. Blunt thoracic trauma in children: review of 137 cases. Eur J Cardiothorac Surg 2004;26:387-92.
4. Fabian TC, Richardson JD, Croce MA et al. Prospective study of blunt aortic injury: multicenter trial of the American association for the surgery of trauma. J Trauma 1997;42:374-80.
37. Rousseau H, Soula P, Perreault P et al. Delayed treatment of traumatic rupture of the thoracic aorta with endoluminal covered stent. Circulation 1999;99:498-504. 38. Lachat ML, Pfammatter T, Witzke HJ et al. Endovascular repair with bifurcated stent-grafts under local anaesthesia to improve outcome of ruptured aortoiliac aneurysms. Eur J Vasc Endovasc Surg 2002;23:528-36.
22. Miller FB, Richardson JD, Thomas HA et al. Role of CT in diagnosis of major arterial injury after blunt thoracic trauma. Surgery 1989;106:596-603.
3. Smith RS, Chang FC. Traumatic rupture of the aorta: still a lethal injury. Am J Surg 1986;152:660-3.
18. Symbas PJ, Horsley WS, Symbas PN. Rupture of the ascending aorta caused by blunt trauma. Ann Thorac Surg 1998;66:113-7.
TRAUMA DE BIBLIOGRÁFICAS
45. Bortone AS, Schena S, D’Agostino D et al. Immediate versus delayed endovascular treatment of post-traumatic aortic pseudoaneurysms and type B dissections: retrospective analysis and premises to the upcoming European trial. Circulation 2002;106:1234-40.
8. Parmley LF, Mattingly TW, Manion WC et al. Nonpenetrating traumatic injury of the aorta. Circulation 1958;17:1086-101.
7. Feczko JD, Lynch L, Pless JE et al. An autopsy case review of 142 nonpenetrating (blunt) injuries of the aorta. J Trauma 1992;33:846-49.
24. Smith MD, Cassidy JM, Souther S et al. Transesophageal echocardiography in the diagnosis of traumatic rupture of the aorta. N Engl J Med 1995;332:356-62.
61. Neuhaser B, Czermak B, Jaschke W et al. Stent-graft repair for acute traumatic thoracic aortic rupture. Am Surg 2004;70:1039-44. 62. Uzieblo M, Sanchez LA, Rubin BG et al. Endovascular repair of traumatic descending thoracic aortic disruptions: should endovascular therapy become the gold standard? Vasc Endovascular Surg 2004;38:331-7.
64. Amabile P, Collart F, Gariboldi V et al. Surgical versus endovascular treatment of traumatic thoracic aortic rupture. J Vasc Surg 2004;40:873-9. 65. Dunham MB, Zygun D, Petrasek P et al. Endovascular stent grafts for acute aortic injury. J Trauma 2004;56:1173-8. 66. Melnitchouk S, Pfammatter T, Kadner A et al. Emergency stent-graft placement for hemorrhage control in acute thoracic aortic rupture. Eur J Cardiothorac Surg 2004;25:1032-8. 67. Rousseau H, Dambrin C, Marcheix B et al. Acute traumatic aortic rupture: a comparison of surgical and stent-graft repair. J Thorac Cardiovasc Surg 2005;129:1050-5. 68. Rabin J, DuBose J, Sliker CW, O’Connor JV, Scalea TM, Griffith BP. J Thorac Cardiovasc Surg 2014 Jan;147(1):143-9. 69. Klocker J, Koell A, Erlmeier M, Goebel G, Jaschke W, Fraedrich G. J Vasc Surg 2014 Jul;60(1):64-9. 70. Cavari Y, Ginzburg V, Szendro G, Leytzin A, Novik Farkash E, Lazar I. Isr Med Assoc J 2018 Jul;20(7):451-3. 71. Apodaka Diez A, Mikelarena Monteiro E, Gallardo Hoyos Y, Fonseca Legrand JL. Ann Vasc Surg 2018 Feb;47:281 72. Agostinelli A, Carino D, Borrello B, Marcato C, Volpi A, Gherli T, Nicolini F. Interact Cardiovasc Thorac Surg 2018 Jul 10. 73. Steuer J, Björck M, Sonesson B, Resch T, Dias N, Hultgren R, Tunesi R, Wanhainen A, Lachat M, Pfammatter T. Eur J Vasc Endovasc Surg 2015 Oct;50(4):460-5
57. Kato M, Yatsu S, Sato H et al. Endovascular stent-graft treatment for blunt aortic injury. Circ J 2004;68:553-7.
54. Daenen G, Maleux G, Daenens K et al. Thoracic aorta endoprosthesis: the final countdown for open surgery after traumatic aortic rupture. Ann Vasc Surg 2003;17:185-91.
52. Karmy-Jones R, Hoffer E, Meissner MH et al. Endovascular stent grafts and aortic rupture: a case series. J Trauma 2003;55:805-10.
63. Bortone AS, DeCillis E, D’Agostino D et al. Stent graft treatment of thoracic aortic disease. Surg Technol Int 2004;12:189-93.
55. Iannelli G, Piscione F, Di Tommaso L et al. Thoracic aortic emergencies: impact of endovascular surgery. Ann Thorac Surg 2004;77-591-6.
56. Wellons ED, Milner R, Solis M et al. Stent-graft repair of traumatic thoracic aortic disruptions. J Vasc Surg 2004;40:1095-100.
58. Scheinert D, Krankenberg H, Schmidt A et al. Endoluminal stent-graft placement for acute rupture of the descending thoracic aorta. Eur Heart J 2004;25:694-700. 59. Czermak BV, Fraedrich G, Perkmann R et al. Endovascular repair of thoracic aortic disease: what we have learned. Curr Probl Diagn Radiol 2004;33:269-82.
334 Parte XTRAUMA VASCULAR 46. Orend KH, Pamler R, Kapfer X et al. Endovascular repair of traumatic descending aortic transection. J Endovasc Ther 2002;9:573-78. 47. Thompson CS, Gaxotte VD, Rodriguez JA et al. Endoluminal stent grafting of the thoracic aorta: initial experience with the Gore Excluder. J Vasc Surg 2002;35:1163-70. 48. Fattori R, Napoli G, Lavato L et al. Indications for, timing of, and results of catheter-based treatment of traumatic injury to the aorta. AJR Am J Roentgenol 2002;179:603-9. 49. Lachat M, Pfammatter T, Witzke H et al. Acute traumatic aortic rupture: early stent-graft repair. Euro J Cardiothorac Surg 2002;21:959-63. 50. Czermak BV, Fraedrich G, Perkmann R et al. Endovascular repair of thoracic aortic disease: what we have learned.Curr Probl Diagn Radiol 2004;33:269-82. 51. Kasirajan K, Heffernan D, Langsfeld M. Acute thoracic aortic trauma: a comparison of endoluminal stent grafts with open repair and nonoperative management. Ann Vasc Surg 2003;17:589-95.
53. Marty-Ane CH, Berthet JP, Branchereau P et al. Endovascular repair for acute traumatic rupture of the thoracic aorta. Ann Thorac Surg 2003;75:1803-7.
60. Morishita K, Kurimoto Y, Kawaharada N et al. Descending thoracic aortic rupture role of endovascular stent-grafting. Ann Thorac Surg 2004;78:1630-4.
TRAUMA DOS VASOS ABDOMINAIS
BIBLIOGRAFIA Baker SP, O’Neill B, Haddon W, et al. The injury severity score: a method for describing patients with multiple injuries and evaluating emergency care. J Trauma 1974;14:187-96. Bricker DL, Morton JR, Okies JE, et al. Surgical management of injuries to the vena cava: changing patterns of injury and newer techniques of repair: J Trauma 1971;11:725-35 Burch JM, Feliciano DV, Mattox KL, Edelman M. Injuries of the inferior vena cava. Am J Surg 1988;156:548-52. Burch JM, Feliciano DV, Mattox KL. The atriocaval shunt. Facts and fiction. Ann Surg 1988;207:555-68. Champion HR, Sacco WJ, Carnazzo AJ: Trauma score. Crit Care Med 1981, Ciresi9:672-6.KF,Lim RC. Hepatic vein and retrohepatic vena caval injury. World J Surg Coimbra1990;14:472-7.R,AguidaHC, Soler W, Romani D, et al. Penetrating abdominal aortic injuries. Rev Col Bras Cir 1993;20:128-32. Coimbra R, Prado P A, Araujo L H, Candelária P A, Caffaro R A, Rasslan S: Factor related to mortality in inferior vein cava injuries. 5 year experience. Int Surg 1994;79:138-41 Coimbra R, Razuk A, Neser R, Rasslan S: Outcome from traumatic injury of the portal and superior mesenteric veins. Vasc Endovascular Coimbra2004;38:249-55R,SantosPE, Caffaro RA, Rasslan S, Rahal F: Inferior vena cava trauma: analysis of 36 cases. Rev Assoc Med Bras 1993:39:229-33 Coimbra R, Yang J, Hoyt DB: Injuries of the abdominal aorta and inferior vena cava in association with thoracolumbar fractures: a lethal combination. J Trauma 1996;41:533-5 Feliciano DV. Abdominal vascular injuries. Surg Clin N Am 1988;68:741-55. Frame SB, Timberlake GA, Rush DS, McSwain NE, et al. Penetrating injuries of the abdominal aorta. Am Surg 1990;56:651-4. Jackson MR, Olson DW, Beckett WC, Olsen SB, et al. Abdominal vascular trauma: a review of 106 injuries. Am Surg 1992;58:622-6. Kashuk JL, Moore EE, Millikan JS, Moore JB. Major abdominal vascular trauma. A unified approach. J Trauma 1982;22:672-9. Lopez-Viego MA, Snyder WH, Valentine RJ, Clagett GP. Penetrating abdominal aortic trauma: a report of 129 cases. J Vasc Surg 1992;16:332-6. Mattox KL, McCollum WB, Jordan GL Jr, et al. Management of upper abdominal vascular trauma. Am Surg Clin 1974;128:823-8. Mattox KL. Burch JM, Richardson R, et al. Retroperitoneal vascular injury. Surg Clin N Am 1990;70:635-53. Mattox KL, Burch JM, Richardson R, Martin RR. Retroperitoneal vascular injury. Surg Clin N Am 1990;70:635-653. Mattox KL, McCollum WB, Jordan GL, Beall AC, et al. Management of upper abdominal vascular trauma. Am J Surg 1974;128:823-8. Maull KI, Rozycki GS, Vinsant GO, Pedigo RE. Retroperitoneal injuries: Pitfalls in diagnosis and management. South Med J 1987;80:1111-5. McMillan RW, Landreneau MD, McCormick GM, McDonald JC. Major vascular injuries of the torso. South Med J 1992;85:375-7. Millikan JS, Moore EE. Critical factors in determining mortality from abdominal aortic trauma. Surg Gynecol Obstet 1985;160:313-6. Moore EE, Cogbill TH, Jurkovich GJ, McAninch JW, et al. Organ injury scaling III: chest wall, abdominal vascular, ureter, bladder, and urethra. J Trauma 1992;33:337-9. Mullins RJ, Huckfeldt R, Trunkey DD. Abdominal vascular injuries. Surg Clin N Am 1996;76:813-32. Razuk A, Coimbra R. Trauma de veia porta e veia mesentérica superior. In: Freire E, editor. Trauma, a doença dos séculos. São Paulo: Atheneu; 2001. p. 1713-18. Smith SRG. Traumatic retroperitoneal venous haemorrhage. Br J Surg Stewart1988;75:632-6.MT,Stone HH. Injuries of the inferior vena cava. Am Surg Stone1896;52:9-13.HH,Fabian TC, Turkleson ML. Wounds of the portal venous system. World J Surg 1982;6:335-41. Teruya TH, Bianchi C, Abou-Zamzam AM, Ballard JL. Endovascular treatment of a blunt abdominal aortic injury with a commercially available stent graft. Ann Vasc Surg 2005;19:474-8. Trunkey DD. Torso trauma. Curr Probl Surg 1987;24:209-65. Wiencek RG, Wilson RF. Abdominal venous injuries. J Trauma 1986;26:771-8. Wiencek RG, Wilson RF. Inferior vena cava injuries. The challenge continues. Am Surg 1988;54:423-8. Wiencek RG, Wilson RF. Injuries to the abdominal vascular system: How much does aggressive resuscitation and prelaparotomy really help? Surgery 1987;102:731-6.
335 172Capítulo
336 173Capítulo TRAUMA PÉLVICO REFERÊNCIAS BIBLIOGRÁFICAS
24. Degiannis E, Velmahos GC, Levy RD, Wouters S, Badicel TV, Saadia R. Penetrating injuries of the iliac arteries: a South African experience. Surgery 1996;119:146-50.
4. Pereira GJC, Ribeiro DE, et al. Epidemiology of pelvic ring fractures and injuries. Rev Bras Ortop 2017 Jun 1;52(3):260-9.
17. Coccolini F, et al. Pelvic trauma: WSES classification and guideline. World J Emerg Surg 2017;12:5.
11. Vrahas M, Hern TC, Diangelo D, et al. Ligamentous contributions to pelvic stability. Orthopedics 1995;18(3):271-4.
15.
2. Demetriades D, Karaiskakis M, Toutouzas K, Velmahos G, Chan L. Pelvic fractures: epidemiology and predictors of associated abdominal injuries and outcomes. J Am Coll Surg 2002;195:1-10.
18. Olson SA, Burgess A. Classification and initial management of patients with unstable pelvic ring injuries. Instr Course Lect 2005;54:383-93.
19. Burgess AR, Eastridge BJ, Young JWR, et al. Pelvic ring disruptions: effective classification system and treatment protocols. J Trauma 1990; 30:848-56.
8. Meredith L, Baldock M, et al. Motorcycle fuel tanks and pelvic fractures: a motorcycle fuel tank syndrome. Traffic Inj Prev 2016 Aug 17;17(6):644-9. 9. Rudloff MI, Triantafillou KM. Management of pelvic ring injuries in unstable patients. Orthop Clin N Am 2016;47:551-63. 10. Giannoudis PV, Pape HC. Damage control orthopaedics in unstable pelvic ring injuries. Inj Int J Care Inj 2004;35:671-7.
3. Starr AJ, Griffin DR, Reinert CM, et al. Pelvic ring disruptions: prediction of associated injuries, transfusion requirement, pelvic arteriography, complications, and mortality. J Orthop Trauma 2002;16:553-61.
20. Manson T, O’Toole RV, Whitney A, Duggan B, Sciadini M, Nascone J. Young–Burgess classification of pelvic ring fractures: does it predict mortality, transfusion requirements, and non-orthopaedic injuries? J Orthop Trauma 2010 Oct;24(10):603-9.
47.
21. Tile M. Acute pelvic fractures: I Causation and classification. J Am Acad Orthop Surg 1996;4:143-51. 22. O’Sullivan R, White T, Keating J. Major pelvic fractures –identification of patients at high risk. J Bone Joint Surg Br 2005;87-B:530-3. 23. Asensio JA, Petrone P, Roldan G, Kuncir E, Rowe VL, Chan L, et al. Analysis of 185 iliac vessel injuries: risk factors and predictors of outcome. Arch Surg 2003;138:1187-93.
5. Giannoudis PV, Grotz M, Tzioupis C, Dinopoulos H, Wells GE, Bouamra O, et al. Prevalence of pelvic fractures associated injuries, and mortality: the United Kingdom perspective. J Trauma 2007;63:875-83.
12. Burch JM, Richardson RJ, et al. Pentrating iliac vascular injuries: experience with 233 consecutive patients. J Trauma 1990;30:1450-9. 13. Hairstone JC, Ghoniem GM. Urinary tract injuries. Recognition and management. Clin Colon Rectal Surg 2003;16:27-37. 14. Fröber R. Surgical atlas. Surgical anatomy of the ureter. Department of Anatomy. Jena, Germany: Friedrich Schiller University; 2007. p. 949-65. Kudsk KA, Sheldon GF. Retroperitoneal hematoma. In: Blaisdell FWT, editor. Abdominal trauma. New York: Thieme-Stratton; 1982. p. 279-93. 16. Feliciano DV. Management of traumatic retroperitoneal hematoma. Ann Surg 1990;211(2):109-23.
1. Freitas CD, Garotti REJ, Nieto J, et al. There have been changes in the incidence and epidemiology of pelvic ring fractures in recent decades? Rev Bras Ortop 2013;48(6):475-81.
25. Mercer DW, Buckman RF, Sood R, et al. Anatomic considerations in penetrating gluteal wounds. Arch Surg 1992;127:407-10. 26. Ivatury RR, Rao PM, Nallathambi M, et al. Penetrating gluteal injuries. J Trauma 1982;22:706-9. 27. DiGiacomo JC, Schwab CW, Rotondo MF, et al. Gluteal gunshot wounds: who warrants exploration? J Trauma 1994;37:622-8. 28. Yang J, Gao JM, Hu P, Li CH, Zhao SH, Lin X. Application of damage control orthopedics in 41 patients with severe multiple injuries. Chin J Traumato. 2008;11:157-60. 29. White CE, Hsu JR, Holcomb JB. Haemodynamically unstable pelvic fractures. Injury 2009;40:1023-30. 30. Moreno C, Moore EE, Rosenberger A, Cleveland HC. Hemorrhage associated with major pelvic fracture: a multispecialty challenge. J Trauma 1986;26:987-94. 31. Hirshberg A, Walden R. Damage control for abdominal trauma. Surg Clin North Am 1997;77:813-20. 32. O’Sullivan R, White T, Keating J. Major pelvic fractures –identification of patients at high risk. J Bone Joint Surg Br 2005;87-B:530-3. 33. Cheek JM, Pope JC, et al, Diagnosis and management of major vascular injuries: A review of 200 operative cases. Am Surg 1975;41:755-760. 34. Duchesne JC, McSwain NE Jr, Cotton BA, et al. Damage control resuscitation: the new face of damage control. J Trauma 2010;69(4):976. 35. Holcomb JB, Jenkins D, Rhee P, et al. Damage control resuscitation: directly addressing the early coagulopathy of trauma. J Trauma 2007;62(2):307. 36. Hess JR, Brohi K, Dutton RP, et al. The coagulopathy of trauma: a review of mechanisms. J Trauma 2008;65(4):748. 37. Inaba K, Demetriades D. The nonoperative management of penetrating abdominal trauma. Adv Surg 2007;41:51-62. 38. Shaftan GW. Indications for operation in abdominal trauma. Am J Surg 1960;99:657-64. 39. Biffl Wl, Leppaniemi A. Management guidelines for penetrating abdominal trauma. World J Surg 2015;39:1373-8. 40. Brown CVR, Velmahos GC, Neville AL, et al. Haemodynamically “stable” patients with peritonitis after penetrating abdominal: identifying those who are bleeding. Arch Surg 2005;140:767-72. 41. Kouraklis G, Spirakos S, Glinavou A. Damage control surgery: an alternative approach for the management of critically injured patients. Surg Today 2002;32:195-202. 42. Stannard A, Eliason JL, Rasmussen TE. Resuscitative endovascular balloon occlusion of the aorta (REBOA) as an adjunct for hemorrhagic shock. J Trauma 2011;71:1869-72. 43. Gupta BK, Khaneja SC, Flores L, et al. The role of intra-aortic balloon occlusion in penetrating abdominal trauma. J Trauma 1989;29:861-5. 44. Klein SR, Saroyan RM, Baumgartner F, Bongard FS. Management strategy of vascular injuries associated with pelvic fractures. J Cardio Vasc Surg (Torino) 1992;33:349-57. 45. Salam AA, Stewart MT. New approach to wounds of the aortic bifurcation and inferior vena cava. Surgery 1985;98:105-8. 46. Ravikumar S, Stahl WM. Intraluminal balloon catheter occlusion for major vena cava injuries. J Trauma 1985;25(5):458-60. Buckman RF, Pathak AS, Badellino MM, Bradley KM. Injuries of the inferior vena cava. Surg Clin North Am 2001;81(6):1431-47. 48. Grieco JG, Perry Jr JF. Retroperitoneal hematoma following trauma: its clinical importance. J Trauma 1980;20(9):733-6.
6. Balogh Z, King KL, Mackay P, McDougall D, Mackenzie S, Evans JA, et al. The epidemiology of pelvic ring fractures: a population-based study. J Trauma 2007;63:1066-73. 7. Filho RMC, Parreira JG, et al. Pelvic fractures as a marker of injury severity in trauma patients. Rev Col Bras Cir 2011;38(5):310-5
75. Papathanasiou K, Tolikas A, Dovas D, et al. Ligation of internal iliac artery for severe obstetric and pelvic haemorrhage: 10 year experience with 11 cases in a university hospital. J Obstet Gynaecol 2008;28:183-4.
77. Yasumura K, Ikegami K, Kamohara T, Nohara Y. High incidence of ischemic necrosis of the gluteal muscle after transcatheter angiographic embolization for severe pelvic fracture. J Trauma 2005;58:985-90.
78. Coccolini F, et al. Pelvic trauma: WSES classification and guideline. W J Emergency Surg 2017;12:5. 79. Rommens PM. Pelvic ring injuries: a challenge for the trauma surgeon. Acta Chir Belg 1996;96:78-84. 80. O’Sullivan R, White T, Keating J. Major pelvic fractures – identification of patients at high risk. J Bone Joint Surg Br 2005;87-B:530-3. 81. Ramzy AI, Murphy D, Long W. The pelvic sheet wrap. Initial management of unstable fractures. JEMS 2003;28:68-78. 82. Bottlang M, Krieg JC. Introducing the pelvic sling: pelvic fracture stabilization made simple. JEMS 2003;28:84-93. 83. Houshian S, Larsern MS, Holm C. Missed injuries in a level I trauma center. J Trauma 2002;52:715-9. 84. Janjua KJ, Sugrue M, Deane SA. Prospective evaluation of early missed injuries and the role of tertary trauma survey. J Trauma 1998;44(6):1000-7. 85. Rothenberger DA, Fischer RP, Strate RG, Velasco R, Perry JF Jr. The mortality associated with pelvic fractures. Surgery 1978;84(3):356-61. 86. Tayal VS, Nielsen A, Jones AE, et al. Accuracy of trauma ultrasound in major pelvic injury. J Trauma 2006;61:1453-7. 87. Schurink GW, Bode PJ, van Luijt PA, van Vugt AB. The value of physical examination in the diagnosis of patients with blunt abdominal trauma: a retrospective study. Injury 1997;28:261-5. 88. Bode PJ, Niezen RA, van Vugt AB, Schipper J. Abdominal ultrasound as a reliable indicator for conclusive laparotomy in blunt abdominal trauma. J Trauma 1993;34:27-31. 89. Gonzalez RP, Fried PQ, Bukhalo M. The utility of clinical examination in screening for pelvic fractures in blunt trauma. J Am Coll Surg 2002;194:121-5. 90. Rozycki G: Abdominal ultrasonography in trauma. Surg Clin North Am 1995;75:175. 91. Davidson BS, Simmons GT, Williamson PR, et al. Pelvic fractures associated with open perineal wounds: a survivable injury. J Trauma 1993;35:36-9. 92. Ganz R, Krushell RJ, Jakob RP, Kuffer J. The antishock pelvic clamp. Clin Orthop Relat Res 1991;267:71-8. 93. Buckle R, Browner B. D., Morandi M. Emergency reduction for pelvic ring disruptions and control of associated hemorrhage using the pelvic stabilizer. Tech Orthop 1994;9(4):258-66. 94. Gonzalez RP, Fried PQ, Bukhalo M. the utility of clinical examination in screening for pelvic fractures in blunt trauma. J Am Coll Surg 2002;194:121-5. 95. Pehle B, Nast-Kolb D, Oberbeck R, Waydhas C, Ruchholtz S. Significance of physical examination and radiography of the pelvis during treatment in the shock emergency room. Unfallchirurg 2003; 106:642-8. 96. Young JWR, Burgess AR, Brumback RJ, Poka A. Pelvic fractures: value of plain radiography in early assessment and management. Radiology 1986;160:445-51. 97. Hilty MP, Behrendt I, Benneker LM, Martinolli L, Stoupis C, Buggy DJ, Zimmermann H, Exadaktylos AK. Pelvic radiography in ATLS algorithms: a diminishing role. World J Emerg Surg 2008; 3:11-5. 98. Falchi M, Rollandi GA. CT of pelvic fractures. Eur J Radiol 2004;50:96-105. 99. Sampson MA, Colquhoun KBM, Hennessy NLM. Computed tomography whole body imaging in multi-trauma: 7 year experience. Clin Radiol 2006;61:365-9. 100. Geusens E, Brys P, Maleux G, Janzing H. Imaging in pelvic trauma. JBR-BTR 2000;83:173-80. 101. Balbachevsky D, Belloti JC, Doca DG, et al. Treatment of pelvic fractures - a national survey. Injury 2014;45 Suppl 5:S46-51. 102. Enninghorst N, Toth L, King KL, McDougall D, Mackenzie S, Balogh ZJ. Acute definitive internal fixation of pelvic ring fractures in polytrauma patients: a feasible option. J Trauma 2010;68:935-41. 103. Schreiber VM, Tarkin IS, Hildebrand F, et al. The timing of definitive fixation for major fractures in polytrauma - a matched-pair comparison between a US and European level I centres: analysis of current fracture management practice in polytrauma. Injury 2011;42:650-4. 104. Vallier HA, Cureton BA, Ekstein C, Oldenburg FP, Wilber JH. Early definitive stabilization of unstable pelvis and acetabulum fractures reduces morbidity. J Trauma 2010;69:677-84. 105. Vallier HA, Moore TA, Como JJ, et al. Complications are reduced with a protocol to standardize timing of fixation based on response to resuscitation. J Orthop Surg Res 2015;10:155. 106. Moss MC, Bircher MD. Volume changes within the true pelvis during disruption of the pelvic ring - where does the haemorrhage go? Injury 1996;27(Suppl. 1):S-A21-3.
57. Haan J, Rodriguez A, Chiu W, Boswell S, Scott J, Scalea T. Operative management and outcome of iliac vessel injury: a ten-year experience. Am Surg 2003;69:581-6. 58. Mattox KL, Rea J, Ennix CL, Beall AC Jr, Debakey ME. Penetrating injuries to the iliac arteries. Am J Surg 1978;136:663-667.
62. Landreneau RJ, Mitchum P, Fry WJ. Iliac artery transposition. Arch Surg 1989;124:978-81.
67.
50. Carrillo EH, Spain DA, Wilson MA, Miller FB, Richardson JD. Alternatives in the management of penetrating injuries to the iliac vessels. J Trauma 1998;44:1024-30.
72.
63. Landercasper RJ, Lewis DM, Snyder WH. Complex iliac arterial trauma: Autologous or prosthetic vascular. Surgery 1993;114:9-12. 64. Feliciano DV, Mattox KL, Graham JM, Bitondo CG. Five year experience with PTFE grafts in vascular wounds. J Trauma 1985;25:71. Onal B, Ilgit ET, Kosar S, Akkan K, Gumus T, Akpek S. Endovascular treatment of peripheral vascular lesions with stent-grafts. Diagn Interv Radiol 2005;11:170-4. Wilson RF, Wiencek RG, Balog M. Factors affecting mortality rate with iliac vein injuries. J Trauma 1985;25:71. Nitecki SS, Karram T, Hoffman A, Bass A. Venous trauma in the Lebanon War 2006. Interact Cardiovasc Thorac Surg 2007;6:647-50. 68. Mullins RJ, Lucas CE, Ledgerwood AM. The natural history following venous ligation for civilian injuries. J Trauma 1980;20:737-43. Peter JP, Paul BH, Edwin PT, et al. Outcome of complex venous reconstructions in patients with trauma. J Vasc Surg 1997;25:398-404. 70. Thomas JH, Pierce GE, Iliopoulos JI, Hermreck AS. Vascular graft selection. Surg Clin North Am 1988;68(4):865-74. Gallo D. Complex venous reconstruction: the use of a spiral vein graft at a combat support hospital. J Trauma 2009;67:170-2. Norman E, Mcswain JR. Cinemática do trauma. In: Mattox KL, Feliciano DV, Moore EE. Trauma. 4. ed. São Paulo: Revinter; 2005. p. 127-51. 73. Ordog GJ, Wasserberger J, Balasubramaniam S. Shotgun wound ballistics. J Trauma 1988;28:624-31. 74. Feliciano DV, Accola KD, Burch JM, Patrinely VS. Extraanatomic bypass for peripheral arterial injuries. Am J Surg 1989;158:506-10.
54. Eger M, Golcman L, Goldstein A, et al. The use of a temporary shunt in the management of arterial vascular injuries. Surg Gynecol Obstet 1971;132(1):67. 55. Rasmussen TE, Clouse WD, Jenkins DH, et al. The use of temporary vascular shunts as a damage control adjunct in the management of wartime vascular injury. J Trauma 2006;61(1):8.
56. Taller J, Kamdar JP, Greene JA, et al. Temporary vascular shunts as initial treatment of proximal extremity vascular injuries during combat operations: the new standard of care at Echelon II facilities? J Trauma 2008;65(3):595.
59. Nicholas JM, Rix EP, Easley KA, Feliciano DV, et al. Changing patterns in the management of penetrating abdominal trauma: the more things change, the more they stay the same. J Trauma 2003;55(6):1095-108.
66.
52. Dawson DL, Putnam AT, Light JT, et al. Temporary arterial shunts to maintain limb perfusion after arterial injury: an animal study. J Trauma 1999;47:64-71. 53. Johansen K, Bandyk D, Thiele B, Hansen Jr ST. Temporary intraluminal shunts: resolution of a management dilemma in complex vascular injuries. J Trauma 1982;22:395-402.
337Capítulo 173 tr AumA PélviCo
49. Sultan J, Bilal BB, Kiran H, Bilal HB, Yusuf A. Management of retroperitoneal haematoma. Professional Med J 2005;12:230-6.
60. Ball CG, Feliciano DV. Damage control techniques for common and external iliac artery injuries: have temporary intravascular shunts replaced the need for ligation? J Trauma 2010;68:1117-20.
61. Landercasper RJ, Lewis DM, Snyder WH. Complex iliac arterial trauma: Autologous or prosthetic vascular. Surgery 1993;114:9-12.
65.
51. Subramanian A, Vercruysse GA, Dente CJ, Wyrzykowski A, King E, Feliciano DV. A decade’s experience with temporary intravascular shunts at a civilian level 1 trauma center. J Trauma 2008;65:316-24.
69.
71.
76. Patterson FP, Morton KS. The cause of death in fractures of the pelvis: with a note on treatment by ligation of the hypogastric (internal iliac) artery. J Trauma 1973;13:849-56.
111. Kellam J. The role of external fixation in pelvic disruptions. Clin Orthop 1989;241:66-82.
115. Kennedy F, Cornwell EE, Lockett C, Demetriades D. Blunt injury to the left common iliac artery. Am Surg 1995;61(4):360-362.
114. Riemer BL, Butterfield SL, Diamond DL, et al. Acute mortality associated with injuries to the pelvic ring: the role of early patient mobilisation and external fixation. J Trauma 1993;35:671-5.
122. Baylis SM, Lansing EH, Glas WW. Traumatic retroperitoneal hematoma. Am J Surg 1962;103:477-80. 123. Holting T, Buhr H, Richter G, et al. Diagnosis and treatment of retroperitoneal hematoma in multiple trauma patients. Arch Orthop Trauma Surg 1992;111:323-6. Dubose J, Inaba K, Barmparas G, Teixeira PG, Schnuriger B, Talving P, et al. Bilateral internal iliac artery ligation as a damage control approach in massive retroperitoneal bleeding after pelvic fracture. J Trauma 2010;69:1507-14. 125. Finan MA, Fiorica JV, Hoffman MS, et al. Massive pelvic hemorrhage during gynecologic cancer surgery: ‘‘pack and go back’’. Gynecol Oncol 1996;62:390-5.
128. Lustenberger T, Wutzler S, Störmann P, Laurer H, Marzi I. The role of angio-embolization in the acute treatment concept of severe pelvic ring injuries. Injury 2015;46:S33-S38.
131. Papakostidis C, Kanakaris N, Dimitriou R, Giannoudis PV. The role of arterial embolization in controlling pelvic fracture haemorrhage: a systematic review of the literature. Eur Radiol 2011.
112. Lindahl J, Hirvensalo E, Bostman O, et al. Failure of reduction with an external fixator in the management of injuries of the pelvic ring. Long-term evaluation of 110 patients. J Bone Joint Surg Br 1999;81:955-62.
138. Hagiwara A, Minakawa K, Fukushima H, Murata A, Masuda H, Shimazaki S. Predictors of death in patients with life-threatening pelvic hemorrhage after successful transcatheter arterial embolization. J Trauma 2003;55:696-703. 139. Travis T, Monsky WL, London J, et al. Evaluation of short-term and long-term complications after emergent internal iliac artery embolization in patients with pelvic trauma. J Vasc Interv Radiol 2008;19:840-7. 140. Yasumura K, Ikegami K, Kamohara T, Nohara Y. High incidence of ischemic necrosis of the gluteal muscle after transcatheter angiographic embolization for severe pelvic fracture. J Trauma 2005;58:985-90.
118. Ghanayem AJ, Wilber JH, Lieberman JM, Motta AO. The effect of laparotomy and external fixator stabilization on pelvic volume in an unstable pelvic injury. J Trauma 1995;38:396-400; discussion 400-401.
135. Kushimoto S, Arai M, Aiboshi J, et al. The role of interventional radiology in patients requiring damage control laparotomy. J Trauma 2003;54:171-6. 136. Salim A, Teixeira PG, DuBose J, et al. Predictors of positive angiography in pelvic fractures: a prospective study. J Am Coll Surg 2008;207:656-62. 137. Frevert S, Dahl B, Lonn L. Update on the roles of angiography and embolisation in pelvic fracture. Injury 2008;39:1290-4.
143. Bach A, Bendix J, Hougaard K, Christensen EF. Retroperitoneal packing as part of damage control surgery in a Danish trauma center-fast, effective, and cost-effective. Scand J Trauma Resusc Emerg Med 2008;16:4.
127. Osborn PM, Smith WR, Moore EE, et al. Direct retroperitoneal pelvic packing versus pelvic angiography: a comparison of two management protocols for haemodynamically unstable pelvic fractures. Injury 2009;40:54-60.
338 Parte XTRAUMA VASCULAR
126. Saueracker AJ, McCroskey BJ, Moore EE, et al. Intra-operative hypogastric artery embolization for life threatening pelvic hemorrhage: a preliminary report. J Trauma 1987;27:1127.
146. Pohlmann T, Gansslen A, Bosch U, Tscherne H. The technique of packing for control of hemorrhage in complex pelvis fractures. Tech Orthop 1995;9:267-70. 147. Tai DK, Li WH, Lee KY, Cheng M, Lee KB, Tang LF, et al. Retroperitoneal pelvic packing in the management of hemodynamically unstable pelvic fractures: a level I trauma center experience. J Trauma 2011;71:E79-86. 148. Cothren CC, Osborn PM, Moore EE, Morgan SJ, Johnson JL, Smith WR. Preperitonal pelvic packing for hemodynamically unstable pelvic fractures: a paradigm shift. J Trauma 2007;62:834-9. discussion 9-42. 149. Sternbergh WC, Conners MS, Ojeda MA, Money SR. Acute bilateral iliac artery occlusion secondary to blunt trauma: successful endovascular treatment. J Vasc Surg 2003;38:589-92.
141. Ramirez JI, Velmahos GC, Best CR, Chan LS, Demetriades D. Male sexual function after bilateral internal iliac artery embolization for pelvic fracture. J Trauma 2004;56:734-9; discussion 739-41.
110. Ganz R, Krushell R, Jakob R, et al. The antishock pelvic clamp. Clin Orthop 1991;267:71-8.
116. Lyden SP, Srivastava SD, Waldman DL, Green RM. Common iliac artery dissection after blunt trauma: case report of endovascular repair and literature review. J Trauma 2001;50(2):339-42.
130. Suzuki T, Smith WR, Moore EE. Pelvic packing or angiography: competitive or complementary? Injury 2009;40:343-53.
121. Templeman DC, Simpson T, Matta JM. Surgical management of pelvic ring injuries. Instr Course Lect 2005;54:395-400.
129. Osborn PM, Smith WR, Moore EE, et al. Direct retroperitoneal pelvic packing versus pelvic angiography: a comparison of two management protocols for haemodynamically unstable pelvic fractures. Injury 2009;40:54-60.
119. Yang J, Gao JM, Hu P, Li CH, Zhao SH, Lin X. Application of damage control orthopedics in 41 patients with severe multiple injuries. Chin J Traumatol 2008;11:157-60. 120. Ruatti S, Guillot S, Brun J, et al. Which pelvic ring fractures are potentially lethal? Injury 2015;46(6):1059-63.
142. Osborn PM, Smith WR, Moore EE, Cothren CC, Morgan SJ, Williams AE, et al. Direct retroperitoneal pelvic packing versus pelvic angiography: a comparison of two management protocols for haemodynamically unstable pelvic fractures. Injury 2009;40:54-60.
109. Beard J, Davidson C. Pelvic injuries associated with traumatic abduction of the leg. Injury 1988;19:353-6.
113. Poka A, Libby E. Indications and techniques for external fixation of the pelvis. Clin Orthop 1996;329:54-9.
107. Baque P, Trojani C, Delotte J, et al. Anatomical consequences of ‘‘open-book’’ pelvic ring disruption: a cadaver experimental study. Surg Radiol Anat 2005;27:487-90.
108. Ertel W, Keel M, Eid K, Platz A, Trentz O. Control of severe hemorrhage using C-clamp and pelvic packing in multiply injured patients with pelvic ring disruption. J Orthop Trauma 2001;15:468-474.
117. Klein SR, Saroyan RM, Baumgartner F, Bongard FS. Management strategy of vascular injuries associated with pelvic fractures. J Cardio Vasc Surg (Torino) 1992;33:349-57.
132. Perez JV, Hughes TM, Bowers K. Angiographic embolization in pelvic fracture. Injury 1998;29:187-91.
144. Smith WR, Moore EE, Osborn P, et al. Retroperitoneal packing as a resuscitation technique for hemodynamically unstable patients with pelvic fractures: report of two representative cases and a description of technique. J Trauma 2005;59:1510-4. 145. Totterman A, Madsen JE, Skaga NO, Roise O. Extraperitoneal pelvic packing: a salvage procedure to control massive traumatic pelvic hemorrhage. J Trauma 2007;62:843-52.
124.
133. AbuRahma AF, Robinson PA, Boland JP, et al. Complications of arteriography in a recent series of 707 cases: Factors affecting outcome. Ann Vasc Surg 1993;7:122-9. 134. Matalon TS, Athanasoulis CA, Margolies MN, et al. Hemorrhage with pelvic fractures: efficacy of transcatheter embolization. AJR 1979;133:859-64.
11. de Luccia N, Albers MT, Wolosker M. Aneurisma de arteria axilar pelo uso de muleta. Rev Paul Med 1979;94(3-4):87-9.
22. Ganapathy A, Khouqeer AF, Todd SR, Mills JL, Gilani R. Endovascular management for peripheral arterial trauma: The new norm? Injury 2017;48(5):1025-30.
26. Rich NM, Hughes CW, Baugh JH. Management of venous injuries. Ann Surg. 1970;171(5):724-30.
4. Lebowitz C, Matzon JL. Arterial injury in the upper extremity: evaluation, strategies, and anticoagulation management. Hand Clin 2018;34(1):85-95.
TRAUMA BIBLIOGRÁFICAS
10. Frech A, Pellegrini L, Fraedrich G, Goebel G, Klocker J. Long-term clinical outcome and functional status after arterial reconstruction in upper extremity injury. Eur J Vasc Endovasc Surg 2016;52(1):119-23.
17. Gregory RT, Gould RJ, Peclet M, Wagner JS, Gilbert DA, Wheeler JR, et al. The mangled extremity syndrome (M.E.S.): a severity grading system for multisystem injury of the extremity. J Trauma 1985;25(12):1147-50.
19. Durham RM, Mistry BM, Mazuski JE, Shapiro M, Jacobs D. Outcome and utility of scoring systems in the management of the mangled extremity. Am J Surg 1996;172(5):569-73; discussion 573-64. 20. Mavrogenis AF, Kokkalis ZT, Koulouvaris P, Megaloikonomos PD, Igoumenou V, et al. Vascular injury in orthopedic trauma. Orthopedics 2016;39(4):249-59.
3. Rozycki GS, Tremblay LN, Feliciano DV, McClelland WB. Blunt vascular trauma in the extremity: diagnosis, management, and outcome. J Trauma 2003;55(5):814-24.
18. Burkhardt GE, Cox M, Clouse WD, Porras C, Gifford SM, Williams K, et al. Outcomes of selective tibial artery repair following combat-related extremity injury. J Vasc Surg 2010;52(1):91-6.
24. Chopra A, Modrall JG, Knowles M, Phelan HA, Valentine RJ, Chung J. Uncertain patency of covered stents placed for traumatic axillosubclavian artery injury. J Am Coll Surg 2016;223(1):174-83.
5. Feliciano DV, Moore FA, Moore EE, West MA, Davis JW, Cocanour CS, et al. Evaluation and management of peripheral vascular injury. Part 1. Western Trauma Association/critical decisions in trauma. J Trauma 2011;70(6):1551-6.
7. Baker AC, Clouse WD. Lesões da extremidade superior e da zona de junção. In: Rassmussen TE. Rich trauma vascular. 3. ed. Elsevier; 2017. p. 149-67. 8. White JM, Stannard A, Burkhardt GE, Eastridge BJ, Blackbourne LH, Rasmussen TE. The epidemiology of vascular injury in the wars in Iraq and Afghanistan. Ann Surg 2011;253(6):1184-9.
21. Johnson BA, Carmack D, Neary M, Tenuta J, Chen J. Operation Iraqi freedom: the Landstuhl Regional Medical Center experience. J Foot Ankle Surg 2005;44(3):177-83.
9. Wahlgren CM, Riddez L. Penetrating vascular trauma of the upper and lower limbs. Current Trauma Reports 2016;2(1):11-20.
1. Perkins ZB, De’Ath HD, Aylwin C, Brohi K, Walsh M, Tai NR. Epidemiology and outcome of vascular trauma at a British Major Trauma Centre. Eur J Vasc Endovasc Surg 2012;44(2):203-9.
13. Scott AR, Gilani R, Tapia NM, Mattox KL, Wall MJ, Suliburk JW. Endovascular management of traumatic peripheral arterial injuries. J Surg Res 2015;199(2):557-63.
16. Johansen K, Daines M, Howey T, Helfet D, Hansen ST. Objective criteria accurately predict amputation following lower extremity trauma. J Trauma 1990;30(5):568-572; discussion 572-63.
23. DuBose JJ, Rajani R, Gilani R, Arthurs ZA, Morrison JJ, Clouse WD, et al. Endovascular management of axillo-subclavian arterial injury: a review of published experience. Injury 2012;43(11):1785-92.
2. Kauvar DS, Wade CE. The epidemiology and modern management of traumatic hemorrhage: US and international perspectives. Crit Care 2005;9(Suppl 5):S1-9.
12. Feliciano DV, Moore EE, West MA, Moore FA, Davis JW, Cocanour CS, et al. Western trauma association critical decisions in trauma: evaluation and management of peripheral vascular injury, part II. J Trauma Acute Care Surg 2013;75(3):391-7.
6. Fox N, Rajani RR, Bokhari F, Chiu WC, Kerwin A, Seamon MJ, et al Evaluation and management of penetrating lower extremity arterial trauma: an Eastern Association for the Surgery of Trauma practice management guideline. J Trauma Acute Care Surg 2012;73(5 Suppl 4):S315-20.
27. Gelberman RH, Nunley JA, Koman LA, Gould JS, Hergenroeder PT, MacClean CR, et al. The results of radial and ulnar arterial repair in the forearm. Experience in three medical centers. J Bone Joint Surg Am 1982;64(3):383-7.
28. Franz RW, Goodwin RB, Hartman JF, Wright ML. Management of upper extremity arterial injuries at an urban level I trauma center. Ann Vasc Surg 2009;23(1):8-16. 29. Conrad MH, Adams WP. Pharmacologic optimization of microsurgery in the new millennium. Plast Reconstr Surg 2001;108(7):2088-96. 30. Atteberry LR, Dennis JW, Russo-Alesi F, Menawat SS, Lenz BJ, Frykberg ER. Changing patterns of arterial injuries associated with fractures and dislocations. J Am Coll Surg 1996;183(4):377-83. 31. Pasquale MD, Frykberg ER, Tinkoff GH. ACS Committee on Trauma; Ad Hoc Committee on Outcomes. Management of complex extremity trauma. Bull Am Coll Surg 2006;91(6):36-8. 32. Hughes CW. Arterial repair during the Korean war. Ann Surg 1958;147(4):555-61. 33. Rich NM, Baugh JH, Hughes CW. Acute arterial injuries in Vietnam: 1,000 cases. J Trauma 1970;10(5):359-69.
339 174Capítulo
14. Swan KG, Wright DS, Barbagiovanni SS, Swan BC. Tourniquets revisited. J Trauma 2009;66(3):672-5.
15. Miranda FE, Dennis JW, Veldenz HC, Dovgan PS, Frykberg ER. Confirmation of the safety and accuracy of physical examination in the evaluation of knee dislocation for injury of the popliteal artery: a prospective study. J Trauma 2002;52(2):247-251; discussion 251-42.
25. Gifford SM, Aidinian G, Clouse WD, Fox CJ, Porras CA, Jones WT, et al. Effect of temporary shunting on extremity vascular injury: an outcome analysis from the Global War on Terror vascular injury initiative. J Vasc Surg 2009;50(3):549-55.
DOS VASOS DOS MEMBROS SUPERIORES REFERÊNCIAS
2. Tai NRM, Rasmussen TE. Epidmeiologia da lesão vascular. In Rich trauma vascular. 3. ed. Elsevier; 2017. p. 13-20.
40. Shah DM, Leather RP, Corson JD, Karmody AM. Polytetrafluoroethylene grafts in the rapid reconstruction of acute contaminated peripheral vascular injuries. Am J Surg 1984 Aug;148(2):229-33.
41. Rush M, Arrington DE, Hsu RJ. Recent advances and future directions in trauma care management of complex extremity injuries. Surg Clin North Am 2012 Aug 1;92(4):987-1007.
6. Tobin SA, Gurry JF, Doyle JC, et al. Vascular trauma at a university teaching hospital. Aust N Z J Surg 1988 Nov;58(11):873-7.
3. Kauvar DS, Sarfati MR, Kraiss LW. National trauma databank analysis of mortality and limb loss in isolated lower extremity vascular trauma. J Vasc Surg 2011. 4. Rossi M, Rina P. Implicações do trauma vascular no Brasil. In Rich trauma vascular. 3. ed. Rio de Janeiro: Elsevier; 2017. p 333-7.
37. Schwartz MR, Weaver FA, Bauer M, et al. Refining the indications for arteriography in penetrating extremity trauma: a prospective analysis. J Vasc Surg 1993 Jan;17(1):116-22; discussion 122-4.
340 175Capítulo TRAUMA DOS VASOS DOS MEMBROS INFERIORES
11. Mattox KL, Feliciano DV, Burch J, et al. Five thousand seven hundred sixty cardiovascular injuries in 4459 patients. Epidemiologic evolution 1958 to 1987. Ann Surg 1989 Jun;209(6):698-705; discussion 706-7.
36. Frykberg E, Crump J, Vines F, et al. A reassessment of the role of arteriography in penetrating proximity extremity trauma: a prospective study. J Trauma 1989;29:1041-50.
12. Rich NM, Baugh JH, Hughes CW. Acute arterial injuries in Vietnam: 1,000 cases. J Trauma 1970 May;10(5):359-69.
13. White JM, Stannard A, Burkhardt GE, Eastridge BJ, Blackbourne LH, Rasmussen TE. The epidemiology of vascular injury in the wars in Iraq and Afghanistan. Ann Surg 2011 Jun;253(6):1184-9.
39. Vertrees A, Fox CJ, Quan RW, Cox MW, Adams ED, Gillespie DL. The use of prosthetic grafts in complex military vascular trauma: a limb salvage strategy for patients with severely limited autologous conduit. J Trauma 2009 Apr;66(4):980-3.
19. Kumar NG, Brian S. Knipp BS, Gillespie D. Trauma vascular na extremidade inferior. In Rasmussen TE, Tai NRN. Rich. Trauma Vascular. 3. ed. Elsevier; 2017. 20. Haddock TN, Weichman EK, Reformat DD, Kligman EB, Levine PJ, Saadeh BP. Lower extremity arterial injury patterns and reconstructive outcomes in patients with severe lower extremity trauma: a 26-year review. J Am Coll Surg 2010 Jan 1;210(1):66-72.
42. Feliciano DV, Herskowitz K, O’Gorman RB, Cruse PA, Brandt ML, Burch JM, et al. Management of vascular injuries in the lower extremities. J Trauma 1988 Mar;28(3):319-28.
22. Franz RW, Shah KJ, Halaharvi D, et al. A 5-year review of management of lower extremity arterial injuries at an urban level I trauma center. J Vasc Surg 2011;53:1604-10.
17. Sherif AA. Vascular injuries: experience during the Afghanistan War. NT Surg 1992 Apr-Jun;77(2):114-7.
BIBLIOGRAFIA
8. Perkins ZB, De’Ath HD, Aylwin C, Brohi K, Walsh M, Tai NRM. Epidemiology and outcome of vascular trauma at a british major trauma centre. What this paper adds. Eur J Vasc Endovasc Surg 2012 Aug 1;44(2):203-9. 9. Feliciano DV. Vascular trauma revisited. J Am Coll Surg 2018 Jan;216(1):1-13. 10. DeBakey ME, Simeone FA. Battle injuries of the arteries in World War II: an analysis of 2,471 cases. Ann Surg 1946;123:534.
7. Kauvar DS, Mark R. Sarfati MR, Kraiss LW. National trauma databank analysis of mortality and limb loss in isolated lower extremity vascular trauma. J Vasc Surg 2011 Jun;53(6):1598-603.
21. Barmparas G, Inaba K, Talving P, David JS, Lam L, Plurad D, Green D, Demetriades D. Pediatric vs adult vascular trauma: a National Trauma Databank review. J Pediatr Surg 2010 Jul;45(7):1404-12.
16. Razmadze A. Vascular injuries of the limbs: a fifteen-year Georgian experience. Eur J Vasc Endovasc Surg 1999 Sep;18(3):235-9.
14. Stannard A, Morrison JJ, Scott DJ, Ivatury RA, Ross JD, Rasmussen TE. The epidemiology of noncompressible torso hemorrhage in the wars in Iraq and Afghanistan. J Trauma Acute Care Surg 2013;74:830-4.
34. Inaba K, Branco BC, Reddy S, Park JJ, Green D, Plurad D, et al Prospective evaluation of multidetector computed tomography for extremity vascular trauma. J Trauma 2011 Apr;70(4);808-15. 35. Hellinger JC, Epelman M, Rubin GD. CT angiography upper extremity computed tomographic angiography: state of the art technique and applications in 2010. Radiol Clin North Am 2010 Mar1;48(2):397-421.
1. Williams TK, Fox C, Rasmussen T. Epidemiology and natural history of vascular trauma. In Rutherford´s vascular surgery and endovascular therapy. 9th ed. Elsevier; 2019. cap 180, p. 2350-64.
18. Rich NM, Leppaniemi A. Vascular trauma: a 40-year experience with extremity vascular emphasis. Scand J Surg 2002;91(1):109-26.
23. Caps MT. The epidemiology of vascular trauma. Semin Vasc Surg 1998 Dec;11(4):227-31. 24. Britt LD, Weireter LJ, Cole FJ. Newer diagnostic modalities for vascular injuries: the way we were, the way we are. Surg Clin North Am 2001 Dec. 25. Dawson DL. Imagens para avaliação e tratamento de trauma vascular. In Rich’s Vascular Trauma, editores. 3. ed. Rio de Janeiro: Elsevier; 2017. p. 44-55. 26. Frykberg ER, Crump JM, Dennis JW, Vines FS, Alexander RH. Nonoperative observation of clinically occult arterial injuries: a prospective evaluation. Surgery 1991 Jan;109(1):85-96. 27. Rozycki GS, et al. Blunt vascular trauma in the extremity: diagnosis, management, and outcome. J Trauma 2003; 55: 814-24. 28. Modrall JG, Weaver FA, Yellin AE. Diagnosis and management of penetrating vascular trauma and the injured extremity. Emerg Med Clin North Am 1998 Feb;16(1):129-44. 29. DB Yellen AE, Weaver FA. Trauma vascular. In: Dean R, editores. Diagnóstico vascular e tratamento. Norwalk, CT Appletour e Lange 1995;405. 30. Velez E, et al. CT-detected traumatic small artery extremity injuries: surgery, embolize, or watch? A 10-year experience. Emerg Radiol 2016;23:57-61. 31. Dennis JW, Frykberg ER, Veldenz HC, Huffman S, Menawat SS. Validation of nonoperative management of occult vascular injuries and accuracy of physical examination alone in penetrating extremity trauma: 5- to 10-year follow-up. J Trauma 1998 Feb; 44(2):243-52; discussion 242-3. 32. Nassoura ZE, Ivatury RR, Simon RJ, et al. A reassessment of Doppler pressure indices in the detection of arterial lesions in proximity penetrating injuries of extremities: a prospective study. Am J Emerg Med 1996 Mar;14(2):151-6. 33. Lynch K, Johansen K. Can Doppler pressure measurement replace “exclusion” arteriography in the diagnosis of occult extremity arterial trauma?.Ann Surg 1991 Dec;214(6):737-41.
38. Weaver FA, Yellin AE, Bauer M, Oberg J, Ghalambor N, Emmanuel RP, Applebaum RM, Pentecost MJ, Shorr RM. Is arterial proximity a valid indication for arteriography in penetrating extremity trauma? A prospective analysis. Surg 1990 Oct;125(10):1256-60.
5. Friend J, Rao S, Sieunarine K, Beng PW. Vascular trauma in Western Australia: a comparison of two study periods over 15 years. 3rd ed. ANZ Surg 2016 Mar 1;86:173-178.
15. Perkins JG, Brosch LR, Beekley AC, Warfield KL, Wade CE, Holcomb JB. Recent advances and future directions in trauma care research and analytics in combat trauma care. Surg Clin North Am 2012 Aug 1;92(4):1041-54.
46. Lundy JB, Hobbs CM. ‘Bastion classification’: evolution of experience mandates caution when considering using class as predictor for method of temporary vascular control. Injury 2012; 5092.
56. Branco BC, Inaba K, Barmparas G, et al. Incidence and predictors for the need for fasciotomy after extremity trauma: a 10-year review in a mature level I trauma centre. Injury 2010;42(10):1157-63.
48. Borut J, Acosta JA, Tadlock M. The use of temporary vascular shunts in military extremity wounds: a preliminary outcome analysis with 2-year follow-up. J Trauma 2010;69:174-8.
58. Rogers GF, Maclellan AR, Liu SA,Taghinia HA, Labow IB, Meara GJ, Greene KA. Extremity fasciotomy wound closure: comparison of skin grafting to staged linear closure. J Plast Reconst Aesth Surg 2013 Mar 1;66(3):e90-e91
59. Farber A, Tan TW, Hamburg NM, Kalish JA, Joglar F, Onigman T, Doros DRG, Eberhardt RT. Early fasciotomy in patients with extremity vascular injury is associated with decreased risk of adverse limb outcomes: A review of the National Trauma Data Bank. Injury 2012 Sep 1;43(9):1486-91.
43. Scott DJ, Rasmussen T. Controle cirúrgico de danos e shunts vasculares temporários. In Rich’s Vascular Trauma, editores. 3.ed. Rio de Janeiro: Elsevier; 2017. p. 198-205. 44. Rasmussen TE, Clouse WD, Jenkins DH, Peck MA, Eliason JL, Smith DL. The use of temporary vascular shunts as a damage control adjunct in the management of wartime vascular injury. J Trauma 2006 Jul;61(1):8-12; discussion 12-5.
51.
64. Woodward EB, Clouse WD, Eliason JL, et al. Penetrating femoropopliteal injury during modern warfare: experience of the Balad Vascular Registry. J Vasc Surg 2008;47:1259-64. 65. Mullenix PS, et al. Limb salvage and outcomes among patients with traumatic popliteal vascular injury: an analysis of the National Trauma Data Bank. J Vasc Surg 2006;44:94-100.
60. Giannoudis PV, Paul J. Harwood PJ, Kontakis G, Allami M, Macdonald D, Kay SP, Kind P. Long-term quality of life in trauma patients following the full spectrum of tibial injury (fasciotomy, closed fracture, grade IIIB/IIIC open fracture and amputation). Injury 2009 Feb 1;40(2):213-9.
341Capítulo 175 tr AumA dos vA sos dos membros inferiores
53. Rich NM, Hobson RW, Collins GJ, et al. The effect of acute popliteal venous interruption. Ann Surg 1976;183:365-8.
54. Stevens WS, Kron IL. Vascular trauma of the extremities: factors causing failure of arterial repair. South Med J 1987 Mar;80(3):305-8.
61. Ritenour AE, Dorlac WC, Fang R, et al. Complications after fasciotomy revision and delayed compartment release in combat patients. J Trauma 2008;64:S153-S161. 62. Silva NCLJ. Anatomia médico-cirúrgica do sistema vascular. In: Brito JC editor. Cirurgia vascular endovascular - angiologia. 2. ed. Rio de Janeiro: Revinter; 2008. p. 25-72.
66. Prichayudh S, Verananvattna A, Sriussadaporn S, Sriussadaporn S, Kritayakirana K, Pakart R, et al. Management of upper extremity vascular injury: outcome related to the mangled extremity severity score. World J Surg 2009 Apr;33(4):857-63.
52. Nypaver TJ, Schuler JJ, McDonnell P, et al. Long-term results of venous reconstruction after vascular trauma in civilian practice. J Vasc Surg 1992 Nov;16(5):762-8.
67. Patterson B, Agel J, Swiontkowski M, et al. Knee dislocations with vascular injury: outcomes in the Lower Extremity Assessment Project (LEAP) study. J Trauma 2007;63:855-8.
68. Durham RM, Mistry BM, Mazuski JE, et al. Outcome and utility of scoring systems in the management of the mangled extremity. Am J Surg 1996 Nov;172(5):569-73; discussion 573-4.
45. Eger M, Golcman L, Goldstein A. The use of a temporary shunt in the management of arterial vascular injuries. Surg Gynecol Obstet 1971;132:67-70.
69. Hettiaratchy S, J Clasper J. Tratamento de lesões em ossos e tecidos moles concomitantes a lesão vascular. In: Rich, editors. 3. ed. Rio de Janeiro: Elsevier; 2017. p. 242-51.
70. Bonanni F, Rhodes M, Lucke JF. The futility of predictive scoring of mangled lower extremities. J Trauma 1993 Jan;34(1):99-104. 71. Hancock HM, Stannard A, Burkhardt GE, et al: Hemorrhagic shock worsens neuromuscular recovery in a porcine model of hind limb vascular injury and ischemia/reperfusion. J Vasc Surg 2011;53(4):1052-62. 72. Loh SA, Rockman CB, Chung C, Maldonado TS, Adelman MA, et al. Existing trauma and critical care scoring systems underestimate mortality among vascular trauma patients. J Vasc Surg 2011 Feb 1;53(2):359-66. 73. McHenry T, Holcomb J, Aoki N, et al. Fractures with major vascular injuries from gunshot wounds: implications of surgical sequence. J Trauma 2002;53:717-21. 74. Gustilo RB, Anderson JT. Prevention of infection in the treatment of one thousand and twenty-five open fractures of long bones. J Bone Joint Surg Am 1976;58-A:453-8. 75. Lange RH, Bach AW, Hansen ST Jr, Johansen KH. Open tibial fractures with associated vascular injuries: prognosis for salvage. Trauma. 1985 Mar;25(3):203-8 76. Johansen K, Daines M, Howey T, Helfet D, Hansen ST Jr. Objective criteria accurately predict amputation following extremity trauma. J Trauma. 1990;30(5):568-72 77. Helfet DL, Howey T, Sanders R, Johansen K. Limb salvage versus amputation. Preliminary results of the Mangled Extremity Severity Score. Clin Orthop 1990 Jul;(256):80-6. 78. Dorlac WC, et al. Mortality from isolated civilian penetrating extremity injury. J Trauma 2005;59:217-22. 79. Reuben BC, et al. Increasing use of endovascular therapy in acute arterial injuries: analysis of the National Trauma Data Bank. J Vasc Surg 2007;46:1222-6. 80. Stewart DK, Brown PM, Tinsley EA, Hope WW, Clancy TV. Use of stent grafts in lower extremity trauma. Ann Vasc Surg 2011 Feb 1;25(2):264.e9-264.e13.
55. Farber A, Hamburg N, Onigman T, Kalish J, Shaw P, Joglar F, et al Delayed fasciotomy in patients with extremity vascular injury is associated with increased risk of adverse limb outcomes: a review of the national trauma data bank. J Vasc Surg 2010 Dec;52(4):1118.
81. Goldstein BH, Hirsch R, Zussman ME, Julie A, Vincent JA, Torres AJ, et al. Percutaneous balloon-expandable covered stent implantation for treatment of traumatic aortic injury in children and adolescents. American Journal of Cardiology 2012 Nov 15;110(10):1541-5. 82. Belczak S, Silva ES, Aun R, et al. Endovascular treatment of peripheral arterial injury with covered stents: an experimental study in pigs. Clinics (Sao Paulo) 2011;66:1425-30. Mavili E, et al. Endovascular treatment of lower limb penetrating arterial traumas. Cardiovasc Intervent Radiol 2007;30:1124-9. 84. Arthurs ZM, Sohn VY, Starnes BW, FACS. Vascular Surgery: Vascular Trauma: endovascular management and techniques. Surg Clin North Am 2007;87(5):1179-92.
83.
57. Javadikasgari H. Incidence and predictors for the need for fasciotomy after extremity trauma. Injury 2012 Jul 1;43(7):1226.
63. Rossi M, Rina P. Implicações do trauma vascular no Brasil. In Rich trauma vascular. 3. ed. Rio de Janeiro: Elsevier; 2017. p 333-7.
49. Subramanian A, Vercruysse G, Dente C, et al. A decades experience with temporary vascular shunts at a Level 1 trauma centre. J Trauma 2008;65:316-26. Quan RW, Gillespie DL, Stuart RP, et al. The effect of vein repair on the risk of venous thromboembolic events: a review of more than 100 traumatic military venous injuries. J Vasc Surg 2008;47:571-7. Kurtoglu M, Yanar H, Taviloglu K, et al. Serious lower extremity venous injury management with ligation: prospective overview of 63 patients. Am Surg 2007;73:1039-43.
50.
47. Taller J, Kamdar JP, Greene JA, et al. Temporary vascular shunts as initial treatment of proximal extremity vascular injuries during combat operations: the new standard of care and Echelon II facilities? J Trauma 2008;65:595-603.
17. Joanides R, Haefeli WE, Linder L et al. Nitric oxide is responsable for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation 1995;91:1314. 18. Simkins TE, Stehbens WE. Vibrations recorded from the adventitial surface of experimental aneurysms and arteriovenous fistulas. Vasc Surg 1974;8:153.
50.
25. Schreiner GE, Freinkel N, Athens JW et al. Dynamics of T-1824 distribution in patients with traumatic arteriovenous fistula. Circ Res 1953;1:548.
13. Schenk WG, Bahn RA, Cordell R et al. The regional hemodynamics of experimental acute arteriovenous fistulas. Surg Gynecol Obstet 1957;105:733. 14. Schenk WG, Martin JW, Portin BA. The regional hemodynamics of chronic experimental arteriovenous fistula. Surg Gynecol Obstet 1960;110:44-50. 15. Keeley JL, Shairer AE, Pesek IG. Peripheral arterial aneurysms and arteriovenous fistulas. Surg Clin North America 1960;40:97-110.
1. Hunter WA. History of aneurysm of the aorta with some remarks on aneurysms in general. Med Obs Inquiries 1757;1:323.
3.
29. Goméz-Marquez J. Fístula arteriovenosa con rápida descompensación cardiaca en um herido múltiple. Angiología 1960;12:22-34. 30. Mason JM. Extreme cardiac descompensation following arteriovenous fistula of the left subclavian vessels. Amer J Surg 1933;20:451. 31. Myhre JR. Supervivencia de diez años después de la ruptura de un aneurisma aortico en la cava superior. Angiología 1959;11:252-4. 32. Eiseman B, Hughes RH. Repair of an abdominal aortic vena caval fistula caused by rupture of an atherosclerotic aneurysm. Surgery 1956;39:498. 33. Baker WH, Sharzer LA, Ehrenhaft JL. Aortocaval fistula as a complication of abdominal aortic aneurysms. Surgery 1972;72:933. 34. Frank CW, Wang H, Lammerant J et al. An experimental study of the immediate hemodynamic adjustements to acute arteriovenous fistulae of various sizes. J Clin Invest 1955;34:772. 35. Wakim KG, Janes JM. Influence of arteriovenous fistula on the distal circulation in the involved extremity. Arch Phys Med 1958;39:413. 36. Roger W, Aust B. The effects of arteriovenous fistula on tissue blood flow in the canine limb. Vasc Surg 1974;8:238. 37. Callander CL. Study of arteriovenous fistulae with analysis of 447 cases. Ann Surg 1920;71:428. 38. Ehrenfeld WK, Grausz H, Wilie EJ. Subcutaneous arteriovenous fistulas for hemodialysis. Am J Surg 1972;124:200. 39. Rowe GG, Castillo CA, Afonso S et al. The systemic and coronary hemodynamic effects of arteriovenous fistula. Am Heart J 1962;64:44. 40. Van Loo A, Heringman EC. Circulatory changes in the dog produced by acute arteriovenous fistula. Am J Physiol 1949;158:103. 41. Holman E. Arteriovenous aneurysm: clinical evidence correlating size of fistula with changes in the heart and proximal vessels. Ann Surg 1924;8:801. 42. Gupta PD, Singh M. Neural mechanism underlying tachycardia induced by nonhypotensive A-V shunt. Am J Physiol 1979;236:H35. 43. Robbs JV, Carrim AM, Kadva AM et al. Traumatic arteriovenous fistula: experience with 202 patients. Br J Surg 1994;81:1296. 44. Brito CJ, Brum O, Arruda S. Traumatic carotid-jugular fistula of long duration. J Cardiovas Surg 1969;10:329. 45. Brito CJ. Fístulas arteriovenosas traumáticas de longa duração. Revista do CBC 1969;7:5-20. 46. Schumacker HB, Wayson EE. Spontaneous cure of aneurysms and arteriovenous fistulas, with some notes on intrasacular thrombosis. Am J Surg 1950;79:532. 47. Rich NM, Spencer FC. Arteriovenous fistulas. In: Rich NM (Ed.). Vascular trauma, 2nd ed. Philadelphia: WB Saunders; 2009. p. 458-524. 48. Elkin DC, Warren JV. Arteriovenous fistulas: their effect on the circulation. JAMA 1947;134:1524. Janes JM, Musgrove JE. Effect of arteriovenous fistula on growth of bone. Surg Clin North America 1950;30:1191-200. Horton BT. Hemihypertrophy of extremities associated with congenital arteriovenous fistula. JAMA 1932;98:373.
4.
7.
20. Freeman LW, Schumacker HB, Finneran JC. Studies with arteriovenous fistulas: Influence of posture on volume flow. Surgery 1952;31:180. 21. Brito CJM. Cirurgia arterial reparadora. Tese apresentada à Faculdade de Medicina da UFRJ. Rio de Janeiro, 1970. 22. Allen EV, Barker NW, Hines Jr EA. Peripheral vascular diseases,3rd ed. Philadelphia: WB Saunders; 1962. p. 475-94.
342 176Capítulo FÍSTULAS ARTERIOVENOSAS TRAUMÁTICAS REFERÊNCIAS BIBLIOGRÁFICAS
12. Ingebrigtsen R, Lie M, Hold R et al. Dilatation of the iliofemoral artery following the opening of an experimental arteriovenous fistula in the dog. Scand J Clin Lab Invest 1973;31:255.
16. Miller VM, Burnett JC. Modulation of NO and endothelin by chronic increases in blood flow in canine femoral arteries. Am J Physiol 1992;263:H108.
23. Hilton JG, Kanter DM, Hays DR et al. The effect of acute arteriovenous fistula on renal functions. J Clin Invest 1955;34:732.
24. Davis JO, Urkuhart J, Higgins Jr JT et al. Hypersecretion of aldosterone in dogs with a chronic aortic-caval fistula and high output heart failure. Circ Res 1964;14:471.
19. Ingelbrigtsen R, Fönstelien E, Solberg LA. Measurement of forces producing longitudinal stretching of the arterial wall, examined in the artery proximal to an arteriovenous fistula. Acta Chir Scand 1970;136:569.
26. Pratt GH. Arteriovenous fistulas and aneurysms. In: Pratt GH. Cardiovascular surgery. Philadelphia: Lea & Febiger; 1954. p. 403-37. 27. George CRP, May J, Schieb M et al. Heart failure due to an arteriovenous fistula for hemodialysis. Med J Aust 1973;1:696. 28. Breslau RC. Complications of arteriovenous fistula induced for augmentation of limb growth. Surgery 1968;63:1012.
49.
2. Fairbairn II JF, Bernatz PE. Arteriovenous fistulas. In: Fairbairn II JF (Ed.). Peripheral vascular diseases, 4th ed. Philadelphia: WB Saunders; 1972. p. 303-25. Nicoladoni Carl. Phlebarteriectasie der rechten oberen extremität. Arch Klin Chir 1875;18:252. Branham HH. Aneurysmal varix of the femoral artery and vein following a gunshut wound. Int J Surg 1890;3:250. 5. Soubbotitich V. Military experience of traumatic aneurysms. Lancet 1913;2:720-1. 6. Stewart FT. Arteriovenous aneurysm treated by angeiorrhaphy. Ann Surg 1913;57:574-80. Reid MR. The effect of arteriovenous fistula upon the heart and blood vessels: an experimental and clinical study. Bull Johns Hopkins Hosp 1920;31:43-50. 8. Reid MR. Studies on abnormal arteriovenous communications acquired and congenital. I. Report of a series of cases. Arch Surg 1925;10:601-38. 9. Holman E. Problems in the dynamics of blood flow. Surgery 1949;26:889-917. 10. Holman E, Taylor G. Problems in the dynamics of blood flow. Angiology 1952;3:415-30. 11. Holman E. Contribution from clinical and experimental observations of abnormal arteriovenous communications. J Cardiovas Surg 1962;3:48-63.
58. Lee-Elliott C, Khaw KT, Prelli PM et al. Iatrogenic arteriovenous fistula in a renal allograft of a TAO guidewire injury. Cardiovasc U Intervent Radiol 1994;23:306-9. 59. Stock V, Link J, Dutschke P. Iatrogenic vertebrojugular arteriovenous fistula. Anaesthesia 1996;51:687-8. 60. Lemaire JM, Dondelinger RF. Percutaneous coil embolization of iatrogenic femoral arteriovenous fistula or pseudo-aneurysm. Eur J Radiol 1994;18:96-100. 61. Ovroutski S, Ewert P, Dchubel J et al. A rare complication of laparoscopic surgery: Iatrogenic arteriovenous fistula with high-output cardiac failure. Surg Laparose Endose Percutan Tech 2001;11:334-7. 62. Baker WH, Mansour MA. Arterivenous fistulae of the aorta and its mayor branches. In: Rutherford RR. (Ed.). Vascular surgery, 5th ed. Philadelphia: WB Saunders; 2000. p. 1440-5. 63. Zapata-Vargas C. Arteriovenous fistula between de common right iliac artery and the inferior vena cava incident to intervertebral disk surgery. Report of two cases. J Cardiovas Surg 1964;5:392. 64. Santos E, Peral V, Aroca M et al. Arteriovenous fistula as a complication of lumbar disc surgery: case report. Neuroradiology 1998;40:459-61. 65. Wideman CL, Gravlee LC, Jones WN. Arteriovenous aneurysm of the uterine artery on vein following total abdominal hysterectomy. Am J Obstet Gynecol 1959;78:200-3. 66. DeTakats G. Arterial injuries. In: DeTakats G (Ed.). Vascular surgery. Philadelphia: WB Saunders; 1959. p. 130. 67. Heaton LD, Hughes GW, Roseway H et al. Military surgical practices of the United States Army in Vietnam. Chicago: Year Book Medical; 1966. 68. Patman RD, Poulos E, Shires GT. The management of civilian arterial injuries. Surg Gynec Obstet 1964;118:725-38. 69. Hewitt RL, Smith AD, Drapanos T. Acute traumatic arteriovenous fistulas. J Trauma 1973;13:901. 70. Toit DF, Leith JG, Strauss DC et al. Endovascular management of traumatic cervicothoracic arteriovenous fistula. Br J Surg 2003;90:1516-21. 71. Rich NM, Hobson RW, Collinns Jr GJ. Traumatic arteriovenous fistulas and false aneurysms: a review of 558 lesions. Surgery 1975;78:817. 72. Beall AC, Harrington OB, Crawford ES et al. Surgical management of traumatic arteriovenous aneurysms. Am J Surg 1963;106:610. 73. Sumner DS. Hemodynamic and pathophysiology of arteriovenous fistulae. In: Rutherford RR (Ed.). Vascular surgery, 5th ed. Philadelphia: WB Saunders; 2000. p. 1400-25. 74. Cakmak M, Cakmak N, Arikan E et al. Congestive heart failure due to traumatic arteriovenous fistula – two cases reports. Angiology 2003;54:625. 75. Porto CLL, Virgini CE, Cunha SSC et al. In: Nectoux Filho JL. (Ed.). Ultrassonografia vascular. Rio de Janeiro: Revinter; 2000. p. 127. 76. Ajzen S, Yaharo M, Christofalo DMJ. Transplante renal. In: Nectoux Filho JL. (Ed.). Ultrassonografia vascular. Rio de Janeiro: Revinter; 2000. p. 260. 77. Franco SBS. Mapeamento dúplex colorido das artérias periféricas. In: Molnár LJ (Ed.). Ultrassonografia vascular. Rio de Janeiro: Revinter; 2004. p. 159. 78. Rutherford RB, Sumner DS. Diagnostic evaluation of arteriovenous fistulae. In: Rutherford RB. (Ed.). Vascular surgery, 5th ed. Philadelphia: WB Saunders; 2000. p. 1425-40. 79. Nickerson JL, Elkin DC, Warren JV. The effect of temporary occlusion of arteriovenous fistulas on heart rate, stroke volume and cardiac output. J Clin Invest 1951;30:215. 80. Boudeghène F, Sapoval M, Bonneau M et al. Aotocaval fistulae: a percutaneous model and treatment with stent graft in sheep Circulation 1996;94:108-12. 81. Marin ME, Veith FJ, Cynnamon J et al. Percutaneous transfemoral insertion of stented graft to repair a traumatic arteriovenous fistula. J Vasc Surg 1993;18(2):299-302. 82. Marin ME, Veith FJ, Cynnamon J et al. Transfemoral endoluminal repair of penetrating vascular injury. J Vasc Inter Radiol 1994;4:592-4. 83. Parodi JC. Endovascular repair of aortic aneurisms and arteriovenous fistulas. World J Surg 1996;20(6):655-63. 84. Dorros G. Closure of a popliteal arteriovenous fistula using na autologus vein covered Palmaz stent. J Endovasc Surg 1995;2(2):177-8. 85. Araujo AP, Gomes CFA. Tratamento endovascular para as complicações do trauma vascular. In: Rossi M (Ed.). Trauma vascular. Rio de Janeiro: Revinter; 2006. p. 241-51. 86. Feliciano DV., Management of penetrating injuries to carotiol artery. Worlol J Surg 2001;25:1028-35. 87. Roberts LHY et al. Vertebral artery injuries. Surg Clin North Am 2001;81:1345-55. 88. Herrera DA, Et al. Endovascular treatment of traumatic injuries of vertebral artery. AJNR Am T Neuroradiol. 2008;87:79-85. 89. Demetriades D et al. Subclavian vascular injuries. Br J Surg 1987;74:1005-1003 90. Mc Kinley AG et al. Management of proximal axillary and subclavian artery injuries. Br J Surg 2000;87:79-85 91. Clouse WD et al. In-theater management of vascular injury: 2 years of the balad vascular registry. J Am Coll Surg 2007;204:625-32. 92. Tran HS et al. Brachial arterio venous fistula as s complication of placement of a peripherally inserted central venous catheter: a case report and review of the literature. Am Surg 2006;72:833-6. 93. Rich NM et al. Traumatic arteriovenous fistulas and false aneurysmas : a revew of 558 lesions. Surgery 1975;78:817-28. 94. Robbs JV et al. Traumatic arteriovenous fistula: experience verth 202 patients. Br J Surg 1994;81:1296-9. 95. Ruckert RI, Rutsch W, Filimonow S et al. Successful stent repair of a vertebrojugular arteriovenous fistula. J Endovasc Ther 2001;8:495-500. 96. McNeil JD, Chiou AC, Gunlock MG et al. Successful endovascular therapy of a penetrating zone III internal carotid injury. J Vasc Surg 2002;36:187-90. 97. Roo RA, Steenvoorde P, Schuttevaer HM et al. Exclusion of a crural pseudoaneurism with a PTFE-covered stent-graft. J Endvasc Ther 2004;11:344-7. 98. White RA, Donayre CE, Walot I et al. Endograft repair of an aortic pseudoaneurysm following gunshot wound injury: impact of imaging on diagnosis and planning of intervention. J Endovasc Surg 1997;4:344-51. 99. Lagattolla N, Matsou M, Self G et al. Traumatic rupture of the aortic arch treated by stent grafting. Eur J Vasc Endovasc Surg 1999;17:84-6. 100. Uflacker R et al. Transcatheter embolization of superior mesenteric arteriovenous fistula. AJR Am J Roentgenol 1982;139:1212-4. 101. Lopera JE. Embolization in trauma: principles and techiniques. Semir Intervent Radial. 2010;27:14-28. 102. Takesawa C et al. Properties of n-butyl cyanoacrylate-iodized oil mixtures for arterial embolization: in vitro and in vivo experiments. J Vasc Interv Radiol 2012;23:1215-21. 103. Hunter GC, Berman SS, Walser EM. Acquered arteriovenous fistulas. In: Rutheford’s (Ed). Vascular surgery. USA: Elsevier; 2018.
343Capítulo 176 fístul A s ArteriovenosA s tr AumátiCA s
51. Kelly PJ, Janes JM, Peterson LFA. The effects of arteriovenous fistulae on the vascular pattern of the femora of the immature dogs (a microangiography study). J Bone and Joint Surg 1959;41:101-8.
54. Reid MR. Abnormal arteriovenous communications acquired and congenital. The effects of abnormal arteriovenous communications on the heart, blood vessels and other structures. Arch Surg 1925;11:25. 55. Doerr GM, Janes JM. Effects of arteriovenous fistula and ligation of the proximal vein on the growth of bone. Proc Staff Meet Mayo Clin 1959;34:555-60. 56. Brochhagen HG, Paperno S, Grune F et al. Color duplex sonographic findings in an iatrogenic arteriovenous fistula of the vertebral artery. Anaesthesist 2002;51:120-2. 57. González A, Mayol A, Gil-Peralta et al. Endovascular stentgraft treatment of an iatrogenic vertebral arteriovenous fistula. Neuroradiology 2001;43:784-6.
52. Stein AH, Morgan H, Porras R. The effect of the arteriovenous fistula in the intremedullary bone pressure. Surg Gynec Obstet 1959;129:287. 53. Hutchinson WJ, Bordeaux Jr BD. The influence of stasis on bone growth. Surg Gynec Obstet 1954;99:413.
344 177Capítulo
12. Balogh Z, King KL, Mackay P et al. The epidemiology of pelvic ring fractures: a population-based study. J Trauma 2007;63(5):1066-73; discussion 1072-3.
15. DuBose JJ, Scalea TM, Brenner M et al. The AAST prospective Aortic Occlusion for Resuscitation in Trauma and Acute Care Surgery (AORTA) registry: Data on contemporary utilization and outcomes of aortic occlusion and resuscitative balloon occlusion of the aorta (REBOA). J Trauma Acute Care Surg 2016;81(3):409-19.
6. Ott MC, Stewart TC, Lawlor DK et al. Management of blunt thoracic aortic injuries: endovascular stents versus open repair. J Trauma 2004;56(3):565-70. PubMed PMID: 15128128.
3. Cohen JE, Gomori JM, Itshayek E et al. Single-center experience on endovascular reconstruction of traumatic internal carotid artery dissections. J Trauma Acute Care Surg 2012;72(1):216-21.
8. Porta RMP, Aun R, Poggetti RS et al. Lesão letal transfixante de veia cava-justa-hepática e tratamento com endoprótese revestida: um novo modelo experimental. São Paulo. Tese [Doutorado em Radiologia] Universidade de São Paulo; 2004. 9. Stassen NA, Bhullar I, Cheng JD et al. Selective nonoperative management of blunt splenic injury: an Eastern Association for the Surgery of Trauma practice management guideline. J Trauma Acute Care Surg 2012;73(5 Suppl 4):S294-300.
10. Stassen NA, Bhullar I, Cheng JD et al. Nonoperative management of blunt hepatic injury: an Eastern Association for the Surgery of Trauma practice management guideline. J Trauma Acute Care Surg 2012;73(5 Suppl 4):S288-93.
13. Schmal H, Markmiller M, Mehlhorn AT, Sudkamp NP. Epidemiology and outcome of complex pelvic injury. Acta Orthop Belg 2005;71(1):41-7.
14. El-Haj M, Bloom A, Mosheiff R et al. Outcome of angiographic embolization for unstable pelvic ring injuries: factors predicting success. Injury 2013;44(12):1750-5.
2. Johnson CA. Endovascular management of peripheral vascular trauma. Semin Intervent Radiol 2010;27(1):38-43.
5. Cowley RA, Turney SZ, Hankins JR et al. Rupture of thoracic aorta caused by blunt trauma. A fifteen-year experience. J Thorac Cardiovasc Surg 1990;100(5):652-60; discussion 660-1.
11. Morey AF, Brandes S, Dugi DD 3rd et al. Urotrauma: AUA guideline. J Urol. 2014;192(2):327-35.
4. Parmley LF, Mattingly TW, Manion WC, Jahnke EJ Jr. Nonpenetrating traumatic injury of the aorta. Circulation 1958;17(6):1086-101.
ENDOVASCULAR NO TRAUMA VASCULAR E NAS IATROGENIAS REFERÊNCIAS
TRATAMENTO BIBLIOGRÁFICAS
1. Perkins ZB, De’Ath HD, Aylwin C et al. Epidemiology and outcome of vascular trauma at a British Major Trauma Centre. Eur J Vasc Endovasc Surg 2012;44(2):203-9.
16. Russo RM, Neff LP, Lamb CM et al. Partial Resuscitative Endovascular Balloon Occlusion of the Aorta in Swine Model of Hemorrhagic Shock. J Am Coll Surg 2016;223(2):359-68.
7. Dua A, Desai S, Holcomb J et al. Mesenteric vascular trauma. In: Dua A, Desai S, Holcomb J et al. (Eds.). Clinical review of vascular trauma. Berlin: Springer Medical Publishing; 2014. p. 213-24.
1. Teixeira PGR, Inaba K, Hadjizacharia P, Brown C, Salim A, Rhee P, et al. Preventable or potentially preventable mortality at a mature trauma center. J Trauma Acute Care Surg 2007 Dec;63(6):1338-46-discussion1346-7.
25. Anderson SA, Day M, Chen MK, Huber T, Lottenberg LL, Kays DW, et al. Traumatic aortic injuries in the pediatric population. J Pediatr Surg 2008 Jun;43(6):1077-81.
22. Dua A, Via KC, Kreishman P, Kragh JF, Spinella PC, Patel B, et al. Early management of pediatric vascular injuries through humanitarian surgical care during U.S. military operations. J Vasc Surg 2013 Sep;58(3):695-700. 23. Branco BC, Naik-Mathuria B, Montero-Baker M, Gilani R, West CA, Mills JL, et al. Increasing use of endovascular therapy in pediatric arterial trauma. J Vasc Surg 2017 Oct;66(4):1175-1183.e1. 24. Sadaghianloo N, Jean-Baptiste E, Breaud J, Declemy S, Kurzenne JY, Hassen-Khodja R. Blunt abdominal aortic trauma in paediatric patients. Injury 2014 Jan;45(1):183-91.
27. Karmy-Jones R, Hoffer E, Meissner M, Bloch RD. Management of traumatic rupture of the thoracic aorta in pediatric patients. Ann Thorac Surg 2003 May;75(5):1513-7.
Pediatric vascular injuries: acute management and early outcomes. J Trauma 2011 Apr;70(4):823-8.
14. de Virgilio C, Mercado PD, Arnell T, Donayre C, Bongard F, White R. Noniatrogenic pediatric vascular trauma: a ten-year experience at a level I trauma center. Am Surg 1997 Sep;63(9):781-4.
20. Gifford SM, Aidinian G, Clouse WD, Fox CJ, Porras CA, Jones WT, et al. Effect of temporary shunting on extremity vascular injury: An outcome analysis from the Global War on Terror vascular injury initiative. J Vasc Surg 2009 Sep;50(3):549-56.
10. Cannon JW, Peck MA. Vascular injuries in the young. Perspect Vasc Surg Endovasc Ther 2011 Jun;23(2):100-10.
9. Whitehouse WM, Coran AG, Stanley JC, Kuhns LR, Weintraub WH, Fry WJ. Pediatric vascular trauma. Manifestations, management, and sequelae of extremity arterial injury in patients undergoing surgical treatment. Arch Surg 1976 Nov;111(11):1269-75.
13. Katz S, Globerman A, Avitzour M, Dolfin T. The ankle-brachial index in normal neonates and infants is significantly lower than in older children and adults. J Pediatr Surg 1997 Feb;32(2):269-71.
VASCULAR
15. Puapong D, Brown CVR, Katz M, Kasotakis G, Applebaum H, Salim A, et al. Angiography and the pediatric trauma patient: a 10-year review. J Pediatr Surg 2006 Nov;41(11):1859-63.
26. Cox CS, Black CT, Duke JH, Cocanour CS, Moore FA, Lally KP, et al Operative treatment of truncal vascular injuries in children and adolescents. J Pediatr Surg 1998 Mar;33(3):462-7.
5. Klinkner DB, Arca MJ, Lewis BD, Oldham KT, Sato TT. Pediatric vascular injuries: patterns of injury, morbidity, and mortality. J Pediatr Surg 2007 Jan;42(1):178-82-discussion182-3.
3. Flanigan DP, Keifer TJ, Schuler JJ, Ryan TJ, Castronuovo JJ. Experience with latrogenic pediatric vascular injuries. Incidence, etiology, management, and results. Ann Surg 1983 Oct;198(4):430-42.
PEDIATRIA
345 178Capítulo
19. Rasmussen TE, Clouse WD, Jenkins DH, Peck MA, Eliason JL, Smith DL. The use of temporary vascular shunts as a damage control adjunct in the management of wartime vascular injury. J Trauma Acute Care Surg 2006 Jul;61(1):8-12-discussion12-5.
8. Myers SI, Reed MK, Black CT, Burkhalter KJ, Lowry PA. Noniatrogenic pediatric vascular trauma. J Vasc Surg 1989 Sep;10(3):258-65.
Pediatric vs adult vascular trauma: a national trauma databank review. J Pediatr Surg 2010 Jul;45(7):1404-12.
12. Allison ND, Anderson CM, Shah SK, Lally KP, Hayes-Jordan A, Tsao KJ, et al. Outcomes of truncal vascular injuries in children. J Pediatr Surg 2009 Oct;44(10):1958-64.
6. Shah SR, Wearden PD, Gaines BA. Pediatric peripheral vascular injuries: a review of our experience. J Surg Res 2009 May 1;153(1):162-6.
11. Kayssi A, Metias M, Langer JC, Roche-Nagle G, Zani A, Forbes TL, et al
16. Lazarides MK, Georgiadis GS, Papas TT, Gardikis S, Maltezos C. Operative and nonoperative management of children aged 13 years or younger with arterial trauma of the extremities. J Vasc Surg 2006 Jan;43(1):72-6-discussion76.
28. Demetriades D, Velmahos GC, Scalea TM, Jurkovich GJ, Karmy-Jones R, Teixeira PGR, et al. Operative repair or endovascular stent graft in blunt traumatic thoracic aortic injuries: results of an American Association for the Surgery of Trauma Multicenter Study. J Trauma Acute Care Surg 2008 Mar;64(3):561-70-discussion570-1. 29. Trust MD, Teixeira PGR. Blunt trauma of the aorta, current guidelines. Cardiol Clin. 2017 Aug;35(3):441-51. 30. DuBose JJ, Azizzadeh A, Estrera AL, Safi HJ. Contemporary management of blunt aortic trauma. J Cardiovasc Surg (Torino) 2015 Oct;56(5):751-62. 31. Milas ZL, Milner R, Chaikoff E, Wulkan M, Ricketts R. Endograft stenting in the adolescent population for traumatic aortic injuries. J Pediatr Surg 2006 May;41(5):e27-30. 32. Ramesh P, Avadhani A, Shetty AP, Dheenadhayalan J, Rajasekaran S. Management of acute “pink pulseless” hand in pediatric supracondylar fractures of the humerus. J Pediatr Orthop B 2011 May;20(3):124-8. 33. Shah AS, Waters PM, Bae DS. Treatment of the “pink pulseless hand” in pediatric supracondylar humerus fractures. J Hand Surg Am 2013 Jul;38(7):1399-403-quiz1404. 34. Sciarretta JD, Macedo FIB, Chung EL, Otero CA, Pizano LR, Namias N. Management of lower extremity vascular injuries in pediatric trauma patients: a single level I trauma center experience. J Trauma Acute Care Surg 2014 Jun;76(6):1386-9. 35. Kirkilas M, Notrica DM, Langlais CS, Muenzer JT, Zoldos J, Graziano K. Outcomes of arterial vascular extremity trauma in pediatric patients. J Pediatr Surg 2016 Nov;51(11):1885-90. 36. Hobson RW, Howard EW, Wright CB, Collins GJ, Rich NM, Colonel L. Hemodynamics of canine femoral venous ligation: significance in combined arterial and venous injuries. Surgery 1973 Dec;74(6):824-9.
7. Barmparas G, Inaba K, Talving P, David JS, Lam L, Plurad D, et al
4. Corneille MG, Gallup TM, Villa C, Richa JM, Wolf SE, Myers JG, et al
REFERÊNCIAS BIBLIOGRÁFICAS
18. Wahlgren CM, Kragsterman B. Management and outcome of pediatric vascular injuries. J Trauma Acute Care Surg 2015 Oct;79(4):563-7.
TRAUMA EM
The spectrum and management of noniatrogenic vascular trauma in the pediatric population. J Pediatr Surg 2018 Apr;53(4):771-4.
2. Dalsing MC, Cikrit DF, Sawchuk AP. Open surgical repair of children less than 13 years old with lower extremity vascular injury. J Vasc Surg 2005 Jun;41(6):983-7.
17. Cardneau JD, Henke PK, Upchurch GR, Wakefield TW, Graham LM, Jacobs LA, et al. Efficacy and durability of autogenous saphenous vein conduits for lower extremity arterial reconstructions in preadolescent children. J Vasc Surg 2001 Jul;34(1):34-40.
21. Quan RW, Adams ED, Cox MW, Eagleton MJ, Weber MA, Fox CJ, et al. The management of trauma venous injury: civilian and wartime experiences. Perspect Vasc Surg Endovasc Ther 2006 Jun 1;18(2):149-56.
2. Cothren CC, Moore EE, Hedegaard HB, Meng K. Epidemiology of urban trauma deaths: a comprehensive reassessment 10 years later. World J Surg 2007;31(7):1507-11.
28. Johnson JW, Gracias VH, Gupta R, et al. Hepatic angiography in patients undergoing damage control laparotomy. J Trauma 2002;52(6):1102-6.
13. Salazar GM, Walker TG. Evaluation and management of acute vascular trauma. Tech Vasc Intervent Rad 2009;12(2):102-16.
31. Kong YL, Zhang HY, He XJ, et al. Angiographic embolization in the treatment of intrahepatic arterial bleeding in patients with blunt abdominal trauma. Hepatobiliary Pancreat Dis Int: HBPD INT 2014;13(2):173-8. 32. Miller PR, Croce MA, Bee TK, Malhotra AK, Fabian TC. Associated injuries in blunt solid organ trauma: implications for missed injury in nonoperative management. J Trauma 2002;53(2):238-42;discussion 42-4. 33. Yoon W, Jeong YY, Kim JK, et al. CT in blunt liver trauma. Radiographics: a Review Publication of the Radiological Society of North America, Inc 2005;25(1):87-104. 34. Skandalakis JE, Skandalakis LJ, Skandalakis PN, Mirilas P. Hepatic surgical anatomy. Surg Clin North Am 2004;84(2):413-35, viii. 35. Vyas S, Ahuja CK, Yadav TD, Khandelwal N. Emergency ultrasoundguided percutaneous embolization of post-traumatic bleeding hepatic artery pseudoaneurysms. Minim Invasive Ther Allied Technol - MITAT: Official Journal of the Society for Minimally Invasive Therapy 2012;21(5):372-6. 36. Wang YC, Fu CY, Chen YF, Hsieh CH, Wu SC, Yeh CC. Role of arterial embolization on blunt hepatic trauma patients with type I contrast extravasation. Am J Emerg Med 2011;29(9):1147-51. 37. Monnin V, Sengel C, Thony F, et al. Place of arterial embolization in severe blunt hepatic trauma: a multidisciplinary approach. Cardiovasc Intervent Radiol 2008;31(5):875-82. 38. Tzeng WS, Wu RH, Chang JM, et al. Transcatheter arterial embolization for hemorrhage caused by injury of the hepatic artery. J Gastroenterol Hepatol 2005;20(7):1062-8.
1. Global, regional, and national age-sex specific all-cause and causespecific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (London, England) 2015;385(9963):117-71.
14. Mutschler M, Paffrath T, Wolfl C, et al. The ATLS® classification of hypovolaemic shock: a well established teaching tool on the edge? Injury 2014;45 Suppl 3:S35-8.
27. Travis T, Monsky WL, London J, et al. Evaluation of short-term and long-term complications after emergent internal iliac artery embolization in patients with pelvic trauma. J Vasc Interv Radiol: JVIR 2008;19(6):840-7.
16. Cullinane DC, Schiller HJ, Zielinski MD, et al. Eastern association for the surgery of trauma practice management guidelines for hemorrhage in pelvic fracture - update and systematic review. J Trauma 2011;71(6):1850-68.
24. Kos S, Gutzeit A, Hoppe H, Liu DM, Jacob AL. Diagnosis and therapy of acute hemorrhage in patients with pelvic fractures. Semin Musculoskelet Radiol 2013;17(4):396-406. 25. Matityahu A, Marmor M, Elson JK, et al. Acute complications of patients with pelvic fractures after pelvic angiographic embolization. Clin Orthop Relat Res 2013;471(9):2906-11.
REFERÊNCIAS BIBLIOGRÁFICAS
9. Martin JG, Shah J, Robinson C, Dariushnia S. Evaluation and management of blunt solid organ trauma. Tech Vasc Intervent Radiol 2017;20(4):230-6.
21. Alarhayem AQ, Myers JG, Dent D, et al. “Blush at first sight”: significance of computed tomographic and angiographic discrepancy in patients with blunt abdominal trauma. Am J Surg 2015;210(6):1104-10;discussion 10-1.
20. Huber-Wagner S, Mand C, Ruchholtz S, et al. Effect of the localisation of the CT scanner during trauma resuscitation on survival - a retrospective, multicentre study. Injury 2014;45 Suppl 3:S76-82.
4. Al-Khatib WK, Lee GK, Casey K, Lee JT. Delayed hypogastric artery pseudoaneurysm following blunt trauma without evidence of pelvic fracture. Ann Vasc Surg 2012;26(3):419.e11-4.
17. Celso B, Tepas J, Langland-Orban B, et al. A systematic review and meta-analysis comparing outcome of severely injured patients treated in trauma centers following the establishment of trauma systems. J Trauma 2006;60(2):371-8;discussion 8.
346 179Capítulo
10. Sanders C, Cipolla J, Stehly C, Hoey B. Blunt breast trauma: is there a standard of care? Am Surg 2011;77(8):1066-9.
15. Hussmann B, Lendemans S. Pre-hospital and early in-hospital management of severe injuries: changes and trends. Injury 2014;45 Suppl 3:S39-42.
11. Spahn DR, Cerny V, Coats TJ, et al. Management of bleeding following major trauma: a European guideline. Critical care (London, England) 2007;11(1):R17.
7. Kawamura S, Nishimaki H, Takigawa M, et al. Internal mammary artery injury after blunt chest trauma treated with transcatheter arterial embolization. J Trauma 2006;61(6):1536-9.
6. Guven K, Rozanes I, Ucar A, Poyanli A, Yanar H, Acunas B. Pushable springcoil embolization of pseudoaneurysms caused by gluteal stab injuries. Eur J Radiol 2010;73(2):391-5.
29. Stassen NA, Bhullar I, Cheng JD, et al. Nonoperative management of blunt hepatic injury: an Eastern Association for the Surgery of Trauma practice management guideline. J Trauma Acute Care Surg 2012;73(5 Suppl 4):S288-93.
30. Ciraulo DL, Luk S, Palter M, et al. Selective hepatic arterial embolization of grade IV and V blunt hepatic injuries: an extension of resuscitation in the nonoperative management of traumatic hepatic injuries. J Trauma 1998;45(2):353-8;discussion 8-9.
18. Johnson JW, Gracias VH, Schwab CW, et al. Evolution in damage control for exsanguinating penetrating abdominal injury. J Trauma 2001;51(2):261-9;discussion 9-71.
19. Parreira JG, Oliari CB, Malpaga JM, Perlingeiro JA, Solda SC, Assef JC. Severity and treatment of “occult” intra-abdominal injuries in blunt trauma victims. Injury 2016;47(1):89-93.
EMBOLIZAÇÃO NO TRAUMA
8. Levey DS, Teitelbaum GP, Finck EJ, Pentecost MJ. Safety and efficacy of transcatheter embolization of axillary and shoulder arterial injuries. J Vasc Intervent Radiol: JVIR 1991;2(1):99-104.
22. Bize PE, Duran R, Madoff DC, et al. Embolization for multicompartmental bleeding in patients in hemodynamically unstable condition: prognostic factors and outcome. J Vasc Interv Radiol: JVIR 2012;23(6):751-60.e4. 23. Leonhardt H, Liedman B, Wingren U, Lonn L. Endovascular treatment in massive uncontrolled intestinal hemorrhage. Stabilization with aortic balloon allows time for angiographic survey. Lakartidningen 2005;102(17):1326-7,9-30.
3. Aksoy M, Taviloglu K, Yanar H, et al. Percutaneous transcatheter embolization in arterial injuries of the lower limbs. Acta radiologica (Stockholm, Sweden: 1987) 2005;46(5):471-5.
26. Shi J, Gomes A, Lee E, et al. Complications after transcatheter arterial embolization for pelvic trauma: relationship to level and laterality of embolization. Eur J Orthop Surg Traumatol: Orthopedie Traumatologie 2016;26(8):877-83.
5. Durai R, Ng PC. Role of angio-embolisation in trauma - review. Acta Chirurgica Belgica 2010;110(2):169-77.
12. Rossaint R, Bouillon B, Cerny V, et al. The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition. Critical care (London, England) 2016;20:100.
49.
40. Saltzherr TP, van der Vlies CH, van Lienden KP, et al. Improved outcomes in the non-operative management of liver injuries. HPB: the Official Journal of the International Hepato Pancreato Biliary Association 2011;13(5):350-5.
54. Shoobridge JJ, Bultitude MF, Koukounaras J, Martin KE, Royce PL, Corcoran NM. A 9-year experience of renal injury at an Australian level 1 trauma centre. BJU International 2013;112 Suppl 2:53-60. Moore EE, Shackford SR, Pachter HL, et al. Organ injury scaling: spleen, liver, and kidney. J Trauma 1989;29(12):1664-6.
60. Kitase M, Mizutani M, Tomita H, Kono T, Sugie C, Shibamoto Y. Blunt renal trauma: comparison of contrast-enhanced CT and angiographic findings and the usefulness of transcatheter arterial embolization. VASA Zeitschrift fur Gefasskrankheiten 2007;36(2):108-13.
69. Stassen NA, Bhullar I, Cheng JD, et al. Selective nonoperative management of blunt splenic injury: an eastern association for the surgery of trauma practice management guideline. J Trauma Acute Care Surg 2012;73(5 Suppl 4):S294-300.
44. Mohan B, Bhoday HS, Aslam N, et al. Hepatic vascular injury: clinical profile, endovascular management and outcomes. Indian Heart J 2013;65(1):59-65.
52. DeFade BP, Tierney JP, Stone PA, Truxillo RR. Selective renal artery embolization following blunt renal trauma: case report and current treatment recommendations for renal trauma. W V Med J 2009;105(1):20-2.
55.
57. Sofocleous CT, Hinrichs C, Hubbi B, et al. Angiographic findings and embolotherapy in renal arterial trauma. Cardiovasc Intervent Radiol 2005;28(1):39-47.
53. Poulakis V, Ferakis N, Becht E, Deliveliotis C, Duex M. Treatment of renal-vascular injury by transcatheter embolization: immediate and long-term effects on renal function. J Endourol 2006;20(6):405-9.
56. Corr P, Hacking G. Embolization in traumatic intrarenal vascular injuries. Clin Radiol 1991;43(4):262-4.
73. Cloutier DR, Baird TB, Gormley P, McCarten KM, Bussey JG, Luks FI. Pediatric splenic injuries with a contrast blush: successful nonoperative management without angiography and embolization. J Pediatr Surg 2004;39(6):969-71. 74. Gross JL, Woll NL, Hanson CA, et al. Embolization for pediatric blunt splenic injury is an alternative to splenectomy when observation fails. J Trauma Acute Care Surg 2013;75(3):421-5.
62. Breyer BN, McAninch JW, Elliott SP, Master VA. Minimally invasive endovascular techniques to treat acute renal hemorrhage. J Urol 2008;179(6):2248-52;discussion 53.
63. Morita S, Inokuchi S, Tsuji T, et al. Arterial embolization in patients with grade-4 blunt renal trauma: evaluation of the glomerular filtration rates by dynamic scintigraphy with 99mTechnetiumdiethylene triamine pentacetic acid. Scand J Trauma, Resusc Emerg Med 2010;18:11. 64. Rong JJ, Liu D, Liang M, et al. The impacts of different embolization techniques on splenic artery embolization for blunt splenic injury: a systematic review and meta-analysis. Mil Med Res 2017;4:17. 65. Chastang L, Bege T, Prudhomme M, et al. Is non-operative management of severe blunt splenic injury safer than embolization or surgery? Results from a French prospective multicenter study. J Visc Surg 2015;152(2):85-91. 66. Carlotto JR, Lopes-Filho G de J, Colleoni-Neto R. Main controversies in the nonoperative management of blunt splenic injuries. Arquivos Brasileiros de Cirurgia Digestiva: ABCD - Brazilian Archives of Digestive Surgery 2016;29(1):60-4. 67. Coccolini F, Montori G, Catena F, et al. Splenic trauma: WSES classification and guidelines for adult and pediatric patients. World J Emerg Surg: WJES 2017;12:40. 68. Schimmer JA, van der Steeg AF, Zuidema WP. Splenic function after angioembolization for splenic trauma in children and adults: a systematic review. Injury 2016;47(3):525-30.
61. Lin WC, Lin CH, Chen JH, et al. Computed tomographic imaging in determining the need of embolization for high-grade blunt renal injury. J Trauma Acute Care Surg 2013;74(1):230-5.
42. Bonariol L, Massani M, Caratozzolo E, et al. Management of grade III-IV blunt liver traumas: a comparative, observational study. Minerva Chirurgica 2015;70(1):7-15.
51.
50.
46.
43. Mohr AM, Lavery RF, Barone A, et al. Angiographic embolization for liver injuries: low mortality, high morbidity. J Trauma 2003;55(6):1077-81;discussion 81-2.
39. Ward J, Alarcon L, Peitzman AB. Management of blunt liver injury: what is new? Eur J Trauma Emerg Surg: Official Publication of the European Trauma Society 2015;41(3):229-37.
58. Brewer ME, Jr., Strnad BT, Daley BJ, et al. Percutaneous embolization for the management of grade 5 renal trauma in hemodynamically unstable patients: initial experience. J Urol 2009;181(4):1737-41.
70. Brillantino A, Iacobellis F, Robustelli U, et al. Non operative management of blunt splenic trauma: a prospective evaluation of a standardized treatment protocol. Eur J Trauma Emerg Surg: official publication of the European Trauma Society 2016;42(5):593-8.
41. Carrillo EH, Wohltmann C, Richardson JD, Polk HC, Jr. Evolution in the treatment of complex blunt liver injuries. Curr Probl Surg 2001;38(1):1-60.
71. Foley PT, Kavnoudias H, Cameron PU, Czarnecki C, Paul E, Lyon SM. Proximal versus distal splenic artery embolisation for blunt splenic trauma: what is the impact on splenic immune function? Cardiovasc Intervent Radiol 2015;38(5):1143-51. 72. Ekeh AP, Khalaf S, Ilyas S, Kauffman S, Walusimbi M, McCarthy MC. Complications arising from splenic artery embolization: a review of an 11-year experience. Am J Surg 2013;205(3):250-4;discussion 4.
76. Skattum J, Gaarder C, Naess PA. Splenic artery embolisation in children and adolescents - an 8 year experience. Injury 2014;45(1):160-3. 77. Olthof DC, Joosse P, Bossuyt PM, et al. Observation versus embolization in patients with blunt splenic injury after trauma: a propensity score analysis. World J Surg 2016;40(5):1264-71. 78. Niola R, Pinto A, Sparano A, Ignarra R, Romano L, Maglione F. Arterial bleeding in pelvic trauma: priorities in angiographic embolization. Curr Probl Diagn Radiol 2012;41(3):93-101. 79. Karadimas EJ, Nicolson T, Kakagia DD, Matthews SJ, Richards PJ, Giannoudis PV. Angiographic embolisation of pelvic ring injuries. Treatment algorithm and review of the literature. Int Orthop 2011;35(9):1381-90. 80. Frevert S, Dahl B, Lonn L. Update on the roles of angiography and embolisation in pelvic fracture. Injury 2008;39(11):1290-4. 81. Hallinan JT, Tan CH, Pua U. Emergency computed tomography for acute pelvic trauma: where is the bleeder? Clin Radiol 2014;69(5):529-37.
347Capítulo 179 emboliz Ação no tr AumA
47. Letoublon C, Amariutei A, Taton N, et al. Management of blunt hepatic trauma. J Visc Surg 2016;153(4 Suppl):33-43. Harper HC, 3rd, Maull KI. Transcatheter arterial embolization in blunt hepatic trauma. South Med J 2000;93(7):663-5. Letoublon C, Morra I, Chen Y, Monnin V, Voirin D, Arvieux C. Hepatic arterial embolization in the management of blunt hepatic trauma: indications and complications. J Trauma 2011;70(5):1032-6;discussion 6-7. Pereira BM. Management of liver injuries: can we really predict the need of operation and damage control surgery? Injury 2014;45(12):2112-3. Bittenbinder EN, Reed AB. Advances in renal intervention for trauma. Sem Vasc Surg 2013;26(4):165-9.
48.
75. Fenton SJ, Sandoval KN, Stevens AM, Scaife ER. The use of angiography in pediatric blunt abdominal trauma patients. J Trauma Acute Care Surg 2016;81(2):261-5.
59. Stewart AF, Brewer ME, Jr., Daley BJ, Klein FA, Kim ED. Intermediateterm follow-up of patients treated with percutaneous embolization for grade 5 blunt renal trauma. J Trauma 2010;69(2):468-70.
45. Bala M, Gazalla SA, Faroja M, et al. Complications of high grade liver injuries: management and outcomewith focus on bile leaks. Scand J Trauma, Resusc Emerg Med 2012;20:20. Beuran M, Nego I, Ispas AT, et al. Nonoperative management of high degree hepatic trauma in the patient with risk factors for failure: have we gone too far? J Med Life 2010;3(3):289-96.